PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bromke, MA; Sabir, JS; Alfassi, FA; Hajarah, NH; Kabli, SA; Al-Malki, AL; Ashworth, MP; Meret, M; Jansen, RK; Willmitzer, L				Bromke, Mariusz A.; Sabir, Jamal S.; Alfassi, Fahad A.; Hajarah, Nahid H.; Kabli, Saleh A.; Al-Malki, Abdulrahman L.; Ashworth, Matt P.; Meret, Michael; Jansen, Robert K.; Willmitzer, Lothar			Metabolomic Profiling of 13 Diatom Cultures and Their Adaptation to Nitrate-Limited Growth Conditions	PLOS ONE			English	Article							FATTY-ACID; THALASSIOSIRA-PSEUDONANA; PHAEODACTYLUM-TRICORNUTUM; MASS-SPECTROMETRY; LIPID-COMPOSITION; CENTRAL CARBON; TRANSFORMATION; MICROALGAE; PENNATE; TRIACYLGLYCEROLS	Diatoms are very efficient in their use of available nutrients. Changes in nutrient availability influence the metabolism and the composition of the cell constituents. Since diatoms are valuable candidates to search for oil producing algae, measurements of diatom-produced compounds can be very useful for biotechnology. In order to explore the diversity of lipophilic compounds produced by diatoms, we describe the results from an analysis of 13 diatom strains. With the help of a lipidomics platform, which combines an UPLC separation with a high resolution/high mass accuracy mass spectrometer, we were able to measure and annotate 142 lipid species. Out of these, 32 were present in all 13 cultures. The annotated lipid features belong to six classes of glycerolipids. The data obtained from the measurements were used to create lipidomic profiles. The metabolomic overview of analysed cultures is amended by the measurement of 96 polar compounds. To further increase the lipid diversity and gain insight into metabolomic adaptation to nitrogen limitation, diatoms were cultured in media with high and low concentrations of nitrate. The growth in nitrogendeplete or nitrogen-replete conditions affects metabolite accumulation but has no major influence on the species-specific metabolomic profile. Thus, the genetic component is stronger in determining metabolic patterns than nitrogen levels. Therefore, lipid profiling is powerful enough to be used as a molecular fingerprint for diatom cultures. Furthermore, an increase of triacylglycerol (TAG) accumulation was observed in low nitrogen samples, although this trend was not consistent across all 13 diatom strains. Overall, our results expand the current understanding of metabolomics diversity in diatoms and confirm their potential value for producing lipids for either bioenergy or as feed stock.	[Bromke, Mariusz A.; Meret, Michael; Willmitzer, Lothar] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Ashworth, Matt P.; Jansen, Robert K.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Sabir, Jamal S.; Alfassi, Fahad A.; Hajarah, Nahid H.; Kabli, Saleh A.; Al-Malki, Abdulrahman L.; Jansen, Robert K.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah 21589, Saudi Arabia	Max Planck Society; University of Texas System; University of Texas Austin; King Abdulaziz University	Bromke, MA (corresponding author), Max Planck Inst Mol Plant Physiol, Muhlenberg 1, D-14476 Potsdam, Germany.	bromke@mpimp-golm.mpg.de	Bromke, Mariusz A./AAZ-4519-2020; Sabir, Jamal S M/C-8102-2014	Bromke, Mariusz A./0000-0002-0806-6608; 	King Abdulaziz University Vice President for Educational Affairs	King Abdulaziz University Vice President for Educational Affairs	The authors (MAB, LW, MPA, RKJ) acknowledge King Abdulaziz University Vice President for Educational Affairs, Prof. Dr. Abdulrahman O. Alyoubi for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Amano Y, 2012, J APPL PHYCOL, V24, P965, DOI 10.1007/s10811-011-9718-8; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; BERGES JA, 1995, J PHYCOL, V31, P85, DOI 10.1111/j.0022-3646.1995.00085.x; Bolling C, 2005, PLANT PHYSIOL, V139, P1995, DOI 10.1104/pp.105.071589; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Bromke MA, 2015, PLANT J, V81, P529, DOI 10.1111/tpj.12739; Bromke MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067340; BROWSE J, 1991, ANNU REV PLANT PHYS, V42, P467, DOI 10.1146/annurev.pp.42.060191.002343; Cermeno P, 2011, MAR ECOL PROG SER, V429, P19, DOI 10.3354/meps09088; Chen JE, 2012, J BIOTECHNOL, V162, P28, DOI 10.1016/j.jbiotec.2012.05.009; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Dodson VJ, 2013, PHYCOL RES, V61, P199, DOI 10.1111/pre.12015; Domergue F, 2003, PLANT PHYSIOL, V131, P1648, DOI 10.1104/pp.102.018317; Dunahay TG, 1996, APPL BIOCHEM BIOTECH, V57-8, P223, DOI 10.1007/BF02941703; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Edwards KF, 2012, LIMNOL OCEANOGR, V57, P554, DOI 10.4319/lo.2012.57.2.0554; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Ge F, 2014, PLANT CELL, V26, P1681, DOI 10.1105/tpc.114.124982; Giavalisco P, 2011, PLANT J, V68, P364, DOI 10.1111/j.1365-313X.2011.04682.x; GOLDMAN JC, 1975, NATURE, V254, P594, DOI 10.1038/254594a0; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hamm Christian, 2007, P311, DOI 10.1016/B978-012370518-1/50015-1; Hildebrand M, 2012, BIOFUELS-UK, V3, P221, DOI 10.4155/bfs.11.157; HITCHCOCK GL, 1982, J PLANKTON RES, V4, P363, DOI 10.1093/plankt/4.2.363; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Juergens MT, 2015, PLANT PHYSIOL, V167, P558, DOI 10.1104/pp.114.250530; Kooistra Wiebe H. C. F., 2007, P207; Levitan O, 2014, TRENDS BIOTECHNOL, V32, P117, DOI 10.1016/j.tibtech.2014.01.004; Li S, 2014, RAPID COMMUN MASS SP, V28, P245, DOI 10.1002/rcm.6784; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Nappo M, 2009, J APPL PHYCOL, V21, P295, DOI 10.1007/s10811-008-9367-8; Obata T, 2013, METABOLITES, V3, P325, DOI 10.3390/metabo3020325; ORCUTT DM, 1975, COMP BIOCHEM PHYS B, V50, P579, DOI 10.1016/0305-0491(75)90093-0; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; R Core Team, 2021, R LANGUAGE ENV STAT; RAVEN JA, 1987, NEW PHYTOL, V106, P357, DOI 10.1111/j.1469-8137.1987.tb00149.x; Renaud SM, 1999, AQUACULTURE, V170, P147, DOI 10.1016/S0044-8486(98)00399-8; Sakaue K, 2008, PHYSIOL PLANTARUM, V133, P59, DOI 10.1111/j.1399-3054.2008.01089.x; Schneider M, 2001, EUR J LIPID SCI TECH, V103, P98, DOI 10.1002/1438-9312(200102)103:2<98::AID-EJLT98>3.0.CO;2-G; Sorhannus U, 2004, CLADISTICS, V20, P487, DOI 10.1111/j.1096-0031.2004.00034.x; Su XL, 2013, METABOLOMICS, V9, P300, DOI 10.1007/s11306-012-0445-1; Theriot EC, 2009, EUR J PHYCOL, V44, P277, DOI 10.1080/09670260902749159; Tomaru Y, 2012, ISME J, V6, P1445, DOI 10.1038/ismej.2011.207; Tonon T, 2002, PHYTOCHEMISTRY, V61, P15, DOI 10.1016/S0031-9422(02)00201-7; Vidoudez C, 2012, METABOLOMICS, V8, P654, DOI 10.1007/s11306-011-0356-6; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Xu JL, 2010, ANAL CHIM ACTA, V663, P60, DOI 10.1016/j.aca.2010.01.026; Yang ZK, 2014, J APPL PHYCOL, V26, P73, DOI 10.1007/s10811-013-0050-3; Yang ZK, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-67; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x	59	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138965	10.1371/journal.pone.0138965	http://dx.doi.org/10.1371/journal.pone.0138965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440112	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300010
J	Balenzuela, P; Pinasco, JP; Semeshenko, V				Balenzuela, Pablo; Pinasco, Juan Pablo; Semeshenko, Viktoriya			The Undecided Have the Key: Interaction-Driven Opinion Dynamics in a Three State Model	PLOS ONE			English	Article							GROUP DECISION; PERSUASION; CONSENSUS; POLARIZATION; PSYCHOLOGY; EXTREMITY; BEHAVIOR	The effects of interpersonal interactions on individual's agreements result in a social aggregation process which is reflected in the formation of collective states, as for instance, groups of individuals with a similar opinion about a given issue. This field, which has been a long-standing concern of sociologists and psychologists, has been extended into an area of experimental social psychology, and even has attracted the attention of physicists and mathematicians. In this article, we present a novel model of opinion formation in which agents may either have a strict preference for a choice, or be undecided. The opinion shift emerges, in a threshold process, as a consequence of a cumulative persuasion for either one of the two opinions in repeated interactions. There are two main ingredients which play key roles in determining the steady states: the initial fraction of undecided agents and the change in agents' persuasion after each interaction. As a function of these two parameters, the model presents a wide range of solutions, among which there are consensus of each opinion and bi-polarization. We found that a minimum fraction of undecided agents is not crucial for reaching consensus only, but also to determine a dominant opinion in a polarized situation. In order to gain a deeper comprehension of the dynamics, we also present the theoretical framework of the model. The master equations are of special interest for their non-trivial properties and difficulties in being solved analytically.	[Balenzuela, Pablo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina; [Balenzuela, Pablo] Consejo Nacl Invest Cient & Tecn, IFIBA, RA-1033 Buenos Aires, DF, Argentina; [Pinasco, Juan Pablo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Matemat, Buenos Aires, DF, Argentina; [Pinasco, Juan Pablo] IMAS UBA CONICET, Buenos Aires, DF, Argentina; [Semeshenko, Viktoriya] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Semeshenko, Viktoriya] Univ Buenos Aires, Fac Ciencias Econ, Inst Interdisciplinario Econ Polit Buenos Aires I, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Balenzuela, P (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina.	balen@df.uba.ar		Pinasco, Juan Pablo/0000-0002-6906-9239; Semeshenko, Viktoriya/0000-0003-0295-5946; Balenzuela, Pablo/0000-0002-8581-4892	Universidad de Buenos Aires grant [20020130100582BA, 20020130100283BA]; AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA [PICT2010 0800]	Universidad de Buenos Aires grant; AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA(ANPCyT)	Pablo Balenzuela was supported by Universidad de Buenos Aires grant nro: 20020130100582BA (http://www.uba.ar/secyt/subsidios). Juan Pablo Pinasco was supported by Universidad de Buenos Aires grant nro: 20020130100283BA (http://www.uba.ar/secyt/subsidios). Viktoriya Semeshenko was supported by AGENCIA NACIONAL DE PROMOCION CIENTIFICA Y TECNOLOGICA, grant nro: PICT2010 0800 (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/agencia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson R. P., 1964, CONTRIBUTIONS MATH P; AKERS RL, 1979, AM SOCIOL REV, V44, P636, DOI 10.2307/2094592; Aletti G, 2007, SIAM J APPL MATH, V67, P837, DOI 10.1137/060658679; Baron RS, 1996, J EXP SOC PSYCHOL, V32, P537, DOI 10.1006/jesp.1996.0024; BERGER RL, 1981, J AM STAT ASSOC, V76, P415, DOI 10.2307/2287844; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Boudet H, 2014, ENERG POLICY, V65, P57, DOI 10.1016/j.enpol.2013.10.017; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Couzin ID, 2011, SCIENCE, V334, P1578, DOI 10.1126/science.1210280; DAVIS JH, 1973, PSYCHOL REV, V80, P97, DOI 10.1037/h0033951; de la Lama MS, 2006, EUR PHYS J B, V51, P435, DOI 10.1140/epjb/e2006-00232-8; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; DEGROOT MH, 1974, J AM STAT ASSOC, V69, P118, DOI 10.2307/2285509; Du Q, 2012, SIAM J APPL MATH, V72, P464, DOI 10.1137/110833233; Eysenck MW, 2002, SIMPLY PSYCHOL; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Friedkin NE, 1999, AM SOCIOL REV, V64, P856, DOI 10.2307/2657407; Galam S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046123; Galdi S, 2008, SCIENCE, V321, P1100, DOI 10.1126/science.1160769; Ghorbel A, 2010, MATH COMPUT, V79, P1535, DOI 10.1090/S0025-5718-10-02326-4; Gordon V. N., 2007, UNDECIDED COLL STUDE; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; Heider F., 1967, READINGS ATTITUDE TH, P39; Homans George C., 1951, HUMAN GROUP; KERR NL, 1992, ORGAN BEHAV HUM DEC, V52, P64, DOI 10.1016/0749-5978(92)90046-A; La Rocca CE, 2014, EPL-EUROPHYS LETT, V106, DOI 10.1209/0295-5075/106/40004; LATANE B, 1981, AM PSYCHOL, V36, P343, DOI 10.1037/0003-066X.36.4.343; Mas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074516; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; Myers D. G., 1982, GROUP DECISION MAKIN, P125; Oakes P.J., 1994, STEREOTYPING SOCIAL; OAKES PJ, 1991, BRIT J SOC PSYCHOL, V30, P125, DOI 10.1111/j.2044-8309.1991.tb00930.x; SALZARULO L, 2006, J ARTIFICIAL SOC SOC, V0009, P00013; SANDERS GS, 1977, J EXP SOC PSYCHOL, V13, P303, DOI 10.1016/0022-1031(77)90001-4; Schelling T., 1978, MICROMOTIVES MACROBE; SMITH PL, 1988, J MATH PSYCHOL, V32, P135, DOI 10.1016/0022-2496(88)90043-0; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Sobkowicz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044489; Souza SR, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056103; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Turner J.C., 1987, REDISCOVERING SOCIAL; Vazquez F, 2004, J PHYS A-MATH GEN, V37, P8479, DOI 10.1088/0305-4470/37/35/006; VINOKUR A, 1978, J PERS SOC PSYCHOL, V36, P872, DOI 10.1037/0022-3514.36.8.872; Weisbuch G, 2005, PHYSICA A, V353, P555, DOI 10.1016/j.physa.2005.01.054; Weisbuch G., 2002, Complexity, V7, P55, DOI 10.1002/cplx.10031; Wood W, 2000, ANNU REV PSYCHOL, V51, P539, DOI 10.1146/annurev.psych.51.1.539	47	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139572	10.1371/journal.pone.0139572	http://dx.doi.org/10.1371/journal.pone.0139572			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0PR	26436421	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200035
J	Min, KY; Ji, B; Zhao, M; Ji, TF; Chen, B; Fang, XD; Ma, QJ				Min, Kaiyin; Ji, Bin; Zhao, Min; Ji, Tiefeng; Chen, Bin; Fang, Xuedong; Ma, Qingjie			Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection	PLOS ONE			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; POSITRON-EMISSION-TOMOGRAPHY; COMPUTED-TOMOGRAPHY; MMP-2; KIT	Breast cancer is one of the most frequent and aggressive primary tumors among women of all races. Matrix metalloproteinase (MMPs), a family of zinc- and calcium-dependent secreted or membrane anchored endopeptidases, is overexpressed in varieties of diseases including breast cancer. Therefore, noninvasive visualization and quantification of MMP in vivo are of great interest in basic research and clinical application for breast cancer early diagnosis. Herein, we developed a (99)mTc labeled membrane type I matrix metalloproteinase (MT1-MMP) specific binding peptide, [(99)mTc]-(HYNIC-AF7p)(tricine)(TPPTS), for in vivo detection of MDA-MB-231 breast tumor by single photon emission computed tomography (SPECT). [(99)mTc]-(HYNIC-AF7p)(tricine)(TPPTS) demonstrated nice biostability and high MT1-MMP binding affinity in vitro and in vivo. Tumor-to-muscle ratio was found to reach to the highest (4.17 +/- 0.49) at 2 hour after intravenously administration of [(99)mTc]-(HYNIC-AF7P)(tricine)(TPPTS) into MDA-MB-231 tumor bearing mice. Overall, [(99)mTc]-(HYNIC-AF7P)(tricine)(TPPTS) demonstrated great potential for MT1-MMP targeted detection in vivo and it would be a promising molecular imaging probe that are probably beneficial to breast cancer early diagnoses.	[Min, Kaiyin; Ji, Bin; Zhao, Min; Ji, Tiefeng; Chen, Bin; Ma, Qingjie] Jilin Univ, Dept Nucl Med, China Japan Union Hosp, Changchun 130033, Peoples R China; [Fang, Xuedong] Jilin Univ, Dept Gen Surg, China Japan Union Hosp, Changchun 130033, Peoples R China	Jilin University; Jilin University	Fang, XD (corresponding author), Jilin Univ, Dept Gen Surg, China Japan Union Hosp, Changchun 130033, Peoples R China.	fangxuedongjlu@163.com; maqingjiejlu@163.com			National Natural Science Foundation of China (NSFC) projects [81271606, 81571708]; Research Fund of Science and Technology Department of Jilin Province [20150520154JH]	National Natural Science Foundation of China (NSFC) projects(National Natural Science Foundation of China (NSFC)); Research Fund of Science and Technology Department of Jilin Province	This research was supported by the National Natural Science Foundation of China (NSFC) projects (No. 81271606 and 81571708), http://www.nsfc.gov.cn/ and the Research Fund of Science and Technology Department of Jilin Province (No. 20150520154JH), http://kjt.jl.gov.cn/kjt/4/tindex.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard F, 2005, BREAST CANCER RES, V7, P153, DOI 10.1186/bcr1201; de Barros ALB, 2012, APPL RADIAT ISOTOPES, V70, P2440, DOI 10.1016/j.apradiso.2012.06.022; COLEMAN RE, 1991, CANCER, V67, P1261; Dadachova E, 2008, NUCL MED BIOL, V35, P755, DOI 10.1016/j.nucmedbio.2008.07.001; Davidson B, 1999, CLIN EXP METASTAS, V17, P799, DOI 10.1023/A:1006723011835; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Garnuszek P, 2003, APPL RADIAT ISOTOPES, V58, P481, DOI 10.1016/S0969-8043(03)00057-5; Jiang WG, 2006, INT J MOL MED, V17, P583; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Laudanski P, 2010, FOLIA HISTOCHEM CYTO, V48, P101, DOI 10.2478/v10042-009-0085-0; Laverman P, 2004, BIOCONJUGATE CHEM, V15, P561, DOI 10.1021/bc034208w; Liu S, 2007, BIOCONJUGATE CHEM, V18, P438, DOI 10.1021/bc0603081; Maquoi E, 2012, ONCOGENE, V31, P480, DOI 10.1038/onc.2011.249; Nowbar AN, 2014, INT J CARDIOL, V174, P293, DOI 10.1016/j.ijcard.2014.04.096; Ozker K, 2000, CURR PHARM DESIGN, V6, P1123, DOI 10.2174/1381612003399824; Piwnica-Worms D, 2006, NEUROIMAG CLIN N AM, V16, P575, DOI 10.1016/j.nic.2006.06.007; Sano K, 2010, BIOL PHARM BULL, V33, P1589, DOI 10.1248/bpb.33.1589; Seiki M, 2003, CANCER LETT, V194, P1, DOI 10.1016/S0304-3835(02)00699-7; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Stellas D, 2012, ANTI-CANCER AGENT ME, V12, P707, DOI 10.2174/187152012802650246; Ulasov I, 2013, CANCER MED-US, V2, P457, DOI 10.1002/cam4.104; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Zhu L, 2011, MOL PHARMACEUT, V8, P2331, DOI 10.1021/mp2002297; Zhu L, 2011, J CONTROL RELEASE, V150, P248, DOI 10.1016/j.jconrel.2011.01.032	25	13	13	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139471	10.1371/journal.pone.0139471	http://dx.doi.org/10.1371/journal.pone.0139471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437463	Green Submitted, gold, Green Published			2022-12-27	WOS:000362499200025
J	Yu, HG; Wang, ZW; Wu, ZC; Zhu, CW				Yu, Hongguang; Wang, Zhiwei; Wu, Zhichao; Zhu, Chaowei			Dynamic Membrane Formation in Anaerobic Dynamic Membrane Bioreactors: Role of Extracellular Polymeric Substances	PLOS ONE			English	Article							WASTE-WATER TREATMENT; TREATMENT PERFORMANCE; FLOC SIZE; SLUDGE; FILTRATION; MICROFILTRATION; REMOVAL; ANDMBR; FUTURE	Dynamic membrane (DM) formation in dynamic membrane bioreactors plays an important role in achieving efficient solid-liquid separation. In order to study the contribution of extracellular polymeric substances (EPS) to DM formation in anaerobic dynamic membrane bioreactor (AnDMBR) processes, EPS extraction from and re-addition to bulk sludge were carried out in short-term filtration tests. DM formation behaviors could be well simulated by cake filtration model, and sludge with EPS re-addition showed the highest resistance coefficient, followed by sludge after EPS extraction. The DM layers exhibited a higher resistance and a lower porosity for the sludge sample after EPS extraction and for the sludge with EPS re-addition. Particle size of sludge flocs decreased after EPS extraction, and changed little with EPS re-addition, which was confirmed by interaction energy analysis. Further investigations by confocal laser scanning microscopy (CLSM) analysis and batch tests suggested that the removal of in-situ EPS stimulated release of soluble EPS, and re-added EPS were present as soluble EPS rather than bound EPS, which thus improved the formation of DM. The present work revealed the role of EPS in anaerobic DM formation, and could facilitate the operation of AnDMBR processes.	[Yu, Hongguang; Wang, Zhiwei; Wu, Zhichao] Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Zhu, Chaowei] Chinese Res Inst Environm Sci, Beijing 100012, Peoples R China	Tongji University; Chinese Research Academy of Environmental Sciences	Wang, ZW (corresponding author), Tongji Univ, Sch Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	zwwang@tongji.edu.cn	Wang, Zhiwei/F-5666-2012	Wang, Zhiwei/0000-0001-6729-2237	Shanghai Rising-Star Program [14QA1403800]; Shanghai Science & Technology Commission Program [13231202002]; National Natural Science Foundation of China [51422811]	Shanghai Rising-Star Program; Shanghai Science & Technology Commission Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Shanghai Rising-Star Program (14QA1403800) ZWW, Shanghai Science & Technology Commission Program (13231202002) ZCW, and National Natural Science Foundation of China (51422811) ZWW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 2012, STANDARD METHODS EXA, DOI [10.2105/SMWW.2882?gclid=CjwKCAiA25v_BRBNEiwAZb4-ZRdKz6ceq6, DOI 10.2105/SMWW.2882?GCLID=CJWKCAIA25V_BRBNEIWAZB4-ZRDKZ6CEQ6]; Chen MY, 2007, APPL MICROBIOL BIOT, V75, P467, DOI 10.1007/s00253-006-0816-5; CHERYAN M, 1996, ULTRAFILTRATION MICR; Chu HQ, 2008, J MEMBRANE SCI, V325, P271, DOI 10.1016/j.memsci.2008.07.040; Chu LB, 2006, SEP PURIF TECHNOL, V51, P173, DOI 10.1016/j.seppur.2006.01.009; Ersahin ME, 2012, BIORESOURCE TECHNOL, V122, P196, DOI 10.1016/j.biortech.2012.03.086; Fan B, 2002, ENVIRON SCI TECHNOL, V36, P5245, DOI 10.1021/es025789n; FROLUND B, 1995, APPL MICROBIOL BIOT, V43, P755, DOI 10.1007/s002530050481; Gaudy A.F., 1962, IND WATER WASTES, V7, P17; Geng ZH, 2007, WATER RES, V41, P4329, DOI 10.1016/j.watres.2007.07.007; HERMIA J, 1982, T I CHEM ENG-LOND, V60, P183; Hwang KJ, 2007, J MEMBRANE SCI, V287, P287, DOI 10.1016/j.memsci.2006.11.004; Kiso Y, 2005, WATER RES, V39, P4887, DOI 10.1016/j.watres.2005.05.025; Kuberkar VT, 2000, J MEMBRANE SCI, V168, P243, DOI 10.1016/S0376-7388(99)00324-5; Laspidou CS, 2002, WATER RES, V36, P2711, DOI 10.1016/S0043-1354(01)00413-4; Lee SYA, 2005, ENVIRON SCI TECHNOL, V39, P6477, DOI 10.1021/es050148o; Li WW, 2011, SEP PURIF TECHNOL, V81, P472, DOI 10.1016/j.seppur.2011.08.026; Liang S, 2013, J MEMBRANE SCI, V436, P186, DOI 10.1016/j.memsci.2013.02.021; Liu XM, 2007, ENVIRON SCI TECHNOL, V41, P4620, DOI 10.1021/es070107n; Liu XM, 2010, ENVIRON SCI TECHNOL, V44, P4355, DOI 10.1021/es9016766; McCarty PL, 2001, WATER SCI TECHNOL, V44, P149, DOI 10.2166/wst.2001.0487; Meng FG, 2009, WATER RES, V43, P1489, DOI 10.1016/j.watres.2008.12.044; Menniti A, 2009, WATER RES, V43, P4305, DOI 10.1016/j.watres.2009.06.052; Mikkelsen LH, 2002, WATER RES, V36, P2451, DOI 10.1016/S0043-1354(01)00477-8; Mulder M., 2000, BASIC PRINCIPLES MEM; Nagaoka H, 1996, WATER SCI TECHNOL, V34, P165, DOI 10.1016/S0273-1223(96)00800-1; Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es034887l; Sheng GP, 2007, APPL MICROBIOL BIOT, V74, P208, DOI 10.1007/s00253-006-0634-9; Wang J, 2008, J MEMBRANE SCI, V321, P132, DOI 10.1016/j.memsci.2008.04.008; Wang QY, 2012, CHEM ENG J, V179, P169, DOI 10.1016/j.cej.2011.10.074; Wang ZW, 2009, SEP SCI TECHNOL, V44, P3571, DOI 10.1080/01496390903182578; Wang ZW, 2009, WATER RES, V43, P2504, DOI 10.1016/j.watres.2009.02.026; Wingender J., 1999, MICROBIAL EXTRACELLU; Xie ZF, 2014, BIORESOURCE TECHNOL, V161, P29, DOI 10.1016/j.biortech.2014.03.014; Yu GH, 2009, ENVIRON ENG SCI, V26, P1533, DOI 10.1089/ees.2009.0001; Yu HG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093710, 10.1371/journal.pone.0103973]; Yu HG, 2013, CHEM ENG J, V231, P206, DOI 10.1016/j.cej.2013.07.012; Zhang XY, 2011, PROCESS BIOCHEM, V46, P1538, DOI 10.1016/j.procbio.2011.04.002; Zhang XY, 2010, CHEM ENG J, V165, P175, DOI 10.1016/j.cej.2010.09.013	39	10	12	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139703	10.1371/journal.pone.0139703	http://dx.doi.org/10.1371/journal.pone.0139703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436551	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200054
J	Canavan, C; West, J; Card, T				Canavan, Caroline; West, Joe; Card, Timothy			Change in Quality of Life for Patients with Irritable Bowel Syndrome following Referral to a Gastroenterologist: A Cohort Study	PLOS ONE			English	Article							WORK PRODUCTIVITY; PRIMARY-CARE; RISK-FACTORS; PREVALENCE; COLONOSCOPY; SYMPTOMS; IMPACT; IMPAIRMENT; COSTS	Background Irritable bowel syndrome (IBS), a chronic functional condition, considerably reduces quality of life (QoL) and referral to gastroenterology is common. Until now, however, the impact of seeing a gastroenterologist for IBS on patients' QoL and utility has not been assessed. Methods Patients referred with "probable IBS" to the Nottingham Treatment Centre between October 2012 and March 2014 were invited to complete a QoL questionnaire (EuroQol-5 Dimension) before their first appointment. Patients with confirmed IBS who completed this baseline assessment were sent follow-up questionnaires three and twelve months later. Global QoL and utility were measured at each time point and change from baseline calculated. Paired t-tests analysed the significance of any change. Results Of 205 invited patients, 69 were eligible and recruited. Response at three and twelve months was 45% and 17% respectively. Median global QoL at baseline was 67.5 (Interquartile range [IQR] 50.0 to 80.0), with a mean increase of 3.25 (95% confidence interval [CI] -5.38 to 11.88) three months later and a mean decrease of -1.82 (95% CI -16.01 to 12.38) after one year. The median utility at baseline was 0.76 (IQR 0.69 to 0.80), with a mean increase of 0.06 (95% CI -0.01 to 0.14) at three months and no change, 0.00 (-0.16 to 0.16), after one year. Conclusion Patients experienced a small but not statistically significant increase in QoL and utility three months after seeing a gastroenterologist for IBS, which was not maintained. Gastroenterology referral does not appear to appreciably improve Qol for most people with IBS.	[Canavan, Caroline; West, Joe; Card, Timothy] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England	University of Nottingham	Canavan, C (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Clin Sci Bldg,City Hosp Campus, Nottingham NG7 2RD, England.	caroline.canavan@nottingham.ac.uk	West, Joe/I-6637-2012; West, Joe/M-3867-2019; Card, Timothy/J-8651-2013	West, Joe/0000-0002-1135-9356; West, Joe/0000-0002-1135-9356; Card, Timothy/0000-0003-2555-2250	UK Medical Research Council [G1002360]; MRC [G1002360] Funding Source: UKRI; Medical Research Council [G1002360] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded through a UK Medical Research Council Population Health Scientist Fellowship awarded to CC, award number G1002360.	Akehurst RL, 2002, PHARMACOECONOMICS, V20, P455, DOI 10.2165/00019053-200220070-00003; Begtrup LM, 2013, CLIN GASTROENTEROL H, V11, P956, DOI 10.1016/j.cgh.2012.12.038; Bracco A, 2007, VALUE HEALTH, V10, P238, DOI 10.1111/j.1524-4733.2007.00179.x; Bushnell DM, 2006, VALUE HEALTH, V9, P90, DOI 10.1111/j.1524-4733.2006.00086.x; Bushnell DM, 2006, VALUE HEALTH, V9, P98, DOI 10.1111/j.1524-4733.2006.00087.x; Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245; Cash B, 2005, AM J MANAG CARE, V11, pS4; Chey WD, 2010, AM J GASTROENTEROL, V105, P859, DOI 10.1038/ajg.2010.55; Dean BB, 2005, AM J MANAG CARE, V11, pS17; Dove LS, 2013, GASTROENTEROLOGY, V145, P329, DOI 10.1053/j.gastro.2013.04.006; Ford AC, 2008, AM J GASTROENTEROL, V103, P1229, DOI 10.1111/j.1572-0241.2007.01740.x; Hulisz Darrell, 2004, J Manag Care Pharm, V10, P299; Kind P., 1999, 172 U YORK YORK HLTH; Levy RL, 2001, AM J GASTROENTEROL, V96, P3122; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; Muller-Lissner SA, 2002, EUR J GASTROEN HEPAT, V14, P1325; National Institute for Health and Care Excellence, 2008, IRR BOW SYNDR AD DIA; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Pare P, 2006, CLIN THER, V28, P1726, DOI 10.1016/j.clinthera.2006.10.010; Patel P, 2015, SCAND J GASTROENTERO, V50, P816, DOI 10.3109/00365521.2015.1007079; Quigley EMM, 2013, ALIMENT PHARM THER, V37, P49, DOI 10.1111/apt.12123; Shivaji U, 2013, GUT, V62, pA102, DOI 10.1136/gutjnl-2013-304907.226; Simren M, 2004, DIGESTION, V69, P254, DOI 10.1159/000079846; Simren M, 2001, SCAND J GASTROENTERO, V36, P545, DOI 10.1080/003655201750153476; Smith GD, 2004, BRIT J GEN PRACT, V54, P503; Spiegel B, 2009, ALIMENT PHARM THER, V30, P1159, DOI 10.1111/j.1365-2036.2009.04144.x; Spiegel BMR, 2005, GASTROINTEST ENDOSC, V62, P892, DOI 10.1016/j.gie.2005.08.016; Spiegel B, 2009, AM J GASTROENTEROL, V104, P1984, DOI 10.1038/ajg.2009.232; Stamuli E, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-149; Szende A, 2007, EQ 5D VALUE SETS INV, V2; Tack J, 2006, ALIMENT PHARM THER, V24, P183, DOI 10.1111/j.1365-2036.2006.02938.x; TALLEY NJ, 1995, AM J EPIDEMIOL, V142, P76, DOI 10.1093/oxfordjournals.aje.a117548; Thompson WG, 1997, EUR J GASTROEN HEPAT, V9, P689; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; Williams RE, 2006, ALIMENT PHARM THERAP, V23, P1667, DOI 10.1111/j.1365-2036.2006.02928.x	35	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139389	10.1371/journal.pone.0139389	http://dx.doi.org/10.1371/journal.pone.0139389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431458	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700050
J	Dunn, JC; Hamer, KC; Benton, TG				Dunn, Jenny C.; Hamer, Keith C.; Benton, Tim G.			Anthropogenically-Mediated Density Dependence in a Declining Farmland Bird	PLOS ONE			English	Article							YELLOWHAMMERS EMBERIZA-CITRINELLA; NEST VISITATION RATES; POPULATION-GROWTH; ECOLOGICAL TRAPS; RELATIVE ABUNDANCE; BREEDING SUCCESS; HABITAT; PREDATION; DYNAMICS; CONSEQUENCES	Land management intrinsically influences the distribution of animals and can consequently alter the potential for density-dependent processes to act within populations. For declining species, high densities of breeding territories are typically considered to represent productive populations. However, as density-dependent effects of food limitation or predator pressure may occur (especially when species are dependent upon separate nesting and foraging habitats), high territory density may limit per-capita productivity. Here, we use a declining but widespread European farmland bird, the yellowhammer Emberiza citrinella L., as a model system to test whether higher territory densities result in lower fledging success, parental provisioning rates or nestling growth rates compared to lower densities. Organic landscapes held higher territory densities, but nests on organic farms fledged fewer nestlings, translating to a 5 times higher rate of population shrinkage on organic farms compared to conventional. In addition, when parental provisioning behaviour was not restricted by predation risk (i.e., at times of low corvid activity), nestling provisioning rates were higher at lower territory densities, resulting in a much greater increase in nestling mass in low density areas, suggesting that food limitation occurred at high densities. These findings in turn suggest an ecological trap, whereby preferred nesting habitat does not provide sufficient food for rearing nestlings at high population density, creating a population sink. Habitat management for farmland birds should focus not simply on creating a high nesting density, but also on ensuring heterogeneous habitats to provide food resources in close proximity to nesting birds, even if this occurs through potentially restricting overall nest density but increasing population-level breeding success.	[Dunn, Jenny C.; Hamer, Keith C.; Benton, Tim G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Dunn, JC (corresponding author), Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England.	Jenny.Dunn@rspb.org.uk	Dunn, Jenny C./H-2867-2019; Benton, Tim G/C-6493-2009	Dunn, Jenny C./0000-0002-6277-2781; Benton, Tim G/0000-0002-7448-1973	Biotechnology and Biological Sciences Research Council (BBSRC) Studentship [BBSSK200512132]	Biotechnology and Biological Sciences Research Council (BBSRC) Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JCD was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Studentship BBSSK200512132. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abson DJ., 2013, AGR FOOD SECUR, V2, P1, DOI DOI 10.1186/2048-7010-2-2; Aebischer NJ, 1999, BIRD STUDY, V46, P22; ALATALO RV, 1984, J ANIM ECOL, V53, P969, DOI 10.2307/4671; Andrew R. J., 1956, Ibis, V98, P502, DOI 10.1111/j.1474-919X.1956.tb01436.x; Arlt D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003006; Barton K., 2012, MUMIN MULTIMODEL INF; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Benton TG, 2006, P R SOC B, V273, P1173, DOI 10.1098/rspb.2006.3495; Bock CE, 2004, FRONT ECOL ENVIRON, V2, P403, DOI 10.2307/3868428; Bradbury RB, 2000, J APPL ECOL, V37, P789, DOI 10.1046/j.1365-2664.2000.00552.x; Bradbury RB, 2003, IBIS, V145, P295, DOI 10.1046/j.1474-919X.2003.00142.x; Brouwer L, 2009, ECOLOGY, V90, P729, DOI 10.1890/07-1437.1; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Burton T, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0311; Chalfoun AD, 2009, J ANIM ECOL, V78, P497, DOI 10.1111/j.1365-2656.2008.01506.x; Chamberlain DE, 2013, J ORNITHOL, V154, P739, DOI 10.1007/s10336-013-0938-3; Christensen R., 2013, R PACKAGE VERSION 20, P08; Cornulier T, 2011, METHODS ECOL EVOL, V2, P86, DOI 10.1111/j.2041-210X.2010.00054.x; Cornulier T, 2009, ECOL LETT, V12, P1184, DOI 10.1111/j.1461-0248.2009.01377.x; Douglas DJT, 2010, AGR ECOSYST ENVIRON, V135, P127, DOI 10.1016/j.agee.2009.09.002; Douglas DJT, 2009, J APPL ECOL, V46, P353, DOI 10.1111/j.1365-2664.2009.01613.x; DUNN E, 1977, J ANIM ECOL, V46, P633, DOI 10.2307/3835; Dunn JC, 2010, BIRD STUDY, V57, P531, DOI 10.1080/00063657.2010.506607; Dunn JC, 2010, J APPL ECOL, V47, P994, DOI 10.1111/j.1365-2664.2010.01856.x; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Eggers S, 2008, BEHAV ECOL, V19, P1056, DOI 10.1093/beheco/arn063; Elmberg J, 2009, J AVIAN BIOL, V40, P317, DOI 10.1111/j.1600-048X.2008.04543.x; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Gabriel D, 2010, ECOL LETT, V13, P858, DOI 10.1111/j.1461-0248.2010.01481.x; Gilroy JJ, 2007, TRENDS ECOL EVOL, V22, P351, DOI 10.1016/j.tree.2007.03.014; GREEN RE, 1994, J APPL ECOL, V31, P677, DOI 10.2307/2404158; Gregory RD, 1996, BIRD STUDY, V43, P28, DOI 10.1080/00063659609460993; Hart JD, 2006, J APPL ECOL, V43, P81, DOI 10.1111/j.1365-2664.2005.01103.x; Hazler KR, 2004, AUK, V121, P707, DOI 10.1642/0004-8038(2004)121[0707:MLRAPA]2.0.CO;2; Henckel L, P R SOC B IN PRESS; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Julliard R, 1997, ECOLOGY, V78, P394, DOI 10.1890/0012-9658(1997)078[0394:PAOCSD]2.0.CO;2; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kristan WB, 2003, OIKOS, V103, P457; Kyrkos A, 1998, BIRD STUDY, V45, P232, DOI 10.1080/00063659809461095; Luginbuhl JM, 2001, J FIELD ORNITHOL, V72, P556, DOI 10.1648/0273-8570-72.4.556; Manolis JC, 2000, AUK, V117, P615, DOI 10.1642/0004-8038(2000)117[0615:UNFISS]2.0.CO;2; Marchant J., 1990, POPULATION TRENDS BR; MAYFIELD HF, 1975, WILSON BULL, V87, P456; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moreby SJ, 2001, AGR ECOSYST ENVIRON, V86, P125, DOI 10.1016/S0167-8809(00)00279-6; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nordby JC, 2009, BIOL INVASIONS, V11, P565, DOI 10.1007/s10530-008-9271-9; Potts JR, 2013, AM NAT, V182, pE73, DOI 10.1086/671260; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson R.A., 2005, 407 BTO; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Saether BE, 2002, PHILOS T ROY SOC B, V357, P1185, DOI 10.1098/rstb.2002.1119; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sillett TS, 2000, SCIENCE, V288, P2040, DOI 10.1126/science.288.5473.2040; Siriwardena GM, 1998, BIRD STUDY, V45, P276, DOI 10.1080/00063659809461099; Stoate C, 1998, BIRD STUDY, V45, P109, DOI 10.1080/00063659809461084; Sutherland WJ, 2002, PHILOS T R SOC B, V357, P1273, DOI 10.1098/rstb.2002.1127; Taborsky B, 2006, P ROY SOC B-BIOL SCI, V273, P741, DOI 10.1098/rspb.2005.3347; Thomson DL, 1998, ANIM BEHAV, V56, P1041, DOI 10.1006/anbe.1998.0895	61	5	6	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139492	10.1371/journal.pone.0139492	http://dx.doi.org/10.1371/journal.pone.0139492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431173	Green Published, gold, Green Accepted			2022-12-27	WOS:000362178700069
J	Ferro, C; Lopez, M; Fuya, P; Lugo, L; Cordovez, JM; Gonzalez, C				Ferro, Cristina; Lopez, Marla; Fuya, Patricia; Lugo, Ligia; Manuel Cordovez, Juan; Gonzalez, Camila			Spatial Distribution of Sand Fly Vectors and Eco-Epidemiology of Cutaneous Leishmaniasis Transmission in Colombia	PLOS ONE			English	Article							DIPTERA PSYCHODIDAE; FLIES DIPTERA; PHLEBOTOMINAE; ECOLOGY; AREAS; FOCUS; CITY	Background Leishmania is transmitted by Phlebotominae insects that maintain the enzootic cycle by circulating between sylvatic and domestic mammals; humans enter the cycles as accidental hosts due to the vector's search for blood source. In Colombia, leishmaniasis is an endemic disease and 95% of all cases are cutaneous (CL), these cases have been reported in several regions of the country where the intervention of sylvatic areas by the introduction of agriculture seem to have an impact on the rearrangement of new transmission cycles. Our study aimed to update vector species distribution in the country and to analyze the relationship between vectors' distribution, climate, land use and CL prevalence. Methods A database with geographic information was assembled, and ecological niche modeling was performed to explore the potential distribution of each of the 21 species of medical importance in Colombia, using thirteen bioclimatic variables, three topographic and three principal components derived from NDVI. Binary models for each species were obtained and related to both land use coverage, and a CL prevalence map with available epidemiological data. Finally, maps of species potential distribution were summed to define potential species richness in the country. Results In total, 673 single records were obtained with Lutzomyia gomezi, Lutzomyia longipalpis, Psychodopygus panamensis, Psathyromyia shannoni and Pintomyia evansi the species with the highest number of records. Eighteen species had significant models, considering the area under the curve and the jackknife results: L. gomezi and P. panamensis had the widest potential distribution. All sand fly species except for Nyssomyia antunesi are mainly distributed in regions with rates of prevalence between 0.33 to 101.35 cases per 100,000 inhabitants and 76% of collection data points fall into transformed ecosystems. Discussion Distribution ranges of sand flies with medical importance in Colombia correspond predominantly to disturbed areas, where the original land coverage is missing therefore increasing the domiciliation potential. We highlight the importance of the use of distribution maps as a tool for the development of strategies for prevention and control of diseases.	[Ferro, Cristina; Fuya, Patricia; Lugo, Ligia] Inst Nacl Salud, Lab Entomol, Subdirecc Red Nacl Labs, Bogota, Colombia; [Lopez, Marla; Gonzalez, Camila] Univ Los Andes, Fac Ciencias, Ctr Invest Microbiol & Parasitol Trop CIMPAT, Bogota, Colombia; [Manuel Cordovez, Juan] Univ Los Andes, Fac Ingn, Biomac, Bogota, Colombia	Instituto Nacional de Salud (Colombia); Universidad de los Andes (Colombia); Universidad de los Andes (Colombia)	Gonzalez, C (corresponding author), Univ Los Andes, Fac Ciencias, Ctr Invest Microbiol & Parasitol Trop CIMPAT, Bogota, Colombia.	c.gonzalez2592@uniandes.edu.co	González, Camila/AAW-9144-2021	FUYA, PATRICIA/0000-0003-3762-0003; Gonzalez, Camila/0000-0001-8089-4056	Colciencias [545-2011]; Faculty of Sciences at Uniandes	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Faculty of Sciences at Uniandes	This study was supported by Colciencias 545-2011 (http://www.colciencias.gov.co) and the Faculty of Sciences at Uniandes funding C. Gonzalez (http://facciencias.uniandes.edu.co). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo LA, 2002, MEM I OSWALDO CRUZ, V97, P641, DOI 10.1590/S0074-02762002000500008; Zuluaga WA, 2012, BIOMEDICA, V32, P321, DOI [10.1590/S0120-41572012000300003, 10.7705/biomedica.v32i3.668]; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2014, SIVIGILA VIG RUT EV; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Barreto P., 1969, PSYCHODIDAE CALDASIA, V10, P459; Bejarano EE, 2002, MEM I OSWALDO CRUZ, V97, P645, DOI 10.1590/S0074-02762002000500010; Cardenas R., 1999, Biomedica, V19, P239; DANE, 2014, EST PROYECC POBL NAC; Davies C R, 2000, Cad Saude Publica, V16, P925, DOI 10.1590/S0102-311X2000000400013; de Almeida PS, 2015, MEM I OSWALDO CRUZ, V110, P551, DOI 10.1590/0074-02760140462; Ferro C, 2011, AM J TROP MED HYG, V85, P847, DOI 10.4269/ajtmh.2011.10-0560; Galati E. A. B., 2015, APOSTILA BIOECOLOGIA; Gonzalez C, 2014, ACTA TROP, V129, P83, DOI 10.1016/j.actatropica.2013.08.014; Gonzalez C, 2011, AM J TROP MED HYG, V85, P839, DOI 10.4269/ajtmh.2011.10-0452; Gramiccia M, 2005, INT J PARASITOL, V35, P1169, DOI 10.1016/j.ijpara.2005.07.001; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Isaza DM, 1999, PAN AM J PUB HLTH, V6, P177; Montoya-Lerma J, 1999, MEM I OSWALDO CRUZ, V94, P277, DOI 10.1590/S0074-02761999000300001; Muñoz Gerardo, 2006, Biomed., V26, P131; Ocampo CB, 2012, TROP MED INT HEALTH, V17, P1309, DOI 10.1111/j.1365-3156.2012.03065.x; [OMS] Organizacion Mundial de la Salud, 2010, REUN COM EXP OMS CON; Osorno-Mesa E. A., 1972, REV ACAD COLOMB CIEN, V14, P45; Ovallos FG, 2013, MEM I OSWALDO CRUZ, V108, P297, DOI 10.1590/S0074-02762013000300007; Pardo Raúl H, 2006, Biomed., V26, P95; Ramirez JR, 2000, J CLIN MICROBIOL, V38, P3768; Rodriguez-Barraquer I, 2008, AM J TROP MED HYG, V78, P276, DOI 10.4269/ajtmh.2008.78.276; Roque Andre Luiz R., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P251, DOI 10.1016/j.ijppaw.2014.08.004; Rotureau B, 2006, AM J TROP MED HYG, V75, P62, DOI 10.4269/ajtmh.2006.75.62; Sandoval Claudia Magaly, 2006, Biomed., V26, P218; Santamaría Erika, 2006, Biomed., V26, P82; Valderrama A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-9; Trujillo AV, 2013, MEM I OSWALDO CRUZ, V108, P463, DOI 10.1590/S0074-0276108042013011; Vergel C, 2005, AM J TROP MED HYG, V72, P423, DOI 10.4269/ajtmh.2005.72.423; Young D, 1994, GUIDE IDENTIFICATION, p[341, 444]; Young D., 1979, REV BLOODSUCKING PSY, p[109, 155]	36	43	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139391	10.1371/journal.pone.0139391	http://dx.doi.org/10.1371/journal.pone.0139391			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431546	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700051
J	Kim, NY; Chang, DS; Kim, Y; Kim, CH; Hur, GH; Yang, JM; Shin, S				Kim, Na Young; Chang, Dong Suk; Kim, Yeonsu; Kim, Chang Hwan; Hur, Gyeung Haeng; Yang, Jai Myung; Shin, Sungho			Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge	PLOS ONE			English	Article							INHALATIONAL ANTHRAX; PLASMID DNA; GENE-EXPRESSION; ANTIGEN; TOXIN; ELECTROPORATION; VIRUS; BIODISTRIBUTION; QUANTIFICATION; IMMUNIZATION	Anthrax has long been considered the most probable bioweapon-induced disease. The protective antigen (PA) of Bacillus anthracis plays a crucial role in the pathogenesis of anthrax. In the current study, we evaluated the efficiency of a genetic vaccination with the fourth domain (D4) of PA, which is responsible for initial binding of the anthrax toxin to the cellular receptor. The eukaryotic expression vector was designed with the immunoglobulin M (IgM) signal sequence encoding for PA-D4, which contains codon-optimized genes. The expression and secretion of recombinant protein was confirmed in vitro in 293T cells transfected with plasmid and detected by western blotting, confocal microscopy, and enzyme-linked immunosorbent assay (ELISA). The results revealed that PA-D4 protein can be efficiently expressed and secreted at high levels into the culture medium. When plasmid DNA was given intramuscularly to mice, a significant PA-D4-specific antibody response was induced. Importantly, high titers of antibodies were maintained for nearly 1 year. Furthermore, incorporation of the SV40 enhancer in the plasmid DNA resulted in approximately a 15-fold increase in serum antibody levels in comparison with the plasmid without enhancer. The antibodies produced were predominantly the immunoglobulin G2 (IgG2) type, indicating the predominance of the Th1 response. In addition, splenocytes collected from immunized mice produced PA-D4-specific interferon gamma (IFN-gamma). The biodistribution study showed that plasmid DNA was detected in most organs and it rapidly cleared from the injection site. Finally, DNA vaccination with electroporation induced a significant increase in immunogenicity and successfully protected the mice against anthrax spore challenge. Our approach to enhancing the immune response contributes to the development of DNA vaccines against anthrax and other biothreats.	[Kim, Na Young; Chang, Dong Suk; Kim, Yeonsu; Yang, Jai Myung; Shin, Sungho] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Kim, Chang Hwan; Hur, Gyeung Haeng] Agcy Def Dev, Daejeon, South Korea	Sogang University; Agency of Defense Development (ADD), Republic of Korea	Shin, S (corresponding author), Sogang Univ, Dept Life Sci, Seoul, South Korea.	shshin@sogang.ac.kr	Yang, Jai Sing/M-1162-2015	Yang, Jai Sing/0000-0001-7302-8248	Agency for Defense Development grant [UD120012ID]	Agency for Defense Development grant	This work was funded by the Agency for Defense Development grant UD120012ID.	Andre S, 1998, J VIROL, V72, P1497; Blomberg P, 2002, BIOCHEM BIOPH RES CO, V298, P505, DOI 10.1016/S0006-291X(02)02486-5; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Collier RJ, 2009, MOL ASPECTS MED, V30, P313; Cote CK, 2011, MICROBES INFECT, V13, P1146, DOI 10.1016/j.micinf.2011.07.005; Cybulski RJ, 2009, MOL ASPECTS MED, V30, P490, DOI 10.1016/j.mam.2009.08.006; Donofrio G, 2006, CLIN VACCINE IMMUNOL, V13, P698, DOI 10.1128/CVI.00071-06; Dupuy LC, 2009, EXPERT REV VACCINES, V8, P1739, DOI 10.1586/ERV.09.132; Flick-Smith HC, 2002, INFECT IMMUN, V70, P1653, DOI 10.1128/IAI.70.3.1653-1656.2002; Galloway D, 2004, VACCINE, V22, P1604, DOI 10.1016/j.vaccine.2003.09.043; Garmory HS, 2005, ADV DRUG DELIVER REV, V57, P1343, DOI 10.1016/j.addr.2005.01.013; Gu ML, 1999, VACCINE, V17, P340, DOI 10.1016/S0264-410X(98)00210-2; Hermanson G, 2004, P NATL ACAD SCI USA, V101, P13601, DOI 10.1073/pnas.0405557101; Kang ES, 2007, ARCH PHARM RES, V30, P355, DOI 10.1007/BF02977618; Kim HG, 2003, BIOCHEM BIOPH RES CO, V305, P488, DOI 10.1016/S0006-291X(03)00795-2; Kintzer AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013888; Krishnanchettiar S, 2003, PROTEIN EXPRES PURIF, V27, P325, DOI 10.1016/S1046-5928(02)00612-5; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Li L, 2012, J BIOTECHNOL, V162, P171, DOI 10.1016/j.jbiotec.2012.08.012; Li S, 2001, GENE THER, V8, P494, DOI 10.1038/sj.gt.3301419; Liu C, 2008, J GENE MED, V10, P298, DOI 10.1002/jgm.1138; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Livingston BD, 2010, VACCINE, V28, P1056, DOI 10.1016/j.vaccine.2009.10.111; Luxembourg A, 2008, VACCINE, V26, P5216, DOI 10.1016/j.vaccine.2008.03.064; Megede J, 2000, J VIROL, V74, P2628; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Park YS, 2008, INFECT IMMUN, V76, P1952, DOI 10.1128/IAI.01722-07; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Qiu JT, 2000, J VIROL, V74, P5997, DOI 10.1128/JVI.74.13.5997-6005.2000; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reuveny S, 2001, INFECT IMMUN, V69, P2888, DOI 10.1128/IAI.69.5.2888-2893.2001; Shaker DS, 2007, MOL THER, V15, P2037, DOI 10.1038/sj.mt.6300286; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Tournier JN, 2007, CELL MICROBIOL, V9, P555, DOI 10.1111/j.1462-5822.2006.00866.x; Valiante NM, 2003, CELL MICROBIOL, V5, P755, DOI 10.1046/j.1462-5822.2003.00318.x; WELKOS SL, 1986, INFECT IMMUN, V51, P795, DOI 10.1128/IAI.51.3.795-800.1986; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Williamson ED, 2005, INFECT IMMUN, V73, P5978, DOI 10.1128/IAI.73.9.5978-5987.2005; Woo Jung Gyu, 2011, Genet Vaccines Ther, V9, P13, DOI 10.1186/1479-0556-9-13; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Yu YZ, 2010, VACCINE, V28, P7529, DOI 10.1016/j.vaccine.2010.08.107; Zhang HY, 2005, VACCINE, V23, P5632, DOI 10.1016/j.vaccine.2005.06.029	45	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139671	10.1371/journal.pone.0139671	http://dx.doi.org/10.1371/journal.pone.0139671			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430894	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700095
J	Ljubisavljevic, MR; Javid, A; Oommen, J; Parekh, K; Nagelkerke, N; Shehab, S; Adrian, TE				Ljubisavljevic, Milos R.; Javid, Asma; Oommen, Joji; Parekh, Khatija; Nagelkerke, Nico; Shehab, Safa; Adrian, Thomas E.			The Effects of Different Repetitive Transcranial Magnetic Stimulation (rTMS) Protocols on Cortical Gene Expression in a Rat Model of Cerebral Ischemic-Reperfusion Injury	PLOS ONE			English	Article							THETA-BURST STIMULATION; NONINVASIVE BRAIN-STIMULATION; LONG-TERM POTENTIATION; ARTERY OCCLUSION; MOTOR CORTEX; C-FOS; MICROARRAY ANALYSIS; NEUROTROPHIC FACTOR; CHRONIC STROKE; HAND FUNCTION	Although repetitive Transcranial Magnetic Stimulation (rTMS) in treatment of stroke in humans has been explored over the past decade the data remain controversial in terms of optimal stimulation parameters and the mechanisms of rTMS long-term effects. This study aimed to explore the potential of different rTMS protocols to induce changes in gene expression in rat cortices after acute ischemic-reperfusion brain injury. The stroke was induced by middle cerebral artery occlusion (MCAO) with subsequent reperfusion. Changes in the expression of 96 genes were examined using low-density expression arrays after MCAO alone and after MCAO combined with 1Hz, 5Hz, continuous (cTBS) and intermittent (iTBS) theta-burst rTMS. rTMS over the lesioned hemisphere was given for two weeks (with a 2-day pause) in a single daily session and a total of 2400 pulses. MCAO alone induced significant upregulation in the expression of 44 genes and downregulation in 10. Two weeks of iTBS induced significant increase in the expression of 52 genes. There were no downregulated genes. 1Hz and 5Hz had no significant effects on gene expression, while cTBS effects were negligible. Upregulated genes included those involved in angiogenesis, inflammation, injury response and cellular repair, structural remodeling, neuroprotection, neurotransmission and neuronal plasticity. The results show that long-term rTMS in acute ischemic-reperfusion brain injury induces complex changes in gene expression that span multiple pathways, which generally promote the recovery. They also demonstrate that induced changes primarily depend on the rTMS frequency (1Hz and 5Hz vs. iTBS) and pattern (cTBS vs. iTBS). The results further underlines the premise that one of the benefits of rTMS application in stroke may be to prime the brain, enhancing its potential to cope with the injury and to rewire. This could further augment its potential to favorably respond to rehabilitation, and to restore some of the loss functions.	[Ljubisavljevic, Milos R.; Javid, Asma; Oommen, Joji; Parekh, Khatija; Adrian, Thomas E.] UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates; [Nagelkerke, Nico] Queen Elizabeth Cent Hosp, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Nagelkerke, Nico] UAE Univ, Coll Med & Hlth Sci, Dept Community Med, Al Ain, U Arab Emirates; [Shehab, Safa] UAE Univ, Dept Anat, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University; University of Malawi; United Arab Emirates University; United Arab Emirates University	Ljubisavljevic, MR (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates.	milos@uaeu.ac.ae		Adrian, Thomas/0000-0002-5051-1111; Ljubisavljevic, Milos/0000-0002-5025-3562	United Arab Emirates University [31M016]	United Arab Emirates University	This work was supported by a United Arab Emirates University Grant 31M016 to Milos Ljubisavljevic.	Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; Bacigaluppi Marco, 2010, Open Neurol J, V4, P34, DOI 10.2174/1874205X01004020034; Bates KA, 2015, RESTOR NEUROL NEUROS, V33, P557, DOI 10.3233/RNN-130359; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benali A, 2011, J NEUROSCI, V31, P1193, DOI 10.1523/JNEUROSCI.1379-10.2011; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boggio PS, 2006, AM J PHYS MED REHAB, V85, P927, DOI 10.1097/01.phm.0000242635.88129.38; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; Di Lazzaro V, 2008, CLIN NEUROPHYSIOL, V119, P715, DOI 10.1016/j.clinph.2007.11.049; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Emara TH, 2010, EUR J NEUROL, V17, P1203, DOI 10.1111/j.1468-1331.2010.03000.x; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Esser SK, 2006, BRAIN RES BULL, V69, P86, DOI 10.1016/j.brainresbull.2005.11.003; Feng Hong-lin, 2005, Chinese Medical Sciences Journal, V20, P226; Feng HL, 2008, CHINESE MED J-PEKING, V121, P1307, DOI 10.1097/00029330-200807020-00012; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Fitzgerald PB, 2005, NEUROREPORT, V16, P1525, DOI 10.1097/01.wnr.0000177005.14108.f1; Fregni F, 2006, COGN BEHAV NEUROL, V19, P21, DOI 10.1097/00146965-200603000-00003; Fujiki M, 1997, MOL BRAIN RES, V44, P301, DOI 10.1016/S0169-328X(96)00232-X; Fujiki M, 2003, J NEUROSURG, V99, P1063, DOI 10.3171/jns.2003.99.6.1063; Funke K, 2011, J PHYSIOL-LONDON, V589, P4423, DOI 10.1113/jphysiol.2011.206573; Furlan M, 1996, ANN NEUROL, V40, P216, DOI 10.1002/ana.410400213; Gao F, 2010, EUR J NUCL MED MOL I, V37, P954, DOI 10.1007/s00259-009-1342-3; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Hausmann A, 2000, MOL BRAIN RES, V76, P355, DOI 10.1016/S0169-328X(00)00024-3; Hoogendam JM, 2010, BRAIN STIMUL, V3, P95, DOI 10.1016/j.brs.2009.10.005; Hoppenrath K, 2013, NEUROSCI LETT, V536, P19, DOI 10.1016/j.neulet.2013.01.003; Hoyer EH, 2011, RESTOR NEUROL NEUROS, V29, P395, DOI 10.3233/RNN-2011-0611; Huang YZ, 2009, BRAIN STIMUL, V2, P2, DOI 10.1016/j.brs.2008.09.007; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hummel FC, 2005, CURR OPIN NEUROL, V18, P667, DOI 10.1097/01.wco.0000189876.37475.42; Hummel FC, 2008, BRAIN STIMUL, V1, P370, DOI 10.1016/j.brs.2008.09.003; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; Ikeda T, 2005, BIOCHEM BIOPH RES CO, V327, P218, DOI 10.1016/j.bbrc.2004.12.009; Ji RR, 1998, P NATL ACAD SCI USA, V95, P15635, DOI 10.1073/pnas.95.26.15635; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Khedr EM, 2005, NEUROLOGY, V65, P466, DOI 10.1212/01.wnl.0000173067.84247.36; Kim EJ, 2006, NEUROSCI LETT, V405, P79, DOI 10.1016/j.neulet.2006.06.023; Kim JB, 2004, J NEUROCHEM, V89, P1271, DOI 10.1111/j.1471-4159.2004.02429.x; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; Kobayashi MS, 2008, BRAIN RES REV, V58, P171, DOI 10.1016/j.brainresrev.2008.03.001; Le Q, 2014, AM J PHYS MED REHAB, V93, P422, DOI 10.1097/PHM.0000000000000027; Li M, 2012, J HUAZHONG U SCI-MED, V32, P746, DOI [10.1007/s11596-012-1028-0, 10.3724/SP.J.1087.2012.00746]; LISZCZAK TM, 1984, ACTA NEUROPATHOL, V65, P150, DOI 10.1007/BF00690469; Liu FD, 2014, METHODS MOL BIOL, V1135, P81, DOI 10.1007/978-1-4939-0320-7_7; Liu FD, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464701; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Mansur CG, 2005, NEUROLOGY, V64, P1802, DOI 10.1212/01.WNL.0000161839.38079.92; Muller D, 2000, P NATL ACAD SCI USA, V97, P4315, DOI 10.1073/pnas.070022697; Muller MB, 2000, NEUROPSYCHOPHARMACOL, V23, P205, DOI 10.1016/S0893-133X(00)00099-3; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nagel S, 2012, NEUROSCIENCE, V208, P109, DOI 10.1016/j.neuroscience.2012.01.048; NEUMANNHAEFELIN T, 1994, J CEREBR BLOOD F MET, V14, P206, DOI 10.1038/jcbfm.1994.27; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; Ogiue-Ikeda M, 2005, BRAIN RES, V1037, P7, DOI 10.1016/j.brainres.2004.10.063; OSSENKOPP KP, 1985, NEUROBEH TOXICOL TER, V7, P95; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Post A, 1999, EUR J NEUROSCI, V11, P3247, DOI 10.1046/j.1460-9568.1999.00747.x; Ronnback A, 2005, NEUROSCI LETT, V385, P173, DOI 10.1016/j.neulet.2005.05.016; Rossini P M, 2007, Eura Medicophys, V43, P241; Sarabi AS, 2008, J NEUROSCI RES, V86, P2912, DOI 10.1002/jnr.21734; Schmidt-Kastner R, 2002, MOL BRAIN RES, V108, P81, DOI 10.1016/S0169-328X(02)00516-8; Schulz R, 2013, NEUROPHARMACOLOGY, V64, P579, DOI 10.1016/j.neuropharm.2012.05.016; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Stansberg C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-94; Stansberg C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-15; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; TAKAGI K, 1995, BRAIN RES, V691, P160, DOI 10.1016/0006-8993(95)00657-C; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; Talelli P, 2007, CLIN NEUROPHYSIOL, V118, P333, DOI 10.1016/j.clinph.2006.10.014; Thickbroom GW, 2006, CLIN NEUROPHYSIOL, V117, P61, DOI 10.1016/j.clinph.2005.09.010; Touge T, 2001, CLIN NEUROPHYSIOL, V112, P2138, DOI 10.1016/S1388-2457(01)00651-4; Trippe J, 2009, EXP BRAIN RES, V199, P411, DOI 10.1007/s00221-009-1961-8; TSUMOTO T, 1992, PROG NEUROBIOL, V39, P209, DOI 10.1016/0301-0082(92)90011-3; Tuma RF, 2012, CURR PHARM BIOTECHNO, V13, P46; Uy J, 2003, NEUROLOGY, V61, P982, DOI 10.1212/01.WNL.0000078809.33581.1F; Vlachos A, 2012, J NEUROSCI, V32, P17514, DOI 10.1523/JNEUROSCI.0409-12.2012; Volz LJ, 2013, BRAIN STIMUL, V6, P598, DOI 10.1016/j.brs.2013.01.008; Wang HN, 2014, J PSYCHIATR RES, V51, P79, DOI 10.1016/j.jpsychires.2014.01.004; Wassermann EM, 2012, PHARMACOL THERAPEUT, V133, P98, DOI 10.1016/j.pharmthera.2011.09.003; Yoon KJ, 2011, EXP BRAIN RES, V214, P549, DOI 10.1007/s00221-011-2853-2; Zhang XQ, 2007, J HUAZHONG U SCI-MED, V27, P415, DOI 10.1007/s11596-007-0416-3; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zille M, 2012, J CEREBR BLOOD F MET, V32, P213, DOI 10.1038/jcbfm.2011.150	88	36	42	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139892	10.1371/journal.pone.0139892	http://dx.doi.org/10.1371/journal.pone.0139892			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431529	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700128
J	Siu, GKH; Chen, JHK; Ng, TK; Lee, RA; Fung, KSC; To, SWC; Wong, BKC; Cheung, S; Wong, IWF; Tam, MMP; Lee, SSW; Yam, WC				Siu, Gilman K. H.; Chen, Jonathan H. K.; Ng, T. K.; Lee, Rodney A.; Fung, Kitty S. C.; To, Sabrina W. C.; Wong, Barry K. C.; Cheung, Sherman; Wong, Ivan W. F.; Tam, Marble M. P.; Lee, Swing S. W.; Yam, W. C.			Performance Evaluation of the Verigene Gram-Positive and Gram-Negative Blood Culture Test for Direct Identification of Bacteria and Their Resistance Determinants from Positive Blood Cultures in Hong Kong	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; NUCLEIC-ACID TEST; RAPID DETECTION; PSEUDOMONAS-AERUGINOSA; POTENTIAL IMPACT; MULTIPLEX PCR; ASSAY; MARKERS; ORGANISMS; GENES	Background A multicenter study was conducted to evaluate the diagnostic performance and the time to identifcation of the Verigene Blood Culture Test, the BC-GP and BC-GN assays, to identify both Gram-positive and Gram-negative bacteria and their drug resistance determinants directly from positive blood cultures collected in Hong Kong. Methods and Results A total of 364 blood cultures were prospectively collected from four public hospitals, in which 114 and 250 cultures yielded Gram-positive and Gram-negative bacteria, and were tested with the BC-GP and BC-GN assay respectively. The overall identification agreement for Gram-positive and Gram-negative bacteria were 89.6% and 90.5% in monomicrobial cultures and 62.5% and 53.6% in polymicrobial cultures, respectively. The sensitivities for most genus/species achieved at least 80% except Enterococcus spp. (60%), K. oxytoca (0%), K. pneumoniae (69.2%), whereas the specificities for all targets ranged from 98.9% to 100%. Of note, 50% (7/14) cultures containing K. pneumoniae that were missed by the BC-GN assay were subsequently identified as K. variicola. Approximately 5.5% (20/364) cultures contained non-target organisms, of which Aeromonas spp. accounted for 25% and are of particular concern. For drug resistance determination, the Verigene test showed 100% sensitivity for identification of MRSA, VRE and carbapenem resistant Acinetobacter, and 84.4% for ESBL-producing Enterobacteriaceae based on the positive detection of mecA, vanA, bla(OXA) and bla(CTXM) respectively. Conclusion Overall, the Verigene test provided acceptable accuracy for identification of bacteria and resistance markers with a range of turnaround time 40.5 to 99.2 h faster than conventional methods in our region.	[Siu, Gilman K. H.; Lee, Swing S. W.] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Chen, Jonathan H. K.; To, Sabrina W. C.; Yam, W. C.] Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ng, T. K.; Cheung, Sherman] Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Lee, Rodney A.; Wong, Ivan W. F.] Pamela Youde Nethersole Eastern Hosp, Dept Clin Pathol, Hong Kong, Hong Kong, Peoples R China; [Fung, Kitty S. C.; Wong, Barry K. C.; Tam, Marble M. P.] United Christian Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; United Christian Hospital	Yam, WC (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	wcyam@hku.hk	SIU, Kit Hang/L-7796-2017	SIU, Kit Hang/0000-0002-4354-3393				Bauer KA, 2010, CLIN INFECT DIS, V51, P1074, DOI 10.1086/656623; Bell JM, 1998, J CLIN MICROBIOL, V36, P2187, DOI 10.1128/JCM.36.8.2187-2190.1998; Bork JT, 2015, ANTIMICROB AGENTS CH, V59, P1593, DOI 10.1128/AAC.04259-14; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brisse S, 2004, CLIN MICROBIOL INFEC, V10, P942, DOI 10.1111/j.1469-0691.2004.00973.x; Buchan BW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001478; Centre for Health Protection DoH Hong Kong SAR, 2013, NUMBER OF DEATHS BY; Chen JHK, 2013, J CLIN MICROBIOL, V51, P3981, DOI 10.1128/JCM.01437-13; Chen JHK, 2013, J CLIN MICROBIOL, V51, P1733, DOI 10.1128/JCM.03259-12; Clinical-and-Laboratory-Standards-Institute, M100S21 CLIN AND LAB; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Del Vecchio M., 2013, K132843 NAN INC; Dodemont M, 2015, EUR J CLIN MICROBIOL, V34, P473, DOI 10.1007/s10096-014-2250-4; Dodemont M, 2014, J CLIN MICROBIOL, V52, P3085, DOI 10.1128/JCM.01099-14; Freitas AR, 2010, ANTIMICROB AGENTS CH, V54, P2660, DOI 10.1128/AAC.00134-10; Grozdanovski K, 2012, Prilozi, V33, P105; Grozdanovski K, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/182324; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Han E, 2015, DIAGN MICR INFEC DIS, V81, P153, DOI 10.1016/j.diagmicrobio.2014.10.009; Hill JT, 2014, J CLIN MICROBIOL, V52, P3805, DOI 10.1128/JCM.01537-14; Ho PL, 2005, J ANTIMICROB CHEMOTH, V55, P326, DOI 10.1093/jac/dki010; Idelevich EA, 2014, CLIN MICROBIOL INFEC, V20, P1001, DOI 10.1111/1469-0691.12640; Idelevich EA, 2014, J CLIN MICROBIOL, V52, P4058, DOI 10.1128/JCM.02400-14; Ko WC, 2000, J INFECTION, V40, P267, DOI 10.1053/jinf.2000.0654; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Ledeboer NA, 2015, J CLIN MICROBIOL, V53, P2460, DOI 10.1128/JCM.00581-15; Lee CC, 2012, AM J EMERG MED, V30, P1447, DOI 10.1016/j.ajem.2011.11.010; Mancini N, 2014, J CLIN MICROBIOL, V52, P1242, DOI 10.1128/JCM.00142-14; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mestas J, 2014, J CLIN MICROBIOL, V52, P283, DOI 10.1128/JCM.02322-13; Mukhopadhyay S, 2012, FEMS MICROBIOL REV, V36, P463, DOI 10.1111/j.1574-6976.2011.00302.x; Peterson LR, 2010, J CLIN MICROBIOL, V48, P1661, DOI 10.1128/JCM.00003-10; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Protonotariou E, 2010, J HOSP INFECT, V75, P225, DOI 10.1016/j.jhin.2009.12.007; Samuel LP, 2013, J CLIN MICROBIOL, V51, P1188, DOI 10.1128/JCM.02982-12; Seki M, 2013, J MED MICROBIOL, V62, P801, DOI 10.1099/jmm.0.051334-0; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Shu JC, 2015, MICROB DRUG RESIST, V21, P149, DOI 10.1089/mdr.2014.0116; Alves MS, 2006, J CLIN MICROBIOL, V44, P3640, DOI 10.1128/JCM.00940-06; Sontakke S, 2009, J MICROBIOL METH, V76, P217, DOI 10.1016/j.mimet.2008.11.002; Sullivan KV, 2014, J CLIN MICROBIOL, V52, P2416, DOI 10.1128/JCM.00737-14; Tan TY, 2008, J CLIN PATHOL, V61, P343, DOI 10.1136/jcp.2007.050757; To KKW, 2013, INT J INFECT DIS, V17, pE120, DOI 10.1016/j.ijid.2012.09.008; Tojo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094064; Verroken A, 2015, EUR J CLIN MICROBIOL, V34, P405, DOI 10.1007/s10096-014-2242-4; Wang CY, 2009, J MICROBIOL IMMUNOL, V42, P510; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wojewoda CM, 2013, J CLIN MICROBIOL, V51, P2072, DOI 10.1128/JCM.00831-13; Woo PCY, 2011, J CLIN MICROBIOL, V49, P1799, DOI 10.1128/JCM.02350-10; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yam WC, 2013, J CLIN MICROBIOL, V51, P2869, DOI 10.1128/JCM.00488-13; Yang JX, 2015, INFECT GENET EVOL, V33, P253, DOI 10.1016/j.meegid.2015.05.012; You JHS, 2010, J HOSP INFECT, V75, P81, DOI 10.1016/j.jhin.2009.12.002	53	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139728	10.1371/journal.pone.0139728	http://dx.doi.org/10.1371/journal.pone.0139728			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431434	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700106
J	Wang, RC; Huang, CY; Pan, TL; Chen, WY; Ho, CT; Liu, TZ; Chang, YJ				Wang, Ruo-Chiau; Huang, Chien-Yu; Pan, Tai-Long; Chen, Wei-Yu; Ho, Chun-Te; Liu, Tsan-Zon; Chang, Yu-Jia			Proteomic Characterization of Annexin 1 (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; CANCER-CELLS; EXPRESSION; PHOSPHORYLATION; DIFFERENTIATION; MODULATION	To search for reliable biomarkers and drug targets for management of hepatocellular carcinoma (HCC), we performed a global proteomic analysis of a pair of HCC cell lines with distinct differentiation statuses using 2-DE coupled with MALDI-TOF MS. In total, 106 and 55 proteins were successfully identified from the total cell lysate and the cytosolic, nuclear and membrane fractions in well-differentiated (HepG2) and poorly differentiated (SK-Hep-1) HCC clonal variants, respectively. Among these proteins, nine spots corresponding to proteins differentially expressed between HCC cell types were selected and confirmed by immunofluorescence staining and western blotting. Notably, Annexin 1 (ANX1), ANX-2, vimentin and stress-associated proteins, such as GRP78, HSP75, HSC-70, protein disulfide isomerase (PDI), and heat shock protein-27 (HSP27), were exclusively up-regulated in SK-Hep-1 cells. Elevated levels of ANX-4 and antioxidant/metabolic enzymes, such as MnSOD, peroxiredoxin, NADP-dependent isocitrate dehydrogenase, a-enolase and UDP-glucose dehydrogenase, were observed in HepG2 cells. We functionally demonstrated that ANX1 and HSP27 were abundantly overexpressed only in highly invasive types of HCC cells, such as Mahlavu and SK-Hep-1. Knockdown of ANX1 or HSP27 in HCC cells resulted in a severe reduction in cell migration. The in-vitro observations of ANX1 and HSP27 expressions in HCC sample was demonstrated by immunohistochemical stains performed on HCC tissue microarrays. Poorly differentiated HCC tended to have stronger ANX1 and HSP27 expressions than well-differentiated or moderately differentiated HCC. Collectively, our findings suggest that ANX1 and HSP27 are two novel biomarkers for predicting invasive HCC phenotypes and could serve as potential treatment targets.	[Wang, Ruo-Chiau] Chang Gung Mem Hosp, Tissue Bank, Chiayi, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, Taipei, Taiwan; [Pan, Tai-Long] Chang Gung Univ, Sch Tradit Chinese Med, Taoyuan, Taiwan; [Pan, Tai-Long] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Pan, Tai-Long] Chang Gung Mem Hosp, Liver Res Ctr, Taoyuan, Taiwan; [Chen, Wei-Yu; Chang, Yu-Jia] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Wei-Yu] Taipei Med Univ, Sch Med, Dept Pathol, Coll Med, Taipei, Taiwan; [Chen, Wei-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Ho, Chun-Te] Taipei Med Univ, Grad Inst Med Sci, Taipei, Taiwan; [Liu, Tsan-Zon; Chang, Yu-Jia] Taipei Med Univ Hosp, Ctr Canc, Translat Res Lab, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Chang, YJ (corresponding author), Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan.	r5424012@tmu.edu.tw						BENNDORF R, 1994, J BIOL CHEM, V269, P20780; CHANG C, 1983, MOL CELL BIOL, V3, P1133, DOI 10.1128/MCB.3.6.1133; CORLU A, 1991, J CELL BIOL, V115, P505, DOI 10.1083/jcb.115.2.505; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Han EKH, 2000, BRIT J CANCER, V83, P83; HSU ML, 1995, CANCER LETT, V94, P41, DOI 10.1016/0304-3835(95)03820-M; Hu TH, 2003, CANCER-AM CANCER SOC, V98, P1444, DOI 10.1002/cncr.11653; Huang MT, 2010, ANN SURG ONCOL, V17, P3379, DOI 10.1245/s10434-010-1163-4; Huang Y.X., 2012, J PATHOGEN BIOL, V7, P5, DOI DOI 10.1371/J0URNAL.P0NE.0037188; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAIGHN ME, 1971, P NATL ACAD SCI USA, V68, P2396, DOI 10.1073/pnas.68.10.2396; King KL, 2000, CANCER, V88, P2464, DOI 10.1002/1097-0142(20000601)88:11<2464::AID-CNCR6>3.0.CO;2-W; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kumar B, 2008, CANCER RES, V68, P1777, DOI 10.1158/0008-5472.CAN-07-5259; Lafaro KJ, 2015, SURG ONCOL CLIN N AM, V24, P1, DOI 10.1016/j.soc.2014.09.001; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Lin KH, 1995, CANCER LETT, V98, P89, DOI 10.1016/0304-3835(95)90208-2; Liu TZ, 2000, CANCER LETT, V151, P49, DOI 10.1016/S0304-3835(99)00404-8; LIU TZ, 1994, CANCER LETT, V87, P193, DOI 10.1016/0304-3835(94)90222-4; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Phizicky E, 2003, NATURE, V422, P208, DOI 10.1038/nature01512; Piotrowicz RS, 1998, FASEB J, V12, P1481, DOI 10.1096/fasebj.12.14.1481; Preville X, 1999, EXP CELL RES, V247, P61, DOI 10.1006/excr.1998.4347; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solanas G, 2008, J CELL SCI, V121, P2224, DOI 10.1242/jcs.021667; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; XANTHOPOULOS KG, 1993, EUR J BIOCHEM, V216, P353, DOI 10.1111/j.1432-1033.1993.tb18152.x; Yang MH, 2009, HEPATOLOGY, V50, P1464, DOI 10.1002/hep.23221; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	37	35	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139232	10.1371/journal.pone.0139232	http://dx.doi.org/10.1371/journal.pone.0139232			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431426	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700036
J	Zhou, N; Xing, G; Zhou, JW; Jin, YL; Liang, CQ; Gu, JY; Hu, BL; Liao, M; Wang, Q; Zhou, JY				Zhou, Niu; Xing, Gang; Zhou, Jianwei; Jin, Yulan; Liang, Cuiqin; Gu, Jinyan; Hu, Boli; Liao, Min; Wang, Qin; Zhou, Jiyong			In Vitro Coinfection and Replication of Classical Swine Fever Virus and Porcine Circovirus Type 2 in PK15 Cells	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; MULTISYSTEMIC WASTING SYNDROME; AVIAN LEUKOSIS VIRUS; ROUS SARCOMA VIRUS; SUPERINFECTION EXCLUSION; ALVEOLAR MACROPHAGES; GLYCOPROTEIN E2; EXPERIMENTAL-INFECTION; ENVELOPE GLYCOPROTEIN; NUCLEAR-LOCALIZATION	Increasing clinical lines of evidence have shown the coinfection/superinfection of porcine circovirus type 2 (PCV2) and classical swine fever virus (CSFV). Here, we investigated whether PCV2 and CSFV could infect the same cell productively by constructing an in vitro coinfection model. Our results indicated that PCV2-free PK15 cells but not ST cells were more sensitive to PCV2, and the PK15 cell line could stably harbor replicating CSFV (PK15-CSFV cells) with a high infection rate. Confocal and super-resolution microscopic analysis showed that PCV2 and CSFV colocalized in the same PK15-CSFV cell, and the CSFV E2 protein translocated from the cytoplasm to the nucleus in PK15-CSFV cells infected with PCV2. Moreover, PCV2-CSFV dual-positive cells increased gradually in PK15-CSFV cells in a PCV2 dose-dependent manner. In PK15-CSFV cells, PCV2 replicated well, and the production of PCV2 progeny was not influenced by CSFV infection. However, CSFV reproduction decreased in a PCV2 dose-dependent manner. In addition, cellular apoptosis was not strengthened in PK15-CSFV cells infected with PCV2 in comparison with PCV2-infected PK15 cells. Moreover, using this coinfection model we further demonstrated PCV2-induced apoptosis might contribute to the impairment of CSFV HCLV strain replication in coinfected cells. Taken together, our results demonstrate for the first time the coinfection/superinfection of PCV2 and CSFV within the same cell, providing an in vitro model to facilitate further investigation of the underlying mechanism of CSFV and PCV2 coinfection.	[Zhou, Niu; Zhou, Jianwei; Jin, Yulan; Liang, Cuiqin; Liao, Min; Zhou, Jiyong] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China; [Xing, Gang; Gu, Jinyan; Hu, Boli; Zhou, Jiyong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Wang, Qin] China Inst Vet Drug & Control, Beijing, Peoples R China; [Zhou, Jiyong] Zhejiang Univ, Affiliated Hosp 1, State Key Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Zhou, Jiyong] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Nanjing Agricultural University; China Institute of Veterinary Drug Control; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China.	jyzhou@zju.edu.cn	Zhou, Niu/GVT-7390-2022		National Natural Science Foundation of China [31230072]; National Key Technology R & D Program of China [2015BAD12B01]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology R & D Program of China(National Key Technology R&D Program); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by grants from the National Natural Science Foundation of China (Project No. 31230072, http://www.nsfc.gov.cn/), the National Key Technology R & D Program of China (Grant No. 2015BAD12B01, http://www.most.gov.cn/) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (http://jsycw.ec.js.edu.cn/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan GM, 2000, J VET MED B, V47, P81, DOI 10.1046/j.1439-0450.2000.00364.x; Allan GM, 1999, J COMP PATHOL, V121, P1, DOI 10.1053/jcpa.1998.0295; Allan GM, 2000, ARCH VIROL, V145, P2421, DOI 10.1007/s007050070031; Andersson M, 2011, VET IMMUNOL IMMUNOP, V142, P72, DOI 10.1016/j.vetimm.2011.04.012; [Anonymous], 1966, VIROLOGY, V29, P642; [Anonymous], 1966, VIROLOGY, V29, P628; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; BRATT MA, 1968, VIROLOGY, V35, P395, DOI 10.1016/0042-6822(68)90218-3; Cao JJ, 2015, J VIROL, V89, P2777, DOI 10.1128/JVI.03117-14; Cecere TE, 2012, VET MICROBIOL, V160, P233, DOI 10.1016/j.vetmic.2012.04.040; Chang HW, 2005, VET MICROBIOL, V108, P167, DOI 10.1016/j.vetmic.2005.03.010; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Cocquerel L, 1998, J VIROL, V72, P2183, DOI 10.1128/JVI.72.3.2183-2191.1998; DELWART EL, 1989, J VIROL, V63, P273, DOI 10.1128/JVI.63.1.273-280.1989; DUTTA SK, 1986, AM J VET RES, V47, P747; Fenaux M, 2002, J VIROL, V76, P541, DOI 10.1128/JVI.76.2.541-551.2002; Finsterbusch T, 2005, VIROLOGY, V343, P36, DOI 10.1016/j.virol.2005.08.021; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gladue DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085324; Hamel AL, 1998, J VIROL, V72, P5262, DOI 10.1128/JVI.72.6.5262-5267.1998; He JL, 2013, J VIROL, V87, P1420, DOI 10.1128/JVI.01443-12; Hsu WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088863; Huang SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033764; Huang YL, 2014, RES VET SCI, V96, P187, DOI 10.1016/j.rvsc.2013.11.020; Huang YL, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-115; Jarosinski KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037428; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; Kim J, 2003, J COMP PATHOL, V128, P52, DOI 10.1053/jcpa.2002.0605; Kohl W, 2004, J GEN VIROL, V85, P1101, DOI 10.1099/vir.0.19740-0; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Lin M, 2000, J VIROL, V74, P11619, DOI 10.1128/JVI.74.24.11619-11625.2000; Liu J, 2005, J VIROL, V79, P8262, DOI 10.1128/JVI.79.13.8262-8274.2005; Liu J, 2006, J VIROL, V80, P5065, DOI 10.1128/JVI.80.10.5065-5073.2006; Liu QG, 2001, VIROLOGY, V285, P91, DOI 10.1006/viro.2001.0922; Lohse L, 2012, VET MICROBIOL, V159, P327, DOI 10.1016/j.vetmic.2012.04.026; Meurens F, 2004, J VIROL, V78, P3872, DOI 10.1128/JVI.78.8.3872-3879.2004; Misinzo G, 2006, J VIROL, V80, P3487, DOI 10.1128/JVI.80.7.3487-3494.2006; Misinzo G, 2005, J GEN VIROL, V86, P2057, DOI 10.1099/vir.0.80652-0; Opriessnig T, 2013, VACCINE, V31, P487, DOI 10.1016/j.vaccine.2012.11.030; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rovira A, 2002, J VIROL, V76, P3232, DOI 10.1128/JVI.76.7.3232-3239.2002; Ruggli N, 2005, VIROLOGY, V340, P265, DOI 10.1016/j.virol.2005.06.033; Shang SB, 2009, MOL IMMUNOL, V46, P327, DOI 10.1016/j.molimm.2008.10.028; Shen HG, 2010, VACCINE, V28, P5960, DOI 10.1016/j.vaccine.2010.07.002; Shi LX, 2009, VIRUS GENES, V39, P46, DOI 10.1007/s11262-008-0313-2; SIMON KO, 1990, VIROLOGY, V177, P375, DOI 10.1016/0042-6822(90)90494-C; Sloutskin A, 2014, J VIROL, V88, P5079, DOI 10.1128/JVI.00252-14; Tang QH, 2011, VIRUS GENES, V42, P355, DOI 10.1007/s11262-011-0582-z; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wei YW, 2006, BIOCHEM BIOPH RES CO, V350, P277, DOI 10.1016/j.bbrc.2006.09.040; Weingartl HM, 2002, J VIROL METHODS, V104, P203, DOI 10.1016/S0166-0934(02)00085-X; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06; Xu XG, 2008, VACCINE, V26, P5455, DOI 10.1016/j.vaccine.2008.07.090; Yu S, 2007, VET IMMUNOL IMMUNOP, V115, P261, DOI 10.1016/j.vetimm.2006.11.006; Yu XF, 2014, J VIROL, V88, P3423, DOI 10.1128/JVI.02059-13; Zhao K, 2014, EMERG INFECT DIS, V20, P1208, DOI 10.3201/eid2007.131118; Zhou JY, 2006, VET RES COMMUN, V30, P205, DOI 10.1007/s11259-006-3203-x; Zhou JY, 2005, J BIOTECHNOL, V118, P201, DOI 10.1016/j.jbiotec.2005.02.017	60	11	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139457	10.1371/journal.pone.0139457	http://dx.doi.org/10.1371/journal.pone.0139457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431319	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700063
J	Elek, Z; Nemeth, N; Nagy, G; Nemeth, H; Somogyi, A; Hosszufalusi, N; Sasvari-Szekely, M; Ronai, Z				Elek, Zsuzsanna; Nemeth, Nora; Nagy, Geza; Nemeth, Helga; Somogyi, Aniko; Hosszufalusi, Nora; Sasvari-Szekely, Maria; Ronai, Zsolt			Micro-RNA Binding Site Polymorphisms in the WFS1 Gene Are Risk Factors of Diabetes Mellitus	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; OPTIC ATROPHY; WOLFRAMIN; PROTEIN; ASSOCIATION; CONTRIBUTE; DATABASE	The absolute or relative lack of insulin is the key factor in the pathogenesis of diabetes mellitus. Although the connection between loss of function mutations of the WFS1 gene and DID-MOAD-syndrome including diabetes mellitus underpins the significance of wolframin in the pathogenesis, exact role of WFS1 polymorphic variants in the development of type 1 and type 2 diabetes has not been discovered yet. In this analysis, 787 patients with diabetes and 900 healthy people participated. Genotyping of the 7 WFS1 SNPs was carried out by TaqMan assays. Association study was performed by chi(2)-test in combination with correction for multiple testing. For functional analysis, the entire 3' UTR of the WFS1 gene was subcloned in a pMIR-Report plasmid and relative luciferase activities were determined. Linkage disequilibrium analysis showed a generally high LD within the investigated region, however the rs1046322 locus was not in LD with the other SNPs. The two miR-SNPs, rs1046322 and rs9457 showed significant association with T1DM and T2DM, respectively. Haplotype analysis also confirmed the association between the 3' UTR loci and both disease types. In vitro experiments showed that miR-185 reduces the amount of the resulting protein, and rs9457 miRSNP significantly influences the rate of reduction in a luciferase reporter assay. Genetic variants of the WFS1 gene might contribute to the genetic risk of T1DM and T2DM. Furthermore demonstrating the effect of rs9457 in binding of miR-185, we suggest that the optimal level of wolframin protein, potentially influenced by miR-regulation, is crucial in normal beta cell function.	[Elek, Zsuzsanna; Nemeth, Nora; Nemeth, Helga; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Nagy, Geza; Somogyi, Aniko] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Hosszufalusi, Nora] Semmelweis Univ, Dept Internal Med 3, Res Lab, H-1085 Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University	Ronai, Z (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	ronai.zsolt@med.semmelweis-univ.hu		Hosszufalusi, Nora/0000-0002-9469-372X; Somogyi, Aniko/0000-0003-0807-260X	Hungarian Scientific Research Fund "OTKA - Orszagos Tudomanyos Kutatasi Alapprogramok" [K83766]	Hungarian Scientific Research Fund "OTKA - Orszagos Tudomanyos Kutatasi Alapprogramok"(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund "OTKA - Orszagos Tudomanyos Kutatasi Alapprogramok", Grant Number: K83766. This grant only covered the costs of the research (lab costs etc.) and provided no personal costs for any author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bao LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116067; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Chen HY, 2014, J ENDOCRINOL, V222, pR1, DOI 10.1530/JOE-13-0544; Chen YH, 2013, DIABETES, V62, P2278, DOI 10.2337/db12-0963; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Dehwah MAS, 2012, J GENET GENOMICS, V39, P11, DOI 10.1016/j.jgg.2011.11.007; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Fawcett KA, 2010, DIABETES, V59, P741, DOI 10.2337/db09-0920; Fonseca SG, 2005, J BIOL CHEM, V280, P39609, DOI 10.1074/jbc.M507426200; Ganie MA, 2009, J PEDIATR ENDOCR MET, V22, P3; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Hofmann S, 2003, HUM MOL GENET, V12, P2003, DOI 10.1093/hmg/ddg214; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Kovacs-Nagy R, 2013, AM J MED GENET B, V162B, P404, DOI 10.1002/ajmg.b.32157; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083471; Meerson A, 2013, DIABETOLOGIA, V56, P1971, DOI 10.1007/s00125-013-2950-9; Muniz-Fernandez F, 2011, BIOINFORMATICS, V27, P1871, DOI 10.1093/bioinformatics/btr301; Osman AA, 2003, J BIOL CHEM, V278, P52755, DOI 10.1074/jbc.M310331200; Pullen TJ, 2011, MOL CELL BIOL, V31, P3182, DOI 10.1128/MCB.01433-10; Ramachandran D, 2011, FEBS J, V278, P1167, DOI 10.1111/j.1742-4658.2011.08042.x; Roggli E, 2012, DIABETES, V61, P1742, DOI 10.2337/db11-1086; Salas-Perez F, 2013, IMMUNOBIOLOGY, V218, P733, DOI 10.1016/j.imbio.2012.08.276; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Wilkin TJ, 2008, PEDIATR DIABETES, V9, P23, DOI 10.1111/j.1399-5448.2007.00343.x; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhao XM, 2012, J BIOL CHEM, V287, P31155, DOI 10.1074/jbc.M112.362632	30	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139519	10.1371/journal.pone.0139519	http://dx.doi.org/10.1371/journal.pone.0139519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426397	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100073
J	Liu, XF; Bai, CL; Ding, XB; Wei, ZY; Guo, H; Li, GP				Liu, Xinfeng; Bai, Chunling; Ding, Xiangbin; Wei, Zhuying; Guo, Hong; Li, Guangpeng			Microarray Analysis of the Gene Expression Profile and Lipid Metabolism in Fat-1 Transgenic Cattle	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; STEAROYL-COA DESATURASE; MICE; OMEGA-3-FATTY-ACIDS; DISEASE; MODEL; ASSOCIATION; CHILDREN; SYNTHASE; MARKERS	Long-chain n-3 polyunsaturated fatty acids (n-3 PUFAs) are beneficial for human health. However, humans and mammals are unable to synthesize n-3 PUFAs because they lack the n-3 desaturase gene fat-1 and must therefore obtain this type of fatty acid through their diet. Through the production of fat-1 transgenic animals, it is possible to obtain animal products that are rich in n-3 PUFAs, such as meat and milk. The aim of this study was to analyze the gene expression profile and the mechanism of lipid metabolism in fat-1 transgenic cattle and to accumulate important basic data that are required to obtain more efficient fat-1 transgenic cattle. Transcriptome profiling of fat-1 transgenic and wild-type cattle identified differentially expressed genes that are involved in 90 biological pathways, eight pathways of which were related to lipid metabolism processes 36 genes of which were related to lipid metabolism. This analysis also identified 11 significantly enriched genes that were involved in the peroxisome proliferator-activated receptor signaling pathway. These findings were verified by quantitative polymerase chain reaction. The information obtained in this study indicated that the introduction of an exogenous fat-1 gene into cattle affects the gene expression profile and the process of lipid metabolism in these animals. These results may provide important insights into how an exogenous fat-1 gene synthesizes n-3 PUFAs in transgenic cattle and other mammals.	[Liu, Xinfeng; Bai, Chunling; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Hohhot, Peoples R China; [Liu, Xinfeng; Ding, Xiangbin; Guo, Hong] Tianjin Agr Univ, Coll Anim Sci & Anim Med, Tianjin, Peoples R China	Inner Mongolia University; Tianjin Agricultural University	Guo, H (corresponding author), Tianjin Agr Univ, Coll Anim Sci & Anim Med, Tianjin, Peoples R China.	guohong64@163.com; gpengli@imu.edu.cn			National Basic Research Program [2012CB22306]; National Transgenic Animal Program of China [2013ZX08007-002]	National Basic Research Program(National Basic Research Program of China); National Transgenic Animal Program of China	This study was funded by the National Basic Research Program (Grant No. 2012CB22306) and National Transgenic Animal Program (Grant No. 2013ZX08007-002) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-6; de Gaudry DK, 2014, UROLOGE, V53, P1620, DOI 10.1007/s00120-014-3612-3; Guo T, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-244; Hathaway CK, 2015, P NATL ACAD SCI USA, V112, P5141, DOI 10.1073/pnas.1504557112; Hiller B, 2012, BRIT J NUTR, V108, P858, DOI 10.1017/S0007114511006179; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kang ZB, 2001, P NATL ACAD SCI USA, V98, P4050, DOI 10.1073/pnas.061040198; Kim EH, 2012, BIOCHEM PHARMACOL, V84, P1359, DOI 10.1016/j.bcp.2012.08.029; KINOSIAN B, 1994, ANN INTERN MED, V121, P641, DOI 10.7326/0003-4819-121-9-199411010-00002; KINSELLA JE, 1990, AM J CLIN NUTR, V52, P1; Kris-Etherton PM, 2004, NUTR REV, V62, P414, DOI 10.1111/j.1753-4887.2004.tb00013.x; Lai LX, 2006, NAT BIOTECHNOL, V24, P435, DOI 10.1038/nbt1198; Lau BYY, 2009, EXP BIOL MED, V234, P632, DOI 10.3181/0808-RM-247; Lebbadi M, 2011, J ALZHEIMERS DIS, V27, P853, DOI 10.3233/JAD-2011-111010; Lee AL, 2013, ANN NUTR METAB, V63, P88, DOI 10.1159/000353120; Lengi AJ, 2007, LIPIDS, V42, P499, DOI 10.1007/s11745-007-3056-2; MacLennan MB, 2013, J NUTR BIOCHEM, V24, P388, DOI 10.1016/j.jnutbio.2012.08.002; Matsa LS, 2014, GENE, V548, P256, DOI 10.1016/j.gene.2014.07.043; Meng NN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062723; Morais S, 2007, PHYSIOL GENOMICS, V28, P239, DOI 10.1152/physiolgenomics.00136.2006; Nagahuedi S, 2009, J EXP BIOL, V212, P1106, DOI 10.1242/jeb.027888; Notarnicola M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-10; Ntambi JM, 1999, J LIPID RES, V40, P1549; Nuruddin S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103607; Ray S, 2015, INDIAN J MED RES, V141, P62; Romanatto T, 2014, BBA-MOL BASIS DIS, V1842, P186, DOI 10.1016/j.bbadis.2013.10.017; Roy R, 2005, CYTOGENET GENOME RES, V111, P65, DOI 10.1159/000085672; Rudkowska I, 2010, MOL NUTR FOOD RES, V54, P543, DOI 10.1002/mnfr.200900085; Tani S, 2015, HEART VESSELS, V30, P9, DOI 10.1007/s00380-013-0442-y; Tarnok A, 2015, J PEDIATR GASTR NUTR, V60, P255, DOI 10.1097/MPG.0000000000000561; Toptas B, 2011, IN VIVO, V25, P425; Vluggens A, 2010, LAB INVEST, V90, P696, DOI 10.1038/labinvest.2010.46; Wang SN, 2014, EXP CELL RES, V323, P56, DOI 10.1016/j.yexcr.2014.02.015; Wu XJ, 2012, TRANSGENIC RES, V21, P1359, DOI 10.1007/s11248-012-9612-4; Yu KF, 2013, INT J BIOL SCI, V9, P108, DOI 10.7150/ijbs.5306; Zhu GM, 2008, TRANSGENIC RES, V17, P717, DOI 10.1007/s11248-008-9171-x	38	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138874	10.1371/journal.pone.0138874	http://dx.doi.org/10.1371/journal.pone.0138874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426396	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100025
J	Zhang, NX; Yu, G; Li, TJ; He, QY; Zhou, Y; Si, FL; Ren, S; Chen, B				Zhang, Nai-Xin; Yu, Guo; Li, Ting-Jing; He, Qi-Yi; Zhou, Yong; Si, Feng-Ling; Ren, Shuang; Chen, Bin			The Complete Mitochondrial Genome of Delia antiqua and Its Implications in Dipteran Phylogenetics	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; STOMOXYS-CALCITRANS; HAEMATOBIA-IRRITANS; NUCLEOTIDE-SEQUENCE; BLOWFLIES DIPTERA; CONTROL REGION; FRUIT-FLY; EVOLUTION; CALYPTRATAE; GENE	Delia antiqua is a major underground agricultural pest widely distributed in Asia, Europe and North America. In this study, we sequenced and annotated the complete mitochondrial genome of this species, which is the first report of complete mitochondrial genome in the family Anthomyiidae. This genome is a double-stranded circular molecule with a length of 16,141 bp and an A+T content of 78.5%. It contains 37 genes (13 protein-coding genes, 22 tRNAs and 2 rRNAs) and a non-coding A+T rich region or control region. The mitochondrial genome of Delia antiqua presents a clear bias in nucleotide composition with a positive AT-skew and a negative GC-skew. All of the 13 protein-coding genes use ATN as an initiation codon except for the COI gene that starts with ATCA. Most protein-coding genes have complete termination codons but COII and ND5 that have the incomplete termination codon T. This bias is reflected in both codon usage and amino acid composition. The protein-coding genes in the D. antiqua mitochondrial genome prefer to use the codon UUA (Leu). All of the tRNAs have the typical clover-leaf structure, except for tRNASer(AGN) that does not contain the dihydrouridine (DHU) arm like in many other insects. There are 7 mismatches with U-U in the tRNAs. The location and structure of the two rRNAs are conservative and stable when compared with other insects. The control region between 12S rRNA and tRNA(Ile) has the highest A+T content of 93.7% in the D. antiqua mitochondrial genome. The control region includes three kinds of special regions, two highly conserved poly-T stretches, a (TA)(n) stretch and several G(A)(n)T structures considered important elements related to replication and transcription. The nucleotide sequences of 13 protein-coding genes are used to construct the phylogenetics of 26 representative Dipteran species. Both maximum likelihood and Bayesian inference analyses suggest a closer relationship of D. antiqua in Anthomyiidae with Calliphoridae, Calliphoridae is a paraphyly, and both Oestroidea and Muscoidea are polyphyletic.	[Zhang, Nai-Xin; Yu, Guo; Li, Ting-Jing; He, Qi-Yi; Zhou, Yong; Si, Feng-Ling; Ren, Shuang; Chen, Bin] Chongqing Normal Univ, Coll Life Sci, Inst Entomol & Mol Biol, Chongqing 401331, Peoples R China	Chongqing Normal University	Chen, B (corresponding author), Chongqing Normal Univ, Coll Life Sci, Inst Entomol & Mol Biol, Chongqing 401331, Peoples R China.	bin.chen@cqnu.edu.cn			Par-Eu Scholars Program; National Natural Science Foundation of China [31372265]; Coordinated Research Project of the International Atomic Energy Agency [18268/R0]; Science and Technology Projects Affiliated to the Education Department of Chongqing Municipality [KJ1400527, KJ1400517]	Par-Eu Scholars Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Coordinated Research Project of the International Atomic Energy Agency; Science and Technology Projects Affiliated to the Education Department of Chongqing Municipality	This work was supported by Par-Eu Scholars Program, and grants from The National Natural Science Foundation of China (31372265), and Coordinated Research Project of the International Atomic Energy Agency (18268/R0), and Science and Technology Projects Affiliated to the Education Department of Chongqing Municipality (KJ1400527 and KJ1400517).	Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Blanchette M, 1999, J MOL EVOL, V49, P193, DOI 10.1007/PL00006542; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Cameron SL, 2014, ANNU REV ENTOMOL, V59, P95, DOI 10.1146/annurev-ento-011613-162007; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-15; Castresana J, 1998, P NATL ACAD SCI USA, V95, P3703, DOI 10.1073/pnas.95.7.3703; Chen B, 2005, GENE, V347, P115, DOI 10.1016/j.gene.2004.12.026; Chen B, 2010, J CHONGQING NORMAL U, V27, p9 ; De Oliveira MT, 2005, DNA SEQUENCE, V16, P156, DOI 10.1080/10425170500039901; Duarte GT, 2008, J MED ENTOMOL, V45, P667, DOI 10.1603/0022-2585(2008)45[667:TMCROB]2.0.CO;2; Fang Shou-Min, 2010, Kunchong Zhishi, V47, P439; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kutty SN, 2008, MOL PHYLOGENET EVOL, V49, P639, DOI 10.1016/j.ympev.2008.08.012; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Macey JR, 2000, SYST BIOL, V49, P257, DOI 10.1093/sysbio/49.2.257; Marinho MAT, 2012, MOL PHYLOGENET EVOL, V65, P840, DOI 10.1016/j.ympev.2012.08.007; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Telford MJ, 2000, P NATL ACAD SCI USA, V97, P11359, DOI 10.1073/pnas.97.21.11359; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wei Shu-Jun, 2011, Chinese Journal of Applied Entomology, V48, P1573; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhai ZH, 2007, CELL BIOL; Zhang DX, 1997, BIOCHEM SYST ECOL, V25, P99, DOI 10.1016/S0305-1978(96)00042-7; Zhang NaiXin, 2013, Acta Entomologica Sinica, V56, P398; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]; Zhou ZJ, 2009, MOL BIOL REP, V36, P7, DOI 10.1007/s11033-007-9145-8; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	14	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139736	10.1371/journal.pone.0139736	http://dx.doi.org/10.1371/journal.pone.0139736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427045	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100091
J	Hagedorn, M; Carter, VL				Hagedorn, Mary; Carter, Virginia L.			Seasonal Preservation Success of the Marine Dinoflagellate Coral Symbiont, Symbiodinium sp.	PLOS ONE			English	Article							THERMAL TOLERANCE; ALGAL SYMBIOSIS; COLD-HARDINESS; CLIMATE-CHANGE; CRYOPRESERVATION; REEF; SPECIFICITY; DIVERSITY; HOST; VITRIFICATION	Coral reefs are some of the most diverse and productive ecosystems on the planet, but are threatened by global and local stressors, mandating the need for incorporating ex situ conservation practices. One approach that is highly protective is the development of genome resource banks that preserve the species and its genetic diversity. A critical component of the reef are the endosymbiotic algae, Symbiodinium sp., living within most coral that transfer energy-rich sugars to their hosts. Although Symbiodinium are maintained alive in culture collections around the world, the cryopreservation of these algae to prevent loss and genetic drift is not well-defined. This study examined the quantum yield physiology and freezing protocols that resulted in survival of Symbiodinium at 24 h post-thawing. Only the ultra-rapid procedure called vitrification resulted in success whereas conventional slow freezing protocols did not. We determined that success also depended on using a thin film of agar with embedded Symbiodinium on Cryotops, a process that yielded a post-thaw viability of >50% in extracted and vitrified Symbiodinium from Fungia scutaria, Pocillopora damicornis and Porites compressa. Additionally, there also was a seasonal influence on vitrification success as the best post-thaw survival of F. scutaria occurred in winter and spring compared to summer and fall (P < 0.05). These findings lay the foundation for developing a viable genome resource bank for the world's Symbiodinium that, in turn, will not only protect this critical element of coral functionality but serve as a resource for understanding the complexities of symbiosis, support selective breeding experiments to develop more thermally resilient strains of coral, and provide a 'gold-standard' genomics collection, allowing for full genomic sequencing of unique Symbiodinium strains.	[Hagedorn, Mary; Carter, Virginia L.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA 22630 USA; [Hagedorn, Mary; Carter, Virginia L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Hawaii System	Hagedorn, M (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Dept Reprod Sci, Front Royal, VA 22630 USA.	hagedornm@si.edu			Smithsonian Institution; Hawaii Institute of Marine Biology; Roddenberry Foundation; Anela Kolohe Foundation; Skippy Frank Translational Medicine Fund; Compton Foundation; Hill Foundation	Smithsonian Institution(Smithsonian Institution); Hawaii Institute of Marine Biology; Roddenberry Foundation; Anela Kolohe Foundation; Skippy Frank Translational Medicine Fund; Compton Foundation; Hill Foundation	These experiments were sponsored by funding provided by the Smithsonian Institution (http://www.si.edu), the Hawaii Institute of Marine Biology (http://www.uhawaii.edu/HIMB), the Roddenberry Foundation (http://roddenberryfoundation.org/), the Anela Kolohe Foundation (http://www.guidestar.org/organizations/54-6794278/anela-kolohe-foundation.aspx), Skippy Frank Translational Medicine Fund (http://www.rockpa.org/page.aspx?pid=340), Compton Foundation (https://www.comptonfoundation.org/), and the Cedar Hill Foundation (no website available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Barshis DJ, 2010, MOL ECOL, V19, P1705, DOI 10.1111/j.1365-294X.2010.04574.x; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bower AD, 2006, CAN J FOREST RES, V36, P1842, DOI 10.1139/X06-067; Coffroth MA, 2005, PROTIST, V156, P19, DOI 10.1016/j.protis.2005.02.004; Comizzoli P, 2012, THERIOGENOLOGY, V78, P1666, DOI 10.1016/j.theriogenology.2012.04.008; Costanzo JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117234; D'Alessandro AG, 2003, ANIM REPROD SCI, V79, P93, DOI 10.1016/S0378-4320(03)00113-1; Day JG, 2005, ALGAL CULTURING TECH, P139; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; FAO, 569 FAO; Fay SA, 2012, J PHYCOL, V48, P1306, DOI 10.1111/j.1529-8817.2012.01220.x; Fuentes-Grunewald C, 2009, J IND MICROBIOL BIOT, V36, P1215, DOI 10.1007/s10295-009-0602-3; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Gomez-Cabrera MD, 2008, CORAL REEFS, V27, P219, DOI 10.1007/s00338-007-0315-x; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Guillard R.R.L., 2005, ALGAL CULTURING TECH, P117; Hagedorn M, 2010, CRYOBIOLOGY, V60, P147, DOI 10.1016/j.cryobiol.2009.10.005; Hagedorn M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117087; Hagedorn M, 2013, CRYOBIOLOGY, V66, P17, DOI 10.1016/j.cryobiol.2012.10.003; Hagedorn M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033354; Hoegh-Guldberg O, 2007, CORAL REEFS, V26, P731, DOI 10.1007/s00338-007-0320-0; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Kawachi M., 2005, ALGAL CULTURING TECH, P65; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Ladner JT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-217; LaJeunesse TC, 2004, CORAL REEFS, V23, P596, DOI 10.1007/s00338-004-0428-4; Ma RY, 2006, ENVIRON ENTOMOL, V35, P881, DOI 10.1603/0046-225X-35.4.881; MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4; Mooney BD, 2007, J PHYCOL, V43, P101, DOI 10.1111/j.1529-8817.2006.00312.x; Oliver TA, 2011, CORAL REEFS, V30, P241, DOI 10.1007/s00338-010-0696-0; Olofsson M, 2012, ENERGIES, V5, P1577, DOI 10.3390/en5051577; Pence VC., 1995, BIOTECHNOLOGY AGR FO, V32; Pochon X, 2010, MOL PHYLOGENET EVOL, V56, P492, DOI 10.1016/j.ympev.2010.03.040; RALL WF, 1985, NATURE, V313, P573, DOI 10.1038/313573a0; Rhodes L, 2006, CRYOBIOLOGY, V52, P152, DOI 10.1016/j.cryobiol.2005.10.003; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Santiago-Vazquez LZ, 2007, MAR BIOL, V152, P549, DOI 10.1007/s00227-007-0704-2; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Stat M, 2009, CORAL REEFS, V28, P709, DOI 10.1007/s00338-009-0509-5; Stat M, 2013, ECOL EVOL, V3, P1317, DOI 10.1002/ece3.556; TAGUCHI S, 1993, MAR ECOL PROG SER, V101, P45, DOI 10.3354/meps101045; Umapathy G, 2007, THERIOGENOLOGY, V67, P1371, DOI 10.1016/j.theriogenology.2007.01.019; Valojerdi MR, 2009, J ASSIST REPROD GEN, V26, P347, DOI 10.1007/s10815-009-9318-6; van Oppen MJH, 2015, P NATL ACAD SCI USA, V112, P2307, DOI 10.1073/pnas.1422301112; Wilkinson C, 2008, STATUS CORAL REEFS W; Yamashita H, 2012, CORAL REEFS, V16, P129, DOI DOI 10.1007/S00338-012-0980-2; Yuyama I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098999; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	54	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0136358	10.1371/journal.pone.0136358	http://dx.doi.org/10.1371/journal.pone.0136358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422237	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700004
J	Grimm, V; Radulovic, K; Riedel, CU				Grimm, Verena; Radulovic, Katarina; Riedel, Christian U.			Colonization of C57BL/6 Mice by a Potential Probiotic Bifidobacterium bifidum Strain under Germ-Free and Specific Pathogen-Free Conditions and during Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; HOST-MICROBE INTERACTIONS; GUT MICROBIOTA; INTESTINAL INFLAMMATION; IMMUNE-RESPONSE; DENDRITIC CELLS; CACO-2 CELLS; MOUSE MODELS; IN-VITRO; EXPRESSION	The effects of at least some probiotics are restricted to live, metabolically active bacteria at their site of action. Colonization of and persistence in the gastrointestinal tract is thus contributing to the beneficial effects of these strains. In the present study, colonization of an anti-inflammatory Bifidobacterium bifidum strain was studied in C57BL/6J mice under germ-free (GF) and specific pathogen-free (SPF) conditions as well as during dextran sulfate sodium (DSS)-induced colitis. B. bifidum S17/pMGC was unable to stably colonize C57BL/6J mice under SPF conditions. Mono-association of GF mice by three doses on consecutive days led to long-term, stable detection of up to 109 colony forming units (CFU) of B. bifidum S17/pMGC per g feces. This stable population was rapidly outcompeted upon transfer of mono-associated animals to SPF conditions. A B. animalis strain was isolated from the microbiota of these re-conventionalized mice. This B. animalis strain displayed significantly higher adhesion to murine CMT-93 intestinal epithelial cells (IECs) than to human Caco-2 IECs (p = 0.018). Conversely, B. bifidum S17/pMGC, i.e., a strain of human origin, adhered at significantly higher levels to human compared to murine IECs (p < 0.001). Disturbance of the gut ecology and induction of colitis by DSS-treatment did not promote colonization of the murine gastrointestinal tract (GIT) by B. bifidum S17/pMGC. Despite its poor colonization of the mouse GIT, B. bifidum S17/pMGC displayed a protective effect on DSS-induced colitis when administered as viable bacteria but not as UV-inactivated preparation. Collectively, these results suggest a selective disadvantage of B. bifidum S17/pMGC in the competition with the normal murine microbiota and an anti-inflammatory effect that requires live, metabolically active bacteria.	[Grimm, Verena; Radulovic, Katarina; Riedel, Christian U.] Univ Ulm, Inst Microbiol & Biotechnol, D-89068 Ulm, Germany	Ulm University	Riedel, CU (corresponding author), Univ Ulm, Inst Microbiol & Biotechnol, D-89068 Ulm, Germany.	christian.riedel@uni-ulm.de		Riedel, Christian U./0000-0001-7134-7085	German Academic Exchange Service/Federal Ministry of Education and Research [D/09/04778]; University of Ulm	German Academic Exchange Service/Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD)); University of Ulm	This study was partially funded by the German Academic Exchange Service/Federal Ministry of Education and Research (grant D/09/04778). The remainder of the study was financed by non-specific in-house funding of the University of Ulm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Bottacini F, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S4; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Duranti S, 2014, APPL ENVIRON MICROB, V80, P6080, DOI 10.1128/AEM.01993-14; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Gareau MG, 2010, NAT REV GASTRO HEPAT, V7, P503, DOI 10.1038/nrgastro.2010.117; Geier MS, 2007, INT J FOOD MICROBIOL, V114, P267, DOI 10.1016/j.ijfoodmicro.2006.09.018; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Gleinser M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-80; Grimm V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/960826; Grimm V, 2014, APPL ENVIRON MICROB, V80, P2842, DOI 10.1128/AEM.04261-13; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P4695, DOI 10.1128/AEM.00124-08; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Heuvelin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005184; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lahtinen Sampo J., 2012, Microbial Ecology in Health and Disease, V23, P10, DOI 10.3402/mehd.v23i0.18567; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Marcobal A, 2011, CELL HOST MICROBE, V10, P507, DOI 10.1016/j.chom.2011.10.007; Mariman R, 2015, J NUTR, V145, P1354, DOI 10.3945/jn.114.199729; Menard O, 2008, APPL ENVIRON MICROB, V74, P660, DOI 10.1128/AEM.01261-07; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; NORIN KE, 1991, APPL ENVIRON MICROB, V57, P1850, DOI 10.1128/AEM.57.6.1850-1852.1991; Pan XL, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.23; Philippe D, 2011, INT J FOOD MICROBIOL, V149, P45, DOI 10.1016/j.ijfoodmicro.2010.12.020; Preising J, 2010, APPL ENVIRON MICROB, V76, P3048, DOI 10.1128/AEM.03127-09; Prisciandaro L, 2009, INFLAMM BOWEL DIS, V15, P1906, DOI 10.1002/ibd.20938; Riedel CU, 2006, WORLD J GASTROENTERO, V12, P3729, DOI 10.3748/wjg.v12.i23.3729; Riedel CU, 2006, INT J FOOD MICROBIOL, V110, P62, DOI 10.1016/j.ijfoodmicro.2006.01.040; Riedel CU, 2014, ADV M C M, P1, DOI 10.1079/9781780640495.0001; Schwarz R, 2002, MAGNET RESON MED, V48, P255, DOI 10.1002/mrm.10207; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Singh N, 2013, FEMS MICROBIOL ECOL, V85, P369, DOI 10.1111/1574-6941.12124; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stewart D, 2002, SHOCK, V18, P342, DOI 10.1097/00024382-200210000-00009; Turroni F, 2014, APPL ENVIRON MICROB, V80, P730, DOI 10.1128/AEM.03313-13; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; Westermann C, 2012, SYMBIOSIS, V58, P191, DOI 10.1007/s13199-012-0205-z; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhurina D, 2011, J BACTERIOL, V193, P301, DOI 10.1128/JB.01180-10	58	34	34	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139935	10.1371/journal.pone.0139935	http://dx.doi.org/10.1371/journal.pone.0139935			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439388	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300080
J	Tada, R; Hidaka, A; Iwase, N; Takahashi, S; Yamakita, Y; Iwata, T; Muto, S; Sato, E; Takayama, N; Honjo, E; Kiyono, H; Kunisawa, J; Aramaki, Y				Tada, Rui; Hidaka, Akira; Iwase, Naoko; Takahashi, Saeko; Yamakita, Yuki; Iwata, Tomoko; Muto, Shoko; Sato, Emi; Takayama, Noriko; Honjo, Emi; Kiyono, Hiroshi; Kunisawa, Jun; Aramaki, Yukihiko			Intranasal Immunization with DOTAP Cationic Liposomes Combined with DC-Cholesterol Induces Potent Antigen-Specific Mucosal and Systemic Immune Responses in Mice	PLOS ONE			English	Article							LOADED BUBBLE LIPOSOMES; NEGATIVELY CHARGED LIPOSOMES; IFN-GAMMA PRODUCTION; INFECTIOUS-DISEASES; RAW264.7 CELLS; DRUG-DELIVERY; PARTICLE-SIZE; SILVER NANOPARTICLES; NASAL IMMUNIZATION; INVOLVEMENT	Despite the progress made by modern medicine, infectious diseases remain one of the most important threats to human health. Vaccination against pathogens is one of the primary methods used to prevent and treat infectious diseases that cause illness and death. Vaccines administered by the mucosal route are potentially a promising strategy to combat infectious diseases since mucosal surfaces are a major route of entry for most pathogens. However, this route of vaccination is not widely used in the clinic due to the lack of a safe and effective mucosal adjuvant. Therefore, the development of safe and effective mucosal adjuvants is key to preventing infectious diseases by enabling the use of mucosal vaccines in the clinic. In this study, we show that intranasal administration of a cationic liposome composed of 1,2-dioleoyl-3-trimethylammonium-propane (DOTAP) and 3 beta-[N-(N',N'-dimethylaminoethane)-carbamoyl] (DC-chol) (DOTAP/DC-chol liposome) has a potentmucosal adjuvant effect in mice. Intranasal vaccination with ovalbumin (OVA) in combination with DOTAP/DC-chol liposomes induced the production of OVA-specific IgA in nasal tissues and increased serum IgG1 levels, suggesting that the cationic DOTAP/DC-chol liposome leads to the induction of a Th2 immune response. Additionally, nasal-associated lymphoid tissue and splenocytes from mice treated with OVA plus DOTAP/DC-chol liposome showed high levels of IL-4 expression. DOTAP/ DC-chol liposomes also enhanced OVA uptake by CD11c(+) dendritic cells in nasal-associated lymphoid tissue. These data demonstrate that DOTAP/DC-chol liposomes elicit immune responses via an antigen-specific Th2 reaction. These results suggest that cationic liposomes merit further development as a mucosal adjuvant for vaccination against infectious diseases.	[Tada, Rui; Hidaka, Akira; Iwase, Naoko; Takahashi, Saeko; Yamakita, Yuki; Iwata, Tomoko; Muto, Shoko; Sato, Emi; Takayama, Noriko; Honjo, Emi; Aramaki, Yukihiko] Tokyo Univ Pharm & Life Sci, Dept Drug Delivery & Mol Biopharmaceut, Sch Pharm, Tokyo, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan; [Kiyono, Hiroshi; Kunisawa, Jun] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Dept Microbiol & Immunol, Inst Med Sci, Tokyo, Japan; [Kunisawa, Jun] Natl Inst Biomed Innovat, Lab Vaccine Mat, Osaka, Japan	Tokyo University of Pharmacy & Life Sciences; University of Tokyo; University of Tokyo; National Institute of Health Sciences - Japan	Tada, R (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Drug Delivery & Mol Biopharmaceut, Sch Pharm, Tokyo, Japan.	rui.tada@gmail.com; aramaki@toyaku.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Tada, Rui/M-3278-2019	Tada, Rui/0000-0003-0098-9587	JSPS KAKENHI Grant [24890255, 19590081]; Editage Inspired Researcher Grant; Ministry of Health and Welfare of Japan; Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST);  [22590073]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Editage Inspired Researcher Grant; Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); 	This study was supported in part by JSPS KAKENHI Grant Number 24890255 (Grant-in-Aid for Research Activity Start-up to R.T.) and Editage Inspired Researcher Grant (R.T.) and JSPS KAKENHI Grant Number 19590081 (Grant-in-Aid for Scientific Research C to Y.A.) and 22590073 (Grant-in-Aid for Scientific Research C to Y.A.). This work was also supported by grants from the Ministry of Health and Welfare of Japan (J.K. and H.K.); from Japan Science and Technology Agency, Core Research for Evolutional Science and Technology (CREST; to H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; ALVING CR, 1991, J IMMUNOL METHODS, V140, P1, DOI 10.1016/0022-1759(91)90120-5; Arisaka M, 2011, ARCH BIOCHEM BIOPHYS, V508, P72, DOI 10.1016/j.abb.2011.02.003; Arisaka M, 2010, FEBS LETT, V584, P1016, DOI 10.1016/j.febslet.2010.01.055; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Borges O, 2010, PHARM RES-DORDR, V27, P211, DOI 10.1007/s11095-009-0011-3; Duchi S, 2013, J NEUROIMMUNOL, V258, P32, DOI 10.1016/j.jneuroim.2013.02.013; Endo-Takahashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03883; Endo-Takahashi Y, 2013, BIOMATERIALS, V34, P2807, DOI 10.1016/j.biomaterials.2012.12.018; Endo-Takahashi Y, 2012, INT J PHARMACEUT, V422, P504, DOI 10.1016/j.ijpharm.2011.11.023; Fauci AS, 2005, EMERG INFECT DIS, V11, P519, DOI 10.3201/eid1104.041167; Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235; Gillgrass AE, 2003, J VIROL, V77, P9845, DOI 10.1128/JVI.77.18.9845-9851.2003; Grassin-Delyle S, 2012, PHARMACOL THERAPEUT, V134, P366, DOI 10.1016/j.pharmthera.2012.03.003; GREGORIADIS G, 1990, IMMUNOL TODAY, V11, P89, DOI 10.1016/0167-5699(90)90034-7; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holmgren Jan, 2003, Expert Rev Vaccines, V2, P205, DOI 10.1586/14760584.2.2.205; Iwaoka S, 2006, J LEUKOCYTE BIOL, V79, P184, DOI 10.1189/jlb.0405181; Kedmi R, 2010, BIOMATERIALS, V31, P6867, DOI 10.1016/j.biomaterials.2010.05.027; Kong IG, 2013, INFECT IMMUN, V81, P1625, DOI 10.1128/IAI.00240-13; Kuroda E, 2013, INT REV IMMUNOL, V32, P209, DOI 10.3109/08830185.2013.773326; Kurono Y, 1999, J INFECT DIS, V180, P122, DOI 10.1086/314827; Leserman L, 2004, J LIPOSOME RES, V14, P175, DOI 10.1081/LPR-200039198; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Lu GL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-62; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Moon HJ, 2012, VET MICROBIOL, V160, P277, DOI 10.1016/j.vetmic.2012.05.035; Mueller T, 2010, ACS NANO, V4, P5647, DOI 10.1021/nn101224j; Nagahiro I, 2000, TRANSPLANTATION, V69, P1802, DOI 10.1097/00007890-200005150-00012; Negishi Y, 2008, J CONTROL RELEASE, V132, P124, DOI 10.1016/j.jconrel.2008.08.019; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Otsuka M, 2004, BIOCHEM BIOPH RES CO, V324, P1400, DOI 10.1016/j.bbrc.2004.09.198; Otsuka M, 2007, FEBS LETT, V581, P325, DOI 10.1016/j.febslet.2006.12.032; Park MVDZ, 2011, BIOMATERIALS, V32, P9810, DOI 10.1016/j.biomaterials.2011.08.085; Pires A, 2009, J PHARM PHARM SCI, V12, P288, DOI 10.18433/J3NC79; Plant A, 2004, CURR TOP MED CHEM, V4, P509, DOI 10.2174/1568026043451230; Sakaue G, 2003, J IMMUNOL, V170, P495, DOI 10.4049/jimmunol.170.1.495; Sarker SR, 2014, MOL PHARMACEUT, V11, P164, DOI 10.1021/mp400363z; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Tada R, 2014, INT IMMUNOPHARMACOL, V19, P5, DOI 10.1016/j.intimp.2013.12.027; Tada R, 2011, BIOCHEM BIOPH RES CO, V404, P1105, DOI 10.1016/j.bbrc.2010.12.125; Tada R, 2011, IMMUNOPHARM IMMUNOT, V33, P302, DOI 10.3109/08923973.2010.503707; Tada R, 2009, INT IMMUNOPHARMACOL, V9, P1431, DOI 10.1016/j.intimp.2009.08.014; Takano K, 2012, ARCH BIOCHEM BIOPHYS, V518, P89, DOI 10.1016/j.abb.2011.12.009; Wegmann F, 2012, NAT BIOTECHNOL, V30, P883, DOI 10.1038/nbt.2344; Yoshida T, 2006, J CONTROL RELEASE, V111, P325, DOI 10.1016/j.jconrel.2005.12.016; Yoshino N, 2004, J IMMUNOL, V173, P6850, DOI 10.4049/jimmunol.173.11.6850; Yotsumoto S, 2005, BIOCHEM BIOPH RES CO, V338, P1719, DOI 10.1016/j.bbrc.2005.10.179; Yotsumoto S, 2004, VACCINE, V22, P3503, DOI 10.1016/j.vaccine.2004.01.071; Yotsumoto S, 2007, VACCINE, V25, P5256, DOI 10.1016/j.vaccine.2007.05.037; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	54	31	31	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139785	10.1371/journal.pone.0139785	http://dx.doi.org/10.1371/journal.pone.0139785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440657	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300053
J	Van Kampen, JM; Baranowski, DC; Robertson, HA; Shaw, CA; Kay, DG				Van Kampen, Jackalina M.; Baranowski, David C.; Robertson, Harold A.; Shaw, Christopher A.; Kay, Denis G.			The Progressive BSSG Rat Model of Parkinson's: Recapitulating Multiple Key Features of the Human Disease	PLOS ONE			English	Article							LIVER X RECEPTORS; ALPHA-SYNUCLEIN; MOUSE MODEL; TYROSINE-HYDROXYLASE; DEMENTIA COMPLEX; PLANT STEROLS; LEWY BODIES; PATHOLOGY; BETA; BRAIN	The development of effective neuroprotective therapies for Parkinson's disease (PD) has been severely hindered by the notable lack of an appropriate animal model for preclinical screening. Indeed, most models currently available are either acute in nature or fail to recapitulate all characteristic features of the disease. Here, we present a novel progressive model of PD, with behavioural and cellular features that closely approximate those observed in patients. Chronic exposure to dietary phytosterol glucosides has been found to be neurotoxic. When fed to rats, beta-sitosterol beta-d-glucoside (BSSG) triggers the progressive development of parkinsonism, with clinical signs and histopathology beginning to appear following cessation of exposure to the neurotoxic insult and continuing to develop over several months. Here, we characterize the progressive nature of this model, its non-motor features, the anatomical spread of synucleinopathy, and response to levodopa administration. In Sprague Dawley rats, chronic BSSG feeding for 4 months triggered the progressive development of a parkinsonian phenotype and pathological events that evolved slowly over time, with neuronal loss beginning only after toxin exposure was terminated. At approximately 3 months following initiation of BSSG exposure, animals displayed the early emergence of an olfactory deficit, in the absence of significant dopaminergic nigral cell loss or locomotor deficits. Locomotor deficits developed gradually over time, initially appearing as locomotor asymmetry and developing into akinesia/bradykinesia, which was reversed by levodopa treatment. Late-stage cognitive impairment was observed in the form of spatial working memory deficits, as assessed by the radial arm maze. In addition to the progressive loss of TH+ cells in the substantia nigra, the appearance of proteinase K-resistant intracellular alpha-synuclein aggregates was also observed to develop progressively, appearing first in the olfactory bulb, then the striatum, the substantia nigra and, finally, hippocampal and cortical regions. The slowly progressive nature of this model, together with its construct, face and predictive validity, make it ideal for the screening of potential neuroprotective therapies for the treatment of PD.	[Van Kampen, Jackalina M.; Baranowski, David C.; Robertson, Harold A.; Kay, Denis G.] Neurodyn Inc, Charlottetown, PE C1A 4P3, Canada; [Van Kampen, Jackalina M.; Robertson, Harold A.] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE C1A 4P3, Canada; [Shaw, Christopher A.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	University of Prince Edward Island; University of British Columbia	Van Kampen, JM (corresponding author), Neurodyn Inc, 550 Univ Ave, Charlottetown, PE C1A 4P3, Canada.	jvankampen@neurodyn.ca		Baranowski, David/0000-0002-5372-7727; Lewis, Patrick/0000-0003-4537-0489	Atlantic Canada Opportunities Agency; Neurodyn Inc.	Atlantic Canada Opportunities Agency; Neurodyn Inc.	This work was supported, in part, by the Atlantic Canada Opportunities Agency (www.acoa-apeca.gc.ca/Eng/Pages/Home.aspx) who had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Neurodyn Inc. provided support in the form of salaries for JVK, DB, and DK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; [Anonymous], 2013, J PARKINSON DIS, V3, P3, DOI 10.3233/JPD-139905; Armstrong RA, 2014, J NEURAL TRANSM, V121, P171, DOI 10.1007/s00702-013-1084-z; Bellucci A, 2011, J NEUROCHEM, V116, P588, DOI 10.1111/j.1471-4159.2010.07143.x; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bezard E, 2013, MOVEMENT DISORD, V28, P61, DOI 10.1002/mds.25108; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Buter TC, 2008, NEUROLOGY, V70, P1017, DOI 10.1212/01.wnl.0000306632.43729.24; Calpe-Berdiel L, 2009, ATHEROSCLEROSIS, V203, P18, DOI 10.1016/j.atherosclerosis.2008.06.026; Cermenati G, 2013, J ENDOCRINOL INVEST, V36, P435, DOI 10.3275/8941; Dai YB, 2012, P NATL ACAD SCI USA, V109, P13112, DOI 10.1073/pnas.1210833109; Daisuke I, 1998, MOL BRAIN RES, V57, P1; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413, DOI 10.1093/jnen/61.5.413; Dickson D, 2010, MOV DISORD S1, V25, P82; Djaldetti R, 2006, LANCET NEUROL, V5, P796, DOI 10.1016/S1474-4422(06)70549-X; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Driver-Dunckley E, 2014, PARKINSONISM RELAT D, V20, P1260, DOI 10.1016/j.parkreldis.2014.08.006; Erickson RR, 2006, J GERONTOL A-BIOL, V61, P435, DOI 10.1093/gerona/61.5.435; Fleming SM, 2008, EUR J NEUROSCI, V28, P247, DOI 10.1111/j.1460-9568.2008.06346.x; Francis PT, 2007, MOVEMENT DISORD, V22, pS351, DOI 10.1002/mds.21683; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grey M, 2015, J BIOL CHEM, V290, P2969, DOI 10.1074/jbc.M114.585703; Hall H, 2014, BRAIN, V137, P2493, DOI 10.1093/brain/awu193; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; Jansen PJ, 2006, BBA-MOL CELL BIOL L, V1761, P445, DOI 10.1016/j.bbalip.2006.03.015; KEMPSTER PA, 1989, J NEUROL NEUROSUR PS, V52, P72, DOI 10.1136/jnnp.52.1.72; Khabazian I, 2002, J NEUROCHEM, V82, P516, DOI 10.1046/j.1471-4159.2002.00976.x; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Kurtenbach S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077509; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Marwarha G, 2011, J NEUROCHEM, V119, P1119, DOI 10.1111/j.1471-4159.2011.07497.x; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Olanow CW, 2009, ANN NEUROL, V66, P432, DOI 10.1002/ana.21832; Pahwa R, 2014, CURR OPIN NEUROL, V27, P442, DOI 10.1097/WCO.0000000000000113; Poletti M, 2013, J CLIN EXP NEUROPSYC, V35, P124, DOI 10.1080/13803395.2012.751966; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; Reid WGJ, 1996, J CLIN NEUROSCI, V3, P327, DOI 10.1016/S0967-5868(96)90028-4; RIACHI NJ, 1988, J PHARMACOL EXP THER, V244, P443; Rolheiser TM, 2011, J NEUROL, V258, P1254, DOI 10.1007/s00415-011-5915-2; Schintu N, 2009, NEUROTOX RES, V16, P127, DOI 10.1007/s12640-009-9061-x; Schulz JD, 2006, MED HYPOTHESES, V66, P1222, DOI 10.1016/j.mehy.2004.12.033; Shen WB, 2010, ANN NEUROL, V68, P70, DOI 10.1002/ana.22018; Siderowf A, 2012, MOVEMENT DISORD, V27, P608, DOI 10.1002/mds.24954; Siderowf A, 2012, MOVEMENT DISORD, V27, P406, DOI 10.1002/mds.24892; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tabata RC, 2008, NEUROMOL MED, V10, P24, DOI 10.1007/s12017-007-8020-z; TAYLOR A, 1989, NEUROLOGY, V39, P610, DOI 10.1212/WNL.39.4.610-a; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Ubeda-Banon I, 2012, BRAIN STRUCT FUNCT, V217, P447, DOI 10.1007/s00429-011-0347-4; Uitti RJ, 2005, NEUROLOGY, V64, P1925, DOI 10.1212/01.WNL.0000163993.82388.C8; Usuki S, 2012, NEUROCHEM RES, V37, P1261, DOI 10.1007/s11064-011-0662-4; Van Kampen JM, 2014, EXP GERONTOL, V50, P95, DOI 10.1016/j.exger.2013.11.012; Wilson JMB, 2002, NEUROMOL MED, V1, P207	58	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139694	10.1371/journal.pone.0139694	http://dx.doi.org/10.1371/journal.pone.0139694			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439489	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300043
J	Charles-Smith, LE; Reynolds, TL; Cameron, MA; Conway, M; Lau, EHY; Olsen, JM; Pavlin, JA; Shigematsu, M; Streichert, LC; Suda, KJ; Corley, CD				Charles-Smith, Lauren E.; Reynolds, Tera L.; Cameron, Mark A.; Conway, Mike; Lau, Eric H. Y.; Olsen, Jennifer M.; Pavlin, Julie A.; Shigematsu, Mika; Streichert, Laura C.; Suda, Katie J.; Corley, Courtney D.			Using Social Media for Actionable Disease Surveillance and Outbreak Management: A Systematic Literature Review	PLOS ONE			English	Article							HEALTH INFORMATION; ADOLESCENTS; NETWORKING; FACEBOOK; WEB; PREVALENCE; REFERENCES; INTERNET; BENEFITS; TWITTER	Objective Research studies show that social media may be valuable tools in the disease surveillance toolkit used for improving public health professionals' ability to detect disease outbreaks faster than traditional methods and to enhance outbreak response. A social media work group, consisting of surveillance practitioners, academic researchers, and other subject matter experts convened by the International Society for Disease Surveillance, conducted a systematic primary literature review using the PRISMA framework to identify research, published through February 2013, answering either of the following questions: 1. Can social media be integrated into disease surveillance practice and outbreak management to support and improve public health? 2. Can social media be used to effectively target populations, specifically vulnerable populations, to test an intervention and interact with a community to improve health outcomes? Examples of social media included are Facebook, MySpace, microblogs (e.g., Twitter), blogs, and discussion forums. For Question 1, 33 manuscripts were identified, starting in 2009 with topics on Influenza-like Illnesses (n = 15), Infectious Diseases (n = 6), Non-infectious Diseases (n = 4), Medication and Vaccines (n = 3), and Other (n = 5). For Question 2, 32 manuscripts were identified, the first in 2000 with topics on Health Risk Behaviors (n = 10), Infectious Diseases (n = 3), Non-infectious Diseases (n = 9), and Other (n = 10). Conclusions The literature on the use of social media to support public health practice has identified many gaps and biases in current knowledge. Despite the potential for success identified in exploratory studies, there are limited studies on interventions and little use of social media in practice. However, information gleaned from the articles demonstrates the effectiveness of social media in supporting and improving public health and in identifying target populations for intervention. A primary recommendation resulting from the review is to identify opportunities that enable public health professionals to integrate social media analytics into disease surveillance and outbreak management practice.	[Charles-Smith, Lauren E.; Corley, Courtney D.] Pacific NW Natl Lab, Data Sci & Analyt Grp, Richland, WA 99352 USA; [Reynolds, Tera L.; Streichert, Laura C.] Int Soc Dis Surveillance, Boston, MA USA; [Cameron, Mark A.] Commonwealth Sci & Ind Res Org Digital Prod Flags, Canberra, ACT, Australia; [Conway, Mike] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA; [Lau, Eric H. Y.] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Olsen, Jennifer M.] Skoll Global Threats Fund, San Francisco, CA USA; [Pavlin, Julie A.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Shigematsu, Mika] Natl Inst Infect Dis, Shinjuku Ku, Tokyo 1628640, Japan; [Suda, Katie J.] US Dept Vet Affairs, Ctr Innovat Complex Chron Healthcare, Hines, IL USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Utah System of Higher Education; University of Utah; University of Hong Kong; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institute of Infectious Diseases (NIID); US Department of Veterans Affairs	Corley, CD (corresponding author), Pacific NW Natl Lab, Data Sci & Analyt Grp, Richland, WA 99352 USA.	court@pnnl.gov	Lau, Eric/AAJ-6588-2021; Lau, Eric Ho Yin/C-4487-2009; Charles, Lauren E./GPX-2297-2022	Lau, Eric/0000-0002-6688-9637; Charles, Lauren E./0000-0003-0727-0479; Corley, Courtney/0000-0003-3741-9705	Pacific Northwest National Laboratory's Laboratory Directed Research and Development Program; International Society for Disease Surveillance; NATIONAL LIBRARY OF MEDICINE [R00LM011393] Funding Source: NIH RePORTER	Pacific Northwest National Laboratory's Laboratory Directed Research and Development Program; International Society for Disease Surveillance; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Project management support for this effort was provided by the International Society for Disease Surveillance. Participation of CDC and LECS was supported in part by Pacific Northwest National Laboratory's Laboratory Directed Research and Development Program.	Achrekar H, 2012, TWITTER IMPROVES SEA, P61; Aramaki E, 2011, TWITTER CATCHES FLU, P1568; Babaie J, 2015, PLOS CURRENTS DISAST; Baptist AP, 2011, J ASTHMA, V48, P824, DOI 10.3109/02770903.2011.608460; Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740; Bian J, 2012, PROCEEDINGS OF THE 2012 INTERNATIONAL WORKSHOP ON SMART HEALTH AND WELLBEING, P25, DOI 10.1145/2389707.2389713; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chunara R, 2012, AM J TROP MED HYG, V86, P39, DOI 10.4269/ajtmh.2012.11-0597; Collier Nigel, 2011, J Biomed Semantics, V2 Suppl 5, pS9, DOI 10.1186/2041-1480-2-S5-S9; Corley CD, 2010, INT J ENV RES PUB HE, V7, P596, DOI 10.3390/ijerph7020596; CULOTTA A., 2010, DETECTING INFLUENZA; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Culotta A, 2013, LANG RESOUR EVAL, V47, P217, DOI 10.1007/s10579-012-9185-0; de Quincey E, 2010, L N INST COMP SCI SO, V27, P21; Diaz-Aviles E, 2012, P 21 INT C COMP WORL, P495, DOI [10.1145/2187980.2188094, DOI 10.1145/2187980.2188094]; Diaz-Aviles E, 2012, PROCEEDINGS OF THE 3RD ANNUAL ACM WEB SCIENCE CONFERENCE, 2012, P82; Doan S., 2012, 2012 IEEE Second International Conference on Healthcare Informatics, Imaging and Systems Biology (HISB), P62, DOI 10.1109/HISB.2012.21; Dumbrell D, 2012, WHAT ARE CHARACTERIS, P115, DOI [10.1145/2414536.2414555, DOI 10.1145/2414536.2414555]; Egan KG, 2011, CIN-COMPUT INFORM NU, V29, P586, DOI 10.1097/NCN.0b013e3182160663; Fisher J, 2012, WORLDV EVID-BASED NU, V9, P100, DOI 10.1111/j.1741-6787.2012.00243.x; Frost J, 2011, J MED INTERNET RES, V13, P129, DOI 10.2196/jmir.1643; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Gomide J., 2011, P 3 INT WEB SCI C, V3, DOI DOI 10.1145/2527031.2527049; Huang CM, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-57; Iafusco D, 2000, DIABETES CARE, V23, P1853, DOI 10.2337/diacare.23.12.1853b; Idriss SZ, 2009, ARCH DERMATOL, V145, P46, DOI 10.1001/archdermatol.2008.529; Ishikawa T, 2012, J NATL I PUBLIC HLTH, P61; Krieck M., 2011, P HLTH WEB SCI WORKS; Ku Y, 2010, GLOBAL DIS SURVEILLA, P170, DOI [10.1109/ISI.2010.5484749, DOI 10.1109/ISI.2010.5484749]; Lampos V., 2010, TRACKING FLU PANDEMI, P411, DOI [10.1109/CIP.2010.5604088, DOI 10.1109/CIP.2010.5604088]; Lieberman MA, 2003, CANCER, V97, P920, DOI 10.1002/cncr.11145; Litt DM, 2011, PSYCHOL ADDICT BEHAV, V25, P708, DOI 10.1037/a0024226; Lowe JB, 2012, AUST NZ J PUBL HEAL, V36, P30, DOI 10.1111/j.1753-6405.2012.00826.x; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Moreno MA, 2009, J ADOLESCENT HEALTH, V44, pS22; Moreno MA, 2012, J SEX RES, V49, P390, DOI 10.1080/00224499.2011.642903; Moreno MA, 2012, ARCH PEDIAT ADOL MED, V166, P157, DOI 10.1001/archpediatrics.2011.180; Moreno MA, 2009, ARCH PEDIAT ADOL MED, V163, P35, DOI 10.1001/archpediatrics.2008.502; Nsoesie E, 2014, J MED INTERNET RES, V16; O'Dea B, 2011, STUD HEALTH TECHNOL, V167, P133, DOI 10.3233/978-1-60750-766-6-133; Okamura N, 2011, TWITTER CATCHES FLU; Paul M.J., 2011, P 5 INT AAAI C WEBL; Paul M.J., 2012, HEALTH-LONDON, V11, P1, DOI DOI 10.1002/YD.20024; Peels DA, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1742; Prier KW, 2011, LECT NOTES COMPUT SC, V6589, P18; Ralph LJ, 2011, SEX RES SOC POLICY, V8, P38, DOI 10.1007/s13178-011-0043-4; Read R, 2009, 18 INT SOC STD RES C; Rhodes SD, 2010, PUBLIC HEALTH REP, V125, P29, DOI 10.1177/00333549101250S105; Ridout B, 2012, DRUG ALCOHOL REV, V31, P20, DOI 10.1111/j.1465-3362.2010.00277.x; Sadilek A, 2012, P 26 AAAI C ART INT, P136; Salathe M, 2012, ARXIV12077274; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Sarker A, 2015, J BIOMED INFORM, V54, P202, DOI 10.1016/j.jbi.2015.02.004; Scanfeld D, 2010, AM J INFECT CONTROL, V38, P182, DOI 10.1016/j.ajic.2009.11.004; Schmidt M, 2009, SEX HEALTH, V6, P369; Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467; Sofean M, 2012, P 23 ACM C HYP SOC M, P309, DOI [10.1145/2309996.2310048, DOI 10.1145/2309996.2310048]; Song H, 2012, J PEDIATR ONCOL NURS, V29, P80, DOI 10.1177/1043454212438964; Stoddard JL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1124; Stroever SJ, 2011, PREV CHRONIC DIS, V8; Stuart Chester Tammy L, 2011, Online J Public Health Inform, V3, DOI 10.5210/ojphi.v3i1.3506; Sullivan PS, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1797; Szomszor M, 2011, TWITTER INFORM TRACK, P320, DOI [10.1109/WI-IAT.2011.311, DOI 10.1109/WI-IAT.2011.311]; Szomszor M, 2011, SWINEFLU TWITTER PRE, P18, DOI [10.1007/978-3-642-23635-8_3, DOI 10.1007/978-3-642-23635-8_3]; Takahashi Y, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1142; Tsaousides T, 2011, BRAIN INJURY, V25, P1155, DOI 10.3109/02699052.2011.613086; Turner-McGrievy G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1841; Vaillant L, 2011, IMED VIENN FRANC; Vayena E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003904; Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038; Walters R, 2009, WILEY HDB SCI TECHNO, P1; Wicks P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1549; Yamauchi E., 2010, SEX TECH C 2010 SAN; Yang M, 2011, PAC AS C INF SYST	76	93	94	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139701	10.1371/journal.pone.0139701	http://dx.doi.org/10.1371/journal.pone.0139701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0PR	26437454	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200052
J	Keith, H; Lindenmayer, D; Macintosh, A; Mackey, B				Keith, Heather; Lindenmayer, David; Macintosh, Andrew; Mackey, Brendan			Under What Circumstances Do Wood Products from Native Forests Benefit Climate Change Mitigation?	PLOS ONE			English	Article							OLD-GROWTH FORESTS; CARBON STORAGE; MANAGEMENT; BIOMASS; BIOENERGY; BIODIVERSITY; AUSTRALIA; EMISSIONS; IMPACTS; BALANCE	Climate change mitigation benefits from the land sector are not being fully realised because of uncertainty and controversy about the role of native forest management. The dominant policy view, as stated in the IPCC's Fifth Assessment Report, is that sustainable forest harvesting yielding wood products, generates the largest mitigation benefit. We demonstrate that changing native forest management from commercial harvesting to conservation can make an important contribution to mitigation. Conservation of native forests results in an immediate and substantial reduction in net emissions relative to a reference case of commercial harvesting. We calibrated models to simulate scenarios of native forest management for two Australian case studies: mixed-eucalypt in New South Wales and Mountain Ash in Victoria. Carbon stocks in the harvested forest included forest biomass, wood and paper products, waste in landfill, and bioenergy that substituted for fossil fuel energy. The conservation forest included forest biomass, and subtracted stocks for the foregone products that were substituted by non-wood products or plantation products. Total carbon stocks were lower in harvested forest than in conservation forest in both case studies over the 100-year simulation period. We tested a range of potential parameter values reported in the literature: none could increase the combined carbon stock in products, slash, landfill and substitution sufficiently to exceed the increase in carbon stock due to changing management of native forest to conservation. The key parameters determining carbon stock change under different forest management scenarios are those affecting accumulation of carbon in forest biomass, rather than parameters affecting transfers among wood products. This analysis helps prioritise mitigation activities to focus on maximising forest biomass. International forest-related policies, including negotiations under the UNFCCC, have failed to recognize fully the mitigation value of native forest conservation. Our analyses provide evidence for decision-making about the circumstances under which forest management provides mitigation benefits.	[Keith, Heather; Lindenmayer, David] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Macintosh, Andrew] Australian Natl Univ, ANU Coll Law, Ctr Climate Law & Policy, Canberra, ACT, Australia; [Mackey, Brendan] Griffith Univ, Griffith Climate Change Response Program, Southport, Qld 4215, Australia	Australian National University; Australian National University; Griffith University	Keith, H (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	Heather.Keith@anu.edu.au	Lindenmayer, David B/P-7183-2017; Mackey, Brendan/ABE-3805-2020	Lindenmayer, David B/0000-0002-4766-4088; Mackey, Brendan/0000-0003-1996-4064	Fujitsu Laboratories Ltd.	Fujitsu Laboratories Ltd.	Fujitsu Laboratories Ltd. (HK DL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2015, AUSTR FOR WOOD PROD; ABARES, 2013, AUSTR STAT FOR REP 2; Ajani J, 2007, THE FOREST WARS; Baur GN, 1979, 17 NSW FOR COMM; Bird DN, 2012, GCB BIOENERGY, V4, P576, DOI 10.1111/j.1757-1707.2011.01137.x; Borough CJ, 1984, EUCALYPTS WOOD PRODU, P201; City of Sydney, 2014, INT WAST STRAT MAN C; Dean C, 2010, PLANT BIOSYST, V144, P180, DOI 10.1080/11263500903560751; Dean C, 2012, AGR FOREST METEOROL, V161, P156, DOI 10.1016/j.agrformet.2012.03.021; Dean C, 2012, AGR ECOSYST ENVIRON, V148, P44, DOI 10.1016/j.agee.2011.11.011; DSE, 2009, MON AN HARV PERF VIC; Dyson F. J., 1977, Energy, V2, P287, DOI 10.1016/0360-5442(77)90033-0; Edenhofer O., 2014, CONTRIBUTION WORKING; Eggleston S, 2006, IPCC NATL GREENHOUSE, P664; England JR, 2013, FOREST ECOL MANAG, V302, P295, DOI 10.1016/j.foreco.2013.03.010; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Flinn D, 2007, FOREST MANAGEMENT AU, P103; Florence R, 2007, FOREST MANAGEMENT AU, P49; Florence R.G, 1996, ECOLOGY SILVICULTURE; Gibbons P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029212; GRIERSON PF, 1992, AUST J BOT, V40, P631, DOI 10.1071/BT9920631; Haberl H, 2012, ENERG POLICY, V45, P18, DOI 10.1016/j.enpol.2012.02.051; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Holtsmark B, 2015, GCB BIOENERGY, V7, P195, DOI 10.1111/gcbb.12110; Hudiburg TW, 2011, NAT CLIM CHANGE, V1, P419, DOI 10.1038/NCLIMATE1264; IFOA, 2013, INT FOR OP APPR ANN; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Johnson E, 2009, ENVIRON IMPACT ASSES, V29, P165, DOI 10.1016/j.eiar.2008.11.002; Keith D.A., 2004, OCEAN SHORES DESERT; Keith H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107126; Keith H, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00051.1; Kilinc M, 2013, AGR FOREST METEOROL, V182, P215, DOI 10.1016/j.agrformet.2013.07.003; Kirschbaum MUF, 2003, BIOMASS BIOENERG, V24, P297, DOI 10.1016/S0961-9534(02)00171-X; Lamers P, 2013, BIOFUEL BIOPROD BIOR, V7, P373, DOI 10.1002/bbb.1407; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Lindenmayer D., 2008, SALVAGE LOGGING ITS; Lippke B, 2011, CARBON MANAG, V2, P303, DOI 10.4155/CMT.11.24; Lutze M. T., 1999, Australian Forestry, V62, P236; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Macintosh A, 2015, NAT CLIM CHANGE, V5, P946, DOI [10.1038/nclimate2695, 10.1038/NCLIMATE2695]; Mackensen J, 1999, 6 NAT CARB ACC SYST; Mackey B., 2002, WILDLIFE FIRE FUTURE; Mackey B, 2015, CONSERV LETT, V8, P139, DOI 10.1111/conl.12120; MARLAND G, 1995, ENERGY, V20, P1131, DOI 10.1016/0360-5442(95)00061-K; Marland G., 1997, MITIGATION ADAPTATIO, V2, P303; McCarthy MA, 1999, FOREST ECOL MANAG, V124, P193, DOI 10.1016/S0378-1127(99)00066-3; McCarthy MA, 2001, INT J WILDLAND FIRE, V10, P73, DOI 10.1071/WF01013; Moroni MT, 2012, FOREST ECOL MANAG, V275, P111, DOI 10.1016/j.foreco.2012.03.001; Moroni M. T., 2010, International Journal of Forestry Research, V2010, P690462, DOI 10.1155/2010/690462; NIR, 2014, NAT INV REP 2014 AUS; NIR, 2012, NAT INV REP 2012 AUS; Oliver CD, 2014, J SUSTAIN FOREST, V33, P248, DOI 10.1080/10549811.2013.839386; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Righelato R, 2007, SCIENCE, V317, P902, DOI 10.1126/science.1141361; Ryan MG, 2012, ISSUES ECOLOGY, V13, P1; Sathre R, 2010, ENVIRON SCI POLICY, V13, P104, DOI 10.1016/j.envsci.2009.12.005; Schlamadinger B, 1999, TELLUS B, V51, P314, DOI 10.1034/j.1600-0889.1999.00014.x; Schlamadinger B, 1996, BIOMASS BIOENERG, V10, P275, DOI 10.1016/0961-9534(95)00113-1; SCHLAMADINGER B, 1995, BIOMASS BIOENERG, V8, P221, DOI 10.1016/0961-9534(95)00020-8; Schlamadinger B, 1996, ENERG CONVERS MANAGE, V37, P813, DOI 10.1016/0196-8904(95)00261-8; Schulze ED, 2000, SCIENCE, V289, P2058, DOI 10.1126/science.289.5487.2058; Schulze ED, 2012, GCB BIOENERGY, V4, P611, DOI 10.1111/j.1757-1707.2012.01169.x; Searchinger TD, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/2/024007; SEEA-EEA. System of Environmental-Economic Accounting, 2013, EXP EC ACC; Smith P, 2014, IPCC CLIMATE CHANGE; Steffen W, 2013, CRITICAL DECADE 2013; Taylor C, 2014, CONSERV LETT, V7, P355, DOI 10.1111/conl.12122; Thompson I, 2009, TECHNICAL SERIES, V43, P67; VicForests, 2014, RES OUTL; Wardell-Johnson Grant W., 2011, Pacific Conservation Biology, V17, P220; Ximenes FA, 2008, WASTE MANAGE, V28, P2344, DOI 10.1016/j.wasman.2007.11.006; Ximenes F. A., 2006, Australian Forestry, V69, P213; Ximenes FA, 2012, HARVESTED FORESTS PR; Ximenes FD, 2012, FORESTS, V3, P653, DOI 10.3390/f3030653; York R, 2012, NAT CLIM CHANGE, V2, P441, DOI 10.1038/NCLIMATE1451; Zanchi G, 2012, GCB BIOENERGY, V4, P761, DOI 10.1111/j.1757-1707.2011.01149.x	77	20	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139640	10.1371/journal.pone.0139640	http://dx.doi.org/10.1371/journal.pone.0139640			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436916	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200039
J	Kim, K; Seo, M; Kang, H; Cho, S; Kim, H; Seo, KS				Kim, Kwondo; Seo, Minseok; Kang, Hyunsung; Cho, Seoae; Kim, Heebal; Seo, Kang-Seok			Application of LogitBoost Classifier for Traceability Using SNP Chip Data	PLOS ONE			English	Article							MULTICLASS CLASSIFICATION; GENETIC TRACEABILITY; COCOA BEANS; MACHINE; IDENTIFICATION; ASSIGNMENT; SELECTION; PRODUCTS	Consumer attention to food safety has increased rapidly due to animal-related diseases; therefore, it is important to identify their places of origin (POO) for safety purposes. However, only a few studies have addressed this issue and focused on machine learning-based approaches. In the present study, classification analyses were performed using a customized SNP chip for POO prediction. To accomplish this, 4,122 pigs originating from 104 farms were genotyped using the SNP chip. Several factors were considered to establish the best prediction model based on these data. We also assessed the applicability of the suggested model using a kinship coefficient-filtering approach. Our results showed that the LogitBoost-based prediction model outperformed other classifiers in terms of classification performance under most conditions. Specifically, a greater level of accuracy was observed when a higher kinship-based cutoff was employed. These results demonstrated the applicability of a machine learning-based approach using SNP chip data for practical traceability.	[Kim, Kwondo; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Kim, Kwondo; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Kwondo; Seo, Minseok; Cho, Seoae; Kim, Heebal] C&K Genom Inc, Seoul 151919, South Korea; [Seo, Minseok; Kim, Heebal] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151747, South Korea; [Kang, Hyunsung; Seo, Kang-Seok] Sunchon Natl Univ, Coll Life Sci & Nat Resources, Dept Anim Sci & Technol, Sunchon 540742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Sunchon National University	Seo, KS (corresponding author), Sunchon Natl Univ, Coll Life Sci & Nat Resources, Dept Anim Sci & Technol, Sunchon 540742, South Korea.	sks@sunchon.ac.kr	Kim, Kwondo/AAF-8321-2022; Kim, Heebal/A-8889-2016; Kim, Kwondo/AFK-1164-2022	Kim, Kwondo/0000-0001-8254-528X; Kim, Heebal/0000-0003-3064-1303; Kim, Kwondo/0000-0001-8254-528X	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea [PJ009274]	"Cooperative Research Program for Agriculture Science & Technology Development" Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was carried out with the support of "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ009274)" Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodersen KH, 2010, PATT REC ICPR 2010 2; Cai YD, 2006, J THEOR BIOL, V238, P172, DOI 10.1016/j.jtbi.2005.05.034; Cornuet JM, 1999, GENETICS, V153, P1989; Dalvit C, 2007, MEAT SCI, V77, P437, DOI 10.1016/j.meatsci.2007.05.027; Dettling M, 2003, BIOINFORMATICS, V19, P1061, DOI 10.1093/bioinformatics/btf867; Dimauro C, 2013, ANIM GENET, V44, P377, DOI 10.1111/age.12021; Ding CHQ, 2001, BIOINFORMATICS, V17, P349, DOI 10.1093/bioinformatics/17.4.349; Even-Zohar Y, 2001, CS0106044 ARXIV; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Goffaux F, 2005, FORENSIC SCI INT, V151, P239, DOI 10.1016/j.forsciint.2005.02.013; Guney S, 2012, SENSOR ACTUAT B-CHEM, V166, P721, DOI 10.1016/j.snb.2012.03.047; Heaton MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094851; Hornik K, 2007, RWEKA R INTERFACE WE; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Iquebal MA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-118; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Koketsu Y, 2000, J AM VET MED ASSOC, V216, P376, DOI 10.2460/javma.2000.216.376; Kotsiantis S., 2006, INT REV COMPUTERS SO, V1, P243; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Metz CE, 1978, SEMINARS NUCL MED; Negrini R, 2008, MEAT SCI, V80, P1212, DOI 10.1016/j.meatsci.2008.05.021; Petroman C., 2012, Porcine Research, V2, P16; Polat K, 2009, EXPERT SYST APPL, V36, P1587, DOI 10.1016/j.eswa.2007.11.051; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramos AM, 2011, ANIM GENET, V42, P613, DOI 10.1111/j.1365-2052.2011.02198.x; Seo M, 2012, CBFS HIGH PERFORMANC; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Smith GC, 2008, MEAT SCI, V80, P66, DOI 10.1016/j.meatsci.2008.05.024; Sun P, 2014, MACH LEARN, V97, P295, DOI 10.1007/s10994-014-5434-3; Teye E, 2014, FOOD ANAL METHOD, V7, P360, DOI 10.1007/s12161-013-9634-4; Teye E, 2013, SPECTROCHIM ACTA A, V114, P183, DOI 10.1016/j.saa.2013.05.063; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Wu TF, 2004, J MACH LEARN RES, V5, P975; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yuan P, 2008, SEM COMP SYST 2008 W	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139685	10.1371/journal.pone.0139685	http://dx.doi.org/10.1371/journal.pone.0139685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436917	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200048
J	Molostvov, G; Hiemstra, TF; Fletcher, S; Bland, R; Zehnder, D				Molostvov, Guerman; Hiemstra, Thomas F.; Fletcher, Simon; Bland, Rosemary; Zehnder, Daniel			Arterial Expression of the Calcium-Sensing Receptor Is Maintained by Physiological Pulsation and Protects against Calcification	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; VITAMIN-D STATUS; VASCULAR CALCIFICATION; SECONDARY HYPERPARATHYROIDISM; CARDIOVASCULAR-DISEASE; CINACALCET HCL; HEMODIALYSIS; DIALYSIS; MINERALIZATION; MORTALITY	Vascular calcification (VC) is common in chronic kidney disease (CKD) and contributes to cardiovascular mortality. The calcium-sensing receptor (CaSR) is present in human artery, senses extracellular calcium and may directly modulate VC. Objective: to investigate the association between arterial cyclic strain, CaSR expression and VC. Methods and Results: human aortic smooth muscle cells (HAoSMC) were cultured under static or strained conditions, with exposure to CaSR agonists, the calcimimetic R568, and after CaSR silencing and over-expression. High extracellular calcium reduced CaSR expression and promoted osteochondrogenic transformation and calcium deposition. This was partially prevented by cyclic strain and exposure to R568. CaSR silencing enhanced calcification and osteochondrogenic transformation, whereas CaSR over-expression attenuated this procalcific response, demonstrating a central role for the CaSR in the response to cyclic strain and regulation of VC. In arterial explants from CKD patients (n = 11) and controls (n = 9), exposure to R568 did not significantly alter calcium deposition, osteochondrogenic markers or total artery calcium content. Conclusions: physiological mechanical strain is important for arterial homeostasis and may protect arteries from VC. The beneficial effects of cyclic strain may be mediated via the CaSR.	[Molostvov, Guerman; Bland, Rosemary; Zehnder, Daniel] Univ Warwick, Warwick Med Sch, Clin Sci Res Lab, Coventry CV4 7AL, W Midlands, England; [Hiemstra, Thomas F.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Hiemstra, Thomas F.] Addenbrookes Hosp, Cambridge Clin Trials Unit, Cambridge, England; [Fletcher, Simon; Zehnder, Daniel] Univ Hosp Coventry & Warwickshire, Dept Nephrol, Coventry, W Midlands, England	University of Warwick; University of Cambridge; Addenbrooke's Hospital; University of Cambridge; University of Warwick	Hiemstra, TF (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge, England.	tfh24@cam.ac.uk			AMGEN; NIHR Cambridge Biomedical Research Centre	AMGEN(Amgen); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	This study was funded by an unrestricted grant from AMGEN (www.amgen.co.uk<http://www.amgen.co.uk/>). AMGEN had no role in the design of the present study, data collection or analysis, the decision to publish, or the preparation of the manuscript. TFH is funded by the NIHR Cambridge Biomedical Research Centre. DZ has received speaking honoraria from AMGEN. TFH has served as consultant for AMGEN.	Alam M, 2009, CARDIOVASC RES, V81, P260, DOI 10.1093/cvr/cvn279; Bellasi A, 2013, J HEART VALVE DIS, V22, P391; Bhat S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027475; Block GA, 2004, NEW ENGL J MED, V350, P1516, DOI 10.1056/NEJMoa031633; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Chang WH, 2002, ENDOCRINOLOGY, V143, P1467, DOI 10.1210/en.143.4.1467; Chertow GM, 2012, NEW ENGL J MED, V367, P2482, DOI 10.1056/NEJMoa1205624; Chertow GM, 2002, KIDNEY INT, V62, P245, DOI 10.1046/j.1523-1755.2002.00434.x; Cunningham J, 2005, KIDNEY INT, V68, P1793, DOI 10.1111/j.1523-1755.2005.00596.x; Drechsler C, 2011, NEPHROL DIAL TRANSPL, V26, P1024, DOI 10.1093/ndt/gfq606; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Graciolli FG, 2009, NEPHROL DIAL TRANSPL, V24, P1416, DOI 10.1093/ndt/gfn686; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Henaut L, 2014, CARDIOVASC RES, V101, P256, DOI 10.1093/cvr/cvt249; Henley C, 2009, EUR J PHARMACOL, V616, P306, DOI 10.1016/j.ejphar.2009.05.013; Ivanovski O, 2009, ATHEROSCLEROSIS, V205, P55, DOI 10.1016/j.atherosclerosis.2008.10.043; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P3799, DOI 10.1093/ndt/gfp370; Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Krause R, 2012, ANTICANCER RES, V32, P391; Li CH, 2007, CELL SIGNAL, V19, P881, DOI 10.1016/j.cellsig.2007.01.004; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Lindberg JS, 2005, J AM SOC NEPHROL, V16, P800, DOI 10.1681/ASN.2004060512; London GM, 2005, CURR OPIN NEPHROL HY, V14, P525, DOI 10.1097/01.mnh.0000168336.67499.c0; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Lopez I, 2009, AM J PHYSIOL-RENAL, V296, pF1376, DOI 10.1152/ajprenal.90737.2008; Mendoza FJ, 2011, CALCIFIED TISSUE INT, V88, P169, DOI 10.1007/s00223-010-9442-4; Moe SM, 2002, KIDNEY INT, V61, P638, DOI 10.1046/j.1523-1755.2002.00170.x; Molostvov G, 2007, AM J PHYSIOL-RENAL, V293, pF946, DOI 10.1152/ajprenal.00474.2006; Molostvov G, 2008, CELL PHYSIOL BIOCHEM, V22, P413, DOI 10.1159/000185484; Nikolovski J, 2003, FASEB J, V17, P455, DOI 10.1096/fj.02-0459fje; Posadzy-Malaczynska A, 2005, INT ANGIOL, V24, P89; Raggi P, 2011, NEPHROL DIAL TRANSPL, V26, P1327, DOI 10.1093/ndt/gfq725; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Shaffi K, 2013, CLIN J AM SOC NEPHRO, V8, P979, DOI 10.2215/CJN.10651012; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shantouf RS, 2010, AM J NEPHROL, V31, P419, DOI 10.1159/000294405; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Simmons CA, 2004, J BIOMECH, V37, P1531, DOI 10.1016/j.jbiomech.2004.01.006; Tfelt-Hansen J, 2006, AM J PHYSIOL-HEART C, V290, pH1165, DOI 10.1152/ajpheart.00821.2005; Ward DT, 2012, BRIT J PHARMACOL, V165, P35, DOI 10.1111/j.1476-5381.2011.01511.x; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Winter LC, 2003, J BIOMED MATER RES A, V67A, P1269, DOI 10.1002/jbm.a.20028; Wolf M, 2007, KIDNEY INT, V72, P1004, DOI 10.1038/sj.ki.5002451; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Wonneberger K, 2000, J MEMBRANE BIOL, V175, P203, DOI 10.1007/s002320001068; Ziegelstein RC, 2006, BIOCHEM BIOPH RES CO, V342, P153, DOI 10.1016/j.bbrc.2006.01.135	51	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138833	10.1371/journal.pone.0138833	http://dx.doi.org/10.1371/journal.pone.0138833			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436544	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200009
J	Abou-Kheir, W; Eid, A; El-Merahbi, R; Assaf, R; Daoud, G				Abou-Kheir, Wassim; Eid, Assaad; El-Merahbi, Rabih; Assaf, Rebecca; Daoud, Georges			A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells	PLOS ONE			English	Article							MOUSE EMBRYOS; DISSOCIATED BLASTOMERES; MESENCHYMAL TRANSITION; CHORIONIC-GONADOTROPIN; CHORIOCARCINOMA CELLS; SURFACE POLARIZATION; INDUCED APOPTOSIS; GROWTH-FACTOR; STEM-CELLS; E-CADHERIN	The placenta, a transient organ in human, is essential for pregnancy maintenance and for fetal growth and development. Trophoblast and stromal cells are the main cell types present in human placenta. Trophoblast cells are present in different subtypes depending on their differentiation state and their temporal and spatial location during pregnancy. The stromal cells are of extraembryonic mesenchymal origin and are important for villous formation and maintenance. Interestingly, many pregnancy-related diseases are associated with defect in trophoblast differentiation and villous integrity. Therefore, it's crucial to specifically identify each type of placental cells using specific markers. Keratins (CK) are widely used as marker of epithelial cells, cancer origin identification and in some cases as marker of stem/progenitor cells. Vimentin is widely used as marker of mesenchymal cells. The aim of this study is to characterize the presence of different keratins in human trophoblast cells and vimentin in stromal cells. Using immunohistochemistry on term placental sections, our results show that vimentin is solely expressed in stromal-mesenchymal cells while keratins 5, 7, 8, 14 and 19 are expressed in trophoblast cells. Interestingly, all keratins tested, except for keratin 14, were evenly expressed in all trophoblast cells. Keratin 14 was expressed in a subset of CK7 positive cells. Moreover, the same results were obtained when using freshly isolated cytotrophoblast cells or BeWo cells. In conclusion, this study is a crucial step in the advancement of our knowledge in placental cell type identification and characterization.	[Abou-Kheir, Wassim; Eid, Assaad; El-Merahbi, Rabih; Assaf, Rebecca; Daoud, Georges] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon	American University of Beirut	Abou-Kheir, W (corresponding author), Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon.	wa12@aub.edu.lb; gd12@aub.edu.lb	Abou-Kheir, Wassim/AAP-2587-2020	Abou-Kheir, Wassim/0000-0001-9719-9324; Daoud, Georges/0000-0001-8043-3882	Medical Practice Plan, American University of Beirut Medical center (MPP-AUBMC) [22425-320081]; National Council for Scientific Research [1683]	Medical Practice Plan, American University of Beirut Medical center (MPP-AUBMC); National Council for Scientific Research(Consiliul National al Cercetarii Stiintifice (CNCS))	This work was supported by the Medical Practice Plan, American University of Beirut Medical center (MPP-AUBMC), Grant Number#22425-320081 and the National Council for Scientific Research, Grant Number# 1683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026112; Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Ahenkorah J, 2009, J CELL MOL MED, V13, P735, DOI 10.1111/j.1582-4934.2008.00363.x; Benirschke K, 2012, PATHOLOGY HUMAN PLAC; Bischof P, 2005, INT J BIOCHEM CELL B, V37, P1, DOI 10.1016/j.biocel.2004.05.014; Bose A, 2013, INT J MOL SCI, V14, P19385, DOI 10.3390/ijms141019385; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Daoud G, 2005, J PHYSIOL-LONDON, V566, P409, DOI 10.1113/jphysiol.2005.089326; Daoud G, 2005, BBA-MOL CELL BIOL L, V1687, P181, DOI 10.1016/j.bbalip.2004.11.017; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; FUCHS E, 1983, J INVEST DERMATOL, V81, pS141, DOI 10.1111/1523-1747.ep12540922; Gauster M, 2013, HISTOL HISTOPATHOL, V28, P817, DOI 10.14670/HH-28.817; Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686; Haigh T, 1999, PLACENTA, V20, P615, DOI 10.1053/plac.1999.0441; HANDYSIDE AH, 1980, J EMBRYOL EXP MORPH, V60, P99; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; Hohn HP, 1998, EXP CELL RES, V244, P249, DOI 10.1006/excr.1998.4184; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; Jaquemar D, 2003, J CELL BIOL, V161, P749, DOI 10.1083/jcb.200210004; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; JOHNSON MH, 1986, J EMBRYOL EXP MORPH, V93, P239; Karantza V, 2011, ONCOGENE, V30, P127, DOI 10.1038/onc.2010.456; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; KLIMAN HJ, 1986, ENDOCRINOLOGY, V118, P1567, DOI 10.1210/endo-118-4-1567; Kohnen G, 1996, HISTOCHEM CELL BIOL, V105, P415, DOI 10.1007/BF01457655; Ku NO, 2003, P NATL ACAD SCI USA, V100, P6063, DOI 10.1073/pnas.0936165100; Ku NO, 2003, HEPATOLOGY, V37, P1006, DOI 10.1053/jhep.2003.50181; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Liu YN, 2012, MOL CELL BIOL, V32, P941, DOI 10.1128/MCB.06306-11; Maldonado-Estrada J, 2004, J IMMUNOL METHODS, V286, P21, DOI 10.1016/j.jim.2003.03.001; Martin P, 2011, AM J PATHOL, V179, P422, DOI 10.1016/j.ajpath.2011.03.035; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Moriwaki K, 2007, DEV BIOL, V312, P509, DOI 10.1016/j.ydbio.2007.09.049; MUHLHAUSER J, 1995, J HISTOCHEM CYTOCHEM, V43, P579, DOI 10.1177/43.6.7539466; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Ohsugi M, 1997, DEV BIOL, V185, P261, DOI 10.1006/dbio.1997.8560; Proll J, 1997, CELL TISSUE RES, V288, P335, DOI 10.1007/s004410050819; REEVE WJD, 1981, J EMBRYOL EXP MORPH, V62, P339; REEVE WJD, 1981, J EMBRYOL EXP MORPH, V62, P351; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; SHIRAYOSHI Y, 1983, CELL, V35, P631, DOI 10.1016/0092-8674(83)90095-8; SPEEG KV, 1976, CANCER RES, V36, P4570; Stackievicz R, 2002, GYNECOL ONCOL, V87, P34, DOI 10.1006/gyno.2002.6799; Taylor CM, 1997, PLACENTA, V18, P451, DOI 10.1016/S0143-4004(97)80047-1; Troy TC, 2005, DEV DYNAM, V232, P293, DOI 10.1002/dvdy.20223	47	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139939	10.1371/journal.pone.0139939	http://dx.doi.org/10.1371/journal.pone.0139939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430881	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700130
J	Kurscheid, J; Millar, J; Abdurrahman, M; Ambarawati, IGAA; Suadnya, W; Yusuf, RP; Fenwick, S; Toribio, JALML				Kurscheid, Johanna; Millar, Joanne; Abdurrahman, Muktasam; Ambarawati, I. Gusti Agung Ayu; Suadnya, Wayan; Yusuf, Ria Puspa; Fenwick, Stanley; Toribio, Jenny-Ann L. M. L.			Knowledge and Perceptions of Highly Pathogenic Avian Influenza (HPAI) among Poultry Traders in Live Bird Markets in Bali and Lombok, Indonesia	PLOS ONE			English	Article							RISK PERCEPTIONS; H5N1; TRANSMISSION; PRODUCERS; RESPONSES; OUTBREAKS; PROGRESS; FLU	Highly Pathogenic Avian Influenza (HPAI) has been prevalent in Indonesia since 2003 causing major losses to poultry production and human deaths. Live bird markets are considered high risk areas due to the density of large numbers of mixed poultry species of unknown disease status. Understanding trader knowledge and perceptions of HPAI and biosecurity is critical to reducing transmission risk and controlling the disease. An interview-administered survey was conducted at 17 live bird markets on the islands of Bali and Lombok in 2008 and 2009. A total of 413 live poultry traders were interviewed. Respondents were mostly male (89%) with a mean age of 45 years (range: 19-81). The main source of AI information was TV (78%), although personal communication was also identified to be an important source, particularly among female traders (60%) and respondents from Bali (43%). More than half (58%) of live poultry traders interviewed knew that infected birds can transmit HPAI viruses but were generally unaware that viruses can be introduced to markets by fomites. Cleaning cages and disposing of sick and dead birds were recognized as the most important steps to prevent the spread of disease by respondents. Two thirds (n = 277) of respondents were unwilling to report sudden or suspicious bird deaths to authorities. Bali vendors perceive biosecurity to be of higher importance than Lombok vendors and are more willing to improve biosecurity within markets than traders in Lombok. Collectors and traders selling large numbers (>214) of poultry, or selling both chickens and ducks, have better knowledge of HPAI transmission and prevention than vendors or traders selling smaller quantities or only one species of poultry. Education was strongly associated with better knowledge but did not influence positive reporting behavior. Our study reveals that most live poultry traders have limited knowledge of HPAI transmission and prevention and are generally reluctant to report bird deaths. Greater efforts are needed to engage local government, market managers and traders in education and awareness programs, regulatory measures and incentive mechanisms. Understanding and evaluating the social responses to such an integrated approach could lead to more effective HPAI prevention and control.	[Kurscheid, Johanna] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia; [Millar, Joanne] Charles Sturt Univ, Fac Sci, Sch Environm Sci, Albury, NSW, Australia; [Abdurrahman, Muktasam; Suadnya, Wayan] Mataram Univ, Res Ctr Rural Development, Mataram, Indonesia; [Ambarawati, I. Gusti Agung Ayu; Yusuf, Ria Puspa] Udayana Univ, Fac Agr, Agribusiness Study Program, Denpasar, Bali, Indonesia; [Fenwick, Stanley] Tufts Univ, Cummings Sch Vet Med, Dept Infect Dis & Global Hlth, Boston, MA 02111 USA; [Toribio, Jenny-Ann L. M. L.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia	Murdoch University; Charles Sturt University; Universitas Mataram; Universitas Udayana; Tufts University; University of Sydney	Kurscheid, J (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA 6150, Australia.	Johanna.kurscheid@gmail.com	Toribio, Jenny-Ann LML/B-5032-2011; Abdurrahman, Muktasam/GQB-2748-2022; Kurscheid, Johanna/X-3956-2019	Kurscheid, Johanna/0000-0002-6858-7501; Millar, Joanne/0000-0002-3333-0538; , Muktasam A/0000-0002-2074-9284	Australian Centre for Internation Agricultural Research [AH/2006/156]	Australian Centre for Internation Agricultural Research	This work was supported by the Australian Centre for Internation Agricultural Research. Project ID AH/2006/156, URL: http://aciar.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate R, 2006, EMERG INFECT DIS, V12, P1762, DOI 10.3201/eid1211.060671; Abdelwhab EM, 2010, AVIAN DIS, V54, P911, DOI 10.1637/9099-100809-RESNOTE.1; Abdullahi M, 2009, INTERNET J INFECT DI, V8; Alders RG, 2009, WORLD POULTRY SCI J, V65, P529, DOI 10.1017/S0043933909000397; Alders R, 2014, ECOHEALTH, V11, P63, DOI 10.1007/s10393-013-0867-x; Australian Centre for International Agricultural Research (ACIAR), 2014, AH2006156 ACIAR; Azhar M, 2010, AVIAN DIS, V54, P749, DOI 10.1637/8713-031809-Reg.1; Barennes H, 2007, EMERG INFECT DIS, V13, P1126, DOI 10.3201/eid1307.061197; Basuno E, 2010, TRANSBOUND EMERG DIS, V57, P7, DOI 10.1111/j.1865-1682.2010.01121.x; Bleich EG, 2009, WORLD POULTRY SCI J, V65, P211, DOI 10.1017/S0043933909000154; Cardona C, 2009, POULTRY SCI, V88, P856, DOI 10.3382/ps.2008-00338; Dairo M. D., 2013, Journal of Public Health and Epidemiology, V5, P202; Desvaux S, 2011, TRANSBOUND EMERG DIS, V58, P492, DOI 10.1111/j.1865-1682.2011.01227.x; F.A.O, 2004, REC PREV CONTR ER HI; Fasina OF, 2009, EMERG INFECT DIS, V15, P616, DOI 10.3201/eid1504.070159; Food and Agriculture Organization of the United Nations (FAO), 2005, FAO OIE WHO CONS AV; Forster P, 2009, 17 STEPS; Fournie G, 2013, P NATL ACAD SCI USA, V110, P9177, DOI 10.1073/pnas.1220815110; Goodwin R, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-166; Hartono D, 2004, NAT WORKSH POST AV I; Hunter C, 2014, RURAL REMOTE HEALTH, V14; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kuo PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024157; Lee HJ, 2010, AVIAN DIS, V54, P738, DOI 10.1637/8785-040109-ResNote.1; MAFRA, 2021, PREVENTION CONTROL A; Manabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047560; Manabe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023711; McLeod A, 2009, WORLD POULTRY SCI J, V65, P217, DOI 10.1017/S0043933909000166; Morris RS, 2005, EPIDEMIOLOGY H5N1 AV; Naysmith S, 2014, ECOHEALTH, V11, P50, DOI 10.1007/s10393-013-0858-y; Neupane D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-76; Rushton J, 2005, WORLD POULTRY SCI J, V61, P491, DOI 10.1079/WPS200570; Samaan G, 2012, B WORLD HEALTH ORGAN, V90, P295, DOI 10.2471/BLT.11.090829; Santhia K, 2009, INFLUENZA OTHER RESP, V3, P81, DOI 10.1111/j.1750-2659.2009.00069.x; Simmons P., 2006, Agribusiness (New York), V22, P435, DOI 10.1002/agr.20101; Sims LD, 2007, AVIAN DIS, V51, P174, DOI 10.1637/7637-042806R.1; Sims LD, 2012, AVIAN DIS, V56, P829, DOI 10.1637/10198-041012-Review.1; Sumiarto B, 2008, 3 AFR IND TEAM HPAI; Thornton R, 2008, BALI LIVE BIRD MARKE; WHO, 2015, CUM NUMB CONF HUM CA; World Health Organization (WHO), 2014, H5N1 AV INFL TIM EV; Yakubu A., 2008, Asia-Pacific Journal of Rural Development, V18, P93; Yu Q, 2013, EMERG INFECT DIS, V19, P313, DOI 10.3201/eid1902.120251	43	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139917	10.1371/journal.pone.0139917	http://dx.doi.org/10.1371/journal.pone.0139917			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430785	Green Published, gold			2022-12-27	WOS:000362178700129
J	Liu, LX; Jin, XJ; Chen, N; Li, X; Li, P; Fu, CX				Liu, Luxian; Jin, Xinjie; Chen, Nan; Li, Xian; Li, Pan; Fu, Chengxin			Phylogeny of Morella rubra and Its Relatives (Myricaceae) and Genetic Resources of Chinese Bayberry Using RAD Sequencing	PLOS ONE			English	Article							INFERRING PHYLOGENY; FRUIT-QUALITY; DRAFT GENOME; SEQ DATA; GC-MS; ZUCC.; SIEB.; DIVERSITY; IDENTIFICATION; OLFACTOMETRY	Phylogenetic relationships among Chinese species of Morella (Myricaceae) are unresolved. Here, we use restriction site-associated DNA sequencing (RAD-seq) to identify candidate loci that will help in determining phylogenetic relationships among Morella rubra, M. adenophora, M. nana and M. esculenta. Three methods for inferring phylogeny, maximum parsimony (MP), maximum likelihood (ML) and Bayesian concordance, were applied to data sets including as many as 4253 RAD loci with 8360 parsimony informative variable sites. All three methods significantly favored the topology of (((M. rubra, M. adenophora), M. nana), M. esculenta). Two species from North America (M. cerifera and M. pensylvanica) were placed as sister to the four Chinese species. According to BEAST analysis, we deduced speciation of M. rubra to be at about the Miocene-Pliocene boundary (5.28 Ma). Intraspecific divergence in M. rubra occurred in the late Pliocene (3.39 Ma). From pooled data, we assembled 29378, 21902 and 23552 de novo contigs with an average length of 229, 234 and 234 bp for M. rubra, M. nana and M. esculenta respectively. The contigs were used to investigate functional classification of RAD tags in a BLASTX search. Additionally, we identified 3808 unlinked SNP sites across the four populations of M. rubra and discovered genes associated with fruit ripening and senescence, fruit quality and disease/defense metabolism based on KEGG database.	[Liu, Luxian; Jin, Xinjie; Chen, Nan; Li, Pan; Fu, Chengxin] Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China; [Liu, Luxian; Jin, Xinjie; Chen, Nan; Li, Pan; Fu, Chengxin] Zhejiang Univ, Lab Systemat & Evolutionary Bot & Biodivers, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Xian] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth,Dev & Qual Improvement, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Li, P (corresponding author), Zhejiang Univ, Key Lab Conservat Biol Endangered Wildlife, Minist Educ, Hangzhou 310058, Zhejiang, Peoples R China.	panli_zju@126.com			Special Fun for Agro-scientific Research [201203089]	Special Fun for Agro-scientific Research	This work was supported by the Special Fun for Agro-scientific Research in the Public Interest (grant no. 201203089) http://www.moa.gov.cn/zwllm/, C.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1991, MOL TECHNIQUES TAXON; [Anonymous], FLORA CHINA; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baird JR, 1970, THESIS U N CAROLINA; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Cariou M, 2013, ECOL EVOL, V3, P846, DOI 10.1002/ece3.512; Chen KunSong, 2004, Horticultural Reviews, V30, P83, DOI 10.1002/9780470650837.ch3; Chen XY, 1988, J ZHEJIANG U AGR LIF, V14, P239; Cheng H, 2015, FOOD RES INT, V72, P8, DOI 10.1016/j.foodres.2015.03.006; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Cronquist A, 1981, INTEGRATED SYSTEM CL, P214; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Fang ZX, 2009, FOOD CHEM, V113, P884, DOI 10.1016/j.foodchem.2008.07.102; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Ferguson A. R., 2007, Horticultural Reviews, V33, P1, DOI 10.1002/9780470168011.ch1; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo L, 2004, CHINESE AGR SCI B, V21, P359; Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066; Herbert J, 2005, NOVON, V15, P293; Herbert J, 2005, THESIS U ST ANDREWS; Hess JE, 2013, MOL ECOL, V22, P2898, DOI 10.1111/mec.12150; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huguet V, 2005, MOL PHYLOGENET EVOL, V34, P557, DOI 10.1016/j.ympev.2004.11.018; Janick J, PLANT BREEDING REV, V25, P5; Jiao Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-201; Kang WH, 2012, J FOOD SCI, V77, pC1030, DOI 10.1111/j.1750-3841.2012.02747.x; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JJ, 1999, CHINESE SCI BULL, V44, P2117, DOI 10.1007/BF03182692; Li L, 2013, MOL ECOL, V22, P5237, DOI 10.1111/mec.12466; Li XL, 2006, EUR FOOD RES TECHNOL, V223, P731, DOI 10.1007/s00217-006-0260-x; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Swofford D.L., 2002, PHYLOGENETIC ANAL US; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wang KT, 2011, FOOD CONTROL, V22, P82, DOI 10.1016/j.foodcont.2010.05.011; Wang KT, 2010, INT J FOOD MICROBIOL, V141, P11, DOI [10.1016/j.ijfoodmicro.2010.05.004, 10.1016/j.ij.foodmicro.2010.05.004]; Wang XQ, 2013, MOL ECOL RESOUR, V13, P938, DOI 10.1111/1755-0998.12136; White TA, 2013, MOL ECOL, V22, P2971, DOI 10.1111/mec.12343; Wolfe J. A., 1987, MIDDLE EOCENE DICOTY; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xie XB, 2011, AM J BOT, V98, pE93, DOI 10.3732/ajb.1000271; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yanthan M, 2011, FUNCT PLANT BIOL, V38, P738, DOI 10.1071/FP10248; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang SM, 2009, HORTSCIENCE, V44, P487, DOI 10.21273/HORTSCI.44.2.487; Zhang WS, 2008, EUR FOOD RES TECHNOL, V227, P1091, DOI 10.1007/s00217-008-0824-z; Zhang WS, 2007, POSTHARVEST BIOL TEC, V46, P195, DOI 10.1016/j.postharvbio.2007.05.001; Zhang WS, 2005, POSTHARVEST BIOL TEC, V37, P241, DOI 10.1016/j.postharvbio.2005.05.005; Zhang YaoJian, 1999, South China Fruits, V28, P24; Zhu CQ, 2013, INT J MOL SCI, V14, P3110, DOI 10.3390/ijms14023110	69	13	14	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139840	10.1371/journal.pone.0139840	http://dx.doi.org/10.1371/journal.pone.0139840			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431030	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700124
J	Pintus, E; Ros-Santaella, JL; Garde, JJ				Pintus, Eliana; Ros-Santaella, Jose Luis; Julian Garde, Jose			Beyond Testis Size: Links between Spermatogenesis and Sperm Traits in a Seasonal Breeding Mammal	PLOS ONE			English	Article							IBERIAN RED DEER; SERTOLI-CELLS; ROE DEER; MALE-FERTILITY; COMPETITION; SPERMATOZOA; EVOLUTION; CYCLE; EFFICIENCY; QUALITY	Spermatogenesis is a costly process that is expected to be under selection to maximise sperm quantity and quality. Testis size is often regarded as a proxy measure of sperm investment, implicitly overlooking the quantitative assessment of spermatogenesis. An enhanced understanding of testicular function, beyond testis size, may reveal further sexual traits involved in sperm quantity and quality. Here, we first estimated the inter-male variation in testicular function and sperm traits in red deer across the breeding and non-breeding seasons. Then, we analysed the relationships between the testis mass, eight parameters of spermatogenic function, and seven parameters of sperm quality. Our findings revealed that the Sertoli cell number and function parameters vary greatly between red deer males, and that spermatogenic activity co-varies with testis mass and sperm quality across the breeding and non-breeding seasons. For the first time in a seasonal breeder, we found that not only is the Sertoli cell number important in determining testis mass (r = 0.619, p = 0.007 and r = 0.248, p = 0.047 for the Sertoli cell number assessed by histology and cytology, respectively), but also sperm function (r = 0.703, p = 0.002 and r = 0.328, p = 0.012 for the Sertoli cell number assessed by histology and cytology, respectively). Testicular histology also revealed that a high Sertoli cell number per tubular cross-section is associated with high sperm production (r = 0.600, p = 0.009). Sperm production and function were also positively correlated (r = 0.384, p = 0.004), suggesting that these traits co-vary to maximise sperm fertilisation ability in red deer. In conclusion, our findings contribute to the understanding of the dynamics of spermatogenesis, and reveal new insights into the role of testicular function and the Sertoli cell number on testis size and sperm quality in red deer.	[Pintus, Eliana] Univ Sassari, Fac Vet Med, Dept Vet Clin & Pathol, I-07100 Sassari, Italy; [Pintus, Eliana] Czech Univ Life Sci, Dept Vet Sci, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic; [Ros-Santaella, Jose Luis] Czech Univ Life Sci, Fac Trop AgriSci, Dept Anim Sci & Food Proc, Prague, Czech Republic; [Julian Garde, Jose] SaBio IREC CSIC UCLM JCCM, Albacete, Spain	University of Sassari; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Pintus, E (corresponding author), Univ Sassari, Fac Vet Med, Dept Vet Clin & Pathol, I-07100 Sassari, Italy.	eliana.pintus27@gmail.com; rossantaella@gmail.com	López-Brea, José Julián Garde/AAE-5894-2019; Garde, Julian J/O-5607-2015; Ros-Santaella, José Luis/F-9890-2019; Pintus, Eliana/AAF-8383-2021	López-Brea, José Julián Garde/0000-0002-3667-6518; Garde, Julian J/0000-0002-3667-6518; Ros-Santaella, José Luis/0000-0002-4186-7730; Pintus, Eliana/0000-0002-8496-0820	CIGA grant [20145001]	CIGA grant	EP and JLRS were supported by the CIGA grant no. 20145001 (Czech University of Life Sciences, Prague, Czech Republic).	AMANN RP, 1981, J ANDROL, V2, P37; Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; BERNDTSON WE, 1987, BIOL REPROD, V37, P60, DOI 10.1095/biolreprod37.1.60; Budaev SV, 2010, ETHOLOGY, V116, P472, DOI 10.1111/j.1439-0310.2010.01758.x; Cameron E, 2007, AM NAT, V169, pE158, DOI 10.1086/516718; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; Comizzoli P, 2001, THERIOGENOLOGY, V56, P261, DOI 10.1016/S0093-691X(01)00561-1; Cooper TG, 2007, ASIAN J ANDROL, V9, P533, DOI 10.1111/j.1745-7262.2007.00285.x; Cooper TG, 2011, ASIAN J ANDROL, V13, P130, DOI 10.1038/aja.2010.97; Dadhich RK, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106708; de Kretser DM, 1998, HUM REPROD, V13, P1; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dominguez-Rebolledo AE, 2010, REPROD FERT DEVELOP, V22, P856, DOI 10.1071/RD09197; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; Fernandez-Santos MR, 2006, THERIOGENOLOGY, V66, P1931, DOI 10.1016/j.theriogenology.2006.05.012; Firman RC, 2010, EVOLUTION, V64, P1245, DOI 10.1111/j.1558-5646.2009.00894.x; Fitzpatrick JL, 2014, MOL HUM REPROD, V20, P1180, DOI 10.1093/molehr/gau067; Franca LR, 1998, BIOL REPROD, V59, P1371, DOI 10.1095/biolreprod59.6.1371; Garde JJ, 1998, ARCH ANDROLOGY, V41, P195, DOI 10.3109/01485019808994891; Goeritz F, 2003, THERIOGENOLOGY, V59, P1487, DOI 10.1016/S0093-691X(02)01201-3; GOMENDIO M, 1993, P ROY SOC B-BIOL SCI, V252, P7, DOI 10.1098/rspb.1993.0039; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Gomendio M, 2007, REPRODUCTION, V134, P19, DOI 10.1530/REP-07-0143; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Griswold MD, 1994, PHYSL REPROD, P949; Griswold MD, 2005, SERTOLI CELL BIOL, P15; GUINNESS F, 1971, J REPROD FERTIL, V27, P427, DOI 10.1530/jrf.0.0270427; Hess R. A., 2005, STRUCTURE SERTOLI CE, P19; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Holsberger DR, 2005, CELL TISSUE RES, V322, P133, DOI 10.1007/s00441-005-1082-z; Howroyd P, 2005, TOXICOL PATHOL, V33, P300, DOI 10.1080/01926230590896145; Jewgenow K, 2009, J ANDROL, V30, P460, DOI 10.2164/jandrol.108.006726; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; JOHNSON L, 1994, J REPROD FERTIL, V100, P315, DOI 10.1530/jrf.0.1000315; Johnson L, 2000, ANIM REPROD SCI, V60, P471, DOI 10.1016/S0378-4320(00)00108-1; Johnson L, 2008, ANIM REPROD SCI, V105, P23, DOI 10.1016/j.anireprosci.2007.11.029; Klonisch T, 2006, INT J ANDROL, V29, P122, DOI 10.1111/j.1365-2605.2005.00603.x; Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721; Leme DP, 2000, EQUINE VET J, V32, P444, DOI 10.2746/042516400777591156; Lupold S, 2013, EVOLUTION, V67, P3052, DOI 10.1111/evo.12132; Lupold S, 2011, REPRODUCTION, V141, P595, DOI 10.1530/REP-10-0501; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Luetjens CM, 2005, BIOL REV, V80, P475, DOI 10.1017/S1464793105006755; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Malo AF, 2005, P ROY SOC B-BIOL SCI, V272, P149, DOI 10.1098/rspb.2004.2933; Malo AF, 2006, BIOL LETTERS, V2, P246, DOI 10.1098/rsbl.2006.0449; Martinez-Pastor F, 2005, THERIOGENOLOGY, V63, P1857, DOI 10.1016/j.theriogenology.2004.08.006; Mossman JA, 2013, HUM REPROD, V28, P22, DOI 10.1093/humrep/des382; Nakanishi Y, 2004, BIOL PHARM BULL, V27, P13, DOI 10.1248/bpb.27.13; Neubauer K, 2004, BIOL REPROD, V71, P1517, DOI 10.1095/biolreprod.104.031062; Okwun OE, 1996, J REPROD FERTIL, V107, P137, DOI 10.1530/jrf.0.1070137; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Peirce EJ, 2001, REPRODUCTION, V121, P239, DOI 10.1530/rep.0.1210239; Pintus E, 2015, REPROD FERT DEVELOP, V27, P812, DOI 10.1071/RD13419; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; PUDNEY J, 1995, MICROSC RES TECHNIQ, V32, P459, DOI 10.1002/jemt.1070320602; QUINN GP, 2002, EXPT DESIGN DATA ANA, P443; Rajak SK, 2014, ASIAN AUSTRAL J ANIM, V27, P1554, DOI 10.5713/ajas.2014.14139; Ramm SA, 2014, BIOL REV, V89, P874, DOI 10.1111/brv.12084; Rowe M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015720; Scharer L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-143; Schulte-Hostedde AI, 2004, BEHAV ECOL SOCIOBIOL, V55, P272, DOI 10.1007/s00265-003-0707-z; Segatelli TM, 2004, J ANDROL, V25, P872; Sharpe Richard M., 1994, P1363; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Soler AJ, 2003, J ANDROL, V24, P393; Thomsen R, 2006, PRIMATES, V47, P272, DOI 10.1007/s10329-005-0171-7; Vahed K, 2012, ETHOLOGY, V118, P107, DOI 10.1111/j.1439-0310.2011.01991.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Xiong WP, 2009, REPRODUCTION, V137, P469, DOI 10.1530/REP-08-0343	71	16	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139240	10.1371/journal.pone.0139240	http://dx.doi.org/10.1371/journal.pone.0139240			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430740	gold, Green Published			2022-12-27	WOS:000362178700038
J	Rodrigues, V; Holzmuller, P; Puech, C; Wesonga, H; Thiaucourt, F; Manso-Silvan, L				Rodrigues, Valerie; Holzmuller, Philippe; Puech, Carinne; Wesonga, Hezron; Thiaucourt, Francois; Manso-Silvan, Lucia			Whole Blood Transcriptome Analysis of Mycoplasma mycoides Subsp mycoides-Infected Cattle Confirms Immunosuppression but Does Not Reflect Local Inflammation	PLOS ONE			English	Article							PERIPHERAL-BLOOD; IMMUNE-RESPONSES; SC INFECTION; BOVINE; EXPRESSION; INTERLEUKIN-1; RECEPTOR; BIOLOGY; SYSTEM; IMPACT	Contagious bovine pleuropneumonia (CBPP), caused by Mycoplasma mycoides subsp. mycoides (Mmm), is a severe respiratory disease of cattle responsible for major economic losses in sub-Saharan Africa. Disease control relies mainly on the use of empirically attenuated vaccines that provide limited protection. Thus, understanding the virulence mechanisms used by Mmm as well as the role of the host immune systemin disease development, persistence, and control is a prerequisite for the development of new, rationally designed control strategies. The aim of this study was to assess the use of whole blood transcriptome analysis to study cattle-Mmm interactions, starting by the characterization of the bovine response to Mmm infection during the acute form of the disease. For that purpose, we compared the transcriptome profile of whole blood from six cattle, before challenge by contact with Mmm infected animals and at the appearance of first clinical signs, using a bovine microarray. Functional analysis revealed that 680 annotated genes were differentially expressed, with an overwhelming majority of down-regulated genes characterizing an immunosuppression. The main bio-functions affected were "organismal survival", "cellular development, morphology and functions" and "cell-to cell signaling and interactions". These affected functions were consistent with the results of previous in vitro immunological studies. However, microarray and qPCR validation results did not highlight pro-inflammatory molecules (such as TNF alpha, TLR2, IL-12B and IL-6), whereas inflammation is one of the most characteristic traits of acute CBPP. This global gene expression pattern may be considered as the result, in blood, of the local pulmonary response and the systemic events occurring during acute CBPP. Nevertheless, to understand the immune events occurring during disease, detailed analyses on the different immune cell subpopulations, either in vivo, at the local site, or in vitro, will be required. Whole blood transcriptome analysis remains an interesting approach for the identification of bio-signatures correlating to recovery and protection, which should facilitate the evaluation and validation of novel vaccine formulations.	[Rodrigues, Valerie; Holzmuller, Philippe; Puech, Carinne; Thiaucourt, Francois; Manso-Silvan, Lucia] CIRAD, CMAEE UMR15, F-34398 Montpellier, France; [Rodrigues, Valerie; Holzmuller, Philippe; Puech, Carinne; Thiaucourt, Francois; Manso-Silvan, Lucia] INRA, CMAEE UMR1309, F-34398 Montpellier, France; [Wesonga, Hezron] Kenyan Agr Res Inst, Nairobi, Kenya	CIRAD; INRAE	Rodrigues, V (corresponding author), CIRAD, CMAEE UMR15, F-34398 Montpellier, France.	valerie.rodrigues@cirad.fr	Holzmuller, Philippe/F-7231-2019	Holzmuller, Philippe/0000-0002-8919-9081; Manso-Silvan, Lucia/0000-0002-5539-3804	European Union [DCI-FOOD/2009/226-409]	European Union(European Commission)	The work performed in France and Kenya was financially supported by the European Union, Grant DCI-FOOD/2009/226-409 Vaccines for neglected animal diseases in Africa: "VACNADA" coordinated by AU-IBAR Nairobi, Kenya. The support of the AU-IBAR Director General, Dr El Sawahli, and the VACNADA coordinator, Dr S. Wakhusama, were greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Asare AL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-474; Berry MPR, 2013, CURR OPIN IMMUNOL, V25, P579, DOI 10.1016/j.coi.2013.08.003; Bertin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068373; Bischof DF, 2008, INFECT IMMUN, V76, P263, DOI 10.1128/IAI.00938-07; Bloom CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070630; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Blanco FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041066; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Cottew, 1987, REV SCI TECH OIE, V6, P625; Crepaldi L, 2001, J IMMUNOL, V167, P2312, DOI 10.4049/jimmunol.167.4.2312; Dedieu L, 2006, SCAND J IMMUNOL, V64, P376, DOI 10.1111/j.1365-3083.2006.01799.x; Dedieu L, 2005, SCAND J IMMUNOL, V62, P528, DOI 10.1111/j.1365-3083.2005.01690.x; Dedieu L, 2005, VET IMMUNOL IMMUNOP, V107, P217, DOI 10.1016/j.vetimm.2005.04.011; Dedieu L, 2006, VET RES, V37, P579, DOI 10.1051/vetres:2006020; DEHOUX MS, 1994, AM J RESP CRIT CARE, V150, P710, DOI 10.1164/ajrccm.150.3.8087341; DINARELLO CA, 1991, BLOOD, V77, P1627; Duale Nur, 2012, BMC Res Notes, V5, P510, DOI 10.1186/1756-0500-5-510; Fernandez-Serrano S, 2003, CLIN DIAGN LAB IMMUN, V10, P813, DOI 10.1128/CDLI.10.5.813-820.2003; Gaurivaud P, 2014, FEMS MICROBIOL LETT, V359, P42, DOI 10.1111/1574-6968.12579; Hartel C, 2001, J IMMUNOL METHODS, V249, P63, DOI 10.1016/S0022-1759(00)00334-3; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Killick KE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-611; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Lahouassa H, 2008, MOL IMMUNOL, V45, P1153, DOI 10.1016/j.molimm.2007.07.011; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Meade KG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-400; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Niang M, 2006, VET RES, V37, P733, DOI 10.1051/vetres:2006032; Nikula T, 2013, TRANSL RES, V161, P181, DOI 10.1016/j.trsl.2012.10.003; OIE-WHO, 2014, MANUAL DIAGNOSTIC TE; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pilo P, 2007, VET J, V174, P513, DOI 10.1016/j.tvjl.2006.10.016; Puech C, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0382-0; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rhodes SG, 2000, IMMUNOLOGY, V99, P195, DOI 10.1046/j.1365-2567.2000.00944.x; Sacchini F, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-44; Sacchini F, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-77; Scacchia M, 2011, VET ITAL, V47, P407; Sheridan MP, 2012, VET IMMUNOL IMMUNOP, V145, P199, DOI 10.1016/j.vetimm.2011.11.006; Thiaucourt F, 2004, DEV BIOLOGICALS, V119, P99; Totte P, 2010, DEV COMP IMMUNOL, V34, P177, DOI 10.1016/j.dci.2009.09.005; Totte P, 2008, VET RES, V39, DOI 10.1051/vetres:2007046; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304	46	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139678	10.1371/journal.pone.0139678	http://dx.doi.org/10.1371/journal.pone.0139678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431338	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700098
J	Zolnik, CP; Falco, RC; Kolokotronis, SO; Daniels, TJ				Zolnik, Christine P.; Falco, Richard C.; Kolokotronis, Sergios-Orestis; Daniels, Thomas J.			No Observed Effect of Landscape Fragmentation on Pathogen Infection Prevalence in Blacklegged Ticks (Ixodes scapularis) in the Northeastern United States	PLOS ONE			English	Article							CLIMATE-BASED MODEL; LYME-DISEASE RISK; BORRELIA-BURGDORFERI; ANAPLASMA-PHAGOCYTOPHILUM; HABITAT FRAGMENTATION; BABESIA-MICROTI; DAMMINI ACARI; COMMUNITY COMPOSITION; FOREST FRAGMENTATION; RESERVOIR COMPETENCE	Pathogen prevalence within blacklegged ticks ( Ixodes scapularis Say, 1821) tends to vary across sites and geographic regions, but the underlying causes of this variation are not well understood. Efforts to understand the ecology of Lyme disease have led to the proposition that sites with higher host diversity will result in lower disease risk due to an increase in the abundance of inefficient reservoir species relative to the abundance of species that are highly competent reservoirs. Although the Lyme disease transmission cycle is often cited as a model for this "dilution effect hypothesis", little empirical evidence exists to support that claim. Here we tested the dilution effect hypothesis for two pathogens transmitted by the blacklegged tick along an urban-to-rural gradient in the northeastern United States using landscape fragmentation as a proxy for host biodiversity. Percent impervious surface and habitat fragment size around each site were determined to assess the effect of landscape fragmentation on nymphal blacklegged tick infection with Borrelia burgdorferi and Anaplasma phagocytophilum. Our results do not support the dilution effect hypothesis for either pathogen and are in agreement with the few studies to date that have tested this idea using either a landscape proxy or direct measures of host biodiversity.	[Zolnik, Christine P.; Kolokotronis, Sergios-Orestis] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Zolnik, Christine P.; Daniels, Thomas J.] Fordham Univ, Vector Ecol Lab, Louis Calder Ctr, Biol Field Stn, Armonk, NY 10504 USA; [Falco, Richard C.] Louis Calder Ctr, New York State Dept Hlth, Armonk, NY USA	Fordham University; Fordham University	Daniels, TJ (corresponding author), Fordham Univ, Vector Ecol Lab, Louis Calder Ctr, Biol Field Stn, Armonk, NY 10504 USA.	thdaniels@fordham.edu	Kolokotronis, Sergios-Orestis/GWM-5773-2022; Kolokotronis, Sergios-Orestis/A-1910-2009; Zolnik, Christine/O-2055-2015	Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Kolokotronis, Sergios-Orestis/0000-0003-3309-8465; Zolnik, Christine/0000-0002-6429-8112	Fordham University's Calder Center Research Grant; Kolokotronis lab	Fordham University's Calder Center Research Grant; Kolokotronis lab	Partial funding was provided by Fordham University's Calder Center Research Grant to CPZ and by the Kolokotronis lab.	Adelson ME, 2004, J CLIN MICROBIOL, V42, P2799, DOI 10.1128/JCM.42.6.2799-2801.2004; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; ANDERSON JF, 1988, ANN NY ACAD SCI, V539, P180, DOI 10.1111/j.1749-6632.1988.tb31852.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], 2014, R LANG ENV STAT COMP; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Bowers MA, 1997, J MAMMAL, V78, P999, DOI 10.2307/1383044; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Brownstein JS, 2003, ENVIRON HEALTH PERSP, V111, P1152, DOI 10.1289/ehp.6052; CDC, 2015, LYM DIS DAT 2014; CDC, 2015, LYM DIS SURV AV DAT; CDC, 2015, ANN CAS AN US 2013; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Courtney JW, 2003, J CLIN MICROBIOL, V41, P1569, DOI 10.1128/JCM.41.4.1569-1573.2003; DANIELS TJ, 1993, J MED ENTOMOL, V30, P1043, DOI 10.1093/jmedent/30.6.1043; Daniels TJ, 1998, APPL ENVIRON MICROB, V64, P4663; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Dunn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115494; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Guerra M, 2002, EMERG INFECT DIS, V8, P289, DOI 10.3201/eid0803.010166; Hersh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099348; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Khatchikian CE, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00134.1; Killilea ME, 2008, ECOHEALTH, V5, P167, DOI 10.1007/s10393-008-0171-3; Kuehn BM, 2013, JAMA-J AM MED ASSOC, V310, P1110, DOI 10.1001/jama.2013.278331; Levin ML, 2002, VECTOR-BORNE ZOONOT, V2, P125, DOI 10.1089/15303660260613693; Levin ML, 2000, INFECT IMMUN, V68, P2183, DOI 10.1128/IAI.68.4.2183-2186.2000; LEVINE JF, 1985, AM J TROP MED HYG, V34, P355, DOI 10.4269/ajtmh.1985.34.355; Lloyd-Smith JO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000180; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; Logiudice K, 2008, ECOLOGY, V89, P2841, DOI 10.1890/07-1047.1; Lotze J.-H., 1979, Mammalian Species, P1, DOI 10.2307/3503959; MAIN AJ, 1981, J MED ENTOMOL, V18, P487, DOI 10.1093/jmedent/18.6.487; Marchinton R.L., 1984, P129; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; MATHER TN, 1989, AM J EPIDEMIOL, V130, P143, DOI 10.1093/oxfordjournals.aje.a115306; MCDONNELL MJ, 1990, ECOLOGY, V71, P1232, DOI 10.2307/1938259; MINEAU P, 1977, CAN J ZOOL, V55, P465, DOI 10.1139/z77-062; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Ostfeld R, 2000, CAN J ZOOL, V78, P2061, DOI 10.1139/cjz-78-12-2061; Ostfeld RS, 2003, ECOLOGY, V84, P1421, DOI 10.1890/02-3125; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; Prusinski MA, 2014, J MED ENTOMOL, V51, P226, DOI 10.1603/ME13101; Randolph SE, 2012, PARASITOLOGY, V139, P847, DOI 10.1017/S0031182012000200; Salkeld DJ, 2013, ECOL LETT, V16, P679, DOI 10.1111/ele.12101; Schmidt KA, 2001, ECOLOGY, V82, P609, DOI 10.1890/0012-9658(2001)082[0609:BATDEI]2.0.CO;2; Schulze TL, 2013, J MED ENTOMOL, V50, P379, DOI 10.1603/ME12088; Sonenshine DE, 2005, TICK-BORNE DISEASES OF HUMANS, P12; States SL, 2014, INFECT GENET EVOL, V27, P566, DOI 10.1016/j.meegid.2014.04.014; Steiner FE, 2008, J MED ENTOMOL, V45, P289, DOI 10.1603/0022-2585(2008)45[289:IACROA]2.0.CO;2; Stickel L, 1968, SPECIAL PUBLICATION, V2, P412; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Turney S, 2014, ECOLOGY, V95, P3244, DOI 10.1890/14-0980.1; Watson T.G., 1976, Journal Wildl Dis, V12, P66; WILSON ML, 1985, ANN ENTOMOL SOC AM, V78, P172, DOI 10.1093/aesa/78.2.172; WILSON ML, 1988, J MED ENTOMOL, V25, P224, DOI 10.1093/jmedent/25.4.224; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Xian G, 2011, PHOTOGRAMM ENG REM S, V77, P758	63	17	17	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139473	10.1371/journal.pone.0139473	http://dx.doi.org/10.1371/journal.pone.0139473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430734	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700066
J	Bolland, MJ; Grey, A; Gamble, GD; Reid, IR				Bolland, Mark J.; Grey, Andrew; Gamble, Greg D.; Reid, Ian R.			Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL ESTROGEN; CARDIOVASCULAR-DISEASE; BETA-CAROTENE; CALCIUM; RISK; HOMOCYSTEINE; CANCER; TRIAL	Background Observational studies (OS) and randomized controlled trials (RCTs) often report discordant results. In the Women's Health Initiative Calcium and Vitamin D (WHI CaD) RCT, women were randomly assigned to CaD or placebo, but were permitted to use personal calcium and vitamin D supplements, creating a unique opportunity to compare results from randomized and observational analyses within the same study. Methods WHI CaD was a 7-year RCT of 1g calcium/400IU vitamin D daily in 36,282 post-menopausal women. We assessed the effects of CaD on cardiovascular events, death, cancer and fracture in a randomized design-comparing CaD with placebo in 43% of women not using personal calcium or vitamin D supplements-and in a observational design-comparing women in the placebo group (44%) using personal calcium and vitamin D supplements with non-users. Incidence was assessed using Cox proportional hazards models, and results from the two study designs deemed concordant if the absolute difference in hazard ratios was <= 0.15. We also compared results from WHI CaD to those from the WHI Observational Study(WHI OS), which used similar methodology for analyses and recruited from the same population. Results In WHI CaD, for myocardial infarction and stroke, results of unadjusted and 6/8 covariate-controlled observational analyses (age-adjusted, multivariate-adjusted, propensity-adjusted, propensity-matched) were not concordant with the randomized design results. For death, hip and total fracture, colorectal and total cancer, unadjusted and covariate-controlled observational results were concordant with randomized results. For breast cancer, unadjusted and age-adjusted observational results were concordant with randomized results, but only 1/3 other covariate-controlled observational results were concordant with randomized results. Multivariate-adjusted results from WHI OS were concordant with randomized WHI CaD results for only 4/8 endpoints. Conclusions Results of randomized analyses in WHI CaD were concordant with observational analyses for 5/8 endpoints in WHI CaD and 4/8 endpoints in WHI OS.	[Bolland, Mark J.; Grey, Andrew; Gamble, Greg D.; Reid, Ian R.] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland	Bolland, MJ (corresponding author), Univ Auckland, Dept Med, Auckland, New Zealand.	m.bolland@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; Gamble, Greg/0000-0003-0412-3203; Reid, Ian/0000-0001-6021-5458	Health Research Council (HRC) of New Zealand; Sir Charles Hercus Health Research Fellowship	Health Research Council (HRC) of New Zealand(Health Research Council of New Zealand); Sir Charles Hercus Health Research Fellowship	AG, and IR have received funding from the Health Research Council (HRC) of New Zealand. MB is the recipient of a Sir Charles Hercus Health Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Bergstralh EJ, 1996, EPIDEMIOLOGY, V7, P331; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Chlebowski RT, 2008, JNCI-J NATL CANCER I, V100, P1581, DOI 10.1093/jnci/djn360; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Grodstein F, 1996, NEW ENGL J MED, V335, P453, DOI 10.1056/NEJM199608153350701; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ioannidis JPA, 2001, JAMA-J AM MED ASSOC, V286, P821, DOI 10.1001/jama.286.7.821; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; LaCroix AZ, 2009, J GERONTOL A-BIOL, V64, P559, DOI 10.1093/gerona/glp006; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Manson JE, 2012, CONTEMP CLIN TRIALS, V33, P159, DOI 10.1016/j.cct.2011.09.009; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; PETO R, 1981, NATURE, V290, P201, DOI 10.1038/290201a0; Prentice RL, 2013, OSTEOPOROSIS INT, V24, P567, DOI 10.1007/s00198-012-2224-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; Tai V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110403; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302	24	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139975	10.1371/journal.pone.0139975	http://dx.doi.org/10.1371/journal.pone.0139975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440516	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300089
J	Kulkarni, KG; Panchang, R				Kulkarni, Kantimati G.; Panchang, Rajani			New Insights into Polychaete Traces and Fecal Pellets: Another Complex Ichnotaxon?	PLOS ONE			English	Article							SEDIMENTS; ENVIRONMENTS; BURROWS	Neoichnological observations help refine paleoichnological records. The present study reports extensive observations on the distribution, morphology, occurrence and association of burrows and fecal pellets of the polychaete Nereis diversicolor in the Kundalika Estuary on the west coast of India. Our holistic study of these modern-day traces suggests it to be a complex trace arising from domichnial, fodinichnial and possibly pascichnial behavior of polychaetes. The study for the first time reports extensive fecal pellet production, distribution and their preservation as thick stacks in modern estuarine environment. These observations testify the fossilization potential of pellets and provide an explanation to their origin in the geological record. Their occurrence as strings associated with mounds not only suggests pascichnial behaviour of polychaetes but also allows the assignment of post-Paleozoic Tomaculum to the activity of polychaete worms. The production of fecal pellets in such large quantities plays a major role in increasing the average grain size of the substrate of these estuarine tidal flats, thereby improving aeration within the substrate.	[Kulkarni, Kantimati G.; Panchang, Rajani] Agharkar Res Inst MACS ARI, Biodivers & Palaeobiol Grp, Pune, Maharashtra, India	Department of Science & Technology (India); Agharkar Research Institute (ARI)	Panchang, R (corresponding author), Indian Inst Sci Educ & Res, Earth & Climate Sci, Pune, Maharashtra, India.	rajani@iiserpune.ac.in			Agharkar Research Institute Fellowship; Department of Science and Technology SERC (WOS-A Scheme), Ministry of Science and Technology, New Delhi, India [100/(IFD)/6854/2011-2012]	Agharkar Research Institute Fellowship(Department of Science & Technology (India)); Department of Science and Technology SERC (WOS-A Scheme), Ministry of Science and Technology, New Delhi, India	Field visits and project implementation costs were funded to KGK by the Agharkar Research Institute Fellowship. Initial funding for pilot studies and sedimentological analysis was awarded to RP by the Department of Science and Technology SERC (WOS-A Scheme), Ministry of Science and Technology, New Delhi, India vide sanction No. 100/(IFD)/6854/2011-2012.	BALUK W, 1979, Acta Geologica Polonica, V29, P339; Bromley RG, 2003, PALAEOGEOGR PALAEOCL, V192, P157, DOI 10.1016/S0031-0182(02)00684-3; Chamberlain C.K., 1977, Nevada Bureau of Mines and Geology Bulletin, V90, P1; Frey R.W., 1970, U KANSAS PALAEONTOLO, V53, P5; Friis H, 1995, B GEOL SOC DENMARK, V42, P68; Groom T, 1902, GEOLOGICAL SOC LONDO, V58, P89; Gurav SS, 2014, P 9 INT C JUR SYST 2, V8, P65; HATAI K, 1970, Saito Ho-On Kai Museum Research Bulletin, V39, P7; Howard JD, 1973, NEOGENE GEORGIA COAS, P1; Howard JD, 1975, ESTUARIES GEORGIA CO, V7, P33; Hoyt JH, 1964, DELTAIC SHALLOW MARI, VI, P170; Kedzierski M, 2015, BIOGEOSCIENCES, V12, P2301, DOI 10.5194/bg-12-2301-2015; Knaust D, 2008, PALAEONTOL Z, V82, P347, DOI 10.1007/BF03184427; Massalongo A., 1856, STUDII PALAEONTOLOGI; Mazumdar A, 2011, MAR GEOL, V289, P117, DOI 10.1016/j.margeo.2011.09.003; Palomo G, 2000, B MAR SCI, V67, P249; Patel SJ, 2009, J GEOL SOC INDIA, V74, P233, DOI 10.1007/s12594-009-0125-6; Pearson EA, 2013, P 1 INT C WAST DISP; Pickerill Ron K., 1995, Ichnos, V4, P53; PRYOR WA, 1975, GEOL SOC AM BULL, V86, P1244, DOI 10.1130/0016-7606(1975)86<1244:BSAAOA>2.0.CO;2; Sundbck K, 2005, INTERACTIONS MACROAN, DOI [10.1029/CE060p0007, DOI 10.1029/CE060P0007]; Uchman A., 1995, BERINGERIA, V15, P3, DOI DOI 10.1016/0031-0182(81)90053-5; Uchman A, 2013, PALAEOGEOGR PALAEOCL, V370, P222, DOI 10.1016/j.palaeo.2012.12.013; Vizcaino D, 2004, GEOBIOS-LYON, V37, P277, DOI 10.1016/j.geobios.2003.08.002; WEIMER RJ, 1964, J PALEONTOL, V38, P761	25	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139933	10.1371/journal.pone.0139933	http://dx.doi.org/10.1371/journal.pone.0139933			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439262	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300079
J	Staudacher, DL; Kaiser, M; Hehrlein, C; Bode, C; Ahrens, I				Staudacher, Dawid L.; Kaiser, Michael; Hehrlein, Christoph; Bode, Christoph; Ahrens, Ingo			Triple Antithrombotic Therapy after Percutaneous Coronary Intervention (PCI) in Patients with Indication for Oral Anticoagulation: Data from a Single Center Registry	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; RISK STRATIFICATION; CONTROLLED-TRIAL; BLEEDING RISK; CLOPIDOGREL; ASPIRIN; SCORE; GUIDELINES; MANAGEMENT	Antithrombotic therapy consisting of a dual anti-platelet therapy (DAPT) and oral anti-coagulation (OAC) with a vitamin k antagonist is often referred to as triple therapy. This combined anticoagulation is applied in patients undergoing coronary artery stent implantation while also having an indication for OAC. Triple therapy increases the risk for bleeding events compared to either DAPT or OAC alone and thereby might be associated with adverse outcomes. Clinical data on the frequency of bleeding events in patients on triple therapy from clinical trials derives from pre-selected patients and may differ from the real world patients. We report data on patient characteristics and bleeding incidence of patients dismissed on triple therapy from a single university hospital. Within the time span from January 2000 to December 2012, we identified a total of 213 patients undergoing PCI who were prescribed a triple therapy for at least 4 weeks (representing 0.86% of all patients treated). The usage of triple therapy significantly increased over the observed time period. The average CHA(2)DS(2)-VASc Score was 3.1 +/- 1.1 with an average HAS-BLED score of 2.5 +/- 0.86 representing a high-risk group for thromboembolic events as well as considerable risk for bleeding events. An on-treatment bleeding incidence of 9.4% was detected, with gastrointestinal and airway bleeding being the most frequent (5.1% and 1.4%, respectively). This is consistent with data from clinical trials and confirms the high risk of bleeding in patients on DAPT plus OAC. 29.0% of all patients receiving triple therapy had an indication for OAC other than non-valvular atrial fibrillation. This substantial patient group is underrepresented by clinical trials and needs further attention.	[Staudacher, Dawid L.; Kaiser, Michael; Hehrlein, Christoph; Bode, Christoph; Ahrens, Ingo] Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, D-79106 Freiburg, Germany	University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Staudacher, DL (corresponding author), Univ Freiburg, Ctr Heart, Dept Cardiol & Angiol 1, Hugstetter Str 55, D-79106 Freiburg, Germany.	dawid.staudacher@universitaets-herzzentrum.de	Staudacher, Dawid L./AAF-5263-2021	Staudacher, Dawid L./0000-0002-9423-9682	German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing.	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Apostolakis S, 2012, J AM COLL CARDIOL, V60, P861, DOI 10.1016/j.jacc.2012.06.019; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hansen ML, 2010, ARCH INTERN MED, V170, P1433, DOI 10.1001/archinternmed.2010.271; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Rossini R, 2008, AM J CARDIOL, V102, P1618, DOI 10.1016/j.amjcard.2008.08.021; Rubboli A, 2009, J CARDIOVASC MED, V10, P200, DOI 10.2459/JCM.0b013e3283212f07; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541	14	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140101	10.1371/journal.pone.0140101	http://dx.doi.org/10.1371/journal.pone.0140101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439131	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300097
J	Lefler, S; Cohen, MA; Kantor, G; Cheishvili, D; Even, A; Birger, A; Turetsky, T; Gil, Y; Even-Ram, S; Aizenman, E; Bashir, N; Maayan, C; Razin, A; Reubinoff, BE; Weil, M				Lefler, Sharon; Cohen, Malkiel A.; Kantor, Gal; Cheishvili, David; Even, Aviel; Birger, Anastasya; Turetsky, Tikva; Gil, Yaniv; Even-Ram, Sharona; Aizenman, Einat; Bashir, Nibal; Maayan, Channa; Razin, Aharon; Reubinoff, Benjamim E.; Weil, Miguel			Familial Dysautonomia (FD) Human Embryonic Stem Cell Derived PNS Neurons Reveal that Synaptic Vesicular and Neuronal Transport Genes Are Directly or Indirectly Affected by IKBKAP Downregulation	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; ELONGATOR COMPLEX; SPLICING DEFECT; MODEL REVEALS; NEURAL CREST; MOUSE MODEL; KINETIN; EXPRESSION; DIAGNOSIS; MUTATION	A splicing mutation in the IKBKAP gene causes Familial Dysautonomia (FD), affecting the IKAP protein expression levels and proper development and function of the peripheral nervous system (PNS). Here we found new molecular insights for the IKAP role and the impact of the FD mutation in the human PNS lineage by using a novel and unique human embryonic stem cell (hESC) line homozygous to the FD mutation originated by pre implantation genetic diagnosis (PGD) analysis. We found that IKBKAP downregulation during PNS differentiation affects normal migration in FD-hESC derived neural crest cells (NCC) while at later stages the PNS neurons show reduced intracellular colocalization between vesicular proteins and IKAP. Comparative wide transcriptome analysis of FD and WT hESC-derived neurons together with the analysis of human brains from FD and WT 12 weeks old embryos and experimental validation of the results confirmed that synaptic vesicular and neuronal transport genes are directly or indirectly affected by IKBKAP downregulation in FD neurons. Moreover we show that kinetin (a drug that corrects IKBKAP alternative splicing) promotes the recovery of IKAP expression and these IKAP functional associated genes identified in the study. Altogether, these results support the view that IKAP might be a vesicular like protein that might be involved in neuronal transport in hESC derived PNS neurons. This function seems to be mostly affected in FD-hESC derived PNS neurons probably reflecting some PNS neuronal dysfunction observed in FD.	[Lefler, Sharon; Kantor, Gal; Even, Aviel; Weil, Miguel] Tel Aviv Univ, Lab Neurodegenerat Dis & Personalized Med, Dept Cell Res & Immunol, George S Wise Fac Life Sci,Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Cohen, Malkiel A.; Birger, Anastasya; Turetsky, Tikva; Gil, Yaniv; Even-Ram, Sharona; Reubinoff, Benjamim E.] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, Jerusalem, Israel; [Cheishvili, David; Razin, Aharon] Hebrew Univ Jerusalem, Sch Med, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel; [Aizenman, Einat; Reubinoff, Benjamim E.] Hadassah Hebrew Univ, Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel; [Bashir, Nibal] Hebrew Univ Jerusalem, Sch Med, Hadassah Hosp Mt Scopus, Dept Obstet & Gynecol, IL-91010 Jerusalem, Israel; [Maayan, Channa] Hebrew Univ Jerusalem, Sch Med, Hadassah Hosp Mt Scopus, Dept Pediat, IL-91010 Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Reubinoff, BE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, Jerusalem, Israel.	BenR@hadassah.org.il; miguelw@tauex.tau.ac.il	Cohen, Malkiel/AAE-1115-2020; Cheishvili, David/AAL-1915-2020	Even-Ram, Sharona/0000-0002-5540-3822; Reubinoff, Benjamin/0000-0003-0353-1299; Cohen, Malkiel/0000-0002-4187-691X	FD research consortium (FD Hope, FD Foundation Inc., FD Israel Foundation); Israel Science Foundation (ISF grant) [1491/09]; FD Israel Foundation	FD research consortium (FD Hope, FD Foundation Inc., FD Israel Foundation); Israel Science Foundation (ISF grant); FD Israel Foundation	The work was supported by the FD research consortium (FD Hope, FD Foundation Inc., FD Israel Foundation) and by the Israel Science Foundation (ISF grant 1491/09) for MW and by FD Israel Foundation for AR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abashidze A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113428; Abdel-Fattah W, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004931; Anderson SL, 2003, BIOCHEM BIOPH RES CO, V306, P303, DOI 10.1016/S0006-291X(03)00971-9; Anderson SL, 2001, AM J HUM GENET, V68, P753, DOI 10.1086/318808; Axelrod FB, 2004, MUSCLE NERVE, V29, P352, DOI 10.1002/mus.10499; Axelrod FB, 2011, PEDIATR RES, V70, P480, DOI 10.1203/PDR.0b013e31822e1825; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Binder E, 2011, J NEUROSCI, V31, P6379, DOI 10.1523/JNEUROSCI.0129-11.2011; Blumenfeld A, 1999, AM J HUM GENET, V64, P1110, DOI 10.1086/302339; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; Bochner R, 2013, HUM MOL GENET, V22, P2785, DOI 10.1093/hmg/ddt126; Boone N, 2012, HUM MUTAT, V33, P530, DOI 10.1002/humu.22010; Boone N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015590; Braude P, 2002, NAT REV GENET, V3, P941, DOI 10.1038/nrg953; Cheishvili D, 2011, HUM MOL GENET, V20, P1585, DOI 10.1093/hmg/ddr036; Chen CC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000561; Chen RHC, 2013, J BIOL CHEM, V288, P7438, DOI 10.1074/jbc.M112.439497; Chen YT, 2009, MOL CELL BIOL, V29, P736, DOI 10.1128/MCB.01313-08; Cimadamore F, 2011, CELL STEM CELL, V8, P538, DOI 10.1016/j.stem.2011.03.011; Cohen M. A., 2007, CURR PROTOC CELL BIO; Cohen-Kupiec R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019147; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cuajungco MP, 2003, AM J HUM GENET, V72, P749, DOI 10.1086/368263; Del Barrio MG, 2004, DEV DYNAM, V229, P136, DOI 10.1002/dvdy.10456; Dietrich P, 2012, HUM MOL GENET, V21, P5078, DOI 10.1093/hmg/dds354; Dietrich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027015; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; George L, 2013, P NATL ACAD SCI USA, V110, P18698, DOI 10.1073/pnas.1308596110; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Hims MM, 2007, GENOMICS, V90, P389, DOI 10.1016/j.ygeno.2007.05.012; Hims MM, 2007, J MOL MED, V85, P149, DOI 10.1007/s00109-006-0137-2; Holmberg C, 2002, J BIOL CHEM, V277, P31918, DOI 10.1074/jbc.M200719200; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Hunnicutt BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032050; Jackson MZ, 2014, DEVELOPMENT, V141, P2452, DOI 10.1242/dev.107797; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lin FJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003516; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Medkova M, 2006, MOL BIOL CELL, V17, P2757, DOI 10.1091/mbc.E05-10-0917; Mehlgarten C, 2010, MOL MICROBIOL, V76, P1082, DOI 10.1111/j.1365-2958.2010.07163.x; Niclis JC, 2009, REPROD BIOMED ONLINE, V19, P106, DOI 10.1016/S1472-6483(10)60053-3; Nowack A, 2010, AM J PHYSIOL-CELL PH, V299, pC960, DOI 10.1152/ajpcell.00259.2010; Pickering SJ, 2005, REPROD BIOMED ONLINE, V10, P390, DOI 10.1016/S1472-6483(10)61801-9; Pros E, 2010, EUR J HUM GENET, V18, P614, DOI 10.1038/ejhg.2009.212; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; RILEY CM, 1949, PEDIATRICS, V3, P468; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Simson GG, 2009, PEDIATR RES, V65, P341, DOI 10.1203/PDR.0b013e318194fd52; Slaugenhaupt SA, 2004, HUM MOL GENET, V13, P429, DOI 10.1093/hmg/ddh046; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turetsky T, 2008, HUM REPROD, V23, P46, DOI 10.1093/humrep/dem351; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Valensi-Kurtz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009290; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3	61	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138807	10.1371/journal.pone.0138807	http://dx.doi.org/10.1371/journal.pone.0138807			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437462	Green Published, gold			2022-12-27	WOS:000362499200007
J	Schar, M; Ding, HY; Herzka, DA				Schaer, Michael; Ding, Haiyan; Herzka, Daniel A.			Improvement in B-1(+) Homogeneity and Average Flip Angle Using Dual-Source Parallel RF Excitation for Cardiac MRI in Swine Hearts	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; TRANSMISSION; INFARCTION; BODY	Cardiac MRI may benefit from increased polarization at high magnetic field strength of 3 Tesla but is challenged by increased field inhomogeneity. Initial human studies have shown that the radiofrequency (RF) excitation field (B-1(+)) used for signal excitation in the heart is both inhomogeneous and significantly lower than desired, potentially leading to image artifacts and biased quantitative measures. Recently, multi-channel transmit systems have been introduced allowing localized patient specific RF shimming based on acquired calibration B-1(+) maps. Some prior human studies have shown lower than desired mean flip angles in the hearts of large patients even after RF shimming. Here, 100 cardiac B-1(+) map pairs before and after RF shimming were acquired in 55 swine. The mean flip angle and the coefficient of variation (CV) of the flip angle in the heart were determined before and after RF shimming. Mean flip angle, CV, and RF shim values (power ratio and phase difference between the two transmit channels) were tested for correlation with cross sectional body area and the Right-Left/Anterior-Posterior ratio. RF shimming significantly increased the mean flip angle in swine heart from 74.4 +/- 6.7% (mean +/- standard deviation) to 94.7 +/- 4.8% of the desired flip angle and significantly reduced CV from 0.11 +/- 0.03 to 0.07 +/- 0.02 (p<<1e-10 for both). These results compare well with several previous human studies, except that the mean flip angle in the human heart only improved to 89% with RF shimming, possibly because the RF shimming routine does not consider safety constraints in very large patients. Additionally, mean flip angle decreased and CV increased with larger cross sectional body area, however, the RF shimming parameters did not correlate with cross sectional body area. RF shim power ratio correlated weakly with Right-Left/Anterior-Posterior ratio but phase difference did not, further substantiating the need for subject specific cardiac RF shimming.	[Schaer, Michael] Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Div Magnet Resonance Res, Baltimore, MD 21218 USA; [Schaer, Michael] Philips Healthcare, Clin Sci MRI, Cleveland, OH USA; [Ding, Haiyan; Herzka, Daniel A.] Johns Hopkins Sch Med, Biomed Engn, Baltimore, MD USA; [Ding, Haiyan] Tsinghua Univ, Biomed Engn, Beijing 100084, Peoples R China	Johns Hopkins University; Philips; Philips Healthcare; Johns Hopkins University; Johns Hopkins Medicine; Tsinghua University	Schar, M (corresponding author), Johns Hopkins Univ, Russell H Morgan Dept Radiol & Radiol Sci, Div Magnet Resonance Res, Baltimore, MD 21218 USA.	michael.schar@gmail.com	Schär, Michael/C-8087-2015	Schär, Michael/0000-0002-7044-9941; Herzka, Daniel/0000-0002-9400-7814	American Heart Association [AHA-11SDG5280025]; NIH [R01 HL094610]; Philips Healthcare; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094610] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philips Healthcare; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the American Heart Association (AHA-11SDG5280025), NIH R01 HL094610, and Prof. Herzka's start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MS was an employee of Philips Healthcare until May 2014. Philips Healthcare provided support in the form of salary for author MS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Childs AS, 2013, MAGN RESON MATER PHY, V26, P401, DOI 10.1007/s10334-012-0360-5; Cunningham CH, 2006, MAGN RESON MED, V55, P1326, DOI 10.1002/mrm.20896; Ding HY, 2015, MAGN RESON MED, V74, P803, DOI 10.1002/mrm.25458; Gharib AM, 2008, CURR PROBL DIAGN RAD, V37, P49, DOI 10.1067/j.cpradiol.2007.11.003; Greenman RL, 2003, J MAGN RESON IMAGING, V17, P648, DOI 10.1002/jmri.10316; HOLM S, 1979, SCAND J STAT, V6, P65; Jia HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066946; Jogiya R, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0090-0; Kahlert P, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-21; Krishnamurthy R, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-68; Lee VS, 2007, RADIOLOGY, V244, P692, DOI 10.1148/radiol.2443060582; Luechinger R, 2005, EUR HEART J, V26, P376, DOI 10.1093/eurheartj/ehi009; Millon A, 2014, VASCULAR, V22, P221, DOI 10.1177/1708538113478758; Mueller A, 2012, RADIOLOGY, V263, P77, DOI 10.1148/radiol.11110347; Oshinski JN, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-55; Rasper M, 2015, CLIN IMAG, V39, P231, DOI 10.1016/j.clinimag.2014.11.007; Schar M, 2010, MAGN RESON MED, V63, P419, DOI 10.1002/mrm.22234; Singerman RW, 1997, J MAGN RESON, V125, P72, DOI 10.1006/jmre.1996.1073; Soleimanifard S, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-85; Sung K, 2008, J MAGN RESON IMAGING, V27, P643, DOI 10.1002/jmri.21253; Vergara GR, 2011, HEART RHYTHM, V8, P295, DOI 10.1016/j.hrthm.2010.10.032; Yang YM, 2011, CONTRAST MEDIA MOL I, V6, P426, DOI 10.1002/cmmi.438	22	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139859	10.1371/journal.pone.0139859	http://dx.doi.org/10.1371/journal.pone.0139859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436658	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200064
J	Jain, A; Rakhi, NK; Bagler, G				Jain, Anupam; Rakhi, N. K.; Bagler, Ganesh			Analysis of Food Pairing in Regional Cuisines of India	PLOS ONE			English	Article							SPICES	Any national cuisine is a sum total of its variety of regional cuisines, which are the cultural and historical identifiers of their respective regions. India is home to a number of regional cuisines that showcase its culinary diversity. Here, we study recipes from eight different regional cuisines of India spanning various geographies and climates. We investigate the phenomenon of food pairing which examines compatibility of two ingredients in a recipe in terms of their shared flavor compounds. Food pairing was enumerated at the level of cuisine, recipes as well as ingredient pairs by quantifying flavor sharing between pairs of ingredients. Our results indicate that each regional cuisine follows negative food pairing pattern; more the extent of flavor sharing between two ingredients, lesser their co-occurrence in that cuisine. We find that frequency of ingredient usage is central in rendering the characteristic food pairing in each of these cuisines. Spice and dairy emerged as the most significant ingredient classes responsible for the biased pattern of food pairing. Interestingly while individual spices contribute to negative food pairing, dairy products on the other hand tend to deviate food pairing towards positive side. Our data analytical study highlighting statistical properties of the regional cuisines, brings out their culinary fingerprints that could be used to design algorithms for generating novel recipes and recipe recommender systems. It forms a basis for exploring possible causal connection between diet and health as well as prospection of therapeutic molecules from food ingredients. Our study also provides insights as to how big data can change the way we look at food.	[Jain, Anupam] Indian Inst Technol Jodhpur, Ctr Syst Sci, Jodhpur, Rajasthan, India; [Rakhi, N. K.; Bagler, Ganesh] Indian Inst Technol Jodhpur, Ctr Biol Inspired Syst Sci, Jodhpur, Rajasthan, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Jodhpur	Bagler, G (corresponding author), Indian Inst Technol Jodhpur, Ctr Biol Inspired Syst Sci, Jodhpur, Rajasthan, India.	bagler@iitj.ac.in	PAN, ZEQIANG/X-6341-2018; Bagler, Ganesh/A-1102-2009	Bagler, Ganesh/0000-0003-1924-6070	seed grant support from Indian Institute of Technology Jodhpur [IITJ/SEED/2014/0003]; Indian Institute of Technology Jodhpur; Ministry of Human Resource Development, Government of India	seed grant support from Indian Institute of Technology Jodhpur; Indian Institute of Technology Jodhpur; Ministry of Human Resource Development, Government of India(Ministry of Human Resource Development (MHRD), Government of India)	G.B. acknowledges the seed grant support from Indian Institute of Technology Jodhpur 298 (IITJ/SEED/2014/0003). A.J. and R.N.K. thank the Ministry of Human Resource 299 Development, Government of India as well as Indian Institute of Technology Jodhpur 300 for scholarship and Junior Research Fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L., 2012, RECIPE RECOMMENDATIO; Ahn YY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00196; Ahnert S. E., 2013, FLAVOUR, V2, P2, DOI DOI 10.1186/2044--7248--2--4; [Anonymous], 2012, SCIENCE, V337, P288, DOI 10.1126/science.337.6092.288-a; APPADURAI A, 1988, COMP STUD SOC HIST, V30, P3, DOI 10.1017/S0010417500015024; Atridevji Gupt, 1948, SWAM AGN CHAR SAMH; Billing J, 1998, Q REV BIOL, V73, P3, DOI 10.1086/420058; Birch LL, 1999, ANNU REV NUTR, V19, P41, DOI 10.1146/annurev.nutr.19.1.41; Blumenthal H., 2008, BIG FAT DUCK COOKBOO; Burdock G. A., 2010, FENAROLIS HDB FLAVOR; Fonseca-Azevedo K, 2012, P NATL ACAD SCI USA, V109, P18571, DOI 10.1073/pnas.1206390109; Jain A., 2015, ACTA DIABETOL, P1; JOHRI RK, 1992, J ETHNOPHARMACOL, V37, P85, DOI 10.1016/0378-8741(92)90067-2; Kashyap A., 2010, ANTIQUITY, V84; Krishnaswamy K, 2008, ASIA PAC J CLIN NUTR, V17, P265; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Pande GS, 2002, BHAVPRAKASH NIGHANTU; Perumal S, 2014, CAPSAICIN INHIBITS C; Pollan Michael, 2014, COOKED NATURAL HIST; Ramalingam C, 2010, J EXP SCI, V1, P33; Sherman PW, 1999, BIOSCIENCE, V49, P453, DOI 10.2307/1313553; Tapsell LC, 2006, MED J AUSTRALIA, V185, pS4; Valiathan MS, 2010, THE LEGACY OF CARAKA; Varshney LR, 2013, BIG DATA APPROACH CO, V1-16; Ventura AK, 2013, CURR BIOL, V23, pR401, DOI 10.1016/j.cub.2013.02.037; Weber S.A., 2011, EXCAVATIONS FARMANA, P808; Wrangham RW, 2009, CATCHING FIRE COOKIN; Zhu YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079161	28	34	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139539	10.1371/journal.pone.0139539	http://dx.doi.org/10.1371/journal.pone.0139539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430895	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700074
J	Prasad, PV; Thacker, J; Li, LP; Haque, M; Li, W; Koenigs, H; Zhou, Y; Sprague, SM				Prasad, Pottumarthi V.; Thacker, Jon; Li, Lu-Ping; Haque, Muhammad; Li, Wei; Koenigs, Heather; Zhou, Ying; Sprague, Stuart M.			Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; RENAL BOLD-MRI; TISSUE OXYGENATION; HYPOXIA; FIBROSIS; PROGRESSION; VOLUME; MODEL	Background The current clinical classification of chronic kidney disease (CKD) is not perfect and may be overestimating both the prevalence and the risk for progressive disease. Novel markers are being sought to identify those at risk of progression. This preliminary study evaluates the feasibility of magnetic resonance imaging based markers to identify early changes in CKD. Methods Fifty-nine subjects (22 healthy, 7 anemics with no renal disease, 30 subjects with CKD) participated. Data using 3D volume imaging, blood oxygenation level dependent (BOLD) and Diffusion MRI was acquired. BOLD MRI acquisition was repeated after 20 mg of iv furosemide. Results Compared to healthy subjects, those with CKD have lower renal parenchymal volumes (329.6 +/- 66.4 vs. 257.1 +/- 87.0 ml, p<0.005), higher cortical R2* values (19.7 +/- 3.2 vs. 23.2 +/- 6.3 s(-1), p = 0.013) (suggesting higher levels of hypoxia) and lower response to furosemide on medullary R2* (6.9 +/- 3.3 vs. 3.1 +/- 7.5 s(-1), p = 0.02). All three parameters showed significant correlation with estimated glomerular filtration rate (eGFR). When the groups were matched for age and sex, cortical R2* and kidney volume still showed significant differences between CKD and healthy controls. The most interesting observation is that a small number of subjects (8 of 29) contributed to the increase in mean value observed in CKD. The difference in cortical R2* between these subjects compared to the rest were highly significant and had a large effect size (Cohen's d = 3.5). While highly suggestive, future studies may be necessary to verify if such higher levels of hypoxia are indicative of progressive disease. Diffusion MRI showed no differences between CKD and healthy controls. Conclusions These data demonstrate that BOLD MRI can be used to identify enhanced hypoxia associated with CKD and the preliminary observations are consistent with the chronic hypoxia model for disease progression in CKD. Longitudinal studies are warranted to further verify these findings and assess their predictive value.	[Prasad, Pottumarthi V.; Li, Lu-Ping; Haque, Muhammad; Li, Wei; Koenigs, Heather] NorthShore Univ HealthSyst, Dept Radiol, Evanston, IL 60201 USA; [Thacker, Jon] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Zhou, Ying] NorthShore Univ HealthSystem, Ctr Biomed Res Informat, Evanston, IL USA; [Sprague, Stuart M.] NorthShore Univ HealthSystem, Dept Med, Evanston, IL USA	NorthShore University Health System; Northwestern University; NorthShore University Health System; NorthShore University Health System	Prasad, PV (corresponding author), NorthShore Univ HealthSyst, Dept Radiol, Evanston, IL 60201 USA.	pprasad@northshore.org		Prasad, Pottumarthi/0000-0002-4214-5465	National Institutes of Health [R21-DK079080, R01-DK093793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL123360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093793, R21DK079080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, R21-DK079080 and R01-DK093793.	Bernhardt WM, 2007, METHOD ENZYMOL, V435, P221, DOI 10.1016/S0076-6879(07)35012-X; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; BREZIS M, 1994, AM J PHYSIOL-RENAL, V267, pF1059, DOI 10.1152/ajprenal.1994.267.6.F1059; Chandarana H, 2011, INVEST RADIOL, V46, P285, DOI 10.1097/RLI.0b013e3181ffc485; Cheong B, 2007, CLIN J AM SOC NEPHRO, V2, P38, DOI 10.2215/CJN.00930306; Devarajan P, 2010, ADV CHRONIC KIDNEY D, V17, P469, DOI 10.1053/j.ackd.2010.09.002; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Epstein FH, 1997, KIDNEY INT, V51, P381, DOI 10.1038/ki.1997.50; Epstein FH, 2000, KIDNEY INT, V57, P2080, DOI 10.1046/j.1523-1755.2000.00057.x; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Fine LG, 2012, KIDNEY INT, V82, P934, DOI 10.1038/ki.2012.283; Harman A, 2014, J COMPUT ASSIST TOMO, V38, P571, DOI 10.1097/RCT.0000000000000086; Inoue T, 2012, KIDNEY INT, V82, P934, DOI 10.1038/ki.2012.282; Inoue T, 2011, J AM SOC NEPHROL, V22, P1429, DOI 10.1681/ASN.2010111143; Khan S, 2008, J EVAL CLIN PRACT, V14, P422, DOI 10.1111/j.1365-2753.2007.00883.x; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Li QH, 2014, EUR J RADIOL, V83, P756, DOI 10.1016/j.ejrad.2014.01.024; Lin WL, 1998, MAGN RESON MED, V40, P857, DOI 10.1002/mrm.1910400611; Lucisano G, 2015, J ULTRAS MED, V34, P299, DOI 10.7863/ultra.34.2.299; Manotham K, 2012, INTERN MED J, V42, pe33, DOI 10.1111/j.1445-5994.2011.02610.x; Michaely HJ, 2012, KIDNEY INT, V81, P684, DOI 10.1038/ki.2011.455; Milani B, 2015, RADIAL R2 DISTRIBUTI, P466; Neugarten J, 2012, KIDNEY INT, V81, P613, DOI 10.1038/ki.2011.462; Pei XL, 2012, MAGN RESON IMAGING, V20, P330, DOI 10.1016/j.mri.2011.10.003; Pruijm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095895; Pruijm M, 2013, DIABETES RES CLIN PR, V99, P136, DOI 10.1016/j.diabres.2012.11.004; Rosenberger C, 2007, J AM SOC NEPHROL, V18, P343, DOI 10.1681/ASN.2006070792; Siddiqi L, 2014, J CLIN HYPERTENS, V16, P214, DOI 10.1111/jch.12263; Storey P, 2011, J MAGN RESON IMAGING, V33, P1091, DOI 10.1002/jmri.22526; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tan H, 2014, MAGN RESON MED, V71, P570, DOI 10.1002/mrm.24692; Temple R, 2010, CLIN PHARMACOL THER, V88, P774, DOI 10.1038/clpt.2010.233; Thacker JM, 2015, INVEST RADIOL; Thoeny HC, 2005, RADIOLOGY, V235, P911, DOI 10.1148/radiol.2353040554; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Tonelli M, 2011, JAMA-J AM MED ASSOC, V305, P1593, DOI 10.1001/jama.2011.502; Wang ZJ, 2011, J MAGN RESON IMAGING, V33, P655, DOI 10.1002/jmri.22501; Xu XQ, 2010, EUR RADIOL, V20, P978, DOI 10.1007/s00330-009-1619-8; Yin WJ, 2012, EUR J RADIOL, V81, P1426, DOI 10.1016/j.ejrad.2011.03.045; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117; Zhao J, 2014, CLIN RADIOL, V69, P1117, DOI 10.1016/j.crad.2014.06.011	41	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139661	10.1371/journal.pone.0139661	http://dx.doi.org/10.1371/journal.pone.0139661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430736	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700094
J	Unverdorben, F; Hutt, M; Seifert, O; Kontermann, RE				Unverdorben, Felix; Hutt, Meike; Seifert, Oliver; Kontermann, Roland E.			A Fab-Selective Immunoglobulin-Binding Domain from Streptococcal Protein G with Improved Half-Life Extension Properties	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; SINGLE-CHAIN DIABODY; FUSION PROTEIN; IGG SUBCLASSES; ANTIBODIES; AFFINITY; COMPLEX; ALBUMIN; THERAPEUTICS; FRAGMENTS	Background Half-life extension strategies have gained increasing interest to improve the pharmacokinetic and pharmacodynamic properties of protein therapeutics. Recently, we established an immunoglobulin-binding domain (IgBD) from streptococcal protein G (SpG(C3)) as module for half-life extension. SpG(C3) is capable of binding to the Fc region as well as the CH1 domain of Fab arms under neutral and acidic conditions. Methodology/Principal Findings Using site-directed mutagenesis, we generated a Fab-selective mutant (SpG(C3Fab)) to avoid possible interference with the FcRn-mediated recycling process and improved its affinity for mouse and human IgG by site-directed mutagenesis and phage display selections. In mice, this affinity-improved mutant (SpG(C3FabRR)) conferred prolonged plasma half-lives compared with SpG(C3Fab) when fused to small recombinant antibody fragments, such as singlechain Fv (scFv) and bispecific single-chain diabody (scDb). Hence, the SpG(C3FabRR) domain seems to be a suitable fusion partner for the half-life extension of small recombinant therapeutics. Conclusions/Significance The half-life extension properties of SpG(C3) can be retained by restricting binding to the Fab fragment of serum immunoglobulins and can be improved by increasing binding activity. The modified SpG(C3) module should be suitable to extend the half-life of therapeutic proteins and, thus to improve therapeutic activity.	[Unverdorben, Felix; Hutt, Meike; Seifert, Oliver; Kontermann, Roland E.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70174 Stuttgart, Germany	University of Stuttgart	Kontermann, RE (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, D-70174 Stuttgart, Germany.	roland.kontermann@izi.uni-stuttgart.de	Seifert, Oliver/D-6350-2015		Deutsche Forschungsgemeinschaft [Ko1461/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Grant Ko1461/5 provided to REK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Benedict CA, 1997, J IMMUNOL METHODS, V201, P223, DOI 10.1016/S0022-1759(96)00227-X; Berger V, 2013, PROTEIN ENG DES SEL, V26, P581, DOI 10.1093/protein/gzt044; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Constantinou A, 2010, BIOTECHNOL LETT, V32, P609, DOI 10.1007/s10529-010-0214-z; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691; ERNTELL M, 1988, MOL IMMUNOL, V25, P121, DOI 10.1016/0161-5890(88)90059-4; FAHNESTOCK SR, 1987, TRENDS BIOTECHNOL, V5, P79, DOI 10.1016/S0167-7799(87)80016-1; Finnern R, 1997, CLIN EXP IMMUNOL, V107, P269, DOI 10.1111/j.1365-2249.1997.254-ce1127.x; Harmsen MM, 2005, VACCINE, V23, P4926, DOI 10.1016/j.vaccine.2005.05.017; Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033; Hoffmann E, 2013, J CONTROL RELEASE, V171, P48, DOI 10.1016/j.jconrel.2013.06.021; Holliger P, 1997, NAT BIOTECHNOL, V15, P632, DOI 10.1038/nbt0797-632; Hopp J, 2010, PROTEIN ENG DES SEL, V23, P827, DOI 10.1093/protein/gzq058; Hutt M, 2012, J BIOL CHEM, V287, P4462, DOI 10.1074/jbc.M111.311522; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kontos S, 2012, CHEM SOC REV, V41, P2686, DOI 10.1039/c2cs15289d; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Muller D, 2007, J BIOL CHEM, V282, P12650, DOI 10.1074/jbc.M700820200; Muller D, 2010, BIODRUGS, V24, P89, DOI 10.2165/11530960-000000000-00000; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Prabhat P, 2007, P NATL ACAD SCI USA, V104, P5889, DOI 10.1073/pnas.0700337104; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Schellenberger V, 2009, NAT BIOTECHNOL, V27, P1186, DOI 10.1038/nbt.1588; Sockolosky JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102566; Spassov VZ, 2013, PROTEINS, V81, P704, DOI 10.1002/prot.24230; Stork R, 2008, J BIOL CHEM, V283, P7804, DOI 10.1074/jbc.M709179200; Szlachcic A, 2011, BIOTECHNOL ADV, V29, P436, DOI 10.1016/j.biotechadv.2011.03.005; Unverdorben F, 2012, PROTEIN ENG DES SEL, V25, P81, DOI 10.1093/protein/gzr061; Watanabe H, 2009, J BIOL CHEM, V284	34	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139838	10.1371/journal.pone.0139838	http://dx.doi.org/10.1371/journal.pone.0139838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430884	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700123
J	Wang, H; Li, B; Feng, YM; Cui, B; Wu, HM; Shi, HB; Yin, SK				Wang, Hui; Li, Bei; Feng, Yanmei; Cui, Biao; Wu, Hongmin; Shi, Haibo; Yin, Shankai			A Pilot Study of EEG Source Analysis Based Repetitive Transcranial Magnetic Stimulation for the Treatment of Tinnitus	PLOS ONE			English	Article							AUDITORY-CORTEX	Objective Repetitive Transcranial Magnetic Stimulation (rTMS) is a novel therapeutic tool to induce a suppression of tinnitus. However, the optimal target sites are unknown. We aimed to determine whether low-frequency rTMS induced lasting suppression of tinnitus by decreasing neural activity in the cortex, navigated by high-density electroencephalogram (EEG) source analysis, and the utility of EEG for targeting treatment. Methods In this controlled three-armed trial, seven normal hearing patients with tonal tinnitus received a 10-day course of 1-Hz rTMS to the cortex, navigated by high-density EEG source analysis, to the left temporoparietal cortex region, and to the left temporoparietal with sham stimulation. The Tinnitus handicap inventory (THI) and a visual analog scale (VAS) were used to assess tinnitus severity and loudness. Measurements were taken before, and immediately, 2 weeks, and 4 weeks after the end of the interventions. Results Low-frequency rTMS decreased tinnitus significantly after active, but not sham, treatment. Responders in the EEG source analysis-based rTMS group, 71.4%(5/7) patients, experienced a significant reduction in tinnitus loudness, as evidenced by VAS scores. The target site of neuronal generators most consistently associated with a positive response was the frontal lobe in the right hemisphere, sourced using high-density EEG equipment, in the tinnitus patients. After left temporoparietal rTMS stimulation, 42.8%(3/7) patients experienced a decrease in tinnitus loudness. Conclusions Active EEG source analysis based rTMS resulted in significant suppression in tinnitus loudness, showing the superiority of neuronavigation-guided coil positioning in dealing with tinnitus. Non-auditory areas should be considered in the pathophysiology of tinnitus. This knowledge in turn can contribute to investigate the pathophysiology of tinnitus.	[Wang, Hui; Li, Bei; Feng, Yanmei; Cui, Biao; Wu, Hongmin; Shi, Haibo; Yin, Shankai] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Otolaryngol Head & Neck Surg, Shanghai 200233, Peoples R China	Shanghai Jiao Tong University	Wu, HM (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Otolaryngol Head & Neck Surg, Shanghai 200233, Peoples R China.	wuhongmin88@126.com; haibo99@hotmail.com	Feng, Yanmei/GQB-1685-2022	Shi, Haibo/0000-0002-2920-0183				Baguley D, 2013, LANCET, V382, P1600, DOI 10.1016/S0140-6736(13)60142-7; De Ridder D, 2013, BRAIN STIMUL, V6, P355, DOI 10.1016/j.brs.2012.07.002; Henry JA, 2014, J AM ACAD AUDIOL, V25, P5, DOI 10.3766/jaaa.25.1.2; Houdayer E, 2015, CLIN NEUROPHYSIOLOGY; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; Kaltenbach JA, 2005, HEARING RES, V206, P200, DOI 10.1016/j.heares.2005.02.013; Khedr EM, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.127712; Landgrebe M, 2009, NEUROIMAGE, V46, P213, DOI 10.1016/j.neuroimage.2009.01.069; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lanting CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110704; Lefaucheur JP, 2012, NEUROPHYSIOL CLIN, V42, P95, DOI 10.1016/j.neucli.2011.12.001; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Mennemeier M, 2011, LARYNGOSCOPE, V121, P815, DOI 10.1002/lary.21425; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nicolas-Puel Cecile, 2006, Int Tinnitus J, V12, P64; Norena AJ, 2003, HEARING RES, V183, P137, DOI 10.1016/S0378-5955(03)00225-9; Peng Z, 2012, OTOLARYNG HEAD NECK, V147, P817, DOI 10.1177/0194599812458771; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; Takano B, 2004, NEUROIMAGE, V23, P849, DOI 10.1016/j.neuroimage.2004.06.032; Tunkel DE, 2014, OTOLARYNGOLOGY HEA S, V151, pS1, DOI [10.1177/0194599814545325, DOI 10.1177/0194599814545325]; Vanneste S, 2015, BRAIN CONNECTIVITY; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Yang HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070831; Yu Lisheng, 2014, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V28, P219	24	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139622	10.1371/journal.pone.0139622	http://dx.doi.org/10.1371/journal.pone.0139622			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430749	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700087
J	Flousek, J; Telensky, T; Hanzelka, J; Reif, J				Flousek, Jiri; Telensky, Tomas; Hanzelka, Jan; Reif, Jiri			Population Trends of Central European Montane Birds Provide Evidence for Adverse Impacts of Climate Change on High-Altitude Species	PLOS ONE			English	Article							ELEVATIONAL RANGE SHIFTS; LIFE-HISTORY TRAITS; ARRIVAL DATE; BOREAL BIRDS; HABITAT LOSS; LAND-USE; PHENOLOGY; DECLINES; NORTHERN; DETECTABILITY	Climate change is among the most important global threats to biodiversity and mountain areas are supposed to be under especially high pressure. Although recent modelling studies suggest considerable future range contractions of montane species accompanied with increased extinction risk, data allowing to test actual population consequences of the observed climate changes and identifying traits associated to their adverse impacts are very scarce. To fill this knowledge gap, we estimated long-term population trends of montane birds from 1984 to 2011 in a central European mountain range, the Giant Mountains (Krkonose), where significant warming occurred over this period. We then related the population trends to several species' traits related to the climate change effects. We found that the species breeding in various habitats at higher altitudes had more negative trends than species breeding at lower altitudes. We also found that the species moved upwards as a response to warming climate, and these altitudinal range shifts were associated with more positive population trends at lower altitudes than at higher altitudes. Moreover, long-distance migrants declined more than residents or species migrating for shorter distances. Taken together, these results indicate that the climate change, besides other possible environmental changes, already influences populations of montane birds with particularly adverse impacts on high-altitude species such as water pipit (Anthus spinoletta). It is evident that the alpine species, predicted to undergo serious climatically induced range contractions due to warming climate in the future, already started moving along this trajectory.	[Flousek, Jiri] Krkonose Natl Pk Adm, CZ-54301 Vrchlabi, Czech Republic; [Telensky, Tomas; Hanzelka, Jan; Reif, Jiri] Charles Univ Prague, Fac Sci, Inst Environm Studies, CZ-12801 Prague 2, Czech Republic; [Telensky, Tomas] Acad Sci Czech Republ, Inst Vertebrate Biol, Vvi, CS-60365 Brno, Czech Republic; [Telensky, Tomas] Czech Soc Ornithol, CZ-15000 Prague 5, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Reif, J (corresponding author), Charles Univ Prague, Fac Sci, Inst Environm Studies, Benatska 2, CZ-12801 Prague 2, Czech Republic.	jirireif@natur.cuni.cz	Hanzelka, Jan/A-4269-2018; Hanzelka, Jan/AAZ-3950-2020; Telenský, Tomáš/AAR-5732-2021; Reif, Jiri/I-9168-2017	Hanzelka, Jan/0000-0002-2377-280X; Hanzelka, Jan/0000-0002-2377-280X; Reif, Jiri/0000-0003-2553-7333; Telensky, Tomas/0000-0002-6783-8938	Grant Agency of Charles University [633212]	Grant Agency of Charles University	This work was supported by Grant Agency of Charles University (http://www.cuni.cz/UK-33.html), grant number 633212. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamik P, 2008, J ZOOL, V275, P209, DOI 10.1111/j.1469-7998.2008.00415.x; Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Auer SK, 2014, GLOBAL ECOL BIOGEOGR, V23, P867, DOI 10.1111/geb.12174; Barbosa A, 2007, POLAR BIOL, V30, P1239, DOI 10.1007/s00300-007-0284-0; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Buttner G., 2002, TECHNICAL GUIDELINES; Caprio E, 2011, BIOL CONSERV, V144, P2958, DOI 10.1016/j.biocon.2011.08.021; Chamberlain D, 2012, IBIS, V154, P205, DOI 10.1111/j.1474-919X.2011.01196.x; Chamberlain DE, 2013, BIOL CONSERV, V167, P127, DOI 10.1016/j.biocon.2013.07.036; Chen IC, 2009, P NATL ACAD SCI USA, V106, P1479, DOI 10.1073/pnas.0809320106; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; European Environment Agency, 2007, CLC2006 TECHN GUID; Fletcher K, 2013, IBIS, V155, P456, DOI 10.1111/ibi.12055; FLOUSEK J, 1989, ANN ZOOL FENN, V26, P255; Flousek J, 1994, BIOSPHERE RESERVES C, P17; Flousek J, 1999, ATLAS BREEDING BIRD; Flousek J, 2007, GIANT MOUNTAINS NATU; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Grytnes JA, 2014, GLOBAL ECOL BIOGEOGR, V23, P876, DOI 10.1111/geb.12170; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Harris JBC, 2014, DIVERS DISTRIB, V20, P773, DOI 10.1111/ddi.12180; HARVEY PH, 1991, NATURE, V351, P619, DOI 10.1038/351619a0; Herrando S, 2014, ECOL INDIC, V45, P235, DOI 10.1016/j.ecolind.2014.04.011; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Kolecek J, 2014, BIOL CONSERV, V172, P109, DOI 10.1016/j.biocon.2014.02.029; Kolecek J, 2011, ACTA ORNITHOL, V46, P143, DOI 10.3161/000164511X625919; Krahulec F, 1997, OPERA CORCONTICA, V33, P3; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Laaksonen T, 2013, BIOL CONSERV, V168, P99, DOI 10.1016/j.biocon.2013.09.007; Laiolo P, 2004, J APPL ECOL, V41, P294, DOI 10.1111/j.0021-8901.2004.00893.x; Lehikoinen A, 2014, J AVIAN BIOL, V45, P3, DOI 10.1111/j.1600-048X.2013.00177.x; Lehikoinen A, 2013, POPUL ECOL, V55, P315, DOI 10.1007/s10144-012-0359-9; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Maggini R, 2011, ECOL MODEL, V222, P21, DOI 10.1016/j.ecolmodel.2010.09.010; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Alvarez-Martinez JM, 2014, J ECOL, V102, P905, DOI 10.1111/1365-2745.12257; Melendez L, 2014, IBIS, V156, P276, DOI 10.1111/ibi.12127; Metelka L, 2006, SYSTEMATIC CHANGES B; Newson SE, 2013, BIRD STUDY, V60, P384, DOI 10.1080/00063657.2013.805729; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; PANNEKOEK J, 2005, TRIM 3 MANUAL; Paradis E, 2006, ANAL PHYLOGENETICS E; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; Pautasso M, 2012, ITAL J ZOOL, V79, P296, DOI 10.1080/11250003.2011.627381; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Reed TE, 2013, J ANIM ECOL, V82, P131, DOI 10.1111/j.1365-2656.2012.02020.x; Reif J, 2013, J ORNITHOL, V154, P359, DOI 10.1007/s10336-012-0900-9; Reif J, 2012, OIKOS, V121, P1053, DOI 10.1111/j.1600-0706.2011.20008.x; Reif J, 2011, BIOL CONSERV, V144, P2524, DOI 10.1016/j.biocon.2011.07.009; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Saether BE, 2005, NATURE, V436, P99, DOI 10.1038/nature03666; Salido L, 2012, ECOGRAPHY, V35, P604, DOI 10.1111/j.1600-0587.2011.06797.x; Sato CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064282; Schaefer HC, 2008, GLOBAL ECOL BIOGEOGR, V17, P38, DOI 10.1111/j.1466-8238.2007.00341.x; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Schropfer L., 2008, BIRD MIGRATION ATLAS; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sol D, 2012, SCIENCE, V337, P580, DOI 10.1126/science.1221523; Soukupova L., 1995, OPERA CORCONTICA, V32, P5; Stursa J, 2013, OPERA CORCONTICA, V50, P55; Tryjanowski P, 2005, DIVERS DISTRIB, V11, P219, DOI 10.1111/j.1366-9516.2005.00140.x; Tryjanowski P, 2001, INT J BIOMETEOROL, V45, P217, DOI 10.1007/s00484-001-0112-0; Tryjanowski P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063482; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Virkkala R, 2014, GLOBAL CHANGE BIOL, V20, P2995, DOI [10.1111/gcb.12573, 10.1111/gcb.1]; Webb CT, 2010, ECOL LETT, V13, P267, DOI 10.1111/j.1461-0248.2010.01444.x; [No title captured]	79	34	36	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139465	10.1371/journal.pone.0139465	http://dx.doi.org/10.1371/journal.pone.0139465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426901	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100065
J	Murakami, T; Hiroshima, Y; Zhang, Y; Chishima, T; Tanaka, K; Bouvet, M; Endo, I; Hoffman, RM				Murakami, Takashi; Hiroshima, Yukihiko; Zhang, Yong; Chishima, Takashi; Tanaka, Kuniya; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Fluorescence-Guided Surgery of Liver Metastasis in Orthotopic Nude-Mouse Models	PLOS ONE			English	Article							HUMAN COLON-CANCER; ANTI-CEA ANTIBODY; KILLER-REPORTER ADENOVIRUS; SURGICAL NAVIGATION; IMAGING-SYSTEM; RESECTION; GFP	We report here the development of fluorescence-guided surgery of liver metastasis. HT29 human colon cancer cells expressing green fluorescent protein (GFP) were initially injected in the spleen of nude mice. Three weeks later, established liver metastases were harvested and implanted on the left lobe of the liver in other nude mice in order to make an orthotopic liver metastasis model. Fourteen mice with a single liver metastasis were randomized into bright-light surgery (BLS) or fluorescence-guided surgery (FGS) groups. Seven mice were treated with BLS, seven were treated with FGS. Three weeks after implantation, the left lobe of the liver with a single metastasis was exposed through a median abdominal incision. BLS was performed under white light. FGS was performed using a hand-held portable fluorescence imaging system (Dino-Lite). Post-surgical residual tumor fluorescence was visualized with the OV100 Small Animal Imaging System. Residual tumor fluorescence after BLS was clearly visualized at high magnification with the OV100. In contrast, residual tumor fluorescence after FGS was not detected even at high magnification with the OV100. These results demonstrate the feasibility of FGS for liver metastasis.	[Murakami, Takashi; Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Murakami, Takashi; Hiroshima, Yukihiko; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Murakami, Takashi; Hiroshima, Yukihiko; Chishima, Takashi; Tanaka, Kuniya; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com		Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA132971, CA142669]; JSPS KAKENHI [26830081, 26462070, 24592009]; AntiCancer Inc.; NATIONAL CANCER INSTITUTE [R01CA132971, R01CA142669] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AntiCancer Inc.(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant numbers CA132971 to MB and CA142669 to MB and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AntiCancer Inc. provided support in the form of salary for an author YZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; Maawy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097965; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Nemunaitis J, 2010, MOL THER, V18, P429, DOI 10.1038/mt.2009.262; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Troyan SL, 2009, ANN SURG ONCOL, V16, P2943, DOI 10.1245/s10434-009-0594-2; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927; Yano S, 2015, CANCER GENE THER, V22, P344, DOI 10.1038/cgt.2015.26; Yano S, 2015, MOL THER, V23, P1182, DOI 10.1038/mt.2015.63; Yano S, 2015, ONCOTARGET, V6, P13133, DOI 10.18632/oncotarget.3811	20	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138752	10.1371/journal.pone.0138752	http://dx.doi.org/10.1371/journal.pone.0138752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427050	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100019
J	Salge, C; Ay, N; Polani, D; Prokopenko, M				Salge, Christoph; Ay, Nihat; Polani, Daniel; Prokopenko, Mikhail			Zipf's Law: Balancing Signal Usage Cost and Communication Efficiency	PLOS ONE			English	Article								We propose a model that explains the reliable emergence of power laws (e.g., Zipf's law) during the development of different human languages. The model incorporates the principle of least effort in communications, minimizing a combination of the information-theoretic communication inefficiency and direct signal cost. We prove a general relationship, for all optimal languages, between the signal cost distribution and the resulting distribution of signals. Zipf's law then emerges for logarithmic signal cost distributions, which is the cost distribution expected for words constructed from letters or phonemes.	[Salge, Christoph; Polani, Daniel] Univ Hertfordshire, Dept Comp Sci, Hatfield AL10 9AB, Herts, England; [Ay, Nihat] Max Planck Inst Math Sci, Leipzig, Germany; [Ay, Nihat] Santa Fe Inst, Santa Fe, NM 87501 USA; [Ay, Nihat] Univ Leipzig, Dept Math & Comp Sci, D-04109 Leipzig, Germany; [Polani, Daniel; Prokopenko, Mikhail] Univ Sydney, Fac Engn & IT, Complex Syst Res Grp, Sydney, NSW 2006, Australia; [Prokopenko, Mikhail] Macquarie Univ, Dept Comp, Sydney, NSW 2109, Australia	University of Hertfordshire; Max Planck Society; The Santa Fe Institute; Leipzig University; University of Sydney; Macquarie University	Prokopenko, M (corresponding author), Univ Sydney, Fac Engn & IT, Complex Syst Res Grp, Sydney, NSW 2006, Australia.	mikhail.prokopenko@sydney.edu.au	Polani, Daniel/AAJ-9529-2020; Prokopenko, Mikhail/A-3995-2008	Prokopenko, Mikhail/0000-0002-4215-0344; Kenyon, Garrett/0000-0003-4836-3938; Salge, Christoph/0000-0001-5520-8755	European Commission, the CORBYS (Cognitive Control Framework for Robotic Systems) project [FP7 ICT-270219]	European Commission, the CORBYS (Cognitive Control Framework for Robotic Systems) project	CS and DP were supported by the European Commission as part of the CORBYS (Cognitive Control Framework for Robotic Systems) project under contract FP7 ICT-270219.	Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; Baixeries J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053227; Cancho RFI, 2005, EUR PHYS J B, V47, P449, DOI 10.1140/epjb/e2005-00340-y; Cancho RFI, 2005, EUR PHYS J B, V44, P249, DOI 10.1140/epjb/e2005-00121-8; Cancho RFI, 2005, PHYSICA A, V345, P275, DOI 10.1016/j.physa.2004.06.158; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Clark E. V, 1995, CAMBRIDGE STUDIES LI, V65; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CRUTCHFIELD JP, 1990, WOODW CONF, P119; Dickman R, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/12/P12022; Ferrer i, 2013, ARXIV13105884; Ferrer i Cancho R, 2014, ARXIV14122486; Cancho RFI, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/06/P06009; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; LI WT, 1992, IEEE T INFORM THEORY, V38, P1842, DOI 10.1109/18.165464; Mandelbrot B., 1953, COMMUN THEOR, P486; MILLER GA, 1957, AM J PSYCHOL, V70, P311, DOI 10.2307/1419346; Naranan S., 1996, J QUANT LINGUIST, V3, P177, DOI DOI 10.1080/09296179608599629; Niven RK, 2010, PHILOS T R SOC B, V365, P1323, DOI 10.1098/rstb.2009.0296; Niven RK, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021113; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; Obst O, 2011, ADV ARTIFICIAL LIFE, P85; Prokopenko M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041116; Prokopenko M, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/11/P11025; Prokopenko M, 2009, HFSP J, V3, P317, DOI 10.2976/1.3175813; Rokhlin V.A., 1967, RUSS MATH SURV+, V22, P1, DOI [10.1070/RM1967v022n05ABEH001224, DOI 10.1070/RM1967V022N05ABEH001224, 10.1070/RM1967v022n0]; Saxton M., 2010, CHILD LANGUAGE ACQUI; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Suzuki R., 2005, ANIM BEHAV, V69, pF9, DOI DOI 10.1016/J.ANBEHAV.2004.08.004; Visser M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/4/043021; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	31	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139475	10.1371/journal.pone.0139475	http://dx.doi.org/10.1371/journal.pone.0139475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427059	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100068
J	Tang, GY; Xu, PL; Liu, W; Liu, ZJ; Shan, L				Tang, Guiying; Xu, Pingli; Liu, Wei; Liu, Zhanji; Shan, Lei			Cloning and Characterization of 5 ' Flanking Regulatory Sequences of AhLEC1B Gene from Arachis Hypogaea L.	PLOS ONE			English	Article							ARABIDOPSIS LEAFY COTYLEDON1; CIS-ACTING ELEMENTS; TRANSCRIPTION FACTORS; NF-Y; EMBRYO DEVELOPMENT; IN-VITRO; EXPRESSION; PROMOTER; BINDING; IDENTIFICATION	LEAFY COTYLEDON1 (LEC1) is a B subunit of Nuclear Factor Y (NF-YB) transcription factor that mainly accumulates during embryo development. We cloned the 50 flanking regulatory sequence of AhLEC1B gene, a homolog of Arabidopsis LEC1, and analyzed its regulatory elements using online software. To identify the crucial regulatory region, we generated a series of GUS expression frameworks driven by different length promoters with 5' terminal and/or 3' terminal deletion. We further characterized the GUS expression patterns in the transgenic Arabidopsis lines. Our results show that both the 65bp proximal promoter region and the 52bp 5' UTR of AhLEC1B contain the key motifs required for the essential promoting activity. Moreover, AhLEC1B is preferentially expressed in the embryo and is co-regulated by binding of its upstream genes with both positive and negative corresponding cis-regulatory elements.	[Tang, Guiying; Xu, Pingli; Liu, Zhanji; Shan, Lei] Shandong Acad Agr Sci, Biotech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan 250100, Peoples R China; [Liu, Wei; Shan, Lei] Shandong Univ, Coll Agr, Jinan 250100, Peoples R China	Shandong Academy of Agricultural Sciences; Shandong University	Shan, L (corresponding author), Shandong Acad Agr Sci, Biotech Res Ctr, Shandong Prov Key Lab Crop Genet Improvement Ecol, Jinan 250100, Peoples R China.	Shlei1025@sina.com			National Natural Science Foundation of China [30971546, 31470349, 31171621]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China, grant No. 30971546 and No. 31470349, to LS, and No. 31171621 to ZJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RD, 1989, PLANT CELL, V1, P623, DOI 10.1105/tpc.1.6.623; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; Casson SA, 2006, PLANT PHYSIOL, V142, P526, DOI 10.1104/pp.106.080895; Ceribelli M, 2008, MOL CELL BIOL, V28, P2047, DOI 10.1128/MCB.01861-07; [陈高 Chen Gao], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P214; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; ELMAYAN T, 1995, TRANSGENIC RES, V4, P388, DOI 10.1007/BF01973757; Filichkin SA, 2004, PLANT PHYSIOL, V134, P1080, DOI 10.1104/pp.103.035998; Fusada N, 2005, PLANT MOL BIOL, V59, P631, DOI 10.1007/s11103-005-0579-x; Gowik U, 2004, PLANT CELL, V16, P1077, DOI 10.1105/tpc.019729; Haralampidis K, 2002, PLANT PHYSIOL, V129, P1138, DOI 10.1104/pp.004044; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jia HY, 2013, PLANT PHYSIOL, V163, P1293, DOI 10.1104/pp.113.220988; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kim MJ, 2006, MOL GENET GENOMICS, V276, P351, DOI 10.1007/s00438-006-0148-2; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Lee HS, 2003, P NATL ACAD SCI USA, V100, P2152, DOI 10.1073/pnas.0437909100; Li Ai-qin, 2009, Xibei Zhiwu Xuebao, V29, P1730; Lotan T, 1998, CELL, V93, P1195, DOI 10.1016/S0092-8674(00)81463-4; MIKAMI K, 1987, FEBS LETT, V223, P273, DOI 10.1016/0014-5793(87)80303-4; Morton T, 2014, PLANT CELL, V26, P2746, DOI 10.1105/tpc.114.125617; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Ogas J, 1999, P NATL ACAD SCI USA, V96, P13839, DOI 10.1073/pnas.96.24.13839; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Peng YW, 2002, BLOOD, V99, P2408, DOI 10.1182/blood.V99.7.2408; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Plesch G, 2001, PLANT J, V28, P455, DOI 10.1046/j.1365-313X.2001.01166.x; QUINN JM, 1995, PLANT CELL, V7, P623, DOI 10.1105/tpc.7.5.623; Rawat R, 2005, PLANT MOL BIOL, V57, P629, DOI 10.1007/s11103-005-0954-7; Rider SD, 2003, PLANT J, V35, P33, DOI 10.1046/j.1365-313X.2003.01783.x; Rogers HJ, 2001, PLANT MOL BIOL, V45, P577, DOI 10.1023/A:1010695226241; Ross EJH, 2004, J EXP BOT, V55, P1721, DOI 10.1093/jxb/erh211; Sahoo DK, 2014, PLANTA, V240, P855, DOI 10.1007/s00425-014-2135-x; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Sutoh K, 2003, PLANT J, V34, P635, DOI 10.1046/j.1365-313X.2003.01753.x; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Teakle GR, 2002, PLANT MOL BIOL, V50, P43, DOI 10.1023/A:1016062325584; TERADA R, 1995, PLANT MOL BIOL, V27, P17, DOI 10.1007/BF00019175; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Wu CY, 2000, PLANT J, V23, P415, DOI 10.1046/j.1365-313x.2000.00797.x; Yamamoto A, 2009, PLANT J, V58, P843, DOI 10.1111/j.1365-313X.2009.03817.x; Yamauchi D, 2001, PLANT CELL PHYSIOL, V42, P635, DOI 10.1093/pcp/pce079; Yanagisawa S, 1999, PLANT J, V17, P209, DOI 10.1046/j.1365-313X.1999.00363.x; Yanagisawa S, 2000, PLANT J, V21, P281, DOI 10.1046/j.1365-313x.2000.00685.x; Zhang ZL, 2004, PLANT PHYSIOL, V134, P1500, DOI 10.1104/pp.103.034967; Zhu C, 2005, PLANT J, V41, P583, DOI 10.1111/j.1365-313X.2004.02320.x	55	5	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139213	10.1371/journal.pone.0139213	http://dx.doi.org/10.1371/journal.pone.0139213			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426444	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100037
J	Guardiola, M; Uriz, MJ; Taberlet, P; Coissac, E; Wangensteen, OS; Turon, X				Guardiola, Magdalena; Uriz, Maria Jesus; Taberlet, Pierre; Coissac, Eric; Wangensteen, Owen Simon; Turon, Xavier			Deep-Sea, Deep-Sequencing: Metabarcoding Extracellular DNA from Sediments of Marine Canyons	PLOS ONE			English	Article							ENVIRONMENTAL DNA; BIODIVERSITY ASSESSMENT; MICROBIAL EUKARYOTES; SEASONAL DYNAMICS; DIVERSITY; PATTERNS; BOTTOM; CONSERVATION; COMMUNITIES; MORPHOLOGY	Marine sediments are home to one of the richest species pools on Earth, but logistics and a dearth of taxonomic work-force hinders the knowledge of their biodiversity. We characterized alpha- and beta-diversity of deep-sea assemblages from submarine canyons in the western Mediterranean using an environmental DNA metabarcoding. We used a new primer set targeting a short eukaryotic 18S sequence (ca. 110 bp). We applied a protocol designed to obtain extractions enriched in extracellular DNA from replicated sediment corers. With this strategy we captured information from DNA (local or deposited from the water column) that persists adsorbed to inorganic particles and buffered short-term spatial and temporal heterogeneity. We analysed replicated samples from 20 localities including 2 deep-sea canyons, 1 shallower canal, and two open slopes (depth range 100-2,250 m). We identified 1,629 MOTUs, among which the dominant groups were Metazoa (with representatives of 19 phyla), Alveolata, Stramenopiles, and Rhizaria. There was a marked small-scale heterogeneity as shown by differences in replicates within corers and within localities. The spatial variability between canyons was significant, as was the depth component in one of the canyons where it was tested. Likewise, the composition of the first layer (1 cm) of sediment was significantly different from deeper layers. We found that qualitative (presence-absence) and quantitative (relative number of reads) data showed consistent trends of differentiation between samples and geographic areas. The subset of exclusively benthic MOTUs showed similar patterns of beta-diversity and community structure as the whole dataset. Separate analyses of the main metazoan phyla (in number of MOTUs) showed some differences in distribution attributable to different lifestyles. Our results highlight the differentiation that can be found even between geographically close assemblages, and sets the ground for future monitoring and conservation efforts on these bottoms of ecological and economic importance.	[Guardiola, Magdalena; Uriz, Maria Jesus; Wangensteen, Owen Simon; Turon, Xavier] Ctr Adv Studies Blanes CEAB CSIC, Dept Marine Ecol, Girona, Spain; [Taberlet, Pierre; Coissac, Eric] Univ Grenoble Alpes, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Taberlet, Pierre; Coissac, Eric] CNRS, Lab Ecol Alpine LECA, F-38000 Grenoble, France; [Wangensteen, Owen Simon] Univ Barcelona, Dept Anim Biol, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Barcelona	Turon, X (corresponding author), Ctr Adv Studies Blanes CEAB CSIC, Dept Marine Ecol, Girona, Spain.	xturon@ceab.csic.es	Coissac, Éric/AAE-8735-2019; Uriz, Maria J./AGP-4595-2022; Turon, Xavier/J-9211-2012; Wangensteen, Owen S./E-9552-2012; Wangensteen, Owen S./E-3559-2018	Coissac, Éric/0000-0001-7507-6729; Uriz, Maria J./0000-0002-8169-3173; Turon, Xavier/0000-0002-9229-5541; Wangensteen, Owen S./0000-0001-5593-348X; Wangensteen, Owen S./0000-0001-5593-348X	European Union [LIFE+ NAT/E/000732]; Spanish Government [CTM2010-21810, CTM2010-22218, CTM2013-48163]; European Science Foundation ConGenOmics Exchange Grant [3919]	European Union(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); European Science Foundation ConGenOmics Exchange Grant	The sampling has been done in the framework of the INDEMARES project (LIFE+ NAT/E/ 000732) of the European Union and the DOSMARES project (CTM2010-21810) of the Spanish Government. A European Science Foundation ConGenOmics Exchange Grant (n 3919) funded MG stay at the LECA lab. This research has been funded by projects BENTHOMICS CTM2010-22218 and CHALLENGEN CTM2013-48163 of the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta J, 1986, INF TEC I ESP OCEANO, V44, P3; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; Austen MC, 2002, BIODIVERS CONSERV, V11, P113, DOI 10.1023/A:1014098917535; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bianchelli S, 2010, DEEP-SEA RES PT I, V57, P420, DOI 10.1016/j.dsr.2009.12.001; Bik HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038550; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Bik HM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-389; Blanquer A, 2013, ENVIRON MICROBIOL, V15, P3008, DOI 10.1111/1462-2920.12261; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bott NJ, 2010, BIOTECHNOL ADV, V28, P706, DOI 10.1016/j.biotechadv.2010.05.018; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brannock PM, 2015, MAR GENOM, V23, P67, DOI 10.1016/j.margen.2015.05.007; Brannock PM, 2014, BIOL BULL-US, V227, P161, DOI 10.1086/BBLv227n2p161; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Canals M, 2013, PROG OCEANOGR, V118, P1, DOI 10.1016/j.pocean.2013.09.004; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Carugati L, 2015, MAR GENOM, V24, P11, DOI 10.1016/j.margen.2015.04.010; Chambouvet A, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-110; Chariton AA, 2015, ENVIRON POLLUT, V203, P165, DOI 10.1016/j.envpol.2015.03.047; Chariton AA, 2010, FRONT ECOL ENVIRON, V8, P233, DOI 10.1890/090115; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Corinaldesi C, 2008, MOL ECOL, V17, P3939, DOI 10.1111/j.1365-294X.2008.03880.x; Cowart DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117562; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Creer S, 2012, MOL ECOL, V21, P1033, DOI 10.1111/j.1365-294X.2012.05437.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dafforn KA, 2014, ADV ECOL RES, V51, P1, DOI 10.1016/B978-0-08-099970-8.00003-8; Danovaro R, 2009, MAR ECOL PROG SER, V396, P197, DOI 10.3354/meps08269; Danovaro R, 2014, TRENDS ECOL EVOL, V29, P465, DOI 10.1016/j.tree.2014.06.002; Danovaro R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011832; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Dell'Anno A, 2005, SCIENCE, V309, P2179, DOI 10.1126/science.1117475; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Elbrecht V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130324; Erwin PM, 2014, ISME J, V8, P575, DOI 10.1038/ismej.2013.188; Evans N.T., 2015, MOL ECOLOGY RESOURCE, DOI [10.1111/1755-0998.12433., DOI 10.1111/17550998.12433]; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-434; Flynn JM, 2015, ECOL EVOL, V5, P2252, DOI 10.1002/ece3.1497; Fonseca VG, 2014, GLOBAL ECOL BIOGEOGR, V23, P1293, DOI 10.1111/geb.12223; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; Guillou L, 2013, NUCLEIC ACIDS RES, V41, pD597, DOI 10.1093/nar/gks1160; Handley LL, 2015, BIOL J LINN SOC, V115, P750, DOI 10.1111/bij.12516; Ingels J, 2013, PROG OCEANOGR, V118, P159, DOI 10.1016/j.pocean.2013.07.021; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Lallias D, 2015, ISME J, V9, P1208, DOI 10.1038/ismej.2014.213; Lastras G, 2007, MAR GEOL, V246, P176, DOI 10.1016/j.margeo.2007.09.002; Lastras G, 2011, MAR GEOL, V280, P20, DOI 10.1016/j.margeo.2010.11.005; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Lejzerowicz F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0283; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lo Iacono C, 2012, ELSEV INSIGHT, P457, DOI 10.1016/B978-0-12-385140-6.00032-3; Logares R, 2014, CURR BIOL, V24, P813, DOI 10.1016/j.cub.2014.02.050; Madurell T, 2013, J SEA RES, V83, P123, DOI 10.1016/j.seares.2013.04.013; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; Pascual A, 2002, J GEOPHYS RES, V107, P1; PATERSON GLJ, 1995, DEEP-SEA RES PT I, V42, P1199, DOI 10.1016/0967-0637(95)00041-4; Pawlowski DR, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017585, 10.1371/journal.pone.0018169]; Pawlowski J, 2014, BIOL BULL-US, V227, P93, DOI 10.1086/BBLv227n2p93; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pochon X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073935; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Pusceddu A, 2014, P NATL ACAD SCI USA, V111, P8861, DOI 10.1073/pnas.1405454111; Pusceddu A, 2010, DEEP-SEA RES PT I, V57, P441, DOI 10.1016/j.dsr.2009.11.008; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez-Llodra E., 2010, BIOGEOSCI DISCUSS, V7, P2361, DOI DOI 10.5194/BGD-7-2361-2010; Ramirez-Llodra E, 2010, MAR ECOL-EVOL PERSP, V31, P167, DOI 10.1111/j.1439-0485.2009.00336.x; Rex MA, 1997, MARINE BIODIVERSITY-BOOK, P94, DOI 10.1017/CBO9780511752360.006; Riaz T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr732; Romano C, 2013, PROG OCEANOGR, V118, P144, DOI 10.1016/j.pocean.2013.07.026; Sarda F, 2004, SCI MAR, V68, P7, DOI 10.3989/scimar.2004.68s37; Sarda R, 1999, ACTA OECOL, V20, P315, DOI 10.1016/S1146-609X(99)00135-6; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Snelgrove PVR, 1999, BIOSCIENCE, V49, P129, DOI 10.2307/1313538; Sun CS, 2015, AQUAT BIOL, V24, P9, DOI 10.3354/ab00629; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tecchio S, 2013, PROG OCEANOGR, V118, P188; Tecchio S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063796; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Turner CR, 2015, BIOL CONSERV, V183, P93, DOI 10.1016/j.biocon.2014.11.017; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Yoder M, 2006, NEMATOLOGY, V8, P367, DOI 10.1163/156854106778493448; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	102	99	103	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139633	10.1371/journal.pone.0139633	http://dx.doi.org/10.1371/journal.pone.0139633			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436773	Green Published, gold			2022-12-27	WOS:000362499200038
J	Ikai, R; Hasegawa, Y; Izumigawa, M; Nagano, K; Yoshida, Y; Kitai, N; Lamont, RJ; Yoshimura, F; Murakami, Y				Ikai, Ryota; Hasegawa, Yoshiaki; Izumigawa, Masashi; Nagano, Keiji; Yoshida, Yasuo; Kitai, Noriyuki; Lamont, Richard J.; Yoshimura, Fuminobu; Murakami, Yukitaka			Mfa4, an Accessory Protein of Mfa1 Fimbriae, Modulates Fimbrial Biogenesis, Cell Auto-Aggregation, and Biofilm Formation in Porphyromonas gingivalis	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; ARG-GINGIPAIN; SURFACE PROTEINS; SECRETION SYSTEM; IDENTIFICATION; VIRULENCE; GENE; INVOLVEMENT; COMPONENTS; LOCALIZATION	Porphyromonas gingivalis, a gram-negative obligate anaerobic bacterium, is considered to be a key pathogen in periodontal disease. The bacterium expresses Mfa1 fimbriae, which are composed of polymers of Mfa1. The minor accessory components Mfa3, Mfa4, and Mfa5 are incorporated into these fimbriae. In this study, we characterized Mfa4 using genetically modified strains. Deficiency in the mfa4 gene decreased, but did not eliminate, expression of Mfa1 fimbriae. However, Mfa3 and Mfa5 were not incorporated because of defects in posttranslational processing and leakage into the culture supernatant, respectively. Furthermore, the mfa4-deficient mutant had an increased tendency to auto-aggregate and form biofilms, reminiscent of a mutant completely lacking Mfa1. Notably, complementation of mfa4 restored expression of structurally intact and functional Mfa1 fimbriae. Taken together, these results indicate that the accessory proteins Mfa3, Mfa4, and Mfa5 are necessary for assembly of Mfa1 fimbriae and regulation of auto-aggregation and biofilm formation of P. gingivalis. In addition, we found that Mfa3 and Mfa4 are processed to maturity by the same RgpA/B protease that processes Mfa1 subunits prior to polymerization.	[Ikai, Ryota; Hasegawa, Yoshiaki; Izumigawa, Masashi; Murakami, Yukitaka] Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu, Japan; [Ikai, Ryota; Izumigawa, Masashi; Kitai, Noriyuki] Asahi Univ, Sch Dent, Dept Orthodont, Mizuho Ku, Gifu, Japan; [Hasegawa, Yoshiaki; Nagano, Keiji; Yoshida, Yasuo; Yoshimura, Fuminobu] Aichi Gakuin Univ, Sch Dent, Dept Microbiol, Nagoya, Aichi 464, Japan; [Lamont, Richard J.] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA	Asahi University; Asahi University; Aichi Gakuin University; University of Louisville	Hasegawa, Y (corresponding author), Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu, Japan.	yhase@dpc.agu.ac.jp	Nagano, Keiji/AAS-4912-2020	Nagano, Keiji/0000-0003-3587-7606	Japan Society for the Promotion of Science [25861752, 23592720]; NIH [DE012505, DE023193]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023193, R01DE012505] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by Grants-in-Aid for Scientific Research (25861752 to YH and 23592720 to YM) from the Japan Society for the Promotion of Science, and by DE012505 and DE023193 from the NIH to RJL.	Allen WJ, 2013, J MOL BIOL, V425, P958, DOI 10.1016/j.jmb.2012.12.024; Carbonnelle E, 2006, MOL MICROBIOL, V61, P1510, DOI 10.1111/j.1365-2958.2006.05341.x; Demmer RT, 2006, J AM DENT ASSOC, V137, p14S, DOI 10.14219/jada.archive.2006.0402; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; El-Awady AR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004647; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Gardner RG, 1996, APPL ENVIRON MICROB, V62, P196, DOI 10.1128/AEM.62.1.196-202.1996; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; Glew MD, 2012, J BIOL CHEM, V287, P24605, DOI 10.1074/jbc.M112.369223; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Hajishengallis G, 2008, ADV EXP MED BIOL, V632, P203, DOI 10.1007/978-0-387-78952-1_15; Hamada N, 1996, INFECT IMMUN, V64, P4788, DOI 10.1128/IAI.64.11.4788-4794.1996; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Hasegawa Y, 2013, MOL ORAL MICROBIOL, V28, P467, DOI 10.1111/omi.12040; Hasegawa Y, 2003, MICROBIOL IMMUNOL, V47, P849, DOI 10.1111/j.1348-0421.2003.tb03451.x; Hasegawa Y, 2014, J ORAL BIOSCI, V56, P86, DOI 10.1016/j.job.2014.04.002; Hasegawa Y, 2009, MICROBIOL-SGM, V155, P3333, DOI 10.1099/mic.0.028928-0; Heiniger RW, 2010, CELL MICROBIOL, V12, P1158, DOI 10.1111/j.1462-5822.2010.01461.x; Imamura T, 2003, CURR PROTEIN PEPT SC, V4, P443, DOI 10.2174/1389203033487027; Itoh S, 2002, BIOL PHARM BULL, V25, P986, DOI 10.1248/bpb.25.986; JACOBDUBUISSON F, 1993, EMBO J, V12, P837, DOI 10.1002/j.1460-2075.1993.tb05724.x; JONES CH, 1995, P NATL ACAD SCI USA, V92, P2081, DOI 10.1073/pnas.92.6.2081; Kadowaki T, 1998, J BIOL CHEM, V273, P29072, DOI 10.1074/jbc.273.44.29072; Kishi M, 2012, MOL ORAL MICROBIOL, V27, P458, DOI 10.1111/j.2041-1014.2012.00659.x; Kuboniwa M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-105; KUEHN MJ, 1992, NATURE, V356, P252, DOI 10.1038/356252a0; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Mantri CK, 2015, MICROBIOLOGYOPEN, V4, P53, DOI 10.1002/mbo3.221; Murakami Y, 2002, EUR J ORAL SCI, V110, P157, DOI 10.1034/j.1600-0722.2002.11171.x; Nagano K, 2010, J DENT RES, V89, P903, DOI 10.1177/0022034510370089; Nagano K, 2007, J MED MICROBIOL, V56, P1536, DOI 10.1099/jmm.0.47289-0; Nagano K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043722; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Nakayama K, 1996, J BACTERIOL, V178, P2818, DOI 10.1128/jb.178.10.2818-2824.1996; NAKAYAMA K, 1995, J BIOL CHEM, V270, P23619, DOI 10.1074/jbc.270.40.23619; Nishiyama SI, 2007, MICROBIOL-SGM, V153, P1916, DOI 10.1099/mic.0.2006/005561-0; OGAWA T, 1994, FEMS MICROBIOL LETT, V120, P23; Onoe T, 1995, MICROB PATHOGENESIS, V19, P351, DOI 10.1016/S0882-4010(96)80006-4; Park Y, 2005, INFECT IMMUN, V73, P3983, DOI 10.1128/IAI.73.7.3983-3989.2005; Sato K, 2013, FEMS MICROBIOL LETT, V338, P68, DOI 10.1111/1574-6968.12028; Sato K, 2010, P NATL ACAD SCI USA, V107, P276, DOI 10.1073/pnas.0912010107; Shoji M, 2004, MOL MICROBIOL, V52, P1513, DOI 10.1111/j.1365-2958.2004.04105.x; Veith PD, 2009, J PROTEOME RES, V8, P4279, DOI 10.1021/pr900372c; Veith PD, 2002, BIOCHEM J, V363, P105, DOI 10.1042/0264-6021:3630105; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Watanabe-Kato T, 1998, MICROB PATHOGENESIS, V24, P25, DOI 10.1006/mpat.1997.0170; Yoneda M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-16; Yoshimura F, 2009, J PERIODONTAL RES, V44, P1, DOI 10.1111/j.1600-0765.2008.01135.x; YOSHIMURA F, 1984, J BACTERIOL, V160, P949, DOI 10.1128/JB.160.3.949-957.1984	49	20	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139454	10.1371/journal.pone.0139454	http://dx.doi.org/10.1371/journal.pone.0139454			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437277	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200023
J	Lin, SL; Chang, FL; Ho, SY; Charoenkwan, P; Wang, KW; Huang, HL				Lin, Shinn-Long; Chang, Fang-Lin; Ho, Shinn-Ying; Charoenkwan, Phasit; Wang, Kuan-Wei; Huang, Hui-Ling			Predicting Neuroinflammation in Morphine Tolerance for Tolerance Therapy from Immunostaining Images of Rat Spinal Cord	PLOS ONE			English	Article							SHAPE REPRESENTATION; GLIAL SCAR; GABAPENTIN; INVOLVEMENT; INHIBITION; ASTROCYTE; MECHANISM; INJURY	Long-term morphine treatment leads to tolerance which attenuates analgesic effect and hampers clinical utilization. Recent studies have sought to reveal the mechanism of opioid receptors and neuroinflammation by observing morphological changes of cells in the rat spinal cord. This work proposes a high-content screening (HCS) based computational method, HCS-Morph, for predicting neuroinflammation in morphine tolerance to facilitate the development of tolerance therapy using immunostaining images for astrocytes, microglia, and neurons in the spinal cord. HCS-Morph first extracts numerous HCS-based features of cellular phenotypes. Next, an inheritable bi-objective genetic algorithm is used to identify a minimal set of features by maximizing the prediction accuracy of neuroinflammation. Finally, a mathematic model using a support vector machine with the identified features is established to predict drug-treated images to assess the effects of tolerance therapy. The dataset consists of 15 saline controls (1 mu l/h), 15 morphine-tolerant rats (15 mu g/h), and 10 rats receiving a co-infusion of morphine (15 mu g/h) and gabapentin (15 mu g/h, Sigma). The three individual models of astrocytes, microglia, and neurons for predicting neuroinflammation yielded respective Jackknife test accuracies of 96.67%, 90.00%, and 86.67% on the 30 rats, and respective independent test accuracies of 100%, 90%, and 60% on the 10 co-infused rats. The experimental results suggest that neuroinflammation activity expresses more predominantly in astrocytes and microglia than in neuron cells. The set of features for predicting neuroinflammation from images of astrocytes comprises mean cell intensity, total cell area, and second-order geometric moment (relating to cell distribution), relevant to cell communication, cell extension, and cell migration, respectively. The present investigation provides the first evidence for the role of gabapentin in the attenuation of morphine tolerance from phenotypic changes of astrocytes and microglia. Based on neuroinflammation prediction, the proposed computer-aided image diagnosis system can greatly facilitate the development of tolerance therapy with anti-inflammatory drugs.	[Lin, Shinn-Long] Triserv Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Lin, Shinn-Long] Natl Def Med Ctr, Taipei, Taiwan; [Chang, Fang-Lin] Kang Ning Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Ho, Shinn-Ying; Charoenkwan, Phasit; Huang, Hui-Ling] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Ho, Shinn-Ying; Huang, Hui-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Wang, Kuan-Wei] Natl Chiao Tung Univ, Inst Mol Med & Bioengn, Hsinchu, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Huang, HL (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hlhuang@mail.nctu.edu.tw	Ho, Shinn-Ying/AAE-9394-2022; Ho, Shinn-Ying/AFD-8402-2022	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353	Ministry of Science and Technology of Taiwan [MOST-103-2221-E-009-117-, MOST 104-2221-E-009-183-]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. [104W962]; Tri-Service General Hospital [TSGH-C100-037]; UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan National Science Council I-RiCE Program [MOST-103-2911-I-009-101-]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C.; Tri-Service General Hospital; UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan National Science Council I-RiCE Program	This work was funded by the Ministry of Science and Technology of Taiwan under the contract number MOST-103-2221-E-009-117-, MOST 104-2221-E-009-183-, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 104W962. This work was also supported in part by the TSGH-C100-037 sponsored by Tri-Service General Hospital and the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan National Science Council I-RiCE Program under Grant Number: MOST-103-2911-I-009-101-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bao YH, 2014, J MOL NEUROSCI; Bekheet SH, 2010, TISSUE CELL, V42, P165, DOI 10.1016/j.tice.2010.03.005; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Charoenkwan P, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S12; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Due MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107399; GOSHTASBY A, 1985, IEEE T PATTERN ANAL, V7, P738, DOI 10.1109/TPAMI.1985.4767734; Harada S, 2013, LIFE SCI, V93, P573, DOI 10.1016/j.lfs.2013.08.009; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; Ho SY, 2004, IEEE T EVOLUT COMPUT, V8, P522, DOI 10.1109/TEVC.2004.835176; Ho SY, 2004, IEEE T SYST MAN CY B, V34, P609, DOI 10.1109/TSMCB.2003.817090; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Huang HL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S47; Huang K, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-78; Hutchinson MR, 2010, BRAIN BEHAV IMMUN, V24, P83, DOI 10.1016/j.bbi.2009.08.004; Ikeda H, 2010, J BIOL CHEM, V285, P38415, DOI 10.1074/jbc.M110.109827; Kilic FS, 2012, INDIAN J MED RES, V135, P630; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Kukkar A, 2013, ARCH PHARM RES, V36, P237, DOI 10.1007/s12272-013-0057-y; Lee KL, 2005, IMAGE VISION COMPUT, V23, P479, DOI 10.1016/j.imavis.2004.12.002; Li Z, 2010, INDIAN J BIOCHEM BIO, V47, P359; Lin SL, 2010, BEHAV BRAIN RES, V207, P30, DOI 10.1016/j.bbr.2009.09.034; Liu W, 2006, NEUROSCI LETT, V410, P174, DOI 10.1016/j.neulet.2006.08.091; Lu GJ, 1999, MULTIMEDIA SYST, V7, P165, DOI 10.1007/s005300050119; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; MARAGOS P, 1989, IEEE T PATTERN ANAL, V11, P701, DOI 10.1109/34.192465; Mattioli TAM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-22; Merighi S, 2013, BIOCHEM PHARMACOL, V86, P487, DOI 10.1016/j.bcp.2013.05.027; Meymandi MS, 2008, EUR J ANAESTH, V25, P129, DOI 10.1017/S0265021507001226; Mukundan R, 2001, IEEE T IMAGE PROCESS, V10, P1357, DOI 10.1109/83.941859; Otsu N, 1975, AUTOMATICA, V11, P23, DOI [DOI 10.1109/TSMC.1979.4310076, 10.1109/TSMC.1979.4310076, 10.1109/tsmc.1979.4310076]; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Shen Ching-Hui, 2012, Acta Anaesthesiol Taiwan, V50, P178, DOI 10.1016/j.aat.2012.12.004; SHENG Y, 1986, J OPT SOC AM A, V3, P885, DOI 10.1364/JOSAA.3.000885; Singh S, 2014, J BIOMOLECULAR SCREE, DOI 1087057114528537; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Stone LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109903; Tai YH, 2007, PAIN, V129, P343, DOI 10.1016/j.pain.2007.01.031; TEAGUE MR, 1980, J OPT SOC AM, V70, P920, DOI 10.1364/JOSA.70.000920; TEH CH, 1988, IEEE T PATTERN ANAL, V10, P496, DOI 10.1109/34.3913; Thomas B, 2011, EXPERT OPIN PHARMACO, V12, P2565, DOI 10.1517/14656566.2011.622267; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; Vonsy JL, 2009, EUR J PAIN, V13, P786, DOI 10.1016/j.ejpain.2008.09.008; Yap PT, 2003, IEEE T IMAGE PROCESS, V12, P1367, DOI 10.1109/TIP.2003.818019; Yuan YM, 2013, NEUROSCI BULL, V29, P421, DOI 10.1007/s12264-013-1358-3; Zhang DS, 2004, PATTERN RECOGN, V37, P1, DOI 10.1016/j.patcog.2003.07.008; Zhang DS, 2002, SIGNAL PROCESS-IMAGE, V17, P825, DOI 10.1016/S0923-5965(02)00084-X; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zou J, 2012, GLIA, V60, P661, DOI 10.1002/glia.22302	52	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139806	10.1371/journal.pone.0139806	http://dx.doi.org/10.1371/journal.pone.0139806			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437460	Green Submitted, gold, Green Published			2022-12-27	WOS:000362499200061
J	Patterson-Lomba, O; Wu, JW; Pagano, M				Patterson-Lomba, Oscar; Wu, Julia W.; Pagano, Marcello			Assessing Biases in the Evaluation of Classification Assays for HIV Infection Recency	PLOS ONE			English	Article							BIOMARKER; SENSITIVITY; PREVENTION; DIVERSITY	Identifying recent HIV infection cases has important public health and clinical implications. It is essential for estimating incidence rates to monitor epidemic trends and evaluate the effectiveness of interventions. Detecting recent cases is also important for HIV prevention given the crucial role that recently infected individuals play in disease transmission, and because early treatment onset can improve the clinical outlook of patients while reducing transmission risk. Critical to this enterprise is the development and proper assessment of accurate classification assays that, based on cross-sectional samples of viral sequences, help determine infection recency status. In this work we assess some of the biases present in the evaluation of HIV recency classification algorithms that rely on measures of within-host viral diversity. Particularly, we examine how the time since infection (TSI) distribution of the infected subjects from which viral samples are drawn affect performance metrics (e.g., area under the ROC curve, sensitivity, specificity, accuracy and precision), potentially leading to misguided conclusions about the efficacy of classification assays. By comparing the performance of a given HIV recency assay using six different TSI distributions (four simulated TSI distributions representing different epidemic scenarios, and two empirical TSI distributions), we show that conclusions about the overall efficacy of the assay depend critically on properties of the TSI distribution. Moreover, we demonstrate that an assay with high overall classification accuracy, mainly due to properly sorting members of the well-represented groups in the validation dataset, can still perform notoriously poorly when sorting members of the less represented groups. This is an inherent issue of classification and diagnostics procedures that is often underappreciated. Thus, this work underscores the importance of acknowledging and properly addressing evaluation biases when proposing new HIV recency assays.	[Patterson-Lomba, Oscar; Pagano, Marcello] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wu, Julia W.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Patterson-Lomba, O (corresponding author), Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	opatters@hsph.harvard.edu			National Institutes of Health (NIH) [T32AI007358-26, R01AI097015-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097015, T32AI007358] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The present work was supported by National Institutes of Health (NIH) grants T32AI007358-26 (OP-L) and R01AI097015-03 (JW and MP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookmeyer R, 2013, JAIDS-J ACQ IMM DEF, V63, pS233, DOI 10.1097/QAI.0b013e3182986fdf; Brookmeyer R, 2010, JAIDS-J ACQ IMM DEF, V54, P406, DOI 10.1097/QAI.0b013e3181dc6d2c; Cohen J, 2015, SCIENCE, V348, P1188, DOI 10.1126/science.348.6240.1188; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cousins MM, 2014, J CLIN MICROBIOL, V52, P115, DOI 10.1128/JCM.02040-13; Exner N, 2014, ADAPTING ENTRO UNPUB; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Kaivanto K, 2008, J CLIN EPIDEMIOL, V61, P517, DOI 10.1016/j.jclinepi.2007.10.011; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2014, AIDS RES HUM RETROV, V30, P45, DOI [10.1089/aid.2013.0113, 10.1089/AID.2013.0113]; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Laeyendecker O, 2012, J INFECT DIS; Laeyendecker O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078818; Maldarelli F, 2013, J VIROL, V87, P10313, DOI 10.1128/JVI.01225-12; Novitsky V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007727; Pagano Marcello, 2000, PRINCIPLES BIOSTATIS, V2; Park SY, 2014, J VIROL, V88, P2977, DOI 10.1128/JVI.03128-13; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; R Core Team, 2012, R LANG ENV STAT COMP; RANSOHOFF DF, 1978, NEW ENGL J MED, V299, P926, DOI 10.1056/NEJM197810262991705; Rosenberg NE, 2015, CURR OPIN HIV AIDS, V10, P61, DOI 10.1097/COH.0000000000000121; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Wassertheil-Smoller S, 2004, BIOSTATISTICS EPIDEM, V1; Xia XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100081; Yang J, 2012, SCI CHINA LIFE SCI, V55, P328, DOI 10.1007/s11427-012-4312-0	27	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139735	10.1371/journal.pone.0139735	http://dx.doi.org/10.1371/journal.pone.0139735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436915	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200057
J	Zhong, N; Loppnau, P; Seitova, A; Ravichandran, M; Fenner, M; Jain, H; Bhattacharya, A; Hutchinson, A; Paduch, M; Lu, V; Olszewski, M; Kossiakoff, AA; Dowdell, E; Koide, A; Koide, S; Huang, HM; Nadeem, V; Sidhu, SS; Greenblatt, JF; Marcon, E; Arrowsmith, CH; Edwards, AM; Graslund, S				Zhong, Nan; Loppnau, Peter; Seitova, Alma; Ravichandran, Mani; Fenner, Maria; Jain, Harshika; Bhattacharya, Anandi; Hutchinson, Ashley; Paduch, Marcin; Lu, Vincent; Olszewski, Michal; Kossiakoff, Anthony A.; Dowdell, Evan; Koide, Akiko; Koide, Shohei; Huang, Haiming; Nadeem, Vincent; Sidhu, Sachdev S.; Greenblatt, Jack F.; Marcon, Edyta; Arrowsmith, Cheryl H.; Edwards, Aled M.; Graeslund, Susanne			Optimizing Production of Antigens and Fabs in the Context of Generating Recombinant Antibodies to Human Proteins	PLOS ONE			English	Article							ESCHERICHIA-COLI; SYNTHETIC ANTIBODIES; HUMAN PROTEOME; PHAGE DISPLAY; IN-VIVO; EXPRESSION; BIOTINYLATION; RECOGNITION; LIBRARIES	We developed and optimized a high-throughput project workflow to generate renewable recombinant antibodies to human proteins involved in epigenetic signalling. Three different strategies to produce phage display compatible protein antigens in bacterial systems were compared, and we found that in vivo biotinylation through the use of an Avi tag was the most productive method. Phage display selections were performed on 265 in vivo biotinylated antigen domains. High-affinity Fabs (<20nM) were obtained for 196. We constructed and optimized a new expression vector to produce in vivo biotinylated Fabs in E. coli. This increased average yields up to 10-fold, with an average yield of 4 mg/L. For 118 antigens, we identified Fabs that could immunoprecipitate their full-length endogenous targets from mammalian cell lysates. One Fab for each antigen was converted to a recombinant IgG and produced in mammalian cells, with an average yield of 15 mg/L. In summary, we have optimized each step of the pipeline to produce recombinant antibodies, significantly increasing both efficiency and yield, and also showed that these Fabs and IgGs can be generally useful for chromatin immunoprecipitation (ChIP) protocols.	[Zhong, Nan; Loppnau, Peter; Seitova, Alma; Ravichandran, Mani; Fenner, Maria; Jain, Harshika; Bhattacharya, Anandi; Hutchinson, Ashley; Arrowsmith, Cheryl H.; Edwards, Aled M.; Graeslund, Susanne] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Paduch, Marcin; Lu, Vincent; Olszewski, Michal; Kossiakoff, Anthony A.; Dowdell, Evan; Koide, Akiko; Koide, Shohei] Univ Chicago, Knapp Ctr Biomed Discovery, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Huang, Haiming; Nadeem, Vincent; Sidhu, Sachdev S.; Greenblatt, Jack F.; Marcon, Edyta] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Greenblatt, Jack F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; Structural Genomics Consortium; University of Chicago; University of Toronto; University of Toronto	Graslund, S (corresponding author), Univ Toronto, Struct Genom Consortium, MaRS S Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	susanne.graslund@ki.se	Gräslund, Susanne/ABB-6339-2020	Arrowsmith, Cheryl/0000-0002-4971-3250; Graslund, Susanne/0000-0003-0077-8333; Koide, Shohei/0000-0001-5473-4358; Edwards, Aled/0000-0002-4782-6016	AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Innovative Medicines Initiative; Janssen; Lilly Canada; Merck Co.; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation; Takeda; Wellcome Trust; National Institute of General Medical Sciences of the National Institutes of Health [GM072688, GM094588]; NIH Common Fund [HG006436]; SGC; Canadian Institutes of Health Research [MOP-136944]; Thermo Fisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, U01GM094588] Funding Source: NIH RePORTER	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Innovative Medicines Initiative; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Merck Co.(Merck & Company); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SGC; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Thermo Fisher Scientific; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, the Innovative Medicines Initiative, Janssen, Lilly Canada, Merck & Co., the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, the Sao Paulo Research Foundation, Takeda and the Wellcome Trust. A.A.K., S.K. and S.S.S. were supported by the National Institute of General Medical Sciences of the National Institutes of Health (GM072688 and GM094588), NIH Common Fund (HG006436) and by SGC. S.S.S. was also supported by a grant from Canadian Institutes of Health Research (MOP-136944). This research was also supported through a grant from Thermo Fisher Scientific. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Barnes HJ, 1996, METHOD ENZYMOL, V272, P3, DOI 10.1016/S0076-6879(96)72003-7; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Blow N, 2007, NATURE, V447, P741, DOI 10.1038/447741a; Bordeaux J, 2010, BIOTECHNIQUES, V48, P197, DOI 10.2144/000113382; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Cull MG, 2000, METHOD ENZYMOL, V326, P430; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Graslund S, 2008, PROTEIN EXPRES PURIF, V58, P210, DOI 10.1016/j.pep.2007.11.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hornsby M, 2015, MOL CELL PROTEOMICS, V14, P2833, DOI 10.1074/mcp.O115.052209; Huang HM, 2011, METHODS MOL BIOL, V781, P87, DOI 10.1007/978-1-61779-276-2_6; Keates T, 2012, NEW BIOTECHNOL, V29, P515, DOI 10.1016/j.nbt.2011.10.007; Mak AB, 2010, MOL CELL PROTEOMICS, V9, P811, DOI 10.1074/mcp.M000002-MCP201; Marcon E, 2015, NAT METHODS, V12, P725, DOI [10.1038/NMETH.3472, 10.1038/nmeth.3472]; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Miller KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043746; MUCHMORE DC, 1989, METHOD ENZYMOL, V177, P44; OKA T, 1985, P NATL ACAD SCI USA, V82, P7212, DOI 10.1073/pnas.82.21.7212; Paduch M, 2013, METHODS, V60, P3, DOI 10.1016/j.ymeth.2012.12.010; Persson H, 2013, J MOL BIOL, V425, P803, DOI 10.1016/j.jmb.2012.11.037; PORATH J, 1992, PROTEIN EXPRES PURIF, V3, P263, DOI 10.1016/1046-5928(92)90001-D; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248	32	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139695	10.1371/journal.pone.0139695	http://dx.doi.org/10.1371/journal.pone.0139695			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437229	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200050
J	Peitzmeier, SM; Yasin, F; Stephenson, R; Wirtz, AL; Delegchoimbol, A; Dorjgotov, M; Baral, S				Peitzmeier, Sarah M.; Yasin, Faiza; Stephenson, Rob; Wirtz, Andrea L.; Delegchoimbol, Altanchimeg; Dorjgotov, Myagmardorj; Baral, Stefan			Sexual Violence against Men Who Have Sex with Men and Transgender Women in Mongolia: A Mixed-Methods Study of Scope and Consequences	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; UNITED-STATES; HIV; PREVENTION; RISK; GAY; ASSAULT; PEOPLE; POPULATIONS; OFFENDERS	The role of sexual violence in health and human rights-related outcomes, including HIV, is receiving increasing attention globally, yet the prevalence, patterns, and correlates of sexual violence have been little-studied among men who have sex with men (MSM) and transgender women in low and middle income countries. A mixed-methods study with quantitative and qualitative phases was conducted among MSM and transgender women in Ulaanbaatar, Mongolia. Methods included respondent-driven sampling (RDS) with structured socio-behavioral surveys (N = 313) as well as qualitative methods including 30 indepth interviews and 2 focus group discussions. Forced sex in the last three years was reported by 14.7% of respondents (RDS-weighted estimate, 95% CI: 9.4-20.1; crude estimate 16.1%, 49/307) in the quantitative phase. A descriptive typology of common scenarios was constructed based on the specific incidents of sexual violence shared by respondents in the qualitative phase (37 incidents across 28 interviews and 2 focus groups). Eight major types of sexual violence were identified, most frequent of which were bias-motivated street violence and alcohol-involved party-related violence. Many vulnerabilities to and consequences of sexual violence described during the qualitative phase were also independently associated with forced sex, including alcohol use at least once per week (AOR = 3.39, 95% CI: 1.69-6.81), and having received payment for sex (AOR = 2.77, 95% CI: 1.14-6.75). Building on the promising strategies used in other settings to prevent and respond to sexual violence, similar strengthening of legal and social sector responses may provide much needed support to survivors and prevent future sexual violence.	[Peitzmeier, Sarah M.; Yasin, Faiza; Wirtz, Andrea L.; Baral, Stefan] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Yasin, Faiza] Boston Univ, Sch Med, Boston, MA 02118 USA; [Stephenson, Rob] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Wirtz, Andrea L.] Johns Hopkins Sch Med, Baltimore, MD USA; [Delegchoimbol, Altanchimeg] UNAIDS Mongolia, Ulaanbaatar, Mongolia; [Dorjgotov, Myagmardorj] Youth Hlth NGO, Ulaanbaatar, Mongolia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Boston University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine	Peitzmeier, SM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	speitzm1@jhu.edu	Baral, Stefan/AAG-4818-2020	Baral, Stefan/0000-0002-5482-2419; Peitzmeier, Sarah/0000-0003-4552-1099	UNAIDS to UNAIDS Mongolia; Center for Public Health and Human Rights at the Johns Hopkins School of Public Health	UNAIDS to UNAIDS Mongolia; Center for Public Health and Human Rights at the Johns Hopkins School of Public Health	This study was funded by a grant from UNAIDS to UNAIDS Mongolia. The Center for Public Health and Human Rights at the Johns Hopkins School of Public Health provided support for the effort of the investigators and students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbey A, 2001, ALCOHOL RES HEALTH, V25, P43; Armstrong EA, 2006, SOC PROBL, V53, P483, DOI 10.1525/sp.2006.53.4.483; Aspin C, 2009, CULT HEALTH SEX, V11, P35, DOI 10.1080/13691050802483711; Aubone A, 2013, REFUG SURV Q, V32, P22, DOI 10.1093/rsq/hdt015; Azyei I, 2014, AIDS BEHAV, V18, P2009, DOI 10.1007/s10461-014-0780-5; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Banyard VL, 2007, J COMMUNITY PSYCHOL, V35, P463, DOI 10.1002/jcop.20159; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Basile K. C., 2002, SEXUAL VIOLENCE SURV; Beattie TSH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-476; Beyrer C, 2007, CLIN INFECT DIS, V44, P981, DOI 10.1086/512371; Braitstein P, 2006, AIDS CARE, V18, P681, DOI 10.1080/13548500500294385; Bryman A., 2006, QUAL RES, V6, P97, DOI [10.1177/1468794106058877, DOI 10.1177/1468794106058877]; Burgess AW, 2007, AGGRESS VIOLENT BEH, V12, P582, DOI 10.1016/j.avb.2007.02.006; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Colfax GN, 2001, J ACQ IMMUN DEF SYND, V28, P373, DOI 10.1097/00126334-200112010-00011; Davies M, 2002, AGGRESS VIOLENT BEH, V7, P203, DOI 10.1016/S1359-1789(00)00043-4; Fenaughty J., 2006, SEXUAL COERCION GAY; Finneran C, 2013, TRAUMA VIOLENCE ABUS, V14, P168, DOI 10.1177/1524838012470034; Foubert JD, 2006, J COLL STUDENT DEV, P133; Fradella HD, 2007, LAW PSYCHOL REV, V31, P1; Gavey N, 2009, J HEALTH PSYCHOL, V14, P1021, DOI 10.1177/1359105309342307; Gen M, 2010, ADDRESSING CONFLICT; Groth A.N., 2013, MEN WHO RAPE PSYCHOL; Guadamuz TE, 2011, ARCH SEX BEHAV, V40, P259, DOI 10.1007/s10508-009-9557-8; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Isikozlu E., 2010, TYPOLOGY WARTIME RAP; Katz-Wise SL, 2012, J SEX RES, V49, P142, DOI 10.1080/00224499.2011.637247; Klot JF, 2013, AM J REPROD IMMUNOL, V69, P2, DOI 10.1111/aji.12037; Knight R.A., 1990, HDB SEXUAL ASSAULT I, P23, DOI DOI 10.1007/978-1-4899-0915-2_3; Lai Y., 2014, DESK REV LEGAL POLIC; Mair JS, 2003, ANNU REV PUBL HEALTH, V24, P209, DOI 10.1146/annurev.publhealth.24.100901.140826; Mansergh G, 2001, AM J PUBLIC HEALTH, V91, P953, DOI 10.2105/AJPH.91.6.953; McCabe MP, 2005, ARCH SEX BEHAV, V34, P241, DOI 10.1007/s10508-005-1801-2; Mendez J., 2013, AHRC2253 UN HUM RIGH AHRC2253 UN HUM RIGH; Mongolia UEi, 2013, 2012 HUM RIGHTS REP; Morrison S, 2004, 207262 NCJ; Quinn ME., 2010, OPEN MINDS OPEN DOOR; Robertiello G, 2007, AGGRESS VIOLENT BEH, V12, P508, DOI 10.1016/j.avb.2007.02.010; Rothman EF, 2011, TRAUMA VIOLENCE ABUS, V12, P55, DOI 10.1177/1524838010390707; Schonlau M, 2012, STATA J, V12, P72, DOI 10.1177/1536867X1201200106; Shaw SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031705; Sivaram S, 2007, J URBAN HEALTH, V84, P563, DOI 10.1007/s11524-007-9196-0; Stephenson R, 2014, CULT HEALTH SEX, V16, P473, DOI 10.1080/13691058.2014.889753; Stephenson R, 2011, WEST J EMERG MED, V12, P343; Stotzer RL, 2009, AGGRESS VIOLENT BEH, V14, P170, DOI 10.1016/j.avb.2009.01.006; UNAIDS, 2014, COUNTR PROGR REP MON; UNDP U., 2014, BEING LGBT AS MONG C; Volz E, 2007, RESPONDENT DRIVEN SA; Walker J, 2005, ARCH SEX BEHAV, V34, P69, DOI 10.1007/s10508-005-1001-0; Weir SS, 2003, AIDS, V17, P895, DOI 10.1097/00002030-200304110-00015; Wheeler J, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.24814; Wyss S., 2004, INT J QUAL STUD ED, V17, P709, DOI [10.1080/0951839042000253676, DOI 10.1080/0951839042000253676]; Yasin F, 2013, AIDS BEHAV, V17, P1378, DOI 10.1007/s10461-013-0412-5	56	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139320	10.1371/journal.pone.0139320	http://dx.doi.org/10.1371/journal.pone.0139320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431311	gold, Green Published			2022-12-27	WOS:000362178700042
J	Temmam, S; Monteil-Bouchard, S; Robert, C; Pascalis, H; Michelle, C; Jardot, P; Charrel, R; Raoult, D; Desnues, C				Temmam, Sarah; Monteil-Bouchard, Sonia; Robert, Catherine; Pascalis, Herve; Michelle, Caroline; Jardot, Priscilla; Charrel, Remi; Raoult, Didier; Desnues, Christelle			Host-Associated Metagenomics: A Guide to Generating Infectious RNA Viromes	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; VIRAL METAGENOMICS; VETERINARY-MEDICINE; DNA VIRUSES; DISCOVERY; VIROLOGY; TOOL	Background Metagenomic analyses have been widely used in the last decade to describe viral communities in various environments or to identify the etiology of human, animal, and plant pathologies. Here, we present a simple and standardized protocol that allows for the purification and sequencing of RNA viromes from complex biological samples with an important reduction of host DNA and RNA contaminants, while preserving the infectivity of viral particles. Principal Findings We evaluated different viral purification steps, random reverse transcriptions and sequence-independent amplifications of a pool of representative RNA viruses. Viruses remained infectious after the purification process. We then validated the protocol by sequencing the RNA virome of human body lice engorged in vitro with artificially contaminated human blood. The full genomes of the most abundant viruses absorbed by the lice during the blood meal were successfully sequenced. Interestingly, random amplifications differed in the genome coverage of segmented RNA viruses. Moreover, the majority of reads were taxonomically identified, and only 7-15% of all reads were classified as "unknown", depending on the random amplification method. Conclusion The protocol reported here could easily be applied to generate RNA viral metagenomes from complex biological samples of different origins. Our protocol allows further virological characterizations of the described viral communities because it preserves the infectivity of viral particles and allows for the isolation of viruses.	[Temmam, Sarah; Monteil-Bouchard, Sonia; Robert, Catherine; Michelle, Caroline; Jardot, Priscilla; Raoult, Didier; Desnues, Christelle] Aix Marseille Univ, CNRS 7278, URMITE UM63, IRD 198,INSERM 1095, Marseille, France; [Pascalis, Herve] Plateforme Rech CYROI, Ctr Rech & Veille Malad Emergentes Ocean Indien C, IRD La Reunion, La Reunion, France; [Charrel, Remi] Aix Marseille Univ, EPV, IRD 190, EHESP, Marseille, France	Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Desnues, C (corresponding author), Aix Marseille Univ, CNRS 7278, URMITE UM63, IRD 198,INSERM 1095, Marseille, France.	christelle.desnues@univ-amu.fr	TEMMAM, Sarah/AAX-3717-2021; Desnues, Christelle/ABG-2910-2021; Pascalis, Herve/M-9410-2019; Desnues, Christelle/B-1383-2010; Pascalis, Herve/F-5726-2014; RAOULT, Didier/A-8434-2008	TEMMAM, Sarah/0000-0003-3655-9220; Desnues, Christelle/0000-0002-2178-0355; Pascalis, Herve/0000-0002-6822-7311; Desnues, Christelle/0000-0002-2178-0355; Pascalis, Herve/0000-0002-6822-7311; RAOULT, Didier/0000-0002-0633-5974; Michelle, Caroline/0000-0002-9235-074X	Agence Nationale de la Recherche [ANR-13-JSV6-0004]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was conducted under the frame of an Agence Nationale de la Recherche Young Investigator fellowship (ANR-13-JSV6-0004) awarded to Christelle Desnues. The work of Remi N. Charrel was conducted under the frame of EurNegVec COST Action TD1303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Berthet N, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-77; Blomstrom AL, 2011, VET QUART, V31, P107, DOI 10.1080/01652176.2011.604971; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Chius CY, 2013, CURR OPIN MICROBIOL, V16, P468, DOI 10.1016/j.mib.2013.05.001; Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Fancello L, 2013, ISME J, V7, P359, DOI 10.1038/ismej.2012.101; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; Granberg F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057459; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Karlsson OE, 2013, BIOSECUR BIOTERROR, V11, pS227, DOI 10.1089/bsp.2013.0008; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; King A.M.Q., 2011, VIRUS TAXONOMY, V1st ed; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Kohl C, 2015, EMERG INFECT DIS, V21, P48, DOI 10.3201/eid2101.140766; Lawrence J., 2010, MANUAL AQUATIC VIRAL, P166, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.166; Maillard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026637; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444; Mathieson W, 2013, ANAL BIOCHEM, V433, P10, DOI 10.1016/j.ab.2012.10.006; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019050; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; Popgeorgiev N, 2013, INTERVIROLOGY, V56, P395, DOI 10.1159/000354561; Rivers TM, 1937, J BACTERIOL, V33, P1; Roossinck MJ, 2012, ANNU REV GENET, V46, P359, DOI 10.1146/annurev-genet-110711-155600; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Rosseel T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076144; Sachsenroder J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034631; Sangare AK, 2015, INT J ANTIMICROB AG, V45, P675, DOI 10.1016/j.ijantimicag.2015.02.008; Stang A, 2005, J CLIN MICROBIOL, V43, P716, DOI 10.1128/JCM.43.2.716-720.2005; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Temmam S, 2014, INT J MOL SCI, V15, P10377, DOI 10.3390/ijms150610377; Terry FFN, 2012, J VIROL, V86, P12161, DOI 10.1128/JVI.00869-12; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Thurber RV, 2011, HDB MOL MICROBIAL EC, P15; Tidona CA, 2001, SPRINGER INDEX VIRUS; Trudel M, 1989, MANUEL TECHNIQUES VI; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Watkins-Riedel T, 2002, DIAGN MICR INFEC DIS, V42, P99, DOI 10.1016/S0732-8893(01)00330-3; Weynberg KD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00206; Whon TW, 2012, J VIROL, V86, P8221, DOI 10.1128/JVI.00293-12; Yang YH, 2014, APPL ENVIRON MICROB, V80, P3334, DOI 10.1128/AEM.03964-13	57	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139810	10.1371/journal.pone.0139810	http://dx.doi.org/10.1371/journal.pone.0139810			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431175	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700118
J	Yeh, KT; Wu, WT; Subeq, YM; Niu, CC; Liao, KW; Chen, IH; Wang, JH; Lee, RP				Yeh, Kuang-Ting; Wu, Wen-Tien; Subeq, Yi-Maun; Niu, Chi-Chien; Liao, Kuang-Wen; Chen, Ing-Ho; Wang, Jen-Hung; Lee, Ru-Ping			Non-Steroid Anti-Inflammatory Drugs Are Better than Acetaminophen on Fever Control at Acute Stage of Fracture	PLOS ONE			English	Article							INDUCED HEPATIC-NECROSIS; PARACETAMOL; MECHANISMS; TRAUMA; IL-10	In addition to adequate surgical fixation and an aggressive rehabilitation program, pain relief is one of the most critical factors in the acute stage of fracture treatment. The most common analgesics are nonsteroid anti-inflammatory drugs and Acetaminophen, both of which relieve pain and reduce body temperature. In clinical experiences, they exhibit effective pain control; however, their influence on body temperature remains controversial. This study is aimed at determining the effects of analgesics at the acute stage of traumatic fracture by performing a clinical retrospective study of patients with fractures and a fracture animal model. The retrospective study revealed that, in the acetaminophen group, the mean value of postmedication body temperature (BT) was significantly higher than that of the premedication BT. The change in BT was highly related with the medication rather than other risk factors. Forty eight 12-week-old male Wistar rats were divided into 6 groups: a control group, fracture group, fracture-Acetaminophen group, Acetaminophen group, fracture-Arcoxia group, and Arcoxia group. Fracture rats were prepared by breaking their unilateral tibia and fibula. Their inflammation conditions were evaluated by measuring their serum cytokine level and their physiological status was evaluated by estimating their central temperature, heart rate, and mean blood pressure. The hepatic adverse effects were assessed by measuring the serum levels of aspartate aminotransferase (sGOT) and alanine aminotransferase (sGPT). The central temperature in the fracture-Acetaminophen group exceeded that in the groups fed normal saline water or Arcoxia. Accumulated hepatic injury was presented as steadily ascending curves of sGOT and sGPT. Inflammation-related cytokine levels were not higher in the Acetaminophen fracture group and were significantly lower in the fracture-Arcoxia group. Fever appeared to be aggravated by acetaminophen and more related to the elevation of hepatic enzymes than to the change in the inflammation-related cytokines. We suggest that acetaminophen may aggravate fever at the acute stage of fracture. This response is highly related to the accumulated and exacerbated side effects of hepatitis that are caused by the medication and trauma.	[Yeh, Kuang-Ting; Wu, Wen-Tien; Lee, Ru-Ping] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Yeh, Kuang-Ting; Wu, Wen-Tien; Chen, Ing-Ho] Hualien Tzu Chi Hosp, Dept Orthoped, Buddhist Tzu Chi Med Fdn, Hualien, Taiwan; [Wu, Wen-Tien; Chen, Ing-Ho] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Subeq, Yi-Maun] Tzu Chi Univ, Dept Nursing, Hualien, Taiwan; [Niu, Chi-Chien] Chang Gung Mem Hosp, Dept Orthopaed Surg, Taoyuan, Taiwan; [Liao, Kuang-Wen] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Wang, Jen-Hung] Hualien Tzu Chi Hosp, Dept Res, Buddhist Tzu Chi Med Fdn Hualien, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Lee, RP (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	fish@mail.tcu.edu.tw	Yeh, Kuang-Ting/ABD-4398-2020; Niu, Chi-Chien/AAT-4229-2021		Buddhist Tzu Chi Medical Foundation [TCRD104-16]; Hualien Tzu Chi Hospital	Buddhist Tzu Chi Medical Foundation; Hualien Tzu Chi Hospital	This work was supported by grants from the Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD104-16).	AN YH, 1994, J ORTHOP TRAUMA, V8, P111; Begum TN, 2010, RES J PHARMACOGNOSY, V2, P454; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; BJORKMAN R, 1994, PAIN, V57, P259, DOI 10.1016/0304-3959(94)90001-9; Choi SS, 2001, BRAIN RES, V921, P233, DOI 10.1016/S0006-8993(01)03126-2; Courade JP, 2001, EUR J PHARMACOL, V432, P1, DOI 10.1016/S0014-2999(01)01464-9; Dimmen S, 2008, ACTA ORTHOP, V79, P438, DOI 10.1080/17453670710015373; Dimmen S, 2009, CLIN ORTHOP RELAT R, V467, P1992, DOI 10.1007/s11999-009-0783-0; Essien AD, 2015, ASIAN J MED SCI, V7, P22; JOLLOW DJ, 1973, J PHARMACOL EXP THER, V187, P195; Lauw FN, 2000, J IMMUNOL, V165, P2783, DOI 10.4049/jimmunol.165.5.2783; Lee RP, 2012, BIOL RES NURS, V14, P286, DOI 10.1177/1099800411408881; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P185; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Mizushima Y, 2009, J TRAUMA, V67, P1062, DOI 10.1097/TA.0b013e3181b848fc; NELSON SD, 1995, DRUG METAB REV, V27, P147, DOI 10.3109/03602539509029821; NELSON SD, 1990, SEMIN LIVER DIS, V10, P267, DOI 10.1055/s-2008-1040482; OBERHOLZER A, 2002, CRIT CARE MED S1, V30, pS58; Pini LA, 1996, EUR J PHARMACOL, V308, P31, DOI 10.1016/0014-2999(96)00261-0; Raffa RB, 2000, J PHARMACOL EXP THER, V295, P291; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Strecker W, 1999, J TRAUMA, V47, P358, DOI 10.1097/00005373-199908000-00025; Vijayakaran K, 2014, ENVIRON TOXICOL PHAR, V37, P438, DOI 10.1016/j.etap.2013.12.015; WRAY J B, 1960, Surg Forum, V11, P444; WRAY JB, 1959, J BONE JOINT SURG AM, V41, P1143, DOI 10.2106/00004623-195941060-00014	26	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0137225	10.1371/journal.pone.0137225	http://dx.doi.org/10.1371/journal.pone.0137225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431202	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700006
J	DiBonaventura, M; Richard, L; Kumar, M; Forsythe, A; Flores, NM; Moline, M				DiBonaventura, Marco; Richard, Lance; Kumar, Maya; Forsythe, Anna; Flores, Natalia M.; Moline, Margaret			The Association between Insomnia and Insomnia Treatment Side Effects on Health Status, Work Productivity, and Healthcare Resource Use	PLOS ONE			English	Article							ACTIVITY IMPAIRMENT; INDIRECT COSTS; ESZOPICLONE; SYMPTOMS; VALIDITY; ZOLPIDEM	The aims of this study were (1) to compare health outcomes (i.e., health-related quality of life [HRQoL], productivity at work, and healthcare resource use visits) between those with insomnia and non-insomnia controls, (2) to compare health outcomes between those treated for insomnia and non-insomnia controls, and (3) to assess the prevalence of side effects of insomnia medications and their relationship with health outcomes. Data from the 2013 US (N = 75,000) and 5EU (N = 62,000) National Health and Wellness Survey (NHWS) were used. The NHWS is a patient-reported survey administered to a demographically representative sample of adults. Those who met DSM-V criteria for insomnia and, separately, those treated for insomnia were compared with equivalently sized control groups who were identified using a propensity score matching method. Outcomes included HRQoL (Short Form 36v2), productivity at work (Work Productivity and Activity Impairment-General Health questionnaire), and healthcare resource use visits in the past 6 months and were analyzed using one-way ANOVAs. Among those with treated insomnia, those with and without side effects were compared on health outcomes using general linearmodels controlling for confounding variables. Patients with insomnia (n = 4147) and treated insomnia (n = 2860) in the 5EU reported significantly worse HRQoL than controls (health utilities: 0.60 vs. 0.74; 0.60 vs. 0.74, respectively), greater overall work impairment (38.74% vs. 14.86%; 39.50% vs. 15.66%), and more physician visits in the past 6 months (9.10 vs. 4.08; 9.58 vs. 4.11). Similar findings were observed in the US. Among those treated for insomnia, 13.56% and 24.55% in the US and 5EU, respectively, were non-adherent due to side effects. In the US, non-adherence was associated with significantly worse HRQoL (health utilities: 0.60 vs. 0.64, p < .05) and greater overall work impairment (37.71% vs. 29.08%, p < .05), among other significant differences. These relationships were not significant in the 5EU. A significant burden of insomnia was observed in both the US and 5EU, and the association remained even after treatment. Non-adherence due to side effects was common and, in the case of the US, associated with significantly poorer health outcomes.	[DiBonaventura, Marco; Kumar, Maya; Flores, Natalia M.] Kantar Hlth, New York, NY 10010 USA; [Richard, Lance] Eisai Europe Ltd, Hatfield, Herts, England; [Forsythe, Anna; Moline, Margaret] Eisai Inc, Woodcliff Lake, NJ USA	Eisai Co Ltd; Eisai Co Ltd	DiBonaventura, M (corresponding author), Kantar Hlth, New York, NY 10010 USA.	marco.dibonaventura@kantarhealth.com	Kumar, Maya/HDM-9018-2022		Eisai Inc.; Eisai Europe Ltd.	Eisai Inc.(Eisai Co Ltd); Eisai Europe Ltd.(Eisai Co Ltd)	Eisai Inc. purchased access to the data source and funded the analysis and preparation of this manuscript. Eisai Inc. provided support in the form of salaries for authors AF and MM, but did not have any additional role in the study design or decision to publish. Eisai Europe Ltd. provided support in the form of a salary for author LR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Kantar Health, itself, provided support in the form of salaries for authors NF, MD, MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There are no other Financial Disclosures to declare and no non-Financial Competing Interests to declare.	Ancoli-Israel S, 1999, SLEEP, V22, pS347; Asnis GM, 1999, J CLIN PSYCHIAT, V60, P668, DOI 10.4088/JCP.v60n1005; Bertisch SM, 2014, SLEEP, V37, P343, DOI 10.5665/sleep.3410; Bolge SC, 2009, QUAL LIFE RES, V18, P415, DOI 10.1007/s11136-009-9462-6; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Brazier J, 2004, HEALTH ECON, V13, P873, DOI 10.1002/hec.866; Butner Katrina L, 2013, N Am J Med Sci, V5, P362, DOI 10.4103/1947-2714.114168; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Daley M, 2009, SLEEP, V32, P55; DiBonaventura Marco DaCosta, 2010, J Med Econ, V13, P709, DOI 10.3111/13696998.2010.535576; Finkelstein EA, 2011, J OCCUP ENVIRON MED, V53, P1025, DOI 10.1097/JOM.0b013e318229aae4; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Ishak Waguih W, 2012, Innov Clin Neurosci, V9, P13; Kato K, 2005, NEUROPHARMACOLOGY, V48, P301, DOI 10.1016/j.neuropharm.2004.09.007; Krystal AD, 2003, SLEEP, V26, P793, DOI 10.1093/sleep/26.7.793; Laugsand LE, 2014, SLEEP, V37, P1776, DOI 10.5665/sleep.4170; Moline M, 2014, NAT SCI SLEEP, V6, P101, DOI 10.2147/NSS.S66696; Morin CM, 2006, SLEEP MED, V7, P123, DOI 10.1016/j.sleep.2005.08.008; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Najib J, 2006, CLIN THER, V28, P491, DOI 10.1016/j.clinthera.2006.04.014; Parsons L., 2011, SAS SUGI, P214; Ramakrishnan K., 2007, S AFR FAM PRACT, V49, P34; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Rosenberg Russell P, 2006, Ann Clin Psychiatry, V18, P49, DOI 10.1080/10401230500464711; Tagaya Hirokuni, 2007, Folia Pharmacologica Japonica, V129, P42, DOI 10.1254/fpj.129.42; Uchiyama M, 2011, SLEEP MED, V12, P119, DOI 10.1016/j.sleep.2010.08.010; Victorri-Vigneau C, 2014, J ADDICT DIS, V33, P15, DOI 10.1080/10550887.2014.882725; Villa KF, 2014, AC MAN CAR PHARM 201; Walters Stephen J, 2003, Health Qual Life Outcomes, V1, P4, DOI 10.1186/1477-7525-1-4; Ware J. E. J., 2002, SCORE VERSION 2 SF 1	30	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0137117	10.1371/journal.pone.0137117	http://dx.doi.org/10.1371/journal.pone.0137117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426805	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100004
J	Saliba, A; Du, YP; Liu, HT; Patel, S; Roberts, R; Berkowitz, BA; Kern, TS				Saliba, Alexandra; Du, Yunpeng; Liu, Haitao; Patel, Shyam; Roberts, Robin; Berkowitz, Bruce A.; Kern, Timothy S.			Photobiomodulation Mitigates Diabetes-Induced Retinopathy by Direct and Indirect Mechanisms: Evidence from Intervention Studies in Pigmented Mice	PLOS ONE			English	Article							MANGANESE-ENHANCED MRI; NEAR-INFRARED LIGHT; MESENCHYMAL STEM-CELLS; LASER IRRADIATION; MOUSE MODEL; OXIDATIVE STRESS; HEME OXYGENASE-1; BONE-MARROW; ION DEMAND; IN-VIVO	Objective Daily application of far-red light from the onset of diabetes mitigated diabetes-induced abnormalities in retinas of albino rats. Here, we test the hypothesis that photobiomodulation (PBM) is effective in diabetic, pigmented mice, even when delayed until weeks after onset of diabetes. Direct and indirect effects of PBM on the retina also were studied. Methods Diabetes was induced in C57Bl/6J mice using streptozotocin. Some diabetics were exposed to PBM therapy (4 min/day; 670 nm) daily. In one study, mice were diabetic for 4 weeks before initiation of PBM for an additional 10 weeks. Retinal oxidative stress, inflammation, and retinal function were measured. In some mice, heads were covered with a lead shield during PBM to prevent direct illumination of the eye, or animals were treated with an inhibitor of heme oxygenase-1. In a second study, PBM was initiated immediately after onset of diabetes, and administered daily for 2 months. These mice were examined using manganese-enhanced MRI to assess effects of PBM on transretinal calcium channel function in vivo. Results PBM intervention improved diabetes-induced changes in superoxide generation, leukostasis, expression of ICAM-1, and visual performance. PBM acted in part remotely from the retina because the beneficial effects were achieved even with the head shielded from the light therapy, and because leukocyte-mediated cytotoxicity of retinal endothelial cells was less in diabetics treated with PBM. SnPP+PBM significantly reduced iNOS expression compared to PBM alone, but significantly exacerbated leukostasis. In study 2, PBM largely mitigated diabetes-induced retinal calcium channel dysfunction in all retinal layers. Conclusions PBM induces retinal protection against abnormalities induced by diabetes in pigmented animals, and even as an intervention. Beneficial effects on the retina likely are mediated by both direct and indirect mechanisms. PBM is a novel non-pharmacologic treatment strategy to inhibit early changes of diabetic retinopathy.	[Saliba, Alexandra; Du, Yunpeng; Liu, Haitao; Kern, Timothy S.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Saliba, Alexandra] Univ Catolica Brasilia, Brasilia, DF, Brazil; [Patel, Shyam; Roberts, Robin; Berkowitz, Bruce A.] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI USA; [Berkowitz, Bruce A.] Wayne State Univ, Dept Ophthalmol, Detroit, MI USA; [Kern, Timothy S.] Cleveland Vet Affairs Med Ctr, Res Serv 151, Cleveland, OH USA	Case Western Reserve University; Universidade Catolica de Brasilia; Wayne State University; Wayne State University	Kern, TS (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	tsk@case.edu	Liu, Haitao/AAY-3944-2021	Liu, Haitao/0000-0002-3757-779X	National Eye Institute [EY00300, EY022938, R24EY024864, EY021619]; Medical Research Service of the Department of Veteran Affairs; Brazilian Institution CAPES; CWRU Visual Science Research Center core facility [P30EY11373]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R21EY021619, P30EY011373, R24EY024864, R56EY000300, R01EY000300, R01EY022938] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002117] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Service of the Department of Veteran Affairs; Brazilian Institution CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CWRU Visual Science Research Center core facility; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the National Eye Institute (EY00300, EY022938, R24EY024864 to TSK and EY021619 to BAB), the Medical Research Service of the Department of Veteran Affairs (TSK), and the Brazilian Institution CAPES (AS). Support was also provided by the CWRU Visual Science Research Center core facility (P30EY11373), and Research to Prevent Blindness to Kresge Eye Institute (BAB).	Albarracin R, 2011, INVEST OPHTH VIS SCI, V52, P3582, DOI 10.1167/iovs.10-6664; Berkowitz BA, 2008, INVEST OPHTH VIS SCI, V49, P3178, DOI 10.1167/iovs.08-1720; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P4753, DOI 10.1167/iovs.07-0433; Berkowitz BA, 2007, INVEST OPHTH VIS SCI, V48, P3796, DOI 10.1167/iovs.06-1278; Berkowitz BA, 2015, INVEST OPHTH VIS SCI, V56, P606, DOI 10.1167/iovs.14-15687; Berkowitz BA, 2014, NEUROBIOL AGING, V35, P1883, DOI 10.1016/j.neurobiolaging.2014.02.020; Berkowitz Bruce A, 2013, Expert Opin Med Diagn, V7, P393, DOI 10.1517/17530059.2013.814639; Berkowitz BA, 2012, MOL VIS, V18, P372; Berkowitz BA, 2009, INVEST OPHTH VIS SCI, V50, P2351, DOI 10.1167/iovs.08-2918; Bissig D, 2009, NEUROIMAGE, V44, P627, DOI 10.1016/j.neuroimage.2008.10.013; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Chan EC, 2014, J HYPERTENS, V32, P1379, DOI 10.1097/HJH.0000000000000179; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; de Carvalho JER, 2014, SURV OPHTHALMOL, V59, P393, DOI 10.1016/j.survophthal.2013.09.005; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Douglas JY, 2012, PROG RETIN EYE RES, V31, P481, DOI 10.1016/j.preteyeres.2012.04.005; DRUMMOND GS, 1981, P NATL ACAD SCI-BIOL, V78, P6466, DOI 10.1073/pnas.78.10.6466; Du Y, 2013, P NATL ACAD SCI USA, V110, P16586, DOI 10.1073/pnas.1314575110; Eells JT, 2000, NEUROTOXICOLOGY, V21, P321; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Eells JT, 2003, P NATL ACAD SCI USA, V100, P3439, DOI 10.1073/pnas.0534746100; Hazra S, 2013, DIABETOLOGIA, V56, P644, DOI 10.1007/s00125-012-2781-0; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Johnstone DM, 2015, NEURAL REGEN RES, V10, P349, DOI 10.4103/1673-5374.153673; Karu TI, 2005, PHOTOMED LASER SURG, V23, P355, DOI 10.1089/pho.2005.23.355; Kusumoto K, 2005, AM J PHYSIOL-GASTR L, V288, pG300, DOI 10.1152/ajpgi.00274.2004; Lee CA, 2013, INVEST OPHTHALMOL VI, V93, P135; Li Calzi S, 2010, EPMA J, V1, P88, DOI 10.1007/s13167-010-0011-8; Li GY, 2012, DIABETES, V61, P3294, DOI 10.2337/db11-1249; Liang HL, 2008, NEUROSCIENCE, V153, P963, DOI 10.1016/j.neuroscience.2008.03.042; Liang HL, 2006, NEUROSCIENCE, V139, P639, DOI 10.1016/j.neuroscience.2005.12.047; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lim J, 2010, J PHOTOCH PHOTOBIO B, V99, P105, DOI 10.1016/j.jphotobiol.2010.03.002; Lim J, 2009, J BIOCHEM MOL TOXIC, V23, P1, DOI 10.1002/jbt.20257; Muili KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030655; Pae HO, 2008, J CLIN BIOCHEM NUTR, V42, P197, DOI 10.3164/jcbn.2008029; Poyton RO, 2011, DISCOV MED, V11, P154; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Quirk Brendan J, 2012, Front Biosci (Elite Ed), V4, P818, DOI 10.2741/E421; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; ROCHKIND S, 1989, LASER SURG MED, V9, P174, DOI 10.1002/lsm.1900090214; Rodrigo SM, 2009, PHOTOMED LASER SURG, V27, P929, DOI 10.1089/pho.2008.2306; Schindl A, 2002, MICROVASC RES, V64, P240, DOI 10.1006/mvre.2002.2429; Stone J, 2013, PROCEEDINGS OF THE 9TH WORLD ASSOCIATION FOR LASER THERAPY CONGRESS (WALT), P17; Su XJ, 2003, MOL VIS, V9, P171; Talahalli R, 2013, J LEUKOCYTE BIOL, V93, P135, DOI 10.1189/jlb.0112025; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068871; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062081; Tang J, 2014, BRIT J OPHTHALMOL, V98, P1013, DOI 10.1136/bjophthalmol-2013-304477; Tang J, 2013, INVEST OPHTH VIS SCI, V54, P3681, DOI 10.1167/iovs.12-11018; Tofts PS, 2010, BRAIN RES BULL, V81, P333, DOI 10.1016/j.brainresbull.2009.06.002; Tuby H, 2007, LASER SURG MED, V39, P373, DOI 10.1002/lsm.20492; Tuby H, 2011, LASER SURG MED, V43, P401, DOI 10.1002/lsm.21063; Tuby H, 2009, PHOTOMED LASER SURG, V27, P227, DOI 10.1089/pho.2008.2272; Veenstra AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078405; Whelan HT, 2003, J CLIN LASER MED SUR, V21, P67, DOI 10.1089/104454703765035484; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu CC, 2008, NEPHROL DIAL TRANSPL, V23, P3082, DOI 10.1093/ndt/gfn247; Yang L, 2013, J PHYSIOL SCI, V63, P419, DOI 10.1007/s12576-013-0279-2; Yeager RL, 2005, PHOTOMED LASER SURG, V23, P268, DOI 10.1089/pho.2005.23.268; Yeager RL, 2006, J BIOCHEM MOL TOXIC, V20, P271, DOI 10.1002/jbt.20146	61	32	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139003	10.1371/journal.pone.0139003	http://dx.doi.org/10.1371/journal.pone.0139003			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426815	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100028
J	Damodaram, KJP; Aurade, RM; Kempraj, V; Roy, TK; Shivashankara, KS; Verghese, A				Damodaram, Kamala Jayanthi Pagadala; Aurade, Ravindra Mahadappa; Kempraj, Vivek; Roy, Tapas Kumar; Shivashankara, Kodthalu Seetharamaiah; Verghese, Abraham			Salicylic Acid Induces Changes in Mango Fruit that Affect Oviposition Behavior and Development of the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							DIPTERA-TEPHRITIDAE; VOLATILE COMPOUNDS; PLANT VOLATILES; RESISTANCE; RESPONSES; DEFENSE; PROTEIN; IDENTIFICATION; PERCEPTION; PREFERENCE	The Oriental fruit fly, Bactrocera dorsalis (Hendel) is an important quarantine pest around the globe. Although measures for its control are implemented worldwide through IPM and male annihilation, there is little effect on their population. Hence, there is a need for new strategies to control this minacious pest. A strategy that has received negligible attention is the induction of 'natural plant defenses' by phytohormones. In this study, we investigated the effect of salicylic acid (SA) treatment of mango fruit (cv. Totapuri) on oviposition and larval development of B. dorsalis. In oviposition choice assays, gravid females laid significantly less eggs in SA treated compared to untreated fruit. Headspace volatiles collected from SA treated fruit were less attractive to gravid females compared to volatiles from untreated fruit. GC-MS analysis of the headspace volatiles from SA treated and untreated fruit showed noticeable changes in their chemical compositions. Cis-ocimene and 3-carene (attractants to B. dorsalis) were reduced in the headspace volatiles of treated fruit. Further, reduced pupae formation and adult emergence was observed in treated fruit compared to control. Increased phenol and flavonoid content was recorded in treated fruit. We also observed differential expression of anti-oxidative enzymes namely catalase (CAT), polyphenoloxidase (PPO) and peroxidase (POD). In summary, the results indicate that SA treatment reduced oviposition, larval development and adult emergence of B. dorsalis and suggest a role of SA in enhancing mango tolerance to B. dorsalis.	[Damodaram, Kamala Jayanthi Pagadala; Aurade, Ravindra Mahadappa; Kempraj, Vivek; Verghese, Abraham] Indian Inst Hort Res, Div Entomol & Nematol, Natl Fellow Lab, Bangalore, Karnataka, India; [Roy, Tapas Kumar; Shivashankara, Kodthalu Seetharamaiah] Indian Inst Hort Res, Div Plant Physiol & Biochem, Bangalore, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Damodaram, KJP (corresponding author), Indian Inst Hort Res, Div Entomol & Nematol, Natl Fellow Lab, Hessaraghatta Lake PO, Bangalore, Karnataka, India.	jaiinsect@gmail.com	Seetharamaiah, Shivashankara/ACL-4390-2022; parepally, saravan kumar/AAH-7186-2019	Kempraj, Vivek/0000-0002-6151-8618	Indian Council for Agricultural Research	Indian Council for Agricultural Research	KJPD is awarded funds through the national fellow project by Indian Council for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Al-Qurashi AD, 2012, J FOOD AGRIC ENVIRON, V10, P120; Al-Wakeel S. A. M., 2013, IUFS Journal of Biology, V72, P9; Aluja M, 2014, AGR ECOSYST ENVIRON, V186, P54, DOI 10.1016/j.agee.2014.01.017; Anjum Suhail, 2000, Arab Journal of Plant Protection, V18, P121; Anshul N, 2013, FLA ENTOMOL, V96, P897, DOI 10.1653/024.096.0325; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Beck JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3931; Beckers GJM, 2006, PLANT BIOLOGY, V8, P1, DOI 10.1055/s-2005-872705; Bernays EA, 1994, HOST PLANT SELECTION; Bruce TJA, 2005, TRENDS PLANT SCI, V10, P269, DOI 10.1016/j.tplants.2005.04.003; Bruce TJA, 2011, PHYTOCHEMISTRY, V72, P1605, DOI 10.1016/j.phytochem.2011.04.011; Bruinsma M, 2007, J CHEM ECOL, V33, P655, DOI 10.1007/s10886-006-9245-2; Chan ZL, 2006, POSTHARVEST BIOL TEC, V39, P314, DOI 10.1016/j.postharvbio.2005.10.009; Chun OK, 2003, J AGR FOOD CHEM, V51, P7240, DOI 10.1021/jf0343579; CONRATH U, 1995, P NATL ACAD SCI USA, V92, P7143, DOI 10.1073/pnas.92.16.7143; Cornelius ML, 2000, ENVIRON ENTOMOL, V29, P14, DOI 10.1603/0046-225X-29.1.14; Damodaram KJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085764; Ding ZS, 2007, PHYSIOL PLANTARUM, V130, P112, DOI 10.1111/j.1399-3054.2007.00893.x; Dudareva N, 2006, CRIT REV PLANT SCI, V25, P417, DOI 10.1080/07352680600899973; Erb M, 2009, PLANT J, V59, P292, DOI 10.1111/j.1365-313X.2009.03868.x; Falk KL, 2014, MOL ECOL, V23, P1188, DOI 10.1111/mec.12610; Farouk S, 2011, J STRESS PHYSL BIOCH, V7, P5; Greany P. D., 1987, Tropical Science, V27, P261; Greany P. D., 1989, WORLD CROP PESTS A, P353; GREANY PD, 1991, FLA ENTOMOL, V74, P570, DOI 10.2307/3495410; GREANY PD, 1983, ENTOMOL EXP APPL, V34, P40, DOI 10.1007/BF00300898; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; He JP, 2011, J PLANT PHYSIOL, V168, P687, DOI 10.1016/j.jplph.2010.10.009; Ishtiaq Ali, 1999, Sarhad Journal of Agriculture, V15, P589; Jayanthi PDK, 2011, CROP PROT, V30, P1557, DOI 10.1016/j.cropro.2011.09.002; Jayanthi PDK, 2014, J CHEM ECOL, V40, P259, DOI 10.1007/s10886-014-0403-7; Jayanthi PDK, 2012, J CHEM ECOL, V38, P361, DOI 10.1007/s10886-012-0093-y; Jordan MD, 2009, CHEM SENSES, V34, P383, DOI 10.1093/chemse/bjp010; Kamala Jayanthi PD, 2001, CURR SCI, V82, P266; Kovats E, 1965, ADV CHROMATOGR, V1, P229; Krantev A, 2008, J PLANT PHYSIOL, V165, P920, DOI 10.1016/j.jplph.2006.11.014; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maffei ME, 2007, PHYTOCHEMISTRY, V68, P2946, DOI 10.1016/j.phytochem.2007.07.016; Martin JP, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00159; MAYER AM, 1979, PHYTOCHEMISTRY, V18, P193, DOI 10.1016/0031-9422(79)80057-6; McDonald RE, 1988, P 6 INT CITR C TEL A, P37; Miller PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016436; Pan YG, 2011, AFR J BIOTECHNOL, V10, P15521, DOI 10.5897/AJB11.2150; Paukku S, 2008, J INSECT BEHAV, V21, P505, DOI 10.1007/s10905-008-9146-z; Peng JY, 2004, Z NATURFORSCH C, V59, P856; Pickett JA, 1998, BIOCHEMIST, V20, P8, DOI DOI 10.1016/J.PHYT0CHEM.2011.04.011; Pinero JC, 2009, J ECON ENTOMOL, V102, P1123, DOI 10.1603/029.102.0334; PREE DJ, 1977, J ECON ENTOMOL, V70, P611, DOI 10.1093/jee/70.5.611; Rajan Katoch, 2005, Journal of Vegetable Science, V11, P67, DOI 10.1300/J484v11n01_07; Rani PU, 2010, ACTA PHYSIOL PLANT, V32, P695, DOI 10.1007/s11738-009-0449-2; ROSSLER Y, 1990, ENTOMOL EXP APPL, V54, P89, DOI 10.1007/BF00353991; ROTHSCHILD M, 1977, NATURE, V266, P352, DOI 10.1038/266352a0; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Serghini K, 2001, J EXP BOT, V52, P2227, DOI 10.1093/jexbot/52.364.2227; Shah J, 2003, CURR OPIN PLANT BIOL, V6, P365, DOI 10.1016/S1369-5266(03)00058-X; Silva R, 2014, ENTOMOL EXP APPL, V151, P239, DOI 10.1111/eea.12188; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Skelton AC, 2010, J MED ENTOMOL, V47, P798, DOI 10.1603/ME09295; Tasin M, 2011, CHEM SENSES, V36, P633, DOI 10.1093/chemse/bjr027; Thakur M, 2014, APPL BIOL RES, V16, P1, DOI 10.5958/0974-4517.2014.00041.X; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; van Poecke RMP, 2002, J EXP BOT, V53, P1793, DOI 10.1093/jxb/erf022; Verghese A, 2004, CROP PROT, V23, P61, DOI 10.1016/S0261-2194(03)00087-5; Verghese A, 2001, PEST MANAGEMENT HORT, P1; Verghese A, 2012, CURR SCI INDIA, V103, P563; War AR, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt053; Wei JN, 2014, J EXP BOT, V65, P3289, DOI 10.1093/jxb/eru181; Yao HJ, 2005, POSTHARVEST BIOL TEC, V35, P253, DOI 10.1016/j.postharvbio.2004.09.001; Yousof F. I., 2014, Research Journal of Seed Science, V7, P52, DOI 10.3923/rjss.2014.52.62; Zhao LY, 2009, CROP PROT, V28, P435, DOI 10.1016/j.cropro.2009.01.005	72	13	13	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139124	10.1371/journal.pone.0139124	http://dx.doi.org/10.1371/journal.pone.0139124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422203	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700071
J	Freel, KC; Krueger, MC; Farasin, J; Brochier-Armanet, C; Barbe, V; Andres, J; Cholley, PE; Dillies, MA; Jagla, B; Koechler, S; Leva, Y; Magdelenat, G; Plewniak, F; Proux, C; Coppee, JY; Bertin, PN; Heipieper, HJ; Arsene-Ploetze, F				Freel, Kelle C.; Krueger, Martin C.; Farasin, Julien; Brochier-Armanet, Celine; Barbe, Valerie; Andres, Jeremy; Cholley, Pierre-Etienne; Dillies, Marie-Agnes; Jagla, Bernd; Koechler, Sandrine; Leva, Yann; Magdelenat, Ghislaine; Plewniak, Frederic; Proux, Caroline; Coppee, Jean-Yves; Bertin, Philippe N.; Heipieper, Hermann J.; Arsene-Ploetze, Florence			Adaptation in Toxic Environments: Arsenic Genomic Islands in the Bacterial Genus Thiomonas	PLOS ONE			English	Article							FUNDAMENTAL UNITS; OPEN SOFTWARE; DIVERSITY; EVOLUTION; OXIDATION; MINE; IDENTIFICATION; COMMUNITIES; THIOBACILLI; ECOLOGY	Acid mine drainage (AMD) is a highly toxic environment for most living organisms due to the presence of many lethal elements including arsenic (As). Thiomonas (Tm.) bacteria are found ubiquitously in AMD and can withstand these extreme conditions, in part because they are able to oxidize arsenite. In order to further improve our knowledge concerning the adaptive capacities of these bacteria, we sequenced and assembled the genome of six isolates derived from the Carnoules AMD, and compared them to the genomes of Tm. arsenitoxydans 3As (isolated from the same site) and Tm. intermedia K12 (isolated from a sewage pipe). A detailed analysis of the Tm. sp. CB2 genome revealed various rearrangements had occurred in comparison to what was observed in 3As and K12 and over 20 genomic islands (GEIs) were found in each of these three genomes. We performed a detailed comparison of the two arsenic-related islands found in CB2, carrying the genes required for arsenite oxidation and As resistance, with those found in K12, 3As, and five other Thiomonas strains also isolated from Carnoules (CB1, CB3, CB6, ACO3 and ACO7). Our results suggest that these arsenic-related islands have evolved differentially in these closely related Thiomonas strains, leading to divergent capacities to survive in As rich environments.	[Freel, Kelle C.; Farasin, Julien; Andres, Jeremy; Cholley, Pierre-Etienne; Koechler, Sandrine; Plewniak, Frederic; Bertin, Philippe N.; Arsene-Ploetze, Florence] Univ Strasbourg, Dept Microorganismes Genomes Environm, Lab Genet Mol Genom & Microbiol,UMR7156, Equipe Ecophysiol Mol Microorganismes,Inst Bot,CN, Strasbourg, France; [Krueger, Martin C.; Heipieper, Hermann J.] UFZ, Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany; [Brochier-Armanet, Celine] Univ Lyon 1, Lab Biometrie & Evol Evolut, CNRS, UMR5558, F-69622 Villeurbanne, France; [Barbe, Valerie; Magdelenat, Ghislaine] CEA IG Genoscope, Lab Biol Mol Etud Genomes, LBioMEG, Evry, France; [Jagla, Bernd; Proux, Caroline; Coppee, Jean-Yves] Inst Pasteur, Dept Genomes & Genet, Ctr Innovat & Rech Technol, Plate Forme Transcriptome & Epigenome, Paris, France; [Leva, Yann] Univ Haute Alsace, Biopole LVBE, Colmar, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA)	Arsene-Ploetze, F (corresponding author), Univ Strasbourg, Dept Microorganismes Genomes Environm, Lab Genet Mol Genom & Microbiol,UMR7156, Equipe Ecophysiol Mol Microorganismes,Inst Bot,CN, Strasbourg, France.	ploetze@unistra.fr	Heipieper, Hermann/D-1864-2010; Arsène-Ploetze, Florence/ABE-5993-2020; Brochier-Armanet, Celine/B-7898-2011	Heipieper, Hermann/0000-0002-3723-9600; Arsène-Ploetze, Florence/0000-0002-8299-447X; Krueger, Martin/0000-0001-8613-5800; Philippe, Bertin/0000-0003-1158-6396; Plewniak, Frederic/0000-0001-6534-8786; Brochier-Armanet, Celine/0000-0003-4669-3589	Universite de Strasbourg (UdS); Centre National de la Recherche Scientifique (CNRS); Region Alsace; EC2CO program (INEE, CNRS) project; RARE project [ANR 07-BLANC-0118]; THIOFILM project [ANR-12-ADAP-0013]; Agence Nationale de la Recherche, ANR THIOFILM [ANR-12-ADAP-0013]; CNRS; Projet d'Avenir (Ancestrome) grant [ANR-10-BINF-01-01]	Universite de Strasbourg (UdS); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Region Alsace(Region Grand-Est); EC2CO program (INEE, CNRS) project; RARE project; THIOFILM project; Agence Nationale de la Recherche, ANR THIOFILM(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Projet d'Avenir (Ancestrome) grant	This work was supported by the Universite de Strasbourg (UdS), the Centre National de la Recherche Scientifique (CNRS) and the Region Alsace to JF. This study was financed by the EC2CO program (INEE, CNRS), the RARE (ANR 07-BLANC-0118) and the THIOFILM (ANR-12-ADAP-0013) projects. JF and KCF were supported by the Agence Nationale de la Recherche, ANR THIOFILM (ANR-12-ADAP-0013). FA-P was supported by the CNRS ("mise en delegation pour activite de recherche au CNRS"). CB-A is member of the Institut Universitaire de France and was supported by a Projet d'Avenir (Ancestrome, ANR-10-BINF-01-01) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiger B, 1999, PLASMID, V41, P30, DOI 10.1006/plas.1998.1372; Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arsene-Ploetze F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000859; Battaglia-Brunet F, 2006, ANTON LEEUW INT J G, V89, P99, DOI 10.1007/s10482-005-9013-2; Bellanger X, 2014, FEMS MICROBIOL REV, V38, P720, DOI 10.1111/1574-6976.12058; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertin PN, 2011, ISME J, V5, P1735, DOI 10.1038/ismej.2011.51; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Bruneel O, 2006, APPL ENVIRON MICROB, V72, P551, DOI 10.1128/AEM.72.1.551-556.2006; Bruneel O, 2003, J APPL MICROBIOL, V95, P492, DOI 10.1046/j.1365-2672.2003.02004.x; Bryan CG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-127; Casiot C, 2003, WATER RES, V37, P2929, DOI 10.1016/S0043-1354(03)00080-0; Cheng HF, 2009, J HAZARD MATER, V165, P13, DOI 10.1016/j.jhazmat.2008.10.070; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Cohan FM, 2001, SYST BIOL, V50, P513, DOI 10.1080/106351501750435077; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Duquesne K, 2008, ENVIRON MICROBIOL, V10, P228, DOI 10.1111/j.1462-2920.2007.01447.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrison JJ, 2007, NAT REV MICROBIOL, V5, P928, DOI 10.1038/nrmicro1774; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Koeppel AF, 2014, ISME J, V8, P531, DOI 10.1038/ismej.2013.180; Kruger MC, 2013, APPL MICROBIOL BIOT, V97, P3827, DOI 10.1007/s00253-013-4838-5; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00347; Madsen JS, 2012, FEMS IMMUNOL MED MIC, V65, P183, DOI 10.1111/j.1574-695X.2012.00960.x; Marchal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023181; MILDE K, 1983, J GEN MICROBIOL, V129, P1327; Moreira D, 1997, INT J SYST BACTERIOL, V47, P522, DOI 10.1099/00207713-47-2-522; Nakagawa S, 2014, ISME J, V8, P40, DOI 10.1038/ismej.2013.131; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RINKEL M, 1994, CURR MICROBIOL, V29, P249, DOI 10.1007/BF01577436; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Slyemi D, 2011, ARCH MICROBIOL, V193, P439, DOI 10.1007/s00203-011-0684-y; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vallenet D, 2013, NUCLEIC ACIDS RES, V41, pE636, DOI 10.1093/nar/gks1194; Volant A, 2012, EXTREMOPHILES, V16, P645, DOI 10.1007/s00792-012-0466-8; Volant A, 2014, FEMS MICROBIOL ECOL, V90, P247, DOI 10.1111/1574-6941.12394; WHEATCROFT R, 1990, MOL PLANT MICROBE IN, V3, P9, DOI 10.1094/MPMI-3-009	50	16	16	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139011	10.1371/journal.pone.0139011	http://dx.doi.org/10.1371/journal.pone.0139011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422469	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700060
J	Zhang, TL; Wang, K; Zhang, XL				Zhang, Tailei; Wang, Kai; Zhang, Xueliang			Modeling and Analyzing the Transmission Dynamics of HBV Epidemic in Xinjiang, China	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SENSITIVITY-ANALYSIS; PATTERN-FORMATION; TUBERCULOSIS; UNCERTAINTY	Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects livers. In this paper, we formulate a hepatitis B model to study the transmission dynamics of hepatitis B in Xinjiang, China. The epidemicmodel involves an exponential birth rate and vertical transmission. For a better understanding of HBV transmission dynamics, we analyze the dynamic behavior of the model. The modified reproductive number sigma is obtained. When sigma < 1, the disease-free equilibrium is locally asymptotically stable, when sigma > 1, the disease-free equilibrium is unstable and the disease is uniformly persistent. In the simulation, parameters are chosen to fit public data in Xinjiang. The simulation indicates that the cumulated HBV infection number in Xinjiang will attain about 600,000 cases unless there are stronger or more effective control measures by the end of 2017. Sensitive analysis results show that enhancing the vaccination rate for newborns in Xinjiang is very effective to stop the transmission of HBV. Hence, we recommend that all infants in Xinjiang receive the hepatitis B vaccine as soon as possible after birth.	[Zhang, Tailei] Changan Univ, Sch Sci, Xian, Peoples R China; [Wang, Kai; Zhang, Xueliang] Xinjiang Med Univ, Dept Med Engn & Technol, Urumqi, Peoples R China	Chang'an University; Xinjiang Medical University	Wang, K (corresponding author), Xinjiang Med Univ, Dept Med Engn & Technol, Urumqi, Peoples R China.	wangkaimath@sina.com			National Natural Science Foundation of China [11461073]; Natural Science Basic Research Plan in Shaanxi Province of China [2014JQ1018]; Fundamental Research Funds for the Central Universities [310812152002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China grant number 11461073 (http://www.nsfc.gov.cn/) (KW); the Natural Science Basic Research Plan in Shaanxi Province of China (grant no. 2014JQ1018); and the Fundamental Research Funds for the Central Universities (grant no. 310812152002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; ANDERSON R M, 1991; [Anonymous], 2014, MED CTR; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; DeLurgio S.A., 1998, FORECASTING PRINCIPL; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Khan MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/150681; Lewis CD, 1982, IND BUSINESS FORECAS; Liang J, 2014, B DIS CONTROL PREVEN; Liu S, 2014, PRACT PREV MED, V21, P641; Liu Y, 2014, MED PEOPLE, V27, P280; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Miao HY, 2009, BIOMETRICS, V65, P292, DOI 10.1111/j.1541-0420.2008.01059.x; Pang JH, 2012, NONLINEAR DYNAM, V67, P723, DOI 10.1007/s11071-011-0022-6; Pang JH, 2010, J THEOR BIOL, V265, P572, DOI 10.1016/j.jtbi.2010.05.038; Public health science data center, 2014, HEP; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1631, DOI 10.1007/s11071-012-0374-6; The Government of Xinjiang Uygur Autonomous Region of China, 2014, IMPR PEOPL LIV STAND; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wang KF, 2010, NONLINEAR ANAL-REAL, V11, P3131, DOI 10.1016/j.nonrwa.2009.11.008; WHO, 2014, IMM VACC BIOL; Xu R, 2009, J THEOR BIOL, V257, P499, DOI 10.1016/j.jtbi.2009.01.001; Zhang SX, 2014, COMMUN NONLINEAR SCI, V19, P2466, DOI 10.1016/j.cnsns.2013.11.004; Zhang SX, 2012, APPL MATH MODEL, V36, P1302, DOI 10.1016/j.apm.2011.07.087; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	32	24	27	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138765	10.1371/journal.pone.0138765	http://dx.doi.org/10.1371/journal.pone.0138765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422614	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700049
J	Chisti, MJ; Salam, MA; Bardhan, PK; Faruque, ASG; Shahid, ASMSB; Shahunja, KM; Das, SK; Hossain, MI; Ahmed, T				Chisti, Mohammod Jobayer; Salam, Mohammed Abdus; Bardhan, Pradip Kumar; Faruque, Abu S. G.; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Hossain, Md Iqbal; Ahmed, Tahmeed			Severe Sepsis in Severely Malnourished Young Bangladeshi Children with Pneumonia: A Retrospective Case Control Study	PLOS ONE			English	Article							SEPTIC SHOCK; MORTALITY; DIARRHEA; MALNUTRITION; EPIDEMIOLOGY; PREDICTORS; MANAGEMENT; REDUCTION; HYPOXEMIA; VACCINES	Background In developing countries, there is no published report on predicting factors of severe sepsis in severely acute malnourished (SAM) children having pneumonia and impact of fluid resuscitation in such children. Thus, we aimed to identify predicting factors for severe sepsis and assess the outcome of fluid resuscitation of such children. Methods In this retrospective case-control study SAM children aged 0-59 months, admitted to the Intensive Care Unit ICU) of the Dhaka Hospital of the International Centre for Diarrhoeal Disease Research, Bangladesh from April 2011 through July 2012 with history of cough or difficult breathing and radiologic pneumonia, who were assessed for severe sepsis at admission constituted the study population. We compared the pneumonic SAM children with severe sepsis cases = 50) with those without severe sepsis controls = 354). Severe sepsis was defined with objective clinical criteria and managed with fluid resuscitation, in addition to antibiotic and other supportive therapy, following the standard hospital guideline, which is very similar to the WHO guideline. Results The case-fatality-rate was significantly higher among the cases than the controls 40% vs. 4%; p<0.001). In logistic regression analysis after adjusting for potential confounders, lack of BCG vaccination, drowsiness, abdominal distension, acute kidney injury, and metabolic acidosis at admission remained as independent predicting factors for severe sepsis in pneumonic SAM children p<0.05 for all comparisons). Conclusion and Significance We noted a much higher case fatality among under-five SAM children with pneumonia and severe sepsis who required fluid resuscitation in addition to standard antibiotic and other supportive therapy compared to those without severe sepsis. Independent risk factors and outcome of the management of severe sepsis in our study children highlight the importance for defining optimal fluid resuscitation therapy aiming at reducing the case fatality in such children.	[Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar; Faruque, Abu S. G.; Shahid, Abu S. M. S. B.; Shahunja, K. M.; Das, Sumon Kumar; Hossain, Md Iqbal; Ahmed, Tahmeed] Icddr B, CNFS, Dhaka, Bangladesh; [Chisti, Mohammod Jobayer; Bardhan, Pradip Kumar; Hossain, Md Iqbal] Icddr B, Dhaka Hosp, Dhaka, Bangladesh; [Salam, Mohammed Abdus] Icddr B, RCAS, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Icddr B, CNFS, Dhaka, Bangladesh.	chisti@icddrb.org	Das, Sumon Kumar/T-6384-2019; Shahunja, K M/AAR-6229-2020; Das, Sumon Kumar/AAD-1551-2019; Chisti, Mohammod J/A-7216-2018	Shahunja, K M/0000-0002-9345-206X; 	International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) [Gr- 00233]; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b); Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Swedish International Development Cooperation Agency (Sida); Department for International Development, UK (DFID)	This research study was funded by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b; grant no Gr- 00233) and its donors, which provide unrestricted support to ICDDR, B for its operations and research. MJC received the funding. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Swedish International Development Cooperation Agency (Sida), and the Department for International Development, UK (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Faddan NH, 2010, ANN PEDIAT CARDIOL, V3, P113, DOI 10.4103/0974-2069.74036; Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Biban P, PEDIAT REPORTS, V4; Blatt NB, 2014, PEDIATR NEPHROL, V29, P2273, DOI 10.1007/s00467-013-2677-3; Bushell T, 2013, J Neonatal Perinatal Med, V6, P53, DOI 10.3233/NPM-1363612; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Chisti MJ, 2011, ANN TROP PAEDIATR, V31, P311, DOI 10.1179/1465328111Y.0000000033; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Chisti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039164; Chisti MJ, 2012, TROP MED INT HEALTH, V17, P106, DOI 10.1111/j.1365-3156.2011.02890.x; Chisti MJ, 2011, ACTA PAEDIATR, V100, pE275, DOI 10.1111/j.1651-2227.2011.02368.x; Chisti MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073728; Chisti MJ, 2009, TROP MED INT HEALTH, V14, P1173, DOI 10.1111/j.1365-3156.2009.02364.x; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Ebrahim GJ, 2011, J TROP PEDIATRICS, V57, P77, DOI 10.1093/tropej/fmr022; Eisenhut Michael, 2006, J Inflamm (Lond), V3, P5, DOI 10.1186/1476-9255-3-5; Eisenhut M, 2007, MED HYPOTHESES, V68, P361, DOI 10.1016/j.mehy.2006.07.012; El-Sayed HL, 2006, EUR J CLIN NUTR, V60, P502, DOI 10.1038/sj.ejcn.1602344; Golden MHN, 1998, BRIT MED BULL, V54, P433, DOI 10.1093/oxfordjournals.bmb.a011699; Han YY, 2003, PEDIATRICS, V112, P793, DOI 10.1542/peds.112.4.793; Inwald DP, 2009, ARCH DIS CHILD, V94, P348, DOI 10.1136/adc.2008.153064; Khilnani P, INDIAN J CRITICAL CA, V14, P41; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Morgan G, 1997, LANCET, V349, P1693, DOI 10.1016/S0140-6736(96)12038-9; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Olivares JL, 2005, J AM COLL NUTR, V24, P38, DOI 10.1080/07315724.2005.10719441; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sarmin M, 2014, ACTA PAEDIATR, V103, pe306, DOI 10.1111/apa.12640; Shann F, 2013, CLIN THER, V35, P109, DOI 10.1016/j.clinthera.2013.01.007; Shann F, 2010, PEDIATR INFECT DIS J, V29, P457, DOI 10.1097/INF.0b013e3181c91361; SUSKIND D, 1990, NESTLE NUTR WORKS SE, V19, P1; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; WHO, 2006, POCK BOOK HOSP CAR C, P173; World Health Organization, 2013, GUIDELINES MANAGEMEN	40	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139966	10.1371/journal.pone.0139966	http://dx.doi.org/10.1371/journal.pone.0139966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440279	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300087
J	Malik, A; Kondratov, RV; Jamasbi, RJ; Geusz, ME				Malik, Astha; Kondratov, Roman V.; Jamasbi, Roudabeh J.; Geusz, Michael E.			Circadian Clock Genes Are Essential for Normal Adult Neurogenesis, Differentiation, and Fate Determination	PLOS ONE			English	Article							NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; RHYTHM GENERATION; EXPRESSION; MEMORY; CYCLE; BMAL1; TIME; PROLIFERATION; OSCILLATIONS	Adult neurogenesis creates new neurons and glia from stem cells in the human brain throughout life. It is best understood in the dentate gyrus (DG) of the hippocampus and the subventricular zone (SVZ). Circadian rhythms have been identified in the hippocampus, but the role of any endogenous circadian oscillator cells in hippocampal neurogenesis and their importance in learning or memory remains unclear. Any study of stem cell regulation by intrinsic circadian timing within the DG is complicated by modulation from circadian clocks elsewhere in the brain. To examine circadian oscillators in greater isolation, neurosphere cultures were prepared from the DG of two knockout mouse lines that lack a functional circadian clock and from mPer1::luc mice to identify circadian oscillations in gene expression. Circadian mPer1 gene activity rhythms were recorded in neurospheres maintained in a culture medium that induces neurogenesis but not in one that maintains the stem cell state. Although the differentiating neural stem progenitor cells of spheres were rhythmic, evidence of any mature neurons was extremely sparse. The circadian timing signal originated in undifferentiated cells within the neurosphere. This conclusion was supported by immunocytochemistry for mPER1 protein that was localized to the inner, more stem cell-like neurosphere core. To test for effects of the circadian clock on neurogenesis, media conditions were altered to induce neurospheres from BMAL1 knockout mice to differentiate. These cultures displayed unusually high differentiation into glia rather than neurons according to GFAP and NeuN expression, respectively, and very few BetaIII tubulin-positive, immature neurons were observed. The knockout neurospheres also displayed areas visibly devoid of cells and had overall higher cell death. Neurospheres from arrhythmic mice lacking two other core clock genes, Cry1 and Cry2, showed significantly reduced growth and increased astrocyte proliferation during differentiation, but they generated normal percentages of neuronal cells. Neuronal fate commitment therefore appears to be controlled through a nonclock function of BMAL1. This study provides insight into how cell autonomous circadian clocks and clock genes regulate adult neural stem cells with implications for treating neuro-degenerative disorders and impaired brain functions by manipulating neurogenesis.	[Malik, Astha; Jamasbi, Roudabeh J.; Geusz, Michael E.] Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA; [Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Jamasbi, Roudabeh J.] Bowling Green State Univ, Dept Publ & Allied Hlth, Bowling Green, OH 43403 USA	University System of Ohio; Bowling Green State University; University System of Ohio; Cleveland State University; University System of Ohio; Bowling Green State University	Geusz, ME (corresponding author), Bowling Green State Univ, Dept Biol, Bowling Green, OH 43403 USA.	mgeusz@bgsu.edu	Malik, Astha/AAH-2431-2020	Malik, Astha/0000-0001-6957-8044; Kondratov, Roman/0000-0003-3449-745X	National Institutes of Health [NIH R01 AG039547]; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support was provided by the National Institutes of Health [www.nih.gov] NIH R01 AG039547 to RVK.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Alvarez JD, 2003, BIOL REPROD, V69, P81, DOI 10.1095/biolreprod.102.011833; Becker-Weimann S, 2004, BIOPHYS J, V87, P3023, DOI 10.1529/biophysj.104.040824; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bouchard-Cannon P, 2013, CELL REP, V5, P961, DOI 10.1016/j.celrep.2013.10.037; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cevik IU, 2003, CELL DEATH DIFFER, V10, P928, DOI 10.1038/sj.cdd.4401250; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; De Bundel D, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00152; Destici E, 2011, CELL CYCLE, V10, P3788, DOI 10.4161/cc.10.21.17974; Dickmeis T, 2011, MOL CELL ENDOCRINOL, V331, P11, DOI 10.1016/j.mce.2010.09.001; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eckel-Mahan KL, 2009, EMBO REP, V10, P584, DOI 10.1038/embor.2009.123; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Gerstner JR, 2010, AGING-US, V2, P251, DOI 10.18632/aging.100144; Gerstner JR, 2009, J NEUROSCI, V29, P12824, DOI 10.1523/JNEUROSCI.3353-09.2009; Geusz ME, 2010, INT J CANCER, V126, P620, DOI 10.1002/ijc.24788; Gheusi Gilles, 2013, Curr Top Behav Neurosci, V15, P49, DOI 10.1007/7854_2012_228; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Gilhooley MJ, 2011, NEUROSCI LETT, V489, P177, DOI 10.1016/j.neulet.2010.12.011; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Hagemann TL, 2013, J NEUROSCI, V33, P18698, DOI 10.1523/JNEUROSCI.3693-13.2013; Harbour VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103309; Hrushesky W, 2015, METHODS MOL BIOL, V1235, P81, DOI 10.1007/978-1-4939-1785-3_8; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Hughes ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002835; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Jilg A, 2010, HIPPOCAMPUS, V20, P377, DOI 10.1002/hipo.20637; Kalsbeek A, 2011, FEBS LETT, V585, P1412, DOI 10.1016/j.febslet.2011.03.021; Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; Kimiwada T, 2009, NEUROCHEM INT, V54, P277, DOI 10.1016/j.neuint.2008.12.005; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2010, AGING-US, V2, P285; Konefal S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00021; Kott J, 2012, NEUROSCI LETT, V515, P177, DOI 10.1016/j.neulet.2012.03.048; Kowalska E, 2010, J BIOL RHYTHM, V25, P442, DOI 10.1177/0748730410385281; Laranjeiro R, 2013, P NATL ACAD SCI USA, V110, P6835, DOI 10.1073/pnas.1217912110; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Lin FW, 2013, CELL BIOCHEM FUNCT, V31, P166, DOI 10.1002/cbf.2871; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Malik A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122937; Manda K, 2010, PROG NEUROBIOL, V90, P60, DOI 10.1016/j.pneurobio.2009.10.019; Masri S, 2013, CURR OPIN CELL BIOL, V25, P730, DOI 10.1016/j.ceb.2013.07.013; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moreno MM, 2012, J NEUROSCI, V32, P3748, DOI 10.1523/JNEUROSCI.6335-11.2012; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Oishi K, 1998, BIOCHEM BIOPH RES CO, V253, P199, DOI 10.1006/bbrc.1998.9779; Pan YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050455; Paulose JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049555; Rakai BD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099527; Ramirez-Rodriguez G, 2009, NEUROPSYCHOPHARMACOL, V34, P2180, DOI 10.1038/npp.2009.46; Rawashdeh O, 2014, HIPPOCAMPUS, V24, P712, DOI 10.1002/hipo.22262; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schnell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099883; Sharma VP, 2014, CANCER LETT, V345, P65, DOI 10.1016/j.canlet.2013.11.009; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Smarr BL, 2014, BEHAV NEUROSCI, V128, P283, DOI 10.1037/a0035963; Song J, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/374520; Tamai SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003835; Tamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082006; Taupin P, 2010, STEM CELLS LAB CLIN, P1; Van der Zee EA, 2008, CURR BIOL, V18, P844, DOI 10.1016/j.cub.2008.04.077; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Westermark PO, 2013, CELL REP, V3, P1228, DOI 10.1016/j.celrep.2013.03.013; Winocur G, 2004, NEUROBIOL AGING, V25, P1107, DOI 10.1016/j.neurobiolaging.2003.10.005; Wreschnig D, 2014, J BIOL RHYTHM, V29, P299, DOI 10.1177/0748730414545086; Xu WZ, 1998, BIOCHEM BIOPH RES CO, V247, P814, DOI 10.1006/bbrc.1998.8897; Yagita K, 2000, FEBS LETT, V465, P79, DOI 10.1016/S0014-5793(99)01724-X; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yoshiura S, 2007, P NATL ACAD SCI USA, V104, P11292, DOI 10.1073/pnas.0701837104; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018	78	35	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139655	10.1371/journal.pone.0139655	http://dx.doi.org/10.1371/journal.pone.0139655			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439128	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300040
J	Choi, Y; Oh, DY; Kim, TY; Lee, KH; Han, SW; Im, SA; Kim, TY; Bang, YJ				Choi, Younak; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue			Skeletal Muscle Depletion Predicts the Prognosis of Patients with Advanced Pancreatic Cancer Undergoing Palliative Chemotherapy, Independent of Body Mass Index	PLOS ONE			English	Article							SARCOPENIC OBESITY; PREVALENCE; TOXICITY; CARE; TOMOGRAPHY; INFECTION; CACHEXIA; RECOVERY; SURVIVAL; MEN	Introduction Body composition has emerged as a prognostic factor in cancer patients. We investigated whether sarcopenia at diagnosis and loss of skeletal muscle during palliative chemotherapy were associated with survival in patients with pancreatic cancer. Methods We retrospectively reviewed the clinical outcomes of pancreatic cancer patients receiving palliative chemotherapy between 2003 and 2010. The cross-sectional area of skeletal muscle at L3 by computed tomography was analyzed with Rapidia 3D software. We defined sarcopenia as a skeletal muscle index (SMI)<42.2 cm(2)/m(2) (male) and <33.9 cm(2)/m(2) (female) using ROC curve. Results Among 484 patients, 103 (21.3%) patients were sarcopenic at diagnosis. Decrease in SMI during chemotherapy was observed in 156 (60.9%) male and 65 (40.6%) female patients. Decrease in body mass index (BMI) was observed in 149 patients (37.3%), with no gender difference. By multivariate analysis, sarcopenia (P<0.001), decreasedBMI and SMI during chemotherapy (P = 0.002, P = 0.004, respectively) were poor prognostic factors for overall survival (OS). While the OS of male patients was affected with sarcopenia (P<0.001) and decreased SMI (P = 0.001), the OS of female patients was influenced with overweight at diagnosis (P = 0.006), decreased BMI (P = 0.032) and decreased SMI (P = 0.014). Particularly, while the change of BMI during chemotherapy did not have impact on OS within the patients with maintained SMI (P = 0.750), decrease in SMI was associated with poor OS within the patients with maintained BMI (HR 1.502; P = 0.002). Conclusions Sarcopenia at diagnosis and depletion of skeletal muscle, independent of BMI change, during chemotherapy were poor prognostic factors in advanced pancreatic cancer.	[Choi, Younak; Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Oh, Do-Youn; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Oh, DY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	ohdoyoun@snu.ac.kr	Bang, Yung Jue/J-2759-2012	Bang, Yung Jue/0000-0001-6000-4597				Andreyev HJN, 1998, EUR J CANCER, V34, P503, DOI 10.1016/S0959-8049(97)10090-9; Antoun S, 2010, ANN ONCOL, V21, P1594, DOI 10.1093/annonc/mdp605; Aslani A, 2000, CANCER-AM CANCER SOC, V88, P796, DOI 10.1002/(SICI)1097-0142(20000215)88:4<796::AID-CNCR10>3.0.CO;2-P; Aversa Z, 2012, ANN SURG ONCOL, V19, P1350, DOI 10.1245/s10434-011-1720-5; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Biolo G, 2005, INT J BIOCHEM CELL B, V37, P2169, DOI 10.1016/j.biocel.2005.05.001; Biolo G, 2014, CLIN NUTR, V33, P737, DOI 10.1016/j.clnu.2014.03.007; Choi Y, 2014, J PAIN SYMPTOM MANAG, V48, P13, DOI 10.1016/j.jpainsymman.2013.08.017; Cosqueric G, 2006, BRIT J NUTR, V96, P895, DOI 10.1017/BJN20061943; Demontis F, 2013, AGING CELL, V12, P943, DOI 10.1111/acel.12126; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Huillard O, 2013, BRIT J CANCER, V108, P1034, DOI 10.1038/bjc.2013.58; Kim YS, 2012, J GERONTOL A-BIOL, V67, P1107, DOI 10.1093/gerona/gls071; Kyle UG, 2005, CLIN NUTR, V24, P133, DOI 10.1016/j.clnu.2004.08.012; Lau EMC, 2005, J GERONTOL A-BIOL, V60, P213, DOI 10.1093/gerona/60.2.213; Lieffers JR, 2012, BRIT J CANCER, V107, P931, DOI 10.1038/bjc.2012.350; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Muller MJ, 2013, CURR OPIN CLIN NUTR, V16, P501, DOI 10.1097/MCO.0b013e328363bdf9; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Rodrigues HV, 2013, EUR J CANCER, V49, P3068, DOI 10.1016/j.ejca.2013.06.026; Tan BHL, 2009, CLIN CANCER RES, V15, P6973, DOI 10.1158/1078-0432.CCR-09-1525; Washington TA, 2011, ACTA PHYSIOL, V202, P657, DOI 10.1111/j.1748-1716.2011.02281.x	27	101	104	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139749	10.1371/journal.pone.0139749	http://dx.doi.org/10.1371/journal.pone.0139749			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437072	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200058
J	Gabbita, SP; Johnson, MF; Kobritz, N; Eslami, P; Poteshkina, A; Varadarajan, S; Turman, J; Zemlan, F; Harris-White, ME				Gabbita, S. Prasad; Johnson, Ming F.; Kobritz, Naomi; Eslami, Pirooz; Poteshkina, Aleksandra; Varadarajan, Sridhar; Turman, John; Zemlan, Frank; Harris-White, Marni E.			Oral TNF alpha Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HIPPOCAMPAL-LESIONS; PRECURSOR PROTEIN; A-BETA; MICROGLIA; BEHAVIOR; BRAIN; LEUKOCYTES; INNATE; NEUROINFLAMMATION	Cytokines such as TNF alpha can polarize microglia/macrophages into different neuroinflammatory types. Skewing of the phenotype towards a cytotoxic state is thought to impair phagocytosis and has been described in Alzheimer's Disease (AD). Neuroinflammation can be perpetuated by a cycle of increasing cytokine production and maintenance of a polarized activation state that contributes to AD progression. In this study, 3xTgAD mice, age 6 months, were treated orally with 3 doses of the TNF alpha modulating compound isoindolin-1,3 dithione (IDT) for 10 months. We demonstrate that IDT is a TNF alpha modulating compound both in vitro and in vivo. Following long-term IDT administration, mice were assessed for learning & memory and tissue and serum were collected for analysis. Results demonstrate that IDT is safe for long-term treatment and significantly improves learning and memory in the 3xTgAD mouse model. IDT significantly reduced paired helical filament tau and fibrillar amyloid accumulation. Flow cytometry of brain cell populations revealed that IDT increased the infiltrating neutrophil population while reducing TNF alpha expression in this population. IDT is a safe and effective TNF alpha and innate immune system modulator. Thus small molecule, orally bioavailable modulators are promising therapeutics for Alzheimer's disease.	[Gabbita, S. Prasad; Zemlan, Frank] P2D Biosci Inc, Cincinnati, OH USA; [Varadarajan, Sridhar; Turman, John] Univ N Carolina, Dept Chem & Biochem, Wilmington, NC 28401 USA; [Johnson, Ming F.; Kobritz, Naomi; Eslami, Pirooz; Poteshkina, Aleksandra; Harris-White, Marni E.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; [Harris-White, Marni E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of North Carolina; University of North Carolina Wilmington; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Harris-White, ME (corresponding author), Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA.	marni@ucla.edu			United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [1OI1BX000867]; National Institutes of Health [R43 AG044213-01]; P2D Bioscience, Inc.; NATIONAL INSTITUTE ON AGING [R43AG044213] Funding Source: NIH RePORTER	United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); P2D Bioscience, Inc.; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Merit Award #1OI1BX000867 from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service to MHW and a National Institutes of Health grant (R43 AG044213-01) to MHW and SPG. P2D Bioscience, Inc. provided support in the form of salaries for authors SPG and FZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonawich FJ, 1997, BRAIN RES, V764, P249, DOI 10.1016/S0006-8993(97)00488-5; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brosseron F, 2014, MOL NEUROBIOL, V50, P534, DOI 10.1007/s12035-014-8657-1; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Cheng X, 2014, AM J PATHOL, V184, P141, DOI 10.1016/j.ajpath.2013.10.002; Davydova TV, 2003, B EXP BIOL MED+, V136, P355, DOI 10.1023/B:BEBM.0000010950.53560.e2; Deacon RMJ, 2002, BEHAV BRAIN RES, V133, P57, DOI 10.1016/S0166-4328(01)00451-X; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Dinkel K, 2004, P NATL ACAD SCI USA, V101, P331, DOI 10.1073/pnas.0303510101; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Filali M, 2009, BRAIN RES, V1292, P93, DOI 10.1016/j.brainres.2009.07.066; Gabbita SP, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-99; Giuliani F, 2009, BRAIN RES BULL, V80, P302, DOI 10.1016/j.brainresbull.2009.07.009; GLICKMAN SE, 1970, PHYSIOL BEHAV, V5, P931, DOI 10.1016/0031-9384(70)90185-X; Guerreiro RJ, 2007, NEURODEGENER DIS, V4, P406, DOI 10.1159/000107700; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; He P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055091; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Jaillon S, 2013, SEMIN IMMUNOPATHOL, V35, P377, DOI 10.1007/s00281-013-0374-8; Jaremo P, 2013, EUR J CLIN INVEST, V43, P545, DOI 10.1111/eci.12072; Jiang H, 2014, HUM MOL GENET, V23, P4906, DOI 10.1093/hmg/ddu206; KIM C, 1960, J COMP PHYSIOL PSYCH, V53, P11, DOI 10.1037/h0038350; KIMBLE DP, 1967, J COMP PHYSIOL PSYCH, V63, P401, DOI 10.1037/h0024605; Koenigsknecht-Talboo J, 2005, J NEUROSCI, V25, P8240, DOI 10.1523/JNEUROSCI.1808-05.2005; Kwak M, 2014, NANOSCALE, V6, P6537, DOI 10.1039/c3nr06465d; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; LING EA, 1978, J ANAT, V125, P101; Ly PTT, 2011, JOVE-J VIS EXP, DOI 10.3791/2831; Lynch MA, 2014, IMMUNOLOGY, V141, P292, DOI 10.1111/imm.12156; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McAlpine FE, 2008, J INFLAMM RES, V1, P29; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Montgomery SL, 2011, AM J PATHOL, V179, P2053, DOI 10.1016/j.ajpath.2011.07.001; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oh Kwang-Jin, 2010, Int J Alzheimers Dis, V2010, DOI 10.4061/2010/780102; OHNO K, 1978, AM J PHYSIOL, V235, pH299, DOI 10.1152/ajpheart.1978.235.3.H299; Porzig R, 2007, BIOCHEM BIOPH RES CO, V358, P644, DOI 10.1016/j.bbrc.2007.04.187; Scheinfeld N, 2004, J Dermatolog Treat, V15, P280; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shi JQ, 2011, BRAIN RES, V1368, P239, DOI 10.1016/j.brainres.2010.10.053; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Slifman NR, 2003, ARTHRITIS RHEUM, V48, P319, DOI 10.1002/art.10758; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Spagnuolo C, 2011, BRIT J CANCER, V105, P221, DOI 10.1038/bjc.2011.229; Tarkowski E, 2003, J NEUROL NEUROSUR PS, V74, P1200, DOI 10.1136/jnnp.74.9.1200; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Town T, 2008, NAT MED, V14, P681, DOI 10.1038/nm1781; Tweedie D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-106; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wallis RS, 2004, CLIN INFECT DIS, V39, P1254, DOI 10.1086/424455; Wallis RS, 2004, CLIN INFECT DIS, V38, P1261, DOI 10.1086/383317; Weekman EM, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-127; Wilcock DM, 2011, ASN NEURO, V3, DOI 10.1042/AN20110018; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie Z, 2005, J NEUROCHEM, V93, P1038, DOI 10.1111/j.1471-4159.2005.03065.x; Zheng X, 2015, NEUROPHARMACOLOGY, V96, P94, DOI 10.1016/j.neuropharm.2014.06.020; Zhu XX, 2003, J MED CHEM, V46, P5222, DOI 10.1021/jm030152f	62	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0137305	10.1371/journal.pone.0137305	http://dx.doi.org/10.1371/journal.pone.0137305			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436670	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200001
J	Kayisli, OG; Kayisli, UA; Basar, M; Semerci, N; Schatz, F; Lockwood, CJ				Kayisli, Ozlem Guzeloglu; Kayisli, Umit A.; Basar, Murat; Semerci, Nihan; Schatz, Frederick; Lockwood, Charles J.			Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive-Associated Abnormal Uterine Bleeding	PLOS ONE			English	Article							LONG-TERM PROGESTIN; HORMONAL CONTRACEPTION; ONLY CONTRACEPTIVES; ANIMAL-MODELS; DECIDUAL CELLS; TISSUE FACTOR; GUINEA-PIG; PREGNANCY; THROMBIN; MECHANISMS	Use of long-acting progestin only contraceptives (LAPCs) offers a discrete and highly effective family planning method. Abnormal uterine bleeding (AUB) is the major side effect of, and cause for, discontinuation of LAPCs. The endometria of LAPC-treated women display abnormally enlarged, fragile blood vessels, decreased endometrial blood flow and oxidative stress. To understanding to mechanisms underlying AUB, we propose to identify LAPC-modulated unique gene cluster(s) in human endometrial stromal cells (HESCs). Protein and RNA isolated from cultured HESCs treated 7 days with estradiol (E-2) or E-2+ medroxyprogesterone acetate (MPA) or E-2+ etonogestrel (ETO) or E-2+ progesterone (P4) were analyzed by quantitative Real-time (q)-PCR and immunoblotting. HSCORES were determined for immunostained-paired endometria of pre-and 3 months post-Depot MPA (DMPA) treated women and ovariectomized guinea pigs (GPs) treated with placebo or E-2 or MPA or E-2+ MPA for 21 days. In HESCs, whole genome analysis identified a 67 gene group regulated by all three progestins, whereas a 235 gene group was regulated by E-2+ ETO and E-2+ MPA, but not E-2+ P4. Ingenuity pathway analysis identified glucocorticoid receptor (GR) activation as one of upstream regulators of the 235 MPA and ETO-specific genes. Among these, microarray results demonstrated significant enhancement of FKBP51, a repressor of PR/GR transcriptional activity, by both MPA and ETO. q-PCR and immunoblot analysis confirmed the microarray results. In endometria of post-DMPA versus pre-DMPA administered women, FKBP51 expression was significantly increased in endometrial stromal and glandular cells. In GPs, E-2+ MPA or MPA significantly increased FKBP51 immunoreactivity in endometrial stromal and glandular cells versus placebo-and E-2-administered groups. MPA or ETO administration activates GR signaling and increases endometrial FKBP51 expression, which could be one of the mechanisms causing AUB by inhibiting PR and GR-mediated transcription. The resultant PR and/or GR-mediated functional withdrawal may contribute to associated endometrial inflammation, aberrant angiogenesis, and bleeding.	[Kayisli, Ozlem Guzeloglu; Kayisli, Umit A.; Semerci, Nihan; Schatz, Frederick; Lockwood, Charles J.] Univ S Florida, Dept Obstet & Gynecol, Morsani Coll Med, Tampa, FL 33620 USA; [Basar, Murat] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06510 USA	State University System of Florida; University of South Florida; Yale University	Lockwood, CJ (corresponding author), Univ S Florida, Dept Obstet & Gynecol, Morsani Coll Med, Tampa, FL 33620 USA.	cjlockwood@health.usf.edu	Basar, Murat/AAG-8235-2021	BASAR, MURAT/0000-0001-7766-409X	NIH/NICHD [2 RO1 HD 033937]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033937] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by NIH/NICHD 2 RO1 HD 033937 to CJL.	Affandi B, 1998, CONTRACEPTION, V58, p99S, DOI 10.1016/S0010-7824(98)00123-1; Africander D, 2011, STEROIDS, V76, P636, DOI 10.1016/j.steroids.2011.03.001; Basar M, 2010, REPRODUCTION, V140, P605, DOI 10.1530/REP-10-0263; Benagiano G, 2003, HUM REPROD UPDATE, V9, P373, DOI 10.1093/humupd/dmg025; Birgisson NE, 2015, J WOMENS HEALTH, V24, P349, DOI 10.1089/jwh.2015.5191; Byrns MC, 2014, J STEROID BIOCHEM, V139, P173, DOI 10.1016/j.jsbmb.2013.01.015; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chaovisitsaree Somsak, 2005, Journal of the Medical Association of Thailand, V88, P314; Chegini N, 2007, HUM REPROD, V22, P427, DOI 10.1093/humrep/del398; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Govender Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096497; Guzeloglu-Kayisli O, 2014, J CLIN ENDOCR METAB, V99, pE1957, DOI 10.1210/jc.2014-1770; Hickey M, 2006, J CLIN ENDOCR METAB, V91, P3633, DOI 10.1210/jc.2006-0724; Hickey M, 2000, HUM REPROD, V15, P57, DOI 10.1093/humrep/15.suppl_3.57; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; HUTZ RJ, 1990, BIOL REPROD, V42, P266, DOI 10.1095/biolreprod42.2.266; Jaaskelainen T, 2011, CURR OPIN PHARMACOL, V11, P326, DOI 10.1016/j.coph.2011.04.006; Kaunitz AM, 2000, OBSTET GYN CLIN N AM, V27, P741, DOI 10.1016/S0889-8545(05)70171-6; Krikun G, 2002, AM J PATHOL, V161, P979, DOI 10.1016/S0002-9440(10)64258-7; Krikun G, 2012, REPROD SCI, V19, P400, DOI 10.1177/1933719111424452; Krikun G, 2011, ANN NY ACAD SCI, V1221, P119, DOI 10.1111/j.1749-6632.2010.05930.x; Krikun G, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-8; Lee KY, 2004, REPRODUCTION, V128, P679, DOI 10.1530/rep.1.00340; Lockwood CJ, 2012, AM J PATHOL, V181, P2138, DOI 10.1016/j.ajpath.2012.08.036; Lockwood CJ, 2011, MENOPAUSE, V18, P408, DOI [10.1097/GME.0b013e31820bf288, 10.1097/gme.0b013e31820bf288]; Lockwood CJ, 2004, J CLIN ENDOCR METAB, V89, P1467, DOI 10.1210/jc.2003-030141; Lockwood CJ, 2004, HISTOL HISTOPATHOL, V19, P167, DOI 10.14670/HH-19.167; Lockwood CJ, 2002, J CLIN ENDOCR METAB, V87, P4280, DOI 10.1210/jc.2001-011969; Lockwood CJ, 2000, HUM REPROD, V15, P144, DOI 10.1093/humrep/15.suppl_3.144; Makker A, 2006, J ENDOCRINOL, V188, P121, DOI 10.1677/joe.1.06324; Mutihir JT, 2008, NIGER J CLIN PRACT, V11, P320; Papp C, 2000, Early Pregnancy, V4, P230; ROSENBERG MJ, 1995, J REPROD MED, V40, P355; Runic R, 2000, J CLIN ENDOCR METAB, V85, P3853, DOI 10.1210/jc.85.10.3853; Sanchez ER, 2012, BBA-MOL CELL RES, V1823, P722, DOI 10.1016/j.bbamcr.2011.11.006; Schindler AE, 2003, MATURITAS, V46, pS7, DOI 10.1016/j.maturitas.2003.09.014; Schrager S, 2002, AM FAM PHYSICIAN, V65, P2073; Secura GM, 2014, NEW ENGL J MED, V371, P1316, DOI 10.1056/NEJMoa1400506; Stechschulte LA, 2011, CURR OPIN PHARMACOL, V11, P332, DOI 10.1016/j.coph.2011.04.012; Tatro ET, 2009, BRAIN RES, V1286, P1, DOI 10.1016/j.brainres.2009.06.036; Tomasicchio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062895; Varney SJ, 2004, PHARMACOECONOMICS, V22, P1141, DOI 10.2165/00019053-200422170-00004; Vincent AJ, 2002, HUM REPROD, V17, P1189, DOI 10.1093/humrep/17.5.1189; Vincent AJ, 2000, HUM REPROD, V15, P135, DOI 10.1093/humrep/15.suppl_3.135; Weisberg E, 2014, EUR J CONTRACEP REPR, V19, P5, DOI 10.3109/13625187.2013.853034	47	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0137855	10.1371/journal.pone.0137855	http://dx.doi.org/10.1371/journal.pone.0137855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436918	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200003
J	Sguassero, Y; Cuesta, CB; Roberts, KN; Hicks, E; Comande, D; Ciapponi, A; Sosa-Estani, S				Sguassero, Yanina; Cuesta, Cristina B.; Roberts, Karen N.; Hicks, Elizabeth; Comande, Daniel; Ciapponi, Agustin; Sosa-Estani, Sergio			Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies	PLOS ONE			English	Article							CHRONIC CHAGAS-DISEASE; THERAPEUTIC-EFFICACY; ETIOLOGIC TREATMENT; BENZNIDAZOLE TREATMENT; TRYPANOCIDE TREATMENT; NIFURTIMOX TREATMENT; RANDOMIZED-TRIAL; BLOOD CULTURE; CHILDREN; CURE	Background Chagas disease is caused by the flagellate protozoan Trypanosoma cruzi (T. cruzi). It is endemic in Latin American countries outside the Caribbean. The current criterion for cure in the chronic phase of the disease is the negativization of at least two serological tests such as enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence assay (IIF) and indirect hemagglutination assay (IHA). The serological evolution of treated subjects with chronic T. cruzi infection is variable. Treatment failure is indicated by a positive parasitological and/or molecular test (persistence of parasitemia). Objectives To summarize the pattern of response to treatment of parasitological, molecular and serological tests performed during the follow-up of subjects with chronic T. cruzi infection. Methods Electronic searches in relevant databases and screening of citations of potentially eligible articles were accomplished. Organizations focusing on neglected infectious diseases were asked for help in identifying relevant studies. Included studies were randomized controlled trials (RCTs), quasi-RCTs, and cohort studies involving adults and children with chronic infection who received trypanocidal treatment (benznidazole or nifurtimox) and were followed over time. The assessment of risk of bias was performed separately for each study design. The Cochrane Collaboration's tool and the guidelines developed by Hayden et al. were used. Two reviewers extracted all data independently. A third review author was consulted in case of discordant opinion. Additional analyses were defined in ad-hoc basis. Scatter plots for percentage of positive parasitological and molecular tests and for negative serological tests were developed by using the lowess curve technique. Heterogeneity was measured by I-2. The protocol was registered in PROSPERO, an international prospective register of systematic review protocols (Registration Number CRD42012002162). Results Out of 2,136 citations screened, 54 studies (six RCTs and 48 cohort studies) were included. The smoothed curves for positive xenodiagnosis and positive polymerase chain reaction (PCR) were characterized by a sharp decrease at twelve month posttreatment. Afterwards, they reached 10-20% and 40% for xenodiagnosis and PCR, respectively. The smoothed curves for negative conventional serological tests increased up to 10% after 48 months of treatment. In the long-term, the rate of negativization was between 20% and 45%. The main sources of bias identified across cohort studies were the lack of control for confounding and attrition bias. In general, RCTs were judged as low risk of bias in all domains. The level of heterogeneity across included studies was moderate to high. Additional analysis were incomplete because of the limited availability of data. In this regard, the country of origin of study participants might affect the results of parasitological and molecular tests, while the level of risk of bias might affect serological outcomes. Subgroup analysis suggested that seronegativization occurs earlier in children compared to adults. Conclusions We acknowledge that there is a dynamic pattern of response based on parasitological, molecular and serological tests in subjects chronically infected with T. cruzi after treatment. Our findings suggest a trypanocidal effect in the long-term follow-up. Further research is needed to explore potential sources of heterogeneity and to conduct reliable subgroup analysis.	[Sguassero, Yanina] Cochrane Ctr CREP, CREP, Rosario, Santa Fe, Argentina; [Sguassero, Yanina; Sosa-Estani, Sergio] ANLIS, INP, Buenos Aires, DF, Argentina; [Cuesta, Cristina B.; Roberts, Karen N.] Univ Nacl Rosario, Fac Ciencias Econ & Estadist, RA-2000 Rosario, Santa Fe, Argentina; [Hicks, Elizabeth] Duke Univ, Sch Med, Durham, NC USA; [Comande, Daniel; Ciapponi, Agustin] Cochrane Ctr IECS, IECS, Buenos Aires, DF, Argentina	National University of Rosario; Duke University	Sosa-Estani, S (corresponding author), ANLIS, INP, Buenos Aires, DF, Argentina.	ssosa@msal.gov.ar		Comande, Daniel/0000-0002-7111-5169; Sguassero, Yanina/0000-0003-0698-3899; Ciapponi, Agustin/0000-0001-5142-6122	Savant, Inc.	Savant, Inc.	The protocol was partially sponsored by Savant, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to state that there was no additional external funding received for this study.	Aguiar C, 2012, TROP MED INT HEALTH, V17, P368, DOI 10.1111/j.1365-3156.2011.02936.x; Amato Neto V., 1998, ARQ BRAS CARDIOL, V70, P63, DOI [10.1590/s0066-782x1998000100013, DOI 10.1590/S0066-782X1998000100013]; Andrade ALSS, 2004, AM J TROP MED HYG, V71, P594, DOI 10.4269/ajtmh.2004.71.594; Andrade MC, 2013, REV SOC BRAS MED TRO, V46, P776, DOI 10.1590/0037-8682-1646-2013; [Anonymous], 2011, EARL REV ORG SOFTW E; [Anonymous], 2006, OPSHDMCD42506; [Anonymous], 2012, REV MAN REVMAN VERS; [Anonymous], GUIAS AT PAC INF CON; [Anonymous], 2015, CHAG DIS AMTRYP; APT W, 1986, T ROY SOC TROP MED H, V80, P1010, DOI 10.1016/0035-9203(86)90309-3; Bertocchi GL, 2013, T ROY SOC TROP MED H, V107, P372, DOI 10.1093/trstmh/trt029; Bianchi F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003465; Britto C, 2001, MEM I OSWALDO CRUZ, V96, P823, DOI 10.1590/S0074-02762001000600014; Cancado J. R., 1976, Revista Goiana de Medicina, V22, P203; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Villar JC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003463.pub2; Carpintero DJ, 1993, CM PUBLICACION MED, V6, P117; Cerisola J A, 1977, Bol Chil Parasitol, V32, P51; Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Coura J R, 1997, Rev Soc Bras Med Trop, V30, P139, DOI 10.1590/S0037-86821997000200009; de Bilbao Ninfa Vera, 2004, Revista de Patologia Tropical, V33, P301; de Castro AM, 2006, PARASITOL RES, V99, P379, DOI 10.1007/s00436-006-0172-5; de Lana M, 2009, MEM I OSWALDO CRUZ, V104, P1139, DOI 10.1590/S0074-02762009000800011; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Diniz Marques R, 2003, REV BRAS MED, V60, P748; Escriba JM, 2009, MEM I OSWALDO CRUZ, V104, P986, DOI 10.1590/S0074-02762009000700008; Estani SS, 1998, AM J TROP MED HYG, V59, P526, DOI 10.4269/ajtmh.1998.59.526; Fabbro de Suasnabar Diana, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P99; Fabbro D, 2013, REV INST MED TROP SP, V55, P167, DOI 10.1590/S0036-46652013000300005; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Fabbro DL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003312; Fabbro DL, 2010, SALUD CIENC, V17, P72; Fernandes CD, 2009, MEM I OSWALDO CRUZ, V104, P27, DOI 10.1590/S0074-02762009000100004; Fernandez-Villegas A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-206; Ferreira H. O., 1990, Revista da Sociedade Brasileira de Medicina Tropical, V23, P209, DOI 10.1590/S0037-86821990000400005; Flores-Chavez M, 2006, AM J TROP MED HYG, V75, P497, DOI 10.4269/ajtmh.2006.75.497; Franco-Paredes Carlos, 2007, BMC Int Health Hum Rights, V7, P7, DOI 10.1186/1472-698X-7-7; Fuentes R, 2012, REV CHIL INFECTOL, V29, P82, DOI 10.4067/S0716-10182012000100013; Gallerano R R, 2000, Rev Fac Cien Med Univ Nac Cordoba, V57, P135; Galvao LMC, 2003, J CLIN MICROBIOL, V41, P5066, DOI 10.1128/JCM.41.11.5066-5070.2003; GALVAO LMC, 1993, T ROY SOC TROP MED H, V87, P220, DOI 10.1016/0035-9203(93)90501-G; Gascon Joaquim, 2000, EVOLUTION SEROLOGIC; GUEVARA AG, 1995, T ROY SOC TROP MED H, V89, P447, DOI 10.1016/0035-9203(95)90052-7; Guhl F, 2004, 9 EUR MULT PAR SPAIN; Gurtler RE, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000168; Hasslocher-Moreno AM, 2010, EVOLUCAO ELETROCARDI; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Horsley T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001270.pub2; IANNI BM, 1993, ARQ BRAS CARDIOL S2, V61, P130; Jackson Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-85; Lacunza C. D., 2006, Revista de Patologia Tropical, V35, P227; Lacunza Carlos Diego, 2015, Revista de Patologia Tropical, V44, P21, DOI 10.5216/rpt.v44i1.34815; Lauria-Pires L, 2000, AM J TROP MED HYG, V63, P111, DOI 10.4269/ajtmh.2000.63.111; LEVI G C, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P369; Libonatti E, 1979, SEGUIMIENTO LONGITUD; Luquetti AO, PERSPECTIVA USO SERO; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Machado-de-Assis GF, 2012, CLIN VACCINE IMMUNOL, V19, P1283, DOI 10.1128/CVI.00274-12; Machado-de-Assis GF, 2013, MEM I OSWALDO CRUZ, V108, P873, DOI 10.1590/0074-0276130122; MAEKELT G A, 1969, Boletin Chileno de Parasitologia, V24, P95; Maldonado M, 1995, AN REPORTS IICS, P154; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Marin JA, 2007, CIRCULATION, V115, P1109, DOI 10.1161/CIRCULATIONAHA.106.624296; Meira WSF, 2004, J CLIN MICROBIOL, V42, P707, DOI 10.1128/JCM.42.2.707-712.2004; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Rumi MMM, 2013, ACTA TROP, V128, P130, DOI 10.1016/j.actatropica.2013.07.003; Moretti E, 1998, Bol Chil Parasitol, V53, P3; Morillo CA., 2012, 8 TALL ENF CHAG IMP; Munoz C, 2013, ANTIMICROB AGENTS CH, V57, P4518, DOI 10.1128/AAC.00227-13; Murcia L, 2010, J ANTIMICROB CHEMOTH, V65, P1759, DOI 10.1093/jac/dkq201; Neves da Silva N, 1974, REV SOC BRAS MED TRO, V18, P325; Oliveira CCS de, 2013, ACOMPANHAMENTO PARAS; Pan American Health Organization, 2014, CHAG DIS AM TRYP; Perez-Ayala A, 2011, CLIN MICROBIOL INFEC, V17, P1108, DOI 10.1111/j.1469-0691.2010.03423.x; Perez-Molina JA, 2009, J ANTIMICROB CHEMOTH, V64, P1139, DOI 10.1093/jac/dkp357; Pinazo MJ, 2014, EXPERT REV ANTI-INFE, V12, P479, DOI 10.1586/14787210.2014.899150; Riarte A, 2012, 8 TALL ENF CHAG IMP; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Negrette OS, 2008, CLIN VACCINE IMMUNOL, V15, P297, DOI 10.1128/CVI.00106-07; Schenone H, 2003, REV MED CHILE, V131, P1089; SCHENONE H, 1981, Boletin Chileno de Parasitologia, V36, P59; Silveira C A, 2000, Rev Soc Bras Med Trop, V33, P191, DOI 10.1590/S0037-86822000000200006; Solari A, 1998, Bol Chil Parasitol, V53, P27; Solari A, 2001, J ANTIMICROB CHEMOTH, V48, P515, DOI 10.1093/jac/48.4.515; Sosa-Estani S, 2000, MEDICINA-BUENOS AIRE, V60, P42; Sosa-Estani S, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/292138; Sosa-Estani S, 2009, REV SOC BRAS MED TRO, V42, P484, DOI 10.1590/S0037-86822009000500002; Sosa-Estani S, 2009, MEM I OSWALDO CRUZ, V104, P167, DOI 10.1590/S0074-02762009000900023; Streiger Mirtha L., 2004, Rev. Soc. Bras. Med. Trop., V37, P365; Vallejo M, 2013, COCHRANE DATABASE SY; Vera de Bilbao N, 2006, Mem. Inst. Investig. Cienc. Salud, V4, P5; Vigliano C, 1989, SEGUIMIENTO LONGITUD; VIOTTI R, 1994, AM HEART J, V127, P151, DOI 10.1016/0002-8703(94)90521-5; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Viotti R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001314; Viotti R, 2009, SALUD CIENC, V16, P855; Yun O, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000488; Zingales B, 2014, MEM I OSWALDO CRUZ, V109, P828, DOI 10.1590/0074-0276140156; Zingales B, 2012, INFECT GENET EVOL, V12, P240, DOI 10.1016/j.meegid.2011.12.009	102	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139363	10.1371/journal.pone.0139363	http://dx.doi.org/10.1371/journal.pone.0139363			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436678	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200019
J	Araujo, SBL; Braga, MP; Brooks, DR; Agosta, SJ; Hoberg, EP; von Hartenthal, FW; Boeger, WA				Araujo, Sabrina B. L.; Braga, Mariana Pires; Brooks, Daniel R.; Agosta, Salvatore J.; Hoberg, Eric P.; von Hartenthal, Francisco W.; Boeger, Walter A.			Understanding Host-Switching by Ecological Fitting	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASES; HISTORICAL BIOGEOGRAPHY; COEVOLUTION; DIVERSIFICATION; EVOLUTION; COLONIZATION; ASSOCIATIONS; SPECIATION; PHYLOGENY; EUCESTODA	Despite the fact that parasites are highly specialized with respect to their hosts, empirical evidence demonstrates that host switching rather than co-speciation is the dominant factor influencing the diversification of host-parasite associations. Ecological fitting in sloppy fitness space has been proposed as a mechanism allowing ecological specialists to hostswitch readily. That proposal is tested herein using an individual-based model of host switching. The model considers a parasite species exposed to multiple host resources. Through time host range expansion can occur readily without the prior evolution of novel genetic capacities. It also produces non-linear variation in the size of the fitness space. The capacity for host colonization is strongly influenced by propagule pressure early in the process and by the size of the fitness space later. The simulations suggest that co-adaptation may be initiated by the temporary loss of less fit phenotypes. Further, parasites can persist for extended periods in sub-optimal hosts, and thus may colonize distantly related hosts by a "stepping-stone" process.	[Araujo, Sabrina B. L.; Braga, Mariana Pires; Brooks, Daniel R.; Boeger, Walter A.] Univ Fed Parana, Lab Ecol Mol & Parasitol Evolut, BR-81531980 Curitiba, Parana, Brazil; [Araujo, Sabrina B. L.] Univ Fed Parana, Dept Fis, BR-81531980 Curitiba, Parana, Brazil; [Agosta, Salvatore J.] Virginia Commonwealth Univ, Ctr Environm Studies, Richmond, VA USA; [Agosta, Salvatore J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Hoberg, Eric P.] ARS, US Natl Parasite Collect, USDA, Beltsville, MD USA; [von Hartenthal, Francisco W.] Setor Ciencias Biol, Posgrad Ecol & Conservacao, BR-81531990 Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Virginia Commonwealth University; Virginia Commonwealth University; United States Department of Agriculture (USDA)	Boeger, WA (corresponding author), Univ Fed Parana, Lab Ecol Mol & Parasitol Evolut, Caixa Postal 19073, BR-81531980 Curitiba, Parana, Brazil.	wboeger@gmail.com	Boeger, Walter/G-1820-2012; Araujo, Sabrina Borges Lino/I-9274-2012; Braga, Mariana Pires/AAB-3069-2022	Boeger, Walter/0000-0002-6004-2822; Araujo, Sabrina Borges Lino/0000-0002-8759-8310; Braga, Mariana Pires/0000-0002-1253-2536	"Exploring a new paradigm for the evolution of host-parasites associations," of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [404344/2013-5]	"Exploring a new paradigm for the evolution of host-parasites associations," of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)	This work was supported by a grant to WAB entitled "Exploring a new paradigm for the evolution of host-parasites associations," number 404344/2013-5 of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) (http://www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosta SJ, 2008, ECOL LETT, V11, P1123, DOI 10.1111/j.1461-0248.2008.01237.x; Agosta SJ, 2006, OIKOS, V114, P556, DOI 10.1111/j.2006.0030-1299.15025.x; Agosta SJ, 2010, ZOOLOGIA-CURITIBA, V27, P151, DOI 10.1590/S1984-46702010000200001; Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; Bengis RH, 2004, REV SCI TECH OIE, V23, P497; Blasco-Costa I, 2015, ECOGRAPHY, V38, P301, DOI 10.1111/ecog.01020; Boeger WA, 2003, ZOOL SCR, V32, P437, DOI 10.1046/j.1463-6409.2003.00130.x; Braga MP, 2015, J ANIM ECOL, V84, P487, DOI 10.1111/1365-2656.12298; BROOKS D. R., 2007, EVOLUTION ED OUTREAC, V1, P2; Brooks D. R., 2002, NATURE DIVERSITY EVO; Brooks DR, 2007, TRENDS PARASITOL, V23, P571, DOI 10.1016/j.pt.2007.08.016; Brooks Daniel R., 2006, Rev. Mex. Biodiv., V77, P225; Brooks DR, 2006, ECOLOGY, V87, pS76, DOI 10.1890/0012-9658(2006)87[76:EFAADO]2.0.CO;2; Brooks Daniel R., 2013, P215; Brooks DR, 2014, COMP PARASITOL, V81, P155, DOI 10.1654/4724b.1; Brooks DR, 2012, ZOOLOGIA-CURITIBA, V29, P497, DOI 10.1590/S1984-46702012000600002; BROOKS DR, 1979, SYST ZOOL, V28, P299, DOI 10.2307/2412584; Brooks DR, 2005, J BIOGEOGR, V32, P1291, DOI 10.1111/j.1365-2699.2005.01315.x; Brooks DR, 1993, PARASCRIPT PARASITES; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Combes Claude., 2001, PARASITISM ECOLOGY E; DARWIN C, ORIGIN OF SPECIES; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dominguez M, 2015, J EVOLUTION BIOL, V28, P1290, DOI 10.1111/jeb.12649; Ellisa VA, 2015, P NATL ACAD SCI USA, V112, P11294, DOI 10.1073/pnas.1515309112; Erwin T.L., 1985, Series Entomologica (Dordrecht), V33, P437; Futuyma D.J., 1983, COEVOLUTION; Givnish Thomas J., 1997, P1; GORMAN OT, 1990, J VIROL, V64, P1487, DOI 10.1128/JVI.64.4.1487-1497.1990; GORMAN OT, 1990, J VIROL, V64, P4893, DOI 10.1128/JVI.64.10.4893-4902.1990; Habermannova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064537; Heard Stephen B., 1995, Historical Biology, V10, P151; Hoberg E.P., 2000, Bulletin of the Scandinavian Society for Parasitology, V10, P19; Hoberg E.P., 2010, BIOGEOGRAPHY HOST PA, P7; Hoberg EP, 1999, SYST PARASITOL, V42, P51, DOI 10.1023/A:1006100629059; HOBERG EP, 1995, CAN J ZOOL, V73, P45, DOI 10.1139/z95-006; Hoberg EP, 2005, J PARASITOL, V91, P358, DOI 10.1645/GE-3466; Hoberg EP, 1999, SYST PARASITOL, V42, P1, DOI 10.1023/A:1006099009495; Hoberg ER, 2004, J PARASITOL, V90, P1085, DOI 10.1645/GE-3309; Hoberg EP, 2008, J BIOGEOGR, V35, P1533, DOI 10.1111/j.1365-2699.2008.01951.x; Hoberg EP, 2015, TRENDS PARASITOL, V31, P128, DOI 10.1016/j.pt.2014.11.005; Hoberg EP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0553; Janz N, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P203; JANZEN DH, 1985, OIKOS, V45, P308, DOI 10.2307/3565565; Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010; KROLL JS, 1990, J BACTERIOL, V172, P1374, DOI 10.1128/jb.172.3.1374-1379.1990; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Malcicka M, 2015, GLOBAL CHANGE BIOL, V21, P3210, DOI 10.1111/gcb.12928; Meinila M, 2004, INT J PARASITOL, V34, P515, DOI 10.1016/j.ijpara.2003.12.002; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nylin S, 2014, EVOLUTION, V68, P105, DOI 10.1111/evo.12227; Paladini G, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0576-5; Ricklefs RE, 2014, P NATL ACAD SCI USA, V111, P14816, DOI 10.1073/pnas.1416356111; Ronquist F, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P22; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Thompson J. N., 2005, INTERSPEC INTERACT; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Xue ZS, 2015, MBIO, V6, DOI 10.1128/mBio.00022-15	60	127	128	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139225	10.1371/journal.pone.0139225	http://dx.doi.org/10.1371/journal.pone.0139225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431199	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700034
J	Lai, YY; Li, YM; Lang, JD; Tong, XL; Zhang, LN; Fang, JH; Xing, JL; Cai, M; Xu, HT; Deng, Y; Xiao, F; Tian, G				Lai, Yi Yu; Li, Yanming; Lang, Jidong; Tong, Xunliang; Zhang, Lina; Fang, Jianhuo; Xing, Jingli; Cai, Meng; Xu, Hongtao; Deng, Yan; Xiao, Fei; Tian, Geng			RETRACTED: Metagenomic Human Repiratory Air in a Hospital Environment (Retracted article. See vol. 11, e0147243, 2016)	PLOS ONE			English	Article; Retracted Publication							EXPOSURE; GENOME; PNEUMONIA; SEQUENCES; MICROBES; OUTBREAK	Hospital-acquired infection (HAI) or nosocomial infection is an issue that frequent hospital environment. We believe conventional regulated Petri dish method is insufficient to evaluate HAI. To address this problem, metagenomic sequencing was applied to screen airborne microbes in four rooms of Beijing Hospital. With air-in amount of sampler being setup to one person's respiration quantity, metagenomic sequencing identified huge numbers of species in the rooms which had already qualified widely accepted petridish exposing standard, imposing urgency for new technology. Meanwhile, the comparative culture only got small portion of recovered species and remain blind for even cultivable pathogens reminded us the limitations of old technologies. To the best of our knowledge, the method demonstrated in this study could be broadly applied in hospital indoor environment for various monitoring activities as well as HAI study. It is also potential as a transmissible pathogen real-time modelling system worldwide.	[Lai, Yi Yu; Lang, Jidong; Zhang, Lina; Fang, Jianhuo; Xing, Jingli; Tian, Geng] Tsinghua Univ, Genom & Synthet Biol Ctr, Beijing 100084, Peoples R China; [Li, Yanming; Tong, Xunliang] Beijing Hosp, Dept Resp & Crit Care Med, Beijing, Peoples R China; [Lang, Jidong; Tian, Geng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Cai, Meng] Beijing Hosp, Dept Hosp Infect Control, Beijing, Peoples R China; [Xu, Hongtao] Beijing Hosp, Dept Lab Med, Beijing, Peoples R China; [Deng, Yan] Tsinghua Univ, State Key Lab Precis Measurement Technol & Instru, Beijing 100084, Peoples R China; [Xiao, Fei] Beijing Hosp, Minist Hlth, Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China	Tsinghua University; Beijing Hospital; Tsinghua University; Beijing Hospital; Beijing Hospital; Tsinghua University; Beijing Hospital	Xiao, F (corresponding author), Beijing Hosp, Minist Hlth, Beijing Inst Geriatr, Key Lab Geriatr, Beijing, Peoples R China.	xiaofei@bjhmoh.cn; tiangeng@biomed.tsinghua.edu.cn	li, yan/GTI-4638-2022	Xing, Jingli/0000-0002-9703-1115	Tsinghua University initiative scientific research program [20131089296]; Innocentive grant [9932993]	Tsinghua University initiative scientific research program; Innocentive grant	Support was provided by Tsinghua University initiative scientific research program under Grant 20131089296 and Innocentive grant no. 9932993.	Aimanianda V, 2009, NATURE, V460, P1117, DOI 10.1038/nature08264; Bowman JP, 1997, INT J SYST BACTERIOL, V47, P1040, DOI 10.1099/00207713-47-4-1040; Cao C, 2014, ENVIRON SCI TECHNOL, V48, P1499, DOI 10.1021/es4048472; Chen K, 2005, PLOS COMPUT BIOL, V1, P106, DOI 10.1371/journal.pcbi.0010024; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; *COMM MET CHALL FU, 2007, NEW SCI MET REV SECR; Dali P, 2001, ANTIMICROB AGENTS CH, V45, P2969, DOI 10.1128/AAC.45.10.2969-2970.2001; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Eames I, 2009, J R SOC INTERFACE, V6, pS697, DOI 10.1098/rsif.2009.0407.focus; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Embers ME, 2011, VET MICROBIOL, V147, P367, DOI 10.1016/j.vetmic.2010.06.029; Gershman MD, 2008, CLIN INFECT DIS, V47, P1372, DOI 10.1086/592968; GILRANE T, 1985, AM J MED, V78, P1038, DOI 10.1016/0002-9343(85)90230-X; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Griffith CJ, 2000, J HOSP INFECT, V45, P19, DOI 10.1053/jhin.1999.0717; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hensel M, 2009, SECRETED PROTEINS VI; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Jain SK, 2005, EMERG INFECT DIS, V11, P1097, DOI 10.3201/eid1107.050092; Kishore J, 2012, INDIAN J MED RES, V135, P341; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Koulenti D, 2009, CRIT CARE MED, V37, P2360, DOI 10.1097/CCM.0b013e3181a037ac; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Li J, 2013, ENVIRON SCI TECHNOL, V47, P10660, DOI 10.1021/es402848d; Loman NJ, 2013, JAMA-J AM MED ASSOC, V309, P1502, DOI 10.1001/jama.2013.3231; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; Moon HS, 2009, ENVIRON SCI TECHNOL, V43, P5857, DOI 10.1021/es900078z; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; Pasanen AL, 2001, INDOOR AIR, V11, P87, DOI 10.1034/j.1600-0668.2001.110203.x; Patterson MJ, 1996, MED MICROBIOLOGY, V4th; Peccia J, 2008, ENVIRON SCI TECHNOL, V42, P4631; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; RYAN KJ, 2004, SHERRIS MED MICROBIO; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Seth-Smith HMB, 2013, GENOME RES, V23, P855, DOI 10.1101/gr.150037.112; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Tronel H, 2001, CLIN MICROBIOL INFEC, V7, P275, DOI 10.1046/j.1469-0691.2001.00241.x; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wan XF, 2013, VIRUS GENES, V46, P441, DOI 10.1007/s11262-013-0878-2; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yooseph S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081862	47	26	27	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139044	10.1371/journal.pone.0139044	http://dx.doi.org/10.1371/journal.pone.0139044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431488	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700029
J	Patruno, A; Pesce, M; Grilli, A; Speranza, L; Franceschelli, S; De Lutiis, MA; Vianale, G; Costantini, E; Amerio, P; Muraro, R; Felaco, M; Reale, M				Patruno, Antonia; Pesce, Mirko; Grilli, Alfredo; Speranza, Lorenza; Franceschelli, Sara; De Lutiis, Maria Anna; Vianale, Giovina; Costantini, Erica; Amerio, Paolo; Muraro, Raffaella; Felaco, Mario; Reale, Marcella			mTOR Activation by PI3K/Akt and ERK Signaling in Short ELF-EMF Exposed Human Keratinocytes	PLOS ONE			English	Article							PULSED ELECTROMAGNETIC-FIELDS; CELL-PROLIFERATION; TUBEROUS SCLEROSIS; MAGNETIC-FIELDS; GROWTH; EXPRESSION; PATHWAYS; KINASE; CANCER; PHOSPHORYLATION	Several reports suggest that ELF-EMF exposures interact with biological processes including promotion of cell proliferation. However, the molecular mechanisms by which ELF-EMF controls cell growth are not completely understood. The present study aimed to investigate the effect of ELF-EMF on keratinocytes proliferation and molecular mechanisms involved. Effect of ELF-EMF (50 Hz, 1 mT) on HaCaT cell cycle and cells growth and viability was monitored by FACS analysis and BrdU assay. Gene expression profile by microarray and qRT-PCR validation was performed in HaCaT cells exposed or not to ELF-EMF. mTOR, Akt and MAPKs expressions were evaluated by Western blot analysis. In HaCaT cells, short ELF-EMF exposure modulates distinct patterns of gene expression involved in cell proliferation and in the cell cycle. mTOR activation resulted the main molecular target of ELF-EMF on HaCaT cells. Our data showed the increase of the canonical pathway of mTOR regulation (PI3K/Akt) and activation of ERK signaling pathways. Our results indicate that ELF-EMF selectively modulated the expression of multiple genes related to pivotal biological processes and functions that play a key role in physio-pathological mechanisms such as wound healing.	[Patruno, Antonia; Speranza, Lorenza; Franceschelli, Sara; De Lutiis, Maria Anna; Amerio, Paolo; Felaco, Mario] Univ G DAnnunzio, Dept Med & Aging Sci, Chieti, Italy; [Pesce, Mirko; Grilli, Alfredo] Univ G DAnnunzio, Dept Psychol Hlth & Territorial Sci, Chieti, Italy; [Vianale, Giovina; Costantini, Erica; Muraro, Raffaella; Reale, Marcella] Univ G DAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Pesce, M (corresponding author), Univ G DAnnunzio, Dept Psychol Hlth & Territorial Sci, Chieti, Italy.	mirkopesce@unich.it	Franceschelli, Sara/G-1738-2015; Costantini, erica/AAD-9167-2020; Franceschelli, Sara/ABA-6335-2020; Amerio, Paolo/F-4573-2010; Reale, Marcella/G-4299-2013	Costantini, erica/0000-0003-2175-4226; Amerio, Paolo/0000-0003-1589-9672; Reale, Marcella/0000-0002-4164-8781; Franceschelli, Sara/0000-0002-1580-6520; Pesce, Mirko/0000-0001-8836-2564	Ministero dell'Universita e della Ricerca (MIUR)	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by Ministero dell'Universita e della Ricerca (MIUR).	Adie S, 2011, J BONE JOINT SURG AM, V93A, P1569, DOI 10.2106/JBJS.J.00869; Callaghan MJ, 2008, PLAST RECONSTR SURG, V121, P130, DOI 10.1097/01.prs.0000293761.27219.84; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; CHIABRERA A, 1984, BIOELECTROMAGNETICS, V5, P173, DOI 10.1002/bem.2250050206; Choudhury GG, 1997, AM J PHYSIOL-RENAL, V273, pF931, DOI 10.1152/ajprenal.1997.273.6.F931; Collard JF, 2015, CELL SIGNAL, V27, P889, DOI 10.1016/j.cellsig.2015.02.007; Duran V, 1991, Med Pregl, V44, P485; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Gervais M, 2006, MOL BIOL CELL, V17, P3940, DOI 10.1091/mbc.E06-06-0501; Hao JJ, 2010, SYST BIO, V1, P505, DOI 10.1007/978-1-4419-5797-9_21; HECKMAN JD, 1981, CLIN ORTHOP RELAT R, P58; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104732; Huo R, 2010, J SURG RES, V162, P299, DOI 10.1016/j.jss.2009.02.016; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Kobbert C, 2008, ELECTROMAGN BIOL MED, V27, P41, DOI 10.1080/15368370701878929; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Matic M, 2009, LASER MED SCI, V24, P321, DOI 10.1007/s10103-008-0564-0; Memmott RM, 2009, CELL SIGNAL, V21, P656, DOI 10.1016/j.cellsig.2009.01.004; Mizuno H, 2001, GENES CELLS, V6, P261, DOI 10.1046/j.1365-2443.2001.00418.x; OTTANI V, 1988, BIOELECTROMAGNETICS, V9, P53, DOI 10.1002/bem.2250090105; Park JE, 2013, NEUROCHEM INT, V62, P418, DOI 10.1016/j.neuint.2013.02.002; Patruno A, 2010, BRIT J DERMATOL, V162, P258, DOI 10.1111/j.1365-2133.2009.09527.x; Patruno A, 2012, J CELL PHYSIOL, V227, P2767, DOI 10.1002/jcp.23024; Pesce M, 2013, AGGRESSIVE BEHAV, V39, P141, DOI 10.1002/ab.21457; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reale M, 2006, NITRIC OXIDE-BIOL CH, V15, P50, DOI 10.1016/j.niox.2005.11.010; Repacholi MH, 1999, BIOELECTROMAGNETICS, V20, P133, DOI 10.1002/(SICI)1521-186X(1999)20:3<133::AID-BEM1>3.0.CO;2-O; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sheng HM, 2001, J BIOL CHEM, V276, P14498, DOI 10.1074/jbc.M010093200; Shi HF, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-35; Sisken B F, 1990, Restor Neurol Neurosci, V1, P303, DOI 10.3233/RNN-1990-13419; Soda A, 2008, J MED INVESTIG, V55, P267, DOI 10.2152/jmi.55.267; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; STILLER MJ, 1992, BRIT J DERMATOL, V127, P147, DOI 10.1111/j.1365-2133.1992.tb08047.x; Sunkari VG, 2011, ELECTROMAGN BIOL MED, V30, P80, DOI 10.3109/15368378.2011.566774; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vianale G, 2008, BRIT J DERMATOL, V158, P1189, DOI 10.1111/j.1365-2133.2008.08540.x; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; WANG AM, 1989, P NATL ACAD SCI USA, V86, P9717, DOI 10.1073/pnas.86.24.9717; Wang J, 2004, CANCER RES, V64, P1861, DOI 10.1158/0008-5472.CAN-03-2968; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zwirska-Korczala K, 2005, J Physiol Pharmacol, V56 Suppl 6, P101	45	24	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139644	10.1371/journal.pone.0139644	http://dx.doi.org/10.1371/journal.pone.0139644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431550	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700093
J	Yadav, MK; Go, YY; Chae, SW; Song, JJ				Yadav, Mukesh Kumar; Go, Yoon Young; Chae, Sung-Won; Song, Jae-Jun			The Small Molecule DAM Inhibitor, Pyrimidinedione, Disrupts Streptococcus pneumoniae Biofilm Growth In Vitro	PLOS ONE			English	Article							DNA ADENINE METHYLATION; EAR EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; OTITIS-MEDIA; PNEUMOCOCCAL PNEUMONIA; CATABOLITE REPRESSION; BACTERIAL BIOFILMS; EXTRACELLULAR DNA; BACILLUS-SUBTILIS	Streptococcus pneumoniae persist in the human nasopharynx within organized biofilms. However, expansion to other tissues may cause severe infections such as pneumonia, otitis media, bacteremia, and meningitis, especially in children and the elderly. Bacteria within biofilms possess increased tolerance to antibiotics and are able to resist host defense systems. Bacteria within biofilms exhibit different physiology, metabolism, and gene expression profiles than planktonic cells. These differences underscore the need to identify alternative therapeutic targets and novel antimicrobial compounds that are effective against pneumococcal biofilms. In bacteria, DNA adenine methyltransferase (Dam) alters pathogenic gene expression and catalyzes the methylation of adenine in the DNA duplex and of macromolecules during the activated methyl cycle (AMC). In pneumococci, AMC is involved in the biosynthesis of quorum sensing molecules that regulate competence and biofilm formation. In this study, we examine the effect of a small molecule Dam inhibitor, pyrimidinedione, on Streptococcus pneumoniae biofilm formation and evaluate the changes in global gene expression within biofilms via microarray analysis. The effects of pyrimidinedione on in vitro biofilms were studied using a static microtiter plate assay, and the architecture of the biofilms was viewed using confocal and scanning electron microscopy. The cytotoxicity of pyrimidinedione was tested on a human middle ear epithelium cell line by CCK-8. In situ oligonucleotide microarray was used to compare the global gene expression of Streptococcus pneumoniae D39 within biofilms grown in the presence and absence of pyrimidinedione. Real-time RT-PCR was used to study gene expression. Pyrimidinedione inhibits pneumococcal biofilm growth in vitro in a concentration-dependent manner, but it does not inhibit planktonic cell growth. Confocal microscopy analysis revealed the absence of organized biofilms, where cell-clumps were scattered and attached to the bottom of the plate when cells were grown in the presence of pyrimidinedione. Scanning electron microscopy analysis demonstrated the absence of an extracellular polysaccharide matrix in pyrimidinedione-grown biofilms compared to control-biofilms. Pyrimidinedione also significantly inhibited MRSA, MSSA, and Staphylococcus epidermidis biofilm growth in vitro. Furthermore, pyrimidinedione does not exhibit eukaryotic cell toxicity. In a microarray analysis, 56 genes were significantly up-regulated and 204 genes were significantly down-regulated. Genes involved in galactose metabolism were exclusively up-regulated in pyrimidinedione-grown biofilms. Genes related to DNA replication, cell division and the cell cycle, pathogenesis, phosphate-specific transport, signal transduction, fatty acid biosynthesis, protein folding, homeostasis, competence, and biofilm formation were down regulated in pyrimidinedione-grown biofilms. This study demonstrated that the small molecule Dam inhibitor, pyrimidinedione, inhibits pneumococcal biofilm growth in vitro at concentrations that do not inhibit planktonic cell growth and down regulates important metabolic-, virulence-, competence-, and biofilm-related genes. The identification of a small molecule (pyrimidinedione) with S. pneumoniae biofilm-inhibiting capabilities has potential for the development of new compounds that prevent biofilm formation.	[Yadav, Mukesh Kumar; Go, Yoon Young; Chae, Sung-Won; Song, Jae-Jun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea; [Yadav, Mukesh Kumar] Korea Univ, Coll Med, Inst Med Device Clin Trials, Seoul 136705, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Song, JJ (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 136705, South Korea.	jjsong23@gmail.com	Yadav, Mukesh Kumar/M-9154-2015	Yadav, Mukesh Kumar/0000-0002-4703-8554	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2A10004451]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2A10004451). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal M, 2014, APPL ENVIRON MICROB, V80, P5349, DOI 10.1128/AEM.01370-14; Ajdic D, 1998, J BACTERIOL, V180, P5727; Allegrucci M, 2008, J BACTERIOL, V190, P6330, DOI 10.1128/JB.00707-08; Ash SY, 2013, MED CLIN N AM, V97, P647, DOI 10.1016/j.mcna.2013.03.005; Baldassarri L, 2006, J CLIN MICROBIOL, V44, P2721, DOI 10.1128/JCM.00512-06; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Beeston AL, 2002, J BACTERIOL, V184, P3450, DOI 10.1128/JB.184.13.3450-3456.2002; Bethe G, 2001, FEMS MICROBIOL LETT, V205, P99, DOI 10.1016/S0378-1097(01)00453-0; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Chauvaux S, 1996, RES MICROBIOL, V147, P518, DOI 10.1016/0923-2508(96)84006-X; Chun YM, 2002, ANN OTO RHINOL LARYN, V111, P507, DOI 10.1177/000348940211100606; Cornell KA, 2009, J ANTIMICROB CHEMOTH, V63, P1163, DOI 10.1093/jac/dkp129; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; del Prado G, 2010, DIAGN MICR INFEC DIS, V67, P311, DOI 10.1016/j.diagmicrobio.2010.03.016; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Falker S, 2005, MICROBIOL-SGM, V151, P2291, DOI 10.1099/mic.0.27946-0; Fridovich-Keil JL, 2006, J CELL PHYSIOL, V209, P701, DOI 10.1002/jcp.20820; Garcia-Castillo M, 2007, J ANTIMICROB CHEMOTH, V59, P301, DOI 10.1093/jac/dkl482; Garcia-Del Portillo F, 1999, P NATL ACAD SCI USA, V96, P11578, DOI 10.1073/pnas.96.20.11578; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; HENKIN TM, 1991, MOL MICROBIOL, V5, P575, DOI 10.1111/j.1365-2958.1991.tb00728.x; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kania RE, 2008, LARYNGOSCOPE, V118, P128, DOI 10.1097/MLG.0b013e318155a464; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; Klugman KP, 2008, CLIN INFECT DIS, V47, pS202, DOI 10.1086/591405; Koopman JA, 2015, ANTIMICROB AGENTS CH, V59, P76, DOI 10.1128/AAC.03407-14; Lee MS, 1999, J BACTERIOL, V181, P5004, DOI 10.1128/JB.181.16.5004-5016.1999; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizcano A, 2010, MICROB PATHOGENESIS, V48, P124, DOI 10.1016/j.micpath.2010.01.002; Lobner-Olesen A, 2005, CURR OPIN MICROBIOL, V8, P154, DOI 10.1016/j.mib.2005.02.009; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Markham GD, 2009, CELL MOL LIFE SCI, V66, P636, DOI 10.1007/s00018-008-8516-1; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Martin CA, 2008, EUR J CLIN MICROBIOL, V27, P635, DOI 10.1007/s10096-008-0489-3; Mashhoon N, 2006, J BIOMOL SCREEN, V11, P497, DOI 10.1177/1087057106287933; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Novak R, 1999, J BACTERIOL, V181, P1126, DOI 10.1128/JB.181.4.1126-1133.1999; Oggioni MR, 2006, MOL MICROBIOL, V61, P1196, DOI 10.1111/j.1365-2958.2006.05310.x; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Parveen N, 2011, MOL MICROBIOL, V79, P7, DOI 10.1111/j.1365-2958.2010.07455.x; Paterson GK, 2006, MICROBES INFECT, V8, P145, DOI 10.1016/j.micinf.2005.06.009; Pichichero ME, 2013, PEDIATR CLIN N AM, V60, P391, DOI 10.1016/j.pcl.2012.12.007; Polissi A, 1998, INFECT IMMUN, V66, P5620, DOI 10.1128/IAI.66.12.5620-5629.1998; Reisenauer A, 1999, J BACTERIOL, V181, P5135, DOI 10.1128/JB.181.17.5135-5139.1999; Rybtke Morten T., 2011, Inflammation & Allergy Drug Targets, V10, P141; Sakai F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067147; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Shakl JR, 2013, TRENDS MICROBIOL, V21, P129, DOI 10.1016/j.tim.2012.11.005; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Song JJ, 2012, INT J PEDIATR OTORHI, V76, P334, DOI 10.1016/j.ijporl.2011.12.003; Talekar SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097314; Trappetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019844; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vlastarakos PV, 2007, LARYNGOSCOPE, V117, P668, DOI 10.1097/MLG.0b013e318030e422; Watson ME, 2004, MOL MICROBIOL, V53, P651, DOI 10.1111/j.1365-2958.2004.04140.x; Weimer KED, 2010, J INFECT DIS, V202, P1068, DOI 10.1086/656046; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Yadav MK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119564; Yadav MK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/156987; Yadav MK, 2012, MICROB PATHOGENESIS, V53, P219, DOI 10.1016/j.micpath.2012.08.003; Zeng L, 2012, APPL ENVIRON MICROB, V78, P5597, DOI 10.1128/AEM.01393-12	70	13	13	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139238	10.1371/journal.pone.0139238	http://dx.doi.org/10.1371/journal.pone.0139238			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431532	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700037
J	Romero, MD; Sabater, D; Fernandez-Lopez, JA; Remesar, X; Alemany, M				del Mar Romero, Maria; Sabater, David; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria			Glycerol Production from Glucose and Fructose by 3T3-L1 Cells: A Mechanism of Adipocyte Defense from Excess Substrate	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; INTESTINAL ALKALINE-PHOSPHATASE; LIPID-ACCUMULATION; FATTY-ACID; METABOLISM; GLUCONEOGENESIS; DIFFERENTIATION; LIVER; DEHYDROGENASE; BIOSYNTHESIS	Cultured adipocytes (3T3-L1) produce large amounts of 3C fragments; largely lactate, depending on medium glucose levels. Increased glycolysis has been observed also in vivo in different sites of rat white adipose tissue. We investigated whether fructose can substitute glucose as source of lactate, and, especially whether the glycerol released to the medium was of lipolytic or glycolytic origin. Fructose conversion to lactate and glycerol was lower than that of glucose. The fast exhaustion of medium glucose was unrelated to significant changes in lipid storage. Fructose inhibited to a higher degree than glucose the expression of lipogenic enzymes. When both hexoses were present, the effects of fructose on gene expression prevailed over those of glucose. Adipocytes expressed fructokinase, but not aldolase b. Substantive release of glycerol accompanied lactate when fructose was the substrate. The mass of cell triacylglycerol (and its lack of change) could not justify the comparatively higher amount of glycerol released. Consequently, most of this glycerol should be derived from the glycolytic pathway, since its lipolytic origin could not be (quantitatively) sustained. Proportionally (with respect to lactate plus glycerol), more glycerol was produced from fructose than from glucose, which suggests that part of fructose was catabolized by the alternate (hepatic) fructose pathway. Earlier described adipose glycerophophatase activity may help explain the glycolytic origin of most of the glycerol. However, no gene is known for this enzyme in mammals, which suggests that this function may be carried out by one of the known phosphatases in the tissue. Break up of glycerol-3P to yield glycerol, may be a limiting factor for the synthesis of triacylglycerols through control of glycerol-3P availability. A phosphatase pathway such as that described may have a potential regulatory function, and explain the production of glycerol by adipocytes in the absence of lipolytic stimulation.	[del Mar Romero, Maria; Sabater, David; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, E-08028 Barcelona, Spain; [del Mar Romero, Maria; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria] Univ Barcelona, Inst Biomed, E-08028 Barcelona, Spain; [del Mar Romero, Maria; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria] CIBER Obes & Nutr, Barcelona, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Alemany, M (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Ave Diagonal 643, E-08028 Barcelona, Spain.	malemany@ub.edu	Remesar, Xavier/L-4555-2019; del Mar Romero, Maria/K-9004-2017; Alemany, Marià/H-5224-2011; López, José Antonio Fernández/C-5467-2017; Remesar, Xavier/G-5703-2013	Remesar, Xavier/0000-0002-9707-7287; del Mar Romero, Maria/0000-0001-6274-5743; Alemany, Marià/0000-0002-9783-8293; López, José Antonio Fernández/0000-0002-2856-7223; Remesar, Xavier/0000-0002-9707-7287; Sabater Martinez, David/0000-0001-8113-8594	Plan Nacional de Investigacion en Biomedicina [SAF2012-34895]; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain [AGL-2011-23635]; CIBER-OBN (Centro de Investigaciones Biomedicas en Red- Obesidad y Nutricion), Institute of Health Carlos III of the Government of Spain	Plan Nacional de Investigacion en Biomedicina; Plan Nacional de Ciencia y Tecnologia de los Alimentos of the Government of Spain; CIBER-OBN (Centro de Investigaciones Biomedicas en Red- Obesidad y Nutricion), Institute of Health Carlos III of the Government of Spain	This study was done with the partial support of grants of the Plan Nacional de Investigacion en Biomedicina (SAF2012-34895) and the Plan Nacional de Ciencia y Tecnologia de los Alimentos (AGL-2011-23635) of the Government of Spain, as well as of CIBER-OBN (Centro de Investigaciones Biomedicas en Red- Obesidad y Nutricion), Institute of Health Carlos III of the Government of Spain, which paid the salary of Dr. Romero.	Ahima RS, 2008, MOL ENDOCRINOL, V22, P1023, DOI 10.1210/me.2007-0529; Alemany M, 2013, NUTR RES, V33, P1, DOI 10.1016/j.nutres.2012.11.013; Alemany M, 2011, J CLIN ENDOCR METAB, V96, P66, DOI 10.1210/jc.2010-2541; Ali AT, 2006, ANAL BIOCHEM, V354, P247, DOI 10.1016/j.ab.2006.04.028; Arriaran S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119572; Camargo A, 2014, EUR J NUTR, V53, P617, DOI 10.1007/s00394-013-0570-2; Cinti S, 2012, DIS MODEL MECH, V5, P588, DOI 10.1242/dmm.009662; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; Cori C F, 1981, Curr Top Cell Regul, V18, P377; Romero MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090995; ENGSTROEM L, 1961, BIOCHIM BIOPHYS ACTA, V52, P36, DOI 10.1016/0006-3002(61)90901-5; FROESCH ER, 1962, J BIOL CHEM, V237, P3317; FROESCH ER, 1972, ACTA MED SCAND, P37; Froesch ER, 2011, COMPREHENS PHYSL, V1, P281; Grethen E, 2012, J CLIN ENDOCR METAB, V97, P1655, DOI 10.1210/jc.2011-2280; HAGSTROM E, 1990, AM J PHYSIOL, V258, pE888, DOI 10.1152/ajpendo.1990.258.5.E888; Hausberger FX, 1939, N-S ARCH EX PATH PH, V193, P110, DOI 10.1007/BF01861255; HEINZ F, 1968, J CLIN INVEST, V47, P1826, DOI 10.1172/JCI105872; HERS HG, 1952, BIOCHIM BIOPHYS ACTA, V8, P416, DOI 10.1016/0006-3002(52)90067-X; HERS HG, 1953, BIOCHIM BIOPHYS ACTA, V11, P427, DOI 10.1016/0006-3002(53)90062-6; Hodson L, 2013, DIABETES, V62, P1417, DOI 10.2337/db12-1032; JAMDAR SC, 1973, J LIPID RES, V14, P509; JANSSON PA, 1992, J CLIN INVEST, V89, P1610, DOI 10.1172/JCI115756; Karpe F, 2005, DIABETES, V54, P1297, DOI 10.2337/diabetes.54.5.1297; Lakhan SE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-114; Legeza B, 2014, FEBS LETT, V588, P490, DOI 10.1016/j.febslet.2013.12.014; Lynes M, 2011, AM J PHYSIOL-REG I, V301, pR1738, DOI 10.1152/ajpregu.00235.2011; MARGOLIS S, 1962, J BIOL CHEM, V237, P44; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; de Castro UGM, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-136; MOORE BW, 1959, J AM CHEM SOC, V81, P5837, DOI 10.1021/ja01530a078; Munoz S, 2010, DIABETOLOGIA, V53, P2417, DOI 10.1007/s00125-010-1840-7; NURJHAN N, 1988, METABOLISM, V37, P386, DOI 10.1016/0026-0495(88)90140-0; Pahlman AK, 2001, J BIOL CHEM, V276, P3555, DOI 10.1074/jbc.M007164200; POND CM, 1984, BRIT J NUTR, V51, P415, DOI 10.1079/BJN19840047; PROSCH W, 1974, COMP BIOCHEM PHYSIOL, V48, P629, DOI 10.1016/0305-0491(74)90143-6; Randle PJ, 1998, DIABETES METAB REV, V14, P263, DOI 10.1002/(SICI)1099-0895(199812)14:4&lt;263::AID-DMR233&gt;3.0.CO;2-C; RATTIGAN S, 1986, BRIT J NUTR, V56, P73, DOI 10.1079/BJN19860086; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; ROGNSTAD R, 1982, ARCH BIOCHEM BIOPHYS, V217, P498, DOI 10.1016/0003-9861(82)90530-6; Romero MD, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-26; Sabater D, 2014, SCI REP-UK, V4, DOI 10.1038/srep03663; Sabater D, 2013, ANAL BIOANAL CHEM, V405, P5605, DOI 10.1007/s00216-013-6970-6; Saiki A, 2008, METABOLISM, V57, P1093, DOI 10.1016/j.metabol.2008.03.014; SILLERO MAG, 1969, EUR J BIOCHEM, V10, P345, DOI 10.1111/j.1432-1033.1969.tb00696.x; Taylor CT, 2014, BIOCHEM BIOPH RES CO, V447, P660, DOI 10.1016/j.bbrc.2014.04.062; TSUBOI KK, 1957, J BIOL CHEM, V224, P621; WAPNIR RA, 1985, BIOCHEM MED METAB B, V33, P141, DOI 10.1016/0006-2944(85)90022-5; WAPNIR RA, 1987, BIOCHEM MED METAB B, V37, P228, DOI 10.1016/0885-4505(87)90031-4; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Woods SC, 2000, NUTRITION, V16, P894, DOI 10.1016/S0899-9007(00)00454-8	51	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139502	10.1371/journal.pone.0139502	http://dx.doi.org/10.1371/journal.pone.0139502			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426115	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100070
J	Gaviria, AM; Franco, JG; Aguado, V; Rico, G; Labad, J; de Pablo, J; Vilella, E				Gaviria, Ana M.; Franco, Jose G.; Aguado, Victor; Rico, Guillem; Labad, Javier; de Pablo, Joan; Vilella, Elisabet			A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona	PLOS ONE			English	Article							2ND-GENERATION ANTIPSYCHOTICS; CLINICAL-PRACTICE; POLYPHARMACY; ARIPIPRAZOLE; EFFICACY; DRUGS; TOLERABILITY; METAANALYSIS; ASSOCIATION; OUTPATIENTS	Background The analysis of prescribing patterns in entire catchment areas contributes to global mapping of the use of antipsychotics and may improve treatment outcomes. Objective To determine the pattern of long-term antipsychotic prescription in outpatients with schizophrenia in the province of Tarragona (Catalonia-Spain). Methods A naturalistic, observational, retrospective, non-interventional study based on the analysis of registries of computerized medical records from an anonymized database of 1,765 patients with schizophrenia treated between 2011 and 2013. Results The most used antipsychotic was risperidone, identified in 463 (26.3%) patients, followed by olanzapine in 249 (14.1%), paliperidone in 225 (12.7%), zuclopenthixol in 201 (11.4%), quetiapine in 141 (8%), aripiprazole in 100 (5.7%), and clozapine in 100 (5.7%). Almost 8 out of 10 patients (79.3%) were treated with atypical or second-generation antipsychotics. Long-acting injectable (LAI) formulations were used in 44.8% of patients. Antipsychotics were generally prescribed in their recommended doses, with clozapine, ziprasidone, LAI paliperidone, and LAI risperidone being prescribed at the higher end of their therapeutic ranges. Almost 7 out of 10 patients (69.6%) were on antipsychotic polypharmacy, and 81.4% were on psychiatric medications aside from antipsychotics. Being prescribed quetiapine (OR 14.24, 95% CI 4.94-40.97), LAI (OR 9.99, 95% CI 6.45-15.45), psychiatric co-medications (OR 4.25, 95% CI 2.72-6.64), and paliperidone (OR 3.13, 95% CI 1.23-7.92) were all associated with an increased likelihood of polypharmacy. Being prescribed risperidone (OR 0.54, 95% CI 0.35-0.83) and older age (OR 0.98, 95% CI 0.97-0.99) were related to a low polypharmacy probability. Conclusions Polypharmacy is the most common pattern of antipsychotic use in this region of Spain. Use of atypical antipsychotics is extensive. Most patients receive psychiatric co-medications such as anxiolytics or antidepressants. Polypharmacy is associated with the use of quetiapine or paliperidone, use of a LAI, younger age, and psychiatric co-medication.	[Gaviria, Ana M.; Franco, Jose G.; Labad, Javier; de Pablo, Joan; Vilella, Elisabet] Univ Rovira & Virgili, Hosp Univ Inst Pere Mata, CIBERSAM, IISPV Reus, Tarragona, Spain; [Aguado, Victor; Rico, Guillem] Hosp Univ Inst Pere Mata, Reus, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Franco, JG (corresponding author), Univ Rovira & Virgili, Hosp Univ Inst Pere Mata, CIBERSAM, IISPV Reus, Tarragona, Spain.	josefranco11@hotmail.com	Franco, José G./N-2850-2014; Labad, Javier/AAF-6632-2020; Gaviria, Ana M./AAL-7201-2021; DE PABLO, JOAN/A-4179-2010	Franco, José G./0000-0001-9255-8084; Gaviria, Ana M./0000-0001-5082-7733; Labad, Javier/0000-0003-2214-1886	Hospital Universitari Institut Pere Mata; Otsuka Pharmaceutical, S.A.; Lundbeck Espana S.A.	Hospital Universitari Institut Pere Mata; Otsuka Pharmaceutical, S.A.; Lundbeck Espana S.A.	This work was supported by Hospital Universitari Institut Pere Mata, Lundbeck Espana S.A., and Otsuka Pharmaceutical, S.A. There is no grant number. The funding went to AMG. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argo T, 2007, TEXAS MED ALGORITHM, P1; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Bernardo M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-42; Bruggemann BR, 2008, PSYCHOPHARMAKOTHERAP, V15, P75; Buchanan RW, 2010, SCHIZOPHRENIA BULL, V36, P71, DOI 10.1093/schbul/sbp116; Carvajal A, 2009, UTILIZACION ANTIPSIC, P1; Correll CU, 2011, SCHIZOPHR RES, V131, P58, DOI 10.1016/j.schres.2011.02.016; Croxtall JD, 2012, CNS DRUGS, V26, P155, DOI 10.2165/11208400-000000000-00000; Davis JM, 2003, ARCH GEN PSYCHIAT, V60, P553, DOI 10.1001/archpsyc.60.6.553; Fleischhacker WW, 2014, INT J NEUROPSYCHOPH, V17, P1083, DOI 10.1017/S1461145712000399; Franco José Gabriel, 2007, Rev. bras. epidemiol., V10, P370, DOI 10.1590/S1415-790X2007000300008; Frangou S, 2000, EUR PSYCHIAT, V15, P220, DOI 10.1016/S0924-9338(00)00222-4; Gallego JA, 2012, SCHIZOPHR RES, V138, P18, DOI 10.1016/j.schres.2012.03.018; Goren JL, 2013, PSYCHIAT SERV, V64, P527, DOI 10.1176/appi.ps.002022012; Goodwin G, 2009, EUR NEUROPSYCHOPHARM, V19, P520, DOI 10.1016/j.euroneuro.2009.04.003; Hanssens L, 2006, CLIN PRACT EPIDEMIOL, V30, P1; Jaracz J, 2014, PHARMACOL REP, V66, P613, DOI 10.1016/j.pharep.2014.02.024; Kane JM, 2009, J CLIN PSYCHIAT, V70, P1348, DOI 10.4088/JCP.09m05154yel; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Leucht S, 2009, LANCET, V373, P31, DOI 10.1016/S0140-6736(08)61764-X; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Messer T, 2006, FORTSCHR NEUROL PSYC, V74, P377, DOI 10.1055/s-2005-915576; Montalvo I, 2013, INT CLIN PSYCHOPHARM, V28, P46, DOI 10.1097/YIC.0b013e32835ba832; National Collaborating Centre for Mental Health, 2014, PROT ACC MED ACT JEO, P1; Pandurangi AK, 2008, J PSYCHIATR PRACT, V14, P345, DOI 10.1097/01.pra.0000341890.05383.45; Park SC, 2014, J KOREAN MED SCI, V29, P719, DOI 10.3346/jkms.2014.29.5.719; Patel MX, 2014, EUR NEUROPSYCHOPHARM, V24, P499, DOI 10.1016/j.euroneuro.2014.01.014; Pigott TA, 2003, J CLIN PSYCHIAT, V64, P1048, DOI 10.4088/JCP.v64n0910; Rosenheck R, 2001, MED CARE, V39, P302, DOI 10.1097/00005650-200103000-00010; Seeman P, 1998, MOL PSYCHIATR, V3, P123, DOI 10.1038/sj.mp.4000336; Sernyak MJ, 2008, PSYCHIAT SERV, V59, P567, DOI 10.1176/ps.2008.59.5.567; Stafford MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117166; Stahl SM, 1999, J CLIN PSYCHIAT, V60, P425, DOI 10.4088/JCP.v60n0701; Stahl SM, 2014, CNS SPECTRUMS, V19, P279, DOI 10.1017/S1092852914000418; Tandon R, 2008, SCHIZOPHR RES, V100, P20, DOI 10.1016/j.schres.2007.11.033; Tapp A, 2003, PSYCHIAT SERV, V54, P55, DOI 10.1176/appi.ps.54.1.55; van Bennekom MWHL, 2013, J PSYCHOPHARMACOL, V27, P327, DOI 10.1177/0269881113477709; Weinbrenner S, 2009, PHARMACOPSYCHIATRY, V42, P66, DOI 10.1055/s-0028-1103293; Wheeler Amanda, 2006, N Z Med J, V119, pU2055	39	16	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139403	10.1371/journal.pone.0139403	http://dx.doi.org/10.1371/journal.pone.0139403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26427051	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100055
J	Gong, J; Chen, XG; Li, SJ				Gong, Jie; Chen, Xinguang; Li, Sijian			Efficacy of a Community-Based Physical Activity Program KM2H(2) for Stroke and Heart Attack Prevention among Senior Hypertensive Patients: A Cluster Randomized Controlled Phase-II Trial	PLOS ONE			English	Article							BLOOD-PRESSURE CONTROL; TRANSTHEORETICAL MODEL; SECONDARY PREVENTION; BEHAVIOR-CHANGE; RURAL ADULTS; PREVALENCE; EXERCISE; AWARENESS; DISEASE; HEALTH	Objective To evaluate the efficacy of the program Keep Moving toward Healthy Heart and Healthy Brain (KM2H(2)) in encouraging physical activities for the prevention of heart attack and stroke among hypertensive patients enrolled in the Community-Based Hypertension Control Program (CBHCP). Design Cluster randomized controlled trial with three waves of longitudinal assessments at baseline, 3 and 6 months post intervention. Setting Community-based and patient-centered self-care for behavioral intervention in urban settings of China. Participants A total of 450 participants diagnosed with hypertension from 12 community health centers in Wuhan, China were recruited, and were randomly assigned by center to receive either KM2H(2) plus standard CBHCP care (6 centers and 232 patients) or the standard care only (6 centers and 218 patients). Intervention KM2H(2) is a behavioral intervention guided by the Transtheoretical Model, the Model of Personalized Medicine and Social Capital Theory. It consists of six intervention sessions and two booster sessions engineered in a progressive manner. The purpose is to motivate and maintain physical activities for the prevention of heart attack and stroke. Outcome Measures Heart attack and stroke (clinically diagnosed, primary outcome), blood pressure (measured, secondary outcome), and physical activity (self-report, tertiary outcome) were assessed at the individual level during the baseline, 3- and 6-month post-intervention. Results Relative to the standard care, receiving KM2H(2) was associated with significant reductions in the incidence of heart attack (3.60% vs. 7.03%, p < .05) and stroke (5.11% vs. 9.90%, p < 0.05), andmoderate reduction in blood pressure (-3.72mmHg in DBP and -2.92mmHg in DBP) at 6-month post-intervention; and significant increases in physical activity at 3-(d = 0.53, 95% CI: 0.21, 0.85) and 6-month (d = 0.45, 95% CI: 0.04, 0.85) post-intervention, respectively. Conclusion The program KM2H(2) is efficacious to reduce the risk of heart attack and stroke among senior patients who are on anti-hypertensive medication. Findings of this study provide solid data supporting a formal phase-III trial to establish the effectiveness of KM2H(2) for use in community settings for prevention.	[Gong, Jie; Chen, Xinguang] Wuhan Ctr Dis Prevent & Control, Dept Chron Dis, Wuhan, Peoples R China; [Chen, Xinguang] Univ Florida, Dept Epidemiol, Gainesville, FL USA; [Li, Sijian] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	State University System of Florida; University of Florida; Hong Kong Polytechnic University	Gong, J (corresponding author), Wuhan Ctr Dis Prevent & Control, Dept Chron Dis, Wuhan, Peoples R China.	gongjie@whcdc.org; jimax.chen@ufl.edu			Wuhan Center for Disease Prevention and Control; School of Nursing, the Hong Kong Polytechnic University; University of Florida	Wuhan Center for Disease Prevention and Control; School of Nursing, the Hong Kong Polytechnic University(Hong Kong Polytechnic University); University of Florida(University of Florida)	This project was funded in part by Wuhan Center for Disease Prevention and Control, School of Nursing, the Hong Kong Polytechnic University, and University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams E, 2005, AM J PHARMACOGENOMIC, V5, P345, DOI 10.2165/00129785-200505060-00002; Abrahams E, 2008, CTS-CLIN TRANSL SCI, V1, P11, DOI 10.1111/j.1752-8062.2008.00003.x; Barengo NC, 2005, J HYPERTENS, V23, P293, DOI 10.1097/00004872-200502000-00011; Brown RE, 2013, AM J HYPERTENS, V26, P1005, DOI 10.1093/ajh/hpt063; BuHamra SS, 2010, STAT PAP, V51, P775, DOI 10.1007/s00362-008-0165-9; Chang L, 2003, HEALTH PROMOT INT, V18, P219, DOI 10.1093/heapro/dag017; Chen X, 2009, HEALTH EDUC RES, V24, P306, DOI 10.1093/her/cyn020; Chen XG, 2015, SOC INDIC RES, V120, P669, DOI 10.1007/s11205-014-0611-0; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chogahara M, 2004, J AGING PHYS ACTIV, V12, P400; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Darden D, 2013, CURR CARDIOVASC RISK, V7, P411, DOI 10.1007/s12170-013-0354-5; Diaz KM, 2013, CURR HYPERTENS REP, V15, P659, DOI 10.1007/s11906-013-0386-8; Eden KB, 2002, ANN INTERN MED, V137, P208, DOI 10.7326/0003-4819-137-3-200208060-00015; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Halpern D., 2004, SOCIAL CAPITAL; Heo M, 2014, J BIOPHARM STAT, V24, P507, DOI 10.1080/10543406.2014.888442; Hu S, 2003, CHINESE HLTH EC, V22, P32; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Huang JS, 1960, NAT S HEART VASC DIS; Hutchison AJ, 2009, HEALTH EDUC BEHAV, V36, P829, DOI 10.1177/1090198108318491; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Karmisholt K, 2005, DAN MED BULL, V52, P90; Lewsey JD, 2004, STAT MED, V23, P897, DOI 10.1002/sim.1665; Lin GS, 2007, REPORT CHRONIC NONIN; Lindstrom M, 2011, PUBLIC HEALTH, V125, P442, DOI 10.1016/j.puhe.2011.01.015; Liu L, 2012, 2010 CHINESE GUIDELI; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Marcus B., 2009, MOTIVATING PEOPLE BE; Murray DM, 1998, DESIGN ANAL GROUP RA; Mutrie, 2008, PSYCHOL PHYS ACTIVIT; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; O'Donovan C, 2014, J PHYS ACT HEALTH, V11, P272, DOI 10.1123/jpah.2012-0075; Ogden LG, 2000, HYPERTENSION, V35, P539, DOI 10.1161/01.HYP.35.2.539; Pang WY, 2010, MED PRIN PRACT, V19, P22, DOI 10.1159/000252830; Prochaska JO, 2008, APPL PSYCHOL-INT REV, V57, P561, DOI 10.1111/j.1464-0597.2008.00345.x; Roberts CK, 2013, AM J PHYSIOL-REG I, V305, pR552, DOI 10.1152/ajpregu.00131.2013; Seals JG, 2007, J AM ACAD NURSE PRAC, V19, P63, DOI 10.1111/j.1745-7599.2006.00196.x; Semlitsch T, 2013, SPORTS MED, V43, P1009, DOI 10.1007/s40279-013-0065-6; Sun ZQ, 2013, INT J STROKE, V8, P701, DOI 10.1111/j.1747-4949.2012.00897.x; Swift DL, 2013, CIRC J, V77, P281, DOI 10.1253/circj.CJ-13-0007; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; WHELTON PK, 2004, CLIN TRIALS CARDIOVA, P282; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Xi B, 2012, INT J CARDIOL, V158, P326, DOI 10.1016/j.ijcard.2012.04.140; Yan Ya-qiong, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P779; ZHAO YM, 2013, PLOS COMPUT BIOL, V9, DOI DOI 10.1371/JOURNAL.PONE.0061779; Zhu CY, 2012, CHINESE J PUBLIC H S, V28, P1	48	26	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139442	10.1371/journal.pone.0139442	http://dx.doi.org/10.1371/journal.pone.0139442			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426421	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100061
J	Lin, TJ; Liang, WM; Hsiao, PW; Pradeep, MS; Wei, WC; Lin, HT; Yin, SY; Yang, NS				Lin, Tien-Jen; Liang, Wen-Miin; Hsiao, Pei-Wen; Pradeep, M. S.; Wei, Wen-Chi; Lin, Hsin-Ting; Yin, Shu-Yi; Yang, Ning-Sun			Rapamycin Promotes Mouse 4T1 Tumor Metastasis that Can Be Reversed by a Dendritic Cell-Based Vaccine	PLOS ONE			English	Article							T-REGULATORY CELLS; SUPPRESSOR-CELLS; BREAST-CANCER; LIFE-SPAN; AUTOPHAGY; MTOR; INHIBITOR; DISCOVERY; MELANOMA; STAGE	Suppression of tumor metastasis is a key strategy for successful cancer interventions. Previous studies indicated that rapamycin (sirolimus) may promote tumor regression activity or enhance immune response against tumor targets. However, rapamycin also exhibits immunosuppressant effects and is hence used clinically as an organ transplantation drug. We hypothesized that the immunosuppressive activities of rapamycin might also negatively mediate host immunity, resulting in promotion of tumor metastasis. In this study, the effects of rapamycin and phytochemical shikonin were investigated in vitro and in vivo in a 4T1 mouse mammary tumor model through quantitative assessment of immunogenic cell death (ICD), autophagy, tumor growth and metastasis. Tumor-bearing mice were immunized with test vaccines to monitor their effect on tumor metastasis. We found that intraperitoneal (ip) administration of rapamycin after a tumor-resection surgery drastically increased the metastatic activity of 4T1 tumors. Possible correlation of this finding to human cancers was suggested by epidemiological analysis of data from Taiwan's National Health Insurance Research Database (NHIRD). Since our previous studies showed that modified tumor cell lysate (TCL)-pulsed, dendritic cell (DC)-based cancer vaccines can effectively suppress metastasis in mouse tumor models, we assessed whether such vaccines may help offset this rapamycin-promoted metastasis. We observed that shikonin efficiently induced ICD of 4T1 cells in culture, and DC vaccines pulsed with shikonin-treated TCL (SK-TCL-DC) significantly suppressed rapamycin-enhanced metastasis and Treg cell expansion in test mice. In conclusion, rapamycin treatment in mice (and perhaps in humans) promotes metastasis and the effect may be offset by treatment with a DC-based cancer vaccine.	[Lin, Tien-Jen] Taipei Med Univ, Grad Inst Injury Prevent & Control, Taipei, Taiwan; [Lin, Tien-Jen; Lin, Hsin-Ting] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Tien-Jen; Hsiao, Pei-Wen; Pradeep, M. S.; Wei, Wen-Chi; Lin, Hsin-Ting; Yin, Shu-Yi; Yang, Ning-Sun] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Lin, Tien-Jen; Hsiao, Pei-Wen; Pradeep, M. S.; Yang, Ning-Sun] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung 40227, Taiwan; [Liang, Wen-Miin] China Med Univ, Ctr Biostat, Taichung, Taiwan; [Liang, Wen-Miin] China Med Univ, Inst Environm Hlth, Dept Publ Hlth, Sch Publ Hlth, Taichung, Taiwan; [Lin, Tien-Jen; Hsiao, Pei-Wen; Pradeep, M. S.; Yang, Ning-Sun] Acad Sinica, TIGP, Mol & Biol Agr Sci Program, Taipei 115, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Academia Sinica - Taiwan; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan	Yin, SY (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	yinshuyi@gate.sinica.edu.tw; nsyang@gate.sinica.edu.tw	Hsiao, Pei-Wen/V-5653-2018	Hsiao, Pei-Wen/0000-0002-3589-6754	National Science Council of Taiwan [NSC 103-2320-B-001-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a National Science Council of Taiwan grant (NSC 103-2320-B-001-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2010, AM J PATHOL, V176, P2092, DOI 10.2353/ajpath.2010.091050; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bunn PA, 2008, ONCOLOGIST, V13, P1, DOI 10.1634/theoncologist.13-S1-1; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chang WT, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/932040; Chen HM, 2012, CANCER IMMUNOL IMMUN, V61, P1989, DOI 10.1007/s00262-012-1258-9; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Drake CG, 2010, NAT REV IMMUNOL, V10, P580, DOI 10.1038/nri2817; Ebert LM, 2008, CANCER RES, V68, P3001, DOI 10.1158/0008-5472.CAN-07-5664; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Facciabene A, 2012, CANCER RES, V72, P2162, DOI 10.1158/0008-5472.CAN-11-3687; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Fong S, 2003, P NATL ACAD SCI USA, V100, P14253, DOI 10.1073/pnas.2332307100; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Garg AD, 2013, AUTOPHAGY, V9, P1292, DOI 10.4161/auto.25399; Gligorov J, 2007, CRIT REV ONCOL HEMAT, V64, P115, DOI 10.1016/j.critrevonc.2007.06.010; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Kabani M, 2008, CURR GENOMICS, V9, P338, DOI 10.2174/138920208785133280; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Li X, 2013, ONCOL LETT, V5, P167, DOI 10.3892/ol.2012.986; Li YH, 2008, CANCER RES, V68, P6889, DOI 10.1158/0008-5472.CAN-08-0161; Li YH, 2012, CANCER RES, V72, P3535, DOI 10.1158/0008-5472.CAN-11-3103; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Sakaguchi S, 2009, EUR J IMMUNOL, V39, P2331, DOI 10.1002/eji.200939688; Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2; Seto B, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-29; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Vincent J, 2010, CANCER RES, V70, P3052, DOI 10.1158/0008-5472.CAN-09-3690; Yin T, 2014, TRANSL ONCOL, V7, P221, DOI 10.1016/j.tranon.2014.02.007	40	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138335	10.1371/journal.pone.0138335	http://dx.doi.org/10.1371/journal.pone.0138335			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426423	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100013
J	Gubhaju, L; Banks, E; MacNiven, R; McNamara, BJ; Joshy, G; Bauman, A; Eades, SJ				Gubhaju, Lina; Banks, Emily; MacNiven, Rona; McNamara, Bridgette J.; Joshy, Grace; Bauman, Adrian; Eades, Sandra J.			Physical Functional Limitations among Aboriginal and Non-Aboriginal Older Adults: Associations with Socio-Demographic Factors and Health	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; RISK; INEQUALITIES; PREVALENCE; PROFILE	Background Australian Aboriginal people are disproportionately affected by physical disability; the reasons for this are unclear. This study aimed to quantify associations between severe physical functional limitations and socio-demographic and health-related factors among older Aboriginal and non-Aboriginal adults. Methods Questionnaire data from 1,563 Aboriginal and 226,802 non-Aboriginal participants aged >= 45 years from the Sax Institute's 45 and Up Study (New South Wales, Australia) were used to calculate age- and sex-adjusted prevalence ratios (aPRs) for severe limitation [MOS-PF score <60] according to socio-demographic and health-related factors. Results Overall, 26% (410/1563) of Aboriginal participants and 13% (29,569/226,802) of non-Aboriginal participants had severe limitations (aPR 2.8, 95% CI 2.5-3.0). In both Aboriginal and non-Aboriginal participants, severe limitation was significantly associated with: being >= 70 vs <70 years old (aPRs 1.8, 1.3-2.4 and 5.3, 5.0-5.5, within Aboriginal and non-Aboriginal participants, respectively), none vs tertiary educational qualifications (aPRs 2.4, 1.7-3.3 and 3.1, 3.0-3.2), lower vs higher income (aPRs 6.6, 4.2-10.5 and 5.5, 5.2-5.8), current vs never-smoking (aPRs 2.0, 1.6-2.5 and 2.2, 2.1-2.3), obese vs normal weight (aPRs 1.7, 1.3-2.2 and 2.7, 2.7-2.8) and sitting for >= 7 vs <7 hours/day (aPRs 1.6, 1.2-2.0 and 1.6, 1.6-1.7). Severe limitations increased with increasing ill-health, with aPRs rising to 5-6 for >= 5 versus no chronic conditions. It was significantly higher in those with few vs many social contacts (aPRs 1.7, 1.4-2.0 and 1.4, 1.4-1.4) and with very high vs low psychological distress (aPRs 4.4, 3.6-5.4 and 5.7, 5.5-5.9). Conclusions Although the prevalence of severe physical limitation among Aboriginal people in this study is around three-fold that of non-Aboriginal people, the factors related to it are similar, indicating that Aboriginal people have higher levels of risk factors for and consequences of severe limitations. Effective management of chronic disease and reducing the prevalence of obesity and smoking are important areas for attention.	[Gubhaju, Lina; McNamara, Bridgette J.; Eades, Sandra J.] Aboriginal Hlth, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Banks, Emily; Joshy, Grace] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Chron Dis Epidemiol, Acton, ACT 2601, Australia; [MacNiven, Rona; Bauman, Adrian] Univ Sydney, Prevent Res Collaborat, Sydney Sch Publ Hlth, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia	Baker Heart and Diabetes Institute; Australian National University; University of Sydney	Eades, SJ (corresponding author), Aboriginal Hlth, Baker IDI Heart & Diabet Inst, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	Sandra.Eades@bakeridi.edu.au	; Eades, Sandra/C-1286-2014	Banks, Emily/0000-0002-4617-1302; McNamara, Bridgette/0000-0003-3539-4153; Eades, Sandra/0000-0001-8629-3390; Macniven, Rona/0000-0002-2967-7977; Joshy, Grace/0000-0002-0718-6368	Victorian Government's OIS Program; National Health and Medical Research Council of Australia [1013418]; National Health and Medical Research Council of Australia Centre for Research Excellence Grant; Lowitja Institute	Victorian Government's OIS Program; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Centre for Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); Lowitja Institute	This work was supported in part by the Victorian Government's OIS Program, National Health and Medical Research Council of Australia (Grant Number 1013418) (recipient: Sandra Eades), National Health and Medical Research Council of Australia Centre for Research Excellence Grant (recipient: Sandra Eades), and Lowitja Institute (recipient: Lina Gubhaju). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2013, LIF TABL AB TORR STR; ABS, 2006, INTR SOC IND; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; Australian Institute of Health and Welfare, 2018, AB TORR STRAIT ISL A; Australian Institute of health and Welfare (AIHW), 2014, DIS SUPP SERV SERV P; Australian Institute of Health and Welfare (AIHW), 2004, RUR REG REM HLTH GUI; Australian Institute of Health and Wellfare (AIHW), 2003, ACT AUSTR SURV GUID; Backholer K, 2012, OBES REV, V13, P456, DOI 10.1111/j.1467-789X.2011.00970.x; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Byles JE, 2014, DEPRESS ANXIETY, V31, P524, DOI 10.1002/da.22162; Carson B., 2007, SOCIAL DETERMINANTS; Goldberg R, 2015, PROC FACTOR INTERPRE; Gubhaju L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-661; Hays RD., 1995, USERS MANUAL MED OUT; HealthInfoNet AI, 2015, OVERVIEW AUSTR INDIG; Holden L, 2010, AUST NZ J PUBL HEAL, V34, P304, DOI 10.1111/j.1753-6405.2010.00531.x; Hopwood CJ, 2009, J CLIN PSYCHOL, V65, P769, DOI 10.1002/jclp.20584; Johnson T, 2010, CROSS CULTURAL RES M; Kavanagh AM, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-73; Mathur SML., 2006, ABORIGINAL TORRES ST; McNamara BJ, 2014, AUST NZ J PUBL HEAL, V38, P567, DOI 10.1111/1753-6405.12271; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Minges KE, 2011, DIABETES RES CLIN PR, V93, P139, DOI 10.1016/j.diabres.2011.06.012; Mithen J, 2015, SOC SCI MED, V126, P26, DOI 10.1016/j.socscimed.2014.12.009; National Aboriginal and Torres Strait Islander Health Worker Association, 2020, PREF TERM; NHMRC, 2003, DIET GUID AUSTR AD; Piane GM, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140211; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rasul F, 2005, J EPIDEMIOL COMMUN H, V59, P140, DOI 10.1136/jech.2004.019786; Sargent M, 1997, NEW SOCIOLOGY AUSTR; Scott KM, 2000, SOC SCI MED, V51, P1655, DOI 10.1016/S0277-9536(00)00083-6; SCRGSP, 2014, OV IND DIS KEY IND 2; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Stewart AL, 1992, MEASURING FUNCTIONIN; Thommasen Harvey V, 2006, Rural Remote Health, V6, P528; Vos T, 2007, BURDEN DIS INJURY AB; World Health Organisation, 2000, REP WHO CONS; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139364	10.1371/journal.pone.0139364	http://dx.doi.org/10.1371/journal.pone.0139364			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422239	Green Published, gold			2022-12-27	WOS:000362175700100
J	Jones, BA; Lessler, J; Bianco, S; Kaufman, JH				Jones, Barbara A.; Lessler, Justin; Bianco, Simone; Kaufman, James H.			Statistical Mechanics and Thermodynamics of Viral Evolution	PLOS ONE			English	Article							MUTATIONAL ROBUSTNESS; VIRUS; FITNESS	This paper uses methods drawn from physics to study the life cycle of viruses. The paper analyzes a model of viral infection and evolution using the "grand canonical ensemble" and formalisms from statistical mechanics and thermodynamics. Using this approach we enumerate all possible genetic states of a model virus and host as a function of two independent pressures-immune response and system temperature. We prove the system has a real thermodynamic temperature, and discover a new phase transition between a positive temperature regime of normal replication and a negative temperature "disordered" phase of the virus. We distinguish this from previous observations of a phase transition that arises as a function of mutation rate. From an evolutionary biology point of view, at steady state the viruses naturally evolve to distinct quasispecies. This paper also reveals a universal relationship that relates the order parameter (as a measure of mutational robustness) to evolvability in agreement with recent experimental and theoretical work. Given that real viruses have finite length RNA segments that encode proteins which determine virus fitness, the approach used here could be refined to apply to real biological systems, perhaps providing insight into immune escape, the emergence of novel pathogens and other results of viral evolution.	[Jones, Barbara A.; Bianco, Simone; Kaufman, James H.] IBM Corp, Almaden Res Ctr, San Jose, CA 95134 USA; [Lessler, Justin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	International Business Machines (IBM); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kaufman, JH (corresponding author), IBM Corp, Almaden Res Ctr, San Jose, CA 95134 USA.	jhkauf@us.ibm.com		Lessler, Justin/0000-0002-9741-8109				Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; Alonso J, 2010, PHILOS T R SOC A, V368, P5569, DOI 10.1098/rsta.2010.0274; ANDERSON R M, 1991; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Burch CL, 1999, GENETICS, V151, P921; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; EIGEN M, 1979, P92; Hart GR, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.032705; Hartl D, 2007, PRINCIPLES POPULATIO, P112; Janeway C., 2004, IMMUNOBIOLOGY; Knipe DM, 2007, FIELDS VIROLOGY; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-1; Lakadamyali M, 2004, MICROBES INFECT, V6, P929, DOI 10.1016/j.micinf.2004.05.002; Landau L. D., 1980, STAT PHYS; Levine R. D., 2005, MOL REACTION DYNAMIC; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; NOVELLA IS, 1995, P NATL ACAD SCI USA, V92, P5841, DOI 10.1073/pnas.92.13.5841; Nowak MA., 2000, VIRUS DYNAMICS MATH; Ramsey CL, 1998, LECT NOTES COMPUT SC, V1498, P345, DOI 10.1007/BFb0056877; Reif F, 1965, FUNDAMENTALS STAT TH, P66; Schulte MB, 2015, ELIFE, V4, DOI 10.7554/eLife.03753; Schulte MB, 2014, J VIROL, V88, P6205, DOI 10.1128/JVI.03539-13; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Shekhar K, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062705; Stern A, 2014, CELL REP, V8, P1026, DOI 10.1016/j.celrep.2014.07.011; Summers J, 2006, J VIROL, V80, P20, DOI 10.1128/JVI.80.1.20-26.2006; Tian JP, 1921, LECT NOTES MATH, V2008, DOI [10.1007/ 978- 3- 540- 742845, DOI 10.1007/978-3-540-742845]; Tripathi K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002684; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569; Wright S, 1984, EVOLUTION GENETICS P, V1	32	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137482	10.1371/journal.pone.0137482	http://dx.doi.org/10.1371/journal.pone.0137482			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422205	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700015
J	Zito Marino, F; Liguori, G; Aquino, G; La Mantia, E; Bosari, S; Ferrero, S; Rosso, L; Gaudioso, G; De Rosa, N; Scrima, M; Martucci, N; La Rocca, A; Normanno, N; Morabito, A; Rocco, G; Botti, G; Franco, R				Zito Marino, Federica; Liguori, Giuseppina; Aquino, Gabriella; La Mantia, Elvira; Bosari, Silvano; Ferrero, Stefano; Rosso, Lorenzo; Gaudioso, Gabriella; De Rosa, Nicla; Scrima, Marianna; Martucci, Nicola; La Rocca, Antonello; Normanno, Nicola; Morabito, Alessandro; Rocco, Gaetano; Botti, Gerardo; Franco, Renato			Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; FACTOR RECEPTOR MUTATIONS; INTERNATIONAL ASSOCIATION; HISTOLOGIC TYPES; EML4-ALK FUSION; CANCER; GENE; CARCINOMA; CLASSIFICATION; FEATURES	Background Non Small Cell Lung Cancer is a highly heterogeneous tumor. Histologic intratumor heterogeneity could be 'major', characterized by a single tumor showing two different histologic types, and 'minor', due to at least 2 different growth patterns in the same tumor. Therefore, a morphological heterogeneity could reflect an intratumor molecular heterogeneity. To date, few data are reported in literature about molecular features of the mixed adenocarcinoma. The aim of our study was to assess EGFR-mutations and ALK-rearrangements in different intratumor subtypes and/or growth patterns in a series of mixed adenocarcinomas and adenosquamous carcinomas. Methods 590 Non Small Cell Lung Carcinomas tumor samples were revised in order to select mixed adenocarcinomas with available tumor components. Finally, only 105 mixed adenocarcinomas and 17 adenosquamous carcinomas were included in the study for further analyses. Two TMAs were built selecting the different intratumor histotypes. ALK-rearrangements were detected through FISH and IHC, and EGFR-mutations were detected through IHC and confirmed by RT-PCR. Results 10/122 cases were ALK-rearranged and 7 from those 10 showing an intratumor heterogeneity of the rearrangements. 12/122 cases were EGFR-mutated, uniformly expressing the EGFR-mutated protein in all histologic components. Conclusion Our data suggests that EGFR-mutations is generally homogeneously expressed. On the contrary, ALK-rearrangement showed an intratumor heterogeneity in both mixed adenocarcinomas and adenosquamous carcinomas. The intratumor heterogeneity of ALK-rearrangements could lead to a possible impact on the therapeutic responses and the disease outcomes.	[Zito Marino, Federica; Liguori, Giuseppina; Aquino, Gabriella; La Mantia, Elvira; Botti, Gerardo; Franco, Renato] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Pathol Unit, Naples, Italy; [Bosari, Silvano; Gaudioso, Gabriella] Univ Milan, Sch Med, Dept Pathophysiol & Organ Transplantat, Milan, Italy; [Bosari, Silvano; Ferrero, Stefano; Gaudioso, Gabriella] Osped Maggiore Policlin Milan, Fdn IRCCS Ca Granda, Div Pathol, Milan, Italy; [Ferrero, Stefano] Univ Milan, Sch Med, Dept Biomed Surg & Dent Sci, Milan, Italy; [Rosso, Lorenzo] Osped Maggiore Policlin Milan, Fdn IRCCS Ca Granda, Thorac Surg & Lung Transplantat Unit, Milan, Italy; [De Rosa, Nicla] Hosp Natl Relevance AORN Vincenzo Monaldi, Dept Oncol & Anat Pathol, Naples, Italy; [Scrima, Marianna] Biogem Scarl, Inst Genet Res Gaetano Salvatore, Ariano Irpino, Avellino, Italy; [Scrima, Marianna; Martucci, Nicola; Botti, Gerardo] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Div Thorac Surg,Dept Thorac Surg & Med Oncol, Naples, Italy; [Normanno, Nicola] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Cell Biol & Biotherapy Unit, Naples, Italy; [Morabito, Alessandro] IRCCS, Fdn G Pascale, Ist Nazl Tumori, Med Oncol Unit,Dept Thorac Surg & Med Oncol, Naples, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale	Franco, R (corresponding author), IRCCS, Fdn G Pascale, Ist Nazl Tumori, Pathol Unit, Naples, Italy.	r.franco@istitutotumori.na.it	Rocco, Gaetano/K-4801-2016; Normanno, Nicola/AAT-1107-2021; Marino, Federica ZMF Zito/K-8634-2016; Ionna, F/K-4564-2016; LIGUORI, GIUSEPPINA/AAA-1679-2020; Scrima, Marianna/S-3320-2017; Rosso, Lorenzo/O-6063-2017; Rosso, Lorenzo Paolo/J-6815-2015; scrima, marianna/J-7431-2016; Aquino, Gabriella/AAA-4788-2020; scrima, marianna/ABE-3003-2021; Bosari, Silvano/K-7744-2016	Rocco, Gaetano/0000-0003-4150-8604; Ionna, F/0000-0002-0512-274X; LIGUORI, GIUSEPPINA/0000-0002-0726-7889; Scrima, Marianna/0000-0003-4636-7695; Rosso, Lorenzo/0000-0002-9809-7140; Rosso, Lorenzo Paolo/0000-0002-9809-7140; scrima, marianna/0000-0003-4636-7695; Aquino, Gabriella/0000-0002-8777-6279; scrima, marianna/0000-0003-4636-7695; Normanno, Nicola/0000-0002-7158-2605; Gaudioso, Gabriella/0000-0002-3010-3268; Zito Marino, Federica/0000-0002-1071-757X; Franco, Renato/0000-0002-8340-3184; Botti, Gerardo/0000-0002-6287-733X; Bosari, Silvano/0000-0002-9744-6951				Andrechek ER, 2010, J MOL MED, V88, P1095, DOI 10.1007/s00109-010-0644-z; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Cadioli A, 2014, AM J SURG PATHOL, V38, P502, DOI 10.1097/PAS.0000000000000154; Camidge DR, 2010, CLIN CANCER RES, V16, P5581, DOI 10.1158/1078-0432.CCR-10-0851; Chaft JE, 2012, J THORAC ONCOL, V7, P768, DOI 10.1097/JTO.0b013e31824c9485; Chen ZY, 2012, ONCOLOGIST, V17, P978, DOI 10.1634/theoncologist.2011-0385; Franco R, 2013, EXPERT REV ANTICANC, V13, P407, DOI [10.1586/era.13.18, 10.1586/ERA.13.18]; Gerashchenko TS, 2013, BIOCHEMISTRY-MOSCOW+, V78, P1201, DOI 10.1134/S0006297913110011; Haneda H, 2006, JPN J CLIN ONCOL, V36, P69, DOI 10.1093/jjco/hyi228; Inamura K, 2008, J THORAC ONCOL, V3, P13, DOI 10.1097/JTO.0b013e31815e8b60; Inamura K, 2009, MODERN PATHOL, V22, P508, DOI 10.1038/modpathol.2009.2; Jakobsen JN, 2012, CANCER CHEMOTH PHARM, V69, P289, DOI 10.1007/s00280-011-1791-9; Kang SM, 2007, CANCER, V109, P581, DOI 10.1002/cncr.22413; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Nassar A, 2010, APPL IMMUNOHISTO M M, V18, P433, DOI 10.1097/PAI.0b013e3181dddb20; NOGUCHI M, 1995, CANCER-AM CANCER SOC, V75, P2844, DOI 10.1002/1097-0142(19950615)75:12<2844::AID-CNCR2820751209>3.0.CO;2-#; Ohashi K, 2008, CANCER SCI, V99, P1747, DOI 10.1111/j.1349-7006.2008.00875.x; Popat S, 2011, J THORAC ONCOL, V6, P1962, DOI 10.1097/JTO.0b013e31822eec5e; Rodig SJ, 2009, CLIN CANCER RES, V15, P5216, DOI 10.1158/1078-0432.CCR-09-0802; Sasaki H, LUNG CANC, V55, P129; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shim HS, 2011, ARCH PATHOL LAB MED, V135, P1329, DOI 10.5858/arpa.2010-0493-OA; Sica G, 2010, AM J SURG PATHOL, V34, P1155, DOI 10.1097/PAS.0b013e3181e4ee32; Soh J, 2008, J THORAC ONCOL, V3, P340, DOI 10.1097/JTO.0b013e318168d20a; Suda K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/645681; Tiseo M, 2011, LUNG CANCER, V71, P241, DOI 10.1016/j.lungcan.2010.11.014; Tomonaga N, 2013, CLIN LUNG CANCER, V14, P521, DOI 10.1016/j.cllc.2013.04.005; Travis WD, 1996, CANCER-AM CANCER SOC, V77, P2464, DOI 10.1002/(SICI)1097-0142(19960615)77:12<2464::AID-CNCR8>3.0.CO;2-M; Travis WD., 2004, TRAVIS WB WHO CLASSI; TRAVIS WD, 2011, J THORAC ONCOL, V6, P244, DOI DOI 10.1097/JT0.0B013E318206A221; Wong DWS, 2009, CANCER-AM CANCER SOC, V115, P1723, DOI 10.1002/cncr.24181; Yatabe Y, 2008, CANCER RES, V68, P2106, DOI 10.1158/0008-5472.CAN-07-5211; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Yi ES, 2011, J THORAC ONCOL, V6, P459, DOI 10.1097/JTO.0b013e318209edb9; Yoshizawa A, 2011, MODERN PATHOL, V24, P653, DOI 10.1038/modpathol.2010.232; Zhang XC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-188; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep07163	37	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139264	10.1371/journal.pone.0139264	http://dx.doi.org/10.1371/journal.pone.0139264			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422230	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700085
J	Rocque, R; Leanza, Y				Rocque, Rhea; Leanza, Yvan			A Systematic Review of Patients' Experiences in Communicating with Primary Care Physicians: Intercultural Encounters and a Balance between Vulnerability and Integrity	PLOS ONE			English	Review							QUALITY-OF-CARE; GENERAL-PRACTICE CONSULTATIONS; HEALTH-CARE; PATIENTS PERCEPTIONS; DIABETES PATIENTS; DECISION-MAKING; CHRONIC PAIN; DONT TELL; DOCTORS; PEOPLE	Communication difficulties persist between patients and physicians. In order to improve care, patients' experiences of this communication must be understood. The main objective of this study is to synthesize qualitative studies exploring patients' experiences in communicating with a primary care physician. A secondary objective is to explore specific factors pertaining to ethnic minority or majority patients and their influence on patients' experiences of communication. Pertinent health and social sciences electronic databases were searched systematically (PubMed, Cinahl, PsychNet, and IBSS). Fifty-seven articles were included in the review on the basis of being qualitative studies targeting patients' experiences of communication with a primary care physician. The meta-ethnography method for qualitative studies was used to interpret data and the COREQ checklist was used to evaluate the quality of included studies. Three concepts emerged from analyses: negative experiences, positive experiences, and outcomes of communication. Negative experiences related to being treated with disrespect, experiencing pressure due to time constraints, and feeling helpless due to the dominance of biomedical culture in the medical encounter. Positive experiences are attributed to certain relational skills, technical skills, as well as certain approaches to care privileged by the physician. Outcomes of communication depend on patients' evaluation of the consultation. Four categories of specific factors exerted mainly a negative influence on consultations for ethnic minorities: language barriers, discrimination, differing values, and acculturation. Ethnic majorities also raised specific factors influencing their experience: differing values and discrimination. Findings of this review are limited by the fact that more than half of the studies did not explore cultural aspects relating to this experience. Future research should address these aspects in more detail. In conclusion, all patients seemed to face additional cultural challenges. Findings provide a foundation for the development of tailored interventions to patients' preferences, thus ensuring more satisfactory experiences. Health care providers should be sensitive to specific factors (cultural and micro-cultural) during all medical encounters.	[Rocque, Rhea; Leanza, Yvan] Univ Laval, Sch Psychol, Quebec City, PQ, Canada	Laval University	Rocque, R (corresponding author), Univ Laval, Sch Psychol, Quebec City, PQ, Canada.	rhea.rocque.1@ulaval.ca		Leanza, Yvan/0000-0003-0059-7049	CELAT (Centre interuniversitaire d'etudes sur les lettres, les arts et les traditions)	CELAT (Centre interuniversitaire d'etudes sur les lettres, les arts et les traditions)	The author(s) received no specific funding for this work. However, authors received funding from the CELAT (Centre interuniversitaire d'etudes sur les lettres, les arts et les traditions) for the publication of this manuscript (to cover the publication fees).	Abdulhadi N, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-162; Ali N, 2006, ETHNIC HEALTH, V11, P389, DOI 10.1080/13557850600824286; Ashton CM, 2003, J GEN INTERN MED, V18, P146, DOI 10.1046/j.1525-1497.2003.20532.x; Barth F., 1969, ETHNIC GROUPS AND BO; Baumbusch J, 2014, CAN FAM PHYSICIAN, V60, pE356; Bayliss K, 2014, PRIM HEALTH CARE RES, V15, P143, DOI 10.1017/S1463423613000145; Beagan BL, 2000, SOC SCI MED, V51, P1253, DOI 10.1016/S0277-9536(00)00043-5; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; Beresford BA, 2003, J ADOLESCENT HEALTH, V33, P172, DOI 10.1016/S1054-139X(03)00047-8; Bergman AA, 2013, PAIN MED, V14, P1689, DOI 10.1111/pme.12172; Berry J. W., 1980, ACCULTURATION THEORY, P9, DOI DOI 10.1525/AE.1981.8.4.02A00200; Black HK, 2012, J RELIG SPIRITUAL SO, V31, P226, DOI 10.1080/15426432.2012.679839; Borgsteede SD, 2007, PATIENT EDUC COUNS, V66, P156, DOI 10.1016/j.pec.2006.10.006; Bowes AM, 1995, SOCIAL SCI HLTH, V1, P22; Brisset C, 2013, PATIENT EDUC COUNS, V91, P131, DOI 10.1016/j.pec.2012.11.008; Britten Nicky, 2002, J Health Serv Res Policy, V7, P209, DOI 10.1258/135581902320432732; Burton LL, 2012, HOWARD J COMMUN, V23, P119, DOI 10.1080/10646175.2012.667723; Cant B, 2006, DIV HLTH SOC CARE, V3, P271; Clanet C., 1990, INTRODUCTION AUX APP; Claramita M, 2013, ADV HEALTH SCI EDUC, V18, P15, DOI 10.1007/s10459-012-9352-5; Cocksedge S, 2013, BRIT J GEN PRACT, V63, pE283, DOI 10.3399/bjgp13X665251; Cote L, 2005, LA COMMUNICATION PRO; Dahm MR, 2012, HEALTH COMMUN, V27, P682, DOI 10.1080/10410236.2011.629411; Deledda G, 2013, PATIENT EDUC COUNS, V90, P297, DOI 10.1016/j.pec.2012.05.005; Dube CE, 2005, PREV MED, V40, P628, DOI 10.1016/j.ypmed.2004.10.021; Ellis MR, 2005, J RELIG HEALTH, V44, P39, DOI 10.1007/s10943-004-1144-7; Esquibel AY, 2014, PAIN, V155, P2575, DOI 10.1016/j.pain.2014.09.018; Fagerli RA, 2007, HEALTH-LONDON, V11, P109, DOI 10.1177/1363459307070810; Garrard J, 2011, HEALTH SCIENCES LITE; Gask L, 2003, BRIT J GEN PRACT, V53, P278; Gould S, 1981, THE MISMEASURE OF MA; Harmsen H, 2003, PATIENT EDUC COUNS, V51, P99, DOI 10.1016/S0738-3991(02)00195-7; Harmsen JAM, 2008, PATIENT EDUC COUNS, V72, P155, DOI 10.1016/j.pec.2008.03.018; Hartley S, 2012, AUST J PRIM HEALTH, V18, P308, DOI 10.1071/PY11111; Holmvall C, 2012, CAN FAM PHYSICIAN, V58, pE159; Hughes AK, 2013, FAM MED, V45, P252; Irurita V F, 1999, Collegian, V6, P10, DOI 10.1016/S1322-7696(08)60310-8; Isajiw W, 1992, CHALLENGES OF MEASUR; Jagosh J, 2011, PATIENT EDUC COUNS, V85, P369, DOI 10.1016/j.pec.2011.01.028; Johansson EE, 1996, FAM PRACT, V13, P498, DOI 10.1093/fampra/13.6.498; Julliard K, 2008, ANN FAM MED, V6, P543, DOI 10.1370/afm.912; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101191; Kokanovic R, 2007, J GEN INTERN MED, V22, P459, DOI 10.1007/s11606-007-0143-2; Lee C, 2009, SOC SCI MED, V68, P1183, DOI 10.1016/j.socscimed.2008.12.036; Li HZ, 2008, HEALTH EDUC, V108, P411, DOI 10.1108/09654280810900026; Lowe P., 2007, DIV HLTH SOC CARE, V4, P69; LUBORSKY MR, 1995, RES AGING, V17, P89, DOI 10.1177/0164027595171005; Marcinowicz L, 2014, EUR J AGEING, V11, P361, DOI 10.1007/s10433-014-0313-0; Matthias MS, 2014, EUR J PAIN, V18, P835, DOI 10.1002/j.1532-2149.2013.00426.x; Matthias MS, 2010, PAIN MANAG NURS, V11, P26, DOI 10.1016/j.pmn.2008.12.003; Melton C, 2014, J ASTHMA, V51, P703, DOI 10.3109/02770903.2014.906605; Mercer SW, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-22; Moffat Mandy, 2006, Prim Care Respir J, V15, P159, DOI 10.1016/j.pcrj.2006.02.006; Neuliep J.W., 2018, INTERCULTURAL COMMUN; Nguyen GT, 2008, J GEN INTERN MED, V23, P45, DOI 10.1007/s11606-007-0455-2; Noblit G., 1988, METAETHNOGRAPHY SYNT; O'Day B, 2005, PSYCHIATR REHABIL J, V28, P339, DOI 10.2975/28.2005.339.345; Oetzel, 2009, INTERCULTURAL COMMUN; Oliffe J, 2007, QUAL HEALTH RES, V17, P149, DOI 10.1177/1049732306297695; ONG LML, 1995, SOC SCI MED, V40, P903, DOI 10.1016/0277-9536(94)00155-M; Peek ME, 2010, SOC SCI MED, V71, P1, DOI 10.1016/j.socscimed.2010.03.014; Pollock K, 2002, BRIT MED J, V325, P687, DOI 10.1136/bmj.325.7366.687; PUNAMAKI RL, 1995, SOC SCI MED, V40, P231, DOI 10.1016/0277-9536(94)E0071-Y; Ritholz MD, 2014, CHRONIC ILLN, V10, P303, DOI 10.1177/1742395314525647; Rodriguez MA, 1998, J FAM PRACTICE, V47, P309; Rose VK, 2015, PSYCHOL HEALTH MED, V20, P114, DOI 10.1080/13548506.2014.897915; Roter DL, 2006, DOCTORS TALKING WITH; Sankar P, 2005, ARCH INTERN MED, V165, P2378, DOI 10.1001/archinte.165.20.2378; Schouten BC, 2006, PATIENT EDUC COUNS, V64, P21, DOI 10.1016/j.pec.2005.11.014; Schouten BC, 2009, J IMMIGR MINOR HEALT, V11, P468, DOI 10.1007/s10903-008-9131-9; Shannon Patricia, 2012, Ment Health Fam Med, V9, P47; Shelley BM, 2009, ANN FAM MED, V7, P139, DOI 10.1370/afm.947; Silver MP, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3588; Smith JA, 2008, MED J AUSTRALIA, V189, P618, DOI 10.5694/j.1326-5377.2008.tb02214.x; Sommer J, 2012, AUST J PRIM HEALTH, V18, P197, DOI 10.1071/PY11030; SpencerOatey H, 2009, RES PRACT APPL LINGU, P1, DOI 10.1057/9780230244511; Swenson SL, 2004, J GEN INTERN MED, V19, P1069, DOI 10.1111/j.1525-1497.2004.30384.x; Thom DH, 1997, J FAM PRACTICE, V44, P169; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Towle A, 2006, PATIENT EDUC COUNS, V62, P340, DOI 10.1016/j.pec.2006.06.006; Van Wieringen JCM, 2002, EUR J PUBLIC HEALTH, V12, P63, DOI 10.1093/eurpub/12.1.63; Vickers KA, 2006, BMC COMPLEM ALTERN M, V6, P1; Walseth LT, 2011, SCAND J PRIM HEALTH, V29, P99, DOI 10.3109/02813432.2011.553995; Walter FM, 2004, PATIENT EDUC COUNS, V53, P121, DOI 10.1016/j.pec.2003.11.001; Weber LR, 2012, ETHNIC DIS, V22, P79; Wheatley RR, 2008, QUAL HEALTH RES, V18, P1586, DOI 10.1177/1049732308324986; Wilkinson J, 2013, J INTELL DISABIL RES, V57, P1058, DOI 10.1111/j.1365-2788.2012.01606.x; Williams DR, 2003, AM J PUBLIC HEALTH, V93, P200, DOI 10.2105/AJPH.93.2.200; Wullink M, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-82; Yorkston KM, 2010, QUAL LIFE RES, V19, P243, DOI 10.1007/s11136-009-9572-1; Zaner RM, 2006, HUM STUD, V29, P283, DOI 10.1007/s10746-006-9028-3; Ziviani J, 2004, J INTELLECT DEV DIS, V29, P211, DOI 10.1080/13668250412331285163	92	84	83	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139577	10.1371/journal.pone.0139577	http://dx.doi.org/10.1371/journal.pone.0139577			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26440647	Green Published, gold			2022-12-27	WOS:000362510300033
J	Bermejo, R; Firth, S; Hodge, A; Jimenez-Soto, E; Zeck, W				Bermejo, Raoul, III; Firth, Sonja; Hodge, Andrew; Jimenez-Soto, Eliana; Zeck, Willibald			Overcoming Stagnation in the Levels and Distribution of Child Mortality: The Case of the Philippines	PLOS ONE			English	Article							HEALTH; INEQUALITIES; NEWBORN; COUNTDOWN; EQUITY; CARE; CONTINUUM; SERVICES; GAP	Background Health-related within-country inequalities continue to be a matter of great interest and concern to both policy makers and researchers. This study aims to assess the level and the distribution of child mortality outcomes in the Philippines across geographical and socioeconomic indicators. Methodology Data on 159,130 children ever borne were analysed from five waves of the Philippine Demographic and Health Survey. Direct estimation was used to construct under-five and neonatal mortality rates for the period 1980-2013. Rate differences and ratios, and where possible, slope and relative indices of inequality were calculated to measure disparities on absolute and relative scales. Stratification was undertaken by levels of rural/urban location, island groups and household wealth. Findings National under-five and neonatal mortality rates have shown considerable albeit differential reductions since 1980. Recently released data suggests that neonatal mortality has declined following a period of stagnation. Declines in under-five mortality have been accompanied by decreases in wealth and geography-related absolute inequalities. However, relative inequalities for the same markers have remained stable over time. For neonates, mixed evidence suggests that absolute and relative inequalities have remained stable or may have risen. Conclusion In addition to continued reductions in under-five mortality, new data suggests that the Philippines have achieved success in addressing the commonly observed stagnated trend in neonatal mortality. This success has been driven by economic improvement since 2006 as well as efforts to implement a nationwide universal health care campaign. Yet, such patterns, nonetheless, accorded with persistent inequalities, particularly on a relative scale. A continued focus on addressing universal coverage, the influence of decentralisation and armed conflict, and issues along the continuum of care is advocated.	[Bermejo, Raoul, III] UNICEF Philippines, Makati, Philippines; [Bermejo, Raoul, III; Zeck, Willibald] Inst Trop Med, B-2000 Antwerp, Belgium; [Firth, Sonja; Hodge, Andrew; Jimenez-Soto, Eliana] Univ Queensland, Sch Publ Hlth, Brisbane, Qld, Australia; [Zeck, Willibald] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria	Institute of Tropical Medicine (ITM); University of Queensland; Medical University of Graz	Bermejo, R (corresponding author), UNICEF Philippines, Makati, Philippines.	rabermejo@yahoo.com						Ahmed S, 2011, B WORLD HEALTH ORGAN, V89, P12, DOI 10.2471/BLT.10.076851; Arsenio M, 2003, PHILIPPINE EC DEV PO; Barros AJD, 2012, LANCET, V379, P1225, DOI 10.1016/S0140-6736(12)60113-5; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Chaudhury N., 2013, WORLD BANK REPORT; Cleveland W, 1996, STAT THEORY COMPUTAT; Dean SV, 2014, REPROD HEALTH, V11, DOI [10.1186/1742-4755-11-S3-S1, 10.1186/1742-4755-11-S3-S3]; Department of Health, 2009, IMPL HLTH REF RAP RE; Do M, 2015, MATERN CHILD HLTH J, V19, P755, DOI 10.1007/s10995-014-1561-5; Dupont P, 2013, FACTS VIEWS VIS OBGY, V5, P274; Duysburgh E, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-46; Fox K, 2012, J RURAL HEALTH, V28, P380, DOI 10.1111/j.1748-0361.2012.00408.x; Greene H., 2003, ECONOMETRIC ANAL; Harper S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063362; Hayes LJ, 2002, J EPIDEMIOL COMMUN H, V56, P762, DOI 10.1136/jech.56.10.762; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Hodge A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103597; Houweling Tanja Aj, 2007, Int J Equity Health, V6, P15, DOI 10.1186/1475-9276-6-15; Huntington D, 2012, B WORLD HEALTH ORGAN, V90, P104, DOI 10.2471/BLT.11.092825; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS EST 20; Jimenez-Soto E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109044; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Nguyen KH, 2013, J EPIDEMIOL COMMUN H, V67, P311, DOI 10.1136/jech-2012-201503; King G, 2000, AM J POLIT SCI, V44, P347, DOI 10.2307/2669316; King NB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5774; Kozhimannil KB, 2009, HEALTH POLICY, V92, P55, DOI 10.1016/j.healthpol.2009.02.009; Kraft AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053696; Langford Ann, 2010, Health Stat Q, P5, DOI 10.1057/hsq.2010.14; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Minnery M, 2015, MATERN CHILD HLTH J; Mulholland EK, 2008, B WORLD HEALTH ORGAN, V86, P399, DOI 10.2471/BLT.07.044545; National Statistics Office [Philippines] ICF Macro, 2009, NAT DEM HLTH SURV 20; National Statistics Office [Philippines] Macro International, 1999, NAT DEM HLTH SURV 19; National Statistics Office [Philippines] Macro International, 1994, NAT DEM SURV 1993; National Statistics Office [Philippines] ORC Macro, 2004, NAT DEM HLTH SURV 20; OECD, 2013, EC OUTL SE AS CHIN I; PAMUK ER, 1985, POP STUD-J DEMOG, V39, P17, DOI 10.1080/0032472031000141256; Philippine Obstetrical and Gynecological Society, 2010, CAP ENH PROJ MIDW MA; Philippine Statistics Authority ICF International, 2014, NAT DEM HLTH SURV 20; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Romualdez AG, 2011, PHILIPPINES HLTH SYS; Rutstein SO, 2004, DHS COMP REPORTS, V6; STEWART F, 2003, J HUMAN DEV, V4, P325; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; United Nations Development Programme, 2013, 20122013 PHDR UNDP; van de Poel E, 2011, 111553 TINB I; Wang HD, 2012, LANCET, V380, P2071, DOI 10.1016/S0140-6736(12)61719-X; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; World Bank, 2011, PHIL HLTH SECT REV T	53	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139458	10.1371/journal.pone.0139458	http://dx.doi.org/10.1371/journal.pone.0139458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431409	gold, Green Published			2022-12-27	WOS:000362178700064
J	de Oliveira, MF; Gianella, S; Letendre, S; Scheffler, K; Pond, SLK; Smith, DM; Strain, M; Ellis, RJ				de Oliveira, Michelli Faria; Gianella, Sara; Letendre, Scott; Scheffler, Konrad; Pond, Sergei L. Kosakovsky; Smith, Davey M.; Strain, Matt; Ellis, Ronald J.			Comparative Analysis of Cell-Associated HIV DNA Levels in Cerebrospinal Fluid and Peripheral Blood by Droplet Digital PCR	PLOS ONE			English	Article							MONONUCLEAR-CELLS; PROVIRAL DNA; ACTIVATION; REPLICATION; MARKERS; RNA	Background Measurement of HIV DNA-bearing cells in cerebrospinal fluid (CSF) is challenging because few cells are present. We present a novel application of the sensitive droplet digital (dd) PCR in this context. Methods We analyzed CSF cell pellets and paired peripheral blood mononuclear cells (PBMC) from 28 subjects, 19 of whom had undetectable HIV RNA (< 48 copies/mL) in both compartments. We extracted DNA from PBMC using silica-based columns and used direct lysis on CSF cells. HIV DNA and the host housekeeping gene (RPP30) were measured in CSF and PBMC by (dd) PCR. We compared HIV DNA levels in virally-suppressed and-unsuppressed subgroups and calculated correlations between HIV DNA and RNA levels in both compartments using non-parametric tests. Results HIV DNA was detected in 18/28 (64%) CSF cell pellets, including 10/19 (53%) samples with undetectable HIV RNA. HIV DNA levels in CSF cell pellets were not correlated with RPP30 (p = 0.3), but correlated positively with HIV RNA in CSF (p = 0.04) and HIV DNA in PBMC (p = 0.03). Cellular HIV DNA in CSF was detected in comparable levels in HIV RNA-suppressed and unsuppressed subjects (p = 0.14). In contrast, HIV DNA levels in PBMC were significantly lower in HIV RNA-suppressed than in unsuppressed subjects (p = 0.014). Among subjects with detectable HIV DNA in both compartments, HIV DNA levels in CSF were significantly higher than in PBMC (p < 0.001). Conclusions Despite low mononuclear cell numbers in CSF, HIV DNA was detected in most virally suppressed individuals. In contrast to PBMC, suppressive ART was not associated with lower HIV DNA levels in CSF cells, compared to no ART, perhaps due to poorer ART penetration, slower decay of HIV DNA, or enrichment of HIV DNA-bearing mononuclear cells into the CSF, compared to blood. Future studies should determine what fraction of HIV DNA is replication-competent in CSF leukocytes, compared to PBMC.	[de Oliveira, Michelli Faria; Gianella, Sara; Scheffler, Konrad; Pond, Sergei L. Kosakovsky; Smith, Davey M.; Strain, Matt] Univ Calif San Diego, La Jolla, CA 92093 USA; [Letendre, Scott; Ellis, Ronald J.] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Scheffler, Konrad] Univ Stellenbosch, ZA-7600 Stellenbosch, South Africa; [Smith, Davey M.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Stellenbosch University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	de Oliveira, MF (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	mfariadeoliveira@ucsd.edu; roellis@ucsd.edu	Ellis, Ronald/K-3543-2015; Letendre, Scott L./GLU-6874-2022; Pond, Sergei LK/G-9830-2012; Smith, David/GQQ-8257-2022; de Oliveira, Michelli Faria/J-4189-2019	Ellis, Ronald/0000-0003-4931-752X; Pond, Sergei LK/0000-0003-4817-4029; de Oliveira, Michelli Faria/0000-0001-5045-7939; Strain, Matthew/0000-0002-0726-8814; Gianella, Sara/0000-0002-9927-0849; Smith, Davey/0000-0003-3603-1733	Department of Veterans Affairs; National Institutes of Health [R01-MH073419, P30-MH62512, MH101012, AI100665, MH097520, DA034978, AI036214, AI007384, AI027763, AI106039]; James B. Pendleton Charitable Trust [AI100665, DA034978, AI106039, AI43638, AI074621, 7-UM1 AI068636-07, P30-AI027763, UL1TR000100]; CNPq-Brazil, Interdisciplicinary Research Fellowship in NeuroAIDS [R25-MH081482]; HNRP developmental grant [PST-HN39]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007384, UM1AI068636, R21AI077304, K24AI100665, U01AI043638, P01AI074621, P30AI036214, P30AI027763, R24AI106039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097520, R01MH073419, R25MH081482, R01MH101012, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034978] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James B. Pendleton Charitable Trust; CNPq-Brazil, Interdisciplicinary Research Fellowship in NeuroAIDS(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); HNRP developmental grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Department of Veterans Affairs and grants from the National Institutes of Health: R01-MH073419, P30-MH62512, MH101012, AI100665, MH097520, DA034978, AI036214, AI007384, AI027763, AI106039; the James B. Pendleton Charitable Trust: AI100665, DA034978, AI43638, AI074621, AI106039, 7-UM1 AI068636-07, P30-AI027763, UL1TR000100; CNPq-Brazil, Interdisciplicinary Research Fellowship in NeuroAIDS (R25-MH081482), and HNRP developmental grant PST-HN39. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agsalda-Garcia M, 2013, J HEALTH CARE POOR U, V24, P8, DOI 10.1353/hpu.2014.0010; Alidjinou EK, 2015, PATHOL BIOL, V63, P53, DOI 10.1016/j.patbio.2014.07.007; Avettand-Fenoel V, 2008, AIDS, V22, P1880, DOI 10.1097/QAD.0b013e32830fbdbc; Burdo TH, 2013, AIDS, V27, P1387, DOI 10.1097/QAD.0b013e32836010bd; Burgard M, 2000, AIDS RES HUM RETROV, V16, P1939, DOI 10.1089/088922200750054666; Choi JY, 2012, J NEUROVIROL, V18, P81, DOI 10.1007/s13365-011-0059-9; Christopherson C, 2000, J CLIN MICROBIOL, V38, P630, DOI 10.1128/JCM.38.2.630-634.2000; Cusini A, 2013, JAIDS-J ACQ IMM DEF, V62, P28, DOI 10.1097/QAI.0b013e318274e2b0; Ellis RJ, 1997, ANN NEUROL, V42, P679, DOI 10.1002/ana.410420503; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Kiselinova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085999; Lafeuillade A, 1996, INFECTION, V24, P367, DOI 10.1007/BF01716081; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Neuenburg JK, 2005, JAIDS-J ACQ IMM DEF, V39, P16, DOI 10.1097/01.qai.0000155036.03004.a0; Neuenburg JK, 2005, AIDS, V19, P1351, DOI 10.1097/01.aids.0000181008.39514.ee; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Schrier RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116526; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; Shiramizu B, 2006, J INVEST MED, V54, P468, DOI 10.2310/6650.2006.06007; Shiramizu B, 2007, J NEUROPSYCH CLIN N, V19, P157, DOI 10.1176/appi.neuropsych.19.2.157; Shiramizu B, 2009, J NEUROPSYCH CLIN N, V21, P68, DOI 10.1176/appi.neuropsych.21.1.68; STAPRANS SI, 1995, J EXP MED, V182, P1727, DOI 10.1084/jem.182.6.1727; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Valcour VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070164	25	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139510	10.1371/journal.pone.0139510	http://dx.doi.org/10.1371/journal.pone.0139510			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431315	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700070
J	Glover, KP; Chen, ZQ; Markell, LK; Han, X				Glover, Kyle P.; Chen, Zhongqiang; Markell, Lauren K.; Han, Xing			Synergistic Gene Expression Signature Observed in TK6 Cells upon Co-Exposure to UVC-Irradiation and Protein Kinase C-Activating Tumor Promoters	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PLASMINOGEN-ACTIVATOR; NONGENOTOXIC CARCINOGENS; PROFILES; CANCER; P53; TPA; DISCRIMINATION; SUPPRESSION; SENESCENCE	Activation of stress response pathways in the tumor microenvironment can promote the development of cancer. However, little is known about the synergistic tumor promoting effects of stress response pathways simultaneously induced in the tumor microenvironment. Therefore, the purpose of this study was to establish gene expression signatures representing the interaction of pathways deregulated by tumor promoting agents and pathways induced by DNA damage. Human lymphoblastoid TK6 cells were pretreated with the protein kinase C activating tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) and exposed to UVC-irradiation. The time and dose-responsive effects of the co-treatment were captured with RNA-sequencing (RNA-seq) in two separate experiments. TK6 cells exposed to both TPA and UVC had significantly more genes differentially regulated than the theoretical sum of genes induced by either stress alone, thus indicating a synergistic effect on global gene expression patterns. Further analysis revealed that TPA+UVC co-exposure caused synergistic perturbation of specific genes associated with p53, AP-1 and inflammatory pathways important in carcinogenesis. The 17 gene signature derived from this model was confirmed with other PKC-activating tumor promoters including phorbol-12,13-dibutyrate, sapintoxin D, mezerein, (-)-Indolactam V and resiniferonol 9,13,14-ortho-phenylacetate (ROPA) with quantitative real-time PCR (QPCR). Here we show a novel gene signature that may represent a synergistic interaction in the tumor microenvironment that is relevant to the mechanisms of chemical induced tumor promotion.	[Glover, Kyle P.; Markell, Lauren K.; Han, Xing] DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19714 USA; [Glover, Kyle P.; Markell, Lauren K.; Han, Xing] DuPont Haskell Global Ctr Environm Sci, Newark, DE USA; [Glover, Kyle P.] Univ Sci, Cell & Mol Biol Grad Program, Dept Biol Sci, Philadelphia, PA USA; [Chen, Zhongqiang] DuPont Ind Biosci, Wilmington, DE USA	DuPont; DuPont	Glover, KP (corresponding author), DuPont Haskell Global Ctr Hlth & Environm Sci, Newark, DE 19714 USA.	kyle.p.glover@dupont.com	Chen, Zhongqiang/Y-5954-2018		Dupont	Dupont	The authors received no specific funding for this work. Dupont provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akerman GS, 2005, ENVIRON MOL MUTAGEN, V45, P188, DOI 10.1002/em.20091; Akerman GS, 2004, MUTAT RES-FUND MOL M, V549, P43, DOI 10.1016/j.mrfmmm.2003.11.013; Amundson SA, 2005, ONCOGENE, V24, P4572, DOI 10.1038/sj.onc.1208653; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bajou K, 1998, NAT MED, V4, P923, DOI 10.1038/nm0898-923; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Blagosklonny MV, 2002, NAT REV CANCER, V2, P221, DOI 10.1038/nrc743; Caino MC, 2009, APOPTOSIS, V14, P392, DOI 10.1007/s10495-009-0316-z; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chaturvedi V, 2004, J CELL PHYSIOL, V198, P100, DOI 10.1002/jcp.10392; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Ellinger-Ziegelbauer H, 2009, TOXICOL SCI, V110, P341, DOI 10.1093/toxsci/kfp103; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Glover KP, 2014, TOXICOL LETT, V229, P210, DOI 10.1016/j.toxlet.2014.06.030; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GRONDAHLHANSEN J, 1993, CANCER RES, V53, P2513; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HOLLANDER MC, 1989, CANCER RES, V49, P1687; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islaih M, 2005, MUTAT RES-FUND MOL M, V578, P100, DOI 10.1016/j.mrfmmm.2005.04.012; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Komarova EA, 1998, ONCOGENE, V17, P1089, DOI 10.1038/sj.onc.1202303; Mathijs K, 2009, TOXICOL SCI, V112, P374, DOI 10.1093/toxsci/kfp229; Mukherjee JJ, 2006, CARCINOGENESIS, V27, P631, DOI 10.1093/carcin/bgi247; Novakova Z, 2010, ONCOGENE, V29, P273, DOI 10.1038/onc.2009.318; PEDERSEN H, 1994, CANCER RES, V54, P4671; Platel A, 2010, MUTAT RES-FUND MOL M, V689, P21, DOI 10.1016/j.mrfmmm.2010.04.004; Rundhaug Joyce E, 2010, Cancers (Basel), V2, P436, DOI 10.3390/cancers2020436; Schafer J, 2002, RADIAT RES, V158, P699, DOI 10.1667/0033-7587(2002)158[0699:SOAACS]2.0.CO;2; Schwartz JL, 1997, CARCINOGENESIS, V18, P201, DOI 10.1093/carcin/18.1.201; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; SHERMAN ML, 1990, P NATL ACAD SCI USA, V87, P5663, DOI 10.1073/pnas.87.15.5663; SKOUV J, 1994, CELL GROWTH DIFFER, V5, P329; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tapiainen T, 1996, CARCINOGENESIS, V17, P1377, DOI 10.1093/carcin/17.6.1377; Unsicker K, 2013, CYTOKINE GROWTH F R, V24, P373, DOI 10.1016/j.cytogfr.2013.05.003; Watanabe T, 2012, MUTAT RES-GEN TOX EN, V747, P164, DOI 10.1016/j.mrgentox.2012.04.011; Waters MD, 2010, MUTAT RES-REV MUTAT, V705, P184, DOI 10.1016/j.mrrev.2010.04.005; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861	44	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139850	10.1371/journal.pone.0139850	http://dx.doi.org/10.1371/journal.pone.0139850			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431317	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700126
J	Ishii, S; Ogawa, S; Akishita, M				Ishii, Shinya; Ogawa, Sumito; Akishita, Masahiro			The State of Health in Older Adults in Japan: Trends in Disability, Chronic Medical Conditions and Mortality	PLOS ONE			English	Article							CHRONIC DISEASE; RISK-FACTORS; POPULATION; PREVALENCE; DEMENTIA	Both life expectancy and healthy life expectancy in Japan have been increasing and are among the highest in the world, but the gap between them has also been widening. To examine the recent trends in old age disability, chronic medical conditions and mortality in Japan, we retrospectively analyzed three nationally representative datasets: Comprehensive Survey of Living Conditions (2001-2013), Patient Survey (1996-2011) and Vital Statistics (1995-2010). We obtained the sex-and age-stratified trends in disability rate, treatment rates of nine selected chronic medical conditions (cerebrovascular diseases, joint disorders, fractures, osteoporosis, ischemic heart disease, diabetes mellitus, hypertension, pneumonia and malignant neoplasms), total mortality rate and mortality rates from specific causes (cerebrovascular diseases, heart diseases, pneumonia and malignant neoplasms) in both sexes in four age strata (65-69, 70-74, 75-79, 80-84 years). Disability rates declined significantly in both sexes. Treatment rates of all selected medical conditions also decreased significantly, except for fractures in women and pneumonia. Both total mortality rate and cause-specific mortality rates decreased in both sexes. We concluded that the recent decline in disability rates, treatment rates of chronic medical conditions and mortality rates points toward overall improvement in health conditions in adults over the age of 65 years in Japan. Nonetheless, considering the increase in the number of older adults, the absolute number of older adults with disability or chronic medical conditions will continue to increase and challenge medical and long-term care systems.	[Ishii, Shinya; Ogawa, Sumito; Akishita, Masahiro] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan	University of Tokyo	Akishita, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan.	akishita-tky@umin.ac.jp						Barnett K, 2012, LANCET, DOI [10.1016/S2213-2600(12)70053-X, DOI 10.1016/S2213-2600(12)70053-X]; Cabinet Office Government of Japan, SURV SEN CIT ATT DAI; Cabinet Office Government of Japan, ANN REP AG SOC 2014; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Connolly A, 2011, AGING MENT HEALTH, V15, P978, DOI 10.1080/13607863.2011.596805; Hashimoto S, 2010, J EPIDEMIOL, V20, P308, DOI 10.2188/jea.JE20090190; Health Statistics Office Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, PAT SURV 2011; Health Statistics Office Statistics and Information Department Minister's Secretariat Ministry of Health Labour and Welfare, COMPR SURV LIV COND; Hirai Hiroshi, 2009, Nihon Koshu Eisei Zasshi, V56, P501; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Ministry of Health Labour and Welfare, ETH GUID MED HLTH RE; Ministry of Health Labour and Welfare of Japan, SPEC HLTH CHECK SPEC; Moriya S, 2013, AUSTRALAS J AGEING, V32, P79, DOI 10.1111/j.1741-6612.2012.00601.x; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nguyen ND, 2005, J BONE MINER RES, V20, P1921, DOI 10.1359/JBMR.050520; Nutrition Institute of Health and Nutrition, NAT HLTH NUTR SURV 2; Okamura H, 2013, DEMENT GERIATR COGN, V36, P111, DOI 10.1159/000353444; Okochi J, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-55; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; Salomon JA, 2012, LANCET, V380, P2144, DOI 10.1016/S0140-6736(12)61690-0; Schoeni RF, 2006, POP STUD-J DEMOG, V60, P39, DOI 10.1080/00324720500462280; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; Waterloo S, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-163; Yoshida D, 2012, J EPIDEMIOL, V22, P222, DOI 10.2188/jea.JE20110083	26	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139639	10.1371/journal.pone.0139639	http://dx.doi.org/10.1371/journal.pone.0139639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431468	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700092
J	Kalliolia, E; Silajdzic, E; Nambron, R; Costelloe, SJ; Martin, NG; Hill, NR; Frost, C; Watt, HC; Hindmarsh, P; Bjorkqvist, M; Warner, TT				Kalliolia, Eirini; Silajdzic, Edina; Nambron, Rajasree; Costelloe, Sean J.; Martin, Nicholas G.; Hill, Nathan R.; Frost, Chris; Watt, Hilary C.; Hindmarsh, Peter; Bjorkqvist, Maria; Warner, Thomas T.			A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease	PLOS ONE			English	Article							GROWTH-HORMONE-SECRETION; PITUITARY-ADRENAL AXIS; LATERAL TUBERAL NUCLEUS; TRANSGENIC MOUSE MODEL; GH-RELEASING HORMONE; CAG REPEAT NUMBER; PROLACTIN SECRETION; PLASMA THYROTROPIN; DIABETES-MELLITUS; ENDOGENOUS-DEPRESSION	Background Huntington's disease is an inherited neurodegenerative disorder characterised by motor, cognitive and psychiatric disturbances. Patients exhibit other symptoms including sleep and mood disturbances, muscle atrophy and weight loss which may be linked to hypothalamic pathology and dysfunction of hypothalamo-pituitary axes. Methods We studied neuroendocrine profiles of corticotropic, somatotropic and gonadotropic hypothalamo-pituitary axes hormones over a 24-hour period in controlled environment in 15 healthy controls, 14 premanifest and 13 stage II/III Huntington's disease subjects. We also quantified fasting levels of vasopressin, oestradiol, testosterone, dehydroepiandrosterone sulphate, thyroid stimulating hormone, free triiodothyronine, free total thyroxine, prolactin, adrenaline and noradrenaline. Somatotropic axis hormones, growth hormone releasing hormone, insulin-like growth factor-1 and insulin-like factor binding protein-3 were quantified at 06:00 (fasting), 15:00 and 23:00. A battery of clinical tests, including neurological rating and function scales were performed. Results 24-hour concentrations of adrenocorticotropic hormone, cortisol, luteinizing hormone and follicle-stimulating hormone did not differ significantly between the Huntington's disease group and controls. Daytime growth hormone secretion was similar in control and Huntington's disease subjects. Stage II/III Huntington's disease subjects had lower concentration of post-sleep growth hormone pulse and higher insulin-like growth factor-1: growth hormone ratio which did not reach significance. In Huntington's disease subjects, baseline levels of hypothalamo-pituitary axis hormones measured did not significantly differ from those of healthy controls. Conclusions The relatively small subject group means that the study may not detect subtle perturbations in hormone concentrations. A targeted study of the somatotropic axis in larger cohorts may be warranted. However, the lack of significant results despite many variables being tested does imply that the majority of them do not differ substantially between HD and controls.	[Kalliolia, Eirini; Nambron, Rajasree; Warner, Thomas T.] UCL Inst Neurol, Dept Clin Neurosci, London, England; [Silajdzic, Edina; Bjorkqvist, Maria] Lund Univ, Brain Dis Biomarker Unit, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Lund, Sweden; [Costelloe, Sean J.; Martin, Nicholas G.] Royal Free Hosp, Dept Biochem, London NW3 2QG, England; [Hill, Nathan R.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Frost, Chris] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Watt, Hilary C.] Univ London Imperial Coll Sci Technol & Med, Dept Publ Hlth & Primary Care, London, England; [Hindmarsh, Peter] UCL Inst Child Hlth, Dev Endocrinol Res Grp, London, England; [Warner, Thomas T.] UCL Inst Neurol, Reta Lila Weston Inst Neurol Studies, London, England	University of London; University College London; Lund University; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; University College London; University of London; University College London	Warner, TT (corresponding author), UCL Inst Neurol, Dept Clin Neurosci, London, England.	t.warner@ucl.ac.uk	Warner, Thomas T/A-1454-2013; Hill, Nathan/B-9679-2014	Warner, Thomas T/0000-0001-6195-6995; Frost, Chris/0000-0003-0098-9915; Hill, Nathan/0000-0001-7927-8678; Bjorkqvist, Maria/0000-0001-8550-0431	Cure Huntington's Disease Initiative [A-2377]	Cure Huntington's Disease Initiative	The study was funded by a contract from Cure Huntington's Disease Initiative # A-2377. Scientific advisors from CHDI contributed to study design.	Andreassen OA, 2002, NEUROBIOL DIS, V11, P410, DOI 10.1006/nbdi.2002.0562; Arnulf I, 2008, ARCH NEUROL-CHICAGO, V65, P482, DOI 10.1001/archneur.65.4.482; Aziz NA, 2008, NEUROLOGY, V71, P1506, DOI 10.1212/01.wnl.0000334276.09729.0e; Aziz NA, 2007, REV NEUROSCIENCE, V18, P223; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P540, DOI 10.1111/j.1365-2265.2010.03836.x; Aziz NA, 2010, PARKINSONISM RELAT D, V16, P345, DOI 10.1016/j.parkreldis.2010.02.009; Aziz NA, 2009, J CLIN ENDOCR METAB, V94, P1223, DOI 10.1210/jc.2008-2543; Bjorkqvist M, 2006, HUM MOL GENET, V15, P1713, DOI 10.1093/hmg/ddl094; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; BRABANT G, 1990, J CLIN ENDOCR METAB, V70, P403, DOI 10.1210/jcem-70-2-403; BRANDT J, 1991, HDB NEUROPSYCHOLOGY, V5, P241; BRUYN GW, 1972, BRIT MED J, V1, P506, DOI 10.1136/bmj.1.5798.506-b; Buxton OM, 1997, AM J PHYSIOL-ENDOC M, V273, pE536, DOI 10.1152/ajpendo.1997.273.3.E536; CAINE E, 1978, LIFE SCI, V22, P911, DOI 10.1016/0024-3205(78)90616-1; CARACENI T, 1977, J CLIN ENDOCR METAB, V44, P870, DOI 10.1210/jcem-44-5-870; CARNES M, 1989, NEUROENDOCRINOLOGY, V50, P17, DOI 10.1159/000125197; CARROLL BJ, 1976, ARCH GEN PSYCHIAT, V33, P1051; Caufriez A, 2002, AM J PHYSIOL-ENDOC M, V282, pE1147, DOI 10.1152/ajpendo.00525.2001; CHALMERS RJ, 1978, J NEUROL NEUROSUR PS, V41, P135, DOI 10.1136/jnnp.41.2.135; DESIR D, 1982, J CLIN ENDOCR METAB, V55, P849, DOI 10.1210/jcem-55-5-849; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Douaud G, 2006, NEUROIMAGE, V32, P1562, DOI 10.1016/j.neuroimage.2006.05.057; DURSO R, 1983, J NEUROL NEUROSUR PS, V46, P1134, DOI 10.1136/jnnp.46.12.1134; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; FARRER LA, 1985, CLIN GENET, V27, P62; FARRER LA, 1985, AM J MED GENET, V21, P307, DOI 10.1002/ajmg.1320210213; FARRER LA, 1985, AM J PHYS ANTHROPOL, V67, P185, DOI 10.1002/ajpa.1330670304; FISHER BM, 1989, J CLIN ENDOCR METAB, V68, P688, DOI 10.1210/jcem-68-3-688; FOLLENIUS M, 1987, J ENDOCRINOL INVEST, V10, P261, DOI 10.1007/BF03348128; Freedman D., 1983, J BUS ECON STAT, V1, P292, DOI [10.2307/1391660, DOI 10.2307/1391660]; Gabery S, 2015, NEUROPATH APPL NEURO, V41, P843, DOI 10.1111/nan.12236; Gabery S, 2010, ACTA NEUROPATHOL, V120, P777, DOI 10.1007/s00401-010-0742-6; GOICHOT B, 1992, J SLEEP RES, V1, P186, DOI 10.1111/j.1365-2869.1992.tb00036.x; Goodman AOG, 2008, EXP NEUROL, V210, P691, DOI 10.1016/j.expneurol.2007.12.026; GRONFIER C, 1995, NEUROSCI LETT, V200, P97, DOI 10.1016/0304-3940(95)12082-F; HALBREICH U, 1985, ARCH GEN PSYCHIAT, V42, P904; Hamilton JM, 2004, J NEUROL NEUROSUR PS, V75, P209, DOI 10.1136/jnnp.2003.017822; HARRIS GW, 1966, BRIT MED BULL, V22, P266, DOI 10.1093/oxfordjournals.bmb.a070485; HAYDEN MR, 1977, LANCET, V2, P423; Hill NR, 2008, THESIS U OXFORD; Hirschfeld U, 1996, J CLIN ENDOCR METAB, V81, P3270, DOI 10.1210/jc.81.9.3270; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; HOLL RW, 1991, J CLIN ENDOCR METAB, V72, P854, DOI 10.1210/jcem-72-4-854; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Kalliolia E, 2014, MOVEMENT DISORD, V29, P1511, DOI 10.1002/mds.26003; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; KREMER HPH, 1989, J NEUROL SCI, V90, P335, DOI 10.1016/0022-510X(89)90120-2; KREMER HPH, 1991, NEUROSCI LETT, V132, P101, DOI 10.1016/0304-3940(91)90443-W; KREMER HPH, 1990, J NEUROPATH EXP NEUR, V49, P371, DOI 10.1097/00005072-199007000-00002; Kudo T, 2011, EXP NEUROL, V228, P80, DOI 10.1016/j.expneurol.2010.12.011; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; LAVIN PJM, 1981, J NEUROL NEUROSUR PS, V44, P414, DOI 10.1136/jnnp.44.5.414; LEBLHUBER F, 1995, J NEUROL SCI, V132, P76, DOI 10.1016/0022-510X(95)00114-H; LEVY CL, 1979, LIFE SCI, V24, P743, DOI 10.1016/0024-3205(79)90357-6; Lopez M, 2010, FRONT NEUROENDOCRIN, V31, P113, DOI 10.1016/j.yfrne.2009.07.001; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Markianos M, 2005, ANN NEUROL, V57, P520, DOI 10.1002/ana.20428; Markianos M, 2009, NEUROCHEM RES, V34, P917, DOI 10.1007/s11064-008-9851-1; MATTHEWS DR, 1988, ACTA PAEDIATR SCAND, P55; Meeking DR, 1999, EUR J ENDOCRINOL, V141, P22, DOI 10.1530/eje.0.1410022; Morton AJ, 2013, EXP NEUROL, V243, P34, DOI 10.1016/j.expneurol.2012.10.014; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; MULLER EE, 1977, LANCET, V2, P764; MURRI L, 1980, EUR NEUROL, V19, P198, DOI 10.1159/000115147; Nance MA, 1996, MOVEMENT DISORD, V11, P542, DOI 10.1002/mds.870110509; OcampoLim B, 1996, J CLIN ENDOCR METAB, V81, P4396, DOI 10.1210/jc.81.12.4396; Papalexi E, 2005, EUR J NEUROSCI, V22, P1541, DOI 10.1111/j.1460-9568.2005.04324.x; Penney JB, 1997, ANN NEUROL, V41, P689, DOI 10.1002/ana.410410521; Petersen A, 2005, HUM MOL GENET, V14, P39, DOI 10.1093/hmg/ddi004; Petersen A, 2006, EUR J NEUROSCI, V24, P961, DOI 10.1111/j.1460-9568.2006.04985.x; PHILLIPSON OT, 1976, CLIN SCI MOL MED, V50, P551, DOI 10.1042/cs0500551; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; PODOLSKY S, 1972, LANCET, V1, P1356; Politis M, 2008, BRAIN, V131, P2860, DOI 10.1093/brain/awn244; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; RUBIN RT, 1987, ARCH GEN PSYCHIAT, V44, P328; Russell W, 2008, J CLIN ENDOCR METAB, V93, P2300, DOI 10.1210/jc.2007-2674; Saleh N, 2010, NEUROLOGY, V75, P57, DOI 10.1212/WNL.0b013e3181e62076; Saleh N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004962; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Shadrokh A, 2010, APPL MATH SCI, V4, P857; Shah N, 1999, AM J PHYSIOL-REG I, V276, pR1351, DOI 10.1152/ajpregu.1999.276.5.R1351; Shirbin CA, 2013, J NEUROL, V260, P891, DOI 10.1007/s00415-012-6732-y; SHOULSON I, 1981, NEUROLOGY, V31, P1333, DOI 10.1212/WNL.31.10.1333; Siesling S, 1998, MOVEMENT DISORD, V13, P915, DOI 10.1002/mds.870130609; Soneson C, 2010, NEUROBIOL DIS, V40, P531, DOI 10.1016/j.nbd.2010.07.013; SPATHSCHWALBE E, 1991, BIOL PSYCHIAT, V29, P575, DOI 10.1016/0006-3223(91)90093-2; SPIEGEL K, 1995, SLEEP, V18, P543; SPIEGEL K, 1994, SLEEP, V17, P20, DOI 10.1093/sleep/17.1.20; Sulcova J, 1997, J ENDOCRINOL, V154, P57, DOI 10.1677/joe.0.1540057; TOMINAGA K, 1992, NEUROREPORT, V3, P809, DOI 10.1097/00001756-199209000-00022; Tonsfeldt KJ, 2012, MOL CELL ENDOCRINOL, V349, P3, DOI 10.1016/j.mce.2011.07.003; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; VALCAVI R, 1993, CLIN ENDOCRINOL, V39, P193, DOI 10.1111/j.1365-2265.1993.tb01773.x; Van Cauter E, 1998, SLEEP, V21, P553; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; van Duijn E, 2010, BRAIN RES BULL, V83, P232, DOI 10.1016/j.brainresbull.2010.08.006; Van Raamsdonk JM, 2007, NEUROBIOL DIS, V26, P512, DOI 10.1016/j.nbd.2007.01.006; van Wamelen DJ, 2012, BRAIN PATHOL, V22, P654, DOI 10.1111/j.1750-3639.2012.00565.x; VANCAUTER E, 1992, J CLIN ENDOCR METAB, V74, P1451, DOI 10.1210/jc.74.6.1451; VANCAUTER E, 1992, J CLIN ENDOCR METAB, V74, P1441, DOI 10.1210/jc.74.6.1441; VELDHUIS JD, 1990, J CLIN ENDOCR METAB, V71, P1616, DOI 10.1210/jcem-71-6-1616; VELDHUIS JD, 1990, J CLIN ENDOCR METAB, V71, P452, DOI 10.1210/jcem-71-2-452; Veldhuis JD, 2008, ENDOCR REV, V29, P823, DOI 10.1210/er.2008-0005; Videnovic A, 2009, PARKINSONISM RELAT D, V15, P471, DOI 10.1016/j.parkreldis.2008.10.002; Waldstreicher J, 1996, J CLIN ENDOCR METAB, V81, P1483, DOI 10.1210/jc.81.4.1483; WIEGAND M, 1991, J NEUROL, V238, P203, DOI 10.1007/BF00314781; William GH, 1998, HYPERFUNCTION ADRENA; Wood NI, 2008, BRAIN RES BULL, V76, P70, DOI 10.1016/j.brainresbull.2007.12.007; Yoshimura F, 1986, P 1 INT S PIT GLAND, Vxiv; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P881, DOI 10.1016/S0893-133X(01)00301-3; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P267, DOI 10.1016/S0893-133X(00)00236-0; Zoeller RT, 2007, CRIT REV TOXICOL, V37, P11, DOI 10.1080/10408440601123446	121	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138848	10.1371/journal.pone.0138848	http://dx.doi.org/10.1371/journal.pone.0138848			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431314	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700021
J	Liang, WJ; Cao, J; Fan, Y; Zhu, KF; Dai, QW				Liang, Wanjie; Cao, Jing; Fan, Yan; Zhu, Kefeng; Dai, Qiwei			Modeling and Implementation of Cattle/Beef Supply Chain Traceability Using a Distributed RFID-Based Framework in China	PLOS ONE			English	Article							PRODUCT TRACEABILITY; EPCGLOBAL NETWORK; FOOD-PRODUCTS; TRACE SYSTEM; BUSINESS; TECHNOLOGIES; AQUACULTURE; RECALL; SAFETY	In recent years, traceability systems have been developed as effective tools for improving the transparency of supply chains, thereby guaranteeing the quality and safety of food products. In this study, we proposed a cattle/beef supply chain traceability model and a traceability system based on radio frequency identification (RFID) technology and the EPCglobal network. First of all, the transformations of traceability units were defined and analyzed throughout the cattle/beef chain. Secondly, we described the internal and external traceability information acquisition, transformation, and transmission processes throughout the beef supply chain in detail, and explained a methodology for modeling traceability information using the electronic product code information service (EPCIS) framework. Then, the traceability system was implemented based on Fosstrak and FreePastry software packages, and animal ear tag code and electronic product code (EPC) were employed to identify traceability units. Finally, a cattle/beef supply chain included breeding business, slaughter and processing business, distribution business and sales outlet was used as a case study to evaluate the beef supply chain traceability system. The results demonstrated that the major advantages of the traceability system are the effective sharing of information among business and the gapless traceability of the cattle/beef supply chain.	[Liang, Wanjie; Cao, Jing; Fan, Yan; Zhu, Kefeng; Dai, Qiwei] Jiangsu Acad Agr Sci, Inst Agr Econ & Informat, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Liang, WJ (corresponding author), Jiangsu Acad Agr Sci, Inst Agr Econ & Informat, Nanjing, Jiangsu, Peoples R China.	wanjie.liang@163.com			Jiangsu Agriculture Science and Technology Innovation Fund [CX(13)5060]	Jiangsu Agriculture Science and Technology Innovation Fund	This research was supported and funded by the Jiangsu Agriculture Science and Technology Innovation Fund (grant CX(13)5060). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad E, 2009, J FOOD ENG, V93, P394, DOI 10.1016/j.jfoodeng.2009.02.004; Attaran M, 2007, SUPPLY CHAIN MANAG, V12, P249, DOI 10.1108/13598540710759763; Banterle A, 2008, FOOD POLICY, V33, P560, DOI 10.1016/j.foodpol.2008.06.002; Barge P, 2014, J FOOD ENG, V125, P119, DOI 10.1016/j.jfoodeng.2013.10.019; Bechini A, 2008, INFORM SOFTWARE TECH, V50, P342, DOI 10.1016/j.infsof.2007.02.017; Bertolini M, 2006, FOOD CONTROL, V17, P137, DOI 10.1016/j.foodcont.2004.09.013; Canavari M, 2010, BRIT FOOD J, V112, P171, DOI 10.1108/00070701011018851; Comba L, 2013, BIOSYST ENG, V116, P51, DOI [10.1016/j.biosystemseng.2013.06.006, 10.1016/j.biosystem]; Costa C, 2013, FOOD BIOPROCESS TECH, V6, P353, DOI 10.1007/s11947-012-0958-7; Dabbene F, 2014, BIOSYST ENG, V120, P65, DOI 10.1016/j.biosystemseng.2013.09.006; Donnelly KAM, 2012, BRIT FOOD J, V114, P1016, DOI 10.1108/00070701211241590; Donnelly KAM, 2009, MEAT SCI, V83, P68, DOI 10.1016/j.meatsci.2009.04.006; Engelseth P, 2009, J BUS IND MARK, V24, P421, DOI 10.1108/08858620910966291; EPC Tag Data Standard, 2014, EPC TAG DAT STAND DE; Feng JY, 2013, FOOD CONTROL, V31, P314, DOI 10.1016/j.foodcont.2012.10.016; Framling K, 2006, COMPUT IND, V57, P72, DOI 10.1016/j.compind.2005.04.004; Frederiksen M, 2001, FOOD AUST, V53, P117; Hong IH, 2011, J FOOD ENG, V106, P119, DOI 10.1016/j.jfoodeng.2011.04.014; Hu JY, 2013, FOOD CONTROL, V30, P341, DOI 10.1016/j.foodcont.2012.06.037; Jakkhupan W, 2011, J NETW COMPUT APPL, V34, P949, DOI 10.1016/j.jnca.2010.04.003; Jones P, 2004, INT J RETAIL DISTRIB, DOI DOI 10.1108/09590550410524957; Kang YS, 2013, COMPUT IND, V64, P609, DOI 10.1016/j.compind.2013.03.004; Karlsen KM, 2013, FOOD CONTROL, V32, P409, DOI 10.1016/j.foodcont.2012.12.011; Karlsen KM, 2011, FOOD CONTROL, V22, P1209, DOI 10.1016/j.foodcont.2011.01.020; Ko JM, 2011, EXPERT SYST APPL, V38, P1583, DOI 10.1016/j.eswa.2010.07.077; Koutsoumanis K, 2005, INT J FOOD MICROBIOL, V100, P253, DOI 10.1016/j.ijfoodmicro.2004.10.024; Li M, 2010, COMPUT ELECTRON AGR, V70, P69, DOI 10.1016/j.compag.2009.09.009; Mainetti L, 2013, COMPUT ELECTRON AGR, V98, P146, DOI 10.1016/j.compag.2013.07.015; Manzanares-Lopez P, 2011, J NETW COMPUT APPL, V34, P925, DOI 10.1016/j.jnca.2010.04.018; MOA Ministry of Agriculture of the People's Republic of China, 2006, REG ADM LIV POULTR I, V67; Moe T, 1998, TRENDS FOOD SCI TECH, V9, P211, DOI 10.1016/S0924-2244(98)00037-5; Musa A, 2014, EXPERT SYST APPL, V41, P176, DOI 10.1016/j.eswa.2013.07.020; Nam T, 2011, J NETW COMPUT APPL, V34, P958, DOI 10.1016/j.jnca.2010.04.021; National Bureau of Statistics of China (NBSC), 2006, COD ADM REG PEOPL RE; Parreno-Marchante A, 2014, J FOOD ENG, V122, P99, DOI 10.1016/j.jfoodeng.2013.09.007; Munoz-Gea JP, 2010, COMPUT IND, V61, P480, DOI 10.1016/j.compind.2010.01.006; Piramuthu S, 2013, EUR J OPER RES, V225, P253, DOI 10.1016/j.ejor.2012.09.024; Pizzuti T, 2015, J FOOD ENG, V159, P16, DOI 10.1016/j.jfoodeng.2015.03.001; Pizzuti T, 2014, J FOOD ENG, V120, P17, DOI 10.1016/j.jfoodeng.2013.07.017; Qi L, 2011, MATH COMPUT MODEL, V53, P2162, DOI 10.1016/j.mcm.2010.08.023; Qian JP, 2012, COMPUT ELECTRON AGR, V89, P76, DOI 10.1016/j.compag.2012.08.004; Shi J, 2012, COMPUT IND, V63, P574, DOI 10.1016/j.compind.2012.03.006; Thakur M, 2011, J FOOD ENG, V103, P417, DOI 10.1016/j.jfoodeng.2010.11.012; Thakur M, 2009, J FOOD ENG, V95, P617, DOI 10.1016/j.jfoodeng.2009.06.028; Twist DC, 2005, J FACIL MANAG, V3, P226, DOI 10.1108/14725960510808491	45	20	21	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139558	10.1371/journal.pone.0139558	http://dx.doi.org/10.1371/journal.pone.0139558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431340	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700077
J	Wang, FF; Gong, HY; Zhang, HS; Zhou, YZ; Cao, J; Zhou, JL				Wang, Fangfang; Gong, Haiyan; Zhang, Houshuang; Zhou, Yongzhi; Cao, Jie; Zhou, Jinlin			Lipopolysaccharide-Induced Differential Expression of miRNAs in Male and Female Rhipicephalus haemaphysaloides Ticks	PLOS ONE			English	Article							CONSERVED MICRORNA MIR-8; IMMUNE HOMEOSTASIS; IDENTIFICATION; PROTEIN; GENES	Lipopolysaccharide (LPS) stimulates the innate immune response in arthropods. In tick vectors, LPS activates expression of immune genes, including those for antibacterial peptides. miRNAs are 21-24 nt non-coding small RNAs that regulate target mRNAs at the post-transcriptional level. However, our understanding of tick innate immunity is limited to a few cellular immune reactions and some characterized immune molecules. Moreover, there is little information on the regulation of the immune system in ticks by miRNA. Therefore, this study aimed to analyze the differential expression of miRNAs in male and female ticks after LPS injection. LPS was injected into male and female Rhipicephalus haemaphysaloides ticks to stimulate immune response, with phosphate buffered saline (PBS)-injected ticks as negative controls. miRNAs from each group were sequenced and analyzed. In the PBS- and LPS-injected female ticks, 11.46 and 12.82 million reads of 18-30 nt were obtained respectively. There were 13.92 and 15.29 million reads of 18-30 nt obtained in the PBS-and LPS-injected male ticks, respectively. Expression of miRNAs in male ticks was greater than that in female ticks. There were 955 and 984 conserved miRNA families in the PBS-and LPS-injected female ticks, respectively, and correspondingly 1684 and 1552 conserved miRNA families in male ticks. Nine novel miRNAs were detected as common miRNAs in two or more tested samples. There were 37 known miRNAs up-regulated > 10-fold and 33 down-regulated > 10-fold in LPS-injected female ticks; and correspondingly 52 and 59 miRNAs in male ticks. Differential expression of miRNAs in PBS-and LPS-injected samples supports their involvement in the regulation of innate immunity. These data provide an important resource for more detailed functional analysis of miRNAs in this species.	[Wang, Fangfang; Gong, Haiyan; Zhang, Houshuang; Zhou, Yongzhi; Cao, Jie; Zhou, Jinlin] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Minist Agr, Key Lab Anim Parasitol, Shanghai, Peoples R China; [Zhou, Jinlin] Jiangsu Coinnovat Ctr Prevent & Control Importan, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Zhou, JL (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Minist Agr, Key Lab Anim Parasitol, Shanghai, Peoples R China.	jinlinzhou@shvri.ac.cn		Wang, Fangfang/0000-0002-0493-974X	Special Fund for National Commonweal Institute of China [2013JB14]	Special Fund for National Commonweal Institute of China	This work was supported by grants from the Special Fund for National Commonweal Institute of China (No. 2013JB14).	Aalaei-Andabili SH, 2013, J INFECTION, V67, P251, DOI 10.1016/j.jinf.2013.07.016; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-328; Bryant B, 2010, P NATL ACAD SCI USA, V107, P22391, DOI 10.1073/pnas.1016230107; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Cheng GF, 2013, PARASITOLOGY, V140, P1751, DOI 10.1017/S0031182013000917; Choi IK, 2012, DEV COMP IMMUNOL, V37, P50, DOI 10.1016/j.dci.2011.12.008; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; Etebari K, 2013, RNA BIOL, V10, P1356, DOI 10.4161/rna.25481; Freitak D, 2012, BIOL LETTERS, V8, P860, DOI 10.1098/rsbl.2012.0273; Fullaondo A, 2012, DEV COMP IMMUNOL, V36, P267, DOI 10.1016/j.dci.2011.03.034; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haas JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020171; Hajdusek O, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00026; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kopacek P, 2010, ADV EXP MED BIOL, V708, P137; Lee GJ, 2014, DEV COMP IMMUNOL, V45, P245, DOI 10.1016/j.dci.2014.03.015; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu C, 2014, INTERNATIONAL CONFERENCE ON ELECTRONIC AND ELECTRICAL ENGINEERING (CEEE 2014), P1; Liu GD, 2013, INT J OPHTHALMOL-CHI, V6, P280, DOI 10.3980/j.issn.2222-3959.2013.03.05; Lucas K, 2013, INSECT BIOCHEM MOLEC, V43, P24, DOI 10.1016/j.ibmb.2012.10.009; Luo J, 2015, GENE, V564, P125, DOI 10.1016/j.gene.2015.01.019; Nava S, 2009, FRONT BIOSCI-LANDMRK, V14, P2857, DOI 10.2741/3418; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Tanaka H, 2009, INSECT MOL BIOL, V18, P71, DOI 10.1111/j.1365-2583.2009.00851.x; Wang H, 1998, NATURE, V391, P753, DOI 10.1038/35773; Weitzel RP, 2011, LEUKEMIA, V25, P169, DOI 10.1038/leu.2010.227; Yin Y, 2014, CELL RES, V24, P1164, DOI 10.1038/cr.2014.121; Zhou J, 2007, PEPTIDES, V28, P1304, DOI 10.1016/j.peptides.2007.04.019; Zhou JL, 2006, PARASITOL RES, V100, P77, DOI 10.1007/s00436-006-0243-7; Zhou JL, 2013, EXP APPL ACAROL, V59, P339, DOI 10.1007/s10493-012-9604-3	31	15	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139241	10.1371/journal.pone.0139241	http://dx.doi.org/10.1371/journal.pone.0139241			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430879	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700039
J	Xu, Y; Liu, YL; Shu, T; Yang, W; Liang, MH				Xu, Ye; Liu, Yuanli; Shu, Ting; Yang, Wei; Liang, Minghui			Variations in the Quality of Care at Large Public Hospitals in Beijing, China: A Condition-Based Outcome Approach	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; MORTALITY-RATES; ADMINISTRATIVE DATA; GENDER-DIFFERENCES; PERFORMANCE; REGISTRY; SURGERY; FAILURE; RESCUE; STROKE	Background Public hospitals deliver over ninety percent of all outpatient and inpatient services in China. Their quality is graded into three levels (A, B, and C) largely based on structural resources, but empirical evidence on the quality of process and outcome of care is extremely scarce. As expectations for quality care rise with higher living standards and cost of care, such evidence is urgently needed and vital to improve care and to inform future health reforms. Methods We compiled and analyzed a multicenter database of over 4 million inpatient discharge summary records to provide a comprehensive assessment of the level and variations in clinical outcomes of hospitalization at 39 tertiary hospitals in Beijing. We assessed six outcome measures of clinical quality: in-hospital mortality rates (RSMR) for AMI, stroke, pneumonia and CABG, post-procedural complication rate (RS-CR), and failure-to-rescue rate (RS-FTR). The measures were adjusted for pre-admission patient case-mix using indirect standardization method with hierarchical linear mixed models. Results We found good overall quality with large variations by hospital and condition (mean/range, in %): RSMR-AMI: 6.23 (2.37-14.48), RSMR-stroke: 4.18 (3.58-4.44), RSMR-pneumonia: 7.78 (7.20-8.59), RSMR-CABG: 1.93 (1.55-2.23), RS-CR: 11.38 (9.9-12.88), and RSFTR: 6.41 (5.17-7.58). Hospital grade was not significantly associated with any risk-adjusted outcome measures. Conclusions Going to a higher grade public hospital does not always lead to better patient outcome because hospital grade only contains information about hospital structural resources. A hospital report card with some outcome measures of quality would provide valuable information to patients in choosing providers, and for regulators to identify gaps in health care quality. Reducing the variations in clinical practice and patient outcome should be a focus for policy makers in the next round of health sector reforms in China.	[Xu, Ye; Liu, Yuanli] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Shu, Ting; Yang, Wei; Liang, Minghui] Natl Hlth & Family Planning Commiss, Natl Inst Hosp Adm, Beijing, Peoples R China	Harvard University; Harvard T.H. Chan School of Public Health	Xu, Y (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA.	yex287@mail.harvard.edu			China Initiative at Harvard School of Public Health	China Initiative at Harvard School of Public Health	This study was funded by China Initiative at Harvard School of Public Health.	Anderson RD, 2007, CIRCULATION, V115, P823, DOI 10.1161/CIRCULATIONAHA.106.685859; Ash AS, 2012, STAT ISSUES ASSESSIN; Borzecki AM, 2010, MED CARE, V48, P1117, DOI 10.1097/MLR.0b013e3181ef9d53; Bradley EH, 2012, INT J QUAL HEALTH C, V24, P547, DOI 10.1093/intqhc/mzs065; Center for Health Statistics, 2010, NAT SURV STUD PAT DO; Diercks DB, 2010, AM HEART J, V160, P80, DOI 10.1016/j.ahj.2010.04.017; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Hesketh T, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5730; Hibbard JH, 2003, HEALTH AFFAIR, V22, P84, DOI 10.1377/hlthaff.22.2.84; Hibbard JH, 2012, HEALTH AFFAIR, V31, P560, DOI 10.1377/hlthaff.2011.1168; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Koennecke HC, 2011, NEUROLOGY, V77, P965, DOI 10.1212/WNL.0b013e31822dc795; Koopman C, 2012, INT J CARDIOLOGY; Kristoffersen DT, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-364; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; MOH, 2010, OP REG PUBL HOSP REF; MOH, 2012, CHIN ANN HLTH STAT; NHFPC, ANN EST CTR MED SERV; Pasquali SK, 2012, ANN THORACIC SURG; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shehab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055508; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; Zhao LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072166	26	15	16	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138948	10.1371/journal.pone.0138948	http://dx.doi.org/10.1371/journal.pone.0138948			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26430748	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700024
J	Laroche, A; Tran-Cong, K; Chaire, V; Lagarde, P; Hostein, I; Coindre, JM; Chibon, F; Neuville, A; Lesluyes, T; Lucchesi, C; Italiano, A				Laroche, Audrey; Tran-Cong, Kevin; Chaire, Vanessa; Lagarde, Pauline; Hostein, Isabelle; Coindre, Jean-Michel; Chibon, Frederic; Neuville, Agnes; Lesluyes, Tom; Lucchesi, Carlo; Italiano, Antoine			Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; SOFT-TISSUE SARCOMA; MDM2 ANTAGONIST; CANCER-CELLS; INDUCED CYTOTOXICITY; DRUG-RESISTANCE; CARCINOMA-CELLS; P53 PATHWAY; AUTOPHAGY; ACTIVATION	Nutlin inhibits TP53-MDM2 interaction and is under investigation in soft-tissue sarcomas (STS) and other malignancies. Molecular mechanisms of secondary resistance to nutlin in STS are unknown. We performed whole-transcriptome sequencing (RNA-seq) on three pretreatment and secondary resistant STS cell lines selected based on their high primary sensitivity to nutlin. Our data identified a subset of cancer genemutations and ploidy variations that were positively selected following treatment, including TP53 mutations in 2 out of 3 resistant cell lines. Further, secondary resistance to nutlin was associated with deregulation of apoptosis-related genes and marked productive autophagy, the inhibition of which resulted in significant restoration of nutlin-induced cell death. Collectively, our findings argue that secondary resistance to nutlin in STS involved heterogeneous mechanisms resulting from clonal evolution and several biological pathways. Alternative dosing regimens and combination with other targeted agents are needed to achieve successful development of nutlin in the clinical setting.	[Laroche, Audrey; Tran-Cong, Kevin; Chaire, Vanessa; Lagarde, Pauline; Chibon, Frederic; Lesluyes, Tom; Lucchesi, Carlo; Italiano, Antoine] Inst Bergonie, INSERM, U916, Bordeaux, France; [Laroche, Audrey; Tran-Cong, Kevin; Chaire, Vanessa; Lagarde, Pauline; Coindre, Jean-Michel; Chibon, Frederic; Neuville, Agnes; Lesluyes, Tom; Lucchesi, Carlo; Italiano, Antoine] Inst Bergonie, Sarcoma Unit, Bordeaux, France; [Hostein, Isabelle; Coindre, Jean-Michel; Neuville, Agnes] Inst Bergonie, Dept Pathol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie; UNICANCER; Institut Bergonie	Italiano, A (corresponding author), Inst Bergonie, INSERM, U916, Bordeaux, France.	a.italiano@bordeaux.unicancer.fr	Lesluyes, Tom/GSD-4621-2022; Lesluyes, Tom/AAB-6229-2019; chibon, frederic/A-2651-2013	Lesluyes, Tom/0000-0003-2251-5884; Lesluyes, Tom/0000-0003-2251-5884; Lucchesi, Carlo/0000-0001-6657-2341; chibon, Frederic/0000-0002-6548-2181	 [INCa-DGOS-Inserm 6046]		All authors received Grant INCa-DGOS-Inserm 6046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aparicio S, 2013, NEW ENGL J MED, V368, P842, DOI 10.1056/NEJMra1204892; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Delgado M, 2013, CELL CYCLE, V12, P3453, DOI 10.4161/cc.26696; Duesberg P, 2007, DRUG RESIST UPDATE, V10, P51, DOI 10.1016/j.drup.2007.02.003; Galvani E, 2013, CURR PHARM DESIGN, V19, P818, DOI 10.2174/138161213804547222; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gorka M, 2005, ANTI-CANCER DRUG, V16, P777; Italiano A, 2008, INT J CANCER, V122, P2233, DOI 10.1002/ijc.23380; Italiano A, 2011, CANCER-AM CANCER SOC, V117, P1049, DOI 10.1002/cncr.25538; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lee SY, 2013, INT J ONCOL, V42, P1027, DOI 10.3892/ijo.2013.1764; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Linch M, 2014, NAT REV CLIN ONCOL, V11, P187, DOI 10.1038/nrclinonc.2014.26; Liu JR, 2002, CANCER RES, V62, P924; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Meaux I, 2014, P 105 ANN M AM ASS C; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Moll UM, 2003, MOL CANCER RES, V1, P1001; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Paglin S, 2001, CANCER RES, V61, P439; Pishas KI, 2011, CLIN CANCER RES, V17, P494, DOI 10.1158/1078-0432.CCR-10-1587; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Scoumanne A, 2006, CANCER RES, V66, P6271, DOI 10.1158/0008-5472.CAN-06-0121; Shao Y, 2012, CELL DEATH DIFFER, V19, P2029, DOI 10.1038/cdd.2012.94; Shen H, 2008, CANCER RES, V68, P8260, DOI 10.1158/0008-5472.CAN-08-1901; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shingu T, 2009, INT J CANCER, V124, P1060, DOI 10.1002/ijc.24030; Siu LL, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.2535; Srougi MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017108; Tansey W. P., 2006, CSH PROTOC, V2006; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wang B, 2012, ACTA BIOCH BIOPH SIN, V44, P685, DOI 10.1093/abbs/gms053; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0137794	10.1371/journal.pone.0137794	http://dx.doi.org/10.1371/journal.pone.0137794			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427052	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100007
J	Murata, Y; Yasuda, T; Watanabe-Asaka, T; Oda, S; Mantoku, A; Takeyama, K; Chatani, M; Kudo, A; Uchida, S; Suzuki, H; Tanigaki, F; Shirakawa, M; Fujisawa, K; Hamamoto, Y; Terai, S; Mitani, H				Murata, Yasuhiko; Yasuda, Takako; Watanabe-Asaka, Tomomi; Oda, Shoji; Mantoku, Akiko; Takeyama, Kazuhiro; Chatani, Masahiro; Kudo, Akira; Uchida, Satoko; Suzuki, Hiromi; Tanigaki, Fumiaki; Shirakawa, Masaki; Fujisawa, Koichi; Hamamoto, Yoshihiko; Terai, Shuji; Mitani, Hiroshi			Histological and Transcriptomic Analysis of Adult Japanese Medaka Sampled Onboard the International Space Station	PLOS ONE			English	Article							AMPHIBIAN PLEURODELES-WALTL; GENE-EXPRESSION; IMMUNE FUNCTION; SPACEFLIGHT; FISH; MICROGRAVITY; ENVIRONMENT	To understand how humans adapt to the space environment, many experiments can be conducted on astronauts as they work aboard the Space Shuttle or the International Space Station (ISS). We also need animal experiments that can apply to human models and help prevent or solve the health issues we face in space travel. The Japanese medaka (Oryzias latipes) is a suitable model fish for studying space adaptation as evidenced by adults of the species having mated successfully in space during 15 days of flight during the second International Microgravity Laboratory mission in 1994. The eggs laid by the fish developed normally and hatched as juveniles in space. In 2012, another space experiment ("Medaka Osteoclast") was conducted. Six-week-old male and female Japanese medaka (Cab strain osteoblast transgenic fish) were maintained in the Aquatic Habitat system for two months in the ISS. Fish of the same strain and age were used as the ground controls. Six fish were fixed with paraformaldehyde or kept in RNA stabilization reagent (n = 4) and dissected for tissue sampling after being returned to the ground, so that several principal investigators working on the project could share samples. Histology indicated no significant changes except in the ovary. However, the RNA-seq analysis of 5345 genes from six tissues revealed highly tissue-specific space responsiveness after a two-month stay in the ISS. Similar responsiveness was observed among the brain and eye, ovary and testis, and the liver and intestine. Among these six tissues, the intestine showed the highest space response with 10 genes categorized as oxidation-reduction processes (gene ontogeny term GO: 0055114), and the expression levels of choriogenin precursor genes were suppressed in the ovary. Eleven genes including klf9, klf13, odc1, hsp70 and hif3a were upregulated in more than four of the tissues examined, thus suggesting common immunoregulatory and stress responses during space adaptation.	[Murata, Yasuhiko] Tohoku Univ, Dept Radiat Biol, Grad Sch Med, Sendai, Miyagi 980, Japan; [Yasuda, Takako; Watanabe-Asaka, Tomomi; Oda, Shoji; Mitani, Hiroshi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba, Japan; [Mantoku, Akiko; Takeyama, Kazuhiro; Chatani, Masahiro; Kudo, Akira] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa, Japan; [Uchida, Satoko; Suzuki, Hiromi] Japan Space Forum, Tokyo, Japan; [Tanigaki, Fumiaki; Shirakawa, Masaki] Japan Aerosp Explorat Agcy, Ibaraki, Japan; [Fujisawa, Koichi] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi, Japan; [Hamamoto, Yoshihiko] Yamaguchi Univ, Grad Sch Med, Dept Biomol Engn, Yamaguchi, Japan; [Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan	Tohoku University; University of Tokyo; Tokyo Institute of Technology; Japan Aerospace Exploration Agency (JAXA); Yamaguchi University; Yamaguchi University; Niigata University	Terai, S (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.	terais@med.niigata-u.ac.jp; mitani@k.u-tokyo.ac.jp	fujisawa, koichi/AAC-1392-2022	Chatani, Masahiro/0000-0002-1002-1775	Ministry of Education, Culture, Sports, Science [25220102]; Technology of Japan; Japan Aerospace eXploration Agency; Grants-in-Aid for Scientific Research [15K12201] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Technology of Japan; Japan Aerospace eXploration Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Grant-in-Aid for Scientific Research (S) Number 25220102 to H.M. from the Ministry of Education, Culture, Sports, Science and the unspecified fund from Technology of Japan and Japan Aerospace eXploration Agency.	Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Bascove M, 2009, FASEB J, V23, P1607, DOI 10.1096/fj.08-121327; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Capulli M, 2009, J CELL BIOCHEM, V107, P240, DOI 10.1002/jcb.22120; Chapes SK, 1999, ADV SPACE RES, V23, P1955, DOI 10.1016/S0273-1177(99)00456-1; Chatani M, 2011, DEV BIOL, V360, P96, DOI 10.1016/j.ydbio.2011.09.013; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Droppert P M, 1990, J Br Interplanet Soc, V43, P19; Forsman AD, 2012, ADV SPACE RES, V49, P807, DOI 10.1016/j.asr.2011.11.033; Frippiat JP, 2013, MOL IMMUNOL, V56, P434, DOI 10.1016/j.molimm.2013.06.011; Gabriel Martin, 2012, J Exp Zool A Ecol Genet Physiol, V317, P333, DOI 10.1002/jez.1727; Gleimer M, 2003, IMMUNITY, V19, P469, DOI 10.1016/S1074-7613(03)00272-3; Gridley DS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075097, 10.1371/annotation/e66bdc4e-2409-4582-b163-7bc182db275e]; Gueguinou N, 2009, J LEUKOCYTE BIOL, V86, P1027, DOI 10.1189/jlb.0309167; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hughes-Fulford M, 2011, FASEB J, V25, P2858, DOI 10.1096/fj.11-0902ufm; Ijiri K, 2003, ADV SPACE B, V9, P201, DOI 10.1016/S1569-2574(03)09008-7; Inohaya K, 2010, DEVELOPMENT, V137, P1807, DOI 10.1242/dev.051540; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031292; Mao XW, 2013, RADIAT RES, V180, P340, DOI 10.1667/RR3309.1; Masini MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035418; Masukawa M, 2003, ADV SPACE RES, V32, P1541, DOI 10.1016/S0273-1177(03)90393-0; Morey-Holton E. R., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P17; Naumenko VS, 2015, NEUROSCIENCE, V284, P730, DOI 10.1016/j.neuroscience.2014.10.045; Oda S, 2014, CYTOMET RES, V24, P9; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Ronca AE, 2013, GRAVITAT SPACE RES, V1, P105; Sakimura Toru, 2003, Biol Sci Space, V17, P240; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Santucci D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040112; Smith IM, 2012, GRAVITAT SPACE RES, V26, P30; Takei Y, 2008, GEN COMP ENDOCR, V157, P3, DOI 10.1016/j.ygcen.2008.03.021; Terada M., 2013, ADV BIOSCI BIOTECHNO, V04, P75, DOI [10.4236/abb.2013.410A3009, DOI 10.4236/ABB.2013.410A3009]; Watanabe-Asaka T., 2010, BIOL SCI SPACE, V24, P3, DOI [10.2187/bss.24.3, DOI 10.2187/BSS.24.3]; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yasuda T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.133; Yoshioka H, 1976, SEIBUTSU KYOZAI, V11, P5	39	15	15	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138799	10.1371/journal.pone.0138799	http://dx.doi.org/10.1371/journal.pone.0138799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427061	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100020
J	Schindler, R; Korner, A; Bauer, S; Hadji, S; Rudolph, U				Schindler, Rose; Koerner, Andre; Bauer, Sylvia; Hadji, Sarina; Rudolph, Udo			Causes and Consequences of Schadenfreude and Sympathy: A Developmental Analysis	PLOS ONE			English	Article							HELPING-BEHAVIOR; GENDER; ENVY	Moral judgments and moral emotions are a ubiquitous feature of social interactions. Humans decide quickly and intuitively whether an action is morally right or wrong. Schadenfreude and sympathy, as emotional reactions to the misfortunes of others, are prototypical moral emotions. So far, however, little evidence exists concerning children's understanding of schadenfreude. Within three studies, we investigated the experience of schadenfreude and sympathy among N = 364 children of different age groups. We interviewed the children while showing them picture stories. In the picture stories, we varied the behavior of the protagonist prior to a misfortune: (1) whether his behavior had been morally right or wrong, (2) whether the protagonist attained his goal, (3) whether the protagonist was responsible for the misfortune. In addition, in one study we varied (4) the emotional relationship of the interviewed children to the protagonist. Furthermore, we asked the children to decide whether they want to sit next to the protagonist or do him a favor. Results show that children experience sympathy as well as schadenfreude at the age of 4 years. Sympathy is more likely to arise when the protagonists of a story are likable, when these actors typically pursue morally positive goals, and if they are not responsible for their misfortune. In contrast, schadenfreude is more likely when the protagonist is disliked, when actors pursue immoral goals and if they are responsible for their misfortune. In addition, sympathy increases approach (helping behavior, sitting next to the agent and doing favors), whereas schadenfreude increases avoidance tendencies.	[Schindler, Rose; Koerner, Andre; Bauer, Sylvia; Hadji, Sarina; Rudolph, Udo] Tech Univ Chemnitz, Dept Psychol, D-09111 Chemnitz, Germany	Technische Universitat Chemnitz	Schindler, R (corresponding author), Tech Univ Chemnitz, Dept Psychol, D-09111 Chemnitz, Germany.	rose.schindler@allpsy2.de	Korner, Andre/F-8491-2015	Korner, Andre/0000-0002-6630-3368	University Library of Technische Universitat Chemnitz	University Library of Technische Universitat Chemnitz	The fees for publication were supported by the University Library of Technische Universitat Chemnitz. The University Library had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson E., 2008, SOZIALPSYCHOLOGIE; Arsenio WF, 2006, HANDBOOK OF MORAL DEVELOPMENT, P581; Ben-Ze'ev A., 1992, IYYUN, V41, P41; Ben-Ze'ev A., 2001, SUBTLETY EMOTIONS; BIRCH LL, 1986, CHILD DEV, V57, P387, DOI 10.1111/j.1467-8624.1986.tb00038.x; CECI SJ, 1993, PSYCHOL BULL, V113, P403, DOI 10.1037/0033-2909.113.3.403; Dahle KP., 2010, FOR PSYCH DIAGN STRA; EAGLY AH, 1986, PSYCHOL BULL, V100, P283, DOI 10.1037/0033-2909.100.3.283; Elster J., 2008, J ECON PERSPECT, V3, P99; Ervin-Tripp S., 1978, CHILD DISCOURSE, P165; Feather N T, 1999, Pers Soc Psychol Rev, V3, P86, DOI 10.1207/s15327957pspr0302_1; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Gigerenzer G., 1999, SIMPLE HEURISTICS MA, P3; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hareli S, 2002, MOTIV EMOTION, V26, P257, DOI 10.1023/A:1022818803399; Harris P. L., 2008, HDB EMOTIONS, P320; Hartup W W, 1993, New Dir Child Dev, P3, DOI 10.1002/cd.23219936003; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Karniol R, 1997, SEX ROLES, V36, P195, DOI 10.1007/BF02766267; Keller M, 2003, BRIT J DEV PSYCHOL, V21, P1, DOI 10.1348/026151003321164582; Lagattuta KH, 2005, CHILD DEV, V76, P713, DOI 10.1111/j.1467-8624.2005.00873.x; LERNER MJ, 1978, PSYCHOL BULL, V85, P1030, DOI 10.1037/0033-2909.85.5.1030; MEINONG A., 1906, ARCH GESAMTE PSYCHOL, V6, P22; Ortony A., 1988, COGNITIVE STRUCTURE; Piaget J., 1932, MORAL JUDGMENT CHILD; Portmann John., 2000, BAD THINGS HAPPEN OT; Resch F., 1999, ENTWICKLUNGSPSYCHOPA; Rudolph U, 2004, COGNITION EMOTION, V18, P815, DOI 10.1080/02699930341000248; Rudolph U., 2013, INT J ADV PSYCHOL, V2, P69; Rudolph U, 2014, EMOT REV, V6, P344, DOI 10.1177/1754073914534507; SAGI A, 1976, DEV PSYCHOL, V12, P175, DOI 10.1037/0012-1649.12.2.175; Schulz K, 2013, BRIT J DEV PSYCHOL, V31, P363, DOI 10.1111/bjdp.12013; SEVERY LJ, 1971, CHILD DEV, V42, P1017, DOI 10.2307/1127788; Spence Susan H, 2003, Child Adolesc Ment Health, V8, P84, DOI 10.1111/1475-3588.00051; van Dijk WW, 2008, J SOC PSYCHOL, V148, P631, DOI 10.3200/SOCP.148.5.631-636; van Dijk WW, 2006, EMOTION, V6, P156, DOI 10.1037/1528-3542.6.1.156; van Dijk WW, 2005, COGNITION EMOTION, V19, P933, DOI 10.1080/02699930541000066; WEINER B, 1993, AM PSYCHOL, V48, P957, DOI 10.1037/0003-066X.48.9.957; Weiner B., 2006, SOCIAL MOTIVATION JU; WEISNER TS, 1990, CHILD DEV, V61, P1915; ZAHNWAXLER C, 1990, MOTIV EMOTION, V14, P107, DOI 10.1007/BF00991639; ZAHNWAXLER C, 1992, HDB SOCIAL DEV LIFES, P229, DOI DOI 10.1007/978-1-4899-0694-6_10	43	13	14	4	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0137669	10.1371/journal.pone.0137669	http://dx.doi.org/10.1371/journal.pone.0137669			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426903	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100005
J	Serrano-Cinca, C; Gutierrez-Nieto, B; Lopez-Palacios, L				Serrano-Cinca, Carlos; Gutierrez-Nieto, Begona; Lopez-Palacios, Luz			Determinants of Default in P2P Lending	PLOS ONE			English	Article							INTEREST-RATES; CREDIT; INFORMATION; SURVIVAL; BANKING; MARKETS; RISK; MICROFINANCE; BORROWERS; LENDER	This paper studies P2P lending and the factors explaining loan default. This is an important issue because in P2P lending individual investors bear the credit risk, instead of financial institutions, which are experts in dealing with this risk. P2P lenders suffer a severe problem of information asymmetry, because they are at a disadvantage facing the borrower. For this reason, P2P lending sites provide potential lenders with information about borrowers and their loan purpose. They also assign a grade to each loan. The empirical study is based on loans' data collected from Lending Club (N = 24,449) from 2008 to 2014 that are first analyzed by using univariate means tests and survival analysis. Factors explaining default are loan purpose, annual income, current housing situation, credit history and indebtedness. Secondly, a logistic regression model is developed to predict defaults. The grade assigned by the P2P lending site is the most predictive factor of default, but the accuracy of the model is improved by adding other information, especially the borrower's debt level.	[Serrano-Cinca, Carlos; Gutierrez-Nieto, Begona; Lopez-Palacios, Luz] Univ Zaragoza, Dept Accounting & Finance, Zaragoza, Spain	University of Zaragoza	Gutierrez-Nieto, B (corresponding author), Univ Zaragoza, Dept Accounting & Finance, Zaragoza, Spain.	bgn@unizar.es	Serrano-Cinca, Carlos/K-1744-2017	Serrano-Cinca, Carlos/0000-0003-2596-9638; Gutierrez Nieto, Begona/0000-0003-3044-4983	Spanish Ministry of Education [ECO2010-20228, ECO2013-45568-R]; European Regional Development Fund; Government of Aragon [S-14/2]	Spanish Ministry of Education(Spanish Government); European Regional Development Fund(European Commission); Government of Aragon(Gobierno de Aragon)	This work was supported by grants ECO2010-20228 and ECO2013-45568-R of the Spanish Ministry of Education and the European Regional Development Fund and by grant Ref. S-14/2 of the Government of Aragon.	Abdou HA, 2011, INTELL SYST ACCOUNT, V18, P59, DOI 10.1002/isaf.325; Agarwal S., 2007, HOUSEHOLD CREDIT USA; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; Altman Edward., 2004, ECON NOTES, V33, P183, DOI [10.1111/j.0391-5026.2004.00129.x, DOI 10.1111/J.0391-5026.2004.00129.X]; Anderson C., 2006, LONG TAIL WHY FUTURE; [Anonymous], 2012, LOVE LOANS EFFECT BE; [Anonymous], MITIGATING ADVERSE S; Arya S, 2013, J ECON BEHAV ORGAN, V95, P175, DOI 10.1016/j.jebo.2011.05.005; Asch L.A., 1995, J COMMERCIAL LENDING, V77, P10; Bachmann A, 2011, J INTERNET BANK COMM, V16, P1; Baesens B, 2005, J OPER RES SOC, V56, P1089, DOI 10.1057/palgrave.jors.2601990; Baklouti I, 2013, INT J RES STUD MANAG, V2; Belk R, 2014, J BUS RES, V67, P1595, DOI 10.1016/j.jbusres.2013.10.001; BENSTON GJ, 1976, J FINANC, V31, P215, DOI 10.2307/2326596; Berger AN, 2011, J BANK FINANC, V35, P724, DOI 10.1016/j.jbankfin.2010.09.004; Berger C.S., 2009, BUR BUSINESS RES, V2, P39, DOI DOI 10.1007/BF03343528; BHADURI A, 1977, CAMBRIDGE J ECON, V1, P341; Bravo C, 2013, EUR J OPER RES, V227, P358, DOI 10.1016/j.ejor.2012.10.040; Cader HA, 2011, SMALL BUS ECON, V37, P155, DOI 10.1007/s11187-009-9240-4; CAMPBELL TS, 1980, J FINANC, V35, P863, DOI 10.2307/2327206; Christensen CM, 2000, HARVARD BUS REV, V78, P66; Crone SF, 2012, INT J FORECASTING, V28, P224, DOI 10.1016/j.ijforecast.2011.07.006; Crouhy M., 2006, ESSENTIALS RISK MANA, V1; de Andrade FWM, 2007, EUR J OPER RES, V183, P1569, DOI 10.1016/j.ejor.2006.07.049; Dehejia R, 2012, J DEV ECON, V97, P437, DOI 10.1016/j.jdeveco.2011.06.001; Demirguc-Kunt A, 1999, WORLD BANK ECON REV, V13, P379, DOI 10.1093/wber/13.2.379; Duarte J, 2012, REV FINANC STUD, V25, P2455, DOI 10.1093/rfs/hhs071; Durkin TA, 2010, OXFORD HDB BANKING; Edelberg W, 2006, J MONETARY EC, V5; Emekter R, 2015, APPL ECON, V47, P54, DOI 10.1080/00036846.2014.962222; Faraway Julian J., 2014, STATS COMPUTING, V26, P1; Fiaschi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094237; Fuller J, 2007, CONVENIENT INVASIVE, P21; Gao R., 2014, INT BUSINESS MANAGEM, V8, P14; Gonzalez L, 2014, J BEHAV EXP FINANC, V2, P44, DOI 10.1016/j.jbef.2014.04.002; Hales MG, 1995, BANK MARKETING, V27, P29; HIRSCH RP, 1991, BIOMETRICS, V47, P1193; Jarrow R, 2001, FINANC ANAL J, V57, P75, DOI 10.2469/faj.v57.n5.2483; Jarrow RA, 2011, FINANC RES LETT, V8, P2, DOI 10.1016/j.frl.2010.08.002; Jimenez G, 2004, J BANK FINANC, V28, P2191, DOI 10.1016/j.jbankfin.2003.09.002; JOY OM, 1975, J FINANC QUANT ANAL, V10, P723, DOI 10.2307/2330267; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knaup AE, 2007, MON LABOR REV, V130, P3; Koch R., 1997, 80 20 PRINCIPLE SECR; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI [10.1007/978-1-4614-6849-3_4, DOI 10.1007/978-1-4614-6849-3_4]; LAU AHL, 1987, J ACCOUNTING RES, V25, P127, DOI 10.2307/2491262; Lee E, 2012, ELECTRON COMMER R A, V11, P495, DOI 10.1016/j.elerap.2012.02.001; LELAND HE, 1977, J FINANC, V32, P371, DOI 10.2307/2326770; Lessmann S, 2015, EUR J OPER IN PRESS; Lin MF, 2013, MANAGE SCI, V59, P17, DOI 10.1287/mnsc.1120.1560; Marques AI, 2013, J OPER RES SOC, V64, P1384, DOI 10.1057/jors.2012.145; Maudos J, 2004, J BANK FINANC, V28, P2259, DOI 10.1016/j.jbankfin.2003.09.004; Mersland R, 2010, WORLD DEV, V38, P28, DOI 10.1016/j.worlddev.2009.05.006; MERTON RC, 1974, J FINANC, V29, P449, DOI 10.2307/2978814; Mester L. J., 1997, BUS REV, V3, P3; Mild A, 2015, J BUS RES, V68, P1291, DOI 10.1016/j.jbusres.2014.11.021; Miller S, 2015, J FINANC INTERMED, V24, P45, DOI 10.1016/j.jfi.2014.06.003; Mills K.G., 2014, HARVARD BUSINESS SCH; Moro S, 2015, EXPERT SYST APPL, V42, P1314, DOI 10.1016/j.eswa.2014.09.024; Muscettola M, 2015, J APPL FINANC BANK, V5, P19; MYERS SC, 1984, J FINANC ECON, V13, P187, DOI 10.1016/0304-405X(84)90023-0; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Peppard J., 2000, EUR MANAG J, V18, P312, DOI [DOI 10.1016/S0263-2373(00)00013-X, 10.1016/S0263-2373(00)00013-X]; Phillips B.D., 1989, SMALL BUS ECON, V1, P65, DOI [https://doi.org/10.1007/BF00389917, DOI 10.1007/BF00389917]; Pope DG, 2011, J HUM RESOUR, V46, P53, DOI 10.1353/jhr.2011.0025; Rajan U, 2015, J FINANC ECON, V115, P237, DOI 10.1016/j.jfineco.2014.09.012; Sarlija N, 2009, EXPERT SYST APPL, V36, P8778, DOI 10.1016/j.eswa.2008.11.042; Schuermann T., 2004, CREDIT RISK MODELS M, V2nd; Serrano-Cinca C, 2014, INT BUS REV, V23, P181, DOI 10.1016/j.ibusrev.2013.03.006; Stalnaker S, 2008, HARVARD BUS REV, V86, P18; STIGLITZ JE, 1981, AM ECON REV, V71, P393; Tedeschi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052749; Thomas LC, 2010, J OPER RES SOC, V61, P41, DOI 10.1057/jors.2009.104; Thomas LC, 2000, INT J FORECASTING, V16, P149, DOI 10.1016/S0169-2070(00)00034-0; Tong ENC, 2012, EUR J OPER RES, V218, P132, DOI 10.1016/j.ejor.2011.10.007; TOWNSEND RM, 1979, J ECON THEORY, V21, P265, DOI 10.1016/0022-0531(79)90031-0; Wang YY, 2014, 2014 INTERNATIONAL CONFERENCE ON MANAGEMENT OF E-COMMERCE AND E-GOVERNMENT (ICMECG), P318, DOI 10.1109/ICMeCG.2014.71; Wardrop R, 2015, MOVING MAINSTREAM; Yum H, 2012, ELECTRON COMMER R A, V11, P469, DOI 10.1016/j.elerap.2012.05.003; Zeng R., 2013, US CHINA LAW REV, V10, P229; Zhang JJ, 2012, MANAGE SCI, V58, P892, DOI 10.1287/mnsc.1110.1459; ZMIJEWSKI ME, 1984, J ACCOUNTING RES, V22, P59, DOI 10.2307/2490859	83	128	132	6	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139427	10.1371/journal.pone.0139427	http://dx.doi.org/10.1371/journal.pone.0139427			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26425854	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100057
J	Hayes, JE; Trynka, G; Vijai, J; Offit, K; Raychaudhuri, S; Klein, RJ				Hayes, James E.; Trynka, Gosia; Vijai, Joseph; Offit, Kenneth; Raychaudhuri, Soumya; Klein, Robert J.			Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC LYMPHOCYTIC-LEUKEMIA; HODGKIN-LYMPHOMA; SUSCEPTIBILITY LOCI; COMMON VARIANTS; RESOURCE; 8Q24.21; SETS	Though numerous polymorphisms have been associated with risk of developing lymphoma, how these variants function to promote tumorigenesis is poorly understood. Here, we report that lymphoma risk SNPs, especially in the non-Hodgkin's lymphoma subtype chronic lymphocytic leukemia, are significantly enriched for co-localization with epigenetic marks of active gene regulation. These enrichments were seen in a lymphoid-specific manner for numerous ENCODE datasets, including DNase-hypersensitivity as well as multiple segmentation-defined enhancer regions. Furthermore, we identify putatively functional SNPs that are both in regulatory elements in lymphocytes and are associated with gene expression changes in blood. We developed an algorithm, UES, that uses a Monte Carlo simulation approach to calculate the enrichment of previously identified risk SNPs in various functional elements. This multiscale approach integrating multiple datasets helps disentangle the underlying biology of lymphoma, and more broadly, is generally applicable to GWAS results from other diseases as well.	[Hayes, James E.; Vijai, Joseph; Offit, Kenneth; Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Hayes, James E.; Vijai, Joseph; Offit, Kenneth; Klein, Robert J.] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Hayes, James E.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Cell & Dev Biol Grad Program, New York, NY USA; [Hayes, James E.; Klein, Robert J.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Trynka, Gosia; Raychaudhuri, Soumya] Partners Ctr Personalized Genet Med, Boston, MA USA; [Trynka, Gosia; Raychaudhuri, Soumya] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Raychaudhuri, Soumya] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Manchester	Klein, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	robert.klein@mssm.edu	Klein, Robert/ABI-7857-2020; Joseph, Vijai/J-9158-2013	Klein, Robert/0000-0003-3539-5391; Raychaudhuri, Soumya/0000-0002-1901-8265; Joseph, Vijai/0000-0002-7933-151X	NHGRI [U01 HG007033]; Lymphoma Foundation; Barbara K. Lipman Lymphoma Research Fund [74419]; Netherlands Organization for Scientific Research - Rubicon [825.11.024]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007033] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Lymphoma Foundation; Barbara K. Lipman Lymphoma Research Fund; Netherlands Organization for Scientific Research - Rubicon(Netherlands Organization for Scientific Research (NWO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by NHGRI - U01 HG007033 (https://www.genome.gov) RJK; Lymphoma Foundation (www.lymphoma.org) KO; Barbara K. Lipman Lymphoma Research Fund 74419 (www.mskcc.org) KO; Netherlands Organization for Scientific Research - Rubicon 825.11.024 (http://www.nwo.nl) GT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2014, CANC FACTS FIG 2014; Berndt SI, 2013, NAT GENET, V45, P868, DOI 10.1038/ng.2652; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Coetzee SG, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks542; Conde L, 2010, NAT GENET, V42, P661, DOI 10.1038/ng.626; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; Crowther-Swanepoel D, 2010, NAT GENET, V42, P132, DOI 10.1038/ng.510; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Enciso-Mora V, 2010, NAT GENET, V42, P1126, DOI 10.1038/ng.696; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Goldin LR, 2004, CANCER-AM CANCER SOC, V100, P1902, DOI 10.1002/cncr.20189; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; HARRIS GJ, 1991, J SURG ONCOL, V46, P273, DOI 10.1002/jso.2930460413; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Ito Y, 2015, NATURE REVIEWS CANCE; Kumar V, 2011, J HUM GENET, V56, P436, DOI 10.1038/jhg.2011.35; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Levenstien MA, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-26; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Scott DW, 2012, BLOOD, V119, P4949, DOI 10.1182/blood-2012-02-414441; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Skibola CF, 2009, NAT GENET, V41, P873, DOI 10.1038/ng.419; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; Spender LC, 2002, J VIROL, V76, P4919, DOI 10.1128/JVI.76.10.4919-4927.2002; Trynka G, 2014, DISENTANGLING EFFECT; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Urayama KY, 2012, JNCI-J NATL CANCER I, V104, P240, DOI 10.1093/jnci/djr516; Vijai J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003220; Wade R, 2011, HAEMATOL-HEMATOL J, V96, P1496, DOI 10.3324/haematol.2011.043471; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756	42	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139360	10.1371/journal.pone.0139360	http://dx.doi.org/10.1371/journal.pone.0139360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422229	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700099
J	Jin, TS; Hou, XL; Li, PF; Zhou, FF				Jin, Taisong; Hou, Xueliang; Li, Pifan; Zhou, Feifei			A Novel Method of Automatic Plant Species Identification Using Sparse Representation of Leaf Tooth Features	PLOS ONE			English	Article							CLASSIFICATION; MORPHOMETRICS	Automatic species identification has many advantages over traditional species identification. Currently, most plant automatic identification methods focus on the features of leaf shape, venation and texture, which are promising for the identification of some plant species. However, leaf tooth, a feature commonly used in traditional species identification, is ignored. In this paper, a novel automatic species identification method using sparse representation of leaf tooth features is proposed. In this method, image corners are detected first, and the abnormal image corner is removed by the PauTa criteria. Next, the top and bottom leaf tooth edges are discriminated to effectively correspond to the extracted image corners; then, four leaf tooth features (Leaf-num, Leaf-rate, Leaf-sharpness and Leaf-obliqueness) are extracted and concatenated into a feature vector. Finally, a sparse representation-based classifier is used to identify a plant species sample. Tests on a real-world leaf image dataset show that our proposed method is feasible for species identification.	[Jin, Taisong; Li, Pifan; Zhou, Feifei] Xiamen Univ, Sch Informat Sci & Engn, Xiamen 361005, Peoples R China; [Hou, Xueliang] Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Hou, XL (corresponding author), Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China.	houxueliang@xmu.edu.cn						Agarwal G, 2006, TAXON, V55, P597, DOI 10.2307/25065637; Backes AR, 2010, PATTERN RECOGN, V43, P685, DOI 10.1016/j.patcog.2009.07.017; Bao BK, 2013, IEEE T IMAGE PROCESS, V22, P860, DOI 10.1109/TIP.2012.2219543; Bruckstein AM, 2009, SIAM REV, V51, P34, DOI 10.1137/060657704; Clark JY, 2009, BOT J LINN SOC, V159, P300, DOI 10.1111/j.1095-8339.2008.00891.x; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; Corney DPA, 2012, TAXON, V61, P231, DOI 10.1002/tax.611016; Du JX, 2007, APPL MATH COMPUT, V185, P883, DOI 10.1016/j.amc.2006.07.072; Du JX, 2013, NEUROCOMPUTING, V116, P150, DOI 10.1016/j.neucom.2012.03.028; Elhamifar E, 2013, IEEE T PATTERN ANAL, V35, P2765, DOI 10.1109/TPAMI.2013.57; Ingrouille MJ, 1986, LON NAT, V65, P35, DOI DOI 10.6041/J.ISSN.1000-1298.2017.03.004; Jensen RJ, 2002, TAXON, V51, P475, DOI 10.2307/1554860; Larese MG, 2014, PATTERN RECOGN, V47, P158, DOI 10.1016/j.patcog.2013.06.012; Lexer C, 2009, TAXON, V58, P349, DOI 10.1002/tax.582003; Martins J, 2013, MACH VISION APPL, V24, P567, DOI 10.1007/s00138-012-0417-5; Meade C, 2003, BOT J LINN SOC, V143, P231, DOI 10.1046/j.1095-8339.2003.00223.x; Mokhtarian F, 2004, IEEE T IMAGE PROCESS, V13, P653, DOI 10.1109/TIP.2004.826126; Neto JC, 2006, COMPUT ELECTRON AGR, V50, P121, DOI 10.1016/j.compag.2005.09.004; Park J, 2008, J SYST SOFTWARE, V81, P71, DOI 10.1016/j.jss.2007.05.001; Ramos E, 2009, ECOL INFORM, V4, P177, DOI 10.1016/j.ecoinf.2009.06.003; Smith SM, 1997, INT J COMPUT VISION, V23, P45, DOI 10.1023/A:1007963824710; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; [郑小东 Zheng Xiaodong], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P152; [郑小东 Zheng Xiaodong], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P174	24	21	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139482	10.1371/journal.pone.0139482	http://dx.doi.org/10.1371/journal.pone.0139482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440281	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300030
J	Kim, DK; Jin, HR; Eun, KM; Mutusamy, S; Cho, SH; Oh, S; Kim, DW				Kim, Dong-Kyu; Jin, Hong Ryul; Eun, Kyoung Mi; Mutusamy, Somasundran; Cho, Seong H.; Oh, Sohee; Kim, Dae Woo			Non-Eosinophilic Nasal Polyps Shows Increased Epithelial Proliferation and Localized Disease Pattern in the Early Stage	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; INFLAMMATION; FEATURES; SUBCLASSIFICATION; ASTHMA	Background Non-eosinophilic nasal polyps (NPs) show less inflammatory changes and are less commonly associated with lower airway inflammatory disorders such as asthma, compared with eosinophilic NPs. However, the development of non-eosinophilic NPs which is a predominant subtype in Asian population still remains unclear. Methods A total of 81 patients (45 with non-eosinophilic NPs and 36 with eosinophilic NPs) were enrolled. Clinical information and computed tomography (CT), endoscopic, and histological findings were investigated. Tissue samples were analyzed for total IgE levels and for mRNA expression levels of interleukin (IL)-4, IL-5, IL-13, interferon (IFN)-gamma, tumor necrosis factor (TNF)-alpha, IL-17A, IL-22, IL-23p19, transforming growth factor (TGF)-beta 1, TGF-beta 2, TGF-beta 3, and periostin. Immunostaining assessment of Ki-67 as a proliferation marker was performed. Results We found that epithelial in-growing patterns such as pseudocysts were more frequently observed in histological and endoscopic evaluations of non-eosinophilic NPs, which was linked to increase epithelial staining of Ki-67, a proliferating marker. Eosinophilic NPs were characterized by high infiltration of inflammatory cells, compared with non-eosinophilic NPs. To investigate the developmental course of each subtype, CT was analyzed according to CT scores and subtypes. Non-eosinophilic NPs showed more localized pattern and maxillary sinus involvement, but lesser olfactory involvement in early stage whereas eosinophilic NPs were characterized by diffuse ethmoidal and olfactory involvement. In addition, high ethmoidal/maxillary (E/M) CT scores, indicating ethmoidal dominant involvement, were one of surrogate markers for eosinophilic NP. E/M CT scores was positively correlated with levels of T(H)2 inflammatory markers, including IL-4, IL-5, periostin mRNA expression and total IgE levels in NPs, whereas levels of the T(H)1 cytokine, IFN-gamma were inversely correlated. Moreover, if the combinatorial algorithm meet the three of the four markers, including IL-5 (<2.379), periostin (<3.889), IFN-gamma (>0.316), and E/M ratio (<2.167), non-eosinophilic CRSwNP are diagnosed with a sensitivity of 84.4% and a specificity of 84.8%. Conclusion Histologic, immunologic and clinical data suggest that non-eosinophilic NPs showed enhanced epithelial alteration and more localized maxillary involvement. Combination of cutoff value on IL-5, periostin, IFN-gamma, and E/M scores may be one of surrogate markers for non-eosinophil NP subtype.	[Kim, Dong-Kyu] Hallym Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Chuncheon Sacred Heart Hosp, Chunchon, South Korea; [Kim, Dong-Kyu] Hallym Univ, Coll Med, Nanobio Regenerat Med Inst, Chunchon, South Korea; [Jin, Hong Ryul; Eun, Kyoung Mi; Mutusamy, Somasundran; Kim, Dae Woo] Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Seoul, South Korea; [Cho, Seong H.] Univ S Florida, Dept Internal Med, Div Allergy Immunol, Morsani Coll Med, Tampa, FL 33612 USA; [Oh, Sohee] Seoul Natl Univ, Coll Med, Dept Biostat, Boramae Med Ctr, Seoul, South Korea	Hallym University; Hallym University; Seoul National University (SNU); Seoul National University Hospital; State University System of Florida; University of South Florida; Seoul National University (SNU); Seoul National University Hospital	Kim, DW (corresponding author), Seoul Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Boramae Med Ctr, Seoul, South Korea.	kicubi@daum.net		Kim, Dong-Kyu/0000-0003-4917-0177	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center [03-2013-7]; SK Telecom Research Fund [01-2014-10]; Hallym University Research Fund [HURF-2014-41]	Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center; SK Telecom Research Fund; Hallym University Research Fund	This research was supported by a clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center (03-2013-7), by the SK Telecom Research Fund (01-2014-10), and by the Hallym University Research Fund 2014 (HURF-2014-41).	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Alatas N, 2006, OTOLARYNG HEAD NECK, V135, P236, DOI 10.1016/j.otohns.2006.03.033; Bachert C, 2012, J INTERN MED, V272, P133, DOI 10.1111/j.1365-2796.2012.02559.x; Basinski TM, 2009, J ALLERGY CLIN IMMUN, V124, P74, DOI 10.1016/j.jaci.2009.04.019; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Cho JS, 2012, CLIN EXP ALLERGY, V42, P872, DOI 10.1111/j.1365-2222.2011.03931.x; Derycke L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097581; Diaz-Vazquez C, 2009, PEDIAT ALLERG IMM-UK, V20, P601, DOI 10.1111/j.1399-3038.2008.00827.x; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gevaert P, 2011, J ALLERGY CLIN IMMUN, V128, P989, DOI 10.1016/j.jaci.2011.07.056; Han JK, 2013, LARYNGOSCOPE, V123, pS15, DOI 10.1002/lary.23979; Haruna S, 2009, RHINOLOGY, V47, P66; Hu Y, 2012, LARYNGOSCOPE, V122, P498, DOI 10.1002/lary.22507; Ikeda K, 2013, LARYNGOSCOPE, V123, pE1, DOI 10.1002/lary.24154; Ishitoya Junichi, 2010, Allergol Int, V59, P239, DOI 10.2332/allergolint.10-RAI-0231; Jeong WJ, 2011, OTOLARYNG HEAD NECK, V144, P241, DOI 10.1177/0194599810391738; KANAI N, 1994, AM J RESP CRIT CARE, V150, P1094, DOI 10.1164/ajrccm.150.4.7921442; Kim DW, 2013, CLIN EXP OTORHINOLAR, V6, P146, DOI 10.3342/ceo.2013.6.3.146; Kim DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111352; Kim JW, 2007, OTOLARYNG HEAD NECK, V137, P925, DOI 10.1016/j.otohns.2007.07.036; Kountakis SE, 2004, LARYNGOSCOPE, V114, P1895, DOI 10.1097/01.mlg.0000147917.43615.c0; Lund VJ, 1997, OTOLARYNG HEAD NECK, V117, pS35, DOI 10.1016/S0194-5998(97)70005-6; Mahdavinia M, 2015, J ALLERGY CLIN IMMUN, V135, P576, DOI 10.1016/j.jaci.2014.08.031; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Nakayama T, 2011, RHINOLOGY, V49, P392, DOI 10.4193/Rhino10.261; Polzehl D, 2006, ALLERGY, V61, P1275, DOI 10.1111/j.1398-9995.2006.01132.x; Ragab A, 2005, RHINOLOGY, V43, P11; Richer SL, 2008, AM J RHINOL, V22, P228, DOI 10.2500/ajr.2008.22.3162; Sakuma Y, 2011, AURIS NASUS LARYNX, V38, P583, DOI 10.1016/j.anl.2011.01.007; Shi LL, 2013, ALLERGY, V68, P101, DOI 10.1111/all.12064; Snidvongs K, 2012, RHINOLOGY, V50, P299, DOI [10.4193/Rhin12.022, 10.4193/Rhino12.022]; Van Bruaene N, 2011, CURR OPIN ALLERGY CL, V11, P8, DOI 10.1097/ACI.0b013e32834233ef; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Yamada T, 2000, AM J RHINOL, V14, P143, DOI 10.2500/105065800782102717; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang N, 2006, AM J RHINOL, V20, P445, DOI 10.2500/ajr.2006.20.2887; Zuo KJ, 2014, EUR ARCH OTO-RHINO-L, V271, P2461, DOI 10.1007/s00405-014-2910-0	38	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139945	10.1371/journal.pone.0139945	http://dx.doi.org/10.1371/journal.pone.0139945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439628	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300082
J	Pauchet, Y; Wielsch, N; Wilkinson, PA; Sakaluk, SK; Svatos, A; Ffrench-Constant, RH; Hunt, J; Heckel, DG				Pauchet, Yannick; Wielsch, Natalie; Wilkinson, Paul A.; Sakaluk, Scott K.; Svatos, Ales; Ffrench-Constant, Richard H.; Hunt, John; Heckel, David G.			What's in the Gift? Towards a Molecular Dissection of Nuptial Feeding in a Cricket	PLOS ONE			English	Article							FREE AMINO-ACIDS; SEXUAL CONFLICT; CARBONIC-ANHYDRASES; DECORATED CRICKETS; FOOD GIFTS; INSECTS; FAMILY; SPERMATOPHYLAX; ORTHOPTERA; PROTEINS	Nuptial gifts produced by males and transferred to females during copulation are common in insects. Yet, their precise composition and subsequent physiological effects on the female recipient remain unresolved. Male decorated crickets Gryllodes sigillatus transfer a spermatophore to the female during copulation that is composed of an edible gift, the spermatophylax, and the ampulla that contains the ejaculate. After transfer of the spermatophore, the female detaches the spermatophylax and starts to eat it while sperm from the ampulla are evacuated into the female reproductive tract. When the female has finished consuming the spermatophylax, she detaches the ampulla and terminates sperm transfer. Hence, one simple function of the spermatophylax is to ensure complete sperm transfer by distracting the female from prematurely removing the ampulla. However, the majority of orally active components of the spermatophylax itself and their subsequent effects on female behavior have not been identified. Here, we report the first analysis of the proteome of the G. sigillatus spermatophylax and the transcriptome of the male accessory glands that make these proteins. The accessory gland transcriptome was assembled into 17,691 transcripts whilst about 30 proteins were detected within the mature spermatophylax itself. Of these 30 proteins, 18 were encoded by accessory gland encoded messages. Most spermatophylax proteins show no similarity to proteins with known biological functions and are therefore largely novel. A spermatophylax protein shows similarity to protease inhibitors suggesting that it may protect the biologically active components from digestion within the gut of the female recipient. Another protein shares similarity with previously characterized insect polypeptide growth factors suggesting that it may play a role in altering female reproductive physiology concurrent with fertilization. Characterization of the spermatophylax proteome provides the first step in identifying the genes encoding these proteins in males and in understanding their biological functions in the female recipient.	[Pauchet, Yannick; Heckel, David G.] Max Planck Inst Chem Ecol, Entomol, Jena, Germany; [Wielsch, Natalie; Svatos, Ales] Max Planck Inst Chem Ecol, Mass Spectrometry, Jena, Germany; [Wilkinson, Paul A.; Ffrench-Constant, Richard H.; Hunt, John] Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, England; [Sakaluk, Scott K.] Illinois State Univ, Sch Biol Sci, Behav Ecol Evolut & Systemat Sect, Normal, IL 61761 USA	Max Planck Society; Max Planck Society; University of Exeter; Illinois State University	Pauchet, Y (corresponding author), Max Planck Inst Chem Ecol, Entomol, Jena, Germany.	ypauchet@ice.mpg.de	Heckel, David G/K-2138-2013; Svatos, Ales/A-3305-2014; Pauchet, Yannick/AAU-9751-2021	Heckel, David G/0000-0001-8991-2150; Svatos, Ales/0000-0003-1032-7288; Pauchet, Yannick/0000-0002-2918-8946; ffrench-Constant, Richard/0000-0001-5385-9888; Hunt, John/0000-0002-4962-8750	Max Planck Gesellschaft; National Science Foundation [IOS-0718140]; Biotechnology and Biological Sciences Research Council; Royal Society [URF04053]; Direct For Biological Sciences [1118160] Funding Source: National Science Foundation	Max Planck Gesellschaft(Max Planck Society); National Science Foundation(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Max Planck Gesellschaft (YP, NW, AS, DGH); National Science Foundation IOS-0718140 (http://www.nsf.gov/) (SKS); Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/) (RHFC); and Royal Society URF04053 (https://royalsociety.org/) (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Bailey NW, 2013, G3-GENES GENOM GENET, V3, P225, DOI 10.1534/g3.112.004341; Biagio FP, 2009, J INSECT PHYSIOL, V55, P1125, DOI 10.1016/j.jinsphys.2009.08.015; BOWEN BJ, 1984, AUST J ZOOL, V32, P23, DOI 10.1071/ZO9840023; Braswell WE, 2006, GENOME, V49, P1069, DOI 10.1139/G06-061; Breugelmans B, 2011, PEPTIDES, V32, P539, DOI 10.1016/j.peptides.2010.08.006; Breugelmans B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-97; Breugelmans B, 2009, PEPTIDES, V30, P622, DOI 10.1016/j.peptides.2008.07.026; Ewen-Campen B, 2013, CURR BIOL, V23, P835, DOI 10.1016/j.cub.2013.03.063; Gershman SN, 2013, J EVOLUTION BIOL, V26, P693, DOI 10.1111/jeb.12078; Gershman SN, 2012, P ROY SOC B-BIOL SCI, V279, P2531, DOI 10.1098/rspb.2011.2592; Gordon DG, 2012, ANIM BEHAV, V83, P369, DOI 10.1016/j.anbehav.2011.11.005; Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; Harrison JF, 2001, ANNU REV ENTOMOL, V46, P221, DOI 10.1146/annurev.ento.46.1.221; Heller KG, 1998, J INSECT PHYSIOL, V44, P1001, DOI 10.1016/S0022-1910(97)00171-6; Hu S, 1998, J NEUROBIOL, V35, P77, DOI 10.1002/(SICI)1097-4695(199804)35:1<77::AID-NEU7>3.0.CO;2-8; Ivy TM, 2005, EVOLUTION, V59, P152, DOI 10.1111/j.0014-3820.2005.tb00902.x; Jung G, 1998, J BIOCHEM-TOKYO, V124, P446, DOI 10.1093/oxfordjournals.jbchem.a022133; Kasuya E, 1998, ZOOL SCI, V15, P127, DOI 10.2108/zsj.15.127; Kawamura K, 1999, DEVELOPMENT, V126, P211; Kirsch Roy, 2012, BMC Genomics, V13, P587, DOI 10.1186/1471-2164-13-587; Lewis SM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0336; Linser PJ, 2009, J EXP BIOL, V212, P1662, DOI 10.1242/jeb.028084; Marchini D, 2009, J MORPHOL, V270, P880, DOI 10.1002/jmor.10727; NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905; Papanicolaou A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-447; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P467, DOI 10.1016/j.ibmb.2009.05.001; Pelosi P, 2014, APPL MICROBIOL BIOT, V98, P61, DOI 10.1007/s00253-013-5383-y; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Sakaluk SK, 2006, AM NAT, V167, P94, DOI 10.1086/498279; SAKALUK SK, 1984, SCIENCE, V223, P609, DOI 10.1126/science.223.4636.609; Sakaluk SK, 2000, P ROY SOC B-BIOL SCI, V267, P339, DOI 10.1098/rspb.2000.1006; Sakaluk SK, 2002, EVOLUTION, V56, P1999, DOI 10.1111/j.0014-3820.2002.tb00126.x; Shevchenko A, 2005, J PROTEOME RES, V4, P862, DOI 10.1021/pr0500051; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Simonet G, 2005, BIOCHEM J, V388, P281, DOI 10.1042/BJ20041414; SLY WS, 1995, ANNU REV BIOCHEM, V64, P375, DOI 10.1146/annurev.bi.64.070195.002111; Takekata H, 2014, J INSECT PHYSIOL, V68, P16, DOI 10.1016/j.jinsphys.2014.06.012; Vahed K, 1998, BIOL REV, V73, P43, DOI 10.1017/S0006323197005112; Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x; Warwick S, 2009, BIOL LETTERS, V5, P194, DOI 10.1098/rsbl.2008.0731; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wedell N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-204; WILL MW, 1994, ANIM BEHAV, V48, P1309, DOI 10.1006/anbe.1994.1367; Zhang JQ, 2013, CHEMOSPHERE, V93, P1207, DOI 10.1016/j.chemosphere.2013.06.081; Zhang J, 2006, INSECT BIOCHEM MOLEC, V36, P536, DOI 10.1016/j.ibmb.2006.04.002; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031	50	7	7	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140191	10.1371/journal.pone.0140191	http://dx.doi.org/10.1371/journal.pone.0140191			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439494	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300100
J	Peng, XE; Wu, YL; Zhu, YB; Huang, RD; Lu, QQ; Lin, X				Peng, Xian-E; Wu, Yun-Li; Zhu, Yi-bing; Huang, Rong-dong; Lu, Qing-Qing; Lin, Xu			Association of a Human FABP1 Gene Promoter Region Polymorphism with Altered Serum Triglyceride Levels	PLOS ONE			English	Article							FATTY-ACID-BINDING; PROTEIN KNOCKOUT MICE; CARDIOVASCULAR-DISEASE; LIVER-DISEASE; PPAR-ALPHA; BLOOD-PRESSURE; C/EBP-ALPHA; EXPRESSION; RISK; METABOLISM	Liver fatty acid-binding protein (L-FABP), also known as fatty acid-binding protein 1 (FABP1), is a key regulator of hepatic lipid metabolism. Elevated FABP1 levels are associated with an increased risk of cardiovascular disease (CVD) and metabolic syndromes. In this study, we examine the association of FABP1 gene promoter variants with serum FABP1 and lipid levels in a Chinese population. Four promoter single-nucleotide polymorphisms (SNPs) of FABP1 gene were genotyped in a cross-sectional survey of healthy volunteers (n = 1,182) from Fuzhou city of China. Results showed that only the rs2919872 G>A variant was significantly associated with serum TG concentration(P = 0.032). Compared with the rs2919872 G allele, rs2919872 A allele contributed significantly to reduced serum TG concentration, and this allele dramatically decreased the FABP1 promoter activity(P < 0.05). The rs2919872 A allele carriers had considerably lower serum FABP1 levels than G allele carriers (P < 0.01). In the multivariable linear regression analysis, the rs2919872 A allele was negatively associated with serum FABP1 levels (beta = -0.320, P = 0.003), while serum TG levels were positively associated with serum FABP1 levels (beta = 0.487, P = 0.014). Our data suggest that compared with the rs2919872 G allele, the rs2919872 A allele reduces the transcriptional activity of FABP1 promoter, and thereby may link FABP1 gene variation to TG level in humans.	[Peng, Xian-E; Wu, Yun-Li; Zhu, Yi-bing; Lin, Xu] Fujian Med Univ, Sch Basic Med Sci, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Peoples R China; [Peng, Xian-E; Huang, Rong-dong] Fujian Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Fuzhou, Peoples R China; [Wu, Yun-Li; Lin, Xu] Fujian Med Univ, Dept Med Microbiol, Fujian Key Lab Tumor Microbiol, Fuzhou, Peoples R China; [Lu, Qing-Qing] Fujian Med Univ, Dept Gastroenterol, Union Hosp, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University; Fujian Medical University	Lin, X (corresponding author), Fujian Med Univ, Sch Basic Med Sci, Minist Educ Gastrointestinal Canc, Key Lab, Fuzhou, Peoples R China.	linxu@mail.fjmu.edu.cn			National Natural Science Foundation of China [81473047, 81271822]; Natural Science Foundation of Fujian province [2015J01303]; Training Program Foundation for Middle-aged and Young Talents from Sanitation System of Fujian province [2014-ZQN-ZD-23]; New Century Excellent Talents in Fujian Province University [JA11106, JA14127]; Foundation of Fujian Educational Committee [JK2013021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian province(Natural Science Foundation of Fujian Province); Training Program Foundation for Middle-aged and Young Talents from Sanitation System of Fujian province; New Century Excellent Talents in Fujian Province University(Program for New Century Excellent Talents in University (NCET)); Foundation of Fujian Educational Committee	This work was supported by the National Natural Science Foundation of China,(http://www.nsfc.gov.cn/), Grant Number: No. 81473047 to X-EP, the National Natural Science Foundation of China, (http://www.nsfc.gov.cn/), Grant Number: No. 81271822 to XL, the Natural Science Foundation of Fujian province (http://xmgl.fjkjt.gov.cn/), Grant Number: No. 2015J01303 to X-EP, the Training Program Foundation for Middle-aged and Young Talents from Sanitation System of Fujian province (http://www.fjhfpc.gov.cn/), Grant Number: No. 2014-ZQN-ZD-23 to X-EP, the New Century Excellent Talents in Fujian Province University, Grant Number: No. JA11106 and No. JA14127 to X-EP and the Foundation of Fujian Educational Committee (http://www.fjedu.gov.cn/), Grant Number: No. JK2013021 to Y-LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; BASS NM, 1986, BIOCHEM BIOPH RES CO, V137, P929, DOI 10.1016/0006-291X(86)90314-1; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Brahe LK, 2013, BRIT J NUTR, V110, P790, DOI 10.1017/S0007114512006058; Brouillette C, 2004, J HUM GENET, V49, P424, DOI 10.1007/s10038-004-0171-2; Chen AP, 2013, HEPATOLOGY, V57, P2202, DOI 10.1002/hep.26318; Chen BD, 2015, METAB SYNDR RELAT DI; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Eeg-Olofsson K, 2014, DIABETES RES CLIN PR, V106, P136, DOI 10.1016/j.diabres.2014.07.010; Fisher E, 2007, MOL GENET METAB, V91, P278, DOI 10.1016/j.ymgme.2007.03.002; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hong KW, 2010, J HUM HYPERTENS, V24, P763, DOI 10.1038/jhh.2010.9; Hong KW, 2011, J HUM GENET, V56, P205, DOI 10.1038/jhg.2010.167; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; McIntosh AL, 2014, AM J PHYSIOL-GASTR L, V307, pG164, DOI 10.1152/ajpgi.00369.2013; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Murphy EJ, 1998, AM J PHYSIOL-GASTR L, V275, pG244, DOI 10.1152/ajpgi.1998.275.2.G244; Murphy EJ, 1996, BBA-LIPID LIPID MET, V1301, P191, DOI 10.1016/0005-2760(96)00024-0; Neeli I, 2007, J BIOL CHEM, V282, P17974, DOI 10.1074/jbc.M610765200; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Newberry EP, 2009, MOL CELL BIOCHEM, V326, P79, DOI 10.1007/s11010-008-0002-4; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; Peng XE, 2012, GENE, V500, P54, DOI 10.1016/j.gene.2012.03.050; Petrescu AD, 2013, BBA-MOL CELL BIOL L, V1831, P1412, DOI 10.1016/j.bbalip.2013.05.008; Riva A, 2012, NUCLEIC ACIDS RES, V40, pD155, DOI 10.1093/nar/gkr1080; VEERKAMP JH, 1993, MOL CELL BIOCHEM, V123, P101, DOI 10.1007/BF01076480; Weickert MO, 2007, AM J PHYSIOL-ENDOC M, V293, pE1078, DOI 10.1152/ajpendo.00337.2007; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wolfrum C, 1999, BBA-MOL CELL BIOL L, V1437, P194, DOI 10.1016/S1388-1981(99)00008-6; Wu YL, 2012, BIOCHIMIE, V94, P384, DOI 10.1016/j.biochi.2011.08.006; Zhang Y, 2010, PHYSIOL GENOMICS, V42, P168, DOI 10.1152/physiolgenomics.00038.2010	34	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139417	10.1371/journal.pone.0139417	http://dx.doi.org/10.1371/journal.pone.0139417			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439934	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300028
J	Rahimi, P; Vahabpour, R; Aghasadeghi, MR; Sadat, SM; Howaizi, N; Mostafavi, E; Eslamifar, A; Fallahian, V				Rahimi, Pooneh; Vahabpour, RouhAllah; Aghasadeghi, Mohammad Reza; Sadat, Syed Mehdi; Howaizi, Nader; Mostafavi, Ehsan; Eslamifar, Ali; Fallahian, Vida			Neutralizing Antibody Response after Intramuscular Purified Vero Cell Rabies Vaccination (PVRV) in Iranian Patients with Specific Medical Conditions	PLOS ONE			English	Article							POSTEXPOSURE PROPHYLAXIS; PREGNANCY; EXPERIENCE; SCHEDULE; SAFETY; CHINA	Objective Post exposure prophylaxis using one of the WHO-approved vaccines is the method of choice for preventing rabies. Abnormal immune function in patients with some specific medical conditions, such as pregnancy, chronic hepatitis B virus infection, different types of cancers like lymphoma, diabetes I and II, corticosteroid consumption by patients with rheumatoid arthritis and lupus erythematosus, could impair the immunologic response to various vaccines. The immune response to rabies vaccination has never been examined in patients with any of these described medical conditions. This study purposed to evaluate the neutralyzing antibody response after vaccination with purified Vero cell rabies vaccine (PVRV) according to the WHO-recommended Post-Exposure Prophylaxis (PEP) "ESSEN" regimen. Methods Thirty healthy volunteers and 50 volunteers with different medical conditions who were exposed to a suspected rabid animal in the 2nd or 3rd category of exposure received 5 doses of PVRV under the ESSEN protocol. Three blood samples were collected on days 0 (before the first dose), 14, and 35. The anti-rabies antibody titer was measured using the Rapid Fluorescent Foci Inhibition Test (RFFIT) and an ELISA Bio-Rad, Platelia, Rabies II kit. Results All subjects reached NAb titers above 0.5 IU/ml by day 14 after vaccination. On day 35 (1 week after receiving the last rabies vaccine), anti-rabies antibodies were in the protective level (> 0.5 IU/ml) in both groups. There was no statistically significant difference in anti-rabies antibody response due to the type of exposure (category 2 or 3), and successful seroconversion was confirmed in both groups. Conclusion In conclusion, the ESSEN protocol using the PVRV vaccine is sufficient for rabies prophylaxis in patients with specific medical conditions.	[Rahimi, Pooneh; Vahabpour, RouhAllah; Aghasadeghi, Mohammad Reza; Sadat, Syed Mehdi] Inst Pasteur, Dept Hepatitis & AIDS, Tehran, Iran; [Howaizi, Nader] Inst Pasteur, WHO Collaborating Ctr Reference & Res Rabies, Tehran, Iran; [Eslamifar, Ali; Fallahian, Vida] Inst Pasteur, Dept Vaccinat, Rabies Postexposure Prophylaxis, Tehran, Iran; [Mostafavi, Ehsan] Inst Pasteur, Dept Epidemiol, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Rahimi, P (corresponding author), Inst Pasteur, Dept Hepatitis & AIDS, Tehran, Iran.	prahimi@pasteur.ac.ir	aghasadeghi, mohammad reza/K-9497-2017; Rahimi, Pooneh/Q-8405-2017; Mostafavi, Ehsan/A-7627-2011; Sadat, Seyed Mehdi/L-8867-2017	aghasadeghi, mohammad reza/0000-0003-2186-0774; Rahimi, Pooneh/0000-0001-8829-5373; Mostafavi, Ehsan/0000-0002-1997-517X; Sadat, Mehdi/0000-0001-7739-179X	Pasteur Institute of Iran [624]	Pasteur Institute of Iran	This project was financially supported by Pasteur Institute of Iran under the project number 624.	[Anonymous], 2005, TECHN REP SER WHO, V931; [Anonymous], 2007, WKLY EPIDEMIOL REC, V82, P425; CHUTIVONGSE S, 1989, VACCINE, V7, P546, DOI 10.1016/0264-410X(89)90280-6; Fayaz A., 1997, 2 DECADES EXPERIENCE; FESCHAREK R, 1990, VACCINE, V8, P409, DOI 10.1016/0264-410X(90)90120-B; Hay E, 2001, JAMA-J AM MED ASSOC, V285, P166, DOI 10.1001/jama.285.2.166; Huang GH, 2013, HUM VACC IMMUNOTHER, V9, P177, DOI 10.4161/hv.22377; Jaijaroensup W, 1999, CLIN INFECT DIS, V28, P913, DOI 10.1086/517241; KORVER K, 1987, CLIN EXP IMMUNOL, V70, P328; Liu HZ, 2011, HUM VACCINES, V7, P220, DOI 10.4161/hv.7.2.14003; Lyles D, 2007, FIELDS VIROLOGY, P1364; Meslin FX, 1996, LAB TECHNIQUES RABIE, p[181, 383]; Rupprecht Charles E., 2010, Morbidity and Mortality Weekly Report, V59, P1; Rupprecht CE, 2009, VACCINE, V27, P7141, DOI 10.1016/j.vaccine.2009.09.029; Sudarshan M. K., 1999, Journal of Communicable Diseases, V31, P229; SUNTHARASAMAI P, 1988, T ROY SOC TROP MED H, V82, P633, DOI 10.1016/0035-9203(88)90539-1; Suwansrinon K, 2006, VACCINE, V24, P3878, DOI 10.1016/j.vaccine.2006.02.027; Thisyakorn U, 2001, VACCINE, V19, P1534, DOI 10.1016/S0264-410X(00)00322-4; Wiwanitkit V, 2009, ANATOL J OBSTET GYNE, V4, P2	19	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139171	10.1371/journal.pone.0139171	http://dx.doi.org/10.1371/journal.pone.0139171			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440665	Green Published, gold			2022-12-27	WOS:000362510300015
J	Maestri, A; Sortica, VA; Tovo-Rodrigues, L; Santos, MC; Barbagelata, L; Moraes, MR; de Mello, WA; Gusmao, L; Sousa, RCM; dos Santos, SEB				Maestri, Alvino; Sortica, Vinicius Albuquerque; Tovo-Rodrigues, Luciana; Santos, Mirleide Cordeiro; Barbagelata, Luana; Moraes, Milene Raiol; de Mello, Wyller Alencar; Gusmao, Leonor; Medeiros Sousa, Rita Catarina; Batista dos Santos, Sidney Emanuel			Siaa2-3Gal beta 1-Receptor Genetic Variants Are Associated with Influenza A(H1N1)pdm09 Severity	PLOS ONE			English	Article							H1N1 INFLUENZA; BIPOLAR DISORDER; VIRUS; FAMILY; 8Q24; TOOL	Different host genetic variants may be related to the virulence and transmissibility of pandemic Influenza A(H1N1)pdm09, influencing events such as binding of the virus to the entry receptor on the cell of infected individuals and the host immune response. In the present study, two genetic variants of the ST3GAL1 gene, which encodes the Siaa2-3Gal beta 1-receptor to which influenza A(H1N1)pdm09 virus binds for entry into the host cell, were investigated in an admixed Brazilian population. First, the six exons encoding the ST3GAL1 gene were sequenced in 68 patients infected with strain A(H1N1)pdm09. In a second phase of the study, the rs113350588 and rs1048479 polymorphisms identified in this sample were genotyped in a sample of 356 subjects from the northern and northeastern regions of Brazil with a diagnosis of pandemic influenza. Functional analysis of the polymorphisms was performed in silico and the influence of these variants on the severity of infection was evaluated. The results suggest that rs113350588 and rs1048479 may alter the function of ST3GAL1 either directly through splicing regulation alteration and/or indirectly through LD with SNP with regulatory function. In the study the rs113350588 and rs1048479 polymorphisms were in linkage disequilibrium in the population studied (D' = 0.65). The GC haplotype was associated with an increased risk of death in subjects with influenza (OR = 4.632, 95% CI = 2.10; 1.21). The AT haplotype was associated with an increased risk of severe disease and death (OR = 1.993, 95% CI = 1.09; 3.61 and OR 4.476, 95% CI = 2.37; 8.44, respectively). This study demonstrated for the first time the association of ST3GAL1 gene haplotypes on the risk of more severe disease and death in patients infected with Influenza A(H1N1)pdm09 virus.	[Maestri, Alvino; Moraes, Milene Raiol; Batista dos Santos, Sidney Emanuel] Fed Univ Para, Lab Human & Med Genet, BR-66059 Belem, Para, Brazil; [Sortica, Vinicius Albuquerque] Fed Univ Para, Ctr Canc Studies, BR-66059 Belem, Para, Brazil; [Santos, Mirleide Cordeiro; Barbagelata, Luana; de Mello, Wyller Alencar; Medeiros Sousa, Rita Catarina] Evandro Chagas Inst, Virol Sect, Lab Resp Viruses, Ananindeua, Para, Brazil; [Gusmao, Leonor] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal; [Medeiros Sousa, Rita Catarina] Fed Univ Para, Inst Trop Med, BR-66059 Belem, Para, Brazil; [Tovo-Rodrigues, Luciana] Univ Fed Pelotas, Ctr Epidemiol Res, Pelotas, Rio Grande Do S, Brazil	Universidade Federal do Para; Universidade Federal do Para; Instituto Evandro Chagas; Universidade do Porto; Universidade Federal do Para; Universidade Federal de Pelotas	Maestri, A (corresponding author), Fed Univ Para, Lab Human & Med Genet, BR-66059 Belem, Para, Brazil.	alvimaestri@hotmail.com	Gusmao, Leonor/B-3122-2013; Tovo-Rodrigues, Luciana/D-4256-2018; Barbagelata, Luana/AAE-8243-2019; Sortica, Vinicius A/G-5772-2017; Gusmão, Leonor/L-8931-2019	Gusmao, Leonor/0000-0003-0432-6481; Sortica, Vinicius A/0000-0001-6185-0832; Gusmão, Leonor/0000-0003-0432-6481	Brazilian Ministry of Health (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES); Abroad Sandwich Doctorate Program (Programa de Doutorado Sanduiche no Exterior - PDSE); Fundacao Amazonia Paraense/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (FAPESPA/CNPq); Programa de Pesquisa para o SUS (PPSUS)	Brazilian Ministry of Health (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES); Abroad Sandwich Doctorate Program (Programa de Doutorado Sanduiche no Exterior - PDSE); Fundacao Amazonia Paraense/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (FAPESPA/CNPq); Programa de Pesquisa para o SUS (PPSUS)	AM was the recipient of a Doctoral fellowship from the Brazilian Ministry of Health (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES) and the Abroad Sandwich Doctorate Program (Programa de Doutorado Sanduiche no Exterior - PDSE). The project was supported by Fundacao Amazonia Paraense/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (FAPESPA/CNPq) and Programa de Pesquisa para o SUS (PPSUS).	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; [Anonymous], 2009, CDC PROT REALT RTPCR; Boonarkart C, 2012, J MED VIROL, V84, P380, DOI 10.1002/jmv.23201; CHANG ML, 1995, GLYCOBIOLOGY, V5, P319, DOI 10.1093/glycob/5.3.319; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Cabral MG, 2010, IMMUNOL LETT, V131, P89, DOI 10.1016/j.imlet.2010.02.009; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Kumlin U, 2008, INFLUENZA OTHER RESP, V2, P147, DOI 10.1111/j.1750-2659.2008.00051.x; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Monteerarat Y, 2010, ARCH VIROL, V155, P889, DOI 10.1007/s00705-010-0658-4; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Stephens M, 2003, AM J HUM GENET, V73, P8; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Viboud Cecile, 2010, PLoS Curr, V2, pRRN1153; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zandi PP, 2008, AM J MED GENET B, V147B, P612, DOI 10.1002/ajmg.b.30651; Zandi PP, 2007, AM J MED GENET B, V144B, P625, DOI 10.1002/ajmg.b.30486; Zhang L, 2009, INFECT GENET EVOL, V9, P1148, DOI 10.1016/j.meegid.2009.07.006	26	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139681	10.1371/journal.pone.0139681	http://dx.doi.org/10.1371/journal.pone.0139681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436774	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200047
J	Schachat, SR; Brown, RL				Schachat, Sandra R.; Brown, Richard L.			Color Pattern on the Forewing of Micropterix (Lepidoptera: Micropterigidae): Insights into the Evolution of Wing Pattern and Wing Venation in Moths	PLOS ONE			English	Article							GROUND-PLAN; TORTRICIDAE; MORPHOLOGY; PHYLOGENY; BARCODES; ELEMENTS; HUBNER	Wing patterns are key taxonomic characters that have long been used in descriptions of Lepidoptera; however, wing pattern homologies are not understood among different moth lineages. Here, we examine the relationship between wing venation and wing pattern in the genus Micropterix, among the most basal extant Lepidoptera, in order to evaluate the two existing predictive models that have the potential to establish wing pattern element homologies for the order. The location of wing pattern elements along the costal margin of the wing in Micropterix is consistent with the predictions of the model proposed for Tortricidae by Brown and Powell in 1991, later modified by Baixeras in 2002. The predictive power of this model for such distantly related taxa suggests that the model may hold across various superfamilies within Lepidoptera, and supports the long-held notion that fasciae, not spots, are the most likely primitive wing pattern elements for the order. In addition, the location of wing pattern elements suggests that the wing vein commonly termed Sc-1 may in fact be a different vein, which Comstock identified in Trichoptera and referred to as "a."	[Schachat, Sandra R.; Brown, Richard L.] Mississippi Entomol Museum, Mississippi State, MS 39762 USA; [Schachat, Sandra R.] Smithsonian Inst, Dept Paleobiol, Washington, DC 20560 USA	Mississippi State University; Smithsonian Institution; Smithsonian National Museum of Natural History	Schachat, SR (corresponding author), Mississippi Entomol Museum, Mississippi State, MS 39762 USA.	schachatsr@si.edu	Schachat, Sandra R/M-5399-2014; Schachat, Sandra/W-6395-2019	Schachat, Sandra R/0000-0003-3237-5619; Schachat, Sandra/0000-0003-3237-5619	National Institute of Food and Agriculture; United States Department of Agriculture [MIS-012040]; National Science Foundation Graduate Research Fellowship Program [DGE-1125191]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	The research was supported in part by the National Institute of Food and Agriculture (http://nifa.usda.gov), United States Department of Agriculture (http://www.usda.gov), under project MIS-012040. SRS is supported by the National Science Foundation (http://www.nsf.gov) Graduate Research Fellowship Program (https://www.nsfgrfp.org/) under Grant No. DGE-1125191. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baixeras J, 2002, ANN ENTOMOL SOC AM, V95, P422, DOI 10.1603/0013-8746(2002)095[0422:AOOGLT]2.0.CO;2; Braun A.F., 1914, J ACAD NATURAL SCI P, V16, P103; BROWN RL, 1991, PAN-PAC ENTOMOL, V67, P107; Collins MM, 2013, J LEPID SOC, V67, P49; Comstock JH, 1918, WINGS INSECTS; Danilevsky A, 1968, FAUNA SSSR, V5, P635; FAL'KOVICH M. I., 1966, TR ZOOL INST AKAD NAUK SSSR, V37, P208; Gibbs G. W., 2004, P 22 INT C ENT BRISB; Gibbs GW, 2014, MEM MUS NAT HIST NAT, V206, P239; Gibbs George W., 2014, FAUNA OF NEW ZEALAND, P7, DOI 10.7931/J2/FNZ.72; GILLIGAN T. M., 2008, OHIO BIOL SURV B, V16, P1; Giribet G, 2015, ZOOL ANZ, V256, P96, DOI 10.1016/j.jcz.2015.01.003; Heath J, 1976, MOTHS BUTTERFLIES GR; Heikkila M, 2014, CLADISTICS, V30, P563, DOI 10.1111/cla.12064; HENKE KARL, 1928, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V12, P240, DOI 10.1007/BF00407635; Imada Y, 2011, P ROY SOC B-BIOL SCI, V278, P3026, DOI 10.1098/rspb.2011.0134; Kawahara AY, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-182; Keys DN, 1999, SCIENCE, V283, P532, DOI 10.1126/science.283.5401.532; Koch PB, 2002, EUR J ENTOMOL, V99, P67, DOI 10.14411/eje.2002.012; Kozlov M. V., 1988, CRETACEOUS BIOCOENOT, P16; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; KRISTENSEN N P, 1979, Steenstrupia, V5, P69; KRISTENSEN NP, 1982, ENTOMOL SCAND, V13, P513; Kuhne W.G., 1973, MITTEILUNGEN DTSCH E, V32, P61; Kupryjanowicz J., 2001, AMBER TREASURE TRO 1, P19; Kusnezov N., 1941, REVISION AMBER LEPID; Kuznetsov V, 1989, KEYS INSECTS EUROPEA, V1, P279; Lees DC, 2010, ZOOL SCR, V39, P642, DOI 10.1111/j.1463-6409.2010.00447.x; Lemche H, 1937, SAETRYK ZOOLOGISCHE, V63, P183; Lemche H, 1935, VIDENSKABELIGE MEDDE, V99, P45, DOI DOI 10.1093/MOLBEV/MSQ173; Martin A, 2010, MOL BIOL EVOL, V27, P2864, DOI 10.1093/molbev/msq173; Mey W, 2011, ZOOKEYS, P331, DOI 10.3897/zookeys.130.1480; Meyrick E, 1912, GENERA INSECTORUM, P1, DOI DOI 10.1126/SCIENCE.36.934.716; Monteiro A, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-52; Monteiro A, 2015, ANNU REV ENTOMOL, V60, P253, DOI 10.1146/annurev-ento-010814-020942; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Nijhout H.F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1994, DEVELOPMENT, P225; Nijhout HF, 2001, J EXP ZOOL, V291, P213, DOI 10.1002/jez.1099; Nijhout HF, 2003, 3 COLORATION PATTERN, V2, P23; Pyron RA, 2015, TRENDS ECOL EVOL, V30, P384, DOI 10.1016/j.tree.2015.04.016; Reed RD, 2004, CURR BIOL, V14, P1159, DOI 10.1016/j.cub.2004.06.046; Regier JC, 2015, SYST ENTOMOL, V40, P671, DOI 10.1111/syen.12129; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058568, 10.1371/journal.pone.0072678]; Schmid F., 1989, ENTOMOLOGIE, V59, P1; SCHWANWITSCH B. N., 1928, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V11, P1, DOI 10.1007/BF02425767; Schwanwitsch BN, 1924, P ZOOL SOC LOND, V1924, P509; Scoble M. J., 1995, LEPIDOPTERA FORM FUN; Scotland RW, 2003, SYST BIOL, V52, P539, DOI 10.1080/10635150390223613; Simonsen TJ, 2012, ARTHROPOD STRUCT DEV, V41, P307, DOI 10.1016/j.asd.2012.04.006; Skalski A.W., 1979, Paleontologicheskii Zhurnal, V1979, P90; SKALSKI A W, 1976, Linneana Belgica, V6, P221; SKALSKI A W, 1976, Linneana Belgica, V6, P195; SOHN JC, 2012, ZOOTAXA 0430, P1; Suffert F., 1927, BIOL ZENTRALBLATT, V47, P385; Suffert Fritz, 1929, Wilhelm Roux Arch Entwickl Mech Org, V120, P299, DOI 10.1007/BF02109666; Sukatsheva ID, 2013, PALEONTOL J+, V47, P77, DOI 10.1134/S0031030113010139; Suzuki TK, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-158; Tillyard R. J., 1919, Proceedings of the Linnean Society of New South Wales, V44; van Bemmelen JF, 1916, P K AKAD WET-AMSTERD, V18, P1255; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Zeller-Lukashort H. Christof, 2007, Nota Lepidopterologica, V30, P235; Zhang WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079500	64	17	17	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139972	10.1371/journal.pone.0139972	http://dx.doi.org/10.1371/journal.pone.0139972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437004	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200067
J	Takeda, F; Noguchi, H; Monma, T; Tamiya, N				Takeda, Fumi; Noguchi, Haruko; Monma, Takafumi; Tamiya, Nanako			How Possibly Do Leisure and Social Activities Impact Mental Health of Middle-Aged Adults in Japan?: An Evidence from a National Longitudinal Survey	PLOS ONE			English	Article							QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; PHYSICAL-ACTIVITY; EXERCISE PROGRAM; STRESS; METAANALYSIS; PERFORMANCE	Objectives This study aimed to investigate longitudinal relations between leisure and social activities and mental health status, considering the presence or absence of other persons in the activity as an additional variable, among middle-aged adults in Japan. This study used nationally representative data in Japan with a five-year follow-up period. Methods This study focused on 16,642 middle-aged adults, age 50-59 at baseline, from a population-based, six-year panel survey conducted by the Japanese Ministry of Health, Labour and Welfare. To investigate the relations between two leisure activities ('hobbies or cultural activities' and 'exercise or sports') and four social activities ('community events', 'support for children', 'support for elderly individuals' and 'other social activities') at baseline and mental health status at follow-up, multiple logistic regression analysis was used. We also used multiple logistic regression analysis to investigate the association between ways of participating in these activities ('by oneself', 'with others', or 'both' (both 'by oneself' and 'with others')) at baseline and mental health status at follow-up. Results Involvement in both leisure activity categories, but not in social activities, was significantly and positively related to mental health status in both men and women. Furthermore, in men, both 'hobbies or cultural activities' and 'exercise or sports' were significantly related to mental health status only when conducted 'with others'. In women, the effects of 'hobbies or cultural activities' on mental health status were no differences regardless of the ways of participating, while the result of 'exercise or sports' was same as that in men. Conclusions Leisure activities appear to benefit mental health status among this age group, whereas specific social activities do not. Moreover, participation in leisure activities would be effective especially if others are present. These findings should be useful for preventing the deterioration of mental health status in middle-aged adults in Japan.	[Takeda, Fumi; Monma, Takafumi] Univ Tsukuba, Fac Hlth & Sport Sci, Ibaraki, Japan; [Noguchi, Haruko] Waseda Univ, Fac Polit Sci & Econ, Tokyo, Japan; [Tamiya, Nanako] Univ Tsukuba, Fac Med, Ibaraki, Japan	University of Tsukuba; Waseda University; University of Tsukuba	Takeda, F (corresponding author), Univ Tsukuba, Fac Hlth & Sport Sci, Ibaraki, Japan.	takeda@taiiku.tsukuba.ac.jp	Noguchi, Haruko/ABF-3059-2020	Noguchi, Haruko/0000-0002-4437-8238	Ministry of Health, Labour and Welfare [H27-seisaku-senryaku-012]	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Ministry of Health, Labour and Welfare (H27-seisaku-senryaku-012).	Aoki K, 2009, ARCH YAMAGUCHI PREFE, V2, P100; Barbato A, 2008, PSYCHIAT QUART, V79, P121, DOI 10.1007/s11126-008-9068-0; Barcelos-Ferreira R, 2013, J AFFECT DISORDERS, V150, P616, DOI 10.1016/j.jad.2013.02.024; Chiao C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-292; Conn VS, 2010, NURS RES, V59, P224, DOI 10.1097/NNR.0b013e3181dbb2f8; Director General for Policies on Cohesive Society Cabinet Office, 2013, 2013 WHIT PAP SUIC P; Eyigor S, 2007, ARCH GERONTOL GERIAT, V45, P259, DOI 10.1016/j.archger.2006.12.001; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Hong SI, 2009, GERONTOLOGIST, V49, P1, DOI 10.1093/geront/gnp006; Inoue A, 2010, J OCCUP HEALTH, V52, P227, DOI 10.1539/joh.O10002; Iwasaki Y, 2003, LEISURE SCI, V25, P107, DOI 10.1080/01490400306567; Iwasaki Y, 2000, LEISURE SCI, V22, P163, DOI 10.1080/01490409950121843; Kanamori S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051061; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lee CT, 2012, ARCH GERONTOL GERIAT, V54, pE221, DOI 10.1016/j.archger.2011.06.014; Li YQ, 2005, J HEALTH SOC BEHAV, V46, P68, DOI 10.1177/002214650504600106; Ministry of Health Labour and Welfare, 2012, 2011 SUMM PAT SURV; National Institute of Public Health, 2002, ETHICAL GUIDELINES F; Netz Y, 2005, PSYCHOL AGING, V20, P272, DOI 10.1037/0882-7974.20.2.272; Park SH, 2014, APPL NURS RES, V27, P219, DOI 10.1016/j.apnr.2014.01.004; Pfeiffer PN, 2011, GEN HOSP PSYCHIAT, V33, P29, DOI 10.1016/j.genhosppsych.2010.10.002; Potocnik K, 2013, J OCCUP ORGAN PSYCH, V86, P497, DOI 10.1111/joop.12003; Sakurai K, 2010, SOC SCI MED, V70, P1832, DOI 10.1016/j.socscimed.2010.01.019; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Sugihara Y, 2008, J GERONTOL B-PSYCHOL, V63, pP227, DOI 10.1093/geronb/63.4.P227; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; Timonen L, 2002, INT J GERIATR PSYCH, V17, P1106, DOI 10.1002/gps.757; Wada K, 2007, IND HEALTH, V45, P181, DOI 10.2486/indhealth.45.181; Wakui T, 2012, AGING MENT HEALTH, V16, P500, DOI 10.1080/13607863.2011.644263; Windle G, 2010, AGING MENT HEALTH, V14, P652, DOI 10.1080/13607861003713232	30	35	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139777	10.1371/journal.pone.0139777	http://dx.doi.org/10.1371/journal.pone.0139777			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431536	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700114
J	Tong, X; Zhang, DQ; Guha, A; Arthurs, B; Cazares, V; Gupta, N; Yin, L				Tong, Xin; Zhang, Deqiang; Guha, Anirvan; Arthurs, Blake; Cazares, Victor; Gupta, Neil; Yin, Lei			CUL4-DDB1-CDT2 E3 Ligase Regulates the Molecular Clock Activity by Promoting Ubiquitination-Dependent Degradation of the Mammalian CRY1	PLOS ONE			English	Article							CIRCADIAN CLOCK; GENE-EXPRESSION; DNA-DAMAGE; PROTEIN; CRL4(CDT2); UBIQUITYLATION; DDB1; CRYPTOCHROME; COMPLEX; CELLS	The CUL4-DDB1 E3 ligase complex serves as a critical regulator in various cellular processes, including cell proliferation, DNA damage repair, and cell cycle progression. However, whether this E3 ligase complex regulates clock protein turnover and the molecular clock activity in mammalian cells is unknown. Here we show that CUL4-DDB1-CDT2 E3 ligase ubiquitinates CRY1 and promotes its degradation both in vitro and in vivo. Depletion of the major components of this E3 ligase complex, including Ddb1, Cdt2, and Cdt2-cofactor Pcna, leads to CRY1 stabilization in cultured cells or in the mouse liver. CUL4A-DDB1-CDT2 E3 ligase targets lysine 585 within the C-terminal region of CRY1 protein, shown by the CRY1 585KA mutant's resistance to ubiquitination and degradation mediated by the CUL4A-DDB1 complex. Surprisingly, both depletion of Ddb1 and over-expression of Cry1-585KA mutant enhance the oscillatory amplitude of the Bmal1 promoter activity without altering its period length, suggesting that CUL4A-DDB1-CDT2 E3 targets CRY1 for degradation and reduces the circadian amplitude. All together, we uncovered a novel biological role for CUL4A-DDB1-CDT2 E3 ligase that regulates molecular circadian behaviors via promoting ubiquitination-dependent degradation of CRY1.	[Tong, Xin; Zhang, Deqiang; Guha, Anirvan; Arthurs, Blake; Cazares, Victor; Gupta, Neil; Yin, Lei] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yin, L (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	leiyin@umich.edu	Zhang, Deqiang/J-9199-2016	TONG, XIN/0000-0002-4832-8940; Guha, Anirvan/0000-0001-6018-1438; Cazares, Victor A/0000-0002-6625-7103	NIH [DK077449, DK099593]; Michigan Obesity Center [5P3ODKO34933]; University of Michigan Diabetes Research Training Center [P60DK020572]; STEP Program at the University of Michigan - National Institutes of Health [R25 DK088752]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK077449, R01DK099593, P60DK020572, R25DK088752] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Obesity Center; University of Michigan Diabetes Research Training Center; STEP Program at the University of Michigan - National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH K99/R00 (DK077449) and RO1 (DK099593) to LY. Part of the work was also supported by pilot grants to LY from Michigan Obesity Center (5P3ODKO34933) and from University of Michigan Diabetes Research Training Center to XT (P60DK020572). Both AG and NG were supported by the STEP Program at the University of Michigan funded by National Institutes of Health Grant R25 DK088752. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Froy O, 2011, CLIN SCI, V120, P65, DOI 10.1042/CS20100327; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guerrero-Santoro J, 2008, CANCER RES, V68, P5014, DOI 10.1158/0008-5472.CAN-07-6162; Havens CG, 2011, GENE DEV, V25, P1568, DOI 10.1101/gad.2068611; He YZJ, 2006, GENE DEV, V20, P2949, DOI 10.1101/gad.1483206; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Huh J, 2013, MOL CELL BIOL, V33, P213, DOI 10.1128/MCB.00847-12; Iovine B, 2011, INT J BIOCHEM CELL B, V43, P1664, DOI 10.1016/j.biocel.2011.09.001; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaur M, 2012, NUCLEIC ACIDS RES, V40, P7332, DOI 10.1093/nar/gks366; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MARCHEVA B, 2013, HDB EXP PHARM, V217, P127, DOI DOI 10.1007/978-3-642-25950-0_; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Ozturk N, 2013, P NATL ACAD SCI USA, V110, P4980, DOI 10.1073/pnas.1303234110; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shibata E, 2011, MOL CELL BIOL, V31, P3136, DOI 10.1128/MCB.05496-11; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; Todo T, 1996, SCIENCE, V272, P109, DOI 10.1126/science.272.5258.109; Tong X, 2012, J BIOL CHEM, V287, P25280, DOI 10.1074/jbc.M112.340786; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; Vollmers C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003457; Yagita K, 2002, EMBO J, V21, P1301, DOI 10.1093/emboj/21.6.1301; Yamaji S, 2010, P NATL ACAD SCI USA, V107, P22237, DOI 10.1073/pnas.1015793108; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055	47	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139725	10.1371/journal.pone.0139725	http://dx.doi.org/10.1371/journal.pone.0139725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431207	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700104
J	Vogt, K; Yarali, A; Tanimoto, H				Vogt, Katrin; Yarali, Ayse; Tanimoto, Hiromu			Reversing Stimulus Timing in Visual Conditioning Leads to Memories with Opposite Valence in Drosophila	PLOS ONE			English	Article							PAIN-RELIEF; TRACE; PUNISHMENT; REWARD; HONEYBEES; AMYGDALA; OFFSET; FLIES; RATS; FEAR	Animals need to associate different environmental stimuli with each other regardless of whether they temporally overlap or not. Drosophila melanogaster displays olfactory trace conditioning, where an odor is followed by electric shock reinforcement after a temporal gap, leading to conditioned odor avoidance. Reversing the stimulus timing in olfactory conditioning results in the reversal of memory valence such that an odor that follows shock is later on approached (i.e. relief conditioning). Here, we explored the effects of stimulus timing on memory in another sensory modality, using a visual conditioning paradigm. We found that flies form visual memories of opposite valence depending on stimulus timing and can associate a visual stimulus with reinforcement despite being presented with a temporal gap. These results suggest that associative memories with non-overlapping stimuli and the effect of stimulus timing on memory valence are shared across sensory modalities.	[Vogt, Katrin; Yarali, Ayse; Tanimoto, Hiromu] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Yarali, Ayse] Leibniz Inst Neurobiol LIN, Res Grp Mol Syst Biol Learning, D-39118 Magdeburg, Germany; [Yarali, Ayse] Ctr Behav Brain Sci, D-39118 Magdeburg, Germany; [Tanimoto, Hiromu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 9808577, Japan	Max Planck Society; Leibniz Institut fur Neurobiologie (LIN); Tohoku University	Vogt, K (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	katrin-vogt@gmx.de	Tanimoto, Hiromu/J-6810-2016; Vogt, Katrin/ABD-3580-2020	Vogt, Katrin/0000-0002-8763-342X	Deutsche Forschungsgemeinschaft [TA 552/5-1, YA 272/2-1]; German Federal Ministry for Education and Research (BMBF) Bernstein Focus Neurobiology of Learning [01GQ0932]; MEXT/JSPS KAKENHI [26250001, 26120705, 26119503]; Strategic Research Program for Brain Sciences "Bioinformatics for Brain Sciences"; Naito Foundation; Schram-Stiftung; Max-Planck-Gesellschaft; Leibniz Institut fur Neurobiologie	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry for Education and Research (BMBF) Bernstein Focus Neurobiology of Learning; MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Program for Brain Sciences "Bioinformatics for Brain Sciences"; Naito Foundation(Naito Memorial Foundation); Schram-Stiftung; Max-Planck-Gesellschaft(Max Planck Society); Leibniz Institut fur Neurobiologie	This work was supported by Deutsche Forschungsgemeinschaft (TA 552/5-1 to H.T. and YA 272/2-1 to A.Y.) (http://www.dfg.de), German Federal Ministry for Education and Research (BMBF) (http://www.bmbf.de/) Bernstein Focus Neurobiology of Learning (01GQ0932 to H.T.), MEXT/JSPS KAKENHI (26250001, 26120705 and 26119503 to H.T.)(http://www.jsps.go.jp/english/e-grants/), the Strategic Research Program for Brain Sciences "Bioinformatics for Brain Sciences" (to H.T.), Naito Foundation (to H.T.), Schram-Stiftung (to A.Y.) (http://www.stifterservice.de/t287/), Max-Planck-Gesellschaft (to H.T.) and Leibniz Institut fur Neurobiologie ( to A.Y.). The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta M, 2012, LEARN MEMORY, V19, P518, DOI 10.1101/lm.026864.112; Andreatta M, 2010, P ROY SOC B-BIOL SCI, V277, P2411, DOI 10.1098/rspb.2010.0103; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Burman MA, 2004, LEARN MEMORY, V11, P205, DOI 10.1101/lm.66004; Chang RC, 2003, J EXP PSYCHOL ANIM B, V29, P171, DOI 10.1037/0097-7403.29.3.171; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Dylla KV, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00067; Franklin JC, 2013, PSYCHOL SCI, V24, P521, DOI 10.1177/0956797612458805; Galili DS, 2011, J NEUROSCI, V31, P7240, DOI 10.1523/JNEUROSCI.6667-10.2011; GARCIA J, 1974, SCIENCE, V185, P824, DOI 10.1126/science.185.4154.824; Gerber B, 2014, LEARN MEMORY, V21, P232, DOI 10.1101/lm.032995.113; GROSSMANN K E, 1971, Zeitschrift fuer Tierpsychologie, V29, P28; GROSSMANN K E, 1970, Zeitschrift fuer Tierpsychologie, V27, P553; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; Khurana S, 2009, J BIOSCIENCES, V34, P621, DOI 10.1007/s12038-009-0080-9; Menzel R, 1983, LEARNING HONEYBEES U, P206; Menzel R, 1968, Z VERGL PHYSIOL, V102, P82; Murakami S, 2010, J NEUROSCI METH, V188, P195, DOI 10.1016/j.jneumeth.2010.02.007; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Niewalda T, 2015, J NEUROSCI, V35, P7487, DOI 10.1523/JNEUROSCI.4454-14.2015; O'Donnell S, 2010, J APPL ECOL, V47, P558, DOI 10.1111/j.1365-2664.2010.01802.x; Opfinger E., 1931, Z VERGL PHYSIOL, V15, P431, DOI [10.1007/BF00338108, DOI 10.1007/BF00338108]; Pavlov I.P., 1927, CONDITIONED REFLEXES; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; Schnaitmann C, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00010; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Shuai YC, 2011, P NATL ACAD SCI USA, V108, P20201, DOI 10.1073/pnas.1107489109; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Tanimoto H, 2004, NATURE, V430, P983, DOI 10.1038/430983a; Vogt K, 2014, ELIFE, V3, DOI 10.7554/eLife.02395; Wagner A.R., 1981, P5; Yarali A, 2008, ANIM BEHAV, V76, P1173, DOI 10.1016/j.anbehav.2008.05.025; Yarali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032885; Yarali A, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00189; Yarali A, 2009, J NEUROGENET, V23, P235, DOI 10.1080/01677060802441372	42	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139797	10.1371/journal.pone.0139797	http://dx.doi.org/10.1371/journal.pone.0139797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430885	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700116
J	Devi, MJ; Sinclair, TR; Taliercio, E				Devi, Mura Jyostna; Sinclair, Thomas R.; Taliercio, Earl			Comparisons of the Effects of Elevated Vapor Pressure Deficit on Gene Expression in Leaves among Two Fast-Wilting and a Slow-Wilting Soybean	PLOS ONE			English	Article							WRKY TRANSCRIPTION FACTORS; DROUGHT STRESS; ARABIDOPSIS-THALIANA; WATER-DEFICIT; TRANSPIRATION RESPONSE; ABIOTIC STRESSES; STOMATAL DENSITY; FERULIC ACID; WHEAT LEAVES; PLANTS	Limiting the transpiration rate (TR) of a plant under high vapor pressure deficit (VPD) has the potential to improve crop yield under drought conditions. The effects of elevated VPD on the expression of genes in the leaves of three soybean accessions, Plant Introduction (PI) 416937, PI 471938 and Hutcheson (PI 518664) were investigated because these accessions have contrasting responses to VPD changes. Hutcheson, a fast-wilting soybean, and PI 471938, a slow-wilting soybean, respond to increased VPD with a linear increase in TR. TR of the slow-wilting PI 416937 is limited when VPD increases to greater than about 2 kPa. The objective of this study was to identify the response of the transcriptome of these accessions to elevated VPD under well-watered conditions and identify responses that are unique to the slow-wilting accessions. Gene expression analysis in leaves of genotypes PI 471938 and Hutcheson showed that 22 and 1 genes, respectively, were differentially expressed under high VPD. In contrast, there were 944 genes differentially expressed in PI 416937 with the same increase in VPD. The increased alteration of the transcriptome of PI 416937 in response to elevated VPD clearly distinguished it from the other slow-wilting PI 471938 and the fast-wilting Hutcheson. The inventory and analysis of differentially expressed genes in PI 416937 in response to VPD is a foundation for further investigation to extend the current understanding of plant hydraulic conductivity in drought environments.	[Devi, Mura Jyostna; Sinclair, Thomas R.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Taliercio, Earl] USDA ARS, Soybean & Nitrogen Fixat Unit, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA)	Taliercio, E (corresponding author), USDA ARS, Soybean & Nitrogen Fixat Unit, Raleigh, NC 27695 USA.	Earl.Taliercio@ars.usda.gov		Mura, Jyostna Devi/0000-0001-7502-614X	United Soybean Board [1213]	United Soybean Board	This work was funded by the United Soybean Board, Project 1213.	Andre CM, 2009, PHYTOCHEMISTRY, V70, P1107, DOI 10.1016/j.phytochem.2009.07.008; Berger D, 2000, GENE DEV, V14, P1119; Bunce JA, 1997, PLANT CELL ENVIRON, V20, P131, DOI 10.1046/j.1365-3040.1997.d01-3.x; Cal AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054537; Coskun D, 2012, J EXP BOT, V63, P151, DOI 10.1093/jxb/err267; de Abreu IN, 2005, PLANT PHYSIOL BIOCH, V43, P241, DOI 10.1016/j.plaphy.2005.01.020; Devi MJ, 2015, J EXP BOT, V66, P1845, DOI 10.1093/jxb/eru520; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Feng L, 2014, PLANT MOL BIOL REP, V32, P1158, DOI 10.1007/s11105-014-0718-0; Fletcher AL, 2007, ENVIRON EXP BOT, V61, P145, DOI 10.1016/j.envexpbot.2007.05.004; Ge XM, 2015, PLANT J, V82, P138, DOI 10.1111/tpj.12799; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Hara M, 2004, PLANT PHYSIOL BIOCH, V42, P657, DOI 10.1016/j.plaphy.2004.06.004; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hura T, 2007, ANN BOT-LONDON, V100, P767, DOI 10.1093/aob/mcm162; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451; Kawase M, 2013, J PLANT RES, V126, P517, DOI 10.1007/s10265-013-0548-4; Kikuzaki H, 2002, J AGR FOOD CHEM, V50, P2161, DOI 10.1021/jf011348w; Kjellbom P, 1999, TRENDS PLANT SCI, V4, P308, DOI 10.1016/S1360-1385(99)01438-7; Kramer P.J., 1995, WATER RELATIONS PLAN; Kumar V, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue2-fulltext-1; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Ma DY, 2014, PLANT PHYSIOL BIOCH, V80, P60, DOI 10.1016/j.plaphy.2014.03.024; Maeda H, 2012, ANNU REV PLANT BIOL, V63, P73, DOI 10.1146/annurev-arplant-042811-105439; Marshall A, 2012, PLANT CELL, V24, P2262, DOI 10.1105/tpc.112.096677; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Meyer S, 2003, J EXP BOT, V54, P757, DOI 10.1093/jxb/erg063; Munne-Bosch S, 2009, J PLANT PHYSIOL, V166, P136, DOI 10.1016/j.jplph.2008.02.011; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Osorio MB, 2012, GENET MOL BIOL, V35, P233, DOI 10.1590/S1415-47572012000200005; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pereira SS, 2011, GENET MOL RES, V10, P3689, DOI 10.4238/2011.October.21.5; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poltronieri P., 2013, CLIMATE CHANGE PLANT, P325, DOI [10.1002/9783527675265.ch13, DOI 10.1002/9783527675265.CH13]; Poulson ME, 2002, PHOTOSYNTH RES, V72, P55, DOI 10.1023/A:1016054027464; Sadok W, 2010, J EXP BOT, V61, P821, DOI 10.1093/jxb/erp350; Sadok W, 2009, CROP SCI, V49, P955, DOI 10.2135/cropsci2008.09.0560; Santos L., 2006, ADV AGRIL FOOD BIOTE, V37, P1; Savitri ES, 2013, AM J MOL BIOL, V3, P32, DOI DOI 10.4236/AJMB.2013.31004; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shaik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077261; Shin JH, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0422-8; Sinclair TR, 2008, PHYSIOL PLANTARUM, V132, P446, DOI 10.1111/j.1399-3054.2007.01028.x; Sinclair TR, 2010, AGRON J, V102, P475, DOI 10.2134/agronj2009.0195; SLOANE RJ, 1990, CROP SCI, V30, P118, DOI 10.2135/cropsci1990.0011183X003000010027x; Staudt M, 2005, GEOPH RES ABSTR, P7; Stolf-Moreira R, 2011, PLANT MOL BIOL REP, V29, P19, DOI 10.1007/s11105-010-0203-3; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Treutter D, 2010, INT J MOL SCI, V11, P807, DOI 10.3390/ijms11030807; Tzin V, 2010, MOL PLANT, V3, P956, DOI 10.1093/mp/ssq048; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wan LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025216; Wang YH, 2011, PLANT SIGNAL BEHAV, V6, P494, DOI 10.4161/psb.6.4.14558; Xoconostle-Cazares B., 2010, American Journal of Plant Physiology, V5, P241, DOI 10.3923/ajpp.2010.241.256; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	62	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139134	10.1371/journal.pone.0139134	http://dx.doi.org/10.1371/journal.pone.0139134			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427064	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100032
J	El-Kashlan, AM; Nooh, MM; Hassan, WA; Rizk, SM				El-Kashlan, Akram M.; Nooh, Mohammed M.; Hassan, Wafaa A.; Rizk, Sherine M.			Therapeutic Potential of Date Palm Pollen for Testicular Dysfunction Induced by Thyroid Disorders in Male Rats	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; OXIDATIVE STRESS; ESTROGEN; GRAINS; TESTIS; MICE	Hyper- or hypothyroidism can impair testicular function leading to infertility. The present study was designed to examine the protective effect of date palm pollen (DPP) extract on thyroid disorder-induced testicular dysfunction. Rats were divided into six groups. Group I was normal control. Group II received oral DPP extract (150 mg kg(-1)), group III (hyperthyroid group) received intraperitoneal injection of L-thyroxine (L-T4, 300 mu g kg(-1); i.p.), group IV received L-T4 plus DPP extract, group V (hypothyroid group) received propylthiouracil (PTU, 10 mg kg(-1); i.p.) and group VI received PTU plus DPP extract. All treatments were given every day for 56 days. L-T4 or PTU lowered genital sex organs weight, sperm count and motility, serum levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and testosterone (T), testicular function markers and activities of testicular 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) and 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD). Moreover, L-T4 or PTU increased estradiol (E2) serum level, testicular oxidative stress, DNA damage and apoptotic markers. Morphometric and histopathologic studies backed these observations. Treatment with DPP extract prevented LT4- or PTU induced changes. In addition, supplementation of DPP extract to normal rats augmented sperm count and motility, serum levels of LH, T and E2 paralleled with increased activities of 3 beta-HSD and 17 beta-HSD as well as testicular antioxidant status. These results provide evidence that DPP extract may have potential protective effects on testicular dysfunction induced by altered thyroid hormones.	[El-Kashlan, Akram M.; Hassan, Wafaa A.] Natl Org Drug Control & Res, Hormone Evaluat Dept, Giza, Egypt; [Nooh, Mohammed M.; Rizk, Sherine M.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo 11562, Egypt	National Organization for Drug Control & Research (NODCAR); Egyptian Knowledge Bank (EKB); Cairo University	Nooh, MM (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Kasr Al Aini St, Cairo 11562, Egypt.	mohamed.nooh@pharma.cu.edu.eg		Nooh, Mohammed/0000-0001-9794-4099				Abbas F. A., 2011, Australian Journal of Basic and Applied Sciences, V5, P606; Abedi A, 2013, ADV SEX MED, V3, P28; Ali BH, 1999, FOOD CHEM, V66, P437, DOI 10.1016/S0308-8146(98)00060-0; AOAC, 2005, OFFICIAL METHODS ANA; Asker ME, 2015, ANDROLOGIA, V47, P644, DOI 10.1111/and.12312; Assinder S, 2007, REPRODUCTION, V133, P11, DOI 10.1530/rep.1.01211; Bahmanpour S, 2006, IRAN J MED SCI, V31, P208; Barrett K E, 2010, GANONGS REV MED PHYS, P301; Bauza E, 2002, INT J TISSUE REACT, V24, P131; Bharti S, 2014, MOL CELL ENDOCRINOL, V383, P10, DOI 10.1016/j.mce.2013.11.021; Bishr M., 2012, Journal of Pharmacy and Nutrition Sciences, V2, P50; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Chattopadhyay S, 2010, GEN COMP ENDOCR, V169, P39, DOI 10.1016/j.ygcen.2010.07.014; CHAUNCEY B, 1988, ENZYME, V39, P231, DOI 10.1159/000469124; Conde-Hernandez LA, 2014, FOOD CHEM, V142, P455, DOI 10.1016/j.foodchem.2013.07.078; Corpuz MJAT, 2012, INT FOOD RES J, V20, P291; El-Neweshy MS, 2013, ANDROLOGIA, V45, P369, DOI 10.1111/and.12025; Elberry AA, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-40; ELRIDI MS, 1960, Z NATURFORSCH PT B, V15, P45, DOI 10.1515/znb-1960-0109; Faraone-Mennella MR, 2009, MOL CELL BIOCHEM, V323, P119, DOI 10.1007/s11010-008-9970-7; Hassan H. M. M., 2011, Global Journal of Biotechnology & Biochemistry, V6, P1; Hess RA, 2001, MOL CELL ENDOCRINOL, V178, P29, DOI 10.1016/S0303-7207(01)00412-9; Ibrahim W, 2011, GEN COMP ENDOCR, V174, P143, DOI 10.1016/j.ygcen.2011.08.012; JARABAK J, 1962, J BIOL CHEM, V237, P345; Krassas GE, 2013, WERNER INGBARS THYRO, P582; Kumar Anand, 2014, Indian J Endocrinol Metab, V18, P23, DOI 10.4103/2230-8210.126523; Lee KH, 2009, J ANAT, V214, P916, DOI 10.1111/j.1469-7580.2009.01080.x; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Metwaly MS, 2014, BIOLOGIA, V69, P254, DOI 10.2478/s11756-013-0297-9; Miller CJ, 2003, EUR J CLIN NUTR, V57, P427, DOI 10.1038/sj.ejcn.1601565; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Nantia EA, 2009, ANDROLOGIA, V19, P148, DOI DOI 10.1007/S12610-009-0030-2; Parmar HS, 2009, CHEM-BIOL INTERACT, V177, P254, DOI 10.1016/j.cbi.2008.11.006; Robertson KM, 2002, ENDOCRINOLOGY, V143, P2913, DOI 10.1210/en.143.8.2913; Russell L. D., 1990, HISTOLOGICAL HISTOPA, P41; Saafi EB, 2011, EXP TOXICOL PATHOL, V63, P433, DOI 10.1016/j.etp.2010.03.002; Sahoo D.K., 2013, WEBMED CENTRAL ENDOC, V4, P1; Sahoo DK, 2008, CHEM-BIOL INTERACT, V176, P121, DOI 10.1016/j.cbi.2008.07.009; Saleh AAS, 2015, J BASIC APPL ZOOL, V72, P173, DOI [DOI 10.1016/J.JOBAZ.2015.01.001, 10.1016/j.jobaz.2015.01.001]; Shiva M, 2011, CLIN BIOCHEM, V44, P319, DOI 10.1016/j.clinbiochem.2010.11.009; TALALAY P, 1962, METHOD ENZYMOL, V5, P512, DOI 10.1016/S0076-6879(62)05269-6; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Wagner MS, 2009, MICROSC RES TECHNIQ, V72, P796, DOI 10.1002/jemt.20759; Zargari A, 1999, MED PLANTS, V3, P33	44	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139493	10.1371/journal.pone.0139493	http://dx.doi.org/10.1371/journal.pone.0139493			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26425844	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100069
J	Knop, J; Misaka, S; Singer, K; Hoier, E; Muller, F; Glaeser, H; Konig, J; Fromm, MF				Knop, Jana; Misaka, Shingen; Singer, Katrin; Hoier, Eva; Mueller, Fabian; Glaeser, Hartmut; Koenig, Joerg; Fromm, Martin F.			Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein	PLOS ONE			English	Article							DRUG-DRUG INTERACTIONS; MULTIDRUG-RESISTANCE; IN-VITRO; DETERMINANTS; PHARMACOKINETICS; MECHANISM; CATECHINS; CELLS; JUICE	Green tea catechins inhibit the function of organic anion transporting polypeptides (OATPs) that mediate the uptake of a diverse group of drugs and endogenous compounds into cells. The present study was aimed at investigating the effect of green tea and its most abundant catechin epigallocatechin gallate (EGCG) on the transport activity of several drug transporters expressed in enterocytes, hepatocytes and renal proximal tubular cells such as OATPs, organic cation transporters (OCTs), multidrug and toxin extrusion proteins (MATEs), and P-glycoprotein (P-gp). Uptake of the typical substratesmetformin for OCTs and MATEs and bromosulphophthalein (BSP) and atorvastatin for OATPs was measured in the absence and presence of a commercially available green tea and EGCG. Transcellular transport of digoxin, a typical substrate of P-gp, was measured over 4 hours in the absence and presence of green tea or EGCG in Caco-2 cell monolayers. OCT1-, OCT2-, MATE1- and MATE2-K-mediated metformin uptake was significantly reduced in the presence of green tea and EGCG (P < 0.05). BSP net uptake by OATP1B1 and OATP1B3 was inhibited by green tea [IC50 2.6% (v/v) and 0.39% (v/v), respectively]. Green tea also inhibited OATP1B1- and OATP1B3-mediated atorvastatin net uptake with IC50 values of 1.9% (v/v) and 1.0% (v/v), respectively. Basolateral to apical transport of digoxin was significantly decreased in the presence of green tea and EGCG. These findings indicate that green tea and EGCG inhibit multiple drug transporters in vitro. Further studies are necessary to investigate the effects of green tea on prototoypical substrates of these transporters in humans, in particular on substrates of hepatic uptake transporters (e.g. statins) as well as on P-glycoprotein substrates.	[Knop, Jana; Misaka, Shingen; Singer, Katrin; Hoier, Eva; Mueller, Fabian; Glaeser, Hartmut; Koenig, Joerg; Fromm, Martin F.] Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany; [Misaka, Shingen] Fukushima Med Univ, Sch Med, Dept Pharmacol, Fukushima, Japan	University of Erlangen Nuremberg; Fukushima Medical University	Fromm, MF (corresponding author), Univ Erlangen Nurnberg, Inst Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany.	martin.fromm@fau.de		Koenig, Joerg/0000-0001-7016-5482	Sanofi-Aventis Deutschland	Sanofi-Aventis Deutschland(Sanofi-Aventis)	F.M. holds a minor share of stock in Novartis, received research funding from Sanofi-Aventis Deutschland and is now an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. M. F.F. reported receiving personal compensation for expert testimony from Boehringer Ingelheim Pharma and payments for lectures from Bayer-Schering Pharma, Boehringer Ingelheim Pharma, Sanofi-Aventis Deutschland and Merck KGaA. M.F.F.'s institution received compensation for commissioned research of his group from Merck KGaA and Sanofi-Aventis Deutschland and for supply for in vitro studies from Gilead. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The remaining authors declare no conflicts of interest.	Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797; Chow HHS, 2006, CANCER EPIDEM BIOMAR, V15, P2473, DOI 10.1158/1055-9965.EPI-06-0365; Cui YH, 1999, MOL PHARMACOL, V55, P929; Donovan JL, 2004, DRUG METAB DISPOS, V32, P906, DOI 10.1124/dmd.104.000083; Engdal S, 2008, XENOBIOTICA, V38, P559, DOI [10.1080/00498250801986969, 10.1080/00498250801986969 ]; Fleisher B, 2015, J PHARM SCI-US, V104, P266, DOI 10.1002/jps.24289; Fujita Ken-ichi, 2004, Drug Metabolism and Drug Interactions, V20, P195; Glaeser H, 2007, CLIN PHARMACOL THER, V81, P362, DOI 10.1038/sj.clpt.6100056; Huber S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133743; Ito K, 1998, PHARMACOL REV, V50, P387; Jodoin J, 2002, BBA-MOL CELL RES, V1542, P149, DOI 10.1016/S0167-4889(01)00175-6; Kindla J, 2009, EXPERT OPIN DRUG MET, V5, P489, DOI [10.1517/17425250902911463 , 10.1517/17425250902911463]; Konig J, 2011, BRIT J PHARMACOL, V163, P546, DOI 10.1111/j.1476-5381.2010.01052.x; Konig J, 2013, PHARMACOL REV, V65, P944, DOI 10.1124/pr.113.007518; Lin LC, 2007, J AGR FOOD CHEM, V55, P1517, DOI 10.1021/jf062816a; Link E, 2008, NEW ENGL J MED, V359, P789, DOI 10.1056/NEJMoa0801936; Misaka S, 2014, CLIN PHARMACOL THER, V95, P432, DOI 10.1038/clpt.2013.241; Mizukami Y, 2007, J AGR FOOD CHEM, V55, P4957, DOI 10.1021/jf070323f; Muller F, 2013, BIOCHEM PHARMACOL, V86, P808, DOI 10.1016/j.bcp.2013.07.008; Muller F, 2011, ANTIMICROB AGENTS CH, V55, P3091, DOI 10.1128/AAC.01835-10; Nies AT, 2011, HANDB EXP PHARMACOL, V201, P105, DOI 10.1007/978-3-642-14541-4_3; Paine MF, 2007, EXPERT OPIN DRUG MET, V3, P67, DOI 10.1517/17425255.3.1.67; Qian F, 2005, BIOMED PHARMACOTHER, V59, P64, DOI 10.1016/j.biopha.2005.01.002; Roth M, 2011, DRUG METAB DISPOS, V39, P920, DOI 10.1124/dmd.110.036640; Schmidt LE, 2002, DRUGS, V62, P1481, DOI 10.2165/00003495-200262100-00005; Seithel A, 2007, DRUG METAB DISPOS, V35, P779, DOI 10.1124/dmd.106.014407; Werba JP, 2015, CURR PHARM DESIGN, V21, P1213, DOI 10.2174/1381612820666141013135045; Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409; Zhu M, 2001, XENOBIOTICA, V31, P51, DOI 10.1080/00498250010024988; Zolk O, 2009, N-S ARCH PHARMACOL, V379, P337, DOI 10.1007/s00210-008-0369-5	30	60	62	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139370	10.1371/journal.pone.0139370	http://dx.doi.org/10.1371/journal.pone.0139370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426900	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100053
J	Lee, KS; Kwak, Y; Nam, KH; Kim, DW; Kang, SB; Choe, G; Kim, WH; Lee, HS				Lee, Kyu Sang; Kwak, Yoonjin; Nam, Kyung Han; Kim, Duck-Woo; Kang, Sung-Bum; Choe, Gheeyoung; Kim, Woo Ho; Lee, Hye Seung			c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer	PLOS ONE			English	Article							KI-RAS; AMPLIFICATION; GENE; KRAS; MUTATION; EXPRESSION; METASTASES; CARCINOMA; CETUXIMAB; SURVIVAL	Background The aim of this study was to determine the incidence and clinicopathological significance of c-MYC gene copy-number (GCN) gain in patients with primary colorectal cancer (CRC). Methods The c-MYC GCN was investigated in 367 consecutive CRC patients (cohort 1) by using dual-color silver in situ hybridization. Additionally, to evaluate regional heterogeneity, we examined CRC tissue from 3 sites including the primary cancer, distant metastasis, and lymph-node metastasis in 152 advanced CRC patients (cohort 2). KRAS exons 2 and 3 were investigated for mutations. Results In cohort 1, c-MYC gene amplification, defined by a c-MYC: centromere of chromosome 8 ratio >= 2.0, was detected in 31 (8.4%) of 367 patients. A c-MYC GCN gain, defined by >= 4.0 c-MYC copies/nucleus, was found in 63 (17.2%) patients and was associated with poor prognosis (P = 0.015). Multivariate Cox regression analysis showed that the hazard ratio for c-MYC GCN gain was 2.35 (95% confidence interval, 1.453-3.802; P < 0.001). In a subgroup of stage II-III CRC patients, c-MYC GCN gain was significantly associated with poor prognosis by univariate (P = 0.034) and multivariate (P = 0.040) analyses. c-MYC protein overexpression was observed in 201 (54.8%) out of 367 patients and weakly correlated with c-MYC GCN gain (rho, 0.211). In cohort 2, the c-MYC genetic status was heterogenous in advanced CRC patients. Discordance between GCN gain in the primary tumor and either distant or lymph-node metastasis was 25.7% and 30.4%, respectively. A similar frequency for c-MYC GCN gain and amplification was observed in CRC patients with both wild-type and mutated KRAS. Conclusions c-MYC GCN gain was an independent factor for poor prognosis in consecutive CRC patients and in the stage II-III subgroup. Our findings indicate that the status of c-MYC may be helpful in predicting the patients' outcome and for managing CRC patients.	[Lee, Kyu Sang; Choe, Gheeyoung; Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Kwak, Yoonjin; Choe, Gheeyoung; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Nam, Kyung Han] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Pathol, Busan, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Inje University; Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1813]	grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1813, https://www.khidi.or.kr/eps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kuraya K, 2007, J CLIN PATHOL, V60, P768, DOI 10.1136/jcp.2006.038281; Albanese I, 2004, BIOCHEM BIOPH RES CO, V325, P784, DOI 10.1016/j.bbrc.2004.10.111; [Anonymous], 2004, C D STAT MATHS PSYCH; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Choi JS, 2012, ANTICANCER RES, V32, P5031; Darcy KM, 2009, GYNECOL ONCOL, V114, P472, DOI 10.1016/j.ygyno.2009.05.012; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Dimova I, 2006, EUR J CANCER, V42, P674, DOI 10.1016/j.ejca.2005.11.022; ERISMAN MD, 1988, CANCER RES, V48, P1350; Fromont G, 2013, HUM PATHOL, V44, P1617, DOI 10.1016/j.humpath.2013.01.012; Gnanasampanthan G, 2001, J PATHOL, V195, P543, DOI 10.1002/path.990; Junttila MR, 2008, CELL CYCLE, V7, P592, DOI 10.4161/cc.7.5.5492; Kim Jung Ho, 2014, Korean J Pathol, V48, P276, DOI 10.4132/KoreanJPathol.2014.48.4.276; Knijn N, 2010, DISCOV MED, V9, P328; Lee HS, 2007, CLIN CANCER RES, V13, P4154, DOI 10.1158/1078-0432.CCR-07-0173; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Park JH, 2011, CANCER CHEMOTH PHARM, V68, P1045, DOI 10.1007/s00280-011-1586-z; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Rochlitz CF, 1996, ONCOLOGY, V53, P448; Secombe J, 2004, CELL, V117, P153, DOI 10.1016/S0092-8674(04)00336-8; Seo AN, 2014, BRIT J CANCER, V110, P2688, DOI 10.1038/bjc.2014.218; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith DR, 1996, CLIN CANCER RES, V2, P1049; Toon CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087456; Van Cutsem E, 2007, CLIN COLORECTAL CANC, V6, pS60, DOI 10.3816/CCC.2007.s.004; Vita M, 2006, SEMIN CANCER BIOL, V16, P318, DOI 10.1016/j.semcancer.2006.07.015; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	35	30	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139727	10.1371/journal.pone.0139727	http://dx.doi.org/10.1371/journal.pone.0139727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426996	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100090
J	Rojewska, E; Popiolek-Barczyk, K; Kolosowska, N; Piotrowska, A; Zychowska, M; Makuch, W; Przewlocka, B; Mika, J				Rojewska, Ewelina; Popiolek-Barczyk, Katarzyna; Kolosowska, Natalia; Piotrowska, Anna; Zychowska, Magdalena; Makuch, Wioletta; Przewlocka, Barbara; Mika, Joanna			PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; SPINAL NERVE LIGATION; NITRIC-OXIDE SYNTHASE; MORPHINE ANTINOCICEPTIVE TOLERANCE; MECHANICAL ALLODYNIA; P38 MAPK; PAIN HYPERSENSITIVITY; CENTRAL SENSITIZATION; INFLAMMATORY PAIN	Neuropathic pain treatment remains challenging due to ineffective therapy and resistance to opioid analgesia. Mitogen-activated protein kinase kinase (MAPKK) have been identified as the crucial regulators of pro- and antinociceptive factors. We used PD98059, an inhibitor of the MAPKK family members MEK1/2. The aim of study was to examine the influence of single and/or repeated PD98059 on nociception and opioid effectiveness in neuropathy. Moreover, we examined how PD98059 influences selected members of cellular pathways and cytokines. The PD98059 (2.5 mcg) was intrathecally preemptively administered before chronic constriction injury (CCI), and then once daily for 7 days. Additionally, at day 7 after CCI the PD98059-treated rats received a single injection of opioids. Using Western blot and qRT-PCR techniques in PD98059-treated rats we analyzed the mRNA and/or protein level of p38, ERK1/2, JNK, NF-kappaB, IL-1beta, IL-6, iNOS and IL-10 in the lumbar spinal cord. Our results indicate that PD98059 has an analgesic effects and potentiates morphine and/or buprenorphine analgesia. Parallel we observed that PD98059 inhibit upregulation of the CCI-elevated p38, ERK1/2, JNK and NF-kappaB protein levels. Moreover, PD98059 also prevented increase of pro- (IL-1beta, IL-6, and iNOS) but enhances anti-nociceptive (IL-10) factors. Summing up, PD98059 diminished pain and increased the effectiveness of opioids in neuropathy. The inhibition of MEKs might inactivate a variety of cell signaling pathways that are implicated in nociception.	[Rojewska, Ewelina; Popiolek-Barczyk, Katarzyna; Kolosowska, Natalia; Piotrowska, Anna; Zychowska, Magdalena; Makuch, Wioletta; Przewlocka, Barbara; Mika, Joanna] Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland	Polish Academy of Sciences	Mika, J (corresponding author), Polish Acad Sci, Inst Pharmacol, Dept Pain Pharmacol, Krakow, Poland.	joamika@if-pan.krakow.pl		Rojewska, Ewelina/0000-0001-8383-7356; Popiolek-Barczyk, Katarzyna/0000-0003-4366-6577; Makuch, Wioletta/0000-0002-1579-3643; PRZEWLOCKA, BARBARA/0000-0002-6672-1906; Piotrowska, Anna/0000-0002-2091-2678; Mika, Joanna/0000-0003-1986-7205	National Science Centre, Poland [OPUSNCN 2011/03/B/NZ4/00042]; KNOW; Ministry of Science and Higher Education, Republic of Poland	National Science Centre, Poland(National Science Centre, Poland); KNOW; Ministry of Science and Higher Education, Republic of Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the National Science Centre, Poland, grant OPUSNCN 2011/03/B/NZ4/00042 grant and statutory funds. Katarzyna Popiolek-Barczyk and Magdalena Zychowska are Ph. D. students and have a scholarships from the KNOW, sponsored by the Ministry of Science and Higher Education, Republic of Poland.	Alessandrini A, 1999, P NATL ACAD SCI USA, V96, P12866, DOI 10.1073/pnas.96.22.12866; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bethea JR, 1998, J NEUROSCI, V18, P3251; Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010; Chen YL, 2006, J BIOL CHEM, V281, P3067, DOI 10.1074/jbc.M506721200; Cheng XP, 2003, NEUROSCIENCE, V119, P701, DOI 10.1016/S0306-4522(03)00035-6; Clemons AP, 2002, PANCREAS, V25, P251, DOI 10.1097/00006676-200210000-00007; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Cui Y, 2008, BRAIN BEHAV IMMUN, V22, P114, DOI 10.1016/j.bbi.2007.07.014; Daulhac L, 2006, MOL PHARMACOL, V70, P1246, DOI 10.1124/mol.106.025478; DeLeo JA, 1996, J INTERF CYTOK RES, V16, P695, DOI 10.1089/jir.1996.16.695; DeLeo JA, 2004, NEUROSCIENTIST, V10, P40, DOI 10.1177/1073858403259950; Di Paola R, 2009, INT J IMMUNOPATH PH, V22, P937, DOI 10.1177/039463200902200409; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FIORE RS, 1993, J NEUROCHEM, V61, P1626, DOI 10.1111/j.1471-4159.1993.tb09796.x; Foey AD, 1998, J IMMUNOL, V160, P920; Gao YJ, 2009, J NEUROSCI, V29, P4096, DOI 10.1523/JNEUROSCI.3623-08.2009; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Ji RR, 2009, BRAIN RES REV, V60, P135, DOI 10.1016/j.brainresrev.2008.12.011; Jin SX, 2003, J NEUROSCI, V23, P4017; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kawasaki Y, 2006, J PHARMACOL EXP THER, V316, P601, DOI 10.1124/jpet.105.093583; Komatsu T, 2007, NEUROPHARMACOLOGY, V52, P1237, DOI 10.1016/j.neuropharm.2007.01.003; Kraus J, 2003, MOL PHARMACOL, V64, P876, DOI 10.1124/mol.64.4.876; Law PY, 2004, NEUROPHARMACOLOGY, V47, P300, DOI 10.1016/j.neuropharm.2004.07.013; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lee HL, 2004, NEUROREPORT, V15, P2807; Lee MK, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-57; Levy D, 2001, J NEUROPATH EXP NEUR, V60, P411, DOI 10.1093/jnen/60.5.411; Ma VY, 1998, BRAIN RES, V797, P243, DOI 10.1016/S0006-8993(98)00380-1; Ma WY, 2002, PAIN, V99, P175, DOI 10.1016/S0304-3959(02)00097-0; Meng Z, 2013, ACTA PHARMACOL SIN, V34, P901, DOI 10.1038/aps.2013.24; Mika J, 2008, PHARMACOL REP, V60, P297; Mika J, 2007, EUR J PHARMACOL, V560, P142, DOI 10.1016/j.ejphar.2007.01.013; Mika J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104420; Mika J, 2009, BRAIN BEHAV IMMUN, V23, P75, DOI 10.1016/j.bbi.2008.07.005; Milligan ED, 2003, J NEUROSCI, V23, P1026; Milligan ED, 2006, PAIN, V126, P294, DOI 10.1016/j.pain.2006.07.009; Miyoshi K, 2008, J NEUROSCI, V28, P12775, DOI 10.1523/JNEUROSCI.3512-08.2008; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Pollock G, 2005, EXP BRAIN RES, V165, P470, DOI 10.1007/s00221-005-2318-6; Popiolek-Barczyk K, 2015, NEURAL PLAST; Popiolek-Barczyk K, 2014, PHARMACOL REP, V66, P845, DOI 10.1016/j.pharep.2014.05.001; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Rojewska E, 2014, J NEUROIMMUNOL, V277, P57, DOI 10.1016/j.jneuroim.2014.09.020; Rojewska E, 2014, NEUROPHARMACOLOGY, V86, P301, DOI 10.1016/j.neuropharm.2014.08.001; Sawada M, 1999, J NEUROCHEM, V72, P1466, DOI 10.1046/j.1471-4159.1999.721466.x; Schmidt H, 2000, J NEUROCHEM, V74, P414, DOI 10.1046/j.1471-4159.2000.0740414.x; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Song P, 2001, NEUROSCI RES, V39, P281, DOI 10.1016/S0168-0102(00)00226-1; Sung CS, 2005, J NEUROCHEM, V94, P742, DOI 10.1111/j.1471-4159.2005.03226.x; Svensson CI, 2003, J NEUROCHEM, V86, P1534, DOI 10.1046/j.1471-4159.2003.01969.x; Tanabe K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-68; Tanabe K, 2009, BRAIN RES, V1274, P11, DOI 10.1016/j.brainres.2009.03.063; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; van den Heuvel I, 2015, EUR J PAIN, V19, P225, DOI 10.1002/ejp.540; Wang ZY, 2010, PEPTIDES, V31, P2179, DOI 10.1016/j.peptides.2010.08.020; Wen YR, 2007, ANESTHESIOLOGY, V107, P312, DOI 10.1097/01.anes.0000270759.11086.e7; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Zang Y, 2011, CHINESE J PHYSIOL, V54, P241, DOI 10.4077/CJP.2011.AMM075; Zhang Q, 2013, BRAIN RES BULL, V99, P132, DOI 10.1016/j.brainresbull.2013.10.008; Zhou CH, 2014, ANESTH ANALG, V118, P1090, DOI 10.1213/ANE.0000000000000174; Zhu JY, 2015, INFLAMMATION, V38, P637, DOI 10.1007/s10753-014-9971-5; Zhuang ZY, 2005, PAIN, V114, P149, DOI 10.1016/j.pain.2004.12.022; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	77	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138583	10.1371/journal.pone.0138583	http://dx.doi.org/10.1371/journal.pone.0138583			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426693	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100015
J	Santiago-Rodriguez, TM; Fornaciari, G; Luciani, S; Dowd, SE; Toranzos, GA; Marota, I; Cano, RJ				Santiago-Rodriguez, Tasha M.; Fornaciari, Gino; Luciani, Stefania; Dowd, Scot E.; Toranzos, Gary A.; Marota, Isolina; Cano, Raul J.			Gut Microbiome of an 11th Century AD Pre-Columbian Andean Mummy	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; BACTERIAL-DNA; ANTIBIOTIC-RESISTANCE; SEQUENCE-ANALYSIS; NEXT-GENERATION; DISEASE; DIVERSITY; BIOLOGY; SHIFTS; COLON	The process of natural mummification is a rare and unique process from which little is known about the resulting microbial community structure. In the present study, we characterized the microbiome of paleofeces, and ascending, transverse and descending colon of an 11th century A.D. pre-Columbian Andean mummy by 16S rRNA gene high-throughput sequencing and metagenomics. Firmicutes were the most abundant bacterial group, with Clostridium spp. comprising up to 96.2% of the mummified gut, while Turicibacter spp. represented 89.2% of the bacteria identified in the paleofeces. Microbiome profile of the paleofeces was unique when compared to previously characterized coprolites that did not undergo natural mummification. We identified DNA sequences homologous to Clostridium botulinum, Trypanosoma cruzi and human papillomaviruses (HPVs). Unexpectedly, putative antibiotic-resistance genes including beta-lactamases, penicillin-binding proteins, resistance to fosfomycin, chloramphenicol, aminoglycosides, macrolides, sulfa, quinolones, tetracycline and vancomycin, and multi-drug transporters, were also identified. The presence of putative antibiotic-resistance genes suggests that resistance may not necessarily be associated with a selective pressure of antibiotics or contact with European cultures. Identification of pathogens and antibiotic-resistance genes in ancient human specimens will aid in the understanding of the evolution of pathogens as a way to treat and prevent diseases caused by bacteria, microbial eukaryotes and viruses.	[Santiago-Rodriguez, Tasha M.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Fornaciari, Gino] Univ Pisa, Dept Translat Res New Technol Med & Surg, Div Paleopathol, Pisa, Italy; [Fornaciari, Gino] Univ Sassari, Ctr Anthropol Paleopathol & Hist Studies Sardinia, Dept Biomed Sci, I-07100 Sassari, Italy; [Luciani, Stefania; Marota, Isolina] Univ Camerino, Sch Biosci & Vet Med, Lab Mol Archaeoanthropol Ancient DNA, I-62032 Camerino, Italy; [Dowd, Scot E.] Mol Res LP MR DNA, Shallowater, TX USA; [Toranzos, Gary A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Cano, Raul J.] Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA	University of California System; University of California San Diego; University of Pisa; University of Sassari; University of Camerino; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; California State University System; California Polytechnic State University San Luis Obispo	Cano, RJ (corresponding author), Calif Polytech State Univ San Luis Obispo, Ctr Applicat Biotechnol, San Luis Obispo, CA 93407 USA.	rcano@calpoly.edu	Dowd, Scot E/M-5386-2017	Dowd, Scot E/0000-0002-6296-1427; Fornaciari, Gino/0000-0002-1334-1707	MG-RAST under the project PeruvianFemaleMummy [4630170.3-4630172.3, 4644219.3-4644222.3]	MG-RAST under the project PeruvianFemaleMummy	Data are publicly available in MG-RAST under the project PeruvianFemaleMummy (MGRAST IDs 4630170.3-4630172.3 and 4644219.3-4644222.3).	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Appelt S, 2014, APPL ENVIRON MICROB, V80, P2648, DOI 10.1128/AEM.03242-13; Appelt S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088376; Bosshard PP, 2002, INT J SYST EVOL MICR, V52, P1263, DOI [10.1099/ijs.0.02056-0, 10.1099/00207713-52-4-1263]; Breton J, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-62; Cano RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106833; Cano RJ, 2000, AM J PHYS ANTHROPOL, V112, P297; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Cuiv PO, 2011, J BACTERIOL, V193, P1288, DOI 10.1128/JB.01328-10; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dunne WM, 2012, EUR J CLIN MICROBIOL, V31, P1719, DOI 10.1007/s10096-012-1641-7; Ekeowa-Anderson AL, 2007, CLIN EXP DERMATOL, V32, P304, DOI 10.1111/j.1365-2230.2007.02388.x; FAVRE M, 1989, J VIROL, V63, P4909, DOI 10.1128/JVI.63.11.4909-.1989; FORNACIARI G, 1992, LANCET, V339, P128, DOI 10.1016/0140-6736(92)91043-8; Fornaciari G, 2003, LANCET, V362, P1160, DOI 10.1016/S0140-6736(03)14487-X; Fornaciari G, 1992, ARCH ANTROP ETNOL, V122, P369; GHANEM FM, 1991, J CLIN MICROBIOL, V29, P1114, DOI 10.1128/JCM.29.6.1114-1124.1991; Greenblatt CL, 1999, MICROBIAL ECOL, V38, P58, DOI 10.1007/s002489900153; Greenblatt CL, 2004, MICROBIAL ECOL, V48, P120, DOI 10.1007/s00248-003-2016-5; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hyde ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077733; Janaway RC, 2009, CRIMINAL AND ENVIRONMENTAL SOIL FORENSICS, P341, DOI 10.1007/978-1-4020-9204-6_22; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Lambert LH, 1998, INT J SYST BACTERIOL, V48, P511, DOI 10.1099/00207713-48-2-511; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Luciani S, 2006, AM J PHYS ANTHROPOL, V129, P620, DOI 10.1002/ajpa.20314; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860; Mulle JG, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0337-0; ONG CK, 1993, J VIROL, V67, P6424, DOI 10.1128/JVI.67.11.6424-6431.1993; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rollo F, 2000, AM J PHYS ANTHROPOL, V111, P211, DOI 10.1002/(SICI)1096-8644(200002)111:2<211::AID-AJPA7>3.0.CO;2-M; Santiago-Rodriguez TM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00014; Santiago-Rodriguez TM, 2014, FEMS MICROBIOL LETT, V350, P117, DOI 10.1111/1574-6968.12275; Santiago-Rodriguez TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065191; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Tito RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051146; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubaldi M, 1998, AM J PHYS ANTHROPOL, V107, P285, DOI 10.1002/(SICI)1096-8644(199811)107:3<285::AID-AJPA5>3.0.CO;2-U; Warinner C, 2014, NAT GENET, V46, P336, DOI 10.1038/ng.2906; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Wright GD, 2012, TRENDS MICROBIOL, V20, P157, DOI 10.1016/j.tim.2012.01.002	50	42	43	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138135	10.1371/journal.pone.0138135	http://dx.doi.org/10.1371/journal.pone.0138135			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422376	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700031
J	Zhao, J; Hao, XY; Liu, D; Huang, YB; Chen, YX				Zhao, Jing; Hao, Xueyu; Liu, Dong; Huang, Yibing; Chen, Yuxin			In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES	In this study, HPRP-A2, a synthetic 15-mer cationic peptides with all D-amino acids, effectively inhibited the survival of gastric cell lines in a dose-dependent manner. Gastric tumor cells killing by HPRP-A2 involves a rapid collapse of the membrane integrity and intracellular pathways. Propidium iodide (PI) and lactate dehydrogenase (LDH) assays demonstrated that one-hour treatment with HPRP-A2 led to membrane permeability changes of BGC-823 cells in a dose-dependent manner. Moreover, HPRP-A2 induced apoptosis in BGC-823 cells involves a marked increase in generation of reactive oxygen species (ROS), caspase-3, -8 and -9 activation, a reduction of mitochondrial membrane potential (MMP), and cell cycle arrest in G1 phase. In addition to its inherent cytotoxicity, HPRP-A2 synergized strongly with doxorubicin (DOX) to enhance the efficacy of killing gastric tumor cells in vitro. We believe that HPRP-A2 with all D-amino acids could be a potent candidate of anticancer therapeutics, especially in combination therapy.	[Zhao, Jing; Hao, Xueyu; Liu, Dong; Huang, Yibing; Chen, Yuxin] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China; [Zhao, Jing; Hao, Xueyu; Liu, Dong; Huang, Yibing; Chen, Yuxin] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Huang, Yibing; Chen, Yuxin] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Huang, YB (corresponding author), Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China.	huangyibing@jlu.edu.cn; chen_yuxin@jlu.edu.cn	Huang, Yibing/M-9462-2018	Huang, Yibing/0000-0002-2655-535X	National Natural Science Foundation of China [81373445, 21442001]; Natural Science Foundation of Jilin Province [20150101189JC, 20140101042JC]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This study was supported by the National Natural Science Foundation of China (No. 81373445, YXC and No. 21442001, YBH) and the Natural Science Foundation of Jilin Province (No. 20150101189JC, YC and No. 20140101042JC, YBH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2011, INT J MOL SCI, V12, P8027, DOI 10.3390/ijms12118027; BAKER MA, 1993, CANCER RES, V53, P3052; Chan SC, 1998, ANTICANCER RES, V18, P4467; CRUCIANI RA, 1992, EUR J PHARM-MOLEC PH, V226, P287, DOI 10.1016/0922-4106(92)90045-W; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Huang YB, 2011, MOL CANCER THER, V10, P416, DOI 10.1158/1535-7163.MCT-10-0811; Jin Z., 1980, ACTA PHARMACOL SIN, V1, P70; Johnstone SA, 2000, ANTI-CANCER DRUG DES, V15, P151; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; OHSAKI Y, 1992, CANCER RES, V52, P3534; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; Ran S, 2002, CANCER RES, V62, P6132; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Smith LL, 2000, CRIT REV TOXICOL, V30, P571, DOI 10.1080/10408440008951120; Yoon WH, 1996, BIOCHEM BIOPH RES CO, V222, P694, DOI 10.1006/bbrc.1996.0806; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhao J, 2015, ONCOTARGET, V6, P1769, DOI 10.18632/oncotarget.2754	18	10	11	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139578	10.1371/journal.pone.0139578	http://dx.doi.org/10.1371/journal.pone.0139578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422386	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700130
J	Abrahim, O; Linnander, E; Mohammed, H; Fetene, N; Bradley, E				Abrahim, Orit; Linnander, Erika; Mohammed, Halima; Fetene, Netsanet; Bradley, Elizabeth			A Patient-Centered Understanding of the Referral System in Ethiopian Primary Health Care Units	PLOS ONE			English	Article							DELIVERY	Background Primary healthcare systems in sub-Saharan Africa have undergone substantial development in an effort to expand access to appropriate facilities through a well-functioning referral system. The objective of this study was to evaluate the current patterns of seeking prior care before arriving at a health center or a hospital as a key aspect of the referral system of the primary health care unit (PHCU) in three regions in Ethiopia. We examined what percentage of patients had either sought prior care or had been referred to the present facility and identified demographic and clinical factors associated with having sought prior care or having been referred. Methods and Findings We conducted a cross-sectional study using face-to-face interviews in the local language with 796 people (99% response rate) seeking outpatient care in three primary health care units serving approximately 100,000 people each and reflecting regional and ethnic diversity; 53%(N = 418) of the sample was seeking care at hospital outpatient departments, and 47% of the sample was seeking care at health centers (N = 378). We used unadjusted and adjusted logistic regression to identify factors associated with having been referred or sought prior care. Our findings indicated that only 10% of all patients interviewed had been referred to their current place of care. Among those in the hospital population, 14% had been referred; among those in the health center population, only 6% had been referred. Of those who had been referred to the hospital, most (74%) had been referred by a health center. Among those who were referred to the health center, the plurality portion (32%) came from a nearby hospital (most commonly for continued HIV treatment or early childhood vaccinations); only 18% had come from a health post. Among patients who had not been formally referred, an additional 25% in the hospital sample and 10% in the health center sample had accessed some prior source of care for their present health concern. In the adjusted analysis, living a longer distance from the source of care and needing more specialized care were correlated with having sought prior care in the hospital sample. We found no factors significantly associated with having sought prior care in the health center sample. Conclusions The referral system among health facilities in Ethiopia is used by a minority of patients, suggesting that intended connections between health posts, health centers, and hospitals may need strengthening to increase the efficiency of primary care nationally.	[Abrahim, Orit; Linnander, Erika; Mohammed, Halima; Fetene, Netsanet; Bradley, Elizabeth] Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA	Yale University	Bradley, E (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06520 USA.	Elizabeth.Bradley@yale.edu		Netsanet, Fetene/0000-0002-3208-0055; Linnander, Erika/0000-0002-3417-1049	Robert C. Bates Fellowship; Global Health Fellows Program at Yale University; Harvard School of Public Health	Robert C. Bates Fellowship; Global Health Fellows Program at Yale University; Harvard School of Public Health	Support was provided to OA by Robert C. Bates Fellowship; Global Health Fellows Program at Yale University; and Harvard School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Bekele, 2008, Ethiopian Journal of Health Development, V22, P302; Akande T., 2004, ANN AFR MED, V3, P130; Bossyns P, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-51; Bradley E, 2011, INT J QUAL HEALTH C; Curry LA, 2013, EVALUATION ETHIOPIAN; Federal Democratic Republic of Ethiopia MOH, 2010, 2010 HLTH SECT DEV P; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Low A, 2001, INT J HEALTH PLAN M, V16, P243, DOI 10.1002/hpm.628; Nordberg E, 1996, TROP MED INT HEALTH, V1, P107, DOI 10.1046/j.1365-3156.1996.d01-2.x; Pearson L, 2011, INT J GYNECOL OBSTET, V115, P310, DOI 10.1016/j.ijgo.2011.09.007; Ringheim Karin, 2009, ETHIOPIA CROSSROADS; Sanders D, 1998, HEALTH POLICY PLANN, V13, P359, DOI 10.1093/heapol/13.4.359; Sipsma H, 2013, GLOB PUBLIC HEALTH, V8, P1014, DOI 10.1080/17441692.2013.835434; United Nations Development Program, 2012, ASS PROGR MILL DEV G; Van Lerberghe W, 2008, WORLD HLTH REPORT 20	15	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139024	10.1371/journal.pone.0139024	http://dx.doi.org/10.1371/journal.pone.0139024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0PR	26436759	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200011
J	Kuhs, KAL; Kuniholm, MH; Pfeiffer, RM; Chen, S; Desai, S; Edlin, BR; Peters, MG; Plankey, M; Sharp, GB; Strickler, HD; Villacres, MC; Quinn, TC; Gange, SJ; Prokunina-Olsson, L; Greenblatt, RM; O'Brien, TR				Kuhs, Krystle A. Lang; Kuniholm, Mark H.; Pfeiffer, Ruth M.; Chen, Sabrina; Desai, Seema; Edlin, Brian R.; Peters, Marion G.; Plankey, Michael; Sharp, Gerald B.; Strickler, Howard D.; Villacres, Maria C.; Quinn, Thomas C.; Gange, Stephen J.; Prokunina-Olsson, Ludmila; Greenblatt, Ruth M.; O'Brien, Thomas R.			Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes	PLOS ONE			English	Article							WOMENS INTERAGENCY HIV; HEPATITIS-C VIRUS; GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; SPONTANEOUS CLEARANCE; IL28B; THERAPY; WIHS	IFNL4-Delta G/TT (rs368234815) genotype is associated with hepatitis C virus clearance and may play a role in other infections. IFN-lambda 4 protein is generated only in individuals who carry the IFNL4-Delta G allele. The IFNL4 rs12979860-T allele, which is in strong linkage disequilibrium with IFNL4-Delta G, was recently reported to be associated with more frequent and severe oral herpes episodes. We investigated the association of IFNL4-Delta G/TT with herpes simplex virus (HSV)-related outcomes among 2,192 African American and European American participants in the Women's Interagency HIV Study (WIHS). WIHS is a prospective cohort study of human immunodeficiency virus (HIV)-infected and at-risk women that began in 1994. This report includes follow-up through 2013. Available data included: HSV-1 and HSV-2 antibodies at study entry; bi-annually ascertained episodes of (self-reported) oral herpes, (self-reported) genital sores and (clinician-observed) genital ulcers; HSV-2 DNA in cervicovaginal lavage (CVL) specimens. IFNL4-Delta G/TT genotyping was determined by Taq-Man. We compared women with IFNL4-Delta G/Delta G or IFNL4-TT/Delta G genotypes (i.e., IFNL4-Delta G carriers) to those with the IFNL4-TT/TT genotype, adjusting for age, race and HIV status. For outcomes with repeated measurements, the adjusted odds ratio (aOR), 95% confidence interval [CI] and p-value were determined using a generalized estimating equations approach. Median participant age at enrollment was 36 years; 81% were African American, 74% were HIV-infected. Among 1,431 participants tested for antibodies, 72.8% were positive for HSV-1 and 79.0% were positive for HSV-2. We observed no association between IFNL4-Delta G/TT genotype and any outcome: HSV-1 or HSV-2 antibody prevalence (p>0.1, all comparisons); oral herpes (aOR, 1.2; p = 0.35); genital sores (aOR, 1.0; p = 0.71); genital ulcers (aOR, 1.1; p = 0.53); detectable HSV-2 DNA in CVL (N = 322; aOR, 0.71; p = 0.49); HSV-2 DNA level (p = 0.68). In this large prospective study, IFNL4-Delta G/TT genotype was not associated with HSV-related outcomes, including episodes of oral or genital herpes.	[Kuhs, Krystle A. Lang; O'Brien, Thomas R.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Kuniholm, Mark H.; Strickler, Howard D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Pfeiffer, Ruth M.] NCI, Biostat Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Chen, Sabrina] Informat Management Serv Inc, Calverton, MD USA; [Desai, Seema] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Edlin, Brian R.] Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA; [Peters, Marion G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Plankey, Michael] Georgetown Univ, Med Ctr, Div Infect Dis, Washington, DC 20007 USA; [Sharp, Gerald B.] NIAID, Epidemiol Branch, Div Aids, Bethesda, MD 20892 USA; [Villacres, Maria C.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Quinn, Thomas C.] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Gange, Stephen J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Prokunina-Olsson, Ludmila] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Rush University; National Development & Research Institutes, Inc; University of California System; University of California San Francisco; Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kuhs, KAL (corresponding author), NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	Krystle.Kuhs@nih.gov	Prokunina-Olsson, Ludmila/V-7960-2019; Gange, Stephen/AGY-5004-2022; Edlin, Brian R/F-2966-2018; Prokunina-Olsson, Ludmila/A-8240-2019	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Gange, Stephen/0000-0001-7842-512X; Edlin, Brian R/0000-0001-8172-8797; Prokunina-Olsson, Ludmila/0000-0002-9622-2091	National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP005782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034993, U01AI034994, U01AI031834, U01AI103408, U01AI103390, U01AI103397, U01AI034989, U01AI042590, Z01AI000732, U01AI035004, U01AI103401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen), U01-AI-034993; Metropolitan Washington WIHS (Mary Young), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt, Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Alexandra Levine and Marek Nowicki), U01-HD-032632 (WIHS I - WIHS IV). The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSF CTSA) and UL1-TR000454 (Atlanta CTSA). This specific study was supported by the Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics). The funders of WIHS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Sabrina Chen, an employee of Information Management Services (IMS), performed data analysis for this manuscript under a contract between IMS and the Division of Cancer Epidemiology and Genetics. IMS had no other role in the study design, data collection, decision to publish, or preparation of the manuscript. The specific role of author Sabrina Chen is articulated in the 'author contributions' section." This specific study was supported by the Intramural Research Program of the US National Institutes of Health (National Cancer Institute, Division of Cancer Epidemiology and Genetics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aka PV, 2014, J INFECT DIS, V209, P350, DOI 10.1093/infdis/jit433; Ameli N, 2006, AIDS, V20, P1051, DOI 10.1097/01.aids.0000222078.75867.77; Aumakhan B, 2011, INT J STD AIDS, V22, P273, DOI 10.1258/ijsa.2009.009296; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Greenblatt RM, 1999, SEX TRANSM DIS, V26, P143, DOI 10.1097/00007435-199903000-00004; Griffiths SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003514; Key FM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004681; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; O'Brien TR, 2014, J INTERF CYTOK RES, V34, P829, DOI 10.1089/jir.2013.0136; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	18	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138827	10.1371/journal.pone.0138827	http://dx.doi.org/10.1371/journal.pone.0138827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431156	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700020
J	Lin, CC; Potter, CJ				Lin, Chun-Chieh; Potter, Christopher J.			Re-Classification of Drosophila melanogaster Trichoid and Intermediate Sensilla Using Fluorescence-Guided Single Sensillum Recording	PLOS ONE			English	Article							TARGETED GENE-EXPRESSION; OLFACTORY NEURONS; Q-SYSTEM; RECEPTOR; ORGANIZATION; MAP	Drosophila olfactory receptor neurons are found within specialized sensory hairs on antenna and maxillary palps. The linking of odorant-induced responses to olfactory neuron activities is often accomplished via Single Sensillum Recordings (SSR), in which an electrode inserted into a single sensory hair records the neuronal activities of all the neurons housed in that sensillum. The identification of the recorded sensillum requires matching the neuronal responses with known odor-response profiles. To record from specific sensilla, or to systematically screen all sensillar types, requires repetitive and semi-random SSR experiments. Here, we validate an approach in which the GAL4/UAS binary expression system is used for targeting specific sensilla for recordings. We take advantage of available OrX-Gal4 lines, in combination with recently generated strong membrane targeted GFP reporters, to guide electrophysiological recordings to GFP-labeled sensilla. We validate a full set of reagents that can be used to rapidly screen the odor-response profiles of all basiconic, intermediate, and trichoid sensilla. Fluorescence-guided SSR further revealed that two antennal trichoid sensilla types should be re-classified as intermediate sensilla. This approach provides a simple and practical addition to a proven method for investigating olfactory neurons, and can be extended by the addition of UAS-geneX effectors for gain-of-function or loss-of-function studies.	[Lin, Chun-Chieh; Potter, Christopher J.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA	Johns Hopkins University	Potter, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21218 USA.	cpotter@jhmi.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112	National Institute on Deafness and Other Communication Disorders [R01 DC013070]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013079, P30DC005211] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was funded by grant R01 DC013070 from the National Institute on Deafness and Other Communication Disorders to CJP (http://www.nidcd.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; BRAND AH, 1993, DEVELOPMENT, V118, P401; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dweck HKM, 2015, P NATL ACAD SCI USA, V112, pE2829, DOI 10.1073/pnas.1504527112; Dweck HKM, 2013, CURR BIOL, V23, P2472, DOI 10.1016/j.cub.2013.10.047; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Klapoetke NC, 2014, NAT METH, P1; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Riabinina O, 2015, NAT METHODS, V12, P219, DOI [10.1038/NMETH.3250, 10.1038/nmeth.3250]; Ronderos DS, 2014, J NEUROSCI, V34, P3959, DOI 10.1523/JNEUROSCI.4582-13.2014; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	29	25	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139675	10.1371/journal.pone.0139675	http://dx.doi.org/10.1371/journal.pone.0139675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431203	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700097
J	Pooja, S; Pushpanathan, M; Gunasekaran, P; Rajendhran, J				Pooja, Sharma; Pushpanathan, Muthuirulan; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash			Endocytosis-Mediated Invasion and Pathogenicity of Streptococcus agalactiae in Rat Cardiomyocyte (H9C2)	PLOS ONE			English	Article							GROUP-B STREPTOCOCCI; LIPOTEICHOIC ACID; TEICHOIC-ACIDS; C5A PEPTIDASE; CELLS; ENDOCARDITIS; MYOCARDITIS; DISEASE; DIFFERENTIATION; EPIDEMIOLOGY	Streptococcus agalactiae infection causes high mortality in cardiovascular disease (CVD) patients, especially in case of setting prosthetic valve during cardiac surgery. However, the pathogenesis mechanism of S. agalactiae associate with CVD has not been well studied. Here, we have demonstrated the pathogenicity of S. agalactiae in rat cardiomyocytes (H9C2). Interestingly, both live and dead cells of S. agalactiae were uptaken by H9C2 cells. To further dissect the process of S. agalactiae internalization, we chemically inhibited discrete parts of cellular uptake system in H9C2 cells using genistein, chlorpromazine, nocodazole and cytochalasin B. Chemical inhibition of microtubule and actin formation by nocodazole and cytochalasin B impaired S. agalactiae internalization into H9C2 cells. Consistently, reverse. transcription PCR (RT-PCR) and quantitative real time. PCR (RT-qPCR) analyses also detected higher levels of transcripts for cytoskeleton forming genes, Acta1 and Tubb5 in S. agalactiae. infected H9C2 cells, suggesting the requirement of functional cytoskeleton in pathogenesis. Host survival assay demonstrated that S. agalactiae internalization induced cytotoxicity in H9C2 cells. S. agalactiae cells grown with benzyl penicillin reduced its ability to internalize and induce cytotoxicity in H9C2 cells, which could be attributed with the removal of surface lipoteichoic acid (LTA) from S. agalactiae. Further, the LTA extracted from S. agalactiae also exhibited dose. dependent cytotoxicity in H9C2 cells. Taken together, our data suggest that S. agalactiae cells internalized H9C2 cells through energy. dependent endocytic processes and the LTA of S. agalactiae play major role in host cell internalization and cytotoxicity induction.	[Pooja, Sharma; Pushpanathan, Muthuirulan; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash] Madurai Kamaraj Univ, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India	Madurai Kamaraj University	Rajendhran, J (corresponding author), Madurai Kamaraj Univ, Sch Biol Sci, Dept Genet, Madurai 625021, Tamil Nadu, India.	jrajendhran@gmail.com	Rajendhran, Jeyaprakash/ABD-3893-2020; Pushpanathan, Muthuirulan/K-7302-2019	Pushpanathan, Muthuirulan/0000-0001-6240-3073; Rajendhran, Jeyaprakash/0000-0002-1898-1607				Abad C, 1996, MED CLIN-BARCELONA, V106, P119; Andersson LIM, 2008, HUM IMMUNOL, V69, P625, DOI 10.1016/j.humimm.2008.07.010; Bateman AC, 1998, J INFECTION, V36, P354, DOI 10.1016/S0163-4453(98)95071-X; Beckmann C, 2002, INFECT IMMUN, V70, P2869, DOI 10.1128/IAI.70.6.2869-2876.2002; Branco AF, 2011, CARDIOVASC TOXICOL, V11, P191, DOI 10.1007/s12012-011-9111-5; BROCKMAN MD, 1979, SOUTHERN MED J, V72, P1629, DOI 10.1097/00007611-197912000-00050; Cheng Q, 2002, INFECT IMMUN, V70, P2408, DOI 10.1128/IAI.70.5.2408-2413.2002; Dinakaran V, 2012, HEART LUNG CIRC, V21, P281, DOI 10.1016/j.hlc.2012.02.007; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Friman G, 1995, EUR HEART J, V16, P36, DOI 10.1093/eurheartj/16.suppl_O.36; GOLDSCHMIDT JC, 1984, INFECT IMMUN, V43, P670, DOI 10.1128/IAI.43.2.670-677.1984; GOLTZ JS, 1992, P NATL ACAD SCI USA, V89, P7026, DOI 10.1073/pnas.89.15.7026; Gutierrez-Venegas G, 2010, MICROBIOL IMMUNOL, V57, P849; Hogg SD, 1997, INT J SYST BACTERIOL, V47, P62, DOI 10.1099/00207713-47-1-62; Kristian SA, 2005, J BACTERIOL, V187, P6719, DOI 10.1128/JB.187.19.6719-6725.2005; LIU SM, 1993, J CELL PHYSIOL, V156, P311, DOI 10.1002/jcp.1041560213; Machado C, 2012, REV PORT CARDIOL, V31, P619, DOI 10.1016/j.repc.2012.01.017; MACLEANFLETCHER S, 1980, CELL, V20, P329, DOI 10.1016/0092-8674(80)90619-4; MCCARTY M, 1959, J EXP MED, V109, P361, DOI 10.1084/jem.109.4.361; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Narkwiboonwong T., 2011, Journal of Infectious Diseases and Antimicrobial Agents, V28, P179; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rollan MJ, 2003, AM HEART J, V146, P1095, DOI 10.1016/S0002-8703(03)00444-7; ROSENSHINE I, 1994, METHOD ENZYMOL, V236, P467; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; Schuchat A, 1998, CLIN MICROBIOL REV, V11, P497, DOI 10.1128/CMR.11.3.497; SCULLY BE, 1987, INFECTION, V15, P169, DOI 10.1007/BF01646041; Segura M, 1999, INFECT IMMUN, V67, P4646, DOI 10.1128/IAI.67.9.4646-4654.1999; Siciliano RF, 2010, HEART LUNG, V39, P331, DOI 10.1016/j.hrtlng.2009.06.018; SIJTSMA L, 1990, J BACTERIOL, V172, P7126, DOI 10.1128/jb.172.12.7126-7130.1990; SIT KH, 1993, IN VITRO CELL DEV-AN, V29A, P395, DOI 10.1007/BF02633988; SLABYJ BM, 1976, J BACTERIOL, V127, P855, DOI 10.1128/JB.127.2.855-862.1976; Spellerberg B, 2000, MICROBES INFECT, V2, P1733, DOI 10.1016/S1286-4579(00)01328-9; Stinson MW, 2003, INFECT IMMUN, V71, P2365, DOI 10.1128/IAI.71.5.2365-2372.2003; Sunkara B, 2012, INT J INFECT DIS, V16, pE182, DOI 10.1016/j.ijid.2011.11.008; TETI G, 1987, INFECT IMMUN, V55, P3057, DOI 10.1128/IAI.55.12.3057-3064.1987; Tsai PJ, 1999, INFECT IMMUN, V67, P4334, DOI 10.1128/IAI.67.9.4334-4339.1999; Ulett GC, 2005, J IMMUNOL, V175, P2555, DOI 10.4049/jimmunol.175.4.2555; WAREJCKA DJ, 1985, INFECT IMMUN, V48, P560, DOI 10.1128/IAI.48.2.560-564.1985; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wenger NK, 2005, HEART, V91, P277, DOI 10.1136/hrt.2004.047860; WICKEN AJ, 1975, SCIENCE, V187, P1161, DOI 10.1126/science.46620; WICKEN AJ, 1980, BIOCHIM BIOPHYS ACTA, V604, P1, DOI 10.1016/0304-4157(80)90002-7	47	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139733	10.1371/journal.pone.0139733	http://dx.doi.org/10.1371/journal.pone.0139733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431539	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700107
J	Xiong, JQ; Lu, ZY; Wu, M; Zhang, JJ; Cheng, J; Luo, AY; Shen, W; Fang, L; Zhou, S; Wang, SX				Xiong, Jiaqiang; Lu, Zhiyong; Wu, Meng; Zhang, Jinjin; Cheng, Jing; Luo, Aiyue; Shen, Wei; Fang, Li; Zhou, Su; Wang, Shixuan			Intraovarian Transplantation of Female Germline Stem Cells Rescue Ovarian Function in Chemotherapy-Injured Ovaries	PLOS ONE			English	Article							MOUSE; OOGENESIS; CANCER; FERTILITY; STATISTICS; ROLES; MICE	Early menopause and infertility often occur in female cancer patients after chemotherapy (CTx). For these patients, oocyte/embryo cryopreservation or ovarian tissue cryopreservation is the current modality for fertility preservation. However, the above methods are limited in the long-term protection of ovarian function, especially for fertility preservation (very few females with cancer have achieved pregnancy with cryopreserved ovarian tissue or eggs until now). In addition, the above methods are subject to their scope (females with no husband or prepubertal females with no mature oocytes). Thus, many females who suffer from cancers would not adopt the above methods pre- and post-CTx due to their uncertainty, safety and cost-effectiveness. Therefore, millions of women have achieved long-term survival after thorough CTx treatment and have desired to rescue their ovarian function and fertility with economic, durable and reliable methods. Recently, some studies showed that mice with infertility caused by CTx can produce normal offspring through intraovarian injection of exogenous female germline stem cells (FGSCs). Though exogenous FGSC can be derived from mice without immune rejection in the same strain, it is difficult to obtain human female germline stem cells (hFGSCs), and immune rejection could occur between different individuals. In this study, infertility in mice was caused by CTx, and the ability of FGSCs to restore ovarian function or even produce offspring was assessed. We had successfully isolated and purified the FGSCs from adult female mice two weeks after CTx. After infection with GFP-carrying virus, the FGSCs were transplanted into ovaries of mice with infertility caused by CTx. Finally, ovarian function was restored and the recipients produced offspring long-term. These findings showed that mice with CTx possessed FGSCs, restoring ovarian function and avoiding immune rejection from exogenous germline stem cells.	[Xiong, Jiaqiang; Lu, Zhiyong; Wu, Meng; Zhang, Jinjin; Cheng, Jing; Luo, Aiyue; Shen, Wei; Fang, Li; Zhou, Su; Wang, Shixuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China; [Lu, Zhiyong] Hubei Univ Med, Tai He Hosp, Hubei Key Lab Embryon Stem Cell Res, Shiyan, Hubei, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine	Wang, SX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Hubei, Peoples R China.	sxwang@tjh.tjmu.edu.cn	zhang, jin/GXV-9154-2022	Xiong, Jiaqiang/0000-0002-8490-6613	National Natural Science Foundation of China [81300453, 81370469]; Program of International Science and Technology Cooperation of China [2013DFA31400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International Science and Technology Cooperation of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81300453; 81370469) and Program of International Science and Technology Cooperation of China (No. 2013DFA31400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dunlop CE, 2013, MATURITAS, V76, P279, DOI 10.1016/j.maturitas.2013.04.017; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lee HJ, 2007, J CLIN ONCOL, V25, P3198, DOI 10.1200/JCO.2006.10.3028; Lee SJ, 2006, J CLIN ONCOL, V24, P2917, DOI 10.1200/JCO.2006.06.5888; Lei L, 2013, P NATL ACAD SCI USA, V110, P8585, DOI 10.1073/pnas.1306189110; Meirow D, 2009, NEW ENGL J MED, V360, P2682; Park ES, 2015, MOL HUM REPROD, V21, P58, DOI 10.1093/molehr/gau071; Park MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01384; Partridge A H, 2001, Breast Dis, V14, P41; Roness H, 2014, HUM REPROD UPDATE, V20, P759, DOI 10.1093/humupd/dmu019; Sklar CA, 2006, J NATL CANCER I, V98, P890, DOI 10.1093/jnci/djj243; Swerdlow AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju207; Terraciano P, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/720753; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wan JF, 2015, CLIN COLORECTAL CANC, V14, P31, DOI 10.1016/j.clcc.2014.09.012; White YAR, 2012, NAT MED, V18, P413, DOI 10.1038/nm.2669; Wong TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062660; Woods DC, 2013, NAT PROTOC, V8, P966, DOI 10.1038/nprot.2013.047; Yuan JH, 2013, STEM CELLS, V31, P2538, DOI 10.1002/stem.1480; Zhang H, 2014, P NATL ACAD SCI USA, V111, P17983, DOI 10.1073/pnas.1421047111; Zhang H, 2012, P NATL ACAD SCI USA, V109, P12580, DOI 10.1073/pnas.1206600109; Zou K, 2009, NAT CELL BIOL, V11, P631, DOI 10.1038/ncb1869	24	31	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139824	10.1371/journal.pone.0139824	http://dx.doi.org/10.1371/journal.pone.0139824			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431320	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700119
J	Zammit, AR; Katz, MJ; Derby, C; Bitzer, M; Lipton, RB				Zammit, Andrea R.; Katz, Mindy J.; Derby, Carol; Bitzer, Markus; Lipton, Richard B.			Chronic Kidney Disease in Non-Diabetic Older Adults: Associated Roles of the Metabolic Syndrome, Inflammation, and Insulin Resistance	PLOS ONE			English	Article							C-REACTIVE PROTEIN; 3RD NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE; COGNITIVE IMPAIRMENT; RISK-FACTORS; US ADULTS; PREVALENCE; DYSLIPIDEMIA; PATHOGENESIS; PREDICTION	Background The aims of the study were to examine the association between CKD and the metabolic syndrome (MetS) and its components in older adults. We also explored two possible pathways linking the metabolic syndrome with CKD: inflammation as measured by high sensitivity C-Reactive Protein (hsCRP) and insulin resistance as measured by HOMA-IR. Methods Community-dwelling non-diabetic 70+ adults from the Einstein Aging Study participated in the study. We defined CKD as eGFR below 60mL/min/1.73m(2). MetS was defined according to recent guidelines from the National Cholesterol Education Program. Binary logistic regressions were used to assess the association between the metabolic syndrome, its components and CKD with adjustments for demographics, HOMA-IR and hsCRP. Results Of 616 participants (mean age = 79.3 years, 65.5% female), 25% had MetS and 26.5% had CKD. Participants with CKD had a significantly higher prevalence of the MetS than individuals without CKD (34.4% vs. 24.3%). Binary logistic regression models showed that CKD was associated with MetS (OR = 1.72, 95% CI = 1.13-2.61). The association was unaltered by adjustment for hsCRP but altered by adjustment for HOMA-IR. As the number of MetS components increased the relative odds of CKD also increased. None of the individual components was independently associated with CKD. Conclusion MetS is associated with CKD in non-diabetic older adults. Results showed that as the number of MetS components increased so did the odds for CKD. HOMA-IR seems to be in the casual pathway linking MetS to CKD.	[Zammit, Andrea R.; Katz, Mindy J.; Derby, Carol; Lipton, Richard B.] Albert Einstein Coll Med, Saul B Korey Dept Neurol, Bronx, NY 10467 USA; [Zammit, Andrea R.; Katz, Mindy J.; Derby, Carol; Lipton, Richard B.] Albert Einstein Coll Med, Einstein Aging Study, Bronx, NY 10467 USA; [Lipton, Richard B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Bitzer, Markus] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan	Zammit, AR (corresponding author), Albert Einstein Coll Med, Saul B Korey Dept Neurol, Bronx, NY 10467 USA.	andrea.zammit@einstein.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Lipton, Richard B/B-5060-2011	Bitzer, Markus/0000-0002-3711-2984	National Institutes on Aging program [PO1 AG03949]; National Institutes of Health CTSA from the National Center for Advancing Translational Sciences (NCATS) [1UL1TR001073]; Sylvia and Lenard Marx Foundation; Czap Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003949] Funding Source: NIH RePORTER	National Institutes on Aging program; National Institutes of Health CTSA from the National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Sylvia and Lenard Marx Foundation; Czap Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Einstein Aging Study (PO1 AG03949) from the National Institutes on Aging program; the National Institutes of Health CTSA (1UL1TR001073) from the National Center for Advancing Translational Sciences (NCATS); the Sylvia and Lenard Marx Foundation; and the Czap Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NI.	American Psychiatric Association, DIAGN STAT MAN MENT; Beddhu S, 2005, AM J KIDNEY DIS, V46, P577, DOI 10.1053/j.ajkd.2005.06.014; Boden G, 2001, ENDOCRIN METAB CLIN, V30, P801, DOI 10.1016/S0889-8529(05)70216-4; Bonferroni C. E., 1936, TEORIA STAT CLASSI C; Chen J, 2003, J AM SOC NEPHROL, V14, P469, DOI 10.1097/01.ASN.0000046029.53933.09; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Chen J, 2007, NEPHROL DIAL TRANSPL, V22, P1100, DOI 10.1093/ndt/gfl759; Chen S, 2003, PLOS ONE, V8; Chen SY, 2013, KIDNEY BLOOD PRESS R, V37, P392, DOI 10.1159/000355718; Cheng HT, 2012, J CLIN ENDOCR METAB, V97, P1268, DOI 10.1210/jc.2011-2658; Cirillo M, 2005, NEPHROL DIAL TRANSPL, V20, P1791, DOI 10.1093/ndt/gfh962; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Deedwania P, 2011, J CLIN HYPERTENS, V13, P52, DOI 10.1111/j.1751-7176.2010.00386.x; Ford ES, 2004, ATHEROSCLEROSIS, V173, P309, DOI 10.1016/j.atherosclerosis.2003.12.022; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Gluba A, 2013, INT J CARDIOL, V164, P141, DOI 10.1016/j.ijcard.2012.01.013; Hui WS, 2010, EUR J EPIDEMIOL, V25, P375, DOI 10.1007/s10654-010-9459-z; Katz MJ, 2012, ALZ DIS ASSOC DIS, V26, P335, DOI 10.1097/WAD.0b013e31823dbcfc; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Lebovitz HE, 2001, EXP CLIN ENDOCR DIAB, V109, pS135, DOI 10.1055/s-2001-18576; Lee JE, 2007, AM J HYPERTENS, V20, P1189, DOI 10.1016/j.amjhyper.2007.04.020; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liao MT, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/691369; Locatelli F, 2006, J AM SOC NEPHROL, V17, pS81, DOI 10.1681/ASN.2005121332; Lucove J, 2008, AM J KID DIS; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ming J, 2014, CLIN CHIM ACTA, V430, P115, DOI 10.1016/j.cca.2014.01.004; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Nashar K, 2014, DIABET METAB SYND OB, V7, P421, DOI 10.2147/DMSO.S45183; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Segura B, 2009, NEUROSCI LETT, V462, P49, DOI 10.1016/j.neulet.2009.06.071; Tsimihodimos V, 2008, AM J NEPHROL, V28, P958, DOI 10.1159/000144024; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237; Yaffe K, 2010, J AM GERIATR SOC, V58, P338, DOI 10.1111/j.1532-5415.2009.02670.x; Yang T, 2014, ENDOCR RES, V39, P94, DOI 10.3109/07435800.2013.840652; Zammit AR, 2014, J GERONTOL MED SCI	40	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139369	10.1371/journal.pone.0139369	http://dx.doi.org/10.1371/journal.pone.0139369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431218	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700048
J	DePaul, MA; Lin, CY; Silver, J; Lee, YS				DePaul, Marc A.; Lin, Ching-Yi; Silver, Jerry; Lee, Yu-Shang			Peripheral Nerve Transplantation Combined with Acidic Fibroblast Growth Factor and Chondroitinase Induces Regeneration and Improves Urinary Function in Complete Spinal Cord Transected Adult Mice	PLOS ONE			English	Article							AXONAL REGENERATION; CORTICOSPINAL TRACT; LOCOMOTOR RECOVERY; CONTUSION INJURY; PARAPLEGIC RATS; CELL BRIDGES; FIBRIN GLUE; IN-VIVO; GRAFTS; ABC	The loss of lower urinary tract (LUT) control is a ubiquitous consequence of a complete spinal cord injury, attributed to a lack of regeneration of supraspinal pathways controlling the bladder. Previous work in our lab has utilized a combinatorial therapy of peripheral nerve autografts (PNG), acidic fibroblast growth factor (aFGF), and chondroitinase ABC (ChABC) to treat a complete T8 spinal cord transection in the adult rat, resulting in supraspinal control of bladder function. In the present study we extended these findings by examining the use of the combinatorial PNG+aFGF+ChABC treatment in a T8 transected mouse model, which more closely models human urinary deficits following spinal cord injury. Cystometry analysis and external urethral sphincter electromyograms reveal that treatment with PNG+aFGF+ChABC reduced bladder weight, improved bladder and external urethral sphincter histology, and significantly enhanced LUT function, resulting in more efficient voiding. Treated mice's injured spinal cord also showed a reduction in collagen scaring, and regeneration of serotonergic and tyrosine hydroxylase-positive axons across the lesion and into the distal spinal cord. Regeneration of serotonin axons correlated with LUT recovery. These results suggest that our mouse model of LUT dysfunction recapitulates the results found in the rat model and may be used to further investigate genetic contributions to regeneration failure.	[DePaul, Marc A.; Silver, Jerry] Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA; [Lin, Ching-Yi; Lee, Yu-Shang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Lee, YS (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA.	leey2@ccf.org	DePaul, Marc/H-9010-2017	DePaul, Marc/0000-0002-3249-9550	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH.GOV) [NS069765]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [NS025713]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069765, R37NS025713, R01NS025713] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH.GOV); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH.GOV) NS069765 to YSL, and National Institutes of Health/National Institute of Neurological Disorders and Stroke NS025713 to JS.	Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Bartus K, 2014, J NEUROSCI, V34, P4822, DOI 10.1523/JNEUROSCI.4369-13.2014; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Busch SA, 2011, J NEUROSCI, V31, P944, DOI 10.1523/JNEUROSCI.3566-10.2011; Cajal S., 1928, DEGENERATION REGENER; Chang HY, 2007, AM J PHYSIOL-RENAL, V292, pF1044, DOI 10.1152/ajprenal.00175.2006; Cheng CL, 2004, EXP NEUROL, V187, P445, DOI 10.1016/j.expneurol.2004.02.014; Cheng H, 2004, SPINE, V29, pE284, DOI 10.1097/01.BRS.0000131217.61390.2C; CHENG H, 1995, EXP NEUROL, V136, P149, DOI 10.1006/exnr.1995.1092; Cheng H, 1996, SCIENCE, V273, P510, DOI 10.1126/science.273.5274.510; Chu TC, 2014, BRAIN RES BULL, V107, P18, DOI 10.1016/j.brainresbull.2014.05.003; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Deng LX, 2013, J NEUROSCI, V33, P5655, DOI 10.1523/JNEUROSCI.2973-12.2013; Eto H, 2012, LAB INVEST, V92, P214, DOI 10.1038/labinvest.2011.127; Farooque M, 2001, ACTA NEUROPATHOL, V102, P132; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Fowler CJ, 2008, NAT REV NEUROSCI, V9, P453, DOI 10.1038/nrn2401; Gauthier P, 2002, J NEUROSCI RES, V70, P65, DOI 10.1002/jnr.10379; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Grimpe B, 2005, MOL CELL NEUROSCI, V28, P18, DOI 10.1016/j.mcn.2004.06.010; Guest JD, 1997, J NEUROSCI RES, V50, P888, DOI 10.1002/(SICI)1097-4547(19971201)50:5<888::AID-JNR24>3.0.CO;2-W; Hodgetts SI, 2013, CELL TRANSPLANT, V22, P393, DOI 10.3727/096368912X656081; Houle JD, 2006, J NEUROSCI, V26, P7405, DOI 10.1523/JNEUROSCI.1166-06.2006; Kadekawa K, 2015, CHARACTERIZATION BLA, V241, P49; Kakizaki H, 1997, J UROLOGY, V158, P1562, DOI 10.1016/S0022-5347(01)64280-0; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Kanno H, 2015, REV NEUROSCIENCE, V26, P121, DOI 10.1515/revneuro-2014-0068; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kuo HS, 2011, J NEUROSCI, V31, P4137, DOI 10.1523/JNEUROSCI.2592-10.2011; Kuscha V, 2012, J COMP NEUROL, V520, P933, DOI 10.1002/cne.22739; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee YS, 2002, J NEUROTRAUM, V19, P357, DOI 10.1089/089771502753594927; Lee YS, 2002, J NEUROTRAUM, V19, P1203, DOI 10.1089/08977150260338001; Lee YS, 2007, J APPL PHYSIOL, V103, P1808, DOI 10.1152/japplphysiol.00588.2007; Lee YS, 2013, J NEUROSCI, V33, P10591, DOI 10.1523/JNEUROSCI.1116-12.2013; Levi ADO, 2002, J NEUROSURG, V96, P197, DOI 10.3171/spi.2002.96.2.0197; Lu P, 2004, J NEUROSCI, V24, P6402, DOI 10.1523/JNEUROSCI.1492-04.2004; Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020; Ma MH, 2001, EXP NEUROL, V169, P239, DOI 10.1006/exnr.2001.7679; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Milbreta U, 2014, J NEUROTRAUM, V31, P803, DOI 10.1089/neu.2013.3143; MUNZ M, 1985, BRAIN RES, V340, P115, DOI 10.1016/0006-8993(85)90780-2; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ramon-Cueto A, 1998, J NEUROSCI, V18, P3803; Sasaki S, 2004, J NEUROPHYSIOL, V92, P3142, DOI 10.1152/jn.00342.2004; Slawinska U, 2000, EXP BRAIN RES, V132, P27, DOI 10.1007/s002219900323; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831; Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736; Stamegna JC, 2011, EXP NEUROL, V229, P120, DOI 10.1016/j.expneurol.2010.07.002; Starkey ML, 2012, EUR J NEUROSCI, V36, P3665, DOI 10.1111/ejn.12017; Tabakow P, 2014, CELL TRANSPLANT, V23, P1631, DOI 10.3727/096368914X685131; TAN EML, 1993, AM J PATHOL, V142, P463; Tsai EC, 2005, J NEUROPATH EXP NEUR, V64, P230, DOI 10.1093/jnen/64.3.230; Tuszynski MH, 1996, EXP NEUROL, V137, P157, DOI 10.1006/exnr.1996.0016; Weld KJ, 2000, UROLOGY, V55, P490, DOI 10.1016/S0090-4295(99)00553-1; WRATHALL JR, 1985, EXP NEUROL, V88, P108, DOI 10.1016/0014-4886(85)90117-7; Yoshihara T, 2007, J NEUROTRAUM, V24, P1026, DOI 10.1089/neu.2007.132R	66	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139335	10.1371/journal.pone.0139335	http://dx.doi.org/10.1371/journal.pone.0139335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426529	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100050
J	Nagaoka, N; Jonas, JB; Morohoshi, K; Moriyama, M; Shimada, N; Yoshida, T; Ohno-Matsui, K				Nagaoka, Natsuko; Jonas, Jost B.; Morohoshi, Kei; Moriyama, Muka; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko			Glaucomatous-Type Optic Discs in High Myopia	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NERVE DAMAGE; RISK-FACTORS; EYES; PROGRESSION; POPULATION; ZONE	Purpose To assess the prevalence of glaucoma in patients with high myopia defined as myopic refractive error of >-8 diopters or axial length >= 26.5 mm. Methods The hospital-based observational study included 172 patients (336 eyes) with a mean age of 61.9 +/- 12.3 years and mean axial length of 30.1 +/- 2.3 mm (range: 24.7-39.1mm). Glaucomatous-type optic discs were defined by glaucomatous optic disc appearance. Glaucoma was defined by glaucomatous optic disc appearance and glaucomatous Goldmann visual field defects not corresponding with myopic macular changes. Results Larger disc area (mean: 3.18 +/- 1.94 mm(2)) was associated with longer axial length (P<0.001; standardized correlation coefficient: 0.45). Glaucoma was detected in 94 (28%; 95% Confidence intervals: 23%, 33%) eyes. In multivariate analysis, glaucoma prevalence was 3.2 times higher (P<0.001) in megalodiscs (>3.79 mm(2)) than in normal-sized discs or small discs (<1.51 mm(2)) after adjusting for older age. Axial length was not significantly (P = 0.38) associated with glaucoma prevalence in that model. Glaucoma prevalence increased by a factor of 1.39 for each increase in optic disc area by one mm(2). Again, axial length was not significantly (P = 0.38) associated with glaucoma prevalence when added to this multivariate model. Conclusion Within highly myopic individuals, glaucoma prevalence increased with larger optic disc size beyond a disc area of 3.8 mm(2). Highly myopic megalodiscs as compared to normal sized discs or small discs had a 3.2 times higher risk for glaucomatous optic nerve neuropathy. The increased glaucoma prevalence in axial high myopia was primarily associated with axial myopia associated disc enlargement and not with axial elongation itself.	[Nagaoka, Natsuko; Morohoshi, Kei; Moriyama, Muka; Shimada, Noriaki; Yoshida, Takeshi; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, Tokyo 1138519, Japan; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, D-68167 Mannheim, Germany	Tokyo Medical & Dental University (TMDU); Ruprecht Karls University Heidelberg	Ohno-Matsui, K (corresponding author), Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	k.ohno.oph@tmd.ac.jp			Japan Society for the Promotion of Science, Tokyo, Japan [25670727, 15H04993, 15K15629]; Grants-in-Aid for Scientific Research [15K10889] Funding Source: KAKEN	Japan Society for the Promotion of Science, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by research grants 25670727, 15H04993 and 15K15629 from the Japan Society for the Promotion of Science, Tokyo, Japan.	ARAIE M, 1994, OPHTHALMOLOGY, V101, P1440; Blackwell B, 2002, AM J OPHTHALMOL, V134, P499; Chihara E, 1997, OPHTHALMOLOGICA, V211, P66, DOI 10.1159/000310760; Dai Y, 2015, RETINA-J RET VIT DIS, V35, P655, DOI 10.1097/IAE.0000000000000358; Dai Y, 2013, INVEST OPHTH VIS SCI, V54, P2013, DOI 10.1167/iovs.12-11255; Jonas JB, 2005, EUR J OPHTHALMOL, V15, P41, DOI 10.1177/112067210501500107; Jonas JB, 2004, INVEST OPHTH VIS SCI, V45, P2660, DOI 10.1167/iovs.03-1363; Jonas JB, 2002, AM J OPHTHALMOL, V134, P547, DOI 10.1016/S0002-9394(02)01644-6; JONAS JB, 1989, AM J OPHTHALMOL, V107, P137, DOI 10.1016/0002-9394(89)90212-2; Jonas JB, 2013, INVEST OPHTH VIS SCI, V54, P1295, DOI 10.1167/iovs.12-11352; Jonas JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047237; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas JB, 2011, ACTA OPHTHALMOL, V89, P505, DOI 10.1111/j.1755-3768.2010.01915.x; Kuzin AA, 2010, OPHTHALMOLOGY, V117, P1713, DOI 10.1016/j.ophtha.2010.01.035; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; Ramakrishnan R, 2003, OPHTHALMOLOGY, V110, P1484, DOI 10.1016/S0161-6420(03)00564-5; Spaide R, 2014, PATHOLOGIC MYOPIA MY; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Wong TY, 2003, OPHTHALMOLOGY, V110, P211, DOI 10.1016/S0161-6420(02)01260-5; Xu L, 2007, OPHTHALMOLOGY, V114, P121, DOI 10.1016/j.ophtha.2006.05.071; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050	25	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138825	10.1371/journal.pone.0138825	http://dx.doi.org/10.1371/journal.pone.0138825			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26425846	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100021
J	Saini, Y; Proper, SP; Dornbos, P; Greenwood, KK; Kopec, AK; Lynn, SG; Grier, E; Burgoon, LD; Zacharewski, TR; Thomas, RS; Harkema, JR; LaPres, JJ				Saini, Yogesh; Proper, Steven P.; Dornbos, Peter; Greenwood, Krista K.; Kopec, Anna K.; Lynn, Scott G.; Grier, Elizabeth; Burgoon, Lyle D.; Zacharewski, Timothy R.; Thomas, Russell S.; Harkema, Jack R.; LaPres, John J.			Loss of Hif-2 alpha Rescues the Hif-1 alpha Deletion Phenotype of Neonatal Respiratory Distress In Mice	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RESISTIN-LIKE MOLECULE; HUMAN LUNG DEVELOPMENT; FACTOR 2-ALPHA PLAYS; FACTOR 1-ALPHA; GENE-EXPRESSION; PULMONARY DEVELOPMENT; IN-VIVO; MORPHOGENESIS; MATURATION	Hypoxia is a state of decreased oxygen reaching the tissues of the body. During prenatal development, the fetus experiences localized occurrences of hypoxia that are essential for proper organogenesis and survival. The response to decreased oxygen availability is primarily regulated by hypoxia-inducible factors (HIFs), a family of transcription factors that modulate the expression of key genes involved in glycolysis, angiogenesis, and erythropoiesis. HIF-1 alpha and HIF-2 alpha, two key isoforms, are important in embryonic development, and likely are involved in lung morphogenesis. We have recently shown that the inducible loss of Hif-1 alpha in lung epithelium starting at E4.5 leads to death within an hour of parturition, with symptoms similar to neonatal respiratory distress syndrome (RDS). In addition to Hif-1 alpha, Hif-2 alpha is also expressed in the developing lung, although the overlapping roles of Hif-1 alpha and Hif-2 alpha in this context are not fully understood. To further investigate the independent role of Hif-2 alpha in lung epithelium and its ability to alter Hif-1 alpha-mediated lung maturation, we generated two additional lung-specific inducible Hif-alpha knockout models (Hif-2 alpha and Hif-1 alpha + Hif-2 alpha). The intrauterine loss of Hif-2 alpha in the lungs does not lead to decreased viability or observable phenotypic changes in the lung. More interestingly, survivability observed after the loss of both Hif-1 alpha and Hif-2 alpha suggests that the loss of Hif-2 alpha is capable of rescuing the neonatal RDS phenotype seen in Hif-1 alpha-deficient pups. Microarray analyses of lung tissue from these three genotypes identified several factors, such as Scd1, Retln gamma, and Il-1r2, which are differentially regulated by the two HIF-alpha isoforms. Moreover, network analysis suggests that modulation of hormone-mediated, NF-kappa B, C/EBP alpha, and c-MYC signaling are central to HIF-mediated changes in lung development.	[Saini, Yogesh; Proper, Steven P.; Dornbos, Peter; Greenwood, Krista K.; Kopec, Anna K.; Lynn, Scott G.; Grier, Elizabeth; Burgoon, Lyle D.; Zacharewski, Timothy R.; LaPres, John J.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Saini, Yogesh] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Saini, Yogesh; Proper, Steven P.; Dornbos, Peter; Greenwood, Krista K.; Kopec, Anna K.; Lynn, Scott G.; Zacharewski, Timothy R.; Harkema, Jack R.; LaPres, John J.] Michigan State Univ, Ctr Integrat Toxicol, E Lansing, MI 48824 USA; [Proper, Steven P.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Thomas, Russell S.] Hamner Inst Hlth Sci, Res Triangle Pk, NC USA; [Harkema, Jack R.] Michigan State Univ, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [LaPres, John J.] Michigan State Univ, Ctr Mitochondrial Sci & Med, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine; The Hamner Institutes for Health Sciences; Michigan State University; Michigan State University	LaPres, JJ (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	lapres@msu.edu	Burgoon, Lyle D./I-2894-2019; Saini, Yogesh/AAM-5046-2020	Burgoon, Lyle D./0000-0003-4977-5352; Proper, Steven/0000-0002-4146-0420; Saini, Yogesh/0000-0002-8324-2122	National Institutes of Health (NIH) [R01-ES12186]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012186] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (NIH) R01-ES12186. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott BD, 2000, DEV DYNAM, V219, P526, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1080>3.0.CO;2-N; Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Angelini DJ, 2009, AM J RESP CELL MOL, V41, P553, DOI 10.1165/rcmb.2008-0271OC; [Anonymous], 2015, LUNG DEV AGING ENV; Bridges JP, 2012, DEV BIOL, V362, P24, DOI 10.1016/j.ydbio.2011.10.033; Bry K, 1997, J CLIN INVEST, V99, P2992, DOI 10.1172/JCI119494; Burgoon LD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni167; Burgoon LD, 2007, PHARMACOGENOMICS, V8, P287, DOI 10.2217/14622416.8.3.287; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Dahl KDC, 2005, MOL CELL BIOL, V25, P10479, DOI 10.1128/MCB.25.23.10479-10491.2005; deFelice M, 2003, J BIOL CHEM, V278, P35574, DOI 10.1074/jbc.M304885200; Dong L, 2008, J ASTHMA, V45, P648, DOI 10.1080/02770900802126941; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Eckel J E, 2004, J Biopharm Stat, V14, P647, DOI 10.1081/BIP-200025656; Eckel JE, 2005, BIOINFORMATICS, V21, P1078, DOI 10.1093/bioinformatics/bti105; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Greenwood KK, 2012, AM J PHYSIOL-LUNG C, V302, pL455, DOI 10.1152/ajplung.00193.2011; Groenman F, 2005, BIOL NEONATE, V87, P164, DOI 10.1159/000082595; Groenman F, 2007, J HISTOCHEM CYTOCHEM, V55, P355, DOI 10.1369/jhc.6A7129.2006; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Huang YD, 2012, AM J RESP CELL MOL, V46, P224, DOI 10.1165/rcmb.2011-0024OC; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kaluz S, 2008, CLIN CHIM ACTA, V395, P6, DOI 10.1016/j.cca.2008.05.002; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Lee YM, 2001, DEV DYNAM, V220, P175, DOI 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Londhe VA, 2008, DEV DYNAM, V237, P328, DOI 10.1002/dvdy.21413; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; METCALFE J, 1967, PHYSIOL REV, V47, P782, DOI 10.1152/physrev.1967.47.4.782; Mishra A, 2007, AM J PHYSIOL-LUNG C, V293, pL305, DOI 10.1152/ajplung.00147.2007; Mottet D, 2003, J BIOL CHEM, V278, P31277, DOI 10.1074/jbc.M300763200; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; Muhlfeld C, 2013, AM J PHYSIOL-LUNG C, V305, P1205, DOI 10.1152/ajplung.00427.2012; Muraoka RS, 2000, DEV BIOL, V225, P322, DOI 10.1006/dbio.2000.9824; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; R Core Team, 2013, R LANG ENV STAT COMP; Rajatapiti P, 2008, PEDIATR DEVEL PATHOL, V11, P193, DOI 10.2350/07-04-0257.1; Ryan HE, 2000, CANCER RES, V60, P4010; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Saini Y, 2010, AM J PHYSIOL-LUNG C, V298, pL139, DOI 10.1152/ajplung.00252.2009; Saini Y, 2008, J BIOL CHEM, V283, P33650, DOI 10.1074/jbc.M805927200; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Shimoda LA, 2011, AM J RESP CRIT CARE, V183, P152, DOI 10.1164/rccm.201009-1393PP; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tibboel J, 2015, AM J RESP CELL MOL, V52, P448, DOI 10.1165/rcmb.2014-0037OC; Vadivel A, 2014, AM J RESP CELL MOL, V50, P96, DOI 10.1165/rcmb.2012-0250OC; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wagner KF, 2004, AM J RESP CELL MOL, V31, P276, DOI 10.1165/rcmb.2003-0319OC; Wan HJ, 2004, P NATL ACAD SCI USA, V101, P14449, DOI 10.1073/pnas.0404424101; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310; Whitsett JA, 2011, AM J RESP CRIT CARE, V184, P401, DOI 10.1164/rccm.201103-0495PP; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Xu Y, 2012, J ENG FIBER FABR, V7, P7	64	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139270	10.1371/journal.pone.0139270	http://dx.doi.org/10.1371/journal.pone.0139270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422241	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700086
J	Yu, G; Chi, XM; Wu, RH; Wang, XM; Gao, XZ; Kong, F; Feng, XW; Gao, YD; Huang, XX; Jin, JL; Qi, Y; Tu, ZK; Sun, B; Zhong, J; Pan, Y; Niu, JQ				Yu, Ge; Chi, Xiumei; Wu, Ruihong; Wang, Xiaomei; Gao, Xiuzhu; Kong, Fei; Feng, Xiangwei; Gao, Yuanda; Huang, Xinxing; Jin, Jinglan; Qi, Yue; Tu, Zhengkun; Sun, Bing; Zhong, Jin; Pan, Yu; Niu, Junqi			Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population	PLOS ONE			English	Article							TERM-FOLLOW-UP; VIROLOGICAL PROFILES; DUAL INFECTION; COINFECTION; ANTIGEN; SUPERINFECTION; PREVALENCE; VIREMIA; HCV; EXPRESSION	Background Hepatitis B virus (HBV) and hepatitis C virus (HCV) co-infections contributes to a substantial proportion of liver disease worldwide. The aim of this study was to assess the clinical and virological features of HBV-HCV co-infection. Methods Demographic data were collected for 3238 high-risk people from an HCV-endemic region in China. Laboratory tests included HCV antibody and HBV serological markers, liver function tests, and routine blood analysis. Anti-HCV positive samples were analyzed for HCV RNA levels and subgenotypes. HBsAg-positive samples were tested for HBV DNA. Results A total of 1468 patients had chronic HCV and/or HBV infections. Among them, 1200 individuals were classified as HCV mono-infected, 161 were classified as HBV mono-infected, and 107 were classified as co-infected. The HBV-HCV co-infected patients not only had a lower HBV DNA positive rate compared to HBV mono-infected patients (84.1% versus 94.4%, respectively; P<0.001). The median HCV RNA levels in HBV-HCV co-infected patients were significantly lower than those in the HCV mono-infected patients (1.18[Interquartile range (IQR) 0-5.57] versus 5.87[IQR, 3.54-6.71] Log(10) IU/mL, respectively; P<0.001). Furthermore, co-infected patients were less likely to have detectable HCV RNA levels than HCV mono-infected patients (23.4% versus 56.5%, respectively; P<0.001). Those HBV-HCV co-infected patients had significantly lower median HBV DNA levels than those mono-infected with HBV (1.97[IQR, 1.3-3.43] versus 3.06[IQR, 2-4.28] Log(10) IU/mL, respectively; P<0.001). The HBV-HCV co-infection group had higher ALT, AST, ALP, GGT, APRI and FIB-4 levels, but lower ALB and total platelet compared to the HBV mono-infection group, and similar to that of the HCV mono-infected group. Conclusion These results suggest that co-infection with HCV and HBV inhibits the replication of both viruses. The serologic results of HBV-HCV co-infection in patients suggests more liver injury compared to HBV mono-infected patients, but is similar to HCV mono-infection.	[Yu, Ge; Chi, Xiumei; Wu, Ruihong; Wang, Xiaomei; Gao, Xiuzhu; Kong, Fei; Feng, Xiangwei; Gao, Yuanda; Huang, Xinxing; Jin, Jinglan; Qi, Yue; Tu, Zhengkun; Pan, Yu; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Jilin Province, Peoples R China; [Chi, Xiumei; Wu, Ruihong; Wang, Xiaomei; Gao, Xiuzhu; Feng, Xiangwei; Gao, Yuanda] Jilin Univ, Minist Educ, Key Lab Zoonosis Res, Changchun 130023, Jilin Province, Peoples R China; [Chi, Xiumei; Wu, Ruihong; Wang, Xiaomei; Gao, Xiuzhu; Feng, Xiangwei; Gao, Yuanda] Jilin Prov Key Lab Infect Dis, Mol Virol Lab, Changchun, Jilin Province, Peoples R China; [Sun, Bing; Zhong, Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Pan, Y (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130023, Jilin Province, Peoples R China.	panyu20000@163.com; junqiniu@aliyun.com	Zhong, Jin/J-4613-2019; Zhong, Jin/M-6859-2018	Gao, Xiuzhu/0000-0001-6310-1456; Tu, Zhengkun/0000-0001-6803-2015; Zhong, Jin/0000-0002-3554-1275	National Science and Technology Major Project [2014ZX10002002, 2013ZX10002008]; National Natural Science Foundation of China [81373057, 81202377, 81301472, 81301415]; National Basic Research Program of China (973 Program) [2015CB554300]	National Science and Technology Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The study was sponsored by National Science and Technology Major Project 2014ZX10002002 to Junqi Niu, National Science and Technology Major Project 2013ZX10002008 to Junqi Niu, National Natural Science Foundation of China 81373057 to Junqi Niu, National Basic Research Program of China (973 Program) 2015CB554300 to Jin Zhong, National Natural Science Foundation of China 81202377 to Xiumei Chi, National Natural Science Foundation of China 81301472 to Xiaomei Wang, and National Natural Science Foundation of China 81301415 to Ruihong Wu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI A, 1995, J HEPATOL, V22, P38; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; [Anonymous], 2002, HEPATOLOGY, V36, pS3, DOI 10.1053/jhep.2002.37117; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; Bini EJ, 2010, HEPATOLOGY, V51, P759, DOI 10.1002/hep.23461; Brass V, 2009, J HEPATOL, V51, P423, DOI 10.1016/j.jhep.2009.06.003; Caccamo G, 2014, WORLD J GASTROENTERO, V20, P14559, DOI 10.3748/wjg.v20.i40.14559; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Chu CJ, 2008, J GASTROEN HEPATOL, V23, P512, DOI 10.1111/j.1440-1746.2008.05384.x; Chu CM, 1998, J CLIN MICROBIOL, V36, P2084, DOI 10.1128/JCM.36.7.2084-2086.1998; CRESPO J, 1994, AM J GASTROENTEROL, V89, P1147; Crockett Seth D, 2005, Ann Clin Microbiol Antimicrob, V4, P13, DOI 10.1186/1476-0711-4-13; Eyre NS, 2009, J HEPATOL, V51, P446, DOI 10.1016/j.jhep.2009.04.025; FONG TL, 1991, HEPATOLOGY, V14, P64, DOI 10.1002/hep.1840140111; Gaeta GB, 2003, J HEPATOL, V39, P1036, DOI 10.1016/S0168-8278(03)00470-7; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Lee LP, 2007, J GASTROEN HEPATOL, V22, P515, DOI 10.1111/j.1440-1746.2006.04547.x; LIAW YF, 1991, INFECTION, V19, P250, DOI 10.1007/BF01644957; Liaw YF, 2004, GASTROENTEROLOGY, V126, P1024, DOI 10.1053/j.gastro.2004.01.011; Liaw YF, 2002, J GASTROENTEROL, V37, P65, DOI 10.1007/BF02990102; Liu CJ, 2009, HEPATOL INT, V3, P517, DOI 10.1007/s12072-009-9147-9; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Mohamed AE, 1997, HEPATO-GASTROENTEROL, V44, P1404; Morota K, 2009, J VIROL METHODS, V157, P8, DOI 10.1016/j.jviromet.2008.12.009; Muerhoff AS, 2002, TRANSFUSION, V42, P349, DOI 10.1046/j.1537-2995.2002.00052.x; OHKAWA K, 1994, J HEPATOL, V21, P509, DOI 10.1016/S0168-8278(94)80094-4; OHKAWA K, 1995, J MED VIROL, V46, P258, DOI 10.1002/jmv.1890460316; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Park Y, 2010, J CLIN MICROBIOL, V48, P2253, DOI 10.1128/JCM.01856-09; PONTISSO P, 1993, GASTROENTEROLOGY, V105, P1529, DOI 10.1016/0016-5085(93)90161-5; Prati D, 2010, DIGEST LIVER DIS, V42, P81, DOI 10.1016/j.dld.2009.08.001; Raimondo G, 2006, HEPATOLOGY, V43, P100, DOI 10.1002/hep.20944; Raimondo G, 2008, J HEPATOL, V49, P677, DOI 10.1016/j.jhep.2008.08.003; Sagnelli E, 2004, INFECTION, V32, P144, DOI 10.1007/s15010-004-3080-6; Sagnelli E, 2009, HEPATOLOGY, V49, P1090, DOI 10.1002/hep.22794; SATO S, 1994, J HEPATOL, V21, P159, DOI 10.1016/S0168-8278(05)80389-7; SHEEN IS, 1992, J INFECT DIS, V165, P831, DOI 10.1093/infdis/165.5.831; SHEEN IS, 1994, J INFECT DIS, V170, P358, DOI 10.1093/infdis/170.2.358; SHIH CM, 1993, J VIROL, V67, P5823, DOI 10.1128/JVI.67.10.5823-5832.1993; Squadrito G, 2002, AM J GASTROENTEROL, V97, P1518, DOI 10.1111/j.1572-0241.2002.05707.x; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Wiegand SB, 2015, CLIN MICROBIOL INFEC, V21, p710e1, DOI [10.1016/j.cmi.2015.03.003S1198-743X (15)00367-5, DOI 10.1016/J.CMI.2015.03.003S1198-743X]; Zarski JP, 1998, J HEPATOL, V28, P27, DOI 10.1016/S0168-8278(98)80198-0	43	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139015	10.1371/journal.pone.0139015	http://dx.doi.org/10.1371/journal.pone.0139015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422607	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700061
J	Makowska-Grzyska, M; Kim, YC; Gorla, SK; Wei, Y; Mandapati, K; Zhang, MJ; Maltseva, N; Modi, G; Boshoff, HI; Gu, MY; Aldrich, C; Cuny, GD; Hedstrom, L; Joachimiak, A				Makowska-Grzyska, Magdalena; Kim, Youngchang; Gorla, Suresh Kumar; Wei, Yang; Mandapati, Kavitha; Zhang, Minjia; Maltseva, Natalia; Modi, Gyan; Boshoff, Helena I.; Gu, Minyi; Aldrich, Courtney; Cuny, Gregory D.; Hedstrom, Lizbeth; Joachimiak, Andrzej			Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds	PLOS ONE			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; MYCOPHENOLIC ADENINE-DINUCLEOTIDE; 5'-MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; INHIBITORS; MECHANISM; BINDING; PROTEIN; BIOLOGY	Tuberculosis (TB) remains a worldwide problem and the need for new drugs is increasingly more urgent with the emergence of multidrug-and extensively-drug resistant TB. Inosine 5'-monophosphate dehydrogenase 2 (IMPDH2) from Mycobacterium tuberculosis (Mtb) is an attractive drug target. The enzyme catalyzes the conversion of inosine 5'-monophosphate into xanthosine 5'-monophosphate with the concomitant reduction of NAD(+) to NADH. This reaction controls flux into the guanine nucleotide pool. We report seventeen selective IMPDH inhibitors with antitubercular activity. The crystal structures of a deletion mutant of MtbIMPDH2 in the apo form and in complex with the product XMP and substrate NAD+ are determined. We also report the structures of complexes with IMP and three structurally distinct inhibitors, including two with antitubercular activity. These structures will greatly facilitate the development of MtbIMPDH2-targeted antibiotics.	[Makowska-Grzyska, Magdalena; Kim, Youngchang; Maltseva, Natalia; Gu, Minyi; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA; [Kim, Youngchang; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Biosci, Argonne, IL 60439 USA; [Gorla, Suresh Kumar; Wei, Yang; Mandapati, Kavitha; Zhang, Minjia; Modi, Gyan; Hedstrom, Lizbeth] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA; [Boshoff, Helena I.] NIAID, TB Res Sect, Bethesda, MD 20892 USA; [Aldrich, Courtney] Univ Minnesota, Acad Hlth Ctr, Ctr Drug Design, Minneapolis, MN USA; [Cuny, Gregory D.] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77030 USA; [Cuny, Gregory D.; Hedstrom, Lizbeth] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; Brandeis University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; University of Houston System; University of Houston; Brandeis University	Hedstrom, L (corresponding author), Brandeis Univ, Dept Biol, 415 South St, Waltham, MA 02254 USA.	hedstrom@brandeis.edu; andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209; Kim, Youngchang/0000-0002-1610-4889; Cuny, Gregory/0000-0002-3188-4748	National Institute of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700058C, HHSN272201200026C]; Intramural Research Program of NIAID; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357];  [AI093459]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093459, ZIAAI000693] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural Research Program of NIAID; U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Health (NIH) and the National Institute of Allergy and Infectious Diseases (NIAID) [contracts HHSN272200700058C and HHSN272201200026C to the Center of Structural Genomics of Infectious Diseases], grant AI093459 (to LH) and the Intramural Research Program of NIAID (HB). The use of Structural Biology Center beamlines was supported by the U.S. Department of Energy, Office of Biological and Environmental Research [contract DE-AC02-06CH11357]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; CARR SF, 1993, J BIOL CHEM, V268, P27286; Cegielski JP, 2010, CLIN INFECT DIS, V50, pS195, DOI 10.1086/651491; Chakraborty S, 2013, SCIENCE, V339, P88, DOI 10.1126/science.1228980; Chen LQ, 2007, CURR OPIN DRUG DISC, V10, P403; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COONEY D, 1987, BIOCHIM BIOPHYS ACTA, V916, P89, DOI 10.1016/0167-4838(87)90214-7; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cotton NPJ, 2001, STRUCTURE, V9, P165, DOI 10.1016/S0969-2126(01)00571-8; Duckworth BP, 2012, ACS CHEM BIOL, V7, P1653, DOI 10.1021/cb300112x; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gollapalli DR, 2010, CHEM BIOL, V17, P1084, DOI 10.1016/j.chembiol.2010.07.014; Gorla SK, 2014, ANTIMICROB AGENTS CH, V58, P1603, DOI 10.1128/AAC.02075-13; Gorla SK, 2013, J MED CHEM, V56, P4028, DOI 10.1021/jm400241j; Gorla SK, 2012, J MED CHEM, V55, P7759, DOI 10.1021/jm3007917; HAGER PW, 1995, BIOCHEM PHARMACOL, V49, P1323, DOI 10.1016/0006-2952(95)00026-V; Hedstrom L, 2011, CURR MED CHEM, V18, P1909, DOI 10.2174/092986711795590129; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Johnson CR, 2013, BIOORG MED CHEM LETT, V23, P1004, DOI 10.1016/j.bmcl.2012.12.037; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Kirubakaran S, 2012, BIOORG MED CHEM LETT, V22, P1985, DOI 10.1016/j.bmcl.2012.01.029; Kuppuraj G, 2011, J PHYS CHEM B, V115, P7932, DOI 10.1021/jp1118663; Lesiak K, 1998, J MED CHEM, V41, P618, DOI 10.1021/jm970705k; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Makowska-Grzyska M, 2015, J BIOL CHEM, V290, P5893, DOI 10.1074/jbc.M114.619767; Makowska-Grzyska M, 2012, BIOCHEMISTRY-US, V51, P6148, DOI 10.1021/bi300511w; Mandapati K, 2014, ACS MED CHEM LETT, V5, P846, DOI 10.1021/ml500203p; Maurya SK, 2009, J MED CHEM, V52, P4623, DOI 10.1021/jm900410u; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Mortimer SE, 2005, BIOCHEM J, V390, P41, DOI 10.1042/BJ20042051; Prosise GL, 2003, J MOL BIOL, V326, P517, DOI 10.1016/S0022-2836(02)01383-9; Prosise GL, 2002, J BIOL CHEM, V277, P50654, DOI 10.1074/jbc.M208330200; Rejman D, 2006, J MED CHEM, V49, P5018, DOI 10.1021/jm060479r; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sharling L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000794; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Sun ZM, 2014, J MED CHEM, V57, P10544, DOI 10.1021/jm501527z; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Umejiego NN, 2008, CHEM BIOL, V15, P70, DOI 10.1016/j.chembiol.2007.12.010; Usha V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033886; Usha V, 2011, MICROBIOL-SGM, V157, P290, DOI 10.1099/mic.0.042549-0; Voth AR, 2009, NAT CHEM, V1, P74, DOI [10.1038/NCHEM.112, 10.1038/nchem.112]; Wakamoto Y, 2013, SCIENCE, V339, P91, DOI 10.1126/science.1229858; Wang W, 1997, BIOCHEMISTRY-US, V36, P8479, DOI 10.1021/bi970226n; Warner DF, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0001-2013; World Health Organization, 2014, GLOB TUB REP; Xiang BS, 1997, ARCH BIOCHEM BIOPHYS, V348, P378, DOI 10.1006/abbi.1997.0439; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8	55	31	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138976	10.1371/journal.pone.0138976	http://dx.doi.org/10.1371/journal.pone.0138976			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440283	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300011
J	Willenberg, I; Meschede, AK; Gueler, F; Jang, MS; Shushakova, N; Schebb, NH				Willenberg, Ina; Meschede, Anna K.; Gueler, Faikah; Jang, Mi-Sun; Shushakova, Nelli; Schebb, Nils Helge			Food Polyphenols Fail to Cause a Biologically Relevant Reduction of COX-2 Activity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SOLUBLE EPOXIDE HYDROLASE; NF-KAPPA-B; CYCLOOXYGENASE-2 EXPRESSION; RESVERATROL ANALOGS; PROSTAGLANDIN E-2; OXIDATIVE STRESS; ARACHIDONIC-ACID; FLAVONOIDS; INHIBITION	Epidemiologic studies show a correlation between the dietary intake of food polyphenols and beneficial health effects. Several in vitro studies indicate that the anti-inflammatory potential of polyphenols is, at least in part, mediated by a modulation of the enzymes of the arachidonic acid cascade, such as the prostaglandin forming cyclooxygenases (COXs). Evidence that this mode of action can be transferred to the situation in vivo is scarce. This study characterized effects of a subset of polyphenols on COX-2 expression and activity in vitro and compared the potency with known drugs. Next, the in vivo relevance of the observed in vitro effects was tested. Enzyme assays and incubations of polyphenols with the cancer cell line HCA-7 and lipopolysaccharide (LPS) stimulated primary monocytes support the hypothesis that polyphenols can effect COX-2 expression and activity in vitro. The effects were most pronounced in the monocyte assay for wogonin, apigenin, resveratrol and genistein with IC50 values of 1.5 mu M, 2.6 mu M, 2.8 mu M and 7.4 mu M. However, these values are 100- to 1000-fold higher in comparison to those of the known pharmaceuticals celecoxib, indomethacin and dexamethasone. In an animal model of LPS induced sepsis, pretreatment with polyphenols (i.p. 100 mg/kg bw) did not result in decreased plasma or tissue prostaglandin levels, whereas the positive control celecoxib effectively attenuated LPS induced prostaglandin formation. These data suggest that despite the moderate potency in vitro, an effect of polyphenols on COX-2 during acute inflammation is unlikely, even if a high dose of polyphenols is ingested.	[Willenberg, Ina; Meschede, Anna K.; Schebb, Nils Helge] Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, D-30173 Hannover, Germany; [Gueler, Faikah; Jang, Mi-Sun; Shushakova, Nelli] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany; [Shushakova, Nelli] Phenos GmbH, D-30625 Hannover, Germany; [Schebb, Nils Helge] Berg Univ Wuppertal, Inst Food Chem, D-42119 Wuppertal, Germany	University of Veterinary Medicine Hannover, Foundation; Hannover Medical School; University of Wuppertal	Schebb, NH (corresponding author), Univ Vet Med Hannover, Inst Food Toxicol & Analyt Chem, Bischofsholer Damm 15, D-30173 Hannover, Germany.	schebb@wwu.de		Schebb, Nils Helge/0000-0003-1299-6629	Fonds der Chemischen Industrie; German Research Foundation (DFG) [SCHE 1801]; European Union [CIG 293536]; Phenos GmbH	Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); European Union(European Commission); Phenos GmbH	This work was supported by the Fonds der Chemischen Industrie, the German Research Foundation (DFG, Grant SCHE 1801) and the European Union (Grant CIG 293536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author Nelli Shushakovab is employed by Phenos GmbH. Phenos GmbH provided support in the form of salary for author NS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Al-Fayez M, 2006, CANCER CHEMOTH PHARM, V58, P816, DOI 10.1007/s00280-006-0228-3; Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cao HM, 2011, J PHARMACEUT BIOMED, V54, P230, DOI 10.1016/j.jpba.2010.08.001; Chao CL, 2010, NUTR RES, V30, P858, DOI 10.1016/j.nutres.2010.10.011; Chi YS, 2001, BIOCHEM PHARMACOL, V62, P1185, DOI 10.1016/S0006-2952(01)00773-0; Choi SY, 2007, J ETHNOPHARMACOL, V113, P149, DOI 10.1016/j.jep.2007.05.021; Detampel P, 2012, DRUG METAB REV, V44, P253, DOI 10.3109/03602532.2012.700715; Erlund I, 2001, J NUTR, V131, P235, DOI 10.1093/jn/131.2.235; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; GRYGLEWSKI RJ, 1987, BIOCHEM PHARMACOL, V36, P317, DOI 10.1016/0006-2952(87)90288-7; Kang SS, 2009, BIOORGAN MED CHEM, V17, P1044, DOI 10.1016/j.bmc.2008.04.031; Larrosa M, 2011, EUR J NUTR, V50, P673, DOI 10.1007/s00394-011-0178-3; Liang YC, 1999, CARCINOGENESIS, V20, P1945, DOI 10.1093/carcin/20.10.1945; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Martin AR, 2006, BRIT J PHARMACOL, V147, P873, DOI 10.1038/sj.bjp.0706469; Mitjavila MT, 2012, BIOCHEM PHARMACOL, V84, P1113, DOI 10.1016/j.bcp.2012.07.017; Murakami A, 2000, CANCER RES, V60, P5059; Murakami A, 2007, INT J CANCER, V121, P2357, DOI 10.1002/ijc.23161; Murias M, 2004, BIOORGAN MED CHEM, V12, P5571, DOI 10.1016/j.bmc.2004.08.008; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Ostermann AI, 2015, ANAL BIOANAL CHEM, V407, P1403, DOI 10.1007/s00216-014-8377-4; Peng G, 2006, MOL CARCINOGEN, V45, P309, DOI 10.1002/mc.20166; Raso GM, 2001, LIFE SCI, V68, P921, DOI 10.1016/S0024-3205(00)00999-1; Reddy RC, 2001, AM J PHYSIOL-LUNG C, V281, pL537, DOI 10.1152/ajplung.2001.281.3.L537; Riboli E, 2003, AM J CLIN NUTR, V78, p559S, DOI 10.1093/ajcn/78.3.559S; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649; Romier B, 2008, BRIT J NUTR, V100, P542, DOI 10.1017/S0007114508966666; Sale S, 2005, INT J CANCER, V115, P194, DOI 10.1002/ijc.20884; Scalbert A, 2000, J NUTR, V130, p2073S, DOI 10.1093/jn/130.8.2073S; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Sharma RA, 2001, CARCINOGENESIS, V22, P1557, DOI 10.1093/carcin/22.9.1557; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Subbaramaiah K, 1998, J BIOL CHEM, V273, P21875, DOI 10.1074/jbc.273.34.21875; Tam AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045078; Tsatsanis C, 2006, INT J BIOCHEM CELL B, V38, P1654, DOI 10.1016/j.biocel.2006.03.021; Ungprasert P, 2015, EUR J INTERN MED, V26, P285, DOI 10.1016/j.ejim.2015.03.008; Wakabayashi I, 2000, EUR J PHARMACOL, V406, P477, DOI 10.1016/S0014-2999(00)00695-6; Willenberg I, 2015, J CHROMATOGR A, V1391, P40, DOI 10.1016/j.chroma.2015.02.059; Willenberg I, 2012, J AGR FOOD CHEM, V60, P7844, DOI 10.1021/jf302136t; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]	46	22	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139147	10.1371/journal.pone.0139147	http://dx.doi.org/10.1371/journal.pone.0139147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440517	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300013
J	Ismail, BS; Eng, OK; Tayeb, MA				Ismail, B. S.; Eng, O. K.; Tayeb, M. A.			Degradation of Triazine-2-C-14 Metsulfuron-Methyl in Soil from an Oil Palm Plantation	PLOS ONE			English	Article							MALAYSIAN AGRICULTURAL SOILS; CHINESE PADDY SOILS; SULFONYLUREA HERBICIDES; THIFENSULFURON-METHYL; BOUND RESIDUES; PERSISTENCE; CHLORSULFURON; HYDROLYSIS; MOISTURE; C-14-METSULFURON-METHYL	Triazine-2-C-14 metsulfuron-methyl is a selective, systemic sulfonylurea herbicide. Degradation studies in soils are essential for the evaluation of the persistence of pesticides and their breakdown products. The purpose of the present study was to investigate the degradation of triazine-2-C-14 metsulfuron-methyl in soil under laboratory conditions. A High Performance Liquid Chromatograph (HPLC) equipped with an UV detector and an on-line radiochemical detector, plus a Supelco Discovery column (250 x 4.6 mm, 5 mu m), and PRP-1 column (305 x 7.0 mm, 10 mu m) was used for the HPLC analysis. The radioactivity was determined by a Liquid Scintillation Counter (LSC) in scintillation fluid. The soil used was both sterilized and non-sterilized in order to observe the involvement of soil microbes. The estimated DT50 and DT90 values of metsulfuron-methyl in a non-sterile system were observed to be 13 and 44 days, whereas in sterilized soil, the DT50 and DT90 were 31 and 70 days, respectively. The principal degradation product after 60 days was CO2. The higher cumulative amount of (CO2)-C-14 in C-14-triazine in the non-sterilized soil compared to that in the sterile system suggests that biological degradation by soil micro-organisms significantly contributes to the dissipation of the compound. The major routes of degradation were O-demethylation, sulfonylurea bridge cleavage and the triazine "ring-opened."	[Ismail, B. S.; Eng, O. K.; Tayeb, M. A.] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Ismail, BS (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi 43600, Selangor, Malaysia.	ismail@ukm.edu.my			Universiti Kebangsaan Malaysia [06-01-02- SF 0827]; Ministry of Higher Education of Malaysia	Universiti Kebangsaan Malaysia; Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia)	This study was supported by research grant no: 06-01-02- SF 0827 from the Universiti Kebangsaan Malaysia and the Ministry of Higher Education of Malaysia.	Abdullah AR, 2001, B ENVIRON CONTAM TOX, V66, P762, DOI 10.1007/s001280074; Andersen SM, 2001, CHEMOSPHERE, V45, P775, DOI 10.1016/S0045-6535(01)00132-1; Bray LD, 1997, PESTIC SCI, V51, P56, DOI 10.1002/(SICI)1096-9063(199709)51:1&lt;56::AID-PS590&gt;3.0.CO;2-Z; BROWN HM, 1991, ACS SYM SER, V443, P32; BROWN HM, 1990, PESTIC SCI, V29, P263, DOI 10.1002/ps.2780290304; Cambon JP, 1996, J AGR FOOD CHEM, V44, P333, DOI 10.1021/jf950194f; Cessna AJ, 2006, J ENVIRON QUAL, V35, P2395, DOI 10.2134/jeq2005.0462; Dungan RS, 2001, PEST MANAG SCI, V57, P1107, DOI 10.1002/ps.400; Ismail BS, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4600-9; Ismail BS, 2015, SAINS MALAYS, V44, P83, DOI 10.17576/jsm-2015-4401-12; Ismail B. S., 2013, International Journal of Plant, Animal and Environmental Sciences, V3, P23; ISMAIL BS, 1995, J ENVIRON SCI HEAL B, V30, P485, DOI 10.1080/03601239509372949; Ismail BS, 1996, J ENVIRON SCI HEAL B, V31, P987, DOI 10.1080/03601239609373049; Ismail BS, 2015, J ENVIRON BIOL, V36, P1; JAMES TK, 1995, WEED RES, V35, P113, DOI 10.1111/j.1365-3180.1995.tb02024.x; Johannesen H, 2003, J ENVIRON QUAL, V32, P1250, DOI 10.2134/jeq2003.1250; Kjaer C, 2006, CHEMOSPHERE, V63, P853, DOI 10.1016/j.chemosphere.2005.07.058; Lee-Yin C, 2013, J ENVIRON BIOL, V34, P957; Li YT, 1999, PESTIC SCI, V55, P434, DOI 10.1002/(SICI)1096-9063(199904)55:4&lt;434::AID-PS909&gt;3.0.CO;2-Z; Li ZJ, 2005, CHEMOSPHERE, V58, P1177, DOI 10.1016/j.chemosphere.2004.09.056; Mirsal IA, 2004, SOIL POLLUTION ORIGI, P252; REISER RW, 1991, J CHROMATOGR, V554, P91, DOI 10.1016/S0021-9673(01)88440-5; SABADIE J, 1990, WEED RES, V30, P413, DOI 10.1111/j.1365-3180.1990.tb01729.x; SABADIE J, 1993, WEED RES, V33, P397, DOI 10.1111/j.1365-3180.1993.tb01955.x; Sarmah AK, 2002, J AGR FOOD CHEM, V50, P6253, DOI 10.1021/jf025575p; Strek HJ, 1998, PESTIC SCI, V53, P29, DOI 10.1002/(SICI)1096-9063(199805)53:1&lt;29::AID-PS749&gt;3.0.CO;2-A; Tayeb M. A., 2015, International Journal of ChemTech Research, V7, P2612; Tayeb MA, 2014, 8 INT C PLANT PROT T, P109; Wang HZ, 2009, J ENVIRON QUAL, V38, P164, DOI 10.2134/jeq2007.0607; Wang HZ, 2008, PEST MANAG SCI, V64, P1074, DOI 10.1002/ps.1607; Wang HZ, 2007, GEODERMA, V142, P325, DOI 10.1016/j.geoderma.2007.09.001; Wang HZ, 2010, CHEMOSPHERE, V78, P335, DOI 10.1016/j.chemosphere.2009.10.023; Ye QF, 2003, ENVIRON POLLUT, V126, P417, DOI 10.1016/S0269-7491(03)00233-1; Zanini GP, 2009, GEODERMA, V149, P110, DOI 10.1016/j.geoderma.2008.11.025	34	10	10	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138170	10.1371/journal.pone.0138170	http://dx.doi.org/10.1371/journal.pone.0138170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437264	Green Published, gold			2022-12-27	WOS:000362499200005
J	Rummer, JL; Brauner, CJ				Rummer, Jodie L.; Brauner, Colin J.			Root Effect Haemoglobins in Fish May Greatly Enhance General Oxygen Delivery Relative to Other Vertebrates	PLOS ONE			English	Article							CHOROID RETE-MIRABILE; RED-CELL PH; RAINBOW-TROUT; CARBON-DIOXIDE; HUMAN-BLOOD; DISSOCIATION CURVES; TISSUE OXYGENATION; BOHR COEFFICIENT; SALMO-GAIRDNERI; PROTON RELEASE	The teleost fishes represent over half of all extant vertebrates; they occupy nearly every body of water and in doing so, occupy a diverse array of environmental conditions. We propose that their success is related to a unique oxygen (O-2) transport system involving their extremely pH-sensitive haemoglobin (Hb). A reduction in pH reduces both Hb-O-2 affinity (Bohr effect) and carrying capacity (Root effect). This, combined with a large arterial-venous pH change (Delta pH(a-v)) relative to other vertebrates, may greatly enhance tissue oxygen delivery in teleosts (e.g., rainbow trout) during stress, beyond that in mammals (e.g., human). We generated oxygen equilibrium curves (OECs) at five different CO2 tensions for rainbow trout and determined that, when Hb-O-2 saturation is 50% or greater, the change in oxygen partial pressure (Delta PO2) associated with Delta pH(a-v) can exceed that of the mammalian Bohr effect by at least 3-fold, but as much as 21-fold. Using known Delta pH(a-v) and assuming a constant arterial-venous PO2 difference (Pa-vO2), Root effect Hbs can enhance O-2 release to the tissues by 73.5% in trout; whereas, the Bohr effect alone is responsible for enhancing O-2 release by only 1.3% in humans. Disequilibrium states are likely operational in teleosts in vivo, and therefore the Delta pH(a-v), and thus enhancement of O-2 delivery, could be even larger. Modeling with known Pa-vO2 in fish during exercise and hypoxia indicates that O-2 release from the Hb and therefore potentially tissue O-2 delivery may double during exercise and triple during some levels of hypoxia. These characteristics may be central to performance of athletic fish species such as salmonids, but may indicate that general tissue oxygen delivery may have been the incipient function of Root effect Hbs in fish, a trait strongly associated with the adaptive radiation of teleosts.	[Rummer, Jodie L.; Brauner, Colin J.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Rummer, Jodie L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	University of British Columbia; James Cook University	Rummer, JL (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	jodie.rummer@jcu.edu.au	Rummer, Jodie/A-6524-2015	Rummer, Jodie/0000-0001-6067-5892	Natural Sciences and Engineering Research Council (NSERC) of Canada; UBC Graduate Fellowship; Australian Research Council (ARC) Super Science Fellowship program; ARC Centre of Excellence for Coral Reef Studies; ARC Discovery Early Career Fellowship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC Graduate Fellowship; Australian Research Council (ARC) Super Science Fellowship program(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); ARC Discovery Early Career Fellowship(Australian Research Council)	This project was funded by a Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery grant and Accelerator Supplement to C.J.B. and a UBC Graduate Fellowship to J.L.R. During the modelling and writing portion of this study, J.L.R. was funded by the Australian Research Council (ARC) Super Science Fellowship program, the ARC Centre of Excellence for Coral Reef Studies, and an ARC Discovery Early Career Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROGUE HJ, 1989, NEW ENGL J MED, V320, P1312, DOI 10.1056/NEJM198905183202004; Behnke BJ, 2001, RESP PHYSIOL, V126, P53, DOI 10.1016/S0034-5687(01)00195-5; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; BOUTILIER RG, 1984, FISH PHYSIOL, V10, P403; BOUTILIER RG, 1986, J EXP BIOL, V123, P145; Brauner C.J., 1998, Fish Physiology, V17, P283, DOI 10.1016/S1546-5098(08)60264-2; Brauner CJ, 1996, RESP PHYSIOL, V106, P65, DOI 10.1016/0034-5687(96)00061-8; Brauner CJ, 2000, RESP PHYSIOL, V119, P83, DOI 10.1016/S0034-5687(99)00095-X; Brauner CJ, 1998, J EXP BIOL, V201, P2507; Brauner CJ, 2001, FISH PHYSIOL BIOCHEM, V24, P97, DOI 10.1023/A:1011944407938; Brauner CJ, 1999, BIOL TROPICAL FISHES, P393; Caldwell S, 2006, COMP BIOCHEM PHYS A, V144, P188, DOI 10.1016/j.cbpa.2006.02.029; DAFRE AL, 1989, COMP BIOCHEM PHYS A, V92, P467, DOI 10.1016/0300-9629(89)90350-2; Eliason EJ, 2011, SCIENCE, V332, P109, DOI 10.1126/science.1199158; Farrell AP, 2003, J EXP BIOL, V206, P487, DOI 10.1242/jeb.00100; Hutter J, 1999, J APPL PHYSIOL, V86, P860, DOI 10.1152/jappl.1999.86.3.860; JENSEN FB, 1986, J EXP ZOOL, V238, P119, DOI 10.1002/jez.1402380115; Jung F, 1999, CLIN HEMORHEOL MICRO, V21, P25; Kelly AM, 2001, EMERG MED J, V18, P340, DOI 10.1136/emj.18.5.340; KICENIUK JW, 1977, J EXP BIOL, V69, P247; LAPENNAS GN, 1983, RESP PHYSIOL, V54, P161, DOI 10.1016/0034-5687(83)90054-3; Malatesha G, 2007, EMERG MED J, V24, P569, DOI 10.1136/emj.2007.046979; McKenzie DJ, 2004, J EXP BIOL, V207, P3629, DOI 10.1242/jeb.01199; MEIER U, 1974, PFLUG ARCH EUR J PHY, V349, P203, DOI 10.1007/BF00592448; Middleton P, 2006, EMERG MED J, V23, P622, DOI 10.1136/emj.2006.035915; NIKINMAA M, 1979, ANN ZOOL FENN, V16, P217; Nikinmaa M, 1997, J EXP BIOL, V200, P369; NIKINMAA M, 1984, BIOCHIM BIOPHYS ACTA, V773, P317, DOI 10.1016/0005-2736(84)90096-8; NIKINMAA M, 1993, J EXP BIOL, V180, P315; North BP, 2006, AQUACULTURE, V255, P466, DOI 10.1016/j.aquaculture.2006.01.004; Pelster B., 1991, Advances in Comparative and Environmental Physiology, V8, P51; Randall DJ, 2014, J EXP BIOL, V217, P1205, DOI 10.1242/jeb.093526; Rang Louise C F, 2002, CJEM, V4, P7; Root RW, 1943, BIOL BULL-US, V84, P207, DOI 10.2307/1538003; Root RW, 1931, BIOL BULL-US, V61, P427, DOI 10.2307/1536959; ROUGHTON FJ, 1973, J APPL PHYSIOL, V35, P861, DOI 10.1152/jappl.1973.35.6.861; Rummer J.L, 2010, THESIS U BRIT COLUMB; Rummer JL, 2013, SCIENCE, V340, P1327, DOI 10.1126/science.1233692; Rummer JL, 2011, J EXP BIOL, V214, P2319, DOI 10.1242/jeb.054049; SCHOLANDER PF, 1954, BIOL BULL, V107, P247, DOI 10.2307/1538611; Suttner SW, 2002, ANESTHESIOLOGY, V96, P1103, DOI 10.1097/00000542-200205000-00012; TETENS V, 1988, J EXP BIOL, V134, P267; TUCKER VA, 1967, J APPL PHYSIOL, V23, P410, DOI 10.1152/jappl.1967.23.3.410; TYUMA I, 1975, BIOCHEM BIOPH RES CO, V65, P1278, DOI 10.1016/S0006-291X(75)80368-8; VORGER P, 1985, COMP BIOCHEM PHYS A, V82, P915, DOI 10.1016/0300-9629(85)90505-5; Wells RMG, 1989, MEASUREMENT OXYGEN A, P279; Winslow R, 2005, OXYGEN TRANSPORT AGE; WINSLOW RM, 1977, J BIOL CHEM, V252, P2331; WITTENBERG JB, 1974, BIOL BULL-US, V146, P116, DOI 10.2307/1540402; WITTENBERG JB, 1974, BIOL BULL-US, V146, P137, DOI 10.2307/1540403; WOLF KENNETH W., 1963, PROGR FISH CULT, V25, P135, DOI 10.1577/1548-8659(1963)25[135:PSFFT]2.0.CO;2; ZEIDLER R, 1977, J GEN PHYSIOL, V70, P385, DOI 10.1085/jgp.70.3.385	52	42	43	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139477	10.1371/journal.pone.0139477	http://dx.doi.org/10.1371/journal.pone.0139477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436414	Green Published, Green Accepted, gold			2022-12-27	WOS:000362499200026
J	Singh, R; Nagar, S; Nanavati, AA				Singh, Raghavendra; Nagar, Seema; Nanavati, Amit A.			Analysing Local Sparseness in the Macaque Brain Network	PLOS ONE			English	Article							PRIMATE CEREBRAL-CORTEX; FUNCTIONAL CONNECTIVITY; VISUAL-SYSTEM; SMALL-WORLD; ORGANIZATION; STABILITY; TOPOLOGY	Understanding the network structure of long distance pathways in the brain is a necessary step towards developing an insight into the brain's function, organization and evolution. Dense global subnetworks of these pathways have often been studied, primarily due to their functional implications. Instead we study sparse local subnetworks of the pathways to establish the role of a brain area in enabling shortest path communication between its non-adjacent topological neighbours. We propose a novel metric to measure the topological communication load on a vertex due to its immediate neighbourhood, and show that in terms of distribution of this local communication load, a network of Macaque long distance pathways is substantially different from other real world networks and random graph models. Macaque network contains the entire range of local subnetworks, from star-like networks to clique-like networks, while other networks tend to contain a relatively small range of subnetworks. Further, sparse local subnetworks in the Macaque network are not only found across topographical super-areas, e.g., lobes, but also within a super-area, arguing that there is conservation of even relatively short-distance pathways. To establish the communication role of a vertex we borrow the concept of brokerage from social science, and present the different types of brokerage roles that brain areas play, highlighting that not only the thalamus, but also cingulate gyrus and insula often act as "relays" for areas in the neocortex. These and other analysis of communication load and roles of the sparse subnetworks of the Macaque brain provide new insights into the organisation of its pathways.	[Singh, Raghavendra; Nanavati, Amit A.] IBM Res, Delhi, India; [Nagar, Seema] IBM Res, Bangalore, Karnataka, India		Singh, R (corresponding author), IBM Res, Delhi, India.	raghavsi@in.ibm.com			IBM	IBM(International Business Machines (IBM))	IBM provided support in the form of salaries for authors RS, SN, AAN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Betzel R.F., 2013, PHYS REV E, V1, P353, DOI [DOI 10.1103/PhysRevE.72.026132, 10.1017/nws.2013.19, DOI 10.1017/NWS.2013.19]; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cherniak C, 2004, P NATL ACAD SCI USA, V101, P1081, DOI 10.1073/pnas.0305212101; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Csardi G., 2006, INT J COMPLEX SYST, V2006, P1695, DOI DOI 10.1093/NAR/; Erdos P, 1960, EVOLUTION RANDOM GRA, P5; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Foster JG, 2010, P NATL ACAD SCI USA, V107, P10815, DOI 10.1073/pnas.0912671107; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Goni J, 2014, P NATL ACAD SCI USA, V111, P833, DOI 10.1073/pnas.1315529111; Gould R. V., 1989, SOCIOL METHODOL, V19, P89, DOI DOI 10.2307/270949; Govindan R, 1997, IEEE INFOCOM SER, P850; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harriger L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046497; Hilgetag CC, 1996, SCIENCE, V271, P776, DOI 10.1126/science.271.5250.776; Joanes DN, 1998, J ROY STAT SOC D-STA, V47, P183; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Klimmt YY, 2004, P CEAS; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003982; Misic B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003427; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stephan KE, 2000, PHILOS T R SOC B, V355, P111, DOI 10.1098/rstb.2000.0552; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; Varshney Lav R., 2011, 2011 49th Annual Allerton Conference on Communication, Control, and Computing (Allerton), P1757; Vertes PE, 2012, P NATL ACAD SCI USA, V109, P5868, DOI 10.1073/pnas.1111738109; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0	41	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138148	10.1371/journal.pone.0138148	http://dx.doi.org/10.1371/journal.pone.0138148			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437077	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200004
J	Fueller, J; Egorov, MV; Walther, KA; Sabet, O; Mallah, J; Grabenbauer, M; Kinkhabwala, A				Fueller, Julia; Egorov, Mikhail V.; Walther, Kirstin A.; Sabet, Ola; Mallah, Jana; Grabenbauer, Markus; Kinkhabwala, Ali			Subcellular Partitioning of Protein Tyrosine Phosphatase 1B to the Endoplasmic Reticulum and Mitochondria Depends Sensitively on the Composition of Its Tail Anchor	PLOS ONE			English	Article							MEMBRANE-PROTEINS; OUTER-MEMBRANE; SECRETORY PATHWAY; NUCLEAR-ENVELOPE; YEAST GENES; 2 ISOFORMS; INSERTION; PHOSPHORYLATION; RECEPTOR; SIGNAL	The canonical protein tyrosine phosphatase PTP1B is an important regulator of diverse cellular signaling networks. PTP1B has long been thought to exert its influence solely from its perch on the endoplasmic reticulum (ER); however, an additional subpopulation of PTP1B has recently been detected in mitochondria extracted from rat brain tissue. Here, we show that PTP1B's mitochondrial localization is general (observed across diverse mammalian cell lines) and sensitively dependent on the transmembrane domain length, C-terminal charge and hydropathy of its short (<= 35 amino acid) tail anchor. Our electron microscopy of specific DAB precipitation revealed that PTP1B localizes via its tail anchor to the outer mitochondrial membrane (OMM), with fluorescence lifetime imaging microscopy establishing that this OMM pool contributes to the previously reported cytoplasmic interaction of PTP1B with endocytosed epidermal growth factor receptor. We additionally examined the mechanism of PTP1B's insertion into the ER membrane through heterologous expression of PTP1B's tail anchor in wild-type yeast and yeast mutants of major conserved ER insertion pathways: In none of these yeast strains was ER targeting significantly impeded, providing in vivo support for the hypothesis of spontaneous membrane insertion (as previously demonstrated in vitro). Further functional elucidation of the newly recognized mitochondrial pool of PTP1B will likely be important for understanding its complex roles in cellular responses to external stimuli, cell proliferation and diseased states.	[Fueller, Julia; Egorov, Mikhail V.; Walther, Kirstin A.; Sabet, Ola; Mallah, Jana; Grabenbauer, Markus; Kinkhabwala, Ali] Max Planck Inst Mol Physiol, Dept System Cell Biol, D-44227 Dortmund, Germany; [Fueller, Julia] Heidelberg Univ, Ctr Mol Biol ZMBH, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany; [Egorov, Mikhail V.; Grabenbauer, Markus] Heidelberg Univ, Inst Anat & Cell Biol, D-69120 Heidelberg, Germany	Max Planck Society; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Kinkhabwala, A (corresponding author), Max Planck Inst Mol Physiol, Dept System Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	alikink@gmail.com			Max Planck Society; German Ministry of Education and Research (BMBF)	Max Planck Society(Max Planck Society); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	Funding provided by Max Planck Society and German Ministry of Education and Research (BMBF Grant NanoCombine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell BM, 2007, J CELL SCI, V120, P1743, DOI 10.1242/jcs.002410; Abell BM, 2004, EMBO J, V23, P2755, DOI 10.1038/sj.emboj.7600281; Anderie I, 2007, EXP CELL RES, V313, P3189, DOI 10.1016/j.yexcr.2007.05.025; Arachiche A, 2008, J BIOL CHEM, V283, P24406, DOI 10.1074/jbc.M709217200; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BROWNSHIMER S, 1990, P NATL ACAD SCI USA, V87, P5148, DOI 10.1073/pnas.87.13.5148; Burdisso JE, 2013, J CELL SCI, V126, P1820, DOI 10.1242/jcs.118828; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; CAPALDI RA, 1990, ARCH BIOCHEM BIOPHYS, V280, P252, DOI 10.1016/0003-9861(90)90327-U; Cesaro L, 2010, BIOFACTORS, V36, P437, DOI 10.1002/biof.123; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2012, CURR OPIN STRUC BIOL, V22, P217, DOI 10.1016/j.sbi.2012.03.001; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; CHERNOFF J, 1990, P NATL ACAD SCI USA, V87, P2735, DOI 10.1073/pnas.87.7.2735; Colombo SF, 2009, J CELL SCI, V122, P2383, DOI 10.1242/jcs.049460; Combs AP, 2010, J MED CHEM, V53, P2333, DOI 10.1021/jm901090b; Cournia Z, 2007, J PHYS CHEM B, V111, P1786, DOI 10.1021/jp065172i; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Denic V, 2012, TRENDS BIOCHEM SCI, V37, P411, DOI 10.1016/j.tibs.2012.07.004; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2236; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Egan B, 1999, FEBS LETT, V451, P243, DOI 10.1016/S0014-5793(99)00581-5; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; GUAN KL, 1990, P NATL ACAD SCI USA, V87, P1501, DOI 10.1073/pnas.87.4.1501; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Haj FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036633; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; Hernandez MV, 2006, J CELL SCI, V119, P1233, DOI 10.1242/jcs.02846; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Isenmann S, 1998, MOL BIOL CELL, V9, P1649, DOI 10.1091/mbc.9.7.1649; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Khmelinskii A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023794; Kirchner J, 2003, J CELL SCI, V116, P975, DOI 10.1242/jcs.00284; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lebiedzinska M, 2009, INT J BIOCHEM CELL B, V41, P1805, DOI 10.1016/j.biocel.2009.02.017; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411; Mariappan M, 2011, NATURE, V477, P61, DOI 10.1038/nature10362; Martell JD, 2012, NAT BIOTECHNOL, V30, P1143, DOI 10.1038/nbt.2375; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Offterdinger M, 2004, J BIOL CHEM, V279, P36972, DOI 10.1074/jbc.M405830200; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; OGG SC, 1992, MOL BIOL CELL, V3, P895, DOI 10.1091/mbc.3.8.895; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Ozawa T, 2007, ACS CHEM BIOL, V2, P176, DOI 10.1021/cb600492a; Pedrazzini E, 1996, P NATL ACAD SCI USA, V93, P4207, DOI 10.1073/pnas.93.9.4207; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Salvi M, 2005, FREE RADICAL BIO MED, V38, P1267, DOI 10.1016/j.freeradbiomed.2005.02.006; Salvi M, 2004, CELL MOL LIFE SCI, V61, P2393, DOI 10.1007/s00018-004-4211-z; Salvi M, 2002, BBA-MOL CELL RES, V1589, P181, DOI 10.1016/S0167-4889(02)00174-X; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; SHIFRIN VI, 1993, J BIOL CHEM, V268, P25376; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Souza CM, 2011, METAB ENG, V13, P555, DOI 10.1016/j.ymben.2011.06.006; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TONKS NK, 1988, J BIOL CHEM, V263, P6722; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Walther KA, 2011, MOL BIOSYST, V7, P322, DOI 10.1039/c0mb00132e; Wang F, 2011, MOL CELL, V43, P738, DOI 10.1016/j.molcel.2011.07.020; Whitley P, 1996, J BIOL CHEM, V271, P7583, DOI 10.1074/jbc.271.13.7583; Yabal M, 2003, J BIOL CHEM, V278, P3489, DOI 10.1074/jbc.M210253200; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zang QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043424	96	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139429	10.1371/journal.pone.0139429	http://dx.doi.org/10.1371/journal.pone.0139429			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431424	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700057
J	Han, JS; Lee, MJ; Park, KS; Han, SH; Yoo, TH; Oh, KH; Park, SK; Lee, J; Hyun, YY; Chung, W; Kim, YH; Ahn, C; Choi, KH				Han, Ji Suk; Lee, Mi Jung; Park, Kyoung Sook; Han, Seung Hyeok; Yoo, Tae-Hyun; Oh, Kook-Hwan; Park, Sue Kyung; Lee, Joongyub; Hyun, Young Youl; Chung, Wookyung; Kim, Yeong Hoon; Ahn, Curie; Choi, Kyu Hun			Albuminuria as a Risk Factor for Anemia in Chronic Kidney Disease: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)	PLOS ONE			English	Article							URINARY ALBUMIN; ESTIMATED GFR; MORTALITY; COMPLICATIONS; ASSOCIATIONS; TRANSFERRIN; PROTEINURIA; REDUCTION; EXCRETION	Background Anemia is a common complication among patients with chronic kidney disease (CKD), and it is associated with unfavorable clinical outcomes in patients with CKD independent of the estimated glomerular filtration rate (eGFR). We assessed the association of the urinary albumin-to-creatinine ratio (ACR) and eGFR with anemia in CKD patients. Methods We conducted a cross-sectional study using baseline data from the KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease (KNOW-CKD). Multiple regression analysis was performed to identify the independent association of albuminuria with anemia. Furthermore, odds ratios for anemia were calculated by cross-categorization of ACR and eGFR. Results Among 1,456 patients, the mean age was 53.5 +/- 12.4 years, and the mean eGFR and ACR were 51.9 +/- 30.5 mL/min per 1.73 m(2) and 853.2 +/- 1,330.3 mg/g, respectively. Anemia was present in 644 patients (40.5%). Multivariate analysis showed that the odds ratio of anemia increased according to ACR levels, after adjusting for age, sex, eGFR, body mass index, pulse pressure, cause of CKD, use of erythropoiesis stimulating agents, serum calcium and ferritin (ACR < 30 mg/g as a reference group; 30-299 mg/g, adjusted odds ratio (OR) = 1.43, 95% confidence interval (CI) = 0.88-2.33; >= 300 mg/g, adjusted OR = 1.86, 95% CI = 1.12-3.10). In addition, graded associations were observed in cross-categorized groups of a higher ACR and eGFR compared to the reference group with an ACR < 30mg/g and eGFR >= 60mL/min per 1.73 m(2). Conclusion The present study demonstrated that albuminuria was a significant risk factor for anemia in CKD patients independent of the eGFR.	[Han, Ji Suk; Lee, Mi Jung; Park, Kyoung Sook; Han, Seung Hyeok; Yoo, Tae-Hyun; Choi, Kyu Hun] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea; [Park, Sue Kyung] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Lee, Joongyub] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul 110744, South Korea; [Lee, Joongyub] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Hyun, Young Youl] Sungkyunkwan Univ, Kangbuk Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Chung, Wookyung] Gachon Univ, Gil Hosp, Dept Internal Med, Inchon, South Korea; [Kim, Yeong Hoon] Inje Univ, Pusan Paik Hosp, Dept Internal Med, Busan, South Korea	Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University; Inje University	Choi, KH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	khchoi6@yuhs.ac	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Yoo, Tae-Hyun/0000-0002-9183-4507; Choi, Kyu Hun/0000-0003-0095-9011; Lee, Mi Jung/0000-0001-8888-029X	Research Program - Korea Centers for Disease Control and Prevention [2011-2013-E33016-02#]; Korean Society of Nephrology (KSN) [NCT01630486]	Research Program - Korea Centers for Disease Control and Prevention; Korean Society of Nephrology (KSN)	This study was supported by the Research Program funded by the Korea Centers for Disease Control and Prevention (2011-2013-E33016-02#). The study is supervised by the CKD Advisory Committee composed of the members from the KCDC and the Korean Society of Nephrology (KSN, NCT01630486 at http://www.clinicaltrials.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adetunji OR, 2009, DIABETES RES CLIN PR, V85, P179, DOI 10.1016/j.diabres.2009.04.028; Ajmal Adnan, 2013, BMC Res Notes, V6, P443, DOI 10.1186/1756-0500-6-443; Al-Ahmad A, 2001, J AM COLL CARDIOL, V38, P955, DOI 10.1016/S0735-1097(01)01470-X; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Babazono T, 2006, DIABETOLOGIA, V49, P1387, DOI 10.1007/s00125-006-0247-y; Baumbil, 2012, WE NEED STOR ROOTS I; Bello AK, 2011, CLIN J AM SOC NEPHRO, V6, P1418, DOI 10.2215/CJN.09741110; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Fisher H, 2013, AM J KIDNEY DIS, V62, P1102, DOI 10.1053/j.ajkd.2013.07.013; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; HOWARD RL, 1991, KIDNEY INT, V40, P923, DOI 10.1038/ki.1991.295; Inker LA, 2011, J AM SOC NEPHROL, V22, P2322, DOI 10.1681/ASN.2010111181; Kovesdy CP, 2006, KIDNEY INT, V69, P560, DOI 10.1038/sj.ki.5000105; Lambers Heerspink HJ, 2010, J AM SOC NEPHROL, V21, P1355, DOI 10.1681/ASN.2010010063; Lea J, 2005, ARCH INTERN MED, V165, P947, DOI 10.1001/archinte.165.8.947; Leshem-Rubinow E, 2012, MAYO CLIN PROC, V87, P1189, DOI 10.1016/j.mayocp.2012.07.020; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Oh KH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-80; Okada H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129192; Prinsen BHCMT, 2001, J AM SOC NEPHROL, V12, P1017, DOI 10.1681/ASN.V1251017; Thomas MC, 2005, ARCH INTERN MED, V165, P466, DOI 10.1001/archinte.165.4.466; Thomas MC, 2006, DIABETOLOGIA, V49, P1151, DOI 10.1007/s00125-006-0215-6; Thomas MC, 2003, DIABETES CARE, V26, P1164, DOI 10.2337/diacare.26.4.1164; Thomas M, 2005, CURR DIABETES REV, V1, P107, DOI 10.2174/1573399052952587; Thomas MC, 2007, NAT CLIN PRACT NEPHR, V3, P20, DOI 10.1038/ncpneph0378; Unal A, 2013, TRANSPL P, V45, P949, DOI 10.1016/j.transproceed.2013.02.066; Weiner DE, 2005, J AM SOC NEPHROL, V16, P1803, DOI 10.1681/ASN.2004070597	33	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139747	10.1371/journal.pone.0139747	http://dx.doi.org/10.1371/journal.pone.0139747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430892	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700109
J	Herold, S; Kumar, P; Wichert, SP; Kretzschmar, B; Bahr, M; Rossner, MJ; Hein, K				Herold, Sabine; Kumar, Prateek; Wichert, Sven P.; Kretzschmar, Benedikt; Baehr, Mathias; Rossner, Moritz J.; Hein, Katharina			Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; GANGLION-CELL DEATH; MULTIPLE-SCLEROSIS; RAT MODEL; NERVE; TRANSECTION; EXPRESSION; BETA; DEGENERATION; PATHOGENESIS	Multiple Sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS). Histopathological and radiological analysis revealed that neurodegeneration occurs early in the disease course. However, the pathological mechanisms involved in neurodegeneration are poorly understood. Myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in Brown Norway rats (BN-rats) is a well-established animal model, especially of the neurodegenerative aspects of MS. Previous studies in this animal model indicated that loss of retinal ganglion cells (RGCs), the neurons that form the axons of the optic nerve, occurs in the preclinical phase of the disease and is in part independent of overt histopathological changes of the optic nerve. Therefore, the aim of this study was to identify genes which are involved in neuronal cell loss at different disease stages of EAE. Furthermore, genes that are highly specific for autoimmune-driven neurodegeneration were compared to those regulated in RGCs after optic nerve axotomy at corresponding time points. Using laser capture micro dissection we isolated RNA from unfixed RGCs and performed global transcriptome analysis of retinal neurons. In total, we detected 582 genes sequentially expressed in the preclinical phase and 1150 genes in the clinical manifest EAE (P < 0.05, fold-induction >1.5). Furthermore, using ingenuity pathway analysis (IPA), we identified amyloid precursor protein (APP) as a potential upstream regulator of changes in gene expression in the preclinical EAE but neither in clinical EAE, nor at any time point after optic nerve transection. Therefore, the gene pathway analysis lead to the hypothesis that altered cleavage of APP in neurons in the preclinical phase of EAE leads to the enhanced production of APP intracellular domain (AICD), which in turn acts as a transcriptional regulator and thereby initiates an apoptotic signaling cascade via up-regulation of the target gene p53.	[Herold, Sabine; Kumar, Prateek; Kretzschmar, Benedikt; Baehr, Mathias; Hein, Katharina] Univ Med Gottingen, Dept Neurol, Gottingen, Germany; [Wichert, Sven P.; Rossner, Moritz J.] Univ Munich, Dept Psychiat, Mol & Behav Neurobiol, D-80539 Munich, Germany	University of Gottingen; University of Munich	Hein, K (corresponding author), Univ Med Gottingen, Dept Neurol, Gottingen, Germany.	k.hein@uni-goettingen.de	kumar, prateek/AHA-0283-2022	kumar, prateek/0000-0001-5875-4065; Rossner, Moritz/0000-0002-0667-3420	Sixth Research Framework Programme (FP6) of European Union [LSHM-CT-2005-018637]; Medical Faculty of the University of Gottingen; Germany; Open Access Publication Funds of the Gottingen University	Sixth Research Framework Programme (FP6) of European Union; Medical Faculty of the University of Gottingen; Germany; Open Access Publication Funds of the Gottingen University	This study was funded by Sixth Research Framework Programme (FP6) of European Union from a grant (LSHM-CT-2005-018637, Neuropromise). KH was funded by the Medical Faculty of the University of Gottingen; Germany. The authors acknowledge support from the Open Access Publication Funds of the Gottingen University. The URL for Sixth Research Framework Programme: http://ec.europa.eu/research/fp6/pdf/fp6-in-brief_en.pdf. The URL for Medical Faculty of the University of Gottingen: http://www.med.uni-goettingen.de/de/ content/forschung/182.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr M, 2000, TRENDS NEUROSCI, V23, P483, DOI 10.1016/S0166-2236(00)01637-4; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Branca C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04618; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Das A, 2008, CNS NEUROL DISORD-DR, V7, P313, DOI 10.2174/187152708784936699; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Dziedzic T, 2010, BRAIN PATHOL, V20, P976, DOI 10.1111/j.1750-3639.2010.00401.x; Fairless R, 2012, J NEUROSCI, V32, P5585, DOI 10.1523/JNEUROSCI.5705-11.2012; Friese MA, 2014, NAT REV NEUROL, V10, P225, DOI 10.1038/nrneurol.2014.37; Hebb Andrea L O, 2008, Curr Drug Discov Technol, V5, P75; Hobom M, 2004, BRAIN PATHOL, V14, P148, DOI 10.1111/j.1750-3639.2004.tb00047.x; Isenmann S, 1997, EUR J NEUROSCI, V9, P1763, DOI 10.1111/j.1460-9568.1997.tb01534.x; Kermer P, 2001, BRAIN RES PROTOC, V7, P255, DOI 10.1016/S1385-299X(01)00076-9; Kim DH, 2014, GENE, V545, P185, DOI 10.1016/j.gene.2014.05.031; Kogel D, 2012, EXP BRAIN RES, V217, P471, DOI 10.1007/s00221-011-2932-4; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kumar P, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0172-4; Kumar P, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0241-8; Lassmann H, 2011, FEBS LETT, V585, P3715, DOI 10.1016/j.febslet.2011.08.004; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Maier K, 2006, AM J PATHOL, V169, P1353, DOI 10.2353/ajpath.2006.060159; Martin G, 1996, NEUROSCI LETT, V212, P95, DOI 10.1016/0304-3940(96)12776-2; Meyer R, 2001, J NEUROSCI, V21, P6214, DOI 10.1523/JNEUROSCI.21-16-06214.2001; Mitosek-Szewczyk K, 2011, FOLIA NEUROPATHOL, V49, P191; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raddatz BBR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086643; Rau CR, 2011, AM J PATHOL, V178, P1770, DOI 10.1016/j.ajpath.2011.01.003; Sattler MB, 2010, EXP NEUROL, V225, P40, DOI 10.1016/j.expneurol.2009.08.016; Schirmer L, 2011, BRAIN PATHOL, V21, P428, DOI 10.1111/j.1750-3639.2010.00466.x; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Takasugi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064050; Tezel G, 2000, ARCH OPHTHALMOL-CHIC, V118, P511, DOI 10.1001/archopht.118.4.511; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719; Weise J, 2001, CELL DEATH DIFFER, V8, P801, DOI 10.1038/sj.cdd.4400872; Weissert R, 1998, J CLIN INVEST, V102, P1265, DOI 10.1172/JCI3022; WEKERLE H, 1994, ANN NEUROL, V36, pS47, DOI 10.1002/ana.410360714; Wellington CL, 2000, CLIN GENET, V57, P1, DOI 10.1034/j.1399-0004.2000.570101.x; Zeis T, 2015, BRAIN BEHAV IMMUN, V48, P313, DOI 10.1016/j.bbi.2015.04.013	41	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138852	10.1371/journal.pone.0138852	http://dx.doi.org/10.1371/journal.pone.0138852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426258	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100023
J	Li, CH; Tang, LS; Jia, ZJ; Li, Y				Li, Chen-hua; Tang, Li-song; Jia, Zhong-jun; Li, Yan			Profile Changes in the Soil Microbial Community When Desert Becomes Oasis	PLOS ONE			English	Article							CROP-ROTATION SYSTEMS; BACTERIAL COMMUNITIES; FUNCTIONAL DIVERSITY; MANAGEMENT; CRUSTS; FERTILIZATION; QUALITY; EFFLUX; DEPTH	The conversion of virgin desert into oasis farmland creates two contrasting types of land-cover. During oasis formation with irrigation and fertilizer application, however, the changes in the soil microbial population, which play critical roles in the ecosystem, remain poorly understood. We applied high-throughput pyrosequencing to investigate bacterial and archaeal communities throughout the profile (0-3 m) in an experimental field, where irrigation and fertilization began in 1990 and cropped with winter wheat since then. To assess the effects of cultivation, the following treatments were compared with the virgin desert: CK (no fertilizer), PK, NK, NP, NPK, NPKR, and NPKM (R: straw residue; M: manure fertilizer). Irrigation had a greater impact on the overall microbial community than fertilizer application. The greatest impact occurred in topsoil (0-0.2 m), e.g., Cyanobacteria (25% total abundance) were most abundant in desert soil, while Actinobacteria (26%) were most abundant in oasis soil. The proportions of extremophilic and photosynthetic groups (e.g., Deinococcus-Thermus and Cyanobacteria) decreased, while the proportions of R-strategy (e.g., Gammaproteobacteria including Xanthomonadales), nitrifying (e.g., Nitrospirae), and anaerobic bacteria (e.g., Anaerolineae) increased throughout the oasis profile. Archaea occurred only in oasis soil. The impact of fertilizer application was mainly reflected in the non-dominant communities or finer taxonomic divisions. Oasis formation led to a dramatic shift in microbial community and enhanced soil enzyme activities. The rapidly increased soil moisture and decreased salt caused by irrigation were responsible for this shift. Furthermore, difference in fertilization and crop growth altered the organic carbon contents in the soil, which resulted in differences of microbial communities within oasis.	[Li, Chen-hua; Tang, Li-song; Li, Yan] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China; [Jia, Zhong-jun] Chinese Acad Sci, Nanjing Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Soil Science, CAS	Li, Y (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Xinjiang, Peoples R China.	liyan@ms.xjb.ac.cn	Jia, Zhongjun/B-9770-2011	Jia, Zhongjun/0000-0003-2915-8648	National Natural Science Foundation of China [41301102]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA05050405]; International Science & Technology Cooperation Program of China [2010DFA92720]; Knowledge Innovation Project of the Chinese Academy of Sciences [KZCX2-YW-T09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); International Science & Technology Cooperation Program of China; Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	The work was supported by the following: 1) National Natural Science Foundation of China (grant no: 41301102 to CL); 2) Strategic Priority Research Program of the Chinese Academy of Sciences (grant no: XDA05050405 to LT); 3) The International Science & Technology Cooperation Program of China (grant no: 2010DFA92720 to YL); and 4) The Knowledge Innovation Project of the Chinese Academy of Sciences (grant no: KZCX2-YW-T09 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Braak Ter C., 1998, CANOCO REFERENCE MAN; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Chanal A, 2006, ENVIRON MICROBIOL, V8, P514, DOI 10.1111/j.1462-2920.2005.00921.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; Elgersma KJ, 2011, OECOLOGIA, V167, P733, DOI 10.1007/s00442-011-2022-0; Evans RD, 1999, CRIT REV PLANT SCI, V18, P183, DOI 10.1016/S0735-2689(99)00384-6; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; Franchini JC, 2007, SOIL TILL RES, V92, P18, DOI 10.1016/j.still.2005.12.010; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; Govindasamy V, 2010, MICROBIOL MONOGR, V18, P333, DOI 10.1007/978-3-642-13612-2_15; Guan S.Y, 1986, SOIL ENZYME RES METH; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; Johnson MJ, 2003, GEODERMA, V114, P279, DOI 10.1016/S0016-7061(03)00045-4; Koberl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024452; Kourtev PS, 2003, SOIL BIOL BIOCHEM, V35, P895, DOI 10.1016/S0038-0717(03)00120-2; Kuklinsky-Sobral J, 2004, ENVIRON MICROBIOL, V6, P1244, DOI 10.1111/j.1462-2920.2004.00658.x; Lacey J., 1973, SOC APPL BACTERIOLOG, V2; Leps J, 2003, MULTIVARIATE ANAL EC; Li CH, 2014, SOIL BIOL BIOCHEM, V75, P264, DOI 10.1016/j.soilbio.2014.04.023; Li CH, 2010, ENVIRON EARTH SCI, V60, P549, DOI 10.1007/s12665-009-0195-1; Li K, 2013, MICROB ECOL, V66, P40, DOI 10.1007/s00248-012-0164-1; Motavalli PP, 2000, AGR ECOSYST ENVIRON, V79, P17, DOI 10.1016/S0167-8809(99)00139-5; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Nowinski NS, 2008, ECOSYSTEMS, V11, P16, DOI 10.1007/s10021-007-9104-1; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Papatheodorou EM, 2008, EUR J SOIL BIOL, V44, P429, DOI 10.1016/j.ejsobi.2008.06.002; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seneviratne G, 2009, CURR SCI INDIA, V96, P633; Suzuki C, 2012, SOIL SCI PLANT NUTR, V58, P288, DOI 10.1080/00380768.2012.694119; Tabatabai M. A., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P903; Veldkamp E, 2003, GLOBAL CHANGE BIOL, V9, P1171, DOI 10.1046/j.1365-2486.2003.00656.x; Wang Z.Q., 2002, NUTR CIRCULATION FAR; Whitbeck Julie L., 2007, pXV, DOI 10.1016/B978-012088775-0/50002-1; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Yin CT, 2010, SOIL BIOL BIOCHEM, V42, P2111, DOI 10.1016/j.soilbio.2010.08.006	46	18	20	6	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139626	10.1371/journal.pone.0139626	http://dx.doi.org/10.1371/journal.pone.0139626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426279	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100083
J	Zhang, XD; Huang, L; Wu, T; Feng, YF; Ding, YY; Ye, PF; Yin, ZJ				Zhang, Xiaodong; Huang, Long; Wu, Tao; Feng, Yifang; Ding, Yueyun; Ye, Pengfei; Yin, Zongjun			Transcriptomic Analysis of Ovaries from Pigs with High And Low Litter Size	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MOLECULAR-CLONING; ADULT BERKSHIRE; GENE-EXPRESSION; LARGE WHITE; TRAITS; HSD3B; SEQ; POLYMORPHISMS; REPRODUCTION	Litter size is one of the most important economic traits for pig production as it is directly related to the production efficiency. Litter size is affected by interactions between multiple genes and the environment. While recent studies have identified some genes associated with prolificacy in pigs, transcriptomic studies of specific genes affecting litter size in porcine ovaries are rare. In order to identify candidate genes associated with litter size in swine, we assessed gene expression differences between the ovaries of Yorkshire pigs with extremely high and low litter sizes using the RNA-Seq method. A total of 1 243 differentially expressed genes were identified: 897 genes were upregulated and 346 genes were down-regulated in high litter size ovary samples compared with low litter size ovary samples. A large number of these genes related to steroid hormone regulation in animal ovaries, including 59 Gene Ontology terms and 27 Kyoto Encyclopedia of Genes and Genomes pathways involved in steroid biosynthesis and ovarian steroidogenesis. From these differentially expressed genes, we identified a total of 11 genes using a bioinformatics screen that may be associated with high litter size in Yorkshire pigs. These results provide a list of new candidate genes for porcine litter size and prolificacy to be further investigated.	[Zhang, Xiaodong; Huang, Long; Wu, Tao; Feng, Yifang; Ding, Yueyun; Ye, Pengfei; Yin, Zongjun] Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Local Anim Genet Resources Conservat & Bi, Hefei, Anhui, Peoples R China	Anhui Agricultural University	Yin, ZJ (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Local Anim Genet Resources Conservat & Bi, Hefei, Anhui, Peoples R China.	yinzongjun@ahau.edu.cn	ding, yy/HHS-9589-2022		National Natural Science Foundation of China [31402037, 31171200]; Anhui Provincial Natural Science Foundation [1408085QC55, 1508085QC52]; Project of Anhui Province Scientific Technology Plan [1301031032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Project of Anhui Province Scientific Technology Plan	This research was supported by grants from the National Natural Science Foundation of China (Nos. 31402037 and 31171200), the Anhui Provincial Natural Science Foundation (Nos. 1408085QC55 and 1508085QC52), and the Project of Anhui Province Scientific Technology Plan (No. 1301031032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango J, 2005, J ANIM SCI, V83, P499; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Cao SL, 2015, CLIN RES HEPATOL GAS, V39, P198, DOI 10.1016/j.clinre.2014.09.003; Chen HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120170; Chen K F, 2000, Yi Chuan Xue Bao, V27, P853; Chen L, 2012, J GENET GENOMICS, V39, P181, DOI 10.1016/j.jgg.2012.03.002; Distl O, 2007, REPROD DOMEST ANIM, V42, P10, DOI 10.1111/j.1439-0531.2007.00887.x; Du HL, 2009, GENET MOL BIOL, V32, P69, DOI 10.1590/S1415-47572009000100010; Duan JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059636; Fernandez-Rodriguez A, 2011, BIOL REPROD, V84, P299, DOI 10.1095/biolreprod.110.085589; Franchi NA, 2008, REPRODUCTION, V136, P157, DOI 10.1530/REP-08-0032; Gan L, 2015, GENE, V560, P96, DOI 10.1016/j.gene.2015.01.051; Gao HJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100479; Goluch D, 2009, NEUROENDOCRINOL LETT, V30, P525; Guo F, 2013, POULTRY SCI, V92, P2737, DOI 10.3382/ps.2013-03189; Hogarth CA, 2010, DEV DYNAM, V239, P3106, DOI 10.1002/dvdy.22442; Hsieh CW, 2011, J LIPID RES, V52, P1352, DOI 10.1194/jlr.M012666; Jacobsen M, 2005, J INFECT DIS, V192, P1211, DOI 10.1086/444428; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kerpedjiev P, 2014, BMC BIOINFORMATICS, V15, DOI [10.1186/1471-2105-15-15, DOI 10.1186/1471-2105-15-15]; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Lan DL, 2014, SCI CHINA LIFE SCI, V57, P925, DOI 10.1007/s11427-014-4678-2; Lee DG, 2015, BIOSCI BIOTECH BIOCH, V79, P1414, DOI 10.1080/09168451.2015.1039478; Ling YH, 2014, GENE, V550, P148, DOI 10.1016/j.gene.2014.08.008; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Metges CC, 2014, J NUTR, V144, P155, DOI 10.3945/jn.113.182691; Moazeni M, 2012, PARASITOL RES, V110, P2379, DOI 10.1007/s00436-011-2774-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz G, 2007, GENET SEL EVOL, V39, P195, DOI 10.1051/gse:2006042; Nakamoto M, 2012, GEN COMP ENDOCR, V176, P222, DOI 10.1016/j.ygcen.2012.01.019; Nakazawa H, 2012, J NEUROSCI, V32, P12712, DOI 10.1523/JNEUROSCI.0989-12.2012; Noguera JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-636; Paeschke K D, 1970, Fortschr Geburtshilfe Gynakol, V43, P1; Pan ZX, 2012, MOL BIOL REP, V39, P10823, DOI 10.1007/s11033-012-1976-2; Paradis F, 2009, REPRODUCTION, V138, P115, DOI 10.1530/REP-08-0538; Ramirez O, 2009, ANIM REPROD SCI, V115, P317, DOI 10.1016/j.anireprosci.2008.12.013; Rantakari P, 2008, MOL ENDOCRINOL, V22, P665, DOI 10.1210/me.2007-0257; ROJAS FJ, 1995, HUM REPROD, V10, P2219; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Sechman A, 2011, DOMEST ANIM ENDOCRIN, V41, P137, DOI 10.1016/j.domaniend.2011.05.007; Sechman A, 2014, TOXICOL LETT, V225, P264, DOI 10.1016/j.toxlet.2013.12.021; Shen Z, 2008, J BONE MINER RES, V23, P1217, DOI 10.1359/JBMR.080322; Shimizu T, 2004, REPRODUCTION, V128, P537, DOI 10.1530/rep.1.00224; Sodhi SS, 2014, MOL BIOL REP, V41, P6305, DOI 10.1007/s11033-014-3513-y; Sodhi SS, 2014, GENE, V546, P233, DOI 10.1016/j.gene.2014.06.005; Spotter A, 2009, REPROD DOMEST ANIM, V44, P100, DOI 10.1111/j.1439-0531.2007.01004.x; Steibel JP, 2009, GENOMICS, V94, P146, DOI 10.1016/j.ygeno.2009.04.008; Stephens SM, 2009, AM J PHYSIOL-ENDOC M, V297, pE1235, DOI 10.1152/ajpendo.00575.2009; Sun Yan-Xiao, 2009, Yichuan, V31, P63, DOI 10.3724/SP.J.1005.2009.00063; Tian ZC, 2013, INFECT GENET EVOL, V18, P13, DOI 10.1016/j.meegid.2013.04.002; Tosser-Klopp G, 1998, ANIM GENET, V29, P23, DOI 10.1046/j.1365-2052.1998.00226.x; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061; Wang CL, 2013, MOL BIOL REP, V40, P1073, DOI 10.1007/s11033-012-2149-z; Wang JJ, 2014, REPROD FERT DEVELOP, V26, P587, DOI 10.1071/RD12380; Wang XL, 2014, GENE, V549, P252, DOI 10.1016/j.gene.2014.07.072; WEINER S, 1975, FERTIL STERIL, V26, P363; Wolf J, 2010, J ANIM SCI, V88, P2893, DOI 10.2527/jas.2009-2555; Xia JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113724; Zhao H, 2015, CURR PROTEIN PEPT SC, V16, P316, DOI 10.2174/138920371604150429154840; Zhao YF, 1998, SCI CHINA SER C, V41, P664, DOI 10.1007/BF02882910; Zhongyi S, 2007, ENDOCRINOLOGY, V148, P3827, DOI 10.1210/en.2007-0365; Zhou GL, 2010, MEAT SCI, V85, P270, DOI 10.1016/j.meatsci.2010.01.011; Zhou GL, 2010, MOL BIOL REP, V37, P603, DOI 10.1007/s11033-009-9860-4	68	40	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139514	10.1371/journal.pone.0139514	http://dx.doi.org/10.1371/journal.pone.0139514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426260	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100071
J	Castro, EM; Santiago, LE; Jimenez, JC; Davila-Vargas, D; Rosal, MC				Castro, Eida M.; Santiago, Lydia E.; Jimenez, Julio C.; Davila-Vargas, Daira; Rosal, Milagros C.			A Social-Ecological View of Barriers and Facilitators for HIV Treatment Adherence: Interviews with Puerto Rican HIV Patients	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; MEDICATION ADHERENCE; INFECTED PATIENTS; MENTAL-HEALTH; PEOPLE; IMPACT; DEPRESSION; STIGMA	Purpose To identify perceived barriers and facilitators for HAART adherence among people living with HIV/AIDS in Southern Puerto Rico using a Social Ecological framework. Patients and Methods Individual in-depths interviews were conducted with 12 HIV patients with a history of HAART non-adherence. Interviews were audio-taped and transcribed. Content analysis was performed for each transcribed interview by three independent coders using a code-book. Using Atlas TI, super-codes and families were generated to facilitate the categorization tree as well as grounded analyses and density estimates Results Most participants reported a monthly income of $500 or less (n = 7), a high school education level (n = 7), being unemployed (n = 9) and being recipients of government health insurance (n = 11). Three out of six women reported living alone with their children and most men informed living with their parents or other relatives (n = 4). For the grounded analyses, the top four subcategories linked to high number of quotations were mental health barriers (G = 32) followed by treatment regimen (G = 28), health system (G = 24) and interpersonal relations (G = 16). The top four sub-categories linked to high number of codes are treatment regimen (D = 4), health status perception (D = 3), interpersonal relations (D = 3) and health system (D = 3). Conclusion The results of this study suggest the interconnection of HIV treatment adherence barriers at various system levels. Future studies on HIV treatment barriers should explore these interactions and investigate the possible synergistic effect on non-adherent behavior	[Castro, Eida M.; Jimenez, Julio C.; Davila-Vargas, Daira] Ponce Sch Med & Hlth Sci, Clin Psychol Programs, Ponce, PR 00716 USA; [Castro, Eida M.] Ponce Sch Med & Hlth Sci, Dept Psychiat, Ponce, PR USA; [Santiago, Lydia E.] Univ Puerto Rico, Sch Nursing, San Juan, PR 00936 USA; [Rosal, Milagros C.] Univ Massachusetts, Sch Med, Div Prevent & Behav Med, Worcester, MA USA	University of Puerto Rico; University of Massachusetts System; University of Massachusetts Worcester	Castro, EM (corresponding author), Ponce Sch Med & Hlth Sci, Clin Psychol Programs, Ponce, PR 00716 USA.	ecastro@psm.edu			National Center for Research Resources [S21MD001830, U54 RR026139]; National Institute of Minority Health and Health Disparities [8U54MD 007587-03, 2-G12-MD007579-29]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026139] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [S21MD001830] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, U54MD007579, G12MD007579] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The project was supported by Grant Number S21MD001830 and Award Number U54 RR026139 from the National Center for Research Resources(http://www.ncrr.nih.gov/) and the Award Number 8U54MD 007587-03 and 2-G12-MD007579-29 from the National Institute of Minority Health and Health Disparities (http://www.nimhd.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achieng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032727; [Anonymous], 2014, PUERT RIC HIV AIDS S; Arrivillaga M, 2011, WOMEN HEALTH ISS, V21, P177, DOI 10.1016/j.whi.2010.09.003; Berben L, 2012, WESTERN J NURS RES, V34, P635, DOI 10.1177/0193945911434518; Bezabhe WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097353; Bravo P, 2010, AIDS REV, V12, P76; Cardarelli Roberto, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P123, DOI 10.1177/1545109708318526; Carter AE, 2014, WORLD J CLIN CASES, V2, P642, DOI 10.12998/wjcc.v2.i11.642; Castano PM, 2013, CLIN OBSTET GYNECOL, V56, P434, DOI 10.1097/GRF.0b013e3182988a3b; Chanbrier M, 2013, B CANC, V100, P1017, DOI [10.1684/bdc.2013.1824, DOI 10.1684/BDC.2013.1824]; Claborn KR, 2015, PSYCHOL HEALTH MED, V20, P255, DOI 10.1080/13548506.2014.945601; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; Curioso WH, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-13; De Santis JP, 2012, J PSYCHIATR MENT HLT, V19, P860, DOI 10.1111/j.1365-2850.2011.01865.x; Departamento de Salud de Puerto Rico: Secretarilia Auxiliar de Salud Familiar Servicios Integrados y Promocion de la Salud Oficina Central de Asuntos del SIDA y Enfermedades Transmisibles, 2012, PUERT RIC HIV UNM NE; DiIorio C, 2009, AIDS BEHAV, V13, P10, DOI 10.1007/s10461-007-9318-4; Gokarn Anant, 2012, J Assoc Physicians India, V60, P16; Kvale S, 1996, INTERVIEWS INTRO QUA; Lewis LM, 2012, J CARDIOVASC NURS, V27, P208, DOI 10.1097/JCN.0b013e318215bb8f; Lowther K, 2014, INT J NURS STUD, V51, P1171, DOI 10.1016/j.ijnurstu.2014.01.015; Mathes T, 2013, HIV MED, V14, P583, DOI 10.1111/hiv.12051; Merten S, 2010, TROP MED INT HEALTH, V15, P16, DOI 10.1111/j.1365-3156.2010.02510.x; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Naar-King S, 2006, AIDS PATIENT CARE ST, V20, P44, DOI 10.1089/apc.2006.20.44; Nachega Jean B., 2011, Infectious Disorders - Drug Targets, V11, P167; Nel A, 2011, AIDS CARE, V23, P1360, DOI 10.1080/09540121.2011.565025; Onwuegbuzie AJ, 2007, QUAL QUANT, V41, P105, DOI 10.1007/s11135-005-1098-1; Pence BW, 2009, J ANTIMICROB CHEMOTH, V63, P636, DOI 10.1093/jac/dkp006; Penn C, 2011, PATIENT EDUC COUNS, V83, P310, DOI 10.1016/j.pec.2011.02.018; Puerto Rico Health Department: Office of Epidemiology and Research & HIV/AIDS Surveillance Program, 2014, EP HUM IMM VIR HIV P; Russell S, 2007, HEALTH POLICY PLANN, V22, P344, DOI 10.1093/heapol/czm023; The White House. The White House Office of National AIDS Policy, 2010, NAT HIV AIDS STRAT F; US Department of Health and Human Services, 2005, SID EFF ANT MED HLTH; Vanable PA, 2006, AIDS BEHAV, V10, P473, DOI 10.1007/s10461-006-9099-1; Waller J, 2009, PREV MED, V48, P415, DOI 10.1016/j.ypmed.2008.11.004; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; Wroe EB, 2015, INT J STD AIDS, V26, P257, DOI 10.1177/0956462414535206	38	9	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0125582	10.1371/journal.pone.0125582	http://dx.doi.org/10.1371/journal.pone.0125582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422049	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700001
J	Galper, BZ; Wang, YC; Einstein, AJ				Galper, Benjamin Z.; Wang, Y. Claire; Einstein, Andrew J.			Strategies for Primary Prevention of Coronary Heart Disease Based on Risk Stratification by the ACC/AHA Lipid Guidelines, ATP III Guidelines, Coronary Calcium Scoring, and C-Reactive Protein, and a Global Treat-All Strategy: A Comparative-Effectiveness Modeling Study	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; LOW-DOSE ASPIRIN; COST-EFFECTIVENESS; STATIN THERAPY; ARTERY CALCIUM; CARDIOVASCULAR-RISK; MYOCARDIAL-INFARCTION; COMPUTED-TOMOGRAPHY; SMOKING-CESSATION; CLINICAL-OUTCOMES	Background Several approaches have been proposed for risk-stratification and primary prevention of coronary heart disease (CHD), but their comparative and cost-effectiveness is unknown. Methods We constructed a state-transition microsimulation model to compare multiple approaches to the primary prevention of CHD in a simulated cohort of men aged 45-75 and women 55-75. Risk-stratification strategies included the 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines on the treatment of blood cholesterol, the Adult Treatment Panel (ATP) III guidelines, and approaches based on coronary artery calcium (CAC) scoring and C-reactive protein (CRP). Additionally we assessed a treat-all strategy in which all individuals were prescribed either moderate-dose or high-dose statins and all males received low-dose aspirin. Outcome measures included CHD events, costs, medication- related side effects, radiation-attributable cancers, and quality-adjusted-life-years (QALYs) over a 30-year timeframe. Results Treat-all with high-dose statins dominated all other strategies for both men and women, gaining 15.7 million QALYs, preventing 7.3 million myocardial infarctions, and saving over $238 billion, compared to the status quo, far outweighing its associated adverse events including bleeding, hepatitis, myopathy, and new-onset diabetes. ACC/AHA guidelines were more cost-effective than ATP III guidelines for both men and women despite placing 8.7 million more people on statins. For women at low CHD risk, treat-all with high-dose statins was more likely to cause a statin-related adverse event than to prevent a CHD event. Conclusions Despite leading to a greater proportion of the population placed on statin therapy, the ACC/AHA guidelines are more cost-effective than ATP III. Even so, at generic prices, treating all men and women with statins and all men with low-dose aspirin appears to be more cost-effective than all risk-stratification approaches for the primary prevention of CHD. Especially for low-CHD risk women, decisions on the appropriate primary prevention strategy should be based on shared decision making between patients and healthcare providers.	[Galper, Benjamin Z.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; [Wang, Y. Claire] Columbia Univ, Med Ctr, Mailman Sch Publ Hlth, New York, NY USA; [Einstein, Andrew J.] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Einstein, Andrew J.] New York Presbyterian Hosp, Dept Med, New York, NY USA; [Einstein, Andrew J.] New York Presbyterian Hosp, Div Cardiol, New York, NY USA; [Einstein, Andrew J.] New York Presbyterian Hosp, Dept Radiol, New York, NY USA	Harvard University; Brigham & Women's Hospital; Columbia University; Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital	Einstein, AJ (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.	andrew.einstein@columbia.edu	Galper, Benjamin/AAT-5236-2020	Catapano, Alberico Luigi/0000-0002-7593-2094	Herbert Irving Associate Professorship; Victoria and Esther Aboodi Cardiology Researcher; Louis V. Gerstner, Jr. Scholars Program; Lewis Katz Cardiovascular Research Prize for a Young Investigator; National Center for Advancing Translational Sciences, National Institutes of Health [KL2 TR000081]; National Heart, Lung, and Blood Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000081] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	Herbert Irving Associate Professorship; Victoria and Esther Aboodi Cardiology Researcher; Louis V. Gerstner, Jr. Scholars Program; Lewis Katz Cardiovascular Research Prize for a Young Investigator; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding Sources include a Herbert Irving Associate Professorship, a Victoria and Esther Aboodi Cardiology Researcher, the Louis V. Gerstner, Jr. Scholars Program, the Lewis Katz Cardiovascular Research Prize for a Young Investigator, the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number KL2 TR000081, formerly the National Center for Research Resources, Grant Number KL2 RR024157, and the National Heart, Lung, and Blood Institute through Grant Number T32 HL007604. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Amarenco P, 2004, CIRCULATION, V109, P44, DOI 10.1161/01.CIR.0000131518.25959.8F; Anderson JL, 2014, J AM COLL CARDIOL, V63, P2304, DOI 10.1016/j.jacc.2014.03.016; [Anonymous], 2013, 2013 REPORT ASSESSME; [Anonymous], 2009, CLIN LAB FEE SCHED P; [Anonymous], 2009, PHYS FEE SCHED PAYM; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Beller GA, 2009, J NUCL CARDIOL, V16, P681, DOI 10.1007/s12350-009-9139-0; Berger JS, JAMA, V295, P306; Berglund E, 2013, PATIENT EDUC COUNS, V91, P105, DOI 10.1016/j.pec.2012.11.001; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Blaha MJ, 2012, JAMA-J AM MED ASSOC, V307, P1489, DOI 10.1001/jama.2012.425; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Blumenthal RS, 2012, WALL STREET J; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Brown ML, 2002, MED CARE, V40, P104; Bruckert E, 2005, CARDIOVASC DRUG THER, V19, P403, DOI 10.1007/s10557-005-5686-z; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Choudhry NK, 2011, J AM COLL CARDIOL, V57, P784, DOI 10.1016/j.jacc.2010.07.059; Cohen DJ, 2012, CATHETER CARDIO INTE, V79, P198, DOI 10.1002/ccd.23147; Cohen DJ, 2001, CIRCULATION, V104, P3039, DOI 10.1161/hc5001.100794; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Deambrosis P, 2009, PHARMACOL RES, V60, P397, DOI 10.1016/j.phrs.2009.06.009; Desai Chintan S, 2014, BMJ, V349, pg3743, DOI 10.1136/bmj.g3743; Diamond GA, 2007, AM J CARDIOL, V99, P1013, DOI 10.1016/j.amjcard.2006.10.070; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Franc S, 2003, CARDIOVASC DRUG THER, V17, P459, DOI 10.1023/B:CARD.0000015861.26111.ab; Galper BZ, 2012, CIRCULATION, V125, P260, DOI 10.1161/CIRCULATIONAHA.111.041293; Genders TSS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3485; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Greenland P, 2015, JAMA-J AM MED ASSOC, V314, P127, DOI 10.1001/jama.2015.7434; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hachamovitch R, 1998, CIRCULATION, V97, P535; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Heidenreich PA, 2008, J GEN INTERN MED, V23, P509, DOI 10.1007/s11606-008-0515-2; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jacobson KM, 2007, QUAL SAF HEALTH CARE, V16, P154, DOI 10.1136/qshc.2006.019331; Jukema JW, 2012, J AM COLL CARDIOL, V60, P875, DOI 10.1016/j.jacc.2012.07.007; Kalia N, 2012, J AM COLL CARDIOL, V59, pE1118; Kalia NK, 2006, ATHEROSCLEROSIS, V185, P394, DOI 10.1016/j.atherosclerosis.2005.06.018; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Keevil JG, 2007, CIRCULATION, V115, P1363, DOI 10.1161/CIRCULATIONAHA.106.645473; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Ko CY, 2003, J SURG RES, V114, P1, DOI 10.1016/S0022-4804(03)00167-7; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Ladapo JA, 2011, ARCH INTERN MED, V171, P39, DOI 10.1001/archinternmed.2010.479; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Lee KK, 2010, CIRCULATION, V122, P1478, DOI 10.1161/CIRCULATIONAHA.110.947960; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Lin GA, 2014, CIRC-CARDIOVASC QUAL, V7, P328, DOI 10.1161/CIRCOUTCOMES.113.000322; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Loftus P., 2014, WALL STREET J; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; *NAT CHOL ED PROGR, 2002, NIH PUBL; Nationwide Inpatient Sample, 2006, HLTH COST UT PROJ; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Oliveria G, 2009, RELATING HLTH BENEFI; Pandya A, 2015, JAMA-J AM MED ASSOC, V314, P142, DOI 10.1001/jama.2015.6822; PEDERSEN TR, 1994, LANCET, V344, P1383; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Pletcher MJ, 2014, CIRC-CARDIOVASC QUAL, V7, P276, DOI 10.1161/CIRCOUTCOMES.113.000799; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Pursnani A, JAMA-J AM MED ASSOC, V314, P134, DOI [10.1001/jama.2015.7515, DOI 10.1001/JAMA.2015]; Redberg RF, 2012, JAMA-J AM MED ASSOC, V307, P1491, DOI 10.1001/jama.2012.423; Reed SD, 2004, CANCER-AM CANCER SOC, V101, P2574, DOI 10.1002/cncr.20694; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Riley RF, 2011, CIRC-CARDIOVASC QUAL, V4, P193, DOI 10.1161/CIRCOUTCOMES.110.958744; Roux L, 2006, OBESITY, V14, P1093, DOI 10.1038/oby.2006.125; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P303, DOI 10.1097/WAD.0b013e3181a80242; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Simons LA, 1996, MED J AUSTRALIA, V164, P208, DOI 10.5694/j.1326-5377.1996.tb94138.x; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Unni EJ, 2008, THESIS U IOWA; van Kempen BJH, 2011, J AM COLL CARDIOL, V58, P1690, DOI 10.1016/j.jacc.2011.05.056; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wu JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067611; Zanchetti A, 2002, J HYPERTENS, V20, P2301, DOI 10.1097/00004872-200211000-00031; 2010, 2010 RED BOOK PHARM	107	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138092	10.1371/journal.pone.0138092	http://dx.doi.org/10.1371/journal.pone.0138092			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422204	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700029
J	Jain, D; Weber, G; Eberhard, D; Mehana, AE; Eglinger, J; Welters, A; Bartosinska, B; Jeruschke, K; Weiss, J; Path, G; Ariga, H; Seufert, J; Lammert, E				Jain, Deepak; Weber, Gesine; Eberhard, Daniel; Mehana, Amir E.; Eglinger, Jan; Welters, Alena; Bartosinska, Barbara; Jeruschke, Kay; Weiss, Juergen; Paeth, Guenter; Ariga, Hiroyoshi; Seufert, Jochen; Lammert, Eckhard			DJ-1 Protects Pancreatic Beta Cells from Cytokine- and Streptozotocin-Mediated Cell Death	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLUCOSE-HOMEOSTASIS; ISLET INFLAMMATION; OXIDATIVE STRESS; MOUSE; DISEASE; MICE; EXPRESSION; APOPTOSIS; INSULITIS	A hallmark feature of type 1 and type 2 diabetes mellitus is the progressive dysfunction and loss of insulin-producing pancreatic beta cells, and inflammatory cytokines are known to trigger beta cell death. Here we asked whether the anti-oxidant protein DJ-1 encoded by the Parkinson's disease gene PARK7 protects islet cells from cytokine-and streptozotocin-mediated cell death. Wild type and DJ-1 knockout mice (KO) were treated with multiple low doses of streptozotocin (MLDS) to induce inflammatory beta cell stress and cell death. Subsequently, glucose tolerance tests were performed, and plasma insulin as well as fasting and random blood glucose concentrations were monitored. Mitochondrial morphology and number of insulin granules were quantified in beta cells. Moreover, islet cell damage was determined in vitro after streptozotocin and cytokine treatment of isolated wild type and DJ-1 KO islets using calcein AM/ethidium homodimer-1 staining and TUNEL staining. Compared to wild type mice, DJ-1 KO mice became diabetic following MLDS treatment. Insulin concentrations were substantially reduced, and fasting blood glucose concentrations were significantly higher in MLDS-treated DJ-1 KO mice compared to equally treated wild type mice. Rates of beta cell apoptosis upon MLDS treatment were twofold higher in DJ-1 KO mice compared to wild type mice, and in vitro inflammatory cytokines led to twice as much beta cell death in pancreatic islets from DJ-1 KO mice versus those of wild type mice. In conclusion, this study identified the anti-oxidant protein DJ-1 as being capable of protecting pancreatic islet cells from cell death induced by an inflammatory and cytotoxic setting.	[Jain, Deepak; Weber, Gesine; Eberhard, Daniel; Eglinger, Jan; Welters, Alena; Bartosinska, Barbara; Lammert, Eckhard] Univ Dusseldorf, Inst Metab Physiol, Dusseldorf, Germany; [Jain, Deepak; Eberhard, Daniel; Eglinger, Jan; Welters, Alena; Lammert, Eckhard] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Beta Cell Biol, Dusseldorf, Germany; [Jain, Deepak; Eglinger, Jan; Welters, Alena; Lammert, Eckhard] German Ctr Diabet Res DZD eV, Dusseldorf Partner Inst, Dusseldorf, Germany; [Mehana, Amir E.; Paeth, Guenter; Seufert, Jochen] Univ Hosp Freiburg, Div Endocrinol & Diabetol, Dept Internal Med 2, Freiburg, Germany; [Mehana, Amir E.] Suez Canal Univ, Fac Sci, Dept Zool, Ismailia, Egypt; [Welters, Alena] Univ Childrens Hosp Dusseldorf, Dept Gen Pediat Neonatol & Pediat Cardiol, Dusseldorf, Germany; [Jeruschke, Kay; Weiss, Juergen] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Biochem & Pathobiochem, Dusseldorf, Germany; [Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 060, Japan	Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Freiburg; Egyptian Knowledge Bank (EKB); Suez Canal University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Hokkaido University	Lammert, E (corresponding author), Univ Dusseldorf, Inst Metab Physiol, Dusseldorf, Germany.	Lammert@uni-duesseldorf.de	Eglinger, Jan/P-3560-2019; Mehana, Amir E./H-1126-2014; Eglinger, Jan/C-2707-2014	Eglinger, Jan/0000-0001-7234-1435; Mehana, Amir E./0000-0001-9421-4090; Eglinger, Jan/0000-0001-7234-1435; Path, Gunter/0000-0003-1966-247X	German Centre for Diabetes Research (DZD e.V.) of the Federal Ministry for Education and Research (BMBF); Deutsche Forschungsgemeinschaft DFG [La1216/6-1]	German Centre for Diabetes Research (DZD e.V.) of the Federal Ministry for Education and Research (BMBF); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	DJ, JE and EL were supported by the German Centre for Diabetes Research (DZD e.V.) of the Federal Ministry for Education and Research (BMBF). DE and EL were supported by the Deutsche Forschungsgemeinschaft DFG (La1216/6-1).	Abdulreda MH, 2013, DIABETES OBES METAB, V15, P105, DOI 10.1111/dom.12160; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen HN, 2005, DIABETES, V54, P1437, DOI 10.2337/diabetes.54.5.1437; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337/dc06-1834; Donath MY, 2008, DIABETES CARE, V31, pS161, DOI 10.2337/dc08-s243; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Emre Y, 2007, P NATL ACAD SCI USA, V104, P19085, DOI 10.1073/pnas.0709557104; Evans-Molina C, 2013, DIABETES OBES METAB, V15, P159, DOI 10.1111/dom.12163; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Goldberg MS, 2005, NEURON, V45, P489, DOI 10.1016/j.neuron.2005.01.041; Guzman JN, 2010, NATURE, V468, P696, DOI 10.1038/nature09536; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Hwang S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003412; Inberg A, 2010, J BIOL CHEM, V285, P25686, DOI 10.1074/jbc.M110.109751; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Jorns A, 2014, DIABETOLOGIA, V57, P512, DOI 10.1007/s00125-013-3125-4; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kim JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04805; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Lundh M, 2013, DIABETES OBES METAB, V15, P176, DOI 10.1111/dom.12158; Mabley JG, 2003, MOL MED, V9, P96, DOI 10.2119/2003-00016.Mabley; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mitsumoto A, 2001, FREE RADICAL RES, V35, P885, DOI 10.1080/10715760100301381; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ren HG, 2011, J BIOL CHEM, V286, P35308, DOI 10.1074/jbc.M110.207134; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seyfarth K, 2015, J NUTR BIOCHEM, V26, P75, DOI 10.1016/j.jnutbio.2014.09.002; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wang XL, 2012, J NEUROCHEM, V121, P830, DOI 10.1111/j.1471-4159.2012.07734.x; Xiang FL, 2010, DIABETES, V59, P2603, DOI 10.2337/db09-1562; Yamaguchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038144; Zhou WB, 2011, J BIOL CHEM, V286, P14941, DOI 10.1074/jbc.M110.211029	41	19	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138535	10.1371/journal.pone.0138535	http://dx.doi.org/10.1371/journal.pone.0138535			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422139	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700042
J	Sondergaard, D; Pedersen, CNS				Sondergaard, Dan; Pedersen, Christian Norgaard Storm			PATBox: A Toolbox for Classification and Analysis of P-Type ATPases	PLOS ONE			English	Article								P-Type ATPases are part of the regulatory system of the cell where they are responsible for transporting ions and lipids through the cell membrane. These pumps are found in all eukaryotes and their malfunction has been found to cause several severe diseases. Knowing which substrate is pumped by a certain P-Type ATPase is therefore vital. The P-Type ATPases can be divided into 11 subtypes based on their specificity, that is, the substrate that they pump. Determining the subtype experimentally is time-consuming. Thus it is of great interest to be able to accurately predict the subtype based on the amino acid sequence only. We present an approach to P-Type ATPase sequence classification based on the k-nearest neighbors, similar to a homology search, and show that this method provides performs very well and, to the best of our knowledge, better than any existing method despite its simplicity. The classifier is made available as a web service at http://services.birc.au.dk/patbox/ which also provides access to a database of potential P-Type ATPases and their predicted subtypes.	[Sondergaard, Dan; Pedersen, Christian Norgaard Storm] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Sondergaard, Dan] Aarhus Univ, Ctr Membrane Pumps Cells & Dis, Aarhus, Denmark	Aarhus University; Aarhus University	Sondergaard, D (corresponding author), Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark.	das@birc.au.dk						Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bublitz M, 2011, J CELL SCI, V124, P2515, DOI 10.1242/jcs.088716; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Espeholt L, 2014, THESIS AARHUS U; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Ifrim G., 2008, P 14 ACM SIGKDD INT, P354, DOI [10.1145/1401890.1401936, DOI 10.1145/1401890.1401936]; Ifrim G., 2011, P 17 ACM SIGKDD INT, DOI [10.1145/2020408.2020519, DOI 10.1145/2020408.2020519]; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Moller AB, 2008, MOL PHYLOGENET EVOL, V46, P619, DOI 10.1016/j.ympev.2007.10.023; Pedersen BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085139	11	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139571	10.1371/journal.pone.0139571	http://dx.doi.org/10.1371/journal.pone.0139571			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422234	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700128
J	Carpenet, H; Cuvillier, A; Monteil, J; Quelven, I				Carpenet, Helene; Cuvillier, Armelle; Monteil, Jacques; Quelven, Isabelle			Anti-CD20 Immunoglobulin G Radiolabeling with a Tc-99m-Tricarbonyl Core: In Vitro and In Vivo Evaluations	PLOS ONE			English	Article							IMMUNOREACTIVE FRACTION; MONOCLONAL-ANTIBODIES; TC-99M; RITUXIMAB; IMINOTHIOLANE; ACTIVATION; CELLS; MODEL	In recent years, the diagnostic and therapeutic uses of radioisotopes have shown significant progress. Immunoglobulin (Ig) appears to be a promising tracer, particularly due to its ability to target selected antigens. The main objective of this study is to optimize and assess an Ig radiolabeling method with Technetium 99m (Tc-99m), an attractive radioelement used widely for diagnostic imaging. Monoclonal anti-CD20 IgG was retained to study in vitro and in vivo radiolabeling impact. After IgG derivatization with 2-iminothiolane, IgG-SH was radiolabeled by an indirect method, using a Tc-99m-tricarbonyl core. Radiolabeling stability was evaluated over 24h by thin-layer chromatography. IgG integrity was checked by sodium dodecyl sulfate- polyacrylamide gel electrophoresis coupled with Western blot and autoradiography. The radiolabeled Ig's immunoaffinity was assessed in vitro by a radioimmunoassay method and binding experiments with cells (EL4-hCD20 and EL4-WT). Biodistribution studies were performed in normal BALB/c mice. Tumor uptake was assessed in mice bearing EL4-hCD20 and EL4-WT subcutaneous xenografts. With optimized method, high radiolabeling yields were obtained (95.9 +/- 3.5%). Tc-99m-IgG-SH was stable in phosphate-buffered saline (4 degrees C and 25 degrees C) and in serum (37 degrees C), even if important sensitivity to transchelation was observed. IgG was not degraded by derivatization and radiolabeling, as shown by Western blot and autoradiography results. Tc-99m-anti-CD20 IgG-SH immunoaffinity was estimated with Kd = 35 nM by both methods. In vivo biodistribution studies for 48h showed significant accumulation of radioactivity in plasma, liver, spleen, lungs and kidneys. Planar scintigraphy of mice bearing tumors showed a significant uptake of Tc-99m-anti-CD20 IgG-SH in CD20(+) tumor versus CD20(-) tumor. Radiolabeling of derivatized IgG with Tc-99m-tricarbonyl was effective, stable and required few antibody amounts. This attractive radiolabeling method is "antibody safe" and preserves Ig affinity for antigen, as shown by both in vitro and in vivo experiments. This method could easily be used with noncommercial IgG or other antibody isotypes.	[Carpenet, Helene; Monteil, Jacques; Quelven, Isabelle] Dupuytren Univ Hosp, Dept Nucl Med, Limoges, France; [Carpenet, Helene; Monteil, Jacques; Quelven, Isabelle] Fac Med & Pharm, EA 3842, Limoges, France; [Cuvillier, Armelle] B Cell Design Soc, Limoges, France	CHU Limoges	Quelven, I (corresponding author), Dupuytren Univ Hosp, Dept Nucl Med, Limoges, France.	isabelle.quelven@unilim.fr	Monteil, Jacques/O-8822-2016; Quelven, Isabelle/O-8689-2016	Monteil, Jacques/0000-0002-7255-709X; Quelven, Isabelle/0000-0002-5877-8937	CORC (Comite d'Orientation de la Recherche sur le Cancer) Limousin; B Cell Design Society	CORC (Comite d'Orientation de la Recherche sur le Cancer) Limousin; B Cell Design Society	Some of the work presented here was supported in part by CORC (Comite d'Orientation de la Recherche sur le Cancer) Limousin. Mallinckrodt Medical for supply of IsoLink. F. Dalmay (INSERM UMR-S 1094 NET) for assistance with statistical analyses. M. Cogne for gift of EL4-WTand EL4-CD20 cells. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. B Cell Design Society provided support in the form of a salary for author AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section.	Alberto R, 1998, J AM CHEM SOC, V120, P7987, DOI 10.1021/ja980745t; Alberto R, 2001, J AM CHEM SOC, V123, P3135, DOI 10.1021/ja003932b; Aurlien E, 2000, BRIT J CANCER, V83, P1375, DOI 10.1054/bjoc.2000.1453; Becker W, 1996, CLIN ORTHOP RELAT R, P263; Biechlin ML, 2008, NUCL MED BIOL, V35, P679, DOI 10.1016/j.nucmedbio.2008.05.009; Biechlin ML, 2005, J LABELLED COMPD RAD, V48, P873, DOI 10.1002/jlcr.999; Camacho X, 2013, ONCOLOGY-BASEL, V84, P200, DOI 10.1159/000338961; Chen WJ, 2008, APPL RADIAT ISOTOPES, V66, P340, DOI 10.1016/j.apradiso.2007.09.007; Di Gaetano N, 2003, J IMMUNOL, V171, P1581, DOI 10.4049/jimmunol.171.3.1581; Dias CR, 2011, NUCL MED BIOL, V38, P19, DOI 10.1016/j.nucmedbio.2010.05.010; Egli A, 1999, J NUCL MED, V40, P1913; Ernst JA, 2005, BIOCHEMISTRY-US, V44, P15150, DOI 10.1021/bi0511078; Faintuch BL, 2011, CLINICS, V66, P327, DOI 10.1590/S1807-59322011000200024; FDA, 1997, 970260 FDA BLA; Fonti R, 1999, NUCL MED BIOL, V26, P681, DOI 10.1016/S0969-8051(99)00026-8; Gano L, 1998, NUCL MED BIOL, V25, P395, DOI 10.1016/S0969-8051(97)00225-4; Goedemans WT, 1995, BIFUNCTIONAL CHELATI; LINDMO T, 1986, METHOD ENZYMOL, V121, P678; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Malviya G, 2012, MOL IMAGING BIOL, V14, P637, DOI 10.1007/s11307-011-0527-x; MEARES CF, 1990, BRIT J CANCER, V62, P21; Pandey U, 2014, APPL RADIAT ISOTOPES, V86, P52, DOI 10.1016/j.apradiso.2013.12.036; Richter WS, 2011, EUR J NUCL MED MOL I, V38, P899, DOI 10.1007/s00259-011-1731-2; Singh T, 2012, J PHARM BIOALLIED SC, V4, P286, DOI 10.4103/0975-7406.103245; Stopar TG, 2006, EUR J NUCL MED MOL I, V33, P53, DOI 10.1007/s00259-005-1838-4	25	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139835	10.1371/journal.pone.0139835	http://dx.doi.org/10.1371/journal.pone.0139835			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439852	Green Published, gold			2022-12-27	WOS:000362510300065
J	Greenberg, RN; Hurley, Y; Dinh, DV; Mraz, S; Vera, JG; von Bredow, D; von Krempelhuber, A; Roesch, S; Virgin, G; Arndtz-Wiedemann, N; Meyer, TP; Schmidt, D; Nichols, R; Young, P; Chaplin, P				Greenberg, Richard N.; Hurley, Yadira; Dinh, Dinh V.; Mraz, Serena; Vera, Javier Gomez; von Bredow, Dorothea; von Krempelhuber, Alfred; Roesch, Siegfried; Virgin, Garth; Arndtz-Wiedemann, Nathaly; Meyer, Thomas Peter; Schmidt, Darja; Nichols, Richard; Young, Philip; Chaplin, Paul			A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis	PLOS ONE			English	Article							IMMUNE-RESPONSE; ANKARA; VIRUS; COMPLICATIONS; PROTECTION; CONTACT	Background Replicating smallpox vaccines can cause severe complications in individuals with atopic dermatitis (AD). Prior studies evaluating Modified Vaccinia Ankara virus (MVA), a non-replicating vaccine in humans, showed a favorable safety and immunogenicity profile in healthy volunteers. Objective This Phase II study compared the safety and immunogenicity of MVA enrolling groups of 350 subjects with AD (SCORAD <= 30) and 282 healthy subjects. Methods Subjects were vaccinated twice with MVA, each dose given subcutaneously 4 weeks apart. Adverse events, cardiac parameters, and the development of vaccinia virus humoral immune responses were monitored. Results The overall safety of the vaccine was similar in both groups. Adverse events affecting skin were experienced significantly more often in subjects with AD, but the majority of these events were mild to moderate in intensity. Seroconversion rates and geometric mean titers for total and neutralizing vaccinia-specific antibodies in the AD group were non-inferior compared to the healthy subjects. Limitations The size of the study population limited the detection of serious adverse events occurring at a frequency less than 1%. Conclusion MVA has a favorable safety profile and the ability to elicit vaccinia-specific immune responses in subjects with AD.	[Greenberg, Richard N.] Univ Kentucky, Sch Med, Lexington, KY 40536 USA; [Hurley, Yadira] St Louis Univ, Dept Dermatol, St Louis, MO 63103 USA; [Dinh, Dinh V.] Rx Clin Res Inc, Garden Grove, CA USA; [Mraz, Serena] Vallejo Dermatol Off, Vallejo, CA USA; [Vera, Javier Gomez] Hosp Reg Lic Adolfo Lopez Mateos, ISSSTE, Mexico City, DF, Mexico; [von Bredow, Dorothea; von Krempelhuber, Alfred; Roesch, Siegfried; Virgin, Garth; Arndtz-Wiedemann, Nathaly; Meyer, Thomas Peter; Schmidt, Darja; Nichols, Richard; Young, Philip; Chaplin, Paul] Bavarian Nord GmbH, Martinsried, Germany	University of Kentucky; Saint Louis University; Bavarian Nordic	Greenberg, RN (corresponding author), Univ Kentucky, Sch Med, Lexington, KY 40536 USA.	Rngree01@uky.edu	Young, Philip/ABI-1480-2020	Young, Philip/0000-0003-0201-9277; Nichols, Rick/0000-0002-2761-3400	Bavarian Nordic through NIAID contract [N01-AI-40072]; National Institute of Allergy and Infectious Diseases (NIAID); Bavarian Nordic; Rx Clinical Research, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI040072] Funding Source: NIH RePORTER	Bavarian Nordic through NIAID contract; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bavarian Nordic; Rx Clinical Research, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by Bavarian Nordic through NIAID contract #N01-AI-40072 (http://www.niaid.nih.gov/Pages/default.aspx), and The National Institute of Allergy and Infectious Diseases (NIAID). These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bavarian Nordic provided grants to Rx Clinical Research, Inc. Rx Clinical Research, Inc. provided support in the form of salary for author DVD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Bavarian Nordic provided support in the form of salaries for several authors (DB, AK, SR, GV, NA, TM, DS, RN, PY and PC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Artenstein AW, 2008, EXPERT REV VACCINES, V7, P1225, DOI 10.1586/14760584.7.8.1225; Bohme M, 2001, ACTA DERM-VENEREOL, V81, P193, DOI 10.1080/000155501750376294; COPEMAN PWM, 1964, BRIT MED J, V2, P906, DOI 10.1136/bmj.2.5414.906; Damon IK, 2009, J GEN VIROL; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; Elizaga ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054407; Engler RJM, 2002, J ALLERGY CLIN IMMUN, V110, P357, DOI 10.1067/mai.2002.128052; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; GOLDSTEIN JA, 1975, PEDIATRICS, V55, P342; Greenberg RN, 2013, J INFECT DIS, V207, P749, DOI 10.1093/infdis/jis753; Hanifin IM, 2007, DERMATITIS, V18, P82, DOI 10.2310/6620.2007.06034; Henderson DA, 1999, EMERG INFECT DIS, V5, P537, DOI 10.3201/eid0504.990415; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kim MJ, 2010, J KOREAN MED SCI, V25, P1828, DOI 10.3346/jkms.2010.25.12.1828; Kunz B, 1997, DERMATOLOGY, V195, P10, DOI 10.1159/000245677; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; MAYR A, 1974, INFECTION, V2, P64, DOI 10.1007/BF01642023; Moberg C, 2006, BRIT J DERMATOL, V155, P557, DOI 10.1111/j.1365-2133.2006.07372.x; Nalca A, 2010, DRUG DES DEV THER, V4, P71; Naleway AL, 2003, ANN INTERN MED, V139, P1, DOI 10.7326/0003-4819-139-1-200307010-00006; Neff JM, 2002, JAMA-J AM MED ASSOC, V288, P1901, DOI 10.1001/jama.288.15.1901; Overton E, 2015, IMMUNOGENICITY MODIF, P1; Roongsritong C, 2004, CHEST, V125, P1877, DOI 10.1378/chest.125.5.1877; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Scott JE, 2007, J ALLERGY CLIN IMMUN, V120, P1382, DOI 10.1016/j.jaci.2007.08.004; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; von Sonnenburg F, 2014, VACCINE, V32, P5696, DOI 10.1016/j.vaccine.2014.08.022; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; Waddington E, 1964, T ST JOHNS HOSP DERM, V50, P22	38	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138348	10.1371/journal.pone.0138348	http://dx.doi.org/10.1371/journal.pone.0138348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439129	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300002
J	Kim, H; Gong, JR; Lee, SA; Kim, BJ				Kim, Hong; Gong, Jeong-Ryeol; Lee, Seoung-Ae; Kim, Bum-Joon			Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA PATIENT; FULL GENOME SEQUENCES; GENOTYPE-C; MOLECULAR EPIDEMIOLOGY; GENDER DISPARITY; SURFACE PROTEIN; LIVER-DISEASES; HBV INFECTION; PROGRESSION; PREVALENCE	Universal infantile hepatitis B virus (HBV) vaccination may lead to an increase in vaccine escape variants, which may pose a threat to the long-term success of massive vaccination. To determine the prevalence of occult infections in Korean vaccinated individuals, 87 vaccinated subjects were screened for the presence of HBV DNA using both the nested PCR protocol and the VERSANT HBV DNA 3.0 assay. The mutation patterns of variants were analyzed in full-length HBV genome sequences. Their HBsAg secretion and replication capacities were investigated using both in vitro transient transfection and in vivo hydrodynamic injection. The presence of HBV DNA was confirmed in 6 subjects (6.9%). All six variants had a common mutation type (X8Del) composed of an 8-bp deletion in the C-terminal region of the HBV X gene (HBxAg). Our in vitro and in vivo analyses using the full-length HBV genome indicated that the X8Del HBxAg variant reduced the secretion of HBsAg and HBV virions compared to the wild type. In conclusion, our data suggest that a novel mutation (X8Del) may contribute to occult HBV infection in Korean vaccinated individuals via a reduced secretion of HBsAg and virions, possibly by compromising HBxAg's transacting capacity.	[Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Microbiol & Immunol,Liver Res Inst, Seoul, South Korea; Seoul Natl Univ, Coll Med, SNUMRC, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Microbiol & Immunol,Liver Res Inst, Seoul, South Korea.	kbumjoon@snu.ac.kr	Gong, Jeong-Ryeol/AAP-9956-2020; Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709; Kim, Hong/0000-0003-1383-6803	National Research Foundation of Korea (NRF) - Korea government (MEST) [2013-005810]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2013-005810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian T, 2013, J VIROL, V87, P12196, DOI 10.1128/JVI.02127-13; Bonino F, 1999, J HEPATOL, V31, P197, DOI 10.1016/S0168-8278(99)80401-2; Chun BY, 1992, KOREAN J EPIDEMIOL, V14, P54; Conjeevaram H, 2001, HEPATOLOGY, V34, P204, DOI 10.1053/jhep.2001.25225; de la Hoz F, 2008, INT J INFECT DIS, V12, P183, DOI 10.1016/j.ijid.2007.06.010; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Kao JH, 2002, J CLIN MICROBIOL, V40, P1207, DOI 10.1128/JCM.40.4.1207-1209.2002; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kim BJ, 2014, WORLD J GASTROENTERO, V20, P460, DOI 10.3748/wjg.v20.i2.460; Kim DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087773; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Kim H, 2007, INTERVIROLOGY, V50, P273, DOI 10.1159/000103915; Kim H, 2007, J MICROBIOL BIOTECHN, V17, P701; Kim H, 2007, J MED VIROL, V79, P212, DOI 10.1002/jmv.20789; Kim H, 2007, INTERVIROLOGY, V50, P52, DOI 10.1159/000096313; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054486; Kim HJ, 2008, J MED VIROL, V80, P1337, DOI 10.1002/jmv.21219; Kim S, 2008, ONCOGENE, V27, P3457, DOI 10.1038/sj.onc.1210998; Koike K, 1998, J MED VIROL, V54, P249, DOI 10.1002/(SICI)1096-9071(199804)54:4&lt;249::AID-JMV3&gt;3.0.CO;2-4; Lavanchy D, 2005, J CLIN VIROL, V34, pS1, DOI 10.1016/S1386-6532(05)00384-7; Lee SA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0303-7; Lee SA, 2013, J CLIN MICROBIOL, V51, P3928, DOI 10.1128/JCM.01505-13; Lee SA, 2012, J HEPATOL, V56, P63, DOI 10.1016/j.jhep.2011.06.028; Lee SA, 2011, J MED VIROL, V83, P405, DOI 10.1002/jmv.21988; Lee SA, 2011, J MED VIROL, V83, P65, DOI 10.1002/jmv.21938; Mun HS, 2008, J MED VIROL, V80, P1189, DOI 10.1002/jmv.21208; Mun HS, 2011, J VIROL, V85, P123, DOI 10.1128/JVI.01524-10; Murakami S, 2001, J GASTROENTEROL, V36, P651, DOI 10.1007/s005350170027; Murakami S, 1999, SEIKAGAKU, V71, P1309; Ono-Nita SK, 1999, J CLIN INVEST, V103, P1635, DOI 10.1172/JCI5882; OON CJ, 1995, VACCINE, V13, P699, DOI 10.1016/0264-410X(94)00080-7; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; Park SG, 2003, J BIOL CHEM, V278, P39851, DOI 10.1074/jbc.M301618200; Prevention KCfDCa, 2012, KOR NAT HLTH NUTR EX, P464; Raimondo G, 2000, DIGEST LIVER DIS, V32, P822, DOI 10.1016/S1590-8658(00)80362-X; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Sirma H, 1999, ONCOGENE, V18, P4848, DOI 10.1038/sj.onc.1202867; Song BC, 2005, J MED VIROL, V76, P194, DOI 10.1002/jmv.20354; Song BC, 2005, J MED VIROL, V75, P13, DOI 10.1002/jmv.20230; Tang Shi-Gang, 2005, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V30, P525; Tu H, 2001, CANCER RES, V61, P7803; Wei Y, 1996, J VIROL, V70, P6455, DOI 10.1128/JVI.70.9.6455-6458.1996; WONG VCW, 1984, LANCET, V1, P921	43	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139551	10.1371/journal.pone.0139551	http://dx.doi.org/10.1371/journal.pone.0139551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437447	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200034
J	Mei, ZD; Chen, SM; Chen, C; Xiao, BK; Li, F; Wang, YP; Tao, ZZ				Mei, Zhidan; Chen, Shiming; Chen, Chen; Xiao, Bokui; Li, Fen; Wang, Yongping; Tao, Zezhang			Interleukin-23 Facilitates Thyroid Cancer Cell Migration and Invasion by Inhibiting SOCS4 Expression via MicroRNA-25	PLOS ONE			English	Article							GASTRIC-CANCER; LUNG-CANCER; INCREASING INCIDENCE; COLORECTAL-CANCER; UNITED-STATES; GROWTH; CARCINOMA; HYPERMETHYLATION; PROLIFERATION; CYTOKINE	Interleukin-23 (IL-23) is a conventional proinflammatory cytokine that plays a role in tumor progression by inducing inflammation in the tumor microenvironment. However, the role of IL-23 in thyroid cancer migration and invasion remains unclear. In the present study, we observed that the treatment with IL-23, induced migration and invasion in human thyroid cancer cells. Additional data demonstrate that SOCS4 negatively regulates IL-23-mediated migration and invasion. On investigating the mechanisms involved in IL-23 mediated migration and invasion, we observed that miR-25 promotes the migration and invasion of thyroid cancer cells by directly binding to the 3'-UTR of SOCS4 that leads to the inhibition of SOCS4. In addition, we also demonstrated that IL-23 increases miR-25 expression levels, and overexpressed miR-25 is involved in IL-23-associated SOCS4 inhibition and cell migration and invasion. Together, our data suggest that IL-23 induces migration and invasion in thyroid cancer cells by mediating the miR-25/SOCS4 signaling pathway.	[Mei, Zhidan; Chen, Shiming; Wang, Yongping; Tao, Zezhang] Wuhan Univ, Dept Otolaryngol Head & Neck Surg, Remin Hosp, Wuhan 430060, Hubei Province, Peoples R China; [Chen, Chen; Xiao, Bokui; Li, Fen; Tao, Zezhang] Wuhan Univ, Res Inst Otolaryngol Head & Neck Surg, Renmin Hosp, Wuhan 430060, Hubei Province, Peoples R China	Wuhan University; Wuhan University	Tao, ZZ (corresponding author), Wuhan Univ, Dept Otolaryngol Head & Neck Surg, Remin Hosp, Wuhan 430060, Hubei Province, Peoples R China.	taozezhang@hotmail.com			National Natural Science Foundation of China [81372880]; Independent research project of Wuhan University [2042014kf0184, 2042014kf0119]; doctoral program of Higher Education Research Fund [20130141120093, 20110141110062]; Natural Science Foundation of Hubei province [2012FFA045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent research project of Wuhan University; doctoral program of Higher Education Research Fund; Natural Science Foundation of Hubei province(Natural Science Foundation of Hubei Province)	This work was supported by the grants from the National Natural Science Foundation of China (No.81372880); the Independent research project of Wuhan University (No. 2042014kf0184; NO. 2042014kf0119); the doctoral program of Higher Education Research Fund (No. 20130141120093; No. 20110141110062); the Natural Science Foundation of Hubei province (No.2012FFA045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen AY, 2009, CANCER-AM CANCER SOC, V115, P3801, DOI 10.1002/cncr.24416; Chen DY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08604; Chen DY, 2012, HUM IMMUNOL, V73, P1068, DOI 10.1016/j.humimm.2012.07.333; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Feng SJ, 2014, TUMOR BIOL, V35, P12339, DOI 10.1007/s13277-014-2546-0; Fujitake S, 2004, J GASTROENTEROL, V39, P120, DOI 10.1007/s00535-003-1262-0; He B, 2003, P NATL ACAD SCI USA, V100, P14133, DOI 10.1073/pnas.2232790100; Hilton DJ, 1999, CELL MOL LIFE SCI, V55, P1568, DOI 10.1007/s000180050396; Klein A, 2015, J PATHOL; Kobayashi D, 2012, WORLD J SURG, V36, P362, DOI 10.1007/s00268-011-1358-2; Lai RH, 2010, CANCER LETT, V288, P75, DOI 10.1016/j.canlet.2009.06.025; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046264; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Li J, 2013, CARCINOGENESIS, V34, P658, DOI 10.1093/carcin/bgs384; Li Q, 2013, CANCER LETT, V335, P168, DOI 10.1016/j.canlet.2013.02.029; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Ram PA, 1999, J BIOL CHEM, V274, P35553, DOI 10.1074/jbc.274.50.35553; Sasi W, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-178; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Storojeva I, 2005, ONCOLOGY-BASEL, V68, P246, DOI 10.1159/000086781; Sutherland KD, 2004, ONCOGENE, V23, P7726, DOI 10.1038/sj.onc.1207787; Suzuki H, 2012, ONCOL LETT, V4, P199, DOI 10.3892/ol.2012.739; To KF, 2004, BRIT J CANCER, V91, P1335, DOI 10.1038/sj.bjc.6602133; Weber A, 2005, ONCOGENE, V24, P6699, DOI 10.1038/sj.onc.1208818; Xiong T, 2013, J BIOMED NANOTECHNOL, V9, P274, DOI 10.1166/jbn.2013.1485; Yang T, 2015, TUMOR BIOL, V36, P1903, DOI 10.1007/s13277-014-2793-0; Yu H, 2007, NAT REV IMMUNOL, V7, P41, DOI 10.1038/nri1995; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhao HY, 2014, MOL CELL BIOCHEM, V385, P207, DOI 10.1007/s11010-013-1829-x	33	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139456	10.1371/journal.pone.0139456	http://dx.doi.org/10.1371/journal.pone.0139456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437444	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200024
J	Page, CM; Baranzini, SE; Mevik, BH; Bos, SD; Harbo, HF; Andreassen, BK				Page, Christian Magnus; Baranzini, Sergio E.; Mevik, Bjorn-Helge; Bos, Steffan Daniel; Harbo, Hanne F.; Andreassen, Bettina Kulle			Assessing the Power of Exome Chips	PLOS ONE			English	Article							LOW-FREQUENCY; RARE-VARIANT; ASSOCIATION; LOCI; DISEASE; DESIGNS; AGE	Genotyping chips for rare and low-frequent variants have recently gained popularity with the introduction of exome chips, but the utility of these chips remains unclear. These chips were designed using exome sequencing data from mainly American-European individuals, enriched for a narrow set of common diseases. In addition, it is well-known that the statistical power of detecting associations with rare and low-frequent variants is much lower compared to studies exclusively involving common variants. We developed a simulation program adaptable to any exome chip design to empirically evaluate the power of the exome chips. We implemented the main properties of the Illumina HumanExome BeadChip array. The simulated data sets were used to assess the power of exome chip based studies for varying effect sizes and causal variant scenarios. We applied two widely-used statistical approaches for rare and low-frequency variants, which collapse the variants into genetic regions or genes. Under optimal conditions, we found that a sample size between 20,000 to 30,000 individuals were needed in order to detect modest effect sizes (0.5% < PAR > 1%) with 80% power. For small effect sizes (PAR <0.5%), 60,000-100,000 individuals were needed in the presence of non-causal variants. In conclusion, we found that at least tens of thousands of individuals are necessary to detect modest effects under optimal conditions. In addition, when using rare variant chips on cohorts or diseases they were not originally designed for, the identification of associated variants or genes will be even more challenging.	[Page, Christian Magnus; Bos, Steffan Daniel; Harbo, Hanne F.; Andreassen, Bettina Kulle] Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway; [Page, Christian Magnus; Bos, Steffan Daniel; Harbo, Hanne F.] Oslo Univ Hosp, Dept Neurol, N-0424 Oslo, Norway; [Baranzini, Sergio E.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Mevik, Bjorn-Helge] Univ Oslo, Univ Ctr Informat Technol, N-0316 Oslo, Norway; [Andreassen, Bettina Kulle] Canc Registry Norway, Dept Res, N-0304 Oslo, Norway	University of Oslo; University of Oslo; University of California System; University of California San Francisco; University of Oslo; University of Oslo	Andreassen, BK (corresponding author), Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway.	b.k.andreassen@kreftregisteret.no	Page, Christian/J-7129-2019	Page, Christian/0000-0002-1897-3666; Baranzini, Sergio/0000-0003-0067-194X	University of Oslo [531217/1231]; Norwegian Research Council (NOTUR) [NN9311K/1734]	University of Oslo; Norwegian Research Council (NOTUR)	The study was funded by the University of Oslo (www.uio.no), grant number 531217/1231 (CMP); and Norwegian Research Council (NOTUR), grant number NN9311K/1734 (CMP, BKA, BHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bates D., 2014, MATRIX SPARSE DENSE; Chen JA, 2015, JAMA NEUROLOGY; Chung S. J., 2014, NEUROBIOL AGING, V35, P1958, DOI DOI 10.1016/J; Clayton D, 2013, SNPMATRIX XSNPMATRIX; Coin L, 2014, MULTIPHEN MULTIPPHEN; Exome Chip Consortia, EX CHIP DES; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Gudmundsson J, 2012, NAT GENET, V44, P1326, DOI 10.1038/ng.2437; Hallengren E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128348; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Holmen OL, 2014, HUM MOL GENET, V23, P4721, DOI 10.1093/hmg/ddu175; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Igartua C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6965; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Larson NB, 2014, GENET EPIDEMIOL, V38, P104, DOI 10.1002/gepi.21783; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lettre G, 2014, J MED GENETICS; Lim ET, 2014, AM J HUM GENET, V95, P509, DOI 10.1016/j.ajhg.2014.09.015; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094337; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Lunetta KL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8756; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matern B., 1960, SPATIAL VARIATION, V2nd; Mauer AC, 2015, J AM COLL CARDIOLOGY, V65; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moutsianas L, 2014, BRIEF FUNCT GENOMICS, V13, P362, DOI 10.1093/bfgp/elu012; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Peloso GM, 2014, AM J HUM GENET, V94, P223, DOI 10.1016/j.ajhg.2014.01.009; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; R Core Team, 2013, R LANG ENV STAT COMP; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Tachmazidou I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3872; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vrieze SI, 2014, PSYCHOPHYSIOLOGY, V51, P1300, DOI 10.1111/psyp.12349; Vrieze SI, 2014, BIOL PSYCHIAT, V75, P783, DOI 10.1016/j.biopsych.2013.08.027; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zuo XB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7793	48	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139642	10.1371/journal.pone.0139642	http://dx.doi.org/10.1371/journal.pone.0139642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437075	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200040
J	Pauli, A; Montague, TG; Lennox, KA; Behlke, MA; Schier, AF				Pauli, Andrea; Montague, Tessa G.; Lennox, Kim A.; Behlke, Mark A.; Schier, Alexander F.			Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish	PLOS ONE			English	Article							ONE-EYED-PINHEAD; DORSOVENTRAL PATTERN-FORMATION; GENE-EXPRESSION; VASCULAR INTEGRITY; CELL FATE; NO TAIL; RNA; EMBRYO; RECEPTOR; TECHNOLOGIES	Antisense oligonucleotides (ASOs) are synthetic, single-strand RNA-DNA hybrids that induce catalytic degradation of complementary cellular RNAs via RNase H. ASOs are widely used as gene knockdown reagents in tissue culture and in Xenopus and mouse model systems. To test their effectiveness in zebrafish, we targeted 20 developmental genes and compared the morphological changes with mutant and morpholino (MO)induced phenotypes. ASO-mediated transcript knockdown reproduced the published loss-of-function phenotypes for oep, chordin, dnd, ctnnb2, bmp7a, alk8, smad2 and smad5 in a dosage-sensitive manner. ASOs knocked down both maternal and zygotic transcripts, as well as the long noncoding RNA (lncRNA) MALAT1. ASOs were only effective within a narrow concentration range and were toxic at higher concentrations. Despite this drawback, quantitation of knockdown efficiency and the ability to degrade lncRNAs make ASOs a useful knockdown reagent in zebrafish.	[Pauli, Andrea; Montague, Tessa G.; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lennox, Kim A.; Behlke, Mark A.] Integrated DNA Technol Inc, Coralville, IA USA	Harvard University	Pauli, A (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	andreapauli77@gmail.com; schier@fas.harvard.edu		Montague, Tessa/0000-0002-5918-6327; Schier, Alexander Franz/0000-0001-7645-5325; Behlke, Mark/0000-0002-4218-857X	HFSP postdoctoral fellowship [LT000307/2010-L]; NDSEG graduate student fellowship; Integrated DNA Technologies, Inc. (IDT); National Institutes of Health [K99 HD076935, R01 HD076708]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076708, K99HD076935] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007598, R01GM056211] Funding Source: NIH RePORTER	HFSP postdoctoral fellowship; NDSEG graduate student fellowship; Integrated DNA Technologies, Inc. (IDT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a HFSP postdoctoral fellowship (LT000307/2010-L (AP)), by an NDSEG graduate student fellowship (TGM), by Integrated DNA Technologies, Inc. (IDT) (KAL, MAB), and by the National Institutes of Health (K99 HD076935 (AP); R01 HD076708 (AFS)). Integrated DNA Technologies, Inc. (IDT) provided support in the form of salaries for authors (MAB, KAL), scientific input, designed and provided the ASOs and were involved in the preparation of this manuscript but did not have any additional role in the data collection and analysis, or decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Bauer H, 2001, DEVELOPMENT, V128, P849; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Ciruna B, 2002, P NATL ACAD SCI USA, V99, P14919, DOI 10.1073/pnas.222459999; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Connors SA, 1999, DEVELOPMENT, V126, P3119; Dick A, 2000, DEVELOPMENT, V127, P343; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Dubrulle J, 2015, ELIFE, V4, DOI 10.7554/eLife.05042; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fisher S, 1999, NAT GENET, V23, P442, DOI 10.1038/70557; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; Hammerschmidt M, 1996, DEVELOPMENT, V123, P95; HEASMAN J, 1994, DEVELOPMENT, V120, P49; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hild M, 1999, DEVELOPMENT, V126, P2149; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Kelly A, 2011, BRIEF FUNCT GENOMICS, V10, P189, DOI 10.1093/bfgp/elr014; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Levin AA, 1999, BBA-GENE STRUCT EXPR, V1489, P69, DOI 10.1016/S0167-4781(99)00140-2; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lorenz P, 2000, NUCLEIC ACIDS RES, V28, P582, DOI 10.1093/nar/28.2.582; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MartinezBarbera JP, 1997, GENE, V198, P53, DOI 10.1016/S0378-1119(97)00292-8; MENG L, 2014, NATURE, V518, P409, DOI DOI 10.1038/NATURE13975; Mintzer KA, 2001, DEVELOPMENT, V128, P859; Mir Adnan, 2008, V469, P417, DOI 10.1007/978-1-60327-469-2_26; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Nguyen VH, 1998, DEV BIOL, V199, P93, DOI 10.1006/dbio.1998.8927; Pan WH, 2006, CURR MED CHEM, V13, P3083, DOI 10.2174/092986706778521788; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Peek AS, 2007, CURR OPIN MOL THER, V9, P110; Prakash TP, 2011, CHEM BIODIVERS, V8, P1616, DOI 10.1002/cbdv.201100081; Prasanth KV, 2005, CELL, V123, P249, DOI 10.1016/j.cell.2005.08.033; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmid B, 2000, EQUIVALENT GENETIC R; Schulte-Merker S, 2014, DEVELOPMENT, V141, P3103, DOI 10.1242/dev.112003; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Summerton J, 1999, BBA-GENE STRUCT EXPR, V1489, P141, DOI 10.1016/S0167-4781(99)00150-5; TORPEY N, 1992, NATURE, V357, P413, DOI 10.1038/357413a0; van Impel A, 2014, DEVELOPMENT, V141, P1228, DOI 10.1242/dev.105031; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Watanabe M, 2006, EMBO REP, V7, P893, DOI 10.1038/sj.embor.7400757; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang J, 1998, CELL, V94, P515, DOI 10.1016/S0092-8674(00)81592-5; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	69	19	19	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139504	10.1371/journal.pone.0139504	http://dx.doi.org/10.1371/journal.pone.0139504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436892	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200030
J	Galvin, JJ; Oba, SI; Baskent, D; Chatterjee, M; Fu, QJ				Galvin, John J., III; Oba, Sandra I.; Baskent, Deniz; Chatterjee, Monita; Fu, Qian-Jie			Envelope Interactions in Multi-Channel Amplitude Modulation Frequency Discrimination by Cochlear Implant Users	PLOS ONE			English	Article							MASKED EXCITATION PATTERNS; CARRIER PULSE-RATE; INTENSITY DISCRIMINATION; ELECTRICAL-STIMULATION; SPEECH RECOGNITION; LOUDNESS; LEVEL; LISTENERS; PITCH; MODE	Rationale Previous cochlear implant (CI) studies have shown that single-channel amplitude modulation frequency discrimination (AMFD) can be improved when coherent modulation is delivered to additional channels. It is unclear whether the multi-channel advantage is due to increased loudness, multiple envelope representations, or to component channels with better temporal processing. Measuring envelope interference may shed light on how modulated channels can be combined. Methods In this study, multi-channel AMFD was measured in CI subjects using a 3-alternative forced-choice, non-adaptive procedure ("which interval is different?"). For the reference stimulus, the reference AM (100 Hz) was delivered to all 3 channels. For the probe stimulus, the target AM (101, 102, 104, 108, 116, 132, 164, 228, or 256 Hz) was delivered to 1 of 3 channels, and the reference AM (100 Hz) delivered to the other 2 channels. The spacing between electrodes was varied to be wide or narrow to test different degrees of channel interaction. Results Results showed that CI subjects were highly sensitive to interactions between the reference and target envelopes. However, performance was non-monotonic as a function of target AM frequency. For the wide spacing, there was significantly less envelope interaction when the target AM was delivered to the basal channel. For the narrow spacing, there was no effect of target AM channel. The present data were also compared to a related previous study in which the target AM was delivered to a single channel or to all 3 channels. AMFD was much better with multiple than with single channels whether the target AM was delivered to 1 of 3 or to all 3 channels. For very small differences between the reference and target AM frequencies (2-4 Hz), there was often greater sensitivity when the target AM was delivered to 1 of 3 channels versus all 3 channels, especially for narrowly spaced electrodes. Conclusions Besides the increased loudness, the present results also suggest that multiple envelope representations may contribute to the multi-channel advantage observed in previous AMFD studies. The different patterns of results for the wide and narrow spacing suggest a peripheral contribution to multi-channel temporal processing. Because the effect of target AM frequency was non-monotonic in this study, adaptive procedures may not be suitable to measure AMFD thresholds with interfering envelopes. Envelope interactions among multiple channels may be quite complex, depending on the envelope information presented to each channel and the relative independence of the stimulated channels.	[Galvin, John J., III; Oba, Sandra I.; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA; [Galvin, John J., III; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Groningen, Netherlands; [Galvin, John J., III; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands; [Chatterjee, Monita] Boys Town Natl Res Hosp, Auditory Prostheses & Percept Lab, Omaha, NE 68131 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Groningen; University of Groningen; Boys Town National Research Hospital	Galvin, JJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA.	Jgalvin@ucla.edu		Baskent, Deniz/0000-0002-6560-1451; Chatterjee, Monita/0000-0002-8286-2557	National Institutes of Health (NIH) [DC004993]; NIH [R01 DC014233]; VIDI grant from the Netherlands Organization for Scientific Research (NWO) [016.096.397]; VIDI grant from the Netherlands Organization for Health Research and Development (ZonMw); Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014233, R01DC004993] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VIDI grant from the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VIDI grant from the Netherlands Organization for Health Research and Development (ZonMw); Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	John Galvin, Sandy Oba, and Qian-Jie Fu were supported by National Institutes of Health (NIH) grant DC004993. Monita Chatterjee was supported by NIH grant R01 DC014233. Deniz Baskent was supported by VIDI grant 016.096.397 from the Netherlands Organization for Scientific Research (NWO) and the Netherlands Organization for Health Research and Development (ZonMw), and a Rosalind Franklin Fellowship from University of Groningen, University Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann U, 2004, HEARING RES, V196, P49, DOI 10.1016/j.heares.2004.06.008; Carlyon RP, 2010, J ACOUST SOC AM, V127, P2997, DOI 10.1121/1.3372711; CAZALS Y, 1994, J ACOUST SOC AM, V96, P2048, DOI 10.1121/1.410146; Chatterjee M, 2006, JARO-J ASSOC RES OTO, V7, P15, DOI 10.1007/s10162-005-0019-2; Chatterjee M, 2005, J ACOUST SOC AM, V118, P993, DOI 10.1121/1.1929258; Chatterjee M, 1998, J ACOUST SOC AM, V103, P2565, DOI 10.1121/1.422777; Chatterjee M, 2004, JARO-J ASSOC RES OTO, V5, P360, DOI 10.1007/s10162-004-4050-5; Chatterjee M, 2003, J ACOUST SOC AM, V113, P2042, DOI 10.1121/1.1555613; Chatterjee M, 2001, JARO-J ASSOC RES OTO, V2, P159, DOI 10.1007/s101620010079; Chatterjee M, 2009, C AUD IMPL PROSTH, P218; Chatterjee M, 2015, 2015 MIDW M ASS RES, P152; Chatterjee M, 2008, HEARING RES, V235, P143, DOI 10.1016/j.heares.2007.11.004; Chatterjee M, 2011, J ACOUST SOC AM, V130, P1567, DOI 10.1121/1.3621445; Chatterjee M, 2010, J ACOUST SOC AM, V127, P415, DOI 10.1121/1.3257591; Deroche MLD, 2012, J ACOUST SOC AM, V131, P2938, DOI 10.1121/1.3692230; Deroche ML, 2014, FRONT NEUROSCI; Donaldson GS, 2000, J ACOUST SOC AM, V108, P760, DOI 10.1121/1.429609; Drennan WR, 2006, JARO-J ASSOC RES OTO, V7, P308, DOI 10.1007/s10162-006-0045-8; Fraser M, 2012, HEARING RES, V283, P59, DOI 10.1016/j.heares.2011.11.009; Fu QJ, 2002, NEUROREPORT, V13, P1635, DOI 10.1097/00001756-200209160-00013; Galvin JJ, 2005, JARO-J ASSOC RES OTO, V6, P269, DOI 10.1007/s10162-005-0007-6; Galvin JJ, 2014, PLOS ONE, V96; Galvin JJ, 2015, HEARING RES, V324, P7, DOI 10.1016/j.heares.2015.02.007; Galvin JJ, 2014, J NEUROSCI METH, V222, P207, DOI 10.1016/j.jneumeth.2013.10.016; Galvin JJ, 2009, HEARING RES, V250, P46, DOI 10.1016/j.heares.2009.01.009; Geurts L, 2001, J ACOUST SOC AM, V109, P713, DOI 10.1121/1.1340650; Green T, 2012, EAR HEARING, V33, P233, DOI 10.1097/AUD.0b013e318230fff8; JESTEADT W, 1980, PERCEPT PSYCHOPHYS, V28, P85, DOI 10.3758/BF03204321; Kreft HA, 2013, JARO-J ASSOC RES OTO, V14, P591, DOI 10.1007/s10162-013-0391-2; Kreft HA, 2010, J ACOUST SOC AM, V127, P656, DOI 10.1121/1.3282947; Luo X, 2008, EAR HEARING, V29, P957, DOI 10.1097/AUD.0b013e3181888f61; Macherey O, 2011, JARO-J ASSOC RES OTO, V12, P233, DOI 10.1007/s10162-010-0248-x; McKay CM, 2003, J ACOUST SOC AM, V113, P2054, DOI 10.1121/1.1558378; McKay CM, 2001, J ACOUST SOC AM, V110, P1514, DOI 10.1121/1.1394222; McKay CM, 2010, JARO-J ASSOC RES OTO, V11, P101, DOI 10.1007/s10162-009-0188-5; Middlebrooks JC, 2004, J ACOUST SOC AM, V116, P452, DOI 10.1121/1.1760795; Middlebrooks JC, 2010, J NEUROSCI, V30, P1937, DOI 10.1523/JNEUROSCI.4949-09.2010; Pfingst BE, 2007, J ACOUST SOC AM, V121, P2236, DOI 10.1121/1.2537501; Vandali A, 2013, HEARING RES, V302, P32, DOI 10.1016/j.heares.2013.05.004; Wygonski J, 2002, HOUSE EAR I NUCL RES; ZENG FG, 1991, Q J EXP PSYCHOL-A, V43, P565, DOI 10.1080/14640749108400987	41	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139546	10.1371/journal.pone.0139546	http://dx.doi.org/10.1371/journal.pone.0139546			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431043	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700075
J	Li, SL; Quarto, N; Senarath-Yapa, K; Grey, N; Bai, X; Longaker, MT				Li, Shuli; Quarto, Natalina; Senarath-Yapa, Kshemendra; Grey, Nathaniel; Bai, Xue; Longaker, Michael T.			Enhanced Activation of Canonical Wnt Signaling Confers Mesoderm-Derived Parietal Bone with Similar Osteogenic and Skeletal Healing Capacity to Neural Crest-Derived Frontal Bone	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; OSTEOBLAST; APOPTOSIS; FGF-2; AXIN; REGENERATION; EXPRESSION; PROTEINS; ORIGIN	Bone formation and skeletal repair are dynamic processes involving a fine-tuned balance between osteoblast proliferation and differentiation orchestrated by multiple signaling pathways. Canonical Wnt (cWnt) signaling is known to playing a key role in these processes. In the current study, using a transgenic mouse model with targeted disruption of axin2, a negative regulator of cWnt signaling, we investigated the impact of enhanced activation of cWnt signaling on the osteogenic capacity and skeletal repair. Specifically, we looked at two calvarial bones of different embryonic tissue origin: the neural crest-derived frontal bone and the mesoderm-derived parietal bone, and we investigated the proliferation and apoptotic activity of frontal and parietal bones and derived osteoblasts. We found dramatic differences in cell proliferation and apoptotic activity between Axin2(-/-) and wild type calvarial bones, with Axin2(-/-) showing increased proliferative activity and reduced levels of apoptosis. Furthermore, we compared osteoblast differentiation and bone regeneration in Axin2(-/-) and wild type neural crest-derived frontal and mesoderm-derived parietal bones, respectively. Our results demonstrate a significant increase either in osteoblast differentiation or bone regeneration in Axin(2-/-) mice as compared to wild type, with Axin2(-/-) parietal bone and derived osteoblasts displaying a "neural crest-derived frontal bone-like" profile, which is typically characterized by higher osteogenic capacity and skeletal repair than parietal bone. Taken together, our results strongly suggest that enhanced activation of cWnt signaling increases the skeletal potential of a calvarial bone of mesoderm origin, such as the parietial bone to a degree similar to that of a neural crest origin bone, like the frontal bone. Thus, providing further evidence for the central role played by the cWnt signaling in osteogenesis and skeletal-bone regeneration.	[Li, Shuli; Quarto, Natalina; Senarath-Yapa, Kshemendra; Grey, Nathaniel; Bai, Xue; Longaker, Michael T.] Stanford Univ, Dept Surg, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA; [Quarto, Natalina] Univ Naples Federico II, Dipartimento Sci Biomed Avanzate, Naples, Italy	Stanford University; University of Naples Federico II	Quarto, N (corresponding author), Stanford Univ, Dept Surg, Sch Med, Hagey Lab Pediat Regenerat Med, Stanford, CA 94305 USA.	quarto@unina.it; longaker@stanford.edu			Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health NIH [R01 DE021683-01, R01 DE19434, U01HL099776]; John and Cynthia Gunn; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021683, R01DE019434] Funding Source: NIH RePORTER	Oak Foundation; Hagey Laboratory for Pediatric Regenerative Medicine; National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John and Cynthia Gunn; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the Oak Foundation, John and Cynthia Gunn, the Hagey Laboratory for Pediatric Regenerative Medicine, and the National Institutes of Health NIH grants R01 DE021683-01, R01 DE19434, U01HL099776 to M.T.L.	Almeida M, 2005, J BIOL CHEM, V280, P41342, DOI 10.1074/jbc.M502168200; Behr B, 2011, STEM CELLS, V29, P286, DOI 10.1002/stem.581; Behr B, 2010, BONE, V47, P281, DOI 10.1016/j.bone.2010.05.008; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bodine PVN, 2008, CELL RES, V18, P248, DOI 10.1038/cr.2008.13; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; Bodine PVN, 2005, J CELL BIOCHEM, V96, P1212, DOI 10.1002/jcb.20599; Canalis E, 2005, J Endocrinol Invest, V28, P3; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; dePollak C, 1997, J CELL BIOCHEM, V64, P128, DOI 10.1002/(SICI)1097-4644(199701)64:1<128::AID-JCB15>3.0.CO;2-H; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Herberg S, 2014, TISSUE ENG PT A, V20, P1444, DOI [10.1089/ten.TEA.2013.0442, 10.1089/ten.tea.2013.0442]; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Kondel J, 1985, Cesk Farm, V34, P401; Li SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058610; Li SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014033; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Macsai CE, 2008, J CELL PHYSIOL, V215, P578, DOI 10.1002/jcp.21342; Marie PJ, 2002, HISTOL HISTOPATHOL, V17, P877, DOI 10.14670/HH-17.877; Quarto N, 2005, GENE, V356, P49, DOI 10.1016/j.gene.2005.05.014; Quarto N, 2009, J BONE MINER RES; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Quarto N, 2010, J BONE MINER RES, V25, P1680, DOI 10.1359/jbmr.091116; Rodriguez-Carballo E, 2011, J BONE MINER RES, V26, P718, DOI 10.1002/jbmr.260; Senarath-Yapa K, 2013, INT J MOL SCI, V14, P5978, DOI 10.3390/ijms14035978; Wan DC, 2006, DENT CLIN N AM, V50, pvii, DOI [10.1016/j.cden.2005.11.003, DOI 10.1016/J.CDEN.2005.11.003]; Wan DC, 2008, J CRANIOFAC SURG, V19, P1292, DOI 10.1097/SCS.0b013e3181843609; Wan Derrick C, 2006, Dent Clin North Am, V50, P175, DOI 10.1016/j.cden.2005.11.003; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	34	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138059	10.1371/journal.pone.0138059	http://dx.doi.org/10.1371/journal.pone.0138059			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431534	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700009
J	Ochiai, A; Miyata, S; Shimizu, M; Inoue, J; Sato, R				Ochiai, Ayasa; Miyata, Shingo; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro			Piperine Induces Hepatic Low-Density Lipoprotein Receptor Expression through Proteolytic Activation of Sterol Regulatory Element-Binding Proteins	PLOS ONE			English	Article							HIGH-FAT DIET; LDL RECEPTOR; GENE-EXPRESSION; MESSENGER-RNA; BLACK PEPPER; TARGET GENES; CELLS; MICE; CHOLESTEROL; RATS	Elevated plasma low-density lipoprotein (LDL) cholesterol is considered as a risk factor for atherosclerosis. Because the hepatic LDL receptor (LDLR) uptakes plasma lipoproteins and lowers plasma LDL cholesterol, the activation of LDLR is a promising drug target for atherosclerosis. In the present study, we identified the naturally occurring alkaloid piperine, as an inducer of LDLR gene expression by screening the effectors of human LDLR promoter. The treatment of HepG2 cells with piperine increased LDLR expression at mRNA and protein levels and stimulated LDL uptake. Subsequent luciferase reporter gene assays revealed that the mutation of sterol regulatory element-binding protein (SREBP)-binding element abolished the piperine-mediated induction of LDLR promoter activity. Further, piperine treatments increased mRNA levels of several SREBP targets and mature forms of SREBPs. However, the piperine-mediated induction of the mature forms of SREBPs was not observed in SRD-15 cells, which lack insulin-induced gene-1 (Insig-1) and Insig-2. Finally, the knockdown of SREBPs completely abolished the piperine-meditated induction of LDLR gene expression in HepG2 cells, indicating that piperine stimulates the proteolytic activation of SREBP and subsequent induction of LDLR expression and activity.	[Ochiai, Ayasa; Miyata, Shingo; Shimizu, Makoto; Inoue, Jun; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	University of Tokyo	Inoue, J (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	ajinoue@mail.ecc.u-tokyo.ac.jp; aryosato@mail.ecc.u-tokyo.ac.jp	INOUE, Jun/O-7352-2016	INOUE, Jun/0000-0003-4145-3754	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Council for Science, Technology and Innovation (CSTI); Ministry of Agriculture, Forestry and Fisheries (Development of Fundamental Technology for analysis and evaluation of functional agricultural products and functional foods); Cross-ministerial Strategic Innovation Promotion Program [14533567]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Council for Science, Technology and Innovation (CSTI); Ministry of Agriculture, Forestry and Fisheries (Development of Fundamental Technology for analysis and evaluation of functional agricultural products and functional foods); Cross-ministerial Strategic Innovation Promotion Program	This work was supported by research grants from Ministry of Education, Culture, Sports, Science, and Technology of Japan, Japanese Council for Science, Technology and Innovation (CSTI), Ministry of Agriculture, Forestry and Fisheries (Development of Fundamental Technology for analysis and evaluation of functional agricultural products and functional foods), and Cross-ministerial Strategic Innovation Promotion Program (SIP Project ID 14533567). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amemiya-Kudo M, 2002, J LIPID RES, V43, P1220, DOI 10.1194/jlr.M100417-JLR200; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Bao LD, 2012, PHARM BIOL, V50, P962, DOI 10.3109/13880209.2012.654395; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Choi S, 2013, FOOD CHEM, V141, P3627, DOI 10.1016/j.foodchem.2013.06.028; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Greenshields AL, 2015, CANCER LETT, V357, P129, DOI 10.1016/j.canlet.2014.11.017; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Inoue Jun, 2013, Biomol Concepts, V4, P417, DOI 10.1515/bmc-2013-0009; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Jwa H, 2012, BIOCHEM PHARMACOL, V84, P1501, DOI 10.1016/j.bcp.2012.09.009; KEYS A, 1971, ARCH INTERN MED, V128, P201, DOI [10.1001/archinte.128.2.201, 10.1001/archinte.1971.00310200037002]; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Meghwal M, 2013, PHYTOTHER RES, V27, P1121, DOI 10.1002/ptr.4972; Nakahara M, 2002, J BIOL CHEM, V277, P37229, DOI 10.1074/jbc.M206749200; Okumura Y, 2010, BIOSCI BIOTECH BIOCH, V74, P1545, DOI 10.1271/bbb.100117; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Ren RB, 2015, SCIENCE, V349, P187, DOI 10.1126/science.aab1091; Sato R, 1996, J BIOL CHEM, V271, P26461, DOI 10.1074/jbc.271.43.26461; Shah SS, 2011, INDIAN J PHARMACOL, V43, P296, DOI 10.4103/0253-7613.81516; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; SPADY DK, 1992, SEMIN LIVER DIS, V12, P373, DOI 10.1055/s-2008-1040407; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Suresh D, 2010, INDIAN J MED RES, V131, P682; Tai MH, 2014, MOL NUTR FOOD RES, V58, P2133, DOI 10.1002/mnfr.201400366; Urban D, 2013, J AM COLL CARDIOL, V62, P1401, DOI 10.1016/j.jacc.2013.07.056; Wattanathorn J, 2008, FOOD CHEM TOXICOL, V46, P3106, DOI 10.1016/j.fct.2008.06.014; Yashiro T, 2012, ATHEROSCLEROSIS, V220, P369, DOI 10.1016/j.atherosclerosis.2011.11.006; Yashiro T, 2011, BIOCHEM BIOPH RES CO, V409, P155, DOI 10.1016/j.bbrc.2011.04.006; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974; Zhang J, 2015, INT IMMUNOPHARMACOL, V24, P50, DOI 10.1016/j.intimp.2014.11.012	34	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139799	10.1371/journal.pone.0139799	http://dx.doi.org/10.1371/journal.pone.0139799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431033	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700117
J	Swenson, CE; Haemmerich, D; Maul, DH; Knox, B; Ehrhart, N; Reed, RA				Swenson, Christine E.; Haemmerich, Dieter; Maul, Donald H.; Knox, Bridget; Ehrhart, Nicole; Reed, Robert A.			Increased Duration of Heating Boosts Local Drug Deposition during Radiofrequency Ablation in Combination with Thermally Sensitive Liposomes (ThermoDox) in a Porcine Model	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; TUMOR XENOGRAFT MODEL; MILD HYPERTHERMIA; THERMOSENSITIVE LIPOSOMES; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; HEPATIC RESECTION; LIVER-TUMORS; DOXORUBICIN; DELIVERY	Introduction Radiofrequency ablation (RFA) is used for the local treatment of liver cancer. RFA is effective for small (<3cm) tumors, but for tumors > 3 cm, there is a tendency to leave viable tumor cells in the margins or clefts of overlapping ablation zones. This increases the possibility of incomplete ablation or local recurrence. Lyso-Thermosensitive Liposomal Doxorubicin (LTLD), is a thermally sensitive liposomal doxorubicin formulation for intravenous administration, that rapidly releases its drug content when exposed to temperatures >40 degrees C. When used with RFA, LTLD releases its doxorubicin in the vasculature around the zone of ablation-induced tumor cell necrosis, killing micrometastases in the ablation margin. This may reduce recurrence and be more effective than thermal ablation alone. Purpose The purpose of this study was to optimize the RFA procedure used in combination with LTLD to maximize the local deposition of doxorubicin in a swine liver model. Pigs were anaesthetized and the liver was surgically exposed. Each pig received a single, 50 mg/m(2) dose of the clinical LTLD formulation (ThermoDox (R)). Subsequently, ablations were performed with either 1, 3 or 6 sequential, overlapping needle insertions in the left medial lobe with total ablation time of 15, 45 or 90 minutes respectively. Two different RFA generators and probes were evaluated. After the final ablation, the ablation zone (plus 3 cm margin) was dissected out and examined for doxorubicin concentration by LC/MS and fluorescence. Conclusion The mean Cmax of plasma total doxorubicin was 26.5 mu g/ml at the end of the infusion. Overall, increased heat time from 15 to 45 to 90 minutes shows an increase in both the amount of doxorubicin deposited (up to similar to 100 mu g/g) and the width of the ablation target margin to which doxorubicin is delivered as determined by tissue homogenization and LC/MS detection of doxorubicin and by fluorescent imaging of tissues.	[Swenson, Christine E.; Reed, Robert A.] Celsion Corp, Lawrenceville, NJ 08648 USA; [Haemmerich, Dieter] Med Univ S Carolina, Charleston, SC 29425 USA; [Maul, Donald H.; Knox, Bridget] PreClin Res Serv Inc, Ft Collins, CO USA; [Ehrhart, Nicole] Colorado State Univ, Anim Canc Ctr, Ft Collins, CO 80523 USA	Medical University of South Carolina; Colorado State University	Swenson, CE (corresponding author), Celsion Corp, Lawrenceville, NJ 08648 USA.	chrisswenson2003@gmail.com		Haemmerich, Dieter/0000-0003-1127-7024	Celsion Corporation; NATIONAL CANCER INSTITUTE [R01CA181664] Funding Source: NIH RePORTER	Celsion Corporation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Celsion Corporation, a commercial organization developing pharmaceutical products including the subject of this study, LTLD or ThermoDox. The funder provided support in the form of salaries for CES and RAR. The funder (Celsion Corporation) requested that its employees, CES and RAR conduct a non-clinical study to evaluate the effect of ablation time on the efficacy of LTLD, but did not have any additional role in the study design, data collection and analysis, or decision to publish. The funder compensated another commercial organization, PreClinical Research Services, Inc. for this work. DHM, BK and NE were employed by PreClinical Reseach Services during the conduct of this study. DH has received research funding from Celsion Corporation.	Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Al-Jamal WT, 2012, BIOMATERIALS, V33, P4608, DOI 10.1016/j.biomaterials.2012.03.018; Aloia TA, 2006, ARCH SURG-CHICAGO, V141, P460, DOI 10.1001/archsurg.141.5.460; Anyarambhatla GR, 1999, J LIPOSOME RES, V9, P491, DOI 10.3109/08982109909035549; AUGUST DA, 1995, BRIT J CANCER, V72, P65, DOI 10.1038/bjc.1995.278; Cady B, 1998, ANN SURG, V227, P566, DOI 10.1097/00000658-199804000-00019; de Baere T, 2001, AM J ROENTGENOL, V176, P187, DOI 10.2214/ajr.176.1.1760187; El-Kareh AW, 2000, NEOPLASIA, V2, P325, DOI 10.1038/sj.neo.7900096; Gao JM, 2002, J BIOMED MATER RES, V62, P308, DOI 10.1002/jbm.10292; Gasselhuber A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047453; Gasselhuber A, 2010, INT J HYPERTHER, V26, P499, DOI 10.3109/02656731003623590; Grull H, 2012, J CONTROL RELEASE, V161, P317, DOI 10.1016/j.jconrel.2012.04.041; KERR DJ, 1986, BIOCHEM PHARMACOL, V35, P2817, DOI 10.1016/0006-2952(86)90195-4; Kong G, 2000, CANCER RES, V60, P6950; Lencioni R, 2014, J CLIN ONCOL S, V32; Li L, 2010, J CONTROL RELEASE, V143, P274, DOI 10.1016/j.jconrel.2010.01.006; Livraghi T, 2000, RADIOLOGY, V214, P761, DOI 10.1148/radiology.214.3.r00mr02761; Machi J, 2001, J GASTROINTEST SURG, V5, P477, DOI 10.1016/S1091-255X(01)80085-8; Manzoor AA, 2012, CANCER RES, V72, P5566, DOI 10.1158/0008-5472.CAN-12-1683; Morotti M, 2011, EXPERT OPIN DRUG MET, V7, P707, DOI 10.1517/17425255.2011.570330; Needham D, 2000, CANCER RES, V60, P1197; Negussie AH, 2011, INT J HYPERTHER, V27, P140, DOI 10.3109/02656736.2010.528140; Pereira PL, 2004, RADIOLOGY, V232, P482, DOI 10.1148/radiol.2322030184; Poon RTP, 2009, EXPERT OPIN PHARMACO, V10, P333, DOI [10.1517/14656560802677874 , 10.1517/14656560802677874]; Ranjan A, 2012, J CONTROL RELEASE, V158, P487, DOI 10.1016/j.jconrel.2011.12.011; Sasaki A, 2005, CANCER-AM CANCER SOC, V103, P299, DOI 10.1002/cncr.20798; Siperstein A, 2000, SURG ENDOSC-ULTRAS, V14, P400, DOI 10.1007/s004640000067; Solbiati L, 2001, RADIOLOGY, V221, P159, DOI 10.1148/radiol.2211001624; Staruch RM, 2012, INT J HYPERTHER, V28, P776, DOI 10.3109/02656736.2012.736670; Szebeni J, 2011, ADV DRUG DELIVER REV, V63, P1020, DOI 10.1016/j.addr.2011.06.017; Tocchi A, 2004, INT J COLORECTAL DIS, V19, P580, DOI 10.1007/s00384-004-0594-4; van Duijnhoven FH, 2006, ANN SURG ONCOL, V5, P477; Wood BJ, 2012, J VASC INTERV RADIOL, V23, P248, DOI 10.1016/j.jvir.2011.10.018; Yarmolenko PS, 2010, INT J HYPERTHER, V26, P485, DOI 10.3109/02656731003789284; YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652	35	50	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139752	10.1371/journal.pone.0139752	http://dx.doi.org/10.1371/journal.pone.0139752			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431204	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700111
J	Kristensen, T; Naesset, E; Ohlson, M; Bolstad, PV; Kolka, R				Kristensen, Terje; Naesset, Erik; Ohlson, Mikael; Bolstad, Paul V.; Kolka, Randall			Mapping Above- and Below-Ground Carbon Pools in Boreal Forests: The Case for Airborne Lidar	PLOS ONE			English	Article							COARSE WOODY DEBRIS; FINE-ROOT BIOMASS; NORWAY SPRUCE; UNDERSTORY VEGETATION; OLD-GROWTH; SCOTS PINE; BIOPHYSICAL PROPERTIES; VACCINIUM-MYRTILLUS; INDIVIDUAL TREES; SOIL PROPERTIES	A large and growing body of evidence has demonstrated that airborne scanning light detection and ranging (lidar) systems can be an effective tool in measuring and monitoring above-ground forest tree biomass. However, the potential of lidar as an all-round tool for assisting in assessment of carbon (C) stocks in soil and non-tree vegetation components of the forest ecosystem has been given much less attention. Here we combine the use airborne small footprint scanning lidar with fine-scale spatial C data relating to vegetation and the soil surface to describe and contrast the size and spatial distribution of C pools within and among multilayered Norway spruce (Picea abies) stands. Predictor variables from lidar derived metrics delivered precise models of above-and below-ground tree C, which comprised the largest C pool in our study stands. We also found evidence that lidar canopy data correlated well with the variation in field layer C stock, consisting mainly of ericaceous dwarf shrubs and herbaceous plants. However, lidar metrics derived directly from understory echoes did not yield significant models. Furthermore, our results indicate that the variation in both the mosses and soil organic layer C stock plots appears less influenced by differences in stand structure properties than topographical gradients. By using topographical models from lidar ground returns we were able to establish a strong correlation between lidar data and the organic layer C stock at a stand level. Increasing the topographical resolution from plot averages (similar to 2000 m(2)) towards individual grid cells (1 m(2)) did not yield consistent models. Our study demonstrates a connection between the size and distribution of different forest C pools and models derived from airborne lidar data, providing a foundation for future research concerning the use of lidar for assessing and monitoring boreal forest C.	[Kristensen, Terje; Naesset, Erik; Ohlson, Mikael] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, As, Norway; [Kristensen, Terje; Bolstad, Paul V.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Kolka, Randall] US Forest Serv, USDA, Grand Rapids, MN USA	Norwegian University of Life Sciences; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Forest Service	Kristensen, T (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.	terjekrist@gmail.com		Ohlson, Mikael/0000-0003-0237-149X; Kristensen, Terje/0000-0002-4542-2915	Fulbright Foundation	Fulbright Foundation	Funding was provided by Fulbright Foundation, http://www.cies.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahem FJ, 1998, STRATEGY GLOBAL OBSE; Alexander C, 2013, REMOTE SENS ENVIRON, V134, P152, DOI 10.1016/j.rse.2013.02.028; [Anonymous], 1999, NATL ATLAS NORWAY VE; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Baritz R, 2010, FOREST ECOL MANAG, V260, P262, DOI 10.1016/j.foreco.2010.03.025; Beets PN, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P391, DOI 10.1007/978-90-481-3233-1_25; Binkley D., 2012, ECOLOGY MANAGEMENT F, V4th; Bitterlich W., 1984, RELASCOPE IDEA RELAT; Bollandsas OM, 2008, FOREST ECOL MANAG, V255, P953, DOI 10.1016/j.foreco.2007.10.017; Bradford J, 2009, CAN J FOREST RES, V39, P802, DOI 10.1139/X09-010; Cajander AK., 1949, FOREST TYPES THEIR S; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Finer L, 2003, FOREST ECOL MANAG, V174, P51, DOI 10.1016/S0378-1127(02)00019-1; Gangodagamage C, 2014, WATER RESOUR RES, V50, P6339, DOI 10.1002/2013WR014283; GESSLER PE, 1995, INT J GEOGR INF SYST, V9, P421, DOI 10.1080/02693799508902047; Guisan A, 1999, PLANT ECOL, V143, P107, DOI 10.1023/A:1009841519580; Hakkinen M., 2011, BIOGEOSCIENCES DISCU, V8, P1015; Hansson K, 2011, FOREST ECOL MANAG, V262, P522, DOI 10.1016/j.foreco.2011.04.021; HAVAS P, 1983, ANN BOT FENN, V20, P115; Helmisaari HS, 1999, FOREST ECOL MANAG, V119, P99, DOI 10.1016/S0378-1127(98)00514-3; Hill RA, 2009, ISPRS J PHOTOGRAMM, V64, P223, DOI 10.1016/j.isprsjprs.2008.12.004; Hill RA, 2005, INT J REMOTE SENS, V26, P3763, DOI 10.1080/01431160500114706; Hogberg P, 1996, SOIL BIOL BIOCHEM, V28, P1131, DOI 10.1016/0038-0717(96)00124-1; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Holmgren J, 2008, INT J REMOTE SENS, V29, P1537, DOI 10.1080/01431160701736471; Holmgren J, 2004, SCAND J FOREST RES, V19, P543, DOI 10.1080/02827580410019472; Holmgren J, 2003, FOREST SCI, V49, P419; Hyyppa H, 2005, INT ARCH PHOTOGRAMME, P85; Hyyppa J, 2008, INT J REMOTE SENS, V29, P1339, DOI 10.1080/01431160701736489; KIELLAND-LUND J, 1981, Phytocoenologia, V9, P53; Korhonen L, 2011, REMOTE SENS ENVIRON, V115, P1065, DOI 10.1016/j.rse.2010.12.011; Korpela IS, 2008, REMOTE SENS ENVIRON, V112, P3891, DOI 10.1016/j.rse.2008.06.007; Krankina ON, 1999, CAN J FOREST RES, V29, P20, DOI 10.1139/cjfr-29-1-20; Kristensen T, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4741-x; Kurz WA, 2008, PHILOS T R SOC B, V363, P2261, DOI 10.1098/rstb.2007.2198; Laamrani A, 2014, FOREST SCI, V60, P579, DOI 10.5849/forsci.13-025; Lefsky MA, 1999, REMOTE SENS ENVIRON, V70, P339, DOI 10.1016/S0034-4257(99)00052-8; Lie MH, 2012, SCAND J FOREST RES, V27, P270, DOI 10.1080/02827581.2011.628950; Lie MH, 2009, BIODIVERS CONSERV, V18, P3579, DOI 10.1007/s10531-009-9661-z; Lindgren B., 1993, STAT THEORY; Lindholm T., 1987, Silva Fennica, V21, P259; Liski J, 2002, FOREST ECOL MANAG, V169, P159, DOI 10.1016/S0378-1127(02)00306-7; Liu CJ, 2009, BOREAL ENVIRON RES, V14, P875; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Luyssaert S, 2008, NATURE, V455, P213, DOI 10.1038/nature07276; Magnussen S, 1999, FOREST SCI, V45, P407; Makipaa R, 1999, J VEG SCI, V10, P17, DOI 10.2307/3237156; Makkonen K, 2001, TREE PHYSIOL, V21, P193, DOI 10.1093/treephys/21.2-3.193; Maltamo M, PREDICTING TREE ATTR; Marklund L.G, 1988, BIOMASSAFUNKTIONER T; Martinuzzi S, 2009, REMOTE SENS ENVIRON, V113, P2533, DOI 10.1016/j.rse.2009.07.002; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Messier C, 1998, J VEG SCI, V9, P511, DOI 10.2307/3237266; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Muukkonen P, 2006, BOREAL ENVIRON RES, V11, P355; Muukkonen P, 2009, ENVIRON MONIT ASSESS, V158, P67, DOI 10.1007/s10661-008-0565-2; Nabuurs GJ, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P541; Naesset E, 1997, ISPRS J PHOTOGRAMM, V52, P49, DOI 10.1016/S0924-2716(97)83000-6; Naesset E, 1997, REMOTE SENS ENVIRON, V61, P246, DOI 10.1016/S0034-4257(97)00041-2; Naesset E, 2002, REMOTE SENS ENVIRON, V80, P88, DOI 10.1016/S0034-4257(01)00290-5; Naesset E, 2004, REMOTE SENS ENVIRON, V91, P243, DOI 10.1016/j.rse.2004.03.009; Naesset E, 2002, REMOTE SENS ENVIRON, V79, P105, DOI 10.1016/S0034-4257(01)00243-7; Naesset E, 2005, REMOTE SENS ENVIRON, V94, P541, DOI 10.1016/j.rse.2004.11.010; Naesset E., 2004, INT ARCH PHOTOGRAMME, V36, P145, DOI DOI 10.1016/J.RSE.2008.03.004; Naesset E, 2008, REMOTE SENS ENVIRON, V112, P3079, DOI 10.1016/j.rse.2008.03.004; Naesset E, 2007, SCAND J FOREST RES, V22, P433, DOI 10.1080/02827580701672147; Naesset E, 2013, REMOTE SENS ENVIRON, V130, P108, DOI 10.1016/j.rse.2012.11.010; Nielsen A, 2007, BASIC APPL ECOL, V8, P231, DOI 10.1016/j.baae.2006.05.009; Nijland W, 2014, J APPL REMOTE SENS, V8, DOI 10.1117/1.JRS.8.083572; Nilsson M, 1996, REMOTE SENS ENVIRON, V56, P1, DOI 10.1016/0034-4257(95)00224-3; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; Orka HO, 2009, REMOTE SENS ENVIRON, V113, P1163, DOI 10.1016/j.rse.2009.02.002; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Pase CP, 1958, P SOC AM FOR M 1957; Pearson T. R. H., 2007, MEASUREMENT GUIDELIN; Peckham SD, 2009, REMOTE SENS ENVIRON, V113, P1127, DOI 10.1016/j.rse.2009.02.008; Pesonen A, 2008, FOREST ECOL MANAG, V255, P3288, DOI 10.1016/j.foreco.2008.02.017; Petersson H, 2006, SCAND J FOREST RES, V21, P84, DOI 10.1080/14004080500486864; Pfeifer N., 2004, INT ARCH PHOTOGRAMM, V36, pW2; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reich PB, 2001, ECOLOGY, V82, P1703; Repola J., 2007, WORKING PAPERS FINNI, V53; Riley S.J., 1999, INTERMOUNTAIN J SCI, V5, P23, DOI DOI 10.1016/j.geomorph.2010.11.003; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; Siitonen J, 2000, FOREST ECOL MANAG, V128, P211, DOI 10.1016/S0378-1127(99)00148-6; SIMONSON ROY W., 1959, SOIL SCI SOC AMER PROC, V23, P152; Solberg S, 2009, REMOTE SENS ENVIRON, V113, P2317, DOI 10.1016/j.rse.2009.06.010; STAGE AR, 1976, FOREST SCI, V22, P457; Stendahl J, 2010, SILVA FENN, V44, P5, DOI 10.14214/sf.159; Stephens PR, 2012, REMOTE SENS ENVIRON, V117, P348, DOI 10.1016/j.rse.2011.10.009; Thompson JA, 2005, SOIL SCI SOC AM J, V69, P1086, DOI 10.2136/sssaj2004.0322; Van Pelt R, 2000, CAN J FOREST RES, V30, P1231, DOI 10.1139/cjfr-30-8-1231; Vehmas M, 2009, FOREST ECOL MANAG, V257, P46, DOI 10.1016/j.foreco.2008.08.016; Vepakomma U, 2008, REMOTE SENS ENVIRON, V112, P2326, DOI 10.1016/j.rse.2007.10.001; Vesterdal L, 2013, FOREST ECOL MANAG, V309, P4, DOI 10.1016/j.foreco.2013.01.017; Wahba G., 1990, SPLINE MODELS OBSERV; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wardle DA, 2012, J ECOL, V100, P16, DOI 10.1111/j.1365-2745.2011.01907.x; Yarwood SA, 2009, FEMS MICROBIOL ECOL, V70, P151, DOI 10.1111/j.1574-6941.2009.00733.x; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107	102	15	15	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138450	10.1371/journal.pone.0138450	http://dx.doi.org/10.1371/journal.pone.0138450			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426532	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000362177100014
J	Li, SG; Xu, MC; Niu, Q; Xu, SZ; Ding, YS; Yan, YZ; Guo, SX; Li, F				Li, Shugang; Xu, Mengchuan; Niu, Qiang; Xu, Shangzhi; Ding, Yusong; Yan, Yizhong; Guo, Shuxia; Li, Feng			Efficacy of Procyanidins against In Vivo Cellular Oxidative Damage: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							SEED PROANTHOCYANIDIN EXTRACT; STRESS	Aims In this study, the efficacy of proanthocyanidins (PCs) against oxidative damage was systematically reviewed to facilitate their use in various applications. Methods A meta-analysis was performed by two researchers. Each investigator independently searched electronic databases, including Cochrane, PubMed, Springer, Web of Science, China National Knowledge Infrastructure (CKNI), China Science and Technology Journal Database (CSTJ), and WanFang Data, and analyzed published data from 29 studies on the effects of PCs against oxidative damage. Oxidative stress indexes included superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT), glutathione (GSH), glutathione peroxidase (GPx), and total antioxidative capacity (T-AOC). Results Compared with the oxidative damage model group, PCs effectively improved the T-AOC, SOD, GSH, GPx, and CAT levels, and reduced the MDA levels; these differences were statistically significant (P < 0.05). In studies that used the gavage method, SOD (95% CI, 2.33-4.00) and GPx (95% CI, 2.10-4.05) were 3.16-fold and 3.08-fold higher in the PC group than in the control group, respectively. In studies that used the feeding method, SOD (95% CI, 0.32-1.74) and GPx (95% CI, -0.31 to 1.65) were 1.03-fold and 0.67-fold higher in the PC group than in the control group, respectively. Statistically significant differences in the effects of PCs (P < 0.00001) were observed between these two methods. MDA estimated from tissue samples (95% CI, -5.82 to -2.60) was 4.32-fold lower in the PC group than in the control group. In contrast, MDA estimated using serum samples (95% CI, -4.07 to -2.06) was 3.06-fold lower in the PC group than in the control group. The effect of PCs on MDA was significantly greater in tissue samples than in serum samples (P = 0.02). Conclusion PCs effectively antagonize oxidative damage and enhance antioxidant capacity. The antagonistic effect may be related to intervention time, intervention method, and the source from which the indexes are estimated.	[Li, Shugang; Xu, Mengchuan; Niu, Qiang; Xu, Shangzhi; Ding, Yusong; Yan, Yizhong; Guo, Shuxia] Shihezi Univ, Sch Med, Minist Educ, Dept Publ Hlth, Shihezi 832002, Xinjiang, Peoples R China; [Li, Shugang; Xu, Mengchuan; Niu, Qiang; Xu, Shangzhi; Ding, Yusong; Yan, Yizhong; Guo, Shuxia; Li, Feng] Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi 832002, Xinjiang, Peoples R China; [Li, Feng] Shihezi Univ, Sch Med, Minist Educ, Dept Pathol, Shihezi 832002, Xinjiang, Peoples R China	Shihezi University; Shihezi University; Shihezi University	Guo, SX (corresponding author), Shihezi Univ, Sch Med, Minist Educ, Dept Publ Hlth, Shihezi 832002, Xinjiang, Peoples R China.	pge888@sina.com; lifeng78551@126.com		zhong, yan/0000-0003-1957-5421	Key Areas of Science and Technology Research Project of Xinjiang Production and Construction Corps [2014BA039, 2015AG014]; High-tech Intellectual Project of Shi Hezi University [RCZX201112]; National Natural Science Foundation of China [81560517]	Key Areas of Science and Technology Research Project of Xinjiang Production and Construction Corps; High-tech Intellectual Project of Shi Hezi University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Areas of Science and Technology Research Project of Xinjiang Production and Construction Corps (No. 2014BA039, No. 2015AG014); High-tech Intellectual Project of Shi Hezi University (No. RCZX201112); and the National Natural Science Foundation of China (No. 81560517).	Al-Sowayan N. S., 2014, Advances in Bioscience and Biotechnology, V5, P1078, DOI 10.4236/abb.2014.514123; Anunciato TP, 2012, J COSMET DERMATOL-US, V11, P51, DOI 10.1111/j.1473-2165.2011.00600.x; Aruoma OI, 2006, BIOFACTORS, V27, P245, DOI 10.1002/biof.5520270121; Ashour OM, 2011, MED SCI MONITOR, V17, pBR110, DOI 10.12659/MSM.881711; Bagchi D, 1997, RES COMMUN MOL PATH, V95, P179; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Bakar E, 2015, BIOTECH HISTOCHEM, V90, P69, DOI 10.3109/10520295.2014.954620; Bingzheng Z, 2014, J TOXICOLOGY, V05, P397; Cheng F, 2015, IMMUNOPHARM IMMUNOT, V37, P329, DOI 10.3109/08923973.2015.1049704; Cheng W, 2014, J ENV HYGIENE, V4, P430; Choi SK, 2012, NUTR RES PRACT, V6, P3, DOI 10.4162/nrp.2012.6.1.3; Deng Y, 2012, BIOL TRACE ELEM RES, V146, P213, DOI 10.1007/s12011-011-9242-3; [丁玉松 Ding Yusong], 2013, [毒理学杂志, Journal of Toxicology], V27, P423; Feng G, 2010, CHINESE J PUBLIC HLT, V9, P99; [高璐 Gao Lu], 2014, [食品科学, Food Science], V35, P253; Gao MJ, 2015, REDOX BIOL, V6, P206, DOI 10.1016/j.redox.2015.06.013; Geng X, 2012, PROCEEDINGS OF THE XI'AN 2012 INTERNATIONAL CONFERENCE OF SPORT SCIENCE & PHYSICAL EDUCATION, VOL I: SCIENCE AND INNOVATION IN SPORTS, P394; [龚晴丽 Gong Qingli], 2013, [中国细胞生物学学报, Chinese Journal of Cell Biology], V35, P1540; Guler A, 2011, MED SCI MONITOR, V17, pBR326, DOI 10.12659/MSM.882042; Hanaa A, 2013, CYTOTECHNOLOGY, V65, P851, DOI [10.1007/s10616-012-9525-3, DOI 10.1007/S10616-012-9525-3]; Huang QiLiang, 2011, Medicinal Plant, V2, P43; [姜燕飞 Jiang Yanfei], 2013, [食品科学, Food Science], V34, P262; Khoubnasab Jafari M, 2015, IRAN J PUBLIC HEALTH, V44, P714; Lee SJ, 2009, NUTR RES PRACT, V3, P279, DOI 10.4162/nrp.2009.3.4.279; Li JianLing, 2011, Chinese Journal of Biochemical Pharmaceutics, V32, P463; Li SG, 2015, BIOMED ENVIRON SCI, V28, P272, DOI 10.3967/bes2015.038; Lijun B, 2013, J NEW CHINESE MED, V45, P169; Limei X, 2011, J ENV HLTH, V28, P725; Liming D, 2013, CHINESE ARCH TRADITI, V31, P582; Mansouri E, 2015, VET RES FORUM, V6, P119; Mansouri E, 2015, IRAN J PHARM RES, V14, P329; Neus Martinez M, 2005, OFFICIAL PUBLICATION, V19, P479; Peng Z, 2012, J TOXICOLOGY, V26, P434; Sabitha Vijayakumar, 2012, J Ayurveda Integr Med, V3, P188, DOI 10.4103/0975-9476.104432; Saita E, 2014, CLIN MED INSIGHTS-CA, V8, P61, DOI 10.4137/CMC.S17071; Schroeter H, 2010, MOL ASPECTS MED, V31, P546, DOI 10.1016/j.mam.2010.09.008; Shin MO, 2010, NUTR RES PRACT, V4, P369, DOI 10.4162/nrp.2010.4.5.369; ShuGang L, 2015, HUMAN EXPT TOXICOLOG, V1, P1; Shugang L, 2015, BIOMED RES INT, P1; Tao J, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0088-0; Tingting R, 2014, OXIDATIVE MED CELLUL, P1; Valacchi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131097; [王金晶 Wang Jinjing], 2013, [食品工业科技, Science & Technology of Food Industry], V34, P118; Weifen W, 2012, STUDIES TRACE ELEMEN, V29, P1; Wiesneth S, 2015, MOLECULES, V20, P13764, DOI 10.3390/molecules200813764; Xiao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112773; Ying G, 2014, MED PLANT, V5, P8; Yuan X, 2010, MODERN CHINESE DOCTO, V48, P8; Yujie J, 2006, CHINESE J CLIN REHAB, V10, P65; Zhang H, 2014, INT J CLIN EXP MED, V7, P5730; Zhang X, 2012, J HUAZHONG U SCI-MED, V32, P613, DOI 10.1007/s11596-012-1006-6; [张妍 Zhang Yan], 2011, [中药药理与临床, Pharmacology and Clinics of Chinese Materia Medica], V27, P112; Zhiru M, 2013, J PHARM PRACTICE, V31, P362	53	34	38	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139455	10.1371/journal.pone.0139455	http://dx.doi.org/10.1371/journal.pone.0139455			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426531	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100062
J	Fogliati, P; Straneo, M; Brogi, C; Fantozzi, PL; Salim, RM; Msengi, HM; Azzimonti, G; Putoto, G				Fogliati, Piera; Straneo, Manuela; Brogi, Cosimo; Fantozzi, Pier Lorenzo; Salim, Robert Mahimbo; Msengi, Hamis Mwendo; Azzimonti, Gaetano; Putoto, Giovanni			How Can Childbirth Care for the Rural Poor Be Improved? A Contribution from Spatial Modelling in Rural Tanzania	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; EARLY NEONATAL-MORTALITY; NEWBORN HEALTH; REFERRAL SYSTEM; ACCESS; SERVICES; DISTANCE; FACILITY; INTERVENTIONS; BOTTLENECKS	Introduction Maternal and perinatal mortality remain a challenge in resource-limited countries, particularly among the rural poor. To save lives at birth health facility delivery is recommended. However, increasing coverage of institutional deliveries may not translate into mortality reduction if shortage of qualified staff and lack of enabling working conditions affect quality of services. In Tanzania childbirth care is available in all facilities; yet maternal and newborn mortality are high. The study aimed to assess in a high facility density rural context whether a health system organization with fewer delivery sites is feasible in terms of population access. Methods Data on health facilities' location, staffing and delivery caseload were examined in Ludewa and Iringa Districts, Southern Tanzania. Geospatial raster and network analysis were performed to estimate access to obstetric services in walking time. The present geographical accessibility was compared to a theoretical scenario with a 40% reduction of delivery sites. Results About half of first-line health facilities had insufficient staff to offer full-time obstetric services (45.7% in Iringa and 78.8% in Ludewa District). Yearly delivery caseload at first-line health facilities was low, with less than 100 deliveries in 48/70 and 43/52 facilities in Iringa and Ludewa District respectively. Wide geographical overlaps of facility catchment areas were observed. In Iringa 54% of the population was within 1-hour walking distance from the nearest facility and 87.8% within 2 hours, in Ludewa, the percentages were 39.9% and 82.3%. With a 40% reduction of delivery sites, approximately 80% of population will still be within 2 hours' walking time. Conclusions Our findings from spatial modelling in a high facility density context indicate that reducing delivery sites by 40% will decrease population access within 2 hours by 7%. Focused efforts on fewer delivery sites might assist strengthening delivery services in resource-limited settings.	[Fogliati, Piera; Putoto, Giovanni] Doctors Africa CUAMM, Padua, Italy; [Straneo, Manuela; Azzimonti, Gaetano] Doctors Africa CUAMM, Iringa, Tanzania; [Brogi, Cosimo; Fantozzi, Pier Lorenzo] Univ Siena, Dept Phys Sci Earth & Environm, I-53100 Siena, Italy; [Salim, Robert Mahimbo] Reg Med Off, Iringa, Tanzania; [Msengi, Hamis Mwendo] Ludewa Dist Council, Council Med Off, Ludewa, Tanzania	University of Siena	Fogliati, P (corresponding author), Doctors Africa CUAMM, Padua, Italy.	p.fogliati@cuamm.org	Brogi, Cosimo/AAA-7106-2020; Brogi, Cosimo/ABT-3431-2022; Putoto, Giovanni/ABG-2069-2020; Brogi, Cosimo/AAS-8792-2020	Brogi, Cosimo/0000-0003-4597-7045; Straneo, Manuela/0000-0002-2464-1633	European Union [DCI - SANTE/2010/251-162]	European Union(European Commission)	The study was conducted as part of a development project funded by European Union, project identification code DCI - SANTE/2010/251-162 and implemented by the non-governmental organization Doctors with Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Amer S., 2007, THESIS U UTRECHT; [Anonymous], 2007, PRIM HLTH SERV DEV P; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Bailey PE, 2011, INT J GYNECOL OBSTET, V115, P300, DOI 10.1016/j.ijgo.2011.09.004; Baker U, 2015, B WORLD HEALTH ORGAN, V93, P380, DOI 10.2471/BLT.14.141879; Bartels DB, 2007, EUR J EPIDEMIOL, V22, P791, DOI 10.1007/s10654-007-9182-6; Blanford JI, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-24; Delamater PL, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-15; Department of Human Resources Development, 2014, HUM RES HLTH STRAT P; Dickson KE, 2014, LANCET, V384, P438, DOI 10.1016/S0140-6736(14)60582-1; Dogba M, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-7; Gabrysch S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000394; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Guenther T, 2012, AM J TROP MED HYG, V87, P77, DOI 10.4269/ajtmh.2012.11-0747; Hanson C, 2015, LANCET GLOB HEALTH, V3, pE387, DOI 10.1016/S2214-109X(15)00048-0; Hanson Claudia, 2013, BMC Res Notes, V6, P435, DOI 10.1186/1756-0500-6-435; Human Resources Directorate Ministry of Health and Social Welfare, 2013, HUM RES HLTH COUNTR; Iringa District Council Health Department, 2011, COMPR COUNC HLTH PLA; Kadobera D, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19099; Knight HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063846; Kruk ME, 2015, TROP MED INT HEALTH, V20, P1057, DOI 10.1111/tmi.12518; Kruk ME, 2014, B WORLD HEALTH ORGAN, V92, P246, DOI 10.2471/BLT.13.126417; Langmuir E., 1984, MOUNTAIN CRAFT LEADE; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; Ludewa District Council Health Department, 2011, COMPR COUNC HLTH PLA; Maine D, 1997, GUIDELINES MONITORIN, V1997; Manongi R, 2014, TROP MED INT HEALTH, V19, P555, DOI 10.1111/tmi.12294; McKinnon B, 2014, TROP MED INT HEALTH, V19, P780, DOI 10.1111/tmi.12323; Ministry of Health and Social Welfare, 2006, ZANZ HLTH SECT REF S; Ministry of Health and Social Welfare, 2014, NAT ROAD MAP STRAT P; Ministry of Health and Social Welfare of Tanzania, 2015, HLTH SECT STRAT PLAN; Ministry of Health and Social Welfare United Republic of Tanzania, 2014, NAT ROAD MAP STRAT P; Mkoka DA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-108; National Bureau of Statistics and Office of Chief Statistician Zanzibar United Republic of Tanzania, 2012, 2012 POP HOUS CENS D; Nesbitt RC, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-25; Noor AM, 2006, TROP MED INT HEALTH, V11, P188, DOI 10.1111/j.1365-3156.2005.01555.x; Okwaraji YB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033564; Pembe AB, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-326; Penfold S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-61; Pozzi Francesca., 2008, 1108 INT AUTH DEV LI; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Sabde Y, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-57; Schellenberg JRA, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-194; Shaw NT, 2012, HEALTHC INFORM RES, V18, P88, DOI 10.4258/hir.2012.18.2.88; Straneo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113995; Tanser Frank C, 2002, Int J Health Geogr, V1, P4, DOI 10.1186/1476-072X-1-4; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; ten Hoope-Bender P, 2014, LANCET, V384, P1226, DOI 10.1016/S0140-6736(14)60930-2; UNFPA, 2004, PROGR MAN PLANN MON; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization UNFPA UNICEF AMDD, 2009, UNFPA UNICEF AMDD MO	53	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139460	10.1371/journal.pone.0139460	http://dx.doi.org/10.1371/journal.pone.0139460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422687	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700118
J	Liu, RL				Liu, Rey-Long			Passage-Based Bibliographic Coupling: An Inter-Article Similarity Measure for Biomedical Articles	PLOS ONE			English	Article							FULL-TEXT; COCITATION ANALYSIS; CITATION; INFORMATION; RETRIEVAL; DATABASE; ASSOCIATION; REFERENCES; DOCUMENTS; NETWORKS	Biomedical literature is an essential source of biomedical evidence. To translate the evidence for biomedicine study, researchers often need to carefully read multiple articles about specific biomedical issues. These articles thus need to be highly related to each other. They should share similar core contents, including research goals, methods, and findings. However, given an article r, it is challenging for search engines to retrieve highly related articles for r. In this paper, we present a technique PBC Passage-based Bibliographic Coupling) that estimates inter-article similarity by seamlessly integrating bibliographic coupling with the information collected from context passages around important out-link citations references) in each article. Empirical evaluation shows that PBC can significantly improve the retrieval of those articles that biomedical experts believe to be highly related to specific articles about gene-disease associations. PBC can thus be used to improve search engines in retrieving the highly related articles for any given article r, even when r is cited by very few or even no) articles. The contribution is essential for those researchers and text mining systems that aim at cross-validating the evidence about specific gene-disease associations.	Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan	Tzu Chi University	Liu, RL (corresponding author), Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan.	rlliutcu@mail.tcu.edu.tw			Ministry of Science and Technology, Taiwan [MOST 103-2221-E-320-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding provided by grant ID: MOST 103-2221-E-320-006, funder: Ministry of Science and Technology, Taiwan (R. O. C.); URL of the funder: http://www.most.gov.tw/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljaber B, 2010, INFORM RETRIEVAL, V13, P101, DOI 10.1007/s10791-009-9108-x; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Bernstam EV, 2006, J AM MED INFORM ASSN, V13, P96, DOI 10.1197/jamia.M1909; Boyack KW, 2013, J AM SOC INF SCI TEC, V64, P1759, DOI 10.1002/asi.22896; Boyack KW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018029; Boyack KW, 2010, J AM SOC INF SCI TEC, V61, P2389, DOI 10.1002/asi.21419; Calado P., 2003, P 2003 ACM CIKM INT; Councill IG, 2008, P 6 INT LANG RES EV; Couto T, 2006, OPENING INFORMATION HORIZONS, P75; Elkiss A, 2008, J AM SOC INF SCI TEC, V59, P51, DOI 10.1002/asi.20707; Genetic Home Reference, EXP REV; Genetics Home Reference, LAST 12 MONTHS; Gipp B, 2009, PRO INT CONF SCI INF, V2, P571; Glenisson P, 2005, INFORM PROCESS MANAG, V41, P1548, DOI 10.1016/j.ipm.2005.03.021; Heck T, 2013, P 16 ACM C COMP SUPP; Janssens F, 2008, SCIENTOMETRICS, V75, P607, DOI 10.1007/s11192-007-2002-7; Janssens F, 2009, INFORM PROCESS MANAG, V45, P683, DOI 10.1016/j.ipm.2009.06.003; Jimeno-Yepes AJ, BMC BIOINFORMATICS, V14, P171; KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103; Kumar Sushanta, 2011, P ACM IND COMPUTE C, P17, DOI 10.1145/1980422.1980439; Lin J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-423; Liu R-L, 2015, P 28 INT C IND ENG O; Liu RL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-286; Liu SB, 2014, SCIENTOMETRICS, V101, P1293, DOI 10.1007/s11192-014-1233-7; Liu XZ, 2013, J AM SOC INF SCI TEC, V64, P1852, DOI 10.1002/asi.22883; Liu XH, 2010, J AM SOC INF SCI TEC, V61, P1105, DOI 10.1002/asi.21312; Lu Z, 2006, P PAC S BIOC HAW; Lu ZY, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas043; Meuschke N., 2011, P 11 ACM S DOC ENG M; Nakov PI., 2004, P SIGIR, V4, P81; Online Mendelian Inheritance in Man, AB OMIM; Ortuno FM, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-113; Powley B, 2007, P 8 RIAO INT C LARG; PubMed, 2014, COMP REL CIT; Ritchie A., 2006, P WORKSH CAN COMP LI, P25; Ritchie A, 2008, LECT NOTES COMPUT SC, V4956, P211; Robertson SE, 1998, P 7 TEXT RETRIEVAL C, P253; Schuemie MJ, 2008, BIOINFORMATICS, V24, P727, DOI 10.1093/bioinformatics/btn006; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; Small H, 2011, SCIENTOMETRICS, V87, P373, DOI 10.1007/s11192-011-0349-2; Tudor CO, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-418; Whissell JS, 2013, P 22 ACM INT C C INF, P1361; WHITE HD, 1981, J AM SOC INFORM SCI, V32, P163, DOI 10.1002/asi.4630320302; Wiegers TC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-326; Zhang M, 2012, P IEEE WIC ACM INT C	45	10	10	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139245	10.1371/journal.pone.0139245	http://dx.doi.org/10.1371/journal.pone.0139245			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26440794	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300016
J	Martins, TS; Sanglard, LMP; Silva, W; Chizzotti, ML; Renno, LN; Serao, NVL; Silva, FF; Guimaraes, SEF; Ladeira, MM; Dodson, MV; Du, M; Duarte, MS				Martins, Taiane S.; Sanglard, Leticia M. P.; Silva, Walmir; Chizzotti, Mario L.; Renno, Luciana N.; Serao, Nick V. L.; Silva, Fabyano F.; Guimaraes, Simone E. F.; Ladeira, Marcio M.; Dodson, Michael V.; Du, Min; Duarte, Marcio S.			Molecular Factors Underlying the Deposition of Intramuscular Fat and Collagen in Skeletal Muscle of Nellore and Angus Cattle	PLOS ONE			English	Article							MESSENGER-RNA; PPAR-GAMMA; MESENCHYMAL PROGENITORS; HOLSTEIN STEERS; BEEF-CATTLE; EXPRESSION; ADIPOGENESIS; TISSUE; CELLS; INFLAMMATION	Studies have shown that intramuscular adipogenesis and fibrogenesis may concomitantly occur in skeletal muscle of beef cattle. Thus, we hypothesized that the discrepancy of intramuscular fat content in beef from Nellore and Angus was associated with differences in intramuscular adipogenesis and fibrogenesis during the finishing phase. To test our hypothesis, longissimus muscle samples of Nellore (n = 6; BW=372.5 +/- 37.3 kg) and Angus (n = 6; BW = 382.8 +/- 23.9 kg) cattle were collected for analysis of gene and protein expression, and quantification of intramuscular fat and collagen. Least-squares means were estimated for the effect of Breed and differences were considered at P <= 0.05. A greater intramuscular fat content was observed in skeletal muscle of Angus compared to Nellore cattle (P <= 0.05). No differences were observed for mRNA expression of lipogenic and lipolytic markers ACC, FAS, FABP4, SERBP-1, CPT-2, LPL, and ACOX (P > 0.05) in skeletal muscle of Nellore and Angus cattle. Similarly, no differences were observed in mRNA expression of adipogenic markers Zfp423, PPAR gamma, and C/EBP alpha (P>0.05) However, a greater PPAR. protein content was observed in skeletal muscle of Angus compared to Nellore cattle (P <= 0.05). A greater abundance of adipo/fibrogenic cells, evaluated by the PDGFR alpha content, was observed in skeletal muscle of Angus than Nellore cattle (P <= 0.05). No differences in fibrogenesis were observed in skeletal muscle of Angus and Nellore cattle, which is in accordance with the lack of differences in intramuscular collagen content in beef from both breeds (P>0.05). These findings demonstrate that difference in intramuscular fat content is associated with a slightly enhanced adipogenesis in skeletal muscle of Angus compared to Nellore cattle, while no difference in fibrogenesis.	[Martins, Taiane S.; Sanglard, Leticia M. P.; Silva, Walmir; Chizzotti, Mario L.; Renno, Luciana N.; Silva, Fabyano F.; Guimaraes, Simone E. F.; Duarte, Marcio S.] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil; [Sanglard, Leticia M. P.; Silva, Walmir; Silva, Fabyano F.; Guimaraes, Simone E. F.; Duarte, Marcio S.] Univ Fed Vicosa, Anim Biotechnol Lab LABTEC, Vicosa, MG, Brazil; [Serao, Nick V. L.] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [Ladeira, Marcio M.] Univ Fed Lavras, Dept Anim Sci, Lavras, Brazil; [Dodson, Michael V.; Du, Min] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Universidade Federal de Vicosa; Universidade Federal de Vicosa; University of North Carolina; North Carolina State University; Universidade Federal de Lavras; Washington State University	Duarte, MS (corresponding author), Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil.	marcio.duarte@ufv.br	Rennó, Luciana Navajas/AAX-9399-2021; Ladeira, Marcio Machado/GRS-4472-2022; Silva, Fabyano Fonseca/D-8158-2017; Duarte, Marcio/G-3815-2015; Chizzotti, Mario/C-4854-2013; Ladeira, Marcio M/G-9816-2012; Martins, Taiane S/P-7136-2016; Du, Min/H-4311-2011; Serão, Nick/AAE-5868-2019; Silva, Fabyano/Y-9223-2019	Rennó, Luciana Navajas/0000-0002-7125-7781; Ladeira, Marcio Machado/0000-0002-1585-8486; Duarte, Marcio/0000-0002-5795-6420; Chizzotti, Mario/0000-0001-9770-6891; Ladeira, Marcio M/0000-0002-1585-8486; Martins, Taiane S/0000-0002-1040-9358; Du, Min/0000-0002-7232-072X; Serão, Nick/0000-0002-6758-208X; Silva, Walmir/0000-0003-3188-8076	Conselho nacional de Pesquisa e Desenvolvimento (CNPq); Instituto Nacional de Ciencia e Tecnologia Animal (INCT-CA); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); FUNARBE [456309/2014-4]	Conselho nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia Animal (INCT-CA); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FUNARBE	The authors thank Conselho nacional de Pesquisa e Desenvolvimento (CNPq), Instituto Nacional de Ciencia e Tecnologia Animal (INCT-CA), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), and FUNARBE for the financial support through Grant# 456309/2014-4: Conselho Nacional de Pesquisa e Desenvolvimento; Receiver: MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2011, MEAT SCI, V89, P13, DOI 10.1016/j.meatsci.2011.03.012; AOAC, 2007, OFFICIAL METHODS ANA, V18th; AOCS, 2009, OFFICIAL METHODS REC; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; CROSS HR, 1973, J FOOD SCI, V38, P998, DOI 10.1111/j.1365-2621.1973.tb02133.x; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Du M, 2013, J ANIM SCI, V91, P1419, DOI 10.2527/jas.2012-5670; Duarte MS, 2013, J ANIM SCI, V91, P2938, DOI 10.2527/jas.2012-5892; Ducatti T, 2009, ASIAN AUSTRAL J ANIM, V22, P433, DOI 10.5713/ajas.2009.80255; Gosselin LE, 2004, MUSCLE NERVE, V30, P645, DOI 10.1002/mus.20150; Greiner SP, 2003, J ANIM SCI, V81, P676; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Huang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047496; Huff PW, 2004, CAN J ANIM SCI, V84, P49, DOI 10.4141/A02-058; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kennedy L, 2008, MATRIX BIOL, V27, P274, DOI 10.1016/j.matbio.2008.01.004; Lee JE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-29; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moisa SJ, 2014, GENE REGUL SYST BIO, V8, P17, DOI 10.4137/GRSB.S11782; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Salvadori C, 2005, MUSCLE NERVE, V31, P192, DOI 10.1002/mus.20252; Tan CK, 2012, NUTR DIABETES, V5, pe29, DOI DOI 10.1038/NUTD.2012.1; Uezumi A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.161; Uezumi A, 2011, J CELL SCI, V124, P3654, DOI 10.1242/jcs.086629; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Voge JL, 2004, DOMEST ANIM ENDOCRIN, V26, P241, DOI 10.1016/j.domaniend.2003.11.002; WILLIAMS CB, 1995, J ANIM SCI, V73, P665; Yamada T, 2009, MEAT SCI, V81, P86, DOI 10.1016/j.meatsci.2008.06.022	29	34	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139943	10.1371/journal.pone.0139943	http://dx.doi.org/10.1371/journal.pone.0139943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436893	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200066
J	Tivarus, ME; Pester, B; Schmidt, C; Lehmann, T; Zhu, T; Zhong, JH; Leistritz, L; Schifitto, G				Tivarus, Madalina E.; Pester, Britta; Schmidt, Christoph; Lehmann, Thomas; Zhu, Tong; Zhong, Jianhui; Leistritz, Lutz; Schifitto, Giovanni			Are Structural Changes Induced by Lithium in the HIV Brain Accompanied by Changes in Functional Connectivity?	PLOS ONE			English	Article							PARTIAL DIRECTED COHERENCE; PATTERNS; THERAPY; MODEL	Lithium therapy has been shown to affect imaging measures of brain function and microstructure in human immunodeficiency virus (HIV)-infected subjects with cognitive impairment. The aim of this proof-of-concept study was to explore whether changes in brain microstructure also entail changes in functional connectivity. Functional MRI data of seven cognitively impaired HIV infected individuals enrolled in an open-label lithium study were included in the connectivity analysis. Seven regions of interest (ROI) were defined based on previously observed lithium induced microstructural changes measured by Diffusion Tensor Imaging. Generalized partial directed coherence (gPDC), based on time-variant multivariate autoregressive models, was used to quantify the degree of connectivity between the selected ROIs. Statistical analyses using a linear mixed model showed significant differences in the average node strength between pre and post lithium therapy conditions. Specifically, we found that lithium treatment in this population induced changes suggestive of increased strength in functional connectivity. Therefore, by exploiting the information about the strength of functional interactions provided by gPDC we can quantify the connectivity changes observed in relation to a given intervention. Furthermore, in conditions where the intervention is associated with clinical changes, we suggest that this methodology could enable an interpretation of such changes in the context of disease or treatment induced modulations in functional networks.	[Tivarus, Madalina E.; Zhong, Jianhui; Schifitto, Giovanni] Univ Rochester, Med Ctr, Dept Imaging Sci, Rochester, NY 14642 USA; [Pester, Britta; Schmidt, Christoph; Lehmann, Thomas; Leistritz, Lutz] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany; [Zhu, Tong] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [Schifitto, Giovanni] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; Friedrich Schiller University of Jena; University of Michigan System; University of Michigan; University of Rochester	Leistritz, L (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Jena, Germany.	Lutz.Leistritz@med.uni-jena.de	Tivarus, Madalina/ABB-4966-2021; Zhong, Jianhui/AAE-6061-2020	Tivarus, Madalina/0000-0001-7481-5913; Zhu, Tong/0000-0002-0012-0091	German Federal Ministry of Education and Research [01GQ1202]; National Institutes of Health [R01DA034977-01, R01MH099921]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034977] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by grant 01GQ1202, from the German Federal Ministry of Education and Research (http://www.bmbf.de/en/index.php), as well as by the National Institutes of Health (http://www.nih.gov), grants R01DA034977-01 and R01MH099921. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansmann G, 2012, J NEUROSCI METH, V208, P165, DOI 10.1016/j.jneumeth.2012.05.008; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Astolfi L, 2006, IEEE T BIO-MED ENG, V53, P1802, DOI 10.1109/TBME.2006.873692; Babiloni F, 2005, NEUROIMAGE, V24, P118, DOI 10.1016/j.neuroimage.2004.09.036; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, PROCEEDINGS OF THE 2007 15TH INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING, P163, DOI 10.1109/ICDSP.2007.4288544; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brzezicka A, 2011, BRAIN TOPOGR, V24, P1, DOI 10.1007/s10548-010-0158-6; Buchel C, 1997, CEREB CORTEX, V7, P768, DOI 10.1093/cercor/7.8.768; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dou HY, 2005, J NEUROSCI, V25, P8375, DOI 10.1523/JNEUROSCI.2164-05.2005; Eichler M, 2005, PHILOS T R SOC B, V360, P953, DOI 10.1098/rstb.2005.1641; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fallani FD, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0521; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Garavan H, 2000, CEREB CORTEX, V10, P585, DOI 10.1093/cercor/10.6.585; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hafeman DM, 2012, BIPOLAR DISORD, V14, P375, DOI 10.1111/j.1399-5618.2012.01023.x; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Horwitz B, 2003, NEUROIMAGE, V19, P466, DOI 10.1016/S1053-8119(03)00112-5; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; KAMINSKI MJ, 1991, BIOL CYBERN, V65, P203, DOI 10.1007/BF00198091; Khalid A, 2014, NEUROIMAGE, V101, P351, DOI 10.1016/j.neuroimage.2014.07.040; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Letendre SL, 2006, AIDS, V20, P1885, DOI 10.1097/01.aids.0000244208.49123.1b; Maggirwar SB, 1999, J NEUROCHEM, V73, P578, DOI 10.1046/j.1471-4159.1999.0730578.x; Marder K, 1996, NEUROLOGY, V47, P1247; Marder K, 2003, NEUROLOGY, V60, P1467, DOI 10.1212/01.WNL.0000064172.46685.82; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Pester B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129293; Plomp G, 2014, NEUROIMAGE, V97, P206, DOI 10.1016/j.neuroimage.2014.04.016; Rogers BP, 2007, MAGN RESON IMAGING, V25, P1347, DOI 10.1016/j.mri.2007.03.007; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sato JR, 2009, HUM BRAIN MAPP, V30, P452, DOI 10.1002/hbm.20513; Sato JR, 2006, NEUROIMAGE, V31, P187, DOI 10.1016/j.neuroimage.2005.11.039; Schifitto G, 2009, J NEUROVIROL, V15, P176, DOI 10.1080/13550280902758973; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Yiannoutsos CT, 2004, NEUROIMAGE, V23, P928, DOI 10.1016/j.neuroimage.2004.07.033; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zhu T, 2013, J NEUROVIROL, V19, P10, DOI 10.1007/s13365-012-0135-9	44	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139118	10.1371/journal.pone.0139118	http://dx.doi.org/10.1371/journal.pone.0139118			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436895	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200012
J	Zhang, XX; Lv, JL; Hu, Y; Wang, BM; Chen, X; Xu, XN; Wang, ED				Zhang, Xiaoxiao; Lv, Jiale; Hu, Yue; Wang, Boming; Chen, Xi; Xu, Xuenong; Wang, Endong			Prey Preference and Life Table of Amblyseius orientalis on Bemisia tabaci and Tetranychus cinnabarinus	PLOS ONE			English	Article							PREDATORY MITE; BIOLOGICAL-CONTROL; PHYTOSEIID PREDATORS; GENERALIST PREDATOR; ACARI; FOOD; TEMPERATURE; RESISTANCE; RESPONSES; CUCUMBER	Amblyseius orientalis (Ehara) (Acari: Phytoseiidae) is a native predatory mite species in China. It used to be considered as a specialist predator of spider mites. However, recent studies show it also preys on other small arthropod pests, such as Bemisia tabaci (Gennadius) (Hemiptera: Aleyrodidae). Experiments were conducted to investigate (1) prey preference of A. orientalis between Tetranychus cinnabarinus (Boisd.) (Acari: Tetranychidae) and B. tabaci, and (2) development, consumption and life table parameters of A. orientalis when reared on T. cinnabarinus, B. tabaci or a mix of both prey species. When preying on different stages of T. cinnabarinus, A. orientalis preferred protonymphs, whereas when preying on different stages of B. tabaci, A. orientalis preferred eggs. When these two most preferred stages were provided together (T. cinnabarinus protonymphs and B. tabaci eggs), A. orientalis randomly selected its prey. Amblyseius orientalis was able to complete its life cycle on B. tabaci eggs, T. cinnabarinus protonymphs, or a mix of both prey. However, its developmental duration was 53.9% and 30.0% longer when reared on B. tabaci eggs than on T. cinnabarinus and a mix of both prey, respectively. In addition, it produced only a few eggs and its intrinsic rate of increase was negative when reared on B. tabaci eggs, which indicates that B. tabaci is not sufficient to maintain A. orientalis population. The intrinsic rates of increase were 0.16 and 0.23 when A. orientalis was fed on the prey mix and T. cinnabarinus, respectively. These results suggest that although B. tabaci is a poor food resource for A. orientalis in comparison to T. cinnabarinus, A. orientalis is able to sustain its population on a mix of both prey. This predatory mite may thus be a potential biological control agent of B. tabaci when this pest co-occurs with the alternative minor pest T. cinnabarinus.	[Zhang, Xiaoxiao; Lv, Jiale; Wang, Boming; Xu, Xuenong; Wang, Endong] Chinese Acad Agr Sci, Inst Plant Protect, Lab Predatory Mites, Beijing 100193, Peoples R China; [Hu, Yue; Chen, Xi] Syngenta Biotechnol China Co Ltd, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Syngenta	Xu, XN (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Lab Predatory Mites, Beijing 100193, Peoples R China.	xnxu@ippcaas.cn; endong_2000@126.com			study and demonstration project in the industrialization of natural enemies of modern urban agriculture, Beijing Science & Technology Committee [D14110000914002]; earmarked fund for Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System [blvt-11]; Institute of Plant Protection, Chinese Academy of Agricultural Sciences (IPP-CAAS) [TK0224262]; Syngenta Biotechnology China Co Ltd [TK0224262]	study and demonstration project in the industrialization of natural enemies of modern urban agriculture, Beijing Science & Technology Committee; earmarked fund for Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System; Institute of Plant Protection, Chinese Academy of Agricultural Sciences (IPP-CAAS); Syngenta Biotechnology China Co Ltd(Syngenta)	This study was financially supported by the study and demonstration project in the industrialization of natural enemies of modern urban agriculture, Beijing Science & Technology Committee (D14110000914002), the earmarked fund for Beijing Leafy Vegetables Innovation Team of Modern Agro-industry Technology Research System (blvt-11), and the research collaboration between Institute of Plant Protection, Chinese Academy of Agricultural Sciences (IPP-CAAS) and Syngenta Biotechnology China Co Ltd (TK0224262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinejad M, 2014, EXP APPL ACAROL, V64, P361, DOI 10.1007/s10493-014-9830-y; Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; BEDDINGTON JR, 1976, J ANIM ECOL, V45, P165, DOI 10.2307/3773; Blackwood JS, 2001, ENVIRON ENTOMOL, V30, P1103, DOI 10.1603/0046-225X-30.6.1103; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Calvo FJ, 2011, BIOCONTROL, V56, P185, DOI 10.1007/s10526-010-9319-5; Chailleux A, 2014, PEST MANAG SCI, V70, P1769, DOI 10.1002/ps.3916; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Denholm I, 1998, PHILOS T R SOC B, V353, P1757, DOI 10.1098/rstb.1998.0328; Denholm I, 2008, J INSECT SCI, V8, P16; Desneux N, 2008, B ENTOMOL RES, V98, P631, DOI 10.1017/S0007485308006238; Dicke M, 1998, EXP APPL ACAROL, V22, P311, DOI 10.1023/A:1024528507803; Nguyen DT, 2013, BIOCONTROL, V58, P369, DOI 10.1007/s10526-012-9502-y; Enkegaard A, 2001, ENTOMOL EXP APPL, V101, P81, DOI 10.1023/A:1019230603364; Eubanks MD, 2000, ECOL ENTOMOL, V25, P140, DOI 10.1046/j.1365-2311.2000.00243.x; Gan M, 2001, J NANCHANG U, V25, P131; Gilioli G, 2014, PEST MANAG SCI, V70, P1611, DOI 10.1002/ps.3734; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Guo YW., 2014, THESIS CHINESE ACAD; HAYES AJ, 1988, RES POPUL ECOL, V30, P13, DOI 10.1007/BF02512599; Hu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016061; Huang Y.B., 2012, J AGR, V61, P37, DOI DOI 10.1016/B978-0-12-803265-7.00011-7; Jandricic SE, 2010, ENVIRON ENTOMOL, V39, P1631, DOI 10.1603/EN09351; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Ji J, 2007, EXP APPL ACAROL, V43, P171, DOI 10.1007/s10493-007-9114-x; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Lee HS, 2011, EXP APPL ACAROL, V53, P17, DOI 10.1007/s10493-010-9385-5; Lenteren J.C., 1999, DEV PLANT PATHOL, P202; Messelink GJ, 2010, BIOCONTROL, V55, P387, DOI 10.1007/s10526-009-9258-1; MEYER JS, 1986, ECOLOGY, V67, P1156, DOI 10.2307/1938671; Midthassel A, 2013, EXP APPL ACAROL, V61, P69, DOI 10.1007/s10493-013-9682-x; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Nomikou M, 2002, EXP APPL ACAROL, V27, P57, DOI 10.1023/A:1021559421344; Nomikou M, 2001, EXP APPL ACAROL, V25, P271, DOI 10.1023/A:1017976725685; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; R Core Team, 2021, R LANGUAGE ENV STAT; Rahmani H, 2009, BEHAV ECOL, V20, P946, DOI 10.1093/beheco/arp081; Sato Y, 2011, EXP APPL ACAROL, V54, P319, DOI 10.1007/s10493-011-9455-3; Schausberger P, 2010, BEHAVIOUR, V147, P883, DOI 10.1163/000579510X495799; Sheng FJ., 2013, THESIS CHINESE ACAD; Sun Qing-tian, 2001, Journal of Jilin Agricultural University, V23, P24; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; Ugine TA, 2012, ENVIRON ENTOMOL, V41, P1, DOI 10.1603/EN10210; Xiao YF, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.0801; Xu HP, 2008, AGR SERV, V25, P67; Xu X, 1994, J ANHUI AGR U, V21, P81; Xu XN, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14109; Yang Z., 1987, Natural Enemies of Insects, V9, P203; Zhang S. Y., 1990, Natural Enemies of Insects, V12, P21; Zhang S. Y., 1992, Natural Enemies of Insects, V14, P21; ZHANG ZQ, 1993, CAN J ZOOL, V71, P1997, DOI 10.1139/z93-284; [郑方强 ZHENG FangQiang], 2008, [生态学报, Acta Ecologica Sinica], V28, P4830; Zhu ZM, 1983, JIANGXI PLANT PROT, V4, P20	56	173	175	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138820	10.1371/journal.pone.0138820	http://dx.doi.org/10.1371/journal.pone.0138820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436422	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200008
J	Haab, BB; Huang, Y; Balasenthil, S; Partyka, K; Tang, HY; Anderson, M; Allen, P; Sasson, A; Zeh, H; Kaul, K; Kletter, D; Ge, SK; Bern, M; Kwon, R; Blasutig, I; Srivastava, S; Frazier, ML; Sen, S; Hollingsworth, MA; Rinaudo, JA; Killary, AM; Brand, RE				Haab, Brian B.; Huang, Ying; Balasenthil, Seetharaman; Partyka, Katie; Tang, Huiyuan; Anderson, Michelle; Allen, Peter; Sasson, Aaron; Zeh, Herbert; Kaul, Karen; Kletter, Doron; Ge, Shaokui; Bern, Marshall; Kwon, Richard; Blasutig, Ivan; Srivastava, Sudhir; Frazier, Marsha L.; Sen, Subrata; Hollingsworth, Michael A.; Rinaudo, Jo Ann; Killary, Ann M.; Brand, Randall E.			Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; CARCINOEMBRYONIC ANTIGEN; DIAGNOSIS; CA19-9; BIOMARKERS; ADENOCARCINOMA; IDENTIFICATION; CARCINOMA; DISEASES; MARKERS	The validation of candidate biomarkers often is hampered by the lack of a reliable means of assessing and comparing performance. We present here a reference set of serum and plasma samples to facilitate the validation of biomarkers for resectable pancreatic cancer. The reference set includes a large cohort of stage I-II pancreatic cancer patients, recruited from 5 different institutions, and relevant control groups. We characterized the performance of the current best serological biomarker for pancreatic cancer, CA 19-9, using plasma samples from the reference set to provide a benchmark for future biomarker studies and to further our knowledge of CA 19-9 in early-stage pancreatic cancer and the control groups. CA 19-9 distinguished pancreatic cancers from the healthy and chronic pancreatitis groups with an average sensitivity and specificity of 70-74%, similar to previous studies using all stages of pancreatic cancer. Chronic pancreatitis patients did not show CA 19-9 elevations, but patients with benign biliary obstruction had elevations nearly as high as the cancer patients. We gained additional information about the biomarker by comparing two distinct assays. The two CA 9-9 assays agreed well in overall performance but diverged in measurements of individual samples, potentially due to subtle differences in antibody specificity as revealed by glycan array analysis. Thus, the reference set promises be a valuable resource for biomarker validation and comparison, and the CA 19-9 data presented here will be useful for benchmarking and for exploring relationships to CA 19-9.	[Haab, Brian B.; Partyka, Katie; Tang, Huiyuan] Van Andel Res Inst, Grand Rapids, MI USA; [Huang, Ying; Ge, Shaokui] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Balasenthil, Seetharaman; Frazier, Marsha L.; Sen, Subrata; Killary, Ann M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Anderson, Michelle; Kwon, Richard] Univ Michigan, Ann Arbor, MI 48109 USA; [Allen, Peter] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Sasson, Aaron; Hollingsworth, Michael A.] Univ Nebraska Med Ctr, Omaha, NE USA; [Zeh, Herbert; Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA; [Kaul, Karen] Northshore Univ Healthsyst, Evanston, IL USA; [Kletter, Doron; Bern, Marshall] Xerox Corp, Palo Alto Res Ctr, Palo Alto, CA 94304 USA; [Blasutig, Ivan] Univ Hlth Network, Toronto, ON, Canada; [Srivastava, Sudhir; Killary, Ann M.] NCI, Rockville, MD USA	Van Andel Institute; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; University of Nebraska System; University of Nebraska Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; NorthShore University Health System; Xerox; University of Toronto; University Toronto Affiliates; University Health Network Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Brand, RE (corresponding author), Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA.	brandre@upmc.edu		Blasutig, Ivan/0000-0001-7310-2647	Early Detection Research Network of the National Cancer Institute [U01CA152653, U01CA111302]; NATIONAL CANCER INSTITUTE [U01CA152653, P30CA008748, U01CA111302] Funding Source: NIH RePORTER	Early Detection Research Network of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Early Detection Research Network of the National Cancer Institute (U01CA152653 to B. B. Haab, R. E. Brand, and P. Allen; and U01CA111302 to A. M. Killary, M. L. Frazier, and S. Sen). The authors would also like to thank the Early Detection Research Network for providing the pancreatic samples used for this study.	Andicoechea A, 1999, WORLD J SURG, V23, P227, DOI 10.1007/PL00013182; Asuthkar S, 2012, EXPERT OPIN INV DRUG, V21, P143, DOI 10.1517/13543784.2012.651124; Balasenthil S, 2011, CANCER PREV RES, V4, P137, DOI 10.1158/1940-6207.CAPR-10-0025; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Feng ZD, 2013, CLIN CHEM, V59, P68, DOI 10.1373/clinchem.2012.185140; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; HERLYN M, 1979, P NATL ACAD SCI USA, V76, P1438, DOI 10.1073/pnas.76.3.1438; Iacobuzio-Donahue CA, 2012, CLIN CANCER RES, V18, P4257, DOI 10.1158/1078-0432.CCR-12-0315; Jenkinson C, 2015, J PROTEOMICS, V113, P400, DOI 10.1016/j.jprot.2014.10.001; Kim HJ, 1999, AM J GASTROENTEROL, V94, P1941; Kletter D., 2013, CURR PROTOCOLS CHEM, V5, P1, DOI DOI 10.1002/9780470559277.CH130028; KOBAYASHI T, 1991, SCAND J GASTROENTERO, V26, P787, DOI 10.3109/00365529108998600; Li DH, 2010, CLIN CANCER RES, V16, P4313, DOI 10.1158/1078-0432.CCR-09-1942; Liu Y, 2009, BIOL CHEM, V390, P647, DOI 10.1515/BC.2009.071; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; MAGNANI JL, 1982, J BIOL CHEM, V257, P4365; MAGNANI JL, 1983, CANCER RES, V43, P5489; Malesci A, 1987, GASTROENTEROLOGY, V92, P60, DOI 10.1016/0016-5085(87)90840-7; Manimala JC, 2007, GLYCOBIOLOGY, V17, p17C, DOI 10.1093/glycob/cwm047; Menon U, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2079; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; NISHIHARA S, 1993, BIOCHEM BIOPH RES CO, V196, P624, DOI 10.1006/bbrc.1993.2295; O'Brien DP, 2015, CLIN CANCER RES, V21, P622, DOI 10.1158/1078-0432.CCR-14-0365; OHSHIO G, 1990, AM J GASTROENTEROL, V85, P1370; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Partyka K, 2012, PROTEOMICS, V12, P2212, DOI 10.1002/pmic.201100676; Passerini R, 2007, CLIN CHEM LAB MED, V45, P100, DOI 10.1515/CCLM.2007.003; Pepe M. S., 2003, STAT EVALUATION MED; Ransohoff DF, 2007, J CLIN EPIDEMIOL, V60, P1205, DOI 10.1016/j.jclinepi.2007.04.020; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Rye PD, 1998, TUMOR BIOL, V19, P390, DOI 10.1159/000030032; SATAKE K, 1994, PANCREAS, V9, P720, DOI 10.1097/00006676-199411000-00008; STEINBERG W, 1990, AM J GASTROENTEROL, V85, P350; Stern P, 2001, CLIN CHEM LAB MED, V39, P1278, DOI 10.1515/CCLM.2001.205; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Whatcott Clifford J., 2013, Critical Reviews in Oncogenesis, V18, P135; Yue TT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029180; Yue TT, 2011, PROTEOMICS, V11, P3665, DOI 10.1002/pmic.201000827	39	25	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139049	10.1371/journal.pone.0139049	http://dx.doi.org/10.1371/journal.pone.0139049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431551	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000362178700030
J	Hu, Y; Yu, SY; Zuo, LJ; Piao, YS; Cao, CJ; Wang, F; Chen, ZJ; Du, Y; Lian, TH; Liu, GF; Wang, YJ; Chan, P; Chen, SD; Wang, XM; Zhang, W				Hu, Yang; Yu, Shu-Yang; Zuo, Li-Jun; Piao, Ying-Shan; Cao, Chen-Jie; Wang, Fang; Chen, Ze-Jie; Du, Yang; Lian, Teng-Hong; Liu, Gai-Fen; Wang, Ya-Jie; Chan, Piu; Chen, Sheng-Di; Wang, Xiao-Min; Zhang, Wei			Investigation on Abnormal Iron Metabolism and Related Inflammation in Parkinson Disease Patients with Probable RBD	PLOS ONE			English	Article							SLEEP BEHAVIOR DISORDER; NEURODEGENERATIVE DISEASES; SCREENING QUESTIONNAIRE; BRAIN IRON; SYSTEM; CONTRIBUTES; ACTIVATION; EXPRESSION; MICROGLIA; INCREASES	Objective To investigate potential mechanisms involving abnormal iron metabolism and related inflammation in Parkinson disease (PD) patients with probable rapid eye movement sleep behavior disorder (PRBD). Methods Total 210 PD patients and 31 controls were consecutively recruited. PD patients were evaluated by RBD Screening Questionnaire (RBDSQ) and classified into PRBD and probable no RBD (NPRBD) groups. Demographics information were recorded and clinical symptoms were evaluated by series of rating scales. Levels of iron and related proteins and inflammatory factors in cerebrospinal fluid (CSF) and serum were detected. Comparisons among control, NPRBD and PRBD groups and correlation analyses between RBDSQ score and levels of above factors were performed. Results (1) The frequency of PRBD in PD patients is 31.90%. (2) PRBD group has longer disease duration, more advanced disease stage, severer motor symptoms and more non-motor symptoms than NPRBD group. (3) In CSF, levels of iron, transferrin, NO and IL-1 beta in PRBD group are prominently increased. RBDSQ score is positively correlated with the levels of iron, transferrin, NO and IL-1 beta in PD group. Iron level is positively correlated with the levels of NO and IL-1 beta in PD group. (4) In serum, transferrin level is prominently decreased in PRBD group. PGE(2) level in PRBD group is drastically enhanced. RBDSQ score exhibits a positive correlation with PGE(2) level in PD group. Conclusions PRBD is common in PD patients. PRBD group has severer motor symptoms and more nonmotor symptoms. Excessive iron in brain resulted from abnormal iron metabolism in central and peripheral systems is correlated with PRBD through neuroinflammation.	[Hu, Yang; Yu, Shu-Yang; Piao, Ying-Shan; Zhang, Wei] Capital Med Univ, Beijing Tiantan Hosp, Dept Geriatr, Beijing 100050, Peoples R China; [Zuo, Li-Jun; Cao, Chen-Jie; Wang, Fang; Chen, Ze-Jie; Du, Yang; Lian, Teng-Hong; Liu, Gai-Fen; Zhang, Wei] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China; [Liu, Gai-Fen; Zhang, Wei] China Natl Clin Res Ctr Neurol Dis, Beijing 100050, Peoples R China; [Zhang, Wei] Beijing Inst Brain Disorders, Ctr Parkinsons Dis, Beijing 100053, Peoples R China; [Zhang, Wei] Beijing Key Lab Parkinson Dis, Beijing 100053, Peoples R China; [Wang, Ya-Jie] Capital Med Univ, Beijing Tiantan Hosp, Core Lab Clin Med Res, Beijing 100050, Peoples R China; [Chan, Piu] Capital Med Univ, Beijing Inst Geriatr, Dept Neurol & Neurobiol, Xuanwu Hosp, Beijing 10053, Peoples R China; [Chen, Sheng-Di] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200025, Peoples R China; [Wang, Xiao-Min] Capital Med Univ, Dept Physiol, Beijing 100069, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Shanghai Jiao Tong University; Capital Medical University	Zhang, W (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Geriatr, Beijing 100050, Peoples R China.	ttyyzw@163.com	Chan, Piu/I-4580-2016	Chan, Piu/0000-0003-1346-881X	Beijing Healthcare Research Project [JING-15-2]; National Key Basic Research Program of China [2011CB504100]; National Natural Science Foundation of China [81071015, 30770745]; Natural Science Foundation of Beijing, China [7082032]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2013BAI09B03]; Beijing Institute for Brain Disorders [BIBD PXM2013_014226_07_000084]; High Level Technical Personnel Training Project of Beijing Health System, China [2009-3-26]; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality [IDHT20140514]; Capital Clinical Characteristic Application Research [Z121107001012161]; Excellent Personnel Training Project of Beijing, China [20071D0300400076]; Important National Science & Technology Specific Projects [2011ZX09102-003-01]; Key Project of Beijing Natural Science Foundation [kz200910025001]; Basic-Clinical Research Cooperation Funding of Capital Medical University [10JL49, 14JL15, 2015-JL-PT-X04]; Key Project of National Natural Science Foundation of China [81030062]	Beijing Healthcare Research Project; National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing, China(Beijing Natural Science Foundation); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Beijing Institute for Brain Disorders; High Level Technical Personnel Training Project of Beijing Health System, China; Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality; Capital Clinical Characteristic Application Research; Excellent Personnel Training Project of Beijing, China; Important National Science & Technology Specific Projects; Key Project of Beijing Natural Science Foundation(Beijing Natural Science Foundation); Basic-Clinical Research Cooperation Funding of Capital Medical University; Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Beijing Healthcare Research Project (JING-15-2), the National Key Basic Research Program of China (2011CB504100), the National Natural Science Foundation of China (81071015, 30770745), the Natural Science Foundation of Beijing, China (7082032), the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2013BAI09B03), the project of Beijing Institute for Brain Disorders (BIBD PXM2013_014226_07_000084), the High Level Technical Personnel Training Project of Beijing Health System, China (2009-3-26), the Project of Construction of Innovative Teams and Teacher Career Development for Universities and Colleges Under Beijing Municipality (IDHT20140514), the Capital Clinical Characteristic Application Research (Z121107001012161), the Excellent Personnel Training Project of Beijing, China (20071D0300400076), the Important National Science & Technology Specific Projects (2011ZX09102-003-01), the Key Project of National Natural Science Foundation of China (81030062), the Key Project of Beijing Natural Science Foundation (kz200910025001) and the Basic-Clinical Research Cooperation Funding of Capital Medical University (10JL49, 14JL15, 2015-JL-PT-X04).	Andersen HH, 2014, CELL MOL LIFE SCI, V71, P1607, DOI 10.1007/s00018-013-1509-8; Arnulf I, 2012, MOVEMENT DISORD, V27, P677, DOI 10.1002/mds.24957; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; CONNOR JR, 1994, J NEUROSCI RES, V37, P461, DOI 10.1002/jnr.490370405; De Pablos V, 2009, NEUROSCI LETT, V463, P37, DOI 10.1016/j.neulet.2009.07.069; Farhoudi Mehdi, 2012, Pak J Biol Sci, V15, P1094; Fellner L, 2011, ACTA NEUROPATHOL, V121, P675, DOI 10.1007/s00401-011-0833-z; Gjerstad MD, 2008, J NEUROL NEUROSUR PS, V79, P387, DOI 10.1136/jnnp.2007.116830; Haack M, 2009, PAIN, V145, P136, DOI 10.1016/j.pain.2009.05.029; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Hunter Randy L, 2008, Curr Aging Sci, V1, P112; Kang WS, 2013, NEUROSCI LETT, V556, P73, DOI 10.1016/j.neulet.2013.09.050; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Lindqvist D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047387; Logroscino G, 1997, NEUROLOGY, V49, P714, DOI 10.1212/WNL.49.3.714; Madenci G, 2012, NEUROCHEM RES, V37, P1436, DOI 10.1007/s11064-012-0729-x; Mariani S, 2013, NEUROBIOL AGING, V34, P632, DOI 10.1016/j.neurobiolaging.2012.05.015; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Nomura T, 2011, SLEEP MED, V12, P711, DOI 10.1016/j.sleep.2011.01.015; Postuma RB, 2008, J NEUROL NEUROSUR PS, V79, P1117, DOI 10.1136/jnnp.2008.149195; Qian ZM, 2001, TRENDS MOL MED, V7, P103, DOI 10.1016/S1471-4914(00)01910-9; Rhodes SL, 2014, NEUROBIOL DIS, V62, P172, DOI 10.1016/j.nbd.2013.09.019; Romenets Silvia Rios, 2012, Mov Disord, V27, P996, DOI 10.1002/mds.25086; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; SOFIC E, 1988, J NEURAL TRANSM, V74, P199, DOI 10.1007/BF01244786; Stiasny-Kolster K, 2007, MOVEMENT DISORD, V22, P2386, DOI 10.1002/mds.21740; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Villaran RF, 2010, J NEUROCHEM, V114, P1687, DOI 10.1111/j.1471-4159.2010.06879.x; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang J, 2013, BBA-MOL BASIS DIS, V1832, P618, DOI 10.1016/j.bbadis.2013.01.021; Whitton PS, 2007, BRIT J PHARMACOL, V150, P963, DOI 10.1038/sj.bjp.0707167; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Zhang W, 2014, MOL NEUROBIOL, V49, P1153, DOI 10.1007/s12035-013-8586-4; Zhang W, 2011, NEUROTOX RES, V19, P63, DOI 10.1007/s12640-009-9140-z; Zheng W, 2012, PHARMACOL THERAPEUT, V133, P177, DOI 10.1016/j.pharmthera.2011.10.006	37	21	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138997	10.1371/journal.pone.0138997	http://dx.doi.org/10.1371/journal.pone.0138997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431210	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700027
J	Limbourg, A; von Felden, J; Jagavelu, K; Krishnasamy, K; Napp, LC; Kapopara, PR; Gaestel, M; Schieffer, B; Bauersachs, J; Limbourg, FP; Bavendiek, U				Limbourg, Anne; von Felden, Johann; Jagavelu, Kumaravelu; Krishnasamy, Kashyap; Napp, L. Christian; Kapopara, Piyushkumar R.; Gaestel, Matthias; Schieffer, Bernhard; Bauersachs, Johann; Limbourg, Florian P.; Bavendiek, Udo			MAP-Kinase Activated Protein Kinase 2 Links Endothelial Activation and Monocyte/macrophage Recruitment in Arteriogenesis	PLOS ONE			English	Article							COLLATERAL ARTERY GROWTH; POSTNATAL ARTERIOGENESIS; KAPPA-B; EXPRESSION; OCCLUSION; LIGAND; CELLS; MICE	Arteriogenesis, the growth of natural bypass arteries, is triggered by hemodynamic forces within vessels and requires a balanced inflammatory response, involving induction of the chemokine MCP-1 and recruitment of leukocytes. However, little is known how these processes are coordinated. The MAP-kinase-activated-proteinkinase-2 (MK2) is a critical regulator of inflammatory processes and might represent an important link between cytokine production and cell recruitment during postnatal arteriogenesis. Therefore, the present study investigated the functional role of MK2 during postnatal arteriogenesis. In a mouse model of hindlimb ischemia (HLI) MK2-deficiency (MK2KO) significantly impaired ischemic blood flow recovery and growth of collateral arteries as well as perivascular recruitment of mononuclear cells and macrophages. This was accompanied by induction of endothelial MCP-1 expression in wildtype (WT) but not in MK2KO collateral arteries. Following HLI, MK2 activation rapidly occured in the endothelium of growing WT arteries in vivo. In vitro, inflammatory cytokines and cyclic stretch activated MK2 in endothelial cells, which was required for stretch- and cytokine-induced release of MCP-1. In addition, a monocyte cell autonomous function of MK2 was uncovered potentially regulating MCP-1-dependent monocyte recruitment to vessels: MCP-1 stimulation of WT monocytes induced MK2 activation and monocyte migration in vitro. The latter was reduced in MK2KO monocytes, while in vivo MK2 was activated in monocytes recruited to collateral arteries. In conclusion, MK2 regulates postnatal arteriogenesis by controlling vascular recruitment of monocytes/macrophages in a dual manner: regulation of endothelial MCP-1 expression in response to hemodynamic and inflammatory forces as well as MCP-1 dependent monocyte migration.	[Limbourg, Anne; Krishnasamy, Kashyap; Limbourg, Florian P.] Hannover Med Sch, Dept Hypertens & Nephrol, Vasc Med Res, Hannover, Germany; [Limbourg, Anne; Limbourg, Florian P.] Hannover Med Sch, Integriertes Forsch & Behandlungszentrum Transpla, Hannover, Germany; [von Felden, Johann; Jagavelu, Kumaravelu; Napp, L. Christian; Kapopara, Piyushkumar R.; Schieffer, Bernhard; Bauersachs, Johann; Bavendiek, Udo] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany; [Gaestel, Matthias] Hannover Med Sch, Dept Biochem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Bavendiek, U (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.	Bavendiek.Udo@mh-hannover.de	Limbourg, Florian/AAF-5010-2019; Krishnasamy, Kashyap/W-4128-2019; Gaestel, Matthias/A-6560-2013; Jagavelu, Kumaravelu/L-8053-2019; Napp, L. Christian/AAD-2498-2020	Limbourg, Florian/0000-0002-8313-7226; Gaestel, Matthias/0000-0002-4944-4652; Jagavelu, Kumaravelu/0000-0002-9235-0600; Napp, L. Christian/0000-0001-9945-0842	ADUMED-Foundation; DFG [Li948-5/1]; BMBF [GU01GU1105B]; IFB-Tx [01EO1302]; GIF [1089]	ADUMED-Foundation; DFG(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); IFB-Tx; GIF(German-Israeli Foundation for Scientific Research and Development)	This work was funded by grants from the ADUMED-Foundation to U.B. and DFG (Li948-5/1), BMBF (GU01GU1105B), IFB-Tx (01EO1302) and GIF (1089) to F.P.L.	Bavendiek U, 2002, J BIOL CHEM, V277, P25032, DOI 10.1074/jbc.M204003200; Cambien B, 2001, BLOOD, V97, P359, DOI 10.1182/blood.V97.2.359; Chen ZM, 2010, CIRC RES, V107, P1355, DOI 10.1161/CIRCRESAHA.110.229955; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Green SR, 2006, J IMMUNOL, V176, P7412, DOI 10.4049/jimmunol.176.12.7412; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Heil M, 2004, CIRC RES, V94, P671, DOI 10.1161/01.RES.0000122041.73808.B5; Heil M, 2002, AM J PHYSIOL-HEART C, V283, pH2411, DOI 10.1152/ajpheart.01098.2001; Heil M, 2007, CURR PHARM BIOTECHNO, V8, P35, DOI 10.2174/138920107779941408; Ito WD, 1997, CIRC RES, V80, P829; Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075; Jagielska J, 2009, ATHEROSCLEROSIS, V206, P390, DOI 10.1016/j.atherosclerosis.2009.03.019; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Resnick N, 2003, ENDOTHELIUM-J ENDOTH, V10, P197, DOI 10.1080/713715231; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHYY YJ, 1994, P NATL ACAD SCI USA, V91, P4678, DOI 10.1073/pnas.91.11.4678; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566	23	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138542	10.1371/journal.pone.0138542	http://dx.doi.org/10.1371/journal.pone.0138542			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431421	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700015
J	Chou, YY; Lai, KL; Chen, DY; Lin, CH; Chen, H				Chou, Yin-Yi; Lai, Kuo-Lung; Chen, Der-Yuan; Lin, Ching-Heng; Chen, Hua			Rheumatoid Arthritis Risk Associated with Periodontitis Exposure: A Nationwide, Population-Based Cohort Study	PLOS ONE			English	Article							CITRULLINATED PROTEINS; DIABETES-MELLITUS; TOOTH LOSS; DISEASE; HEALTH	Background The risk of periodontitis (PD) is increased in the patient group of rheumatoid arthritis (RA). RA and PD also shared some pathological mechanism. The aim of this study is to investigate the risk of RA associated with PD exposure. Methods and Findings This study identified 3 mutually exclusive cohorts using the 1999-2010 Taiwanese National Health Insurance Research Database (NHIRD) to investigate the association between PD and the risk of incident RA. All patients with PD in 2000 were identified from the database of all enrollees as the PD cohort. From the representative database of 1,000,000 enrollees randomly selected in 2010 (LHID2010), individuals without any periodontal disease (PO) during 1999-2010 were selected as the non-PO cohort. Individuals who were not included in the non-PO cohort and received dental scaling (DS) no more than two times per year during 1999-2010 were selected as the DS cohort from LHID2010. Using cox proportional regression analysis, hazard ratios (HRs) with 95% confidence intervals (Cis) were calculated to quantify the association between PD exposure and RA development. In the three-group comparison using the non-PO cohort as reference, we found that the risk of RA was higher in the PD and DS cohorts (HRs, 1.89 and 1.43; 95% CIs, 1.56-2.29 and 1.09-1.87, respectively). For comparisons between two cohorts, the PD cohort had a higher risk of RA than the non-PO and DS cohorts (HRs, 1.91 and 1.35; 95% CIs, 1.57-2.30 and 1.09-1.67, respectively). Conclusion PD was associated with an increased risk of RA development.	[Chou, Yin-Yi; Lai, Kuo-Lung; Chen, Der-Yuan; Chen, Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lai, Kuo-Lung; Chen, Der-Yuan; Chen, Hua] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Der-Yuan; Chen, Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hua] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Lin, Ching-Heng; Chen, Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Chen, Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chen, Hua] Natl Yang Ming Univ, Inst Hosp, Taipei 112, Taiwan; [Chen, Hua] Natl Yang Ming Univ, Hlth Care Adm, Taipei 112, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Shan Medical University; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, H (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.	shc5555@hotmail.com						Arkema EV, 2010, J RHEUMATOL, V37, P1800, DOI 10.3899/jrheum.091398; Berthelot JM, 2010, JOINT BONE SPINE, V77, P537, DOI 10.1016/j.jbspin.2010.04.015; Chen HHC, 2009, HLTH RELATED QUALITY; Chen HH, 2014, REV BRAS REUMATOL, V54, P124, DOI [10.1016/j.rbr.2014.03.007, 10.1016/j.rbre.2014.03.007]; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Christensen Anne Friesgaard, 2008, Ugeskr Laeger, V170, P2864; Colmers IN, 2013, DIABETES CARE, V36, P3070, DOI 10.2337/dc13-0045; de Pablo P, 2008, J RHEUMATOL, V35, P70; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Kasser U, 1997, ARTHRITIS RHEUM, V40, P2248; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lindhardsen J, 2011, ANN RHEUM DIS, V70, P929, DOI 10.1136/ard.2010.143396; Maresz KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003627; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Nilsson M, 2008, J PERIODONTOL, V79, P1689, DOI 10.1902/jop.2008.070599 ; Pischon N, 2008, J PERIODONTOL, V79, P979, DOI [10.1902/jop.2008.070501, 10.1902/jop.2008.070501 ]; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Rutger Persson G., 2012, J ORAL MICROBIOL, V4; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x	26	42	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139693	10.1371/journal.pone.0139693	http://dx.doi.org/10.1371/journal.pone.0139693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426533	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100086
J	Fujita, Y; Fujiwara, K; Zenitani, S; Yamashita, T				Fujita, Yuki; Fujiwara, Kei; Zenitani, Shigetake; Yamashita, Toshihide			Acetylation of NDPK-D Regulates Its Subcellular Localization and Cell Survival	PLOS ONE			English	Article							NUCLEOSIDE-DIPHOSPHATE-KINASE; SIRT1 DEACETYLASE; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; SYNAPTIC PLASTICITY; CALORIE RESTRICTION; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; P53; MITOCHONDRIA	Nucleoside diphosphate kinases (NDPK) are ubiquitous enzymes that catalyze the reversible phosphotransfer of gamma-phosphates between di- and triphosphonucleosides. NDPK-D (Nm23-H4) is the only member of the NDPK family with a mitochondrial targeting sequence. Despite the high expression of NDPK-D in the developing central nervous system, its function remains to be determined. In this study, we show that NDPK-D knockdown induces apoptosis in neuroblastoma cells as well as in mouse cortex, suggesting that NDPK-D is required for neuronal survival. We identified NDPK-D as a binding partner of NAD+-dependent histone deacetylase, SIRT1, by yeast two-hybrid screening. NDPK-D co-localized with SIRT1, and the association of these molecules was confirmed by co-immunoprecipitation. Inhibition of SIRT1 increases the acetylation of NDPK-D. Overexpression of NDPK-D along with SIRT1, or mutation in the acetylated lysine residues in NDPK-D, increases its nuclear accumulation. Furthermore, the NDPK-D acetylation-mimic mutant increased apoptosis in N1E-115 cells. Our data demonstrate that acetylation regulates the shuttling of NDPK-D between nucleus and cytoplasm, and increased acetylation of NDPK-D causes apoptosis.	[Fujita, Yuki; Fujiwara, Kei; Zenitani, Shigetake; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, Suita, Osaka, Japan; [Fujita, Yuki; Fujiwara, Kei; Yamashita, Toshihide] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo, Japan	Osaka University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Science (JSPS) [26830028]; JSPS [25221309]; Grants-in-Aid for Scientific Research [26830028] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (26830028) to Y.F. and a Grant-in-Aid for Scientific Research (S) from the JSPS (25221309) to T.Y.	Amrein L, 2005, CELL TISSUE RES, V322, P365, DOI 10.1007/s00441-005-0036-9; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Bilitou A, 2009, MOL CELL BIOCHEM, V329, P17, DOI 10.1007/s11010-009-0121-6; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fujita Y, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.85; Fujita Y, 2011, EMBO J, V30, P1389, DOI 10.1038/emboj.2011.55; Fujita Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-6; Galluzzi L, 2012, EMBO REP, V13, P322, DOI 10.1038/embor.2012.19; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guarente L, 2011, COLD SH Q B, V76, P81, DOI 10.1101/sqb.2011.76.010629; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Hoppins S, 2012, SCIENCE, V337, P1052, DOI 10.1126/science.1224709; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Janin J, 2000, J BIOENERG BIOMEMBR, V32, P215, DOI 10.1023/A:1005528811303; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; KLAR AJS, 1979, GENETICS, V93, P37; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Koyama Y, 2008, J CHEM NEUROANAT, V36, P209, DOI 10.1016/j.jchemneu.2008.08.006; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo JY, 2004, P NATL ACAD SCI USA, V101, P2259, DOI 10.1073/pnas.0308762101; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Michan S, 2010, J NEUROSCI, V30, P9695, DOI 10.1523/JNEUROSCI.0027-10.2010; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Muller FL, 2007, FREE RADICAL BIO MED, V43, P477, DOI 10.1016/j.freeradbiomed.2007.03.034; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ogawa T, 2011, CONGENIT ANOM, V51, P70, DOI 10.1111/j.1741-4520.2010.00304.x; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; RINE J, 1979, GENETICS, V93, P877; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rumi M, 2006, BIOCHEM BIOPH RES CO, V339, P540, DOI 10.1016/j.bbrc.2005.11.037; Sack MN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013102; Schlattner U, 2013, J BIOL CHEM, V288, P111, DOI 10.1074/jbc.M112.408633; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tokarska-Schlattner M, 2008, J BIOL CHEM, V283, P26198, DOI 10.1074/jbc.M803132200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhao YN, 2013, BIOCHEM BIOPH RES CO, V435, P597, DOI 10.1016/j.bbrc.2013.05.025	59	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139616	10.1371/journal.pone.0139616	http://dx.doi.org/10.1371/journal.pone.0139616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426123	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100082
J	Gates, I; Olson, V; Smith, S; Patel, N; Damon, I; Karem, K				Gates, Irina; Olson, Victoria; Smith, Scott; Patel, Nishi; Damon, Inger; Karem, Kevin			Development of a High-Content Orthopoxvirus Infectivity and Neutralization Assays	PLOS ONE			English	Article							SMALLPOX	Currently, a number of assays measure Orthopoxvirus neutralization with serum from individuals, vaccinated against smallpox. In addition to the traditional plaque reduction neutralization test (PRNT), newer higher throughput assays are based on neutralization of recombinant vaccinia virus, expressing reporter genes such as beta-galactosidase or green fluorescent protein. These methods could not be used to evaluate neutralization of variola virus, since genetic manipulations of this virus are prohibited by international agreements. Currently, PRNT is the assay of choice to measure neutralization of variola virus. However, PRNT assays are time consuming, labor intensive, and require considerable volume of serum sample for testing. Here, we describe the development of a high-throughput, cell-based imaging assay that can be used to measure neutralization, and characterize replication kinetics of various Orthopoxviruses, including variola, vaccinia, monkeypox, and cowpox.	[Gates, Irina] Atlanta Res & Educ Fdn, Decatur, GA 30033 USA; [Olson, Victoria; Smith, Scott; Patel, Nishi; Damon, Inger; Karem, Kevin] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, DHCPP, NCEZID, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Gates, I (corresponding author), Atlanta Res & Educ Fdn, Decatur, GA 30033 USA.	irina.gates@gmail.com			U.S. Department of Health and Human Services (HHS) / The Centers for Disease Control and Prevention (CDC)	U.S. Department of Health and Human Services (HHS) / The Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The U.S. Department of Health and Human Services (HHS) / The Centers for Disease Control and Prevention (CDC) approved government funds were used to support this work.	[Anonymous], 2008, WHO RECOMMENDATIONS; Centers for Disease Control and Prevention (CDC), 2003, MMWR-MORBID MORTAL W, V23, P537; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Dominguez J, 1998, J IMMUNOL METHODS, V220, P115, DOI 10.1016/S0022-1759(98)00156-2; Earl PL, 2003, J VIROL, V77, P10684, DOI 10.1128/JVI.77.19.10684-10688.2003; ELAD B, 1990, J INFECT DIS, V161, P446, DOI 10.1093/infdis/161.3.446; Frey SE, 2002, NEW ENGL J MED, V346, P1275, DOI 10.1056/NEJMoa013431; Henderson DA, 1999, JAMA-J AM MED ASSOC, V281, P2127, DOI 10.1001/jama.281.22.2127; Hutson CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055488; Jezek Z, 1988, HUMAN MONKEYPOX; Johnson MC, 2008, J VIROL METHODS, V150, P14, DOI 10.1016/j.jviromet.2008.02.009; Manischewitz J, 2003, J INFECT DIS, V188, P440, DOI 10.1086/376557; MCCARTHY K., 1958, JOUR HYGIENE, V56, P466; Schwartz B, 2005, INT J DERMATOL, V44, P289, DOI 10.1111/j.1365-4632.2004.02568.x; Sokrin A, 1976, VOPR OKHR MATERIN DE, V21, P29; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	16	1	1	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138836	10.1371/journal.pone.0138836	http://dx.doi.org/10.1371/journal.pone.0138836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426117	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100022
J	Pang, ZY; Wei, CS; Teng, DD; Chen, DH; Tan, HZ				Pang, Zhiyong; Wei, Chuansheng; Teng, Dongdong; Chen, Dihu; Tan, Hongzhou			Robust Eye Center Localization through Face Alignment and Invariant Isocentric Patterns	PLOS ONE			English	Article							GAZE TRACKING SYSTEM; LOCATION; FEATURES; MANIFOLD	The localization of eye centers is a very useful cue for numerous applications like face recognition, facial expression recognition, and the early screening of neurological pathologies. Several methods relying on available light for accurate eye-center localization have been exploited. However, despite the considerable improvements that eye-center localization systems have undergone in recent years, only few of these developments deal with the challenges posed by the profile (non-frontal face). In this paper, we first use the explicit shape regression method to obtain the rough location of the eye centers. Because this method extracts global information from the human face, it is robust against any changes in the eye region. We exploit this robustness and utilize it as a constraint. To locate the eye centers accurately, we employ isophote curvature features, the accuracy of which has been demonstrated in a previous study. By applying these features, we obtain a series of eye-center locations which are candidates for the actual position of the eye-center. Among these locations, the estimated locations which minimize the reconstruction error between the two methods mentioned above are taken as the closest approximation for the eye centers locations. Therefore, we combine explicit shape regression and isophote curvature feature analysis to achieve robustness and accuracy, respectively. In practical experiments, we use BioID and FERET datasets to test our approach to obtaining an accurate eye-center location while retaining robustness against changes in scale and pose. In addition, we apply our method to non-frontal faces to test its robustness and accuracy, which are essential in gaze estimation but have seldom been mentioned in previous works. Through extensive experimentation, we show that the proposed method can achieve a significant improvement in accuracy and robustness over state-of-the-art techniques, with our method ranking second in terms of accuracy. According to our implementation on a PC with a Xeon 2.5Ghz CPU, the frame rate of the eye tracking process can achieve 38 Hz.	[Pang, Zhiyong; Wei, Chuansheng; Teng, Dongdong; Chen, Dihu] Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Tan, Hongzhou] Sun Yat Sen Univ, Sch Informat Sci & Technol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Dihu; Tan, Hongzhou] SYSU CMU Shunde Int Joint Res Inst, Foshan, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Pang, ZY (corresponding author), Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou 510275, Guangdong, Peoples R China.	stspzy@mail.sysu.edu.cn; issthz@mail.sysu.edu.cn		Tan, Hong-Zhou/0000-0002-5214-997X	National Natural Science Foundation of China [81471787, 61473322]; Natural Science Foundation of Guangdong Province [2015A030310142]; Guangzhou Technical Plan Project [201510010280]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangzhou Technical Plan Project	This work was supported by the National Natural Science Foundation of China under Grant nos 81471787 and 61473322, a grant from Natural Science Foundation of Guangdong Province under 2015A030310142, and a Guangzhou Technical Plan Project under No. 201510010280.	Agustin JS, 2009, THESIS IT U; [Anonymous], 2013, ICCV; [Anonymous], 2013, IEEE T PATTERN ANAL; [Anonymous], 2005, 2005 IEEE COMP VIS P; Asadifard M, 2010, IMECS; Belhumeur P. N., 2011, CVPR; Campadelli P, 2006, BMVC; Cao X., 2012, P CVPR; Cho DC, 2012, IEEE T CONSUM ELECTR, V58, P1119, DOI 10.1109/TCE.2012.6414976; Corcoran PM, 2012, IEEE T CONSUM ELECTR, V58, P347, DOI 10.1109/TCE.2012.6227433; CRISTINACCE D., 2004, P BRIT MACH VIS C, P277; Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658; Froba B, 2004, SIXTH IEEE INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION, PROCEEDINGS, P91, DOI 10.1109/AFGR.2004.1301514; Hamouz M, 2005, IEEE T PATTERN ANAL, V27, P1490, DOI 10.1109/TPAMI.2005.179; Hansen DW, 2010, IEEE T PATTERN ANAL, V32, P478, DOI 10.1109/TPAMI.2009.30; Hansen Dan Witzner, 2010, P 2010 S EYE TRACK R, P13; Huang G. B, 0749 U MASS; Huang J, 2000, IEEE T EVOLUT COMPUT, V4, P73, DOI 10.1109/4235.843496; Kervrann C., 2002, International Journal of Computer Vision, V50, P63, DOI 10.1023/A:1020276319925; Kim S, 2007, MULTISCALE GABOR FEA; Lee HC, 2010, IEEE T CONSUM ELECTR, V56, P2577, DOI 10.1109/TCE.2010.5681143; Leo M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102829; Lichtenauer J, 2005, PROC CVPR IEEE, P649; Liu MY, 2014, PROC CVPR IEEE, P1749, DOI 10.1109/CVPR.2014.226; Markus N, 2014, PATTERN RECOGN, V47, P578, DOI 10.1016/j.patcog.2013.08.008; Moriyama T, 2006, IEEE T PATTERN ANAL, V28, P738, DOI 10.1109/TPAMI.2006.98; Niu Z, 2006, 2D CASCADED ADABOOST; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Reale M, 2011, IEEE T MULTIMEDIA, V13; Rudovic O, 2013, IEEE T PATTERN ANAL, V35, P1357, DOI 10.1109/TPAMI.2012.233; Tan X, 2009, CVPR, P20; Timm F., 2011, VISAPP; Valenti R., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587529; Valenti R, 2012, IEEE T PATTERN ANAL, V34, P1785, DOI 10.1109/TPAMI.2011.251; Valenti R, 2012, IEEE T IMAGE PROCESS, V21, P802, DOI 10.1109/TIP.2011.2162740; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wang HG, 2005, COMPUT VIS IMAGE UND, V98, P83, DOI 10.1016/j.cviu.2004.07.008; Wang J, 2007, ACM T MULTIM COMPUT, V3, DOI 10.1145/1314303.1314306; Wang SF, 2013, PATTERN RECOGN, V46, P2613, DOI 10.1016/j.patcog.2013.03.001; Zhang W, 2011, OPT ENG, V50, DOI 10.1117/1.3562327; Zhao SC, 2013, NEUROCOMPUTING, V119, P101, DOI 10.1016/j.neucom.2012.04.042; Zheng ZL, 2005, PATTERN RECOGN LETT, V26, P2252, DOI 10.1016/j.patrec.2005.03.033	42	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139098	10.1371/journal.pone.0139098	http://dx.doi.org/10.1371/journal.pone.0139098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426929	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100029
J	Ribot, EJ; Wecker, D; Trotier, AJ; Dallaudiere, B; Lefrancois, W; Thiaudiere, E; Franconi, JM; Miraux, S				Ribot, Emeline J.; Wecker, Didier; Trotier, Aurelien J.; Dallaudiere, Benjamin; Lefrancois, William; Thiaudiere, Eric; Franconi, Jean-Michel; Miraux, Sylvain			Water Selective Imaging and bSSFP Banding Artifact Correction in Humans and Small Animals at 3T and 7T, Respectively	PLOS ONE			English	Article							STATE FREE PRECESSION; STEADY-STATE; ARTICULAR-CARTILAGE; FAT-SUPPRESSION; KNEE; PHASE; EXCITATION; SEPARATION; SEQUENCES; 3.0T	Introduction The purpose of this paper is to develop an easy method to generate both fat signal and banding artifact free 3D balanced Steady State Free Precession (bSSFP) images at high magnetic field. Methods In order to suppress fat signal and bSSFP banding artifacts, two or four images were acquired with the excitation frequency of the water-selective binomial radiofrequency pulse set On Resonance or shifted by a maximum of 3/4TR. Mice and human volunteers were imaged at 7T and 3T, respectively to perform whole-body and musculoskeletal imaging. "Sum-Of-Square" reconstruction was performed and combined or not with parallel imaging. Results The frequency selectivity of 1-2-3-2-1 or 1-3-3-1 binomial pulses was preserved after (3/4TR) frequency shifting. Consequently, whole body small animal 3D imaging was performed at 7T and enabled visualization of small structures within adipose tissue like lymph nodes. In parallel, this method allowed 3D musculoskeletal imaging in humans with high spatial resolution at 3T. The combination with parallel imaging allowed the acquisition of knee images with similar to 500 mu m resolution images in less than 2min. In addition, ankles, full head coverage and legs of volunteers were imaged, demonstrating the possible application of the method also for large FOV. Conclusion In conclusion, this robust method can be applied in small animals and humans at high magnetic fields. The high SNR and tissue contrast obtained in short acquisition times allows to prescribe bSSFP sequence for several preclinical and clinical applications.	[Ribot, Emeline J.; Trotier, Aurelien J.; Dallaudiere, Benjamin; Lefrancois, William; Thiaudiere, Eric; Franconi, Jean-Michel; Miraux, Sylvain] Univ Bordeaux, Ctr Resonance Magnet Syst Biol, CNRS, UMR 5536, Bordeaux, France; [Wecker, Didier] Bruker Biospin MRI GMBH, Ettlingen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Bruker Corporation; Bruker BioSpin GmbH	Ribot, EJ (corresponding author), Univ Bordeaux, Ctr Resonance Magnet Syst Biol, CNRS, UMR 5536, Bordeaux, France.	ribot@rmsb.u-brodeaux2.fr	Miraux, Sylvain/AAF-1023-2019; TROTIER, Aurélien Julien/ABE-9012-2021	TROTIER, Aurélien Julien/0000-0001-8860-1406; Thiaudiere, Eric/0000-0002-9993-4035; Miraux, Sylvain/0000-0002-3642-2390; RIBOT, Emeline/0000-0002-3063-1263	French National Research Agency (ANR) [ANR-12-TECS-0011 TecSAN IneoV]; ANR [ANR-10-LABX-57]; Bruker Biospin	French National Research Agency (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Bruker Biospin	This work was supported by a public grant from the French National Research Agency (ANR) ANR-12-TECS-0011 TecSAN IneoV. Emeline Ribot is also partly supported by a public grant from ANR within the context of the Investments for the Future Program, referenced "NewFISP" ANR-10-LABX-57 and named TRAIL. Author Didier Wecker is employed by Bruker Biospin. Bruker Biospin provided support in the form of salary for author DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al Saleh H, 2014, J MAGN RESON IMAGING, V40, P796, DOI 10.1002/jmri.24425; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Bangerter NK, 2004, MAGN RESON MED, V51, P1038, DOI 10.1002/mrm.20052; Bernas LM, 2007, J NEUROSURG, V106, P306, DOI 10.3171/jns.2007.106.2.306; Chen CA, 2010, J MAGN RESON IMAGING, V32, P173, DOI 10.1002/jmri.22213; Cukur T, 2011, J MAGN RESON IMAGING, V33, P931, DOI 10.1002/jmri.22479; Cukur T, 2009, MAGN RESON MED, V62, P193, DOI 10.1002/mrm.21990; Duc SR, 2007, RADIOLOGY, V245, P216, DOI 10.1148/radiol.2451060990; FREEMAN R, 1971, J MAGN RESON, V4, P366, DOI 10.1016/0022-2364(71)90047-3; Gold GE, 2006, RADIOLOGY, V240, P546, DOI 10.1148/radiol.2402050288; Gold GE, 2006, RADIOLOGY, V238, P712, DOI 10.1148/radiol.2381042183; Hargreaves BA, 2006, MAGN RESON IMAGING, V24, P113, DOI 10.1016/j.mri.2005.10.013; Hargreaves BA, 2003, MAGNET RESON MED, V50, P210, DOI 10.1002/mrm.10488; Hargreaves BA, 2003, MAGNET RESON MED, V49, P700, DOI 10.1002/mrm.10424; Kijowski R, 2006, J MAGN RESON IMAGING, V24, P168, DOI 10.1002/jmri.20596; Kornaat PR, 2005, OSTEOARTHR CARTILAGE, V13, P338, DOI 10.1016/j.joca.2004.12.008; Kornaat PR, 2004, J MAGN RESON IMAGING, V20, P850, DOI 10.1002/jmri.20194; Leupold J, 2006, MAGN RESON MED, V55, P557, DOI 10.1002/mrm.20790; Lu AM, 2005, MAGN RESON MED, V54, P1051, DOI 10.1002/mrm.20715; Mallett CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018361; Miraux S, 2008, J MAGN RESON IMAGING, V28, P497, DOI 10.1002/jmri.21449; Miyake H, 1996, CANCER RES, V56, P2440; Munch B, 2009, OPT EXPRESS, V17, P8567, DOI 10.1364/OE.17.008567; Nayak KS, 2004, MAGNET RESON MED, V51, P655, DOI 10.1002/mrm.20053; Overall WR, 2003, MAGNET RESON MED, V50, P550, DOI 10.1002/mrm.10542; Paul D, 2006, MAGN RESON MED, V56, P1328, DOI 10.1002/mrm.21084; Perera M, 2012, TRANSL ONCOL, V5, P217, DOI 10.1593/tlo.12109; Quist B, 2015, MAGN RESON MED, V74, P706, DOI 10.1002/mrm.25449; Quist B, 2012, MAGN RESON MED, V67, P1004, DOI 10.1002/mrm.23076; Reeder SB, 2003, AM J ROENTGENOL, V180, P357, DOI 10.2214/ajr.180.2.1800357; Scheffler K, 2001, MAGNET RESON MED, V45, P1075, DOI 10.1002/mrm.1142; Schick F, 1998, MAGNET RESON MED, V40, P194, DOI 10.1002/mrm.1910400205; Vasanawala SS, 2005, AM J ROENTGENOL, V184, P1450, DOI 10.2214/ajr.184.5.01841450; Vasanawala SS, 1999, MAGNET RESON MED, V42, P876, DOI 10.1002/(SICI)1522-2594(199911)42:5<876::AID-MRM6>3.0.CO;2-Z; Vasanawala SS, 2000, MAGNET RESON MED, V43, P82, DOI 10.1002/(SICI)1522-2594(200001)43:1<82::AID-MRM10>3.0.CO;2-9; Weckbach S, 2006, INVEST RADIOL, V41, P189, DOI 10.1097/01.rli.0000195837.32417.f9; Yuan J, 2011, J MAGN RESON, V208, P219, DOI 10.1016/j.jmr.2010.11.005; Zhu YD, 2004, MAGNET RESON MED, V51, P775, DOI 10.1002/mrm.20011; Zivadinov R, 2010, INT ANGIOL, V29, P158	39	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139249	10.1371/journal.pone.0139249	http://dx.doi.org/10.1371/journal.pone.0139249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426849	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100040
J	Nobukawa, S; Nishimura, H; Yamanishi, T; Liu, JQ				Nobukawa, Sou; Nishimura, Haruhiko; Yamanishi, Teruya; Liu, Jian-Qin			Analysis of Chaotic Resonance in Izhikevich Neuron Model	PLOS ONE			English	Article							STOCHASTIC RESONANCE; COMPUTATION; BRAIN; NOISE	In stochastic resonance (SR), the presence of noise helps a nonlinear system amplify a weak (sub-threshold) signal. Chaotic resonance (CR) is a phenomenon similar to SR but without stochastic noise, which has been observed in neural systems. However, no study to date has investigated and compared the characteristics and performance of the signal responses of a spiking neural system in some chaotic states in CR. In this paper, we focus on the Izhikevich neuron model, which can reproduce major spike patterns that have been experimentally observed. We examine and classify the chaotic characteristics of this model by using Lyapunov exponents with a saltation matrix and Poincare section methods in order to address the measurement challenge posed by the state-dependent jump in the resetting process. We found the existence of two distinctive states, a chaotic state involving primarily turbulent movement and an intermittent chaotic state. In order to assess the signal responses of CR in these classified states, we introduced an extended Izhikevich neuron model by considering weak periodic signals, and defined the cycle histogram of neuron spikes as well as the corresponding mutual correlation and information. Through computer simulations, we confirmed that both chaotic states in CR can sensitively respond to weak signals. Moreover, we found that the intermittent chaotic state exhibited a prompter response than the chaotic state with primarily turbulent movement.	[Nobukawa, Sou; Yamanishi, Teruya] Fukui Univ Technol, Dept Management Informat Sci, Fukui, Japan; [Nishimura, Haruhiko; Liu, Jian-Qin] Univ Hyogo, Grad Sch Appl Informat, Kobe, Hyogo 6500044, Japan	University of Hyogo	Nobukawa, S (corresponding author), Fukui Univ Technol, Dept Management Informat Sci, Fukui, Japan.	nobukawa@fukui-ut.ac.jp	Nobukawa, Sou/AAL-9021-2020	Nishimura, Haruhiko/0000-0003-1572-6747	Japan Society for the Promotion of Science [15K21471]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	SN has been supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/index.html), Grant-in-Aid for Young Scientists (B), grant number (15K21471) since April 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishchenko V.S., 2007, NONLINEAR DYNAMICS C; Arbib MA., 2003, HDB BRAIN THEORY NEU; Berget P, 1991, ORDER CHAOS DETERMIN; Bizzarri F, 2013, J COMPUT NEUROSCI, V35, P201, DOI 10.1007/s10827-013-0448-6; CARROLL TL, 1993, PHYS REV LETT, V70, P576, DOI 10.1103/PhysRevLett.70.576; CARROLL TL, 1993, PHYS REV E, V47, P3941, DOI 10.1103/PhysRevE.47.3941; CRISANTI A, 1994, J PHYS A-MATH GEN, V27, pL597, DOI 10.1088/0305-4470/27/17/001; El Boustani S, 2010, INT J BIFURCAT CHAOS, V20, P1687, DOI 10.1142/S0218127410026769; Freeman WJ, 2003, CHAOS, V13, P1067, DOI 10.1063/1.1596553; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gottwald GA, 2004, P ROY SOC A-MATH PHY, V460, P603, DOI 10.1098/rspa.2003.1183; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kim Y, 2010, J KOREAN PHYS SOC, V57, P1363, DOI 10.3938/jkps.57.1363; Korn H, 2003, CR BIOL, V326, P787, DOI 10.1016/j.crvi.2003.09.011; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; MOSS F, 1995, SCI AM, V273, P66, DOI 10.1038/scientificamerican0895-66; Nagashima H., 1998, INTODUCTION CHAOS PH; NICOLIS G, 1993, J STAT PHYS, V70, P125, DOI 10.1007/BF01053958; Nishimura H, 2000, NEURAL PROCESS LETT, V12, P49, DOI 10.1023/A:1009626028831; Nobukawa Sou, 2013, Transactions of the Institute of Electronics, Information and Communication Engineers A, Vj96-a, P1; Nobukawa Sou, 2012, Transactions of the Institute of Electronics, Information and Communication Engineers A, VJ95-A, P357; Nobukawa S., 2011, SICE 2011 - 50th Annual Conference of the Society of Instrument and Control Engineers of Japan, P1242; Nobukawa S, 2011, PROCEEDINGS OF NONLI, V8147, P423; Nobukawa S, 2014, JOINT INT CONF SOFT, P813, DOI 10.1109/SCIS-ISIS.2014.7044746; Nobukawa S, 2012, JOINT INT CONF SOFT, P49, DOI 10.1109/SCIS-ISIS.2012.6505173; Parker T.S., 2012, PRACTICAL NUMERICAL; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Schweighofer N, 2004, P NATL ACAD SCI USA, V101, P4655, DOI 10.1073/pnas.0305966101; Sinha S, 1998, PHYS REV E, V58, P8009, DOI 10.1103/PhysRevE.58.8009; Tamura A., 2009, DYNAM CONT DIS SER A, V16, P759; Tokuda IT, 2010, NEURAL NETWORKS, V23, P836, DOI 10.1016/j.neunet.2010.04.006	36	41	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138919	10.1371/journal.pone.0138919	http://dx.doi.org/10.1371/journal.pone.0138919			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422140	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700056
J	Zollo, F; Novak, PK; Del Vicario, M; Bessi, A; Mozetic, I; Scala, A; Caldarelli, G; Quattrociocchi, W				Zollo, Fabiana; Novak, Petra Kralj; Del Vicario, Michela; Bessi, Alessandro; Mozetic, Igor; Scala, Antonio; Caldarelli, Guido; Quattrociocchi, Walter			Emotional Dynamics in the Age of Misinformation	PLOS ONE			English	Article							SOCIAL MEDIA; INCIVILITY; AGREEMENT; ONLINE; POWER	According to the World Economic Forum, the diffusion of unsubstantiated rumors on online social media is one of the main threats for our society. The disintermediated paradigm of content production and consumption on online social media might foster the formation of homogeneous communities (echo-chambers) around specific worldviews. Such a scenario has been shown to be a vivid environment for the diffusion of false claim. Not rarely, viral phenomena trigger naive (and funny) social responses-e.g., the recent case of Jade Helm 15 where a simple military exercise turned out to be perceived as the beginning of the civil war in the US. In this work, we address the emotional dynamics of collective debates around distinct kinds of information-i.e., science and conspiracy news-and inside and across their respective polarized communities. We find that for both kinds of content the longer the discussion the more the negativity of the sentiment. We show that comments on conspiracy posts tend to be more negative than on science posts. However, the more the engagement of users, the more they tend to negative commenting (both on science and conspiracy). Finally, zooming in at the interaction among polarized communities, we find a general negative pattern. As the number of comments increases-i.e., the discussion becomes longer-the sentiment of the post is more and more negative.	[Zollo, Fabiana; Del Vicario, Michela; Bessi, Alessandro; Caldarelli, Guido; Quattrociocchi, Walter] IMT Inst Adv Studies, Lucca, Italy; [Novak, Petra Kralj; Mozetic, Igor] Jozef Stefan Inst, Ljubljana 1000, Slovenia; [Bessi, Alessandro] IUSS, Pavia, Italy; [Scala, Antonio] CNR, ISC, Rome, Italy	IMT School for Advanced Studies Lucca; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; IUSS PAVIA; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Quattrociocchi, W (corresponding author), IMT Inst Adv Studies, Lucca, Italy.	walterquattrociocchi@gmail.com	Scala, Antonio/A-2098-2012; Scala, Antonio/GRS-5823-2022; Caldarelli, Guido/AAB-8206-2022; Scala, Antonio/H-9153-2019; Novak, Petra Kralj/AAE-5852-2020; Zollo, Fabiana/Z-1506-2019; Caldarelli, Guido/A-5274-2010; Quattrociocchi, Walter/L-4550-2016	Scala, Antonio/0000-0002-3414-2686; Scala, Antonio/0000-0002-3414-2686; Zollo, Fabiana/0000-0002-0833-5388; Caldarelli, Guido/0000-0001-9377-3616; Del Vicario, Michela/0000-0002-8561-4364; Mozetic, Igor/0000-0002-5466-0608; Bessi, Alessandro/0000-0001-6260-4422; Kralj Novak, Petra/0000-0003-3385-6430; Quattrociocchi, Walter/0000-0002-4374-9324	MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and system) [317532]; SIMPOL (Financial Systems SIMulation and POLicy Modelling) [610704]; DOLFINS (Distributed Global Financial Systems for Society) [640772]; SoBigData (Social Mining & Big Data Ecosystem) [654024]	MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and system); SIMPOL (Financial Systems SIMulation and POLicy Modelling); DOLFINS (Distributed Global Financial Systems for Society); SoBigData (Social Mining & Big Data Ecosystem)	Funding for this work was provided by the MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and system) grant number 317532, SIMPOL (Financial Systems SIMulation and POLicy Modelling) grant number 610704, DOLFINS (Distributed Global Financial Systems for Society) grant number 640772, and SoBigData (Social Mining & Big Data Ecosystem) grant number 654024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; Anagnostopoulos A., 2014, ARXIV14112893; Anderson AA, 2014, J COMPUT-MEDIAT COMM, V19, P373, DOI 10.1111/jcc4.12009; Bessi A, 2014, EC ATTENTION AGE MIS; Bessi A, 2014, P SOCINFO 2014; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134641; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Bo Pang, 2008, Foundations and Trends in Information Retrieval, V2, P1, DOI 10.1561/1500000001; Bonabeau E, 2009, MIT SLOAN MANAGE REV, V50, P45; Brabazon T, 2015, UNIQUE URBANITY, P85; Byford J, 2011, CONSPIRACY THEORIES: A CRITICAL INTRODUCTION, P1, DOI 10.1057/9780230349216; Coe K, 2014, J COMMUN, V64, P658, DOI 10.1111/jcom.12104; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Colleoni E, 2014, J COMMUN, V64, P317, DOI 10.1111/jcom.12084; Del Vicario M, 2015, ARXIV150900189; Ellison NB, 2007, J COMPUT-MEDIAT COMM, V12, P1143, DOI 10.1111/j.1083-6101.2007.00367.x; Farley E, 2014, WHAT HAPPENS EVERYON; Fine GA, RUMOR MILLS SOCIAL I; Frank E., 2001, SIMPLE APPROACH ORDI; Franks B, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00424; Frenda SJ, 2011, CURR DIR PSYCHOL SCI, V20, P20, DOI 10.1177/0963721410396620; Friggeri Adrien, 2014, 8 INT AAAI C WEBL SO; Gaudette L, 2009, LECT NOTES COMPUT SC, V5549, P207, DOI 10.1007/978-3-642-01818-3_25; Go A., 2009, CS224N PROJECT REPOR, V1; Hogg MA, 2011, BLACKWELL CLAREMONT; Joinson AN, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P1027; Josang A., 2011, TRUST MANAGEMENT, P312, DOI DOI 10.1007/978-3-642-22200-9_25; Kiritchenko S, 2014, J ARTIF INTELL RES, V50, P723, DOI 10.1613/jair.4272; Kuklinski JH, 2000, J POLIT, V62, P790, DOI 10.1111/0022-3816.00033; L?vy P., 1997, COLLECTIVE INTELLIGE; Lamothe D., 2015, WHY OPERATION J HELM; Loader BD, 2014, INFORM COMMUN SOC, V17, P143, DOI 10.1080/1369118X.2013.871571; Luong TT, 2015, IC 2015 P; Magro MJ, 2012, ADM SCI, V2, P148, DOI 10.3390/admsci2020148; Meraz S, 2009, J COMPUT-MEDIAT COMM, V14, P682, DOI 10.1111/j.1083-6101.2009.01458.x; Mocanu D, 2015, COMPUT HUM BEHAV, V51, P1198, DOI 10.1016/j.chb.2015.01.024; Pak A, 2010, LREC, V10, P1320, DOI DOI 10.17148/IJARCCE.2016.51274; Pang B, 2002, PROCEEDINGS OF THE 2002 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING, P79, DOI 10.3115/1118693.1118704; Quattrociocchi W, 2010, SIMULATING OPINION D; Quattrociocchi W, 2014, SCI REP-UK, V4, DOI 10.1038/srep04938; Quattrociocchi W, 2011, ADV COMPLEX SYST, V14, P567, DOI 10.1142/S0219525911003165; Scott S. V., 2014, ENTANGLEMENTS PRACTI; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Surowiecki J., 2005, WISDOM CROWDS WHY MA; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Vapnik V., 2013, NATURE STAT LAERNING; Viswanath B, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P37; Yardi S., 2010, B SCI TECHNOL SOC, V30, P316, DOI 10.1177/0270467610380011; Zhu B, 2010, PERS INDIV DIFFER, V48, P889, DOI 10.1016/j.paid.2010.02.016	50	86	85	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138740	10.1371/journal.pone.0138740	http://dx.doi.org/10.1371/journal.pone.0138740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422473	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000362175700048
J	Loskill, P; Marcus, SG; Mathur, A; Reese, WM; Healy, KE				Loskill, Peter; Marcus, Sivan G.; Mathur, Anurag; Reese, Willie Mae; Healy, Kevin E.			mu Organo: A Lego (R)-Like Plug & Play System for Modular Multi-Organ-Chips	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MICROFLUIDIC SYSTEM; DRUG DEVELOPMENT; ON-CHIPS; TISSUE; CULTURE; LIVER; CARDIOMYOCYTES; BIOREACTOR; PLATFORM	Human organ-on-a-chip systems for drug screening have evolved as feasible alternatives to animal models, which are unreliable, expensive, and at times erroneous. While chips featuring single organs can be of great use for both pharmaceutical testing and basic organ-level studies, the huge potential of the organ-on-a-chip technology is revealed by connecting multiple organs on one chip to create a single integrated system for sophisticated fundamental biological studies and devising therapies for disease. Furthermore, since most organ-on-a-chip systems require special protocols with organ-specific media for the differentiation and maturation of the tissues, multi-organ systems will need to be temporally customizable and flexible in terms of the time point of connection of the individual organ units. We present a customizable Lego (R)-like plug & play system, mu Organo, which enables initial individual culture of single organ-on-a-chip systems and subsequent connection to create integrated multi-organ microphysiological systems. As a proof of concept, the mu Organo system was used to connect multiple heart chips in series with excellent cell viability and spontaneously physiological beat rates.	[Loskill, Peter; Marcus, Sivan G.; Mathur, Anurag; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Loskill, Peter; Mathur, Anurag; Reese, Willie Mae; Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Loskill, Peter; Mathur, Anurag; Healy, Kevin E.] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Loskill, P (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	ploskill@berkeley.edu; kehealy@berkeley.edu	Loskill, Peter/AAU-8978-2020; Loskill, Peter/D-9252-2013	Loskill, Peter/0000-0002-5000-0581	NIH [UH2TR000487, UH3TR000487]; German Research Foundation [LO 2081/1-1]; CIRM training program [TG2-01164]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); CIRM training program	This research was supported by NIH grants UH2TR000487 & UH3TR000487 (K.E.H.). P.L. is supported by a postdoctoral fellowship from the German Research Foundation, LO 2081/1-1. A.M. is postdoctoral fellow of CIRM training program TG2-01164. We acknowledge assistance from the Berkeley Stem Cell Shared Facility, Biomolecular Nanotechnology Center, and Marvell Nanofabrication Facility.	Ashraf MW, 2011, INT J MOL SCI, V12, P3648, DOI 10.3390/ijms12063648; Au AK, 2011, MICROMACHINES-BASEL, V2, P179, DOI 10.3390/mi2020179; Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155; Chen YW, 2012, LAB CHIP, V12, P3348, DOI 10.1039/c2lc40805h; Desai SP, 2009, LAB CHIP, V9, P1631, DOI 10.1039/b822081f; Dhurjati R, 2006, TISSUE ENG, V12, P3045, DOI 10.1089/ten.2006.12.3045; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Esch MB, 2014, ADV DRUG DELIVER REV, V69, P158, DOI 10.1016/j.addr.2013.12.003; Fabre KM, 2014, EXP BIOL MED, V239, P1073, DOI 10.1177/1535370214538916; Grodzinski P, 2003, BIOMED MICRODEVICES, V5, P303, DOI 10.1023/A:1027357713526; Hsieh YF, 2014, SENSOR ACTUAT B-CHEM, V204, P489, DOI 10.1016/j.snb.2014.07.122; Hsu YH, 2013, LAB CHIP, V13, P2990, DOI 10.1039/c3lc50424g; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Huh D, 2012, LAB CHIP, V12, P2156, DOI 10.1039/c2lc40089h; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Li AP, 2001, DRUG DISCOV TODAY, V6, P357, DOI 10.1016/S1359-6446(01)01712-3; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Markov DA, 2012, LAB CHIP, V12, P4560, DOI 10.1039/c2lc40304h; Marx U., 2007, DRUG TESTING IN VITR; Mathur A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08883; Mathur A, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt375; Nazareth EJP, 2013, NAT METHODS, V10, P1225, DOI [10.1038/nmeth.2684, 10.1038/NMETH.2684]; Park J, 2010, BIOMED MICRODEVICES, V12, P345, DOI 10.1007/s10544-009-9390-9; Prodanov L, 2015, BIOTECHNOL BIOENG; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Sei Y, 2014, MICROFLUID NANOFLUID, V16, P907, DOI 10.1007/s10404-014-1341-y; Shaikh KA, 2005, P NATL ACAD SCI USA, V102, P9745, DOI 10.1073/pnas.0504082102; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a; Wagner I, 2013, LAB CHIP, V13, P3538, DOI 10.1039/c3lc50234a; Wikswo JP, 2013, IEEE T BIO-MED ENG, V60, P682, DOI 10.1109/TBME.2013.2244891; Williamson A, 2013, LAB CHIP; Yuen PK, 2008, LAB CHIP, V8, P1374, DOI 10.1039/b805086d; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h; Zhu WZ, 2011, METHODS MOL BIOL, V767, P419, DOI 10.1007/978-1-61779-201-4_31	41	72	74	10	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139587	10.1371/journal.pone.0139587	http://dx.doi.org/10.1371/journal.pone.0139587			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440672	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300034
J	Pesce, G; Locatelli, F; Cerveri, I; Bugiani, M; Pirina, P; Johannessen, A; Accordini, S; Zanolin, ME; Verlato, G; de Marco, R				Pesce, Giancarlo; Locatelli, Francesca; Cerveri, Isa; Bugiani, Massimiliano; Pirina, Pietro; Johannessen, Ane; Accordini, Simone; Zanolin, Maria Elisabetta; Verlato, Giuseppe; de Marco, Roberto			Seventy Years of Asthma in Italy: Age, Period and Cohort Effects on Incidence and Remission of Self-Reported Asthma from 1940 to 2010	PLOS ONE			English	Article							RESPIRATORY-HEALTH-SURVEY; UNITED-STATES; ONSET ASTHMA; RISK-FACTORS; PREVALENCE; ADULTS; TRENDS; SENSITIZATION; SEVERITY; RHINITIS	Background It is well known that asthma prevalence has been increasing all over the world in the last decades. However, few data are available on temporal trends of incidence and remission of asthma. Objective To evaluate the rates of asthma incidence and remission in Italy from 1940 to 2010. Methods The subjects were randomly sampled from the general Italian population between 1991 and 2010 in the three population-based multicentre studies: ECRHS, ISAYA, and GEIRD. Individual information on the history of asthma (age at onset, age at the last attack, use of drugs for asthma control, co-presence of hay-fever) was collected on 35,495 subjects aged 20-84 and born between 1925-1989. Temporal changes in rates of asthma incidence and remission in relation to age, birth cohort and calendar period (APC) were modelled using Poisson regression and APC models. Results The average yearly rate of asthma incidence was 2.6/1000 (3,297 new cases among 1,263,885 person-years). The incidence rates have been linearly increasing, with a percentage increase of +3.9% (95% CI: 3.1-4.5), from 1940 up to the year 1995, when the rates begun to level off. The stabilization of asthma incidence was mainly due to a decrease in the rates of atopic asthma after 1995, while non-atopic asthma has continued to increase. The overall rate of remission was 43.2/1000person-years, and it did not vary significantly across generations, but was associated with atopy, age at asthma onset and duration of the disease. Conclusions After 50 years of a continuous upward trend, the rates of asthma incidence underwent a substantial stabilization in the late 90s. Despite remarkable improvements in the treatment of asthma, the rate of remission did not change significantly in the last seventy years. Some caveats are required in interpreting our results, given that our estimates are based on self-reported events that could be affected by the recall bias.	[Pesce, Giancarlo; Locatelli, Francesca; Accordini, Simone; Zanolin, Maria Elisabetta; Verlato, Giuseppe; de Marco, Roberto] Univ Verona, Dept Publ Hlth & Community Med, Unit Epidemiol & Med Stat, I-37100 Verona, Italy; [Cerveri, Isa] Univ Pavia, IRCCS Policlin San Matteo, Unit Resp Dis, I-27100 Pavia, Italy; [Bugiani, Massimiliano] ASL TO 2, Resp Med Unit, Turin, Italy; [Pirina, Pietro] Univ Sassari, Inst Resp Dis, I-07100 Sassari, Italy; [Johannessen, Ane] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway	University of Verona; IRCCS Fondazione San Matteo; University of Pavia; University of Sassari; University of Bergen; Haukeland University Hospital	de Marco, R (corresponding author), Univ Verona, Dept Publ Hlth & Community Med, Unit Epidemiol & Med Stat, I-37100 Verona, Italy.	roberto.demarco@univr.it	Pesce, Giancarlo/K-4539-2019; Pesce, Giancarlo/K-2804-2019	Pesce, Giancarlo/0000-0003-4925-6325; Johannessen, Ane/0000-0003-3269-8354; LOCATELLI, Francesca/0000-0001-9190-7190; Cerveri, Isa/0000-0003-0337-043X	Italian Ministry of University and Research (MIUR); Italian National Research Council; GlaxoSmithKlein Italia; Chiesi Farmaceutici; Cariverona foundation; Regione Veneto; MIUR; NHS; Italian Medicines Agency (AIFA)	Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); GlaxoSmithKlein Italia; Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Cariverona foundation(Fondazione Cariverona); Regione Veneto(Regione Veneto); MIUR(Ministry of Education, Universities and Research (MIUR)); NHS; Italian Medicines Agency (AIFA)	Data were collected in 3 multicentre studies: Italian arm of the European Community Respiratory Health Survey (ECRHS-Italy), the Italian Study on Asthma in Young Adults (ISAYA) and The Genes Environmental Interaction in Respiratory Diseases (GEIRD). The ECRHS-Italy was supported by the Italian Ministry of University and Research (MIUR), the Italian National Research Council, GlaxoSmithKlein Italia, Chiesi Farmaceutici, Cariverona foundation, and the Regione Veneto. The ISAYA was supported by MIUR, GlaxoSmithKlein Italia, and NHS. The GEIRD study was supported by MIUR, Chiesi Farmaceutici, the Italian Medicines Agency (AIFA). The funding sources had no role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish. All the authors had full access to all the data presented in the study. The corresponding author had final responsibility for the decision to submit for publication.	Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Andersson M, 2013, PEDIATRICS, V132, pE435, DOI 10.1542/peds.2013-0741; Anto JM, 2010, ALLERGY, V65, P1021, DOI 10.1111/j.1398-9995.2009.02301.x; Berger William E, 2008, Ther Clin Risk Manag, V4, P363; Brogger J, 2004, EUR RESPIR J, V23, P281, DOI 10.1183/09031936.03.00041103; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Carstensen B, 2007, STAT MED, V26, P3018, DOI 10.1002/sim.2764; Cazzola M, 2011, RESP MED, V105, P386, DOI 10.1016/j.rmed.2010.09.022; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; de Marco R, 1999, EUR RESPIR J, V14, P1044, DOI 10.1183/09031936.99.14510449; de Marco R, 1998, EUR RESPIR J, V11, P599; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; de Marco R, 2003, ALLERGY, V58, P221, DOI 10.1034/j.1398-9995.2003.00059.x; de Marco R, 2010, INT ARCH ALLERGY IMM, V152, P255, DOI 10.1159/000283034; de Marco R, 2002, J ALLERGY CLIN IMMUN, V110, P228, DOI 10.1067/mai.2002.125600; de Marco R, 2006, J ALLERGY CLIN IMMUN, V117, P1249, DOI 10.1016/j.jaci.2006.03.019; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Eagan TML, 2005, INT J TUBERC LUNG D, V9, P603; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ferrari M, 2014, ALLERGY, V69, P472, DOI 10.1111/all.12354; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Greening AP, 2008, EUR RESPIR REV, V17, P53, DOI 10.1183/09059180.00010801; Holm M, 2007, EUR RESPIR J, V30, P62, DOI 10.1183/09031936.00121705; Jarvis D, 2005, J ALLERGY CLIN IMMUN, V116, P675, DOI 10.1016/j.jaci.2005.05.009; Law M, 2005, BRIT MED J, V330, P1187, DOI 10.1136/bmj.38435.582975.AE; Miravitlles M, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X625111; Nowak D, 2004, EUR RESPIR J, V23, P359, DOI 10.1183/09031936.04.00134004; Pattaro C, 2007, J CLIN EPIDEMIOL, V60, P704, DOI 10.1016/j.jclinepi.2006.10.010; Ronmark E, 2007, RESP MED, V101, P2370, DOI 10.1016/j.rmed.2007.06.011; Rudd RA, 2007, J ASTHMA, V44, P65, DOI 10.1080/02770900601125896; Suissa S, 2000, NEW ENGL J MED, V343, P332, DOI 10.1056/NEJM200008033430504; Tai A, 2014, J ALLERGY CLIN IMMUN, V133, P1572, DOI 10.1016/j.jaci.2013.12.1033; To T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-254; Verlato G, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-879; Viel JF, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-47; Warm K, 2012, J ALLERGY CLIN IMMUN, V129, P136, DOI 10.1016/j.jaci.2011.08.033; Winer RA, 2012, J ASTHMA, V49, P16, DOI 10.3109/02770903.2011.637594; Zhang XY, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1156	38	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138570	10.1371/journal.pone.0138570	http://dx.doi.org/10.1371/journal.pone.0138570			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439263	Green Published, gold			2022-12-27	WOS:000362510300003
J	Pusparini, W; Sievert, PR; Fuller, TK; Randhir, TO; Andayani, N				Pusparini, Wulan; Sievert, Paul R.; Fuller, Todd K.; Randhir, Timothy O.; Andayani, Noviar			Rhinos in the Parks: An Island-Wide Survey of the Last Wild Population of the Sumatran Rhinoceros (vol 10, e0136643, 2015)	PLOS ONE			English	Correction													Randhir, Timothy O/A-7145-2009	Randhir, Timothy O/0000-0002-1084-9716; Pusparini, Wulan/0000-0001-9909-0920; Andayani, Noviar/0000-0002-1888-193X				Pusparini W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136643	1	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139982	10.1371/journal.pone.0139982	http://dx.doi.org/10.1371/journal.pone.0139982			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437186	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200068
J	Durham, E; Jen, S; Wang, L; Nasworthy, J; Elsalanty, M; Weinberg, S; Yu, J; Cray, J				Durham, Emily; Jen, Serena; Wang, Lin; Nasworthy, Joseph; Elsalanty, Mohammed; Weinberg, Seth; Yu, Jack; Cray, James			Effects of Citalopram on Sutural and Calvarial Cell Processes	PLOS ONE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; MATERNAL USE; CRANIOFACIAL DEVELOPMENT; CRANIAL SUTURES; GENE-EXPRESSION; EARLY-PREGNANCY; BIRTH-DEFECTS; IN-VITRO; CRANIOSYNOSTOSIS; EXPOSURE	The use of selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression during pregnancy is suggested to increase the incidence of craniofacial abnormalities including craniosynostosis. Little is known about this mechanism, however based on previous data we propose a mechanism that affects cell cycle. Excessive proliferation, and reduction in apoptosis may lead to hyperplasia within the suture that may allow for differentiation, bony infiltration, and fusion. Here we utilized in vivo and in vitro analysis to investigate this proposed phenomenon. For in vivo analysis we used C57BL-6 wild-type breeders treated with a clinical dose of citalopram during the third trimester of pregnancy to produce litters exposed to the SSRI citalopram in utero. At post-natal day 15 sutures were harvested from resulting pups and subjected to histomorphometric analysis for proliferation (PCNA) and apoptosis (TUNEL). For in vitro studies, we used mouse calvarial pre-osteoblast cells (MC3T3-E1) to assess proliferation (MTS), apoptosis (Caspase 3/7-activity), and gene expression after exposure to titrated doses of citalopram. In vivo analysis for PCNA suggested segregation of effect by location, with the sagittal suture, showing a statistically significant increase in proliferative response. The coronal suture was not similarly affected, however there was a decrease in apoptotic activity at the dural edge as compared to the periosteal edge. No differences in apoptosis by suture or area due to SSRI exposure were observed. In vitro results suggest citalopram exposure increased proliferation and proliferative gene expression, and decreased apoptosis of the MC3T3-E1 cells. Decreased apoptosis was not confirmed in vivo however, an increase in proliferation without a concomitant increase in apoptosis is still defined as hyperplasia. Thus prenatal SSRI exposure may exert a negative effect on post-natal growth through a hyperplasia effect at the cranial growth sites perhaps leading to clinically significant craniofacial abnormalities.	[Durham, Emily; Cray, James] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA; [Jen, Serena] Georgia Regents Univ, Sch Med, Augusta, GA USA; [Wang, Lin] Shanghai Jiao Tong Univ, Inst Plast Surg, Shanghai 200030, Peoples R China; [Nasworthy, Joseph; Elsalanty, Mohammed] Georgia Regents Univ, Dept Oral Biol, Augusta, GA USA; [Elsalanty, Mohammed] Georgia Regents Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Elsalanty, Mohammed] Georgia Regents Univ, Dept Oral Maxillofacial Surg, Augusta, GA USA; [Elsalanty, Mohammed; Yu, Jack] Georgia Regents Univ, Inst Regenerat & Reparat Med, Augusta, GA USA; [Weinberg, Seth] Univ Pittsburgh, Sch Dent Med, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Weinberg, Seth] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA USA; [Yu, Jack] Georgia Regents Univ, Div Plast Surg, Dept Surg, Augusta, GA USA	Medical University of South Carolina; University System of Georgia; Augusta University; Shanghai Jiao Tong University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University	Cray, J (corresponding author), Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA.	crayj@musc.edu		Durham, Emily/0000-0002-6322-9393; Weinberg, Seth/0000-0001-9467-4556	National Institute of General Medicine [P30GM103331]; Departments of Oral Biology at Georgia Regents University; Oral Health Sciences at Medical University of South Carolina; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE017551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER	National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Departments of Oral Biology at Georgia Regents University; Oral Health Sciences at Medical University of South Carolina; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study utilized the facilities and resources of the MUSC Center for Oral Health Research (COHR), which is partially supported by the National Institute of General Medicine grant P30GM103331. Study was funded internally by the Departments of Oral Biology at Georgia Regents University and Oral Health Sciences at Medical University of South Carolina (JC).	Adab K, 2002, Orthod Craniofac Res, V5, P227, DOI 10.1034/j.1600-0544.2002.02227.x; Agresti M, 2005, J CRANIOFAC SURG, V16, P572, DOI 10.1097/01.scs.0000168759.61947.7f; Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Alwan S, 2009, CNS DRUGS, V23, P493, DOI 10.2165/00023210-200923060-00004; Andrade SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.036; Baum AL, 1996, HARVARD REV PSYCHIAT, V4, P117, DOI 10.3109/10673229609030534; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cray JJ, 2011, ORTHOD CRANIOFAC RES, V14, P149, DOI 10.1111/j.1601-6343.2011.01520.x; Cray JJ, 2014, BIRTH DEFECTS RES A, V100, P912, DOI 10.1002/bdra.23323; Cray JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069067; Dinlen N, 2014, GENET COUNSEL, V25, P7; Dubnov-Raz G, 2012, EARLY HUM DEV, V88, P191, DOI 10.1016/j.earlhumdev.2011.08.005; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Ericson A, 1999, EUR J CLIN PHARMACOL, V55, P503, DOI 10.1007/s002280050664; Farra C, 2010, BIRTH DEFECTS RES A, V88, P582, DOI 10.1002/bdra.20674; Fong KD, 2004, PLAST RECONSTR SURG, V113, P2037, DOI 10.1097/01.PRS.0000121182.01199.C1; Greene MF, 2007, NEW ENGL J MED, V356, P2732, DOI 10.1056/NEJMe078079; Hehr U, 1999, MOL GENET METAB, V68, P139, DOI 10.1006/mgme.1999.2915; Hodge JM, 2013, BIOL PSYCHIAT, V74, P32, DOI 10.1016/j.biopsych.2012.11.003; Jiao JW, 2011, PSYCHOPHARMACOLOGY, V213, P509, DOI 10.1007/s00213-010-2140-0; Johnson D, 2011, EUR J HUM GENET, V19, P369, DOI 10.1038/ejhg.2010.235; Kallen BAJ, 2007, BIRTH DEFECTS RES A, V79, P301, DOI 10.1002/bdra.20327; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kumar AGV, 2012, J FORENSIC RES, V03, DOI [10.4172/2157-7145.1000173, DOI 10.4172/2157-7145.1000173]; Lee JY, 2014, LIFE SCI, V114, P57, DOI 10.1016/j.lfs.2014.07.006; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Majewski S, 2007, J ULTRAS MED, V26, P391, DOI 10.7863/jum.2007.26.3.391; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; Marks DM, 2008, EXPERT OPIN DRUG SAF, V7, P783, DOI [10.1517/14740330802423168, 10.1517/14740330802423168 ]; Miraoui H, 2010, GENE, V468, P1, DOI 10.1016/j.gene.2010.07.013; Moiseiwitsch JRD, 2000, CRIT REV ORAL BIOL M, V11, P230, DOI 10.1177/10454411000110020601; Nordeng H, 2012, J CLIN PSYCHOPHARM, V32, P186, DOI 10.1097/JCP.0b013e3182490eaf; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Opperman LA, 2000, DEV DYNAM, V219, P237, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1044>3.0.CO;2-F; Opperman LA, 2005, CELLS TISSUES ORGANS, V181, P127, DOI 10.1159/000091374; Opperman LA, 2002, ANAT RECORD, V267, P120, DOI 10.1002/ar.10094; Opperman LA, 1998, J CRAN GENET DEV BIO, V18, P150; Opperman LA, 1997, J BONE MINER RES, V12, P301, DOI 10.1359/jbmr.1997.12.3.301; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Pratt Laura A, 2011, NCHS Data Brief, P1; Rantamaki T, 2007, NEUROPSYCHOPHARMACOL, V32, P2152, DOI 10.1038/sj.npp.1301345; Rawlins Joseph T., 2008, V12, P178, DOI 10.1159/000115038; Rayburn WF, 2000, DRUG CHEM TOXICOL, V23, P419, DOI 10.1081/DCT-100100126; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407; Slater BJ, 2008, PLAST RECONSTR SURG, V121, p170E, DOI 10.1097/01.prs.0000304441.99483.97; Strekalova T, 2006, BEHAV PHARMACOL, V17, P271, DOI 10.1097/00008877-200605000-00008; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Warren SM, 2012, PLAST RECONSTR SURG, V129, P731, DOI 10.1097/PRS.0b013e3182412a50; Wilkie AOM, 1997, HUM MOL GENET, V6, P1647, DOI 10.1093/hmg/6.10.1647; Yokota M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101693; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	52	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139719	10.1371/journal.pone.0139719	http://dx.doi.org/10.1371/journal.pone.0139719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431045	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000362178700103
J	Guiatti, D; Pomari, E; Radovic, S; Spadotto, A; Stefanon, B				Guiatti, Denis; Pomari, Elena; Radovic, Slobodanka; Spadotto, Alessandro; Stefanon, Bruno			Exome Capture with Heterologous Enrichment in Pig (Sus scrofa)	PLOS ONE			English	Article							SEQUENCING DATA; SELECTION; DESIGN	The discovery of new protein-coding DNA variants related to carcass traits is very important for the Italian pig industry, which requires heavy pigs with higher thickness of subcutaneous fat for Protected Designation of Origin (PDO) productions. Exome capture techniques offer the opportunity to focus on the regions of DNA potentially related to the gene and protein expression. In this research a human commercial target enrichment kit was used to evaluate its performances for pig exome capture and for the identification of DNA variants suitable for comparative analysis. Two pools of 30 pigs each, crosses of Italian Duroc X Large White (DU) and Commercial hybrid X Large White (HY), were used and NGS libraries were prepared with the SureSelectXT Target Enrichment System for Illumina Paired-End Sequencing Library (Agilent). A total of 140.2 M and 162.5 M of raw reads were generated for DU and HY, respectively. Average coverage of all the exonic regions for Sus scrofa (ENSEMBL Sus_scrofa.Sscrofa10.2.73.gtf) was 89.33X for DU and 97.56X for HY; and 35% of aligned bases uniquely mapped to off-target regions. Comparison of sequencing data with the Sscrofa 10.2 reference genome, after applying hard filtering criteria, revealed a total of 232,530 single nucleotide variants (SNVs) of which 20.6% mapped in exonic regions and 49.5% within intronic regions. The comparison of allele frequencies of 213 randomly selected SNVs from exome sequencing and the same SNVs analyzed with a Sequenom MassARRAY (R) system confirms that this "human-on-pig" approach offers new potentiality for the identification of DNA variants in protein-coding genes.	[Guiatti, Denis; Pomari, Elena; Stefanon, Bruno] Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; [Radovic, Slobodanka; Spadotto, Alessandro] IGA Technol Serv Srl, Udine, Italy	University of Udine	Stefanon, B (corresponding author), Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy.	bruno.stefanon@uniud.it	Zecconi, Alfonso/C-7148-2009; Pomari, Elena/J-8184-2018; Stefanon, Bruno/J-1820-2019; Pomari, Elena/ABG-7666-2020	Zecconi, Alfonso/0000-0002-3127-8385; Pomari, Elena/0000-0002-5182-0231; Stefanon, Bruno/0000-0002-7414-5830; Pomari, Elena/0000-0002-5182-0231	project AGER-HEPIGET: Advanced research in genomics and processing technologies for the Italian heavy pig production chain [N. 2011-0279]; IGA Technology Services Srl	project AGER-HEPIGET: Advanced research in genomics and processing technologies for the Italian heavy pig production chain; IGA Technology Services Srl	This research was supported by project AGER-HEPIGET: Advanced research in genomics and processing technologies for the Italian heavy pig production chain (grant N. 2011-0279). [Websites: http://www.progettoager.it; http://ager-hepiget.distal.unibo.it/.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The IGA Technology Services Srl was paid only for exome enrichment and DNA resequencing. The authors [SR, AS] did not receive any extra salary for the contributions reported in the 'author contributions' section. Due to their active contribution in this study, these authors were included in the author list.	Ayele FT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040206; Chilamakuri CSR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-449; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Del Fabbro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085024; Fajardo KVF, 2012, HUM MUTAT, V33, P609, DOI 10.1002/humu.22033; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Guiatti D, 2013, ITALIAN J ANIMAL SCI, V12, P77; Herrero-Medrano JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-601; JIN X, 2012, PLOS ONE, V7; Khlopova N. S., 2012, Russian Agricultural Sciences, V38, P311, DOI 10.3103/S106836741204009X; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Rabbani B, 2014, J HUM GENET, V59, P5, DOI 10.1038/jhg.2013.114; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Robert C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-550; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Steibel JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016766; Tsairidou S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096728; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139328	10.1371/journal.pone.0139328	http://dx.doi.org/10.1371/journal.pone.0139328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431395	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700043
J	Russell, CL; Sallau, A; Emukah, E; Graves, PM; Noland, GS; Ngondi, JM; Ozaki, M; Nwankwo, L; Miri, E; McFarland, DA; Richards, FO; Patterson, AE				Russell, Cheryl L.; Sallau, Adamu; Emukah, Emmanuel; Graves, Patricia M.; Noland, Gregory S.; Ngondi, Jeremiah M.; Ozaki, Masayo; Nwankwo, Lawrence; Miri, Emmanuel; McFarland, Deborah A.; Richards, Frank O.; Patterson, Amy E.			Determinants of Bed Net Use in Southeast Nigeria following Mass Distribution of LLINs: Implications for Social Behavior Change Interventions	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; MOSQUITO NET; PREGNANT-WOMEN; MALARIA PREVENTION; OWNERSHIP; AFRICA; HEALTH; AREA; KNOWLEDGE; COVERAGE	Millions of long-lasting insecticide treated nets (LLINs) have been distributed as part of the global malaria control strategy. LLIN ownership, however, does not necessarily guarantee use. Thus, even in the ideal setting in which universal coverage with LLINs has been achieved, maximal malaria protection will only be achieved if LLINs are used both correctly and consistently. This study investigated the factors associated with net use, independent of net ownership. Data were collected during a household survey conducted in Ebonyi State in southeastern Nigeria in November 2011 following a statewide mass LLIN distribution campaign and, in select locations, a community-based social behavior change (SBC) intervention. Logistic regression analyses, controlling for household bed net ownership, were conducted to examine the association between individual net use and various demographic, environmental, behavioral and social factors. The odds of net use increased among individuals who were exposed to tailored SBC in the context of a home visit (OR = 17.11; 95% CI 4.45-65.79) or who received greater degrees of social support from friends and family (ptrend < 0.001). Factors associated with decreased odds of net use included: increasing education level (ptrend = 0.020), increasing malaria knowledge level (ptrend = 0.022), and reporting any disadvantage of bed nets (OR = 0.39; 95% CI 0.23-0.78). The findings suggest that LLIN use is significantly influenced by social support and exposure to a malaria-related SBC home visit. The malaria community should thus further consider the importance of community outreach, interpersonal communication and social support on adoption of net use behaviors when designing future research and interventions.	[Russell, Cheryl L.; McFarland, Deborah A.] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Sallau, Adamu; Miri, Emmanuel] Carter Ctr, Jos, Nigeria; [Emukah, Emmanuel] Carter Ctr, Owerri, Nigeria; [Graves, Patricia M.; Noland, Gregory S.; Ngondi, Jeremiah M.; Ozaki, Masayo; Richards, Frank O.; Patterson, Amy E.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Graves, Patricia M.] James Cook Univ, Cairns, Qld, Australia; [Ngondi, Jeremiah M.] RTI Int, Dar Es Salaam, Tanzania; [Ozaki, Masayo] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Nwankwo, Lawrence] Ebonyi State Minist Hlth, Abakaliki, Nigeria; [Patterson, Amy E.] Agnes Scott Coll, Dept Publ Hlth, Decatur, GA 30030 USA	Emory University; Rollins School Public Health; Emory University; James Cook University; Research Triangle Institute; University of Alabama System; University of Alabama Birmingham	Noland, GS (corresponding author), Emory Univ, Carter Ctr, Atlanta, GA 30322 USA.	gnoland@emory.edu	McFarland, Deborah A/P-1907-2018; Graves, Patricia M/J-8691-2014	McFarland, Deborah A/0000-0002-0019-5165; Graves, Patricia M/0000-0002-5215-3901; Noland, Gregory/0000-0003-1332-4832; Ngondi, Jeremiah/0000-0003-4357-4816	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was supported by a grant from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adongo PB, 2005, TROP MED INT HEALTH, V10, P366, DOI 10.1111/j.1365-3156.2005.01361.x; AIKINS MK, 1993, T ROY SOC TROP MED H, V87, P25, DOI 10.1016/0035-9203(93)90172-M; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; Ankomah A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-105; [Anonymous], NIG MAL OP PLAN FY 2; [Anonymous], ROAD MAP IMP MAL NIG; [Anonymous], HDB STAT ANAL USING; [Anonymous], STRAT PLAN MAL CONTR; [Anonymous], CART CTR PROGR REV M; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2012, NIG MAL IND SURV 201; [Anonymous], MULT IND CLUST SURV; [Anonymous], 2007, INS TREAT MOSQ NETS; [Anonymous], COUPLE APPROACHES SM; Auta A, 2012, N AM J MED SCI, V4, P40, DOI 10.4103/1947-2714.92903; Baume CA, 2007, AM J TROP MED HYG, V77, P963, DOI 10.4269/ajtmh.2007.77.963; Baume CA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-153; Biadgilign S, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/235015; Cham MK, 1996, HEALTH POLICY PLANN, V11, P292, DOI 10.1093/heapol/11.3.292; De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61; Deressa W, 2011, TROP MED INT HEALTH, V16, P1552, DOI 10.1111/j.1365-3156.2011.02875.x; DiMatteo MR, 2004, HEALTH PSYCHOL, V23, P207, DOI 10.1037/0278-6133.23.2.207; Dunn CE, 2011, SOC SCI MED, V72, P408, DOI 10.1016/j.socscimed.2010.11.009; Eisele TP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-36; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Glanz K., 2008, HLTH BEHAV HLTH ED T; Graves PM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-354; Guyatt H, 2003, LANCET, V362, P1549, DOI 10.1016/S0140-6736(03)14744-7; Heaney CA., 2008, HLTH BEHAV HLTH ED T, V4, P189; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Hwang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011692; Jeffery RW, 2000, HEALTH PSYCHOL, V19, P5, DOI 10.1037/0278-6133.19.Suppl1.5; Keating J, 2005, J BIOSOC SCI, V37, P761, DOI 10.1017/S0021932005007182; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Mwenesi HA, 2005, ACTA TROP, V95, P292, DOI 10.1016/j.actatropica.2005.06.004; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Ngondi JM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-92; Noland GS, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-168; NPC and ICF Macro, 2009, NIG DEM HLTH SURV 20; Okorie PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028347; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Pulford J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-83; Richards FO, 2013, AM J TROP MED HYG, V89, P578, DOI 10.4269/ajtmh.12-0775; Rickard DG, 2011, PROG COMM HLTH PARTN, V5, P123, DOI 10.1353/cpr.2011.0018; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Sallis JF, 2008, HLTH BEHAV HLTH ED, P465, DOI DOI 10.7326/0003-4819-116-4-350_; Singh M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-268; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WINCH PJ, 1994, SOC SCI MED, V39, P63, DOI 10.1016/0277-9536(94)90166-X	55	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139447	10.1371/journal.pone.0139447	http://dx.doi.org/10.1371/journal.pone.0139447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26430747	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000362178700059
J	Borgy, B; Reboud, X; Peyrard, N; Sabbadin, R; Gaba, S				Borgy, Benjamin; Reboud, Xavier; Peyrard, Nathalie; Sabbadin, Regis; Gaba, Sabrina			Dynamics of Weeds in the Soil Seed Bank: A Hidden Markov Model to Estimate Life History Traits from Standing Plant Time Series	PLOS ONE			English	Article							SPECIES COMPOSITION; COMMUNITY; DIVERSITY; FLORA	Predicting the population dynamics of annual plants is a challenge due to their hidden seed banks in the field. However, such predictions are highly valuable for determining management strategies, specifically in agricultural landscapes. In agroecosystems, most weed seeds survive during unfavourable seasons and persist for several years in the seed bank. This causes difficulties in making accurate predictions of weed population dynamics and life history traits (LHT). Consequently, it is very difficult to identify management strategies that limit both weed populations and species diversity. In this article, we present a method of assessing weed population dynamics from both standing plant time series data and an unknown seed bank. We use a Hidden Markov Model (HMM) to obtain estimates of over 3,080 botanical records for three major LHT: seed survival in the soil, plant establishment (including post-emergence mortality), and seed production of 18 common weed species. Maximum likelihood and Bayesian approaches were complementarily used to estimate LHT values. The results showed that the LHT provided by the HMM enabled fairly accurate estimates of weed populations in different crops. There was a positive correlation between estimated germination rates and an index of the specialisation to the crop type (IndVal). The relationships between estimated LHTs and that between the estimated LHTs and the ecological characteristics of weeds provided insights into weed strategies. For example, a common strategy to cope with agricultural practices in several weeds was to produce less seeds and increase germination rates. This knowledge, especially of LHT for each type of crop, should provide valuable information for developing sustainable weed management strategies.	[Borgy, Benjamin; Reboud, Xavier; Gaba, Sabrina] INRA, Agroecol UMR1347, F-21034 Dijon, France; [Peyrard, Nathalie; Sabbadin, Regis] INRA, Unite Math & Informat Appl UR875, F-31931 Toulouse, France; [Borgy, Benjamin] CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, Montpellier, France	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Borgy, B (corresponding author), INRA, Agroecol UMR1347, F-21034 Dijon, France.	benjamin.borgy@gmail.com	Gaba, Sabrina/H-5240-2018	Gaba, Sabrina/0000-0002-7145-6713; Sabbadin, Regis/0000-0002-6286-1821	ANR-OGM VIGIWEED fellowship [ANR-07-POGM-003]; ANR AGROBIOSE [ANR-13-AGRO-0001]	ANR-OGM VIGIWEED fellowship(French National Research Agency (ANR)); ANR AGROBIOSE(French National Research Agency (ANR))	Benjamin Borgy was funded by an ANR-OGM VIGIWEED fellowship (ANR-07-POGM-003). This study was also funding by the ANR AGROBIOSE (ANR-13-AGRO-0001). Data were provided by national Biovigilance-Flore project.	Albrecht H, 1996, VEGETATIO, V125, P1, DOI 10.1007/BF00045200; BARRALIS G, 1980, WEED RES, V20, P231, DOI 10.1111/j.1365-3180.1980.tb00074.x; Barralis G, 1976, DIJ 5 C INT EC BIOL; Bretagnolle V, 2015, AGRON SUST IN PRESS; Caswell, 2000, MATRIX POPULATION MO; Chades I, 2008, P NATL ACAD SCI USA, V105, P13936, DOI 10.1073/pnas.0805265105; Colbach N, 2000, EUR J AGRON, V13, P111, DOI 10.1016/S1161-0301(00)00069-1; David O, 2010, BIOMETRICS, V66, P875, DOI 10.1111/j.1541-0420.2009.01360.x; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Forcella F, 2000, FIELD CROP RES, V67, P123, DOI 10.1016/S0378-4290(00)00088-5; Franke AC, 2009, WEED RES, V49, P131, DOI 10.1111/j.1365-3180.2009.00692.x; Freville H, 2013, J ECOL, V101, P1572, DOI 10.1111/1365-2745.12141; Fried G, 2008, AGR ECOSYST ENVIRON, V128, P68, DOI 10.1016/j.agee.2008.05.003; Gardarin A, 2010, SEED SCI RES, V20, P243, DOI 10.1017/S0960258510000255; Gunton RM, 2011, J VEG SCI, V22, P541, DOI 10.1111/j.1654-1103.2011.01273.x; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Leck M. A., 1989, ECOLOGY SOIL SEED BA; Marshall EJP, 2003, WEED RES, V43, P77, DOI 10.1046/j.1365-3180.2003.00326.x; Murphy K., 2002, THESIS UC BERKELEY C; Perronne R, 2015, J VEG SCI, V26, P348, DOI 10.1111/jvs.12238; Perronne R, 2014, ACTA BOT GALLICA, V161, P243, DOI 10.1080/12538078.2013.868320; Peyrard N, 2007, MODSIM; Poggio SL, 2010, BIOL CONSERV, V143, P2477, DOI 10.1016/j.biocon.2010.06.014; PRICE WL, 1977, COMPUT J, V20, P367, DOI 10.1093/comjnl/20.4.367; Roberts H. A., 1981, Advances in Applied Biology, V6, P1; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Soetaert K., 2009, PRACTICAL GUIDE ECOL; Stearns S.C., 1992, pi; Sutcliffe OL, 2000, BIOL CONSERV, V93, P1, DOI 10.1016/S0006-3207(99)00119-6; Sutherland S, 2004, OECOLOGIA, V141, P24, DOI 10.1007/s00442-004-1628-x; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tixier P, 2013, ADV ECOL RES, V49, P437, DOI 10.1016/B978-0-12-420002-9.00007-X; Westoby M, 1998, PLANT SOIL, V199, P213, DOI 10.1023/A:1004327224729	34	16	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139278	10.1371/journal.pone.0139278	http://dx.doi.org/10.1371/journal.pone.0139278			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427023	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100042
J	Deroy, A; Saiag, F; Kebbi-Benkeder, Z; Touahri, N; Hecker, A; Morel-Rouhier, M; Colin, F; Dumarcay, S; Gerardin, P; Gelhaye, E				Deroy, Aurelie; Saiag, Fanny; Kebbi-Benkeder, Zineb; Touahri, Nassim; Hecker, Arnaud; Morel-Rouhier, Melanie; Colin, Francis; Dumarcay, Stephane; Gerardin, Philippe; Gelhaye, Eric			The GSTome Reflects the Chemical Environment of White-Rot Fungi	PLOS ONE			English	Article							PHANEROCHAETE-CHRYSOSPORIUM; GLUTATHIONE TRANSFERASES; EXTRACTIVES; GENOMES	White-rot fungi possess the unique ability to degrade and mineralize all the different components of wood. In other respects, wood durability, among other factors, is due to the presence of extractives that are potential antimicrobial molecules. To cope with these molecules, wood decay fungi have developed a complex detoxification network including glutathione transferases (GST). The interactions between GSTs from two white-rot fungi, Trametes versicolor and Phanerochaete chrysosporium, and an environmental library of wood extracts have been studied. The results demonstrate that the specificity of these interactions is closely related to the chemical composition of the extracts in accordance with the tree species and their localization inside the wood (sapwood vs heartwood vs knotwood). These data suggest that the fungal GSTome could reflect the chemical environment encountered by these fungi during wood degradation and could be a way to study their adaptation to their way of life.	[Deroy, Aurelie; Saiag, Fanny; Hecker, Arnaud; Morel-Rouhier, Melanie; Gelhaye, Eric] Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France; [Deroy, Aurelie; Saiag, Fanny; Hecker, Arnaud; Morel-Rouhier, Melanie; Gelhaye, Eric] INRA, Interact Arbres Microorganismes, UMR1136, F-54280 Champenoux, France; [Kebbi-Benkeder, Zineb; Touahri, Nassim; Dumarcay, Stephane; Gerardin, Philippe] Univ Lorraine, Lab Etud & Rech Mat Bois, Fac Sci & Technol, USC,INRA,EA4370, F-54506 Vandoeuvre Les Nancy, France; [Kebbi-Benkeder, Zineb; Touahri, Nassim; Colin, Francis] AgroParisTech, UMR 1092, LERFOB, F-54000 Nancy, France; [Kebbi-Benkeder, Zineb; Touahri, Nassim; Colin, Francis] INRA, UMR 1092, LERFOB, F-54280 Champenoux, France	Universite de Lorraine; INRAE; Universite de Lorraine; INRAE; Universite de Lorraine; AgroParisTech; INRAE	Gelhaye, E (corresponding author), Univ Lorraine, Interact Arbres Microorganismes, UMR1136, F-54500 Vandoeuvre Les Nancy, France.	eric.gelhaye@univ-lorraine.fr	HECKER, Arnaud/AAA-4853-2019	HECKER, Arnaud/0000-0003-4511-5410; Morel-Rouhier, Melanie/0000-0001-5149-0474	French National Research Agency (ANR), "Investissements d'Avenir" program (Lab of Excellence ARBRE) [ANR-11-LABX-0002-01]; Institut National de la Recherche Agronomique (INRA) [12-00006889]	French National Research Agency (ANR), "Investissements d'Avenir" program (Lab of Excellence ARBRE)(French National Research Agency (ANR)); Institut National de la Recherche Agronomique (INRA)	This work was supported by a grant overseen by the French National Research Agency (ANR) as part of the "Investissements d'Avenir" program (ANR-11-LABX-0002-01, Lab of Excellence ARBRE). The PhD grant of AD was funded by ANR-11-LABX-0002-01. The authors gratefully acknowledge the Institut National de la Recherche Agronomique (INRA) (CJS contract no. 12-00006889).	Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Boivin S, 2013, PROTEIN EXPRES PURIF, V91, P192, DOI 10.1016/j.pep.2013.08.002; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Kebbi-Benkeder Z, 2014, ANN FOREST SCI, P1; Kirker GT, 2013, INT BIODETER BIODEGR, V82, P53, DOI 10.1016/j.ibiod.2013.03.007; Lallement PA, 2014, BIOCHEM J, V462, P39, DOI 10.1042/BJ20140390; Mathieu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080298; Mathieu Y, 2013, J MICROBIOL METH, V92, P157, DOI 10.1016/j.mimet.2012.11.017; Mathieu Y, 2012, J BIOL CHEM, V287, P39001, DOI 10.1074/jbc.M112.402776; Meux E, 2013, BIOCHIMIE, V95, P336, DOI 10.1016/j.biochi.2012.10.003; Meux E, 2011, J BIOL CHEM, V286, P9162, DOI 10.1074/jbc.M110.194548; Morel M, 2013, MICROB BIOTECHNOL, V6, P248, DOI 10.1111/1751-7915.12015; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Thuillier A, 2014, APPL ENVIRON MICROB, V80, P6316, DOI 10.1128/AEM.02103-14; Thuillier Anne, 2011, Int J Evol Biol, V2011, P938308, DOI 10.4061/2011/938308; WILCE MCJ, 1994, BBA-PROTEIN STRUCT M, V1205, P1, DOI 10.1016/0167-4838(94)90086-8; Willfor S, 2003, HOLZFORSCHUNG, V57, P359, DOI 10.1515/HF.2003.054; Zhuang YD, 2013, ANGEW CHEM INT EDIT, V52, P8124, DOI 10.1002/anie.201302884	22	15	15	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0137083	10.1371/journal.pone.0137083	http://dx.doi.org/10.1371/journal.pone.0137083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426695	Green Published, gold			2022-12-27	WOS:000362177100003
J	Holtzer-Goor, KM; Gaultney, JG; van Houten, P; Wagg, AS; Huygens, SA; Nielen, MMJ; Albers-Heitner, CP; Redekop, WK; Rutten-van Molken, MP; Al, MJ				Holtzer-Goor, K. M.; Gaultney, J. G.; van Houten, P.; Wagg, A. S.; Huygens, S. A.; Nielen, M. M. J.; Albers-Heitner, C. P.; Redekop, W. K.; Rutten-van Molken, M. P.; Al, M. J.			Cost-Effectiveness of Including a Nurse Specialist in the Treatment of Urinary Incontinence in Primary Care in the Netherlands	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; URODYNAMIC STRESS-INCONTINENCE; COMMUNITY-DWELLING WOMEN; QUALITY-OF-LIFE; OVERACTIVE BLADDER; GENERAL-PRACTITIONERS; BEHAVIORAL-THERAPY; UNITED-STATES; HOME-CARE; FOLLOW-UP	Objective Incontinence is an important health problem. Effectively treating incontinence could lead to important health gains in patients and caregivers. Management of incontinence is currently suboptimal, especially in elderly patients. To optimise the provision of incontinence care a global optimum continence service specification (OCSS) was developed. The current study evaluates the costs and effects of implementing this OCSS for community-dwelling patients older than 65 years with four or more chronic diseases in the Netherlands. Method A decision analytic model was developed comparing the current care pathway for urinary incontinence in the Netherlands with the pathway as described in the OCSS. The new care strategy was operationalised as the appointment of a continence nurse specialist (NS) located with the general practitioner (GP). This was assumed to increase case detection and to include initial assessment and treatment by the NS. The analysis used a societal perspective, including medical costs, containment products (out-of-pocket and paid by insurer), home care, informal care, and implementation costs. Results With the new care strategy a QALY gain of 0.005 per patient is achieved while saving (sic)402 per patient over a 3 year period from a societal perspective. In interpreting these findings it is important to realise that many patients are undetected, even in the new care situation (36%), or receive care for containment only. In both of these groups no health gains were achieved. Conclusion Implementing the OCSS in the Netherlands by locating a NS in the GP practice is likely to reduce incontinence, improve quality of life, and reduce costs. Furthermore, the study also highlighted that various areas of the continence care process lack data, which would be valuable to collect through the introduction of the NS in a study setting.	[Holtzer-Goor, K. M.; Gaultney, J. G.; Huygens, S. A.; Redekop, W. K.; Rutten-van Molken, M. P.; Al, M. J.] Erasmus Univ, Inst Med Technol Assessment, Inst Hlth Policy & Management, Rotterdam, Netherlands; [van Houten, P.] Zonnehuisgrp Amstelland, Dept Med, Amstelveen, Netherlands; [Wagg, A. S.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Nielen, M. M. J.] NIVEL Netherlands Inst Hlth Serv Res, Dept Gen Practice, Utrecht, Netherlands; [Albers-Heitner, C. P.] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, NL-6200 MD Maastricht, Netherlands	Erasmus University Rotterdam; University of Alberta; Netherlands Institute for Health Services Research; Maastricht University	Holtzer-Goor, KM (corresponding author), Erasmus Univ, Inst Med Technol Assessment, Inst Hlth Policy & Management, Rotterdam, Netherlands.	goor@bmg.eur.nl	Molken, Maureen PMH Rutten-van/G-8481-2014; Molken, Maureen Rutten-van/X-8712-2019; Redekop, Ken/AAA-2423-2020	Molken, Maureen PMH Rutten-van/0000-0001-8706-3159; Molken, Maureen Rutten-van/0000-0001-8706-3159; Redekop, Ken/0000-0001-9538-4083	SCA (Svenska Cellulosa Aktiebolaget)	SCA (Svenska Cellulosa Aktiebolaget)	The employer of KHG, JG, SH, MRM, KR and MA received an unrestricted grant from SCA (Svenska Cellulosa Aktiebolaget). The funders had no role in the design and conduct of the study, collection, management, analysis and interpretation of data, or preparation, review and approval of the manuscript.	Abrams P, 2014, NEUROUROL URODYNAM, V33, P571, DOI 10.1002/nau.22617; Albers-Heitner CP, 2012, NEUROUROL URODYNAM, V31, P526, DOI 10.1002/nau.21204; Albers-Heitner P, 2008, J EVAL CLIN PRACT, V14, P807, DOI 10.1111/j.1365-2753.2007.00925.x; Albers-Heitner P, 2013, SCAND J CARING SCI, V27, P253, DOI 10.1111/j.1471-6712.2012.01023.x; Albers-Heitner CP, 2011, INT J CLIN PRACT, V65, P705, DOI 10.1111/j.1742-1241.2011.02652.x; Bacher J, 5 GLOB FOR INC BETT; Bo K, 2013, NEUROUROL URODYNAM, V32, P215, DOI 10.1002/nau.22292; Borrie MJ, 2002, CAN MED ASSOC J, V166, P1267; Brown JS, 2000, AM J MANAG CARE, V6, pS574; BURNS PA, 1993, J GERONTOL, V48, pM167; Cassells C, 2003, J ADV NURS, V42, P607, DOI 10.1046/j.1365-2648.2003.02664.x; Coleman EA, 1999, J AM GERIATR SOC, V47, P775, DOI 10.1111/j.1532-5415.1999.tb03832.x; DAE (Deloitte Access Economics), 2011, EC IMP INC AUSTR; de Rekeneire N, 2003, J AM GERIATR SOC, V51, P841, DOI 10.1046/j.1365-2389.2003.51267.x; Dougherty MC, 2002, RES NURS HEALTH, V25, P3, DOI 10.1002/nur.10016; Drutz H P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P283, DOI 10.1007/s001929970003; Du Moulin MFMT, 2007, J WOUND OSTOMY CONT, V34, P631, DOI 10.1097/01.WON.0000299814.98230.13; Du Moulin MFMT, 2008, RES NURS HEALTH, V31, P604, DOI 10.1002/nur.20291; Du Moulin MFMT, 2005, VERPLEEGKUNDE, V20, P278; Dutch Association for Obstetrics & Gynecology [Nederlandse Vereniging voor Obstetrie & Gynaecologie (NVOG)], 2012, GUID UR INC WOM; Eggink E, 2012, UPDATED NURSING CARE; Faber E, 2007, HUISARTS WET, V5, pS9; Gotoh M, 2009, NEUROUROL URODYNAM, V28, P492, DOI 10.1002/nau.20675; Hakkaart van Roijen L, 2011, HANDLEIDING KOSTENON; Halfens RJG, 2012, NATL PREVALENCE MEAS; Harari D, 2014, AGE AGEING; Haywood KL, 2008, QUAL LIFE RES, V17, P475, DOI 10.1007/s11136-008-9311-z; Horrocks EJ, 2014, BRIT J SURG, V101, P457, DOI 10.1002/bjs.9391; Hu TW, 2005, BJU INT, V96, P43, DOI 10.1111/j.1464-410X.2005.05654.x; Hu TW, 2004, UROLOGY, V63, P461, DOI 10.1016/j.urology.2003.10.037; Hunter KF, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-46; Imamura M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14400; Ismail SIMF, 2008, J OBSTET GYNAECOL, V29, P35, DOI 10.1080/01443610802484393; Labrie J, 2013, NEW ENGL J MED, V369, P1124, DOI 10.1056/NEJMoa1210627; Langa KM, 2002, J AM GERIATR SOC, V50, P733, DOI 10.1046/j.1532-5415.2002.50170.x; Lucas MG, 2012, EUR UROL, V62, P1130, DOI 10.1016/j.eururo.2012.08.047; Manca A, 2003, BJOG-INT J OBSTET GY, V110, P255, DOI 10.1016/S1470-0328(03)02915-X; Matsumoto M, 2007, J CROSS-CULT GERONTO, V22, P421, DOI 10.1007/s10823-007-9046-2; McFall SL, 2000, J AGING HEALTH, V12, P301, DOI 10.1177/089826430001200302; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Moore KH, 2003, BJOG-INT J OBSTET GY, V110, P649, DOI 10.1046/j.1471-0528.2003.02264.x; National Collaborating Centre for Women's and Children's Health (UK), 2013, UR INC WOM MAN UR IN; National Institute for Public Health and the Environment [RIVM], 2013, COST OF ILLN; Nielen MMJ, 2013, JUSTIFICATION INCIDE; Nuotio M, 2003, J GERONTOL A-BIOL, V58, P756; O'Halloran J, 2004, FAM PRACT, V21, P381, DOI 10.1093/fampra/cmh407; Richter HE, 2010, OBSTET GYNECOL, V115, P609, DOI 10.1097/AOG.0b013e3181d055d4; Schram MT, 2008, J CLIN EPIDEMIOL, V61, P1104, DOI 10.1016/j.jclinepi.2007.11.021; Sexton CC, 2011, INT J CLIN PRACT, V65, P567, DOI 10.1111/j.1742-1241.2010.02626.x; Slieker-ten Hove MCP, 2010, NEUROUROL URODYNAM, V29, P545, DOI 10.1002/nau.20760; Sorbye LW, 2009, SCAND J CARING SCI, V23, P33, DOI 10.1111/j.1471-6712.2007.00588.x; Subak LL, 2002, OBSTET GYNECOL, V100, P72, DOI 10.1016/S0029-7844(02)01993-2; Teunissen TAM, 2004, INT UROGYNECOL J, V15, P10, DOI 10.1007/s00192-003-1106-8; Uijen Annemarie A, 2008, Eur J Gen Pract, V14 Suppl 1, P28, DOI 10.1080/13814780802436093; van Gerwen MAG, 2009, J EVAL CLIN PRACT, V15, P341, DOI 10.1111/j.1365-2753.2008.01012.x; Verpleegkundigen en Verzorgenden Nederland & Landelijk Expertise centrum Verpleging en Verzorging, 2010, GUID UR INC FRAIL EL; Wagg A, 2011, BJOG-INT J OBSTET GY, V118, P1592, DOI 10.1111/j.1471-0528.2011.03100.x; Wagg AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104129; Wenger NS, 2009, J AM GERIATR SOC, V57, P547, DOI 10.1111/j.1532-5415.2008.02128.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams KS, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-58; Williams KS, 2005, BRIT J GEN PRACT, V55, P696	62	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138225	10.1371/journal.pone.0138225	http://dx.doi.org/10.1371/journal.pone.0138225			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426124	Green Published, gold			2022-12-27	WOS:000362177100010
J	Semali, IA; Leyna, GH; Mmbaga, EJ; Tengia-Kessy, A				Semali, Innocent Antony; Leyna, Germana Henry; Mmbaga, Elia John; Tengia-Kessy, Anna			Social Capital as a Determinant of Pregnant Mother's Place of Delivery: Experience from Kongwa District in Central Tanzania	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; HEALTH; INEQUALITY; COMMUNITY	Introduction Maternal ill health contributes highly to the global burden of diseases in countries South of Sahara including Tanzania. Ensuring that all deliveries take place in health facilities and hence attended by skilled health personnel is one of the strategies advocated by global and national policies, including the Millennium Development Goals (MDGs). However, the number of women delivered by skilled health personnel has remained low in sub Saharan Africa despite of a number of interventions. We sought to determine the role of social capital in facilitating health facility delivery. Methods We randomly selected 744 households with children aged less than five years from two randomly selected wards in a rural area in Tanzania. Mothers were enquired about place of delivery of the last child. Social capital was assessed using a modified questionnaire with both structural and cognitive aspects of social capital, administered in face-to-face interviews. Principal Component Analysis (PCA) was used to develop asocial capital index measure. Uni-variate and multivariable regression models were run using STATA 12. Results Majority (85.9%) of the mothers reported to have delivered in a health facility during their last birth. Compared to the lowest social capital quintile, delivering in a health facility increased significantly with increase in social capital level: low (Adjusted Odds Ratio (AOR) = 2.9; Confidence Interval (CI): 1.4-6.1, p = 0.004); moderate (AOR = 5.5, CI: 2.3-13.3, p-value<0.001); high (AOR = 4.7; CI: 1.9-11.6, p-value<0.001) and highest (AOR = 5.6, CI: 2.4-13.4, p-value<0.001) and chi(2)-test for the trend was significant (chi(2) = 17.21, p<0.001). Conclusion Overall, social capital seems to play an important role in enhancing health facility delivery that may lead to improved maternal and child health. Concerted efforts should focus on promoting and supporting effective social capital and in particular cognitive social capital.	[Semali, Innocent Antony; Leyna, Germana Henry; Mmbaga, Elia John] Sch Publ Hlth & Social Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Tengia-Kessy, Anna] Sch Publ Hlth & Social Sci, Dept Community Hlth, Dar Es Salaam, Tanzania		Semali, IA (corresponding author), Sch Publ Hlth & Social Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.	innosemali@yahoo.com	Leyna, Germana Henry/I-2565-2019	Leyna, Germana Henry/0000-0001-7016-544X	Swedish International Development Agency's research grants	Swedish International Development Agency's research grants	This study was supported by the Swedish International Development Agency's research grants to Muhimbili University of Health and Allied Sciences.	Agampodi TC, 2015, SOC SCI MED, V128, P95, DOI 10.1016/j.socscimed.2015.01.005; Aminzadeh K, 2013, SOC SCI MED, V84, P13, DOI 10.1016/j.socscimed.2013.02.012; [Anonymous], 2011, STATA STAT; [Anonymous], 2011, TANZ DEM HLTH SURV 2; Aremu O, 2011, INT J WOMENS HEALTH, V3, P167, DOI 10.2147/IJWH.S21783; Ataguba JE, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-48; Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; Cheul H., 2014, BETTER HLTH MORE FRI, V2014, P2014; Cresswell JA, 2015, TROP MED INT HEALTH, V20, P607, DOI 10.1111/tmi.12466; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Ediau M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-189; Frumence G, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-38; Frumence G, 2010, SAHARA J-J SOC ASP H, V7, P9, DOI 10.1080/17290376.2010.9724964; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fujiwara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101359; Gitimu A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0442-2; Hawe P, 2000, SOC SCI MED, V51, P871, DOI 10.1016/S0277-9536(00)00067-8; Hu FY, 2014, BIOSCI TRENDS, V8, P290, DOI 10.5582/bst.2014.01138; Idris S. H., 2006, Annals of African Medicine, V5, P68; Idris Suleman Hadejia, 2013, Niger Med J, V54, P27, DOI 10.4103/0300-1652.108890; Jat TR, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-59; Kawachi I, 1997, AM J PUBLIC HEALTH, V87, P1491, DOI 10.2105/AJPH.87.9.1491; Kawachi I, 1999, ANN NY ACAD SCI, V896, P120, DOI 10.1111/j.1749-6632.1999.tb08110.x; Kritsotakis G, 2011, SOC SCI MED, V73, P1653, DOI 10.1016/j.socscimed.2011.09.020; Lasker J, 2011, HEALTH PROMOT PRACT, V12, P102, DOI 10.1177/1524839909353022; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Osorio AM, 2014, CAD SAUDE PUBLICA, V30, P1079, DOI 10.1590/0102-311X00073513; Mekonnen MG, PAN AFR MED J S1, V13, P17; Murayama H, 2012, J EPIDEMIOL, V22, P179, DOI 10.2188/jea.JE20110128; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwaliko E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-212; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Scholmerich VLN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095873; Sheikh Mubashar Riaz, 2009, J Health Organ Manag, V23, P429; Shen YY, 2014, RES AGING, V36, P497, DOI 10.1177/0164027513505624; Story WT, 2014, HEALTH PLACE, V28, P73, DOI 10.1016/j.healthplace.2014.03.011; Suk JE, 2009, EMERG INFECT DIS, V15, P1812, DOI 10.3201/eid1511.090916; Wagle Rajendra Raj, 2004, BMC Pregnancy Childbirth, V4, P8, DOI 10.1186/1471-2393-4-8; WILKINSON RG, 1994, DAEDALUS, V123, P61; Yamada T, 2009, NEW ENGL J MED, V361, P1129, DOI 10.1056/NEJMp0906972	41	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138887	10.1371/journal.pone.0138887	http://dx.doi.org/10.1371/journal.pone.0138887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426538	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100026
J	Shobayashi, K; Inoue, T; Kawai, M; Iwao, K; Ohira, S; Kojima, S; Kuroda, U; Nakashima, KI; Tanihara, H				Shobayashi, Kohei; Inoue, Toshihiro; Kawai, Motofumi; Iwao, Keiichiro; Ohira, Saori; Kojima, Sachi; Kuroda, Utako; Nakashima, Kei-Ichi; Tanihara, Hidenobu			Postoperative Changes in Aqueous Monocyte Chemotactic Protein-1 Levels and Bleb Morphology after Trabeculectomy vs. ExPRESS Shunt Surgery	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; PSEUDOPHAKIC EYES; SCLERAL FLAP; PHACOEMULSIFICATION; HUMOR; CHEMOKINES; MITOMYCIN; DEVICE	Purpose To evaluate the postoperative changes in blebs and levels of aqueous monocyte chemotactic protein-1 (MCP-1) after trabeculectomy vs. Ex-PRESS tube shunt surgery. Methods Rabbits were subjected to trabeculectomy or Ex-PRESS tube shunt surgery and observed for up to 3 months. Intraocular pressure (IOP) was measured using a rebound tonometer. The MCP-1 level was measured by enzyme-linked immunosorbent assay (ELISA). Bleb morphology was evaluated using photos and anterior-segment optical coherence tomography (OCT). Results There were no differences in bleb appearance or IOP at any time between the groups. Bleb wall density in the anterior-segment OCT image was significantly lower 1 week after surgery in the Ex-PRESS group than the trabeculectomy group. The MCP-1 level in control eyes was 304.1 +/- 45.2 pg/mL. In the trabeculectomy group, the mean aqueous MCP-1 level was 1444.9, 1914.3, 1899.8, 516.4, 398.3, 427.3, 609.5, 1612.7, 386.2, and 167.9 pg/mL at 3, 6, and 12 h, and 1, 2, 5, 7, 14, 30, and 90 days after surgery, respectively. In the Ex-PRESS group, the corresponding values were 1744.0, 1372.0, 932.5, 711.7, 396.1, 487.3, 799.5, 1327.9, 293.6, and 184.0 pg/mL. There were no significant differences in the aqueous MCP-1 level between the groups at any time point. Conclusion The postoperative changes were similar in the Ex-PRESS and trabeculectomy groups, except for bleb wall density in the anterior-segment OCT image. The postoperative aqueous MCP-1 level had bimodal peaks in both groups.	[Shobayashi, Kohei; Inoue, Toshihiro; Kawai, Motofumi; Iwao, Keiichiro; Ohira, Saori; Kojima, Sachi; Kuroda, Utako; Nakashima, Kei-Ichi; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Kawai, Motofumi] Asahikawa Med Univ, Dept Ophthalmol, Asahikawa, Hokkaido, Japan	Kumamoto University; Asahikawa Medical College	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Iwao, Keiichiro/0000-0002-4102-9374; Inoue, Toshihiro/0000-0003-3769-7609	JSPS KAKENHI [23390403, 25861640, 23791994]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Numbers 23390403, 25861640 and 23791994. The sponsor or funding organization had no role in the design or conduct of this research. There was no additional external funding received for this study.	Beltran-Agullo L, 2015, J GLAUCOMA, V24, P181, DOI 10.1097/IJG.0b013e31829e1b68; Buys YM, 2013, CURR OPIN OPHTHALMOL, V24, P111, DOI 10.1097/ICU.0b013e32835907a6; Chang L, 2000, SURV OPHTHALMOL, V45, P49, DOI 10.1016/S0039-6257(00)00135-1; Dahan E, 2012, EYE, V26, P703, DOI 10.1038/eye.2012.13; de Jong L, 2011, CLIN OPHTHALMOL, V5, P527, DOI 10.2147/OPTH.S18565; de Jong LAMS, 2009, ADV THER, V26, P336, DOI 10.1007/s12325-009-0017-6; Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]; Fukagawa Kazumi, 2009, Allergology International, V58, P499, DOI 10.2332/allergolint.09-OA-0092; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Good TJ, 2011, AM J OPHTHALMOL, V151, P507, DOI 10.1016/j.ajo.2010.09.004; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Hara T, 1998, GRAEF ARCH CLIN EXP, V236, P420, DOI 10.1007/s004170050100; Inoue T, 2014, CLIN EXP OPHTHALMOL, V42, P334, DOI 10.1111/ceo.12204; Inoue T, 2012, INVEST OPHTH VIS SCI, V53, P8288, DOI 10.1167/iovs.12-10941; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Kawai M, 2012, INVEST OPHTH VIS SCI, V53, P7951, DOI 10.1167/iovs.12-10231; Kojima S, 2015, JAMA OPHTHALMOL, V133, P148, DOI 10.1001/jamaophthalmol.2014.4489; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Maris PJG, 2007, J GLAUCOMA, V16, P14, DOI 10.1097/01.ijg.0000243479.90403.cd; Marzette L, 2011, OPHTHAL SURG LAS IM, V42, P453, DOI 10.3928/15428877-20111017-03; Netland PA, 2014, AM J OPHTHALMOL, V157, P433, DOI 10.1016/j.ajo.2013.09.014; Nyska A, 2003, J GLAUCOMA, V12, P275, DOI 10.1097/00061198-200306000-00017; Ramulu PY, 2007, OPHTHALMOLOGY, V114, P2265, DOI 10.1016/j.ophtha.2007.02.005; Sugiyama T, 2011, CLIN OPHTHALMOL, V5, P1063, DOI 10.2147/OPTH.S23129; Takihara Y, 2014, JAMA OPHTHALMOL, V132, P69, DOI 10.1001/jamaophthalmol.2013.5605; Takihara Y, 2011, ARCH OPHTHALMOL-CHIC, V129, P152, DOI 10.1001/archophthalmol.2010.348; Wagschal LD, J GLAUCOMA IN PRESS	27	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139751	10.1371/journal.pone.0139751	http://dx.doi.org/10.1371/journal.pone.0139751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427058	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100092
J	Greiff, K; Mathiassen, JR; Misimi, E; Hersleth, M; Aursand, IG				Greiff, Kirsti; Mathiassen, John Reidar; Misimi, Ekrem; Hersleth, Margrethe; Aursand, Ida G.			Gradual Reduction in Sodium Content in Cooked Ham, with Corresponding Change in Sensorial Properties Measured by Sensory Evaluation and a Multimodal Machine Vision System	PLOS ONE			English	Article							SALT REDUCTION; REPLACEMENT; QUALITY; COLOR; NACL; CLASSIFICATION; PREDICTION; FEATURES; CHLORIDE; WATER	The European diet today generally contains too much sodium (Na+). A partial substitution of NaCl by KCl has shown to be a promising method for reducing sodium content. The aim of this work was to investigate the sensorial changes of cooked ham with reduced sodium content. Traditional sensorial evaluation and objective multimodal machine vision were used. The salt content in the hams was decreased from 3.4% to 1.4%, and 25% of the Na+ was replaced by K+. The salt reduction had highest influence on the sensory attributes salty taste, after taste, tenderness, hardness and color hue. The multimodal machine vision system showed changes in lightness, as a function of reduced salt content. Compared to the reference ham (3.4% salt), a replacement of Na+-ions by K+-ions of 25% gave no significant changes in WHC, moisture, pH, expressed moisture, the sensory profile attributes or the surface lightness and shininess. A further reduction of salt down to 1.7-1.4% salt, led to a decrease in WHC and an increase in expressible moisture.	[Greiff, Kirsti; Mathiassen, John Reidar; Misimi, Ekrem; Aursand, Ida G.] SINTEF Fisheries & Aquaculture, Trondheim, Norway; [Greiff, Kirsti] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Hersleth, Margrethe] Nofima AS, As, Norway	SINTEF; Norwegian University of Science & Technology (NTNU); Nofima	Greiff, K (corresponding author), SINTEF Fisheries & Aquaculture, Trondheim, Norway.	kirsti.greiff@sintef.no		Misimi, Ekrem/0000-0003-2489-7759	Research Council of Norway [210431/O10, 185063/O10]	Research Council of Norway(Research Council of Norway)	The funding for this study is as follows: Research Council of Norway 210431/O10 to JRM EM IGA MH; Research Council of Norway 185063/O10 to KG. KG, JRM, EM, and IGA are employed by the commercial company SINTEF Fisheries and Aquaculture. This funder provided support in the form of salaries for authors KG, JRM, EM, and IGA but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additionally, MH is employed by the commercial company NOFIMA AS. This funder provided support in the form of salary for author MH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aaslyng MD, 2014, MEAT SCI, V96, P47, DOI 10.1016/j.meatsci.2013.06.004; Albarracin W, 2011, INT J FOOD SCI TECH, V46, P1329, DOI 10.1111/j.1365-2621.2010.02492.x; Alcicek Z, 2012, J FOOD ENG, V111, P46, DOI 10.1016/j.jfoodeng.2012.01.031; Almli VL, 2013, AQUACULT INT, V21, P1091, DOI 10.1007/s10499-012-9615-4; AOAC, 1990, OFFICIAL METHODS ANA; Bombrun L, 2014, MEAT SCI, V96, P5, DOI 10.1016/j.meatsci.2013.06.029; Breslin PAS, 1995, CHEM SENSES, V20, P609, DOI 10.1093/chemse/20.6.609; Chandraratne MR, 2006, J FOOD ENG, V77, P492, DOI 10.1016/j.jfoodeng.2005.06.063; Desmond E, 2006, MEAT SCI, V74, P188, DOI 10.1016/j.meatsci.2006.04.014; EIDE O, 1982, J FOOD SCI, V47, P347, DOI 10.1111/j.1365-2621.1982.tb10078.x; FRYE CB, 1986, J FOOD SCI, V51, P836, DOI 10.1111/j.1365-2621.1986.tb13945.x; Gelabert J, 2003, MEAT SCI, V65, P833, DOI 10.1016/S0309-1740(02)00288-7; Gjerlaug-Enger E, 2010, ANIMAL, V4, P1832, DOI 10.1017/S175173111000114X; Gou P, 1996, POTASSIUM CHLORIDE P; GRAU R, 1953, NATURWISSENSCHAFTEN, V40, P29, DOI 10.1007/BF00595734; Hamm R, 1972, KOLOIDCHEMIE FLEISCH; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; Health Intervention and Technology Assessment Program, 2020, REV REC FISC MON POL; Heymann, 2010, SENSORY EVALUATION F; Honikel KO, 2008, MEAT SCI, V78, P68, DOI 10.1016/j.meatsci.2007.05.030; Iqbal A, 2010, MEAT SCI, V84, P455, DOI 10.1016/j.meatsci.2009.09.016; Jackman P, 2010, J FOOD ENG, V96, P151, DOI 10.1016/j.jfoodeng.2009.07.006; Jackman P, 2009, PATTERN RECOGN, V42, P751, DOI 10.1016/j.patcog.2008.09.009; Kivikari R, 1996, P MEAT DAY SEM 1996; Mathiassen JR, 2011, TRENDS FOOD SCI TECH, V22, P257, DOI 10.1016/j.tifs.2011.03.006; Mendoza F, 2009, MEAT SCI, V81, P313, DOI 10.1016/j.meatsci.2008.08.009; Mossel DAA, 1995, ESSENTIALS MICROBIOL; MURPHY C, 1981, PHYSIOL BEHAV, V26, P1083, DOI 10.1016/0031-9384(81)90213-4; Offer G, 1988, STRUCTURAL BASIS WAT; Olson D, 1982, NATL PROVISIONER, P7; Pietrasik Z, 2014, MEAT SCI, V96, P1165, DOI 10.1016/j.meatsci.2013.11.005; Puolanne EJ, 2001, MEAT SCI, V58, P1, DOI 10.1016/S0309-1740(00)00123-6; Ruusunen M, 2005, MEAT SCI, V69, P53, DOI 10.1016/j.meatsci.2004.06.005; Ruusunen M, 2003, MEAT SCI, V64, P371, DOI 10.1016/S0309-1740(02)00178-X; Ruusunen M, 2001, AGR FOOD SCI FINLAND, V10, P27, DOI 10.23986/afsci.5676; SOFOS JN, 1983, J FOOD SCI, V48, P1692, DOI 10.1111/j.1365-2621.1983.tb05062.x; The Norwegian Directorate of Health, 2011, STRAT RED SALT INT P; Valous NA, 2009, FOOD RES INT, V42, P353, DOI 10.1016/j.foodres.2008.12.012; WHO . World Health Organization, 2006, WHO FOR TECHN; Zanardi E, 2010, MEAT SCI, V86, P742, DOI 10.1016/j.meatsci.2010.06.015	40	12	13	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137805	10.1371/journal.pone.0137805	http://dx.doi.org/10.1371/journal.pone.0137805			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422367	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700018
J	Joseph, K; Ibrahim, F; Cho, JM; Thio, THG; Al-Faqheri, W; Madou, M				Joseph, Karunan; Ibrahim, Fatimah; Cho, Jongman; Thio, Tzer Hwai Gilbert; Al-Faqheri, Wisam; Madou, Marc			Design and Development of Micro-Power Generating Device for Biomedical Applications of Lab-on-a-Disc	PLOS ONE			English	Article							WHOLE-BLOOD; ENERGY	The development of micro-power generators for centrifugal microfluidic discs enhances the platform as a green point-of-care diagnostic system and eliminates the need for attaching external peripherals to the disc. In this work, we present micro-power generators that harvest energy from the disc's rotational movement to power biomedical applications on the disc. To implement these ideas, we developed two types of micro-power generators using piezoelectric films and an electromagnetic induction system. The piezoelectric-based generator takes advantage of the film's vibration during the disc's rotational motion, whereas the electromagnetic induction-based generator operates on the principle of current generation in stacks of coil exposed to varying magnetic flux. We have successfully demonstrated that at the spinning speed of 800 revolutions per minute (RPM) the piezoelectric film-based generator is able to produce up to 24 microwatts using 6 sets of films and the magnetic induction-based generator is capable of producing up to 125 milliwatts using 6 stacks of coil. As a proof of concept, a custom made localized heating system was constructed to test the capability of the magnetic induction-based generator. The heating system was able to achieve a temperature of 58.62 degrees C at 2200 RPM. This development of lab-on-a-disc micro power generators preserves the portability standards and enhances the future biomedical applications of centrifugal microfluidic platforms.	[Joseph, Karunan; Ibrahim, Fatimah; Cho, Jongman; Thio, Tzer Hwai Gilbert; Al-Faqheri, Wisam; Madou, Marc] Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia; [Joseph, Karunan; Ibrahim, Fatimah; Cho, Jongman; Thio, Tzer Hwai Gilbert; Al-Faqheri, Wisam] Univ Malaya, Ctr Innovat Med Engn, Fac Engn, Kuala Lumpur, Malaysia; [Cho, Jongman] Inje Univ, Dept Biomed Engn, Gimhae, South Korea; [Thio, Tzer Hwai Gilbert] INTI Int Univ, Fac Sci Technol Engn & Math, Persiaran Perdana BBN, Nilai, Negeri Sembilan, Malaysia; [Madou, Marc] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Madou, Marc] Univ Calif Irvine, Dept Mech & Aerosp Engn, Irvine, CA 92717 USA	Universiti Malaya; Universiti Malaya; Inje University; INTI International University; University of California System; University of California Irvine; University of California System; University of California Irvine	Ibrahim, F (corresponding author), Univ Malaya, Dept Biomed Engn, Fac Engn, Kuala Lumpur, Malaysia.	fatimah@um.edu.my	IBRAHIM, FATIMAH/B-8506-2010; Madou, Marc J./E-5869-2013; Thio, Tzer Hwai Gilbert/AGG-4429-2022	IBRAHIM, FATIMAH/0000-0003-1804-4362; Madou, Marc J./0000-0003-4847-3117; Thio, Tzer Hwai Gilbert/0000-0002-4192-3720	Fundamental Research Grant Scheme (FRGS) [FP042-2013B]; University of Malaya Research Grant (UMRG) [RG009A-13AET]; Yayasan Sultan Iskandar Johor Foundation; National Institute of Health [1 R01 AI089541-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089541] Funding Source: NIH RePORTER	Fundamental Research Grant Scheme (FRGS); University of Malaya Research Grant (UMRG); Yayasan Sultan Iskandar Johor Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by Fundamental Research Grant Scheme (FRGS: FP042-2013B) and University of Malaya Research Grant (UMRG: RG009A-13AET). Fatimah Ibrahim would like to acknowledge Yayasan Sultan Iskandar Johor Foundation for funding the Special Equipment Grant. Marc Madou acknowledges support of the National Institute of Health (grant 1 R01 AI089541-01).	Abi-Samra K., 2011, MICROFLUID NANOFLUID, P1; Abi-Samra K, 2013, LAB CHIP, V13, P3253, DOI 10.1039/c3lc50472g; Abi-Samra K, 2011, LAB CHIP, V11, P723, DOI 10.1039/c0lc00160k; Aeinehvand MM, 2014, LAB CHIP, V14, P988, DOI 10.1039/c3lc51116b; Al-Faqheri W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058523; Amasia M, 2012, SENSOR ACTUAT B-CHEM, V161, P1191, DOI 10.1016/j.snb.2011.11.080; Amirtharajah R, 1998, IEEE J SOLID-ST CIRC, V33, P687, DOI 10.1109/4.668982; Banazwski B, 2003, P 1 INT C FUEL CELL; Beeby SP, 2006, MEAS SCI TECHNOL, V17, pR175, DOI 10.1088/0957-0233/17/12/R01; Beeby SP, 2009, ENERGY HARVESTING TECHNOLOGIES, P129, DOI 10.1007/978-0-387-76464-1_5; Callaway E.H, 2004, INTERNET COMMUN SER; Carlson C. P., 2011, STRUCT DYNAM-US, V1, P291; Chandrakasan A, 1998, CIRC SYST 1998 ISCAS; Cho YK, 2007, LAB CHIP, V7, P565, DOI 10.1039/b616115d; Chopra I, 2002, AIAA J, V40, P2145, DOI 10.2514/2.1561; Conrad SD, 2007, DEV IN GEN EMB APPL; Davis WR, 2002, IEEE J SOLID-ST CIRC, V37, P420, DOI 10.1109/4.987095; Enz CC, 2004, COMPUTER, V37, P62, DOI 10.1109/MC.2004.109; Epstein AH, 2004, J ENG GAS TURB POWER, V126, P205, DOI 10.1115/1.1739245; Focke M, 2010, LAB CHIP, V10, P2519, DOI 10.1039/c004954a; Glass NR, 2012, SMALL, V8, P1881, DOI 10.1002/smll.201102282; Goldfarb M, 1999, J DYN SYST-T ASME, V121, P566, DOI 10.1115/1.2802517; Gorge G, 2001, HERZ, V26, P64, DOI 10.1007/s00059-001-2263-5; Gorkin R, 2010, LAB CHIP, V10, P1758, DOI 10.1039/b924109d; Gu L, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3481689; Hu YF, 2011, ADV MATER, V23, P4068, DOI 10.1002/adma.201102067; Jacobson SA, 2003, INFORM SURVEY POWER; Kazemzadeh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073002; Khameneifar F, 2011, J VIB ACOUST, V133, DOI 10.1115/1.4002789; Kim HS, 2011, INT J PRECIS ENG MAN, V12, P1129, DOI 10.1007/s12541-011-0151-3; Kim TH, 2013, LAB CHIP, V13, P3747, DOI 10.1039/c3lc50374g; Koeneman PB, 1997, J MICROELECTROMECH S, V6, P355, DOI 10.1109/84.650133; Kong N, 2010, J INTEL MAT SYST STR, V21, P1293, DOI 10.1177/1045389X09357971; Lee BS, 2011, LAB CHIP, V11, P70, DOI [10.1039/c0lc00205d, 10.1039/c01c00205d]; Li TJ, 2013, LAB CHIP, V13, P2634, DOI [10.1039/c3lc00020f, 10.1039/c31c00020f]; Madou M, 2006, ANNU REV BIOMED ENG, V8, P601, DOI 10.1146/annurev.bioeng.8.061505.095758; Manla G., 2009, SOL STAT SENS ACT MI; Martinez-Duarte R, 2010, LAB CHIP, V10, P1030, DOI 10.1039/b925456k; Park J, 2012, ANAL CHEM, V84, P2133, DOI 10.1021/ac203163u; Raghunathan V, 2002, IEEE SIGNAL PROC MAG, V19, P40, DOI 10.1109/79.985679; Roundy S, 2003, COMPUT COMMUN, V26, P1131, DOI 10.1016/S0140-3664(02)00248-7; Shu YC, 2006, SMART MATER STRUCT, V15, P1499, DOI 10.1088/0964-1726/15/6/001; Sodano H. A., 2004, Shock and Vibration Digest, V36, P197, DOI 10.1177/0583102404043275; Thio THG, 2013, LAB CHIP, V13, P3199, DOI 10.1039/c3lc00004d; Toh Tzern T., 2007, Seventh International Workshop on Micro and Nanotechnology for Power Generation and Energy Conversion Applications (PowerMEMS 2007), P327; Toh TT, 2008, CONTINUOUSLY ROTATIN; Toh TT, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/10/104008; Wang YJ, 2010, SENSOR ACTUAT A-PHYS, V159, P196, DOI 10.1016/j.sna.2009.12.007; Warneke B, 2001, COMPUTER, V34, P44, DOI 10.1109/2.895117; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002	50	14	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0136519	10.1371/journal.pone.0136519	http://dx.doi.org/10.1371/journal.pone.0136519			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422249	Green Published, gold			2022-12-27	WOS:000362175700005
J	Mathews, MA; Murray, A; Wijesinghe, R; Cullen, K; Tung, VWK; Camp, AJ				Mathews, Miranda A.; Murray, Andrew; Wijesinghe, Rajiv; Cullen, Karen; Tung, Victoria W. K.; Camp, Aaron J.			Efferent Vestibular Neurons Show Homogenous Discharge Output But Heterogeneous Synaptic Input Profile In Vitro	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; UNILATERALLY LABYRINTHECTOMIZED RAT; SEMICIRCULAR CANAL AFFERENTS; TURTLE POSTERIOR-CRISTA; NUCLEUS NEURONS; GLYCINE RECEPTOR; THALAMIC NEURONS; OPSANUS-TAU; HAIR CELL; INNER-EAR	Despite the importance of our sense of balance we still know remarkably little about the central control of the peripheral balance system. While previous work has shown that activation of the efferent vestibular system results in modulation of afferent vestibular neuron discharge, the intrinsic and synaptic properties of efferent neurons themselves are largely unknown. Here we substantiate the location of the efferent vestibular nucleus (EVN) in the mouse, before characterizing the input and output properties of EVN neurons in vitro. We made transverse serial sections through the brainstem of 4-week-old mice, and performed immunohistochemistry for calcitonin gene-related peptide (CGRP) and choline acetyltransferase (ChAT), both expressed in the EVN of other species. We also injected fluorogold into the posterior canal and retrogradely labelled neurons in the EVN of ChAT:: tdTomato mice expressing tdTomato in all cholinergic neurons. As expected the EVN lies dorsolateral to the genu of the facial nerve (CNVII). We then made whole-cell current-, and voltage-clamp recordings from visually identified EVN neurons. In current-clamp, EVN neurons display a homogeneous discharge pattern. This is characterized by a high frequency burst of action potentials at the onset of a depolarizing stimulus and the offset of a hyperpolarizing stimulus that is mediated by T-type calcium channels. In voltage-clamp, EVN neurons receive either exclusively excitatory or inhibitory inputs, or a combination of both. Despite this heterogeneous mixture of inputs, we show that synaptic inputs onto EVN neurons are predominantly excitatory. Together these findings suggest that the inputs onto EVN neurons, and more specifically the origin of these inputs may underlie EVN neuron function.	[Mathews, Miranda A.; Wijesinghe, Rajiv; Tung, Victoria W. K.; Camp, Aaron J.] Univ Sydney, Bosch Inst, Discipline Biomed Sci, Sydney, NSW 2006, Australia; [Murray, Andrew] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Cullen, Karen] Univ Sydney, Bosch Inst, Discipline Anat & Histol, Sydney, NSW 2006, Australia	University of Sydney; Columbia University; Howard Hughes Medical Institute; University of Sydney	Camp, AJ (corresponding author), Univ Sydney, Bosch Inst, Discipline Biomed Sci, Sydney, NSW 2006, Australia.	aaron.camp@sydney.edu.au	Cullen, Karen M/S-6841-2019	Cullen, Karen M/0000-0001-6651-1418; Wijesinghe, Rajiv/0000-0002-6215-6719				Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Andrade R, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00047; BARBASHENRY HA, 1988, J COMP NEUROL, V277, P234, DOI 10.1002/cne.902770206; Beraneck M, 2003, J NEUROPHYSIOL, V90, P184, DOI 10.1152/jn.01140.2002; Birinyi A, 2001, BRAIN RES, V921, P44, DOI 10.1016/S0006-8993(01)03075-X; BLANKS RHI, 1976, EXP BRAIN RES, V25, P369; BOYLE R, 1990, J NEUROSCI, V10, P1570; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; Brichta AM, 2000, J NEUROPHYSIOL, V83, P1224, DOI 10.1152/jn.2000.83.3.1224; Camp AJ, 2010, NEUROSCIENCE, V170, P348, DOI 10.1016/j.neuroscience.2010.06.040; Camp AJ, 2006, J NEUROPHYSIOL, V95, P3208, DOI 10.1152/jn.01001.2005; CARPENTER MB, 1987, BRAIN RES, V408, P275, DOI 10.1016/0006-8993(87)90387-8; Castellano-Munoz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013777; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chi FL, 2007, NEUROENDOCRINOLOGY, V85, P131, DOI 10.1159/000101959; Cooper NP, 2006, J PHYSIOL-LONDON, V576, P49, DOI 10.1113/jphysiol.2006.114991; Cullen KE, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-11-j0002.2002; Donato R, 2000, J NEUROPHYSIOL, V84, P2715, DOI 10.1152/jn.2000.84.6.2715; Eleore L, 2004, EXP BRAIN RES, V154, P333, DOI 10.1007/s00221-003-1626-y; Eleore L, 2005, EXP BRAIN RES, V160, P166, DOI 10.1007/s00221-004-1997-8; GACEK RR, 1974, ACTA OTO-LARYNGOL, V77, P92, DOI 10.3109/00016487409124603; Goaillard JM, 2002, J PHYSIOL-LONDON, V541, P453, DOI 10.1113/jphysiol.2001.013896; GOLDBERG JM, 1990, HEARING RES, V49, P89, DOI 10.1016/0378-5955(90)90097-9; GOLDBERG JM, 1980, J NEUROPHYSIOL, V43, P986, DOI 10.1152/jn.1980.43.4.986; Graham BA, 2003, J PHYSIOL-LONDON, V551, P905, DOI 10.1113/jphysiol.2003.049064; HARTMANN R, 1980, PFLUG ARCH EUR J PHY, V388, P123, DOI 10.1007/BF00584117; Hellmann B, 1996, BRAIN BEHAV EVOLUT, V47, P185, DOI 10.1159/000113238; HIGHSTEIN SM, 1986, J COMP NEUROL, V243, P309, DOI 10.1002/cne.902430303; HIGHSTEIN SM, 1985, J NEUROPHYSIOL, V54, P370, DOI 10.1152/jn.1985.54.2.370; HIGHSTEIN SM, 1992, ANN NY ACAD SCI, V656, P108, DOI 10.1111/j.1749-6632.1992.tb25203.x; HILDING D, 1962, Acta Otolaryngol, V55, P205, DOI 10.3109/00016486209127354; Holstein GR, 2004, P NATL ACAD SCI USA, V101, P15766, DOI 10.1073/pnas.0402824101; Holt JC, 2006, J NEUROSCI, V26, P13180, DOI 10.1523/JNEUROSCI.3539-06.2006; ISHIYAMA A, 1994, OTOLARYNG HEAD NECK, V111, P385, DOI 10.1177/019459989411100402; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; KLINKE R, 1968, PFLUG ARCH EUR J PHY, V304, P183, DOI 10.1007/BF00587206; Kong WJ, 2002, EUR J NEUROSCI, V15, P487, DOI 10.1046/j.0953-816x.2001.01880.x; Labrakakis C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00424; Lasker DM, 2008, JARO-J ASSOC RES OTO, V9, P334, DOI 10.1007/s10162-008-0120-4; Leijon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098277; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lysakowski A, 1997, J COMP NEUROL, V389, P419, DOI 10.1002/(SICI)1096-9861(19971222)389:3<419::AID-CNE5>3.0.CO;2-3; Lysakowski A, 1996, ANN NY ACAD SCI, V781, P164, DOI 10.1111/j.1749-6632.1996.tb15700.x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MARCO J, 1993, ACTA OTO-LARYNGOL, V113, P229, DOI 10.3109/00016489309135798; Marlinski V, 2004, JARO-J ASSOC RES OTO, V5, P126, DOI 10.1007/s10162-003-4029-7; Matthews EA, 2009, J NEUROSCI, V29, P4750, DOI 10.1523/JNEUROSCI.0384-09.2009; MCCUE MP, 1994, J NEUROSCI, V14, P6071; MEREDITH GE, 1988, ACTA BIOL HUNG, V39, P229; Metts BA, 2006, EXP BRAIN RES, V172, P261, DOI 10.1007/s00221-005-0328-z; Murakami DM, 2002, P NATL ACAD SCI USA, V99, P17078, DOI 10.1073/pnas.252652299; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; O'Brien JA, 2004, RESP PHYSIOL NEUROBI, V141, P35, DOI 10.1016/j.resp.2004.03.009; O'Brien JA, 2001, J NEUROSCI, V21, P8482, DOI 10.1523/JNEUROSCI.21-21-08482.2001; OHNO K, 1991, BRAIN RES, V566, P103, DOI 10.1016/0006-8993(91)91686-U; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng ZC, 2014, NEUROCHEM RES, V39, P1104, DOI 10.1007/s11064-013-1202-1; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Plotnik M, 2005, JARO-J ASSOC RES OTO, V6, P311, DOI 10.1007/s10162-005-0010-y; Plotnik M, 2002, J NEUROPHYSIOL, V88, P1234, DOI 10.1152/jn.2002.88.3.1234; PRECHT W, 1971, EXP BRAIN RES, V13, P378; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Russier M, 2002, J PHYSIOL-LONDON, V541, P123, DOI 10.1113/jphysiol.2001.016063; RYAN SG, 1994, NAT GENET, V7, P131, DOI 10.1038/ng0694-131; Sadeghi SG, 2009, J NEUROPHYSIOL, V101, P988, DOI 10.1152/jn.91112.2008; Saito Y, 2008, EUR J NEUROSCI, V28, P288, DOI 10.1111/j.1460-9568.2008.06338.x; Sans NA, 2000, DEV BRAIN RES, V123, P41, DOI 10.1016/S0165-3806(00)00082-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHMIDT R S, 1963, Acta Otolaryngol, V56, P51, DOI 10.3109/00016486309127679; SCHWARZ DWF, 1986, EXP BRAIN RES, V64, P19; Shao M, 2003, J NEUROPHYSIOL, V90, P1182, DOI 10.1152/jn.00076.2003; Shao M, 2012, J NEUROPHYSIOL, V107, P29, DOI 10.1152/jn.00406.2011; Sherman SM, 2005, PROG BRAIN RES, V149, P107, DOI 10.1016/S0079-6123(05)49009-3; Sienknecht UJ, 2014, BRAIN BEHAV EVOLUT, V83, P150, DOI 10.1159/000357752; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; STURROCK RR, 1989, J ANAT, V166, P227; SUGAI T, 1991, JPN J PHYSIOL, V41, P217, DOI 10.2170/jjphysiol.41.217; Tse YC, 2008, J COMP NEUROL, V508, P343, DOI 10.1002/cne.21688; WACKYM PA, 1991, OTOLARYNG HEAD NECK, V105, P493, DOI 10.1177/019459989110500401; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Wijesinghe R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057961; XIAOCHENG W, 2012, PLOS ONE, V0007; YATES BJ, 1994, J NEUROPHYSIOL, V71, P2087, DOI 10.1152/jn.1994.71.6.2087	84	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139548	10.1371/journal.pone.0139548	http://dx.doi.org/10.1371/journal.pone.0139548			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422206	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700127
J	O'Hare, L; Clarke, ADF; Pollux, PMJ				O'Hare, Louise; Clarke, Alasdair D. F.; Pollux, Petra M. J.			VEP Responses to Op-Art Stimuli	PLOS ONE			English	Article							SPATIAL-FREQUENCY; VISUAL DISCOMFORT; ILLUSORY MOTION; EYE-MOVEMENTS; MICROSACCADES; ILLUSION; ENIGMA; PSYCHOPHYSICS; VISION; STATISTICS	Several types of striped patterns have been reported to cause adverse sensations described as visual discomfort. Previous research using op-art-based stimuli has demonstrated that spurious eye movement signals can cause the experience of illusory motion, or shimmering effects, which might be perceived as uncomfortable. Whilst the shimmering effects are one cause of discomfort, another possible contributor to discomfort is excessive neural responses: As striped patterns do not have the statistical redundancy typical of natural images, they are perhaps unable to be encoded efficiently. If this is the case, then this should be seen in the amplitude of the EEG response. This study found that stimuli that were judged to be most comfortable were also those with the lowest EEG amplitude. This provides some support for the idea that excessive neural responses might also contribute to discomfort judgements in normal populations, in stimuli controlled for perceived contrast.	[O'Hare, Louise; Pollux, Petra M. J.] Lincoln Univ, Sch Psychol, Lincoln, England; [Clarke, Alasdair D. F.] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland	University of Lincoln; University of Aberdeen	O'Hare, L (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	LOHare@lincoln.ac.uk		O'Hare, Louise/0000-0003-0331-3646	BA/Leverhulme Small Research Grant [SG131233]	BA/Leverhulme Small Research Grant	This work was supported by a BA/Leverhulme Small Research Grant, reference number SG131233, (see http://www.britac.ac.uk/funding/guide/srg.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YY, 2014, I-PERCEPTION, V5, P20, DOI 10.1068/i0597; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bulatov A, 1997, BIOL CYBERN, V77, P395, DOI 10.1007/s004220050399; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Chen WT, 2007, INT C SER, V1300, P531, DOI [10.1016/j.ics.2007.03.008, DOI 10.1016/J.ICS.2007.03.008]; Conlon E, 2001, VISION RES, V41, P3063, DOI 10.1016/S0042-6989(01)00204-8; Conlon EG, 1999, VIS COGN, V6, P637, DOI 10.1080/135062899394885; Dimigen O, 2009, J NEUROSCI, V29, P12321, DOI 10.1523/JNEUROSCI.0911-09.2009; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; Field D J, 1987, J OPT SOC AM A, V7, P1113; FIELD DJ, 1994, NEURAL COMPUT, V6, P559, DOI 10.1162/neco.1994.6.4.559; Field DJ, 1999, PHILOS T R SOC A, V357, P2527, DOI 10.1098/rsta.1999.0446; GEORGESON MA, 1975, J PHYSIOL-LONDON, V252, P627, DOI 10.1113/jphysiol.1975.sp011162; Giora E, 2010, VISION RES, V50, P2466, DOI 10.1016/j.visres.2010.08.033; Gori S, 2008, PERCEPTION, V37, P631, DOI 10.1068/p5770; Gori S, 2006, VISION RES, V46, P3267, DOI 10.1016/j.visres.2006.03.009; Gori S, 2006, PERCEPTION, V35, P853, DOI 10.1068/p5531; Gori S, 2015, CEREB CORTEX, V25, P1685, DOI 10.1093/cercor/bhu234; Gori S, 2011, NEURAL NETWORKS, V24, P1082, DOI 10.1016/j.neunet.2011.06.017; Graham DJ, 2008, PERCEPTION, V37, P1341, DOI 10.1068/p5971; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GREGORY RL, 1993, P ROY SOC B-BIOL SCI, V253, P123, DOI 10.1098/rspb.1993.0090; Hafed ZM, 2013, NEURON, V77, P775, DOI 10.1016/j.neuron.2012.12.014; Hermens F, 2015, VIS COGN, V23, P432, DOI 10.1080/13506285.2015.1042539; Hibbard PB, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140535; Huang J, 2011, CEPHALALGIA, V31, P925, DOI 10.1177/0333102411409076; Ito H, 2012, I-PERCEPTION, V3, P59, DOI 10.1068/i0430; Jainta S, 2010, J VISION, V10, DOI 10.1167/10.13.2; Juricevic I, 2010, PERCEPTION, V39, P884, DOI 10.1068/p6656; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Kleiner M, 2007, PERCEPTION, V36, P14; KOWLER E, 1980, VISION RES, V20, P273, DOI 10.1016/0042-6989(80)90113-3; Kumar T, 2006, P NATL ACAD SCI USA, V103, P1947, DOI 10.1073/pnas.0510236103; KUPIN JJ, 1973, PERCEPT PSYCHOPHYS, V14, P298, DOI 10.3758/BF03212394; MACKAY DM, 1957, NATURE, V180, P849, DOI 10.1038/180849a0; MARCUS DA, 1989, ARCH NEUROL-CHICAGO, V46, P1129, DOI 10.1001/archneur.1989.00520460125024; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; McCamy MB, 2014, J NEUROSCI, V34, P2956, DOI 10.1523/JNEUROSCI.4448-13.2014; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; Mon-Williams M, 1996, P BIOL SCI, V263, P537; O'Hare L, 2011, VISION RES, V51, P1767, DOI 10.1016/j.visres.2011.06.002; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Otero-Millan J, 2014, FRONTIERS INTEGRATIV, V8, P1; Otero-Millan J, 2012, J NEUROSCI, V32, P6043, DOI 10.1523/JNEUROSCI.5823-11.2012; PARKER DM, 1982, INVEST OPHTH VIS SCI, V22, P675; Parry NRA, 1999, VISION RES, V39, P3491, DOI 10.1016/S0042-6989(99)00098-X; Patzwahl DR, 2000, EUR J NEUROSCI, V12, P273, DOI 10.1046/j.1460-9568.2000.00885.x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PLANT GT, 1983, J NEUROL NEUROSUR PS, V46, P1125, DOI 10.1136/jnnp.46.12.1125; Rolfs M, 2005, EXP BRAIN RES, V166, P427, DOI 10.1007/s00221-005-2382-y; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; Ruzzoli M, 2011, NEUROPSYCHOLOGIA, V49, P3648, DOI 10.1016/j.neuropsychologia.2011.09.020; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Shibata T, 2011, PURE APPL CHEM, V83, P597, DOI 10.1351/PAC-CON-10-09-03; Souza GS, 2007, INVEST OPHTH VIS SCI, V48, P3396, DOI 10.1167/iovs.07-0018; Spillmann L, 2013, PERCEPTION, V42, P413, DOI 10.1068/p7384; TOBIMATSU S, 1993, J NEUROL SCI, V118, P17, DOI 10.1016/0022-510X(93)90239-U; Tolhurst D J, 1992, AMPLITUDE SPECTRA NA, V12, P229; Troncoso XG, 2008, P NATL ACAD SCI USA, V105, P16033, DOI 10.1073/pnas.0709389105; Vannucci M, 2014, COGN NEUROSCI-UK, V5, P143, DOI 10.1080/17588928.2014.976188; Wade NJ, 2003, PERCEPTION, V32, P1029, DOI 10.1068/p3209ed; WILKINS A, 1984, BRAIN, V107, P989, DOI 10.1093/brain/107.4.989; Wilkins A. J, 2001, PATTERN GLARE TEST; Wilkins AJ, 2007, PERCEPTION, V36, P1788, DOI 10.1068/p5651; Yazdanbakhsh A, 2011, NEURAL NETWORKS, V24, P1093, DOI 10.1016/j.neunet.2011.06.016; Zanker JM, 2004, SPATIAL VISION, V17, P75, DOI 10.1163/156856804322778279; Zanker JM, 2003, PERCEPTION, V32, P1037, DOI 10.1068/p5128; Zanker JM, 2010, J VISION, V10, DOI 10.1167/10.2.13; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068	74	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139400	10.1371/journal.pone.0139400	http://dx.doi.org/10.1371/journal.pone.0139400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422207	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000362175700113
J	Silva, CP; Garcia, CE; Estay, SA; Barbosa, O				Paz Silva, Carmen; Garcia, Cristobal E.; Estay, Sergio A.; Barbosa, Olga			Bird Richness and Abundance in Response to Urban Form in a Latin American City: Valdivia, Chile as a Case Study	PLOS ONE			English	Article							SPECIES RICHNESS; LAND-USE; SOCIOECONOMIC-STATUS; RELATIVE IMPORTANCE; AVIAN DIVERSITY; URBANIZATION; COMMUNITY; HABITAT; GARDENS; GREEN	There is mounting evidence that urban areas influence biodiversity. Generalizations however require that multiple urban areas on multiple continents be examined. Here we evaluated the role of urban areas on avian diversity for a South American city, allowing us to examine the effects of urban features common worldwide, using the city of Valdivia, Chile as case study. We assessed the number of birds and their relative abundance in 152 grid cells of equal size (250 m(2)) distributed across the city. We estimated nine independent variables: land cover diversity (DC), building density (BD), impervious surface (IS), municipal green space (MG), non-municipal green space (NG), domestic garden space (DG), distance to the periphery (DP), social welfare index (SW), and vegetation diversity (RV). Impervious surface represent 41.8% of the study area, while municipal green, non-municipal green and domestic garden represent 11.6%, 23.6% and 16% of the non-man made surface. Exotic vegetation species represent 74.6% of the total species identified across the city. We found 32 bird species, all native with the exception of House Sparrow and Rock Pigeon. The most common species were House Sparrow and Chilean Swallow. Total bird richness responds negatively to IS and MG, while native bird richness responds positively to NG and negatively to BD, IS DG and, RV. Total abundance increase in areas with higher values of DC and BD, and decrease in areas of higher values of IS, SW and VR. Native bird abundance responds positively to NG and negatively to BD, IS MG, DG and RV. Our results suggest that not all the general patterns described in previous studies, conducted mainly in the USA, Europe, and Australia, can be applied to Latin American cities, having important implications for urban planning. Conservation efforts should focus on non-municipal areas, which harbor higher bird diversity, while municipal green areas need to be improved to include elements that can enhance habitat quality for birds and other species. These findings are relevant for urban planning in where both types of green space need to be considered, especially non-municipal green areas, which includes wetlands, today critically threatened by urban development.	[Paz Silva, Carmen; Garcia, Cristobal E.; Estay, Sergio A.; Barbosa, Olga] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Estay, Sergio A.] Ctr Appl Ecol & Sustainabil CAPES, Santiago, Chile; [Barbosa, Olga] IEB, Santiago, Chile; [Barbosa, Olga] Ctr Desarrollo Urbano Sustentable CEDEUS, Santiago, Chile	Universidad Austral de Chile	Silva, CP (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	carmenpazsilva@gmail.com; olga.barbosa@uach.cl			CONICYT [24121019, PFB-23]; FONDECYT [11110183, TFB-002]; FONDAP [1510020]; National Science Foundation [BCS-0948229]; Direct For Biological Sciences [1140070] Funding Source: National Science Foundation	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by CONICYT scholarship #24121019, FONDECYT #11110183, CONICYT PFB-23, FONDAP grant #1510020, FONDECY TFB-002 (line 4), and National Science Foundation BCS-0948229. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Barbosa O, 2014, EARTH STEWARDSHIP LI; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Blair R, 2004, ECOL SOC, V9; Blair RB, 1996, ECOL APPL, V6, P506, DOI 10.2307/2269387; Bohnet IC, 2010, LANDSCAPE URBAN PLAN, V97, P239, DOI 10.1016/j.landurbplan.2010.06.007; Burton ML, 2008, PLANT ECOL, V195, P99, DOI 10.1007/s11258-007-9305-x; Cam E, 2000, ECOL APPL, V10, P1196, DOI 10.2307/2641026; Catterall CP, 2009, ECOLOGY OF CITIES AND TOWNS: A COMPARATIVE APPROACH, P129, DOI 10.1017/CBO9780511609763.009; Ceballos G, 2009, CONSERV BIOL, V23, P811, DOI 10.1111/j.1523-1739.2009.01286.x; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chiari C, 2010, J ANIM ECOL, V79, P366, DOI 10.1111/j.1365-2656.2009.01631.x; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Chong KY, 2014, BIOL CONSERV, V171, P299, DOI 10.1016/j.biocon.2014.01.037; Chuvieco E., 2002, TELEDETECCION AMBIEN, V3; Cook EM, 2012, URBAN ECOSYST, V15, P19, DOI 10.1007/s11252-011-0197-0; Crooks KR, 2004, BIOL CONSERV, V115, P451, DOI 10.1016/S0006-3207(03)00162-9; Davies Richard G., 2008, Urban Ecosystems, V11, P269, DOI 10.1007/s11252-008-0062-y; Davies ZG, 2009, BIOL CONSERV, V142, P761, DOI 10.1016/j.biocon.2008.12.016; Diaz I. A, 2005, HIST BIODIVERSIDAD E, P456; Diaz IA, 2005, BIOL CONSERV, V123, P91, DOI 10.1016/j.biocon.2004.10.011; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dures SG, 2010, BIOL CONSERV, V143, P768, DOI 10.1016/j.biocon.2009.12.019; Evans KL, 2007, GLOBAL ECOL BIOGEOGR, V16, P300, DOI 10.1111/j.1466-8238.2006.00288.x; Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4; Fuller RA, 2007, BIOLOGY LETT, V3, P368, DOI 10.1098/rsbl.2007.0134; Gagne SA, 2011, ECOL APPL, V21, P2297, DOI 10.1890/09-1905.1; Garaffa PI, 2009, LANDSCAPE URBAN PLAN, V90, P33, DOI 10.1016/j.landurbplan.2008.10.004; Gaston KJ, 2007, BIODIVERS CONSERV, V16, P3227, DOI 10.1007/s10531-007-9174-6; Gaston KJ, 2005, BIODIVERS CONSERV, V14, P3327, DOI 10.1007/s10531-004-9513-9; Germaine SS, 1998, ECOL APPL, V8, P680, DOI 10.1890/1051-0761(1998)008[0680:RABBHA]2.0.CO;2; Green DA, 2003, LANDSCAPE URBAN PLAN, V63, P225, DOI 10.1016/S0169-2046(02)00195-0; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Guarda G., 2009, 4 SIGLOS EVOLUCION U; INE, 2002, CENS POBL VIV; INE, 2007, DIV POL ADM CENS 200; INE, 2003, MET CLAS SOC HOG CHI; JOKIMAKI J, 1993, ORNIS FENNICA, V70, P71; Juri Maria Dolores, 2005, Acta Zoologica Lilloana, V49, P49; Kinzig AP, 2005, ECOL SOC, V10; Laube I, 2008, J ORNITHOL, V149, P181, DOI 10.1007/s10336-007-0258-6; Lerman SB, 2011, ECOL APPL, V21, P1327, DOI 10.1890/10-0423.1; Leveau L. M., 2004, ARGENTINA HORNERO, V19, P13; Lillesand T.M., 2007, REMOTE SENSING IMAGE; Lim HC, 2004, LANDSCAPE URBAN PLAN, V66, P199, DOI 10.1016/S0169-2046(03)00111-7; Loram A, 2008, ENVIRON MANAGE, V42, P361, DOI 10.1007/s00267-008-9097-3; Loram A, 2007, LANDSCAPE ECOL, V22, P601, DOI 10.1007/s10980-006-9051-9; Loram A, 2011, ENVIRON MANAGE, V48, P808, DOI 10.1007/s00267-011-9723-3; Loss SR, 2009, BIOL CONSERV, V142, P2578, DOI 10.1016/j.biocon.2009.06.004; Luck Gary W., 2010, P88; MacGregor-Fors I, 2011, BASIC APPL ECOL, V12, P372, DOI 10.1016/j.baae.2011.04.003; Martin CA, 2004, LANDSCAPE URBAN PLAN, V69, P355, DOI 10.1016/j.landurbplan.2003.10.034; Marzluff J. M., 2001, AVIAN CONSERV ECOL, P1, DOI DOI 10.1007/978-1-4615-1531-9; MCDONNELL MJ, 1993, HUMANS AS COMPONENTS OF ECOSYSTEMS, P175; Melles S, 2003, CONSERV ECOL, V7; Melles Stephanie J., 2005, Urban Habitats, V3, P25; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, P3, DOI DOI 10.1007/978-3-642-20992-5_1; Moorman MC, 2013, SOC NATUR RESOUR, V26, P1022, DOI 10.1080/08941920.2012.739676; Murgui Enrique, 2009, Urban Ecosystems, V12, P249, DOI 10.1007/s11252-009-0092-0; Oksanen J., 2016, R PACKAG; Ortega-Alvarez R, 2011, AUK, V128, P415, DOI 10.1525/auk.2011.10082; Ortega-Alvarez R, 2009, LANDSCAPE URBAN PLAN, V90, P189, DOI 10.1016/j.landurbplan.2008.11.003; Oyarzun CE, 2005, REV AMBI DESARRO, V20-21, P88; Paker Y, 2014, LANDSCAPE URBAN PLAN, V122, P186, DOI 10.1016/j.landurbplan.2013.10.005; Palomino D, 2007, BIOL CONSERV, V140, P100, DOI 10.1016/j.biocon.2007.07.029; Pauchard Anibal, 2013, P589; R Core Team, 2020, R LANG ENV STAT COMP; Reale Joseph A., 2005, Urban Habitats, V3, P1; Reis E, 2012, LANDSCAPE URBAN PLAN, V107, P31, DOI 10.1016/j.landurbplan.2012.04.009; Rupprecht CDD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099784; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Shochat E, 2004, ECOL APPL, V14, P268, DOI 10.1890/02-5341; Shochat E, 2006, TRENDS ECOL EVOL, V21, P661, DOI 10.1016/j.tree.2006.09.007; Strohbach MW, 2009, ECOL SOC, V14; Swain P.H., 1978, REMOTE SENSING QUANT; Tratalos J, 2007, LANDSCAPE URBAN PLAN, V83, P308, DOI 10.1016/j.landurbplan.2007.05.003; Tratalos J, 2007, GLOBAL CHANGE BIOL, V13, P1685, DOI 10.1111/j.1365-2486.2007.01390.x; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; UN-HABITAT, 2012, STAT WORLD CIT REP 2; White JG, 2005, LANDSCAPE URBAN PLAN, V71, P123, DOI 10.1016/j.landurbplan.2004.02.006; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zhang Y, 2001, PHOTOGRAMM ENG REM S, V67, P1359	84	35	38	3	174	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138120	10.1371/journal.pone.0138120	http://dx.doi.org/10.1371/journal.pone.0138120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422260	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700030
J	Wandelt, S; Leser, U				Wandelt, Sebastian; Leser, Ulf			Sequence Factorization with Multiple References	PLOS ONE			English	Article							COMPRESSION ALGORITHMS; GENOME	The success of high-throughput sequencing has lead to an increasing number of projects which sequence large populations of a species. Storage and analysis of sequence data is a key challenge in these projects, because of the sheer size of the datasets. Compression is one simple technology to deal with this challenge. Referential factorization and compression schemes, which store only the differences between input sequence and a reference sequence, gained lots of interest in this field. Highly-similar sequences, e.g., Human genomes, can be compressed with a compression ratio of 1,000:1 and more, up to two orders of magnitude better than with standard compression techniques. Recently, it was shown that the compression against multiple references from the same species can boost the compression ratio up to 4,000:1. However, a detailed analysis of using multiple references is lacking, e.g., for main memory consumption and optimality. In this paper, we describe one key technique for the referential compression against multiple references: The factorization of sequences. Based on the notion of an optimal factorization, we propose optimization heuristics and identify parameter settings which greatly influence 1) the size of the factorization, 2) the time for factorization, and 3) the required amount of main memory. We evaluate a total of 30 setups with a varying number of references on data from three different species. Our results show a wide range of factorization sizes (optimal to an overhead of up to 300%), factorization speed (0.01 MB/s to more than 600 MB/s), and main memory usage (few dozen MB to dozens of GB). Based on our evaluation, we identify the best configurations for common use cases. Our evaluation shows that multi-reference factorization is much better than single-reference factorization.	[Wandelt, Sebastian; Leser, Ulf] Humboldt Univ, Knowledge Management Bioinformat, Rudower Chaussee 25, D-12489 Berlin, Germany	Humboldt University of Berlin	Wandelt, S (corresponding author), Humboldt Univ, Knowledge Management Bioinformat, Rudower Chaussee 25, D-12489 Berlin, Germany.	wandelt@informatik.hu-berlin.de		Rahman, M. Sohel/0000-0001-9419-6478				Al-Hafeedh A, 2012, ACM COMPUT SURV, V45, DOI 10.1145/2379776.2379781; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Brandon MC, 2009, BIOINFORMATICS, V25, P1731, DOI 10.1093/bioinformatics/btp319; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chern B, 2012, CORR; Christley S, 2009, BIOINFORMATICS, V25, P274, DOI 10.1093/bioinformatics/btn582; Cohn M, 1996, DCC '96 - DATA COMPRESSION CONFERENCE, PROCEEDINGS, P180, DOI 10.1109/DCC.1996.488323; Crochemore M, 2014, THEOR COMPUT SCI, V525, P55, DOI 10.1016/j.tcs.2014.01.013; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Danek A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109384; Deorowicz S, 2013, BIOINFORMATICS, DOI 10.1093/bioinformatics/btt460; Deorowicz S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11565; Deorowicz S, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-25; Deorowicz S, 2013, BIOINFORMATICS, V29, P2572, DOI 10.1093/bioinformatics/btt460; Doring A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-11; Giancarlo R, 2014, BRIEF BIOINFORM, V15, P390, DOI 10.1093/bib/bbt088; Hach F, 2012, BIOINFORMATICS, V28, P3051, DOI 10.1093/bioinformatics/bts593; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Janin L, 2014, BIOINFORMATICS, V30, P24, DOI 10.1093/bioinformatics/btt257; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Karkkainen J, 2013, LECT NOTES COMPUT SC, V7922, P189, DOI 10.1007/978-3-642-38905-4_19; Kempa D., 2013, ALENEX, P103, DOI DOI 10.1137/1.9781611972931.9; Kuruppu S, 2011, AUSTR COMP SCI C; Kuruppu S, 2010, LECT NOTES COMPUT SC, V6393, P201, DOI 10.1007/978-3-642-16321-0_20; Larsson NJ, 1999, IEEE DATA COMPR CONF, P296, DOI 10.1109/DCC.1999.755679; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; Nalbantoglu OU, 2010, ENTROPY-SWITZ, V12, P34, DOI 10.3390/e12010034; Ochoa I, 2014, BIOINFORMATICS; Ochoa I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-187; Ohlebusch E, 2011, LECT NOTES COMPUT SC, V6661, P15; Ohlebusch E, 2010, LECT NOTES COMPUT SC, V6393, P322, DOI 10.1007/978-3-642-16321-0_34; Pinho AJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1124; Rahn R, 2014, BIOINFORMATICS, V30, P3499, DOI 10.1093/bioinformatics/btu438; Roguski L, 2014, BIOINFORMATICS, V30, P2213, DOI 10.1093/bioinformatics/btu208; Saha S, 2015, BIOINFORMATICS, DOI 10.1093/bioinformatics/btv399; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Shibata Y, 2000, LECT NOTES COMPUT SC, V1848, P181; Siren J, 2014, IEEE ACM T COMPUT BI, V11, P375, DOI 10.1109/TCBB.2013.2297101; Sun XQ, 2014, J AIRCRAFT, V51, P216, DOI 10.2514/1.C032296; U S Department of Veteran affairs, 2014, MILL VET PROGR; Wandelt S, 2013, P VLDB ENDOWMENT; Wandelt S, 2014, CURR BIOINFORM, V9, P315, DOI 10.2174/1574893609666140516010143; Wandelt S, 2013, IEEE ACM T COMPUT BI, V10, P1275, DOI 10.1109/TCBB.2013.122; Yoon K.P., 1995, MULTIPLE ATTRIBUTE D, V104; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	47	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139000	10.1371/journal.pone.0139000	http://dx.doi.org/10.1371/journal.pone.0139000			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422374	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700059
J	Yu, F; Jia, YL; Wang, HF; Zheng, J; Cui, Y; Fang, XY; Zhang, LM; Chen, QX				Yu, Feng; Jia, Yu-Long; Wang, Hui-Fang; Zheng, Jing; Cui, Yi; Fang, Xin-Yu; Zhang, Lin-Min; Chen, Qing-Xi			Synthesis of Triazole Schiff's Base Derivatives and Their Inhibitory Kinetics on Tyrosinase Activity	PLOS ONE			English	Article							MUSHROOM TYROSINASE; MECHANISM; MELANIN; THIOSEMICARBAZONES; OXYRESVERATROL; FLAVONOIDS; THERAPY; DESIGN; COPPER; ACID	In the present study, new Schiff's base derivatives: (Z)-4-amino-5-(2-(3-fluorobenzylidene)hydrazinyl)-4H-1,2,4-triazole-3-thiol (Y-1), (Z)-3-((2-(4-amino-5-mercapto-4H-1,2,4-triazol-3-yl)hydrazono)methyl)phenol (Y-2), (Z)-2-((2-(4-amino-5-mercapto-4H-1,2,4-triazol-3-yl) hydrazono)methyl)phenol (Y-3) and 3-((Z)-(2-(4-(((E)-3-hydroxybenzylidene)amino)-5-mercapto-4H-1,2,4-triazol-3-yl)hydrazono)methyl)phenol (Y-4) were synthesized and their structures were characterized by LC-MS, IR and H-1 NMR. The inhibitory effects of these compounds on tyrosinase activites were evaluated. Compounds Y-1, Y-2 and Y-3 showed potent inhibitory effects with respective IC50 value of 12.5, 7.0 and 1.5 mu M on the diphenolase activities. Moreover, the inhibition mechanisms were determined to be reversible and mixed types. Interactions of the compounds with tyrosinase were further analyzed by fluorescence quenching, copper interaction, and molecular simulation assays. The results together with the anti-tyrosinase activities data indicated that substitution on the second position of benzene ring showed superior ant-ityrosinase activities than that on third position, and that hydroxyl substitutes were better than fluorine substitutes. In addition, two benzene rings connecting to the triazole ring would produce larger steric hindrance, and affect the bonding between tyrosinase and inhibitors to decrease the inhibitory effects. The antityrosinase effects of these compounds were in contrast to their antioxidant activities. In summary, this research will contribute to the development and design of antityrosinase agents.	[Yu, Feng; Jia, Yu-Long; Wang, Hui-Fang; Zheng, Jing; Cui, Yi; Fang, Xin-Yu; Zhang, Lin-Min; Chen, Qing-Xi] Xiamen Univ, Sch Life Sci, Minist Educ Coastal & Wetland Ecosyst, State Key Lab Cellular Stress Biol,Key Lab, Xiamen 361005, Peoples R China; [Chen, Qing-Xi] Xiamen Univ, Key Lab Chem Biol Fujian Prov, Xiamen 361005, Peoples R China	Xiamen University; Xiamen University	Chen, QX (corresponding author), Xiamen Univ, Sch Life Sci, Minist Educ Coastal & Wetland Ecosyst, State Key Lab Cellular Stress Biol,Key Lab, Xiamen 361005, Peoples R China.	chenqx@xmu.edu.cn	jia, yu/HHR-9047-2022	Jia, Yulong/0000-0002-1761-8355	Natural Science Foundation of China [31271952, 31371857]; Fundamental Research Funds for the Central Universities [20720140541]; National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China [J1310027]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China	This work was supported by the Natural Science Foundation of China, grant no. 31271952 and 31371857 (http://www.nsfc.gov.cn/), the Fundamental Research Funds for the Central Universities, grant no. 20720140541 (http://www.moe.gov.cn/) and the National Science Foundation for Fostering Talents in Basic Research of the National Natural Science Foundation of China, grant no. J1310027 (http://www.nsfc.gov.cn/).	Akhtar MN, 2015, J MOL STRUCT, V1085, P97, DOI 10.1016/j.molstruc.2014.12.073; BREATHNACH AC, 1989, CLIN DERMATOL, V7, P106, DOI 10.1016/0738-081X(89)90061-8; Chen LH, 2012, J AGR FOOD CHEM, V60, P1542, DOI 10.1021/jf204420x; Chen QX, 2004, PROTEIN J, V23, P135, DOI 10.1023/B:JOPC.0000020080.21417.ff; Chen QX, 2003, BIOCHEMISTRY-MOSCOW+, V68, P644, DOI 10.1023/A:1024665709631; Chen XX, 2013, INT J BIOL MACROMOL, V62, P726, DOI 10.1016/j.ijbiomac.2013.09.052; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Clare BW, 2001, J MED CHEM, V44, P2253, DOI 10.1021/jm010087e; Croney JC, 2001, BIOCHEM MOL BIOL EDU, V29, P60, DOI 10.1111/j.1539-3429.2001.tb00071.x; Cui Y, 2015, J AGR FOOD CHEM, V63, P716, DOI 10.1021/jf505469k; Curto EV, 1999, BIOCHEM PHARMACOL, V57, P663, DOI 10.1016/S0006-2952(98)00340-2; Demirkiran O, 2013, J AGR FOOD CHEM, V61, P12598, DOI 10.1021/jf403669k; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Chiari ME, 2011, BIOORGAN MED CHEM, V19, P3474, DOI 10.1016/j.bmc.2011.04.025; FITZPATR.TB, 1966, ARCH DERMATOL, V93, P589, DOI 10.1001/archderm.93.5.589; FUNAYAMA M, 1995, BIOSCI BIOTECH BIOCH, V59, P143, DOI 10.1271/bbb.59.143; Goto M, 2004, J DERMATOL SCI, V35, P215, DOI 10.1016/j.jdermsci.2004.06.007; Hamidian H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/207181; Hermanns J. F., 2000, International Journal of Cosmetic Science, V22, P67, DOI 10.1046/j.1467-2494.2000.00021.x; Hu GQ, 2008, CHINESE J CHEM, V26, P1145, DOI 10.1002/cjoc.200890205; Hu YH, 2014, J BIOSCI BIOENG, V117, P142, DOI 10.1016/j.jbiosc.2013.07.002; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; Jimenez M, 2001, J AGR FOOD CHEM, V49, P4060, DOI 10.1021/jf010194h; Kim D, 2006, J AGR FOOD CHEM, V54, P935, DOI 10.1021/jf0521855; Kim YJ, 2005, CELL MOL LIFE SCI, V62, P1707, DOI 10.1007/s00018-005-5054-y; Kim YM, 2002, J BIOL CHEM, V277, P16340, DOI 10.1074/jbc.M200678200; Kumar CM, 2011, BIOCHIMIE, V93, P562, DOI 10.1016/j.biochi.2010.11.014; Li ZC, 2010, J AGR FOOD CHEM, V58, P12537, DOI 10.1021/jf1033625; Lin M, 2010, FOOD CHEM, V119, P660, DOI 10.1016/j.foodchem.2009.07.013; Lin YF, 2013, J AGR FOOD CHEM, V61, P2889, DOI 10.1021/jf305481h; Makawana JA, 2014, BIOORG MED CHEM LETT, V24, P1734, DOI 10.1016/j.bmcl.2014.02.041; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; MISHIMA Y, 1988, PIGM CELL RES, V1, P367, DOI 10.1111/j.1600-0749.1988.tb00136.x; Nerya O, 2003, J AGR FOOD CHEM, V51, P1201, DOI 10.1021/jf020935u; Olivares C, 2009, PIGM CELL MELANOMA R, V22, P750, DOI 10.1111/j.1755-148X.2009.00636.x; Park KH, 2006, CHEM PHARM BULL, V54, P1266, DOI 10.1248/cpb.54.1266; Parvez S, 2006, PHYTOTHER RES, V20, P921, DOI 10.1002/ptr.1954; PASSI S, 1981, BRIT J DERMATOL, V104, P659, DOI 10.1111/j.1365-2133.1981.tb00752.x; REISH O, 1995, AM J HUM GENET, V57, P127; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Shin NH, 1998, BIOCHEM BIOPH RES CO, V243, P801, DOI 10.1006/bbrc.1998.8169; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Sun XH, 2008, CHINESE J CHEM, V26, P1133, DOI 10.1002/cjoc.200890202; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yang CY, 2012, J SEP SCI, V35, P977, DOI 10.1002/jssc.201101104; Zhang XD, 2009, BIOL PHARM BULL, V32, P86, DOI 10.1248/bpb.32.86; Zhu LF, 2012, J AGR FOOD CHEM, V60, P12170, DOI 10.1021/jf302726t; Zimmerman WC, 1995, MYCOLOGIA, V87, P857, DOI 10.2307/3760861	48	15	16	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138578	10.1371/journal.pone.0138578	http://dx.doi.org/10.1371/journal.pone.0138578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422245	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700045
J	Hadaegh, F; Hasheminia, M; Abdi, H; Khalili, D; Bozorgmanesh, M; Arshi, B; Azizi, F				Hadaegh, Farzad; Hasheminia, Mitra; Abdi, Hengameh; Khalili, Davood; Bozorgmanesh, Mohammadreza; Arshi, Banafsheh; Azizi, Fereidoun			Prehypertension Tsunami: A Decade Follow-Up of an Iranian Adult Population	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; BLOOD-PRESSURE; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ALL-CAUSE; NUTRITION TRANSITION; HYPERTENSION; PREVALENCE; HYPERFILTRATION; MORTALITY	Objective Prehypertension is associated with cardiovascular disease (CVD). There is no study to examine the incidence and risk factors of prehypertension in a sex stratified setting. The aim of this study was to examine the effect modification of sex for different risk factors which predicts the progression from normotension to prehypertension in a Middle East population-based cohort, during a median follow-up of 9.2 years. Methods A multivariate Cox analysis was performed among 1466 and 2131 Iranian men and women, respectively, who were free of prehypertension, hypertension, CVD and diabetes at baseline and free of incident hypertension without preceding prehypertension at follow-up. Incident prehypertension at follow-up was defined as systolic blood pressure (SBP) of 120-139 mmHg and/or diastolic blood pressure (DBP) of 80-89 mmHg. Results Overall, 1440 new cases of prehypertension were identified resulting in an incidence rate of 593/10000 person-years; the corresponding values for women and men were 489/10000 and 764/10000person-years, respectively. There were significant interactions between gender with age, DBP, waist-to-hip-ratio (WHpR) and estimated glomerular filtration rate (eGFR) (all P-values <0.05) in multivariate analysis. Strong associations were found between age, body mass index (BMI) and SBP with incident prehypertension in both genders. However, the effect of DBP and WHpR was significant among women and 2-hour post challenge plasma glucose (2h-PCPG) was an independent risk factor for men. In the sex-adjusted analysis, glomerular hyperfiltration [Hazard ratio (HR) and 95%CI: 1.01 (1.00-1.01), P-value = 0.02], age, BMI, WHpR, SBP and DBP had higher risks while being female [HR (95%CI): 0.81(0.69-0.94), P-value = 0.01] had a lower risk for incident prehypertension. Conclusion According to this study results, among Iranian population with high incidence of prehypertension, general adiposity and glomerular hyperfiltration in total, 2h-PCPG in men and central adiposity in women should be emphasized as risk factors for prehypertension.	[Hadaegh, Farzad; Hasheminia, Mitra; Khalili, Davood; Bozorgmanesh, Mohammadreza; Arshi, Banafsheh] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Abdi, Hengameh; Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Endocrine Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	Fzhadaegh@endocrine.ac.ir	bozorgmanesh, mohammadreza/AAE-1001-2022; Khalili, Davood/T-2913-2017; hadaegh, farzad/K-2460-2017; Arshi, Banafsheh/AAO-5651-2021; Abdi, Hengameh/K-1592-2017; Azizi, Fereidoun/ABD-4136-2021	Khalili, Davood/0000-0003-4956-1039; Azizi, Fereidoun/0000-0002-6470-2517; Hadaegh, Farzad/0000-0002-8935-2744; hadaegh, farzad/0000-0002-0352-8666; abdi, hengameh/0000-0002-6850-0090	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Arshi B, 2014, J HUMAN HYPERTENSION; Asayama K, 2004, STROKE, V35, P2356, DOI 10.1161/01.STR.0000141679.42349.9f; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bozorgmanesh M, 2011, INT J CLIN PRACT, V65, P264, DOI 10.1111/j.1742-1241.2010.02529.x; Bozorgmanesh M, 2011, J HYPERTENS, V29, P1486, DOI 10.1097/HJH.0b013e328348fdb2; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi KM, 2006, J HYPERTENS, V24, P1515, DOI 10.1097/01.hjh.0000239286.02389.0f; Denton KM, 2013, HYPERTENSION, V62, P674, DOI 10.1161/HYPERTENSIONAHA.113.00922; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; Donahue RP, 2014, NUTR METAB CARDIOVAS, V24, P162, DOI 10.1016/j.numecd.2013.06.006; Echouffo-Tcheugui Justin B, 2013, PLoS One, V8, pe67370, DOI 10.1371/journal.pone.0067370; Esteghamati A, 2011, J PHYS ACT HEALTH, V8, P27, DOI 10.1123/jpah.8.1.27; Esteghamati A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-167; Fateh M, 2014, J HYPERTENS, V32, P1782, DOI 10.1097/HJH.0000000000000260; Fava C, 2012, HYPERTENSION; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Greenlund KJ, 2004, ARCH INTERN MED, V164, P2113, DOI 10.1001/archinte.164.19.2113; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guo XF, 2011, TEX HEART I J, V38, P643; Hadaegh F, 2013, J HUM HYPERTENS, V27, P18, DOI 10.1038/jhh.2011.112; Hadaegh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076304; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Huang YL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006551; Huang YL, 2014, AM HEART J, V167, P160, DOI 10.1016/j.ahj.2013.10.023; IPAQ Research Committee, 2005, GUIDELINES DATA PROC; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Jahangiri-Noudeh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112639; Jin Nan, 2013, Nan Fang Yi Ke Da Xue Xue Bao, V33, P1738; Johnson KC, 2008, J AM GERIATR SOC, V56, P1449, DOI 10.1111/j.1532-5415.2008.01806.x; Kshirsagar AV, 2010, J CLIN HYPERTENS, V12, P800, DOI 10.1111/j.1751-7176.2010.00343.x; Levey A, 2000, SIMPLIFIED EQUATION; Li Z, 2014, J CLIN HYPERTENS, V16, P664, DOI 10.1111/jch.12378; Mohammadifard N, 2012, ARCH IRAN MED, V15, P320, DOI 012155/AIM.0015; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Najafipour H, 2014, INT J PUBLIC HEALTH, V59, P999, DOI 10.1007/s00038-014-0602-6; Okosun IS, 2004, J HUM HYPERTENS, V18, P849, DOI 10.1038/sj.jhh.1001771; Pausova Z, 2012, HYPERTENSION, V59, P572, DOI 10.1161/HYPERTENSIONAHA.111.180372; Pimenta E, 2010, NAT REV NEPHROL, V6, P21, DOI 10.1038/nrneph.2009.191; Pourmalek F, 2009, East Mediterr Health J, V15, P76; Qureshi AI, 2005, MED SCI MONITOR, V11, pCR403; Sharabi Y, 2004, J HYPERTENS, V22, pS130, DOI 10.1097/00004872-200406002-00453; So WY, 2006, DIABETES CARE, V29, P2046, DOI 10.2337/dc06-0248; STEVENS VJ, 1993, ARCH INTERN MED, V153, P849, DOI 10.1001/archinte.153.7.849; Szklo M, 2014, EPIDEMIOLOGY BASICS; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tsai PS, 2005, J HYPERTENS, V23, P1355, DOI 10.1097/01.hjh.0000173517.68234.c3; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WEIR MR, 1995, HYPERTENSION, V25, P1339, DOI 10.1161/01.HYP.25.6.1339; Zabetian A, 2007, DIABETES RES CLIN PR, V77, P251, DOI 10.1016/j.diabres.2006.12.001; Zhang Y, 2006, HYPERTENSION, V47, P410, DOI 10.1161/01.HYP.0000205119.19804.08	54	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139412	10.1371/journal.pone.0139412	http://dx.doi.org/10.1371/journal.pone.0139412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439847	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300027
J	Liu, Y; Liu, WB; Liu, KJ; Ao, L; Cao, J; Li Zhong, J; Liu, JY				Liu, Yong; Liu, Wen-Bin; Liu, Kai-Jun; Ao, Lin; Cao, Jia; Li Zhong, Julia; Liu, Jin-Yi			Extremely Low-Frequency Electromagnetic Fields Affect the miRNA-Mediated Regulation of Signaling Pathways in the GC-2 Cell Line	PLOS ONE			English	Article							OXIDATIVE STRESS; MAGNETIC-FIELDS; OVER-EXPRESSION; MICRORNAS; EXPOSURE; CANCER; PROLIFERATION; SPERMATOGENESIS; TARGETS; DNA	Extremely low-frequency electromagnetic fields (ELF-EMFs) can affect male reproductive function, but the underlying mechanism of this effect remains unknown. miRNA-mediated regulation has been implicated as an important epigenetic mechanism for regulatory pathways. Herein, we profiled miRNA expression in response to ELF-EMFs in vitro. Mouse spermatocyte-derived GC-2 cells were intermittently exposed to a 50 Hz ELF-EMF for 72 h (5 min on/10 min off) at magnetic field intensities of 1 mT, 2 mT and 3 mT. Cell viability was assessed using the CCK-8 assay. Apoptosis and the cell cycle were analyzed with flow cytometry. miRNA expression was profiled using Affymetrix Mouse Genechip miRNA 3.0 arrays. Our data showed that the growth, apoptosis or cell cycle arrest of GC-2 cells exposed to the 50 Hz ELF-EMF did not significantly change. However, we identified a total of 55 miRNAs whose expression significantly changed compared with the sham group, including 19 differentially expressed miRNAs (7 miRNAs were upregulated, and 12 were downregulated) in the 1 mT exposure group and 36 (9 miRNAs were upregulated, and 27 were downregulated) in the 3 mT exposure group. The changes in the expression of 15 selected miRNAs measured by real-time PCR were consistent with the microarray results. A network analysis was used to predict core miRNAs and target genes, including miR-30e-5p, miR-210-5p, miR-196b-5p, miR-504-3p, miR-669c-5p and miR-455-3p. We found that these miRNAs were differentially expressed in response to different magnetic field intensities of ELF-EMFs. GO term and KEGG pathway annotation based on the miRNA expression profiling results showed that miRNAs may regulate circadian rhythms, cytokine-cytokine receptor interactions and the p53 signaling pathway. These results suggested that miRNAs could serve as potential biomarkers, and the miRNA-mediated regulation of signaling pathways might play significant roles in the biological effects of ELF-EMFs.	[Liu, Yong; Liu, Wen-Bin; Liu, Kai-Jun; Ao, Lin; Cao, Jia; Liu, Jin-Yi] Third Mil Med Univ, Inst Toxicol, Coll Prevent Med, Chongqing, Peoples R China; [Liu, Yong; Li Zhong, Julia] Chongqing Univ, Coll Bioengn, Chongqing 630044, Peoples R China	Army Medical University; Chongqing University	Li Zhong, J (corresponding author), Chongqing Univ, Coll Bioengn, Chongqing 630044, Peoples R China.	jlzhong@cqu.edu.cn; jinyiliutmmu@163.com	liu, wen/HGE-3071-2022		National Basic Research Program of China (National 973 Program) [2011CB503700]	National Basic Research Program of China (National 973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (National 973 Program) (Grant No. 2011CB503700).	Abe W, 2013, HUM REPROD, V28, P750, DOI 10.1093/humrep/des446; Baer C, 2013, CANCER RES, V73, P473, DOI 10.1158/0008-5472.CAN-12-3731; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernabo N, 2010, THERIOGENOLOGY, V73, P1293, DOI 10.1016/j.theriogenology.2009.12.010; Brooks Gavin, 2004, V296, P291; Burdak-Rothkamm S, 2009, MUTAT RES-GEN TOX EN, V672, P82, DOI 10.1016/j.mrgentox.2008.10.016; Busacca S, 2010, AM J RESP CELL MOL, V42, P312, DOI 10.1165/rcmb.2009-0060OC; Chen CH, 2011, NEUROTOX RES, V20, P15, DOI 10.1007/s12640-010-9214-y; Davalos V, 2010, CURR OPIN ONCOL, V22, P35, DOI 10.1097/CCO.0b013e328333dcbb; Druz A, 2012, NUCLEIC ACIDS RES, V40, P7291, DOI 10.1093/nar/gks452; Duan WX, 2014, BIOELECTROMAGNETICS, V35, P58, DOI 10.1002/bem.21816; Ebisuya M, 2008, NAT CELL BIOL, V10, P1106, DOI 10.1038/ncb1771; Fatemi N, 2014, J ASSIST REPROD GEN, V31, P1287, DOI 10.1007/s10815-014-0302-4; Focke F, 2010, MUTAT RES-FUND MOL M, V683, P74, DOI 10.1016/j.mrfmmm.2009.10.012; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Grellier J, 2014, ENVIRON INT, V62, P55, DOI 10.1016/j.envint.2013.09.017; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Han YY, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105106; Hirsch ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027520; Huang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104732; Huang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030638; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Kanwar Jagat R, 2010, Front Biosci (Schol Ed), V2, P1113; Khazaie Y, 2014, INT J FERTIL STERIL, V8, P113; Koeman T, 2014, CANCER CAUSE CONTROL, V25, P203, DOI 10.1007/s10552-013-0322-x; Lee D, 2012, ANN NY ACAD SCI, V1271, P118, DOI 10.1111/j.1749-6632.2012.06745.x; Lee SK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/567183; Liu XX, 2011, FEBS LETT, V585, P1363, DOI 10.1016/j.febslet.2011.04.018; Ma QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090041; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Pedersen C, 2014, CANCER CAUSE CONTROL, V25, P171, DOI 10.1007/s10552-013-0319-5; Perez-Oliva AB, 2015, EMBO J, V34, P326, DOI 10.15252/embj.201489184; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Roychoudhury S, 2009, J ENVIRON SCI HEAL A, V44, P1041, DOI 10.1080/10934520902997029; Ruzhynsky VA, 2007, J NEUROSCI, V27, P5926, DOI 10.1523/JNEUROSCI.1538-07.2007; Schuderer J, 2004, BIOELECTROMAGNETICS, V25, P582, DOI 10.1002/bem.20037; Segura MF, 2012, CARCINOGENESIS, V33, P1823, DOI 10.1093/carcin/bgs205; Shen PF, 2014, PROSTATE, V74, P756, DOI 10.1002/pros.22795; Song CL, 2014, VIROLOGY, V462, P149, DOI 10.1016/j.virol.2014.05.027; Soutto M, 2014, ONCOTARGET, V5, P5663, DOI 10.18632/oncotarget.2156; Sun GX, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-100; Tanaka K, 2013, J BIOL CHEM, V288, P23990, DOI 10.1074/jbc.M113.478891; Vazquez-Garcia M, 2004, PHYSIOL BEHAV, V82, P685, DOI 10.1016/j.physbeh.2004.06.004; Wang L, 2015, REPRODUCTION, V149, pR127, DOI 10.1530/REP-14-0239; Xu JF, 2014, SCI CHINA LIFE SCI, V57, P989, DOI 10.1007/s11427-014-4725-z; Yuan SQ, 2015, BIOL OPEN, V4, P212, DOI 10.1242/bio.201410959; Zhao HN, 2014, ONCOL REP, V32, P1003, DOI 10.3892/or.2014.3311	49	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139949	10.1371/journal.pone.0139949	http://dx.doi.org/10.1371/journal.pone.0139949			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439850	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300084
J	Shapira, S; Ben-Amotz, O; Sher, O; Kazanov, D; Mashiah, J; Kraus, S; Gur, E; Arber, N				Shapira, Shiran; Ben-Amotz, Oded; Sher, Osnat; Kazanov, Dina; Mashiah, Jacob; Kraus, Sarah; Gur, Eyal; Arber, Nadir			Delayed Wound Healing in Heat Stable Antigen (HSA/CD24)-Deficient Mice	PLOS ONE			English	Article							P-SELECTIN; COLORECTAL-CANCER; CD24; CELLS; ANGIOGENESIS; GROWTH; CARCINOGENESIS; ONCOGENE; SYSTEM; MOUSE	Background Healthy individuals rarely have problems with wound healing. Most skin lesions heal rapidly and efficiently within one to two weeks. However, many medical and surgical complications can be attributed to deficiencies in wound repair. Open wounds have lost the barrier that protects tissues from bacterial invasion and allows the escape of vital fluids. Without expeditious healing, infections become more frequent. The CD24 gene encodes a heavily-glycosylated cell surface protein anchored to the membrane by phosphatidylinositol. CD24 plays an important role in the adaptive immune response and controls an important genetic checkpoint for homeostasis and autoimmune diseases in both mice and humans. We have previously shown that overexpression of CD24 results in increased proliferation and migration rates. Aim To examine the role of CD24 in the wound healing process. Methods An excisional model of wound healing was used and delayed wound healing was studied in genetically modified heat stable antigen (HSA/CD24)-deficient mice (HSA(-/-)) compared to wild-type (WT) mice. Results Large full-thickness skin wounds, excised on the back of mice, exhibited a significant delay in the formation of granulation tissue, and in wound closure when compared to their WTHSA(+/+) littermates. Wounds were histologically analyzed and scored, based on the degree of cellular invasion, granulation tissue formation, vascularity, and re-epithelialization. Additionally, in stitched wounds, the HSA(-/-) mice failed to maintain their stitches; they did not hold and fell already 24 hours, revealing erythematous wound fields. Re-expression of HSA, delivered by lentivirus, restored the normal healing phenotype, within 24 hours post-injury, and even improved the healing in WT, and in BalbC mice. Conclusions Delayed wound-healing in the absence of HSA/CD24 suggests that CD24 plays an important role in this process. Increased expression of CD24, even in the normal state, may be used to enhance wound repair.	[Shapira, Shiran; Ben-Amotz, Oded; Kazanov, Dina; Kraus, Sarah; Arber, Nadir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel; [Sher, Osnat] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Unit Bone & Soft Tissue Oncol, Inst Pathol, IL-69978 Tel Aviv, Israel; [Ben-Amotz, Oded; Gur, Eyal] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Plast & Reconstruct Surg, IL-69978 Tel Aviv, Israel; [Mashiah, Jacob; Arber, Nadir] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Dermatol, IL-69978 Tel Aviv, Israel; [Shapira, Shiran; Kraus, Sarah] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Arber, N (corresponding author), Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Integrated Canc Prevent Ctr, IL-69978 Tel Aviv, Israel.	narber@post.tau.ac.il		Arber, Nadir/0000-0001-5283-6991				Ahmed MAH, 2010, INFLAMM BOWEL DIS, V16, P795, DOI 10.1002/ibd.21134; Aigner S, 1998, FASEB J, V12, P1241, DOI 10.1096/fasebj.12.12.1241; Aigner S, 1997, BLOOD, V89, P3385, DOI 10.1182/blood.V89.9.3385; AIGNER S, 1995, INT IMMUNOL, V7, P1557, DOI 10.1093/intimm/7.10.1557; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Bretz N, 2012, CLIN EXP METASTAS, V29, P27, DOI 10.1007/s10585-011-9426-4; Dauer DJ, 2005, ONCOGENE, V24, P3397, DOI 10.1038/sj.onc.1208469; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jaakkola P, 1998, FASEB J, V12, P959, DOI 10.1096/fasebj.12.11.959; Jacobi J, 2004, GENE THER, V11, P302, DOI 10.1038/sj.gt.3302162; KADMON G, 1994, BIOCHEM BIOPH RES CO, V198, P1209, DOI 10.1006/bbrc.1994.1171; Kristiansen G, 2004, J MOL HISTOL, V35, P255; Lim SC, 2005, PATHOL RES PRACT, V201, P479, DOI 10.1016/j.prp.2005.05.004; Maffulli N, 2008, CLIN ORTHOP RELAT R, V466, P1605, DOI 10.1007/s11999-008-0261-0; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Naumov I, 2014, INT J CANCER, V135, P1048, DOI 10.1002/ijc.28762; Sagiv E, 2006, GASTROENTEROLOGY, V131, P630, DOI 10.1053/j.gastro.2006.04.028; Shapira S, 2011, J BIOL CHEM, V286, P40548, DOI 10.1074/jbc.M111.286534; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Suzuki T, 2001, J IMMUNOL, V166, P5567, DOI 10.4049/jimmunol.166.9.5567; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Wang WF, 2010, CANCER SCI, V101, P112, DOI 10.1111/j.1349-7006.2009.01370.x; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Zcharia E, 2005, FASEB J, V19, P211, DOI 10.1096/fj.04-1970com	27	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139787	10.1371/journal.pone.0139787	http://dx.doi.org/10.1371/journal.pone.0139787			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440795	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300054
J	Vega, A; Martinot, E; Baptissart, M; De Haze, A; Vaz, F; Kulik, W; Damon-Soubeyrand, C; Baron, S; Caira, F; Volle, DH				Vega, Aurelie; Martinot, Emmanuelle; Baptissart, Marine; De Haze, Angelique; Vaz, Frederic; Kulik, Wim; Damon-Soubeyrand, Christelle; Baron, Silvere; Caira, Francoise; Volle, David H.			Bile Acid Alters Male Mouse Fertility in Metabolic Syndrome Context	PLOS ONE			English	Article							Y GASTRIC BYPASS; X RECEPTOR; ENERGY-EXPENDITURE; OBESITY; MICE	Bile acids have recently been demonstrated as molecules with endocrine activities controlling several physiological functions such as immunity and glucose homeostases. They act mainly through two receptors, the nuclear receptor Farnesol-X-Receptor alpha (FXR alpha) and the G-protein coupled receptor (TGR5). These recent studies have led to the idea that molecules derived from bile acids (BAs) and targeting their receptors must be good targets for treatment of metabolic diseases such as obesity or diabetes. Thus it might be important to decipher the potential long term impact of such treatment on different physiological functions. Indeed, BAs have recently been demonstrated to alter male fertility. Here we demonstrate that in mice with overweight induced by high fat diet, BA exposure leads to increased rate of male infertility. This is associated with the altered germ cell proliferation, default of testicular endocrine function and abnormalities in cell-cell interaction within the seminiferous epithelium. Even if the identification of the exact molecular mechanisms will need more studies, the present results suggest that both FXR alpha and TGR5 might be involved. We believed that this work is of particular interest regarding the potential consequences on future approaches for the treatment of metabolic diseases.	[Vega, Aurelie; Martinot, Emmanuelle; Baptissart, Marine; De Haze, Angelique; Damon-Soubeyrand, Christelle; Baron, Silvere; Volle, David H.] INSERM, Genet Reprod & Dev GReD, U 1103, F-63178 Aubiere, France; [Vega, Aurelie; Martinot, Emmanuelle; Baptissart, Marine; De Haze, Angelique; Damon-Soubeyrand, Christelle; Baron, Silvere; Caira, Francoise; Volle, David H.] Univ Clermont Auvergne, GReD, F-63178 Aubiere, France; [Vega, Aurelie; Martinot, Emmanuelle; Baptissart, Marine; De Haze, Angelique; Damon-Soubeyrand, Christelle; Baron, Silvere; Caira, Francoise; Volle, David H.] CNRS, GReD, UMR 6293, F-63178 Aubiere, France; [Vega, Aurelie; Martinot, Emmanuelle; Baptissart, Marine; De Haze, Angelique; Damon-Soubeyrand, Christelle; Baron, Silvere; Caira, Francoise; Volle, David H.] Ctr Rech Nutr Humaine Auvergne, F-63000 Clermont Ferrand, France; [Vaz, Frederic; Kulik, Wim] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1100 DE Amsterdam, Netherlands	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); University of Amsterdam; Academic Medical Center Amsterdam	Volle, DH (corresponding author), INSERM, Genet Reprod & Dev GReD, U 1103, F-63178 Aubiere, France.	david.volle@inserm.fr	Volle, David H/P-6155-2014; VEGA, Aurelie/X-9434-2019	Volle, David H/0000-0003-0843-0550; VEGA, Aurelie/0000-0002-9693-2173; Vaz, Frederic/0000-0002-9048-1041	Inserm; CNRS; Clermont Universite; Ministere de l'Enseignement Superieur et de la Recherche; Ligue contre le Cancer (Comite Puy de Dome); Nouveau Chercheur Auvergne [R12087CC]; ANR Jeune Chercheur [1103]	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Clermont Universite; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Ligue contre le Cancer (Comite Puy de Dome); Nouveau Chercheur Auvergne; ANR Jeune Chercheur(French National Research Agency (ANR))	This work was funded by Inserm, CNRS, Clermont Universite, Ministere de l'Enseignement Superieur et de la Recherche (to MB), Ligue contre le Cancer (Comite Puy de Dome to DHV), Nouveau Chercheur Auvergne (to SB and #R12087CC to DHV), and ANR Jeune Chercheur (#1103 to DHV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baptissart M, 2014, HEPATOLOGY, V60, P1054, DOI 10.1002/hep.27204; Baptissart M, 2013, CELL MOL LIFE SCI, V70, P4511, DOI 10.1007/s00018-013-1387-0; Baptissart M, 2013, BIOCHIMIE, V95, P504, DOI 10.1016/j.biochi.2012.06.022; di Frega AS, 2005, HUM REPROD, V20, P997, DOI 10.1093/humrep/deh707; Hinz S, 2010, WORLD J UROL, V28, P631, DOI 10.1007/s00345-009-0498-6; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Lutz TA, 2014, AM J PHYSIOL-REG I, V307, pR1275, DOI 10.1152/ajpregu.00185.2014; Maqdasy S, 2012, MOL CELL ENDOCRINOL, DOI [10.1016/j.2012.06.011, DOI 10.1016/J.2012.06.011]; RUPP H, 1991, BASIC RES CARDIOL, V86, P65; Vega A, 2015, ENDOCRINOLOGY, V156, P660, DOI 10.1210/en.2014-1418; Vega A, 2014, EXPERT OPIN THER TAR, V18, P1367, DOI 10.1517/14728222.2014.964209; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277; Volle DH, 2007, GENE DEV, V21, P303, DOI 10.1101/gad.409307; Volle DH, 2009, J CLIN INVEST, V119, P3752, DOI 10.1172/JCI38521; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203	16	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139946	10.1371/journal.pone.0139946	http://dx.doi.org/10.1371/journal.pone.0139946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439743	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300083
J	Sharma, D; Kumar, B; Lata, M; Joshi, B; Venkatesan, K; Shukla, S; Bisht, D				Sharma, Divakar; Kumar, Bhavnesh; Lata, Manju; Joshi, Beenu; Venkatesan, Krishnamurthy; Shukla, Sangeeta; Bisht, Deepa			Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets	PLOS ONE			English	Article							FAST INTERACTION REFINEMENT; MEMBRANE-PROTEINS; OUTER-MEMBRANE; PLASMA-MEMBRANE; MESSENGER-RNA; CELL-WALL; ELECTROPHORESIS; IDENTIFICATION; PROTEASOME; DISCOVERY	Aminoglycosides, amikacin (AK) and kanamycin (KM) are second line anti-tuberculosis drugs used to treat tuberculosis (TB) and resistance to them affects the treatment. Membrane and membrane associated proteins have an anticipated role in biological processes and pathogenesis and are potential targets for the development of new diagnostics/vaccine/therapeutics. In this study we compared membrane and membrane associated proteins of AK and KM resistant and susceptible Mycobacterium tuberculosis isolates by 2DE coupled with MALDI-TOF/TOF-MS and bioinformatic tools. Twelve proteins were found to have increased intensities (PDQuest Advanced Software) in resistant isolates and were identified as ATP synthase subunit alpha (Rv1308), Trigger factor (Rv2462c), Dihydrolipoyl dehydrogenase (Rv0462), Elongation factor Tu (Rv0685), Transcriptional regulator MoxR1 (Rv1479), Universal stress protein (Rv2005c), 35kDa hypothetical protein (Rv2744c), Proteasome subunit alpha (Rv2109c), Putative short-chain type dehydrogenase/reductase (Rv0148), Bacterioferritin (Rv1876), Ferritin (Rv3841) and Alpha-crystallin/HspX (Rv2031c). Among these Rv2005c, Rv2744c and Rv0148 are proteins with unknown functions. Docking showed that both drugs bind to the conserved domain (Usp, PspA and SDR domain) of these hypothetical proteins and GPS-PUP predicted potential pupylation sites within them. Increased intensities of these proteins and proteasome subunit alpha might not only be neutralized/modulated the drug molecules but also involved in protein turnover to overcome the AK and KM resistance. Besides that Rv1876, Rv3841 and Rv0685 were found to be associated with iron regulation signifying the role of iron in resistance. Further research is needed to explore how these potential protein targets contribute to resistance of AK and KM.	[Sharma, Divakar; Kumar, Bhavnesh; Lata, Manju; Venkatesan, Krishnamurthy; Bisht, Deepa] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Biochem, Agra, Uttar Pradesh, India; [Joshi, Beenu] Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Immunol, Agra, Uttar Pradesh, India; [Shukla, Sangeeta] Jiwaji Univ, Sch Studies Zool, Gwalior 474011, India	Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Jiwaji University Gwalior	Bisht, D (corresponding author), Natl JALMA Inst Leprosy & Other Mycobacterial Dis, Dept Biochem, Agra, Uttar Pradesh, India.	abd1109@rediffmail.com	Kumar, Bhavnesh/AAZ-6726-2021	Kumar, Bhavnesh/0000-0003-2269-3672; Bisht, Deepa/0000-0001-5599-0775; Sharma, Divakar/0000-0002-8735-5562	ICMR New Delhi	ICMR New Delhi(Indian Council of Medical Research (ICMR))	This work was supported by ICMR New Delhi.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; [Anonymous], 2013, WHO REPORT 2013 GLOB; BEAUCLERK AAD, 1987, J MOL BIOL, V193, P661, DOI 10.1016/0022-2836(87)90349-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodie A F, 1979, Methods Enzymol, V55, P175; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Corvaisier S, 2003, J BIOL CHEM, V278, P14788, DOI 10.1074/jbc.M212830200; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; de Souza GA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002527; Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272; Gautam US, 2011, J BACTERIOL, V193, P4849, DOI 10.1128/JB.05051-11; Geluk A, 2007, INFECT IMMUN, V75, P2914, DOI 10.1128/IAI.01990-06; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Gu S, 2003, MOL CELL PROTEOMICS, V2, P1284, DOI 10.1074/mcp.M300060-MCP200; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; Heo DR, 2011, BIOCHEM BIOPH RES CO, V411, P642, DOI 10.1016/j.bbrc.2011.07.013; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hu YM, 2001, FEMS MICROBIOL LETT, V202, P59, DOI 10.1016/S0378-1097(01)00280-4; Hwang SA, 2009, INT IMMUNOL, V21, P1185, DOI 10.1093/intimm/dxp084; Jadaun GRS, 2007, J ANTIMICROB CHEMOTH, V60, P152, DOI 10.1093/jac/dkm117; Jungblut PR, 1999, MOL MICROBIOL, V33, P1103, DOI 10.1046/j.1365-2958.1999.01549.x; Kerns PW, 2014, PATHOG DIS, V70, P347, DOI 10.1111/2049-632X.12142; Kinsella RJ, 2003, TRENDS GENET, V19, P687, DOI 10.1016/j.tig.2003.10.001; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kumar B, 2013, J PROTEOMICS, V94, P68, DOI 10.1016/j.jprot.2013.08.025; Liu ZX, 2011, MOL BIOSYST, V7, P2737, DOI 10.1039/c1mb05217a; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Magnet S, 2003, ANTIMICROB AGENTS CH, V47, P1577, DOI 10.1128/AAC.47.5.1577-1583.2003; Malen H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-18; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mattow J, 2007, PROTEOMICS, V7, P1687, DOI 10.1002/pmic.200600928; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Palomino JC, 2002, ANTIMICROB AGENTS CH, V46, P2720, DOI 10.1128/AAC.46.8.2720-2722.2002; Pandey R, 2012, INFECT IMMUN, V80, P3650, DOI 10.1128/IAI.00229-12; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Roupie V, 2007, INFECT IMMUN, V75, P941, DOI 10.1128/IAI.01137-06; Sajid A, 2011, J BACTERIOL, V193, P5347, DOI 10.1128/JB.05469-11; Samanovic Marie I, 2013, Subcell Biochem, V66, P267, DOI 10.1007/978-94-007-5940-4_10; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Sigler K, 1997, CRIT REV BIOTECHNOL, V17, P69, DOI 10.3109/07388559709146607; Singhal N, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-14; Sinha S, 2002, COMPAR FUNCT GENOM, V3, P470, DOI 10.1002/cfg.211; Vandal OH, 2009, J BACTERIOL, V191, P625, DOI 10.1128/JB.00932-08; Velayati AA, 2009, CHEMOTHERAPY, V55, P303, DOI 10.1159/000226425; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Welch KT, 2005, BIOORGAN MED CHEM, V13, P6252, DOI 10.1016/j.bmc.2005.06.059; White MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018175; Xiong Y, 2005, J PROTEOME RES, V4, P855, DOI 10.1021/pr0500049; Zhang JT, 2011, J PROTEOME RES, V10, P2863, DOI 10.1021/pr200141c; Zhang L, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-12; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	60	43	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139414	10.1371/journal.pone.0139414	http://dx.doi.org/10.1371/journal.pone.0139414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436944	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200021
J	Shevtsov, J; Rael, R				Shevtsov, Jane; Rael, Rosalyn			Indirect Energy Flows in Niche Model Food Webs: Effects of Size and Connectance	PLOS ONE			English	Article							BODY-SIZE; TROPHIC INTERACTIONS; ECOLOGICAL NETWORKS; ENVIRON ANALYSIS; GENERAL-MODEL; OYSTER REEF; ECOSYSTEMS; DYNAMICS; SCALE; PATH	Indirect interactions between species have long been of interest to ecologists. One such interaction type takes place when energy or materials flow via one or more intermediate species between two species with a direct predator-prey relationship. Previous work has shown that, although each such flow is small, their great number makes them important in ecosystems. A new network analysis method, dynamic environ approximation, was used to quantify the fraction of energy flowing from prey to predator over paths of length greater than 1 (flow indirectness or FI) in a commonly studied food web model. Web structure was created using the niche model and dynamics followed the Yodzis-Innes model. The effect of food web size (10 to 40 species) and connectance (0.1 to 0.48) on FI was examined. For each of 250 model realizations run for each pair of size and connectance values, the FI of every predator-prey interaction in the model was computed and then averaged over the whole network. A classification and regression tree (CART) analysis was then used to find the best predictors of FI. The mean FI of the model food webs is 0.092, with a standard deviation of 0.0279. It tends to increase with system size but peaks at intermediate connectance levels. Of 27 potential predictor variables, only five (mean path length, dominant eigenvalue of the adjacency matrix, connectance, mean trophic level and fraction of species belonging to intermediate trophic levels) were selected by the CART algorithm as best accounting for variation in the data; mean path length and the dominant eigenvalue of the adjacency matrix were dominant.	[Shevtsov, Jane] UCLA, Div Life Sci, Los Angeles, CA 90095 USA; [Rael, Rosalyn] Tulane Univ, Tulane Xavier Ctr Bioenvironm Res, New Orleans, LA 70118 USA	University of California System; University of California Los Angeles; Tulane University; Xavier University of Louisiana	Shevtsov, J (corresponding author), UCLA, Div Life Sci, Los Angeles, CA 90095 USA.	jaia@ucla.edu						Agnarsson G., 2006, GRAPH THEORY MODELIN; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Anderson WN, 1971, TECHNICAL REPORT; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Berlow EL, 2009, P NATL ACAD SCI USA, V106, P187, DOI 10.1073/pnas.0806823106; Borrett SR, 2007, J THEOR BIOL, V245, P98, DOI 10.1016/j.jtbi.2006.09.024; Borrett SR, 2010, OIKOS, V119, P1136, DOI 10.1111/j.1600-0706.2009.18104.x; Brose U, 2006, ECOL LETT, V9, P1228, DOI 10.1111/j.1461-0248.2006.00978.x; Brose U, 2006, ECOLOGY, V87, P2411, DOI 10.1890/0012-9658(2006)87[2411:CBRINF]2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; COHEN JE, 1985, PROC R SOC SER B-BIO, V224, P421, DOI 10.1098/rspb.1985.0042; COHEN JE, 1978, FOOD WEBS NICHE SPAC; Csermely P, 2006, WEAK LINKS STABILIZE; DAME RF, 1981, MAR ECOL PROG SER, V5, P115, DOI 10.3354/meps005115; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Fath BD, 2004, ECOL MODEL, V171, P329, DOI 10.1016/S0304-3800(03)00275-8; Fath BD, 1999, ECOL MODEL, V123, P193, DOI 10.1016/S0304-3800(99)00130-1; Fath BD, 1999, ECOSYSTEMS, V2, P167, DOI 10.1007/s100219900067; Fath BD, 2007, ECOL MODEL, V208, P17, DOI 10.1016/j.ecolmodel.2007.04.020; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; GURNEY WSC, 1998, ECOLOGICAL DYNAMICS; Halnes G, 2007, ECOL MODEL, V208, P9, DOI 10.1016/j.ecolmodel.2007.04.034; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; HIGASHI M, 1993, ECOL MODEL, V66, P1, DOI 10.1016/0304-3800(93)90037-S; HIGASHI M, 1986, ECOL MODEL, V31, P69, DOI 10.1016/0304-3800(86)90056-6; HIGASHI M, 1989, AM NAT, V133, P288, DOI 10.1086/284919; Illiam JAFG, 2001, ECOLOGY, V82, P3083, DOI [10.1890/0012-9658(2001)082%5B3083:FRWPIV%5D2.0.CO;2, DOI 10.1890/0012-9658(2001)082%5B3083:FRWPIV%5D2.0.CO;2]; LEVINE S, 1980, J THEOR BIOL, V83, P195, DOI 10.1016/0022-5193(80)90288-X; Matis J. H., 1981, B INT STAT I, V48, P527; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Mohar B., 1991, GRAPH THEORY COMBINA, P871; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Patten B.C., 1976, P457; Patten B.C., 1986, CAN B FISH AQUAT SCI, V213, P119; PATTEN BC, 1982, ECOL MODEL, V16, P1, DOI 10.1016/0304-3800(82)90071-0; PATTEN BC, 1985, ECOL MODEL, V28, P1, DOI 10.1016/0304-3800(85)90013-4; PATTEN BC, 1978, OHIO J SCI, V78, P206; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; R Core Team, 2020, R LANG ENV STAT COMP; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shevtsov J, 2009, ECOL MODEL, V220, P3219, DOI 10.1016/j.ecolmodel.2009.07.022; Therneau T. M., 2010, RPART RECURSIVE PART; Townsend CR, 1998, ECOL LETT, V1, P200; Wardle DA, 2005, OIKOS, V111, P348, DOI 10.1111/j.0030-1299.2005.14092.x; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Whipple SJ, 1999, ECOL MODEL, V114, P251, DOI 10.1016/S0304-3800(98)00154-9; Williams RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012092; Williams Richard J., 2007, P37; Williams RJ, 2004, AM NAT, V163, P458, DOI 10.1086/381964; Williams RJ, 2000, NATURE, V404, P180, DOI 10.1038/35004572; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; YODZIS P, 1992, AM NAT, V139, P1151, DOI 10.1086/285380; Yodzis P, 1998, J ANIM ECOL, V67, P635, DOI 10.1046/j.1365-2656.1998.00224.x	59	2	2	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0137829	10.1371/journal.pone.0137829	http://dx.doi.org/10.1371/journal.pone.0137829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436775	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200002
J	Smith, L; Baxter, EW; Chambers, PA; Green, CA; Hanby, AM; Hughes, TA; Nash, CE; Millican-Slater, RA; Stead, LF; Verghese, ET; Speirs, V				Smith, Laura; Baxter, Euan W.; Chambers, Philip A.; Green, Caroline A.; Hanby, Andrew M.; Hughes, Thomas A.; Nash, Claire E.; Millican-Slater, Rebecca A.; Stead, Lucy F.; Verghese, Eldo T.; Speirs, Valerie			Down-Regulation of miR-92 in Breast Epithelial Cells and in Normal but Not Tumour Fibroblasts Contributes to Breast Carcinogenesis	PLOS ONE			English	Article							RECEPTOR BETA ISOFORMS; GENE-EXPRESSION; EPIGENETIC REGULATION; STROMAL CELLS; TGF-BETA; CANCER; MICRORNAS; GROWTH; ER-BETA-2; SIGNATURE	Background MicroRNA (miR) expression is commonly dysregulated in many cancers, including breast. MiR-92 is one of six miRs encoded by the miR-17-92 cluster, one of the best-characterised oncogenic miR clusters. We examined expression of miR-92 in the breast epithelium and stroma during breast cancer progression. We also investigated the role of miR-92 in fibroblasts in vitro and showed that down-regulation in normal fibroblasts enhances the invasion of breast cancer epithelial cells. Methodology/Principal Findings We used laser microdissection (LMD) to isolate epithelial cells from matched normal, DCIS and invasive tissue from 9 breast cancer patients and analysed miR-92 expression by qRT-PCR. Expression of ER beta 1, a direct miR-92 target, was concurrently analysed for each case by immunohistochemistry. LMD was also used to isolate matched normal (NFs) and cancer-associated fibroblasts (CAFs) from 14 further cases. Effects of miR-92 inhibition in fibroblasts on epithelial cell invasion in vitro was examined using a Matrigel T assay. miR-92 levels decreased in microdissected epithelial cells during breast cancer progression with highest levels in normal breast epithelium, decreasing in DCIS (p<0.01) and being lowest in invasive breast tissue (p<0.01). This was accompanied by a shift in cell localisation of ER beta 1 from nuclear expression in normal breast epithelium to increased cytoplasmic expression during progression to DCIS (p = 0.0078) and invasive breast cancer (p = 0.031). ER beta 1 immunoreactivity was also seen in stromal fibroblasts in tissues. Where miR-92 expression was low in microdissected NFs this increased in matched CAFs; a trend also seen in cultured primary fibroblasts. Down-regulation of miR-92 levels in NFs but not CAFs enhanced invasion of both MCF-7 and MDA-MB-231 breast cancer epithelial cells. Conclusions miR-92 is gradually lost in breast epithelial cells during cancer progression correlating with a shift in ER beta 1 immunoreactivity from nuclei to the cytoplasm. Our data support a functional role in fibroblasts where modification of miR-92 expression can influence the invasive capacity of breast cancer epithelial cells. However in silico analysis suggests that ER beta 1 may not be the most important miR-92 target in breast cancer.	[Smith, Laura; Baxter, Euan W.; Chambers, Philip A.; Green, Caroline A.; Hanby, Andrew M.; Nash, Claire E.; Stead, Lucy F.; Verghese, Eldo T.; Speirs, Valerie] Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Hughes, Thomas A.] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England; [Millican-Slater, Rebecca A.] St James Univ Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England	University of Leeds; University of Leeds; Saint James's University Hospital	Speirs, V (corresponding author), Univ Leeds, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England.	v.speirs@leeds.ac.uk	Chambers, Philip/AAK-8549-2020; Stead, Lucy Frances/H-7378-2019; Hughes, Thomas/M-7063-2019; Hughes, Thomas A/O-8031-2015; Speirs, Valerie/ABE-7377-2021	Chambers, Philip/0000-0002-0926-717X; Stead, Lucy Frances/0000-0002-9550-4150; Hughes, Thomas A/0000-0003-1169-3386; Speirs, Valerie/0000-0002-0602-4666; Millican-Slater, Rebecca/0000-0001-6280-4598	Breast Cancer [2010NovPR56, TB2009LEE]; Medical Research Council [G0902032]; Yorkshire Cancer Research Grant [L316]; MRC [G0902032] Funding Source: UKRI	Breast Cancer; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Yorkshire Cancer Research Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Breast Cancer Now (formerly Breast Cancer Campaign) Grant numbers 2010NovPR56, TB2009LEE (http://breastcancernow.org/) to VS, Medical Research Council Grant number G0902032 (http://www.mrc.ac.uk/) to ETV, and Yorkshire Cancer Research Grant number L316 (http://yorkshirecancerresearch.org.uk/) to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nakhle H, 2010, CANCER RES, V70, P4778, DOI 10.1158/0008-5472.CAN-09-4104; Allred DC, 1998, MODERN PATHOL, V11, P155; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boersma BJ, 2008, INT J CANCER, V122, P1324, DOI 10.1002/ijc.23237; Busch S, 2015, ONCOGENE, V34, P27, DOI 10.1038/onc.2013.527; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chen Beibei, 2012, Int J Cell Biol, V2012, P672462, DOI 10.1155/2012/672462; Ciucci A, 2014, GYNECOL ONCOL, V132, P351, DOI 10.1016/j.ygyno.2013.12.027; Cummings M, 2009, CELL ONCOL, V31, P467, DOI 10.3233/CLO-2009-0495; Dakhlallah D, 2013, AM J RESP CRIT CARE, V187, P397, DOI 10.1164/rccm.201205-0888OC; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jones DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044294; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Manni I, 2009, FASEB J, V23, P3957, DOI 10.1096/fj.09-131847; Nilsson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036051; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Owens P, 2012, P NATL ACAD SCI USA, V109, P2814, DOI 10.1073/pnas.1101139108; Pardo I, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3627; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Pouliot F, 2003, CANCER RES, V63, P277; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Saito Y, 2006, CELL CYCLE, V5, P2220, DOI 10.4161/cc.5.19.3340; Shaaban AM, 2008, CLIN CANCER RES, V14, P5228, DOI 10.1158/1078-0432.CCR-07-4528; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; Siletz A, 2013, CANCER MICROENVIRON, V6, P91, DOI 10.1007/s12307-012-0121-z; Simpkins SA, 2012, J PATHOL, V227, P490, DOI 10.1002/path.4034; Smith L, 2010, J CELL MOL MED, V14, P2172, DOI 10.1111/j.1582-4934.2009.00867.x; Smith L, 2010, BIOCHEM J, V429, P283, DOI 10.1042/BJ20100373; Tili E, 2010, NUCLEIC ACIDS RES, V38, P7673, DOI 10.1093/nar/gkq637; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tripathi A, 2008, INT J CANCER, V122, P1557, DOI 10.1002/ijc.23267; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Verghese ET, 2013, J PATHOL, V231, P388, DOI 10.1002/path.4248; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhao LY, 2012, INT J BIOCHEM CELL B, V44, P2051, DOI 10.1016/j.biocel.2012.08.005	51	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139698	10.1371/journal.pone.0139698	http://dx.doi.org/10.1371/journal.pone.0139698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437339	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200051
J	Ferdousi, M; Azmi, S; Petropoulos, IN; Fadavi, H; Ponirakis, G; Marshall, A; Tavakoli, M; Malik, I; Mansoor, W; Malik, RA				Ferdousi, Maryam; Azmi, Shazli; Petropoulos, Ioannis Nikolaos; Fadavi, Hassan; Ponirakis, Georgios; Marshall, Andrew; Tavakoli, Mitra; Malik, Imaan; Mansoor, Wasat; Malik, Rayaz Ahmed			Corneal Confocal Microscopy Detects Small Fibre Neuropathy in Patients with Upper Gastrointestinal Cancer and Nerve Regeneration in Chemotherapy Induced Peripheral Neuropathy	PLOS ONE			English	Article							DAMAGE; CAPECITABINE; OXALIPLATIN; CISPLATIN; SURROGATE	There are multiple neurological complications of cancer and its treatment. This study assessed the utility of the novel non-invasive ophthalmic technique of corneal confocal microscopy in identifying neuropathy in patients with upper gastrointestinal cancer before and after platinum based chemotherapy. In this study, 21 subjects with upper gastrointestinal (oesophageal or gastric) cancer and 21 healthy control subjects underwent assessment of neuropathy using the neuropathy disability score, quantitative sensory testing for vibration perception threshold, warm and cold sensation thresholds, cold and heat induced pain thresholds, nerve conduction studies and corneal confocal microscopy. Patients with gastro-oesophageal cancer had higher heat induced pain (P = 0.04) and warm sensation (P = 0.03) thresholds with a significantly reduced sural sensory (P<0.01) and peroneal motor (P<0.01) nerve conduction velocity, corneal nerve fibre density (CNFD), nerve branch density (CNBD) and nerve fibre length (CNFL) (P<0.0001). Furthermore, CNFD correlated significantly with the time from presentation with symptoms to commencing chemotherapy (r = -0.54, P = 0.02), and CNFL (r = -0.8, P<0.0001) and CNBD (r = 0.63, P = 0.003) were related to the severity of lymph node involvement. After the 3rd cycle of chemotherapy, there was no change in any measure of neuropathy, except for a significant increase in CNFL (P = 0.003). Corneal confocal microscopy detects a small fibre neuropathy in this cohort of patients with upper gastrointestinal cancer, which was related to disease severity. Furthermore, the increase in CNFL after the chemotherapy may indicate nerve regeneration.	[Ferdousi, Maryam; Azmi, Shazli; Petropoulos, Ioannis Nikolaos; Fadavi, Hassan; Ponirakis, Georgios; Marshall, Andrew; Tavakoli, Mitra; Malik, Rayaz Ahmed] Univ Manchester, Inst Human Dev, Ctr Endocrinol & Diabet, Fac Med & Human Sci, Manchester, Lancs, England; [Ferdousi, Maryam; Azmi, Shazli; Petropoulos, Ioannis Nikolaos; Fadavi, Hassan; Ponirakis, Georgios; Marshall, Andrew; Tavakoli, Mitra; Malik, Rayaz Ahmed] NIHR Wellcome Trust Clin Res Facil, Manchester, Lancs, England; [Marshall, Andrew] Cent Manchester Univ Hosp NHS Fdn Trust, Dept Clin Neurophysiol, Manchester Royal Infirm, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Petropoulos, Ioannis Nikolaos; Ponirakis, Georgios; Malik, Rayaz Ahmed] Qatar Fdn, Div Res, Weill Cornell Med Coll Qatar, Doha, Qatar; [Malik, Imaan; Mansoor, Wasat] Christie NHS Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Christie NHS Foundation Trust	Malik, RA (corresponding author), Univ Manchester, Inst Human Dev, Ctr Endocrinol & Diabet, Fac Med & Human Sci, Manchester, Lancs, England.	ram2045@qatar-med.cornell.edu	TAVAKOLI, MITRA/N-1402-2016; Ponirakis, Georgios/T-7207-2019; Tavakoli, Mitra/F-6707-2011; Malik, Rayaz/H-9231-2019; Marshall, Andrew/AAE-5203-2019	TAVAKOLI, MITRA/0000-0003-2319-1543; Ponirakis, Georgios/0000-0002-6936-1248; Malik, Rayaz/0000-0002-7188-8903; Ferdousi, Maryam/0000-0002-7989-8233; Azmi, Shazli/0000-0002-1789-6988				Alejandro LM, 2013, AM J CLIN ONCOL-CANC, V36, P331, DOI 10.1097/COC.0b013e318246b50d; Bhatnagar B, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-366; BRITLAND ST, 1992, PAIN, V48, P361, DOI 10.1016/0304-3959(92)90085-P; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cavaletti G, 2014, J PERIPHER NERV SYST; Chhibber A, 2014, PHARMACOGENOMICS J, V14, P336, DOI 10.1038/tpj.2014.2; Cobianchi S, 2014, EXP NEUROL, V255, P1, DOI 10.1016/j.expneurol.2014.02.008; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dabbah MA, 2011, MED IMAGE ANAL, V15, P738, DOI 10.1016/j.media.2011.05.016; Ferrari G, 2013, EXP EYE RES, V113, P148, DOI 10.1016/j.exer.2013.05.016; Ferrari G, 2010, ARCH NEUROL-CHICAGO, V67, P364, DOI 10.1001/archneurol.2010.17; Gemignani F, 2010, J NEUROL NEUROSUR PS, V81, P731, DOI 10.1136/jnnp.2009.177303; Griffith KA, 2010, J PERIPHER NERV SYST, V15, P314, DOI 10.1111/j.1529-8027.2010.00292.x; HANSEN SW, 1989, J CLIN ONCOL, V7, P1457, DOI 10.1200/JCO.1989.7.10.1457; Koskinen MJ, 2011, ANTICANCER RES, V31, P4413; KRARUPHANSEN A, 1993, BRAIN, V116, P1017, DOI 10.1093/brain/116.5.1017; Lalive PH, 2009, ARCH NEUROL-CHICAGO, V66, P403, DOI 10.1001/archneurol.2008.587; Lauria G, 2012, CURR OPIN NEUROL, V25, P542, DOI 10.1097/WCO.0b013e32835804c5; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Mols F, 2014, SUPPORT CARE CANCER, V22, P2261, DOI 10.1007/s00520-014-2255-7; Pachman DR, 2014, SUPPORT CARE CANCER, V22, P2281, DOI 10.1007/s00520-014-2289-x; Petropoulos IN, 2014, INVEST OPHTH VIS SCI, V55, P2071, DOI 10.1167/iovs.13-13787; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Rosenfeld MR, 2012, MEMO-MAG EUR MED ONC, V5, P197, DOI 10.1007/s12254-012-0034-z; Tavakoli M, 2007, DIABETES CARE, V30, P1895, DOI 10.2337/dc07-0175; Tavakoli M, 2012, MUSCLE NERVE, V46, P698, DOI 10.1002/mus.23377; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Tavakoli M, 2010, EXP NEUROL, V223, P245, DOI 10.1016/j.expneurol.2009.08.033; Tavakoli M, 2009, MUSCLE NERVE, V40, P976, DOI 10.1002/mus.21383; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Vasquez S, 2014, IRISH J MED SCI, V183, P53, DOI 10.1007/s11845-013-0971-5; Waddell T, 2013, LANCET ONCOL, V14, P481, DOI 10.1016/S1470-2045(13)70096-2; Windebank AJ, 2008, J PERIPHER NERV SYST, V13, P27, DOI 10.1111/j.1529-8027.2008.00156.x	33	69	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139394	10.1371/journal.pone.0139394	http://dx.doi.org/10.1371/journal.pone.0139394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430773	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700052
J	Noor, Z; Afzal, N; Rashid, S				Noor, Zainab; Afzal, Noreen; Rashid, Sajid			Exploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation Assays	PLOS ONE			English	Article							HYDROXAMIC ACID INHIBITORS; HDAC INHIBITORS; BIOLOGICAL EVALUATION; ANTITUMOR-ACTIVITY; NUCLEOSOMAL DNA; PHASE-II; ANTICANCER AGENTS; LIGAND EFFICIENCY; FUNCTIONAL-GROUP; PROSTATE-CANCER	Histone deacetylases (HDAC) are metal-dependent enzymes and considered as important targets for cell functioning. Particularly, higher expression of class I HDACs is common in the onset of multiple malignancies which results in deregulation of many target genes involved in cell growth, differentiation and survival. Although substantial attempts have been made to control the irregular functioning of HDACs by employing various inhibitors with high sensitivity towards transformed cells, limited success has been achieved in epigenetic cancer therapy. Here in this study, we used ligand-based pharmacophore and 2-dimensional quantitative structure activity relationship (QSAR) modeling approaches for targeting class I HDAC isoforms. Pharmacophore models were generated by taking into account the known IC50 values and experimental energy scores with extensive validations. The QSAR model having an external R-2 value of 0.93 was employed for virtual screening of compound libraries. 10 potential lead compounds (C1-C10) were short-listed having strong binding affinities for HDACs, out of which 2 compounds (C8 and C9) were able to interact with all members of class I HDACs. The potential binding modes of HDAC2 and HDAC8 to C8 were explored through molecular dynamics simulations. Overall, bioactivity and ligand efficiency (binding energy/non-hydrogen atoms) profiles suggested that proposed hits may be more effective inhibitors for cancer therapy.	[Noor, Zainab; Afzal, Noreen; Rashid, Sajid] Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan	Quaid I Azam University	Rashid, S (corresponding author), Quaid I Azam Univ, Natl Ctr Bioinformat, Islamabad, Pakistan.	sajidrwp@yahoo.co.uk	Rashid, Sajid/K-8640-2019	Noor, Zainab/0000-0002-9314-5705	Functional Informatics Lab, National Center for Bioinformatics	Functional Informatics Lab, National Center for Bioinformatics	We acknowledge members of Functional Informatics Lab, National Center for Bioinformatics for their indispensable support and encouragement.	ANDREWS PR, 1984, J MED CHEM, V27, P1648, DOI 10.1021/jm00378a021; [Anonymous], BIOL WIND VERS 1 5; [Anonymous], 2014, ACD CHEMSKETCH FREEW; [Anonymous], 2012, IBM SPSS STAT WINDOW; [Anonymous], 2013, DISC STUD MOD ENV; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; Attenni B, 2009, BIOORG MED CHEM LETT, V19, P3081, DOI 10.1016/j.bmcl.2009.04.011; Auzzas L, 2010, J MED CHEM, V53, P8387, DOI 10.1021/jm101092u; Baradari V, 2006, ENDOCR-RELAT CANCER, V13, P1237, DOI 10.1677/erc.1.01249; Baraldi PG, 2003, BIOORGAN MED CHEM, V11, P2381, DOI 10.1016/S0968-0896(03)00144-5; Baraldi PG, 2000, J MED CHEM, V43, P2675, DOI 10.1021/jm9911229; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bibi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070843; Blackburn C, 2013, J MED CHEM, V56, P7201, DOI 10.1021/jm400385r; Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Botta CB, 2011, J MED CHEM, V54, P2165, DOI 10.1021/jm101373a; Bouchain G, 2003, J MED CHEM, V46, P820, DOI 10.1021/jm020377a; Bressi JC, 2010, BIOORG MED CHEM LETT, V20, P3142, DOI 10.1016/j.bmcl.2010.03.091; Cheminformatics M., 2013, MOLINSPIRATION CHEMI; Chen JB, 2013, J MED CHEM, V56, P3645, DOI 10.1021/jm400179b; Chen Y, 2008, J MED CHEM, V51, P3437, DOI 10.1021/jm701606b; Cheng FX, 2012, J CHEM INF MODEL, V52, P3099, DOI 10.1021/ci300367a; Cho YS, 2010, J MED CHEM, V53, P2952, DOI 10.1021/jm100007m; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; Cronin CN, 2009, CRYSTALLIZATION HIST; Dallavalle S, 2009, EUR J MED CHEM, V44, P1900, DOI 10.1016/j.ejmech.2008.11.005; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Di Gennaro E, 2004, AMINO ACIDS, V26, P435, DOI 10.1007/s00726-004-0087-3; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Feng TT, 2013, BIOORGAN MED CHEM, V21, P5339, DOI 10.1016/j.bmc.2013.06.009; Fenrick R, 1998, J CELL BIOCHEM, P194; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Giannini G, 2014, J MED CHEM, V57, P8358, DOI 10.1021/jm5008209; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Guerra-Bubb JM, 2013, BIOORG MED CHEM LETT, V23, P6025, DOI 10.1016/j.bmcl.2013.06.012; Gupta PK, 2010, BIOORG MED CHEM LETT, V20, P7067, DOI 10.1016/j.bmcl.2010.09.100; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Halkidou K, 2004, PROSTATE, V59, P177, DOI 10.1002/pros.20022; Hayashi A, 2010, INT J CANCER, V127, P1332, DOI 10.1002/ijc.25151; HAYES JJ, 1990, P NATL ACAD SCI USA, V87, P7405, DOI 10.1073/pnas.87.19.7405; He R, 2010, J MED CHEM, V53, P1347, DOI 10.1021/jm901667k; Hirata Y, 2012, BIOORG MED CHEM LETT, V22, P1926, DOI 10.1016/j.bmcl.2012.01.053; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Hou JL, 2011, EUR J MED CHEM, V46, P3190, DOI 10.1016/j.ejmech.2011.04.027; Hranjec M, 2013, EUR J MED CHEM, V59, P111, DOI 10.1016/j.ejmech.2012.11.009; Huang BH, 2005, CELL DEATH DIFFER, V12, P395, DOI 10.1038/sj.cdd.4401567; Huang DW, 2012, EUR J MED CHEM, V52, P111, DOI 10.1016/j.ejmech.2012.03.009; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Jones P, 2006, BIOORG MED CHEM LETT, V16, P5948, DOI 10.1016/j.bmcl.2006.09.002; Kalin JH, 2013, J MED CHEM, V56, P6297, DOI 10.1021/jm4001659; Kalyaanamoorthy S, 2013, BBA-PROTEINS PROTEOM, V1834, P317, DOI 10.1016/j.bbapap.2012.08.009; Kausar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076730; Kemp MM, 2011, BIOORG MED CHEM LETT, V21, P4164, DOI 10.1016/j.bmcl.2011.05.098; Keseru GM, 2009, NAT REV DRUG DISCOV, V8, P203, DOI 10.1038/nrd2796; Kim DK, 2003, J MED CHEM, V46, P5745, DOI 10.1021/jm030377q; Kim HJ, 2011, AM J TRANSL RES, V3, P166; Kim YB, 2000, J ANTIBIOT, V53, P1191, DOI 10.7164/antibiotics.53.1191; Kinzel O, 2009, J MED CHEM, V52, P3453, DOI 10.1021/jm9004303; Kozikowski AP, 2008, J MED CHEM, V51, P4370, DOI 10.1021/jm8002894; Kozikowski AP, 2007, J MED CHEM, V50, P3054, DOI 10.1021/jm070178x; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lai MJ, 2012, J MED CHEM, V55, P3777, DOI 10.1021/jm300197a; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Loeffler H. H., 2012, TECHNICAL REPORT; Mackay HJ, 2010, EUR J CANCER, V46, P1573, DOI 10.1016/j.ejca.2010.02.047; Mahboobi S, 2007, J MED CHEM, V50, P4405, DOI 10.1021/jm0703136; Mahboobi S, 2010, J MED CHEM, V53, P8546, DOI 10.1021/jm100665z; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2005, MED RES REV, V25, P261, DOI 10.1002/med.20024; Marks PA, 2004, ADV CANCER RES, V91, P137, DOI 10.1016/S0065-230X(04)91004-4; Marson CM, 2013, J MED CHEM, V56, P6156, DOI 10.1021/jm400634n; McKinsey TA, 2012, ANNU REV PHARMACOL, V52, P303, DOI 10.1146/annurev-pharmtox-010611-134712; Melagraki G, 2009, MOL DIVERS, V13, P301, DOI 10.1007/s11030-009-9115-2; Mercurio C, 2010, PHARMACOL RES, V62, P18, DOI 10.1016/j.phrs.2010.02.010; Methot JL, 2008, BIOORG MED CHEM LETT, V18, P973, DOI 10.1016/j.bmcl.2007.12.031; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Monneret C, 2005, EUR J MED CHEM, V40, P1, DOI 10.1016/j.ejmech.2004.10.001; Moradei OM, 2007, J MED CHEM, V50, P5543, DOI 10.1021/jm701079h; Mortenson PN, 2011, J COMPUT AID MOL DES, V25, P663, DOI 10.1007/s10822-011-9435-z; Nair SB, 2012, COMPUT BIOL MED, V42, P697, DOI 10.1016/j.compbiomed.2012.04.001; Neelarapu R, 2011, J MED CHEM, V54, P4350, DOI 10.1021/jm2001025; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Oger F, 2010, J MED CHEM, V53, P1937, DOI 10.1021/jm901561u; Olsen CA, 2009, J MED CHEM, V52, P7836, DOI 10.1021/jm900850t; Olson DE, 2013, J MED CHEM, V56, P4816, DOI 10.1021/jm400390r; Pan LN, 2007, CELL MOL IMMUNOL, V4, P337; Park H, 2004, J COMPUT AID MOL DES, V18, P375, DOI 10.1007/s10822-004-2283-3; Park H, 2010, CHEMMEDCHEM, V5, P591, DOI 10.1002/cmdc.200900500; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Remiszewski SW, 2002, J MED CHEM, V45, P753, DOI 10.1021/jm015568c; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Reynolds CH, 2007, BIOORG MED CHEM LETT, V17, P4258, DOI 10.1016/j.bmcl.2007.05.038; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Ryckmans T, 2009, BIOORG MED CHEM LETT, V19, P4406, DOI 10.1016/j.bmcl.2009.05.062; Saku O, 2010, BIOORG MED CHEM LETT, V20, P1090, DOI 10.1016/j.bmcl.2009.12.028; Sander T., 2001, ORGANIC CHEM PORTAL; Schaefer EW, 2009, HAEMATOL-HEMATOL J, V94, P1375, DOI 10.3324/haematol.2009.009217; Seidel T., 2011, DRUG DISCOV TODAY TE, V7, pe221; Shahlaei M, 2013, CHEM REV, V113, P8093, DOI 10.1021/cr3004339; Sidoli S, 2012, J PROTEOMICS, V75, P3419, DOI 10.1016/j.jprot.2011.12.029; Song J, 2005, APMIS, V113, P264, DOI 10.1111/j.1600-0463.2005.apm_04.x; SUMMERS JB, 1990, J MED CHEM, V33, P992, DOI 10.1021/jm00165a017; Swain M, 2012, J CHEM INF MODEL, V52, P613, DOI 10.1021/ci300046g; Taddei M, 2014, BIOORG MED CHEM LETT, V24, P61, DOI 10.1016/j.bmcl.2013.11.072; Tang H, 2009, J CHEM INF MODEL, V49, P461, DOI 10.1021/ci800366f; Tapadar S, 2009, BIOORG MED CHEM LETT, V19, P3023, DOI 10.1016/j.bmcl.2009.04.058; Terracciano S, 2010, BIOORGAN MED CHEM, V18, P3252, DOI 10.1016/j.bmc.2010.03.022; Thomas EA, 2009, MOL NEUROBIOL, V40, P33, DOI 10.1007/s12035-009-8067-y; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vadivelan S, 2008, J MOL GRAPH MODEL, V26, P935, DOI 10.1016/j.jmgm.2007.07.002; Vaidya AS, 2012, BIOORG MED CHEM LETT, V22, P5025, DOI 10.1016/j.bmcl.2012.06.017; Verma J, 2010, CURR TOP MED CHEM, V10, P95, DOI 10.2174/156802610790232260; VetteseDadey M, 1996, EMBO J, V15, P2508, DOI 10.1002/j.1460-2075.1996.tb00608.x; Wagner FF, 2013, J MED CHEM, V56, P1772, DOI 10.1021/jm301355j; Wagner JM, 2010, CLIN EPIGENETICS, V1, DOI 10.1007/s13148-010-0012-4; Wang DF, 2005, J MED CHEM, V48, P6936, DOI 10.1021/jm0505011; Wang T, 2013, BIOORG MED CHEM LETT, V23, P4790, DOI 10.1016/j.bmcl.2013.07.001; Wang YQ, 2003, J MED CHEM, V46, P634, DOI 10.1021/jm0203433; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Witter DJ, 2008, BIOORG MED CHEM LETT, V18, P726, DOI 10.1016/j.bmcl.2007.11.047; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Wu TYH, 2004, BIOORG MED CHEM LETT, V14, P449, DOI 10.1016/j.bmcl.2003.10.055; Yan CL, 2008, PROTEINS, V73, P134, DOI 10.1002/prot.22047; Younes A, 2012, J CLIN ONCOL, V30, P2197, DOI 10.1200/JCO.2011.38.1350; Yu CW, 2013, J MED CHEM, V56, P6775, DOI 10.1021/jm400564j; Zhang T, 2014, NEOPLASIA, V16, P665, DOI 10.1016/j.neo.2014.07.009; Zhang X, 2013, BIOORGAN MED CHEM, V21, P6981, DOI 10.1016/j.bmc.2013.09.023; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhou N, 2008, J MED CHEM, V51, P4072, DOI 10.1021/jm800251w; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X	146	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139588	10.1371/journal.pone.0139588	http://dx.doi.org/10.1371/journal.pone.0139588			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431201	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700083
J	Saito, J; Tabuchi, T; Shibanuma, A; Yasuoka, J; Nakamura, M; Jimba, M				Saito, Junko; Tabuchi, Takahiro; Shibanuma, Akira; Yasuoka, Junko; Nakamura, Masakazu; Jimba, Masamine			'Only Fathers Smoking' Contributes the Most to Socioeconomic Inequalities: Changes in Socioeconomic Inequalities in Infants' Exposure to Second Hand Smoke over Time in Japan	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; CHILDRENS EXPOSURE; SECONDHAND SMOKE; PASSIVE SMOKING; HOME; BEHAVIOR; TRENDS; DISPARITIES; ENGLAND; ASTHMA	Background Exposure to second hand smoke (SHS) is one of the major causes of premature death and disease among children. While socioeconomic inequalities exist for adult smoking, such evidence is limited for SHS exposure in children. Thus, this study examined changes over time in socioeconomic inequalities in infants' SHS exposure in Japan. Methods This is a repeated cross-sectional study of 41,833 infants born in 2001 and 32,120 infants born in 2010 in Japan from nationally representative surveys using questionnaires. The prevalence of infants' SHS exposure was determined and related to household income and parental education level. The magnitudes of income and educational inequalities in infants' SHS exposure were estimated in 2001 and 2010 using both absolute and relative inequality indices. Results The prevalence of SHS exposure in infants declined from 2001 to 2010. The relative index of inequality increased from 0.85 (95% confidence interval [CI], 0.80 to 0.89) to 1.47 (95% CI, 1.37 to 1.56) based on income and from 1.22 (95% CI, 1.17 to 1.26) to 2.09 (95% CI, 2.00 to 2.17) based on education. In contrast, the slope index of inequality decreased from 30.9 (95% CI, 29.3 to 32.6) to 20.1 (95% CI, 18.7 to 21.5) based on income and from 44.6 (95% CI, 43.1 to 46.2) to 28.7 (95% CI, 27.3 to 30.0) based on education. Having only a father who smoked indoors was a major contributor to absolute income inequality in infants' SHS exposure in 2010, which increased in importance from 45.1% in 2001 to 67.0% in 2010. Conclusions The socioeconomic inequalities in infants' second hand smoke exposure increased in relative terms but decreased in absolute terms from 2001 to 2010. Further efforts are needed to encourage parents to quit smoking and protect infants from second hand smoke exposure, especially in low socioeconomic households that include non-smoking mothers.	[Saito, Junko; Shibanuma, Akira; Yasuoka, Junko; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Tabuchi, Takahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Ctr Canc Control & Stat, Higashinari Ku, Osaka 5378511, Japan; [Nakamura, Masakazu] Japan Assoc Dev Community Med, Inst Community Med, Hlth Promot Res Ctr, Chiyoda Ku, Tokyo 1020093, Japan	University of Tokyo; Osaka Medical Center for Cancer & Cardiovascular Diseases	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mjimba@m.u-tokyo.ac.jp	saito, junko/AAA-4866-2019; Shibanuma, Akira/C-7652-2016; Yasuoka, Junko/GVT-8950-2022; Jimba, Masamine/AAF-5630-2020	Shibanuma, Akira/0000-0003-2058-1722; Tabuchi, Takahiro/0000-0002-1050-3125	Ministry of Health, Labour and Welfare [H25-010]; Department of Community and Global Health, Graduate School of Medicine, The University of Tokyo	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Department of Community and Global Health, Graduate School of Medicine, The University of Tokyo	This study was funded by the Ministry of Health, Labour and Welfare (Grant; Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus (H25-010)) and the Department of Community and Global Health, Graduate School of Medicine, The University of Tokyo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Blackburn C, 2005, SOC SCI MED, V61, P517, DOI 10.1016/j.socscimed.2004.12.009; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Bolte G, 2009, EUR J PUBLIC HEALTH, V19, P52, DOI 10.1093/eurpub/ckn114; Chen CM, 2015, J WOMENS HEALTH, V16, P869; Crone MR, 2001, PREV MED, V32, P209, DOI 10.1006/pmed.2000.0787; Everett SA, 1999, PREV MED, V29, P327, DOI 10.1006/pmed.1999.0560; Fujiwara T, 2013, AM J EPIDEMIOL, V177, P1042, DOI 10.1093/aje/kws355; Gartner CE, 2013, TOB CONTROL, V22, P344, DOI 10.1136/tobaccocontrol-2011-050297; Giskes K, 2005, J EPIDEMIOL COMMUN H, V59, P395, DOI 10.1136/jech.2004.025684; Graham H, 2003, TOB CONTROL, V12, P434, DOI 10.1136/tc.12.4.434; Halterman JS, 2007, J ASTHMA, V44, P83, DOI 10.1080/02770900601180545; Harper S, 2005, METHODS MEASURING CA; Harper S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063362; Holliday JC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-430; Japan Pediatric Society, 2002, ACTA PAEDIATR JAPON, V106, P436; Jarvis MJ, 2015, ADDICTION, V110, P1484, DOI 10.1111/add.12962; Jones LL, 2011, NICOTINE TOB RES, V13, P479, DOI 10.1093/ntr/ntr030; Kaneita Y, 2006, PREV MED, V42, P210, DOI 10.1016/j.ypmed.2005.11.017; Karp I, 2005, ANN EPIDEMIOL, V15, P445, DOI 10.1016/j.annepidem.2004.10.002; Kashiwabara M, 2011, ASIAN PAC J CANCER P, V12, P1909; Kondo R, 2011, SHINSHU MED J, V59, P169; Mackay J, 2013, LANCET, V381, P1581, DOI 10.1016/S0140-6736(13)60854-5; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; Ministry of Health Labour and Welfare Japan, 2011, REP IMPL STAT ADV SE; National Cancer Institute, 2013, HLTH DISP CALC VERS; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Orton S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112690; PAMUK ER, 1985, POP STUD-J DEMOG, V39, P17, DOI 10.1080/0032472031000141256; Pisinger C, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-65; Rosen LJ, 2012, PEDIATRICS, V129, P141, DOI 10.1542/peds.2010-3209; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Shipton D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4347; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Singh GK, 2010, PEDIATRICS, V126, P4, DOI 10.1542/peds.2009-2744; Sockrider MM, 2003, NICOTINE TOB RES, V5, P901, DOI 10.1080/14622200310001615240; Streja L, 2014, J IMMIGR MINOR HEALT, V16, P256, DOI 10.1007/s10903-012-9713-4; Tabuchi T, 2015, DRUG ALCOHOL DEPEN, V147, P103, DOI 10.1016/j.drugalcdep.2014.12.001; US Surgeon General, 2006, HLTH CONS EXP TOB SM; World Health Organization, 2014, 4 WHO FCTC; Yasuda T, 2013, J OBSTET GYNAECOL RE, V39, P1505, DOI 10.1111/jog.12098; Zhang X, 2012, TOB CONTROL, V21, P330, DOI 10.1136/tc.2011.043802	42	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139512	10.1371/journal.pone.0139512	http://dx.doi.org/10.1371/journal.pone.0139512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431400	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700071
J	Voigtlander, T; Gupta, SK; Thum, S; Fendrich, J; Manns, MP; Lankisch, TO; Thum, T				Voigtlaender, Torsten; Gupta, Shashi K.; Thum, Sabrina; Fendrich, Jasmin; Manns, Michael P.; Lankisch, Tim O.; Thum, Thomas			MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER-DISEASE; CANCER CELLS; CONTRIBUTES; EXPRESSION; MANAGEMENT; INVASION; MIR-194; PROGRESSION; METASTASIS	Background and Aim Patients with primary sclerosing cholangitis (PSC) are at high risk for the development of cholangiocarcinoma (CC). Analysis of micro ribonucleic acid (MiRNA) patterns is an evolving research field in biliary pathophysiology with potential value in diagnosis and therapy. Our aim was to evaluate miRNA patterns in serum and bile of patients with PSC and/or CC. Methods Serum and bile from consecutive patients with PSC (n = 40 (serum), n = 52 (bile)), CC (n = 31 (serum), n = 19 (bile)) and patients with CC complicating PSC (PSC/CC) (n = 12 (bile)) were analyzed in a cross-sectional study between 2009 and 2012. As additional control serum samples from healthy individuals were analyzed (n = 12). The miRNA levels in serum and bile were determined with global miRNA profiling and subsequent miRNA-specific polymerase chain reaction-mediated validation. Results Serum analysis revealed significant differences for miR-1281 (p = 0.001), miR-126 (p = 0.001), miR-26a (p = 0.001), miR-30b (p = 0.001) and miR-122 (p = 0.034) between patients with PSC and patients with CC. All validated miRNAs were significantly lower in healthy individuals. MiR-412 (p = 0.001), miR-640 (p = 0.001), miR-1537 (p = 0.003) and miR-3189 (p = 0.001) were significantly different between patients with PSC and PSC/CC in bile. Conclusions Patients with PSC and/or CC have distinct miRNA profiles in serum and bile. Furthermore, miRNA concentrations are different in bile of patients with CC on top of PSC indicating the potential diagnostic value of these miRNAs.	[Voigtlaender, Torsten; Manns, Michael P.; Lankisch, Tim O.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Voigtlaender, Torsten; Manns, Michael P.; Lankisch, Tim O.; Thum, Thomas] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Gupta, Shashi K.; Thum, Sabrina; Fendrich, Jasmin; Thum, Thomas] Hannover Med Sch, Inst Mol & Translat Therapeut Strategies, Hannover, Germany; [Thum, Thomas] Hannover Med Sch, Excellence Cluster REBIRTH, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Lankisch, TO (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany.	lankisch.tim@mh-hannover.de; thum.thomas@mh-hannover.de		Gupta, Shashi Kumar/0000-0003-4898-9877	Integrated Research and Treatment Center-Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany	Integrated Research and Treatment Center-Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany	Funding provided by Integrated Research and Treatment Center-Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany, www.ifb-tx.de.	Bessho K, 2014, J PATHOL, V232, P415; Boberg KM, 2011, BEST PRACT RES CL GA, V25, P753, DOI 10.1016/j.bpg.2011.10.002; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; de Valle MB, 2012, LIVER INT, V32, P441, DOI 10.1111/j.1478-3231.2011.02614.x; Dong J, 2014, MOL MED REP, V10, P1426, DOI 10.3892/mmr.2014.2335; Dubin PH, 2014, J MED VIROL, V86, P1507, DOI 10.1002/jmv.23987; Eaton JE, 2013, GASTROENTEROLOGY, V145, P521, DOI 10.1053/j.gastro.2013.06.052; Farid WRR, 2014, TRANSPL INT, V27, P1222, DOI 10.1111/tri.12379; Gao W, 2011, J CANCER RES CLIN, V137, P557, DOI 10.1007/s00432-010-0918-4; Gentilin E, 2013, ENDOCRINOLOGY, V154, P1690, DOI 10.1210/en.2012-2070; Karlsen TH, 2014, ALIMENT PHARM THER, V39, P282, DOI 10.1111/apt.12581; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Lankisch TO, 2014, LIVER TRANSPLANT, V20, P673, DOI 10.1002/lt.23872; Lankisch TO, 2011, HEPATOLOGY, V53, P875, DOI 10.1002/hep.24103; Li L, 2014, HEPATOLOGY, V60, P896, DOI 10.1002/hep.27050; Li X, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-216; Liao WT, 2013, BMC SYST BIOL, V7, P104; Liu SP, 2012, J HEPATOL, V56, P389, DOI 10.1016/j.jhep.2011.08.008; Marin JJG, 2014, CURR OPIN GASTROEN, V30, P303, DOI 10.1097/MOG.0000000000000051; Meng ZP, 2010, HEPATOLOGY, V52, P2148, DOI 10.1002/hep.23915; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429; Munoz-Garrido P, 2012, WORLD J GASTROENTERO, V18, P6189, DOI 10.3748/wjg.v18.i43.6189; Nakao K, 2014, J GASTROENTEROL, V49, P589, DOI 10.1007/s00535-014-0932-4; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Roest HP, 2015, HEPATOLOGY, V61, P1094, DOI 10.1002/hep.27325; Salvucci O, 2012, HAEMATOL-HEMATOL J, V97, P818, DOI 10.3324/haematol.2011.056945; Shigehara K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023584; Skipworth JRA, 2014, DIGEST DIS, V32, P570, DOI 10.1159/000360507; Song YX, 2012, ANN SURG ONCOL, V19, pS509, DOI 10.1245/s10434-011-1999-2; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Toffanin S, 2012, J HEPATOL, V57, P490, DOI 10.1016/j.jhep.2012.06.005; Tomasetti M, 2014, ANTIOXID REDOX SIGN, V21, P2109, DOI 10.1089/ars.2013.5215; Trauner M, 2012, DIGEST DIS, V30, P39, DOI 10.1159/000341123; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Weismuller TJ, 2011, BEST PRACT RES CL GA, V25, P741, DOI 10.1016/j.bpg.2011.10.003; Williamson KD, 2014, DIGEST DIS, V32, P438, DOI 10.1159/000358150; Yang HP, 2011, GASTROENTEROLOGY, V141, P378, DOI 10.1053/j.gastro.2011.03.044; Zhang J, 2014, ONCOL REP, V31, P1157, DOI 10.3892/or.2013.2960	41	68	71	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139305	10.1371/journal.pone.0139305	http://dx.doi.org/10.1371/journal.pone.0139305			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431155	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700041
J	Li, B; Lou, YZ; Gu, HF; Long, X; Wang, T; Wei, J; Wang, JH; Tu, J; Ning, XJ				Li, Bin; Lou, Yongzhong; Gu, Hongfei; Long, Xue; Wang, Tao; Wei, Jian; Wang, Jinghua; Tu, Jun; Ning, Xianjia			Trends in Incidence of Stroke and Transition of Stroke Subtypes in Rural Tianjin China: A Population-Based Study from 1992 to 2012	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; INTRACEREBRAL HEMORRHAGE; CASE-FATALITY; HONG-KONG; MORTALITY; DISEASE; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; INFARCTION	Objectives The incidence of ischemic stroke has increased and that of hemorrhagic stroke has decreased in urban China; however, the trends in rural areas are unknown. We aimed to explore the secular trends in incidence and transition of stroke subtypes among rural Chinese. Methods This was a population-based stroke surveillance through the Tianjin Brain Study. A total of 14,538 residents in a township of Ji County in Tianjin, China participated in the study since 1985. We investigated the age-standardized stroke incidence (sex-specific, type-specific, and age-specific), the annual proportion of change in the incidence of stroke, and the proportion of intracerebral hemorrhage in the periods 1992-1998, 1999-2005, and 2006-2012, because the neuroimaging technique was available since 1992 in this area. Results The age-standardized incidence per 100,000 person-years increased significantly for both intracerebral hemorrhage (37.8 in 1992-1998, 46.5 in 1999-2005, and 76.5 in 2006-2012) and ischemic stroke (83.9 in 1992-1998, 135.3 in 1999-2005, and 238.0 in 2006-2012). The age-standardized incidence of first-ever stroke increased annually by 4.9% for intracerebral hemorrhage and by 7.3% for ischemic stroke. The greatest increase was observed in men aged 45-64 years for both stroke types (P < 0.001). The proportion of intracerebral hemorrhage was stable overall, increased among men aged 45-64 years, and decreased among men aged >= 65 years. The average age of intracerebral hemorrhage in men reduced by 7.5 years from 1992 to 2012. Conclusion The age-standardized incidence of main stroke subtypes increased significantly in rural China over the past 21 years; the overall proportion of intracerebral hemorrhage was stable, but the incidence increased significantly among middle-aged men. These findings imply that it is crucial to control stroke risk factors in middle-aged men for stroke prevention in future decades.	[Li, Bin; Lou, Yongzhong; Gu, Hongfei; Long, Xue; Wang, Tao; Wei, Jian] Tianjin Haibin Peoples Hosp, Dept Neurol, Tianjin, Peoples R China; [Wang, Jinghua; Tu, Jun; Ning, Xianjia] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China; [Wang, Jinghua; Tu, Jun; Ning, Xianjia] Tianjin Neurol Inst, Dept Epidemiol, Tianjin, Peoples R China	Tianjin Medical University	Li, B (corresponding author), Tianjin Haibin Peoples Hosp, Dept Neurol, Tianjin, Peoples R China.	libin_1971_2008@sina.com; xjn0906@gmail.com			Ministry of Science and Technology of the People's Republic of China [75-62-02-21, 85-915-01-01, 2006BAI01A01]; Tianjin Medical University General Hospital, China	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Tianjin Medical University General Hospital, China	This study was in part funded by the Ministry of Science and Technology of the People's Republic of China (contracts 75-62-02-21, 85-915-01-01, 2006BAI01A01), and Tianjin Medical University General Hospital, China.	Ahmad OB., 2001, AGE STANDARDIZATION; AHO K, 1980, B WORLD HEALTH ORGAN, V58, P113; Andersen KK, 2009, STROKE, V40, P2068, DOI 10.1161/STROKEAHA.108.540112; Carter AM, 2007, STROKE, V38, P1873, DOI 10.1161/STROKEAHA.106.474569; Cesaroni G, 2009, STROKE, V40, P2812, DOI 10.1161/STROKEAHA.108.542944; Chau PH, 2011, CEREBROVASC DIS, V31, P138, DOI 10.1159/000321734; Coull AJ, 2004, STROKE, V35, P2041, DOI 10.1161/01.STR.0000137605.48864.2f; FELDMANN E, 1990, NEUROLOGY, V40, P1541, DOI 10.1212/wnl.40.10.1540; Fuh JL, 2000, NEUROEPIDEMIOLOGY, V19, P258, DOI 10.1159/000026263; Grimaud O, 2011, STROKE, V42, P1201, DOI 10.1161/STROKEAHA.110.596429; Ikram MA, 2012, CURR ATHEROSCLER REP, V14, P300, DOI 10.1007/s11883-012-0252-1; Jeng Jiann-Shing, 2007, Acta Neurol Taiwan, V16, P190; Jiang B, 2006, STROKE, V37, P63, DOI 10.1161/01.STR.0000194955.34820.78; KAY R, 1992, NEUROLOGY, V42, P985, DOI 10.1212/WNL.42.5.985; Kerr GD, 2011, CEREBROVASC DIS, V31, P57, DOI 10.1159/000320855; Kim RB, 2013, J KOREAN MED SCI, V28, P16, DOI 10.3346/jkms.2013.28.1.16; Kleindorfer DO, 2010, STROKE, V41, P1326, DOI 10.1161/STROKEAHA.109.575043; Li CR, 2008, STROKE, V39, P2191, DOI 10.1161/STROKEAHA.107.507756; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Ministry of Health of the People's Republic of China, 2011, CHIN HLTH STAT YB 20; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Pezzini A, 2013, STROKE, V44, P1584, DOI 10.1161/STROKEAHA.111.000069; Redon J, 2011, EUR HEART J, V32, P1424, DOI 10.1093/eurheartj/ehr045; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sivenius J, 2004, STROKE, V35, P420, DOI 10.1161/01.STR.0000110220.63212.59; *SPSS INC, 2006, SPSS VERS 15 0 WIND; Sugama C, 2013, J STROKE CEREBROVASC, V22, pE118, DOI 10.1016/j.jstrokecerebrovasdis.2012.08.016; Sun XG, 2014, J CLIN NEUROSCI, V21, P436, DOI 10.1016/j.jocn.2013.04.028; The Ministry of Health of the People's Republic of China, 2011, CHINA HEALTH STATIST; Tsai CF, 2013, NEUROLOGY, V81, P264, DOI 10.1212/WNL.0b013e31829bfde3; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang JH, 2015, NEUROLOGY, V84, P374, DOI 10.1212/WNL.0000000000001175; Wang JH, 2014, STROKE, V45, P1626, DOI 10.1161/STROKEAHA.113.003899; Wang LD, 2005, LANCET, V366, P1821, DOI 10.1016/S0140-6736(05)67344-8; Wieberdink RG, 2012, EUR J EPIDEMIOL, V27, P287, DOI 10.1007/s10654-012-9673-y; Zhang L, 2011, INT J CARDIOL, V151, P46, DOI 10.1016/j.ijcard.2010.04.056; Zhang LF, 2003, STROKE, V34, P2091, DOI 10.1161/01.STR.0000087149.42294.8C; Zhang XH, 2007, STROKE, V38, P3139, DOI 10.1161/STROKEAHA.107.494336; Zhang YR, 2011, ARCH INTERN MED, V171, P1811, DOI 10.1001/archinternmed.2011.443; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; Zia E, 2007, STROKE, V38, P2681, DOI 10.1161/STROKEAHA.106.479725	46	14	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139461	10.1371/journal.pone.0139461	http://dx.doi.org/10.1371/journal.pone.0139461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426803	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100064
J	Olivares, E; Salgado, S; Maidana, JP; Herrera, G; Campos, M; Madrid, R; Orio, P				Olivares, Erick; Salgado, Simon; Paul Maidana, Jean; Herrera, Gaspar; Campos, Matias; Madrid, Rodolfo; Orio, Patricio			TRPM8-Dependent Dynamic Response in a Mathematical Model of Cold Thermoreceptor	PLOS ONE			English	Article							GUINEA-PIG CORNEA; ACTIVATED POTASSIUM CHANNELS; NERVE-TERMINAL IMPULSES; SENSORY NEURONS; GENE-EXPRESSION; TRPM8 CHANNELS; RECEPTORS; TRANSDUCTION; TEMPERATURE; MECHANISM	Cold-sensitive nerve terminals (CSNTs) encode steady temperatures with regular, rhythmic temperature-dependent firing patterns that range from irregular tonic firing to regular bursting (static response). During abrupt temperature changes, CSNTs show a dynamic response, transiently increasing their firing frequency as temperature decreases and silencing when the temperature increases (dynamic response). To date, mathematical models that simulate the static response are based on two depolarizing/repolarizing pairs of membrane ionic conductance (slow and fast kinetics). However, these models fail to reproduce the dynamic response of CSNTs to rapid changes in temperature and notoriously they lack a specific cold-activated conductance such as the TRPM8 channel. We developed a model that includes TRPM8 as a temperature-dependent conductance with a calcium-dependent desensitization. We show by computer simulations that it appropriately reproduces the dynamic response of CSNTs from mouse cornea, while preserving their static response behavior. In this model, the TRPM8 conductance is essential to display a dynamic response. In agreement with experimental results, TRPM8 is also needed for the ongoing activity in the absence of stimulus (i.e. neutral skin temperature). Free parameters of the model were adjusted by an evolutionary optimization algorithm, allowing us to find different solutions. We present a family of possible parameters that reproduce the behavior of CSNTs under different temperature protocols. The detection of temperature gradients is associated to a homeostatic mechanism supported by the calcium-dependent desensitization.	[Olivares, Erick; Salgado, Simon; Paul Maidana, Jean; Herrera, Gaspar; Orio, Patricio] Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile; [Campos, Matias; Madrid, Rodolfo] Univ Santiago Chile, Fac Quim & Biol, Santiago, Chile; [Orio, Patricio] Univ Valparaiso, Fac Ciencias, Inst Neurociencia, Valparaiso, Chile	Universidad de Valparaiso; Universidad de Santiago de Chile; Universidad de Valparaiso	Orio, P (corresponding author), Univ Valparaiso, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	patricio.orio@uv.cl	Olivares, Erick/AGQ-4582-2022; Orio, Patricio/F-6207-2010	Orio, Patricio/0000-0003-0332-8098; Madrid, Rodolfo/0000-0002-8623-5761; Maidana, Jean Paul/0000-0002-2690-1638; Olivares Bravo, Erick/0000-0003-2069-5789	Fondecyt (Conicyt, Chile) [1130862, 1131064, ACT-1104, ACT-1113, FB0008]; Millennium Scientific Initiative of the Ministerio de Economia (Chile)	Fondecyt (Conicyt, Chile)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative of the Ministerio de Economia (Chile)	This work is funded by Grants Fondecyt 1130862 (PO), Fondecyt 1131064 (RM), ACT-1104 (PO), ACT-1113 (PO, RM) and FB0008 (PO) (Conicyt, Chile). The Centro Interdisciplinario de Neurociencia de Valparaiso (CINV) is a Millennium Institute supported by the Millennium Scientific Initiative of the Ministerio de Economia (Chile). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz L, 2014, HANDB EXP PHARMACOL, V222, P547, DOI 10.1007/978-3-642-54215-2_22; BADE H, 1979, PFLUG ARCH EUR J PHY, V382, P1, DOI 10.1007/BF00585897; Bahl A, 2012, J NEUROSCI METH, V210, P22, DOI 10.1016/j.jneumeth.2012.04.006; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bond CT, 1999, ANN NY ACAD SCI, V868, P370, DOI 10.1111/j.1749-6632.1999.tb11298.x; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; Braun HA, 1998, INT J BIFURCAT CHAOS, V8, P881, DOI 10.1142/S0218127498000681; Brock JA, 2001, J PHYSIOL-LONDON, V533, P493, DOI 10.1111/j.1469-7793.2001.0493a.x; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; Carr RW, 2003, J GEN PHYSIOL, V121, P427, DOI 10.1085/jgp.200308814; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; DeMaria S, 2010, J CELL BIOL, V191, P443, DOI 10.1083/jcb.201008163; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Frisby JP, 2010, SEEING SECOND EDITIO; Fujita F, 2013, J NEUROSCI, V33, P6154, DOI 10.1523/JNEUROSCI.5672-12.2013; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; HEINZ M, 1990, BRAIN RES, V521, P289, DOI 10.1016/0006-8993(90)91554-T; Hensel H., 1984, RECENT ADV MED THERM, P51, DOI [DOI 10.1007/978-1-4684-7697-2_8, 10.1007/978-1-4684-7697-2_8]; Herzog RI, 2001, J NEUROPHYSIOL, V86, P1351, DOI 10.1152/jn.2001.86.3.1351; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hines Michael L, 2009, Front Neuroinform, V3, P1, DOI 10.3389/neuro.11.001.2009; Hines ML, 2001, NEUROSCIENTIST, V7, P123, DOI 10.1177/107385840100700207; Huber MT, 2000, CHAOS SOLITON FRACT, V11, P1895, DOI 10.1016/S0960-0779(99)00126-5; Latorre R, 2011, PHYSIOLOGY, V26, P273, DOI 10.1152/physiol.00004.2011; Longtin A, 1996, NEURAL COMPUT, V8, P215, DOI 10.1162/neco.1996.8.2.215; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; Madrid R, 2014, CURR TOP MEMBR, V74, P293, DOI 10.1016/B978-0-12-800181-3.00011-7; Malkia A, 2007, J PHYSIOL-LONDON, V581, P155, DOI 10.1113/jphysiol.2006.123059; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Orio P, 2012, J NEUROPHYSIOL, V108, P3009, DOI 10.1152/jn.01033.2011; Orio P, 2009, J PHYSIOL-LONDON, V587, P1961, DOI 10.1113/jphysiol.2008.165738; Parra A, 2010, NAT MED, V16, P1396, DOI 10.1038/nm.2264; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PLANT RE, 1976, BIOPHYS J, V16, P227, DOI 10.1016/S0006-3495(76)85683-4; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sarria I, 2011, J NEUROPHYSIOL, V106, P3056, DOI 10.1152/jn.00544.2011; SCHAFER K, 1991, EXPERIENTIA, V47, P47, DOI 10.1007/BF02041249; SCHAFER K, 1982, J NEUROPHYSIOL, V47, P1017, DOI 10.1152/jn.1982.47.6.1017; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voets T, 2007, NAT CHEM BIOL, V3, P174, DOI 10.1038/nchembio862; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Wheeler DG, 2012, CELL, V149, P1112, DOI 10.1016/j.cell.2012.03.041; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	47	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139314	10.1371/journal.pone.0139314	http://dx.doi.org/10.1371/journal.pone.0139314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426259	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100047
J	Friedrich, P; Lam, CG; Itriago, E; Perez, R; Ribeiro, RC; Arora, RS				Friedrich, Paola; Lam, Catherine G.; Itriago, Elena; Perez, Rafael; Ribeiro, Raul C.; Arora, Ramandeep S.			Magnitude of Treatment Abandonment in Childhood Cancer	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MIDDLE-INCOME COUNTRIES; PEDIATRIC ONCOLOGY; CHILDREN; PREDICTORS; INDONESIA; THERAPY; PARENTS; REFUSAL	Background Treatment abandonment (TxA) is recognized as a leading cause of treatment failure for children with cancer in low-and-middle-income countries (LMC). However, its global frequency and burden have remained elusive due to lack of global data. This study aimed to obtain an estimate using survey and population data. Methods Childhood cancer clinicians (medical oncologists, surgeons, and radiation therapists), nurses, social workers, and psychologists involved in care of children with cancer were approached through an online survey February-May 2012. Incidence and population data were obtained from public sources. Descriptive, univariable, and multivariable analyses were conducted. Results 602 responses from 101 countries were obtained from physicians (84%), practicing pediatric hematology/oncology (83%) in general or children's hospitals (79%). Results suggested, 23,854 (15%) of 155,088 children <15 years old newly diagnosed with cancer annually in the countries analyzed, abandon therapy. Importantly, 83% of new childhood cancer cases and 99% of TxA were attributable to LMC. The annual number of cases of TxA expected in LMC worldwide (26,166) was nearly equivalent to the annual number of cancer cases in children <15 years expected in HIC (26,368). Approximately two thirds of LMC had median TxA >= 6%, but TxA >= 6% was reported in high- (9%), upper-middle- (41%), lower-middle- (80%), and low-income countries (90%, p<0.001). Most LMC centers reporting TxA>6% were outside the capital. Lower national income category, higher reliance on out-of-pocket payments, and high prevalence of economic hardship at the center were independent contextual predictors for TxA >= 6% (p<0.001). Global survival data available for more developed and less developed regions suggests TxA may account for at least a third of the survival gap between HIC and LMC. Conclusion Results show TxA is prevalent (compromising cancer survival for 1 in 7 children globally), confirm the suspected high burden of TxA in LMC, and illustrate the negative impact of poverty on its occurrence. The present estimates may appear small compared to the global burden of child death from malnutrition and infection (measured in millions). However, absolute numbers suggest the burden of TxA in LMC is nearly equivalent to annually losing all kids diagnosed with cancer in HIC just to TxA, without even considering deaths from disease progression, relapse or toxicity-the main causes of childhood cancer mortality in HIC. Results document the importance of monitoring and addressing TxA as part of childhood cancer outcomes in at-risk settings.	[Friedrich, Paola; Itriago, Elena] Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA; [Lam, Catherine G.; Ribeiro, Raul C.] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Lam, Catherine G.] St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA; [Perez, Rafael] Villa Victoria Ctr Arts, Boston, MA USA; [Arora, Ramandeep S.] Max Healthcare, Dept Med Oncol, New Delhi, India	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Friedrich, P (corresponding author), Dana Farber Boston Childrens Canc & Blood Disorde, Dept Pediat Oncol, Boston, MA 02215 USA.	paola_friedrich@dfci.harvard.edu	Lam, Catherine/K-6328-2014; Friedrich, Paola/N-8145-2018	Lam, Catherine/0000-0003-1363-5331; Friedrich, Paola/0000-0002-5265-3113; Arora, Ramandeep/0000-0002-2613-4539	Program in Cancer Outcomes Research Training [R25 CA092203]; National Institutes of Health training grant; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R25CA092203] Funding Source: NIH RePORTER	Program in Cancer Outcomes Research Training; National Institutes of Health training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	First author's effort was supported by the Program in Cancer Outcomes Research Training (R25 CA092203); a National Institutes of Health training grant. St. Jude Children's Research Hospital efforts are supported by the American Lebanese Syrian Associated Charities (ALSAC). The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri AJ, 2011, J PAEDIATR CHILD H, V47, P628, DOI 10.1111/j.1440-1754.2011.02170.x; Arora RS, 2010, INDIAN PEDIATR, V47, P1005, DOI 10.1007/s13312-010-0172-5; Arora RS, 2007, PEDIATR BLOOD CANCER, V49, P941, DOI 10.1002/pbc.21127; Bonilla M, 2009, INT J CANCER, V125, P2144, DOI 10.1002/ijc.24534; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Friedrich P, 2014, CANCER-AM CANCER SOC, V120, P112, DOI 10.1002/cncr.28339; Gupta S, 2013, EUR J CANCER, V49, P2555, DOI 10.1016/j.ejca.2013.03.024; Hazar V, 2010, J PEDIAT HEMATOL ONC, V32, pE317, DOI 10.1097/MPH.0b013e3181ed163c; Hord JD, 2006, J CLIN ONCOL, V24, P5454, DOI 10.1200/JCO.2006.06.4709; Israels T, 2008, PEDIATR BLOOD CANCER, V51, P639, DOI 10.1002/pbc.21703; Laengler A, 2011, SIOP M 2011 PED BLOO; LAM C, 2012, J HEALTHCARE SCI HUM, V2, P81; Leander C, 2007, PEDIATR BLOOD CANCER, V49, P817, DOI 10.1002/pbc.21052; Libes J, 2015, PEDIATR BLOOD CANCER, V62, P252, DOI 10.1002/pbc.25312; Madani A, 2006, PEDIATR BLOOD CANCER, V46, P472, DOI 10.1002/pbc.20436; Magrath I, 2013, LANCET ONCOL, V14, pE104, DOI 10.1016/S1470-2045(13)70008-1; Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6; Mostert S, 2006, PEDIATRICS, V118, pE1600, DOI 10.1542/peds.2005-3015; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Njuguna F, 2014, ARCH DIS CHILD, V99, P609, DOI 10.1136/archdischild-2013-305052; Parkin DM, 1998, INT INCIDENCE CHILDH, VII; Quintana Yuri, 2003, AMIA Annu Symp Proc, P978; Ramzan M, 2013, PEDIATR BLOOD CANCER, V60, P159, DOI 10.1002/pbc.24277; Ribeiro RC, 2008, LANCET ONCOL, V9, P721, DOI 10.1016/S1470-2045(08)70194-3; Rodriguez-Galindo C, 2013, CURR OPIN PEDIATR, V25, P3, DOI 10.1097/MOP.0b013e32835c1cbe; Sandlund JT, 1997, LEUKEMIA, V11, P743, DOI 10.1038/sj.leu.2400609; Sitaresm MN, 2010, PSYCHO-ONCOLOGY, V19, P361, DOI 10.1002/pon.1578; Tang YM, 2008, PEDIATR BLOOD CANCER, V51, P380, DOI 10.1002/pbc.21629; United Nations Development Program, INT HUM DEV IND; Viera AJ, 2005, FAM MED, V37, P360; Wang YR, 2011, LEUKEMIA RES, V35, P1628, DOI 10.1016/j.leukres.2011.07.004; Wang YR, 2011, PEDIATR HEMAT ONCOL, V28, P249, DOI 10.3109/08880018.2010.537436	32	61	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0135230	10.1371/journal.pone.0135230	http://dx.doi.org/10.1371/journal.pone.0135230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422208	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700003
J	Liu, X; Wang, SF; Xue, H; Singh, VP				Liu, Xin; Wang, Sufen; Xue, Han; Singh, Vijay P.			Simulating Crop Evapotranspiration Response under Different Planting Scenarios by Modified SWAT Model in an Irrigation District, Northwest China	PLOS ONE			English	Article							SHIYANG RIVER-BASIN; LAND-USE; YIELD; DYNAMICS; IMPACT; REGION; OASIS; AREA; FLOW	Modelling crop evapotranspiration (ET) response to different planting scenarios in an irrigation district plays a significant role in optimizing crop planting patterns, resolving agricultural water scarcity and facilitating the sustainable use of water resources. In this study, the SWAT model was improved by transforming the evapotranspiration module. Then, the improved model was applied in Qingyuan Irrigation District of northwest China as a case study. Land use, soil, meteorology, irrigation scheduling and crop coefficient were considered as input data, and the irrigation district was divided into subdivisions based on the DEM and local canal systems. On the basis of model calibration and verification, the improved model showed better simulation efficiency than did the original model. Therefore, the improved model was used to simulate the crop evapotranspiration response under different planting scenarios in the irrigation district. Results indicated that crop evapotranspiration decreased by 2.94% and 6.01% under the scenarios of reducing the planting proportion of spring wheat (scenario 1) and summer maize (scenario 2) by keeping the total cultivated area unchanged. However, the total net output values presented an opposite trend under different scenarios. The values decreased by 3.28% under scenario 1, while it increased by 7.79% under scenario 2, compared with the current situation. This study presents a novel method to estimate crop evapotranspiration response under different planting scenarios using the SWAT model, and makes recommendations for strategic agricultural water management planning for the rational utilization of water resources and development of local economy by studying the impact of planting scenario changes on crop evapotranspiration and output values in the irrigation district of northwest China.	[Liu, Xin; Wang, Sufen; Xue, Han] China Agr Univ, Dept Water Resources & Civil Engn, Beijing 100094, Peoples R China; [Singh, Vijay P.] Texas A&M Univ, Dept Biol & Agr Engn, College Stn, TX USA	China Agricultural University; Texas A&M University System; Texas A&M University College Station	Wang, SF (corresponding author), China Agr Univ, Dept Water Resources & Civil Engn, Beijing 100094, Peoples R China.	wwwsf71@163.com	Ma, Wujun/F-5957-2010	Ma, Wujun/0000-0002-1264-866X	Chinese National Natural Science Fund [51109211, 51439006, 91425302]; National High Technology Research and Development Program of China (863 Program) [2011AA100502]	Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was financially supported by the Chinese National Natural Science Fund (51109211, 51439006, 91425302), the National High Technology Research and Development Program of China (863 Program, 2011AA100502).	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; ARNOLD JG, 1993, J HYDROL, V142, P47, DOI 10.1016/0022-1694(93)90004-S; Arnold JG, 2013, SWAT 2012 INPUT OUTP; Awan UK, 2014, J HYDROL, V519, P1368, DOI 10.1016/j.jhydrol.2014.08.049; Blum A, 2009, FIELD CROP RES, V112, P119, DOI 10.1016/j.fcr.2009.03.009; Ding RS, 2013, AGR WATER MANAGE, V127, P85, DOI 10.1016/j.agwat.2013.05.018; Hao L, 2011, ENVIRON ENG MANAG J, V10, P899, DOI 10.30638/eemj.2011.126; Huo ZL, 2008, HYDROL PROCESS, V22, P3155, DOI 10.1002/hyp.6900; Kang SZ, 2008, INT J SUST DEV WORLD, V15, P440, DOI 10.3843/SusDev.15.5:5; Kang SZ, 2004, HYDROLOG SCI J, V49, P413, DOI 10.1623/hysj.49.3.413.54347; Li HX, 2012, CHINESE GEOGR SCI, V22, P437, DOI 10.1007/s11769-012-0550-0; Li SE, 2013, J HYDROL, V503, P153, DOI 10.1016/j.jhydrol.2013.07.033; Liu CS, 2007, INT GEOSCI REMOTE SE, P3237, DOI 10.1109/IGARSS.2007.4423534; Liu ML, 2008, J AM WATER RESOUR AS, V44, P1193, DOI 10.1111/j.1752-1688.2008.00243.x; Nagore M, 2014, FIELD CROP RES, V155, P23, DOI 10.1016/j.fcr.2013.09.026; Mishra A, 2007, HYDROL PROCESS, V21, P3035, DOI 10.1002/hyp.6514; Neitsch S.L., 2001, SOIL WATER ASSESSMEN; Papadavid G, 2013, WATER RESOUR MANAG, V27, P3493, DOI 10.1007/s11269-013-0360-x; RIEKERK H, 1989, WATER RESOUR RES, V25, P713, DOI 10.1029/WR025i004p00713; Strauch M, 2013, J ENVIRON MANAGE, V127, pS24, DOI 10.1016/j.jenvman.2013.01.014; Ullrich A, AGR WATER MANAGEMENT, V96, P1207; Van Griensven A, 2006, J HYDROLOGY, V324; Verburg PH, 2002, ENVIRON MANAGE, V30, P391, DOI 10.1007/s00267-002-2630-x; Wang SF, 2008, HYDROL PROCESS, V22, P2502, DOI 10.1002/hyp.6846; Xie XH, 2011, J HYDROL, V396, P61, DOI 10.1016/j.jhydrol.2010.10.032; Zeng LH, 2011, J APPL REMOTE SENS, V5, DOI 10.1117/1.3609840; Zhang YQ, 2011, AGR WATER MANAGE, V98, P1207, DOI 10.1016/j.agwat.2011.03.006; Zhao WZ, 2010, AGR WATER MANAGE, V97, P215, DOI 10.1016/j.agwat.2009.09.011; Zheng J, 2010, MATH COMPUT MODEL, V51, P1312, DOI 10.1016/j.mcm.2009.10.036	30	9	9	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139839	10.1371/journal.pone.0139839	http://dx.doi.org/10.1371/journal.pone.0139839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439928	Green Published, gold			2022-12-27	WOS:000362510300066
J	Yang, T; Fang, L; Zhang, XY; Hu, JG; Bao, SY; Hao, JJ; Li, L; He, YH; Jiang, JY; Wang, F; Tian, SF; Zong, XX				Yang, Tao; Fang, Li; Zhang, Xiaoyan; Hu, Jinguo; Bao, Shiying; Hao, Junjie; Li, Ling; He, Yuhua; Jiang, Junye; Wang, Fang; Tian, Shufang; Zong, Xuxiao			High-Throughput Development of SSR Markers from Pea (Pisum sativum L.) Based on Next Generation Sequencing of a Purified Chinese Commercial Variety	PLOS ONE			English	Article							MICROSATELLITE DEVELOPMENT; VALIDATION; SOFTWARE; POLYMORPHISM; INFERENCE	Pea (Pisum sativum L.) is an important food legume globally, and is the plant species that J.G. Mendel used to lay the foundation of modern genetics. However, genomics resources of pea are limited comparing to other crop species. Application of marker assisted selection (MAS) in pea breeding has lagged behind many other crops. Development of a large number of novel and reliable SSR (simple sequence repeat) or microsatellite markers will help both basic and applied genomics research of this crop. The Illumina HiSeq 2500 System was used to uncover 8,899 putative SSR containing sequences, and 3,275 non-redundant primers were designed to amplify these SSRs. Among the 1,644 SSRs that were randomly selected for primer validation, 841 yielded reliable amplifications of detectable polymorphisms among 24 genotypes of cultivated pea (Pisum sativum L.) and wild relatives (P. ful-vum Sm.) originated from diverse geographical locations. The dataset indicated that the allele number per locus ranged from 2 to 10, and that the polymorphism information content (PIC) ranged from 0.08 to 0.82 with an average of 0.38. These 1,644 novel SSR markers were also tested for polymorphism between genotypes G0003973 and G0005527. Finally, 33 polymorphic SSR markers were anchored on the genetic linkage map of G0003973 x G0005527 F-2 population.	[Yang, Tao; Fang, Li; Jiang, Junye; Wang, Fang; Tian, Shufang; Zong, Xuxiao] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; [Zhang, Xiaoyan; Hao, Junjie] Qingdao Acad Agr Sci, Qingdao, Peoples R China; [Hu, Jinguo] Washington State Univ, USDA ARS, Western Reg Plant Intro Stn, Pullman, WA 99164 USA; [Bao, Shiying; He, Yuhua] Yunnan Acad Agr Sci, Inst Grain Crops, Kunming, Peoples R China; [Li, Ling] Liaoning Acad Agr Sci, Inst Cash Crops, Liaoyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; United States Department of Agriculture (USDA); Washington State University; Yunnan Academy of Agricultural Sciences	Zong, XX (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	zongxuxiao@caas.cn	Hu, Jinguo/W-9337-2019; Wu, Shu-Biao/R-5951-2019; Yang, Tao/GSE-1841-2022	Hu, Jinguo/0000-0002-1488-6557; Wu, Shu-Biao/0000-0002-1790-6015; Yang, Tao/0000-0002-9755-731X; Zong, Xuxiao/0000-0002-9951-660X	National Natural Science Foundation of China [31371695]; China Agriculture Research System [CARS-09]; Social Development of Science and Technology Plan from Yunnan Government [2013BB010]; Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; ARS [ARS-0424494] Funding Source: Federal RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Social Development of Science and Technology Plan from Yunnan Government; Agricultural Science and Technology Innovation Program (ASTIP) in CAAS; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the National Natural Science Foundation of China (No. 31371695), China Agriculture Research System (No. CARS-09), Social Development of Science and Technology Plan (No. 2013BB010) from Yunnan Government, and also granted by the Agricultural Science and Technology Innovation Program (ASTIP) in CAAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burstin J, 2001, PLANT BREEDING, V120, P311, DOI 10.1046/j.1439-0523.2001.00608.x; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dolezel J, 2010, CYTOM PART A, V77A, P635, DOI 10.1002/cyto.a.20915; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Du F, 2015, PLANT MOL BIOL REP, V33, P281, DOI 10.1007/s11105-014-0746-9; Duan CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095458; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; FAO, 2013, STATISTICAL DATABASE; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Loridon K, 2005, THEOR APPL GENET, V111, P1022, DOI 10.1007/s00122-005-0014-3; Malausa T, 2011, MOL ECOL RESOUR, V11, P638, DOI 10.1111/j.1755-0998.2011.02992.x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Mendel G., 1866, VERSUCHE BER PFLANZE, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Ni J, 2002, CROP SCI, V42, P601, DOI 10.2135/cropsci2002.0601; PHILLIPS DA, 1980, ANNU REV PLANT PHYS, V31, P29, DOI 10.1146/annurev.pp.31.060180.000333; Prasad M, 2003, THEOR APPL GENET, V106, P659, DOI 10.1007/s00122-002-1114-y; Pritchard JK, 2000, GENETICS, V155, P945; RCoreTeam, 2012, R LANG ENV STAT COMP; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Sun XL, 2014, CROP J, V2, P170, DOI 10.1016/j.cj.2014.03.004; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; Van Ooijen J.W., 2006, JOINMAP 4 0 SOFTWARE; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu SC, 2012, AM J BOT, V99, pE149, DOI 10.3732/ajb.1100445; Yang T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-65; Yang T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-602; Zhang QianQian, 2012, Australian Journal of Crop Science, V6, P1131; Zhu H, 2012, THEOR APPL GENET, V124, P87, DOI 10.1007/s00122-011-1689-2; Zong XX, 2009, THEOR APPL GENET, V118, P193, DOI 10.1007/s00122-008-0887-z	41	23	27	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139775	10.1371/journal.pone.0139775	http://dx.doi.org/10.1371/journal.pone.0139775			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440522	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300051
J	Beton, D; Marana, SR				Beton, Daniela; Marana, Sandro R.			Half-Barrels Derived from a (beta/alpha)(8) Barrel beta-Glycosidase Undergo an Activation Process	PLOS ONE			English	Article							(BETA-ALPHA)(8)-BARREL ENZYME; EVOLUTION; PROTEINS; FOLD; RESIDUES; FUSION	The evolution of (beta/alpha)(8) barrel proteins is currently thought to have involved the fusion of two (beta/alpha)(4) half-barrels, thereby conferring stability on the protein structure. After the formation of a whole (beta/alpha)(8) barrel, this structure could evolve and diverge to form fully active enzymes. Interestingly, we show here that isolated (beta/alpha)(4) half-barrels derived from the N- and C-terminal domains of the beta-glucosidase Sf beta gly (Sf beta gly-N: residues 1 to 265; Sf beta gly-C: residues 266 to 509) undergo an activation process, which renders them catalytically active. The rate constants of the activation process were calculated to be 0.029 and 0.032 h(-1) for Sf beta gly-N and Sf beta gly-C, respectively. Moreover, the Sf beta gly-N and Sf beta gly-C activation processes were simultaneous with modifications in their initial structure, which reduced the exposure of their tryptophan residues. Importantly, this activation was also coincident with an increase in the sizes of Sf beta gly-N and Sf beta gly-C particles. These novel observations suggest that the change in catalytic activity associated with the transition from a half to whole (beta/alpha)(8) barrel might also have driven such an evolutionary process.	[Beton, Daniela; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil.	srmarana@iq.usp.br	Marana, Sandro/D-3867-2012	Marana, Sandro/0000-0002-5117-1921	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [08/55914-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo" (08/55914-9) and "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanuma S, 2008, J MOL BIOL, V382, P458, DOI 10.1016/j.jmb.2008.07.040; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X; Gerlt JA, 2001, NAT STRUCT BIOL, V8, P5, DOI 10.1038/83048; Harlow E, 1998, LAB MANUAL; Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163; Hocker B, 2001, NAT STRUCT BIOL, V8, P32; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; KEMPTON JB, 1992, BIOCHEMISTRY-US, V31, P9961, DOI 10.1021/bi00156a015; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang D, 2000, SCIENCE, V289, P1546, DOI 10.1126/science.289.5484.1546; Marana SR, 2001, BBA-PROTEIN STRUCT M, V1545, P41, DOI 10.1016/S0167-4838(00)00260-0; Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6; Purich DL, 2010, ENZYME KINETICS: CATALYSIS & CONTROL, P1; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Soberon X, 2004, FEBS LETT, V560, P167, DOI 10.1016/S0014-5793(04)00098-5; Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z	17	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139673	10.1371/journal.pone.0139673	http://dx.doi.org/10.1371/journal.pone.0139673			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431042	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700096
J	Brenig, B; Duan, YY; Xing, YY; Ding, NS; Huang, LS; Schutz, E				Brenig, Bertram; Duan, Yanyu; Xing, Yuyun; Ding, Nengshui; Huang, Lusheng; Schuetz, Ekkehard			Porcine SOX9 Gene Expression Is Influenced by an 18bp Indel in the 5 '-Untranslated Region	PLOS ONE			English	Article							INTERNAL CONTROL PLASMID; PRL-TK; TRANSCRIPTION FACTORS; SEX REVERSAL; POSTNATAL-DEVELOPMENT; RESPONSE ELEMENT; MESSENGER-RNAS; CREB; PROMOTER; PROTEIN	Sex determining region Y-box 9 (SOX9) is an important regulator of sex and skeletal development and is expressed in a variety of embryonal and adult tissues. Loss or gain of function resulting from mutations within the coding region or chromosomal aberrations of the SOX9 locus lead to a plethora of detrimental phenotypes in humans and animals. One of these phenotypes is the so-called male-to-female or female-to-male sex-reversal which has been observed in several mammals including pig, dog, cat, goat, horse, and deer. In 38, XX sex-reversal French Large White pigs, a genome-wide association study suggested SOX9 as the causal gene, although no functional mutations were identified in affected animals. However, besides others an 18bp indel had been detected in the 5'-untranslated region of the SOX9 gene by comparing affected animals and controls. We have identified the same indel (Delta 18) between position +247bp and +266bp downstream the transcription start site of the porcine SOX9 gene in four other pig breeds; i.e., German Large White, Laiwu Black, Bamei, and Erhualian. These animals have been genotyped in an attempt to identify candidate genes for porcine inguinal and/or scrotal hernia. Because the 18bp segment in the wild type 5'-UTR harbours a highly conserved cAMP-response element (CRE) half-site, we analysed its role in SOX9 expression in vitro. Competition and immunodepletion electromobility shift assays demonstrate that the CRE half-site is specifically recognized by CREB. Both binding of CREB to the wild type as well as the absence of the CRE half-site in Delta 18 reduced expression efficiency in HEK293T, PK-15, and ATDC5 cells significantly. Transfection experiments of wild type and Delta 18 SOX9 promoter luciferase constructs show a significant reduction of RNA and protein levels depending on the presence or absence of the 18bp segment. Hence, the data presented here demonstrate that the 18bp indel in the porcine SOX9 5'-UTR is of functional importance and may therefore indeed be a causative variation in SOX9 associated traits.	[Brenig, Bertram; Schuetz, Ekkehard] Univ Gottingen, Inst Vet Med, D-37077 Gottingen, Germany; [Duan, Yanyu; Xing, Yuyun; Ding, Nengshui; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang 330045, Peoples R China; [Duan, Yanyu; Xing, Yuyun; Ding, Nengshui; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang 330045, Peoples R China	University of Gottingen; Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs	Brenig, B (corresponding author), Univ Gottingen, Inst Vet Med, Burckhardtweg 2, D-37077 Gottingen, Germany.	bbrenig@gwdg.de		Brenig, Bertram/0000-0002-7635-9656				Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Arora A, 2008, RNA, V14, P1290, DOI 10.1261/rna.1001708; Brennan CB, 2013, PEDIATR DERMATOL, V30, pE52, DOI 10.1111/j.1525-1470.2011.01668.x; Caron MMJ, 2013, OSTEOARTHR CARTILAGE, V21, P604, DOI 10.1016/j.joca.2013.01.009; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen XX, 2015, VET RES, V46, DOI 10.1186/s13567-015-0168-1; Ciotola F, 2012, SEX DEV, V6, P104, DOI 10.1159/000331480; Colter DC, 2005, MATRIX BIOL, V24, P185, DOI 10.1016/j.matbio.2005.04.001; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Daigle M, 2015, MOL CELL BIOCHEM, V407, P209, DOI 10.1007/s11010-015-2470-7; Dougherty DC, 2005, BIOTECHNIQUES, V39, P203, DOI 10.2144/05392ST02; DYER RB, 1995, NUCLEIC ACIDS RES, V23, P3345; Faucette AN, 2014, J ANIM SCI, V92, P4440, DOI 10.2527/jas.2014-7903; Frojdman K, 2000, HISTOCHEM CELL BIOL, V113, P31, DOI 10.1007/s004180050004; Gordon CT, 2009, J MED GENET, V46, P649, DOI 10.1136/jmg.2009.068361; Guo HC, 2012, J MEMBRANE BIOL, V245, P789, DOI 10.1007/s00232-012-9480-0; Harris ML, 2010, PIGM CELL MELANOMA R, V23, P496, DOI 10.1111/j.1755-148X.2010.00711.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Ho CK, 2004, BMC BIOTECHNOL, V30, P4, DOI DOI 10.1186/1472-6750-4-10; Ibrahim NM, 2000, BIOTECHNIQUES, V29, P782, DOI 10.2144/00294st04; Jakob S, 2011, FEBS J, V278, P1002, DOI 10.1111/j.1742-4658.2011.08029.x; Jo A, 2014, GENES DIS, V1, P149, DOI 10.1016/j.gendis.2014.09.004; Kanai Y, 1999, HUM MOL GENET, V8, P691, DOI 10.1093/hmg/8.4.691; Kent J, 1996, DEVELOPMENT, V122, P2813; Kim CH, 2005, MOL CELL BIOL, V25, P5329, DOI 10.1128/MCB.25.13.5329-5338.2005; Kimura R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108779; Knower KC, 2003, CYTOGENET GENOME RES, V101, P185, DOI 10.1159/000074336; Kothapalli K, 2005, J HERED, V96, P759, DOI 10.1093/jhered/esi129; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Kropatsch R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073734; Kubokawa I, 2010, MOL VIS, V16, P2590; Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717; Leung VYL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002356; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Long FX, 2001, DEVELOPMENT, V128, P541; Martinez-Sanchez A, 2012, J BIOL CHEM, V287, P916, DOI 10.1074/jbc.M111.302430; Matuszyk J, 2002, BIOCHEM BIOPH RES CO, V294, P1036, DOI 10.1016/S0006-291X(02)00601-0; Mead TJ, 2013, NUCLEIC ACIDS RES, V41, P4459, DOI 10.1093/nar/gkt140; Melnikova VO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012452; Mertin S, 1999, NUCLEIC ACIDS RES, V27, P1359, DOI 10.1093/nar/27.5.1359; Moniot B, 2004, DEVELOPMENT, V131, P3795, DOI 10.1242/dev.01259; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Osborne SA, 2002, BIOTECHNIQUES, V33, P1240, DOI 10.2144/02336bm12; Ostrer H, 2014, J CLIN ENDOCR METAB, V99, P1503, DOI 10.1210/jc.2013-3690; PAILHOUX E, 1994, ANIM GENET, V25, P299, DOI 10.1111/j.1365-2052.1994.tb00362.x; Pailhoux E, 2001, DEV DYNAM, V222, P328, DOI 10.1002/dvdy.1194; Passeron T, 2007, P NATL ACAD SCI USA, V104, P13984, DOI 10.1073/pnas.0705117104; Piera-Velazquez S, 2007, EXP CELL RES, V313, P1069, DOI 10.1016/j.yexcr.2007.01.001; Pritchett J, 2011, TRENDS MOL MED, V17, P166, DOI 10.1016/j.molmed.2010.12.001; Purba TS, 2015, EXP DERMATOL, V24, P462, DOI 10.1111/exd.12700; QUINN PG, 1993, J BIOL CHEM, V268, P16999; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Roman AC, 2008, P NATL ACAD SCI USA, V105, P1632, DOI 10.1073/pnas.0708366105; Rossi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101244; Rousseau S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079882; Smyk M, 2013, CHROMOSOME RES, V21, P781, DOI 10.1007/s10577-013-9386-4; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stuhlmiller TJ, 2012, CELL MOL LIFE SCI, V69, P3715, DOI 10.1007/s00018-012-0991-8; Sun M, 2009, AM J HUM GENET, V84, P807, DOI 10.1016/j.ajhg.2009.04.018; Sung D, 1998, PHOTOCHEM PHOTOBIOL, V68, P749, DOI 10.1111/j.1751-1097.1998.tb02540.x; Thavathiru E, 2001, BIOTECHNIQUES, V31, P528, DOI 10.2144/01313st06; Woo JC, 2008, PROTEIN SCI, V17, P725, DOI 10.1110/ps.073355508; Wuelling M, 2011, ENDOCR DEV, V21, P1, DOI 10.1159/000328081; Xing Y., 2010, DISSECTION OF GENETI; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Zalzali H, 2008, ONCOGENE, V27, P7131, DOI 10.1038/onc.2008.331; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]	69	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139583	10.1371/journal.pone.0139583	http://dx.doi.org/10.1371/journal.pone.0139583			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430891	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700081
J	Chen, JH; Zhang, DZ; Zhang, C; Xia, XL; Yin, WL; Tian, QQ				Chen, Jinhuan; Zhang, Dongzhi; Zhang, Chong; Xia, Xinli; Yin, Weilun; Tian, Qianqian			A Putative PP2C-Encoding Gene Negatively Regulates ABA Signaling in Populus euphratica	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2C; ABSCISIC-ACID RESPONSES; EXPRESSION ANALYSIS; ARABIDOPSIS; STRESS; DROUGHT; ABI1; IDENTIFICATION; PHENOTYPES; INSIGHTS	A PP2C homolog gene was cloned from the drought-treated cDNA library of Populus euphratica. Multiple sequence alignment analysis suggested that the gene is a potential ortholog of HAB1. The expression of this HAB1 ortholog (PeHAB1) was markedly induced by drought and moderately induced by ABA. To characterize its function in ABA signaling, we generated transgenic Arabidopsis thaliana plants overexpressing this gene. Transgenic lines exhibited reduced responses to exogenous ABA and reduced tolerance to drought compared to wide-type lines. Yeast two-hybrid analyses indicated that PeHAB1 could interact with the ABA receptor PYL4 in an ABA-independent manner. Taken together; these results indicated that PeHAB1 is a new negative regulator of ABA responses in poplar.	[Chen, Jinhuan; Zhang, Dongzhi; Zhang, Chong; Xia, Xinli; Yin, Weilun; Tian, Qianqian] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China; [Chen, Jinhuan; Zhang, Dongzhi; Zhang, Chong; Xia, Xinli] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Chen, JH (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	chenjh@bjfu.edu.cn		Yin, Weilun/0000-0002-6754-5772	National Natural Science Foundation of China [31370597, 31100492]; Beijing Higher Education Young Elite Teacher Project [YETP0754]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project	This work was supported by National Natural Science Foundation of China (31370597 and 31100492) and Beijing Higher Education Young Elite Teacher Project (YETP0754). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad M, 2014, TREES-STRUCT FUNCT, V28, P531, DOI 10.1007/s00468-013-0969-7; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen JH, 2013, BIOCHEM BIOPH RES CO, V441, P630, DOI 10.1016/j.bbrc.2013.10.103; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fuchs S, 2013, FEBS J, V280, P681, DOI 10.1111/j.1742-4658.2012.08670.x; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Lasi M, 2010, CELL RES, V20, P812, DOI 10.1038/cr.2010.66; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; Ludwikow A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00310; Ma T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3797; Ma Y, 2009, SCIENCE, V324, P1266; Miyakawa T, 2013, TRENDS PLANT SCI, V18, P259, DOI 10.1016/j.tplants.2012.11.002; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Reyes D, 2006, PLANT PHYSIOL, V141, P1414, DOI 10.1104/pp.106.084681; Romero P, 2012, J EXP BOT, V63, P4931, DOI 10.1093/jxb/ers168; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Santiago J, 2012, PLANT SCI, V182, P3, DOI 10.1016/j.plantsci.2010.11.014; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Seki Motoaki, 2002, Funct Integr Genomics, V2, P282, DOI 10.1007/s10142-002-0070-6; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Wang HL, 2014, PHYSIOL PLANTARUM, V152, P529, DOI 10.1111/ppl.12206; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yuan FF, 2013, BIOCHEM BIOPH RES CO, V442, P202, DOI 10.1016/j.bbrc.2013.11.035; Zhang Fangyuan, 2014, Biomed Res Int, V2014, P521794, DOI 10.1155/2014/521794; Zhang FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056697	37	29	33	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139466	10.1371/journal.pone.0139466	http://dx.doi.org/10.1371/journal.pone.0139466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431530	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700065
J	Krauss, M; Tappe, K; Schuppert, A; Kuepfer, L; Goerlitz, L				Krauss, Markus; Tappe, Kai; Schuppert, Andreas; Kuepfer, Lars; Goerlitz, Linus			Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations	PLOS ONE			English	Article							INDIVIDUAL VARIABILITY; TISSUE DISTRIBUTION; MODEL; THEOPHYLLINE; METABOLISM; TRICHLOROETHYLENE; UNCERTAINTY; BIOLOGY	Interindividual variability in anatomical and physiological properties results in significant differences in drug pharmacokinetics. The consideration of such pharmacokinetic variability supports optimal drug efficacy and safety for each single individual, e.g. by identification of individual-specific dosings. One clear objective in clinical drug development is therefore a thorough characterization of the physiological sources of interindividual variability. In this work, we present a Bayesian population physiologically-based pharmacokinetic (PBPK) approach for the mechanistically and physiologically realistic identification of interindividual variability. The consideration of a generic and highly detailed mechanistic PBPK model structure enables the integration of large amounts of prior physiological knowledge, which is then updated with new experimental data in a Bayesian framework. A covariate model integrates known relationships of physiological parameters to age, gender and body height. We further provide a framework for estimation of the a posteriori parameter dependency structure at the population level. The approach is demonstrated considering a cohort of healthy individuals and theophylline as an application example. The variability and co-variability of physiological parameters are specified within the population; respectively. Significant correlations are identified between population parameters and are applied for individual-and population-specific visual predictive checks of the pharmacokinetic behavior, which leads to improved results compared to present population approaches. In the future, the integration of a generic PBPK model into an hierarchical approach allows for extrapolations to other populations or drugs, while the Bayesian paradigm allows for an iterative application of the approach and thereby a continuous updating of physiological knowledge with new data. This will facilitate decision making e.g. from preclinical to clinical development or extrapolation of PK behavior from healthy to clinically significant populations.	[Krauss, Markus; Tappe, Kai; Schuppert, Andreas; Kuepfer, Lars; Goerlitz, Linus] Bayer Technol Serv GmbH, Computat Syst Biol, Leverkusen, Germany; [Krauss, Markus; Schuppert, Andreas] Rhein Westfal TH Aachen, Aachen Inst Adv Study Computat Engn Sci, D-52062 Aachen, Germany	Bayer AG; RWTH Aachen University	Goerlitz, L (corresponding author), Bayer Technol Serv GmbH, Computat Syst Biol, Leverkusen, Germany.	Linus.Goerlitz@Bayer.com	Kuepfer, Lars/F-5795-2012; Kuepfer, Lars/AAD-5884-2022	Kuepfer, Lars/0000-0002-8741-7786; Schuppert, Andreas/0000-0003-3783-6605; Leggas, Markos/0000-0003-4314-4533	German Federal Ministry of Education and Research [0315747]; Bayer Technology Services GmbH	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Bayer Technology Services GmbH	The authors acknowledge financial support by the German Federal Ministry of Education and Research for grant #0315747 (Virtual Liver). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors are employed by Bayer Technology Services GmbH. Bayer Technology Services GmbH provided support in the form of salaries for authors MK, KT, AS, LK and LG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	Andrieu C, 2003, MACH LEARN, V50, P5, DOI 10.1023/A:1020281327116; Beal SL., 1994, NONMEM USERS GUIDE 5; Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Bernillon P, 2000, ENVIRON HEALTH PERSP, V108, P883, DOI 10.2307/3454322; BLOUIN RA, 1980, CLIN PHARMACOL THER, V28, P619, DOI 10.1038/clpt.1980.212; Bois FY, 2010, TOXICOLOGY, V278, P256, DOI 10.1016/j.tox.2010.06.007; Bois FY, 2000, ENVIRON HEALTH PERSP, V108, P275, DOI 10.1289/ehp.00108s2275; Bolstad W. M., 2010, UNDERSTANDING COMPUT; Bouazza N, 2012, BRIT J CLIN PHARMACO, V74, P971, DOI 10.1111/j.1365-2125.2012.04292.x; Bowman AW, 1997, APPL SMOOTHING TECHN; Brooks S, 2011, CH CRC HANDB MOD STA, pXIX; Chiu WA, 2009, TOXICOL APPL PHARM, V241, P36, DOI 10.1016/j.taap.2009.07.032; Cowles MK, 1996, J AM STAT ASSOC, V91, P883, DOI 10.2307/2291683; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; Davidian M., 1995, NONLINEAR MODELS REP; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; Dorne JLCM, 2001, FOOD CHEM TOXICOL, V39, P681, DOI 10.1016/S0278-6915(01)00005-9; Eissing T, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00004; Gelman A, 1996, J AM STAT ASSOC, V91, P1400, DOI 10.2307/2291566; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Girolami M, 2011, J R STAT SOC B, V73, P123, DOI 10.1111/j.1467-9868.2010.00765.x; Haario H, 2005, COMPUTATION STAT, V20, P265, DOI 10.1007/BF02789703; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Huisinga W, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.3; Jamei M, 2009, DRUG METAB PHARMACOK, V24, P53, DOI 10.2133/dmpk.24.53; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Jin RY, 2012, AAPS J, V14, P571, DOI 10.1208/s12248-012-9368-z; Jonsson F, 2007, J BIOPHARM STAT, V17, P65, DOI 10.1080/10543400600851898; Krauss Markus, 2013, In Silico Pharmacology, V1, P6, DOI 10.1186/2193-9616-1-6; Leil TA, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.18; Lippert J, 2012, CPT-PHARMACOMET SYST, V1, DOI [10.1038/psp.2012.14, 10.1038/psp.2012.22]; Lu AYH, 1998, DRUG METAB DISPOS, V26, P1217; Meibohm B, 1997, INT J CLIN PHARM TH, V35, P401; Nestorov I, 2007, EXPERT OPIN DRUG MET, V3, P235, DOI 10.1517/17425255.3.2.235; Obase Y, 2003, CLIN PHARMACOL THER, V73, P468, DOI 10.1016/S0009-9236(03)00013-4; OGILVIE RI, 1978, CLIN PHARMACOKINET, V3, P267, DOI 10.2165/00003088-197803040-00002; Poulin P, 2001, J PHARM SCI-US, V90, P436, DOI 10.1002/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P; POWELL JR, 1978, AM REV RESPIR DIS, V118, P229; Price PS, 2003, CRIT REV TOXICOL, V33, P469, DOI 10.1080/10408440390242324; Rodgers T, 2005, J PHARM SCI-US, V94, P1259, DOI 10.1002/jps.20322; Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502; Rowland M, 2011, ANNU REV PHARMACOL, V51, P45, DOI 10.1146/annurev-pharmtox-010510-100540; Schmidl D, 2013, BAYESIAN ANAL, V8, P1, DOI 10.1214/13-BA801; Schmitt Walter, 2004, Drug Discov Today Technol, V1, P449, DOI 10.1016/j.ddtec.2004.09.006; Stamyr K, 2014, ARCH TOXICOL, P1; Tornoe CW, 2004, COMPUT METH PROG BIO, V76, P31, DOI 10.1016/j.cmpb.2004.01.001; Tsamandouras N, 2014, PHARM RES, P1; Willmann S, 2004, J MED CHEM, V47, P4022, DOI 10.1021/jm030999b; Willmann S, 2003, PHARM RES-DORDR, V20, P1766, DOI 10.1023/B:PHAM.0000003373.72652.c0; Willmann S, 2007, J PHARMACOKINET PHAR, V34, P401, DOI 10.1007/s10928-007-9053-5; Willmann Stefan, 2005, Expert Opin Drug Metab Toxicol, V1, P159, DOI 10.1517/17425255.1.1.159; Willmann Stefan, 2003, Biosilico, V1, P121, DOI 10.1016/S1478-5382(03)02342-4; Willmann S, 2009, J PHARM PHARMACOL, V61, P891, DOI 10.1211/jpp/61.07.0008; Yang F, 2006, J PHARMACOKINET PHAR, V33, P485, DOI 10.1007/s10928-006-9018-0; ZahorskaMarkiewicz B, 1996, INT J CLIN PHARM TH, V34, P393; Zeise L, 2013, ENVIRON HEALTH PERSP, V121, P23, DOI 10.1289/ehp.1205687; Zurlinden T, 2015, EUR J DRUG METAB PH, P1	58	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139423	10.1371/journal.pone.0139423	http://dx.doi.org/10.1371/journal.pone.0139423			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431198	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700055
J	Pogozhykh, D; Prokopyuk, V; Pogozhykh, O; Mueller, T; Prokopyuk, O				Pogozhykh, Denys; Prokopyuk, Volodymyr; Pogozhykh, Olena; Mueller, Thomas; Prokopyuk, Olga			Influence of Factors of Cryopreservation and Hypothermic Storage on Survival and Functional Parameters of Multipotent Stromal Cells of Placental Origin	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CHONDROCYTE VIABILITY; REFRIGERATED STORAGE; AMNIOTIC MEMBRANE; CARTILAGE MATRIX; TISSUE; PRESERVATION; SERUM; TRANSPLANTATION; EXPANSION	Human placenta is a highly perspective source of multipotent stromal cells (MSCs) both for the purposes of patient specific auto-banking and allogeneic application in regenerative medicine. Implementation of new GMP standards into clinical practice enforces the search for relevant methods of cryopreservation and short-term hypothermic storage of placental MSCs. In this paper we analyze the effect of different temperature regimes and individual components of cryoprotective media on viability, metabolic and culture properties of placental MSCs. We demonstrate (I) the possibility of short-term hypothermic storage of these cells; (II) determine DMSO and propanediol as the most appropriate cryoprotective agents; (III) show the possibility of application of volume expanders (plasma substituting solutions based on dextran or polyvinylpyrrolidone); (IV) reveal the priority of ionic composition over the serum content in cryopreservation media; (V) determine a cooling rate of 1 degrees C/min down to -40 degrees C followed by immersion into liquid nitrogen as the optimal cryopreservation regime for this type of cells. This study demonstrates perspectives for creation of new defined cryopreservation methods towards GMP standards.	[Pogozhykh, Denys; Prokopyuk, Volodymyr; Pogozhykh, Olena; Prokopyuk, Olga] Natl Acad Sci Ukraine, Inst Problems Cryobiol & Cryomed, Kharkov, Ukraine; [Pogozhykh, Denys; Pogozhykh, Olena; Mueller, Thomas] Hannover Med Sch, Inst Transfus Med, Hannover, Germany	National Academy of Sciences Ukraine; Institute for Problems of Cryobiology & Cryomedicine of NASU; Hannover Medical School	Pogozhykh, D (corresponding author), Natl Acad Sci Ukraine, Inst Problems Cryobiol & Cryomed, Kharkov, Ukraine.	pogozhykh.denys@mh-hannover.de	Pogozhykh, Olena/AAR-5174-2021; Volodymyr, Prokopiuk/AAZ-3170-2020	Volodymyr, Prokopiuk/0000-0003-4379-4130; Olga, Prokopyuk/0000-0002-3155-7755; Pogozhykh, Olena/0000-0003-1086-5190; Pogozhykh, Denys/0000-0001-7298-5425	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, Germany); Richtlinien zur Forderung der Wissenschaftlich-Technischen Zusammenarbeit (WTZ) mit der Ukraine;  [01DK13013]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, Germany); Richtlinien zur Forderung der Wissenschaftlich-Technischen Zusammenarbeit (WTZ) mit der Ukraine; 	Funding institution: Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research, Germany). Funding Program: Richtlinien zur Forderung der Wissenschaftlich-Technischen Zusammenarbeit (WTZ) mit der Ukraine. Funding Program URL: http://www.bmbf.de/foerderungen/20159.php. Project funding reference number: 01DK13013. Project title: Genetische Modifikation und Langzeitlagerung von plazentalen mesenchymalen Stammzellen fur klinische Anwendungen (Genetic Modification and long term Storage of Placental derived Mesenchymal Stem cells for clinical applications). Funded authors: DP VP O. Pogozhykh TM O. Prokopyuk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saqi SH, 2015, CELL TISSUE BANK, V16, P181, DOI 10.1007/s10561-014-9463-8; Barcena A, 2011, TRANSFUSION, V51, p94S, DOI 10.1111/j.1537-2995.2011.03372.x; Baust JM, 2009, BIOPRESERV BIOBANK, V7, P3, DOI 10.1089/bio.2009.0701.jmb; Brockbank KGM, 2011, TRANSFUS MED HEMOTH, V38, P387, DOI 10.1159/000334595; Cirelli N, 2000, HUM REPROD, V15, P756, DOI 10.1093/humrep/15.4.756; Corwin WL, 2014, CRYOBIOLOGY, V68, P215, DOI 10.1016/j.cryobiol.2014.01.014; Corwin WL, 2013, BIOPRESERV BIOBANK, V11, P33, DOI 10.1089/bio.2012.0045; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckstein M, 2015, VOX SANG, V108, P359, DOI 10.1111/vox.12235; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Heathman TRJ, 2015, BIOTECHNOL BIOENG, V112, P1696, DOI 10.1002/bit.25582; Holm F, 2010, HUM REPROD, V25, P1271, DOI 10.1093/humrep/deq040; Kesting MR, 2008, ANN PLAS SURG, V60, P684, DOI 10.1097/SAP.0b013e31814fb9d2; Kim YH, 2012, YONSEI MED J, V53, P1036, DOI 10.3349/ymj.2012.53.5.1036; Kocaoemer A, 2007, STEM CELLS, V25, P1270, DOI 10.1634/stemcells.2006-0627; Leeb C, 2010, STEM CELL REV REP, V6, P15, DOI 10.1007/s12015-009-9102-0; Liu Q, 2013, TRANSPL P, V45, P3209, DOI 10.1016/j.transproceed.2013.05.005; Luetzkendorf J, 2015, CYTOTHERAPY, V17, P186, DOI 10.1016/j.jcyt.2014.10.018; Lund PK, 2001, J IMMUNOL METHODS, V252, P45, DOI 10.1016/S0022-1759(01)00330-1; Mazur P, 2010, CRYOBIOLOGY, V60, P4, DOI 10.1016/j.cryobiol.2009.12.001; Minor T, 2013, CURR OPIN ORGAN TRAN, V18, P161, DOI 10.1097/MOT.0b013e32835e29de; Murphy MB, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.94; Orellana MD, 2015, CRYOBIOLOGY; Park S, 2013, CELL BIOL INT, V37, P242, DOI 10.1002/cbin.10032; Parsons RF, 2014, CURR OPIN ORGAN TRAN, V19, P100, DOI 10.1097/MOT.0000000000000063; Pereira-Cunha FG, 2015, VOX SANG, V108, P72, DOI 10.1111/vox.12199; Pipino C, 2013, BRIT MED BULL, V105, P43, DOI 10.1093/bmb/lds033; Pogozhykh O, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0146-6; Seo MS, 2013, J VET SCI, V14, P151, DOI 10.4142/jvs.2013.14.2.151; Shevchenko MV, 2012, PROBLEMS CRYOBIOLOGY, V22, P423; Stubbendorff M, 2013, STEM CELLS DEV, V22, P2619, DOI 10.1089/scd.2013.0043; Thirumala S, 2013, EXPERT OPIN BIOL TH, V13, P673, DOI 10.1517/14712598.2013.763925; Thirumala S, 2009, ORGANOGENESIS, V5, P143, DOI 10.4161/org.5.3.9811; van de Kerkhove MP, 2006, CELL TRANSPLANT, V15, P161, DOI 10.3727/000000006783982089; Vellasamy Shalini, 2012, World J Stem Cells, V4, P53; Wright GJ, 2014, CELLS TISSUES ORGANS, V199, P51, DOI 10.1159/000363134	38	20	24	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139834	10.1371/journal.pone.0139834	http://dx.doi.org/10.1371/journal.pone.0139834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431528	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700121
J	Qi, CJ; Wang, L; Zhang, MF; Shao, XH; Chang, XB; Fan, ZP; Cao, Q; Mou, S; Wang, Q; Yan, YC; Desir, G; Ni, ZH				Qi, Chaojun; Wang, Ling; Zhang, Minfang; Shao, Xinghua; Chang, Xinbei; Fan, Zhuping; Cao, Qin; Mou, Shan; Wang, Qin; Yan, Yucheng; Desir, Gary; Ni, Zhaohui			Serum Renalase Levels Correlate with Disease Activity in Lupus Nephritis	PLOS ONE			English	Article							BLOOD-PRESSURE; KIDNEY-FUNCTION; RISK; CLASSIFICATION; PREDICTORS; OXIDASE; BIOPSY	Introduction Lupus nephritis (LN) is among the most serious complications of systemic lupus erythematosus (SLE), which causes significant morbidity and mortality. Renalase is a novel, kidney-secreted cytokine-like protein that promotes cell survival. Here, we aimed to investigate the relationship of serum renalase levels with LN and its role in the disease progression of LN. Methods For this cross-sectional study, 67 LN patients and 35 healthy controls were enrolled. Seventeen active LN patients who received standard therapies were followed up for six months. Disease activity was determined by the SLE Disease Activity-2000 (SLEDAI-2K) scoring system and serum renalase amounts were determined by ELISA. Predictive value of renalase for disease activity was assessed. Furthermore, the expression of renalase in the kidneys of patients and macrophage infiltration was assessed by immunohistochemistry. Results Serum renalase amounts were significantly higher in LN patients than in healthy controls. Moreover, patients with proliferative LN had more elevated serum renalase levels than Class V LN patients. In proliferative LN patients, serum renalase levels were significantly higher in patients with active LN than those with inactive LN. Serum renalase levels were positively correlated with SLEDAI-2K, 24-h urine protein excretion, ds-DNA and ESR but inversely correlated with serum albumin and C3. Renalase amounts decreased significantly after six-months of standard therapy. The performance of renalase as a marker for diagnosis of active LN was 0.906 with a cutoff value of 66.67 mu g/ml. We also observed that the amount of renalase was significantly higher in glomerular of proliferative LN along with the co-expression of macrophages. Conclusion Serum renalase levels were correlated with disease activity in LN. Serum renalase might serve as a potential indicator for disease activity in LN. The marked increase of glomerular renalase and its association with macrophages suggest that it might play an important role in disease progression of LN.	[Qi, Chaojun; Wang, Ling; Zhang, Minfang; Shao, Xinghua; Mou, Shan; Wang, Qin; Yan, Yucheng; Ni, Zhaohui] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, Shanghai 200030, Peoples R China; [Fan, Zhuping; Cao, Qin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Hlth Care Ctr, Shanghai 200030, Peoples R China; [Desir, Gary] Yale Univ, Dept Med, Vet Affairs Connecticut Healthcare Syst, New Haven, CT 06520 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Wang, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Nephrol,Mol Cell Lab Kidney Dis, Shanghai 200030, Peoples R China.	shwangling@126.com; profnizh@126.com	shao, xinghua/GVU-8320-2022	mou, shan/0000-0003-4160-1681	National Basic Research Program of China 973 Program [2012CB517602]; National "Twelfth Five-Year" Plan for Science Technology [2011BAI10B04]; Science and Technology Commission of Shanghai Municipality [14ZR1424800]; National Institutes of Health [RC1DK086465, RC1DK086402, R01DK081037]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081037, RC1DK086465, RC1DK086402] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National "Twelfth Five-Year" Plan for Science Technology; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Basic Research Program of China 973 Program (2012CB517602, http://program.most.gov.cn) and the National "Twelfth Five-Year" Plan for Science & Technology (2011BAI10B04, http://program.most.gov.cn) to Dr Ni, as well as by grant (14ZR1424800, http://www.stcsm.gov.cn) from Science and Technology Commission of Shanghai Municipality to Dr Wang, and grants from the National Institutes of Health (RC1DK086465, RC1DK086402 and R01DK081037, http://www.nih.gov/) to Dr Gary Desir. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj S, 2000, J RHEUMATOL, V27, P2822; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bethunaickan R, 2011, J IMMUNOL, V186, P4994, DOI 10.4049/jimmunol.1003010; Croca SC, 2011, RHEUMATOLOGY, V50, P1424, DOI 10.1093/rheumatology/ker101; Desir GV, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002634; Desir GV, 2012, J AM SOC HYPERTENS, V6, P417, DOI 10.1016/j.jash.2012.09.002; Faurschou M, 2006, J RHEUMATOL, V33, P1563; FERRARIO F, 1985, KIDNEY INT, V28, P513, DOI 10.1038/ki.1985.158; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; Gonzalo E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3856; Hill GS, 2001, KIDNEY INT, V59, P304, DOI 10.1046/j.1523-1755.2001.00492.x; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Howson JMM, 2012, DIABETES, V61, P3012, DOI 10.2337/db11-1694; Kasitanon N, 2006, MEDICINE, V85, P147, DOI 10.1097/01.md.0000224709.70133.f7; Korbet SM, 2000, AM J KIDNEY DIS, V35, P904, DOI 10.1016/S0272-6386(00)70262-9; Lech M, 2013, J AM SOC NEPHROL, V24, P1357, DOI 10.1681/ASN.2013010026; Lee HT, 2013, J AM SOC NEPHROL, V24, P445, DOI 10.1681/ASN.2012090943; Mok CC, 1999, AM J KIDNEY DIS, V34, P315, DOI 10.1016/S0272-6386(99)70361-6; Moroni G, 2007, NEPHROL DIAL TRANSPL, V22, P2531, DOI 10.1093/ndt/gfm245; Przybylowski P, 2013, TRANSPL P, V45, P394, DOI 10.1016/j.transproceed.2012.02.042; Przybylowski P, 2011, TRANSPL P, V43, P3888, DOI 10.1016/j.transproceed.2011.08.075; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Sean Eardley K, 2005, KIDNEY INT, V68, P437, DOI 10.1111/j.1523-1755.2005.00422.x; Wada Y, 2004, NEPHRON CLIN PRACT, V98, pC105, DOI 10.1159/000081551; Wallace C, 2012, HUM MOL GENET, V21, P2815, DOI 10.1093/hmg/dds098; Wang L, 2014, J AM SOC NEPHROL, V25, P1226, DOI 10.1681/ASN.2013060665; Wang YF, 2012, LUPUS, V21, P1472, DOI 10.1177/0961203312458467; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zbroch E, 2012, KIDNEY BLOOD PRESS R, V35, P395, DOI 10.1159/000338178; Zbroch E, 2012, PERITON DIALYSIS INT, V32, P348, DOI 10.3747/pdi.2011.00118; Zhou M, 2015, J CARDIOVASC PHARM T	32	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139627	10.1371/journal.pone.0139627	http://dx.doi.org/10.1371/journal.pone.0139627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431044	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700089
J	Schurz, H; Daya, M; Moller, M; Hoal, EG; Salie, M				Schurz, Haiko; Daya, Michelle; Moeller, Marlo; Hoal, Eileen G.; Salie, Muneeb			TLR1, 2, 4, 6 and 9 Variants Associated with Tuberculosis Susceptibility: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; GENOME-WIDE ASSOCIATION; PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; MICROSATELLITE POLYMORPHISMS; PUBLICATION BIAS; RISK; ACTIVATION; POPULATION; ANCESTRY	Background Studies investigating the influence of toll-like receptor (TLR) polymorphisms and tuberculosis susceptibility have yielded varying and often contradictory results in different ethnic groups. A meta-analysis was conducted to investigate the relationship between TLR variants and susceptibility to tuberculosis, both across and within specific ethnic groups. Methods An extensive database search was performed for studies investigating the relationship between TLR and tuberculosis (TB) susceptibility. Data was subsequently extracted from included studies and statistically analysed. Results 32 articles involving 18907 individuals were included in this-meta-analysis, and data was extracted for 14 TLR polymorphisms. Various genetic models were employed. An increased risk of TB was found for individuals with the TLR2 rs3804100 CC and the TLR9 rs352139 GA and GG genotypes, while decreased risk was identified for those with the AG genotype of TLR1 rs4833095. The T allele of TLR6 rs5743810 conferred protection across all ethnic groups. TLR2 rs5743708 subgroup analysis identified the A allele to increase susceptibility to TB in the Asian ethnic group, while conferring protection in the Hispanic group. The T allele of TLR4 rs4986791 was also found to increase the risk of TB in the Asian subgroup. All other TLR gene variants investigated were not found to be associated with TB in this meta-analysis. Discussion Although general associations were identified, most TLR variants showed no significant association with TB, indicating that additional studies investigating a wider range of pattern recognition receptors is required to gain a better understanding of this complex disease.	[Salie, Muneeb] Univ Stellenbosch, SA MRC Ctr TB Res, ZA-7505 Tygerberg, South Africa; Univ Stellenbosch, DST NRF Ctr Excellence Biomed TB Res, Div Mol Biol & Human Genet, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa	Stellenbosch University; National Research Foundation - South Africa; Stellenbosch University	Salie, M (corresponding author), Univ Stellenbosch, SA MRC Ctr TB Res, ZA-7505 Tygerberg, South Africa.	msalie@sun.ac.za	Moller, Marlo/AAC-6973-2020; Schurz, Haiko/AAX-3928-2020	Moller, Marlo/0000-0002-0805-6741; Schurz, Haiko/0000-0002-0009-3409; Salie, Muneeb/0000-0002-7980-0048				Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arji N, 2014, J INFECT DEV COUNTR, V8, P430, DOI 10.3855/jidc.3820; Bukhari M, 2015, INT J IMMUNOGENET, V42, P46, DOI 10.1111/iji.12170; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chen YL, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-46, 10.1186/1471-2350-11-17]; Chen Z, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0049-4; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cordell HJ, 2005, LANCET, V366, P1121, DOI 10.1016/S0140-6736(05)67424-7; Dalgic N, 2011, DIS MARKERS, V31, P33, DOI [10.1155/2011/545972, 10.3233/DMA-2011-0800]; Dalgic N, 2011, HUM IMMUNOL, V72, P440, DOI 10.1016/j.humimm.2011.02.001; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; Daya M, 2014, TUBERCULOSIS, V94, P413, DOI 10.1016/j.tube.2014.03.012; Di Pietrantonio T, 2013, ADV EXP MED BIOL, V783, P33, DOI 10.1007/978-1-4614-6111-1_2; Dittrich N, 2015, TUBERCULOSIS, V95, P328, DOI 10.1016/j.tube.2015.02.045; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Hashemi-Shahri SM, 2014, GENE CELL TISSUE, V1; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2015, IMMUNOL REV, V264, P344, DOI 10.1111/imr.12255; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang LY, 2005, J IMMUNOL, V175, P3964, DOI 10.4049/jimmunol.175.6.3964; Jahantigh D, 2013, SCI WORLD J, DOI 10.1155/2013/534053; Ji LD, 2013, SCAND J INFECT DIS, V45, P310, DOI 10.3109/00365548.2012.726739; Kobayashi K, 2012, TISSUE ANTIGENS, V79, P190, DOI 10.1111/j.1399-0039.2011.01821.x; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Ma MJ, 2010, HUM IMMUNOL, V71, P1005, DOI 10.1016/j.humimm.2010.07.009; Ma X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001318; Naderi M, 2013, BRAZ J INFECT DIS, V17, P516, DOI 10.1016/j.bjid.2012.12.009; Najmi N, 2010, TISSUE ANTIGENS, V76, P102, DOI 10.1111/j.1399-0039.2010.01481.x; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Cavalcanti YVN, 2012, PULM MED, V2012, DOI 10.1155/2012/745483; Ocejo-Vinyals JG, 2013, INT J TUBERC LUNG D, V17, P652, DOI 10.5588/ijtld.12.0767; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Qi H, 2015, TUBERCULOSIS, V95, P197, DOI 10.1016/j.tube.2014.12.001; Randhawa AK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002174; Rosas-Taraco AG, 2007, J INFECT DIS, V196, P1698, DOI 10.1086/522147; Salie M, 2015, INFECT GENET EVOL, V34, P221, DOI 10.1016/j.meegid.2015.07.004; Sanchez D, 2012, INT J IMMUNOGENET, V39, P216, DOI 10.1111/j.1744-313X.2011.01077.x; Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shey MS, 2010, GENES IMMUN, V11, P561, DOI 10.1038/gene.2010.14; Sinha E, 2014, HUM IMMUNOL, V75, P880, DOI 10.1016/j.humimm.2014.06.014; Sultani Masooma, 2012, Chemother Res Pract, V2012, P490804, DOI 10.1155/2012/490804; Sun Q, 2015, J HUAZHONG U SCI-MED, V35, P157, DOI 10.1007/s11596-015-1405-6; Tao K, 2007, ANN RHEUM DIS, V66, P905, DOI 10.1136/ard.2006.065961; Thada S, 2013, SCAND J IMMUNOL, V78, P221, DOI 10.1111/sji.12066; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Tian T, 2013, INFECT GENET EVOL, V14, P156, DOI 10.1016/j.meegid.2012.11.009; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; Torres-Garcia D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-220; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Wang JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075090; WHO, GLOB TUB REP 2014; Wu LL, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0166-1; Xue Y, 2010, INT J IMMUNOGENET, V37, P135, DOI 10.1111/j.1744-313X.2009.00892.x; Xue Y, 2010, CLIN CHEM LAB MED, V48, P785, DOI 10.1515/CCLM.2010.154; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-511; Yim JJ, 2006, GENES IMMUN, V7, P150, DOI 10.1038/sj.gene.6364274; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134; Zhao LL, 2015, MED SCI MONITOR, V21, P1097, DOI 10.12659/MSM.893755	69	65	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139711	10.1371/journal.pone.0139711	http://dx.doi.org/10.1371/journal.pone.0139711			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430737	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700101
J	Solyanik, O; Hollmann, P; Dettmer, S; Kaireit, T; Schaefer-Prokop, C; Wacker, F; Vogel-Claussen, J; Shin, HO				Solyanik, Olga; Hollmann, Patrick; Dettmer, Sabine; Kaireit, Till; Schaefer-Prokop, Cornelia; Wacker, Frank; Vogel-Claussen, Jens; Shin, Hoen-oh			Quantification of Pathologic Air Trapping in Lung Transplant Patients Using CT Density Mapping: Comparison with Other CT Air Trapping Measures	PLOS ONE			English	Article							PULMONARY-FUNCTION TESTS; BRONCHIOLITIS OBLITERANS SYNDROME; COMPUTED-TOMOGRAPHY; QUANTITATIVE CT; DISEASE; COPD; DIAGNOSIS; AIRWAYS	To determine whether density mapping (DM) is more accurate for detection and quantification of pathologic air trapping (pAT) in patients after lung transplantation compared to other CT air trapping measures. One-hundred forty-seven lung and heart-lung transplant recipients underwent CT-examinations at functional residual capacity (FRC) and total lung capacity (TLC) and PFT six months after lung transplantation. Quantification of air trapping was performed with the threshold-based method in expiration (EXP), density mapping (DM) and the expiratory to inspiratory ratio of the mean lung density (E/I-ratio MLD). A non-rigid registration of inspiration-expiration CT-data with a following voxel-to-voxel mapping was carried out for DM. Systematic variation of attenuation ranges was performed for EXP and DM and correlated with the ratio of residual volume to total lung capacity (RV/ TLC) by Spearman rank correlation test. AT was considered pathologic if RV/TLC was above the 95th percentile of the predicted upper limit of normal values. Receiver operating characteristic (ROC) analysis was performed. The optimal attenuation range for the EXP method was from -790 HU to -950 HU (EXP-790 to -950HU) (r = 0.524, p<0.001) to detect air trapping. Within the segmented lung parenchyma, AT was best defined as voxel difference less than 80 HU between expiration and registered inspiration using the DM method. DM correlated best with RV/TLC (r = 0.663, p<0.001). DM and E/I-ratio MLD showed a larger AUC (0.78; 95% CI 0.69-0.86; 0.76, 95% CI 0.67-0.85) than EXP (-790 HU to -950 HU) (0.71, 95% CI 0.63-0.78). DM and E/I-ratio MLD showed better correlation with RV/TLC and are more suited quantitative CT-methods to detect pAT in lung transplant patients than the EXP-790HU to -950HU.	[Solyanik, Olga; Dettmer, Sabine; Kaireit, Till; Wacker, Frank; Vogel-Claussen, Jens; Shin, Hoen-oh] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Hollmann, Patrick] Kantonsspital, Inst Diagnost & Intervent Radiol, Aarau, Switzerland; [Schaefer-Prokop, Cornelia] Meander Med Ctr, Radiol, Amersfoort, Netherlands; [Schaefer-Prokop, Cornelia] Radboud Univ Nijmegen Med Ctr, Radiol DIAG, Nijmegen, Netherlands; [Solyanik, Olga; Dettmer, Sabine; Kaireit, Till; Wacker, Frank; Vogel-Claussen, Jens; Shin, Hoen-oh] Res Endstage & Obstruct Lung Dis Hannover BREATH, Hannover, Germany	Hannover Medical School; Kantonsspital Aarau AG (KSA); Meander Medisch Centrum; Radboud University Nijmegen	Solyanik, O (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.	solyanik.olga@mh-hannover.de	Vogel-Claussen, Jens/Q-3374-2019	Vogel-Claussen, Jens/0000-0001-5595-6948	German Federal Ministry of Education and Research [01EO0802]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding was provided by German Federal Ministry of Education and Research (reference number: 01EO0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 1998, AM J ROENTGENOL, V170, P1349, DOI 10.2214/ajr.170.5.9574614; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bankier AA, 2001, RADIOLOGY, V218, P533, DOI 10.1148/radiology.218.2.r01fe09533; Boehler A, 2000, Curr Opin Pulm Med, V6, P133, DOI 10.1097/00063198-200003000-00009; Bommart S, 2015, EUR RESPIR J, V45, P1167, DOI 10.1183/09031936.00215314; Bommart S, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-29; Bourdin A, 2010, COPD, V7, P102, DOI 10.3109/15412551003631709; Busacker A, 2009, CHEST, V135, P48, DOI 10.1378/chest.08-0049; Dettmer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093783; Eda S, 1997, AM J RESP CRIT CARE, V155, P1290, DOI 10.1164/ajrccm.155.4.9105069; Friedlander Adam L, 2007, COPD, V4, P355, DOI 10.1080/15412550701629663; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gevenois PA, 1996, RADIOLOGY, V199, P825, DOI 10.1148/radiology.199.3.8638012; Global Initiative for Chronic Obstructive Lung Disease, GLOBAL STRATEGY DIAG; Goris ML, 2003, CHEST, V123, P1655, DOI 10.1378/chest.123.5.1655; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Kauczor HU, 2011, J THORAC IMAG, V26, P290, DOI 10.1097/RTI.0b013e3182277113; Kim SS, 2014, EUR J RADIOL, V83, P57, DOI 10.1016/j.ejrad.2012.02.021; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Kubo K, 1998, AM J RESP CRIT CARE, V158, P979, DOI 10.1164/ajrccm.158.3.9802042; Leung AN, 1998, CHEST, V113, P365, DOI 10.1378/chest.113.2.365; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Mets OM, 2012, LUNG, V190, P629, DOI 10.1007/s00408-012-9422-8; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murphy K., 2010, MED IMAGE ANAL CLIN, V2010, P11; Murphy K, 2012, MED PHYS, V39, P1650, DOI 10.1118/1.3687891; O'Donnell RA, 2004, THORAX, V59, P837, DOI 10.1136/thx.2003.019349; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reilly JJ, 2008, NEW ENGL J MED, V359, P1616, DOI 10.1056/NEJMe0807387; Siegel MJ, 2001, RADIOLOGY, V220, P455, DOI 10.1148/radiology.220.2.r01au19455; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; van Ginneken B, 2009, RAD SOC N AM 95 ANN	33	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139102	10.1371/journal.pone.0139102	http://dx.doi.org/10.1371/journal.pone.0139102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430890	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700032
J	Yayan, J; Ghebremedhin, B; Rasche, K				Yayan, Josef; Ghebremedhin, Beniam; Rasche, Kurt			Antibiotic Resistance of Pseudomonas aeruginosa in Pneumonia at a Single University Hospital Center in Germany over a 10-Year Period	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; INTENSIVE-CARE-UNIT; PIPERACILLIN-TAZOBACTAM; IMPACT; SUSCEPTIBILITY; INFECTIONS; MECHANISMS; DIAGNOSIS; OUTCOMES; THERAPY	Background Pseudomonas aeruginosa is a common cause of community-acquired and nosocomialacquired pneumonia. The development of resistance of P. aeruginosa to antibiotics is increasing globally due to the overuse of antibiotics. This article examines, retrospectively, the antibiotic resistance in patients with community-acquired versus nosocomial-acquired pneumonia caused by P. aeruginosa or multidrug-resistant (MDR) P. aeruginosa. Methods Data from patients with community-acquired and nosocomial-acquired pneumonia caused by P. aeruginosa and MDR P. aeruginosa were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, between January 2004 and August 2014. An antibiogram was created from all study patients with community-acquired and nosocomial-acquired pneumonia caused by P. aeruginosa or MDR P. aeruginosa. Results A total of 168 patients with mean age 68.1 +/- 12.8 (113 [67.3% males and 55 [32.7%] females) were identified; 91 (54.2%) had community-acquired and 77 (45.8%) had nosocomial-acquired pneumonia caused by P. aeruginosa. Patients with community-acquired versus nosocomial-acquired pneumonia had a mean age of 66.4 +/- 13.8 vs. 70.1 +/- 11.4 years [59 vs. 54 (64.8% vs. 70.1%) males and 32 vs. 23 (35.2% vs. 29.9%) females]. They included 41 (24.4%) patients with pneumonia due to MDR P. aeruginosa: 27 (65.9%) community-acquired and 14 (34.1%) nosocomial-acquired cases. P. aeruginosa and MDR P. aeruginosa showed a very high resistance to fosfomycin (community-acquired vs. nosocomial-acquired) (81.0% vs. 84.2%; 0 vs. 85.7%). A similar resistance pattern was seen with ciprofloxacin (35.2% vs. 24.0%; 70.4% vs. 61.5%), levofloxacin (34.6% vs. 24.5%; 66.7% vs. 64.3%), ceftazidime (15.9% vs. 30.9; 33.3% vs. 61.5%), piperacillin (24.2% vs. 29.9%; 44.4% vs. 57.1%), imipenem (28.6% vs. 27.3%; 55.6% vs. 50.0%), piperacillin and tazobactam (23.1% vs. 28.6%; 44.4% vs. 50.0%), tobramycin (28.0% vs. 17.2%; 52.0% vs. 27.3%), gentamicin (26.4% vs. 18.2%; 44.4% vs. 21.4%), and meropenem (20.2% vs. 20.3%; 42.3% vs. 50.0%). An elevated resistance of P. aeruginosa and MDR P. aeruginosa was found for cefepime (11.1% vs. 23.3%; 25.9% vs. 50.0%), and amikacin (10.2% vs. 9.1%; 27.3% vs. 9.1%). Neither pathogen was resistant to colistin (P = 0.574). Conclusion While P. aeruginosa and MDR P. aeruginosa were resistant to a variety of commonly used antibiotics, they were not resistant to colistin in the few isolates recovered from patients with pneumonia.	[Yayan, Josef; Ghebremedhin, Beniam; Rasche, Kurt] Univ Witten Herdecke, Witten, Germany; [Yayan, Josef; Rasche, Kurt] HELIOS Clin, Div Pulm Allergy & Sleep Med, Dept Internal Med, Wuppertal, Germany; [Ghebremedhin, Beniam] HELIOS Clin, Ctr Clin & Translat Res, Inst Med Lab Diagnost, Wuppertal, Germany	Witten Herdecke University	Yayan, J (corresponding author), Univ Witten Herdecke, Witten, Germany.	josef.yayan@hotmail.com	Ghebremedhin, Beniam/AAX-3103-2021					Akter S, 2014, MALAY J PATHOL, V36, P97; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Barlett JG, 1987, CLIN CHEST MED, V8, P119; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Bruns AHW, 2008, EUR RESPIR J, V32, P726, DOI 10.1183/09031936.00003608; Bubonja-Sonje M, 2015, MICROB DRUG RESIST; Bulitta JB, 2015, ANTIMICROB AGENTS CH, V59, P2315, DOI 10.1128/AAC.04099-14; Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P6844, DOI 10.1128/AAC.03681-14; Chaudhary M, 2008, CURR CLIN PHARMACOL, V3, P118, DOI 10.2174/157488408784293660; Clinical and Laboratory Standards Institute, CLSI M100 S22; de Bentzmann Sophie, 2011, Environ Microbiol, V13, P1655, DOI 10.1111/j.1462-2920.2011.02469.x; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; Falagas ME, 2006, J MED MICROBIOL, V55, P1619, DOI 10.1099/jmm.0.46747-0; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Kollef MH, 2014, CRIT CARE MED, V42, P2178, DOI 10.1097/CCM.0000000000000510; Kotwal A, 2014, INDIAN J MED RES, V140, P560; Lodise TP, 2007, CLIN INFECT DIS, V44, P357, DOI 10.1086/510590; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mena KD, 2009, REV ENVIRON CONTAM T, V201, P71, DOI 10.1007/978-1-4419-0032-6_3; Nathwani D, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-32; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Noreddin AM, 2010, EXPERT REV ANTI-INFE, V8, P505, DOI [10.1586/eri.10.35, 10.1586/ERI.10.35]; Pappas G, 2009, DRUG AGING, V26, P363, DOI 10.2165/00002512-200926050-00001; Petrosillo N, 2008, CLIN MICROBIOL INFEC, V14, P816, DOI 10.1111/j.1469-0691.2008.02061.x; Riou M, 2010, INT J ANTIMICROB AG, V36, P513, DOI 10.1016/j.ijantimicag.2010.08.005; Sader HS, 2005, DIAGN MICR INFEC DIS, V52, P265, DOI 10.1016/j.diagmicrobio.2005.02.003; Sheikh AF, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.12289; Shorr AF, 2009, CRIT CARE MED, V37, P1463, DOI 10.1097/CCM.0b013e31819ced02; Somayaji R, 2015, THER DELIV, V6, P121, DOI [10.4155/TDE.14.94, 10.4155/tde.14.94]; Tam VH, 2008, CLIN INFECT DIS, V46, P862, DOI 10.1086/528712; Tam VH, 2006, ANTIMICROB AGENTS CH, V50, P2626, DOI 10.1128/AAC.01165-05; Tan T. Y., 2006, SMJ Singapore Medical Journal, V47, P621; Tran CS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004479; Walkty A, 2009, ANTIMICROB AGENTS CH, V53, P4924, DOI 10.1128/AAC.00786-09; Watkins RR, 2011, AM FAM PHYSICIAN, V83, P1299; World Health Organization, INT CLASS DIS ICD; Zarb P, 2012, EUROSURVEILLANCE, V17, P4	40	100	105	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139836	10.1371/journal.pone.0139836	http://dx.doi.org/10.1371/journal.pone.0139836			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430738	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700122
J	Fontes, RBD; Baptista, JS; Rabbani, R; Traynelis, VC; Liberti, EA				de Vasconcellos Fontes, Ricardo Braganca; Baptista, Josemberg Silva; Rabbani, Rahnamaye; Traynelis, Vincent C.; Liberti, Edson Aparecido			Structural and Ultrastructural Analysis of the Cervical Discs of Young and Elderly Humans	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; COLLAGEN; DEGENERATION; MORPHOLOGY; FIBROSUS; TYPE-1; SPINE	Several studies describing the ultrastructure and extracellular matrix (ECM) of intervertebral discs (IVDs) involve animal models and specimens obtained from symptomatic individuals during surgery for degenerative disease or scoliosis, which may not necessarily correlate to changes secondary to normal aging in humans. These changes may also be segment-specific based on different load patterns throughout life. Our objective was to describe the ECM and collagen profile of cervical IVDs in young (G1 - <35 years) and elderly (G2 - >65 years) presumably-asymptomatic individuals. Thirty cervical discs per group were obtained during autopsies of presumably-asymptomatic individuals. IVDs were analyzed with MRI, a morphological grading scale, light microscopy, scanning electron microscopy (SEM) and immunohistochemistry (IHC) for collagen types I, II, III, IV, V, VI, IX and X. Macroscopic degenerative features such as loss of annulus-nucleus distinction and fissures were found in both groups and significantly more severe in G2 as expected. MRI could not detect all morphological changes when compared even with simple morphological inspection. The loose fibrocartilaginous G1 matrix was replaced by a denser ECM in G2 with predominantly cartilaginous characteristics, chondrocyte clusters and absent elastic fibers. SEM demonstrated persistence of an identifiable nucleus and Sharpey-type insertion of cervical annulus fibers even in highly-degenerated G2 specimens. All collagen types were detected in every disc sector except for collagen X, with the largest area stained by collagens II and IV. Collagen detection was significantly decreased in G2: although significant intradiscal differences were rare, changes may occur faster or earlier in the posterior annulus. These results demonstrate an extensive modification of the ECM with maintenance of basic ultrastructural features despite severe macroscopic degeneration. Collagen analysis supports there is not a "pathologic" collagen type and changes are generally similar throughout the disc. Understanding the collagen and ultrastructural substrate of degenerative changes in the human disc is an essential step in planning restorative therapies.	[de Vasconcellos Fontes, Ricardo Braganca; Liberti, Edson Aparecido] Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, BR-05508 Sao Paulo, SP, Brazil; [de Vasconcellos Fontes, Ricardo Braganca; Traynelis, Vincent C.] Rush Univ, Med Ctr, Dept Neurosurg, Chicago, IL 60612 USA; [Baptista, Josemberg Silva] Univ Fed Espirito Santo, Dept Morphol, Vitoria, ES, Brazil; [Rabbani, Rahnamaye] Univ Sao Paulo, Inst Fis, Dept Gen Phys, BR-01498 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Rush University; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Fontes, RBD (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Anat, BR-05508 Sao Paulo, SP, Brazil.	ricardo_fontes@rush.edu	da Silva Baptista, Josemberg/D-7597-2013	da Silva Baptista, Josemberg/0000-0003-0514-8170	Cervical Spine Research Society; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Cervical Spine Research Society; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	RBVF was the recipient of a resident/fellow research grant from the Cervical Spine Research Society (no grant number). RBVF also received partial financial support through a DS grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (no grant number). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS P, 1976, ANN RHEUM DIS, V35, P289, DOI 10.1136/ard.35.4.289; Alini M, 2008, EUR SPINE J, V17, P2, DOI 10.1007/s00586-007-0414-y; An HS, 2006, J BONE JOINT SURG AM, V88A, P88, DOI 10.2106/JBJS.E.01272; Bach FC, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-3; BEARD HK, 1981, J BONE JOINT SURG BR, V63, P529, DOI 10.1302/0301-620X.63B4.6170646; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P1178, DOI 10.2106/00004623-199072080-00008; Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108; BRICKLEYPARSONS D, 1984, SPINE, V9, P148, DOI 10.1097/00007632-198403000-00005; Christe A, 2005, NEURORADIOLOGY, V47, P721, DOI 10.1007/s00234-005-1412-6; COVENTRY MB, 1945, J BONE JOINT SURG, V27, P233; EYRE DR, 1977, BIOCHIM BIOPHYS ACTA, V492, P29, DOI 10.1016/0005-2795(77)90211-2; EYRE DR, 1974, FEBS LETT, V42, P192, DOI 10.1016/0014-5793(74)80783-0; EYRE DR, 1976, BIOCHEM J, V157, P267, DOI 10.1042/bj1570267; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Fontes RBV, 2006, NEUROSURGERY, V58, P978, DOI 10.1227/01.NEU.0000210224.54816.40; Gantenbein-Ritter Benjamin, 2012, Eur Spine J, V21 Suppl 6, pS819, DOI 10.1007/s00586-011-2026-9; Gruber HE, 2002, SPINE, V27, P798, DOI 10.1097/00007632-200204150-00004; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Luschka H, 1858, HALBEGELENKE MENSCHL; Mercer S, 1999, SPINE, V24, P619, DOI 10.1097/00007632-199904010-00002; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; Nosikova YS, 2012, J ANAT, V221, P577, DOI 10.1111/j.1469-7580.2012.01537.x; Okada E, 2011, EUR SPINE J, V20, P585, DOI 10.1007/s00586-010-1644-y; Okada E, 2009, SPINE, V34, P706, DOI 10.1097/BRS.0b013e31819c2003; Paietta RC, 2013, J STRUCT BIOL, V184, P310, DOI 10.1016/j.jsb.2013.08.011; Park J, 2014, WORLD NEUROSURG; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Roberts S, 1995, SPINE, V20, P2645, DOI 10.1097/00007632-199512150-00005; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Schmorl G, 1927, VERHANDLUNGEN DTSCH, V22, P250; Sitte I, 2012, EUR SPINE J, V21, P1396, DOI 10.1007/s00586-012-2212-4; TAYLOR JR, 1992, J ANAT, V180, P137; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; Ubermuth H, 1930, ARCH KLIN CHIR, V156, P567; Yu J, 2007, J ANAT, V210, P460, DOI 10.1111/j.1469-7580.2007.00707.x; Zar JH, 1999, BIOSTATISTICAL ANAL; Zheng YG, 2004, SPINE, V29, P2140, DOI 10.1097/01.brs.0000141172.99530.e0	38	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139283	10.1371/journal.pone.0139283	http://dx.doi.org/10.1371/journal.pone.0139283			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427056	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100043
J	Jensen, SS; Fomsgaard, A; Larsen, TK; Tingstedt, JL; Gerstoft, J; Kronborg, G; Pedersen, C; Karlsson, I				Jensen, Sanne Skov; Fomsgaard, Anders; Larsen, Tine Kochendorf; Tingstedt, Jeanette Linnea; Gerstoft, Jan; Kronborg, Gitte; Pedersen, Court; Karlsson, Ingrid			Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8(+) T Cells	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; VIRUS; RESPONSES; SUPPRESSION; KINETICS; IMMUNODOMINANCE; REPLICATION; PERSISTENCE; EXPRESSION; VIREMIA	CD8(+) T cell-restricted immunity is important in the control of HIV-1 infection, but continued immune activation results in CD8+ T cell dysfunction. Early initiation of antiretroviral treatment (ART) and the duration of ART have been associated with immune reconstitution. Here, we evaluated whether restoration of CD8+ T cell function in HIV-1-infected individuals was dependent on early initiation of ART. HIV-specific CD107 alpha, IFN gamma, IL-2, TNF alpha and MIP-1 beta expression by CD8(+) T cells and the frequency of CD8+ T cells expressing PD-1, 2B4 and CD160 were measured by flow cytometry. The frequency of CD8(+) T cells expressing the inhibitory markers PD-1, 2B4 and CD160 was lower in ART-treated individuals compared with ART-naive individuals and similar to the frequency in HIV-uninfected controls. The expression of the three markers was similarly independent of when therapy was initiated. Individuals treated before seroconversion displayed an HIV-specific CD8(+) T cell response that included all five functional markers; this was not observed in individuals treated after seroconversion or in ART-naive individuals. In summary, ART appears to restore the total CD8(+) T cell population to a less exhausted phenotype, independent of the time point of initiation. However, to preserve multifunctional, HIV-1-specific CD8(+) T cells, ART might have to be initiated before seroconversion.	[Jensen, Sanne Skov; Fomsgaard, Anders; Larsen, Tine Kochendorf; Tingstedt, Jeanette Linnea; Karlsson, Ingrid] Statens Serum Inst, Dept Microbial Diagnost & Virol, Virus Res & Dev Lab, DK-2300 Copenhagen, Denmark; [Jensen, Sanne Skov; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Jensen, Sanne Skov; Fomsgaard, Anders] Univ Southern Denmark, Inst Clin, Infect Dis Res Unit, Odense, Denmark; [Gerstoft, Jan] Copenhagen Univ Hosp, Dept Infect Dis, Viroimmunol Res Unit, Copenhagen, Denmark; [Kronborg, Gitte] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark	Statens Serum Institut; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Copenhagen; University of Copenhagen	Karlsson, I (corresponding author), Statens Serum Inst, Dept Microbial Diagnost & Virol, Virus Res & Dev Lab, DK-2300 Copenhagen, Denmark.	iks@ssi.dk			Danish AIDS foundation; Region of Southern Denmark	Danish AIDS foundation; Region of Southern Denmark	This work was supported by the Danish AIDS foundation and scholarship support from the Region of Southern Denmark (SSJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinsiku OT, 2011, JAIDS-J ACQ IMM DEF, V58, P132, DOI 10.1097/QAI.0b013e318224d2e9; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Alter G, 2003, J IMMUNOL, V171, P477, DOI 10.4049/jimmunol.171.1.477; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Benlhassan-Chahour K, 2003, J VIROL, V77, P12479, DOI 10.1128/JVI.77.23.12479-12493.2003; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brandt L, 2013, JAIDS-J ACQ IMM DEF, V63, P418, DOI 10.1097/QAI.0b013e31828fa22b; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Casazza JP, 2001, J VIROL, V75, P6508, DOI 10.1128/JVI.75.14.6508-6516.2001; Cellerai C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018164; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fomsgaard A, 2008, AIDS RES HUM RETROV, V24, P463, DOI 10.1089/aid.2006.0294; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Jensen SS, 2015, JAIDS-J ACQ IMM DEF, V68, P103, DOI 10.1097/QAI.0000000000000429; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Lopez M, 2008, EUR J IMMUNOL, V38, P1548, DOI 10.1002/eji.200738054; Malleret B, 2008, BLOOD, V112, P4598, DOI 10.1182/blood-2008-06-162651; Ou R, 2001, J VIROL, V75, P8407, DOI 10.1128/JVI.75.18.8407-8423.2001; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Saez-Cirion A, 2010, NAT PROTOC, V5, P1033, DOI 10.1038/nprot.2010.73; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Turnbull EL, 2009, J IMMUNOL, V182, P7131, DOI 10.4049/jimmunol.0803658; Vigano S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004380; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yamamoto T, 2011, BLOOD, V117, P4805, DOI 10.1182/blood-2010-11-317297; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139573	10.1371/journal.pone.0139573	http://dx.doi.org/10.1371/journal.pone.0139573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426913	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100077
J	Lutz, A; Raina, JB; Motti, CA; Miller, DJ; van Oppen, MJH				Lutz, Adrian; Raina, Jean-Baptiste; Motti, Cherie A.; Miller, David J.; van Oppen, Madeleine J. H.			Host Coenzyme Q Redox State Is an Early Biomarker of Thermal Stress in the Coral Acropora millepora	PLOS ONE			English	Article							SYMBIOTIC SEA-ANEMONE; OXIDATIVE STRESS; ALPHA-TOCOPHEROL; ULTRAVIOLET-RADIATION; ELEVATED-TEMPERATURE; ANTIOXIDANT ACTIVITY; APOPTOTIC EVENTS; MEMBRANE-LIPIDS; SOLAR-RADIATION; REEF CORALS	Bleaching episodes caused by increasing seawater temperatures may induce mass coral mortality and are regarded as one of the biggest threats to coral reef ecosystems worldwide. The current consensus is that this phenomenon results from enhanced production of harmful reactive oxygen species (ROS) that disrupt the symbiosis between corals and their endosymbiotic dinoflagellates, Symbiodinium. Here, the responses of two important antioxidant defence components, the host coenzyme Q (CoQ) and symbiont plastoquinone (PQ) pools, are investigated for the first time in colonies of the scleractinian coral, Acropora millepora, during experimentally-induced bleaching under ecologically relevant conditions. Liquid chromatography-mass spectrometry (LC-MS) was used to quantify the states of these two pools, together with physiological parameters assessing the general state of the symbiosis (including photosystem II photochemical efficiency, chlorophyll concentration and Symbiodinium cell densities). The results show that the responses of the two antioxidant systems occur on different timescales: (i) the redox state of the Symbiodinium PQ pool remained stable until twelve days into the experiment, after which there was an abrupt oxidative shift; (ii) by contrast, an oxidative shift of approximately 10% had occurred in the host CoQ pool after 6 days of thermal stress, prior to significant changes in any other physiological parameter measured. Host CoQ pool oxidation is thus an early biomarker of thermal stress in corals, and this antioxidant pool is likely to play a key role in quenching thermally-induced ROS in the coral-algal symbiosis. This study adds to a growing body of work that indicates host cellular responses may precede the bleaching process and symbiont dysfunction.	[Lutz, Adrian; Raina, Jean-Baptiste] James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia; [Lutz, Adrian; Raina, Jean-Baptiste; Motti, Cherie A.; van Oppen, Madeleine J. H.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Lutz, Adrian; Miller, David J.] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia; [Lutz, Adrian; Miller, David J.] James Cook Univ, Dept Mol & Cell Biol, Townsville, Qld 4811, Australia; [Lutz, Adrian; Raina, Jean-Baptiste; Miller, David J.; van Oppen, Madeleine J. H.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Raina, Jean-Baptiste] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [van Oppen, Madeleine J. H.] Univ Melbourne, Sch BioSci, Parkville, Vic 3052, Australia	James Cook University; Australian Institute of Marine Science; James Cook University; James Cook University; James Cook University; James Cook University; University of Melbourne	Lutz, A (corresponding author), Univ Melbourne, Sch Biosci, Metabol Australia, Parkville, Vic 3052, Australia.	adrian.lutz@my.jcu.edu.au	Lutz, Adrian/O-9805-2016; van Oppen, Madeleine JH/C-3261-2008	Lutz, Adrian/0000-0002-8392-3921; van Oppen, Madeleine/0000-0003-4607-0744; Miller, David/0000-0003-0291-9531; Motti, Cherie/0000-0002-3292-2785; Raina, Jean-Baptiste/0000-0002-7508-0004	Australian Institute of Marine Science; AIMS@JCU; Australian Institute for Marine Science; James Cook University	Australian Institute of Marine Science; AIMS@JCU; Australian Institute for Marine Science; James Cook University	This work has been funded by the Australian Institute of Marine Science (www.aims.gov.au) and AIMS@JCU (aims.jcu.edu.au), a collaborative scheme between the Australian Institute for Marine Science and James Cook University. A.L. and J-B. R. were supported by AIMS@JCU PhD Scholarships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Ainsworth TD, 2011, SCI REP-UK, V1, DOI 10.1038/srep00160; Arroyo A, 1998, PROTOPLASMA, V205, P107, DOI 10.1007/BF01279300; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bellantuono AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050685; Bentinger M, 2007, MITOCHONDRION, V7, pS41, DOI 10.1016/j.mito.2007.02.006; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Berkelmans R., 2009, V205, P103; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Buxton L, 2012, J PHYCOL, V48, P117, DOI 10.1111/j.1529-8817.2011.01099.x; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2012, CORAL REEFS, V31, P215, DOI 10.1007/s00338-011-0833-4; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Dunlap WC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-509; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Dunn SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039024; Dunne RP, 2001, CORAL REEFS, V20, P201; DYKENS JA, 1982, NATURE, V297, P579, DOI 10.1038/297579a0; DYKENS JA, 1992, J EXP BIOL, V168, P219; Eakin C. M., 2009, V205, P41; ERNSTER L, 1993, CLIN INVESTIGATOR, V71, pS60, DOI 10.1007/BF00226842; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fitt WK, 1995, BIOL BULL, V189, P298, DOI 10.2307/1542147; Flores-Ramirez LA, 2007, COMP BIOCHEM PHYS C, V146, P194, DOI 10.1016/j.cbpc.2006.09.008; Furla P, 2005, INTEGR COMP BIOL, V45, P595, DOI 10.1093/icb/45.4.595; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Matus-Ortega MG, 2011, COMP BIOCHEM PHYS D, V6, P256, DOI 10.1016/j.cbd.2011.05.002; Genova ML, 2011, BIOFACTORS, V37, P330, DOI 10.1002/biof.168; GLEASON DF, 1993, NATURE, V365, P836, DOI 10.1038/365836a0; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Halliwell B., 2007, FREE RADICALS BIOL M; Hawkins TD, 2014, CORAL REEFS, V33, P141, DOI 10.1007/s00338-013-1103-4; Hill R, 2011, LIMNOL OCEANOGR, V56, P139, DOI 10.4319/lo.2011.56.1.0139; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Howells EJ, 2012, NAT CLIM CHANGE, V2, P116, DOI 10.1038/NCLIMATE1330; Hundal T, 1995, ARCH BIOCHEM BIOPHYS, V324, P117, DOI 10.1006/abbi.1995.9920; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kruk J, 2008, BBA-BIOENERGETICS, V1777, P154, DOI 10.1016/j.bbabio.2007.10.008; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lenaz G, 2009, BBA-BIOENERGETICS, V1787, P563, DOI 10.1016/j.bbabio.2009.02.019; Lesser MP, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P405, DOI 10.1007/978-94-007-0114-4_23; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Levy O, 2006, J EXP BIOL, V209, P273, DOI 10.1242/jeb.01983; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Lutz A, 2014, J EXP MAR BIOL ECOL, V455, P1, DOI 10.1016/j.jembe.2014.02.006; McClanahan TR, 2004, MAR POLLUT BULL, V48, P327, DOI 10.1016/j.marpolbul.2003.08.024; McDonald AE, 2009, J EXP BIOL, V212, P2627, DOI 10.1242/jeb.032151; McGinty ES, 2012, MICROB ECOL, V64, P1000, DOI 10.1007/s00248-012-0085-z; Miles L, 2005, CLIN CHIM ACTA, V360, P87, DOI 10.1016/j.cccn.2005.04.009; Morre DJ, 2011, BIOFACTORS, V37, P355, DOI 10.1002/biof.156; Moya A, 2012, MOL ECOL, V21, P2440, DOI 10.1111/j.1365-294X.2012.05554.x; MUKAI K, 1992, J BIOL CHEM, V267, P22277; Murata N, 2012, BBA-BIOENERGETICS, V1817, P1127, DOI 10.1016/j.bbabio.2012.02.020; Nii CM, 1997, BIOL BULL, V192, P444, DOI 10.2307/1542753; Nowicka B, 2012, BBA-BIOENERGETICS, V1817, P389, DOI 10.1016/j.bbabio.2011.12.002; Paxton CW, 2013, J EXP BIOL, V216, P2813, DOI 10.1242/jeb.087858; Piller LE, 2012, J EXP BOT, V63, P1609, DOI 10.1093/jxb/ers016; Pinheiro J, 2001, MIXED EFFECTS MODELS; Richier S, 2005, J EXP BIOL, V208, P277, DOI 10.1242/jeb.01368; Richier S, 2003, BBA-GEN SUBJECTS, V1621, P84, DOI 10.1016/S0304-4165(03)00049-7; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Rocker MM, 2015, MAR GENOM, V24, P313, DOI 10.1016/j.margen.2015.08.001; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Schreiber U, 2004, ADV PHOTO RESPIRAT, V19, P279; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Szymanska R, 2010, PLANT CELL PHYSIOL, V51, P537, DOI 10.1093/pcp/pcq017; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2009, P NATL ACAD SCI USA, V106, P3237, DOI 10.1073/pnas.0808363106; TAKAHASHI T, 1995, BIOCHEM J, V309, P883, DOI 10.1042/bj3090883; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Tolleter D, 2013, CURR BIOL, V23, P1782, DOI 10.1016/j.cub.2013.07.041; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Uthicke S, 1998, MAR ECOL PROG SER, V169, P1, DOI 10.3354/meps169001; van Oppen MJH, 2001, P ROY SOC B-BIOL SCI, V268, P1759, DOI 10.1098/rspb.2001.1733; Veal CJ, 2010, CORAL REEFS, V29, P893, DOI 10.1007/s00338-010-0647-9; Venn AA, 2008, J EXP BOT, V59, P1069, DOI 10.1093/jxb/erm328; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Warner ME, 1996, PLANT CELL ENVIRON, V19, P291, DOI 10.1111/j.1365-3040.1996.tb00251.x; Warren CR, 2008, J PLANT NUTR, V31, P1321, DOI 10.1080/01904160802135092; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Yadav DK, 2010, BBA-BIOENERGETICS, V1797, P1807, DOI 10.1016/j.bbabio.2010.07.003; Yamamoto Y, 1997, MOL ASPECTS MED, V18, pS79; Yamashita S, 1997, ANAL BIOCHEM, V250, P66, DOI 10.1006/abio.1997.2187; Zuur Alain F., 2009, P1	101	18	19	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139290	10.1371/journal.pone.0139290	http://dx.doi.org/10.1371/journal.pone.0139290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426118	Green Published, gold, Green Accepted			2022-12-27	WOS:000362177100046
J	Pettersson, M; Quant, M; Min, J; Iconaru, L; Kriwacki, RW; Waddell, MB; Guy, RK; Luthman, K; Grotli, M				Pettersson, Mariell; Quant, Maria; Min, Jaeki; Iconaru, Luigi; Kriwacki, Richard W.; Waddell, M. Brett; Guy, R. Kiplin; Luthman, Kristina; Grotli, Morten			Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction	PLOS ONE			English	Article							RATIONAL DESIGN; P53 PATHWAY; PROTEIN; DERIVATIVES; MODULATORS; MUTATIONS; CHEMISTRY; DISCOVERY; MIMETICS; POTENT	The transcription factor p53 is the main tumour suppressor in cells and many cancer types have p53 mutations resulting in a loss of its function. In tumours that retain wild-type p53 function, p53 activity is down-regulated by MDM2 (human murine double minute 2) via a direct protein-protein interaction. We have designed and synthesised two series of 2,5-diketopiperazines as inhibitors of the MDM2-p53 interaction. The first set was designed to directly mimic the alpha-helical region of the p53 peptide, containing key residues in the i, i+4 and i+7 positions of a natural alpha-helix. Conformational analysis indicated that 1,3,6-trisubstituted 2,5-diketopiperazines were able to place substituents in the same spatial orientation as an alpha-helix template. The key step of the synthesis involved the cyclisation of substituted dipeptides. The other set of tetrasubstituted 2,5-diketopiperazines were designed based on structure-based docking studies and the Ugi multicomponent reaction was used for the synthesis. This latter set comprised the most potent inhibitors which displayed micromolar IC50 values in a biochemical fluorescence polarisation assay.	[Pettersson, Mariell; Quant, Maria; Luthman, Kristina; Grotli, Morten] Univ Gothenburg, Dept Chem & Mol Biol, S-41296 Gothenburg, Sweden; [Min, Jaeki; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Iconaru, Luigi; Kriwacki, Richard W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Waddell, M. Brett] St Jude Childrens Res Hosp, Mol Interact Anal Shared Resource, Memphis, TN 38105 USA	University of Gothenburg; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Grotli, M (corresponding author), Univ Gothenburg, Dept Chem & Mol Biol, S-41296 Gothenburg, Sweden.	grotli@chem.gu.se	Luthman, Kristina/A-7600-2010; Kriwacki, Richard/N-8154-2018; Grötli, Morten/A-8735-2010	Luthman, Kristina/0000-0003-4344-8609; Kriwacki, Richard/0000-0002-9798-6018; Grötli, Morten/0000-0003-3621-4222; Min, Jaeki/0000-0002-0083-3198; Quant, Maria/0000-0002-9768-8838	Swedish Research Council [62120083533]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Research Council (http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html); project #62120083533. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeluri M, 2014, CHEM REV, V114, P4640, DOI 10.1021/cr4004049; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Bharatham N, 2014, J CHEM INF MODEL, V54, P648, DOI 10.1021/ci4004656; Biros SM, 2007, BIOORG MED CHEM LETT, V17, P4641, DOI 10.1016/j.bmcl.2007.05.075; Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Burkhardt ER, 2008, TETRAHEDRON LETT, V49, P5152, DOI 10.1016/j.tetlet.2008.06.095; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; de Turiso FGL, 2013, J MED CHEM, V56, P4053, DOI 10.1021/jm400293z; El-Faham A, 2011, CHEM REV, V111, P6557, DOI 10.1021/cr100048w; Feki A, 2004, CRIT REV ONCOL HEMAT, V52, P103, DOI 10.1016/j.critrevonc.2004.07.002; Fieser LF, 1967, REAGENTS ORGANIC SYN, V1, P191; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Fry DC, 2013, ACS MED CHEM LETT, V4, P95, DOI 10.1021/ml400062c; GASPARRO FP, 1977, J CHEM EDUC, V54, P258, DOI 10.1021/ed054p258; Jam F, 2007, TETRAHEDRON, V63, P9881, DOI 10.1016/j.tet.2007.06.108; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee JH, 2011, J AM CHEM SOC, V133, P676, DOI 10.1021/ja108230s; Michelsen K, 2012, J AM CHEM SOC, V134, P17059, DOI 10.1021/ja305839b; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Mututis F, 2003, MOLECULES, V8, P728, DOI 10.3390/81000728; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Nishizawa R, 2011, BIOORGAN MED CHEM, V19, P4028, DOI 10.1016/j.bmc.2011.05.022; Orner BP, 2001, J AM CHEM SOC, V123, P5382, DOI 10.1021/ja0025548; Papalia G, 2010, ANAL BIOCHEM, V403, P30, DOI 10.1016/j.ab.2010.03.044; Park JD, 2001, BIOORGAN MED CHEM, V9, P237, DOI 10.1016/S0968-0896(00)00239-X; Plante JP, 2009, CHEM COMMUN, P5091, DOI 10.1039/b908207g; Reed D, 2010, J BIOL CHEM, V285, P10786, DOI 10.1074/jbc.M109.056747; Rew Y, 2012, J MED CHEM, V55, P4936, DOI 10.1021/jm300354j; Rognan D, 2015, MEDCHEMCOMM, V6, P51, DOI 10.1039/c4md00328d; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tullberg M, 2007, J ORG CHEM, V72, P195, DOI 10.1021/jo0619635; Tullberg M, 2006, J COMB CHEM, V8, P915, DOI 10.1021/cc0600876; Tullberg M, 2006, TETRAHEDRON, V62, P7484, DOI 10.1016/j.tet.2006.05.010; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P2704, DOI 10.1002/anie.200462316; Zhao YJ, 2013, J MED CHEM, V56, P5553, DOI 10.1021/jm4005708	44	9	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0137867	10.1371/journal.pone.0137867	http://dx.doi.org/10.1371/journal.pone.0137867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427060	Green Published, gold			2022-12-27	WOS:000362177100008
J	Wong, CY; Teoh, ML; Phang, SM; Lim, PE; Beardall, J				Wong, Chiew-Yen; Teoh, Ming-Li; Phang, Siew-Moi; Lim, Phaik-Eem; Beardall, John			Interactive Effects of Temperature and UV Radiation on Photosynthesis of Chlorella Strains from Polar, Temperate and Tropical Environments: Differential Impacts on Damage and Repair	PLOS ONE			English	Article							SOLAR ULTRAVIOLET-RADIATION; DIATOM THALASSIOSIRA-PSEUDONANA; FATTY-ACID-COMPOSITION; CHLOROPHYLL FLUORESCENCE; PHAEODACTYLUM-TRICORNUTUM; DUNALIELLA-TERTIOLECTA; MARINE-PHYTOPLANKTON; OZONE DEPLETION; CARBON-DIOXIDE; DNA-DAMAGE	Global warming and ozone depletion, and the resulting increase of ultraviolet radiation (UVR), have far-reaching impacts on biota, especially affecting the algae that form the basis of the food webs in aquatic ecosystems. The aim of the present study was to investigate the interactive effects of temperature and UVR by comparing the photosynthetic responses of similar taxa of Chlorella from Antarctic (Chlorella UMACC 237), temperate (Chlorella vulgaris UMACC 248) and tropical (Chlorella vulgaris UMACC 001) environments. The cultures were exposed to three different treatments: photosynthetically active radiation (PAR; 400-700 nm), PAR plus ultraviolet-A (320-400 nm) radiation (PAR + UV-A) and PAR plus UV-A and ultraviolet-B (280-320 nm) radiation (PAR + UV-A + UV-B) for one hour in incubators set at different temperatures. The Antarctic Chlorella was exposed to 4, 14 and 20 degrees C. The temperate Chlorella was exposed to 11, 18 and 25 degrees C while the tropical Chlorella was exposed to 24, 28 and 30 degrees C. A pulse-amplitude modulated (PAM) fluorometer was used to assess the photosynthetic response of microalgae. Parameters such as the photoadaptive index (E-k) and light harvesting efficiency (alpha) were determined from rapid light curves. The damage (k) and repair (r) rates were calculated from the decrease in phi PSIIeff over time during exposure response curves where cells were exposed to the various combinations of PAR and UVR, and fitting the data to the Kok model. The results showed that UV-A caused much lower inhibition than UV-B in photosynthesis in all Chlorella isolates. The three isolates of Chlorella from different regions showed different trends in their photosynthesis responses under the combined effects of UVR (PAR + UV-A + UV-B) and temperature. In accordance with the noted strain-specific characteristics, we can conclude that the repair (r) mechanisms at higher temperatures were not sufficient to overcome damage caused by UVR in the Antarctic Chlorella strain, suggesting negative effects of global climate change on microalgae inhabiting (circum-) polar regions. For temperate and tropical strains of Chlorella, damage from UVR was independent of temperature but the repair constant increased with increasing temperature, implying an improved ability of these strains to recover from UVR stress under global warming.	[Wong, Chiew-Yen] Int Med Univ, Dept Human Biol, Kuala Lumpur 57000, Malaysia; [Wong, Chiew-Yen; Teoh, Ming-Li; Phang, Siew-Moi; Lim, Phaik-Eem] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur 50603, Malaysia; [Wong, Chiew-Yen] Univ Malaya, Inst Grad Studies, Natl Antarctic Res Ctr, Kuala Lumpur 50603, Malaysia; [Teoh, Ming-Li] Taylors Univ, Sch Biosci, Subang Jaya 47500, Selangor Darul, Malaysia; [Phang, Siew-Moi; Lim, Phaik-Eem] Univ Malaya, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Beardall, John] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia	International Medical University Malaysia; Universiti Malaya; Universiti Malaya; Taylor's University; Universiti Malaya; Monash University	Wong, CY (corresponding author), Int Med Univ, Dept Human Biol, 126,Jalan Jalil Perkasa 19, Kuala Lumpur 57000, Malaysia.	WongChiewYen@imu.edu.my; phang@um.edu.my	Beardall, John/L-5262-2019; LIM, Phaik Eem/B-5331-2010; Phang, Siew Moi/A-7653-2008	Beardall, John/0000-0001-7684-446X; LIM, Phaik Eem/0000-0001-9186-1487; Teoh, Ming Li/0000-0001-7979-6045; Wong, Chiew-Yen/0000-0003-0534-6206	Antarctic Biodiversity Grants from the Ministry of Science, Technology and Innovation (MOSTI), Malaysia [8123204]; Antarctic Flagship Project, Ministry of Science, Technology & Innovation (MOSTI), Malaysia [FP0712E012]; Knowledge Management [2015: RU009K]; University of Malaya Research Grant Programme [RP002C-13SUS]; Ministry of Education, Malaysia, HiCOE [IOES-2014]	Antarctic Biodiversity Grants from the Ministry of Science, Technology and Innovation (MOSTI), Malaysia; Antarctic Flagship Project, Ministry of Science, Technology & Innovation (MOSTI), Malaysia; Knowledge Management; University of Malaya Research Grant Programme; Ministry of Education, Malaysia, HiCOE	The authors would like to thank the following funding agency in providing research grants for the implementation of the research project: Antarctic Biodiversity Grants (#8123204) from the Ministry of Science, Technology and Innovation (MOSTI), Malaysia, coordinated by the Academy of Sciences Malaysia (ASM): S-MP; Antarctic Flagship Project (FP0712E012), Ministry of Science, Technology & Innovation (MOSTI), Malaysia: C-YW; Knowledge Management (2015: RU009K): S-MP; University of Malaya Research Grant Programme (RP002C-13SUS): P-EL; Ministry of Education, Malaysia, HiCOE research grant (IOES-2014): S-MP, P-EL.	Beardall J, 2014, AQUAT BIOL, V22, P5, DOI 10.3354/ab00582; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Bischof K, 2002, PLANTA, V215, P502, DOI 10.1007/s00425-002-0774-9; Bischof K, 2000, PLANTA, V211, P555, DOI 10.1007/s004250000313; Bischof Kai, 2006, Reviews in Environmental Science and Bio/Technology, V5, P141, DOI 10.1007/s11157-006-0002-3; Buma AGJ, 2001, J PHYCOL, V37, P200, DOI 10.1046/j.1529-8817.2001.037002200.x; Cao K, 2015, J APPL PHYC IN PRESS; Cruces E, 2013, MAR BIOL, V160, P1, DOI 10.1007/s00227-012-2049-8; Deschamps L, 2004, BMRC RES LETT, V1, P1; Dobretsov SV, 2005, MAR ECOL PROG SER, V290, P55, DOI 10.3354/meps290055; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; Doyle SA, 2005, LIMNOL OCEANOGR, V50, P1362, DOI 10.4319/lo.2005.50.5.1362; Forster RM, 1997, PHOTOSYNTHETICA, V33, P541; Franklin LA, 1997, EUR J PHYCOL, V32, P207, DOI 10.1080/09670269710001737149; Gao K, 2008, EUR J PHYCOL, V43, P297, DOI 10.1080/09670260801986837; Gao KS, 2008, J PHYCOL, V44, P777, DOI 10.1111/j.1529-8817.2008.00512.x; Gao KS, 2007, PLANT PHYSIOL, V144, P54, DOI 10.1104/pp.107.098491; Gomez I, 2001, BOT MAR, V44, P9, DOI 10.1515/BOT.2001.002; Grzymski J, 2001, PHOTOSYNTH RES, V68, P181, DOI 10.1023/A:1012904402368; Hader DP, 2005, MUTAT RES-FUND MOL M, V571, P221, DOI 10.1016/j.mrfmmm.2004.11.017; Hader DP, 2002, PHOTOCH PHOTOBIO SCI, V1, P809, DOI 10.1039/b206152j; Hader DP, 2001, HELGOLAND MAR RES, V55, P67, DOI 10.1007/s101520000066; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Hartmann DL, 2000, P NATL ACAD SCI USA, V97, P1412, DOI 10.1073/pnas.97.4.1412; Hegglin MI, 2009, NAT GEOSCI, V2, P687, DOI 10.1038/NGEO604; Heraud P, 2005, J PHYCOL, V41, P1212, DOI 10.1111/j.1529-8817.2005.00149.x; Heraud P, 2000, PHOTOSYNTH RES, V63, P123, DOI 10.1023/A:1006319802047; Herrmann H, 1997, PLANT CELL ENVIRON, V20, P359, DOI 10.1046/j.1365-3040.1997.d01-77.x; Hoffman JR, 2003, J PHYCOL, V39, P268, DOI 10.1046/j.1529-8817.2003.01111.x; HOLMHANSEN O, 1993, PHOTOCHEM PHOTOBIOL, V58, P567, DOI 10.1111/j.1751-1097.1993.tb04933.x; KOK B, 1956, BIOCHIM BIOPHYS ACTA, V21, P234, DOI 10.1016/0006-3002(56)90003-8; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Liang Y, 2006, J PHOTOCH PHOTOBIO B, V82, P161, DOI 10.1016/j.jphotobiol.2005.11.002; Liang Y, 2006, PHYCOLOGIA, V45, P605, DOI 10.2216/04-61.1; Marija S, 2014, PHOTOCH PHOTOBIO SCI, V13, P1066, DOI 10.1039/c3pp50192b; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; McKenzie RL, 2003, PHOTOCH PHOTOBIO SCI, V2, P5, DOI 10.1039/b211155c; Muller R, 2008, CLIM RES, V37, P203, DOI 10.3354/cr00762; Nichols HW., 1975, HDB PHYCOLOGICAL MET, P7; Nilawati J, 1997, J PHYCOL, V33, P215, DOI 10.1111/j.0022-3646.1997.00215.x; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; Phang SM, 2004, JAPANESE J PHYCOLOGY, V52, P221; Prezelin Barbara B., 1994, Antarctic Research Series, V62, P159; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Rautenberger R, 2006, POLAR BIOL, V29, P988, DOI 10.1007/s00300-006-0141-6; Roleda MY, 2007, PHOTOCHEM PHOTOBIOL, V83, P851, DOI 10.1562/2006-08-17-IR-1005; SAKAI N, 1995, ENERG CONVERS MANAGE, V36, P693, DOI 10.1016/0196-8904(95)00100-R; Shelly K, 2003, J PHYCOL, V39, P509, DOI 10.1046/j.1529-8817.2003.02148.x; Shelly K, 2002, J PHYCOL, V38, P713, DOI 10.1046/j.1529-8817.2002.01147.x; Shindell DT, 1998, NATURE, V392, P589, DOI 10.1038/33385; SIEGENTHALER U, 1993, NATURE, V365, P119, DOI 10.1038/365119a0; Sobrino C, 2008, LIMNOL OCEANOGR, V53, P494, DOI 10.4319/lo.2008.53.2.0494; Stamenkovic M, 2013, PHOTOCHEM PHOTOBIOL, V89, P900, DOI 10.1111/php.12083; Teoh ML, 2013, J APPL PHYCOL, V25, P285, DOI 10.1007/s10811-012-9863-8; Teoh ML, 2004, J APPL PHYCOL, V16, P421, DOI 10.1007/s10811-004-5502-3; van de Poll WH, 2002, EUR J PHYCOL, V37, P59, DOI 10.1017/S0967026201003407; Villafane VE, 2003, COMP SER PHOTOCHEM, V1, P357; Watanabe S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD015749; White AL, 2002, PLANT CELL PHYSIOL, V43, P877, DOI 10.1093/pcp/pcf105; Wiencke C, 2007, PHYSIOL PLANTARUM, V130, P601, DOI 10.1111/j.1399-3054.2007.00923.x; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]; Wong CY, 2007, J APPL PHYCOL, V19, P689, DOI 10.1007/s10811-007-9214-3; Wong C. Y., 2011, Malaysian Journal of Science, V30, P3; Wong CY., 2004, MALAYS J SCI, V23, P103; WOODWELL GM, 1968, AM ZOOL, V8, P19	65	37	40	5	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139469	10.1371/journal.pone.0139469	http://dx.doi.org/10.1371/journal.pone.0139469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427046	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100067
J	Gillman, A; Muradrasoli, S; Mardnas, A; Soderstrom, H; Fedorova, G; Lowenthal, M; Wille, M; Daggfeldt, A; Jarhult, JD				Gillman, Anna; Muradrasoli, Shaman; Mardnas, Andreas; Soderstrom, Hanna; Fedorova, Ganna; Lowenthal, Max; Wille, Michelle; Daggfeldt, Annika; Jarhult, Josef D.			Oseltamivir Resistance in Influenza A(H6N2) Caused by an R292K Substitution in Neuraminidase Is Not Maintained in Mallards without Drug Pressure	PLOS ONE			English	Article							A VIRUS; MUTATIONS; SUSCEPTIBILITY; INHIBITORS; EVOLUTION; INFECTION; PATTERNS; SUBTYPE; WATERS	Background Wild waterfowl is the natural reservoir of influenza A virus (IAV); hosted viruses are very variable and provide a source for genetic segments which can reassort with poultry or mammalian adapted IAVs to generate novel species crossing viruses. Additionally, wild waterfowl act as a reservoir for highly pathogenic IAVs. Exposure of wild birds to the antiviral drug oseltamivir may occur in the environment as its active metabolite can be released from sewage treatment plants to river water. Resistance to oseltamivir, or to other neuraminidase inhibitors (NAIs), in IAVs of wild waterfowl has not been extensively studied. Aim and Methods In a previous in vivo Mallard experiment, an influenza A(H6N2) virus developed oseltamivir resistance by the R292K substitution in the neuraminidase (NA), when the birds were exposed to oseltamivir. In this study we tested if the resistance could be maintained in Mallards without drug exposure. Three variants of resistant H6N2/R292K virus were each propagated during 17 days in five successive pairs of naive Mallards, while oseltamivir exposure was decreased and removed. Daily fecal samples were analyzed for viral presence, genotype and phenotype. Results and Conclusion Within three days without drug exposure no resistant viruses could be detected by NA sequencing, which was confirmed by functional NAI sensitivity testing. We conclude that this resistant N2 virus could not compete in fitness with wild type subpopulations without oseltamivir drug pressure, and thus has no potential to circulate among wild birds. The results of this study contrast to previous observations of drug induced resistance in an avian H1N1 virus, which was maintained also without drug exposure in Mallards. Experimental observations on persistence of NAI resistance in avian IAVs resemble NAI resistance seen in human IAVs, in which resistant N2 subtypes do not circulate, while N1 subtypes with permissive mutations can circulate without drug pressure. We speculate that the phylogenetic group N1 NAs may easier compensate for NAI resistance than group N2 NAs, though further studies are needed to confirm such conclusions.	[Gillman, Anna; Mardnas, Andreas; Lowenthal, Max; Jarhult, Josef D.] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Gillman, Anna; Mardnas, Andreas; Lowenthal, Max; Jarhult, Josef D.] Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, Uppsala, Sweden; [Muradrasoli, Shaman] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Soderstrom, Hanna; Fedorova, Ganna] Umea Univ, Dept Chem, Umea, Sweden; [Fedorova, Ganna] Univ South Bohemia Ceske Budejovice, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Fac Fisheries & Protect Waters, Ceske Budejovice, Czech Republic; [Wille, Michelle] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Daggfeldt, Annika] Swedish Vet Inst, Dept Virol Immunobiol & Parasitol, Uppsala, Sweden	Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; Umea University; University of South Bohemia Ceske Budejovice; Linnaeus University	Gillman, A (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	anna.gillman@medsci.uu.se	Fedorova, Ganna/F-8268-2015; Wille, Michelle/F-4819-2013; Jarhult, Josef D./ABE-8149-2020	Wille, Michelle/0000-0002-5629-0196; Jarhult, Josef D./0000-0002-7075-1059; Soderstrom, Hanna/0000-0003-1341-7879	Swedish Research Council FORMAS, the Family Olinder-Nielsen's Foundation [211-2013-1320]	Swedish Research Council FORMAS, the Family Olinder-Nielsen's Foundation	This work was supported by the Swedish Research Council FORMAS (grant no. 211-2013-1320), the Family Olinder-Nielsen's Foundation.	[Anonymous], 2015, Wkly Epidemiol Rec, V90, P97; Azuma T, 2012, ENVIRON SCI TECHNOL, V46, P12873, DOI 10.1021/es303203c; Butler J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004065; Collins PJ, 2009, VACCINE, V27, P6317, DOI 10.1016/j.vaccine.2009.07.017; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Duan S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6029; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Earhart Kenneth C, 2009, J Infect Public Health, V2, P74, DOI 10.1016/j.jiph.2009.04.004; Ferraris O, 2008, J CLIN VIROL, V41, P13, DOI 10.1016/j.jcv.2007.10.020; Forrest Heather L., 2010, Animal Health Research Reviews, V11, P3, DOI 10.1017/S1466252310000071; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; Gillman A, 2015, APPL ENVIRON MICROB, V81, P2378, DOI 10.1128/AEM.04034-14; Gillman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071230; Goncalves C, 2011, ENVIRON SCI TECHNOL, V45, P4307, DOI 10.1021/es1032629; Hurt A., 2007, FLUOROMETRIC NEURAMI; Hurt AC, 2014, CURR OPIN VIROL, V8, P22, DOI 10.1016/j.coviro.2014.04.009; Jarhult JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024742; Khan GA, 2012, J PHARMACEUT BIOMED, V66, P24, DOI 10.1016/j.jpba.2012.02.011; Lackenby A, 2008, DETERMINATION INFLUE, P1; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Marjuki H, 2015, J VIROL, V89, P5419, DOI 10.1128/JVI.03513-14; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2014, STUDY OSELTAMIVIR ZA; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Qi W, 2014, EUROSURVEILLANCE, V26, P19; Rogers MB, 2015, MBIO, V6, DOI 10.1128/mBio.02464-14; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Samson M, 2013, ANTIVIR RES, V98, P174, DOI 10.1016/j.antiviral.2013.03.014; Singer AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108621; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Stoner TD, 2012, ANTIVIR RES, V93, P322, DOI 10.1016/j.antiviral.2011.12.013; Stoner TD, 2010, J VIROL, V84, P9800, DOI 10.1128/JVI.00296-10; Takanami R., 2010, Journal of Water and Environment Technology, V8, P363, DOI 10.2965/jwet.2010.363; Wang TT, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P218; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wille M, 2013, VIROLOGY, V443, P150, DOI 10.1016/j.virol.2013.05.004	38	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139415	10.1371/journal.pone.0139415	http://dx.doi.org/10.1371/journal.pone.0139415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422258	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700114
J	Hamilton, LC; Hartter, J; Lemcke-Stampone, M; Moore, DW; Safford, TG				Hamilton, Lawrence C.; Hartter, Joel; Lemcke-Stampone, Mary; Moore, David W.; Safford, Thomas G.			Tracking Public Beliefs About Anthropogenic Climate Change	PLOS ONE			English	Article							LOCAL WEATHER; PERCEPTIONS; POLITICS; TEMPERATURE; VIEWS	A simple question about climate change, with one choice designed tomatch consensus statements by scientists, was asked on 35 US nationwide, single-state or regional surveys from 2010 to 2015. Analysis of these data (over 28,000 interviews) yields robust and exceptionally well replicated findings on public beliefs about anthropogenic climate change, including regional variations, change over time, demographic bases, and the interacting effects of respondent education and political views. We find that more than half of the US public accepts the scientific consensus that climate change is happening now, caused mainly by human activities. A sizable, politically oppositeminority (about 30 to 40%) concede the fact of climate change, but believe it has mainly natural causes. Few (about 10 to 15%) say they believe climate is not changing, or express no opinion. The overall proportions appear relatively stable nationwide, but exhibit place-to-place variations. Detailed analysis of 21 consecutive surveys within one fairly representative state (New Hampshire) finds a mild but statistically significant rise in agreement with the scientific consensus over 2010-2015. Effects from daily temperature are detectable but minor. Hurricane Sandy, which brushed New Hampshire but caused no disaster there, shows no lasting impact on that state's time series-suggesting that non-immediate weather disasters have limited effects. In all datasets political orientation dominates among individual-level predictors of climate beliefs, moderating the otherwise positive effects from education. Acceptance of anthropogenic climate change rises with education among Democrats and Independents, but not so among Republicans. The continuing series of surveys provides a baseline for tracking how future scientific, political, socioeconomic or climate developments impact public acceptance of the scientific consensus.	[Hamilton, Lawrence C.; Safford, Thomas G.] Univ New Hampshire, Durham, NH 03824 USA; [Hamilton, Lawrence C.; Hartter, Joel; Moore, David W.; Safford, Thomas G.] Univ New Hampshire, Carsey Sch Publ Policy, Durham, NH 03824 USA; [Hartter, Joel] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Lemcke-Stampone, Mary] Dept Geog, Durham, NH USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; University of Colorado System; University of Colorado Boulder	Hamilton, LC (corresponding author), Univ New Hampshire, Durham, NH 03824 USA.	Lawrence.Hamilton@unh.edu		Safford, Thomas/0000-0003-1171-4634; Hamilton, Lawrence/0000-0003-1977-0649	National Science Foundation [EPS-1101245, DUE-1239783, PLR-1303938]; Carsey Institute at the University of New Hampshire; Sustainability Institute at the University of New Hampshire; US Department of Agriculture [2014-68002-21782, 2010-67023-21705, RSA-10-32]; National Oceanographic and Atmospheric Administration [AB-133F-11-SE-0724]; Ford Foundation; Neil and Louise Tillotson Fund; Carsey Institute at University of New Hampshire; College of Liberal Arts at University of New Hampshire; EPSCoR [1101245] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Carsey Institute at the University of New Hampshire; Sustainability Institute at the University of New Hampshire; US Department of Agriculture(United States Department of Agriculture (USDA)); National Oceanographic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Ford Foundation; Neil and Louise Tillotson Fund; Carsey Institute at University of New Hampshire; College of Liberal Arts at University of New Hampshire; EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	Climate questions on the Granite State Poll are supported by three grants from the National Science Foundation (http://www.nsf.gov/): New Hampshire EPSCoR EPS-1101245 (LH), PoLAR Climate Change Education Partnership DUE-1239783 (LH), and Sea Ice Prediction Network PLR-1303938 (LH). Further GSP support came from the Carsey Institute (http://www.carseyinstitute.unh.edu/, LH DM) and Sustainability Institute (http://www.sustainableunh.unh.edu/, LH DM) at the University of New Hampshire. CERA and CAFOR surveys were supported by grants from the US Department of Agriculture (http://www.usda.gov/wps/portal/usda/usdahome): 2014-68002-21782 (JH LH); 2010-67023-21705 (JH LH); RSA-10-32 (JH), National Oceanographic and Atmospheric Administration (http://www.noaa.gov/): AB-133F-11-SE-0724 (TS), Ford Foundation (http://www.fordfoundation.org/, LH TS JH), Neil and Louise Tillotson Fund (http://www.nhcf.org/page.aspx?pid=667, LH TS), and the Carsey Institute (http://www.carseyinstitute.unh.edu/, LH TS JH) and College of Liberal Arts (http://cola.unh.edu/, LH TS JH) at University of New Hampshire. The UNH Survey Center conducted all telephone interviews for NCERA, CERA/CAFOR and the Granite State Poll, while the Carsey Institute provided logistical and administrative support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association for Public Opinion Research (AAPOR), 2006, STAND DEF FIN DISP C; Boag AE, 2015, FORREST VIEWS SHIFTI; Borick CP, 2010, SOC SCI QUART, V91, P777, DOI 10.1111/j.1540-6237.2010.00719.x; Brulle RJ, 2013, CLIMATIC CHANGE; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Burgess J, 1998, ENVIRON PLANN A, V30, P1445, DOI 10.1068/a301445; Cook J, 2013, ENVIRON RES LETT, P8, DOI DOI 10.1088/1748-9326/8/2/024024; Corner A, 2012, CLIMATIC CHANGE, V114, P463, DOI 10.1007/s10584-012-0424-6; Darmofal D, 2005, POLIT RES QUART, V58, P381, DOI 10.1177/106591290505800302; Egan PJ, 2012, J POLIT, V74, P796, DOI 10.1017/S0022381612000448; Funk C., 2015, PUBLIC SCI VIEWS SCI; Goebbert K, 2012, WEATHER CLIM SOC, V4, P132, DOI 10.1175/WCAS-D-11-00044.1; Guber DL, 2013, AM BEHAV SCI, V57, P93, DOI 10.1177/0002764212463361; Hamilton L., 2012, CENGAGE LEARNING; Hamilton LC, 2012, POLAR GEOGR, V35, P155, DOI 10.1080/1088937X.2012.684155; Hamilton LC, 2015, NAT CLIM CHANGE, V5, P704, DOI 10.1038/nclimate2720; Hamilton LC, 2015, ENVIRON POLIT, V24, P212, DOI 10.1080/09644016.2014.976485; Hamilton LC, 2015, SOC NATUR RESOUR, V28, P57, DOI 10.1080/08941920.2014.933926; Hamilton LC, 2014, RURAL SOCIOL, V79, P257, DOI 10.1111/ruso.12023; Hamilton LC, 2014, INT J CLIMATOL, V34, P1723, DOI 10.1002/joc.3796; Hamilton LC, 2013, WEATHER CLIM SOC, V5, P112, DOI 10.1175/WCAS-D-12-00048.1; Hamilton LC, 2012, WEATHER CLIM SOC, V4, P236, DOI 10.1175/WCAS-D-12-00008.1; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Hamilton LC, 2010, RURAL SOCIOL, V75, P326, DOI 10.1111/j.1549-0831.2010.00013.x; Hamilton LC, 2009, INT J CLIMATOL, V29, P2348, DOI 10.1002/joc.1930; Hamilton LC, 2008, ARCT ANTARCT ALP RES, V40, P671, DOI 10.1657/1523-0430(07-105)[HAMILTON]2.0.CO;2; Howe PD, 2013, GLOBAL ENV CHANGE; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Joireman J, 2010, J ENVIRON PSYCHOL, V30, P358, DOI 10.1016/j.jenvp.2010.03.004; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Leiserowitz AA, 2013, AM BEHAV SCI, V57, P818, DOI 10.1177/0002764212458272; Lewandowski GW, 2012, CURR PSYCHOL, V31, P318, DOI 10.1007/s12144-012-9148-z; Li Y, 2011, PSYCHOL SCI, V22, P454, DOI 10.1177/0956797611400913; Marquart-Pyatt ST, 2014, GLOBAL ENVIRON CHANG, V29, P246, DOI 10.1016/j.gloenvcha.2014.10.004; McCright AM, 2014, WEATHER CLIM SOC, V6, P194, DOI 10.1175/WCAS-D-13-00058.1; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; McCright AM, 2014, NATURE CLIMATE CHANG; Mitchell M., 2008, VISUAL GUIDE STATA G; Oreskes N, 2004, SCIENCE, V306, P1686, DOI 10.1126/science.1103618; Risen JL, 2011, J PERS SOC PSYCHOL, V100, P777, DOI 10.1037/a0022460; Schuldt JP, 2015, ANN AM ACAD POLIT SS, V658, P67, DOI 10.1177/0002716214555066; Shao WY, 2016, J RISK RES, V19, P722, DOI 10.1080/13669877.2014.1003956; Shao WY, 2014, WEATHER CLIM SOC, V6, P119, DOI 10.1175/WCAS-D-13-00029.1; Smith Tom W., 2013, GEN SOCIAL SURVEYS 1; Taber CS, 2006, AM J POLIT SCI, V50, P755, DOI 10.1111/j.1540-5907.2006.00214.x; Wood BD, 2007, AM J POLIT SCI, V51, P552, DOI 10.1111/j.1540-5907.2007.00267.x; Zhao XQ, 2009, COMMUN RES, V36, P698, DOI 10.1177/0093650209338911; Zimmerman M., 2009, EOS T AM GEOPHYS UN, V99, P22, DOI DOI 10.1029/2009EO030002	50	105	106	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138208	10.1371/journal.pone.0138208	http://dx.doi.org/10.1371/journal.pone.0138208			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422694	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700034
J	Lemmens, P; Mergeay, J; Van Wichelen, J; De Meester, L; Declerck, SAJ				Lemmens, Pieter; Mergeay, Joachim; Van Wichelen, Jeroen; De Meester, Luc; Declerck, Steven A. J.			The Impact of Conservation Management on the Community Composition of Multiple Organism Groups in Eutrophic Interconnected Man-Made Ponds	PLOS ONE			English	Article							FRESH-WATER BIODIVERSITY; OF-THE-ART; AQUATIC VEGETATION; RELATIVE IMPORTANCE; LEVEL FLUCTUATIONS; ECOSYSTEM SERVICES; HABITAT SELECTION; FISH; PLANT; LAKE	Ponds throughout the world are subjected to a variety of management measures for purposes of biodiversity conservation. Current conservation efforts typically comprise a combination of multiple measures that directly and indirectly impact a wide range of organism groups. Knowledge of the relative impact of individual measures on different taxonomic groups is important for the development of effective conservation programs. We conducted a field study of 28 man-made ponds, representing four management types differing in the frequency of periodic pond drainage and the intensity of fish stock management. We disentangled the relative importance of direct and indirect effects of pond management measures on the community composition of phytoplankton, zooplankton, aquatic macro-invertebrates, submerged and emergent vascular plants. With the exception of phytoplankton, pond management had strong effects on the community composition of all investigated biota. Whether management affected communities directly or indirectly through its impact on fish communities or local environmental conditions in the pond varied between organism groups. Overall, the impact of pond drainage regime and fish community characteristics on the community composition of target organism groups were more important than local environmental conditions. The majority of taxa were negatively associated with fish density, whereas multiple emergent plant species and several taxa of aquatic macro-invertebrates were positively affected by increased drainage frequency. The effects of fish community and drainage tended to be largely independent. The present study indicates that pond drainage is an important element for biodiversity conservation in eutrophicated shallow and interconnected man-made ponds.	[Lemmens, Pieter; Mergeay, Joachim; De Meester, Luc; Declerck, Steven A. J.] Katholieke Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest, Geraardsbergen, Belgium; [Van Wichelen, Jeroen] Univ Ghent, Lab Protistol & Aquat Ecol, B-9000 Ghent, Belgium; [Declerck, Steven A. J.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands	KU Leuven; Research Institute for Nature & Forest; Ghent University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Lemmens, P (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol Evolut & Conservat, Leuven, Belgium.	pieter.lemmens@bio.kuleuven.be	De Meester, Luc/F-3832-2015; Mergeay, Joachim/E-7670-2011; Van+Wichelen, Jeroen/AAP-6900-2021; Declerck, Steven/E-4338-2010; KNAW, NIOO-KNAW/A-4320-2012	De Meester, Luc/0000-0001-5433-6843; Mergeay, Joachim/0000-0002-6504-0551; Van+Wichelen, Jeroen/0000-0002-0255-9591; Declerck, Steven/0000-0001-6179-667X; KNAW, NIOO-KNAW/0000-0002-3835-159X; Lemmens, Pieter/0000-0002-3135-9724	Agency for Nature and Forests via a national TWOL project [LIM/AMINAL/AN/LIM/2004/10]; ERA-Net BiodivERsA; national funder BELSPO (Belgian Science Policy) Belgium, BiodivERsA call; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Flanders)	Agency for Nature and Forests via a national TWOL project; ERA-Net BiodivERsA; national funder BELSPO (Belgian Science Policy) Belgium, BiodivERsA call; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This study was funded by the Agency for Nature and Forests via a national TWOL project (LIM/AMINAL/AN/LIM/2004/10) and by the ERA-Net BiodivERsA, with the national funder BELSPO (Belgian Science Policy) Belgium, part of the 2012 BiodivERsA call for research proposals. PL was financially supported by a grant from the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Flanders).	Abjornsson K, 2002, FRESHWATER BIOL, V47, P1489, DOI 10.1046/j.1365-2427.2002.00883.x; Akasaka M, 2011, OIKOS, V120, P38, DOI 10.1111/j.1600-0706.2010.18497.x; Arnott SE, 2002, ECOL APPL, V12, P138; Arthaud F, 2012, FRESHWATER BIOL, V57, P666, DOI 10.1111/j.1365-2427.2011.02730.x; Bekefi E, 2007, AQUACULT INT, V15, P227, DOI 10.1007/s10499-007-9090-5; BENDELL BE, 1995, HYDROBIOLOGIA, V302, P133, DOI 10.1007/BF00027038; Beresford AL, 2010, FRESHWATER BIOL, V55, P514, DOI 10.1111/j.1365-2427.2009.02366.x; Binckley CA, 2005, BIOL LETTERS, V1, P370, DOI 10.1098/rsbl.2005.0310; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Carpenter S. R., 1996, TROPHIC CASCADE LAKE; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chesson P, 1997, AM NAT, V150, P519, DOI 10.1086/286080; Chester ET, 2013, BIOL CONSERV, V166, P64, DOI 10.1016/j.biocon.2013.06.016; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; COLLINSON NH, 1995, BIOL CONSERV, V74, P125, DOI 10.1016/0006-3207(95)00021-U; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dai YR, 2011, FRESEN ENVIRON BULL, V20, P363; de Vicente I, 2010, HYDROBIOLOGIA, V651, P253, DOI 10.1007/s10750-010-0304-x; Dodds WK, 2013, ENVIRON SCI TECHNOL, V47, P9061, DOI 10.1021/es4021052; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Flossner D, 2000, HAPLOPODA CLADOCERA; Gulati RD, 2002, HYDROBIOLOGIA, V478, P73, DOI 10.1023/A:1021092427559; Hassall C, 2012, BIODIVERS CONSERV, V21, P829, DOI 10.1007/s10531-011-0223-9; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; John DM., 2002, FRESHWATER ALGAL FLO; Jones JI, 2003, ECOLOGY, V84, P2155, DOI 10.1890/02-0422; Kerfoot W. C., 1987, PREDATION DIRECT IND; Kloskowski J, 2012, OIKOS, V121, P1567, DOI 10.1111/j.1600-0706.2011.19942.x; Knorp NE, 2014, FRESHWATER BIOL, V59, P1378, DOI 10.1111/fwb.12352; Knosche R, 2000, FISHERIES MANAG ECOL, V7, P15, DOI 10.1046/j.1365-2400.2000.00198.x; Koroleff F, 1970, 3 INT CONS INT EXPL; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lemmens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072538; Leps J, 2003, MULTIVARIATE ANAL EC; Louette G, 2005, ECOLOGY, V86, P353, DOI 10.1890/04-0403; Maret TJ, 2006, BIOL CONSERV, V127, P129, DOI 10.1016/j.biocon.2005.08.003; McGowan S, 2005, ECOSYSTEMS, V8, P694, DOI 10.1007/s10021-003-0152-x; Miller SA, 2006, FRESHWATER BIOL, V51, P85, DOI 10.1111/j.1365-2427.2005.01477.x; Nicolet P, 2004, BIOL CONSERV, V120, P261, DOI 10.1016/j.biocon.2004.03.010; Nienhuis PH, 2002, HYDROBIOLOGIA, V478, P219, DOI 10.1023/A:1021090900341; Oertli B, 2005, AQUAT CONSERV, V15, P535, DOI 10.1002/aqc.752; Oksanen JF, 2010, VEGAN COMMUNITY ECOL; Pechar L, 2000, FISHERIES MANAG ECOL, V7, P23, DOI 10.1046/j.1365-2400.2000.00193.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Roozen FCJM, 2007, FRESHWATER BIOL, V52, P977, DOI 10.1111/j.1365-2427.2007.01729.x; Sayer C, 2012, AQUAT CONSERV, V22, P626, DOI 10.1002/aqc.2254; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Schilling EG, 2009, FRESHWATER BIOL, V54, P181, DOI 10.1111/j.1365-2427.2008.02096.x; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; Talling JF, 1963, SOME PROBLEMS ESTIMA; Tansley AG, 1946, INTRO PLANT ECOLOGY; Usio N, 2013, CONSERV BIOL, V27, P1429, DOI 10.1111/cobi.12096; Van de Meutter F, 2006, ECOGRAPHY, V29, P223, DOI 10.1111/j.2006.0906-7590.04483.x; Van Geest GJ, 2005, J APPL ECOL, V42, P251, DOI 10.1111/j.1365-2664.2005.00995.x; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vonesh JR, 2009, OIKOS, V118, P1219, DOI 10.1111/j.1600-0706.2009.17369.x; Wagner T, 2002, LAKE RESERV MANAGE, V18, P52, DOI 10.1080/07438140209353929; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wezel A, 2014, LIMNOLOGY, V15, P213, DOI 10.1007/s10201-013-0419-7; Wezel A, 2013, LIMNOLOGY, V15, P1; WILCOX DA, 1991, CAN J BOT, V69, P1542, DOI 10.1139/b91-198; Zambrano L, 2001, OIKOS, V94, P344, DOI 10.1034/j.1600-0706.2001.940215.x; Zedler JB, 2000, TRENDS ECOL EVOL, V15, P402, DOI 10.1016/S0169-5347(00)01959-5	71	8	8	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139371	10.1371/journal.pone.0139371	http://dx.doi.org/10.1371/journal.pone.0139371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422390	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700102
J	Lim, LM; Zhao, X; Chao, MC; Chang, JM; Chang, WC; Kao, HY; Hwang, DY; Chen, HC				Lim, Lee-Moay; Zhao, Xuan; Chao, Mei-Chyn; Chang, Jer-Ming; Chang, Wei-Chiao; Kao, Hung-Ying; Hwang, Daw-Yang; Chen, Hung-Chun			Novel Vitamin D Receptor Mutations in Hereditary Vitamin D Resistant Rickets in Chinese	PLOS ONE			English	Article							BINDING DOMAIN; ALOPECIA; THERAPY; 1,25-DIHYDROXYVITAMIN-D; CALCITRIOL; PROTEIN; LIGAND; HVDRR; GENE	Hereditary 1, 25-dihydroxyvitamin D-resistant rickets (HVDRR), a rare recessive disease, is caused by mutation in the VDR gene encoding the vitamin D receptor leading to the resistance to vitamin D. We described a female toddler with initial presentation of leg tenderness and clinical features of HVDRR including severe rickets, hypocalcemia and hypophosphatemia without alopecia. Genetic analysis revealed novel compound heterozygous mutations of p.M4I and p.H229Q in patient's VDR gene. In cis p.M4I with FOKI-F eliminated both translation start sites of the VDR protein. The p.H229Q VDR exhibited significantly reduced VDR transactivation activity with intact dimerization with RXR. Our report expanded the mutation spectrum of HVDRR, and provided the first case of a benign variant p.M4I plus a common p.M1T polymorphism leading to a pathogenic allele.	[Lim, Lee-Moay; Hwang, Daw-Yang; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Med, Kaohsiung, Taiwan; [Zhao, Xuan; Kao, Hung-Ying] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Chao, Mei-Chyn] Kaohsiung Med Univ Hosp, Dept Pediat, Div Genet Endocrinol & Metab, Kaohsiung, Taiwan; [Chang, Jer-Ming] Kaohsiung Municipal Hsiaokang Hosp, Dept Med, Kaohsiung, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Dept Clin Pharm, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharm, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Hwang, Daw-Yang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Lipid & Glycomed Res, Kaohsiung, Taiwan; [Chang, Jer-Ming; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Case Western Reserve University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Taipei Medical University; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Hwang, DY (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Dept Med, Kaohsiung, Taiwan.	910208@kmuh.org.tw		Hsu, ShuChien/0000-0002-5321-4681; Chang, Wei-Chiao/0000-0002-8573-5924	Kaohsiung Medical University Aim for the Top Universities [KMU-TP103D15]; KMUH Nephrology Research Fund; NIH [RO1 DK078965, HL093269]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	Kaohsiung Medical University Aim for the Top Universities; KMUH Nephrology Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported partially by Kaohsiung Medical University Aim for the Top Universities Grant KMU-TP103D15, KMUH Nephrology Research Fund, and partly supported by NIH RO1 DK078965 and HL093269 to H.-Y. Kao.	Adams JS, 2007, ANN NY ACAD SCI, V1117, P94, DOI 10.1196/annals.1402.036; BLIZIOTES M, 1988, J CLIN ENDOCR METAB, V66, P294, DOI 10.1210/jcem-66-2-294; Chen H, 2006, J BIOL CHEM, V281, P39114, DOI 10.1074/jbc.M608006200; Demay MB, 2012, ARCH BIOCHEM BIOPHYS, V523, P19, DOI 10.1016/j.abb.2011.10.002; Feldman David, 2014, Bonekey Rep, V3, P510, DOI 10.1038/bonekey.2014.5; Forghani N, 2010, J PEDIATR ENDOCR MET, V23, P843, DOI 10.1515/jpem.2010.136; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; HEWISON M, 1993, CLIN ENDOCRINOL, V39, P663, DOI 10.1111/j.1365-2265.1993.tb02424.x; HOCHBERG Z, 1992, J PEDIATR-US, V121, P803, DOI 10.1016/S0022-3476(05)81919-5; Huang K, 2013, GENE, V512, P554, DOI 10.1016/j.gene.2012.09.078; Kraichely DM, 1999, J BIOL CHEM, V274, P14352, DOI 10.1074/jbc.274.20.14352; Lin NUT, 1996, J CLIN ENDOCR METAB, V81, P2564, DOI 10.1210/jc.81.7.2564; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Malloy PJ, 2011, MOL CELL ENDOCRINOL, V347, P90, DOI 10.1016/j.mce.2011.05.045; Malloy PJ, 2011, J BONE MINER RES, V26, P2710, DOI 10.1002/jbmr.484; Malloy PJ, 2010, ENDOCRIN METAB CLIN, V39, P333, DOI 10.1016/j.ecl.2010.02.004; Malloy PJ, 2010, MOL GENET METAB, V99, P72, DOI 10.1016/j.ymgme.2009.09.004; Malloy PJ, 1999, ENDOCR REV, V20, P156, DOI 10.1210/er.20.2.156; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Rochel N, 2006, CURR TOP MED CHEM, V6, P1229, DOI 10.2174/156802606777864926; Srivastava T, 2013, J BONE MINER RES, V28, P992, DOI 10.1002/jbmr.1838; Tiosano D, 2013, J CLIN ENDOCR METAB, V98, P1685, DOI 10.1210/jc.2012-3858; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vaisanen S, 2002, MOL PHARMACOL, V62, P788, DOI 10.1124/mol.62.4.788; Vaisanen S, 1998, FEBS LETT, V440, P203, DOI 10.1016/S0014-5793(98)01436-7; Wu SP, 2011, DISCOV MED, V11, P325	27	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138152	10.1371/journal.pone.0138152	http://dx.doi.org/10.1371/journal.pone.0138152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422470	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700032
J	Sanci, L; Chondros, P; Sawyer, S; Pirkis, J; Ozer, E; Hegarty, K; Yang, F; Grabsch, B; Shiell, A; Cahill, H; Ambresin, AE; Patterson, E; Patton, G				Sanci, Lena; Chondros, Patty; Sawyer, Susan; Pirkis, Jane; Ozer, Elizabeth; Hegarty, Kelsey; Yang, Fan; Grabsch, Brenda; Shiell, Alan; Cahill, Helen; Ambresin, Anne-Emmanuelle; Patterson, Elizabeth; Patton, George			Responding to Young People's Health Risks in Primary Care: A Cluster Randomised Trial of Training Clinicians in Screening and Motivational Interviewing	PLOS ONE			English	Article							PREVENTIVE SERVICES; COMPLEX INTERVENTIONS; GENERAL-PRACTITIONERS; ADOLESCENTS; ENGAGEMENT; CHALLENGE; MORTALITY; EFFICACY; DELIVERY; SYSTEMS	Objective To evaluate the effectiveness of a complex intervention implementing best practice guidelines recommending clinicians screen and counsel young people across multiple psychosocial risk factors, on clinicians' detection of health risks and patients' risk taking behaviour, compared to a didactic seminar on young people's health. Design Pragmatic cluster randomised trial where volunteer general practices were stratified by postcode advantage or disadvantage score and billing type (private, free national health, community health centre), then randomised into either intervention or comparison arms using a computer generated random sequence. Three months post-intervention, patients were recruited from all practices post-consultation for a Computer Assisted Telephone Interview and followed up three and 12 months later. Researchers recruiting, consenting and interviewing patients and patients themselves were masked to allocation status; clinicians were not. Setting General practices in metropolitan and rural Victoria, Australia Participants General practices with at least one interested clinician (general practitioner or nurse) and their 14-24 year old patients. Intervention This complex intervention was designed using evidence based practice in learning and change in clinician behaviour and general practice systems, and included best practice approaches to motivating change in adolescent risk taking behaviours. The intervention involved training clinicians (nine hours) in health risk screening, use of a screening tool and motivational interviewing; training all practice staff (receptionists and clinicians) in engaging youth; provision of feedback to clinicians of patients' risk data; and two practice visits to support new screening and referral resources. Comparison clinicians received one didactic educational seminar (three hours) on engaging youth and health risk screening. Outcome Measures Primary outcomes were patient report of (1) clinician detection of at least one of six health risk behaviours (tobacco, alcohol and illicit drug use, risks for sexually transmitted infection, STI, unplanned pregnancy, and road risks); and (2) change in one or more of the six health risk behaviours, at three months or at 12 months. Secondary outcomes were likelihood of future visits, trust in the clinician after exit interview, clinician detection of emotional distress and fear and abuse in relationships, and emotional distress at three and 12 months. Patient acceptability of the screening tool was also described for the intervention arm. Analyses were adjusted for practice location and billing type, patients' sex, age, and recruitment method, and past health risks, where appropriate. An intention to treat analysis approach was used, which included multilevel multiple imputation for missing outcome data. Results 42 practices were randomly allocated to intervention or comparison arms. Two intervention practices withdrew post allocation, prior to training, leaving 19 intervention (53 clinicians, 377 patients) and 21 comparison (79 clinicians, 524 patients) practices. 69% of patients in both intervention (260) and comparison (360) arms completed the 12 month follow-up. Intervention clinicians discussed more health risks per patient (59.7%) than comparison clinicians (52.7%) and thus were more likely to detect a higher proportion of young people with at least one of the six health risk behaviours (38.4% vs 26.7%, risk difference [RD] 11.6%, Confidence Interval [CI] 2.93% to 20.3%; adjusted odds ratio [OR] 1.7, CI 1.1 to 2.5). Patients reported less illicit drug use (RD -6.0, CI -11 to -1.2; OR 0.52, CI 0.28 to 0.96), and less risk for STI (RD -5.4, CI -11 to 0.2; OR 0.66, CI 0.46 to 0.96) at three months in the intervention relative to the comparison arm, and for unplanned pregnancy at 12 months (RD -4.4; CI -8.7 to -0.1; OR 0.40, CI 0.20 to 0.80). No differences were detected between arms on other health risks. There were no differences on secondary outcomes, apart from a greater detection of abuse (OR 13.8, CI 1.71 to 111). There were no reports of harmful events and intervention arm youth had high acceptance of the screening tool. Conclusions A complex intervention, compared to a simple educational seminar for practices, improved detection of health risk behaviours in young people. Impact on health outcomes was inconclusive. Technology enabling more efficient, systematic health-risk screening may allow providers to target counselling toward higher risk individuals. Further trials require more power to confirm health benefits.	[Sanci, Lena; Chondros, Patty; Hegarty, Kelsey; Yang, Fan; Grabsch, Brenda] Univ Melbourne, Melbourne Med Sch, Dept Gen Practice, Carlton, Vic 3053, Australia; [Sawyer, Susan; Patton, George] Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; [Sawyer, Susan; Patton, George] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Sawyer, Susan; Patton, George] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Pirkis, Jane] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic 3010, Australia; [Ozer, Elizabeth] Univ Calif San Francisco, Div Adolescent & Young Adult Med, San Francisco, CA 94118 USA; [Ozer, Elizabeth] Univ Calif San Francisco, UCSF Off Divers & Outreach, San Francisco, CA 94118 USA; [Shiell, Alan] Ctr Excellence Intervent & Prevent Sci Ltd, Carlton, Vic 3053, Australia; [Cahill, Helen] Univ Melbourne, Melbourne Grad Sch Educ, Youth Res Ctr, Carlton, Vic 3053, Australia; [Ambresin, Anne-Emmanuelle] CHU Vaudois, Div Interdisciplinaire Sante Adolescents, CH-101 Lausanne, Switzerland; [Patterson, Elizabeth] Univ Melbourne, Melbourne Sch Hlth Sci, Dept Nursing, Carlton, Vic 3053, Australia	University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Melbourne; University of Melbourne	Sanci, L (corresponding author), Univ Melbourne, Melbourne Med Sch, Dept Gen Practice, 200 Berkeley St, Carlton, Vic 3053, Australia.	l.sanci@unimelb.edu.au	Shiell, Alan/AAL-4146-2020; Chondros, Patty/AAT-6426-2020; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022	Shiell, Alan/0000-0001-5914-1084; Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Ambresin, Anne-emmanuelle/0000-0001-8386-4231; Chondros, Patty/0000-0003-0393-8734; Hegarty, Kelsey/0000-0002-7532-5147; Cahill, Helen/0000-0002-5395-8920	Australian Health Ministers' Advisory Council [AHMAC PDR 2005/06]; Australian Primary Health Care Research Institute; National Health and Medical Research Council [566849]	Australian Health Ministers' Advisory Council; Australian Primary Health Care Research Institute; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants from the Australian Health Ministers' Advisory Council (AHMAC PDR 2005/06, http://www.health.gov.au/internet/publications/publishing.nsf/Content/min-briefs-vol3-toc similar to min-briefs-vol3-min-council similar to min-briefs-vol3-ahmac); Australian Primary Health Care Research Institute (http://aphcri.anu.edu.au/); National Health and Medical Research Council (566849, https://www.nhmrc.gov.au). The funding bodies had no role in the study design, data collection, analysis, interpretation, or manuscript writing.	American Academy of Pediatrics, 2010, BRIGHT FUT PREV HLTH; Australian Bureau of Statistic, 2006, SEIFA SOC IND AR; Australian Government Department of Health and Ageing, 2014, FACT SHEETS PROF MED; Beilby JJ, 2007, MED J AUSTRALIA, V187, P69, DOI 10.5694/j.1326-5377.2007.tb01141.x; Blackberry ID, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5272; Booth ML, 2008, J PAEDIATR CHILD H, V44, P699, DOI 10.1111/j.1440-1754.2008.01409.x; Borowsky IW, 2003, PEDIATRICS, V112, P129, DOI 10.1542/peds.112.1.129; Bradford S, 2012, ADOLESC HEALTH MED T, V3, P111, DOI 10.2147/AHMT.S38442; Britt H, 2011, GEN PRACTICE ACTIVIT; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Carne A., 2013, SUMMARY DATA REPORT; Chen XG, 2011, J ADOLESCENT HEALTH, V49, P193, DOI 10.1016/j.jadohealth.2010.11.252; Coups EJ, 2004, AM J PREV MED, V27, P34, DOI 10.1016/j.amepre.2004.04.021; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; Department of Health and Aged Care, 2001, MEAS REM ACC REM IND; Department of Health (UK), 2011, QUAL CRIT YOUNG PEOP; DOWNS SM, 1995, ARCH PEDIAT ADOL MED, V149, P374, DOI 10.1001/archpedi.1995.02170160028004; Eldridge Sandra M, 2004, Clin Trials, V1, P80, DOI 10.1191/1740774504cn006rr; Family Medicine Research Centre, 1998, ICPC 2 PLUS DEM; Ford CA, 1997, JAMA-J AM MED ASSOC, V278, P1029, DOI 10.1001/jama.278.12.1029; Goldenring JM, 2004, CONT PEDIAT, V21, P64; Goodman SN, 1998, AM J EPIDEMIOL, V147, P807, DOI 10.1093/oxfordjournals.aje.a009531; Haines A, 2002, GETTING RES FINDINGS, P1; Hegarty K, 2013, LANCET, V382, P249, DOI 10.1016/S0140-6736(13)60052-5; Joseph JG, 2009, AM J PUBLIC HEALTH, V99, P1053, DOI 10.2105/AJPH.2007.131425; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Klein J D, 2002, Minerva Pediatr, V54, P25; Klein JD, 1999, HEALTH SERV RES, V34, P391; Lally P, 2010, EUR J SOC PSYCHOL, V40, P998, DOI 10.1002/ejsp.674; Lustig JL, 2001, PEDIATRICS, V107, P1100, DOI 10.1542/peds.107.5.1100; Margolis PA, 2004, BMJ-BRIT MED J, V328, P388, DOI 10.1136/bmj.38009.706319.47; Moon L., 1999, AUSTR YOUNG PEOPLE T; Moyer VA, 2004, PEDIATRICS, V114, P1511, DOI 10.1542/peds.2004-1076; National Collaborating Centre for Mental Health (UK), 2005, DEPR CHILDR YOUNG PE; NHMRC, 2009, AUSTR GUID RED HLTH; Olson AL, 2009, ARCH PEDIAT ADOL MED, V163, P172, DOI 10.1001/archpediatrics.2008.533; Ozer EM, 2011, J ADOLESCENT HEALTH, V49, P476, DOI 10.1016/j.jadohealth.2011.02.011; Ozer EM, 2009, J ADOLESCENT HEALTH, V44, P520, DOI 10.1016/j.jadohealth.2008.12.016; Ozer EM, 2005, PEDIATRICS, V115, P960, DOI 10.1542/peds.2004-0520; Patel V, 2012, LANCET, V379, P2343, DOI 10.1016/S0140-6736(12)60606-0; Patton GC, 2002, BMJ-BRIT MED J, V325, P1195, DOI 10.1136/bmj.325.7374.1195; Patton GC, 2012, LANCET, V379, P1665, DOI 10.1016/S0140-6736(12)60203-7; Pfaff JJ, 2001, MED J AUSTRALIA, V174, P222, DOI 10.5694/j.1326-5377.2001.tb143241.x; Primary Health Care Research and Information Service, GEN PRACT SIZ AUSTR; Primary Health Care Research & Information Service, 2014, FEM GP NUMB STAT 201; Primary Health Care Research & Information Service, 2013, KEY DIV GEN PRACT CH; Reid SC, 2007, AUST NZ J PSYCHIAT, V41, P436, DOI 10.1080/00048670701264784; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sanci LA, 2000, BRIT MED J, V320, P224, DOI 10.1136/bmj.320.7229.224; Sanci L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-400; Sanci L, 2011, J ADOLESCENT HEALTH, V49, P450, DOI 10.1016/j.jadohealth.2011.09.002; Sawyer SM, 2012, LANCET, V379, P1630, DOI 10.1016/S0140-6736(12)60072-5; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; StataCorp, 2013, STAT STAT SOFTW REL; Stevens MM, 2002, PEDIATRICS, V109, P490, DOI 10.1542/peds.109.3.490; Thom DH, 1997, J FAM PRACTICE, V44, P169; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; Ustin T, 1995, MENTAL ILLNESS GEN H; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2; Walker Z, 2002, BRIT MED J, V325, P524, DOI 10.1136/bmj.325.7363.524; World Health Organisation, UN HLTH COV NEW FRAM; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	64	45	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137581	10.1371/journal.pone.0137581	http://dx.doi.org/10.1371/journal.pone.0137581			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422235	Green Published, gold			2022-12-27	WOS:000362175700016
J	Wang, Y; Huang, L; Wu, SQ; Jia, YS; Yang, YM; Luo, LM; Bi, AH; Fang, M				Wang, Ying; Huang, Lu; Wu, Shuqiang; Jia, Yongshi; Yang, Yunmei; Luo, Limin; Bi, Aihong; Fang, Min			Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FACTOR-BETA; INTERACTION NETWORKS; SIGNALING PATHWAYS; GENE; ANGIOGENESIS; EXPRESSION; ADENOCARCINOMA; BETA-IG-H3; EGFR; P53	Purpose This study was aimed to identify the expression pattern of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC) and to explore its potential correlation with the progression of NSCLC. Methods Gene expression profile GSE39345 was downloaded from the Gene Expression Omnibus database. Twenty healthy controls and 32 NSCLC samples before chemotherapy were analyzed to identify the differentially expressed genes (DEGs). Then pathway enrichment analysis of the DEGs was performed and protein-protein interaction networks were constructed. Particularly, VEGF genes and the VEGF signaling pathway were analyzed. The sub-network was constructed followed by functional enrichment analysis. Results Total 1666 up-regulated and 1542 down-regulated DEGs were identified. The down-regulated DEGs were mainly enriched in the pathways associated with cancer. VEGFA and VEGFB were found to be the initiating factor of VEGF signaling pathway. In addition, in the epidermal growth factor receptor (EGFR), VEGFA and VEGFB associated sub-network, kinase insert domain receptor (KDR), fibronectin 1 (FN1), transforming growth factor beta induced (TGFBI) and proliferating cell nuclear antigen (PCNA) were found to interact with at least two of the three hub genes. The DEGs in this sub-network were mainly enriched in Gene Ontology terms related to cell proliferation. Conclusion EGFR, KDR, FN1, TGFBI and PCNA may interact with VEGFA to play important roles in NSCLC tumorigenesis. These genes and corresponding proteins may have the potential to be used as the targets for either diagnosis or treatment of patients with NSCLC.	[Wang, Ying; Wu, Shuqiang; Jia, Yongshi; Luo, Limin; Bi, Aihong; Fang, Min] Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Hangzhou 310014, Zhejiang, Peoples R China; [Huang, Lu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Orthoped, Hangzhou 310009, Zhejiang, Peoples R China; [Yang, Yunmei] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Geriatr, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang University; Zhejiang University	Wu, SQ (corresponding author), Zhejiang Prov Peoples Hosp, Dept Radiat Oncol, Hangzhou 310014, Zhejiang, Peoples R China.	srmflk123456@163.com	yang, yang/GWB-9426-2022; Lang, Ming/HIK-0758-2022		Zhejiang Provincial Medical Technology Program of China [2013KYB106]; Zhejiang Provincial Natural Science Foundation of China [LQ15H060002]	Zhejiang Provincial Medical Technology Program of China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by Zhejiang Provincial Medical Technology Program of China (No. 2013KYB106) and Zhejiang Provincial Natural Science Foundation of China (No. LQ15H060002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Arakelyan A, 2013, BIOINFORMATICS, V29, P518, DOI 10.1093/bioinformatics/bts730; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Chakraborty S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099743; Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057053; de Castro J, 2014, AM J CLIN PATHOL, V142, P111, DOI 10.1309/AJCP1QUQQLLT8BLI; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; Deng ZC, 2014, TUMOR BIOL, V35, P1805, DOI 10.1007/s13277-013-1241-x; Ellis Lee M, 2006, Clin Adv Hematol Oncol, V4, P1; Fontanini G, 1998, EUR J CANCER, V34, P718, DOI 10.1016/S0959-8049(97)10145-9; Gentleman R., 2006, BIOINFORMATICS COMPU; Gold LI, 1999, CRIT REV ONCOGENESIS, V10, P303; Harpole DH, 1996, ANN THORAC SURG, V61, P1470, DOI 10.1016/0003-4975(96)00104-X; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janssen-Heijnen MLG, 2003, LUNG CANCER-J IASLC, V41, P245, DOI 10.1016/S0169-5002(03)00230-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KIESER A, 1994, ONCOGENE, V9, P963; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Larsen AK, 2011, PHARMACOL THERAPEUT, V131, P80, DOI 10.1016/j.pharmthera.2011.03.012; Li X., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.12942/LRSP-2011-1); Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahapatra A, 2010, ACS CHEM BIOL, V5, P529, DOI 10.1021/cb1001476; Meng XN, 2009, BRIT J CANCER, V101, P327, DOI 10.1038/sj.bjc.6605154; Nguyen VN, 2000, ACTA HISTOCHEM, V102, P323, DOI 10.1078/S0065-1281(04)70039-2; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Pennell NA, 2009, ONCOLOGIST, V14, P399, DOI 10.1634/theoncologist.2008-0276; Rusch Valerie, 1996, Cytokine and Growth Factor Reviews, V7, P133, DOI 10.1016/1359-6101(96)00016-0; Sasaki Hidefumi, 2003, Int J Clin Oncol, V8, P79, DOI 10.1007/s101470300014; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; She J, 2013, CHEST, V143, P1117, DOI 10.1378/chest.11-2948; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tsiambas E, 2007, CANCER INFORM, V3, P275; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	40	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139285	10.1371/journal.pone.0139285	http://dx.doi.org/10.1371/journal.pone.0139285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422603	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700090
J	Farid, K; Hong, YT; Aigbirhio, FI; Fryer, TD; Menon, DK; Warburton, EA; Baron, JC				Farid, Karim; Hong, Young T.; Aigbirhio, Franklin I.; Fryer, Tim D.; Menon, David K.; Warburton, Elizabeth A.; Baron, Jean-Claude			Early-Phase C-11-PiB PET in Amyloid Angiopathy-Related Symptomatic Cerebral Hemorrhage: Potential Diagnostic Value?	PLOS ONE			English	Article							PITTSBURGH COMPOUND-B; MILD COGNITIVE IMPAIRMENT; BRAIN GLUCOSE-UTILIZATION; ALZHEIMERS-DISEASE; PIB-PET; VOLUME; HYPOMETABOLISM; METABOLISM; DIASCHISIS; DEMENTIA	Although late-phase (>35min post-administration) C-11-PiB-PET has good sensitivity in cerebral amyloid angiopathy (CAA), its specificity is poor due to frequently high uptake in healthy aged subjects. By detecting perfusion-like abnormalities, early-phase C-11-PiB-PET might add diagnostic value. Early-frame (1-6min) C-11-PiB-PET was obtained in 11 non-demented patients with probable CAA-related symptomatic lobar intracerebral haemorrhage (70 +/- 7yrs), 9 age-matched healthy controls (HCs) and 10 HCs <55yrs. There was a significant decrease in early-phase atrophy-corrected whole-cortex SUV relative to cerebellar vermis (SUVR) in the CAA vs age-matched HC group. None of the age-matched controls fell below the lower 95% confidence limit derived from the young HCs, while 6/11 CAA patients did (sensitivity = 55%, specificity = 100%). Combining both early-and late-phase C-11-PiB data did not change the sensitivity and specificity of late-phase PiB, but combined early-and late-phase positivity entails a very high suspicion of underlying A beta-related clinical disorder, i.e., CAA or Alzheimer disease (AD). In order to clarify this ambiguity, we then show that the occipital/posterior cingulate ratio is markedly lower in CAA than in AD (N = 7). These pilot data suggest that early-phase C-11-PiB-PET may not only add to late-phase PiB-PET with respect to the unclear situation of late-phase positivity, but also help differentiate CAA from AD.	[Farid, Karim] Hop Hotel Dieu, APHP, Dept Nucl Med, Paris, France; [Farid, Karim] Martinique Univ Hosp, Dept Nucl Med, Fort De France, French West Ind, France; [Hong, Young T.; Aigbirhio, Franklin I.; Fryer, Tim D.] Univ Cambridge, Wolfson Brain Imaging Ctr, Dept Clin Neurosci, Cambridge, England; [Menon, David K.] Univ Cambridge, Div Anesthesia, Cambridge, England; [Warburton, Elizabeth A.; Baron, Jean-Claude] Univ Cambridge, Stroke Res Grp, Dept Clin Neurosci, Cambridge, England; [Warburton, Elizabeth A.] Addenbrookes Hosp, Stroke Unit, Cambridge, England; [Baron, Jean-Claude] Sorbonne Paris Cite, INSERM, U894, Ctr Hosp St Anne, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Martinique; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; GHU PARIS Psychiatrie Neurosciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Baron, JC (corresponding author), Univ Cambridge, Stroke Res Grp, Dept Clin Neurosci, Cambridge, England.	jean-claude.baron@inserm.fr		baron, jean-claude/0000-0002-5264-2588	Cambridge Comprehensive Biomedical Centre; National Institute for Health Research [NF-SI-0512-10090] Funding Source: researchfish	Cambridge Comprehensive Biomedical Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Cambridge Comprehensive Biomedical Centre.	Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Baron JC, 2014, J CEREBR BLOOD F MET, V34, P753, DOI 10.1038/jcbfm.2014.43; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Catafau AM, 2015, CLIN TRANSL IMAGING, V3, P39, DOI 10.1007/s40336-014-0098-3; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; Chetelat G, 2013, NEUROIMAGE-CLIN, V2, P356, DOI 10.1016/j.nicl.2013.02.006; Chung YA, 2009, J NUCL MED, V50, P1969, DOI 10.2967/jnumed.109.062315; Desgranges B, 1998, BRAIN, V121, P611, DOI 10.1093/brain/121.4.611; Dumas A, 2012, ANN NEUROL, V72, P76, DOI 10.1002/ana.23566; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Forsberg A, 2012, BBA-MOL BASIS DIS, V1822, P380, DOI 10.1016/j.bbadis.2011.11.006; Greenberg SM, 2008, ANN NEUROL, V64, P587, DOI 10.1002/ana.21528; Hsiao IT, 2012, EUR J NUCL MED MOL I, V39, P613, DOI 10.1007/s00259-011-2051-2; Iglesias S, 2000, CEREBROVASC DIS, V10, P391, DOI 10.1159/000016096; Iwasaki Yasushi, 2010, Rinsho Shinkeigaku, V50, P651; Johnson KA, 2007, ANN NEUROL, V62, P229, DOI 10.1002/ana.21164; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Koeppe RA, 2005, J NUCL MED, V46, P936; Laymon CM, 2010, NEUROIMAGE, V52, pS219, DOI 10.1016/j.neuroimage.2010.04.178; Lewis DH, 2012, SEMIN NUCL MED, V42, P387, DOI 10.1053/j.semnuclmed.2012.06.002; Linn J, 2010, NEUROLOGY, V74, P1346, DOI 10.1212/WNL.0b013e3181dad605; Lowe VJ, 2014, NEUROLOGY, V82, P1959, DOI 10.1212/WNL.0000000000000467; Marcus C, 2014, CLIN NUCL MED, V39, pE413, DOI 10.1097/RLU.0000000000000547; MASUDA J, 1988, STROKE, V19, P205, DOI 10.1161/01.STR.19.2.205; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MELTZER CC, 1990, J COMPUT ASSIST TOMO, V14, P561, DOI 10.1097/00004728-199007000-00011; Meltzer CC, 1999, J NUCL MED, V40, P2053; Mevel K, 2007, NEUROIMAGE, V37, P18, DOI 10.1016/j.neuroimage.2007.04.048; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Mosconi L, 2013, J ALZHEIMERS DIS, V35, P509, DOI 10.3233/JAD-121867; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Protas HD, 2013, JAMA NEUROL, V70, P320, DOI 10.1001/2013.jamaneurol.286; Quarantelli M, 2004, J NUCL MED, V45, P192; Rocher AB, 2003, NEUROIMAGE, V20, P1894, DOI 10.1016/j.neuroimage.2003.07.002; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Tian J, 2004, PANMINERVA MED, V46, P253; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VINTERS HV, 1983, STROKE, V14, P924, DOI 10.1161/01.STR.14.6.924	38	20	24	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139926	10.1371/journal.pone.0139926	http://dx.doi.org/10.1371/journal.pone.0139926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439113	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300078
J	Henriksen, DP; Rasmussen, L; Hansen, MR; Hallas, J; Pottegard, A				Henriksen, Daniel Pilsgaard; Rasmussen, Lotte; Hansen, Morten Rix; Hallas, Jesper; Pottegard, Anton			Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use-A Descriptive Cross-Sectional Study	PLOS ONE			English	Article							CIVIL REGISTRATION SYSTEM; EPIDEMIOLOGY; REGISTERS; DENMARK	Background While Denmark is well known for its plethora of registers. Many studies are conducted on research databases that only cover parts of Denmark, and regional differences could potentially threaten these studies' external validity. The aim of this study was to assess sociodemographic and health related homogeneity of the five Danish regions. Methods We obtained descriptive data for the five Danish regions, using publicly available data sources: Statbank Denmark, the Danish Ministry of Economic Affairs, and Medstat.dk. These data sources comprise aggregate data from four different nationwide registers: The Danish National Patient Register, The Danish Civil Registration System, The Danish Register of Medicinal Product Statistics, and The Danish National Health Service Register for Primary Care. We compared the Danish regions regarding demographic and socioeconomic characteristics, health care utilization, and use of medication. For each characteristic, one-year prevalence was obtained and analyses were performed for 2013 and 2008 to account for possible change over time. Results In 2013, 5,602,628 persons were living in Denmark. The mean age was 40.7 years in the entire Danish population and ranged between 39.6 to 42.4 years in the five regions (coefficient of variation between regions [CV] = 0.028). The proportion of women in Denmark was 50.4% (CV = 0.009). The proportion of residents with low education level was 28.7% (CV = 0.051). The annual number of GP contacts was 7.1 (range: 6.7-7.4, CV = 0.040), and 114 per 1,000 residents were admitted to the hospital (range: 101-131, CV = 0.107). The annual number of persons redeeming a prescription of any medication was 723 per 1,000 residents (range: 718743, CV = 0.016). Analyses for 2008 showed comparable levels of homogeneity as for 2013. Conclusions We found substantial homogeneity between all of the five Danish regions with regard to sociodemographic and health related characteristics. Epidemiologic studies conducted on regional subsets of Danish citizens have a high degree of generalizability.	[Henriksen, Daniel Pilsgaard] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense C, Denmark; [Rasmussen, Lotte; Hansen, Morten Rix; Hallas, Jesper; Pottegard, Anton] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, Odense, Denmark; [Hansen, Morten Rix; Hallas, Jesper] Odense Univ Hosp, Dept Clin Chem & Pharmacol, DK-5000 Odense C, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Henriksen, DP (corresponding author), Odense Univ Hosp, Dept Resp Med, DK-5000 Odense C, Denmark.	dphenriksen@health.sdu.dk	hansen, morten rix/P-8961-2019	hansen, morten rix/0000-0002-1582-7866; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195; Rasmussen, Lotte/0000-0001-5962-6647; Pottegard, Anton/0000-0001-9314-5679				Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; [Anonymous], 2015, OV DAN ED SYST; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Boyko EJ, 2000, AM J EPIDEMIOL, V151, P307, DOI 10.1093/oxfordjournals.aje.a010207; Danske Regioner (forening), 2012, REG BRIEF; de Lusignan S, 2006, FAM PRACT, V23, P253, DOI 10.1093/fampra/cmi106; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Frank L, 2003, SCIENCE, V301, P163, DOI 10.1126/science.301.5630.163; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Gaist D, 1997, DAN MED BULL, V44, P445; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Gradel KO, 2014, CLIN EPIDEMIOL, V6, P301, DOI 10.2147/CLEP.S66998; Grann Erichsen R, 2011, CLIN EPIDEMIOL, P133, DOI [10.2147/CLEP.S17901, DOI 10.2147/CLEP.S17901]; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Hennessy S, 2012, US GOVT CLAIMS DATAB, P209; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Pobereskin LH, 2000, BRIT MED J, V320, P1277, DOI 10.1136/bmj.320.7244.1277; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Statens Serum Institut, MEDST DK DAT BAS DES; Statistics Denmark, 2015, STATBANK DENM; Statistics Denmark, 2015, US STAT DENM; Thygesen LC, 2011, SCAND J PUBLIC HEALT, V39, P12, DOI 10.1177/1403494811399956; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A	29	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140197	10.1371/journal.pone.0140197	http://dx.doi.org/10.1371/journal.pone.0140197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439627	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300101
J	Kahn, JM; Barnato, AE; Lave, JR; Pike, F; Weissfeld, LA; Le, TQ; Angus, DC				Kahn, Jeremy M.; Barnato, Amber E.; Lave, Judith R.; Pike, Francis; Weissfeld, Lisa A.; Le, Tri Q.; Angus, Derek C.			A Comparison of Free-Standing versus Co-Located Long-Term Acute Care Hospitals	PLOS ONE			English	Article							MECHANICALLY VENTILATED PATIENTS; SURVIVAL; OUTCOMES	Background Long-term acute care hospitals (LTACs) provide specialized treatment for patients with chronic critical illness. Increasingly LTACs are co-located within traditional short-stay hospitals rather than operated as free-standing facilities, which may affect LTAC utilization patterns and outcomes. Methods We compared free-standing and co-located LTACs using 2005 data from the United States Centers for Medicare & Medicaid Services. We used bivariate analyses to examine patient characteristics and timing of LTAC transfer, and used propensity matching and multivariable regression to examine mortality, readmissions, and costs after transfer. Results Of 379 LTACs in our sample, 192 (50.7%) were free-standing and 187 (49.3%) were co-located in a short-stay hospital. Co-located LTACs were smaller (median bed size: 34 vs. 66, p < 0.001) and more likely to be for-profit (72.2% v. 68.8%, p = 0.001) than freestanding LTACs. Co-located LTACs admitted patients later in their hospital course (average time prior to transfer: 15.5 days vs. 14.0 days) and were more likely to admit patients for ventilator weaning (15.9% vs. 12.4%). In the multivariate propensity-matched analysis, patients in co-located LTACs experienced higher 180-day mortality (adjusted relative risk: 1.05, 95% CI: 1.00-1.11, p = 0.04) but lower readmission rates (adjusted relative risk: 0.86, 95% CI: 0.75-0.98, p = 0.02). Costs were similar between the two hospital types (mean difference in costs within 180 days of transfer: -$3,580, 95% CI: -$8,720 -$1,550, p = 0.17). Conclusions Compared to patients in free-standing LTACs, patients in co-located LTACs experience slightly higher mortality but lower readmission rates, with no change in overall resource use as measured by 180 day costs.	[Kahn, Jeremy M.; Barnato, Amber E.; Lave, Judith R.; Pike, Francis; Weissfeld, Lisa A.; Angus, Derek C.] Univ Pittsburgh, Sch Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA 15260 USA; [Kahn, Jeremy M.; Barnato, Amber E.; Lave, Judith R.; Le, Tri Q.; Angus, Derek C.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Ctr Res Hlth Care, Pittsburgh, PA USA; [Pike, Francis] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa A.] Stat Collaborat Inc, Washington, DC USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kahn, JM (corresponding author), Univ Pittsburgh, Sch Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Dept Crit Care Med, Pittsburgh, PA 15260 USA.	kahnjm@upmc.edu	Angus, Derek C/E-9671-2012	Kahn, Jeremy/0000-0001-9688-5576	United States National Institutes of Health [R01HL096651, UL1RR024153, UL1TR000005]; Statistics Collaborative, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096651] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Statistics Collaborative, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was funded by the United States National Institutes of Health (R01HL096651, UL1RR024153 and UL1TR000005) and Statistics Collaborative, Inc. The National Institutes of Health had no role in the collection, analysis or interpretation of data; in the writing of the manuscript, or in the decision to submit the manuscript for publication. Statistics Collaborative, Inc. provided support in the form of salary for author LAW but had no role in the collection, analysis or interpretation of data; in the writing of the manuscript, or in the decision to submit the manuscript for publication. The specific role of LAW is articulated in the "author contributions" section.	Carson SS, 2007, CHEST, V131, P2, DOI 10.1378/chest.06-2513; Carson SS, 2012, CRIT CARE MED, V40, P1171, DOI 10.1097/CCM.0b013e3182387d43; Coulam R F, 1991, Health Care Financ Rev Annu Suppl, P45; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dobson A, 2004, THE CLINICAL AND ECO; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Kahn JM, 2013, JAMA-J AM MED ASSOC, V309, P719, DOI 10.1001/jama.2013.848; Kahn JM, 2012, MED CARE RES REV, V69, P339, DOI 10.1177/1077558711432889; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn Jeremy M, 2010, BMC Res Notes, V3, P205, DOI 10.1186/1756-0500-3-205; Kahn JM, 2010, JAMA-J AM MED ASSOC, V303, P2253, DOI 10.1001/jama.2010.761; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; KOSECOFF J, 1990, JAMA-J AM MED ASSOC, V264, P1980, DOI 10.1001/jama.264.15.1980; Liu K, 2001, HEALTH CARE FINANC R, V23, P1; Long-term care hospital services, 2013, REP C MED PAYM POL; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Pilcher DV, 2005, THORAX, V60, P187, DOI 10.1136/thx.2004.026500; Riley GF, 2009, MED CARE, V47, pS51, DOI 10.1097/MLR.0b013e31819c95aa; Robinson JC, 1996, HEALTH AFFAIR, V15, P7, DOI 10.1377/hlthaff.15.1.7; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Scheinhorn DJ, 2007, CHEST, V131, P85, DOI 10.1378/chest.06-1081; Schonhofer B, 2002, INTENS CARE MED, V28, P908, DOI 10.1007/s00134-002-1287-5; Thoemmes FJ, 2011, MULTIVAR BEHAV RES, V46, P514, DOI 10.1080/00273171.2011.569395; Wilcox ME, 2013, CRIT CARE MED, V41, P2253, DOI 10.1097/CCM.0b013e318292313a	25	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139742	10.1371/journal.pone.0139742	http://dx.doi.org/10.1371/journal.pone.0139742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26440102	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000362510300048
J	Nandety, RS; Sharif, A; Kamita, SG; Ramasamy, A; Falk, BW				Nandety, Raja Sekhar; Sharif, Almas; Kamita, Shizuo G.; Ramasamy, Asokan; Falk, Bryce W.			Identification of Novel and Conserved microRNAs in Homalodisca vitripennis, the Glassy-Winged Sharpshooter by Expression Profiling	PLOS ONE			English	Article							BROWN PLANTHOPPER; RT-PCR; QUANTIFICATION; MIRBASE; TRANSCRIPTOME; ANNOTATION; SEQUENCES; SILKWORM; TOOL	The glassy-winged sharpshooter (GWSS) Homalodisca vitripennis (Hemiptera: Cicadellidae), is a xylem-feeding leafhopper and an important vector of the bacterium Xylella fastidiosa; the causal agent of Pierce's disease of grapevines. MicroRNAs are a class of small RNAs that play an important role in the functional development of various organisms including insects. In H. vitripennis, we identified microRNAs using high-throughput deep sequencing of adults followed by computational and manual annotation. A total of 14 novel microRNAs that are not found in the miRBase were identified from adult H. vitripennis. Conserved microRNAs were also found in our datasets. By comparison to our previously determined transcriptome sequence of H. vitripennis, we identified the potential targets of the microRNAs in the transcriptome. This microRNA profile information not only provides a more nuanced understanding of the biological and physiological mechanisms that govern gene expression in H. vitripennis, but may also lead to the identification of novel mechanisms for biorationally designed management strategies through the use of microRNAs.	[Nandety, Raja Sekhar; Sharif, Almas; Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Kamita, Shizuo G.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Ramasamy, Asokan] Indian Inst Hort Res, Div Biotechnol, Bangalore, Karnataka, India	University of California System; University of California Davis; University of California System; University of California Davis; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research	Falk, BW (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bwfalk@ucdavis.edu		Nandety, Raja Sekhar/0000-0002-1129-0790; Yan, Zhiyong/0000-0001-8253-0694	California Department of Agriculture	California Department of Agriculture	This work was supported by the California Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2013, NUCLEIC ACIDS RES, V41, P727, DOI 10.1093/nar/gks1187; Asgari S, 2013, INSECT BIOCHEM MOLEC, V43, P388, DOI 10.1016/j.ibmb.2012.10.005; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Bagnall RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044744; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonev Boyan, 2012, Methods Mol Biol, V917, P445, DOI 10.1007/978-1-61779-992-1_25; Borchert Glen M, 2011, Mob Genet Elements, V1, P8; Cai YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036599; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen J, 2013, INSECT BIOCHEM MOLEC, V43, P839, DOI 10.1016/j.ibmb.2013.06.002; Enright AJ, 2004, GENOME BIOL, V5; Etebari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084747; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Ge X, 2013, INT J BIOL SCI, V9, P1, DOI 10.7150/ijbs.5249; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Griffiths-Jones Sam, 2010, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1209s29; Guo Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059884; Hussain M, 2014, J INSECT PHYSL; Jiang JH, 2013, INSECT BIOCHEM MOLEC, V43, P692, DOI 10.1016/j.ibmb.2013.05.002; Khajuria C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-187; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Liu B, 2014, INSECT MOL BIOL, V23, P216, DOI 10.1111/imb.12075; Luo GZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-727; Marco A, 2013, NUCLEIC ACIDS RES, V41, P7745, DOI 10.1093/nar/gkt534; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Mecchia MA, 2013, MECH DEVELOP, V130, P2, DOI 10.1016/j.mod.2012.07.005; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nandety RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081681; Nandety RS, 2013, VIROLOGY, V442, P12, DOI 10.1016/j.virol.2013.04.005; Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raccuglia D, 2013, LEARN MEMORY, V20, P410, DOI 10.1101/lm.030205.112; Roberts J.T., 2013, MOB GENET ELEMENTS, V3, DOI [10.4161/mge.27755, DOI 10.4161/MGE.27755]; Rosa C, 2012, PEST MANAG SCI, V68, P995, DOI 10.1002/ps.3253; Rubio M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-386; Sattar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048579; Sattar S, 2012, MOL PLANT MICROBE IN, V25, P839, DOI 10.1094/MPMI-09-11-0252; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Smalheiser Neil R., 2006, V342, P115, DOI 10.1385/1-59745-123-1:115; Tuckow AP, 2013, J MED ENTOMOL, V50, P925, DOI 10.1603/ME12274; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Warnefors M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r83; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059749, 10.1371/journal.pone.0059016]; Wuriyanghan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066050; Xu HJ, 2013, INSECT MOL BIOL, V22, P635, DOI 10.1111/imb.12051; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Zhang XF, 2012, INSECT BIOCHEM MOLEC, V42, P381, DOI 10.1016/j.ibmb.2012.01.006; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	57	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139771	10.1371/journal.pone.0139771	http://dx.doi.org/10.1371/journal.pone.0139771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440407	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300050
J	Kuhl, J; Stock, KF; Wulf, M; Aurich, C				Kuhl, J.; Stock, K. F.; Wulf, M.; Aurich, C.			Maternal Lineage of Warmblood Mares Contributes to Variation of Gestation Length and Bias of Foal Sex Ratio	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; HORSES; DOMESTICATION; VARIABILITY; CONCEPTION; ORIGIN; HERD	Maternal lineage influences performance traits in horses. This is probably caused by differences in mitochondrial DNA (mtDNA) transferred to the offspring via the oocyte. In the present study, we investigated if reproductive traits with high variability-gestation length and fetal sex ratio-are influenced by maternal lineage. Data from 142 Warmblood mares from the Brandenburg State Stud at Neustadt (Dosse), Germany, were available for the study. Mares were grouped according to their maternal lineage. Influences on the reproduction parameters gestation length and sex ratio of offspring were analyzed by simple and multiple analyses of variance. A total of 786 cases were included. From the 142 mares, 119 were assigned to six maternal lineages with n >= 10 mares per lineage, and 23 mares belonged to smaller maternal lineages. The mean number of live foals produced per mare was 4.6 +/- 3.6 (+/- SD). Live foal rate was 83.5%. Mean gestation length was 338.5 +/- 8.9 days (+/- SD) with a range of 313 to 370 days. Gestation length was affected by maternal lineage (p<0.001). Gestation length was also significantly influenced by the individual mare, age of the mare, year of breeding, month of breeding and sex of the foal (p<0.05). Of the 640 foals born alive at term, 48% were male and 52% female. Mare age group and maternal lineage significantly influenced the sex ratio of the foals (p<0.05). It is concluded that maternal lineage influences reproductive parameters with high variation such as gestation length and foal sex ratio in horses. In young primiparous and aged mares, the percentage of female offspring is higher than the expected 1:1 ratio.	[Kuhl, J.; Wulf, M.] Vetmeduni Vienna, Graf Lehndorff Inst Equine Sci, Neustadt, Dosse, Germany; [Kuhl, J.; Aurich, C.] Vetmeduni Vienna, Artificial Inseminat & Embryo Transfer, Vienna, Austria; [Stock, K. F.] Vereinigte Informat Syst Tierhaltung wV Vit, Verden, Aller, Germany	University of Veterinary Medicine Vienna	Kuhl, J (corresponding author), Vetmeduni Vienna, Graf Lehndorff Inst Equine Sci, Neustadt, Dosse, Germany.	juliane.kuhl@vetmeduni.ac.at			Vereinigte Informationssysteme Tierhaltung w.V	Vereinigte Informationssysteme Tierhaltung w.V	Vereinigte Informationssysteme Tierhaltung w.V provided support in the form of salary for author K.F. Stock, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Aoki T, 2013, J EQUINE VET SCI, V33, P437, DOI 10.1016/j.jevs.2012.07.011; Aurich C, 2014, ANIM REPROD SCI, V146, P34, DOI 10.1016/j.anireprosci.2014.01.014; Beckelmann J, 2013, THERIOGENOLOGY, V79, P193, DOI 10.1016/j.theriogenology.2012.10.004; Boichard D., 2002, 7 WORL C GEN APPL LI; Cameron EZ, 2007, BIOL LETTERS, V3, P395, DOI 10.1098/rsbl.2007.0089; Cameron EZ, 1999, BEHAV ECOL, V10, P472, DOI 10.1093/beheco/10.5.472; Cameron EZ, 2000, ANIM BEHAV, V60, P359, DOI 10.1006/anbe.2000.1480; Cameron EZ, 2004, P ROY SOC B-BIOL SCI, V271, P1723, DOI 10.1098/rspb.2004.2773; Choi YH, 2014, THERIOGENOLOGY, V82, P411, DOI 10.1016/j.theriogenology.2014.04.021; Cieslak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015311; Edwards CJ, 2007, P ROY SOC B-BIOL SCI, V274, P1377, DOI 10.1098/rspb.2007.0020; Giuffra E, 2000, GENETICS, V154, P1785; Hamann H, 2008, J ANIM SCI, V86, P1503, DOI 10.2527/jas.2007-0382; Harrison SP, 2006, MITOCHONDRION, V6, P53, DOI 10.1016/j.mito.2006.01.002; Hector C., 2010, MAKING MODERN WARMBL, P80; Heidler B, 2004, THERIOGENOLOGY, V61, P883, DOI 10.1016/S0093-691X(03)00279-6; Jiao F, 2007, MOL REPROD DEV, V74, P1278, DOI 10.1002/mrd.20698; Langlois B, 2012, LIVEST SCI, V146, P133, DOI 10.1016/j.livsci.2012.02.028; Lowe CB, 1895, BREEDING RACEHORSES; McCue PM, 2012, EQUINE VET J, V44, P22, DOI 10.1111/j.2042-3306.2011.00476.x; Monard AM, 1997, BEHAV ECOL SOCIOBIOL, V41, P243, DOI 10.1007/s002650050385; Morel MCGD, 2002, ANIM REPROD SCI, V74, P175, DOI 10.1016/S0378-4320(02)00171-9; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Nagel C, 2012, THERIOGENOLOGY, V78, P759, DOI 10.1016/j.theriogenology.2012.03.023; Reicher S, 2012, J ANIM SCI, V90, P2084, DOI 10.2527/jas.2011-4673; Sairanen J, 2009, ANIMAL, V3, P1662, DOI 10.1017/S1751731109990553; SALTZ D, 1995, ECOL APPL, V5, P327, DOI 10.2307/1942025; Satue K, 2011, LIVEST SCI, V136, P287, DOI 10.1016/j.livsci.2010.09.011; Sutarno, 2002, THERIOGENOLOGY, V57, P1603, DOI 10.1016/S0093-691X(02)00664-7; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Taylor RW, 2003, ANN NEUROL, V54, P521, DOI 10.1002/ana.10673; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Valera M, 2006, ANIM REPROD SCI, V95, P75, DOI 10.1016/j.anireprosci.2005.09.008; Van Blerkom J, 2004, REPRODUCTION, V128, P269, DOI 10.1530/rep.1.00240; Wilsher S, 2003, EQUINE VET J, V35, P476, DOI 10.2746/042516403775600550; Winter GZ, 2007, J EQUINE VET SCI, V27, P531, DOI 10.1016/j.jevs.2007.10.015	37	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139358	10.1371/journal.pone.0139358	http://dx.doi.org/10.1371/journal.pone.0139358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436555	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200018
J	Mocanu, AO; Mulya, A; Huang, H; Dan, O; Shimizu, H; Batayyah, E; Brethauer, SA; Dinischiotu, A; Kirwan, JP				Mocanu, Andreea Oana; Mulya, Anny; Huang, Hazel; Dan, Olivia; Shimizu, Hideharu; Batayyah, Esam; Brethauer, Stacy A.; Dinischiotu, Anca; Kirwan, John P.			Effect of Roux-en-Y Gastric Bypass on the NLRP3 Inflammasome in Adipose Tissue from Obese Rats	PLOS ONE			English	Article							INDUCED WEIGHT-LOSS; BARIATRIC SURGERY; INSULIN-RESISTANCE; INNATE IMMUNITY; MORBID-OBESITY; EXPRESSION; CASPASE-1; MARKERS; WOMEN; ATHEROSCLEROSIS	Objective Obesity is associated with low-grade chronic inflammation. We hypothesized that Roux-en-Y gastric bypass (RYGB) surgery would reduce activation of the NLRP3 inflammasome in metabolically active adipose tissue (AT) of obese rats, and this change would be related to decreases in body weight and improved glycemic control. Methods Omental, mesenteric and subcutaneous fat depots were collected from Sprague-Dawley rats: Sham control and RYGB; 90-days after surgery. NLRP3, caspase-1, apoptosis-associated speck-like protein (ASC), IL-1 beta, IL-18, IL-6 and MCP-1 gene and protein expression were quantified. Glucose metabolism was assessed by oral glucose tolerance test (OGTT). Results Compared to Sham surgery controls, RYGB surgery decreased IL-6, MCP-1, NLRP3, IL-18, caspase-1 and ASC in omental fat, and decreased IL-6, MCP1, IL-1 beta, IL-18, caspase-1 and ASC gene expression in mesenteric fat. We observed differential gene expression between visceral and subcutaneous fat for IL-6 and IL-1 beta, both being downregulated by RYGB in visceral, and upregulated in subcutaneous depots. These changes in gene expression were accompanied by a decrease in NLRP3, ASC, IL-18, caspase-1 and IL-1 beta protein expression in omental tissue. We found a positive correlation between caspase-1, ASC, MCP-1, IL-18 and IL-6 gene expression following surgery and glucose AUC response in omental fat, while the change in glucose AUC response correlated with caspase-1 gene expression in subcutaneous fat. Conclusion This study demonstrates that bariatric surgery reverses inflammation in visceral adipose tissue by suppressing NLRP3 inflammasome activation. These are the first data to implicate the NLRP3 inflammasome in diabetes remission after RYGB surgery.	[Mocanu, Andreea Oana; Dinischiotu, Anca] Univ Bucharest, Dept Biochem, Fac Biol, Bucharest, Romania; [Mulya, Anny; Huang, Hazel; Kirwan, John P.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA; [Dan, Olivia; Shimizu, Hideharu; Batayyah, Esam; Brethauer, Stacy A.] Cleveland Clin, Dept Bariatr Metab Inst, Cleveland, OH 44106 USA; [Kirwan, John P.] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Mocanu, Andreea Oana; Kirwan, John P.] Cleveland Clin, Metab Translat Res Ctr, Cleveland, OH 44106 USA	University of Bucharest; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Kirwan, JP (corresponding author), Cleveland Clin, Dept Pathobiol, Cleveland, OH 44106 USA.	kirwanj@ccf.org	Kirwan, John P/G-6942-2012		American Society of Metabolic and Bariatric Surgery	American Society of Metabolic and Bariatric Surgery	This research was supported by a grant from the American Society of Metabolic and Bariatric Surgery.	Aganna E, 2004, GENES IMMUN, V5, P289, DOI 10.1038/sj.gene.6364070; Alvehus M, 2010, OBESITY, V18, P879, DOI 10.1038/oby.2010.22; Ashrafian H, 2008, CIRCULATION, V118, P2091, DOI 10.1161/CIRCULATIONAHA.107.721027; Bradley D, 2012, J CLIN INVEST, V122, P4667, DOI 10.1172/JCI64895; Buchwald H, 2004, JAMA-J AM MED ASSOC, V292, P1724, DOI 10.1001/jama.292.14.1724; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Couzin J, 2008, SCIENCE, V320, P438, DOI 10.1126/science.320.5875.438; de la Torre NG, 2008, J CLIN ENDOCR METAB, V93, P4276, DOI 10.1210/jc.2007-1370; Dixon JB, 2008, JAMA-J AM MED ASSOC, V299, P316, DOI 10.1001/jama.299.3.316; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Gatmaitan P, 2010, SURG OBES RELAT DIS, V6, P532, DOI 10.1016/j.soard.2010.05.018; Habib P, 2009, AM J CARDIOL, V104, P1251, DOI 10.1016/j.amjcard.2009.06.042; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Konukoglu D, 2007, OBES SURG, V17, P672, DOI 10.1007/s11695-007-9113-3; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; Laimer M, 2002, INT J OBESITY, V26, P659, DOI 10.1038/sj.ijo.0801970; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Meguid MM, 2004, J GASTROINTEST SURG, V8, P621, DOI 10.1016/j.gassur.2004.02.003; Moschen AR, 2011, MOL MED, V17, P840, DOI 10.2119/molmed.2010.00108; Moschen AR, 2010, GUT, V59, P1259, DOI 10.1136/gut.2010.214577; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Poulain-Godefroy O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/823486; Rubino F, 2008, DIABETES CARE, V31, pS290, DOI 10.2337/dc08-s271; Sledzinski T, 2010, OBES SURG, V20, P204, DOI 10.1007/s11695-009-0041-2; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Sturm W, 2009, EUR HEART J, V30, P2038, DOI 10.1093/eurheartj/ehp211; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vazquez LA, 2005, J CLIN ENDOCR METAB, V90, P316, DOI 10.1210/jc.2003-032059; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Yin DP, 2011, J IMMUNOL, V186; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831; Zoico E, 2004, J GERONTOL A-BIOL, V59, P935, DOI 10.1093/gerona/59.9.M935	37	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139764	10.1371/journal.pone.0139764	http://dx.doi.org/10.1371/journal.pone.0139764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437377	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200060
J	Saeed, A; Raouf, GA; Nafee, SS; Shaheen, SA; Al-Hadeethi, Y				Saeed, A.; Raouf, Gehan A.; Nafee, Sherif S.; Shaheen, Salem A.; Al-Hadeethi, Y.			Effects of Very Low Dose Fast Neutrons on Cell Membrane And Secondary Protein Structure in Rat Erythrocytes	PLOS ONE			English	Article							TRANSFORM INFRARED MICROSPECTROSCOPY; RADIATION-INDUCED DAMAGE; FT-IR; LIPID-PEROXIDATION; OXIDATIVE STRESS; BRAIN-TISSUE; SPECTROSCOPY; TOOL; QUANTITATION; IRRADIATION	The effects of ionizing radiation on biological cells have been reported in several literatures. Most of them were mainly concerned with doses greater than 0.01 Gy and were also concerned with gamma rays. On the other hand, the studies on very low dose fast neutrons (VLDFN) are rare. In this study, we have investigated the effects of VLDFN on cell membrane and protein secondary structure of rat erythrocytes. Twelve female Wistar rats were irradiated with neutrons of total dose 0.009 Gy (Am-241-Be, 0.2 mGy/h) and twelve others were used as control. Blood samples were taken at the 0, 4th, 8th, and 12th days postirradiation. Fourier transform infrared (FTIR) spectra of rat erythrocytes were recorded. Second derivative and curve fitting were used to analysis FTIR spectra. Hierarchical cluster analysis (HCA) was used to classify group spectra. The second derivative and curve fitting of FTIR spectra revealed that the most significant alterations in the cell membrane and protein secondary structure upon neutron irradiation were detected after 4 days postirradiation. The increase in membrane polarity, phospholipids chain length, packing, and unsaturation were noticed from the corresponding measured FTIR area ratios. This may be due to the membrane lipid peroxidation. The observed band shift in the CH2 stretching bands toward the lower frequencies may be associated with the decrease in membrane fluidity. The curve fitting of the amide I revealed an increase in the percentage area of alpha-helix opposing a decrease in the beta-structure protein secondary structure, which may be attributed to protein denaturation. The results provide detailed insights into the VLDFN effects on erythrocytes. VLDFN can cause an oxidative stress to the irradiated erythrocytes, which appears clearly after 4 days postirradiation.	[Saeed, A.; Nafee, Sherif S.; Shaheen, Salem A.; Al-Hadeethi, Y.] King Abdulaziz Univ, Fac Sci, Dept Phys, Jeddah, Saudi Arabia; [Raouf, Gehan A.] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Saeed, A (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Phys, Jeddah, Saudi Arabia.	Abdusaeed79@hotmail.com	Al-Hadeethi, Yas M/I-1712-2012; Nafee, Sherif S/J-6067-2012; Al-Hadeethi, Yas/N-7786-2019; Saeed, Abdu/N-6330-2015	Al-Hadeethi, Yas M/0000-0002-2284-1279; Nafee, Sherif S/0000-0001-5717-0818; Al-Hadeethi, Yas/0000-0002-1350-9928; Saeed, Abdu/0000-0002-8506-7188	King Abdulaziz City for Science and Technology (KACST) [A-S-12-1011]	King Abdulaziz City for Science and Technology (KACST)	This work was financially supported by King Abdulaziz City for Science and Technology (KACST) under grant number A-S-12-1011. Author who received the funding: AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysekara S, 2013, SPECTROCHIM ACTA A, V102, P432, DOI 10.1016/j.saa.2012.09.064; Andrus PGL, 1998, BIOSPECTROSCOPY, V4, P37, DOI 10.1002/(SICI)1520-6343(1998)4:1<37::AID-BSPY4>3.0.CO;2-P; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; Benedetti E, 1997, APPL SPECTROSC, V51, P792, DOI 10.1366/0003702971941304; Cakmak G, 2006, AQUAT TOXICOL, V77, P53, DOI 10.1016/j.aquatox.2005.10.015; Cakmak G, 2012, ARCH BIOCHEM BIOPHYS, V520, P67, DOI 10.1016/j.abb.2012.02.012; Cember H., 2009, INTRO HLTH PHYS, Vfourth; Chadwick MB, 1997, RADIAT PROT DOSIM, V70, P1, DOI 10.1093/oxfordjournals.rpd.a031920; Colagar AH, 2011, J BIOSCIENCES, V36, P669, DOI 10.1007/s12038-011-9090-5; Dionet C, 2000, RADIAT RES, V154, P406, DOI 10.1667/0033-7587(2000)154[0406:EOLDNA]2.0.CO;2; Dogan A, 2007, FOOD CHEM, V100, P1106, DOI 10.1016/j.foodchem.2005.11.017; Dovbeshko GI, 2000, TALANTA, V53, P233, DOI 10.1016/S0039-9140(00)00462-8; El-Sersy AR, 2004, NUCL INSTRUM METH B, V226, P345, DOI 10.1016/j.nimb.2004.06.023; Fagan JM, 1999, INT J BIOCHEM CELL B, V31, P751, DOI 10.1016/S1357-2725(99)00034-5; Forina A, 2002, ANAL CHIM ACTA, V454, P13, DOI 10.1016/S0003-2670(01)01517-3; Gault N, 2003, RADIAT RES, V160, P238, DOI 10.1667/RR3020.1; Habif S, 2001, CLIN BIOCHEM, V34, P667, DOI 10.1016/S0009-9120(01)00279-X; Hacker-Klom UB, 2000, RADIAT RES, V154, P667, DOI 10.1667/0033-7587(2000)154[0667:EOSASD]2.0.CO;2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hannig J, 2000, RADIAT RES, V154, P171, DOI 10.1667/0033-7587(2000)154[0171:SSOMPB]2.0.CO;2; Inouye M, 1998, CLIN CHIM ACTA, V276, P163, DOI 10.1016/S0009-8981(98)00112-0; Ishak-Boushaki GM, 2012, APPL RADIAT ISOTOPES, V70, P515, DOI 10.1016/j.apradiso.2011.11.008; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; Kajioka EH, 2000, RADIAT RES, V153, P587, DOI 10.1667/0033-7587(2000)153[0587:AEOWBP]2.0.CO;2; KERGONOU JF, 1986, BIOCHIMIE, V68, P311, DOI 10.1016/S0300-9084(86)80028-1; Krokosz A, 2006, RADIAT PHYS CHEM, V75, P98, DOI 10.1016/j.radphyschem.2005.03.013; Liu KZ, 2007, BRIT J HAEMATOL, V136, P713, DOI 10.1111/j.1365-2141.2006.06474.x; Liu KZ, 2005, BLOOD CELL MOL DIS, V35, P404, DOI 10.1016/j.bcmd.2005.06.009; Liu KZ, 2003, CLIN CHEM, V49, P1125, DOI 10.1373/49.7.1125; Lombardi MH, 2007, RAD SAFETY NUCL MED; Los Alamos National Laboratory, 2000, CONT DOS EQ RAT COMM; Lu XN, 2011, AQUACULTURE, V315, P298, DOI 10.1016/j.aquaculture.2011.01.048; Mahmoud SS, 2011, RADIAT ENVIRON BIOPH, V50, P189, DOI 10.1007/s00411-010-0333-x; Meade AD, 2010, RADIAT RES, V173, P225, DOI 10.1667/RR1836.1; Miller LM, 2013, BBA-BIOMEMBRANES, V1828, P2339, DOI 10.1016/j.bbamem.2013.01.014; Moss RL, 2014, APPL RADIAT ISOTOPES, V88, P2, DOI 10.1016/j.apradiso.2013.11.109; National Research Council (NRC), 2008, COMM RAD SOURC US RE; Palaniappan PLRM, 2008, AQUAT SCI, V70, P314, DOI 10.1007/s00027-008-8053-x; Palaniappan PLRM, 2009, MICROCHEM J, V91, P118, DOI 10.1016/j.microc.2008.08.014; Palaniappan PR, 2010, INFRARED PHYS TECHN, V53, P103, DOI 10.1016/j.infrared.2009.10.003; Petibois C, 2005, CELL BIOL INT, V29, P709, DOI 10.1016/j.cellbi.2005.04.007; Petibois C, 2004, ANALYST, V129, P912, DOI 10.1039/b408931f; Petibois C, 2003, SPORTS MED, V33, P83, DOI 10.2165/00007256-200333020-00001; Petibois C, 2006, TRENDS BIOTECHNOL, V24, P455, DOI 10.1016/j.tibtech.2006.08.005; Puchala M, 2004, J RADIAT RES, V45, P275, DOI 10.1269/jrr.45.275; Raouf GA, 2012, LIFE SCI J, V9, P1686; Rodriguez-Casado A, 2007, BIOPOLYMERS, V86, P437, DOI 10.1002/bip.20753; Sasic S, 2005, VIB SPECTROSC, V37, P217, DOI 10.1016/j.vibspec.2004.09.005; Schrader B., 1995, INFRARED RAMAN SPECT, P411, DOI 10.1002/9783527615438.ch05; Selim NS, 2011, RADIAT PHYS CHEM, V80, P1337, DOI 10.1016/j.radphyschem.2011.07.002; Severcan F, 2005, ANAL BIOCHEM, V339, P36, DOI 10.1016/j.ab.2005.01.011; Sheng DP, 2013, SPECTROCHIM ACTA A, V101, P228, DOI 10.1016/j.saa.2012.09.072; SILLS RH, 1994, ANAL BIOCHEM, V218, P118, DOI 10.1006/abio.1994.1149; Sirikwanpong S, 2010, J CLIN BIOCHEM NUTR, V47, P111, DOI 10.3164/jcbn.10-21; Tominaga H, 2004, J RADIAT RES, V45, P181, DOI 10.1269/jrr.45.181; Tsukada K., 1980, NEUTRON SOURCES MEDI; Turner JE., 2007, ATOMS RAD RAD PROTEC; Zelig U, 2011, BBA-GEN SUBJECTS, V1810, P827, DOI 10.1016/j.bbagen.2011.06.010; [No title captured]	60	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139854	10.1371/journal.pone.0139854	http://dx.doi.org/10.1371/journal.pone.0139854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436416	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200062
J	Brodin, E; Sunnerhagen, KS; Baghaei, F; Tornbom, M				Brodin, Elisabeth; Sunnerhagen, Katharina S.; Baghaei, Fariba; Tornbom, Marie			Persons with Haemophilia in Sweden-Experiences and Strategies in Everyday Life. A Single Centre Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PROPHYLACTIC TREATMENT; ADULT PATIENTS; PHYSICAL-ACTIVITY; IMPACT; EXPLORATION; ADOLESCENTS; ARTHROPATHY; BENEFITS; CHILDREN	Introduction/Aim Haemophilia is caused by deficiency in coagulation factor VIII or IX. Treatment with the missing coagulation factors has been available in most developed countries for several decades. The aim was to explore the experiences of adults living with severe or moderate haemophilia and their coping strategies at a single centre in Sweden. Method The interview study had a qualitative empirical approach and was analyzed on the basis of the method empirical phenomenological psychology. The sample included 14 participants, mean age 42 (19-80 y), who met the inclusion criteria and to saturation of information. Results: General characteristics were; All were satisfied with and grateful for access to medication. An acceptance of the disorder and willingness to live a normal life was identified among all participants. They were all content with the care provided by Haemophilia Treatment Centre (HTC) and felt supported by its multidisciplinary team. Four typologies were identified; Protective adults and assertive children during up-bringing, finding a role in social context, symptoms and treatments, fear of limited resources in the future. Task-, emotional- and avoidance coping strategies were seen in the interviews. The most prominent coping strategy was task oriented. Conclusion This interview study with Swedish PWH shows that they strive for normality and adaptation in social activities throughout life finding their own niche. The PWH expressed the importance of knowledge and support from the comprehensive medical team at HTC and therefore it seems important to continue comprehensive medical care at HTC in order to follow-up the haemophilia persons regularly.	[Brodin, Elisabeth; Sunnerhagen, Katharina S.; Tornbom, Marie] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol Rehabil Med, Sect Clin Neurosci & Rehabil, Gothenburg, Sweden; [Baghaei, Fariba] Sahlgrens Univ Hosp, Dept Med Hematol & Coagulat, Coagulat Ctr, Gothenburg, Sweden; [Sunnerhagen, Katharina S.] Univ Oslo, Sunnaas Hosp, Oslo, Norway; [Tornbom, Marie] Univ Gothenburg, Dept Social Work, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; University of Oslo; University of Gothenburg	Brodin, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol Rehabil Med, Sect Clin Neurosci & Rehabil, Gothenburg, Sweden.	elisabeth.brodin@vgregion.se	Baghaei, Fariba/AAS-3197-2020; Sunnerhagen, Katharina Stibrant/AAE-2405-2020	Sunnerhagen, Katharina Stibrant/0000-0002-5940-4400	Renee' Eanders foundation; Felix Neubergs foundation; Hjalmar Svenssons foundation; Solstickan foundation; Local Research and Development Board for Gothenburg and Sodra Bohuslan, the Region Vastra Gotaland	Renee' Eanders foundation; Felix Neubergs foundation; Hjalmar Svenssons foundation; Solstickan foundation; Local Research and Development Board for Gothenburg and Sodra Bohuslan, the Region Vastra Gotaland	This study was funded by grants to EB from the Local Research and Development Board for Gothenburg and Sodra Bohuslan, the Region Vastra Gotaland http://www.fou.nu/is/gsb, Renee' Eanders foundation for research http://www.fysioterapeuterna.se/Om-forbundet/Distrikt/Halland/Stipendier/, Felix Neubergs foundation for research http://www.felixneubergh.se/, Hjalmar Svenssons foundation for research http://www.nusjukvarden.se/sv/NU-sjukvarden/Om-nusjukvarden/FoU-enheten/Innehall/Nyheter/Stiftelsen-Handlanden-Hjalmar-Svenssons-forskningsfond/ and Solstickan foundation for research http://www.solstickan.se/Om-Stiftelsen/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya SS, 2012, BRIT J HAEMATOL, V156, P13, DOI 10.1111/j.1365-2141.2011.08919.x; Astermark J, 1999, BRIT J HAEMATOL, V105, P1109, DOI 10.1046/j.1365-2141.1999.01463.x; Barlow JH, 2007, PATIENT EDUC COUNS, V68, P235, DOI 10.1016/j.pec.2007.06.006; Beeton K, 2005, HAEMOPHILIA, V11, P123, DOI 10.1111/j.1365-2516.2005.01077.x; Binnema M, 2014, HAEMOPHILIA, V20, P513, DOI 10.1111/hae.12366; Brodin E, 2015, EUROPEAN J HAEMATOLO; Carlsson KS, 2003, HAEMOPHILIA, V9, P555, DOI 10.1046/j.1365-2516.2003.00817.x; Carvalhosa AM, 2014, HAEMOPHILIA, V20, P479, DOI 10.1111/hae.12341; Docteur E, 2012, PATIENT CTR SWEDENS; Flood E, 2014, EUR J HAEMATOL, V93, P9, DOI 10.1111/ejh.12328; Gringeri A, 2011, J THROMB HAEMOST, V9, P700, DOI 10.1111/j.1538-7836.2011.04214.x; Groen WG, 2011, HAEMOPHILIA, V17, pE906, DOI 10.1111/j.1365-2516.2011.02555.x; Grogan A, 2012, HAEMOPHILIA, V18, P875, DOI 10.1111/j.1365-2516.2012.02885.x; Hartl HK, 2008, HAEMOPHILIA, V14, P703, DOI 10.1111/j.1365-2516.2008.01684.x; Holstein K, 2015, HAEMOPHILIA; Karlsson, 1995, PSYCHOL QUALITATIVE; Khair K, 2012, HAEMOPHILIA, V18, pe286, DOI 10.1111/j.1365-2516.2011.02644.x; Lazarus R.S., 1984, EMOTION ADAPTATION; Lindvall K, 2012, HAEMOPHILIA, V18, P527, DOI 10.1111/j.1365-2516.2012.02765.x; Ljung RCR, 1998, HAEMOPHILIA, V4, P409, DOI 10.1046/j.1365-2516.1998.440409.x; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Mason M., 2010, FORUM QUALITATIVE SO, V11; Morse JM, 2008, QUAL HEALTH RES, V18, P3, DOI 10.1177/1049732307309451; MORSE JM, 1995, QUAL HEALTH RES, V5, P147, DOI 10.1177/104973239500500201; Negrier C, 2013, HAEMOPHILIA, V19, P487, DOI 10.1111/hae.12118; NILSSON IM, 1976, ACTA PAEDIATR SCAND, V65, P129, DOI 10.1111/j.1651-2227.1976.tb16525.x; NILSSON IM, 1992, J INTERN MED, V232, P25, DOI 10.1111/j.1365-2796.1992.tb00546.x; O'Mahony B, 2013, HAEMOPHILIA, V19, pe239, DOI 10.1111/hae.12125; Peltoniemi A, 2003, HOITOTIEDE, V16, P111; PETRINI P, 1991, AM J PEDIAT HEMATOL, V13, P280; POOL JG, 1970, CALIF MED, V113, P66; Van den Berg HM, 2003, HAEMOPHILIA, V9, P27, DOI 10.1046/j.1365-2516.9.s1.10.x; Von Mackensen S, 2012, HAEMOPHILIA, V18, P345, DOI 10.1111/j.1365-2516.2011.02643.x; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621	34	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139690	10.1371/journal.pone.0139690	http://dx.doi.org/10.1371/journal.pone.0139690			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431432	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700099
J	Gilbert, R; Martin, RM; Evans, DM; Tilling, K; Smith, GD; Kemp, JP; Lane, JA; Hamdy, FC; Neal, DE; Donovan, JL; Metcalfe, C				Gilbert, Rebecca; Martin, Richard M.; Evans, David M.; Tilling, Kate; Smith, George Davey; Kemp, John P.; Lane, J. Athene; Hamdy, Freddie C.; Neal, David E.; Donovan, Jenny L.; Metcalfe, Chris			Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; BASE-LINE; ANTIGEN; MEN; DIAGNOSIS; IDENTIFICATION; POLYMORPHISMS; SEQUENCE; DISEASE	Introduction Prostate-specific antigen (PSA) testing is a widely accepted screening method for prostate cancer, but with low specificity at thresholds giving good sensitivity. Previous research identified four single nucleotide polymorphisms (SNPs) principally associated with circulating PSA levels rather than with prostate cancer risk (TERT rs2736098, FGFR2 rs10788160, TBX3 rs11067228, KLK3 rs17632542). Removing the genetic contribution to PSA levels may improve the ability of the remaining biologically-determined variation in PSA to discriminate between high and low risk of progression within men with identified prostate cancer. We investigate whether incorporating information on the PSA-SNPs improves the discrimination achieved by a single PSA threshold in men with raised PSA levels. Materials and Methods Men with PSA between 3-10ng/mL and histologically-confirmed prostate cancer were categorised as high or low risk of progression (Low risk: Gleason score <= 6 and stage T1-T2a; High risk: Gleason score 7-10 or stage T2C). We used the combined genetic effect of the four PSA-SNPs to calculate a genetically corrected PSA risk score. We calculated the Area under the Curve (AUC) to determine how well genetically corrected PSA risk scores distinguished men at high risk of progression from low risk men. Results The analysis includes 868 men with prostate cancer (Low risk: 684 (78.8%); High risk: 184 (21.2%)). Receiver operating characteristic (ROC) curves indicate that including the 4 PSA-SNPs does not improve the performance of measured PSA as a screening tool for high/low risk prostate cancer (measured PSA level AU C = 59.5% (95% CI: 54.7,64.2) vs additionally including information from the 4 PSA-SNPs AUC = 59.8% (95% CI: 55.2,64.5) (p-value = 0.40)). Conclusion We demonstrate that genetically correcting PSA for the combined genetic effect of four PSA-SNPs, did not improve discrimination between high and low risk prostate cancer in men with raised PSA levels (3-10ng/mL). Replication and gaining more accurate estimates of the effects of the 4 PSA-SNPs and additional variants associated with PSA levels and not prostate cancer could be obtained from subsequent GWAS from larger prospective studies.	[Gilbert, Rebecca; Martin, Richard M.; Evans, David M.; Tilling, Kate; Smith, George Davey; Kemp, John P.; Lane, J. Athene; Donovan, Jenny L.; Metcalfe, Chris] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Martin, Richard M.; Evans, David M.; Smith, George Davey; Kemp, John P.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Evans, David M.; Kemp, John P.] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Hamdy, Freddie C.] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge, England	University of Bristol; University of Bristol; University of Queensland; University of Oxford; University of Cambridge	Gilbert, R (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Becky.Gilbert@bristol.ac.uk	Kemp, John P./R-3091-2018; Davey Smith, George/A-7407-2013; Tilling, Kate/AAY-1578-2021; Evans, David M/H-6325-2013	Kemp, John P./0000-0002-9105-2249; Davey Smith, George/0000-0002-1407-8314; Evans, David M/0000-0003-0663-4621; Hamdy, Freddie/0000-0003-2627-2154; Tilling, Kate/0000-0002-1010-8926; Martin, Richard/0000-0002-7992-7719; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Metcalfe, Chris/0000-0001-8318-8907; s, hema/0000-0002-3440-9475	Cancer Research UK Population Research Postdoctoral Fellowship [C31211/A15194]; UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme [HTA 96/20/99, ISRCTN20141297]; Medical Research Council; University of Bristol; National Institute for Health Research (NIHR); Cancer Research UK [C11043/A4286, C18281/A8145, C18281/A11326, C18281/A15064]; ProMPT (Prostate Mechanisms of Progression and Treatment) [G0500966/75466]; National Cancer Research Institute (NCRI); University of Cambridge Cancer Research UK; National Institute for Health Research; Cancer Research UK; MRC [MC_UU_12013/1, MC_UU_12013/4] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1, MC_UU_12013/4] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish	Cancer Research UK Population Research Postdoctoral Fellowship; UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); ProMPT (Prostate Mechanisms of Progression and Treatment); National Cancer Research Institute (NCRI); University of Cambridge Cancer Research UK(Cancer Research UKUniversity of Cambridge); National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	RG is recipient of a Cancer Research UK Population Research Postdoctoral Fellowship (C31211/A15194). The study is supported by the UK National Institute for Health Research (NIHR) Health Technology Assessment (HTA) Programme, HTA 96/20/99; ISRCTN20141297. The funding source had no role in the design, conduct of the study, collection, management, analysis and interpretation or preparation, review, or approval of the article. The Integrative Epidemiology Unit is supported by the Medical Research Council and the University of Bristol. The NIHR Bristol Nutrition Biomedical Research Unit is funded by the National Institute for Health Research (NIHR) and is a partnership between University Hospitals Bristol NHS Foundation Trust and the University of Bristol. The authors would like to acknowledge Cancer Research UK grant funding for the CAP (Cluster randomised triAl of PSA testing for Prostate cancer) trial (C11043/A4286, C18281/A8145, C18281/A11326, and C18281/A15064) and the provision of additional epidemiological data by the NHS R&D Directorate supported Prodigal study. Also the ProMPT (Prostate Mechanisms of Progression and Treatment, grant code G0500966/75466) collaboration which has funded tissue and urine collections and is supported by the National Cancer Research Institute (NCRI) formed by the Department of Health, the Medical Research Council and Cancer Research UK. These collaborations are supported by the University of Cambridge Cancer Research UK, and the National Institute for Health Research funded Cambridge Biomedical Research Centre, Cambridge, UK.	Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; Al Olama AA, 2013, HUM MOL GENET, V22, P408, DOI 10.1093/hmg/dds425; Aly M, 2011, EUR UROL, V60, P21, DOI 10.1016/j.eururo.2011.01.017; Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857; Bansal A, 2000, J CLIN ENDOCR METAB, V85, P1272, DOI 10.1210/jc.85.3.1272; Bonilla C, 2013, CANCER EPIDEM BIOMAR, V22, P597, DOI 10.1158/1055-9965.EPI-12-1248; Cancer Research UK, 2014, CANCERSTATS REP PROS; Cheng I, 2010, CANCER EPIDEM BIOMAR, V19, P2124, DOI 10.1158/1055-9965.EPI-10-0268; Cussenot O, 2008, CLIN CANCER RES, V14, P5635, DOI 10.1158/1078-0432.CCR-07-4999; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; FitzGerald LM, 2011, CANCER EPIDEM BIOMAR, V20, P1196, DOI 10.1158/1055-9965.EPI-10-1299; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Gilbert R, 2014, STAT METHODS MED RES; Gilbert R, 2012, INT J CANCER, V131, P1187, DOI 10.1002/ijc.27327; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Helfand BT, 2013, J UROLOGY, V189, P1697, DOI 10.1016/j.juro.2012.12.023; Helfand BT, 2011, PROSTATE, V71, P394, DOI 10.1002/pros.21253; Hindorff LA, CATALOG PUBLISHED GE; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Jin GF, 2013, NEOPLASIA, V15, P95, DOI 10.1593/neo.121620; Johansson M, 2012, INT J CANCER, V130, P129, DOI 10.1002/ijc.25986; Klein RJ, 2012, EUR UROL, V61, P471, DOI 10.1016/j.eururo.2011.10.047; Knipe DW, 2014, CANCER EPIDEM BIOMAR, V23, P1356, DOI 10.1158/1055-9965.EPI-13-0889; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Lane JA, 2014, LANCET ONCOL, V15, P1109, DOI 10.1016/S1470-2045(14)70361-4; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; Loeb S, 2009, J UROLOGY, V182, P101, DOI 10.1016/j.juro.2009.02.126; Nam RK, 2011, CANCER BIOL THER, V12, P997, DOI 10.4161/cbt.12.11.18366; Nam RK, 2009, CLIN CANCER RES, V15, P1787, DOI 10.1158/1078-0432.CCR-08-1593; OHORI M, 1994, CANCER-AM CANCER SOC, V74, P104, DOI 10.1002/1097-0142(19940701)74:1<104::AID-CNCR2820740119>3.0.CO;2-5; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Sundin T, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.1; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Wiklund F, 2009, PROSTATE, V69, P419, DOI 10.1002/pros.20908; Witte JS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001861; Xu JF, 2008, CLIN CANCER RES, V14, P5819, DOI 10.1158/1078-0432.CCR-08-0934; Xu JF, 2010, P NATL ACAD SCI USA, V107, P2136, DOI 10.1073/pnas.0914061107; Xu X, 2010, CANCER EPIDEM BIOMAR, V19, P2035, DOI 10.1158/1055-9965.EPI-10-0431; Zhang XL, 1999, GENE DEV, V13, P2388, DOI 10.1101/gad.13.18.2388	52	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0136735	10.1371/journal.pone.0136735	http://dx.doi.org/10.1371/journal.pone.0136735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431041	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700005
J	Giorgakoudi, K; Gubbins, S; Ward, J; Juleff, N; Zhang, ZD; Schley, D				Giorgakoudi, Kyriaki; Gubbins, Simon; Ward, John; Juleff, Nicholas; Zhang, Zhidong; Schley, David			Using Mathematical Modelling to Explore Hypotheses about the Role of Bovine Epithelium Structure in Foot-And-Mouth Disease Virus-Induced Cell Lysis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RECEPTOR; PATHOGENESIS; INFECTION; CATTLE; ALPHA-V-BETA-6; REPLICATION; DIFFUSION; SITE	Foot-and-mouth disease (FMD) is a highly contagious disease of cloven-hoofed animals. FMD virus (FMDV) shows a strong tropism for epithelial cells, and FMD is characterised by cell lysis and the development of vesicular lesions in certain epithelial tissues (for example, the tongue). By contrast, other epithelial tissues do not develop lesions, despite being sites of viral replication (for example, the dorsal soft palate). The reasons for this difference are poorly understood, but hypotheses are difficult to test experimentally. In order to identify the factors which drive cell lysis, and consequently determine the development of lesions, we developed a partial differential equation model of FMDV infection in bovine epithelial tissues and used it to explore a range of hypotheses about epithelium structure which could be driving differences in lytic behaviour observed in different tissues. Our results demonstrate that, based on current parameter estimates, epithelial tissue thickness and cell layer structure are unlikely to be determinants of FMDV-induced cell lysis. However, differences in receptor distribution or viral replication amongst cell layers could influence the development of lesions, but only if viral replication rates are much lower than current estimates.	[Giorgakoudi, Kyriaki; Gubbins, Simon; Juleff, Nicholas; Schley, David] Pirbright Inst, Pirbright, Surrey, England; [Ward, John] Univ Loughborough, Dept Math Sci, Loughborough, Leics, England; [Zhang, Zhidong] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; Loughborough University; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS	Giorgakoudi, K (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	kg396@cam.ac.uk	Ibrahim, Essam Hassan/G-1960-2018; Giorgakoudi, Kyriaki/GWC-5156-2022; Ward, John/B-6188-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Ward, John/0000-0003-0570-2725; zhang, zhidong/0000-0002-2186-7661; Zhang, Zhixiang/0000-0002-1161-5065; Gubbins, Simon/0000-0003-0538-4173	Biotechnology and Biological Sciences Research Council (BBSRC) [BBS/E/I/00001397]; BBSRC [BBS/E/I/00001397, BBS/E/I/00001717] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001717, BBS/E/I/00001397] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) [grant code: BBS/E/I/00001397], http://www.bbsrc.ac.uk/home/home.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; [Anonymous], 2007, SHIMIZUS TXB DERMATO; [Anonymous], MATLAB2013A; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Baranowski E, 1998, J VIROL, V72, P6362, DOI 10.1128/JVI.72.8.6362-6372.1998; BERINSTEIN A, 1995, J VIROL, V69, P2664, DOI 10.1128/JVI.69.4.2664-2666.1995; BLACKWELL JH, 1981, J GEN VIROL, V56, P207, DOI 10.1099/0022-1317-56-1-207; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BREESE SS, 1960, ANAL BIOCHEM, V1, P307, DOI 10.1016/0003-2697(60)90028-2; BROWN CC, 1992, CAN J VET RES, V56, P189; BUCKLEY A, 1987, J SURG RES, V43, P322, DOI 10.1016/0022-4804(87)90088-6; Canadian Food Inspection Agency, 2012, FOOT AND MOUTH DIS H; Grubman MJ, 2008, FEMS IMMUNOL MED MIC, V53, P8, DOI 10.1111/j.1574-695X.2008.00409.x; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; KUROSAKA D, 1994, INVEST OPHTH VIS SCI, V35, P3408; MASUI H, 1993, J CELL BIOL, V120, P85, DOI 10.1083/jcb.120.1.85; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Monaghan P, 2005, J GEN VIROL, V86, P2769, DOI 10.1099/vir.0.81172-0; Monaghan P, 2005, J VIROL, V79, P6410, DOI 10.1128/JVI.79.10.6410-6418.2005; Monaghan P, 2004, J GEN VIROL, V85, P933, DOI 10.1099/vir.0.19408-0; Monaghan P, 2003, J MICROSC-OXFORD, V212, P62, DOI 10.1046/j.1365-2818.2003.01245.x; Moore J.V., 1987, P295; O'Donnell V, 2009, J COMP PATHOL, V141, P98, DOI 10.1016/j.jcpa.2008.09.008; Schley D, 2011, B MATH BIOL, V73, P1503, DOI 10.1007/s11538-010-9576-6; SEAFMD, 2007, SEAFMD 2020 ROADM FO; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Thorne RG, 2004, J NEUROPHYSIOL, V92, P3471, DOI 10.1152/jn.00352.2004; Young B, 2000, WHEATERS FUNCTIONAL; Zhang ZD, 2009, VET J, V179, P85, DOI 10.1016/j.tvjl.2007.08.012	33	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138571	10.1371/journal.pone.0138571	http://dx.doi.org/10.1371/journal.pone.0138571			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431527	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700016
J	Hu, S; Wang, JL; Wang, L; Zhang, CC; Chen, WL				Hu, Sheng; Wang, Jinglan; Wang, Li; Zhang, Cheng-Cai; Chen, Wen-Li			Dynamics and Cell-Type Specificity of the DNA Double-Strand Break Repair Protein RecN in the Developmental Cyanobacterium Anabaena sp Strain PCC 7120	PLOS ONE			English	Article							BACILLUS-SUBTILIS RECN; HETEROCYST DIFFERENTIATION; ESCHERICHIA-COLI; FILAMENTOUS CYANOBACTERIUM; PATTERN-FORMATION; SP PCC-7120; GENES; DIVISION; REPLICATION; RECRUITMENT	DNA replication and repair are two fundamental processes required in life proliferation and cellular defense and some common proteins are involved in both processes. The filamentous cyanobacterium Anabaena sp. strain PCC 7120 is capable of forming heterocysts for N-2 fixation in the absence of a combined-nitrogen source. This developmental process is intimately linked to cell cycle control. In this study, we investigated the localization of the DNA double-strand break repair protein RecN during key cellular events, such as chromosome damaging, cell division, and heterocyst differentiation. Treatment by a drug causing DNA double-strand breaks (DSBs) induced reorganization of the RecN focus preferentially towards the mid-cell position. RecN-GFP was absent in most mature heterocysts. Furthermore, our results showed that HetR, a central player in heterocyst development, was involved in the proper positioning and distribution of RecN-GFP. These results showed the dynamics of RecN in DSB repair and suggested a differential regulation of DNA DSB repair in vegetative cell and heterocysts. The absence of RecN in mature heterocysts is compatible with the terminal nature of these cells.	[Hu, Sheng; Wang, Jinglan; Wang, Li; Chen, Wen-Li] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Zhang, Cheng-Cai] Aix Marseille Univ, F-13402 Marseille 20, France; [Zhang, Cheng-Cai] Lab Chim Bacterienne UMR7283, F-13402 Marseille 20, France	Huazhong Agricultural University; UDICE-French Research Universities; Aix-Marseille Universite	Chen, WL (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	wlchen@mail.hzau.edu.cn		Zhang, Cheng-Cai/0000-0002-8194-2889	National Natural Science Foundation of China [31570048]; Fundamental Research Funds for the Central Universities [2014PY003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 31570048), and the Fundamental Research Funds for the Central Universities (Grant No. 2014PY003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DG, 1981, J CELL SCI, V49, P341; Alonso JC, 2013, DNA REPAIR, V12, P162, DOI 10.1016/j.dnarep.2012.12.005; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Cardenas PP, 2014, DNA REPAIR, V14, P1, DOI 10.1016/j.dnarep.2013.12.001; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; FRIAS JE, 1994, MOL MICROBIOL, V14, P823, DOI 10.1111/j.1365-2958.1994.tb01318.x; GOLDEN JW, 1985, NATURE, V314, P419, DOI 10.1038/314419a0; Graumann PL, 2009, CHROMOSOME RES, V17, P265, DOI 10.1007/s10577-008-9014-x; HERDMAN M, 1979, J GEN MICROBIOL, V111, P73, DOI 10.1099/00221287-111-1-73; Keyamura K, 2013, J BIOL CHEM, V288, P29229, DOI 10.1074/jbc.M113.485474; Kidane D, 2004, MOL MICROBIOL, V52, P1627, DOI 10.1111/j.1365-2958.2004.04102.x; Kidane D, 2005, J CELL BIOL, V170, P357, DOI 10.1083/jcb.200412090; Kuhn I, 2000, J BACTERIOL, V182, P4640, DOI 10.1128/JB.182.16.4640-4643.2000; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Lemon KP, 1998, SCIENCE, V282, P1516, DOI 10.1126/science.282.5393.1516; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Meddows TR, 2005, MOL MICROBIOL, V57, P97, DOI 10.1111/j.1365-2958.2005.04677.x; Michel-Marks E, 2010, J MOL BIOL, V401, P579, DOI 10.1016/j.jmb.2010.06.013; Nurnberg DJ, 2015, MBIO, V6, DOI 10.1128/mBio.02109-14; Pellegrino S, 2012, STRUCTURE, V20, P2076, DOI 10.1016/j.str.2012.09.010; PICKSLEY SM, 1984, MOL GEN GENET, V195, P267, DOI 10.1007/BF00332758; Reyes ED, 2010, J BIOL CHEM, V285, P16521, DOI 10.1074/jbc.M110.119164; Rippka R, 1979, J GEN MICROBIOL, V111, P61, DOI DOI 10.1099/00221287-111-1-1; Risser DD, 2007, J BACTERIOL, V189, P2460, DOI 10.1128/JB.01241-06; Sakr S, 2006, J BACTERIOL, V188, P1396, DOI 10.1128/JB.188.4.1396-1404.2006; Sakr S, 2006, J BACTERIOL, V188, P5958, DOI 10.1128/JB.00524-06; Sanchez H, 2005, NUCLEIC ACIDS RES, V33, P2343, DOI 10.1093/nar/gki533; Sanchez H, 2006, J BACTERIOL, V188, P353, DOI 10.1128/JB.188.2.353-360.2006; Sanchez H, 2008, NUCLEIC ACIDS RES, V36, P110, DOI 10.1093/nar/gkm759; SARGENTINI NJ, 1986, RADIAT RES, V107, P58, DOI 10.2307/3576850; Simmons LA, 2009, J BACTERIOL, V191, P1152, DOI 10.1128/JB.01292-08; Skaar EP, 2002, J BACTERIOL, V184, P919, DOI 10.1128/jb.184.4.919-927.2002; Vlasic I, 2014, NUCLEIC ACIDS RES, V42, P2295, DOI 10.1093/nar/gkt1194; Wang G, 2008, INFECT IMMUN, V76, P153, DOI 10.1128/IAI.00791-07; Wei XY, 2006, RES MICROBIOL, V157, P227, DOI 10.1016/j.resmic.2005.08.004; Yang Y, 2013, RES MICROBIOL, V164, P127, DOI 10.1016/j.resmic.2012.10.010; ZHANG CC, 1993, P NATL ACAD SCI USA, V90, P11840, DOI 10.1073/pnas.90.24.11840; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhang JY, 2009, MICROBIOL-SGM, V155, P1418, DOI 10.1099/mic.0.027540-0; Zhang SR, 2013, J BACTERIOL, V195, P4536, DOI 10.1128/JB.00724-13; Zhu Mei, 2010, Journal of Biological Dynamics, V4, P621, DOI 10.1080/17513751003777507	45	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139362	10.1371/journal.pone.0139362	http://dx.doi.org/10.1371/journal.pone.0139362			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431054	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700047
J	King, SN; Guille, J; Thibeault, SL				King, Suzanne N.; Guille, Jeremy; Thibeault, Susan L.			Characterization of the Leukocyte Response in Acute Vocal Fold Injury	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; CYTOKINE PRODUCTION; SCAR FORMATION; TGF-BETA; EXPRESSION; INFLAMMATION; RESOLUTION; CHALLENGE	Macrophages location in the superficial layer of the vocal fold (VF) is not only at the first line of defense, but in a place of physiologic importance to voice quality. This study characterizes and compares macrophage function in two models of acute injury. Porcine VF injuries were created bilaterally by either surgical biopsy or lipopolysaccharide (LPS) (1.5 mu g/kg) injection. Animals were sacrificed at 1- or 5-day post LPS or 3-, 7-, or 23-days post-surgical injury (n = 3/time/injury). Flow cytometry characterized immunophenotypes and RT-PCR quantified cytokine gene expression. Uninjured VF were used as controls. Post-surgical and LPS injury, SWC9+/SWC3-cells identified as hi SLA-DR+ (p<0.05) compared to controls along with hi CD16+ expression at 1-day and 3-days respectively compared to all other time points (p<0.05). Surgical injuries, SWC9+/SWC3-cells exhibited hi CD163+ (p<0.05) at 3-days along with upregulation in TNF alpha and TGF beta 1 mRNA compared to 23-days (p<0.05). No measurable changes to IL-12, IFN gamma, IL-10, IL-4 mRNA post-surgery. LPS injuries induced upregulation of TNF alpha, IL-12, IFN gamma, IL-10, and IL-4 mRNA at 1- and 5-days compared to controls (p<0.05). Higher levels of IL-10 mRNA were found 1-day post-LPS compared to 5-days (p<0.05). No changes to CD163 or CD80/86 post-LPS were measured. Acute VF injuries revealed a paradigm of markers that appear to associate with each injury. LPS induced a regulatory phenotype indicated by prominent IL-10 mRNA expression. Surgical injury elicited a complex phenotype with early TNF alpha mRNA and CD163+ and persistent TGF beta 1 transcript expression.	[King, Suzanne N.] Univ Louisville, Kentucky Spinal Cord Injury Res Ctr, Dept Neurol Surg, Louisville, KY 40292 USA; [Guille, Jeremy] Univ Hosp Pointe Pitre, Dept ENT & Head & Neck Surg, Pointe A Pitre, Guadeloupe, France; [Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA	University of Louisville; CHU Guadeloupe; University of Wisconsin System; University of Wisconsin Madison	Thibeault, SL (corresponding author), Univ Wisconsin, Dept Surg, Div Otolaryngol Head & Neck Surg, Madison, WI 53706 USA.	thibeaul@surgery.wisc.edu		King, Suzanne/0000-0002-6557-5492	NIH [NIDCD - 012729, DC4336, DC 012]; NIH [NIDCD - 012729, DC4336, DC 012]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013508, F31DC012729, R01DC004336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by the NIH NIDCD - 012729. DC4336 and DC 012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Branski RC, 2005, ANN OTO RHINOL LARYN, V114, P19, DOI 10.1177/000348940511400105; Catten M, 1998, OTOLARYNG HEAD NECK, V118, P663, DOI 10.1177/019459989811800516; Chang Z, 2014, DIS MODEL MECH, V7, P83, DOI 10.1242/dmm.013326; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; de Fougerolles AR, 2000, J CLIN INVEST, V105, P721, DOI 10.1172/JCI7911; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hornell TMC, 2003, J IMMUNOL, V171, P2374, DOI 10.4049/jimmunol.171.5.2374; Hu R, 2014, ACTA HISTOCHEM, V116, P730, DOI 10.1016/j.acthis.2013.12.014; Imaizumi M, 2014, LARYNGOSCOPE, V124, pE437, DOI 10.1002/lary.24799; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; King SN, 2014, LIPOPOLYSACCHARIDE R; King SN, 2013, CYTOKINE, V61, P228, DOI 10.1016/j.cyto.2012.09.023; Laskin DL, 2009, CHEM RES TOXICOL, V22, P1376, DOI 10.1021/tx900086v; Li NYK, 2012, LARYNGOSCOPE, V122, P364, DOI 10.1002/lary.22435; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Lu MF, 2011, J IMMUNOL, V187, P3314, DOI 10.4049/jimmunol.1004087; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248; Mizuta M, 2012, ANN OTO RHINOL LARYN, V121, P804, DOI 10.1177/000348941212101206; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Mukherjee S, 2009, J BIOL CHEM, V284, P29391, DOI 10.1074/jbc.M109.005272; Myers MJ, 2003, INT IMMUNOPHARMACOL, V3, P571, DOI 10.1016/S1567-5769(03)00048-1; Myers MJ, 1999, DOMEST ANIM ENDOCRIN, V17, P345, DOI 10.1016/S0739-7240(99)00057-0; Pioli PA, 2004, J LEUKOCYTE BIOL, V76, P500, DOI 10.1189/jlb.1203617; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Soulas C, 2011, AM J PATHOL, V178, P2121, DOI 10.1016/j.ajpath.2011.01.023; Wang ZQ, 2001, IMMUNOLOGY, V102, P331, DOI 10.1046/j.1365-2567.2001.01171.x; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145, DOI 10.1177/000348940811700213	36	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139260	10.1371/journal.pone.0139260	http://dx.doi.org/10.1371/journal.pone.0139260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430970	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700040
J	Torres-Gonzalez, P; Cervera-Hernandez, ME; Niembro-Ortega, MD; Leal-Vega, F; Cruz-Hervert, LP; Garcia-Garcia, L; Galindo-Fraga, A; Martinez-Gamboa, A; Bobadilla-del Valle, M; Sifuentes-Osornio, J; Ponce-de-Leon, A				Torres-Gonzalez, Pedro; Enrique Cervera-Hernandez, Miguel; Dolores Niembro-Ortega, Maria; Leal-Vega, Francisco; Pablo Cruz-Hervert, Luis; Garcia-Garcia, Lourdes; Galindo-Fraga, Arturo; Martinez-Gamboa, Areli; Bobadilla-del Valle, Miriam; Sifuentes-Osornio, Jose; Ponce-de-Leon, Alfredo			Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; RISK-FACTORS; INFECTION; COLONIZATION; ACQUISITION	Background Carbapenem-resistant Enterobacteriaceae (CRE) infections have emerged as a serious threat to health worldwide. They are associated with increased morbidity and mortality and are capable of silently colonizing the gastrointestinal tract. Because of this, there is great interest to characterize the epidemiology of CRE carriage and acquisition in healthcare facilities. The aim of this study was to determine the prevalence and factors associated with CRE fecal carriage (CRE-fc), and risk factors for incident cases. Methods/Results A cohort study was conducted at a tertiary care hospital from January 1st to April 30th, 2014 during a CRE outbreak. Weekly rectal swabs were performed in patients considered at risk until discharge. CRE-fc prevalence was 10.9%(CI 95% 7.7-14.7) among 330 patients. Treatment with carbapenems (OR 2.54, CI 95% 1.15-5.62); transfer from an institution (OR 2.16, CI 95% 1.02-4.59); multi-drug resistant infection within the previous six months (OR 2.81, CI 95% 1.47-5.36); intensive care unit admission (OR 0.42, CI 95% 0.20-0.88); hematologic malignancy (OR 4.02, CI 95% 1.88-8.06); invasive procedures (OR 2.18, CI 95% 1.10-4.32); and sharing a room with a known CRE carrier (OR 3.0, CI 95% 1.43-6.31) were independently associated factors for CRE-fc. Risk factors associated with CRE-fc incidence were determined for 87 patients initially negative and with subsequent screening; the incidence rate was 2.5 cases, per 1000 person-years (CI 95% 1.5-3.9). Independently associated risk factors were carbapenem treatment (HR 2.68, CI 95% 1.03-6.98), hematologic malignancy (HR 5.74, 95% CI 2.46-13.4) and a mean daily colonization pressure >= 10% (HR 5.03, IC 95% 1.77-14.28). OXA-48-like (OXA-232) and CTX-M-15 were the predominantly identified mechanisms of resistance. Conclusions We found an elevated incidence and prevalence of CRE-fc in our hospital. Hematologic patients need to be considered a population at risk, and antibiotic stewardship along with infection control programs need to be improved to avoid nosocomial spread.	[Torres-Gonzalez, Pedro; Enrique Cervera-Hernandez, Miguel; Dolores Niembro-Ortega, Maria; Leal-Vega, Francisco; Martinez-Gamboa, Areli; Bobadilla-del Valle, Miriam; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Lab Clin Microbiol, Mexico City, DF, Mexico; [Pablo Cruz-Hervert, Luis; Garcia-Garcia, Lourdes] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Galindo-Fraga, Arturo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Div Hosp Epidemiol, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Med, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Salud Publica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Ponce-de-Leon, A (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Lab Clin Microbiol, Mexico City, DF, Mexico.	alf.poncedeleon@gmail.com	Bobadilla-del-Valle, Miriam/AAD-6418-2020; Cruz-Hervert, Luis Pablo/AEI-4595-2022; García, Maria de Lourdes/I-2724-2019	Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Galindo-Fraga, Arturo/0000-0002-2818-1160; Ponce-de-Leon, Alfredo/0000-0003-2640-2916; Cervera-Hernandez, Miguel/0000-0002-2854-243X; Torres-Gonzalez, Pedro/0000-0002-2944-2721	Senosiain; Pfizer; Merck Sharp Dhome; Sanofi Pasteur; AstraZeneca; bioMerieux	Senosiain; Pfizer(Pfizer); Merck Sharp Dhome; Sanofi Pasteur; AstraZeneca(AstraZeneca); bioMerieux	The authors of this manuscript have the following competing interests: J. Sifuentes-Osornio has received research grants from Senosiain, Pfizer, Merck Sharp & Dhome, Sanofi Pasteur, AstraZeneca, and bioMerieux; personal fees from Pfizer, Merck Sharp & Dhome, and Sanofi Pasteur; and non-financial support from Pfizer, Merck Sharp & Dhome, Sanofi Pasteur, and bioMerieux. P. Torres-Gonzalez has received research grants from Pfizer and Sanofi Pasteur. A. Ponce-de-Leon has received research grants from Merck Sharp & Dhome and Pfizer; and is on the advisory board for Merck Sharp & Dhome, Pfizer, Janssen-Cilag, and Novartis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Akova M, 2012, CLIN MICROBIOL INFEC, V18, P439, DOI 10.1111/j.1469-0691.2012.03823.x; Ben-David D, 2011, INFECT CONT HOSP EP, V32, P845, DOI 10.1086/661279; Bonten MJM, 1998, ARCH INTERN MED, V158, P1127, DOI 10.1001/archinte.158.10.1127; Borer A, 2012, AM J INFECT CONTROL, V40, P421, DOI 10.1016/j.ajic.2011.05.022; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CLSI, 2013, PERFORMANCE STANDARD; Husni R, 2002, INFECT CONT HOSP EP, V23, P102, DOI 10.1086/502016; Landman D, 2005, J CLIN MICROBIOL, V43, P5639, DOI 10.1128/JCM.43.11.5639-5641.2005; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, J CLIN MICROBIOL, V49, P718, DOI 10.1128/JCM.01773-10; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pantel A, 2015, EUR J CLIN MICROBIOL, V34, P899, DOI 10.1007/s10096-014-2298-1; Papadimitriou-Olivgeris M, 2012, J ANTIMICROB CHEMOTH, V67, P2976, DOI 10.1093/jac/dks316; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; Rodriguez-Osorio CA, 2015, J ANTIMICROB CHEMOTH, V70, P914, DOI 10.1093/jac/dku471; Saidel-Odes L, 2014, INFECT DRUG RESIST, V7, P9, DOI 10.2147/IDR.S44358; Schwaber MJ, 2008, ANTIMICROB AGENTS CH, V52, P1028, DOI 10.1128/AAC.01020-07; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Solomon SL, 2014, AM FAM PHYSICIAN, V89, P938; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Wiener-Well Y, 2010, J HOSP INFECT, V74, P344, DOI 10.1016/j.jhin.2009.07.022; WINGARD JR, 1986, ANTIMICROB AGENTS CH, V30, P435, DOI 10.1128/AAC.30.3.435; Zhao ZC, 2014, AM J INFECT CONTROL, V42, pE61, DOI 10.1016/j.ajic.2014.01.024	26	51	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139883	10.1371/journal.pone.0139883	http://dx.doi.org/10.1371/journal.pone.0139883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431402	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700127
J	Arloth, J; Bader, DM; Roh, S; Altmann, A				Arloth, Janine; Bader, Daniel M.; Roeh, Simone; Altmann, Andre			Re-Annotator: Annotation Pipeline for Microarray Probe Sequences	PLOS ONE			English	Article								Microarray technologies are established approaches for high throughput gene expression, methylation and genotyping analysis. An accurate mapping of the array probes is essential to generate reliable biological findings. However, manufacturers of the microarray platforms typically provide incomplete and outdated annotation tables, which often rely on older genome and transcriptome versions that differ substantially from up-to-date sequence databases. Here, we present the Re-Annotator, a re-annotation pipeline for microarray probe sequences. It is primarily designed for gene expression microarrays but can also be adapted to other types of microarrays. The Re-Annotator uses a custom-built mRNA reference database to identify the positions of gene expression array probe sequences. We applied Re-Annotator to the Illumina Human-HT12 v4 microarray platform and found that about one quarter (25%) of the probes differed from the manufacturer's annotation. In further computational experiments on experimental gene expression data, we compared Re-Annotator to another probe re-annotation tool, ReMOAT, and found that Re-Annotator provided an improved re-annotation of microarray probes. A thorough re-annotation of probe information is crucial to any microarray analysis. The Re-Annotator pipeline is freely available at http://sourceforge.net/projects/reannotator along with re-annotated files for Illumina microarrays HumanHT-12 v3/v4 and MouseRef-8 v2.	[Arloth, Janine; Bader, Daniel M.; Roeh, Simone] Max Planck Inst Psychiat, Translat Res Dept, D-80804 Munich, Germany; [Bader, Daniel M.] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Altmann, Andre] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA	Max Planck Society; University of Munich; Stanford University	Arloth, J (corresponding author), Max Planck Inst Psychiat, Translat Res Dept, Kraepelinstr 2-10, D-80804 Munich, Germany.	arloth@psych.mpg.de	Altmann, Andre/ABF-1675-2020	Altmann, Andre/0000-0002-9265-2393; Bader, Daniel Magnus/0000-0003-1875-6044; Roeh, Simone/0000-0002-7450-0871	European Union under European Research Council [281338]; DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM)	European Union under European Research Council; DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM)	This study was supported by the European Union under European Research Council GA no. 281338 (JA). DB was supported by a DFG Fellowship through the Graduate School of Quantitative Biosciences Munich (QBM).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Derrien T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030377; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603	13	47	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139516	10.1371/journal.pone.0139516	http://dx.doi.org/10.1371/journal.pone.0139516			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426330	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100072
J	Chen, SF; Li, MW; Jing, HJ; Zhou, RC; Yang, GL; Wu, W; Fan, Q; Liao, WB				Chen, Su-Fang; Li, Ming-Wan; Jing, Hui-Juan; Zhou, Ren-Chao; Yang, Gui-Li; Wu, Wei; Fan, Qiang; Liao, Wen-Bo			De Novo Transcriptome Assembly in Firmiana danxiaensis, a Tree Species Endemic to the Danxia Landform	PLOS ONE			English	Article							MODEL-PLANT; GENERATION; PLATFORM; GENOME; GENES	Many Firmiana species are locally endemic, providing an interesting system for studying adaptation and speciation. Among these species, F. danxiaensis is a tree species endemic to Mount Danxia in Guangdong, China, which is an area known for presenting the Danxia landform. How F. danxiaensis could have adapted to the stressful environment of rocky cliffs covered with barren soils in the Danxia landform is still unknown. In this study, we performed de novo assembly of the transcriptome of F. danxiaensis, obtaining 47,221 unigenes with an N50 value of 987 bp. Homology analysis showed that 32,318 of the unigenes presented hits in the NCBI non-redundant database, and 31,857 exhibited significant matches with the protein database of Theobroma cacao. Gene Ontology (GO) annotation showed that hundreds of unigenes participated in responses to various stresses or nutritional starvation, which may help us to understand the adaptation of F. danxiaensis to Danxia landform. Additionally, we found 263 genes related to responses to Cd, partially explaining the high accumulation of Cd observed in Firmiana species. The EuKaryotic Orthologous Groups (KOG) and Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations revealed many genes playing roles in the biosynthesis of secondary metabolites and environmental adaptation, which may also contribute to the survivor and success of Firmiana species in extreme environments. Based on the obtained transcriptome, we further identified a Firmiana-specific whole-genome duplication event that occurred approximately 20 Mya, which may have provided raw materials for the diversification of Firmiana species.	[Chen, Su-Fang; Li, Ming-Wan; Jing, Hui-Juan; Zhou, Ren-Chao; Fan, Qiang; Liao, Wen-Bo] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Su-Fang; Li, Ming-Wan; Jing, Hui-Juan; Zhou, Ren-Chao; Fan, Qiang; Liao, Wen-Bo] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Gui-Li] South China Agr Univ, Natl Engn Resarch Ctr Plant Space Breeding, Guangzhou 510642, Guangdong, Peoples R China; [Wu, Wei] Chinese Acad Sci, South China Bot Garden, Guangzhou 510650, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; South China Agricultural University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Fan, Q (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	fanqiang@mail.sysu.edu.cn; lsslwb@mail.sysu.edu.cn			National Natural Science Foundation of China [31170202, 31100159, 31170213]; Doctoral Foundation of Ministry of Education of China [20090171120034, 20110171110032]; Fundamental Research Funds for the Central Universities [13lgpy07]; Foundation of Administrative Committee of Mount Danxia National Park [2010-0042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Foundation of Administrative Committee of Mount Danxia National Park	Support for this study was provided by a grant by the National Natural Science Foundation of China (Project 31170202) to WL, a grant by the National Natural Science Foundation of China (Project 31100159) to QF, a grant by the National Natural Science Foundation of China (Project 31170213) to RZ, a grant by the Doctoral Foundation of Ministry of Education of China (Project 20090171120034) to QF, a grant by the Doctoral Foundation of Ministry of Education of China (Project 20110171110032) to WL, a grant by the Fundamental Research Funds for the Central Universities (Project 13lgpy07) to QF, and a grant by the Foundation of Administrative Committee of Mount Danxia National Park (Project 2010-0042) to WL. QF and WL played roles in designing the experiment and writing the manuscript; RZ played a role in analyzing the data.	Annadurai RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056217; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Appel C, 2002, J ENVIRON QUAL, V31, P581, DOI 10.2134/jeq2002.0581; Argout X, 2011, NAT GENET, V43, P101, DOI 10.1038/ng.736; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Chen SF, 2011, MAR GENOM, V4, P129, DOI 10.1016/j.margen.2011.03.005; Chinnusamy V, 2008, J INTEGR PLANT BIOL, V50, P1187, DOI 10.1111/j.1744-7909.2008.00727.x; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crozier A., 2006, PLANT SECONDARY META, P1, DOI [10.1002/9780470988558, DOI 10.1002/9780470988558, 10.1002/9780470988558.ch1]; Fan Q, 2015, PHYTOTAXA, V197, P15, DOI 10.11646/phytotaxa.197.1.2; Flagel LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-195; Fu XinHui, 2004, Plant Molecular Biology Reporter, V22, P197, DOI 10.1007/BF02772728; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hartmann T, 2004, PLANTA, V219, P1, DOI 10.1007/s00425-004-1249-y; HEINRICHS H, 1980, GEOCHIM COSMOCHIM AC, V44, P1519, DOI 10.1016/0016-7037(80)90116-7; Hsue H.H., 1987, J S CHINA AGR U, V8, P1; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jiang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071054; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092087; KOSTERMANS AJGH, 1989, BLUMEA, V34, P117; Kostermans AJGH, 1954, REINWARDTIA, V4, P281; Liang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120615; Liu W.O., 1996, J SUN YS U S, P61; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mabberley D. J., 1997, PLANT BOOK PORTABLE; Makkar Harinder P S, 2007, Methods Mol Biol, V393, P1; McLachlan G., 1999, J STAT SOFTW, V4, P1, DOI DOI 10.18637/jss.v004.i02; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Peng H, 2009, 1 INT S DANX LANDF S; Peng S.L., 2011, INTEGRATED BIOL SURV; Shen RJ, 2010, NORD J BOT, V28, P728, DOI 10.1111/j.1756-1051.2010.00885.x; Tang QA, 2010, J HAZARD MATER, V179, P95, DOI 10.1016/j.jhazmat.2010.02.062; Tang Y, 2007, STERCULIACEAE; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang S., 2004, CHINA SPECIES RED LI; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wu LL, 2010, MOL ECOL, V19, P1691, DOI 10.1111/j.1365-294X.2010.04613.x; Xie HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099177; Xie SP, 2014, GEOBIOS-LYON, V47, P271, DOI 10.1016/j.geobios.2014.03.005; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu YF, 1999, PLANTS, V151, P3; Zhai JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060371	51	8	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139373	10.1371/journal.pone.0139373	http://dx.doi.org/10.1371/journal.pone.0139373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427005	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100054
J	Pusceddu, MM; El Aidy, S; Crispie, F; O'Sullivan, O; Cotter, P; Stanton, C; Kelly, P; Cryan, JF; Dinan, TG				Pusceddu, Matteo M.; El Aidy, Sahar; Crispie, Fiona; O'Sullivan, Orla; Cotter, Paul; Stanton, Catherine; Kelly, Philip; Cryan, John F.; Dinan, Timothy G.			N-3 Polyunsaturated Fatty Acids (PUFAs) Reverse the Impact of Early-Life Stress on the Gut Microbiota	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; MATERNAL SEPARATION; PRENATAL STRESS; BRAIN; OMEGA-3; INFLAMMATION; BEHAVIOR; HEALTH	Background Early life stress is a risk factor for many psychiatric disorders ranging from depression to anxiety. Stress, especially during early life, can induce dysbiosis in the gut microbiota, the key modulators of the bidirectional signalling pathways in the gut-brain axis that underline several neurodevelopmental and psychiatric disorders. Despite their critical role in the development and function of the central nervous system, the effect of n-3 polyunsaturated fatty acids (n-3 PUFAs) on the regulation of gut-microbiota in early-life stress has not been explored. Methods and Results Here, we show that long-term supplementation of eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) (80% EPA, 20% DHA) n-3 PUFAs mixture could restore the disturbed gut-microbiota composition of maternally separated (MS) female rats. Sprague-Dawley female rats were subjected to an early-life stress, maternal separation procedure from postnatal days 2 to 12. Non-separated (NS) and MS rats were administered saline, EPA/DHA 0.4 g/kg/day or EPA/DHA 1 g/kg/day, respectively. Analysis of the gut microbiota in adult rats revealed that EPA/DHA changes composition in the MS, and to a lesser extent the NS rats, and was associated with attenuation of the corticosterone response to acute stress. Conclusions In conclusion, EPA/DHA intervention alters the gut microbiota composition of both neurodevelopmentally normal and early-life stressed animals. This study offers insights into the interaction between n-3 PUFAs and gut microbes, which may play an important role in advancing our understanding of disorders of mood and cognitive functioning, such as anxiety and depression.	[Pusceddu, Matteo M.; Stanton, Catherine; Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, Dept Psychiat & Neurobehav Sci, Cork, Ireland; [Pusceddu, Matteo M.; El Aidy, Sahar; Cotter, Paul; Stanton, Catherine; Cryan, John F.; Dinan, Timothy G.] Natl Univ Ireland Univ Coll Cork, APC Microbiome Inst, Cork, Ireland; [Crispie, Fiona; O'Sullivan, Orla; Cotter, Paul; Stanton, Catherine; Kelly, Philip] TEAGASC, Cork, Ireland; [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Cork; Teagasc; University College Cork	Dinan, TG (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Psychiat & Neurobehav Sci, Cork, Ireland.	t.dinan@ucc.ie	Stanton, Catherine/A-9549-2015; Dinan, Timothy/ABA-8284-2020; O'Sullivan, Orla/ABE-5980-2020; Aidy, Sahar El/J-5246-2017; Cryan, John F./A-6950-2013	Stanton, Catherine/0000-0002-6724-7011; O'Sullivan, Orla/0000-0002-4332-1109; Aidy, Sahar El/0000-0001-8950-4392; Cryan, John F./0000-0001-5887-2723; Pusceddu, Matteo/0000-0002-4934-3501; Dinan, Timothy/0000-0002-2316-7220	Food Institutional Research Measure (FIRM) [10/RD/TMFRC/709]; APC Microbiome Institute [07/CE/B1368, 12/RC/2273]; Science Foundation Ireland (SFI) [12/IA/1537]	Food Institutional Research Measure (FIRM); APC Microbiome Institute; Science Foundation Ireland (SFI)(Science Foundation Ireland)	Research was funded by Food Institutional Research Measure (FIRM) under Grant No. 10/RD/TMFRC/709, the APC Microbiome Institute under Grant No. 07/CE/B1368 and 12/RC/2273, Science Foundation Ireland (SFI) under Grant No. 12/IA/1537.	Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bailey MT, 1999, DEV PSYCHOBIOL, V35, P146, DOI 10.1002/(SICI)1098-2302(199909)35:2<146::AID-DEV7>3.0.CO;2-G; Bakunina N, 2015, IMMUNOLOGY, V144, P365, DOI 10.1111/imm.12443; Bercik P, 2014, ADV EXP MED BIOL, V817, P279, DOI 10.1007/978-1-4939-0897-4_13; Bowens N, 2012, PHYSIOL BEHAV, V105, P958, DOI 10.1016/j.physbeh.2011.10.032; Calviello G, 2004, CARCINOGENESIS, V25, P2303, DOI 10.1093/carcin/bgh265; Clarke G, 2014, ACTA PAEDIATR, V103, P812, DOI 10.1111/apa.12674; Cohen H, 2006, BIOL PSYCHIAT, V59, P1208, DOI 10.1016/j.biopsych.2005.12.003; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Das UN, 2000, PROSTAG LEUKOTR ESS, V63, P351, DOI 10.1054/plef.2000.0226; Dinan TG, 2005, J ANAT, V207, P259, DOI 10.1111/j.1469-7580.2005.00443.x; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; El Aidy S, 2015, CLIN THER; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Golubeva AV, 2015, PSYCHONEUROENDOCRINO, V60, P58, DOI 10.1016/j.psyneuen.2015.06.002; Grosso G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/313570; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hibbeln JR, 2014, MIL MED, V179, P117, DOI 10.7205/MILMED-D-14-00153; Jasarevic E, 2015, ENDOCRINOLOGY; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jiang H, 2015, BRAIN BEHAV IMMUN; Kankaanpaa PE, 2001, FEMS MICROBIOL LETT, V194, P149, DOI 10.1016/S0378-1097(00)00519-X; Logan AC, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-22; Marques TM, 2015, BRIT J NUTR, V113, P728, DOI 10.1017/S0007114514004206; Mayer EA, 2014, J NEUROSCI, V34, P15490, DOI 10.1523/JNEUROSCI.3299-14.2014; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; McNamara RK, 2015, WORLD J PSYCHIATR, V5, P15, DOI 10.5498/wjp.v5.i1.15; Molitoris E, 1997, CLIN INFECT DIS, V25, pS264, DOI 10.1086/516234; Moloney RD, 2014, MAMM GENOME, V25, P49, DOI 10.1007/s00335-013-9488-5; O'Mahony S, 2008, NEUROGASTROENT MOTIL, V20, P680, DOI 10.1111/j.1365-2982.2007.01065.x; O'Mahony SM, 2011, PSYCHOPHARMACOLOGY, V214, P71, DOI 10.1007/s00213-010-2010-9; O'Mahony SM, 2009, BIOL PSYCHIAT, V65, P263, DOI 10.1016/j.biopsych.2008.06.026; Patterson E, 2014, BRIT J NUTR, V111, P1905, DOI 10.1017/S0007114514000117; Peet M, 2008, ISR J PSYCHIATR REL, V45, P19; Pusceddu MM, 2015, PSYCHONEUROENDOCRINO, V58, P79, DOI 10.1016/j.psyneuen.2015.04.015; Russo C, 1995, J HYPERTENS, V13, P1823; Scher JU, 2013, ELIFE, V2, DOI 10.7554/eLife.01202; Song C, 2013, MOD TR PHARMACOPSYCH, V28, P75, DOI 10.1159/000343970; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603; Yehuda R, 2005, J CLIN ENDOCR METAB, V90, P4115, DOI 10.1210/jc.2005-0550; Yilmaz HR, 2004, PROSTAG LEUKOTR ESS, V71, P131, DOI 10.1016/j.plefa.2004.03.002; Yu HN, 2014, ARCH MED RES, V45, P195, DOI 10.1016/j.arcmed.2014.03.008; Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006	47	119	128	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139721	10.1371/journal.pone.0139721	http://dx.doi.org/10.1371/journal.pone.0139721			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426902	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100089
J	ten Harkel, B; Schoenmaker, T; Picavet, DI; Davison, NL; de Vries, TJ; Everts, V				ten Harkel, Bas; Schoenmaker, Ton; Picavet, Daisy I.; Davison, Noel L.; de Vries, Teun J.; Everts, Vincent			The Foreign Body Giant Cell Cannot Resorb Bone, But Dissolves Hydroxyapatite Like Osteoclasts	PLOS ONE			English	Article							ATP SYNTHASE; IN-VITRO; FUSION; MACROPHAGES; DIFFERENTIATION; RESORPTION; MONOCYTES; OSTEOPETROSIS; ARCHITECTURE; PHOSPHATE	Foreign body multinucleated giant cells (FBGCs) and osteoclasts share several characteristics, like a common myeloid precursor cell, multinuclearity, expression of tartrate-resistant acid phosphatase (TRAcP) and dendritic cell-specific transmembrane protein (DC-STAMP). However, there is an important difference: osteoclasts form and reside in the vicinity of bone, while FBGCs form only under pathological conditions or at the surface of foreign materials, like medical implants. Despite similarities, an important distinction between these cell types is that osteoclasts can resorb bone, but it is unknown whether FBGCs are capable of such an activity. To investigate this, we differentiated FBGCs and osteoclasts in vitro from their common CD14(+) monocyte precursor cells, using different sets of cytokines. Both cell types were cultured on bovine bone slices and analyzed for typical osteoclast features, such as bone resorption, presence of actin rings, formation of a ruffled border, and characteristic gene expression over time. Additionally, both cell types were cultured on a biomimetic hydroxyapatite coating to discriminate between bone resorption and mineral dissolution independent of organic matrix proteolysis. Both cell types differentiated into multinucleated cells on bone, but FBGCs were larger and had a higher number of nuclei compared to osteoclasts. FBGCs were not able to resorb bone, yet they were able to dissolve the mineral fraction of bone at the surface. Remarkably, FBGCs also expressed actin rings, podosome belts and sealing zones-cytoskeletal organization that is considered to be osteoclast-specific. However, they did not form a ruffled border. At the gene expression level, FBGCs and osteoclasts expressed similar levels of mRNAs that are associated with the dissolution of mineral (e.g., anion exchange protein 2 (AE2), carbonic anhydrase 2 (CAII), chloride channel 7 (CIC7), and vacuolar-type H+-ATPase (v-ATPase)), in contrast the matrix degrading enzyme cathepsin K, which was hardly expressed by FBGCs. Functionally, the latter cells were able to dissolve a biomimetic hydroxyapatite coating in vitro, which was blocked by inhibiting v-ATPase enzyme activity. These results show that FBGCs have the capacity to dissolve the mineral phase of bone, similar to osteoclasts. However, they are not able to digest the matrix fraction of bone, likely due to the lack of a ruffled border and cathepsin K.	[ten Harkel, Bas; Everts, Vincent] Univ Amsterdam, MOVE Res Inst, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [ten Harkel, Bas; Schoenmaker, Ton; de Vries, Teun J.; Everts, Vincent] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Schoenmaker, Ton; de Vries, Teun J.] Univ Amsterdam, MOVE Res Inst, Acad Ctr Dent Amsterdam ACTA, Dept Periodontol, Amsterdam, Netherlands; [Picavet, Daisy I.] Univ Amsterdam, Acad Med Ctr, Ctr Adv Microscopy, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [Davison, Noel L.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Davison, Noel L.] Xpand Biotechnol BV, Bilthoven, Netherlands	Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Twente	ten Harkel, B (corresponding author), Univ Amsterdam, MOVE Res Inst, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands.	b.t.harkel@acta.nl		Schoenmaker, Ton/0000-0001-6649-374X; de Vries, Teun/0000-0001-6464-5172	Dutch government [1672802]; Xpand Biotechnology BV	Dutch government; Xpand Biotechnology BV	This work was supported by a grant from the Dutch government to the Netherlands Institute for Regenerative Medicine (NIRM, grant No. 1672802). Xpand Biotechnology BV provided support in the form of salaries for authors [NLD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Albrektsson T, 2014, CLIN IMPLANT DENT R, V16, P155, DOI 10.1111/cid.12142; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F; Chambers TJ, 2000, J PATHOL, V192, P4; Davison NL, 2014, BIOMATERIALS, V35, P7441, DOI 10.1016/j.biomaterials.2014.05.048; de Vries TJ, 2005, J CELL BIOCHEM, V94, P954, DOI 10.1002/jcb.20326; DeFife KM, 1997, J IMMUNOL; Engelbrecht S, 1997, FEBS LETT, V414, P485, DOI 10.1016/S0014-5793(97)00997-6; Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090; Forman Henry Jay, 2001, Molecular Aspects of Medicine, V22, P189; Halleen JM, 2003, J BONE MINER RES, V18, P1908, DOI 10.1359/jbmr.2003.18.10.1908; Helming L, 2009, J CELL SCI, V122, P453, DOI 10.1242/jcs.037200; Henriksen K, 2008, CALCIFIED TISSUE INT, V83, P230, DOI 10.1007/s00223-008-9168-8; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Jonckheere AI, 2012, J INHERIT METAB DIS, V35, P211, DOI 10.1007/s10545-011-9382-9; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Khan UA, 2013, J CELL BIOCHEM, V114, P1772, DOI 10.1002/jcb.24518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCNALLY AK, 1995, AM J PATHOL, V147, P1487; McNally AK, 2015, J BIOMED MATER RES A, V103, P1380, DOI 10.1002/jbm.a.35280; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Miyamoto Takeshi, 2013, JAKSTAT, V2, pe24777, DOI 10.4161/jkst.24777; Miyamoto Takeshi, 2011, Keio Journal of Medicine, V60, P101; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Neale SD, 1999, ACTA ORTHOP SCAND, V70, P452, DOI 10.3109/17453679909000980; Okahashi N, 1997, J BONE MINER RES, V12, P1116, DOI 10.1359/jbmr.1997.12.7.1116; Quinn JMW, 1998, CALCIFIED TISSUE INT, V62, P527, DOI 10.1007/s002239900473; QUINN JMW, 1991, HISTOCHEMISTRY, V96, P169, DOI 10.1007/BF00315989; Revell PA, 2008, J R SOC INTERFACE, V5, P1263, DOI 10.1098/rsif.2008.0142; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; Srinivasan S, 2010, ANN NY ACAD SCI, V1192, P245, DOI 10.1111/j.1749-6632.2009.05377.x; Sun-Wada GH, 2003, J BIOENERG BIOMEMBR, V35, P347, DOI 10.1023/A:1025780932403; VIGNERY A, 1989, J HISTOCHEM CYTOCHEM, V37, P1265, DOI 10.1177/37.8.2546991; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75	41	57	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139564	10.1371/journal.pone.0139564	http://dx.doi.org/10.1371/journal.pone.0139564			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426806	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100076
J	Feng, YE; Kou, GS				Feng YongE; Kou GaoShan			Identify Beta-Hairpin Motifs with Quadratic Discriminant Algorithm Based on the Chemical Shifts	PLOS ONE			English	Article							SECONDARY-STRUCTURE; RANDOM FORESTS; PREDICTION; PROTEINS; CLASSIFICATION; PEPTIDES; MODEL	Successful prediction of the beta-hairpin motif will be helpful for understanding the of the fold recognition. Some algorithms have been proposed for the prediction of beta-hairpin motifs. However, the parameters used by these methods were primarily based on the amino acid sequences. Here, we proposed a novel model for predicting beta-hairpin structure based on the chemical shift. Firstly, we analyzed the statistical distribution of chemical shifts of six nuclei in not beta-hairpin and beta-hairpin motifs. Secondly, we used these chemical shifts as features combined with three algorithms to predict beta-hairpin structure. Finally, we achieved the best prediction, namely sensitivity of 92%, the specificity of 94% with 0.85 of Mathew's correlation coefficient using quadratic discriminant analysis algorithm, which is clearly superior to the same method for the prediction of beta-hairpin structure from 20 amino acid compositions in the three-fold cross-validation. Our finding showed that the chemical shift is an effective parameter for beta-hairpin prediction, suggesting the quadratic discriminant analysis is a powerful algorithm for the prediction of beta-hairpin.	[Feng YongE; Kou GaoShan] Inner Mongolia Agr Univ, Coll Sci, Hohhot, Peoples R China	Inner Mongolia Agricultural University	Feng, YE (corresponding author), Inner Mongolia Agr Univ, Coll Sci, Hohhot, Peoples R China.	fengyonge@163.com			Inner Mongolia autonomous region higher school science and technology research projects [NJZY067]; Basic Science of Inner Mongolia Agriculture University Research Fund [JC2013004]	Inner Mongolia autonomous region higher school science and technology research projects; Basic Science of Inner Mongolia Agriculture University Research Fund	The work was supported by the Inner Mongolia autonomous region higher school science and technology research projects (No. NJZY067) and Basic Science of Inner Mongolia Agriculture University Research Fund (No. JC2013004).	Bim J, 2004, J AM CHEM SOC, V126, P8529, DOI 10.1021/ja049879z; Brender JR, 2001, J AM CHEM SOC, V123, P914, DOI 10.1021/ja001980q; Burke DF, 2001, PROTEIN ENG, V14, P473, DOI 10.1093/protein/14.7.473; Bystroff C, 2000, J MOL BIOL, V301, P173, DOI 10.1006/jmbi.2000.3837; Case DA, 1998, CURR OPIN STRUC BIOL, V8, P624, DOI 10.1016/S0959-440X(98)80155-3; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Chou KC, 1997, J PEPT RES, V49, P120; Chou KC, 1997, J PROTEIN CHEM, V16, P575, DOI 10.1023/A:1026366706677; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2015, MED CHEM, V11, P218, DOI 10.2174/1573406411666141229162834; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; de la Cruz X, 2002, P NATL ACAD SCI USA, V99, P11157, DOI 10.1073/pnas.162376199; Durr UHN, 2007, J AM CHEM SOC, V129, P6670, DOI 10.1021/ja069028m; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Feng YE, 2008, AMINO ACIDS, V35, P607, DOI 10.1007/s00726-008-0089-7; Feng YG, 2014, ACTA BIOTHEOR, V62, P1, DOI 10.1007/s10441-013-9203-7; Fernandez-Fuentes N, 2004, PROTEINS, V56, P539, DOI 10.1002/prot.20136; Goldstein BA, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1691; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Hayat M, 2012, PROTEIN PEPTIDE LETT, V19, P411, DOI 10.2174/092986612799789387; Hu XZ, 2008, PROTEIN J, V27, P115, DOI 10.1007/s10930-007-9114-z; Hu XZ, 2010, AMINO ACIDS, V38, P915, DOI 10.1007/s00726-009-0299-7; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kou GS, 2015, J THEOR BIOL, V380, P392, DOI 10.1016/j.jtbi.2015.06.006; Kuhn M, 2004, PROTEINS, V54, P282, DOI 10.1002/prot.10589; Kumar M, 2005, NUCLEIC ACIDS RES, V33, pW154, DOI 10.1093/nar/gki588; Lee DK, 1998, J AM CHEM SOC, V120, P8868, DOI 10.1021/ja981599u; Lian JJ, 2004, STAT PROBABIL LETT, V70, P183, DOI 10.1016/j.spl.2004.10.002; Lin H, 2013, ACTA BIOTHEOR, V61, P259, DOI 10.1007/s10441-013-9181-9; Lin H, 2012, J BIOMOL STRUCT DYN, V29, P643, DOI 10.1080/07391102.2011.672628; Liu Z, 2015, ANAL BIOCHEM, V474, P69, DOI 10.1016/j.ab.2014.12.009; Mao WS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083532; Mechelke M, 2013, PROTEINS, V81, P984, DOI 10.1002/prot.24249; Mielke SP, 2003, BIOINFORMATICS, V19, P2054, DOI 10.1093/bioinformatics/btg280; PASTORE A, 1990, J MAGN RESON, V90, P165, DOI 10.1016/0022-2364(90)90375-J; Poon A, 2004, J PHYS CHEM B, V108, P16577, DOI 10.1021/jp0471913; Ramamoorthy A, 2004, ANNU REP NMR SPECTRO, V52, P1, DOI 10.1016/S0066-4103(04)52001-X; Saito H, 2010, PROG NUCL MAG RES SP, V57, P181, DOI 10.1016/j.pnmrs.2010.04.005; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shen Y, 2012, J BIOMOL NMR, V52, P211, DOI 10.1007/s10858-012-9602-0; Sprinthall R.C., 2011, BASIC STAT ANAL; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Sun ZR, 1997, PROTEIN ENG, V10, P763, DOI 10.1093/protein/10.7.763; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang YJ, 2004, J BIOMOL NMR, V30, P233, DOI 10.1007/s10858-004-3098-1; Wishart DS, 2001, METHOD ENZYMOL, V338, P3; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105018; Yang JS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01403; Yonge F, 2014, SCI WORLD J, DOI 10.1155/2014/978503; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	54	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139280	10.1371/journal.pone.0139280	http://dx.doi.org/10.1371/journal.pone.0139280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422468	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700089
J	Qi, ML; Lin, KR; Li, XZ; Sammis, TW; Miller, DR; Wang, JM				Qi, Meilan; Lin, Kairong; Li, Xiangzhen; Sammis, Ted W.; Miller, David R.; Wang, Junming			Particulate Matter Contributions from Agricultural Tilling Operations in an Irrigated Desert Region	PLOS ONE			English	Article							EMISSION FACTORS; MODEL; DISPERSION; SENSITIVITY	Sources of regional particulate matter (PM), particularly agricultural operations, must be understood in order to manage the air quality in irrigated dry climates. Direct monitoring measurements alone are useful, but not sufficient, to estimate regional PM source concentrations. This paper combines modeling with ground (point) and airplane (spatial) measurement methods to estimate regional PM10 (PM diameter <= 10 mu m) contributions from agricultural operations. Hourly data from three air quality monitoring stations positioned at a 2-m height located on the west and east mesas of New Mexico's Mesilla Valley and in the valley at Anthony, NM were acquired from the New Mexico Air Quality Bureau. The study spanned the agricultural tilling season, March 1 to April 30, for the years 2008 to 2012. One-second spatial PM10 concentrations at 200 m above the valley floor were measured during a two-hour controlled field tilling operation on April 1, 2008. The HYSPLIT 4.0 (Hybrid Single-Particle Lagrangian Integrated Trajectory version 4) model was run at the corresponding times and heights, outputting PM10 concentrations from all potential agricultural tilling operations. The calculated percentage contribution (modeled PM10 concentration/measured PM10 concentration) indicated that the near-surface (2-m height) proportion from the agricultural operations for five seasonal averages ranged from 0.7% to 1.5% on the west and east mesas and 1.3% for the valley site at Anthony. There were 71 hourly high values of contribution ratios ranging from 30 to 100% at the three sites, depending on the wind speed and direction.	[Qi, Meilan] Wuhan Univ Technol, Sch Sci, Wuhan 430070, Hubei, Peoples R China; [Lin, Kairong] Sun Yat Sen Univ, Dept Water Resources & Environm, Guangzhou 510275, Guangdong, Peoples R China; [Li, Xiangzhen] Chinese Acad Sci, Chengdu Inst Biol, Ecol Restorat Biodivers Conservat Key Lab Sichuan, Key Lab Mt Ecol Restorat & Bioresource Utilizat, Chengdu, Sichuan, Peoples R China; [Sammis, Ted W.] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA; [Miller, David R.] Univ Connecticut, Dept Nat Resources & Environm, Storrs, CT USA; [Wang, Junming] Univ Illinois, Prairie Res Inst, Climate & Atmospher Sci Sect, Illinois State Water Survey, Champaign, IL 61820 USA	Wuhan University of Technology; Sun Yat Sen University; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; New Mexico State University; University of Connecticut; Illinois State Water Survey; University of Illinois System; University of Illinois Urbana-Champaign	Wang, JM (corresponding author), Univ Illinois, Prairie Res Inst, Climate & Atmospher Sci Sect, Illinois State Water Survey, Champaign, IL 61820 USA.	wangjim@illinois.edu			National Research Initiative Competitive from the U.S. Department of Agriculture's Cooperative State Research, Education, and Extension Service Air Quality Program [2007-55112-17849, 2004-35112-14230]; New Mexico State University's Agricultural Experiment Station; Illinois State Water Survey, University of Illinois at Urbana-Champaign	National Research Initiative Competitive from the U.S. Department of Agriculture's Cooperative State Research, Education, and Extension Service Air Quality Program; New Mexico State University's Agricultural Experiment Station; Illinois State Water Survey, University of Illinois at Urbana-Champaign	This project was supported by National Research Initiative Competitive grants 2007-55112-17849 and 2004-35112-14230 from the U.S. Department of Agriculture's Cooperative State Research, Education, and Extension Service Air Quality Program. It also was supported by New Mexico State University's Agricultural Experiment Station and the Illinois State Water Survey, University of Illinois at Urbana-Champaign.	Appel KW, 2007, ATMOS ENVIRON, V41, P9603, DOI 10.1016/j.atmosenv.2007.08.044; CASSEL T, 2003, 12 INT EM INV C EM I; Chow JC, 1999, J AIR WASTE MANAGE, V49, P641, DOI 10.1080/10473289.1999.10463837; Draxler R.R., 1997, ERLARL224 NOAA; Faulkner WB, 2008, J AIR WASTE MANAGE, V58, P1288, DOI 10.3155/1047-3289.58.10.1288; Holmen B, 2008, J ATMOS CHEM, V59, P117, DOI 10.1007/s10874-007-9086-6; Holmen BA, 2001, ATMOS ENVIRON, V35, P3265, DOI 10.1016/S1352-2310(00)00519-7; Kantha L.H, 2000, INT GEOPHYS SERIES, V68, P883; Levy JI, 2002, ATMOS ENVIRON, V36, P1063, DOI 10.1016/S1352-2310(01)00493-9; New Mexico Air Quality Bureau, 2013, NON AR NEW MEX; New Mexico Air Quality Bureau, 2013, AIR MON WEBS 2013C; Stein AF, 2011, WEATHER FORECAST, V26, P236, DOI 10.1175/WAF-D-10-05044.1; USDA, 2007, USDA GEOGR AR SER 31, V1; Wang J, 2008, T ASABE, V51, P1763, DOI 10.13031/2013.25310; Wang J, 2011, T ASABE, V54, P1659, DOI 10.13031/2013.39855; Wang JM, 2010, SOIL SCI, V175, P194, DOI 10.1097/SS.0b013e3181dae283; Wen DY, 2012, ATMOS ENVIRON, V54, P373, DOI 10.1016/j.atmosenv.2012.02.042	17	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138577	10.1371/journal.pone.0138577	http://dx.doi.org/10.1371/journal.pone.0138577			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422232	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700044
J	Schmid, R				Schmid, Ramona			The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France	PLOS ONE			English	Article							UNINTENDED PREGNANCY; INCREASED ACCESS; RISK-FACTORS; MISCARRIAGE; SAVINGS; WOMEN	Objective To evaluate the cost-effectiveness of ulipristal acetate and levonorgestrel inminors in France, and analyze whether it is worthwhile to provide ulipristal acetate tominors free of charge. Methods The cost-effectiveness of two emergency contraceptive methods was compared based on a decision-analytical model. Pregnancy rates, outcomes of unintended pregnancies, and resource utilization were derived from the literature. Resources and their costs were considered until termination or a few days after delivery. Deterministic and probabilistic sensitivity analyses were performed. Results The cost of an unintended pregnancy in a French minor is estimated to be 1,630 (sic) (range 1,330 (sic) -1,803 (sic) ). Almost 4 million (sic) (3.1 (sic) -13.7 (sic) million) in unintended pregnancy spending in 2010 could have been saved by the use of ulipristal acetate instead of levonorgestrel. The incremental cost of ulipristal acetate compared to levonorgestrel is 3.30 (sic) per intake, or 418 (sic) per pregnancy avoided (intake within 72 hours). In the intake within 24 hours subgroup, ulipristal acetate was found to be more efficacious at a lower cost compared to levonorgestrel. Conclusions Ulipristal acetate dominates levonorgestrel when taken within 24 hours after unprotected intercourse, i.e., it is more effective at a lower cost. When taken within 72 hours, ulipristal acetate is a cost-effective alternative to levonorgestrel, given that the cost of avoiding an additional pregnancy with ulipristal acetate is less than the average cost of these pregnancies. In the light of these findings, it is worthwhile to provide free access to minors.	HRA Pharma, Paris, France		Schmid, R (corresponding author), HRA Pharma, Paris, France.	Ramona.schmid@gmail.com			HRA Pharma	HRA Pharma	The author was employed by HRA Pharma at that time. HRA Pharma provided support in the form of salary for the author and sponsored the master studies, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section. The author received editorial support in preparation of this manuscript provided by Tessa Hartog, PhD, of Excerpta Medica, funded HRA Pharma.	Aballea P, 2007, 200754P RM IGAS; Agence Technique de l'Information sur l'Hospitalisation (ATIH), 2010, GUID ET NAT COUTS ME; Arck PC, 2008, REPROD BIOMED ONLINE, V17, P101, DOI 10.1016/S1472-6483(10)60300-8; Bajos N, 2003, HUM REPROD, V18, P994, DOI 10.1093/humrep/deg215; Bayer LL, 2013, CONTRACEPTION, V87, P385, DOI 10.1016/j.contraception.2012.08.034; Blohm F, 2008, BJOG-INT J OBSTET GY, V115, P176, DOI 10.1111/j.1471-0528.2007.01426.x; Caisse Allocation Familiales, SIM PREST ACC JEUN E; Caisse Allocation Familiales, PRIM NAISS PRIM AD; Cheng L, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001324.pub3, 10.1002/14651858.CD001324.pub4]; Child Trends Inc., 2007, NAT CAMP PREV TEEN U; Comite Economique des Produits de Sante, PRIX MED; Ellish NJ, 1996, HUM REPROD, V11, P406, DOI 10.1093/HUMREP/11.2.406; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; Foster DG, 2013, WOMEN HEALTH ISS, V23, P265; Foster DG, 2009, AM J PUBLIC HEALTH, V99, P446, DOI 10.2105/AJPH.2007.129353; Glasier AF, 2010, LANCET, V375, P555, DOI 10.1016/S0140-6736(10)60101-8; Groupement pour l'elaboration et la realisation statistique (GERS), 2012, AV HAUT AUT SANT MIS; Harper CC, 2005, OBSTET GYNECOL, V106, P483, DOI 10.1097/01.AOG.0000174000.37962.a1; Haute Autorite de Sante, 2012, CHOIC METH EC EV; Haute Autorite de Sante, 2013, CONTR URG PRESCR DEL; Herbert D, 2009, WOMEN HEALTH ISS, V19, P21, DOI 10.1016/j.whi.2008.08.007; Hunter C, 2014, EUR J CONTRACEP REPR, V19, pS75; Institut national de la statistique et des etudes economiques, PREM ENF 28 ANS INSE; Institut national de prevention et d'education pour la sante, 2013, COMP SANT JEUN AN BA; Klepinger D, 1999, J HUM RESOUR, V34, P421, DOI 10.2307/146375; Lipetz C, 2009, CONTRACEPTION, V79, P304, DOI 10.1016/j.contraception.2008.11.003; Maconochie N, 2007, BJOG-INT J OBSTET GY, V114, P170, DOI 10.1111/j.1471-0528.2006.01193.x; Mavranezouli I, 2008, HUM REPROD, V23, P1338, DOI 10.1093/humrep/den091; Mavranezouli I, 2009, BEST PRACT RES CL OB, V23, P187, DOI 10.1016/j.bpobgyn.2008.11.007; Moffitt TE, 2002, J CHILD PSYCHOL PSYC, V43, P727, DOI 10.1111/1469-7610.00082; Moreau C, 2012, J ADOLESCENT HEALTH, V50, P389, DOI 10.1016/j.jadohealth.2011.07.013; Nappi RE, 2013, USE ATTITUDES EMERGE, P1; ORINGANJE C, 2009, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD005215.PUB2; Pang F, 2012, USE METAANALYSIS EC; Pawlak C, 2000, DICT PSYCHOPATHOLOGI, P304; Polis CB, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005497.pub2; Raine TR, 2005, JAMA-J AM MED ASSOC, V293, P54, DOI 10.1001/jama.293.1.54; Raymond EG, 2013, CONTRACEPTION, V87, P504, DOI 10.1016/j.contraception.2012.11.013; Rubio-Terres C, 2012, PHARMACOECONOMICS SR, V9, P53, DOI DOI 10.1007/BF03320874; Savitz DA, 2002, EPIDEMIOL REV, V24, P91, DOI 10.1093/epirev/mxf006; Schwarz EB, 2008, CONTRACEPTION, V78, P204, DOI 10.1016/j.contraception.2008.04.120; Thomas CM, 2010, J FAM PLAN REPROD H, V36, P197, DOI 10.1783/147118910793048656; Trussell J, 1997, AM J PUBLIC HEALTH, V87, P932, DOI 10.2105/AJPH.87.6.932; Trussell J, 1997, FAM PLANN PERSPECT, V29, P248, DOI 10.2307/2953412; Trussell J, 2014, CONTRACEPTION, V89, P451, DOI 10.1016/j.contraception.2013.10.019; Trussell J, 2013, CONTRACEPTION, V87, P154, DOI 10.1016/j.contraception.2012.07.016; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003	47	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138990	10.1371/journal.pone.0138990	http://dx.doi.org/10.1371/journal.pone.0138990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422259	gold, Green Published			2022-12-27	WOS:000362175700058
J	McCool, ME; Wahl, J; Schlecht, I; Apfelbacher, C				McCool, Megan E.; Wahl, Josepha; Schlecht, Inga; Apfelbacher, Christian			Evaluating Written Patient Information for Eczema in German: Comparing the Reliability of Two Instruments, DISCERN and EQIP	PLOS ONE			English	Article							ENSURING QUALITY INFORMATION; BRAIN-TUMOR INFORMATION; HEALTH INFORMATION; INTERNET; RESOURCES; LANGUAGE	Patients actively seek information about how to cope with their health problems, but the quality of the information available varies. A number of instruments have been developed to assess the quality of patient information, primarily though in English. Little is known about the reliability of these instruments when applied to patient information in German. The objective of our study was to investigate and compare the reliability of two validated instruments, DISCERN and EQIP, in order to determine which of these instruments is better suited for a further study pertaining to the quality of information available to German patients with eczema. Two independent raters evaluated a random sample of 20 informational brochures in German. All the brochures addressed eczema as a disorder and/or therapy options and care. Intra-rater and inter-rater reliability were assessed by calculating intraclass correlation coefficients, agreement was tested with weighted kappas, and the correlation of the raters' scores for each instrument was measured with Pearson's correlation coefficient. DISCERN demonstrated substantial intra-and inter-rater reliability. It also showed slightly better agreement than EQIP. There was a strong correlation of the raters' scores for both instruments. The findings of this study support the reliability of both DISCERN and EQIP. However, based on the results of the inter-rater reliability, agreement and correlation analyses, we consider DISCERN to be the more precise tool for our project on patient information concerning the treatment and care of eczema.	[McCool, Megan E.; Wahl, Josepha; Schlecht, Inga; Apfelbacher, Christian] Univ Regensburg, Dept Med, Inst Epidemiol & Prevent Med, D-93053 Regensburg, Germany	University of Regensburg	McCool, ME (corresponding author), Univ Regensburg, Dept Med, Inst Epidemiol & Prevent Med, D-93053 Regensburg, Germany.	megan.mccool@klinik.uni-regensburg.de	McCool-Myers, Megan/R-4873-2019; Apfelbacher, Christian/X-1051-2019	McCool-Myers, Megan/0000-0003-3000-9172; Apfelbacher, Christian/0000-0003-3805-8219				BARTKO JJ, 1976, J NERV MENT DIS, V163, P307, DOI 10.1097/00005053-197611000-00003; Batchelor Jonathan M., 2009, Allergology International, V58, P141, DOI 10.2332/allergolint.08-SC-0022; Berth-Jones J, 2006, BRIT J DERMATOL, V155, P707, DOI 10.1111/j.1365-2133.2006.07389.x; BMA, 1997, PAT APPR FORM; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Charvet-Berard AI, 2008, PATIENT EDUC COUNS, V70, P407, DOI 10.1016/j.pec.2007.11.018; Coulter A., 2006, ASSESSING QUALITY IN; Dierks MLLM, 1999, PUBLIC HLTH F, P16; Elwyn G, 2006, BMJ-BRIT MED J, V333, P417, DOI 10.1136/bmj.38926.629329.AE; Goslin RA, 2013, LARYNGOSCOPE, V123, P1626, DOI 10.1002/lary.23773; Grewal P, 2013, INT J SURG, V11, P410, DOI 10.1016/j.ijsu.2013.03.006; GROVE WA, 1981, AM J PSYCHIAT, V138, P1644; Hargrave D, 2003, B CANCER, V90, P650; Hubner J, 2013, FORSCH KOMPLEMENTMED, V20, P120, DOI 10.1159/000350049; Kaicker J, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-59; Knapp TR, 1990, J ED PSYCHOL MEASURE, V50, P225; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lau L, 2006, CHILD NERV SYST, V22, P346, DOI 10.1007/s00381-005-1238-x; Matsoukas Konstantina, 2008, AMIA Annu Symp Proc, P1048; Melloul E, 2012, LIVER TRANSPLANT, V18, P892, DOI 10.1002/lt.23442; Montoya A, 2011, Educ Health (Abingdon), V24, P577; Moult B, 2004, HEALTH EXPECT, V7, P165, DOI 10.1111/j.1369-7625.2004.00273.x; NUNNALLY JC, 1979, CC/SOC BEHAV SCI, P12; Perdaens S, 2011, Tijdschr Psychiatr, V53, P695; Saenger SHA, 2002, CHECK IN INSTRUMENT; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Steckelberg Anke, 2005, Z Arztl Fortbild Qualitatssich, V99, P343; Vaona A, 2011, PRIM CARE DIABETES, V5, P257, DOI 10.1016/j.pcd.2011.08.001; Zahedi Razieh, 2013, Acta Inform Med, V21, P46, DOI 10.5455/AIM.2012.21.46-50	31	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139895	10.1371/journal.pone.0139895	http://dx.doi.org/10.1371/journal.pone.0139895			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26440612	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300071
J	Chin, WCB; Wen, TH				Chin, Wei-Chien-Benny; Wen, Tzai-Hung			Geographically Modified PageRank Algorithms: Identifying the Spatial Concentration of Human Movement in a Geospatial Network	PLOS ONE			English	Article							WORLDWIDE AIR; CITIES; MOBILITY; COMMUNITIES; CENTRALITY; SEARCH; GROWTH; TRADE; SPACE; MODEL	A network approach, which simplifies geographic settings as a form of nodes and links, emphasizes the connectivity and relationships of spatial features. Topological networks of spatial features are used to explore geographical connectivity and structures. The PageRank algorithm, a network metric, is often used to help identify important locations where people or automobiles concentrate in the geographical literature. However, geographic considerations, including proximity and location attractiveness, are ignored in most network metrics. The objective of the present study is to propose two geographically modified PageRank algorithms-Distance-Decay PageRank (DDPR) and Geographical PageRank (GPR)-that incorporate geographic considerations into PageRank algorithms to identify the spatial concentration of human movement in a geospatial network. Our findings indicate that in both intercity and within-city settings the proposed algorithms more effectively capture the spatial locations where people reside than traditional commonly-used network metrics. In comparing location attractiveness and distance decay, we conclude that the concentration of human movement is largely determined by the distance decay. This implies that geographic proximity remains a key factor in human mobility.	[Chin, Wei-Chien-Benny; Wen, Tzai-Hung] Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan	National Taiwan University	Wen, TH (corresponding author), Natl Taiwan Univ, Dept Geog, Taipei 10764, Taiwan.	wenthung@ntu.edu.tw	Chin, Wei Chien Benny/AAH-2292-2019; Wen, Tzai-Hung/H-2635-2018	Chin, Wei Chien Benny/0000-0001-7215-3303; Wen, Tzai-Hung/0000-0002-9151-8336	Ministry of Science and Technology in Taiwan [MOST 103-2622-M-002-003-CC2]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	The research was supported by the grant of Ministry of Science and Technology in Taiwan (MOST 103-2622-M-002-003-CC2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson AS, 2004, AM J SOCIOL, V109, P811, DOI 10.1086/378930; Baier SL, 2001, J INT ECON, V53, P1, DOI 10.1016/S0022-1996(00)00060-X; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; BATTEN DF, 1995, URBAN STUD, V32, P313, DOI 10.1080/00420989550013103; Batty M., 2013, NEW SCI CITIES; BERGSTRAND JH, 1985, REV ECON STAT, V67, P474, DOI 10.2307/1925976; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Commoner M, 1971, CLOSING CIRCLE NATUR; Department of Household Registration Ministry of Interior (Taiwan), 2015, CONT INF HOUS REG OF; Dobkins LH, 2001, REG SCI URBAN ECON, V31, P701; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Ducruet C, 2011, CYBERGEO, DOI 10.4000/cybergeo.23603; Ducruet C, 2010, MARIT POLICY MANAG, V37, P17, DOI 10.1080/03088830903461175; El-Geneidy A, 2011, NETW SPAT ECON, V11, P643, DOI 10.1007/s11067-011-9153-z; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; FOTHERINGHAM AS, 1981, ANN ASSOC AM GEOGR, V71, P425; Gallotti R, 2015, SCI DATA, V2, DOI 10.1038/sdata.2014.56; Gao S, 2013, T GIS, V17, P463, DOI 10.1111/tgis.12042; Gargiulo F, 2012, JASSS-J ARTIF SOC S, V15, P13; Grolmusz V, 2015, INFORM PROCESS LETT, V115, P633, DOI 10.1016/j.ipl.2015.02.015; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Institute of Transportation Ministry of Transportation and Communications (Taiwan), 2009, DIG STREET RAILW NET; Institute of Transportation Ministry of Transportation and Communications (Taiwan), 2009, DEM MOD INT TRANSP S; Jiang B, 2011, INT J GEOGR INF SCI, V25, P51, DOI 10.1080/13658811003712864; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Jiang B, 2009, INT J GEOGR INF SCI, V23, P823, DOI 10.1080/13658810802022822; KILLWORTH PD, 1978, SOC NETWORKS, V1, P159, DOI 10.1016/0378-8733(78)90018-7; Lenormand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045985; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu H, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60232-1; Masucci AP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022812; Ministry of Interior (Taiwan), 2005, MONTHL B INT STAT; PLANE DA, 1984, ANN ASSOC AM GEOGR, V74, P244, DOI 10.1111/j.1467-8306.1984.tb01451.x; RATP Group, OP DAT; Reggiani A, NETWORK MEASURES CIV; Reggiani A, 2011, NETW SPAT ECON, V11, P621, DOI 10.1007/s11067-010-9149-0; Riccardo G, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500611; Rodrigue J.-P., 2013, GEOGRAPHY TRANSPORT; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Scholz AB, 2011, WORKING PAPER SERIES, P20; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Spiekermann K., 2006, SCI REGIONALI, V5, P15; STEWART JQ, 1950, AM J PHYS, V18, P239, DOI 10.1119/1.1932559; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Transport for London, OP DAT US; Wang FH, 2011, J TRANSP GEOGR, V19, P285, DOI 10.1016/j.jtrangeo.2010.01.004; Xing W, 2 ANN C COMM NETW SE; [钟斌青 Zhong Binqing], 2011, [地理与地理信息科学, Geography and Geo-information Science], V27, P82; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	53	27	29	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139509	10.1371/journal.pone.0139509	http://dx.doi.org/10.1371/journal.pone.0139509			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0PR	26437000	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200031
J	Joyce, BL; Zheljazkov, VD; Sykes, R; Cantrell, CL; Hamilton, C; Mann, DGJ; Rodriguez, M; Mielenz, JR; Astatkie, T; Stewart, CN				Joyce, Blake L.; Zheljazkov, Valtcho D.; Sykes, Robert; Cantrell, Charles L.; Hamilton, Choo; Mann, David G. J.; Rodriguez, Miguel; Mielenz, Jonathan R.; Astatkie, Tess; Stewart, C. Neal, Jr.			Ethanol and High-Value Terpene Co-Production from Lignocellulosic Biomass of Cymbopogon flexuosus and Cymbopogon martinii	PLOS ONE			English	Article							VAR. MOTIA BURK.; ESSENTIAL OIL; SACCHAROMYCES-CEREVISIAE; LEMONGRASS; NITROGEN; YIELD; SWITCHGRASS; IRRIGATION; PROFILES; QUALITY	Cymbopogon flexuosus, lemongrass, and C. martinii, palmarosa, are perennial grasses grown to produce essential oils for the fragrance industry. The objectives of this study were (1) to evaluate biomass and oil yields as a function of nitrogen and sulfur fertilization, and (2) to characterize their utility for lignocellulosic ethanol compared to Panicum virgatum (switchgrass). Mean biomass yields were 12.83 Mg lemongrass ha(-1) and 15.11 Mg palmarosa ha(-1) during the second harvest year resulting in theoretical biofuel yields of 2541 and 2569 L ethanol ha(-1) respectively compared to reported 1749-3691 L ethanol ha(-1) for switchgrass. Pretreated lemongrass yielded 198 mL ethanol (g biomass)(-1) and pretreated palmarosa yielded 170 mL ethanol (g biomass)(-1). Additionally, lemongrass yielded 85.7 kg essential oil ha(-1) and palmarosa yielded 67.0 kg ha(-1) with an estimated value of USD $857 and $1005 ha(-1). These data suggest that dual-use crops such as lemongrass and palmarosa may increase the economic viability of lignocellulosic biofuels.	[Joyce, Blake L.; Mann, David G. J.; Stewart, C. Neal, Jr.] Univ Tennessee, Dept Plant Sci, Knoxville, TN 37996 USA; [Zheljazkov, Valtcho D.] Oregon State Univ, Columbia Basin Agr Res Stn, Adams, OR 97810 USA; [Sykes, Robert] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Sykes, Robert; Hamilton, Choo; Mann, David G. J.; Rodriguez, Miguel; Mielenz, Jonathan R.] Oak Ridge Natl Lab, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Cantrell, Charles L.] ARS, USDA, NPURU, University, MS 38677 USA; [Hamilton, Choo; Rodriguez, Miguel; Mielenz, Jonathan R.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Astatkie, Tess] Dalhousie Univ, Fac Agr, Truro, NS B2N 5E3, Canada	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Oregon State University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Agriculture (USDA); United States Department of Energy (DOE); Oak Ridge National Laboratory; Dalhousie University	Zheljazkov, VD (corresponding author), Oregon State Univ, Columbia Basin Agr Res Stn, 48037 Co 788 Rd, Adams, OR 97810 USA.	valtcho.jeliazkov@oregonstate.edu	Astatkie, Tessema/J-7231-2012	Astatkie, Tessema/0000-0002-9779-8789; Mann, David/0000-0002-4088-9284; Joyce, Blake/0000-0002-4784-2251	Bioenergy Science Center (BESC), Oak Ridge National Laboratory [DE-PS02-06ER64304]; ARS Specific Crop Agreement with Mississippi State University [58-6402-026]; ARS [ARS-0429247] Funding Source: Federal RePORTER	Bioenergy Science Center (BESC), Oak Ridge National Laboratory; ARS Specific Crop Agreement with Mississippi State University; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported partly by grant (DE-PS02-06ER64304) from the Bioenergy Science Center (BESC), Oak Ridge National Laboratory. The field research was funded in part by ARS Specific Crop Agreement 58-6402-026 with Mississippi State University. Specific project: "Field establishment of medicinal herbs and potential for commercial production" awarded to Dr. V.D. Jeliazkov (Zheljazkov).	Aniruddha Sarma, 2005, Journal of Essential Oil-Bearing Plants, V8, P250; Bozell JJ, 2008, CLEAN-SOIL AIR WATER, V36, P641, DOI 10.1002/clen.200800100; CALVIN M, 1980, NATURWISSENSCHAFTEN, V67, P525, DOI 10.1007/BF00450661; Chowdhury J. U., 1998, Journal of Essential Oil Research, V10, P301; Dutt D, 2007, CELL CHEM TECHNOL, V41, P161; Fu CX, 2011, P NATL ACAD SCI USA, V108, P3803, DOI 10.1073/pnas.1100310108; Ganjewala D, 2010, NAT PROD COMMUN, V5, P163; Helal GA, 2006, J BASIC MICROB, V46, P375, DOI 10.1002/jobm.200510084; Kulkarni R. N., 1992, Journal of Essential Oil Research, V4, P511; KULKARNI RN, 1994, EUPHYTICA, V78, P103; Montgomery D.C., 2013, DESIGN ANAL EXPT; Muni Ram, 1997, Journal of Herbs, Spices & Medicinal Plants, V5, P53, DOI 10.1300/J044v05n01_06; Peralta-Yahya PP, 2010, BIOTECHNOL J, V5, P147, DOI 10.1002/biot.200900220; Pinzi S, 2009, ENERG FUEL, V23, P2325, DOI 10.1021/ef801098a; Prashar A, 2003, PHYTOCHEMISTRY, V63, P569, DOI 10.1016/S0031-9422(03)00226-7; Rao BRR, 2009, J ESSENT OIL RES, V21, P519; Rao BRR, 2005, IND CROP PROD, V21, P121, DOI 10.1016/j.indcrop.2004.02.002; Rao BRR, 2001, IND CROP PROD, V14, P171, DOI 10.1016/S0926-6690(01)00081-4; SAS Institute Inc, 2010, SAS STAT 9 3 US GUID; Schmer MR, 2012, AGRON J, V104, P54, DOI 10.2134/agronj2011.0195; Singh M, 1999, J AGR SCI-CAMBRIDGE, V132, P201, DOI 10.1017/S0021859698006236; Singh M, 1996, J AGRON CROP SCI, V177, P101, DOI 10.1111/j.1439-037X.1996.tb00598.x; Singh M, 2001, J HORTIC SCI BIOTECH, V76, P180; Singh M, 2001, EUR J AGRON, V14, P157, DOI 10.1016/S1161-0301(00)00083-6; SINGH N, 1989, PLANTA MED, P254; Sykes R, 2009, METHODS MOL BIOL, V581, P169, DOI 10.1007/978-1-60761-214-8_12; Vogel KP, 2011, BIOENERG RES, V4, P96, DOI 10.1007/s12155-010-9104-4; Weiss E.A., 1997, ESSENTIAL OIL CROPS; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Wullschleger SD, 2010, AGRON J, V102, P1158, DOI 10.2134/agronj2010.0087; Zhang JH, 2012, BIORESOURCE TECHNOL, V121, P8, DOI 10.1016/j.biortech.2012.07.010; Zheljazkov VD, 2008, J AGR FOOD CHEM, V56, P380, DOI 10.1021/jf0725629; Zheljazkov VD, 2011, AGRON J, V103, P805, DOI 10.2134/agronj2010.0446; Zheljazkov VD, 2010, AGRON J, V102, P102, DOI DOI 10.2134/AGR0NJ2009.0258	34	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139195	10.1371/journal.pone.0139195	http://dx.doi.org/10.1371/journal.pone.0139195			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437026	Green Published, gold			2022-12-27	WOS:000362499200013
J	Liu, CY; Song, GL; Mao, L; Long, Y; Li, Q; Cui, ZB				Liu, Chunyan; Song, Guili; Mao, Lin; Long, Yong; Li, Qing; Cui, Zongbin			Generation of an Enhancer-Trapping Vector for Insertional Mutagenesis in Zebrafish	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; GENE-EXPRESSION; TRANSPOSON; GENOME; VIVO; DISSECTION; MUTATIONS; TOOLS	Enhancer trapping (ET) is a powerful approach to establish tissue-or cell-specific reporters and identify expression patterns of uncharacterized genes. Although a number of enhancer-trapping vectors have been developed and a large library of fish lines with distinct tissue- or cell-specific expression of reporter genes have been generated, the specificity and efficiency of trapping vectors need to be improved because of the bias interaction of minimal promoters with genomic enhancers. Accordingly, we generated an enhancer-trapping vector pTME that contains a minimal mouse metallothionein gene (mMTI) promoter upstream of EGFP reporter. In the first round of screening, twelve zebrafish lines that carry a single copy of ET cassettes were characterized to have tissue-or cell-specific EGFP expression. One of the highly conserved noncoding elements near an insertion site of trapping cassettes was characterized as an enhancer that can specifically regulate the expression of EGFP in cells of the central nervous system. In addition, the pTME vector contains a mutation-cassette that is able to effectively block the transcription of an endogenous gene in an ET line with ubiquitous EGFP expression. Thus, the pTME vector can be used as an alternative tool for both enhancer trapping and mutagenesis across a target genome.	[Liu, Chunyan; Song, Guili; Mao, Lin; Long, Yong; Li, Qing; Cui, Zongbin] Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Hubei, Peoples R China; [Liu, Chunyan; Song, Guili; Mao, Lin; Long, Yong; Li, Qing; Cui, Zongbin] Chinese Acad Sci, Inst Hydrobiol, Wuhan 430072, Hubei, Peoples R China; [Liu, Chunyan; Mao, Lin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, Q (corresponding author), Chinese Acad Sci, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Hubei, Peoples R China.	qli@ihb.ac.cn; zbcui@ihb.ac.cn			National Natural Science Foundation of China [30871442]; National Basic Research Program of China [2012CB944500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was financially supported by the National Natural Science Foundation of China (No. 30871442) to Z. Cui and the National Basic Research Program of China (No. 2012CB944500).	Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Asakawa K, 2009, METHODS, V49, P275, DOI 10.1016/j.ymeth.2009.01.004; Balciunas D, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-62; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Bellen HJ, 1999, PLANT CELL, V11, P2271, DOI 10.1105/tpc.11.12.2271; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Bonkowsky Joshua L, 2008, BMC Dev Biol, V8, P103, DOI 10.1186/1471-213X-8-103; Cadwallader AB, 2006, DEV DYNAM, V235, P3432, DOI 10.1002/dvdy.20990; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Ding HL, 2013, DEV DYNAM, V242, P67, DOI 10.1002/dvdy.23895; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Driever W, 1996, DEVELOPMENT, V123, P37; Ellingsen S, 2005, DEVELOPMENT, V132, P3799, DOI 10.1242/dev.01951; Haffter P, 1996, DEVELOPMENT, V123, P1; Haque S, 2014, ZEBRAFISH, V11, P499, DOI 10.1089/zeb.2014.0994; Hoegler KJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2964; Kagi J H, 1979, Ciba Found Symp, P223; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kawakami K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-105; Kelsch W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038593; Kondrychyn I, 2011, ZEBRAFISH, V8, P181, DOI 10.1089/zeb.2011.0718; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Korzh V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S8; Li Q, 2010, DEV BIOL, V337, P484, DOI 10.1016/j.ydbio.2009.10.019; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Moghadam HK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-278; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Murphy BJ, 1999, CANCER RES, V59, P1315; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nakada T, 2007, AM J PHYSIOL-REG I, V293, pR1743, DOI 10.1152/ajpregu.00248.2007; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309; Poon KL, 2010, DEV DYNAM, V239, P914, DOI 10.1002/dvdy.22203; Royo JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033617; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Scott EK, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.013.2009; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; Song GL, 2012, J GENET GENOMICS, V39, P503, DOI 10.1016/j.jgg.2012.05.010; Song GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044123; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tay SY, 2005, DEVELOPMENT, V132, P625, DOI 10.1242/dev.01606; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trinh LA, 2013, DEV GROWTH DIFFER, V55, P434, DOI 10.1111/dgd.12055; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wingert RA, 2011, DEV DYNAM, V240, P2011, DOI 10.1002/dvdy.22691; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yasmin L, 2011, COMP BIOCHEM PHYS D, V6, P76, DOI 10.1016/j.cbd.2010.05.002; Young RM, 2002, MECH DEVELOP, V117, P269, DOI 10.1016/S0925-4773(02)00180-6	55	8	9	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139612	10.1371/journal.pone.0139612	http://dx.doi.org/10.1371/journal.pone.0139612			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436547	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200036
J	Panigrahi, P; Sule, M; Ghanate, A; Ramasamy, S; Suresh, CG				Panigrahi, Priyabrata; Sule, Manas; Ghanate, Avinash; Ramasamy, Sureshkumar; Suresh, C. G.			Engineering Proteins for Thermostability with iRDP Web Server	PLOS ONE			English	Article							THERMAL-STABILITY; DISULFIDE BONDS; CRYSTAL-STRUCTURE; PROLINE RESIDUES; CONFORMATIONAL STABILITY; STRUCTURAL MOTIFS; GLUCOSE-ISOMERASE; HYDROGEN-BONDS; ALPHA-HELICES; STABILIZATION	Engineering protein molecules with desired structure and biological functions has been an elusive goal. Development of industrially viable proteins with improved properties such as stability, catalytic activity and altered specificity by modifying the structure of an existing protein has widely been targeted through rational protein engineering. Although a range of factors contributing to thermal stability have been identified and widely researched, the in silico implementation of these as strategies directed towards enhancement of protein stability has not yet been explored extensively. A wide range of structural analysis tools is currently available for in silico protein engineering. However these tools concentrate on only a limited number of factors or individual protein structures, resulting in cumbersome and time-consuming analysis. The iRDP web server presented here provides a unified platform comprising of iCAPS, iStability and iMutants modules. Each module addresses different facets of effective rational engineering of proteins aiming towards enhanced stability. While iCAPS aids in selection of target protein based on factors contributing to structural stability, iStability uniquely offers in silico implementation of known thermostabilization strategies in proteins for identification and stability prediction of potential stabilizing mutation sites. iMutants aims to assess mutants based on changes in local interaction network and degree of residue conservation at the mutation sites. Each module was validated using an extensively diverse dataset. The server is freely accessible at http://irdp.ncl.res.in and has no login requirements.	[Panigrahi, Priyabrata; Sule, Manas; Ramasamy, Sureshkumar; Suresh, C. G.] CSIR Natl Chem Lab, Div Biochem Sci, Pune 411008, Maharashtra, India; [Ghanate, Avinash] CSIR Natl Chem Lab, Div Chem Engn & Proc Dev, Pune 411008, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Ramasamy, S (corresponding author), CSIR Natl Chem Lab, Div Biochem Sci, Pune 411008, Maharashtra, India.	s.ramasamy@ncl.res.in; cg.suresh@ncl.res.in		Ghanate, Avinash/0000-0002-6284-7667	Council of Scientific and Industrial Research, New Delhi; Department of Biotechnology, Government of India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	PP, MS and AG thank Council of Scientific and Industrial Research, New Delhi for Senior Research Fellowship. SKR is DST Ramanujan Fellow. This research is carried out under CSIR-NCL's Centre of Excellence in Scientific Computation (CoESC). We also acknowledge computational facilities funded by Department of Biotechnology, Government of India.	Agah S, 2003, BIOCHEMISTRY-US, V42, P10886, DOI 10.1021/bi034721x; Allen MJ, 1998, PROTEIN ENG, V11, P783, DOI 10.1093/protein/11.9.783; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreini C, 2012, BIOINFORMATICS, V28, P1658, DOI 10.1093/bioinformatics/bts246; ARAKAWA T, 1993, PROTEIN ENG, V6, P541, DOI 10.1093/protein/6.5.541; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bezsonova I, 2005, BIOCHEMISTRY-US, V44, P15550, DOI 10.1021/bi0512795; Bogin O, 1998, PROTEIN SCI, V7, P1156, DOI 10.1002/pro.5560070509; Borgo B, 2012, P NATL ACAD SCI USA, V109, P1494, DOI 10.1073/pnas.1115172109; Cammett TJ, 2003, J MOL BIOL, V327, P285, DOI 10.1016/S0022-2836(03)00043-3; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chakravarty S, 2000, FEBS LETT, V470, P65, DOI 10.1016/S0014-5793(00)01267-9; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi EJ, 2006, PROTEIN ENG DES SEL, V19, P285, DOI 10.1093/protein/gzl007; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Davoodi J, 2007, BIOPHYS CHEM, V125, P453, DOI 10.1016/j.bpc.2006.10.006; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Dehouck Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-151; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Ding HT, 2013, ENZYME MICROB TECH, V53, P365, DOI 10.1016/j.enzmictec.2013.08.001; Fu HL, 2009, PROTEINS, V77, P491, DOI 10.1002/prot.22509; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Han ZL, 2009, APPL MICROBIOL BIOT, V85, P117, DOI 10.1007/s00253-009-2067-8; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; HERNING T, 1992, BIOCHEMISTRY-US, V31, P7077, DOI 10.1021/bi00146a008; Hubbard SJ, 1993, NACCESS COMPUTER PRO, V2; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jager M, 2009, PROTEIN SCI, V18, P1806, DOI 10.1002/pro.172; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KASUMI T, 1982, AGR BIOL CHEM TOKYO, V46, P21, DOI 10.1080/00021369.1982.10865021; Kawamura S, 1996, BIOCHEMISTRY-US, V35, P1195, DOI 10.1021/bi951581l; Kim J, 2003, J MOL BIOL, V328, P951, DOI 10.1016/S0022-2836(03)00321-8; KIMURA S, 1992, J BIOL CHEM, V267, P22014; Knapp S, 1999, J MOL BIOL, V285, P689, DOI 10.1006/jmbi.1998.2344; Kumar MDS, 2006, NUCLEIC ACIDS RES, V34, pD204, DOI 10.1093/nar/gkj103; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; LOEWENTHAL R, 1992, J MOL BIOL, V224, P759, DOI 10.1016/0022-2836(92)90560-7; Mainfroid V, 1996, BIOCHEMISTRY-US, V35, P4110, DOI 10.1021/bi952692n; MARG GA, 1990, ENZYME MICROB TECH, V12, P367, DOI 10.1016/0141-0229(90)90166-N; Marshall SA, 2002, J MOL BIOL, V316, P189, DOI 10.1006/jmbi.2001.5326; Masso M, 2011, ENG MED BIOL SOC EMB; MATSUMURA M, 1989, NATURE, V342, P291, DOI 10.1038/342291a0; MILLA ME, 1994, NAT STRUCT BIOL, V1, P518, DOI 10.1038/nsb0894-518; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NICHOLSON H, 1992, BIOPOLYMERS, V32, P1431, DOI 10.1002/bip.360321103; NICHOLSON H, 1988, NATURE, V336, P651, DOI 10.1038/336651a0; Ohage EC, 1997, PROTEIN SCI, V6, P233; PANTOLIANO MW, 1987, BIOCHEMISTRY-US, V26, P2077, DOI 10.1021/bi00382a002; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; PERRY LJ, 1984, SCIENCE, V226, P555, DOI 10.1126/science.6387910; Predki PF, 1996, NAT STRUCT BIOL, V3, P54, DOI 10.1038/nsb0196-54; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Raffen R, 1999, PROTEIN SCI, V8, P509; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; SERRANO L, 1992, J MOL BIOL, V224, P783, DOI 10.1016/0022-2836(92)90562-X; Smith CA, 1999, J MOL BIOL, V294, P1027, DOI 10.1006/jmbi.1999.3291; STITES WE, 1994, J MOL BIOL, V235, P27, DOI 10.1016/S0022-2836(05)80008-7; Suemori A, 2013, PROTEIN ENG DES SEL, V26, P479, DOI 10.1093/protein/gzt026; SUZUKI Y, 1989, P JPN ACAD B-PHYS, V65, P146, DOI 10.2183/pjab.65.146; SUZUKI Y, 1987, APPL MICROBIOL BIOT, V26, P546, DOI 10.1007/BF00253030; Takano K, 2001, PROTEINS, V44, P233, DOI 10.1002/prot.1088; Takano K, 1999, PROTEIN ENG, V12, P663, DOI 10.1093/protein/12.8.663; Theillet Francois-Xavier, 2013, Intrinsically Disord Proteins, V1, pe24360, DOI 10.4161/idp.24360; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Usher KC, 1998, PROTEIN SCI, V7, P403; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vogt G, 1997, FOLD DES, V2, pS40, DOI 10.1016/S1359-0278(97)00062-X; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WATANABE K, 1994, EUR J BIOCHEM, V226, P277, DOI 10.1111/j.1432-1033.1994.tb20051.x; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; ZAMOST BL, 1991, J IND MICROBIOL, V8, P71, DOI 10.1007/BF01578757; ZHANG T, 1994, NAT STRUCT BIOL, V1, P434, DOI 10.1038/nsb0794-434	83	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139486	10.1371/journal.pone.0139486	http://dx.doi.org/10.1371/journal.pone.0139486			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436543	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200027
J	Reinardy, JL; Corey, DM; Golzio, C; Mueller, SB; Katsanis, N; Kontos, CD				Reinardy, Jessica L.; Corey, Daniel M.; Golzio, Christelle; Mueller, Sarah B.; Katsanis, Nicholas; Kontos, Christopher D.			Phosphorylation of Threonine 794 on Tie1 by Rac1/PAK1 Reveals a Novel Angiogenesis Regulatory Pathway	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; GROWTH-FACTOR RECEPTOR; VESSEL DEVELOPMENT; ANGIOPOIETIN-2; MORPHOGENESIS; LETHALITY; EMBRYOS; LIGAND; ROLES; AKT	The endothelial receptor tyrosine kinase (RTK) Tie1 was discovered over 20 years ago, yet its precise function and mode of action remain enigmatic. To shed light on Tie1's role in endothelial cell biology, we investigated a potential threonine phosphorylation site within the juxtamembrane domain of Tie1. Expression of a non-phosphorylatable mutant of this site (T794A) in zebrafish (Danio rerio) significantly disrupted vascular development, resulting in fish with stunted and poorly branched intersomitic vessels. Similarly, T794A-expressing human umbilical vein endothelial cells formed significantly shorter tubes with fewer branches in three-dimensional Matrigel cultures. However, mutation of T794 did not alter Tie1 or Tie2 tyrosine phosphorylation or downstream signaling in any detectable way, suggesting that T794 phosphorylation may regulate a Tie1 function independent of its RTK properties. Although T794 is within a consensus Akt phosphorylation site, we were unable to identify a physiological activator of Akt that could induce T794 phosphorylation, suggesting that Akt is not the physiological Tie1-T794 kinase. However, the small GTPase Ras-related C3 botulinum toxin substrate 1 (Rac1), which is required for angiogenesis and capillary morphogenesis, was found to associate with phospho-T794 but not the non-phosphory-latable T794A mutant. Pharmacological activation of Rac1 induced downstream activation of p21-activated kinase (PAK1) and T794 phosphorylation in vitro, and inhibition of PAK1 abrogated T794 phosphorylation. Our results provide the first demonstration of a signaling pathway mediated by Tie1 in endothelial cells, and they suggest that a novel feedback loop involving Rac1/PAK1 mediated phosphorylation of Tie1 on T794 is required for proper angiogenesis.	[Reinardy, Jessica L.; Mueller, Sarah B.; Kontos, Christopher D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Corey, Daniel M.; Kontos, Christopher D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Golzio, Christelle; Katsanis, Nicholas] Duke Univ, Med Ctr, Dept Pediat, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Mueller, Sarah B.; Kontos, Christopher D.] Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Kontos, CD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.	chris.kontos@duke.edu		Mueller, Sarah/0000-0002-7985-2155; Golzio, Christelle/0000-0002-4420-3921	American Heart Association [12PRE10950006, 12PRE11380009]; National Heart, Lung, and Blood Institute of the National Institutes of Health [F32 HL097547-01]; Duke Core Facility Voucher Program of the Duke Translational Medicine Institute; CTSA grant [UL1TR001117]; Department of Medicine at Duke University Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001117] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL124444, R21HL118661, F32HL097547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007105] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Duke Core Facility Voucher Program of the Duke Translational Medicine Institute; CTSA grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Department of Medicine at Duke University Medical Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JLR (12PRE10950006) and SBM (12PRE11380009) were supported by Pre-Doctoral Fellowship Awards from the American Heart Association (http://research.americanheart.org). DMC was supported by a Post-Doctoral National Research Service Award (F32 HL097547-01) from the National Heart, Lung, and Blood Institute of the National Institutes of Health (http://www.nhlbi.nih.gov). The proteomic analysis was performed by the Duke Proteomics Core Facility and was funded by the Duke Core Facility Voucher Program of the Duke Translational Medicine Institute (http://www.dtmi.duke.edu), which was supported by CTSA grant UL1TR001117. This work was supported in part by an Integrated Research Award from the Department of Medicine at Duke University Medical Center (http://medicine.duke.edu) to CDK and NK.	Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Bioukar EB, 1999, J BIOL CHEM, V274, P21457, DOI 10.1074/jbc.274.30.21457; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Crampton Steve P, 2007, J Vis Exp, P183, DOI 10.3791/183; D'Amico G, 2014, J CLIN INVEST, V124, P824, DOI 10.1172/JCI68897; D'Amico G, 2010, ARTERIOSCL THROM VAS, V30, P207, DOI 10.1161/ATVBAHA.109.196618; Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Felcht M, 2012, J CLIN INVEST, V122, P1991, DOI 10.1172/JCI58832; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; GILLESPIE LL, 1995, J BIOL CHEM, V270, P22758, DOI 10.1074/jbc.270.39.22758; Hakanpaa L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6962; Hanna S, 2013, CELL SIGNAL, V25, P1955, DOI 10.1016/j.cellsig.2013.04.009; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Kontos CD, 2002, MOL CELL BIOL, V22, P1704, DOI 10.1128/MCB.22.6.1704-1713.2002; Lee J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006666; Li KG, 2010, BLOOD, V115, P133, DOI 10.1182/blood-2009-09-242180; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Moldovan L, 2006, CARDIOVASC RES, V71, P236, DOI 10.1016/j.cardiores.2006.05.003; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Peppel K, 2000, CIRCULATION, V102, P793, DOI 10.1161/01.CIR.102.7.793; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; Qin L, 2011, J BIOCHEM, V150, P151, DOI 10.1093/jb/mvr066; Qu XH, 2015, DEV BIOL, V399, P117, DOI 10.1016/j.ydbio.2014.12.021; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Saharinen P, 2005, J CELL BIOL, V169, P239, DOI 10.1083/jcb.200411105; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Seegar TCM, 2010, MOL CELL, V37, P643, DOI 10.1016/j.molcel.2010.02.007; Singh H., 2012, INT J SCI RES PUBL, V2, P1; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Woo KV, 2011, J CLIN INVEST, V121, P1624, DOI 10.1172/JCI42040; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Yuan HT, 2007, FASEB J	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139614	10.1371/journal.pone.0139614	http://dx.doi.org/10.1371/journal.pone.0139614			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436659	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200037
J	Vanier, G; Hempel, F; Chan, P; Rodamer, M; Vaudry, D; Maier, UG; Lerouge, P; Bardor, M				Vanier, Gaetan; Hempel, Franziska; Chan, Philippe; Rodamer, Michael; Vaudry, David; Maier, Uwe G.; Lerouge, Patrice; Bardor, Muriel			Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum	PLOS ONE			English	Article							N-GLYCOSYLATION PATHWAY; ENDOPLASMIC-RETICULUM; ASPARAGINE DEAMIDATION; PROTEIN GLYCOSYLATION; RECOMBINANT PROTEINS; MANNOSE GLYCANS; SERUM CLEARANCE; IGG ANTIBODIES; CHO-CELLS; PEPTIDE	Monoclonal antibodies (mAbs) represent actually the major class of biopharmaceuticals. They are produced recombinantly using living cells as biofactories. Among the different expression systems currently available, microalgae represent an emerging alternative which displays several biotechnological advantages. Indeed, microalgae are classified as generally recognized as safe organisms and can be grown easily in bioreactors with high growth rates similarly to CHO cells. Moreover, microalgae exhibit a phototrophic lifestyle involving low production costs as protein expression is fueled by photosynthesis. However, questions remain to be solved before any industrial production of algae-made biopharmaceuticals. Among them, protein heterogeneity as well as protein post-translational modifications need to be evaluated. Especially, N-glycosylation acquired by the secreted recombinant proteins is of major concern since most of the biopharmaceuticals including mAbs are N-glycosylated and it is well recognized that glycosylation represent one of their critical quality attribute. In this paper, we assess the quality of the first recombinant algae-made mAbs produced in the diatom, Phaeodactylum tricornutum. We are focusing on the characterization of their C-and N-terminal extremities, their signal peptide cleavage and their post-translational modifications including N-glycosylation macro-and microheterogeneity. This study brings understanding on diatom cellular biology, especially secretion and intracellular trafficking of proteins. Overall, it reinforces the positioning of P. tricornutum as an emerging host for the production of biopharmaceuticals and prove that P. tricornutum is suitable for producing recombinant proteins bearing high mannose-type N-glycans.	[Vanier, Gaetan; Lerouge, Patrice; Bardor, Muriel] Normandie Univ, Univ Rouen, Inst Rech & Innovat Biomed,Vegetale Agron Sol Inn, Fac Sci & Tech,Lab Glycobiol & Matrice Extracellu, Mont St Aignan, France; [Hempel, Franziska; Maier, Uwe G.] Univ Marburg, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Chan, Philippe; Vaudry, David] Normandie Univ, PISSARO Prote Platform, Inst Rech & Innovat Biomed, Mont St Aignan, France; [Rodamer, Michael] Agilent Technol, Waldbronn, Germany; [Bardor, Muriel] Inst Univ France, Paris, France	Universite de Rouen Normandie; Philipps University Marburg; Agilent Technologies; Institut Universitaire de France	Bardor, M (corresponding author), Normandie Univ, Univ Rouen, Inst Rech & Innovat Biomed,Vegetale Agron Sol Inn, Fac Sci & Tech,Lab Glycobiol & Matrice Extracellu, Mont St Aignan, France.	muriel.bardor@univ-rouen.fr	VAUDRY, David/M-1454-2018	VAUDRY, David/0000-0003-3567-7452; Vanier, Gaetan/0000-0002-5497-6979	University of Rouen; IUF (Institut Universitaire de France), France; LOEWE Centre SYNMIKRO in Marburg, Germany; Agilent Technologies	University of Rouen; IUF (Institut Universitaire de France), France; LOEWE Centre SYNMIKRO in Marburg, Germany; Agilent Technologies	The authors would like to thank the University of Rouen and the IUF (Institut Universitaire de France), France as well as the LOEWE Centre SYNMIKRO in Marburg, Germany for their financial support. Agilent Technologies provided support in the form of a salary for author MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this authors is articulated in the 'author contributions' section.	Aggarwal S, 2011, NAT BIOTECHNOL, V29, P1083, DOI 10.1038/nbt.2060; Aghamohseni H, 2014, J BIOTECHNOL, V186, P98, DOI 10.1016/j.jbiotec.2014.05.024; Alessandri L, 2012, MABS-AUSTIN, V4, P509, DOI 10.4161/mabs.20450; Arcalis E, 2013, PLANT MOL BIOL, V83, P105, DOI 10.1007/s11103-013-0049-9; Baiet B, 2011, J BIOL CHEM, V286, P6152, DOI 10.1074/jbc.M110.175711; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Beck A, 2012, MABS-AUSTIN, V4, P419, DOI 10.4161/mabs.20996; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brorson K, 2014, CURR OPIN BIOTECH, V30, P140, DOI 10.1016/j.copbio.2014.06.012; Butler M, 2006, CYTOTECHNOLOGY, V50, P57, DOI 10.1007/s10616-005-4537-x; De Meyer T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00473; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Eichler-Stahlberg A, 2009, PLANTA, V229, P873, DOI 10.1007/s00425-008-0879-x; Elbers IJW, 2001, PLANT PHYSIOL, V126, P1314, DOI 10.1104/pp.126.3.1314; Elvin JG, 2013, INT J PHARMACEUT, V440, P83, DOI 10.1016/j.ijpharm.2011.12.039; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; He X, 2012, GLYCOBIOLOGY, V22, P492, DOI 10.1093/glycob/cwr157; Hempel F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-126; Hempel F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028424; Holland T, 2010, BIOTECHNOL BIOENG, V107, P278, DOI 10.1002/bit.22800; Hossler P, 2009, GLYCOBIOLOGY, V19, P936, DOI 10.1093/glycob/cwp079; Ivarsson M, 2014, J BIOTECHNOL, V188, P88, DOI 10.1016/j.jbiotec.2014.08.026; Jayapal KR, 2007, CHEM ENG PROG, V103, P40; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; KAPLAN AP, 1971, IMMUNOCHEMISTRY, V8, P801, DOI 10.1016/0019-2791(71)90447-2; Ko KS, 2003, P NATL ACAD SCI USA, V100, P8013, DOI 10.1073/pnas.0832472100; Kober L, 2013, BIOTECHNOL BIOENG, V110, P1164, DOI 10.1002/bit.24776; Le Mauff F, 2014, PLANT BIOTECHNOL J, DOI 10.1111/pbi.12301; LEATHERBARROW RJ, 1984, MOL IMMUNOL, V21, P321, DOI 10.1016/0161-5890(84)90103-2; Levy-Ontman O, 2014, INT J MOL SCI, V15, P2305, DOI 10.3390/ijms15022305; Levy-Ontman O, 2011, J BIOL CHEM, V286, P21340, DOI 10.1074/jbc.M110.175042; Lingg N, 2012, BIOTECHNOL J, V7, P1462, DOI 10.1002/biot.201200078; Liu B, 2014, J BIOTECHNOL, V170, P17, DOI 10.1016/j.jbiotec.2013.11.007; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Luo J, 2012, BIOTECHNOL BIOENG, V109, P2306, DOI 10.1002/bit.24510; Mathieu-Rivet E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00359; Mathieu-Rivet E, 2013, MOL CELL PROTEOMICS, V12, P3160, DOI 10.1074/mcp.M113.028191; Mayfield SP, 2003, P NATL ACAD SCI USA, V100, P438, DOI 10.1073/pnas.0237108100; Mimura Y, 2001, J BIOL CHEM, V276, P45539, DOI 10.1074/jbc.M107478200; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Raju TS, 2000, GLYCOBIOLOGY, V10, P477, DOI 10.1093/glycob/10.5.477; Rasala BA, 2015, PHOTOSYNTH RES, V123, P227, DOI 10.1007/s11120-014-9994-7; Rasala BA, 2010, PLANT BIOTECHNOL J, V8, P719, DOI 10.1111/j.1467-7652.2010.00503.x; Rehder DS, 2006, J CHROMATOGR A, V1102, P164, DOI 10.1016/j.chroma.2005.10.053; Rosales-Mendoza S, 2012, PLANT CELL REP, V31, P479, DOI 10.1007/s00299-011-1186-8; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Shaaltiel Y, 2007, PLANT BIOTECHNOL J, V5, P579, DOI 10.1111/j.1467-7652.2007.00263.x; Song Y, 2001, J PHARM SCI, V90, P141, DOI 10.1002/1520-6017(200102)90:2<141::AID-JPS5>3.0.CO;2-Y; Song Z, 2014, Patent No. [WO2014058389 A1, 2014058389]; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; Stern B., 2007, TRENDS CELL MOL BIOL, V2, P1; Stratton LP, 2001, J PHARM SCI, V90, P2141, DOI 10.1002/jps.1165; TAGA EM, 1984, BIOCHEMISTRY-US, V23, P815, DOI 10.1021/bi00300a006; Tang LJ, 2013, MABS-AUSTIN, V5, P114, DOI 10.4161/mabs.22695; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Tran M, 2009, BIOTECHNOL BIOENG, V104, P663, DOI 10.1002/bit.22446; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Triguero A, 2005, PLANT BIOTECHNOL J, V3, P449, DOI 10.1111/j.1467-7652.2005.00137.x; Triguero A, 2010, ANAL BIOCHEM, V400, P173, DOI 10.1016/j.ab.2010.01.027; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; Vlasak J, 2009, ANAL BIOCHEM, V392, P145, DOI 10.1016/j.ab.2009.05.043; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917; Weinreb NJ, 2008, IMIGLUCERASE ITS USE; Wright A, 1998, J IMMUNOL, V160, P3393; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	69	31	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139282	10.1371/journal.pone.0139282	http://dx.doi.org/10.1371/journal.pone.0139282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437211	Green Published, gold			2022-12-27	WOS:000362499200014
J	McCausland, MR; Juchnowski, SM; Zidar, DA; Kuritzkes, DR; Andrade, A; Sieg, SF; Lederman, MM; Funderburg, NT				McCausland, Marie R.; Juchnowski, Steven M.; Zidar, David A.; Kuritzkes, Daniel R.; Andrade, Adriana; Sieg, Scott F.; Lederman, Michael M.; Funderburg, Nicholas T.			Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy	PLOS ONE			English	Article							PERIPHERAL-BLOOD MONOCYTES; MEMORY T-CELLS; IMMUNE ACTIVATION; HLA-DR; INFLAMMATION; INDIVIDUALS; EXPRESSION; MARKERS; SYSTEM; SUBSET	Background Monocytes are increasingly implicated in the inflammatory consequences of HIV-1 disease, yet their phenotype following antiretroviral therapy (ART) initiation is incompletely defined. Here, we define more completely monocyte phenotype both prior to ART initiation and during 48 weeks of ART. Methods Cryopreserved peripheral blood mononuclear cells (PBMCs) were obtained at baseline (prior to ART initiation) and at weeks 12, 24, and 48 of treatment from 29 patients participating in ACTG clinical trial A5248, an open label study of raltegravir/emtricitibine/tenofovir administration. For comparison, cryopreserved PBMCs were obtained from 15 HIV-1 uninfected donors, each of whom had at least two cardiovascular risk factors. Thawed samples were stained for monocyte subset markers (CD14 and CD16), HLA-DR, CCR2, CX3CR1, CD86, CD83, CD40, CD38, CD36, CD13, and CD163 and examined using flow cytometry. Results In untreated HIV-1 infection there were perturbations in monocyte subset phenotypes, chiefly a higher frequency and density (mean fluorescence intensity-MFI) of HLA-DR (%-p = 0.004, MFI-p = .0005) and CD86 (%-p = 0.012, MFI-p = 0.005) expression and lower frequency of CCR2 (p = 0.0002) expression on all monocytes, lower CCR2 density on inflammatory monocytes (p = 0.045) when compared to the expression and density of these markers in controls' monocytes. We also report lower expression of CX3CR1 (p = 0.014) on patrolling monocytes at baseline, compared to levels seen in controls. After ART, these perturbations tended to improve, with decreasing expression and density of HLA-DR and CD86, increasing CCR2 density on inflammatory monocytes, and increasing expression and density of CX3CR1 on patrolling monocytes. Conclusions In HIV-1 infected patients, ART appears to attenuate the high levels of activation (HLA-DR, CD86) and to increase expression of the chemokine receptors CCR2 and CX3CR1 on monocyte populations. Circulating monocyte phenotypes are altered in untreated infection and tend to normalize with ART; the role of these cells in the inflammatory environment of HIV-1 infection warrants further study.	[McCausland, Marie R.; Zidar, David A.; Sieg, Scott F.; Lederman, Michael M.] Case Western Reserve Univ, Sch Med, Div Infect Dis, Cleveland, OH 44106 USA; [Juchnowski, Steven M.; Zidar, David A.] Univ Hosp Case Med Ctr, Harrington Heart & Vasc Inst, Cleveland, OH USA; [Kuritzkes, Daniel R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Andrade, Adriana] Johns Hopkins Univ, Div Infect Dis, Dept Med, Baltimore, MD USA; [Funderburg, Nicholas T.] Ohio State Univ, Div Med Lab Sci, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University System of Ohio; Ohio State University	Lederman, MM (corresponding author), Case Western Reserve Univ, Sch Med, Div Infect Dis, Cleveland, OH 44106 USA.	mxl6@case.edu	Funderburg, Nicholas/L-8022-2013; Sieg, Scott/AAV-2429-2021	Funderburg, Nicholas/0000-0003-3113-1217	National Institute of Allergy and Infectious Diseases and Laboratory Center [U01AI068636]; Center for AIDS Research at Case Western Reserve University [AI36219];  [UM1 AI106701];  [AI 68636]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL108743, R56HL126563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068636, UM1AI068636, P30AI036219, UM1AI106701] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases and Laboratory Center; Center for AIDS Research at Case Western Reserve University; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by Award Number U01AI068636 from the National Institute of Allergy and Infectious Diseases and Laboratory Center, Grant Numbers UM1 AI106701, AI 68636, and the Center for AIDS Research at Case Western Reserve University AI36219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade A, 2013, J INFECT DIS, V208, P884, DOI 10.1093/infdis/jit272; Baker JV, 2014, AIDS, V28, P831, DOI 10.1097/QAD.0000000000000145; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Carey VJ., 2012, GEE GENERALIZED ESTI; CHEADLE WG, 1993, AM J SURG, V165, pS75, DOI 10.1016/S0002-9610(05)81210-3; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Engel P, COSTIMULATORY MOLECU, P1402; Espinosa E, 2010, JAIDS-J ACQ IMM DEF, V55, P439, DOI 10.1097/QAI.0b013e3181ef991d; Fitch KV, 2013, J INFECT DIS, V208, P1737, DOI 10.1093/infdis/jit508; FREEMAN GJ, 1995, IMMUNITY, V2, P523, DOI 10.1016/1074-7613(95)90032-2; Funderburg NT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083514; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Gascon RL, 2002, J ACQ IMMUN DEF SYND, V30, P146, DOI [10.1097/01.QA1.0000017720.31903.6E, 10.1097/00042560-200206010-00002]; Grinspoon S. K., 2008, Circulation, V118, P198, DOI 10.1161/CIRCULATIONAHA.107.189622; Grover SA, 2005, AM J CARDIOL, V95, P586, DOI 10.1016/j.amjcard.2004.11.004; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Hearps AC, 2012, AIDS, V26, P843, DOI 10.1097/QAD.0b013e328351f756; Hileman CO, 2015, J INFECT DIS, V212, P345, DOI 10.1093/infdis/jiv004; Jiang W, 2005, J VIROL, V79, P4109, DOI 10.1128/JVI.79.7.4109-4119.2005; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Martin GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055279; MCDEVITT HO, 1980, NEW ENGL J MED, V303, P1514, DOI 10.1056/NEJM198012253032606; MCLEISH KR, 1987, CELL IMMUNOL, V108, P242, DOI 10.1016/0008-8749(87)90209-7; Meijerink M, 2011, J IMMUNOL METHODS, V373, P136, DOI 10.1016/j.jim.2011.08.010; Mina-Osorio P, 2008, J LEUKOCYTE BIOL, V84, P448, DOI 10.1189/jlb.1107802; Olvera-Garcia G, 2014, AIDS, V28, P311, DOI 10.1097/QAD.0000000000000162; Pearson LL, 2001, INT IMMUNOL, V13, P273, DOI 10.1093/intimm/13.3.273; Petrov V, 2013, IMMUNOLOGY, V140, P413, DOI 10.1111/imm.12148; R Development Core Team, 2010, R A LANGUAGE AND ENV; RStudio, 2014, RSTUDIO INTEGRATED D; Silveira GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071291; Tseng ZH, 2012, J AM COLL CARDIOL, V59, P1891, DOI 10.1016/j.jacc.2012.02.024; Weinberg A, 2009, CLIN VACCINE IMMUNOL, V16, P1176, DOI 10.1128/CVI.00342-08; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Williams DW, 2015, J LEUKOCYTE BIOL, V97, P401, DOI 10.1189/jlb.5A0714-347R; Wilson EMP, 2014, J INFECT DIS, V210, P1396, DOI 10.1093/infdis/jiu275; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhang R, 2004, J IMMUNOL, V172, P2678, DOI 10.4049/jimmunol.172.4.2678; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	42	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139474	10.1371/journal.pone.0139474	http://dx.doi.org/10.1371/journal.pone.0139474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430882	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700067
J	Wang, Q; Wang, WJ; He, XY; Zhang, WT; Song, KS; Han, SJ				Wang, Qiong; Wang, Wenjie; He, Xingyuan; Zhang, Wentian; Song, Kaishan; Han, Shijie			Role and Variation of the Amount and Composition of Glomalin in Soil Properties in Farmland and Adjacent Plantations with Reference to a Primary Forest in North-Eastern China	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; DISSOLVED ORGANIC-MATTER; TEMPORAL-CHANGES; PARALLEL FACTOR; PROTEIN FILMS; CARBON; AFFORESTATION; RHIZOSPHERE; SPECTROSCOPY; ORGANIZATION	The glycoprotein known as glomalin-related soil protein (GRSP) is abundantly produced on the hyphae and spores of arbuscular mycorrhizal fungi (AMF) in soil and roots. Few studies have focused on its amount, composition and associations with soil properties and possible land-use influences, although the data hints at soil rehabilitation. By choosing a primary forest soil as a non-degraded reference, it is possible to explore whether afforestation can improve degraded farmland soil by altering GRSP. In this paper, close correlations were found between various soil properties (soil organic carbon, nitrogen, pH, electrical conductivity (EC), and bulk density) and the GRSP amount, between various soil properties and GRSP composition (main functional groups, fluorescent substances, and elements). Afforestation on farmland decreased the EC and bulk density (p < 0.05). The primary forest had a 2.35-2.56-fold higher GRSP amount than those in the plantation forest and farmland, and GRSP composition (tryptophan-like and fulvic acid-like fluorescence; functional groups of C-H, C-O, and O-H; elements of Al, O, Si, C, Ca, and N) in primary forest differed from those in plantation forest and farmland (p < 0.05). However, no evident differences in GRSP amount and composition were observed between the farmland and the plantation forest. Our finding highlights that 30 years poplar afforestation on degraded farmland is not enough to change GRSP-related properties. A longer period of afforestation with close-to-nature managements may favor the AMF-related underground recovery processes.	[Wang, Wenjie; Zhang, Wentian] Northeast Forestry Univ, Key Lab Forest Plant Ecol, Harbin, Peoples R China; [Wang, Qiong; He, Xingyuan; Song, Kaishan] Chinese Acad Sci, Northeast Inst Geog & Agr Ecol, Urban Forests & Wetlands Res Grp, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China; [Han, Shijie] Chinese Acad Sci, Inst Appl Ecol, Res Inst Forest Ecol & Forestry Ecol Engn, Shenyang 110016, Peoples R China	Northeast Forestry University - China; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Wang, WJ (corresponding author), Northeast Forestry Univ, Key Lab Forest Plant Ecol, Harbin, Peoples R China.	wjwang225@hotmail.com	wang, wenjie/G-9041-2014	wang, wenjie/0000-0003-0465-686X	Heilongjiang Province Fund for Distinguished Young Scientists [JC201401]; China's National Foundation of Natural Sciences [31170575, 41373075]; Fundamental Research Funds for the Central Universities [2572014EA01]	Heilongjiang Province Fund for Distinguished Young Scientists; China's National Foundation of Natural Sciences; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported financially by Heilongjiang Province Fund for Distinguished Young Scientists (JC201401), China's National Foundation of Natural Sciences (31170575, 41373075) and Fundamental Research Funds for the Central Universities (2572014EA01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera P, 2011, SOIL BIOL BIOCHEM, V43, P2427, DOI 10.1016/j.soilbio.2011.09.001; Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; Chen Z, 2012, SYMBIOSIS, V57, P149, DOI 10.1007/s13199-012-0186-y; Dai J, 2013, J SOIL SEDIMENT, V13, P1, DOI 10.1007/s11368-012-0576-z; Deng L, 2012, INT J SEDIMENT RES, V27, P120, DOI 10.1016/S1001-6279(12)60021-3; Fan ZhiPing, 2004, Journal of Beijing Forestry University, V26, P81; Fang Sheng-zuo, 2008, Yingyong Shengtai Xuebao, V19, P2308; Gil-Cardeza ML, 2014, SCI TOTAL ENVIRON, V493, P828, DOI 10.1016/j.scitotenv.2014.06.080; Gillespie AW, 2011, SOIL BIOL BIOCHEM, V43, P766, DOI 10.1016/j.soilbio.2010.12.010; Gong HL, 2013, CHINESE GEOGR SCI, V23, P562, DOI 10.1007/s11769-013-0626-5; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Guo WD, 2007, MAR CHEM, V107, P357, DOI 10.1016/j.marchem.2007.03.006; [郭卫东 GUO Weidong], 2007, [海洋通报, Marine Science Bulletin], V26, P98; Guo XJ, 2012, MICROCHEM J, V102, P115, DOI 10.1016/j.microc.2011.12.006; He XS, 2013, CHEMOSPHERE, V93, P2208, DOI 10.1016/j.chemosphere.2013.04.039; [贺学礼 He Xueli], 2011, [生态学报, Acta Ecologica Sinica], V31, P2159; Hunt JF, 2007, J AGR FOOD CHEM, V55, P2121, DOI 10.1021/jf063336m; Ji Chang-Ping, 2014, Bulletin of Botanical Research, V34, P372, DOI 10.7525/j.issn.1673-5102.2014.03.014; [汲常萍 Ji Changping], 2015, [生态学报, Acta Ecologica Sinica], V35, P5675; Kravchenko AN, 2003, SOIL SCI SOC AM J, V67, P1564, DOI 10.2136/sssaj2003.1564; Lemenih M, 2004, FOREST ECOL MANAG, V195, P57, DOI 10.1016/j.foreco.2004.02.055; Li HuiQing, 2007, World Forestry Research, V20, P6; Li Yan-Hong, 2013, Bulletin of Botanical Research, V33, P404, DOI 10.7525/j.issn.1673-5102.2013.04.004; Li YH, 2013, SCI WORLD J, DOI 10.1155/2013/698752; Lin GW., 2014, INNER MONGOLIA FORES, V37, P34; Liu Hailong, 2008, Chinese Journal of Lasers, V35, P685, DOI 10.3788/CJL20083505.0685; Liu Ying, 2006, Acta Optica Sinica, V26, P1580; Liu ZhenKun, 2013, Scientia Silvae Sinicae, V49, P89; Lu GC, 2010, CHINESE J ANAL CHEM, V38, P1144, DOI 10.3724/SP.J.1096.2010.01144; McArthur S. L., 2014, SURFACE ANAL TECHNIQ, P9, DOI DOI 10.1007/978-3-319-01360-2_2; Meier S, 2015, J PLANT NUTR SOIL SC, V178, P126, DOI 10.1002/jpln.201400092; Monte IP, 2012, J SCI FOOD AGR, V92, P654, DOI 10.1002/jsfa.4626; Ni YN, 2005, SPECTROSC SPECT ANAL, V25, P1641; Nichols K., 2003, CHARACTERIZATION GLO; Olszewska M, 2008, PLANT SOIL, V305, P157, DOI 10.1007/s11104-008-9537-0; Oust A, 2006, APPL ENVIRON MICROB, V72, P228, DOI 10.1128/AEM.72.1.228-232.2006; PAYNTER RW, 1984, J COLLOID INTERF SCI, V101, P233, DOI 10.1016/0021-9797(84)90023-7; RATNER BD, 1981, J COLLOID INTERF SCI, V83, P630, DOI 10.1016/0021-9797(81)90358-1; Rausch C, 2001, NATURE, V414, P462, DOI 10.1038/35106601; Rillig MC, 2001, PLANT SOIL, V233, P167, DOI 10.1023/A:1010364221169; Rillig MC, 2004, CAN J SOIL SCI, V84, P355, DOI 10.4141/S04-003; Rillig MC, 2003, SOIL BIOL BIOCHEM, V35, P1257, DOI 10.1016/S0038-0717(03)00185-8; Rillig MC, 2002, PLANT SOIL, V238, P325, DOI 10.1023/A:1014483303813; Rillig MC, 2003, PLANT SOIL, V253, P293, DOI 10.1023/A:1024807820579; Schindler FV, 2007, SOIL BIOL BIOCHEM, V39, P320, DOI 10.1016/j.soilbio.2006.08.017; Singh PK, 2013, PROTOPLASMA, V250, P663, DOI 10.1007/s00709-012-0453-z; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Wang CX, 2013, SCI WORLD J, DOI 10.1155/2013/968432; Wang CM, 2006, J INTEGR PLANT BIOL, V48, P503, DOI 10.1111/j.1744-7909.2006.00264.x; Wang HM, 2014, ECOL EVOL, V4, P1039, DOI 10.1002/ece3.947; Wang P, 2015, PEDOSPHERE, V25, P160, DOI 10.1016/S1002-0160(14)60086-2; Wang Q., 2015, FULVIC HUMIC ACIDS C, P39; Wang Q, 2014, SCI WORLD; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111740; Wang WJ, 2014, FOREST ECOL MANAG, V325, P8, DOI 10.1016/j.foreco.2014.03.023; Wang ZQ, 2009, SCI CHINA SER D, V52, P1005, DOI 10.1007/s11430-009-0093-0; Wang Zhong-dong, 2006, Chinese Journal of Lasers, V33, P1003; Woignier T, 2014, EUR J SOIL SCI, V65, P531, DOI 10.1111/ejss.12151; Wright SF, 1998, SOIL BIOL BIOCHEM, V30, P1853, DOI 10.1016/S0038-0717(98)00047-9; Wright SF, 1996, PLANT SOIL, V181, P193, DOI 10.1007/BF00012053; Wright SF, 1996, SOIL SCI, V161, P575, DOI 10.1097/00010694-199609000-00003; Wu FS, 2011, PLANT SOIL, V342, P233, DOI 10.1007/s11104-010-0688-4; Wu HY, 2012, BIORESOURCE TECHNOL, V110, P174, DOI 10.1016/j.biortech.2012.01.149; Wu QS, 2015, MYCORRHIZA, V25, P121, DOI 10.1007/s00572-014-0594-3; [许伟 Xu Wei], 2015, [生态学报, Acta Ecologica Sinica], V35, P1124; [衣晓丹 Yi Xiaodan], 2013, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V33, P34; Yuan G, 1998, GEODERMA, V86, P169, DOI 10.1016/S0016-7061(98)00049-4; Zhang J, 2015, SOIL BIOL BIOCHEM, V83, P142, DOI 10.1016/j.soilbio.2015.01.023; Zhu YG, 2003, TRENDS PLANT SCI, V8, P407, DOI 10.1016/S1360-1385(03)00184-5; Zu YG, 2009, CLIMATIC CHANGE, V96, P137, DOI 10.1007/s10584-009-9601-7	72	39	48	15	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139623	10.1371/journal.pone.0139623	http://dx.doi.org/10.1371/journal.pone.0139623			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430896	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700088
J	Hagenaars, TJ; Windig, JJ				Hagenaars, Thomas J.; Windig, Jack J.			Investigation of a Simple Model for Within-Flock Transmission of Scrapie	PLOS ONE			English	Article							PRION-PROTEIN; GREAT-BRITAIN; BRITISH SHEEP; PROGRAM; PREVALENCE; DYNAMICS; TISSUES; RISK	Genetic control programs for scrapie in sheep build on solid knowledge of how susceptibility to scrapie is modulated by the prion protein genotype at the level of an individual sheep. In order to satisfactorily analyze the effectivity of control programs at the population level, insight is needed at the flock level, i.e., how the grouping of sheep in flocks affects the population-level transmission risk. In particular, one would like to understand how this risk is affected by between-flock differences in genotype frequency distribution. A first step is to model the scrapie transmission risk within a flock as a function of the flock genotype profile. Here we do so by estimating parameters for a model of within-flock transmission using genotyping data on Dutch flocks affected by scrapie. We show that the data are consistent with a relatively simple transmission model assuming horizontal transmission and homogeneous mixing between animals. The model expresses the basic reproduction number for within-flock scrapie as a weighted average of genotype-specific susceptibilities, multiplied by a single overall transmission parameter. The value of the overall transmission parameter may vary between flocks to account for random between-flock variation in non-genetic determinants such as management practice. Here we provide an estimate of its mean value and variation for Dutch flocks.	[Hagenaars, Thomas J.] Cent Vet Inst, NL-8200 AB Lelystad, Netherlands; [Windig, Jack J.] Wageningen UR Livestock Res, Anim Breeding & Genom Ctr, NL-6700 AH Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Hagenaars, TJ (corresponding author), Cent Vet Inst, POB 65, NL-8200 AB Lelystad, Netherlands.	thomas.hagenaars@wur.nl			Dutch Ministry of Economic Affairs [WOT-01-002-01.06, WOT-01-002-001.01]	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by the Dutch Ministry of Economic Affairs, research project codes WOT-01-002-01.06 and WOT-01-002-001.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Arnold M, 2002, PREV VET MED, V56, P227, DOI 10.1016/S0167-5877(02)00159-9; Baylis M, 2004, J GEN VIROL, V85, P2735, DOI 10.1099/vir.0.79876-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Bozzetta E, 2011, J VIROL METHODS, V173, P161, DOI 10.1016/j.jviromet.2011.01.008; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Diekmann O., 2012, MATH TOOLS UNDERSTAN; Gonzalez L, 2008, VET REC, V162, P397, DOI 10.1136/vr.162.13.397; Gubbins S, 2006, PREV VET MED, V73, P17, DOI 10.1016/j.prevetmed.2005.08.001; Gubbins S, 2005, PREV VET MED, V69, P175, DOI 10.1016/j.prevetmed.2004.12.009; Gubbins S, 2008, J R SOC INTERFACE, V5, P1343, DOI 10.1098/rsif.2008.0021; Gubbins S, 2010, VET RES, V41, DOI 10.1051/vetres/2010014; Hagenaars TJ, 2000, MATH BIOSCI, V168, P117, DOI 10.1016/S0025-5564(00)00048-1; Hagenaars TJ, 2001, EPIDEMIOL INFECT, V127, P157, DOI 10.1017/S0950268801005738; Hagenaars TJ, 2010, BMC VET RES, V6; Healy AM, 2004, PREV VET MED, V64, P73, DOI 10.1016/j.prevetmed.2004.06.002; Kao RR, 2001, MATH BIOSCI, V174, P61, DOI 10.1016/S0025-5564(01)00082-7; Matthews L, 1999, P ROY SOC B-BIOL SCI, V266, P1085, DOI 10.1098/rspb.1999.0747; McIntyre KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003994; Melchior MB, 2010, BMC VET RES, V6; Meydan H, 2013, ANIM GENET, V44, P588, DOI 10.1111/age.12019; Moreno CR, 2008, GENETICS, V179, P723, DOI 10.1534/genetics.108.088146; Nodelijk G, 2011, VET RES, V42; Sivam SK, 2006, VET REC, V158, P501, DOI 10.1136/vr.158.15.501; Tongue SC, 2009, PREV VET MED, V92, P309, DOI 10.1016/j.prevetmed.2009.08.009; Truscott JE, 2009, EPIDEMIOL INFECT, V137, P775, DOI 10.1017/S0950268808001064; Vaccari G, 2009, VET RES, V40, DOI [10.1051/vetres/2009048, DOI 10.1051/VETRES/2009048]; van Keulen LJM, 2000, ARCH VIROL, P57; van Keulen LJM, 2008, VET RES, V39, DOI 10.1051/vetres:2007061; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; Vilas VJDR, 2008, VET RES, V39, DOI 10.1051/vetres:2008014; Woolhouse MEJ, 1999, PHILOS T R SOC B, V354, P751, DOI 10.1098/rstb.1999.0427; Wright S., 1969, THEORY GENE FREQUENC, V2, P520	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139436	10.1371/journal.pone.0139436	http://dx.doi.org/10.1371/journal.pone.0139436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426269	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100059
J	Li, TF; Shui, SF; Han, XW; Yan, L; Ma, J; Guo, D; Zhu, HC; Wang, SK; He, YH; Chen, WW; Wei, LP; Wang, MK; Song, TM				Li, Teng-Fei; Shui, Shao-Feng; Han, Xin-Wei; Yan, Lei; Ma, Ji; Guo, Dong; Zhu, Hong-Can; Wang, Shu-Kai; He, Yuan-Hong; Chen, Wen-Wu; Wei, Li-Ping; Wang, Ming-Ke; Song, Tai-Min			The Use of Solitaire AB Stents in Coil Embolization of Wide-Necked Cerebral Aneurysms	PLOS ONE			English	Article							INTRACRANIAL ANEURYSMS; ASSISTED COILING; FOLLOW-UP; ENDOVASCULAR TREATMENT; ENTERPRISE STENT; NEUROFORM; COMPLICATIONS; EXPERIENCE	Background The Solitaire AB stent is one of many assistant stents used for treating wide-necked cerebral aneurysm, and has been used since 2003. However, large sample studies on its safety and effectiveness are lacking. The objective of this study was to evaluate the effectiveness and safety of the Solitaire AB stent in the coil embolization of wide-necked cerebral aneurysms. Methods Retrospective review of the clinical and image data of 116 patients with wide-necked cerebral aneurysms who had been enrolled at six interventional neuroradiology centers from February 2010 to February 2014 and had been treated by coil embolization; in total, 120 Solitaire AB stents were used. The degree of aneurysm occlusion was examined using digital subtraction angiography (DSA) immediately after the procedure and during follow-up, and was graded using the modified Raymond classification. We also observed complications to evaluate the safety and effectiveness of this therapy. Results The 120 Solitaire AB stents (4 mm x 15 mm, four stents; 4 mm x 20 mm, 16 stents; 6 mm x 20 mm, 36 stents; 6 mm x 30 mm, 64 stents) were inserted to treat 120 wide-necked cerebral aneurysms. All stents were inserted successfully. DSA immediately post-surgery revealed 55 cases of complete occlusion, 59 cases of neck remnant, and six cases of aneurysm remnant. Perioperatively, there were four cases of hemorrhage and four cases of stent thrombosis. The follow-up spanned 3-37 months; of 92 patients examined by DSA at the 6-month follow up, 12 had disease recurrence. Conclusions The Solitaire AB stent is effective with a good technical success rate and short-term effect for assisting coil embolization of wide-necked cerebral aneurysms.	[Li, Teng-Fei; Shui, Shao-Feng; Han, Xin-Wei; Yan, Lei; Ma, Ji; Guo, Dong] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Peoples R China; [Li, Teng-Fei; Shui, Shao-Feng; Han, Xin-Wei; Yan, Lei; Ma, Ji; Guo, Dong] Zhengzhou Univ, Intervent Inst, Zhengzhou 450052, Peoples R China; [Zhu, Hong-Can] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Peoples R China; [Wang, Shu-Kai] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurosurg, Zhengzhou 450052, Peoples R China; [He, Yuan-Hong] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Peoples R China; [Chen, Wen-Wu] Henan Univ, Affiliated Hosp 1, Dept Neurol, Kaifeng, Peoples R China; [Wei, Li-Ping] Luoyang Cent Hosp, Dept Neurol, Luoyang, Peoples R China; [Wang, Ming-Ke; Song, Tai-Min] Luohe First Peoples Hosp, Dept Neurol, Luohe, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Henan University; Zhengzhou University	Han, XW (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou 450052, Peoples R China.	hanxinwei2006@163.com	黎, 伟/GXM-4040-2022; han, wei/ABG-2691-2021; wei, li/GSD-3630-2022					Chalouhi N, 2013, STROKE, V44, P1348, DOI 10.1161/STROKEAHA.111.000641; Clajus C, 2013, NEURORADIOLOGY, V55, P629, DOI 10.1007/s00234-013-1148-7; Gao X, 2011, NEUROL RES, V33, P841, DOI 10.1179/1743132811Y.0000000012; Gentric JC, 2013, AM J NEURORADIOL, V34, P1203, DOI 10.3174/ajnr.A3379; Geyik S, 2013, AM J NEURORADIOL, V34, P2157, DOI 10.3174/ajnr.A3574; Gory B, 2014, NEUROSURGERY, V75, P215, DOI 10.1227/NEU.0000000000000415; Gory B, 2013, NEURORADIOLOGY, V55, P1373, DOI 10.1007/s00234-013-1277-z; Henkes H, 2003, INTERV NEURORADIOL, V9, P391, DOI 10.1177/159101990300900411; Higashida RT, 1997, J NEUROSURG, V87, P944, DOI 10.3171/jns.1997.87.6.0944; Huded V, 2014, J NEUROSCI RURAL PRA, V5, P254, DOI 10.4103/0976-3147.133577; Jankowitz B, 2008, INTERV NEURORADIOL, V14, P385, DOI 10.1177/159101990801400404; Jia J, 2012, INTERV NEURORADIOL, V18, P426, DOI 10.1177/159101991201800408; Kadkhodayan Y, 2013, AM J ROENTGENOL, V200, P872, DOI 10.2214/AJR.12.8954; Kim Sung Tae, 2013, J Cerebrovasc Endovasc Neurosurg, V15, P299, DOI 10.7461/jcen.2013.15.4.299; King B, 2014, J NEUROINTERV SURG; Klisch J, 2010, NEURORADIOLOGY, V52, P349, DOI 10.1007/s00234-009-0568-x; Klisch J, 2009, NEUROSURGERY, V65, P258, DOI 10.1227/01.NEU.0000348295.44970.C8; Lavine SD, 2009, NEUROSURGERY, V64, P1012, DOI 10.1227/01.NEU.0000343745.18753.D6; Lodi YM, 2012, J NEUROINTERV SURG, V4, P281, DOI 10.1136/neurintsurg-2011-010035; Lovblad KO, 2006, J MAGN RESON IMAGING, V24, P418, DOI 10.1002/jmri.20642; Lubicz B, 2010, J NEURORADIOLOGY, V37, P83, DOI 10.1016/j.neurad.2010.02.003; Lubicz B, 2009, NEURORADIOLOGY, V51, P419, DOI 10.1007/s00234-009-0519-6; Maldonado IL, 2011, AM J NEURORADIOL, V32, P131, DOI 10.3174/ajnr.A2245; Mocco J, 2011, NEUROSURGERY, V69, P908, DOI 10.1227/NEU.0b013e318228490c; Molyneux Andrew, 2002, J Stroke Cerebrovasc Dis, V11, P304, DOI 10.1053/jscd.2002.130390; Roy D, 2001, STROKE, V32, P1998, DOI 10.1161/hs0901.095600; Shapiro M, 2012, AM J NEURORADIOL, V33, P159, DOI 10.3174/ajnr.A2719; Weber W, 2007, NEURORADIOLOGY, V49, P555, DOI 10.1007/s00234-007-0232-2; Yahia AM, 2010, J NEUROIMAGING, V20, P113, DOI 10.1111/j.1552-6569.2009.00390.x; Zhang JB, 2012, NEUROL INDIA, V60, P278, DOI 10.4103/0028-3886.98508	30	4	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139714	10.1371/journal.pone.0139714	http://dx.doi.org/10.1371/journal.pone.0139714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426804	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100088
J	Stone, A; Kartheiser, G; Hauser, PC; Petitto, LA; Allen, TE				Stone, Adam; Kartheiser, Geo; Hauser, Peter C.; Petitto, Laura-Ann; Allen, Thomas E.			Fingerspelling as a Novel Gateway into Reading Fluency in Deaf Bilinguals	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; COMPREHENSION; STUDENTS; ABILITY; READERS; MEMORY; PRINT	Studies have shown that American Sign Language (ASL) fluency has a positive impact on deaf individuals' English reading, but the cognitive and cross-linguistic mechanisms permitting the mapping of a visual-manual language onto a sound-based language have yet to be elucidated. Fingerspelling, which represents English orthography with 26 distinct hand configurations, is an integral part of ASL and has been suggested to provide deaf bilinguals with important cross-linguistic links between sign language and orthography. Using a hierarchical multiple regression analysis, this study examined the relationship of age of ASL exposure, ASL fluency, and fingerspelling skill on reading fluency in deaf college-age bilinguals. After controlling for ASL fluency, fingerspelling skill significantly predicted reading fluency, revealing for the first-time that fingerspelling, above and beyond ASL skills, contributes to reading fluency in deaf bilinguals. We suggest that both fingerspelling-in the visual-manual modality-and reading-in the visual-orthographic modality-are mutually facilitating because they share common underlying cognitive capacities of word decoding accuracy and automaticity of word recognition. The findings provide support for the hypothesis that the development of English reading proficiency may be facilitated through strengthening of the relationship among fingerspelling, sign language, and orthographic decoding en route to reading mastery, and may also reveal optimal approaches for reading instruction for deaf and hard of hearing children.	[Stone, Adam; Kartheiser, Geo; Petitto, Laura-Ann; Allen, Thomas E.] Gallaudet Univ, Educ Neurosci PEN Program, Washington, DC 20002 USA; [Stone, Adam; Kartheiser, Geo; Hauser, Peter C.; Petitto, Laura-Ann; Allen, Thomas E.] Gallaudet Univ, NSF Sci Learning Ctr Visual Language & Visual Lea, Washington, DC 20002 USA; [Hauser, Peter C.] Rochester Inst Technol, Natl Tech Inst Deaf, Deaf Studies Lab, Rochester, NY 14623 USA; [Petitto, Laura-Ann] Gallaudet Univ, Dept Psychol, Washington, DC 20002 USA; [Allen, Thomas E.] Gallaudet Univ, Dept Educ, Washington, DC 20002 USA	National Science Foundation (NSF); Rochester Institute of Technology; US Department of Education	Stone, A (corresponding author), Gallaudet Univ, Educ Neurosci PEN Program, Washington, DC 20002 USA.	adam.stone@gallaudet.edu		Stone, Adam/0000-0002-2026-309X; Stone, Adam/0000-0002-0319-4301	National Science Foundation [SBE-1041725]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation SBE-1041725, http://nsf.gov (LAP TEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu C.T., 1985, SLR 83 P 3 INT S SIG, P126; Allen TE, 2012, ASSESSING LIT DEAF I, P21; Allen TE, 2015, SIGN LANG STUD, V15, P233, DOI 10.1353/sls.2015.0006; Andrew KN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089994; Brentari D, 2001, FOREIGN VOCABULARY IN SIGN LANGUAGES: CROSS-LINGUISTIC INVESTIGATION OF WORD FORMATION, P87; Chamberlain C, 2000, LANGUAGE ACQUISITION BY EYE, P221; Chamberlain C, 2008, APPL PSYCHOLINGUIST, V29, P367, DOI 10.1017/S014271640808017X; Corsi P., 1972, THESIS; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Easterbrooks SR, 2008, J DEAF STUD DEAF EDU, V13, P37, DOI 10.1093/deafed/enm030; Ehri LC, 2014, SCI STUD READ, V18, P5, DOI 10.1080/10888438.2013.819356; Emmorey K, 2012, J DEAF STUD DEAF EDU, V17, P194, DOI 10.1093/deafed/enr051; Enns C, 2007, AM ANN DEAF, V152, P63, DOI 10.1353/aad.2007.0011; Ensor A, 1997, J Deaf Stud Deaf Educ, V2, P61; Freel B.L., 2011, PSYCHOLOGY, V2, P18, DOI [DOI 10.4236/PSYCH.2011.21003, 10.4236/psych.2011.21003]; FUCHS LS, 1988, REM SPEC EDUC, V9, P20, DOI 10.1177/074193258800900206; Gough PB, 1986, REM SPEC EDUC, V7, P10; Grushkin DA, 1998, AM ANN DEAF, V143, P404, DOI 10.1353/aad.2012.0192; Haptonstall-Nykaza TS, 2007, J DEAF STUD DEAF EDU, V12, P172, DOI 10.1093/deafed/enm003; Hauser PC, 2008, SIGN LANGUAGES SPINN; Hermans D, 2008, J DEAF STUD DEAF EDU, V13, P518, DOI 10.1093/deafed/enn009; Hile A, 2009, THESIS U COLORADO BO; HIRSHPASEK K, 1987, READ RES QUART, V22, P455, DOI 10.2307/747702; Hoffmeister RJ, 2000, LANGUAGE ACQUISITION BY EYE, P143; HOOVER WA, 1990, READ WRIT, V2, P127, DOI 10.1007/BF00401799; Humphries T., 1999, VISUAL ANTHR REV, V15, P84, DOI DOI 10.1525/VAR.2000.15.2.84; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Kaufman A. S., 2004, KAUFMANN BRIEF INTEL, VSecond; KELLY LP, 1995, EXCEPT CHILDREN, V61, P318, DOI 10.1177/001440299506100402; Kovelman I, 2008, BILING-LANG COGN, V11, P203, DOI 10.1017/S1366728908003386; Luckner JL, 2012, COMMUN DISORD Q, V33, P230, DOI 10.1177/1525740111412582; Mayberry RI, 2011, J DEAF STUD DEAF EDU, V16, P164, DOI 10.1093/deafed/enq049; Mayberry RI, 2002, NATURE, V417, P38, DOI 10.1038/417038a; Mercer CD, 2000, LEARN DISABIL RES, V15, P177; Morere D., 2012, ASSESSING LITERACY D, DOI [10.1007/978-1-4614-5269-0, DOI 10.1007/978-1-4614-5269-0]; Morere D., 2012, ASSESSING LIT DEAF I, P159; Morere D, 2012, ASSESSING LIT DEAF I, P21; Morere D.A., 2012, ASSESSING LITERACY D; Morere D. A., 2012, ASSESSING LITERACY D, P179; National Reading Panel, 2000, REP NAT READ PAN TEA; Padden C, 1998, TOP LANG DISORD, V18, P30, DOI 10.1097/00011363-199808000-00005; Padden C., 1991, THEORETICAL ISSUES S, P193; Padden C.A., 2003, SIGN LANGUAGE STUDIE, V4, P10, DOI [DOI 10.1353/SLS.2003.0026, 10.1353/sls.2003.0026]; Padden CA, 2000, SIGNS OF LANGUAGE REVISITED, P435; Padden CA, 2006, ADV SIGN LANGUAGE DE, P189, DOI DOI 10.1007/978-1-4614-5269-0; Penner-Wilger M., 2008, READING FLUENCY BRID; Petitto LA, 2009, MIND BRAIN EDUC, V3, P185, DOI 10.1111/j.1751-228X.2009.01069.x; Pinnell G.S., 1995, LISTENING CHILDREN R; Ramus F, 2012, COGN NEUROPSYCHOL, V29, P104, DOI 10.1080/02643294.2012.677420; Samare Y, 1992, PHONETICS FARSI LANG; Samuels S.J., 2006, WHAT RES HAS SAY FLU, P24; Schirmer B. R., 2009, READING IMPROVEMENT, V46, P168; Strong M, 1997, J Deaf Stud Deaf Educ, V2, P37; Torgesen JK., 2006, WHAT RES HAS SAY FLU, P130; Williams J, 2015, J LANG LIT, V6, P156; WILSON MD, 1973, J APPL BEHAV ANAL, V6, P231, DOI 10.1901/jaba.1973.6-231; Woodcock R, 2001, WOODCOCK JOHNSON TES	57	35	38	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139610	10.1371/journal.pone.0139610	http://dx.doi.org/10.1371/journal.pone.0139610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427062	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100080
J	Stulberg, MJ; Huang, Q				Stulberg, Michael J.; Huang, Qi			A TaqMan-Based Multiplex qPCR Assay and DNA Extraction Method for Phylotype IIB Sequevars 1&2 (Select Agent) Strains of Ralstonia solanacearum	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BLOOD-DISEASE BACTERIUM; REAL-TIME PCR; 3 BIOVAR 2; PSEUDOMONAS-SOLANACEARUM; SEQUENCE-ANALYSIS; SP-NOV; AMPLIFICATION; GERANIUM; RACE-3	Ralstonia solanacearum race 3 biovar 2 strains belonging to phylotype IIB, sequevars 1 and 2 (IIB-1&2) cause brown rot of potato in temperate climates, and are quarantined pathogens in Canada and Europe. Since these strains are not established in the U.S. and because of their potential risk to the potato industry, the U.S. government has listed them as select agents. Cultivated geraniums are also a host and have the potential to spread the pathogen through trade, and its extracts strongly inhibits DNA-based detection methods. We designed four primer and probe sets for an improved qPCR method that targets stable regions of DNA. RsSA1 and RsSA2 recognize IIB-1&2 strains, RsII recognizes the current phylotype II (the newly proposed R. solanacearum species) strains (and a non-plant associated R. mannitolilytica), and Cox1 recognizes eight plant species including major hosts of R. solanacearum such as potato, tomato and cultivated geranium as an internal plant control. We multiplexed the RsSA2 with the RsII and Cox1 sets to provide two layers of detection of a positive IIB-1&2 sample, and to validate plant extracts and qPCR reactions. The TaqMan-based uniplex and multiplex qPCR assays correctly identified 34 IIB-1&2 and 52 phylotype II strains out of 90 R. solanacearum species complex strains. Additionally, the multiplex qPCR assay was validated successfully using 169 artificially inoculated symptomatic and asymptomatic plant samples from multiple plant hosts including geranium. Furthermore, we developed an extraction buffer that allowed for a quick and easy DNA extraction from infected plants including geranium for detection of R. solanacearum by qPCR. Our multiplex qPCR assay, especially when coupled with the quick extraction buffer method, allows for quick, easy and reliable detection and differentiation of the IIB-1&2 strains of R. solanacearum.	[Stulberg, Michael J.; Huang, Qi] USDA, Floral & Nursery Plants Res Unit, ARS, Beltsville, MD 20705 USA; [Stulberg, Michael J.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA	United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Huang, Q (corresponding author), USDA, Floral & Nursery Plants Res Unit, ARS, Beltsville, MD 20705 USA.	qi.huang@ars.usda.gov		Stulberg, Michael/0000-0001-8640-1291	U.S. Department of Agriculture (USDA); Agricultuiral Reseach Service (ARS); Animal and Plant Health Inspection Service; U.S. Department of Energy (DOE); USDA; DOE [DE-AC05-06OR23100]; ARS [ARS-0423161] Funding Source: Federal RePORTER	U.S. Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Agricultuiral Reseach Service (ARS); Animal and Plant Health Inspection Service; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); USDA(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was financially supported by the U.S. Department of Agriculture (USDA), Agricultuiral Reseach Service (ARS) and Animal and Plant Health Inspection Service. It was supported in part by an appointment to the ARS Research Participation Program administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy (DOE) and USDA. ORISE is managed by ORAU under DOE contract number DE-AC05-06OR23100.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen THH, 2011, PLANT CELL ENVIRON, V34, P1, DOI 10.1111/j.1365-3040.2010.02232.x; Chen Y, 2010, J MICROBIOL BIOTECHN; CIAMPI L, 1980, AM POTATO J, V57, P307, DOI 10.1007/BF02854025; Coenye T, 2003, INT J SYST EVOL MICR, V53, P1075, DOI 10.1099/ijs.0.02555-0; Denny TP, 2006, PLANT-ASSOCIATED BACTERIA, P573; Elphinstone JG, 1996, POTATO RES, V39, P403, DOI 10.1007/BF02357946; Fegan M., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P449; Fegan M, 1998, BACTERIAL WILT DISEASE, P34; Guidot A, 2009, PHYTOPATHOLOGY, V99, P1105, DOI 10.1094/PHYTO-99-9-1105; Ha Y, 2012, PLANT DIS, V96, P258, DOI 10.1094/PDIS-05-11-0426; Huang Q, 2012, J MICROBIOL METH, V88, P271, DOI 10.1016/j.mimet.2011.12.007; Janse JD, 2004, J PLANT PATHOL, V86, P147; Ji PS, 2007, PLANT DIS, V91, P195, DOI 10.1094/PDIS-91-2-0195; Kang MJ, 2007, J MICROBIOL BIOTECHN, V17, P1765; Kubota R, 2015, INT J MOL SCI, V16, P4786, DOI 10.3390/ijms16034786; Kubota R, 2011, J GEN PLANT PATHOL, V77, P182, DOI 10.1007/s10327-011-0305-2; Llop P, 1999, J MICROBIOL METH, V37, P23, DOI 10.1016/S0167-7012(99)00033-0; Massart S, 2014, EUR J PLANT PATHOL, V138, P29, DOI 10.1007/s10658-013-0294-4; Opina N, 1997, ASIA-PAC J MOL BIOL, V5, P19; Pastrik KH, 2002, EUR J PLANT PATHOL, V108, P831, DOI 10.1023/A:1021218201771; Pastrik KH, 2000, J PHYTOPATHOL, V148, P619, DOI 10.1046/j.1439-0434.2000.00567.x; Poussier S, 2000, EUR J PLANT PATHOL, V106, P255, DOI 10.1023/A:1008742609761; Poussier S, 2002, J MICROBIOL METH, V51, P349, DOI 10.1016/S0167-7012(02)00111-2; Poussier S, 2000, MICROBIOL-SGM, V146, P1679, DOI 10.1099/00221287-146-7-1679; Saddler G. S., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P121; Safni I, 2014, INT J SYST EVOL MICR, V64, P3087, DOI 10.1099/ijs.0.066712-0; SEAL SE, 1993, J GEN MICROBIOL, V139, P1587, DOI 10.1099/00221287-139-7-1587; Smith DS, 2009, EUR J PLANT PATHOL, V124, P405, DOI 10.1007/s10658-008-9427-6; STRIDER DL, 1981, PLANT DIS, V65, P52, DOI 10.1094/PD-65-52; Stulberg MJ, 2015, PLANT DIS, V99, P333, DOI 10.1094/PDIS-05-14-0483-RE; Swanson JK, 2005, PHYTOPATHOLOGY, V95, P136, DOI 10.1094/PHYTO-95-0136; Tsugama D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-22; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Williamson L, 2002, PLANT DIS, V86, P987, DOI 10.1094/PDIS.2002.86.9.987	35	9	9	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139637	10.1371/journal.pone.0139637	http://dx.doi.org/10.1371/journal.pone.0139637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426354	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100084
J	de Greeff, J; Belpaeme, T				de Greeff, Joachim; Belpaeme, Tony			Why Robots Should Be Social: Enhancing Machine Learning through Social Human-Robot Interaction	PLOS ONE			English	Article							ACQUISITION; CONSTRAINTS; CATEGORIES; RESPONSES; LANGUAGE; INFANTS; MODEL	Social learning is a powerful method for cultural propagation of knowledge and skills relying on a complex interplay of learning strategies, social ecology and the human propensity for both learning and tutoring. Social learning has the potential to be an equally potent learning strategy for artificial systems and robots in specific. However, given the complexity and unstructured nature of social learning, implementing social machine learning proves to be a challenging problem. We study one particular aspect of social machine learning: that of offering social cues during the learning interaction. Specifically, we study whether people are sensitive to social cues offered by a learning robot, in a similar way to children's social bids for tutoring. We use a child-like social robot and a task in which the robot has to learn the meaning of words. For this a simple turn-based interaction is used, based on language games. Two conditions are tested: one in which the robot uses social means to invite a human teacher to provide information based on what the robot requires to fill gaps in its knowledge (i.e. expression of a learning preference); the other in which the robot does not provide social cues to communicate a learning preference. We observe that conveying a learning preference through the use of social cues results in better and faster learning by the robot. People also seem to form a "mental model" of the robot, tailoring the tutoring to the robot's performance as opposed to using simply random teaching. In addition, the social learning shows a clear gender effect with female participants being responsive to the robot's bids, while male teachers appear to be less receptive. This work shows how additional social cues in social machine learning can result in people offering better quality learning input to artificial systems, resulting in improved learning performance.	[de Greeff, Joachim; Belpaeme, Tony] Univ Plymouth, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [de Greeff, Joachim] Delft Univ Technol, Interact Intelligence Grp, Delft, Netherlands	University of Plymouth; Delft University of Technology	de Greeff, J (corresponding author), Univ Plymouth, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England.	J.deGreeff@tudelft.nl	Belpaeme, Tony/AAR-8743-2020	Belpaeme, Tony/0000-0001-5207-7745	EPSRC [EP/G008353/1]; EU [FP7-ICT-248116]; Engineering and Physical Sciences Research Council [EP/G008353/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was partially funded by the EPSRC (EP/G008353/1) and the EU FP7 ALIZ-E project (FP7-ICT-248116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, MECH LANGUAGE ACQUIS; [Anonymous], 2002, IMITATION ANIMALS AR; Ashby FG, 2005, TRENDS COGN SCI, V9, P83, DOI 10.1016/j.tics.2004.12.003; Bandura A., 1986, SOCIAL FDN THOUGHT A; Baxter P, 2014, ACMIEEE INT CONF HUM, P126, DOI 10.1145/2559636.2559829; Baxter P, 2012, ACMIEEE INT CONF HUM, P105; Belpaeme T., 2006, ARTIF LIFE, P466; Beuls K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058960; Billard A, 2004, ROBOT AUTON SYST, V47, P69, DOI 10.1016/j.robot.2004.03.002; Billard A, 1998, ROBOT AUTON SYST, V24, P71, DOI 10.1016/S0921-8890(98)00023-2; Breazeal, 2002, DESIGNING SOCIABLE R; Breazeal C, 2005, ARTIF LIFE, V11, P31, DOI 10.1162/1064546053278955; Broadbent E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072589; Bruner J, 1983, CHILDS TALK LEARNING; Cakmak M, 2010, AUTON ROBOT, V29, P309, DOI 10.1007/s10514-010-9197-9; Calinon S, 2010, IEEE ROBOT AUTOM MAG, V17, P44, DOI 10.1109/MRA.2010.936947; Carifio J., 2007, J SOCIAL SCI, V3, P106, DOI DOI 10.3844/JSSP.2007.106.116; Crowell CR, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P3735, DOI 10.1109/IROS.2009.5354204; de Greeff J, 2009, INT C DEV LEARN, P1; De Vylder B, 2006, J THEOR BIOL, V242, P818, DOI 10.1016/j.jtbi.2006.05.024; Deacon T., 1997, SYMBOLIC SPECIES COE; Delaunay Frederic, 2009, RO-MAN 2009 - The 18th IEEE International Symposium on Robot and Human Interactive Communication, P306, DOI 10.1109/ROMAN.2009.5326314; Duffy B., 2003, SPECIAL ISSUE SOCIAL, V42, P3, DOI DOI 10.1016/S0921-; Eyssel F, 2012, ACMIEEE INT CONF HUM, P125; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Fink Julia, 2012, Social Robotics. 4th International Conference (ICSR 2012). Proceedings, P199, DOI 10.1007/978-3-642-34103-8_20; FISHER C, 1994, LINGUA, V92, P333, DOI 10.1016/0024-3841(94)90346-8; Frank A., 2010, UCI MACHINE LEARNING; Frith CD, 2012, ANNU REV PSYCHOL, V63, P287, DOI 10.1146/annurev-psych-120710-100449; Gardenfors P, 2000, CONCEPTUAL SPACES; Gauvain M, 2001, SOCIAL CONTEXT COGNI; GOLDFIELD BA, 1990, J CHILD LANG, V17, P171, DOI 10.1017/S0305000900013167; Howard IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110334; Jansen B, 2006, ROBOT AUTON SYST, V54, P394, DOI 10.1016/j.robot.2006.01.006; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Knox WB, 2013, LECT NOTES ARTIF INT, V8239, P460, DOI 10.1007/978-3-319-02675-6_46; Kozima H, 2003, ECOLOGY LANGUAGE ACQ, P65; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Leyzberg D, 2011, ACMIEEE INT CONF HUM, P347, DOI 10.1145/1957656.1957789; Lyon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038236; Manders K, 2002, J CHILD LANG, V29, P923, DOI 10.1017/S0305000902005391; Margolis E., 1999, CONCEPTS CORE READIN; MARKMAN EM, 1990, COGNITIVE SCI, V14, P57, DOI 10.1207/s15516709cog1401_4; Masataka N., 2003, ONSET LANGUAGE; Murphy G. L., 2002, BIG BOOK CONCEPTS; MURPHY GL, 1991, PSYCHOLOGY OF WORD MEANINGS, P11; Nass C, 2000, J SOC ISSUES, V56, P81, DOI 10.1111/0022-4537.00153; Nomura T., 2011, Proceedings of the 2011 International Conference on User Science and Engineering (i-USEr 2011), P24, DOI 10.1109/iUSEr.2011.6150530; Powers A, 2005, 2005 IEEE INTERNATIONAL WORKSHOP ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION (RO-MAN), P158; Powers A., 2006, P 1 ACM SIGCHI SIGAR, DOI [10.1145/1121241.1121280, DOI 10.1145/1121241.1121280]; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Reeves B., 1998, MEDIA EQUATION MEDIA; RITTER JM, 1991, CHILD DEV, V62, P68, DOI 10.2307/1130705; Sasamoto Y, 2011, DEV LEARN ICDL 2011, V2, P1; Schermerhorn P., 2008, 2008 3rd ACM/IEEE International Conference on Human-Robot Interaction (HRI 2008), P263; Settles B., 2012, ACTIVE LEARNING; Siegel M, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P2563, DOI 10.1109/IROS.2009.5354116; Steels L, 2005, BEHAV BRAIN SCI, V28, P469, DOI 10.1017/S0140525X05000087; Steels L, 1996, P C ART LIF 5 AL 5 N; Steels L, 1999, LINGUISTIC EVOLUTION, P53; STERNGLANZ SH, 1977, ANIM BEHAV, V25, P108, DOI 10.1016/0003-3472(77)90072-0; Takayama L, 2009, 2009 IEEE-RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, P5495, DOI 10.1109/IROS.2009.5354145; Thomaz A.L., 2006, SOCIALLY GUIDED MACH; Thomaz AL, 2008, ARTIF INTELL, V172, P716, DOI 10.1016/j.artint.2007.09.009; Tomasello M., 1988, LANG SCI, V11, P69, DOI DOI 10.1016/0388-0001(88)90006-X; Tomasello M., 1992, SOC DEV, V1, P67, DOI [10.1111/j.1467-9507.1992.tb00135.x, DOI 10.1111/J.1467-9507.1992.TB00135.X]; Vollmer AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091349; Vygotsky L.., 1978, MIND SOC; Weiss A, 2009, RO-MAN 2009: THE 18TH IEEE INTERNATIONAL SYMPOSIUM ON ROBOT AND HUMAN INTERACTIVE COMMUNICATION, VOLS 1 AND 2, P483, DOI 10.1109/ROMAN.2009.5326274	72	26	26	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138061	10.1371/journal.pone.0138061	http://dx.doi.org/10.1371/journal.pone.0138061			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422143	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700028
J	Driessen, E; Hollon, SD; Bockting, CLH; Cuijpers, P; Turner, EH				Driessen, Ellen; Hollon, Steven D.; Bockting, Claudi L. H.; Cuijpers, Pim; Turner, Erick H.			Does Publication Bias Inflate the Apparent Efficacy of Psychological Treatment for Major Depressive Disorder? A Systematic Review and Meta-Analysis of US National Institutes of Health-Funded Trials	PLOS ONE			English	Article							COGNITIVE-BEHAVIOR THERAPY; RANDOMIZED CONTROLLED-TRIAL; INTERPERSONAL PSYCHOTHERAPY; ANTIDEPRESSANT MEDICATION; OLDER-ADULTS; DIAGNOSTIC-CRITERIA; RAW DATA; WOMEN; PHARMACOTHERAPY; NORTRIPTYLINE	Background The efficacy of antidepressant medication has been shown empirically to be overestimated due to publication bias, but this has only been inferred statistically with regard to psychological treatment for depression. We assessed directly the extent of study publication bias in trials examining the efficacy of psychological treatment for depression. Methods and Findings We identified US National Institutes of Health grants awarded to fund randomized clinical trials comparing psychological treatment to control conditions or other treatments in patients diagnosed with major depressive disorder for the period 1972-2008, and we determined whether those grants led to publications. For studies that were not published, data were requested from investigators and included in the meta-analyses. Thirteen (23.6%) of the 55 funded grants that began trials did not result in publications, and two others never started. Among comparisons to control conditions, adding unpublished studies (Hedges' g = 0.20; CI95% -0.11 similar to 0.51; k = 6) to published studies (g = 0.52; 0.37 similar to 0.68; k = 20) reduced the psychotherapy effect size point estimate (g = 0.39; 0.08 similar to 0.70) by 25%. Moreover, these findings may overestimate the "true" effect of psychological treatment for depression as outcome reporting bias could not be examined quantitatively. Conclusion The efficacy of psychological interventions for depression has been overestimated in the published literature, just as it has been for pharmacotherapy. Both are efficacious but not to the extent that the published literature would suggest. Funding agencies and journals should archive both original protocols and raw data from treatment trials to allow the detection and correction of outcome reporting bias. Clinicians, guidelines developers, and decision makers should be aware that the published literature overestimates the effects of the predominant treatments for depression.	[Driessen, Ellen; Cuijpers, Pim] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands; [Driessen, Ellen; Cuijpers, Pim] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Driessen, Ellen; Cuijpers, Pim] Vrije Univ Amsterdam, Med Ctr Amsterdam, Amsterdam, Netherlands; [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands; [Bockting, Claudi L. H.] Univ Utrecht, Dept Clin & Hlth Psychol, Utrecht, Netherlands; [Turner, Erick H.] VA Portland Hlth Care Syst, Behav Hlth & Neurosci Div, Portland, OR USA; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Turner, Erick H.] Oregon Hlth & Sci Univ, Dept Pharmacol, Portland, OR 97201 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vanderbilt University; University of Groningen; Utrecht University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University; Oregon Health & Science University	Driessen, E (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuro & Dev Psychol, Amsterdam, Netherlands.	e.driessen@vu.nl	Driessen, Ellen/W-8123-2019; Turner, Erick/A-4848-2008; Bockting, Claudi L/K-3768-2019; Cuijpers, Pim/G-1703-2013	Turner, Erick/0000-0002-3522-3357; Bockting, Claudi L/0000-0002-9220-9244; 				Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; [Anonymous], 2000, Am J Psychiatry, V157, P1; Arean PA, 2010, AM J PSYCHIAT, V167, P1391, DOI 10.1176/appi.ajp.2010.09091327; Barber JP, 2012, J CLIN PSYCHIAT, V73, P66, DOI 10.4088/JCP.11m06831; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BEUTLER LE, 1991, J CONSULT CLIN PSYCH, V59, P333, DOI 10.1037/0022-006X.59.2.333; Borenstein M., 2009, INTRO METAANALYSIS; Chan AW, 2006, BMJ-BRIT MED J, V332, P1086, DOI 10.1136/bmj.332.7549.1086; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; CLARKIN JF, 1990, J AFFECT DISORDERS, V18, P17, DOI 10.1016/0165-0327(90)90113-M; COVI L, 1987, PSYCHOPHARMACOL BULL, V23, P173; Cuijpers P, 2010, BRIT J PSYCHIAT, V196, P173, DOI 10.1192/bjp.bp.109.066001; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; Cuijpers P, 2009, INT PSYCHOGERIATR, V21, P16, DOI 10.1017/S1041610208008089; Denton WH, 2012, J MARITAL FAM THER, V38, P23, DOI 10.1111/j.1752-0606.2012.00291.x; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; Dickersin K, 1993, ONLINE J CURR CLIN T, V2; DIMASCIO A, 1979, ARCH GEN PSYCHIAT, V36, P1450; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; FEIGHNER JP, 1972, ARCH GEN PSYCHIAT, V26, P57, DOI 10.1001/archpsyc.1972.01750190059011; Flint J, 2015, Psychol Med, V45, P439, DOI 10.1017/S0033291714001421; FOLEY S H, 1989, International Journal of Family Psychiatry, V10, P29; Frank E, 2011, PSYCHOL MED, V41, P151, DOI 10.1017/S0033291710000553; GALLAGHER DE, 1982, PSYCHOTHER-THEOR RES, V19, P482, DOI 10.1037/h0088461; GLICK ID, 1993, HOSP COMMUNITY PSYCH, V44, P869; Goldman RN, 2006, PSYCHOTHER RES, V16, P536, DOI 10.1080/10503300600589456; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hayden T, 2012, J CLIN PSYCHOL MED S, V19, P285, DOI 10.1007/s10880-011-9294-8; HERSEN M, 1984, BEHAV THER, V15, P21, DOI 10.1016/S0005-7894(84)80039-8; HOLLON SD, 1992, ARCH GEN PSYCHIAT, V49, P774; Hollon SD, 2014, JAMA PSYCHIAT, V71, P1157, DOI 10.1001/jamapsychiatry.2014.1054; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P547, DOI 10.1037/0022-006X.59.4.547; Jarrett RB, 1999, ARCH GEN PSYCHIAT, V56, P431, DOI 10.1001/archpsyc.56.5.431; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Linde JA, 2011, ANN BEHAV MED, V41, P119, DOI 10.1007/s12160-010-9232-2; Lustman PJ, 1998, ANN INTERN MED, V129, P613, DOI 10.7326/0003-4819-129-8-199810150-00005; Lynch TR, 2003, AM J GERIAT PSYCHIAT, V11, P33, DOI 10.1176/appi.ajgp.11.1.33; Manber R, 2008, SLEEP, V31, P489, DOI 10.1093/sleep/31.4.489; Marcus SC, 2010, ARCH GEN PSYCHIAT, V67, P1265, DOI 10.1001/archgenpsychiatry.2010.151; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MILLER IW, 1989, BEHAV THER, V20, P25, DOI 10.1016/S0005-7894(89)80116-9; Miranda J, 2003, JAMA-J AM MED ASSOC, V290, P57, DOI 10.1001/jama.290.1.57; Mohr DC, 2001, J CONSULT CLIN PSYCH, V69, P942, DOI 10.1037//0022-006X.69.6.942; MURPHY GE, 1995, PSYCHOL REP, V77, P403, DOI 10.2466/pr0.1995.77.2.403; MURPHY GE, 1984, ARCH GEN PSYCHIAT, V41, P33; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; O'Hara MW, 2000, ARCH GEN PSYCHIAT, V57, P1039, DOI 10.1001/archpsyc.57.11.1039; Orsini N, 2005, HETEROGI STATA MODUL; Perneger TV, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3035; Pierce CA, 2008, ORGAN RES METHODS, V11, P188, DOI 10.1177/1094428106296641; Reynolds CF, 1999, AM J PSYCHIAT, V156, P202; Reynolds CF, 1999, JAMA-J AM MED ASSOC, V281, P39, DOI 10.1001/jama.281.1.39; Rohan KJ, 2007, J CONSULT CLIN PSYCH, V75, P489, DOI 10.1037/0022-006X.75.3.489; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Rush A. J., 1977, COGNITIVE THERAPY RE, V1, P17, DOI DOI 10.1007/BF01173502; Schulberg HC, 1996, ARCH GEN PSYCHIAT, V53, P913; Smith R, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010006; Spinelli MG, 2003, AM J PSYCHIAT, V160, P555, DOI 10.1176/appi.ajp.160.3.555; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; StataCorp, 2009, STAT STAT SOFTW REL; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Strachowski Diane, 2008, Depress Anxiety, V25, pE1, DOI 10.1002/da.20302; Swartz HA, 2008, AM J PSYCHIAT, V165, P1155, DOI 10.1176/appi.ajp.2008.07081339; Talbot NL, 2011, PSYCHIAT SERV, V62, P374, DOI 10.1176/ps.62.4.pss6204_0374; THOMPSON LW, 1987, J CONSULT CLIN PSYCH, V55, P385, DOI 10.1037/0022-006X.55.3.385; Thompson LW, 2001, AM J GERIAT PSYCHIAT, V9, P225, DOI 10.1176/appi.ajgp.9.3.225; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Vickers AJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2323; Wampold BE, 1997, PSYCHOL BULL, V122, P203, DOI 10.1037/0033-2909.122.3.203; Waters SJ, 2015, PSYCHOTHER RES, V16, P1; WEISSMAN M M, 1979, American Journal of Psychiatry, V136, P555; Wright AGC, 2014, J CONSULT CLIN PSYCH, V82, P839, DOI 10.1037/a0034430; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158	83	109	110	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137864	10.1371/journal.pone.0137864	http://dx.doi.org/10.1371/journal.pone.0137864			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422604	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700020
J	Fan, XX; Liu, SQ; Liu, GH; Zhao, JP; Jiao, HC; Wang, XJ; Song, ZG; Lin, H				Fan, Xiaoxiao; Liu, Shaoqiong; Liu, Guanhua; Zhao, Jingpeng; Jiao, Hongchao; Wang, Xiaojuan; Song, Zhigang; Lin, Hai			Vitamin A Deficiency Impairs Mucin Expression and Suppresses the Mucosal Immune Function of the Respiratory Tract in Chicks	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RETINOIC ACID RECEPTOR; GENE-EXPRESSION; IMMUNOGLOBULIN-A; EPITHELIAL-CELLS; MUCOUS DIFFERENTIATION; AIRWAY EPITHELIUM; DENDRITIC CELLS; SMALL-INTESTINE; IGA PRODUCTION	The chicken immune system is immature at the time of hatching. The development of the respiratory immune system after hatching is vital to young chicks. The aim of this study was to investigate the effect of dietary vitamin A supplement levels on respiratory mucin and IgA production in chicks. In this study, 120 one-day-old broiler chicks were randomly divided into 4 groups consisting of three replicates of 10 broilers and subjected to dietary vitamin A supplement levels of 0, 1,500, 6,000, or 12,000 IU/kg for seven days. Compared with control birds, vitamin A supplementation significantly increased the mucin and IgA levels in the bronchoalveolar lavage fluid (BALF) as well as the IgA level in serum. In the lungs, vitamin A supplementation downregulated TNF-alpha and EGFR mRNA expression. The TGF-beta and MUC5AC mRNA expression levels were upregulated by vitamin A supplementation at a dose of 6,000 IU/kg, and the IL-13 mRNA expression level was increased at the 12,000 IU/kg supplement level. Vitamin A deficiency (control) significantly decreased the mRNA expression levels of MUC2, IgA, EGFR, IL-13 and TGF-beta in trachea tissue. Histological section analysis revealed that the number of goblet cells in the tracheal epithelium was less in the 0 and 12,000 IU/kg vitamin A supplement groups than in the other groups. In conclusion, vitamin A deficiency suppressed the immunity of the airway by decreasing the IgA and mucin concentrations in neonatal chicks. This study suggested that a suitable level of vitamin A is essential for the secretion of IgA and mucin in the respiratory tract by regulating the gene expression of cytokines and epithelial growth factors.	[Fan, Xiaoxiao; Liu, Shaoqiong; Liu, Guanhua; Zhao, Jingpeng; Jiao, Hongchao; Wang, Xiaojuan; Song, Zhigang; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Shandong Key Lab Anim Biotechnol & Dis Control, Tai An 271018, Shandong, Peoples R China	Shandong Agricultural University	Song, ZG (corresponding author), Shandong Agr Univ, Dept Anim Sci, Shandong Key Lab Anim Biotechnol & Dis Control, Tai An 271018, Shandong, Peoples R China.	173425201@qq.com; hailin@sdau.edu.cn		Song, Zhigang/0000-0003-1525-5797	Natural Science Foundation of China [31272467, 31472114]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of China (31272467, 31472114). The funders had no role in study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2007, LARYNGOSCOPE, V117, P932, DOI 10.1097/MLG.0b013e3180383651; Amit-Romach E, 2009, J NUTR BIOCHEM, V20, P70, DOI 10.1016/j.jnutbio.2008.01.002; AYDELOTTE MB, 1963, J EMBRYOL EXP MORPH, V11, P279; Bar-Shira E, 2014, DEV COMP IMMUNOL, V44, P186, DOI 10.1016/j.dci.2013.12.010; Bellussi L, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-46; Beum PV, 2005, AM J PHYSIOL-LUNG C, V288, pL116, DOI 10.1152/ajplung.00370.2003; Bogdan S, 2001, CURR BIOL, V11, pR292, DOI 10.1016/S0960-9822(01)00167-1; Borsutzky S, 2004, J IMMUNOL, V173, P3305, DOI 10.4049/jimmunol.173.5.3305; Bossenbroek NM, 1998, CURR EYE RES, V17, P462, DOI 10.1076/ceyr.17.5.462.5189; CARPENTER G, 1985, J CELL SCI, P1; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Chew BP, 2004, J NUTR, V134, p257S, DOI 10.1093/jn/134.1.257S; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cui DM, 2000, J NUTR, V130, P1132, DOI 10.1093/jn/130.5.1132; DAVIS CY, 1983, J NUTR, V113, P1914, DOI 10.1093/jn/113.10.1914; DAVIS CY, 1989, POULTRY SCI, V68, P136, DOI 10.3382/ps.0680136; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; FRIEDMAN A, 1989, BRIT J NUTR, V62, P439, DOI 10.1079/BJN19890044; FRIEDMAN A, 1989, J NUTR, V119, P790, DOI 10.1093/jn/119.5.790; FRIEDMAN A, 1991, J NUTR, V121, P395, DOI 10.1093/jn/121.3.395; FUCHS E, 1981, CELL, V25, P617, DOI 10.1016/0092-8674(81)90169-0; Gangopadhyay IH, 1996, J NUTR, V126, P2960, DOI 10.1093/jn/126.12.2960; Gray T, 2001, TOXICOLOGY, V160, P35, DOI 10.1016/S0300-483X(00)00455-8; Guzman K, 1996, AM J PHYSIOL-LUNG C, V270, pL846, DOI 10.1152/ajplung.1996.270.5.L846; Guzman K, 1995, BIOCHEM BIOPH RES CO, V217, P412, DOI 10.1006/bbrc.1995.2792; Guzman K, 1996, AM J PHYSIOL-LUNG C, V271, pL1023, DOI 10.1152/ajplung.1996.271.6.L1023; Hall JA, 2011, IMMUNITY, V35, P13, DOI 10.1016/j.immuni.2011.07.002; Hall JA, 2011, IMMUNITY, V34, P435, DOI 10.1016/j.immuni.2011.03.003; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; JETTEN AM, 1986, BIOCHEM SOC T, V14, P930, DOI 10.1042/bst0140930; Kallapura G, 2014, POULTRY SCI, V93, P340, DOI 10.3382/ps.2013-03602; Kim KC, 1997, EUR RESPIR J, V10, P2644, DOI 10.1183/09031936.97.10112644; Kim SJ, 2008, TUBERC RESPIR DIS, V64, P347, DOI 10.4046/trd.2008.64.5.347; Kim SW, 2007, MOL CELL BIOL, V27, P6933, DOI 10.1128/MCB.02385-06; Koo JS, 2002, EXP LUNG RES, V28, P315, DOI 10.1080/01902140252964393; Koo JS, 1999, BIOCHEM J, V338, P351, DOI 10.1042/0264-6021:3380351; Lang TG, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-197; LEUTSKAYA ZK, 1977, BIOCHIM BIOPHYS ACTA, V475, P207, DOI 10.1016/0005-2787(77)90012-0; Levine S.J., 1995, CELL MOL BIOL, V12, P196; Liu X, 2014, NUTRITION, V30, P350, DOI 10.1016/j.nut.2013.09.008; MANNA B, 1994, BIOCHEM J, V297, P309, DOI 10.1042/bj2970309; Mantis NJ, 2011, MUCOSAL IMMUNOL, V4, P603, DOI 10.1038/mi.2011.41; Massacand JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002588; Miller LA, 1996, J CLIN INVEST, V97, P1429, DOI 10.1172/JCI118564; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2009, SEMIN IMMUNOL, V21, P28, DOI 10.1016/j.smim.2008.08.002; Moreira A, 2014, J STRENGTH COND RES, V28, P467, DOI 10.1519/JSC.0b013e31829b5512; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Nikawa T, 1999, J NUTR, V129, P934, DOI 10.1093/jn/129.5.934; PECK GL, 1977, J INVEST DERMATOL, V69, P463, DOI 10.1111/1523-1747.ep12511354; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pino-Lagos K, 2011, J EXP MED, V208, P1767, DOI 10.1084/jem.20102358; REARICK JI, 1987, BIOCHEM J, V242, P19, DOI 10.1042/bj2420019; Renegar KB, 2001, J IMMUNOL, V166, P819, DOI 10.4049/jimmunol.166.2.819; Rose MC, 2001, AM J RESP CELL MOL, V25, P533, DOI 10.1165/ajrcmb.25.5.f218; Ross AC, 2011, VITAM HORM, V86, P103, DOI 10.1016/B978-0-12-386960-9.00005-8; Ruhl R, 2007, P NUTR SOC, V66, P458, DOI 10.1017/S002966510600509X; Shahzeidi S, 2003, EXP LUNG RES, V29, P549, DOI 10.1080/01902140390240159; Stephensen CB, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.5.e3; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Tan SH, 2007, AM J RESP CELL MOL, V36, P737, DOI 10.1165/rcmb.2006-0334OC; Tei M, 2000, INVEST OPHTH VIS SCI, V41, P82; TOKUYAMA H, 1993, CELL IMMUNOL, V150, P353, DOI 10.1006/cimm.1993.1203; TSENG SCG, 1987, INVEST OPHTH VIS SCI, V28, P538; Uni Z, 2000, BRIT POULTRY SCI, V41, P410, DOI 10.1080/713654958; Wang CW, 2013, J EXP MED, V210, P475, DOI 10.1084/jem.20121088; Wang XJ, 2013, J LIPID RES, V54, P1860, DOI 10.1194/jlr.M036301; Wei D, 2007, J CLIN IMMUNOL, V27, P88, DOI 10.1007/s10875-006-9059-6; WU R, 1985, J CELL PHYSIOL, V125, P167, DOI 10.1002/jcp.1041250202; Zaiger G, 2004, EUR J NUTR, V43, P259, DOI 10.1007/s00394-004-0466-2; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	72	22	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139131	10.1371/journal.pone.0139131	http://dx.doi.org/10.1371/journal.pone.0139131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422233	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700072
J	Tewawong, N; Prachayangprecha, S; Vichiwattana, P; Korkong, S; Klinfueng, S; Vongpunsawad, S; Thongmee, T; Theamboonlers, A; Poovorawan, Y				Tewawong, Nipaporn; Prachayangprecha, Slinporn; Vichiwattana, Preeyaporn; Korkong, Sumeth; Klinfueng, Sirapa; Vongpunsawad, Sompong; Thongmee, Thanunrat; Theamboonlers, Apiradee; Poovorawan, Yong			Assessing Antigenic Drift of Seasonal Influenza A(H3N2) and A(H1N1)pdm09 Viruses	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; GENETIC DRIFT; A VIRUSES; HEMAGGLUTININ; EVOLUTION; VACCINE; SITES; SELECTION; ADULTS; H1N1	Under selective pressure from the host immune system, antigenic epitopes of influenza virus hemagglutinin (HA) have continually evolved to escape antibody recognition, termed antigenic drift. We analyzed the genomes of influenza A(H3N2) and A(H1N1) pdm09 virus strains circulating in Thailand between 2010 and 2014 and assessed how well the yearly vaccine strains recommended for the southern hemisphere matched them. We amplified and sequenced the HA gene of 120 A(H3N2) and 81 A(H1N1) pdm09 influenza virus samples obtained from respiratory specimens and calculated the perfect-match vaccine efficacy using the p(epitope) model, which quantitated the antigenic drift in the dominant epitope of HA. Phylogenetic analysis of the A(H3N2) HA1 genes classified most strains into genetic clades 1, 3A, 3B, and 3C. The A(H3N2) strains from the 2013 and 2014 seasons showed very low to moderate vaccine efficacy and demonstrated antigenic drift from epitopes C and A to epitope B. Meanwhile, most A(H1N1) pdm09 strains from the 2012-2014 seasons belonged to genetic clades 6A, 6B, and 6C and displayed the dominant epitope mutations at epitopes B and E. Finally, the vaccine efficacy for A(H1N1) pdm09 (79.6-93.4%) was generally higher than that of A(H3N2). These findings further confirmed the accelerating antigenic drift of the circulating influenza A(H3N2) in recent years.	[Tewawong, Nipaporn; Prachayangprecha, Slinporn; Vichiwattana, Preeyaporn; Korkong, Sumeth; Klinfueng, Sirapa; Vongpunsawad, Sompong; Thongmee, Thanunrat; Theamboonlers, Apiradee; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand	Chulalongkorn University	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728; Poovorawan, Yong/0000-0002-2337-6807; Tewawong, Nipaporn/0000-0003-1098-3701	National Research University Project, Office of Higher Education Commission [WCU001-HR-57, WCU007-HR-57, WCU-58-006-HR]; National Research Council of Thailand (NRCT); Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Thailand Research Fund [DPG5480002]; Siam Cement Group; MK Restaurant Company Limited; 100th anniversary Chulalongkorn University Fund; Research Chair Grant from the National Science and Technology Development Agency	National Research University Project, Office of Higher Education Commission; National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Thailand Research Fund(Thailand Research Fund (TRF)); Siam Cement Group; MK Restaurant Company Limited; 100th anniversary Chulalongkorn University Fund; Research Chair Grant from the National Science and Technology Development Agency	This work was supported by The National Research University Project, Office of Higher Education Commission (WCU001-HR-57, WCU007-HR-57, and WCU-58-006-HR), The National Research Council of Thailand (NRCT), The Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), The Outstanding Professor of Thailand Research Fund (DPG5480002), Siam Cement Group, and MK Restaurant Company Limited. The authors thank the 100th anniversary Chulalongkorn University Fund for doctoral scholarship awarded to Nipaporn Tewawong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bragstad K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-40; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dawood FS, 2014, INFLUENZA OTHER RESP, V8, P463, DOI 10.1111/irv.12233; de Jong JC, 2000, J INFECTION, V40, P218, DOI 10.1053/jinf.2000.0652; Deem MW, 2009, PROTEIN ENG DES SEL, V22, P543, DOI 10.1093/protein/gzp027; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Eick-Cost AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041435; Eshaghi A, 2014, INFLUENZA OTHER RESP, V8, P250, DOI 10.1111/irv.12219; Falchi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024471; Fantoni A, 2014, J MED VIROL, V86, P585, DOI 10.1002/jmv.23745; Flannery B, 2015, MMWR-MORBID MORTAL W, V64, P10; Gupta R., 2004, RESEARCHGATE; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Huang JW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S31; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kittikraisak W, 2015, INFLUENZA OTHER RESP, V9, P85, DOI 10.1111/irv.12302; Klein EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093632; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; KRYSTAL M, 1982, P NATL ACAD SCI-BIOL, V79, P4800, DOI 10.1073/pnas.79.15.4800; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Macken C, 2001, INT CONGR SER, V1219, P103, DOI 10.1016/S0531-5131(01)00330-2; Melidou A, 2015, J MED VIROL, V87, P57, DOI 10.1002/jmv.23990; Nakajima K, 2005, J VIROL, V79, P6472, DOI 10.1128/JVI.79.10.6472-6477.2005; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Pan K, 2011, PROTEIN ENG DES SEL, V24, P291, DOI 10.1093/protein/gzq105; Pariani E, 2013, INFECT GENET EVOL, V13, P252, DOI 10.1016/j.meegid.2012.10.019; Prachayangprecha S, 2013, J INFECT DEV COUNTR, V7, P734, DOI 10.3855/jidc.2929; Rondy M, 2015, EURO SURVEILL, V20; Shao TJ, 2014, INT J INFECT DIS, V29, P190, DOI 10.1016/j.ijid.2014.09.013; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Sun SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032119; Suwannakarn K, 2008, J VIROL METHODS, V152, P25, DOI 10.1016/j.jviromet.2008.06.002; Suzuki Y, 2011, GENES GENET SYST, V86, P287, DOI 10.1266/ggs.86.287; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Widgren K, 2013, EUROSURVEILLANCE, V18, P37; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513	46	37	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139958	10.1371/journal.pone.0139958	http://dx.doi.org/10.1371/journal.pone.0139958			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440103	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300086
J	Van 't Hof, FNG; Ruigrok, YM; Medic, J; Sanjabi, B; van der Vlies, P; Rinkel, GJE; Veldink, JH				van 't Hof, Femke N. G.; Ruigrok, Ynte M.; Medic, Jelena; Sanjabi, Bahram; van der Vlies, Pieter; Rinkel, Gabriel J. E.; Veldink, Jan H.			Whole Blood Gene Expression Profiles of Patients with a Past Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							GRAPH-THEORETICAL ANALYSIS; INTRACRANIAL ANEURYSMS; PERIPHERAL-BLOOD; AORTIC-ANEURYSM; BRAIN NETWORKS; RISK-FACTORS; LONG-TERM; IDENTIFICATION; METAANALYSIS; BIOMARKERS	Background The pathogenesis of development and rupture of intracranial aneurysms (IA) is largely unknown. Also, screening for IA to prevent aneurysmal subarachnoid hemorrhage (aSAH) is inefficient, as disease markers are lacking. We investigated gene expression profiles in blood of previous aSAH patients, who are still at risk for future IA, aiming to gain insight into the pathogenesis of IA and aSAH, and to make a first step towards improvement of aSAH risk prediction. Methods and Results We collected peripheral blood of 119 patients with aSAH at least two years prior, and 118 controls. We determined gene expression profiles using Illumina HumanHT-12v4 Bead-Chips. After quality control, we divided the dataset in a discovery (2/3) and replication set (1/ 3), identified differentially expressed genes, and applied (co-) differential co-expression to identify disease-related gene networks. No genes with a significant (false-discovery rate <5%) differential expression were observed. We detected one gene network with significant differential co-expression, but did not find biologically meaningful gene networks related to a history of aSAH. Next, we applied prediction analysis of microarrays to find a gene set that optimally predicts absence or presence of a history of aSAH. We found no gene sets with a correct disease state prediction higher than 40%. Conclusions No gene expression differences were present in blood of previous aSAH patients compared to controls, besides one differentially co-expressed gene network without a clear relevant biological function. Our findings suggest that gene expression profiles, as detected in blood of previous aSAH patients, do not reveal the pathogenesis of IA and aSAH, and cannot be used for aSAH risk prediction.	[van 't Hof, Femke N. G.; Ruigrok, Ynte M.; Medic, Jelena; Rinkel, Gabriel J. E.; Veldink, Jan H.] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Sanjabi, Bahram; van der Vlies, Pieter] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; University of Groningen	Van 't Hof, FNG (corresponding author), Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	f.vanthof@umcutrecht.nl						Aoki T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/535921; Aziz Hamza, 2007, Genomic Med, V1, P105, DOI 10.1007/s11568-008-9017-x; Bilguvar K, 2008, NAT GENET, V40, P1472, DOI 10.1038/ng.240; Bor ASE, 2010, NEUROLOGY, V74, P1671, DOI 10.1212/WNL.0b013e3181e04297; Bor ASE, 2014, LANCET NEUROL, V13, P385, DOI 10.1016/S1474-4422(14)70021-3; BROMBERG JEC, 1995, BRIT MED J, V311, P288, DOI 10.1136/bmj.311.7000.288; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Choi Y, 2009, BIOINFORMATICS, V25, P2780, DOI 10.1093/bioinformatics/btp502; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Giusti B, 2009, EUR J VASC ENDOVASC, V38, P104, DOI 10.1016/j.ejvs.2009.01.020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Juvela S, 2001, STROKE, V32, P485, DOI 10.1161/01.STR.32.2.485; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korja M, 2010, STROKE, V41, P2458, DOI 10.1161/STROKEAHA.110.586420; Kurki MI, 2011, NEUROSURGERY, V68, P1667, DOI 10.1227/NEU.0b013e318210f001; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Pera J, 2013, J CEREBR BLOOD F MET, V33, P1025, DOI 10.1038/jcbfm.2013.37; R Core Team, 2012, R LANG ENV STAT COMP; Raaymakers TWM, 1999, NEUROLOGY, V53, P982, DOI 10.1212/WNL.53.5.982; Roder C, 2012, NEUROSCIENCE, V201, P105, DOI 10.1016/j.neuroscience.2011.10.033; Sabatino G, 2013, J BIOL REG HOMEOS AG, V27, P729; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stamova B, 2010, STROKE, V41, P2171, DOI 10.1161/STROKEAHA.110.588335; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomaszewski M, 2010, HYPERTENSION, V56, P1069, DOI 10.1161/HYPERTENSIONAHA.110.155721; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wang Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001050; Wermer MJH, 2005, BRAIN, V128, P2421, DOI 10.1093/brain/awh587; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Zhan X, 2011, NEUROLOGY, V77, P1718, DOI 10.1212/WNL.0b013e318236eee6	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139352	10.1371/journal.pone.0139352	http://dx.doi.org/10.1371/journal.pone.0139352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439625	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300025
J	Lee, CL; Lin, YS; Chen, YC				Lee, Chun-Liang; Lin, Yi-Shan; Chen, Yaw-Chung			A Hybrid CPU/GPU Pattern-Matching Algorithm for Deep Packet Inspection	PLOS ONE			English	Article							NETWORK INTRUSION DETECTION	The large quantities of data now being transferred via high-speed networks have made deep packet inspection indispensable for security purposes. Scalable and low-cost signature-based network intrusion detection systems have been developed for deep packet inspection for various software platforms. Traditional approaches that only involve central processing units (CPUs) are now considered inadequate in terms of inspection speed. Graphic processing units (GPUs) have superior parallel processing power, but transmission bottlenecks can reduce optimal GPU efficiency. In this paper we describe our proposal for a hybrid CPU/GPU pattern-matching algorithm (HPMA) that divides and distributes the packet-inspecting workload between a CPU and GPU. All packets are initially inspected by the CPU and filtered using a simple pre-filtering algorithm, and packets that might contain malicious content are sent to the GPU for further inspection. Test results indicate that in terms of random payload traffic, the matching speed of our proposed algorithm was 3.4 times and 2.7 times faster than those of the AC-CPU and AC-GPU algorithms, respectively. Further, HPMA achieved higher energy efficiency than the other tested algorithms.	[Lee, Chun-Liang] Chang Gung Univ, Sch Elect & Comp Engn, Dept Comp Sci & Informat Engn, Coll Engn, Taoyuan, Taiwan; [Lin, Yi-Shan; Chen, Yaw-Chung] Natl Chiao Tung Univ, Dept Comp Sci, Hsinchu, Taiwan	Chang Gung University; National Yang Ming Chiao Tung University	Lee, CL (corresponding author), 259 Wen Hwa 1st Rd, Taoyuan 33302, Taiwan.	cllee@mail.cgu.edu.tw			High Speed Intelligent Communication (HSIC) Research Center of Chang Gung University, Taiwan; Ministry of Science and Technology of Taiwan [MOST-101-2221-E-009-004-MY3, MOST-102-2221-E-182-034, MOST-104-2221-E-182-005]; Chang Gung Memorial Hospital [BMRP 942]	High Speed Intelligent Communication (HSIC) Research Center of Chang Gung University, Taiwan; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by the High Speed Intelligent Communication (HSIC) Research Center of Chang Gung University, Taiwan, and by grants from the Ministry of Science and Technology of Taiwan (MOST-101-2221-E-009-004-MY3, MOST-102-2221-E-182-034, and MOST-104-2221-E-182-005) and Chang Gung Memorial Hospital (BMRP 942). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855; Anagnostakis KG, 2003, INT FED INFO PROC, V122, P217; [Anonymous], INT INTR GUID; Antonatos S., 2004, Software Engineering Notes, V29, P207, DOI 10.1145/974043.974078; Bacon DF, 2013, COMMUN ACM, V56, P56, DOI 10.1145/2436256.2436271; Baker Zachary K., 2004, P 2004 ACM SIGDA 12, P223, DOI 10.1145/968280.968312; Beghdad R, 2008, COMPUT SECUR, V27, P168, DOI 10.1016/j.cose.2008.06.001; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; Cabrera JBD, 2004, IEEE DECIS CONTR P, P75, DOI 10.1109/CDC.2004.1428609; Clark CR, 2003, LECT NOTES COMPUT SC, V2778, P956; Clark CR, 2005, P WORKSH NETW PROC A, P136; Fatahalian K, 2008, COMMUN ACM, V51, P50, DOI 10.1145/1400181.1400197; Fog A., 2012, INSTRUCTION TABLES; Handley M, 2001, USENIX ASSOCIATION PROCEEDINGS OF THE 10TH USENIX SECURITY SYMPOSIUM, P115; Huang NF, 2008, 2008 22ND INTERNATIONAL WORKSHOPS ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOLS 1-3, P62, DOI 10.1109/WAINA.2008.145; Intel Corporation, 2007, INTEL SSE4 PROGRAM R; Jacob N, 2006, ANN COMPUT SECURITY, P371, DOI 10.1109/ACSAC.2006.35; Knuth D. E., 1977, SIAM J COMPUT, V6, P127, DOI DOI 10.1137/0206024; Kruegel C, 2002, P IEEE S SECUR PRIV, P285, DOI 10.1109/SECPRI.2002.1004378; Lee J, 2007, APPLIED COMPUTING 2007, VOL 1 AND 2, P1187; Liu R.-T., 2004, ACM T EMBED COMPUT S, V3, P614; Meiners C. R., 2010, P 19 USENIX C SEC, P8; Mitra A., 2007, P 3 ACM IEEE S ARCH, P127; Nickolls John, 2008, ACM Queue, V6, DOI 10.1145/1365490.1365500; Nvidia Corporation, 2009, NVIDIA CUDA ARCH INT; Nvidia Corporation, 2015, NVIDIA CUDA C PROGR; Paxson V, 1999, COMPUT NETW, V31, P2435, DOI 10.1016/S1389-1286(99)00112-7; Scarpazza D. P., 2008, P 5 C COMP FRONT, P33; Schuff DL, 2008, INT SYM PERFORM ANAL, P32, DOI 10.1109/ISPASS.2008.4510736; Sourdis I, 2004, ANN IEEE SYM FIELD P, P258, DOI 10.1109/FCCM.2004.46; Tian DX, 2009, INT J INF SECUR, V8, P25, DOI 10.1007/s10207-008-0061-2; Vallentin M, 2007, LECT NOTES COMPUT SC, V4637, P107; Vasiliadis G, 2008, LECT NOTES COMPUT SC, V5230, P116, DOI 10.1007/978-3-540-87403-4_7; Vasiliadis G, 2011, PROCEEDINGS OF THE 18TH ACM CONFERENCE ON COMPUTER & COMMUNICATIONS SECURITY (CCS 11), P297; Wu CK, 2009, COMM COM INF SC, V58, P298; Wu JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120976; Wu S, 1994, TR9417	37	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139301	10.1371/journal.pone.0139301	http://dx.doi.org/10.1371/journal.pone.0139301			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437335	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200015
J	Rebolledo, RA; Van Erp, AC; Ottens, PJ; Wiersema-Buist, J; Leuvenink, HGD; Romanque, P				Rebolledo, Rolando A.; Van Erp, Anne C.; Ottens, Petra J.; Wiersema-Buist, Janneke; Leuvenink, Henri G. D.; Romanque, Pamela			Anti-Apoptotic Effects of 3,3 ',5-Triiodo-L-Thyronine in the Liver of Brain-Dead Rats	PLOS ONE			English	Article							POTENTIAL ORGAN DONORS; THYROID-HORMONE THERAPY; ISCHEMIA-REPERFUSION; PARTIAL-HEPATECTOMY; CLINICAL-TRIALS; KI-67 PROTEIN; MANAGEMENT; INJURY; TRANSPLANTATION; RESPONSES	Background Thyroid hormone treatment in brain-dead organ donors has been extensively studied and applied in the clinical setting. However, its clinical applicability remains controversial due to a varying degree of success and a lack of mechanistic understanding about the therapeutic effects of 3,3',5-Triiodo-L-thyronine (T-3). T-3 pre-conditioning leads to anti-apoptotic and pro-mitotic effects in liver tissue following ischemia/reperfusion injury. Therefore, we aimed to study the effects of T-3 pre-conditioning in the liver of brain-dead rats. Methods Brain death (BD) was induced in mechanically ventilated rats by inflation of a Fogarty catheter in the epidural space. T-3 (0.1 mg/kg) or vehicle was administered intraperitoneally 2 h prior to BD induction. After 4 h of BD, serum and liver tissue were collected. RT-qPCR, routine biochemistry, and immunohistochemistry were performed. Results Brain-dead animals treated with T-3 had lower plasma levels of AST and ALT, reduced Bax gene expression, and less hepatic cleaved Caspase-3 activation compared to brain-dead animals treated with vehicle. Interestingly, no differences in the expression of inflammatory genes (IL-6, MCP-1, IL-1 beta) or the presence of pro-mitotic markers (Cyclin-D and Ki-67) were found in brain-dead animals treated with T-3 compared to vehicle-treated animals. Conclusion T-3 pre-conditioning leads to beneficial effects in the liver of brain-dead rats as seen by lower cellular injury and reduced apoptosis, and supports the suggested role of T-3 hormone therapy in the management of brain-dead donors.	[Rebolledo, Rolando A.; Van Erp, Anne C.; Ottens, Petra J.; Wiersema-Buist, Janneke; Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands; [Rebolledo, Rolando A.; Romanque, Pamela] Univ Chile, Inst Biomed Sci, Physiopathol Program, Fac Med, Santiago, Chile	University of Groningen; Universidad de Chile	Leuvenink, HGD (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands.	h.g.d.leuvenink@umcg.nl		Rebolledo, Rolando/0000-0003-3501-4042; Leuvenink, Henri/0000-0001-5036-2999	Department of Surgery, UMCG, Groningen	Department of Surgery, UMCG, Groningen	Funding for the project was provided by the Department of Surgery, UMCG, Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrie C, 2010, SHOCK, V33, P353, DOI 10.1097/SHK.0b013e3181b65b99; Alisi A, 2005, CELL PHYSIOL BIOCHEM, V15, P69, DOI 10.1159/000083639; Belzberg H, 2007, J TRAUMA, V63, P1032, DOI 10.1097/01.ta.0000235995.86162.d2; Bockhorn M, 2007, EUR SURG RES, V39, P58, DOI 10.1159/000098443; Bonser Ranasinghe, 2011, BEST PRACTICE RES CL, V25, P14; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Bungay A, 2008, J GASTROEN HEPATOL, V23, P1926, DOI 10.1111/j.1440-1746.2008.05506.x; Callahan DS, 2014, J AM COLL SURGEONS, V219, P752, DOI 10.1016/j.jamcollsurg.2014.04.017; Cecka J M, 1995, Clin Transpl, P1; Cooper DKC, 2009, FRONT BIOSCI-LANDMRK, V14, P3750, DOI [10.2741/3486, 10.2735/3486]; Dare AJ, 2012, CURR NEUROL NEUROSCI, V12, P456, DOI 10.1007/s11910-012-0272-9; Dikdan GS, 2012, TRANSPLANTATION, V94, P425, DOI 10.1097/TP.0b013e3182547537; Fernandez V, 2007, BIOL CHEM, V388, P831, DOI 10.1515/BC.2007.101; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Ferreyra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074960; Fitzgerald RD, 1996, TRANSPLANT INT, V9, P102, DOI 10.1007/BF00336386; Fugate JE, 2011, NEUROLOGY, V77, P399, DOI 10.1212/WNL.0b013e3182270444; HOWLETT TA, 1989, TRANSPLANTATION, V47, P828, DOI 10.1097/00007890-198905000-00016; Huang J, 2014, TRANSPLANTATION, V98, P721, DOI 10.1097/TP.0000000000000316; Jassem W, 2003, TRANSPLANTATION, V75, P2001, DOI 10.1097/01.TP.0000061605.30685.03; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P1301, DOI 10.1097/TA.0000000000000184; Kolkert JLP, 2007, LAB ANIM-UK, V41, P363, DOI 10.1258/002367707781282848; Lam L, 2012, AM SURGEON, V78, P318; Macdonald PS, 2012, CRIT CARE MED, V40, P1635, DOI 10.1097/CCM.0b013e3182416ee7; Mascia L, 2006, CRIT CARE MED, V34, P321, DOI 10.1097/01.CCM.0000196828.87358.6E; MASSON F, 1990, TRANSPLANT INT, V3, P226, DOI 10.1007/BF00366971; McKeown DW, 2012, BRIT J ANAESTH, V108, pI96, DOI 10.1093/bja/aer351; Mi ZB, 2015, CLIN EPIDEMIOL, V7, P17, DOI 10.2147/CLEP.S71403; Morse D, 2005, AM J RESP CRIT CARE, V172, P660, DOI 10.1164/rccm.200404-465SO; Murugan R, 2008, CRIT CARE MED, V36, P1810, DOI 10.1097/CCM.0b013e318174d89f; Nijboer WN, 2005, TRANSPLANT P, V37, P367, DOI 10.1016/j.transproceed.2004.12.262; Novitzky D, 2014, TRANSPLANTATION, V98, P1119, DOI 10.1097/TP.0000000000000187; Novitzky D, 2006, TRANSPLANTATION, V82, P1396, DOI 10.1097/01.tp.0000237195.12342.f1; Pantos C, 2009, BASIC RES CARDIOL, V104, P69, DOI 10.1007/s00395-008-0758-4; Powner David J, 2005, Prog Transplant, V15, P202; Rech TH, 2013, TRANSPLANTATION, V95, P966, DOI 10.1097/TP.0b013e318283298e; Romanque P, 2011, THYROID, V21, P655, DOI 10.1089/thy.2010.0322; Salim A, 2001, ARCH SURG-CHICAGO, V136, P1377, DOI 10.1001/archsurg.136.12.1377; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Taki-Eldin A, 2012, J SURG RES, V178, P646, DOI 10.1016/j.jss.2012.05.069; Tapia G, 2006, FREE RADICAL BIO MED, V40, P1628, DOI 10.1016/j.freeradbiomed.2005.12.033; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; Venditti P, 2003, MOL CELL ENDOCRINOL, V205, P185, DOI 10.1016/S0303-7207(02)00332-5; Videla LA, 2015, EXPERT REV MOL MED, V17, DOI 10.1017/erm.2015.8; Videla LA, 2010, IUBMB LIFE, V62, P460, DOI 10.1002/iub.345; Weiss S, 2007, AM J TRANSPLANT, V7, P1584, DOI 10.1111/j.1600-6143.2007.01799.x; WETZEL RC, 1985, ANESTH ANALG, V64, P125; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103	48	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138749	10.1371/journal.pone.0138749	http://dx.doi.org/10.1371/journal.pone.0138749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437380	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200006
J	Lok, SI; de Jonge, N; van Kuik, J; van Geffen, AJP; Huibers, MMH; van der Weide, P; Siera, E; Winkens, B; Doevendans, PA; de Weger, RA; Martins, PAD				Lok, Sjoukje I.; de Jonge, Nicolaas; van Kuik, Joyce; van Geffen, Ankie J. P.; Huibers, Manon M. H.; van der Weide, Petra; Siera, Erica; Winkens, Bjorn; Doevendans, Pieter A.; de Weger, Roel A.; Martins, Paula A. da Costa			MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices	PLOS ONE			English	Article							VENTRICULAR ASSIST DEVICE; CONTINUOUS-FLOW; CARDIAC-HYPERTROPHY; SIGNATURE; RECOVERY; RNA; REVERSAL; BRIDGE; PLAY	Aim Pulsatile flow left ventricular assist devices (pf-LVADs) are being replaced by continuous flow LVADs (cf-LVADs) in patients with end-stage heart failure (HF). MicroRNAs (miRs) play an important role in the onset and progression of HF. Our aim was to analyze cardiac miR expression patterns associated with each type of device, to analyze differences in the regulation of the induced cardiac changes. Methods and Results Twenty-six miRs were selected (based on micro-array data and literature studies) and validated in myocardial tissue before and after pf- (n = 17) and cf-LVAD (n = 17) support. Of these, 5 miRs displayed a similar expression pattern among the devices (miR-129*, miR-146a, miR-155, miR-221, miR-222), whereas others only changed significantly during pf-LVAD (miR-let-7i, miR-21, miR-378, miR-378*) or cf-LVAD support (miR-137). In addition, 4 miRs were investigated in plasma of cf-LVAD supported patients (n = 18) and healthy controls (n = 10). Circulating miR-21 decreased at 1, 3, and 6 months after LVAD implantation. MiR-146a, miR-221 and miR-222 showed a fluctuating time pattern post-LVAD. Conclusion Our data show a different miR expression pattern after LVAD support, suggesting that differentially expressed miRs are partially responsible for the cardiac morphological and functional changes observed after support. However, the miR expression patterns do not seem to significantly differ between pf- and cf-LVAD implying that most cardiac changes or clinical outcomes specific to each device do not relate to differences in miR expression levels.	[Lok, Sjoukje I.; de Jonge, Nicolaas; Doevendans, Pieter A.] Univ Med Ctr, Dept Cardiol, Utrecht, Netherlands; [Lok, Sjoukje I.; van Kuik, Joyce; van Geffen, Ankie J. P.; Huibers, Manon M. H.; van der Weide, Petra; Siera, Erica; de Weger, Roel A.] Univ Med Ctr, Dept Pathol, Utrecht, Netherlands; [Winkens, Bjorn] Maastricht Univ, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands; [Martins, Paula A. da Costa] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University	Martins, PAD (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands.	p.dacostamartins@maastrichtuniversity.nl		Winkens, Bjorn/0000-0002-6747-6228				Akat KM, 2014, P NATL ACAD SCI USA, V111, P11151, DOI 10.1073/pnas.1401724111; Ambardekar AV, 2011, CIRC-HEART FAIL, V4, P224, DOI 10.1161/CIRCHEARTFAILURE.110.959684; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartoli CR, 2010, ASAIO J, V56, P410, DOI 10.1097/MAT.0b013e3181e7bf3c; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; Bruggink AH, 2006, J HEART LUNG TRANSPL, V25, P1091, DOI 10.1016/j.healun.2006.05.011; Chaudhary KW, 2004, J AM COLL CARDIOL, V44, P837, DOI 10.1016/j.jacc.2004.05.049; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; da Costa Martins PA, 2010, NAT CELL BIOL, V12, P1220, DOI [10.1038/ncb2126., DOI 10.1038/NCB2126]; de Jonge N, 2003, J HEART LUNG TRANSPL, V22, P1028, DOI 10.1016/S1053-2498(02)01160-9; de Jonge N, 2002, J AM COLL CARDIOL, V39, P963, DOI 10.1016/S0735-1097(02)01713-8; Dorn GW, 2008, CIRCULATION, V118, P216, DOI 10.1161/CIRCULATIONAHA.108.789933; Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Ganesan J, 2013, CIRCULATION, V127, P2097, DOI 10.1161/CIRCULATIONAHA.112.000882; Garatti A, 2008, EUR J CARDIO-THORAC, V34, P275, DOI 10.1016/j.ejcts.2008.02.019; Haft J, 2007, CIRCULATION, V116, pI8, DOI 10.1161/CIRCULATIONAHA.106.677898; Hall JL, 2011, J AM COLL CARDIOL, V57, P641, DOI 10.1016/j.jacc.2010.11.010; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Klotz S, 2005, CIRCULATION, V112, P364, DOI 10.1161/CIRCULATIONAHA.104.515106; Klotz S, 2004, ANN THORAC SURG, V77, P143, DOI 10.1016/S0003-4975(03)01336-5; Krabatsch T, 2011, ANN THORAC SURG, V91, P1335, DOI 10.1016/j.athoracsur.2011.01.027; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee SH, 1998, J THORAC CARDIOV SUR, V116, P344, DOI 10.1016/S0022-5223(98)70136-9; Leptidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057800; Lok SI, 2013, CIRC-HEART FAIL, V6, P853, DOI 10.1161/CIRCHEARTFAILURE.112.000255; Mann DL, 2011, J AM COLL CARDIOL, V58, P2279, DOI 10.1016/j.jacc.2011.09.007; Margulies KB, 2005, CIRC RES, V96, P592, DOI 10.1161/01.RES.0000159390.03503.c3; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Matkovich SJ, 2009, CIRCULATION, V119, P1263, DOI 10.1161/CIRCULATIONAHA.108.813576; Morley-Smith AC, 2014, EUR J HEART FAIL, V16, P871, DOI 10.1002/ejhf.116; Muller J, 1997, CIRCULATION, V96, P542; Nagalingam RS, 2013, J BIOL CHEM, V288, P11216, DOI 10.1074/jbc.M112.442384; Pruijsten RV, 2012, EUR J HEART FAIL, V14, P319, DOI 10.1093/eurjhf/hfr181; Ramani R, 2011, J AM COLL CARDIOL, V58, P2270, DOI 10.1016/j.jacc.2011.08.041; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schaffer JM, 2011, J HEART LUNG TRANSPL, V30, P164, DOI 10.1016/j.healun.2010.08.003; Schipper MEI, 2008, J HEART LUNG TRANSPL, V27, P1282, DOI 10.1016/j.healun.2008.09.005; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wohlschlaeger J, 2005, CARDIOVASC RES, V68, P376, DOI 10.1016/j.cardiores.2005.06.030; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Zhang QW, 2011, BIOCHEM BIOPH RES CO, V405, P42, DOI 10.1016/j.bbrc.2010.12.119	46	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0136404	10.1371/journal.pone.0136404	http://dx.doi.org/10.1371/journal.pone.0136404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430739	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700003
J	Nezarat, A; Dastghaibifard, GH				Nezarat, Amin; Dastghaibifard, G. H.			Efficient Nash Equilibrium Resource Allocation Based on Game Theory Mechanism in Cloud Computing by Using Auction	PLOS ONE			English	Article							MARKET; MANAGEMENT	One of the most complex issues in the cloud computing environment is the problem of resource allocation so that, on one hand, the cloud provider expects the most profitability and, on the other hand, users also expect to have the best resources at their disposal considering the budget constraints and time. In most previous work conducted, heuristic and evolutionary approaches have been used to solve this problem. Nevertheless, since the nature of this environment is based on economic methods, using such methods can decrease response time and reducing the complexity of the problem. In this paper, an auction-based method is proposed which determines the auction winner by applying game theory mechanism and holding a repetitive game with incomplete information in a non-cooperative environment. In this method, users calculate suitable price bid with their objective function during several round and repetitions and send it to the auctioneer; and the auctioneer chooses the winning player based the suggested utility function. In the proposed method, the end point of the game is the Nash equilibrium point where players are no longer inclined to alter their bid for that resource and the final bid also satisfies the auctioneer's utility function. To prove the response space convexity, the Lagrange method is used and the proposed model is simulated in the cloudsim and the results are compared with previous work. At the end, it is concluded that this method converges to a response in a shorter time, provides the lowest service level agreement violations and the most utility to the provider.	[Nezarat, Amin] Payame Noor Univ, Dept Comp Engn, Yazd, Iran; [Nezarat, Amin; Dastghaibifard, G. H.] Shiraz Univ, Dept Comp Engn, Shiraz, Iran	Payame Noor University; Shiraz University	Nezarat, A (corresponding author), Shiraz Univ, Dept Comp Sci, Shiraz, Fars, Iran.	aminnezarat@yazdpnu.ac.ir						Abdelzaher TF, 2002, IEEE T PARALL DISTR, V13, P80, DOI 10.1109/71.980028; Altmann J, 2008, P WORKSH GRID EC BUS; An B, 2007, P 20 INT JOINT C ART; Anselmi J, EUR J OPER RES; Ardagna D, 2013, IEEE T SERV COMPUT, V6, P429, DOI 10.1109/TSC.2012.14; Armbrust M., 2009, CLOUDS BERKELEY VIEW; Bredin J, 2003, AUTON AGENT MULTI-AG, V6, P235, DOI 10.1023/A:1022923422570; Buyya R, 2002, CONCURR COMP-PRACT E, V14, P1507, DOI 10.1002/cpe.690; Buyya R, 2010, P 10 INT C ALG ARCH; Calheiros R.N., 2009, 2009 INT C HIGH PERF, P1; Campos-Nanez E, 2007, IEEE T SYST MAN CY A, V37, P878, DOI 10.1109/TSMCA.2007.904822; Chen W, 2012, P 5 IEEE INT C CLOUD; Chohan N, 2010, P 2 USENIX WORKSH HO; Chun BN, 2002, P 2 IEEE ACM INT S C; Das A., 2005, P 19 INT PAR DISTR P; Dash RK, 2007, IEEE T SYST MAN CY A, V37, P391, DOI 10.1109/TSMCA.2007.893474; Ding S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107821; Ding S, 2015, CHAOS SOLITON FRACT, V71, P91, DOI 10.1016/j.chaos.2014.12.014; Ding S, 2014, APPL MATH COMPUT, V247, P941, DOI 10.1016/j.amc.2014.09.058; Ding S, 2014, KNOWL-BASED SYST, V56, P216, DOI 10.1016/j.knosys.2013.11.014; Fan QF, 2009, SENSORS-BASEL, V9, P7177, DOI 10.3390/s90907177; Feitelson D., PARALLEL WORKLOADS A; GAGLIANO RA, 1995, COMMUN ACM, V38, P88, DOI 10.1145/203241.203262; Galstyan A, 2003, P INT C AUT AG MULT; Garg SK, 2011, COOPERATIVE NETWORKING, P277; Garg SK, 2013, J PARALLEL DISTRIBUT; Ghosh R, 2012, P 5 IEEE INT C CLOUD; Gibbons Robert, 1992, PRIMER GAME THEORY; Gibney MA, 1999, P 3 INT WORKSH INT A; Gintis H, 2009, GAME THEORY EVOLVING: A PROBLEM-CENTERED INTRODUCTION TO MODELING STRATEGIC INTERACTION, SECOND EDITION, P1; Gomoluch J, 2003, P 1 INT WORKSH MIDDL; Grosu D., 2004, P 3 INT S PAR DISTR; Joita L, 2007, FUTURE GENER COMP SY, V23, P146, DOI 10.1016/j.future.2006.06.007; Kansal A., 2010, P 1 ACM S CLOUD COMP, P39; Kephart J, 2007, P IEEE INT C AUT COM; Khan S, 2006, PAR DISTR PROC S; Khanna G, 2006, P IEEE NETW OPS MGMT; Kusic D, 2008, INT C AUT COMP; Kusic D, 2006, INT C AUT COMP; Kwok YK, 2005, P INT S CLUST COMP G; Li A, 2010, P 2 USENIX WORKSH HO; Lin W-Y, 2010, P 2010 10 IEEE ACM I; Lynar Timothy M., 2009, WSEAS Transactions on Computers, V8, P1671; Maheswaran RT, 2003, GROUP DECIS NEGOT, V12, P361, DOI 10.1023/B:GRUP.0000003745.98183.8d; Meng X, 2010, P 7 INT C AUT COMP; Ozturan C., 2004, Scientific Programming, V12, P155; Pinheiro E, 2003, DYNAMIC CLUSTER RECO; Qin WB, 2007, IEEE T CONTR SYST T, V15, P259, DOI 10.1109/TCST.2006.886433; Quiroz A, 2009, P 10 IEEE ACM INT C; Raghavendra R, 2008, ACM SIGPLAN NOTICES, V43, P48, DOI 10.1145/1353536.1346289; Ranganathan P, 2006, P IEEE S COMP ARCH; Risch M, 2009, GRIDECON PLATFORM BU; Risch M, 2009, P WORKSH GRID EC BUS; Sandholm TW, 1999, MULTIAGENT SYSTEMS, P201; Sequeira S, 2013, INT J RES COMPUTER A, V1, P96; Stanoevska-Slabeva K, 2008, P INT WORKSH GRID EC; Steinder M, 2007, P IEEE S INT NETW MA; Stratford N, 1999, P 7 WORKSH HOT TOP O; Stuer G, 2007, FUTURE GENER COMP SY, V23, P688, DOI 10.1016/j.future.2006.11.004; SUTHERLAND IE, 1968, COMMUN ACM, V11, P449, DOI 10.1145/363347.363396; Teng F, 2010, P 5 INT C ADV GRID P; Nguyen TMH, 2009, J ALGORITHMS COMPUT, V3, P155, DOI 10.1260/174830109787186596; Van HN, 2009, P ICSE WORKSH SOFTW; Vecchiola C, 2012, FUTURE GENER COMP SY, V28, P58, DOI 10.1016/j.future.2011.05.008; Walker E, 2010, COMPUTER, V43, P44, DOI 10.1109/MC.2010.115; Wang H, 2010, P 2 USENIX WORKSH HO; Wei G, 2009, J SUPERCOMPUT, V54, P1; Wolski R, 2001, INT J HIGH PERFORM C, V15, P258, DOI 10.1177/109434200101500305; Wolski R, 2001, P INT PAR DISTR PROC; Zaman S, 2013, IEEE T CLOUD COMPUT, V1, P129, DOI 10.1109/TCC.2013.9	70	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138424	10.1371/journal.pone.0138424	http://dx.doi.org/10.1371/journal.pone.0138424			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431035	gold, Green Published			2022-12-27	WOS:000362178700012
J	Tam, JCW; Ko, CH; Koon, CM; Cheng, Z; Lok, WH; Lau, CP; Leung, PC; Fung, KP; Chan, WY; Lau, CBS				Tam, Jacqueline Chor Wing; Ko, Chun Hay; Koon, Chi Man; Cheng, Zhang; Lok, Wong Hing; Lau, Ching Po; Leung, Ping Chung; Fung, Kwok Pui; Chan, Wai Yee; Lau, Clara Bik San			Identification of Target Genes Involved in Wound Healing Angiogenesis of Endothelial Cells with the Treatment of a Chinese 2-Herb Formula	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; CHEMOKINE RECEPTOR; MATRIX METALLOPROTEINASE-8; NATRIURETIC PEPTIDE; REHMANNIAE RADIX; ASTRAGALI RADIX; HERBAL FORMULA; BREAST-CANCER; UP-REGULATION; IN-VITRO	Angiogenesis is vitally important in diabetic wound healing. We had previously demonstrated that a Chinese 2-herb formula (NF3) significantly stimulated angiogenesis of HUVEC in wound healing. However, the molecular mechanism has not yet been elucidated. In line with this, global expression profiling of NF3-treated HUVEC was performed so as to assess the regulatory role of NF3 involved in the underlying signaling pathways in wound healing angiogenesis. The microarray results illustrated that different panels of differentially expressed genes were strictly governed in NF3-treated HUVEC in a time-regulated manner. The microarray analysis followed by qRT-PCR and western blotting verification of NF3-treated HUVEC at 6 h revealed the involvement of various genes in diverse biological process, e.g., MAP3K14 in anti-inflammation; SLC5A8 in anti-tumorogenesis; DNAJB7 in protein translation; BIRC5, EPCAM, INSL4, MMP8 and NPR3 in cell proliferation; CXCR7, EPCAM, HAND1 and MMP8 in migration; CXCR7, EPCAM and MMP8 in tubular formation; and BIRC5, CXCR7, EPCAM, HAND1, MMP8 and UBD in angiogenesis. After 16 h incubation of NF3, other sets of genes were shown with differential expression in HUVEC, e.g., IL1RAPL2 and NR1H4 in anti-inflammation; miR28 in anti-tumorogenesis; GRIN1 and LCN1 in anti-oxidation; EPB41 in intracellular signal transduction; PRL and TFAP2A in cell proliferation; miR28, PRL and SCG2 in cell migration; PRL in tubular formation; and miR28, NR1H4 and PRL in angiogenesis. This study provided concrete scientific evidence in support of the regulatory role of NF3 on endothelial cells involved in wound healing angiogenesis.	[Tam, Jacqueline Chor Wing; Ko, Chun Hay; Koon, Chi Man; Cheng, Zhang; Lok, Wong Hing; Lau, Ching Po; Leung, Ping Chung; Fung, Kwok Pui; Lau, Clara Bik San] Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China; [Tam, Jacqueline Chor Wing; Ko, Chun Hay; Koon, Chi Man; Cheng, Zhang; Lok, Wong Hing; Lau, Ching Po; Leung, Ping Chung; Fung, Kwok Pui; Lau, Clara Bik San] Chinese Univ Hong Kong, State Key Lab Phytochem & Plant Resources West Ch, Shatin, Hong Kong, Peoples R China; [Fung, Kwok Pui; Chan, Wai Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Lau, CBS (corresponding author), Chinese Univ Hong Kong, Inst Chinese Med, Shatin, Hong Kong, Peoples R China.	claralau@cuhk.edu.hk	Chan, Wai Yee/R-7442-2018; Fung, Kwok Pui/R-9708-2018; Lau, Clara Bik-San/AAF-3989-2020	Chan, Wai Yee/0000-0002-9714-0936; Fung, Kwok Pui/0000-0001-6214-5123; Lau, Clara Bik-San/0000-0002-7409-1270	UGC Area of Excellence project "Chinese Medicine Research and Further Development" [AoE/B-10/01]	UGC Area of Excellence project "Chinese Medicine Research and Further Development"	This study is supported by a grant from UGC Area of Excellence project "Chinese Medicine Research and Further Development" (Project No. AoE/B-10/01). The authors would like to thank Dr. Cao Hui of the National Engineering Research Centre for Modernization of Traditional Chinese Medicine, Zhuhai, Guangdong, China for his technical help in TCM authentication.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Born TL, 2000, J BIOL CHEM, V275, P29946, DOI 10.1074/jbc.M004077200; Brizzi MF, 1999, CIRC RES, V84, P785; Castilla A, 2010, J VASC RES, V47, P45, DOI 10.1159/000231720; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Conway EM, 2003, AM J PATHOL, V163, P935, DOI 10.1016/S0002-9440(10)63453-0; Ding XF, 2013, INT J BIOCHEM CELL B, V45, P1647, DOI 10.1016/j.biocel.2013.04.024; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Fang CC, 2013, CARDIOVASC RES, V99, P146, DOI 10.1093/cvr/cvt060; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Kahler CM, 1996, EUR J PHARMACOL, V304, P135, DOI 10.1016/0014-2999(96)00135-5; Kahler CM, 1997, ARTERIOSCL THROM VAS, V17, P932, DOI 10.1161/01.ATV.17.5.932; Khambata RS, 2011, BRIT J PHARMACOL, V164, P584, DOI 10.1111/j.1476-5381.2011.01400.x; Ko CH, 2014, J DIABETES, V6, P323, DOI 10.1111/1753-0407.12117; Laurent A, 1998, MOL REPROD DEV, V51, P123, DOI 10.1002/(SICI)1098-2795(199810)51:2<123::AID-MRD1>3.0.CO;2-S; Lechner M, 2001, BIOCHEM J, V356, P129, DOI 10.1042/0264-6021:3560129; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Liu CL, 2013, WOUND REPAIR REGEN, V21, P579, DOI 10.1111/wrr.12055; Liu JS, 2012, J BIOL CHEM, V287, P27326, DOI 10.1074/jbc.M112.366658; Madeddu P, 2005, EXP PHYSIOL, V90, P315, DOI 10.1113/expphysiol.2004.028571; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Millar L, 2005, BIOL REPROD, V73, P695, DOI 10.1095/biolreprod.105.039859; Miyauchi S, 2004, J BIOL CHEM, V279, P13293, DOI 10.1074/jbc.C400059200; Morikawa Y, 2004, DEVELOPMENT, V131, P2195, DOI 10.1242/dev.01091; Or PMY, 2012, PHYTOMEDICINE, V19, P535, DOI 10.1016/j.phymed.2011.12.005; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Reuwer AQ, 2012, J CELL MOL MED, V16, P2035, DOI 10.1111/j.1582-4934.2011.01499.x; Sankpal NV, 2013, MOL CANCER RES, V11, P418, DOI 10.1158/1541-7786.MCR-12-0518; Shan YF, 2011, MED ONCOL, V28, P1012, DOI 10.1007/s12032-010-9600-6; Sharp CD, 2005, AM J PHYSIOL-HEART C, V288, pH1893, DOI 10.1152/ajpheart.01110.2003; Smart N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1041; Stangl K, 2010, CARDIOVASC RES, V85, P281, DOI 10.1093/cvr/cvp315; Stangl V, 2004, FASEB J, V18, P272, DOI 10.1096/fj.03-0054com; Tam JCW, 2014, PROTEOMICS, V14, P2089, DOI 10.1002/pmic.201300547; Tam JCW, 2011, J ETHNOPHARMACOL, V134, P831, DOI 10.1016/j.jep.2011.01.032; Tam JCW, 2014, J DIABETES COMPLICAT, V28, P436, DOI 10.1016/j.jdiacomp.2014.03.004; Tam JC, 2014, J DIABETES; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wong M. W. N., 2001, Hong Kong Medical Journal, V7, P403; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Xiao QZ, 2013, CIRC RES, V112, P35, DOI 10.1161/CIRCRESAHA.112.274019; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Yang XH, 2013, J BIOL CHEM, V288, P21184, DOI 10.1074/jbc.M113.481119; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang Q, 2012, PHYTOMEDICINE, V20, P9, DOI 10.1016/j.phymed.2012.09.006; Zheng K, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-31	52	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139342	10.1371/journal.pone.0139342	http://dx.doi.org/10.1371/journal.pone.0139342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430762	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700045
J	Zhou, CX; Zhou, DH; Elsheikha, HM; Liu, GX; Suo, X; Zhu, XQ				Zhou, Chun-Xue; Zhou, Dong-Hui; Elsheikha, Hany M.; Liu, Guang-Xue; Suo, Xun; Zhu, Xing-Quan			Global Metabolomic Profiling of Mice Brains following Experimental Infection with the Cyst-Forming Toxoplasma gondii	PLOS ONE			English	Article							ACETYL-L-CARNITINE; TAURINE RELEASE; INNATE IMMUNITY; RESPONSES; DISEASE; IDENTIFICATION; BIOSYNTHESIS; GLUTATHIONE; ASTROCYTES; STARVATION	The interplay between the Apicomplexan parasite Toxoplasma gondii and its host has been largely studied. However, molecular changes at the metabolic level in the host central nervous system and pathogenesis-associated metabolites during brain infection are largely unexplored. We used a global metabolomics strategy to identify differentially regulated metabolites and affected metabolic pathways in BALB/c mice during infection with T. gondii Pru strain at 7, 14 and 21 days post-infection (DPI). The non-targeted Liquid Chromatography-Mass Spectrometry (LC-MS) metabolomics analysis detected approximately 2,755 retention time-exact mass pairs, of which more than 60 had significantly differential profiles at different stages of infection. These include amino acids, organic acids, carbohydrates, fatty acids, and vitamins. The biological significance of these metabolites is discussed. Principal Component Analysis and Orthogonal Partial Least Square-Discriminant Analysis showed the metabolites' profile to change over time with the most significant changes occurring at 14 DPI. Correlated metabolic pathway imbalances were observed in carbohydrate metabolism, lipid metabolism, energetic metabolism and fatty acid oxidation. Eight metabolites correlated with the physical recovery from infection-caused illness were identified. These findings indicate that global metabolomics adopted in this study is a sensitive approach for detecting metabolic alterations in T. gondii-infected mice and generated a comparative metabolic profile of brain tissue distinguishing infected from non-infected host.	[Zhou, Chun-Xue; Zhou, Dong-Hui; Liu, Guang-Xue; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Key Lab Vet Parasitol Gansu Prov, Lanzhou 730046, Gansu, Peoples R China; [Zhou, Chun-Xue; Suo, Xun] China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China; [Zhou, Chun-Xue; Suo, Xun] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China; [Elsheikha, Hany M.] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Loughborough LE12 5RD, Leics, England	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; China Agricultural University; China Agricultural University; University of Nottingham	Suo, X (corresponding author), China Agr Univ, Natl Anim Protozoa Lab, Beijing 100193, Peoples R China.	suoxun@cau.edu.cn; xingquanzhu1@hotmail.com	Elsheikha, Hany/G-7573-2011	Elsheikha, Hany/0000-0003-3303-930X	National Natural Science Foundation of China [31230073]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups)	Project support was provided by the National Natural Science Foundation of China (Grant No. 31230073) and the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006) to XQZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Calabrese V, 2006, J NUTR BIOCHEM, V17, P73, DOI 10.1016/j.jnutbio.2005.03.027; Canugovi C, 2013, DNA REPAIR, V12, P578, DOI 10.1016/j.dnarep.2013.04.010; Carruthers VB, 2007, SCHIZOPHRENIA BULL, V33, P745, DOI 10.1093/schbul/sbm008; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Cho K, 2008, J PROTEOME RES, V7, P2980, DOI 10.1021/pr800128q; Coppens I, 2014, INT J PARASITOL, V44, P109, DOI 10.1016/j.ijpara.2013.09.003; Djurkovic-Djakovic O, 2012, EXP PARASITOL, V131, P372, DOI 10.1016/j.exppara.2012.05.006; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Elsheikha HM, 2008, PUBLIC HEALTH, V122, P335, DOI 10.1016/j.puhe.2007.08.009; Fathololoumi S, 2012, OPT EXPRESS, V20, P3866, DOI 10.1364/OE.20.003866; Fischer HG, 1997, EUR J IMMUNOL, V27, P1539, DOI 10.1002/eji.1830270633; Fox BA, 2004, INT J PARASITOL, V34, P323, DOI 10.1016/j.ijpara.2003.12.001; Fu R, 2014, MOL GENET METAB, V112, P280, DOI 10.1016/j.ymgme.2014.05.012; Gatkowska J, 2013, EXP PARASITOL, V133, P1, DOI 10.1016/j.exppara.2012.10.005; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hermes G, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-48; Hill DE, 2006, VET PARASITOL, V141, P9, DOI 10.1016/j.vetpar.2006.05.008; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Ijiri Y, 2014, TOXICOLOGY, V316, P55, DOI 10.1016/j.tox.2013.12.004; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Markovitz JH, 2014, AM J PSYCHIAT; Melzer T C, 2010, J Neuroparasitology, V1, DOI 10.4303/jnp/N100505; Mingorance C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034268; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Pettegrew JW, 2000, MOL PSYCHIATR, V5, P616, DOI 10.1038/sj.mp.4000805; Prandovszky E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023866; Ricciolini R, 1998, J NEUROCHEM, V71, P2510; Sahu A, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-39; Samitas K, 2009, RESP MED, V103, P750, DOI 10.1016/j.rmed.2008.11.009; Saransaari P, 2007, AMINO ACIDS, V32, P439, DOI 10.1007/s00726-006-0375-1; Saransaari P, 2006, AMINO ACIDS, V31, P35, DOI 10.1007/s00726-006-0290-5; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Strack A, 2002, ACTA NEUROPATHOL, V103, P458, DOI 10.1007/s00401-001-0491-7; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Sullivan WJ, 2005, ANTIMICROB AGENTS CH, V49, P2172, DOI 10.1128/AAC.49.6.2172-2179.2005; Tan IL, 2012, LANCET NEUROL, V11, P605, DOI 10.1016/S1474-4422(12)70098-4; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Virmani Ashraf, 2004, Molecular Aspects of Medicine, V25, P533, DOI 10.1016/j.mam.2004.06.003; Wang YL, 2008, P NATL ACAD SCI USA, V105, P6127, DOI 10.1073/pnas.0801777105; Webster JP, 2007, SCHIZOPHRENIA B; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zanjani HS, 1996, J COMP NEUROL, V374, P332, DOI 10.1002/(SICI)1096-9861(19961021)374:3<332::AID-CNE2>3.0.CO;2-2	47	43	45	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139635	10.1371/journal.pone.0139635	http://dx.doi.org/10.1371/journal.pone.0139635			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431205	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700090
J	Cingaram, PKR; Nyeste, A; Dondapati, DT; Fodor, E; Welker, E				Cingaram, Pradeep Kumar Reddy; Nyeste, Antal; Dondapati, Divya Teja; Fodor, Elfrieda; Welker, Ervin			Prion Protein Does Not Confer Resistance to Hippocampus-Derived Zpl Cells against the Toxic Effects of Cu2+, Mn2+, Zn2+ and Co2+ Not Supporting a General Protective Role for PrP in Transition Metal Induced Toxicity	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE ACTIVITY; OCTAPEPTIDE REPEAT REGION; OXIDATIVE STRESS; COPPER-BINDING; INFECTION IMPAIRS; CELLULAR ISOFORM; MICE LACKING; EXPRESSION; NEURONS; MEMBRANE	The interactions of transition metals with the prion protein (PrP) are well-documented and characterized, however, there is no consensus on their role in either the physiology of PrP or PrP-related neurodegenerative disorders. PrP has been reported to protect cells from the toxic stimuli of metals. By employing a cell viability assay, we examined the effects of various concentrations of Cu2+, Zn2+, Mn2+, and Co2+ on Zpl (Prnp(-/-)) and ZW (Prnp(+/+)) hippocampus-derived mouse neuronal cells. Prnp-/-Zpl cells were more sensitive to all four metals than PrP-expressing Zw cells. However, when we introduced PrP or only the empty vector into Zpl cells, we could not discern any protective effect associated with the presence of PrP. This observation was further corroborated when assessing the toxic effect of metals by propidium-iodide staining and fluorescence activated cell sorting analysis. Thus, our results on this mouse cell culture model do not seem to support a strong protective role for PrP against transition metal toxicity and also emphasize the necessity of extreme care when comparing cells derived from PrP knock-out and wild type mice.	[Cingaram, Pradeep Kumar Reddy; Nyeste, Antal; Dondapati, Divya Teja; Fodor, Elfrieda; Welker, Ervin] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Nyeste, Antal; Welker, Ervin] Hungarian Acad Sci, Res Ctr Nat Sci, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Welker, E (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	welker.ervin@brc.mta.hu	Cingaram, Pradeep Reddy/AAG-7322-2019; Welker, Ervin/AAC-6493-2022	Cingaram, Pradeep Reddy/0000-0002-9643-9725; Fodor, Elfrieda/0000-0002-5695-6162; Dondapati, Divya Teja/0000-0001-8137-9582	 [K-82090]		This study was supported by K-82090 administrated by the Orszagos Tudomanyos Kutatasi Alapprogramok (HU), http://www.otka.hu/ to EW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Arlt S, 2002, NEUROBIOL DIS, V10, P150, DOI 10.1006/nbdi.2002.0496; Ayton S, 2013, FREE RADICAL BIO MED, V62, P76, DOI 10.1016/j.freeradbiomed.2012.10.558; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brazier MW, 2008, J BIOL CHEM, V283, P12831, DOI 10.1074/jbc.M709820200; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1998, BIOCHEM J, V334, P423, DOI 10.1042/bj3340423; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Choi CJ, 2007, TOXICOL SCI, V98, P495, DOI 10.1093/toxsci/kfm099; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Di Natale G, 2013, CHEM-EUR J, V19, P3751, DOI 10.1002/chem.201202912; Ford MJ, 2002, NEUROSCIENCE, V111, P533, DOI 10.1016/S0306-4522(01)00603-0; Grabundzija I, 2010, MOL THER, V18, P1200, DOI 10.1038/mt.2010.47; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Guentchev M, 2002, NEUROBIOL DIS, V9, P275, DOI 10.1006/nbdi.2002.0477; Guentchev M, 2000, NEUROBIOL DIS, V7, P270, DOI 10.1006/nbdi.2000.0290; Haigh CL, 2006, J NEUROCHEM, V98, P677, DOI 10.1111/j.1471-4159.2006.03906.x; Holada K, 2002, BLOOD, V100, P341, DOI 10.1182/blood.V100.1.341; Hutter G, 2003, BIOL CHEM, V384, P1279, DOI 10.1515/BC.2003.142; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Jones S, 2005, BIOCHEM J, V392, P309, DOI 10.1042/BJ20051236; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kim BH, 2004, MOL BRAIN RES, V124, P40, DOI 10.1016/j.molbrainres.2004.02.005; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Klamt F, 2001, FREE RADICAL BIO MED, V30, P1137; Kojima A, 2014, BIOMOLECULES, V4, P510, DOI 10.3390/biom4020510; Kolacsek O, 2014, GENE THER, P1; Kozlowski H, 2013, COORDIN CHEM REV, V257, P2625, DOI 10.1016/j.ccr.2013.01.024; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; La Mendola D, 2014, BIOMOLECULES, V4, P546, DOI 10.3390/biom4020546; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lee HG, 1999, J MOL NEUROSCI, V13, P121, DOI 10.1385/JMN:13:1-2:121; Lee JC, 2012, FREE RADICAL BIO MED, V53, P742, DOI 10.1016/j.freeradbiomed.2012.06.002; Lee KS, 2001, J NEUROCHEM, V79, P79, DOI 10.1046/j.1471-4159.2001.00529.x; Li AM, 2004, J BIOL CHEM, V279, P29469, DOI 10.1074/jbc.M402517200; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Loubet D, 2012, FASEB J, V26, P678, DOI 10.1096/fj.11-185579; Mange A, 2002, FEBS LETT, V514, P159, DOI 10.1016/S0014-5793(02)02338-4; Marino T, 2011, INT J QUANTUM CHEM, V111, P1152, DOI 10.1002/qua.22682; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Milhavet O, 2000, P NATL ACAD SCI USA, V97, P13937, DOI 10.1073/pnas.250289197; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Oh JM, 2012, AUTOPHAGY, V8, P1448, DOI 10.4161/auto.21164; Pandey KK, 2010, J PHYS CHEM B, V114, P1127, DOI [10.1021/jp909945c, 10.1021/jp909945e]; Parkin ET, 2004, J BIOL CHEM, V279, P11170, DOI 10.1074/jbc.M312105200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rachidi W, 2003, J BIOL CHEM, V278, P14595, DOI 10.1074/jbc.C300092200; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; Rachidi W, 2009, J TRACE ELEM MED BIO, V23, P214, DOI 10.1016/j.jtemb.2009.02.007; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Rana A, 2009, CHEM-BIOL INTERACT, V181, P282, DOI 10.1016/j.cbi.2009.07.021; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sakudo A, 2003, BIOCHEM BIOPH RES CO, V307, P678, DOI 10.1016/S0006-291X(03)01239-7; Singh N, 2010, CURR ISSUES MOL BIOL, V12, P99; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Waggoner DJ, 2000, J BIOL CHEM, V275, P7455, DOI 10.1074/jbc.275.11.7455; White AR, 1999, AM J PATHOL, V155, P1723, DOI 10.1016/S0002-9440(10)65487-9; Wong BS, 2001, J NEUROCHEM, V79, P689, DOI 10.1046/j.1471-4159.2001.00625.x; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831	80	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139219	10.1371/journal.pone.0139219	http://dx.doi.org/10.1371/journal.pone.0139219			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426582	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100038
J	Cohen, JM; Silva, ML; Caini, S; Ciblak, M; Mosnier, A; Daviaud, I; Matias, G; Badur, S; Valette, M; Enouf, V; Paget, J; Fleming, DM				Cohen, Jean Marie; Silva, Maria Laura; Caini, Saverio; Ciblak, Meral; Mosnier, Anne; Daviaud, Isabelle; Matias, Goncalo; Badur, Selim; Valette, Martine; Enouf, Vincent; Paget, John; Fleming, Douglas M.		IBGP Study Team	Striking Similarities in the Presentation and Duration of Illness of Influenza A and B in the Community: A Study Based on Sentinel Surveillance Networks in France and Turkey, 2010-2012	PLOS ONE			English	Article							SEASONAL INFLUENZA; CLINICAL-FEATURES; QUADRIVALENT; CHILDREN; VACCINE; BURDEN; POPULATION; OUTCOMES; IMPACT; VIRUS	Influenza B represents a high proportion of influenza cases in some seasons (even over 50%). The Influenza B study in General Practice (IBGP) is a multicenter study providing information about the clinical, demographic and socio-economic characteristics of patients affected by lab-confirmed influenza A or B. Influenza B patients and age-matched influenza A patients were recruited within the sentinel surveillance networks of France and Turkey in 2010-11 and 2011-12 seasons. Data were collected for each patient at the swab test day, after 9 +/- 2 days and, if not recovered, after 28 +/- 5 days. It was related to patient's characteristics, symptoms at presentation, vaccination status, prescriptions of antibiotics and antivirals, duration of illness, follow-up consultations in general practice or emergency room. We performed descriptive analyses and developed a multiple regression model to investigate the effect of patients and disease characteristics on the duration of illness. Overall, 774 influenza cases were included in the study: 419 influenza B cases (209 in France and 210 in Turkey) and 355 influenza A cases (205 in France and 150 in Turkey). There were no differences between influenza A and B patients in terms of clinical presentation and number of consultations with a practitioner; however, the use of antivirals was higher among influenza B patients in both countries. The average (median) reported duration of illness in the age groups 0-14 years, 15-64 years and 65+ years was 7.4 (6), 8.7 (8) and 10.5 (9) days in France, and 6.3 (6), 8.2 (7) and 9.2 (6) days in Turkey; it increased with age but did not differ by virus type; increased duration of illness was associated with antibiotics prescription. In conclusion, our findings show that influenza B infection appears not to be milder disease than influenza A infection.	[Cohen, Jean Marie; Silva, Maria Laura; Caini, Saverio; Mosnier, Anne; Daviaud, Isabelle] Open Rome Org & Promote Epidemiol Network, Paris, France; [Cohen, Jean Marie; Mosnier, Anne] Reseau GROG, Paris, France; [Ciblak, Meral; Badur, Selim] Istanbul Univ, Istanbul, Turkey; [Matias, Goncalo] GlaxoSmithKline GSK Biol, Brussels, Belgium; [Valette, Martine] Univ Lyon 1, Natl Influenza Ctr, Dept Virol, F-69365 Lyon, France; [Enouf, Vincent] Univ Paris Diderot Sorbonne Paris Cite, CNRS UMR3569, Inst Pasteur, Virol Dept,Unit Mol Genet RNA Viruses,Natl Influe, Paris, France; [Paget, John] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands; [Fleming, Douglas M.] Royal Coll Gen Practitioners, Surveillance & Res Unit, Birmingham, W Midlands, England	Istanbul University; GlaxoSmithKline; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Netherlands Institute for Health Services Research	Cohen, JM (corresponding author), Open Rome Org & Promote Epidemiol Network, Paris, France.	jmcoco@openrome.org	Silva, Maria Laura/T-1913-2019; Caini, Saverio/AAI-3788-2020; ENOUF, Vincent/H-6494-2017	Silva, Maria Laura/0000-0003-2215-4118; Caini, Saverio/0000-0002-2262-1102; ENOUF, Vincent/0000-0001-7609-4742	GlaxoSmithKline (GSK) Biologicals	GlaxoSmithKline (GSK) Biologicals(GlaxoSmithKline)	IBGP study has been funded by GlaxoSmithKline (GSK) Biologicals - sponsor study. The funder provided support in the form of a salary for author [GM] who also contributed to the study design, but did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambrose CS, 2012, HUM VACC IMMUNOTHER, V8, P81, DOI 10.4161/hv.8.1.17623; Belshe RB, 2010, VACCINE, V28, pD45, DOI 10.1016/j.vaccine.2010.08.028; Chiu SS, 2009, CLIN INFECT DIS, V49, P1016, DOI 10.1086/605570; Ciblak MA, 2013, VACCINE, V31, P518, DOI 10.1016/j.vaccine.2012.11.022; Ciblak MA, 2009, J MED VIROL, V81, P1645, DOI 10.1002/jmv.21546; Cohen AL, 2014, EMERG INFECT DIS, V20, P1162, DOI 10.3201/eid2007.131869; Daley AJ, 2000, J PAEDIATR CHILD H, V36, P332, DOI 10.1046/j.1440-1754.2000.00533.x; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; European Centre for Disease Prevention and Control, ANN EP REP 2012 REP; General Directorate of Primary Health Care, 2005, NOT INF DIS STAND ID; Grant KA, 2009, COMMUN DIS INTELL, V33, P328; HANNOUN C, 1989, EUR J EPIDEMIOL, V5, P285, DOI 10.1007/BF00144828; Hardelid P, 2012, VACCINE, V30, P1371, DOI 10.1016/j.vaccine.2011.12.038; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Irving SA, 2012, INFLUENZA OTHER RESP, V6, P37, DOI 10.1111/j.1750-2659.2011.00263.x; Meijer A, 2007, Euro Surveill, V12, pE11; Nitsch-Osuch A, 2013, ADV EXP MED BIOL, V788, P89, DOI 10.1007/978-94-007-6627-3_14; Perez-Farinos N, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-59; Pitman RJ, 2013, VALUE HEALTH, V16, pA90, DOI 10.1016/j.jval.2013.03.420; Public Health Council, ANT US CIRC A H1N1 P; Reed C, 2012, VACCINE, V30, P1993, DOI 10.1016/j.vaccine.2011.12.098; Rozenbaum MH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6879; Silva ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-56; Truyers C, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-24; Van den Block Lieve, 2007, BMC Palliat Care, V6, P6; WHO, REC COMP INFL VIR VA; WHO, 2011, WHO INF MOL DIAGN IN; Wie SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062685; Yap J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-12	29	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139431	10.1371/journal.pone.0139431	http://dx.doi.org/10.1371/journal.pone.0139431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426119	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100058
J	Fukuyama, Y; Okada, K; Yamaguchi, M; Kiyono, H; Mori, K; Yuki, Y				Fukuyama, Yoshiko; Okada, Kazunari; Yamaguchi, Masahiro; Kiyono, Hiroshi; Mori, Kensaku; Yuki, Yoshikazu			Nasal Administration of Cholera Toxin as a Mucosal Adjuvant Damages the Olfactory System in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; PROTECTIVE IMMUNITY; ANTIBODY-RESPONSES; ODORANT RECEPTORS; NONHUMAN-PRIMATES; SENSORY MAP; TH2 CELLS; INTRANASAL; BULB; VIRUS	Cholera toxin (CT) induces severe diarrhea in humans but acts as an adjuvant to enhance immune responses to vaccines when administered orally. Nasally administered CT also acts as an adjuvant, but CT and CT derivatives, including the B subunit of CT (CTB), are taken up from the olfactory epithelium and transported to the olfactory bulbs and therefore may be toxic to the central nervous system. To assess the toxicity, we investigated whether nasally administered CT or CT derivatives impair the olfactory system. In mice, nasal administration of CT, but not CTB or a non-toxic CT derivative, reduced the expression of olfactory marker protein (OMP) in the olfactory epithelium and olfactory bulbs and impaired odor responses, as determined with behavioral tests and optical imaging. Thus, nasally administered CT, like orally administered CT, is toxic and damages the olfactory system in mice. However, CTB and a non-toxic CT derivative, do not damage the olfactory system. The optical imaging we used here will be useful for assessing the safety of nasal vaccines and adjuvants during their development for human use and CT can be used as a positive control in this test.	[Fukuyama, Yoshiko; Okada, Kazunari; Kiyono, Hiroshi; Yuki, Yoshikazu] Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan; [Yamaguchi, Masahiro; Mori, Kensaku] Univ Tokyo, Grad Sch Med, Dept Physiol, Tokyo, Japan; [Kiyono, Hiroshi; Yuki, Yoshikazu] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccine, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Yuki, Y (corresponding author), Univ Tokyo, Inst Med Sci, Div Mucosal Immunol, Tokyo, Japan.	yukiy@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022; Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Mori, Kensaku/0000-0001-7853-9370	Ministry of Health, Labour, and Welfare of Japan; Global Center of Excellence Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine; control of worldwide infectious diseases - "MEXT" Japan; Grants-in-Aid for Scientific Research [26115506] Funding Source: KAKEN	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine; control of worldwide infectious diseases - "MEXT" Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Health, Labour, and Welfare of Japan to YY, and Global Center of Excellence Program "Center of Education and Research for the Advanced Genome - Based Medicine - For personalized medicine, the control of worldwide infectious diseases - "MEXT" Japan to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bepari AK, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-140; Bodewes R, 2011, AM J PATHOL, V179, P30, DOI 10.1016/j.ajpath.2011.03.026; Bracher M, 1995, Psychoanal Rev, V82, P655; Bracher M, 1995, PSYCHOANAL REV, V82, P703; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CANCALON P, 1982, TISSUE CELL, V14, P717, DOI 10.1016/0040-8166(82)90061-1; Czarnecki LA, 2011, NEUROTOXICOLOGY, V32, P441, DOI 10.1016/j.neuro.2011.03.007; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; EVANS J, 1992, FUND APPL TOXICOL, V19, P275, DOI 10.1016/0272-0590(92)90161-A; GOTTOFREY J, 1991, PHARMACOL TOXICOL, V69, P242, DOI 10.1111/bcpt.1991.69.4.242; Hagiwara Y, 2003, J IMMUNOL, V170, P1754, DOI 10.4049/jimmunol.170.4.1754; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKSON RJ, 1993, INFECT IMMUN, V61, P4272, DOI 10.1128/IAI.61.10.4272-4279.1993; Katoh K, 1994, Neuroimage, V1, P199, DOI 10.1006/nimg.1994.1005; Kweon MN, 2002, J INFECT DIS, V186, P1261, DOI 10.1086/344526; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARINARO M, 1995, J IMMUNOL, V155, P4621; Matsumoto H, 2010, J NEUROPHYSIOL, V103, P3490, DOI 10.1152/jn.00035.2010; MILEDI R, 1989, J PHYSIOL-LONDON, V417, P173, DOI 10.1113/jphysiol.1989.sp017796; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mori I, 2004, REV MED VIROL, V14, P209, DOI 10.1002/rmv.426; Mori I, 2002, MED MICROBIOL IMMUN, V191, P1, DOI 10.1007/s00430-002-0110-9; Mutsch M, 2004, NEW ENGL J MED, V350, P896, DOI 10.1056/NEJMoa030595; Nagao H, 2002, MICROSC RES TECHNIQ, V58, P168, DOI 10.1002/jemt.10146; Nochi T, 2010, NAT MATER, V9, P572, DOI [10.1038/NMAT2784, 10.1038/nmat2784]; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Persson E, 2003, TOXICOL LETT, V145, P19, DOI 10.1016/S0378-4274(03)00266-2; Rasola A, 2011, CELL CALCIUM, V50, P222, DOI 10.1016/j.ceca.2011.04.007; Sanchez-Andrade G, 2005, J REPROD DEVELOP, V51, P547, DOI 10.1262/jrd.17031; Schrauwen EJA, 2012, J VIROL, V86, P3975, DOI 10.1128/JVI.06828-11; Shinya K, 2011, J VIROL, V85, P5202, DOI 10.1128/JVI.00239-11; Staats HF, 1996, J IMMUNOL, V157, P462; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; Taniguchi M, 2003, J NEUROSCI, V23, P1390, DOI 10.1523/JNEUROSCI.23-04-01390.2003; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; Tjalve H, 1999, NEUROTOXICOLOGY, V20, P181; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; van Ginkel FW, 2000, J IMMUNOL, V165, P4778, DOI 10.4049/jimmunol.165.9.4778; van Ginkel FW, 2005, INFECT IMMUN, V73, P6892, DOI 10.1128/IAI.73.10.6892-6902.2005; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; XUAMANO JC, 1993, J EXP MED, V178, P1309, DOI 10.1084/jem.178.4.1309; XUAMANO JC, 1994, VACCINE, V12, P903, DOI 10.1016/0264-410X(94)90033-7; Yamamoto M, 1998, J IMMUNOL, V161, P4115; Yamamoto S, 1997, J EXP MED, V185, P1203, DOI 10.1084/jem.185.7.1203; Yamamoto S, 1997, P NATL ACAD SCI USA, V94, P5267, DOI 10.1073/pnas.94.10.5267; Yoshida S, 2001, BRAIN RES, V892, P102, DOI 10.1016/S0006-8993(00)03240-6; Yoshino N, 2004, J IMMUNOL, V173, P6850, DOI 10.4049/jimmunol.173.11.6850; Yuki Y, 2003, REV MED VIROL, V13, P293, DOI 10.1002/rmv.398; Yuki Y, 2001, BIOTECHNOL BIOENG, V74, P62, DOI 10.1002/bit.1095; Yuki Y, 2010, J IMMUNOL, V185, P5436, DOI 10.4049/jimmunol.1001789	53	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139368	10.1371/journal.pone.0139368	http://dx.doi.org/10.1371/journal.pone.0139368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422280	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700101
J	Yuan, CZ; Liu, XY; Liu, XL; Yang, N; Liu, ZP; Yan, S; Shen, K; Kong, BH				Yuan, Cunzhong; Liu, Xiaoyan; Liu, Xiaolin; Yang, Ning; Liu, Zhenping; Yan, Shi; Shen, Keng; Kong, Beihua			The GADD45A (1506T>C) Polymorphism Is Associated with Ovarian Cancer Susceptibility and Prognosis	PLOS ONE			English	Article							GERMLINE MUTATIONS; GENE; GADD45-ALPHA; INDUCTION; VARIANTS; ARREST; RAD51C; BREAST; CELLS; RISK	GADD45A (growth arrest and DNA damage 45 A) is the first stress-inducible gene identified to be a target of p53. However, no studies to date have assessed variants of the GADD45 gene and their potential relationship to tumor susceptibility. We investigated the association of the GADD45A (1506T>C) polymorphism with ovarian cancer development in 258 ovarian cancer patients and 332 age-matched healthy women as controls using sequence analysis. We found a statistically significant difference in the GADD45A (1506T>C) genotype distributions between the case and control groups (TT vs. TC vs. CC, P = 0.0021) and found that variant 1506T>C was significantly associated with an increased risk of ovarian cancer (P<0.001, OR = 1.71, 95% CI [1.28-2.29]). We observed a statistically significant effect between tumor histology (P = 0.032) and CA125 status (P = 0.021). Carrying the C allele (TC+CC) was associated with an increased risk of positive CA125 (OR = 3.20, 95% CI [1.15-8.71). Carrying the T allele (TT+TC) showed a significant correlation with both higher GADD45A mRNA expression and longer ovarian cancer RFS (relapse-free survival) and OS (overall survival). We are the first group to demonstrate that the GADD45A (1506T>C) polymorphism is associated with ovarian cancer susceptibility and prognosis. These data suggest that GADD45A (1506T>C) is a new tumor susceptibility gene and could be a useful molecular marker for assessing ovarian cancer risk and for predicting ovarian cancer patient prognosis.	[Yuan, Cunzhong; Liu, Xiaoyan; Liu, Xiaolin; Yang, Ning; Liu, Zhenping; Yan, Shi; Kong, Beihua] Shandong Univ, Qilu Hosp, Dept Obstet & Gynecol, Jinan 250100, Shandong, Peoples R China; [Yuan, Cunzhong; Liu, Xiaoyan; Liu, Xiaolin; Yang, Ning; Liu, Zhenping; Yan, Shi; Kong, Beihua] Shandong Univ, Qilu Hosp, Gynecol Oncol Key Lab Shandong Prov, Jinan 250100, Shandong, Peoples R China; [Shen, Keng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China; [Shen, Keng] Peking Union Med Coll, Beijing 100021, Peoples R China	Shandong University; Shandong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shen, K (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing 100730, Peoples R China.	shenkeng@vip.sina.com; kongbeihua@sdu.edu.cn			National High Technology Research and Development Program ("863" Program) of China [2014AA020605, 2012AA02A507]; National Natural Science Foundation of China [81272857]; China Postdoctoral Science Foundation [2014M551918]; Science and Technology Development Project of Shandong Province [2014GSF118071, 2013GNC11306, 2013GSF12202]; Natural Science Foundation of Shandong Province [ZR2014JL019]; Foundation of Shandong Public Health Department [2014WS0123]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Development Project of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Foundation of Shandong Public Health Department	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (2014AA020605, 2012AA02A507), National Natural Science Foundation of China (81272857), China Postdoctoral Science Foundation (2014M551918), Science and Technology Development Project of Shandong Province (2014GSF118071, 2013GNC11306, 2013GSF12202), the Natural Science Foundation of Shandong Province (ZR2014JL019) and Foundation of Shandong Public Health Department (2014WS0123). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Braem MGM, 2011, BBA-REV CANCER, V1816, P132, DOI 10.1016/j.bbcan.2011.05.002; Gao M, 2010, J CELL BIOCHEM, V109, P1264, DOI 10.1002/jcb.22509; Goode LL, 2010, NAT GENET, V42, P874, DOI 10.1038/ng.668; Higashi H, 2006, ANTICANCER RES, V26, P2143; Hoffman B, 2013, ADV EXP MED BIOL, V793, P21, DOI 10.1007/978-1-4614-8289-5_2; Jiang F, 2003, J BIOL CHEM, V278, P48030, DOI 10.1074/jbc.M308430200; Jiang T, 2007, J CELL PHYSIOL, V212, P771, DOI 10.1002/jcp.21073; Levrero M, 2000, J CELL SCI, V113, P1661; Liebermann Dan A., 2011, Critical Reviews in Oncogenesis, V16, P129; Liu XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017582; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Ma XD, 2011, GYNECOL ONCOL, V122, P554, DOI 10.1016/j.ygyno.2011.05.031; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Osorio A, 2013, HUM MUTAT, V34, P1615, DOI 10.1002/humu.22438; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Ramus SJ, 2012, HUM MUTAT, V33, P690, DOI 10.1002/humu.22025; Reddy SP, 2008, CLIN CANCER RES, V14, P2978, DOI 10.1158/1078-0432.CCR-07-4821; Risch HA, 1998, JNCI-J NATL CANCER I, V90, P1774, DOI 10.1093/jnci/90.23.1774; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song HL, 2009, NAT GENET, V41, P996, DOI 10.1038/ng.424; Wang W, 2005, ONCOGENE, V24, P2705, DOI 10.1038/sj.onc.1208464; Yin JK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025559; Yuan CZ, 2013, MOL BIOL REP, V40, P6001, DOI 10.1007/s11033-013-2709-x; Yuan CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051561; Zerbini LF, 2005, CELL CYCLE, V4, P18, DOI 10.4161/cc.4.1.1363; Zhan QM, 1998, MOL CELL BIOL, V18, P2768, DOI 10.1128/MCB.18.5.2768; Zhu N, 2009, MOL BIOL REP, V36, P2075, DOI 10.1007/s11033-008-9419-9	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138692	10.1371/journal.pone.0138692	http://dx.doi.org/10.1371/journal.pone.0138692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422378	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700047
J	Chang, FC; Luo, CB; Lirng, JF; Lin, CJ; Lee, HJ; Wu, CC; Hung, SC; Guo, WY				Chang, Feng-Chi; Luo, Chao-Bao; Lirng, Jiing-Feng; Lin, Chung-Jung; Lee, Han-Jui; Wu, Chih-Chun; Hung, Sheng-Che; Guo, Wan-Yuo			Endovascular Management of Post-Irradiated Carotid Blowout Syndrome	PLOS ONE			English	Article							CANCER-PATIENTS; NECK CANCERS; HEAD; ARTERY; OCCLUSION; REIRRADIATION; EXPERIENCE; OUTCOMES; RISK	Purpose To retrospectively evaluate the clinical and technical factors related to the outcomes of endovascular management in patients with head-and-neck cancers associated with post-irradiated carotid blowout syndrome (PCBS). Materials and Methods Between 2000 and 2013, 96 patients with PCBS underwent endovascular management. The 40 patients with the pathological lesions located in the external carotid artery were classified as group 1 and were treated with embolization. The other 56 patients with the pathological lesions located in the trunk of the carotid artery were divided into 2 groups as follows: group 2A comprised the 38 patients treated with embolization, and group 2B comprised the 18 patients treated with stent-graft placement. Fisher's exact test was used to examine endovascular methods, clinical severities, and postprocedural clinical diseases as predictors of outcomes. Results Technical success and immediate hemostasis were achieved in all patients. The results according to endovascular methods (group 1 vs 2A vs 2B) were as follows: technical complication (1/40[2.5%] vs 9/38[23.7%] vs 9/18[50.0%], P = 0.0001); rebleeding (14/40[35.0%] vs 5/38[13.2%] vs 7/18[38.9%]), P = 0.0435). The results according to clinical severity (acute vs ongoing PCBS) were as follows: technical complication (15/47[31.9%] vs 4/49 [8.2%], P = 0.0035); rebleeding (18/47[38.3%] vs 8/49[16.3%], P = 0.0155). The results according to post-procedural clinical disease (regressive vs progressive change) were as follows: alive (14/21[66.7%] vs 8/75[10.7%], P<0.0001); survival time (34.1 +/- 30.6[0.3-110] vs 3.6 +/- 4.0[0.07-22] months, P<0.0001). Conclusion The outcomes of endovascular management of PCBS can be improved by taking embolization as a prior way of treatment, performing endovascular intervention in slight clinical severity and aggressive management of the post-procedural clinical disease.	[Chang, Feng-Chi; Luo, Chao-Bao; Lirng, Jiing-Feng; Lin, Chung-Jung; Lee, Han-Jui; Wu, Chih-Chun; Hung, Sheng-Che; Guo, Wan-Yuo] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chang, Feng-Chi; Luo, Chao-Bao; Lirng, Jiing-Feng; Lin, Chung-Jung; Lee, Han-Jui; Wu, Chih-Chun; Hung, Sheng-Che; Guo, Wan-Yuo] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, FC (corresponding author), Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan.	fcchang374@gmail.com	Hung, Sheng Che/Q-3778-2019	Hung, Sheng Che/0000-0001-6288-3556	Taipei Veterans General Hospital [V104C-196, CI-104-5]; Ministry of Science and Technology [NSC 102-2314-B-075-068]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported, in part, by grants from Taipei Veterans General Hospital (V104C-196, CI-104-5) and the Ministry of Science and Technology (NSC 102-2314-B-075-068).	Bachar G, 2013, LARYNGOSCOPE, V123, P1220, DOI 10.1002/lary.23996; Biffl WL, 1999, J TRAUMA, V47, P845, DOI 10.1097/00005373-199911000-00004; Carlson AP, 2011, STROKE, V42, P3637, DOI 10.1161/STROKEAHA.111.627745; Chaloupka JC, 1999, AM J NEURORADIOL, V20, P1069; Chaloupka JC, 1996, AM J NEURORADIOL, V17, P843; Chang FC, 2013, CLIN RADIOL, V68, pE561, DOI 10.1016/j.crad.2013.02.015; Chang FC, 2008, J VASC SURG, V47, P936, DOI 10.1016/j.jvs.2007.12.030; CITARDI MJ, 1995, LARYNGOSCOPE, V105, P1086, DOI 10.1288/00005537-199510000-00015; Cohen James, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P110, DOI 10.1097/00020840-200404000-00010; Hakime A, 2013, LARYNGOSCOPE, V123, P1670, DOI 10.1002/lary.24006; Hoppe H, 2008, J VASC INTERV RADIOL, V19, P31, DOI 10.1016/j.jvir.2007.08.024; Lee CW, 2014, AM J NEURORADIOL, V35, P562, DOI 10.3174/ajnr.A3716; Lesley WS, 2003, AM J NEURORADIOL, V24, P975; Lu HJ, 2013, J VASC SURG, V58, P1226, DOI 10.1016/j.jvs.2013.04.056; Ma J, 2007, NEURORADIOLOGY, V49, P317, DOI 10.1007/s00234-006-0193-x; Macdonald S, 2000, J VASC INTERV RADIOL, V11, P1184, DOI 10.1016/S1051-0443(07)61361-X; Mazumdar A, 2009, NEUROIMAG CLIN N AM, V19, P271, DOI 10.1016/j.nic.2009.01.001; Mcdonald MW, 2012, INT J RADIAT ONCOL, V82, P1083, DOI 10.1016/j.ijrobp.2010.08.029; Miller T, 2012, J NEUROINTERV SURG, V4, P426, DOI 10.1136/neurintsurg-2011-010083; Pereira J, 2004, ONCOLOGIST, V9, P561, DOI 10.1634/theoncologist.9-5-561; Wan WS, 2013, EUR J RADIOL, V82, P95, DOI 10.1016/j.ejrad.2011.01.061; Yamazaki H, 2013, RADIOTHER ONCOL, V107, P305, DOI 10.1016/j.radonc.2013.05.005; Zussman B, 2012, WORLD NEUROSURG, V78, DOI 10.1016/j.wneu.2011.08.024	23	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139821	10.1371/journal.pone.0139821	http://dx.doi.org/10.1371/journal.pone.0139821			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439632	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300063
J	Chen, XL; Serrano, D; Mayhue, M; Hoebe, K; Ilangumaran, S; Ramanathan, S				Chen, Xi-Lin; Serrano, Daniel; Mayhue, Marian; Hoebe, Kasper; Ilangumaran, Subburaj; Ramanathan, Sheela			GIMAP5 Deficiency Is Associated with Increased AKT Activity in T Lymphocytes	PLOS ONE			English	Article							BB RAT; CELL-DEVELOPMENT; PROTEIN-KINASE; TUBEROUS SCLEROSIS; IMPAIRED SURVIVAL; BIOBREEDING RATS; IAN FAMILY; MUTATION; ACTIVATION; QUIESCENCE	Long-term survival of T lymphocytes in quiescent state is essential to maintain their cell numbers in secondary lymphoid organs. In mice and in rats, the loss of functional GTPase of the immune associated nucleotide binding protein 5 (GIMAP5) causes peripheral T lymphopenia due to spontaneous death of T cells. The underlying mechanism responsible for the disruption of quiescence in Gimap5 deficient T cells remains largely unknown. In this study, we show that loss of functional Gimap5 results in increased basal activation of mammalian target of rapamycin (mTOR), independent of protein phosphatase 2A (PP2A) or AMP-activated protein kinase (AMPK). Our results suggest that the constitutive activation of the phosphoinositide 3-kinase (PI3K) pathway may be one of the consequences of the absence of functional GIMAP5.	[Chen, Xi-Lin; Serrano, Daniel; Mayhue, Marian; Ilangumaran, Subburaj; Ramanathan, Sheela] Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada; [Hoebe, Kasper] Cincinnati Childrens Hosp Med Ctr, Div Cellular & Mol Immunol, Dept Pediat, Cincinnati, OH 45229 USA; [Ilangumaran, Subburaj; Ramanathan, Sheela] Univ Sherbrooke, Ctr Rech Clin, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke; Cincinnati Children's Hospital Medical Center; University of Sherbrooke	Ramanathan, S (corresponding author), Univ Sherbrooke, Div Immunol, Dept Pediat, Fac Med & Hlth Sci, Sherbrooke, PQ J1H 5N4, Canada.	Sheela.Ramanathan@Usherbrooke.ca		Ilangumaran, Subburaj/0000-0002-7563-576X	Canadian Institutes for Health Research [MOP-86530]; Natural Sciences and Engineering Research Council of Canada; Fonds de Recherche du Quebec	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de Recherche du Quebec	Canadian Institutes for Health Research MOP-86530- SR, Natural Sciences and Engineering Research Council of Canada- SR and Fonds de Recherche du Quebec- XLC.	Aksoylar HI, 2012, J IMMUNOL, V188, P146, DOI 10.4049/jimmunol.1101206; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Angulo I, 2013, SCIENCE, V342, P866, DOI 10.1126/science.1243292; Barnes MJ, 2010, J IMMUNOL, V184, P3743, DOI 10.4049/jimmunol.0903164; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200; Blagih J, 2012, IMMUNOL REV, V249, P59, DOI 10.1111/j.1600-065X.2012.01157.x; Chappert P, 2010, CURR OPIN IMMUNOL, V22, P552, DOI 10.1016/j.coi.2010.08.005; Chen XL, 2013, BIOCHEM J, V449, P353, DOI 10.1042/BJ20120516; Chen YH, 2011, J EXP MED, V208, P923, DOI 10.1084/jem.20101192; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dion C, 2005, INT IMMUNOL, V17, P1257, DOI 10.1093/intimm/dxh302; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Filen Sanna, 2010, J Signal Transduct, V2010, P268589, DOI 10.1155/2010/268589; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heinonen MT, 2015, IMMUNOL CELL BIOL, V93, P158, DOI 10.1038/icb.2014.86; Hernandez-Hoyos G, 1999, EUR J IMMUNOL, V29, P1832, DOI 10.1002/(SICI)1521-4141(199906)29:06&lt;1832::AID-IMMU1832&gt;3.0.CO;2-F; Hillebrands JL, 2011, J IMMUNOL, V186, P1297, DOI 10.4049/jimmunol.1090132; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Ilangumaran S, 2009, MOL IMMUNOL, V46, P1256, DOI 10.1016/j.molimm.2008.09.031; JACKSON R, 1981, DIABETES, V30, P887, DOI 10.2337/diabetes.30.10.887; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Keita M, 2007, BIOCHEM BIOPH RES CO, V361, P481, DOI 10.1016/j.bbrc.2007.07.048; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kurebayashi Y, 2012, CELL REP, V1, P360, DOI 10.1016/j.celrep.2012.02.007; Lau A, 1998, DIABETES, V47, P197, DOI 10.2337/diabetes.47.2.197; Lucas CL, 2014, NAT IMMUNOL, V15, P88, DOI 10.1038/ni.2771; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Malissen B, 2014, NAT IMMUNOL, V15, P790, DOI 10.1038/ni.2959; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Nitta T, 2006, PLOS BIOL, V4, P593, DOI 10.1371/journal.pbio.0040103; O'Brien TF, 2011, EUR J IMMUNOL, V41, P3361, DOI 10.1002/eji.201141411; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Okkenhaug K, 2010, CURR TOP MICROBIOL, V346, P57, DOI 10.1007/82_2010_45; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Poussier P, 2005, J IMMUNOL, V174, P4081, DOI 10.4049/jimmunol.174.7.4081; POUSSIER P, 1982, ENDOCRINOLOGY, V110, P1825, DOI 10.1210/endo-110-5-1825; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Ramanathan S, 2001, IMMUNOL REV, V184, P161, DOI 10.1034/j.1600-065x.2001.1840115.x; Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713; Sandal T, 2003, MOL BIOL CELL, V14, P3292, DOI 10.1091/mbc.e02-10-0700; Schulteis RD, 2008, BLOOD, V112, P4905, DOI 10.1182/blood-2008-03-146555; Schwefel D, 2013, STRUCTURE, V21, P550, DOI 10.1016/j.str.2013.01.014; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; van den Brandt J, 2010, J IMMUNOL, V185, P2285, DOI 10.4049/jimmunol.1000462; Wei SH, 2007, J IMMUNOL, V179, P1586, DOI 10.4049/jimmunol.179.3.1586; Wong Vivian Wy, 2010, Self Nonself, V1, P259, DOI 10.4161/self.1.3.12819; Wu Q, 2011, J IMMUNOL, V187, P1106, DOI 10.4049/jimmunol.1003968; Yang K, 2011, NAT IMMUNOL, V12, P888, DOI 10.1038/ni.2068; Yusuf I, 2003, TRENDS IMMUNOL, V24, P380, DOI 10.1016/S1471-4906(03)00141-8; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002	61	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139019	10.1371/journal.pone.0139019	http://dx.doi.org/10.1371/journal.pone.0139019			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440416	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300012
J	Li, L; Li, L; Chen, C; Yang, J; Li, JX; Hu, N; Li, Y; Zhang, DM; Guo, T; Liu, X; Yang, WM				Li, Lin; Li, Lu; Chen, Chen; Yang, Jian; Li, Jiaxun; Hu, Na; Li, Yang; Zhang, Dongmei; Guo, Tao; Liu, Xuan; Yang, Weimin			Scutellarin's Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-I alpha	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MYOCARDIAL ISCHEMIA-REPERFUSION; NITRIC-OXIDE; CYCLIC-GMP; INDEPENDENT RELAXATION; BAICALENSIS GEORGI; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; CGMP BINDING; ACTIVATION	Scutellarin (SCU), a flavonoid glycoside compound, has been successfully used in clinic for treatment of ischemic diseases in China. In this report, we checked the effects of SCU on endothelium dysfunction (ED) of coronary artery (CA) against myocardial ischemia reperfusion (MIR) injury in vivo. The involvement of PKG-I alpha was further studied using cultured endothelial cells subjected to hypoxia reoxygenation (HR) injury in vitro. In rat MIR model, SCU (45 and 90 mg/kg, iv) significantly reduced ischemic size and restored the endothelium-dependent vasodilation of isolated CA rings. PKG inhibitor Rp-8-Br-cGMP (50 mu g/kg, iv) could ameliorate the protective effects of SCU. Increase in phosphorylation of vasodilator-stimulated phosphoprotein (VASP), a main substrate of PKG, at Ser 239 was observed in both heart tissue and serum of SCU-treated animals. In cultured human cardiac microvascular endothelial cells (HCMECs), SCU (1 and 10 mu M) dose-dependently protected cell viability and increased the mRNA and protein level of PKG-I alpha against HR injury. The activity of PKG was also increased by SCU treatment. The activation of PKG-1 alpha was then studied using targeted proteomic analysis (MRM-MS) checking the phosphorylation state of the autophosphorylation domain (aa42-94). Significant decrease in phosphorylation of PKG-I alpha at Ser50, Ser72, Ser89 was induced by HR injury while SCU treatment significantly increased the phosphorylation of PKG-I alpha, not only at Ser50, Ser72 and Ser89, but also at Ser44 and Thr58 (two novel phosphorylation domains). Our results demonstrate PKG-I alpha might play an important role in the protective effects of SCU on ED against MIR injury.	[Li, Lin; Li, Lu; Chen, Chen; Yang, Jian; Li, Jiaxun; Hu, Na; Li, Yang; Yang, Weimin] Kunming Med Univ, Sch Pharmaceut Sci, Kunming, Peoples R China; [Li, Lin; Li, Lu; Chen, Chen; Yang, Jian; Li, Jiaxun; Hu, Na; Li, Yang; Yang, Weimin] Kunming Med Univ, Yunnan Key Lab Pharmacol Nat Prod, Kunming, Peoples R China; [Li, Lin; Guo, Tao] Kunming Med Univ, Dept Cardiol, Affiliated Hosp 1, Kunming, Peoples R China; [Li, Lu; Zhang, Dongmei; Liu, Xuan] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China	Kunming Medical University; Kunming Medical University; Kunming Medical University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Liu, X (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	xuanliu@simm.ac.cn; ywmbessie@yeah.net	Yang, Wei/GWV-4107-2022; Yang, Wei/HIA-0360-2022		National Natural Science Foundation of China [30960450, 81173110, 81260027, 81560589, 81560072]; Yunnan Provincial Science and Technology Department [2011FA022, 2014FA010, 2014BC012, 2014FB037, 2008CD054, 2008ZC111M]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Provincial Science and Technology Department	This work was partly supported by National Natural Science Foundation of China (No. 30960450, 81173110, 81260027, 81560589, 81560072) and Yunnan Provincial Science and Technology Department (No. 2011FA022, 2014FA010, 2014BC012, 2014FB037, 2008CD054 and 2008ZC111M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah Y, 2005, CARDIOVASC RES, V66, P123, DOI 10.1016/j.cardiores.2005.01.007; Bucci M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053319; Burley DS, 2007, BRIT J PHARMACOL, V152, P855, DOI 10.1038/sj.bjp.0707409; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chang ACY, 2013, ARTERIOSCL THROM VAS, V33, P510, DOI 10.1161/ATVBAHA.112.300840; Chen HJ, 2008, J BIOL CHEM, V283, P4439, DOI 10.1074/jbc.M709439200; Chu DM, 1998, J BIOL CHEM, V273, P14649, DOI 10.1074/jbc.273.23.14649; Costa ADT, 2008, CARDIOVASC RES, V77, P344, DOI 10.1093/cvr/cvm050; Dai Hao, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1014; Das A, 2006, J BIOL CHEM, V281, P38644, DOI 10.1074/jbc.M606142200; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Fiscus RR, 2002, NEUROSIGNALS, V11, P175, DOI 10.1159/000065431; Francis S H, 1988, Second Messengers Phosphoproteins, V12, P301; Fraser M, 2006, ONCOGENE, V25, P2203, DOI 10.1038/sj.onc.1209251; Frelinger AL, 2014, PLATELETS, V25, P27, DOI 10.3109/09537104.2013.770136; Friedewald VE, 2008, AM J CARDIOL, V102, P418, DOI 10.1016/j.amjcard.2008.05.005; Gao ZXZ, 2010, BIOCHEM BIOPH RES CO, V400, P151, DOI 10.1016/j.bbrc.2010.08.034; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Heiss C, 2010, EUR HEART J, V31, P2583, DOI 10.1093/eurheartj/ehq332; HOFMANN F, 1985, EUR J BIOCHEM, V147, P361, DOI 10.1111/j.1432-1033.1985.tb08758.x; Hong H, 2007, J ASIAN NAT PROD RES, V9, P135, DOI 10.1080/10286020412331286470; Hou YL, 2003, J BIOL CHEM, V278, P16706, DOI 10.1074/jbc.M300045200; Inserte J, 2015, BRIT J PHARMACOL, V172, P1996, DOI 10.1111/bph.12959; Inserte J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005975; Johlfs MG, 2010, NEUROCHEM INT, V56, P546, DOI 10.1016/j.neuint.2009.12.017; Kharbanda RK, 2001, CIRCULATION, V103, P1624, DOI 10.1161/01.CIR.103.12.1624; Kohler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029494; Kohler D, 2011, CIRCULATION, V123, P2579, DOI 10.1161/CIRCULATIONAHA.110.014555; LANDGRAF W, 1986, EUR J BIOCHEM, V154, P113, DOI 10.1111/j.1432-1033.1986.tb09365.x; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; Leung EL, 2010, MOL CANCER RES, V8, P578, DOI 10.1158/1541-7786.MCR-09-0178; Lin LL, 2007, J CARDIOVASC PHARM, V50, P327, DOI 10.1097/FJC.0b013e3180cbd0e7; Lin YL, 2010, PHYTOMEDICINE, V17, P760, DOI 10.1016/j.phymed.2010.01.003; Liu H, 2003, ACTA PHARMACOL SIN, V24, P1113; Liu Hong, 2002, Zhong Yao Cai, V25, P491; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; Pan ZW, 2008, PHYTOTHER RES, V22, P1428, DOI 10.1002/ptr.2364; Qian LH, 2011, INT J MOL SCI, V12, P8208, DOI 10.3390/ijms12118208; Qin X, 2007, PFLUG ARCH EUR J PHY, V454, P913, DOI 10.1007/s00424-007-0249-8; Radovits T, 2009, VASC PHARMACOL, V51, P37, DOI 10.1016/j.vph.2009.01.009; Riederer A, 1999, LARYNGO RHINO OTOL, V78, P373, DOI 10.1055/s-2007-996889; Schafer A, 2003, BIOCHEM PHARMACOL, V65, P397, DOI 10.1016/S0006-2952(02)01523-X; Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032; Vinten-Johansen J, 1999, ANN NY ACAD SCI, V874, P354, DOI 10.1111/j.1749-6632.1999.tb09251.x; Wall ME, 2003, P NATL ACAD SCI USA, V100, P2380, DOI 10.1073/pnas.0534892100; Wang S, 2011, NEUROSCIENCE, V185, P150, DOI 10.1016/j.neuroscience.2011.04.005; Wong JC, 2012, J CELL BIOCHEM, V113, P3587, DOI 10.1002/jcb.24237; Wong JC, 2011, J CELL BIOCHEM, V112, P829, DOI 10.1002/jcb.22981; Wong Janica C, 2010, Cardiovasc Pathol, V19, pe221, DOI 10.1016/j.carpath.2009.11.001; Yang WM, 2009, J CARDIOVASC PHARM, V53, P66, DOI 10.1097/FJC.0b013e318195d776; Yao X, 2000, FASEB J, V14, P932, DOI 10.1096/fasebj.14.7.932; Zhang HF, 2009, PLANTA MED, V75, P121, DOI 10.1055/s-0028-1088368; Zhang ML, 2011, TRENDS PHARMACOL SCI, V32, P360, DOI 10.1016/j.tips.2011.02.019; Zhang Wei-dong, 2000, Zhongguo Zhongyao Zazhi, V25, P536; Zhang YY, 2006, J ETHNOPHARMACOL, V108, P355, DOI 10.1016/j.jep.2006.05.022	57	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139570	10.1371/journal.pone.0139570	http://dx.doi.org/10.1371/journal.pone.0139570			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440524	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300032
J	Shin, MK; Park, H; Shin, SW; Jung, M; Lee, SH; Kim, DY; Yoo, HS				Shin, Min-Kyoung; Park, Hongtae; Shin, Seung Won; Jung, Myunghwan; Lee, Su-Hyung; Kim, Dae-Yong; Yoo, Han Sang			Host Transcriptional Profiles and Immunopathologic Response following Mycobacterium avium subsp paratuberculosis Infection in Mice	PLOS ONE			English	Article							CROHNS-DISEASE; IMMUNE-RESPONSES; JOHNES-DISEASE; T-CELL; IN-VITRO; TUBERCULOSIS; MACROPHAGE; EXPRESSION; PROTEIN; GAMMA	Paratuberculosis or Johne's disease is a chronic granulomatous enteropathy in ruminants caused by Mycobacterium avium subsp. paratuberculosis (MAP) infection. In the present study, we examined the host response to MAP infection in spleens of mice in order to investigate the host immunopathology accompanying host-pathogen interaction. Transcriptional profiles of the MAP-infectedmice at 3 and 6 weeks p.i. showed severe histopathological changes, whereas those at 12 weeks p.i. displayed reduced lesion severity in the spleen and liver. MAP-infected mice at 3 and 6 weeks p.i. showed up-regulation of interferon-related genes, scavenger receptor, and complement components, suggesting an initial innate immune reaction, such as macrophage activation, bactericidal activity, and macrophage invasion of MAP. Concurrently, MAP-infectedmice at 3 and 6 weeks p.i. were also suggested to express M2 macrophage phenotype with up-regulation of Mrc1, and Marco and down-regulation of MHC class II, Ccr7, and Irf5, and canonical pathways related to the T cell response including ICOS-ICOSL signaling in T helper cells, calcium-induced T lymphocyte apoptosis, and CD28 signaling in T helper cell. These results provide information which furthers the understanding of the immunopathologic response to MAP infection in mice, thereby providing insights valuable for research into the pathogenesis for MAP infection.	[Shin, Min-Kyoung; Park, Hongtae; Shin, Seung Won; Jung, Myunghwan; Yoo, Han Sang] Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea; [Shin, Min-Kyoung] Gyeonsang Natl Univ, Sch Med, Dept Microbiol, Jinju, South Korea; [Lee, Su-Hyung; Kim, Dae-Yong] Seoul Natl Univ, Coll Vet Med, Dept Vet Pathol, Seoul, South Korea; [Yoo, Han Sang] Seoul Natl Univ, Inst Green Bio Sci & Technol, Pyeongchang, South Korea	Seoul National University (SNU); Gyeongsang National University; Seoul National University (SNU); Seoul National University (SNU)	Yoo, HS (corresponding author), Seoul Natl Univ, Coll Vet Med, Dept Infect Dis, Seoul, South Korea.	yoohs@snu.ac.kr	Jung, Myunghwan/AAO-3582-2021; Jung, Myunghwan/AAL-6549-2021; Dellagostin, Odir/C-2331-2009	Jung, Myunghwan/0000-0001-8124-8945; Jung, Myunghwan/0000-0001-8124-8945; Dellagostin, Odir/0000-0003-2803-4088	Rural Development Administration [PJ00897]; BK21 PLUS; Research Institute for Veterinary Science, Seoul National University, South Korea	Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); BK21 PLUS; Research Institute for Veterinary Science, Seoul National University, South Korea	This study was supported by the Rural Development Administration (PJ00897), BK21 PLUS and the Research Institute for Veterinary Science, Seoul National University, South Korea.	Astarie-Dequeker C, 1999, INFECT IMMUN, V67, P469, DOI 10.1128/IAI.67.2.469-477.1999; Beard PM, 1999, VET REC, V145, P612; Begg DJ, 2011, IMMUNOBIOLOGY, V216, P840, DOI 10.1016/j.imbio.2010.12.004; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Cha SB, 2013, J MICROBIOL BIOTECHN, V23, P1167, DOI 10.4014/jmb.1302.02021; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frosch M, 2004, J LEUKOCYTE BIOL, V75, P198, DOI 10.1189/jlb.0203076; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Hines ME, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00026; Hostetter J, 2005, CLIN DIAGN LAB IMMUN, V12, P793, DOI 10.1128/CDLI.12.6.793-796.2005; Jo EK, 2003, CURR OPIN INFECT DIS, V16, P205, DOI 10.1097/00001432-200306000-00004; Jordao L, 2008, MICROBES INFECT, V10, P1379, DOI 10.1016/j.micinf.2008.08.004; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Koets A, 2006, VACCINE, V24, P2550, DOI 10.1016/j.vaccine.2005.12.019; Koo HC, 2004, INFECT IMMUN, V72, P6870, DOI 10.1128/IAI.72.12.6870-6883.2004; Koo MS, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-2; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Lamont EA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-694; MacHugh DE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-25; Marcuzzi A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/297501; MCCLURE HM, 1987, J INFECT DIS, V155, P1011, DOI 10.1093/infdis/155.5.1011; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Naser SA, 2000, VET MICROBIOL, V77, P497, DOI 10.1016/S0378-1135(00)00334-5; Naser SA, 2004, LANCET, V364, P1039, DOI 10.1016/S0140-6736(04)17058-X; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Page KR, 2005, INFECT IMMUN, V73, P8369, DOI 10.1128/IAI.73.12.8369-8380.2005; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pechkovsky DV, 2000, FEMS IMMUNOL MED MIC, V29, P27, DOI 10.1111/j.1574-695X.2000.tb01501.x; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; PETERSON PK, 1995, INFECT IMMUN, V63, P1598, DOI 10.1128/IAI.63.4.1598-1602.1995; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Pillars RB, 2009, CAN VET J, V50, P1039; Plattner BL, 2009, INT J EXP PATHOL, V90, P587, DOI 10.1111/j.1365-2613.2009.00679.x; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; RAO SP, 1992, INFECT IMMUN, V60, P3652, DOI 10.1128/IAI.60.9.3652-3657.1992; Roupie V, 2008, INFECT IMMUN, V76, P2099, DOI 10.1128/IAI.01137-07; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Sechi LA, 2005, AM J GASTROENTEROL, V100, P1529, DOI 10.1111/j.1572-0241.2005.41415.x; Seeliger S, 2003, AM J PATHOL, V163, P947, DOI 10.1016/S0002-9440(10)63454-2; Shin SJ, 2006, INFECT IMMUN, V74, P3825, DOI 10.1128/IAI.01742-05; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sickert D, 2007, ANTICANCER RES, V27, P1693; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Singh UP, 2007, INFECT IMMUN, V75, P3722, DOI 10.1128/IAI.01770-06; Souza CD, 2008, MICROB PATHOGENESIS, V44, P215, DOI 10.1016/j.micpath.2007.09.006; Stabel JR, 2002, VET IMMUNOL IMMUNOP, V89, P127, DOI 10.1016/S0165-2427(02)00167-8; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Stroncek DF, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-36; Sweeney RW, 2006, RES VET SCI, V80, P253, DOI 10.1016/j.rvsc.2005.07.007; TANAKA S, 1994, J COMP PATHOL, V110, P381, DOI 10.1016/S0021-9975(08)80315-5; Tiron A, 2008, CHIRURGIA-BUCHAREST, V103, P255; Tomioka H, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/635451; Tomioka H, 2011, J INFECT CHEMOTHER, V17, P302, DOI 10.1007/s10156-010-0177-y; Tooker BC, 2002, VET IMMUNOL IMMUNOP, V87, P429, DOI 10.1016/S0165-2427(02)00065-X; Vacchio MS, 2005, EUR J IMMUNOL, V35, P418, DOI 10.1002/eji.200424918; VEAZEY RS, 1995, J COMP PATHOL, V113, P75, DOI 10.1016/S0021-9975(05)80071-4; Villeneuve C, 2005, J LIPID RES, V46, P475, DOI 10.1194/jlr.M400308-JLR200; Weiss DJ, 2002, INFECT IMMUN, V70, P5556, DOI 10.1128/IAI.70.10.5556-5561.2002; Woo SR, 2008, J VET SCI, V9, P1, DOI 10.4142/jvs.2008.9.1.1; Wu CW, 2007, INFECT IMMUN, V75, P2110, DOI 10.1128/IAI.01739-06; Yadav M, 2004, J IMMUNOL, V172, P5588, DOI 10.4049/jimmunol.172.9.5588; Yakes BJ, 2008, CLIN VACCINE IMMUNOL, V15, P227, DOI 10.1128/CVI.00334-07; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025; Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271; Zwick LS, 2002, J VET DIAGN INVEST, V14, P326, DOI 10.1177/104063870201400409	74	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138770	10.1371/journal.pone.0138770	http://dx.doi.org/10.1371/journal.pone.0138770			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439498	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300005
J	Blas, MM; Brown, B; Menacho, L; Alva, IE; Silva-Santisteban, A; Carcamo, C				Blas, Magaly M.; Brown, Brandon; Menacho, Luis; Alva, Isaac E.; Silva-Santisteban, Alfonso; Carcamo, Cesar			HPV Prevalence in Multiple Anatomical Sites among Men Who Have Sex with Men in Peru	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; AGE-SPECIFIC PREVALENCE; OF-THE-LITERATURE; WOMEN; ACQUISITION; LIMA; HIM; MSM	Background Human Papilloma Virus (HPV) infection is the most common sexually transmitted viral infection worldwide. HPV is highly prevalent in sexually active men who have sex with men (MSM) and has been associated with anal cancer, penile cancer, and oropharyngeal cancer. Methods From March to September 2011, we conducted a cross-sectional study of HPV prevalence among MSM above age 18 years. Participants were recruited using respondent driven sampling at Clinica Cayetano Heredia. All participants provided anal, genital, and oral samples for HPV DNA testing, and blood for HIV and HPV antibody testing. Results A total of 200 MSM were recruited in the study. The mean age was 34 years (range 18-59 years, SD = 9.4) and 101 participants were HIV negative (99 HIV positive). HPV 6/11/16/18 or quadrivalent HPV vaccine (HPV4) genotype seroprevalence among HIV negative and positive MSM was 64.3% (55%-75.9%) and 93.8%(87.6%-99.2%) respectively (p<0.001). HIV positivity was associated with a higher prevalence of HPV4 and HPV 16/18 DNA at external genital sites and the anal canal. HPV4 DNA prevalence at external genital sites among HIV negative and positive MSM was 14.9% and 28.7% (p = 0.02) respectively, at anal canal was 50.9% and 79.0% (p = 0.001), and at the oral cavity was 9.9% and 8.5% (p = 0.6). Conclusions HPV4 seroprevalence was high in our study among both HIV positives and negatives, with HPV DNA prevalence much lower, and the anal canal being the anatomical site with the highest HPV DNA prevalence. HPV prevention interventions are needed among MSM at high-risk for HIV infection.	[Blas, Magaly M.; Menacho, Luis; Alva, Isaac E.; Carcamo, Cesar] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru; [Brown, Brandon] UCR Sch Med, Ctr Hlth Communities, Riverside, CA 92521 USA; [Silva-Santisteban, Alfonso] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Unit Hlth Sexual & Human Dev, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Brown, B (corresponding author), UCR Sch Med, Ctr Hlth Communities, Riverside, CA 92521 USA.	brandon.brown@ucr.edu		Silva-Santisteban, Alfonso/0000-0001-7225-3515	Merck Investigator-Initiated Studies Program of Merck Co., Inc.	Merck Investigator-Initiated Studies Program of Merck Co., Inc.	This study was supported by a research grant from the Merck Investigator-Initiated Studies Program of Merck & Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown B, 2012, VIRUSES-BASEL, V4, P3851, DOI 10.3390/v4123851; Chesson HW, 2004, PERSPECT SEX REPRO H, V36, P11, DOI 10.1363/3601104; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Heckathorn DD, 2007, SOCIOL METHODOL, V37, P151, DOI 10.1111/j.1467-9531.2007.00188.x; Hernandez BY, 2008, CANCER-AM CANCER SOC, V113, P2883, DOI 10.1002/cncr.23743; Johnston LG, 2008, AIDS BEHAV, V12, P294, DOI 10.1007/s10461-007-9300-1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Lu BB, 2011, CANCER EPIDEM BIOMAR, V20, P990, DOI 10.1158/1055-9965.EPI-10-1160; Magpi, COLL DAT FAST; Mooij SH, 2013, AIDS, V27, P2117, DOI 10.1097/QAD.0b013e328362395c; Nyitray AG, 2011, SEX TRANSM DIS, V38, P932, DOI 10.1097/OLQ.0b013e31822154f9; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Palefsky JM, 2000, SEMIN ONCOL, V27, P471; Pando MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039834; Quinn R, 2012, AIDS RES HUM RETROV, V28, P1734, DOI [10.1089/aid.2011.0307, 10.1089/AID.2011.0307]; Rosen BJ, 2015, SEX TRANSM INFECT; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Sadlier C, 2014, HIV MED; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; Soares CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102676; van Aar F, 2013, AIDS, V27, P2921, DOI 10.1097/01.aids.0000432541.67409.3c; van der Snoek EM, 2003, SEX TRANSM DIS, V30, P639, DOI 10.1097/01.OLQ.0000079520.04451.59; WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, SUMM REP HUM PAP REL	28	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139524	10.1371/journal.pone.0139524	http://dx.doi.org/10.1371/journal.pone.0139524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437318	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200033
J	Pauly, A; Wolf, C; Mayr, A; Lenz, B; Kornhuber, J; Friedland, K				Pauly, Anne; Wolf, Carolin; Mayr, Andreas; Lenz, Bernd; Kornhuber, Johannes; Friedland, Kristina			Effect of a Multi-Dimensional and Inter-Sectoral Intervention on the Adherence of Psychiatric Patients	PLOS ONE			English	Article							MEDICATION ADHERENCE; ANTIPSYCHOTIC MEDICATION; DEPRESSIVE-DISORDERS; SUBJECTIVE RESPONSE; DRUG-TREATMENT; SELF-REPORT; SCHIZOPHRENIA; NONADHERENCE; IMPACT; ANTIDEPRESSANTS	Background In psychiatry, hospital stays and transitions to the ambulatory sector are susceptible to major changes in drug therapy that lead to complex medication regimens and common non-adherence among psychiatric patients. A multi-dimensional and inter-sectoral intervention is hypothesized to improve the adherence of psychiatric patients to their pharmacotherapy. Methods 269 patients from a German university hospital were included in a prospective, open, clinical trial with consecutive control and intervention groups. Control patients (09/2012-03/2013) received usual care, whereas intervention patients (05/2013-12/2013) underwent a program to enhance adherence during their stay and up to three months after discharge. The program consisted of therapy simplification and individualized patient education (multidimensional component) during the stay and at discharge, as well as subsequent phone calls after discharge (inter-sectoral component). Adherence was measured by the "Medication Adherence Report Scale" (MARS) and the "Drug Attitude Inventory" (DAI). Results The improvement in the MARS score between admission and three months after discharge was 1.33 points (95% CI: 0.73-1.93) higher in the intervention group compared to controls. In addition, the DAI score improved 1.93 points (95% CI: 1.15-2.72) more for intervention patients. Conclusion These two findings indicate significantly higher medication adherence following the investigated multi-dimensional and inter-sectoral program.	[Pauly, Anne; Wolf, Carolin; Friedland, Kristina] Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany; [Lenz, Bernd; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, D-91054 Erlangen, Germany; [Mayr, Andreas] Univ Erlangen Nurnberg, Dept Med Informat Biometry & Epidemiol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Friedland, K (corresponding author), Univ Erlangen Nurnberg, Mol & Clin Pharm, D-91054 Erlangen, Germany.	Kristina.Leuner@fau.de	Kornhuber, Johannes/B-9613-2014; Friedland, Kristina/G-4651-2015	Kornhuber, Johannes/0000-0002-8096-3987; Friedland, Kristina/0000-0001-8603-5957; Lenz, Bernd/0000-0001-6086-0924; Mayr, Andreas/0000-0001-7106-9732	Forderinitiative Pharmazeutische Betreuung e.V.	Forderinitiative Pharmazeutische Betreuung e.V.	The study was funded by the "Forderinitiative Pharmazeutische Betreuung e.V." (www.foerderinitiative.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jumah KA, 2012, PATIENT PREFER ADHER, V6, P87, DOI 10.2147/PPA.S27436; Al-Saffar N, 2005, INT J PHARM PRACT, V13, P123, DOI 10.1211/0022357056181; ALY AF, 2013, KRANKENHAUSPHARMAZIE, V34, P240; AWAD AG, 1993, SCHIZOPHRENIA BULL, V19, P609, DOI 10.1093/schbul/19.3.609; Benkert O, 2013, COMPENDIUM PSYCHIAT; Bowskill R, 2007, J AFFECT DISORDERS, V100, P253, DOI 10.1016/j.jad.2006.10.018; Brain C, 2013, EUR NEUROPSYCHOPHARM, V23, P1754, DOI 10.1016/j.euroneuro.2013.09.001; Butler JA, 2004, TRANSPLANTATION, V77, P786, DOI 10.1097/01.TP.0000110412.20050.36; Canales PL, 2001, AM J HEALTH-SYST PH, V58, P1309, DOI 10.1093/ajhp/58.14.1309; Carow F, 2012, EUR J CLIN PHARMACOL, V68, P1191, DOI 10.1007/s00228-012-1229-2; Chapman SCE, 2013, CURR OPIN PSYCHIATR, V26, P446, DOI 10.1097/YCO.0b013e3283642da4; Chong WW, 2011, INT J CLIN PRACT, V65, P954, DOI 10.1111/j.1742-1241.2011.02746.x; Clatworthy Jane, 2009, Prim Care Respir J, V18, P300, DOI 10.4104/pcrj.2009.00037; Cramer JA, 1998, PSYCHIATR SERV, V49, P196, DOI 10.1176/ps.49.2.196; Cutrona SL, 2010, AM J MANAG CARE, V16, P929; de las Cuevas C, 2007, EUR J CLIN PHARMACOL, V63, P1063, DOI 10.1007/s00228-007-0358-5; De las Cuevas C, 2014, EUR J CLIN PHARMACOL, V70, P89, DOI 10.1007/s00228-013-1582-9; Demoz Z, 2014, PATIENT PREFER ADHER, V8, P1329, DOI 10.2147/PPA.S69702; Farooq S, 2014, NEUROPSYCH DIS TREAT, V10, P1069, DOI 10.2147/NDT.S40777; Finley PR, 2002, AM J HEALTH-SYST PH, V59, P1518, DOI 10.1093/ajhp/59.16.1518; Finley PR, 2003, PHARMACOTHERAPY, V23, P1175, DOI 10.1592/phco.23.10.1175.32760; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; HOGAN TP, 1992, PSYCHOL MED, V22, P347, DOI 10.1017/S0033291700030282; HOGAN TP, 1983, PSYCHOL MED, V13, P177, DOI 10.1017/S0033291700050182; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R., 2005, CONCORDANCE ADHERENC, P1, DOI DOI 10.1007/SPRINGERREFERENCE_64584; Horne R, 1993, J SOC ADMIN PHARM, V10, P150; Jonsdottir H, 2010, J CLIN PSYCHOPHARM, V30, P169, DOI 10.1097/JCP.0b013e3181d2191e; Julius RJ, 2009, J PSYCHIATR PRACT, V15, P34, DOI 10.1097/01.pra.0000344917.43780.77; Kasper S, 2009, INT J PSYCHIAT CLIN, V13, P245, DOI 10.3109/13651500903359861; Kranke P, 2008, KARDIOTECHNIK, V17, P114; Masand PS, 2006, CURR CLIN PHARMACOL, V1, P47, DOI 10.2174/157488406775268255; Medina E, 2012, PATIENT PREFER ADHER, V6, P623, DOI 10.2147/PPA.S34345; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; Mohamed S, 2014, SOC PSYCH PSYCH EPID, V49, P1063, DOI 10.1007/s00127-014-0824-1; Morken G, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-32; Nielsen RE, 2012, EUR NEUROPSYCHOPHARM, V22, P747, DOI 10.1016/j.euroneuro.2012.02.008; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rivero-Santana A, 2013, PATIENT PREFER ADHER, V7, P151, DOI 10.2147/PPA.S39382; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; Rubio-Valera M, 2011, ANN PHARMACOTHER, V45, P39, DOI 10.1345/aph.1P429; Rummel-Kluge C, 2008, AUST NZ J PSYCHIAT, V42, P382, DOI 10.1080/00048670801961107; Stange D, 2013, J MANAGE CARE PHARM, V19, P396, DOI 10.18553/jmcp.2013.19.5.396; Velligan DI, 2007, PSYCHIAT SERV, V58, P1187, DOI 10.1176/appi.ps.58.9.1187; Viktil KK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001461; Viswanathan M, 2012, ANN INTERN MED; World Health Organisation, 2003, ADHERENCE LONG TERM; Zullig LL, 2013, JAMA-J AM MED ASSOC, V310, P2611, DOI 10.1001/jama.2013.282818	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139302	10.1371/journal.pone.0139302	http://dx.doi.org/10.1371/journal.pone.0139302			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0PR	26437449	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200016
J	Bielenberg, DG; Rauh, B; Fan, SH; Gasic, K; Abbott, AG; Reighard, GL; Okie, WR; Wells, CE				Bielenberg, Douglas Gary; Rauh, Bradley; Fan, Shenghua; Gasic, Ksenija; Abbott, Albert Glenn; Reighard, Gregory Lynn; Okie, William R.; Wells, Christina Elizabeth			Genotyping by Sequencing for SNP-Based Linkage Map Construction and QTL Analysis of Chilling Requirement and Bloom Date in Peach [Prunus persica (L.) Batsch]	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; PHENOLOGICAL TRAITS; GENETIC DETERMINISM; HEAT REQUIREMENT; APRICOT; INHERITANCE; BUDBREAK; DORMANCY	Low-cost, high throughput genotyping methods are crucial to marker discovery and marker-assisted breeding efforts, but have not been available for many 'specialty crops' such as fruit and nut trees. Here we apply the Genotyping-By-Sequencing (GBS) method developed for cereals to the discovery of single nucleotide polymorphisms (SNPs) in a peach F-2 mapping population. Peach is a genetic and genomic model within the Rosaceae and will provide a template for the use of this method with other members of this family. Our F-2 mapping population of 57 genotypes segregates for bloom time (BD) and chilling requirement (CR) and we have extensively phenotyped this population. The population derives from a selfed F-1 progeny of a cross between 'Hakuho' (high CR) and 'UFGold' (low CR). We were able to successfully employ GBS and the TASSEL GBS pipeline without modification of the original methodology using the ApeKI restriction enzyme and multiplexing at an equivalent of 96 samples per Illumina HiSeq 2000 lane. We obtained hundreds of SNP markers which were then used to construct a genetic linkage map and identify quantitative trait loci (QTL) for BD and CR.	[Bielenberg, Douglas Gary; Wells, Christina Elizabeth] Clemson Univ, Dept Biol Sci, Coll Agr Forestry & Life Sci, Clemson, SC 29634 USA; [Rauh, Bradley] Clemson Univ, Adv Plant Technol Program, Clemson, SC 29634 USA; [Fan, Shenghua; Abbott, Albert Glenn] Clemson Univ, Dept Biochem & Genet, Coll Agr Forestry & Life Sci, Clemson, SC 29634 USA; [Gasic, Ksenija; Reighard, Gregory Lynn] Clemson Univ, Dept Agr & Environm Sci, Coll Agr Forestry & Life Sci, Clemson, SC 29634 USA; [Okie, William R.] USDA ARS, SE Fruit & Tree Nut Res Lab, Byron, GA 31008 USA	Clemson University; Clemson University; Clemson University; Clemson University; United States Department of Agriculture (USDA)	Bielenberg, DG (corresponding author), Clemson Univ, Dept Biol Sci, Coll Agr Forestry & Life Sci, Clemson, SC 29634 USA.	dbielen@clemson.edu	Bielenberg, Douglas/G-3893-2010; Gasic, Ksenija/AAN-6234-2021; Fan, Shenghua/E-6400-2016; Gasic, Ksenija/H-8254-2017	Bielenberg, Douglas/0000-0002-4853-2984; Gasic, Ksenija/0000-0003-4391-5262; Gasic, Ksenija/0000-0003-4391-5262	Israel United States Binational Agricultural Research and Development program project [US-3746-05R]; USDA-NRI CSREES grant [2007-35304-17896]	Israel United States Binational Agricultural Research and Development program project; USDA-NRI CSREES grant	This research was supported by the Israel United States Binational Agricultural Research and Development program project US-3746-05R to AGA, GLR and DGB and USDA-NRI CSREES grant 2007-35304-17896 to DGB. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba P, 2014, THEOR APPL GENET, V127, P73, DOI 10.1007/s00122-013-2202-x; Bielenberg DG, 2008, TREE GENET GENOMES, V4, P495, DOI 10.1007/s11295-007-0126-9; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Campoy JA, 2011, PLANT MOL BIOL REP, V29, P404, DOI 10.1007/s11105-010-0242-9; Castede S, 2014, NEW PHYTOL, V202, P703, DOI 10.1111/nph.12658; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dennis FG, 2003, HORTSCIENCE, V38, P347, DOI 10.21273/HORTSCI.38.3.347; Dirlewanger E, 2004, P NATL ACAD SCI USA, V101, P9891, DOI 10.1073/pnas.0307937101; Dirlewanger E, 2012, HEREDITY, V109, P280, DOI 10.1038/hdy.2012.38; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fan S, 2010, NEW PHYTOL, V185, P917, DOI 10.1111/j.1469-8137.2009.03119.x; Gardner KM, 2014, G3-GENES GENOM GENET, V4, P1681, DOI 10.1534/g3.114.011023; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Howad W, 2005, GENETICS, V171, P1305, DOI 10.1534/genetics.105.043661; Hyma KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134880; Jimenez S, 2010, PLANT MOL BIOL, V73, P157, DOI 10.1007/s11103-010-9608-5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Luedeling E, 2011, INT J BIOMETEOROL, V55, P411, DOI 10.1007/s00484-010-0352-y; Martinez-Garcia PJ, 2013, TREE GENET GENOMES, V9, P19, DOI 10.1007/s11295-012-0522-7; Okie W.R., 1998, HDB PEACH NECTARINE; Okie WR, 2011, HORTSCIENCE, V46, P245, DOI 10.21273/HORTSCI.46.2.245; Olukolu BA, 2009, GENOME, V52, P819, DOI [10.1139/G09-050, 10.1139/g09-050]; Romeu JF, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-52; Rowe HC, 2011, MOL ECOL, V20, P3499, DOI 10.1111/j.1365-294X.2011.05197.x; Sanchez-Perez R, 2012, TREE GENET GENOMES, V8, P379, DOI 10.1007/s11295-011-0448-5; Sherman WB, 1997, FRUIT VARIETIES J, V51, P76; Trainin T, 2013, TREE GENET GENOMES, V9, P753, DOI 10.1007/s11295-012-0590-8; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2009, MAPQTL 6 SOFTWARE MA; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; WEINBERGER JH, 1950, P AM SOC HORTIC SCI, V56, P122; Wells CE, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0436-2	36	81	81	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139406	10.1371/journal.pone.0139406	http://dx.doi.org/10.1371/journal.pone.0139406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430886	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700053
J	Cakir, O; Turgut-Kara, N; Ari, S; Zhang, B				Cakir, Ozgur; Turgut-Kara, Neslihan; Ari, Sule; Zhang, Baohong			De Novo Transcriptome Assembly and Comparative Analysis Elucidate Complicated Mechanism Regulating Astragalus chrysochlorus Response to Selenium Stimuli	PLOS ONE			English	Article							CYCLOARTANE TRITERPENE GLYCOSIDES; HYPERACCUMULATION; IDENTIFICATION; EXPRESSION; TOLERANCE; EVOLUTION; ROOTS; CDNA	Astragalus species are medicinal plants that are used in the world for years. Some Astragalus species are known for selenium accumulation and tolerance and one of them is Astragalus chrysochlorus, a secondary selenium accumulator. In this study, we employed Illumina deep sequencing technology for the first time to de novo assemble A. chrysochlorus transcriptome and identify the differentially expressed genes after selenate treatment. Totally, 59,656 unigenes were annotated with different databases and 53,960 unigenes were detected in NR database. Transcriptome in A. chrysochlorus is closer to Glycine max than other plant species with 43,1 percentage of similarity. Annotated unigenes were also used for gene ontology enrichment and pathway enrichment analysis. The most significant genes and pathways were ABC transporters, plant pathogen interaction, biosynthesis of secondary metabolites and carbohydrate metabolism. Our results will help to enlighten the selenium accumulation and tolerance mechanisms, respectively in plants.	[Cakir, Ozgur; Turgut-Kara, Neslihan; Ari, Sule] Istanbul Univ, Dept Mol Biol & Genet, Fac Sci, TR-34134 Istanbul, Turkey; [Ari, Sule] Istanbul Univ, Res & Applicat Ctr Biotechnol & Genet Engn, TR-34134 Istanbul, Turkey; [Cakir, Ozgur; Zhang, Baohong] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA	Istanbul University; Istanbul University; Istanbul University - Cerrahpasa; University of North Carolina; East Carolina University	Cakir, O (corresponding author), Istanbul Univ, Dept Mol Biol & Genet, Fac Sci, TR-34134 Istanbul, Turkey.	ozgurckr@istanbul.edu.tr	Çakır, Özgür/AAX-1485-2021; Çakır, Özgür/A-8998-2018; Zhang, Baohong/O-4948-2016; ARI, SULE/B-4143-2018; Kara, Neslihan Turgut/B-4846-2015	Çakır, Özgür/0000-0003-3075-683X; Çakır, Özgür/0000-0003-3075-683X; Kara, Neslihan Turgut/0000-0001-5355-4937	Research Fund of The Istanbul University [39427]; International Postdoctoral Research Fellowship Programme [TUBITAK-BIDEB 2219]	Research Fund of The Istanbul University(Istanbul University); International Postdoctoral Research Fellowship Programme	This work was supported by the Research Fund of The Istanbul University, Project No: 39427. O. Cakir received financial support from TUBITAK-BIDEB 2219-International Postdoctoral Research Fellowship Programme for this study.	Alford ER, 2014, AM J BOT, V101, P1895, DOI 10.3732/ajb.1400223; Ari S, 2010, ACTA PHYSIOL PLANT, V32, P1085, DOI 10.1007/s11738-010-0500-3; Bedir E, 1998, J NAT PROD, V61, P1469, DOI 10.1021/np9801763; Cakir O, 2016, PLANT BIOTECHNOL J, V14, P543, DOI 10.1111/pbi.12397; Cakir O, 2013, PLANT OMICS, V6, P100; Calis I, 1997, PLANTA MED, V63, P183, DOI 10.1055/s-2006-957642; Cappa JJ, 2015, NEW PHYTOL, V205, P583, DOI 10.1111/nph.13071; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Freeman JL, 2006, PLANT PHYSIOL, V142, P124, DOI 10.1104/pp.106.081158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hung CY, 2012, MOL BIOL REP, V39, P7635, DOI 10.1007/s11033-012-1598-8; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kabala K, 2005, ACTA PHYSIOL PLANT, V27, P559, DOI 10.1007/s11738-005-0062-y; Li XX, 2014, MOLECULES, V19, P18850, DOI 10.3390/molecules191118850; Liu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095831; Machado Moara, 2011, Investig Genet, V2, P3, DOI 10.1186/2041-2223-2-3; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pickering IJ, 2003, PLANT PHYSIOL, V131, P1460, DOI 10.1104/pp.014787; Schiavon M, 2015, FRONT PLANT SCI, V6, P1, DOI 10.3389/fpls.2015.00002; SHRIFT A, 1965, BIOCHIM BIOPHYS ACTA, V100, P65, DOI 10.1016/0304-4165(65)90428-9; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Sura-de Jong M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00113; Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI [10.1016/S0005-2736(00)00132-2, 10.1199/tab.0153]; Turgut-Kara N, 2015, PLANT BIOSYST, V149, P329, DOI 10.1080/11263504.2013.824518; Valmonte GR, 2014, PLANT CELL PHYSIOL, V55, P551, DOI 10.1093/pcp/pct200; Van Hoewyk D, 2008, PHYSIOL PLANTARUM, V132, P236, DOI 10.1111/j.1399-3054.2007.01002.x; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X	30	13	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0135677	10.1371/journal.pone.0135677	http://dx.doi.org/10.1371/journal.pone.0135677			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431547	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700002
J	Chen, S; Li, WJ; Zhang, ZL; Min, HY; Li, H; Wang, HQ; Zhuang, YG; Chen, YZ; Gao, CJ; Peng, H				Chen, Sheng; Li, Wenjie; Zhang, Zhonglin; Min, Hongye; Li, Hong; Wang, Huiqi; Zhuang, Yugang; Chen, Yuanzhuo; Gao, Chengjin; Peng, Hu			Evaluating the Quality of Cardiopulmonary Resuscitation in the Emergency Department by Real-Time Video Recording System	PLOS ONE			English	Article							MECHANICAL CHEST COMPRESSOR; HOSPITAL CARDIAC-ARREST; BASIC LIFE-SUPPORT; CPR; RETENTION; TRANSPORT; OUTCOMES; NURSES; SKILLS	Objectives To compare cardiopulmonary resuscitation (CPR) quality between manual CPR and miniaturized chest compressor (MCC) CPR. To improve CPR quality through evaluating the quality of our clinical work of resuscitation by real-time video recording system. Methods The study was a retrospective observational study of adult patients who experienced CPR at the emergency department of Shanghai Tenth People's Hospital from March 2013 to August 2014. All the performance of CPR were checked back by the record of "digital real-time video recording system". Average chest compression rate, actual chest compression rate, the percentage of hands-off period, time lag from patient arrival to chest compression, time lag from patient arrival to manual ventilation, time lag from patient arrival to first IV establish were compared. Causes of chest compression hands-off time were also studied. Results 112 cases of resuscitation attempts were obtained. Average chest compression rate was over 100 compression per minute (cpm) in the majority of cases. However, indicators such as percentage of hands-off periods, time lag from patient arrival to the first manual ventilation and time lag from patient arrival to the first IV establish seemed to be worse in the manual CPR group compared to MCC CPR group. The saving of operators change time seemed to counteract the time spent on MCC equipment. Indicators such as percentage of hands-off periods, time lag between patient arrival to the first chest compression, time lag between patient arrival to the first manual ventilation and time lag from patient arrival to the first IV establish may influence the survival. Conclusion Our CPR quality remained to be improved. MCC may have a potentially positive role in CPR.	[Chen, Sheng; Li, Wenjie; Zhang, Zhonglin; Wang, Huiqi; Zhuang, Yugang; Chen, Yuanzhuo; Gao, Chengjin; Peng, Hu] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Emergency Dept, Shanghai 200092, Peoples R China; [Min, Hongye; Li, Hong] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Nursing, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Chen, YZ (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Emergency Dept, Shanghai 200092, Peoples R China.	chenyuanzhuo021@hotmail.com; denkepeng@189.cn	Li, Wenjie/ABB-7358-2021	Li, Wenjie/0000-0003-3411-0868	National Natural Science Foundation of China [81000024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (No. 81000024).	Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; [Anonymous], 2010, 2010 AM HEART ASS S; Aufderheide TP, 2005, RESUSCITATION, V64, P353, DOI 10.1016/j.resuscitation.2004.10.007; Berg RA, 2010, CIRCULATION, V122, pS685, DOI 10.1161/CIRCULATIONAHA.110.970939; Bonnemeier H, 2011, RESUSCITATION, V82, P155, DOI 10.1016/j.resuscitation.2010.10.019; Brooks SC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007260.pub2; Broomfield R, 1996, J ADV NURS, V23, P1016; Chen W, 2012, CRIT CARE MED, V40, P3007, DOI 10.1097/CCM.0b013e31825d924d; Cunningham LM, 2012, AM J EMERG MED, V30, P1630, DOI 10.1016/j.ajem.2012.02.015; Jiang C, 2010, RESUSCITATION, V81, P1664, DOI 10.1016/j.resuscitation.2010.06.023; KAYE W, 1986, CRIT CARE MED, V14, P620, DOI 10.1097/00003246-198607000-00007; Kern K B., 2000, BAILLIERE CLIN ANAES, V14, P59; Li YQ, 2010, CRIT CARE MED, V38, P910, DOI 10.1097/CCM.0b013e3181cc4944; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Odegaard S, 2009, RESUSCITATION, V80, P843, DOI 10.1016/j.resuscitation.2009.03.032; Ong MEH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-39; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Ristagno G, 2008, RESUSCITATION, V76, P191, DOI 10.1016/j.resuscitation.2007.07.004; Sutton RM, 2014, RESUSCITATION, V85, P70, DOI 10.1016/j.resuscitation.2013.08.014; Sutton RM, 2013, RESUSCITATION, V84, P1680, DOI 10.1016/j.resuscitation.2013.07.029; Tipton M, 2007, RESUSCITATION, V75, P332, DOI 10.1016/j.resuscitation.2007.04.027; Wang HC, 2007, RESUSCITATION, V74, P453, DOI 10.1016/j.resuscitation.2007.01.018; Westfall M, 2013, CRIT CARE MED, V41, P1782, DOI 10.1097/CCM.0b013e31828a24e3; Xu JF, 2014, RESUSCITATION, V85, P683, DOI 10.1016/j.resuscitation.2014.01.014; Yang ZF, 2014, AM J EMERG MED, V32, P50, DOI 10.1016/j.ajem.2013.09.043; Zevitz M E., 2003, VENTRICULAR FIBRILLA	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139825	10.1371/journal.pone.0139825	http://dx.doi.org/10.1371/journal.pone.0139825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431420	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700120
J	Ching, SM; Yee, A; Ramachandran, V; Lim, SMS; Sulaiman, WAW; Foo, YL; Hoo, FK				Ching, Siew Mooi; Yee, Anne; Ramachandran, Vasudevan; Lim, Sazlyna Mohd Sazlly; Sulaiman, Wan Aliaa Wan; Foo, Yoke Loong; Hoo, Fan Kee			Validation of a Malay Version of the Smartphone Addiction Scale among Medical Students in Malaysia	PLOS ONE			English	Article							MOBILE PHONE DEPENDENCE; INTERNET ADDICTION; PROBLEMATIC INTERNET; COLLEGE-STUDENTS; LIFE-STYLE; HEALTH; SYMPTOMS; STRESS	Introduction This study was initiated to determine the psychometric properties of the Smart Phone Addiction Scale (SAS) by translating and validating this scale into the Malay language (SAS-M), which is the main language spoken in Malaysia. This study can distinguish smart phone and internet addiction among multi-ethnic Malaysian medical students. In addition, the reliability and validity of the SAS was also demonstrated. Materials and Methods A total of 228 participants were selected between August 2014 and September 2014 to complete a set of questionnaires, including the SAS and the modified Kimberly Young Internet addiction test (IAT) in the Malay language. Results There were 99 males and 129 females with ages ranging from 19 to 22 years old (21.7 +/- 1.1) included in this study. Descriptive and factor analyses, intra-class coefficients, t-tests and correlation analyses were conducted to verify the reliability and validity of the SAS. Bartlett's test of sphericity was significant (p < 0.01), and the Kaiser-Mayer-Olkin measure of sampling adequacy for the SAS-M was 0.92, indicating meritoriously that the factor analysis was appropriate. The internal consistency and concurrent validity of the SAS-M were verified (Cronbach's alpha = 0.94). All of the subscales of the SAS-M, except for positive anticipation, were significantly related to the Malay version of the IAT. Conclusions This study developed the first smart phone addiction scale among medical students. This scale was shown to be reliable and valid in the Malay language.	[Ching, Siew Mooi] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia; [Ching, Siew Mooi; Ramachandran, Vasudevan] Univ Putra Malaysia, Malaysian Res Inst Ageing, Serdang 43400, Selangor, Malaysia; [Yee, Anne] Univ Malaya, Fac Med, Dept Psychol Med, Ctr Addict Sci, Kuala Lumpur, Malaysia; [Lim, Sazlyna Mohd Sazlly; Sulaiman, Wan Aliaa Wan; Foo, Yoke Loong; Hoo, Fan Kee] Univ Putra Malaysia, Dept Med, Fac Med & Hlth Sci, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Malaya; Universiti Putra Malaysia	Ching, SM (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.	sm_ching@upm.edu.my	Ching, Siew Mooi/I-5817-2013; Hway Ann, Yee/D-7968-2012; Wan Sulaiman, Wan Aliaa Binti/AAF-8072-2021; Lim, Sazlyna Mohd Sazlly/AAN-3407-2021; ramachandran, vasudevan/C-3395-2008; Hoo, Fan Kee/J-2591-2013	Ching, Siew Mooi/0000-0002-4425-7989; Hway Ann, Yee/0000-0002-9835-6798; Wan Sulaiman, Wan Aliaa Binti/0000-0003-4969-0308; Lim, Sazlyna Mohd Sazlly/0000-0001-7977-5957; ramachandran, vasudevan/0000-0003-0044-1626; Hoo, Fan Kee/0000-0003-1687-627X	UPM research fund [UPM/700-2/1/GP- IPM/2014/9436500]	UPM research fund	The authors also would like to thank UPM research fund (grant no: UPM/700-2/1/GP- IPM/2014/9436500) for the financial support. The URL is http://www.rmc.upm.edu.my/.	Acharya JP, 2013, J COMMUNITY MED HLTH, V3, P21; [Anonymous], 2014, HAND PHON US SURV 20; Beranuy M, 2009, COMPUT HUM BEHAV, V25, P1182, DOI 10.1016/j.chb.2009.03.001; Billieux J, 2007, APPL COGNITIVE PSYCH, V21, P527, DOI 10.1002/acp.1289; Derbyshire E, 2013, INT J TELEMED APPL, V2013, DOI 10.1155/2013/782074; Elias H, 2011, PROCD SOC BEHV, V29, DOI 10.1016/j.sbspro.2011.11.288; Emad AS, 2015, INT J COMPUTER NETWO, V2, P52; Ezoe S, 2009, SOC BEHAV PERSONAL, V37, P231, DOI 10.2224/sbp.2009.37.2.231; Gorsuch R., 1983, FACTOR ANAL; Guan NC, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2210, DOI 10.1177/1010539512447808; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Jenaro C, 2007, ADDICT RES THEORY, V15, P309, DOI 10.1080/16066350701350247; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Khazaal Y, 2008, CYBERPSYCHOL BEHAV, V11, P703, DOI 10.1089/cpb.2007.0249; Ko CH, 2012, EUR PSYCHIAT, V27, P1, DOI 10.1016/j.eurpsy.2010.04.011; Kwon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056936; Lane N, 2011, 5 INT C PERV COMP TE; Lin YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098312; Malaysia Communications and Multimedia Commission, 2012, HAND PHON US SURV 20; Mosa AM, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-67; Niemz K, 2005, CYBERPSYCHOL BEHAV, V8, P562, DOI 10.1089/cpb.2005.8.562; Osman MA, 2012, INT J NEW COMPUTER A, V2, P274; Park N, 2012, CYBERPSYCH BEH SOC N, V15, P491, DOI 10.1089/cyber.2011.0580; Patrick K, 2008, AM J PREV MED, V35, P177, DOI 10.1016/j.amepre.2008.05.001; Rashvand HF, 2015, MULTIMEDIA SYST, V21, P103, DOI 10.1007/s00530-013-0335-z; Sarwar M., 2013, EUR J SCI RES, V98, P216; Thomee S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-66; Toda M, 2006, SOC BEHAV PERSONAL, V34, P1277, DOI 10.2224/sbp.2006.34.10.1277; Weinstein A, 2010, AM J DRUG ALCOHOL AB, V36, P277, DOI 10.3109/00952990.2010.491880; Ybama ML, 2004, CYBERPSYCHOL BEHAV, V7, P247; Yen CF, 2009, J ADOLESCENCE, V32, P863, DOI 10.1016/j.adolescence.2008.10.006; Young KS., 1998, CYBERPSYCHOL BEHAV, V1, P25, DOI [10.1089/cpb.1998.1.25, DOI 10.1089/CPB.1998.1.25]	33	54	57	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139337	10.1371/journal.pone.0139337	http://dx.doi.org/10.1371/journal.pone.0139337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431511	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700044
J	Korner, A; Coroiu, A; Copeland, L; Gomez-Garibello, C; Albani, C; Zenger, M; Brahler, E				Koerner, Annett; Coroiu, Adina; Copeland, Laura; Gomez-Garibello, Carlos; Albani, Cornelia; Zenger, Markus; Braehler, Elmar			The Role of Self-Compassion in Buffering Symptoms of Depression in the General Population	PLOS ONE			English	Article							MENTAL-HEALTH; CHILDHOOD MALTREATMENT; VALIDITY; ACCESS; PHQ-9; MINDFULNESS; ASSOCIATION; VALIDATION; RUMINATION; CRITICISM	Self-compassion, typically operationalized as the total score of the Self-Compassion Scale (SCS; Neff, 2003b), has been shown to be related to increased psychological well-being and lower depression in students of the social sciences, users of psychology websites and psychotherapy patients. The current study builds on the existing literature by examining the link between self-compassion and depressive symptomatology in a sample representative of the German general population (n = 2,404). The SCS subscales of self-judgment, isolation, and over-identification, and the "self-coldness", composite score, which encompass these three negative subscales, consistently differed between subsamples of individuals without any depressive symptoms, with any depressive syndromes, and with major depressive disorder. The contribution of the positive SCS subscales of self-kindness, common humanity, and mindfulness to the variance in depressive symptomatology was almost negligible. However, when combined to a "self-compassion composite", the positive SCS subscales significantly moderated the relationship between "self-coldness" and depressive symptoms in the general population. This speaks for self-compassion having the potential to buffer self-coldness related to depression-providing an argument for interventions that foster self-caring, kind, and forgiving attitudes towards oneself.	[Koerner, Annett; Coroiu, Adina; Copeland, Laura; Gomez-Garibello, Carlos] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Koerner, Annett] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Koerner, Annett] McGill Univ, Jewish Gen Hosp, Louise Granofsky Psychosocial Oncol Program, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada; [Koerner, Annett] McGill Univ, Ctr Hlth, Psychosocial Oncol Program, Montreal, PQ, Canada; [Albani, Cornelia; Zenger, Markus; Braehler, Elmar] Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany; [Zenger, Markus] Univ Appl Sci Magdeburg & Stendal, Fac Appl Human Studies, Stendal, Germany; [Braehler, Elmar] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany	McGill University; McGill University; McGill University; McGill University; Leipzig University; Johannes Gutenberg University of Mainz	Zenger, M (corresponding author), Univ Leipzig, Dept Med Psychol & Med Sociol, D-04109 Leipzig, Germany.	markus.zenger@hs-magdeburg.de	Braehler, Elmar/C-6535-2009	Braehler, Elmar/0000-0002-2648-2728	Open Access Publishing Program of the University of Leipzig, Germany; German Research Foundation (DFG)	Open Access Publishing Program of the University of Leipzig, Germany; German Research Foundation (DFG)(German Research Foundation (DFG))	This manuscript was supported by the Open Access Publishing Program of the University of Leipzig, Germany, and the German Research Foundation (DFG). The funders had no role in the study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Akin A., 2010, INT ONLINE J ED SCI, V2, P702; Amireault S, 2015, J CANC SURVIV, P1; Barnard LK, 2011, REV GEN PSYCHOL, V15, P289, DOI 10.1037/a0025754; Barraca J, 2012, INT J CLIN HLTH PSYC, V12, P109; Beucke JC, 2013, JAMA PSYCHIAT, V70, P619, DOI 10.1001/jamapsychiatry.2013.173; Bradley S, 2014, CAN PSYCHOL, V55, P80, DOI 10.1037/a0036453; Cohen KR, 2014, CAN PSYCHOL, V55, P126, DOI 10.1037/a0036499; Cox DW, 2014, CAN PSYCHOL, V55, P68, DOI 10.1037/a0036296; Deci E.L., 1995, EFFICACY AGENCY SELF, P31, DOI [DOI 10.1007/978-1-4899-1280-0_3, 10.1007/978-1-4899-1280-0_3]; Edwards M, 2014, J SPEC GROUP WORK, V39, P145, DOI 10.1080/01933922.2014.891683; Ferguson LJ, 2014, J SPORT EXERCISE PSY, V36, P203, DOI 10.1123/jsep.2013-0096; Gaziano C., 2008, ENCY SURVEY RES METH; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Gilbert P, 2011, PSYCHOL PSYCHOTHER-T, V84, P239, DOI [10.1348/147608310X526511, 10.1111/j.2044-8341.2011.02046.x]; Hayes A.F., 2012, CISC VIS NETW IND GL; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hupfeld J, 2011, Z KL PSYCH PSYCHOTH, V40, P115, DOI 10.1026/1616-3443/a000088; Kelly AC, 2010, J SOC CLIN PSYCHOL, V29, P727, DOI 10.1521/jscp.2010.29.7.727; Kessler RC, 2012, PSYCHIAT CLIN N AM, V35, P1, DOI 10.1016/j.psc.2011.11.005; Kleine-Budde K, 2013, J AFFECT DISORDERS, V147, P137, DOI 10.1016/j.jad.2012.10.024; Kliem S, 2014, J AFFECT DISORDERS, V156, P236, DOI 10.1016/j.jad.2013.11.024; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Koch A., 1994, GEWICHTUNG UMFRAGEPR, P99; Krieger T, 2013, BEHAV THER, V44, P501, DOI 10.1016/j.beth.2013.04.004; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Kutner M. H., 2004, APPL LINEAR REGRESSI; Kuyken W, 2010, BEHAV RES THER, V48, P1105, DOI 10.1016/j.brat.2010.08.003; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Leary MR, 2010, SELF COMPASSIO UNPUB; MacBeth A, 2012, CLIN PSYCHOL REV, V32, P545, DOI 10.1016/j.cpr.2012.06.003; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Mills A, 2007, CLIN PSYCHOL PSYCHOT, V14, P358, DOI 10.1002/cpp.537; Mosewich AD, 2011, J SPORT EXERCISE PSY, V33, P103, DOI 10.1123/jsep.33.1.103; Neff KD., 2009, HDB INDIVIDUAL DIFFE, P561; Neff K, 2003, SELF IDENTITY, V2, P85, DOI 10.1080/15298860390129863; Neff KD, 2008, J CROSS CULT PSYCHOL, V39, P267, DOI 10.1177/0022022108314544; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Neff KD, 2007, J RES PERS, V41, P139, DOI 10.1016/j.jrp.2006.03.004; Neff KD, 2005, SELF IDENTITY, V4, P263, DOI 10.1080/13576500444000317; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Ng JYY, 2012, PERSPECT PSYCHOL SCI, V7, P325, DOI 10.1177/1745691612447309; Noorbala Fatemeh, 2013, Iran J Psychiatry, V8, P113; Nunes M, 2014, CAN PSYCHOL, V55, P101, DOI 10.1037/a0036476; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Raes F, 2010, PERS INDIV DIFFER, V48, P757, DOI 10.1016/j.paid.2010.01.023; Shapira LB, 2010, J POSIT PSYCHOL, V5, P377, DOI 10.1080/17439760.2010.516763; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Statistisches Bundesamt, 2013, STAT JB DEUTSCHL INT; Talbot F, 2014, CAN PSYCHOL, V55, P75, DOI 10.1037/a0036449; Tanaka M, 2011, CHILD ABUSE NEGLECT, V35, P887, DOI 10.1016/j.chiabu.2011.07.003; Van Dam NT, 2011, J ANXIETY DISORD, V25, P123, DOI 10.1016/j.janxdis.2010.08.011; Vettese LC, 2011, INT J MENT HEALTH AD, V9, P480, DOI 10.1007/s11469-011-9340-7; Wong CCY, 2013, J COUNS PSYCHOL, V60, P162, DOI 10.1037/a0030451; World Health Organization, FACTS FIG PREV MENT; World Health Organization, DEPR 2012; Yarnell LM, 2013, SELF IDENTITY, V12, P146, DOI 10.1080/15298868.2011.649545; Ying YW, 2009, J SOC WORK EDUC, V45, P309, DOI 10.5175/JSWE.2009.200700072	59	67	67	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0136598	10.1371/journal.pone.0136598	http://dx.doi.org/10.1371/journal.pone.0136598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26430893	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700004
J	Martin, CW; Hollis, LO; Turner, E				Martin, Charles W.; Hollis, Lauris O.; Turner, Eugene			Effects of Oil-Contaminated Sediments on Submerged Vegetation: An Experimental Assessment of Ruppia maritima	PLOS ONE			English	Article							LOUISIANA SALT MARSHES; CRUDE-OIL; REPRODUCTIVE STRATEGIES; AQUATIC VEGETATION; MACONDO OIL; MARINA L; SPILL; GULF; ESTUARINE; IMPACTS	Oil spills threaten the productivity of ecosystems through the degradation of coastal flora and the ecosystem services these plants provide. While lab and field investigations have quantified the response of numerous species of emergent vegetation to oil, the effects on submerged vegetation remain uncertain. Here, we discuss the implications of oil exposure for Ruppia maritima, one of the most common species of submerged vegetation found in the region affected by the recent Deepwater Horizon oil spill. We grew R. maritima in a range of manipulated sediment oil concentrations: 0, 0.26, 0.53, and 1.05 mL oil/L tank volume, and tracked changes in growth (wet weight and shoot density/length), reproductive activity (inflorescence and seed production), root characteristics (mass, length, diameter, and area), and uprooting force of plants. While no statistical differences were detected in growth, plants exhibited significant changes to reproductive output, root morphology, and uprooting force. We found significant reductions in inflorescences and fruiting bodies at higher oil concentrations. In addition, the roots growing in the high oil were shorter and wider. Plants in medium and high oil required less force to uproot. A second experiment was performed to separate the effects of root morphology and oiled sediment properties and indicated that there were also changes to sediment cohesion that contributed to a reduction in uprooting forces in medium and high oil. Given the importance of sexual reproduction for these plants, oil contamination may have substantial population-level effects. Moreover, areas containing buried oil may be more susceptible to high energy storm events due to the reduction in uprooting force of foundation species such as R. maritima.	[Martin, Charles W.; Hollis, Lauris O.; Turner, Eugene] Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Martin, CW (corresponding author), Louisiana State Univ, Sch Coast & Environm, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	martin.charles.w@gmail.com		Martin, Charles/0000-0001-9240-3824	Gulf of Mexico Research Initiative	Gulf of Mexico Research Initiative	This work was funded by a grant from the Gulf of Mexico Research Initiative (http://gulfresearchinitiative.org/) to the Coastal Waters Consortium (http://cwc.lumcon.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Able KW, 2015, ESTUAR COAST, V38, P1385, DOI 10.1007/s12237-014-9890-6; AGAMI M, 1988, OECOLOGIA, V76, P83, DOI 10.1007/BF00379604; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Boufadel MC, 2010, ENVIRON SCI TECHNOL, V44, P7418, DOI 10.1021/es102046n; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Chanton J, 2015, ENVIRON SCI TECHNOL, V49, P847, DOI 10.1021/es5046524; Chaplin GI, 2009, ESTUAR COAST, V32, P319, DOI 10.1007/s12237-008-9117-9; Chesney EJ, 2000, ECOL APPL, V10, P350; CHILDERS DL, 1990, ESTUARIES, V13, P404, DOI 10.2307/1351785; Cho H.J., 2009, HDB ENV QUALITY, P1; Cho HJ, 2005, AQUAT BOT, V81, P37, DOI 10.1016/j.aquabot.2004.10.002; CONACHER CA, 1994, AQUAT BOT, V49, P47, DOI 10.1016/0304-3770(94)90005-1; Connell EL, 1999, AQUAT BOT, V63, P219, DOI 10.1016/S0304-3770(98)00126-0; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Culbertson JB, 2007, MAR POLLUT BULL, V54, P955, DOI 10.1016/j.marpolbul.2007.02.015; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; De La Cruz A. A., 1981, J E MITCHELL SCI SOC, V97, P14; DELAUNE RD, 1979, ENVIRON POLLUT, V20, P21, DOI 10.1016/0013-9327(79)90050-8; DESBONNET A, 1995, COAST MANAGE, V23, P91, DOI 10.1080/08920759509362259; Dowty RA, 2011, MAR ENVIRON RES, V52, P195; DUNTON KH, 1990, J EXP MAR BIOL ECOL, V143, P147, DOI 10.1016/0022-0981(90)90067-M; Fodrie FJ, 2014, BIOSCIENCE, V64, P778, DOI 10.1093/biosci/biu123; Graham WM, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/045301; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; HARRISON PG, 1992, CAN J BOT, V70, P653, DOI 10.1139/b92-085; Hastings DW, 2015, DEEP SEA RES 2; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hester MW, 1998, POTENTIAL ACCLELERAT; Horel A, 2012, ENVIRON TOXICOL CHEM, V31, P1004, DOI 10.1002/etc.1770; IVERSON RL, 1986, ESTUAR COAST SHELF S, V22, P577, DOI 10.1016/0272-7714(86)90015-6; Judy CR, 2014, MAR POLLUT BULL, V79, P69, DOI 10.1016/j.marpolbul.2013.12.046; Kanouse S, 2006, MAR ECOL PROG SER, V327, P61, DOI 10.3354/meps327061; Khanna S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078989; La Peyre MK, 2003, AQUAT BOT, V77, P235, DOI 10.1016/S0304-3770(03)00109-8; Lellis-Dibble K.A., 2008, ESTUARINE FISH SHELL; Li HL, 2010, NAT GEOSCI, V3, P96, DOI 10.1038/NGEO749; Lin QX, 2012, ENVIRON SCI TECHNOL, V46, P3737, DOI 10.1021/es203552p; Lin QX, 1996, MAR POLLUT BULL, V32, P202, DOI 10.1016/0025-326X(95)00118-7; Martin CW, 2014, HYDROBIOLOGIA, V727, P177, DOI 10.1007/s10750-013-1798-9; Martin CW, 2012, MAR ECOL PROG SER, V449, P109, DOI 10.3354/meps09515; Martin CW, 2011, ESTUAR COAST, V34, P364, DOI 10.1007/s12237-010-9274-5; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; McCall DD, 2007, ECOLOGY, V88, P618, DOI 10.1890/06-0375; McClenachan G, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044030; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; MENDELSSOHN IA, 1990, OIL CHEM POLLUT, V7, P1, DOI 10.1016/S0269-8579(05)80031-0; Meziane T, 2000, MAR ECOL PROG SER, V200, P49, DOI 10.3354/meps200049; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; ORTH RJ, 1988, AQUAT BOT, V32, P291, DOI 10.1016/0304-3770(88)90122-2; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Ortmann AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042548; Pedersen O, 1998, MAR ECOL PROG SER, V169, P283, DOI 10.3354/meps169283; Peneva E, 2008, J COASTAL RES, V24, P850, DOI 10.2112/06-0764.1; Peterson CH, 2012, BIOSCIENCE, V62, P461, DOI 10.1525/bio.2012.62.5.7; PEZESHKI SR, 1993, WATER AIR SOIL POLL, V68, P461, DOI 10.1007/BF00478469; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; PHILLIPS RC, 1983, AQUAT BOT, V16, P1, DOI 10.1016/0304-3770(83)90047-5; Poirrier MA, 2007, STATEWIDE SUMMARY LO, P60; Puntila RI, 2012, B MAR SCI, V88, P1115, DOI 10.5343/bms.2012.1011; Quintana-Rizzo E, 2015, MAR POLLUT BULL, V94, P241, DOI 10.1016/j.marpolbul.2015.02.002; Renner R, 2006, ENVIRON SCI TECHNOL, V40, P6188, DOI 10.1021/es0630036; Rodriguez-Perez H, 2006, OIKOS, V112, P525, DOI 10.1111/j.0030-1299.2006.14307.x; Rozas LP, 2013, MAR ECOL PROG SER, V492, P9, DOI 10.3354/meps10486; Schrope M, 2010, NATURE, V466, P304, DOI 10.1038/466304a; Schwing PT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120565; Silliman BR, 2012, P NATL ACAD SCI USA, V109, P11234, DOI 10.1073/pnas.1204922109; SMITH CJ, 1984, ENVIRON TOXICOL CHEM, V3, P609, DOI 10.1897/1552-8618(1984)3[609:IODAUO]2.0.CO;2; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Tanner CC, 1996, ECOL ENG, V7, P59, DOI 10.1016/0925-8574(95)00066-6; TURNER R E, 1980, Northeast Gulf Science, V4, P44; Turner RE, 2014, MAR POLLUT BULL, V86, P291, DOI 10.1016/j.marpolbul.2014.07.003; Turner RE, 2014, MAR POLLUT BULL, V87, P57, DOI 10.1016/j.marpolbul.2014.08.011; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P15906, DOI 10.1073/pnas.1414873111; Valinoti CE, 2011, J EXP MAR BIOL ECOL, V409, P42, DOI 10.1016/j.jembe.2011.08.001; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wu HM, 2011, ECOL ENG, V37, P560, DOI 10.1016/j.ecoleng.2010.11.020	77	15	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138797	10.1371/journal.pone.0138797	http://dx.doi.org/10.1371/journal.pone.0138797			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430971	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700019
J	Guala, A; Camporeale, C; Ridolfi, L				Guala, Andrea; Camporeale, Carlo; Ridolfi, Luca			Compensatory Effect between Aortic Stiffening and Remodelling during Ageing	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; MIDDLE-AGED MEN; BLOOD-PRESSURE; LOW PREVALENCE; REFLECTION; HEALTHY; HYPERTENSION; STIFFNESS; DISTENSIBILITY; AMPLIFICATION	The arterial tree exhibits a complex spatio-temporal wave pattern, whose healthy behaviour depends on a subtle balance between mechanical and geometrical properties. Several clinical studies demonstrated that such a balance progressively breaks down during ageing, when the aorta stiffens and remodels by increasing its diameter. These two degenerative processes however, have different impacts on the arterial wave pattern. They both tend to compensate for each other, thus reducing the detrimental effect they would have had if they had arisen individually. This remarkable compensatory mechanism is investigated by a validated multi-scale model, with the aim to elucidate how aortic stiffening and remodelling quantitatively impact the complex interplay between forward and reflected backward waves in the arterial network. We focus on the aorta and on the pressure at the ventricular-aortic interface, which epidemiological studies demonstrate to play a key role in cardiovascular diseases.	[Guala, Andrea; Camporeale, Carlo; Ridolfi, Luca] Politecn Torino, DIATI, Turin, Italy	Polytechnic University of Turin	Guala, A (corresponding author), Politecn Torino, DIATI, Turin, Italy.	andrea.guala@polito.it	Camporeale, Carlo/I-1247-2019; Guala, Andrea/L-9857-2019	Camporeale, Carlo/0000-0002-7311-6018; Guala, Andrea/0000-0002-5006-8164				Alastruey J, 2011, J BIOMECH, V44, P2250, DOI 10.1016/j.jbiomech.2011.05.041; AlGhatrif M, 2014, BLOOD PRESSURE ARTER; AlGhatrif M, 2013, CIRCULATION, V62, P128; Avolio AP, 2009, HYPERTENSION, V54, P375, DOI 10.1161/HYPERTENSIONAHA.109.134379; AVOLIO AP, 1985, CIRCULATION, V71, P202, DOI 10.1161/01.CIR.71.2.202; BENETOS A, 1993, ARTERIOSCLER THROMB, V13, P90, DOI 10.1161/01.ATV.13.1.90; Blanco PJ, 2013, MED ENG PHYS, V35, P652, DOI 10.1016/j.medengphy.2012.07.011; Chantler PD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00090; Cheng HM, 2013, INT J CARDIOL, V167, P1867, DOI 10.1016/j.ijcard.2012.04.155; Davies JE, 2012, HYPERTENSION, V60, P778, DOI 10.1161/HYPERTENSIONAHA.111.180604; Devos DGH, 2014, J MAGN RESON, P1; Formaggia L, 2003, J ENG MATH, V47, P251, DOI 10.1023/B:ENGI.0000007980.01347.29; GABE IT, 1969, CIRCULATION, V40, P603, DOI 10.1161/01.CIR.40.5.603; GOSLING RG, 1971, BRIT J RADIOL, V44, P850, DOI 10.1259/0007-1285-44-527-850; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Guala A, 2015, ANN BIOMED ENG, V43, P222, DOI 10.1007/s10439-014-1163-9; Guyton A.C., 2006, TXB MED PHYSL; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Joh JH, 2013, YONSEI MED J, V54, P48, DOI 10.3349/ymj.2013.54.1.48; KAWASAKI T, 1987, CARDIOVASC RES, V21, P678, DOI 10.1093/cvr/21.9.678; Korakianitis T, 2006, J BIOMECH, V39, P1964, DOI 10.1016/j.jbiomech.2005.06.016; Kroner ES, 2013, JMRI-J MAGN RESON IM, P1; LAKATTA EG, 1987, J AM COLL CARDIOL, V10, pA42, DOI 10.1016/S0735-1097(87)80447-3; Lakatta EG, 2001, DIALOGUES CARDIOV ME, V6, P1; LATHAM RD, 1985, CIRCULATION, V72, P1257, DOI 10.1161/01.CIR.72.6.1257; Liang FY, 2009, J BIOMECH, V42, P692, DOI 10.1016/j.jbiomech.2009.01.010; Lighthill J, 1975, CBMS NSF REGIONAL C; Mangoni AA, 2003, AGE AGEING, V32, P326, DOI 10.1093/ageing/32.3.326; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Mitchell GF, 2004, HYPERTENSION, V43, P1239, DOI 10.1161/01.HYP.0000128420.01881.aa; Najjar SS, 2005, HYPERTENSION, V46, P454, DOI 10.1161/01.HYP.0000177474.06749.98; Namasivayam M, 2009, HYPERTENSION, V53, P979, DOI 10.1161/HYPERTENSIONAHA.108.125179; Nichols W., 2005, MCDONALDS BLOOD FLOW, V5th; Olufsen MS, 1999, AM J PHYSIOL-HEART C, V276, pH257, DOI 10.1152/ajpheart.1999.276.1.H257; OROURKE MF, 1968, CIRC RES, V23, P567, DOI 10.1161/01.RES.23.4.567; Pedley TJ., 1980, FLUID MECH LARGE BLO; Protogerou AD, 2007, HYPERTENSION, V50, P172, DOI 10.1161/HYPERTENSIONAHA.107.089797; Redfield MM, 2005, CIRCULATION, V112, P2254, DOI 10.1161/CIRCULATIONAHA.105.541078; Redheuil A, 2010, HYPERTENSION, V55, P319, DOI 10.1161/HYPERTENSIONAHA.109.141275; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Scuteri A, 2014, HYPERTENSION, V64, P1219, DOI 10.1161/HYPERTENSIONAHA.114.04127; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; Segers P, 2009, HYPERTENSION, V54, P414, DOI 10.1161/HYPERTENSIONAHA.109.133009; Sherwin SJ, 2003, J ENG MATH, V47, P217, DOI 10.1023/B:ENGI.0000007979.32871.e2; Sugawara J, 2008, JACC-CARDIOVASC IMAG, V1, P739, DOI 10.1016/j.jcmg.2008.06.010; VIRMANI R, 1991, AM J PATHOL, V139, P1119; Westerhof N, 2010, SNAPSHOTS OF HEMODYNAMICS: AN AID FOR CLINICAL RESEARCH AND GRADUATE EDUCATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-6363-5; Zamir M., 2000, BIOL MED PHYS BIOMED	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139211	10.1371/journal.pone.0139211	http://dx.doi.org/10.1371/journal.pone.0139211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426360	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100036
J	Hansen, MB; Abramoff, MD; Folk, JC; Mathenge, W; Bastawrous, A; Peto, T				Hansen, Morten B.; Abramoff, Michael D.; Folk, James C.; Mathenge, Wanjiku; Bastawrous, Andrew; Peto, Tunde			Results of Automated Retinal Image Analysis for Detection of Diabetic Retinopathy from the Nakuru Study, Kenya	PLOS ONE			English	Article							POPULATION	Objective Digital retinal imaging is an established method of screening for diabetic retinopathy (DR). It has been established that currently about 1% of the world's blind or visually impaired is due to DR. However, the increasing prevalence of diabetes mellitus and DR is creating an increased workload on those with expertise in grading retinal images. Safe and reliable automated analysis of retinal images may support screening services worldwide. This study aimed to compare the Iowa Detection Program (IDP) ability to detect diabetic eye diseases (DED) to human grading carried out at Moorfields Reading Centre on the population of Nakuru Study from Kenya. Participants Retinal images were taken from participants of the Nakuru Eye Disease Study in Kenya in 2007/08 (n = 4,381 participants [NW6 Topcon Digital Retinal Camera]). Methods First, human grading was performed for the presence or absence of DR, and for those with DR this was sub-divided in to referable or non-referable DR. The automated IDP software was deployed to identify those with DR and also to categorize the severity of DR. Main Outcome Measures The primary outcomes were sensitivity, specificity, and positive and negative predictive value of IDP versus the human grader as reference standard. Results Altogether 3,460 participants were included. 113 had DED, giving a prevalence of 3.3%(95% CI, 2.7-3.9%). Sensitivity of the IDP to detect DED as by the human grading was 91.0%(95% CI, 88.0-93.4%). The IDP ability to detect DED gave an AUC of 0.878 (95% CI 0.850-0.905). It showed a negative predictive value of 98%. The IDP missed no vision threatening retinopathy in any patients and none of the false negative cases met criteria for treatment. Conclusions In this epidemiological sample, the IDP's grading was comparable to that of human graders'. It therefore might be feasible to consider inclusion into usual epidemiological grading.	[Hansen, Morten B.; Peto, Tunde] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Hansen, Morten B.; Peto, Tunde] UCL Inst Ophtalmol, London, England; [Hansen, Morten B.] Univ Southern Denmark, Res Unit Ophthalmol, Odense, Denmark; [Abramoff, Michael D.; Folk, James C.] Univ Iowa Hosp & Clin, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Mathenge, Wanjiku] Rwanda Int Inst Ophthalmol, Kigali, Rwanda; [Bastawrous, Andrew] London Sch Hyg & Trop Med, Int Ctr Eye Hlth, Dept Clin Res, Fac Infect & Trop Dis, London WC1, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of Southern Denmark; University of Iowa; University of London; London School of Hygiene & Tropical Medicine	Hansen, MB (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England.	morten.hansen@moorfields.nhs.uk	Abramoff, Michael D/A-5836-2009; Peto, Tunde/G-8812-2018; MATHENGE, WANJIKU/W-3993-2019	Abramoff, Michael D/0000-0002-3490-0037; Peto, Tunde/0000-0001-6265-0381; Folk, James/0000-0002-6271-2906	University of Southern Denmark; Synoptik-Fonden; Familien Hede Nielsens Fond; NIHR BMRC at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; NIH [R01EY017066]; Arnold and Mabel Beckman Initiative for Macular Research [R01EY018853]; Veterans Administration; Medical Research Council; Department for International Development; Fight for Sight; International Glaucoma Association; British Council for the Prevention of Blindness; Queen Elizabeth Diamond Jubilee Trust; NATIONAL EYE INSTITUTE [R01EY018853, R01EY017066] Funding Source: NIH RePORTER; Medical Research Council [G1001934] Funding Source: researchfish; MRC [G1001934] Funding Source: UKRI	University of Southern Denmark; Synoptik-Fonden; Familien Hede Nielsens Fond; NIHR BMRC at Moorfields Eye Hospital NHS Foundation Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UCL Institute of Ophthalmology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Initiative for Macular Research; Veterans Administration(US Department of Veterans Affairs); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department for International Development; Fight for Sight; International Glaucoma Association; British Council for the Prevention of Blindness; Queen Elizabeth Diamond Jubilee Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	MBH is funded from University of Southern Denmark, Synoptik-Fonden and Familien Hede Nielsens Fond. TP is funded from the NIHR BMRC at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. MDA is funded from NIH R01EY017066, Arnold and Mabel Beckman Initiative for Macular Research, R01EY018853, and Veterans Administration. AB is funded from Medical Research Council, Department for International Development, Fight for Sight, International Glaucoma Association, British Council for the Prevention of Blindness and the Queen Elizabeth Diamond Jubilee Trust.	Abramoff MD, 2013, JAMA OPHTHALMOL, V131, P351, DOI 10.1001/jamaophthalmol.2013.1743; Abramoff MD, 2010, OPHTHALMOLOGY, V117, P1147, DOI 10.1016/j.ophtha.2010.03.046; Abramoff MD, 2008, DIABETES CARE, V31, P193, DOI 10.2337/dc07-1312; [Anonymous], 1991, Ophthalmology, V98, P823; Bastawrous A, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-60; Bastawrous A, 2012, BRIT J OPHTHALMOL, V96, P1357, DOI 10.1136/bjophthalmol-2012-302088; Cheung N, 2010, LANCET, V376, P124, DOI 10.1016/S0140-6736(09)62124-3; Ding J, 2012, CURR DIABETES REP, V12, P346, DOI 10.1007/s11892-012-0283-6; Eng J, 2015, ROC ANAL WEB BASED C; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Mathenge W, 2014, OPHTHAL EPIDEMIOL, V21, P169, DOI 10.3109/09286586.2014.903982; Palmer JJ, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-44; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Resnikoff S, 2012, BRIT J OPHTHALMOL, V96, P783, DOI 10.1136/bjophthalmol-2011-301378; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Stevens GA, 2013, OPHTHALMOLOGY, V120, P2377, DOI 10.1016/j.ophtha.2013.05.025; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5	17	36	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139148	10.1371/journal.pone.0139148	http://dx.doi.org/10.1371/journal.pone.0139148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26425849	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100033
J	Khumalo, T; Ferreira, E; Jovanovic, K; Veale, RB; Weiss, SFT				Khumalo, Thandokuhle; Ferreira, Eloise; Jovanovic, Katarina; Veale, Rob B.; Weiss, Stefan F. T.			Knockdown of LRP/LR Induces Apoptosis in Breast and Oesophageal Cancer Cells	PLOS ONE			English	Article							LAMININ-BINDING PROTEIN; RECEPTOR EXPRESSION; PROGNOSTIC-SIGNIFICANCE; DENGUE VIRUS; PRECURSOR; IDENTIFICATION; INVASION; ANTIBODY; REVEALS; LUNG	Cancer is a global burden due to high incidence and mortality rates and is ranked the second most diagnosed disease amongst non-communicable diseases in South Africa. A high expression level of the 37kDa/67kDa laminin receptor (LRP/LR) is one characteristic of cancer cells. This receptor is implicated in the pathogenesis of cancer cells by supporting tumor angiogenesis, metastasis and especially for this study, the evasion of apoptosis. In the current study, the role of LRP/LR on cellular viability of breast MCF-7, MDA-MB 231 and WHCO1 oesophageal cancer cells was investigated. Western blot analysis revealed that total LRP expression levels of MCF-7, MDA-MB 231 and WHCO1 were significantly down-regulated by targeting LRP mRNA using siRNA-LAMR1. This knockdown of LRP/LR resulted in a significant decrease of viability in the breast and oesophageal cancer cells as determined by an MTT assay. Transfection of MDA-MB 231 cells with esiRNA-RPSA directed against a different region of the LRP mRNA had similar effects on LRP/LR expression and cell viability compared to siRNA-LAMR1, excluding an off-target effect of siRNA-LAMR1. This reduction in cellular viability is as a consequence of apoptosis induction as indicated by the exposure of the phosphatidylserine protein on the surface of breast MCF-7, MDA-MB 231 and oesophageal WHCO1 cancer cells, respectively, detected by an Annexin-V/FITC assay as well as nuclear morphological changes observed post-staining with Hoechst. These observations indicate that LRP/LR is crucial for the maintenance of cellular viability of breast and oesophageal cancer cells and recommend siRNA technology targeting LRP expression as a possible novel alternative technique for breast and oesophageal cancer treatment.	[Khumalo, Thandokuhle; Ferreira, Eloise; Jovanovic, Katarina; Veale, Rob B.; Weiss, Stefan F. T.] Univ Witwatersrand, Sch Mol & Cell Biol, ZA-2050 Johannesburg, South Africa	University of Witwatersrand	Weiss, SFT (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Private Bag 3, ZA-2050 Johannesburg, South Africa.	stefan.weiss@wits.ac.za		van der Merwe (nee Ferreira), Eloise/0000-0001-5985-4885	National Research Foundation, the Republic of South Africa, the Republic of South Africa	National Research Foundation, the Republic of South Africa, the Republic of South Africa	This work was supported by the National Research Foundation, the Republic of South Africa, the Republic of South Africa. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s), and therefore, the National Research Foundation does not accept any liability in this regard thereto. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; AlSaleh W, 1997, J PATHOL, V181, P287, DOI 10.1002/(SICI)1096-9896(199703)181:3<287::AID-PATH762>3.0.CO;2-W; BEY E, 1976, IN VITRO CELL DEV B, V12, P107; CASTRONOVO V, 1991, BIOCHEM BIOPH RES CO, V177, P177, DOI 10.1016/0006-291X(91)91965-F; Chetty C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096268; de Manzoni G, 1998, ONCOLOGY-BASEL, V55, P456, DOI 10.1159/000011895; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fontanini G, 1997, CLIN CANCER RES, V3, P227; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gauczynski S, 2006, J INFECT DIS, V194, P702, DOI 10.1086/505914; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jovanovic K, 2015, EXPERT OPIN THER PAT, V25, P567, DOI 10.1517/13543776.2015.1014802; KANEDA Y, 1993, J CELL SCI, V106, P741; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Khusal R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058888; Kinoshita K, 1998, BIOCHEM BIOPH RES CO, V253, P277, DOI 10.1006/bbrc.1998.9699; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Leucht C, 2004, TRANSGENIC RES, V13, P81, DOI 10.1023/B:TRAG.0000017177.35197.89; MALINOFF HL, 1984, INT J CANCER, V33, P651, DOI 10.1002/ijc.2910330516; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Mbazima V, 2010, FRONT BIOSCI-LANDMRK, V15, P1150, DOI 10.2741/3667; MERCURIO AM, 1995, TRENDS CELL BIOL, V5, P419, DOI 10.1016/S0962-8924(00)89100-X; Moodley K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057409; Omar A, 2012, J MOL BIOL, V419, P102, DOI 10.1016/j.jmb.2012.02.035; Pinnock EC J K, 2015, J ALZHEIMER IN PRESS; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Renvoize C, 1998, CELL BIOL TOXICOL, V14, P111, DOI 10.1023/A:1007429904664; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Robertson JD, 2000, J STRUCT BIOL, V129, P346, DOI 10.1006/jsbi.2000.4254; Salama RHM, 2001, EXP CELL RES, V270, P13, DOI 10.1006/excr.2001.5341; Sanjuan X, 1996, J PATHOL, V179, P376, DOI 10.1002/(SICI)1096-9896(199608)179:4<376::AID-PATH591>3.0.CO;2-V; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Susantad T, 2008, CELL MOL BIOL LETT, V13, P452, DOI 10.2478/s11658-008-0017-6; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25; VANDENBRULE FA, 1994, EUR J CANCER, V30A, P1096, DOI 10.1016/0959-8049(94)90464-2; Venticinque L, 2012, J PROTEOME RES, V11, P4863, DOI 10.1021/pr300307h; Waltregny D, 1997, JNCI-J NATL CANCER I, V89, P1224, DOI 10.1093/jnci/89.16.1224; WATAYAKANEDA M, 1987, J CELL BIOL, V104, P1, DOI 10.1083/jcb.104.1.1; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Zuber C, 2008, J MOL BIOL, V378, P530, DOI 10.1016/j.jmb.2008.02.004	45	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139584	10.1371/journal.pone.0139584	http://dx.doi.org/10.1371/journal.pone.0139584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427016	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100078
J	Bounds, CE; Kwilas, SA; Kuehne, AI; Brannan, JM; Bakken, RR; Dye, JM; Hooper, JW; Dupuy, LC; Ellefsen, B; Hannaman, D; Wu, H; Jiao, JA; Sullivan, EJ; Schmaljohn, CS				Bounds, Callie E.; Kwilas, Steven A.; Kuehne, Ana I.; Brannan, Jennifer M.; Bakken, Russell R.; Dye, John M.; Hooper, Jay W.; Dupuy, Lesley C.; Ellefsen, Barry; Hannaman, Drew; Wu, Hua; Jiao, Jin-an; Sullivan, Eddie J.; Schmaljohn, Connie S.			Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses	PLOS ONE			English	Article							EBOLA-VIRUS-INFECTION; DEFECTIVE INTERFERING VIRUS; NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER; IMMUNE-RESPONSES; ELECTROPORATION; PROPHYLAXIS; CHALLENGE; PARTICLES; INFLUENZA	DNA vaccination of transchromosomal bovines (TcBs) with DNA vaccines expressing the codon-optimized (co) glycoprotein (GP) genes of Ebola virus (EBOV) and Sudan virus (SUDV) produce fully human polyclonal antibodies (pAbs) that recognize both viruses and demonstrate robust neutralizing activity. Each TcB was vaccinated by intramuscular electroporation (IM-EP) a total of four times and at each administration received 10 mg of the EBOV-GP(co) DNA vaccine and 10 mg of the SUDV-GP(co) DNA vaccine at two sites on the left and right sides, respectively. After two vaccinations, robust antibody responses (titers > 1000) were detected by ELISA against whole irradiated EBOV or SUDV and recombinant EBOV-GP or SUDV-GP (rGP) antigens, with higher titers observed for the rGP antigens. Strong, virus neutralizing antibody responses (titers > 1000) were detected after three vaccinations when measured by vesicular stomatitis virus-based pseudovirion neutralization assay (PsVNA). Maximal neutralizing antibody responses were identified by traditional plaque reduction neutralization tests (PRNT) after four vaccinations. Neutralizing activity of human immunoglobulins (IgG) purified from TcB plasma collected after three vaccinations and injected intraperitoneally (IP) into mice at a 100 mg/kg dose was detected in the serum by PsVNA up to 14 days after administration. Passive transfer by IP injection of the purified IgG (100 mg/kg) to groups of BALB/c mice one day after IP challenge with mouse adapted (ma) EBOV resulted in 80% protection while all mice treated with non-specific pAbs succumbed. Similarly, interferon receptor 1 knockout (IFNAR(-/-)) mice receiving the purified IgG (100 mg/kg) by IP injection one day after IP challenge with wild type SUDV resulted in 89% survival. These results are the first to demonstrate that filovirus GP DNA vaccines administered to TcBs by IM-EP can elicit neutralizing antibodies that provide post-exposure protection. Additionally, these data describe production of fully human IgG in a large animal system, a system which is capable of producing large quantities of a clinical grade therapeutic product.	[Bounds, Callie E.; Kwilas, Steven A.; Kuehne, Ana I.; Brannan, Jennifer M.; Bakken, Russell R.; Dye, John M.; Hooper, Jay W.; Dupuy, Lesley C.; Schmaljohn, Connie S.] US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Wu, Hua; Jiao, Jin-an; Sullivan, Eddie J.] SAB Biotherapeut, Sioux Falls, SD USA; [Ellefsen, Barry; Hannaman, Drew] Ichor Med Syst Inc, San Diego, CA USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army	Schmaljohn, CS (corresponding author), US Army Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	connie.s.schmaljohn.civ@mail.mil	Hooper, Jay/K-2362-2017	Hooper, Jay/0000-0002-4475-0415; Dye, John/0000-0002-0883-5016; Schnell, Matthias/0000-0001-9040-9405; Sullivan, Eddie/0000-0001-7468-2006	Defense Threat Reduction Agency (DTRA) [HDTRA1-14-1-0054]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by contract HDTRA1-14-1-0054 to SAB Biotherapeutics, Inc., from the Defense Threat Reduction Agency (DTRA). This research was performed under Cooperative Research and Development Agreement (CRADA) W81XWH-14-0315 between USAMRIID and SAB Biotherapeutics, Inc. The funders had no had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRETT ADT, 1986, CURR TOP MICROBIOL, V128, P55; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bray M, 2001, J GEN VIROL, V82, P1365, DOI 10.1099/0022-1317-82-6-1365; Calain P, 1999, VIROLOGY, V262, P114, DOI 10.1006/viro.1999.9915; Chen G, 2014, ACS CHEM BIOL, V9, P2263, DOI 10.1021/cb5006454; Choi WY, 2015, CLIN EXP VACCINE RES, V4, P11, DOI 10.7774/cevr.2015.4.1.11; Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150; DIMMOCK NJ, 1986, J GEN VIROL, V67, P839, DOI 10.1099/0022-1317-67-5-839; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; EMOND RTD, 1977, BMJ-BRIT MED J, V2, P541, DOI 10.1136/bmj.2.6086.541; Feldmann H, 2003, NAT REV IMMUNOL, V3, P677, DOI 10.1038/nri1154; Feldmann H, 1996, ARCH VIROL, P77; Feldmann H., 1996, MED MICROBIOLOGY; Grant-Klein RJ, 2012, HUM VACC IMMUNOTHER, V8, P1703, DOI 10.4161/hv.21873; Grant-Klein RJ, 2015, HUMAN VACCI IN PRESS, V11; Herbert AS, 2013, J VIROL, V87, P4952, DOI 10.1128/JVI.03361-12; Hooper JW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010082; HUANG AS, 1970, NATURE, V226, P325, DOI 10.1038/226325a0; Khawaja G, 2012, VIROLOGY, V433, P192, DOI 10.1016/j.virol.2012.07.014; Kuhn Jens H, 2008, Arch Virol Suppl, V20, P13; Kuroiwa Y, 2014, GOOGLE PATENTS; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Kwilas S, 2014, CURR GENE THER, V14, P200, DOI 10.2174/1566523214666140522122633; Lever MS, 2012, J MED MICROBIOL, V61, P8, DOI 10.1099/jmm.0.036210-0; Littel-van den Hurk SV, 2008, VACCINE, V26, P5503, DOI 10.1016/j.vaccine.2008.07.093; Littel-van den Hurk SV, 2013, CLIN VACCINE IMMUNOL, V20, P166, DOI 10.1128/CVI.00565-12; Martins K, 2015, VIRAL IMMUNOL, V28, P62, DOI 10.1089/vim.2014.0071; Marzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036192; Matsushita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090383; MCLAIN L, 1992, J GEN VIROL, V73, P375, DOI 10.1099/0022-1317-73-2-375; Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298; Ogunremi O, 2013, CLIN VACCINE IMMUNOL, V20, P491, DOI 10.1128/CVI.00577-12; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Oswald WB, 2007, PLOS PATHOG, V3, P62, DOI 10.1371/journal.ppat.0030009; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575; Regules JA, 2015, NEW ENGLAND J MED; ROUX L, 1991, ADV VIRUS RES, V40, P181; Sano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078119; Santak M, 2014, MICROBES INFECT; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137786	10.1371/journal.pone.0137786	http://dx.doi.org/10.1371/journal.pone.0137786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422247	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700017
J	Li, TX; Gao, BL; Cai, DY; Wang, ZL; Zhu, LF; Xue, JY; Bai, WX; He, YK; Li, L				Li, Tian-Xiao; Gao, Bu-Lang; Cai, Dong-Yang; Wang, Zi-Liang; Zhu, Liang-Fu; Xue, Jiang-Yu; Bai, Wei-Xing; He, Ying-Kun; Li, Li			Wingspan Stenting for Severe Symptomatic Intracranial Atherosclerotic Stenosis in 433 Patients Treated at a Single Medical Center	PLOS ONE			English	Article							PREVENTING RECURRENT STROKE; ARTERIAL-STENOSIS; THERAPY; DISEASE; ANGIOPLASTY; MANAGEMENT; STATEMENT; SAMMPRIS; REGISTRY; TRIAL	Purpose To investigate the safety and outcome of intracranial stenting for intracranial atherosclerotic stenosis (IAS). Materials and Methods Between July 2007 and April 2013, 433 consecutive patients with IAS > 70% underwent intracranial Wingspan stenting, and the data were prospectively analyzed. Results Intracranial stenting was successful in 429 patients (99.1%), and the mean stenosis rate was improved from prestenting (82.3 +/- 7.6)% to poststenting (16.6 +/- 6.6)%. During the 30-day perioperative period, 29 patients (6.7%) developed stroke. The total perioperative stroke rate was significantly (P < 0.01) higher in the basilar artery area than in others, whereas the hemorrhagic stroke rate was significantly (P < 0.05) greater in the middle cerebral artery area than in others. The experience accumulation stage (13%) had a significantly (P < 0.05) higher stroke rate than the technical maturation stage (4.8%). Clinical follow-up 6-69 months poststenting revealed ipsilateral stroke in 20 patients (5.5%). The one-and two-year cumulative stroke rates were 9.5% and 11.5%, respectively; the two-year cumulative stroke rate was significantly (P < 0.05) greater in the experience accumulation stage (18.8%) than in the technical maturation stage (9.1%). Conclusion Wingspan stenting for intracranial atherosclerotic stenosis is safe and the long-term stroke rate after stenting is low in a Chinese subpopulation.	[Li, Tian-Xiao; Cai, Dong-Yang; Wang, Zi-Liang; Zhu, Liang-Fu; Xue, Jiang-Yu; Bai, Wei-Xing; He, Ying-Kun; Li, Li] Zhengzhou Univ, Henan Prov Peoples Hosp, Stroke Ctr, Zhengzhou 450052, Henan Province, Peoples R China; [Gao, Bu-Lang] Hebei Med Univ, Shijiazhuang Hosp 1, Dept Med Res, Shijiazhuang, Hebei Province, Peoples R China	Zhengzhou University; Hebei Medical University	Li, TX (corresponding author), Zhengzhou Univ, Henan Prov Peoples Hosp, Stroke Ctr, Zhengzhou 450052, Henan Province, Peoples R China.	litianxiaod@163.com	LI, LI/GVS-5344-2022; li, li/HII-4157-2022; LI, LI QING/GRR-8855-2022; li, li/AAT-2097-2020; Li, Li/AEM-3636-2022; Wang, Zhiquan/HHS-6768-2022; li, li/GPX-3938-2022	He, Yingkun/0000-0003-4168-8158				Abou-Chebl A, 2012, STROKE, V43, P616, DOI 10.1161/STROKEAHA.111.641563; Al Hasan M, 2012, CRIT CARE, V16, DOI 10.1186/cc11326; Albuquerque FC, 2008, NEUROSURGERY, V63, P23, DOI 10.1227/01.NEU.0000335067.53190.A2; Alexander MJ, 2012, J NEUROINTERV SURG, V4, P85, DOI 10.1136/neurintsurg-2012-010269; Bose A, 2007, STROKE, V38, P1531, DOI 10.1161/STROKEAHA.106.477711; Cai QK, 2014, CATHETER CARDIO INTE, V83, pE94, DOI 10.1002/ccd.25038; Chimowitz MI, 2011, NEW ENGL J MED, V365, P993, DOI 10.1056/NEJMoa1105335; Chimowitz MI, 2011, J STROKE CEREBROVASC, V20, P357, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.001; Chimowitz MI1, 2005, NEW ENGL J MED, P352; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Fiorella D, 2007, STROKE, V38, P881, DOI 10.1161/01.STR.0000257963.65728.e8; Fiorella D, 2012, STROKE, V43, P2682, DOI 10.1161/STROKEAHA.112.661173; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Jiang WJ, 2011, STROKE, V42, P1971, DOI 10.1161/STROKEAHA.110.595926; Jiang WJ, 2006, NEUROLOGY, V66, P1868, DOI 10.1212/01.wnl.0000219744.06992.bb; Kasner SE, 2006, CIRCULATION, V113, P555, DOI 10.1161/CIRCULATIONAHA.105.578229; Kurre W, 2010, STROKE, V41, P494, DOI 10.1161/STROKEAHA.109.568063; Meyers PM, 2010, J NEUROINTERV SURG, V2, P177, DOI 10.1161/CIRCULATIONAHA.109.192217; Miao ZRR, 2009, NEUROSURGERY, V64, P79, DOI 10.1227/01.NEU.0000335648.31874.37; Samuels OB, 2000, AM J NEURORADIOL, V21, P643; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0; Wong KS, 1998, NEUROLOGY, V50, P812, DOI 10.1212/WNL.50.3.812; Yu SCH, 2013, HONG KONG MED J, V19, P69; Zaidat OO, 2008, NEUROLOGY, V70, P1518, DOI 10.1212/01.wnl.0000306308.08229.a3	24	17	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139377	10.1371/journal.pone.0139377	http://dx.doi.org/10.1371/journal.pone.0139377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422692	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700105
J	Qin, DZ; Zhang, L; Xiao, Q; Dietrich, C; Matsumura, M				Qin, Daozheng; Zhang, Li; Xiao, Qiang; Dietrich, Christopher; Matsumura, Masaya			Clarification of the Identity of the Tea Green Leafhopper Based on Morphological Comparison between Chinese and Japanese Specimens	PLOS ONE			English	Article							CICADELLIDAE; EXPRESSION; GENE	Tea green leafhopper is one of the most dominant pests in major tea production regions of East Asia. This species has been variously identified as Empoasca vitis (Goethe), Jacobiasca formosana (Paoli) and Empoasca onukii Matsuda in Mainland China, Taiwan and Japan, respectively. Recent study of DNA sequence data suggested that treatment of this pest as different species in these three adjacent regions is incorrect and that they were a single species; but the correct scientific name for the species has remained unclear. Consistent with the prior molecular evidence, morphological study shows that the male genital characters of Chinese specimens are the same as those of specimens from Japan, so the correct scientific name of tea green leafhopper in China is Empoasca (Matsumurasca) onukii Matsuda.	[Qin, Daozheng; Zhang, Li] Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Entomol Museum, Yangling, Shaanxi, Peoples R China; [Xiao, Qiang] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Dietrich, Christopher] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL 61820 USA; [Matsumura, Masaya] Natl Agr & Food Res Org, Kyushu Okinawa Agr Res Ctr, Kumamoto, Japan	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; National Agriculture & Food Research Organization - Japan	Qin, DZ (corresponding author), Northwest A&F Univ, Minist Educ, Key Lab Plant Protect Resources & Pest Management, Entomol Museum, Yangling, Shaanxi, Peoples R China.	qindaozh0426@aliyun.com	Dietrich, Chris/A-9169-2016	Dietrich, Chris/0000-0003-4005-4305	National Natural Science Foundation of China [31270689]; Sci-Tech Popularization Project of Northwest AF University [TGZX2014-15]; Fundamental Research Funds of National Science and Technology [2013FY113200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sci-Tech Popularization Project of Northwest AF University; Fundamental Research Funds of National Science and Technology	Funded by National Natural Science Foundation of China (No. 31270689), http://www.nsfc.gov.cn/(DZQ), the Sci-Tech Popularization Project of Northwest A&F University (No. TGZX2014-15), http://www.nwsuaf.edu.cn/(DZQ), the Fundamental Research Funds of National Science and Technology (No. 2013FY113200), http://www.most.gov.cn/, (QX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANUFRIEV G A, 1973, Annales Zoologici (Warsaw), V30, P537; Chen ZM, 1979, CHINESE TEA, P6; Cho JY, 2007, BIOSCI BIOTECH BIOCH, V71, P1476, DOI 10.1271/bbb.60708; Dai PiaoPiao, 2015, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V23, P9; DWORAKOW.I, 1971, B ACAD POL SCI BIOL, V19, P501; Dworakowska I., 1982, Reichenbachia, V20, P33; Dworakowska Irena, 1993, Entomotaxonomia, V15, P91; Fu JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115259; [付建玉 Fu Jianyu], 2005, [科技通报, Bulletin of Science and Technology], V21, P549; German National Academy of Sciences Leopoldina, 2014, CHALL OPP INT TAX RE; Guo JX, 2008, TEA SCI TECHNOLOGY, P10; Hazarika LK, 2009, ANNU REV ENTOMOL, V54, P267, DOI 10.1146/annurev.ento.53.103106.093359; Ishihara T, 1953, Sci Reps Matsuyama agric Coll, Vno. 11, P1; Kholia BS, 2011, CURR SCI INDIA, V100, P458; Kuoh C.L., 1988, J TEA BUSINESS, V1, P15; Li BH, 2005, 15 ICO MOS GEN ASS I; Li Le, 2013, Chinese Journal of Applied Entomology, V50, P675, DOI 10.7679/j.issn.2095-1353.2013.095; Liu Y, 2011, ZOOTAXA, P22, DOI 10.11646/zootaxa.3003.1.2; Lu SH, 2014, ZOOTAXA, V3779, P9, DOI 10.11646/zootaxa.3779.1.4; Lv W.M., 1964, J TEA SCI, V1, P45; Matsuda R., 1952, Oyo-Kontyu Tokyo, V8, P19; Metcalf ZP, 1968, GENERAL CATALOGUE HO; Mochizuki M., 1994, Bulletin of the National Research Institute of Vegetables, Ornamental Plants and Tea. Series B, P29; Mu D, 2012, INSECT SCI, V19, P229, DOI 10.1111/j.1744-7917.2011.01476.x; Niu Yuqun, 2014, Acta Ecologica Sinica, V34, P5477; Oman PW., 1949, MEMOIRS ENTOMOLOGICA; Qin DZ, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1817.1.2; Qin DaoZheng, 2014, Journal of Northwest A & F University - Natural Science Edition, V42, P124; Rakitov R.A., 1998, Russian Entomological Journal, V6, P7; Reineke A, 2012, J APPL ENTOMOL, V136, P656, DOI 10.1111/j.1439-0418.2011.01699.x; Saha D, 2013, INT J TROP INSECT SC, V33, P46, DOI 10.1017/S1742758412000380; Shi Q.C., 2015, J AGR, V5, P20; Southern PS, 2010, ZOOTAXA, P1; Southern PS, 1982, TECH B N CAROLINA AG; Van Der Wal S., 2008, SUSTAINABILITY ISSUE; [施龙清 Shi Longqing], 2014, [福建农林大学学报. 自然科学版, Journal of Fujian Agriculture and Forestry University. Natural Science Edition], V43, P456; Xiao Q, 2008, CHINA TEA, P25; Yao GK., 2013, MOST WELL KNOWN CHIN; Yokota H, 2005, SOIL SCI PLANT NUTR, V51, P625, DOI 10.1111/j.1747-0765.2005.tb00078.x; [袁红雨 Yuan Hongyu], 2015, [林业科学, Scientia Silvae Sinicae], V51, P147; Zeiss M.R., 2001, TEA IPM ECOLOGICAL G; Zhang Han'gu, 1999, Journal of Tea Science, V19, P81; Zhang J.W., 1980, TEA COMMUNICATION, V4, P63; Zhang YL., 1990, TAXONOMY CICADELLIDA; Zhao DongXiang, 2000, Journal of Tea Science, V20, P101; Zhou Ningning, 2014, Acta Ecologica Sinica, V34, P6879	46	30	45	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139202	10.1371/journal.pone.0139202	http://dx.doi.org/10.1371/journal.pone.0139202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422616	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700077
J	Stumpf, L; Greco, LSL				Stumpf, Liane; Lopez Greco, Laura S.			Compensatory Growth in Juveniles of Freshwater Redclaw Crayfish Cherax quadricarinatus Reared at Three Different Temperatures: Hyperphagia and Food Efficiency as Primary Mechanisms	PLOS ONE			English	Article							CHINESE SHRIMP; BIOCHEMICAL-COMPOSITION; PROCAMBARUS-CLARKII; NEPHROPS-NORVEGICUS; PROTEIN RESTRICTION; OXYGEN-CONSUMPTION; ENERGETIC RESERVES; VON-MARTENS; STARVATION; HEPATOPANCREAS	Feeding restriction, as a trigger for compensatory growth, might be considered an alternative viable strategy for minimizing waste as well as production costs. The study assessed whether juvenile redclaw crayfish Cherax quadricarinatus (initial weight 0.99 +/- 0.03 g) was able to compensate for feeding restriction at different temperatures (23 +/- 1, 27 +/- 1 and 31 +/- 1 degrees C). Hyperphagia, food utilization efficiency, energetic reserves, and hepatopancreas structure were analyzed. Three temperatures and two feeding regimes (DF-daily fed throughout the experiment and CF-4 days food deprivation followed by 4 days of feeding, intermittently) were tested. The restriction period was from day 1 to 45, and the recovery period was from day 45 to 90. The previously restricted crayfish held at 23, 27, and 31 +/- 1 degrees C displayed complete body weight catch-up through compensatory growth following the restriction period with depressed growth. The mechanisms that might explain this response were higher feed intake (hyperphagia), and increased food utilization efficiency. Hepatopancreatic lipids were used as a metabolic fuel and hepatosomatic index was reduced in the previously restricted crayfish, but recovery at the same level of unrestricted crayfish occurred after the shift to daily feeding. The highest temperature affected adversely growth, feed intake, food efficiency, and metabolism of crayfish, whereas the lowest temperature and feeding restriction induced a more efficient growth of the crayfish.	[Stumpf, Liane; Lopez Greco, Laura S.] Univ Buenos Aires, FCEyN, Dept Biodivers & Expt Biol, Biol Reprod & Growth Crustaceans, Buenos Aires, DF, Argentina; [Stumpf, Liane; Lopez Greco, Laura S.] UBA, CONICET, IBBEA, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Greco, LSL (corresponding author), Univ Buenos Aires, FCEyN, Dept Biodivers & Expt Biol, Biol Reprod & Growth Crustaceans, Buenos Aires, DF, Argentina.	laura@bg.fcen.uba.ar			Agencia Nacional de Promocion Cientifica y Tecnologica [01187, 1333]; CONICET [112-201101-00212]; UBACYT [20020100100003, 2014-2017-20020130100186BA]; MINCYT-CONACYT (Mexico) [MX/09/07]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); UBACYT; MINCYT-CONACYT (Mexico)	LSLG is grateful to Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2007 project 01187 and PICT 2012 project 1333), CONICET (PIP 2012-2014 project 112-201101-00212), UBACYT (2011-2014 project 20020100100003), MINCYT-CONACYT (Mexico-MX/09/07) and UBACYT 2014-2017-20020130100186BA for *partial* support of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; Amin MN, 2014, ANIM FEED SCI TECH, V193, P111, DOI 10.1016/j.anifeedsci.2014.04.016; [Anonymous], [No title captured]; BARCLAY MC, 1983, J EXP MAR BIOL ECOL, V68, P229, DOI 10.1016/0022-0981(83)90055-2; Berillis P, 2013, MICRON, V45, P140, DOI 10.1016/j.micron.2012.10.014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brett JR, 1979, FISH PHYSIOL, V8, P599, DOI DOI 10.1016/S1546-5098(08)60033-3; Burel C, 1996, J FISH BIOL, V49, P678, DOI 10.1111/j.1095-8649.1996.tb00064.x; Calvo NS, 2013, AQUACULTURE, V416, P85, DOI 10.1016/j.aquaculture.2013.08.017; Calvo NS, 2011, AQUACULTURE, V319, P355, DOI 10.1016/j.aquaculture.2011.06.033; Comoglio L, 2005, COMP BIOCHEM PHYS B, V140, P411, DOI 10.1016/j.cbpc.2004.11.003; Croll SL, 2004, J WORLD AQUACULT SOC, V35, P478, DOI 10.1111/j.1749-7345.2004.tb00113.x; DALL W, 1981, J EXP MAR BIOL ECOL, V50, P33, DOI 10.1016/0022-0981(81)90061-7; Marques HLD, 2011, REV BRAS ZOOTECN, V40, P701, DOI 10.1590/S1516-35982011000400001; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRINGS CS, 1972, CLIN CHEM, V18, P673; Heide A, 2006, AQUACULTURE, V261, P109, DOI 10.1016/j.aquaculture.2006.06.050; Huang G, 2008, J FISH BIOL, V72, P2534, DOI 10.1111/j.1095-8649.2008.01863.x; Jobling M, 2010, AQUACULT INT, V18, P501, DOI 10.1007/s10499-009-9260-8; Kumar S, 2013, AQUACULT NUTR, V19, P186, DOI 10.1111/j.1365-2095.2012.00951.x; Levi T, 1999, J CRUSTACEAN BIOL, V19, P477, DOI 10.2307/1549256; Greco LSL, 2007, ACTA ZOOL-STOCKHOLM, V88, P223, DOI 10.1111/j.1463-6395.2007.00269.x; Masser M P, 1997, PUBLICATION SO REGIO, V244; Mazlum Y., 2011, TURKISH J FISHERIES, V11, P1; Meade ME, 2002, J WORLD AQUACULT SOC, V33, P188, DOI 10.1111/j.1749-7345.2002.tb00494.x; Nicieza AG, 1997, ECOLOGY, V78, P2385, DOI 10.1890/0012-9658(1997)078[2385:GCIJAS]2.0.CO;2; Nunes ET, 2014, ACTA HISTOCHEM, V116, P243, DOI 10.1016/j.acthis.2013.07.011; Panne Huidobro S, 2004, PERSPECTIVAS ACUICUL; Picha ME, 2006, GEN COMP ENDOCR, V147, P196, DOI 10.1016/j.ygcen.2005.12.020; Picha ME, 2014, AQUACULTURE, V428, P174, DOI 10.1016/j.aquaculture.2014.02.028; Powell ML, 2010, J WORLD AQUACULT SOC, V41, P71, DOI 10.1111/j.1749-7345.2009.00314.x; Saoud IP, 2012, AQUACULT NUTR, V18, P349, DOI 10.1111/j.1365-2095.2011.00925.x; SCHEIRER CJ, 1976, BIOMETRICS, V32, P429, DOI 10.2307/2529511; Sevgili H, 2012, AQUACULTURE, V344, P126, DOI 10.1016/j.aquaculture.2012.03.030; Singh R. K., 2007, Journal of Applied Aquaculture, V19, P39, DOI 10.1300/J028v19n01_04; Sousa LG, 2000, BIOCELL, V24, P189; Stumpf L, 2012, CRUST SOC SUMM M 10; Stumpf L, 2014, J CRUSTACEAN BIOL, V34, P639, DOI 10.1163/1937240X-00002259; Stumpf L, 2014, AQUACULTURE, V433, P404, DOI 10.1016/j.aquaculture.2014.06.037; Stumpf L, 2011, AQUACULTURE, V319, P98, DOI 10.1016/j.aquaculture.2011.06.029; Stumpf L, 2010, AQUACULTURE, V304, P34, DOI 10.1016/j.aquaculture.2010.03.011; Tian XL, 2010, AQUACULTURE, V310, P122, DOI 10.1016/j.aquaculture.2010.10.021; Tian XL, 2004, AQUACULTURE, V235, P273, DOI 10.1016/j.aquaculture.2003.09.055; Tropea C, 2010, AQUACULTURE, V302, P49, DOI 10.1016/j.aquaculture.2010.01.027; VANHANDEL E, 1965, ANAL BIOCHEM, V11, P256, DOI 10.1016/0003-2697(65)90013-8; Wang Y, 2000, AQUACULTURE, V189, P101, DOI 10.1016/S0044-8486(00)00353-7; Wasielesky W, 2013, J SHELLFISH RES, V32, P799, DOI 10.2983/035.032.0323; Watts AJR, 2014, J EXP MAR BIOL ECOL, V457, P81, DOI 10.1016/j.jembe.2014.03.020; Wen XB, 2006, AQUACULTURE, V252, P598, DOI 10.1016/j.aquaculture.2005.07.027; Wu LX, 2002, J CRUSTACEAN BIOL, V22, P511, DOI 10.1651/0278-0372(2002)022[0511:CGRIJC]2.0.CO;2; Wu LX, 2002, AQUACULTURE, V210, P343, DOI 10.1016/S0044-8486(01)00860-2; Wu LX, 2001, J CRUSTACEAN BIOL, V21, P559, DOI 10.1651/0278-0372(2001)021[0559:TEOPFR]2.0.CO;2; Wu LX, 2000, J SHELLFISH RES, V19, P717; Zhu ZM, 2016, AQUAC RES, V47, P283, DOI 10.1111/are.12490	54	17	18	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139372	10.1371/journal.pone.0139372	http://dx.doi.org/10.1371/journal.pone.0139372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422508	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700103
J	Zhang, ZH; Chen, K; Chen, L				Zhang, Zhongheng; Chen, Kun; Chen, Lin			APACHE III Outcome Prediction in Patients Admitted to the Intensive Care Unit with Sepsis Associated Acute Lung Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ILL TRAUMA PATIENTS; HOSPITAL MORTALITY; SEPTIC PATIENTS; ROC CURVE; SCORE; DEFINITIONS; PERFORMANCE; ETIOLOGY; INDEX	Background and objective Acute Physiology and Chronic Health Evaluation (APACHE) III score has been widely used for prediction of clinical outcomes in mixed critically ill patients. However, it has not been validated in patients with sepsis-associated acute lung injury (ALI). The aim of the study was to explore the calibration and predictive value of APACHE III in patients with sepsis-associated ALI. Method The study was a secondary analysis of a prospective randomized controlled trial investigating the efficacy of rosuvastatin in sepsis-associated ALI (Statins for Acutely Injured Lungs from Sepsis, SAILS). The study population was sepsis-related ALI patients. The primary outcome of the current study was the same as in the original trial, 60-day in-hospital mortality, defined as death before hospital discharge, censored 60 days after enrollment. Discrimination of APACHE III was assessed by calculating the area under the receiver operating characteristic (ROC) curve (AUC) with its 95% CI. Hosmer-Lemeshow goodness-of-fit statistic was used to assess the calibration of APACHE III. The Brier score was reported to represent the overall performance of APACHE III in predicting outcome. Main results A total of 745 patients were included in the study, including 540 survivors and 205 non-survivors. Non-survivors were significantly older than survivors (59.71 +/- 16.17 vs 52.00 +/- 15.92 years, p < 0.001). The primary causes of ALI were also different between survivors and non-survivors (p = 0.017). Survivors were more likely to have the cause of sepsis than non-survivors (21.2% vs. 15.1%). APACHE III score was higher in non-survivors than in survivors (106.72 +/- 27.30 vs. 88.42 +/- 26.86; p < 0.001). Discrimination of APACHE III to predict mortality in ALI patients was moderate with an AUC of 0.68 (95% confidence interval: 0.64-0.73). Conclusion this study for the first time validated the discrimination of APACHE III in sepsis associated ALI patients. The result shows that APACHE III score has moderate predictive value for in-hospital mortality among adults with sepsis-associated acute lung injury.	[Zhang, Zhongheng; Chen, Kun; Chen, Lin] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, ZH (corresponding author), Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com	zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011	Zhang, Zhongheng/0000-0002-2336-5323				Agarwal R, 2006, CHEST, V130, P724, DOI 10.1378/chest.130.3.724; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bhadade RR, 2011, J POSTGRAD MED, V57, P286, DOI 10.4103/0022-3859.90077; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Chen Y, 2014, IEEE ENG MED BIO, P4310, DOI 10.1109/EMBC.2014.6944578; Chen YX, 2014, AM J EMERG MED, V32, P982, DOI 10.1016/j.ajem.2014.05.025; Cooke CR, 2009, CRIT CARE MED, V37, P1913, DOI 10.1097/CCM.0b013e3181a009b4; Cui YL, 2014, CHINESE MED J-PEKING, V127, P2623, DOI 10.3760/cma.j.issn.0366-6999.20132684; Damluji A, 2011, CRIT CARE MED, V39, P1023, DOI 10.1097/CCM.0b013e31820ead31; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Ikeda M, 2002, COMPUT METH PROG BIO, V67, P187, DOI 10.1016/S0169-2607(01)00157-2; Irish Critical Care Trials Group, 2008, Crit Care, V12, pR30, DOI 10.1186/cc6808; Keegan MT, 2012, CHEST, V142, P851, DOI 10.1378/chest.11-2164; Keegan MT, 2009, BMC SURG, V9, DOI 10.1186/1471-2482-9-11; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Li Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109665, DOI 10.1371/journal.pone.0109665]; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rufibach K, 2010, J CLIN EPIDEMIOL, V63, P938, DOI 10.1016/j.jclinepi.2009.11.009; Shah CV, 2008, CRIT CARE MED, V36, P2309, DOI 10.1097/CCM.0b013e318180dc74; Treggiari MM, 2004, CRIT CARE MED, V32, P327, DOI 10.1097/01.CCM.0000108870.09693.42; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Zammit SC, 2014, EUR J INTERN MED, V25, P571, DOI 10.1016/j.ejim.2014.04.008; Zhang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120641; Zhou XY, 2015, INT J INFECT DIS, V30, P144, DOI 10.1016/j.ijid.2014.11.005; Zilberberg MD, 1998, AM J RESP CRIT CARE, V157, P1159, DOI 10.1164/ajrccm.157.4.9704088	25	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139374	10.1371/journal.pone.0139374	http://dx.doi.org/10.1371/journal.pone.0139374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422633	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700104
J	Buma, FE; Raemaekers, M; Kwakkel, G; Ramsey, NF				Buma, Floor E.; Raemaekers, Mathijs; Kwakkel, Gert; Ramsey, Nick F.			Brain Function and Upper Limb Outcome in Stroke: A Cross-Sectional fMRI Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; SENSORIMOTOR CORTEX; RECOVERY; ACTIVATION; REPRODUCIBILITY; IMPROVEMENT; MOVEMENTS; IMPACT; TASK; TIME	Objective The nature of changes in brain activation related to good recovery of arm function after stroke is still unclear. While the notion that this is a reflection of neuronal plasticity has gained much support, confounding by compensatory strategies cannot be ruled out. We address this issue by comparing brain activity in recovered patients 6 months after stroke with healthy controls. Methods We included 20 patients with upper limb paresis due to ischemic stroke and 15 controls. We measured brain activation during a finger flexion-extension task with functional MRI, and the relationship between brain activation and hand function. Patients exhibited various levels of recovery, but all were able to perform the task. Results Comparison between patients and controls with voxel-wise whole-brain analysis failed to reveal significant differences in brain activation. Equally, a region of interest analysis constrained to the motor network to optimize statistical power, failed to yield any differences. Finally, no significant relationship between brain activation and hand function was found in patients. Patients and controls performed scanner task equally well. Conclusion Brain activation and behavioral performance during finger flexion-extensions in (moderately) well recovered patients seems normal. The absence of significant differences in brain activity even in patients with a residual impairment may suggest that infarcts do not necessarily induce reorganization of motor function. While brain activity could be abnormal with higher task demands, this may also introduce performance confounds. It is thus still uncertain to what extent capacity for true neuronal repair after stroke exists.	[Buma, Floor E.; Kwakkel, Gert] Rehabil Ctr De Hoogstraat, Ctr Knowledge, Utrecht, Netherlands; [Buma, Floor E.; Kwakkel, Gert] UMCU, Dept Rehabil & Sports Med, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Raemaekers, Mathijs; Ramsey, Nick F.] UMCU, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Kwakkel, Gert] Vrije Univ Amsterdam Med Ctr, Dept Rehabil Med, Res Inst MOVE Amsterdam, Amsterdam, Netherlands	Unilever; Utrecht University; Utrecht University Medical Center; Unilever; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Ramsey, NF (corresponding author), UMCU, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	n.f.ramsey@umcutrecht.nl		Kwakkel, Gert/0000-0002-4041-4043; ramsey, nick/0000-0002-7136-259X	Netherlands Organization for Health Research and Development (ZonMw) [89000001]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The authors have disclosed receipt of the following financial support for the research and/or authorship of this article: The EXPLICIT-stroke research project was supported by a grant from the Netherlands Organization for Health Research and Development (ZonMw; Grant No. 89000001; URL http://www.zonmw.nl/nl/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Buma FE, 2010, NEUROREHAB NEURAL RE, V24, P589, DOI 10.1177/1545968310364058; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Carey LM, 2005, STROKE, V36, P625, DOI 10.1161/01.STR.0000155720.47711.83; CARROLL D, 1965, J CHRON DIS, V18, P479, DOI 10.1016/0021-9681(65)90030-5; Casellato C, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-49; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Dong Y, 2007, NEUROREHAB NEURAL RE, V21, P412, DOI 10.1177/1545968306298598; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Grice KO, 2003, AM J OCCUP THER, V57, P570; Hermes D, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025007; Hermes D, 2012, J NEUROSCI, V32, P9736, DOI 10.1523/JNEUROSCI.0357-12.2012; Heuschmann PU, 2011, NEUROLOGY, V76, P159, DOI 10.1212/WNL.0b013e318206ca1e; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kim YH, 2003, NEUROREPORT, V14, P1329, DOI 10.1097/01.wnr.0000078702.79393.9b; Kitago T, 2013, NEUROREHAB NEURAL RE, V27, P99, DOI 10.1177/1545968312452631; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Kwakkel G, 2006, STROKE, V37, P2348, DOI 10.1161/01.STR.0000238594.91938.1e; Kwakkel G, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-49; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maier MA, 2002, CEREB CORTEX, V12, P281, DOI 10.1093/cercor/12.3.281; Moon SK, 2009, EXP NEUROL, V218, P145, DOI 10.1016/j.expneurol.2009.04.021; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Nijland RHM, 2013, PHYS THER, V93, P460, DOI 10.2522/ptj.20120112; Nijland RHM, 2010, STROKE, V41, P745, DOI 10.1161/STROKEAHA.109.572065; Raemaekers M, 2012, NEUROIMAGE, V60, P717, DOI 10.1016/j.neuroimage.2011.11.061; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; ROTHI LJ, 1983, J CLIN NEUROPSYCHOL, V5, P73, DOI 10.1080/01688638308401152; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Smania N, 2007, STROKE, V38, P1088, DOI 10.1161/01.STR.0000258077.88064.a3; Stinear C, 2010, LANCET NEUROL, V9, P1228, DOI 10.1016/S1474-4422(10)70247-7; Stinear CM, 2012, BRAIN, V135, P2527, DOI 10.1093/brain/aws146; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van Kordelaar J, 2012, PHYS THER, V92, P142, DOI 10.2522/ptj.20100341; van Rootselaar AF, 2008, HUM BRAIN MAPP, V29, P1430, DOI 10.1002/hbm.20477; Ward N S, 2007, Eura Medicophys, V43, P285; Ward NS, 2005, POSTGRAD MED J, V81, P510, DOI 10.1136/pgmj.2004.030809; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Wardlaw JM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4584; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2	51	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139746	10.1371/journal.pone.0139746	http://dx.doi.org/10.1371/journal.pone.0139746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440276	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300049
J	Jiang, XY; Yuan, LY; Engelbach, JA; Cates, J; Perez-Torres, CJ; Gao, F; Thotala, D; Drzymala, RE; Schmidt, RE; Rich, KM; Hallahan, DE; Ackerman, JJH; Garbow, JR				Jiang, Xiaoyu; Yuan, Liya; Engelbach, John A.; Cates, Jeremy; Perez-Torres, Carlos J.; Gao, Feng; Thotala, Dinesh; Drzymala, Robert E.; Schmidt, Robert E.; Rich, Keith M.; Hallahan, Dennis E.; Ackerman, Joseph J. H.; Garbow, Joel R.			A Gamma-Knife-Enabled Mouse Model of Cerebral Single-Hemisphere Delayed Radiation Necrosis	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; TUMOR PROGRESSION; GLIOMA RECURRENCE; ANIMAL-MODEL; DIFFERENTIATION; INJURY; BRAIN; RADIOSURGERY; ADC; MRI	Purpose To develop a Gamma Knife-based mouse model of late time-to-onset, cerebral radiation necrosis (RN) with serial evaluation by magnetic resonance imaging (MRI) and histology. Methods and Materials Mice were irradiated with the Leksell Gamma Knife (R) (GK) Perfexion (TM) (Elekta AB; Stockholm, Sweden) with total single-hemispheric radiation doses (TRD) of 45- to 60-Gy, delivered in one to three fractions. RN was measured using T2-weighted MR images, while confirmation of tissue damage was assessed histologically by hematoxylin & eosin, trichrome, and PTAH staining. Results MRI measurements demonstrate that TRD is a more important determinant of both time-to-onset and progression of RN than fractionation. The development of RN is significantly slower in mice irradiated with 45-Gy than 50- or 60-Gy, where RN development is similar. Irradiated mouse brains demonstrate all of the pathologic features observed clinically in patients with confirmed RN. A semi-quantitative (0 to 3) histologic grading system, capturing both the extent and severity of injury, is described and illustrated. Tissue damage, as assessed by a histologic score, correlates well with total necrotic volume measured by MRI (correlation coefficient = 0.948, with p<0.0001), and with post-irradiation time (correlation coefficient = 0.508, with p<0.0001). Conclusions Following GK irradiation, mice develop late time-to-onset cerebral RN histology mirroring clinical observations. MR imaging provides reliable quantification of the necrotic volume that correlates well with histologic score. This mouse model of RN will provide a platform for mechanism of action studies, the identification of imaging biomarkers of RN, and the development of clinical studies for improved mitigation and neuroprotection.	[Jiang, Xiaoyu; Ackerman, Joseph J. H.] Washington Univ, Dept Chem, St Louis, MO 63130 USA; [Yuan, Liya; Drzymala, Robert E.; Rich, Keith M.] Washington Univ, Dept Neurosurg, St Louis, MO USA; [Engelbach, John A.; Perez-Torres, Carlos J.; Ackerman, Joseph J. H.; Garbow, Joel R.] Washington Univ, Dept Radiol, St Louis, MO 63130 USA; [Cates, Jeremy; Thotala, Dinesh; Drzymala, Robert E.; Rich, Keith M.; Hallahan, Dennis E.] Washington Univ, Dept Radiat Oncol, St Louis, MO USA; [Gao, Feng] Washington Univ, Div Biostat, St Louis, MO USA; [Gao, Feng; Thotala, Dinesh; Hallahan, Dennis E.; Ackerman, Joseph J. H.; Garbow, Joel R.] Washington Univ, Alvin J Siteman Canc Ctr, St Louis, MO USA; [Schmidt, Robert E.] Washington Univ, Dept Neuropathol, St Louis, MO USA; [Ackerman, Joseph J. H.] Washington Univ, Dept Internal Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Garbow, JR (corresponding author), Washington Univ, Dept Radiol, St Louis, MO 63130 USA.	garbow@wustl.edu		Gao, Feng/0000-0002-1425-1623; Perez-Torres, Carlos/0000-0003-3352-011X; jiang, xiaoyu/0000-0002-0369-6301	NIH [R01 CA155365, R01 CA174966, R01 CA140220]; Alvin J. Siteman Comprehensive Cancer Center [P30 CA091842]; Barnes-Jewish Hospital Foundation Cancer Frontier Fund; Mallinckrodt Institute of Radiology; Elekta Instruments AB (Stockholm, Sweden); NATIONAL CANCER INSTITUTE [R01CA155365, R01CA174966, R01CA140220, P30CA091842] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alvin J. Siteman Comprehensive Cancer Center; Barnes-Jewish Hospital Foundation Cancer Frontier Fund; Mallinckrodt Institute of Radiology; Elekta Instruments AB (Stockholm, Sweden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been supported by NIH grants R01 CA155365 (JRG), R01 CA174966 (DEH), and R01 CA140220 (DEH), and funding from the Alvin J. Siteman Comprehensive Cancer Center (P30), P30 CA091842, the Barnes-Jewish Hospital Foundation Cancer Frontier Fund, Mallinckrodt Institute of Radiology, and Elekta Instruments AB (Stockholm, Sweden).	Cha J, 2013, EUR RADIOL, V23, P879, DOI 10.1007/s00330-012-2638-4; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Flickinger JC, 2002, RADIOTHER ONCOL, V63, P347, DOI 10.1016/S0167-8140(02)00103-2; Giglio P, 2003, NEUROLOGIST, V9, P180, DOI 10.1097/01.nrl.0000080951.78533.c4; Glantz S, 2001, PRIMER APPL REGRESSI; Hein PA, 2004, AM J NEURORADIOL, V25, P201; Hu LS, 2009, AM J NEURORADIOL, V30, P552, DOI 10.3174/ajnr.A1377; Hu LS, 2012, NEURO-ONCOLOGY, V14, P919, DOI 10.1093/neuonc/nos112; Jiang XY, 2014, INT J RADIAT ONCOL, V89, P714, DOI 10.1016/j.ijrobp.2014.04.018; Jiang XY, 2014, CLIN CANCER RES, V20, P2695, DOI 10.1158/1078-0432.CCR-13-1941; Jost SC, 2009, INT J RADIAT ONCOL, V75, P527, DOI 10.1016/j.ijrobp.2009.06.007; Kumar AJ, 2000, RADIOLOGY, V217, P377, DOI 10.1148/radiology.217.2.r00nv36377; Kumar S, 2012, J NEURO-ONCOL, V108, P411, DOI 10.1007/s11060-012-0846-z; Mori Y, 2000, NEUROSURGERY, V46, P157, DOI 10.1093/neurosurgery/46.1.157; Perez-Torres CJ, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0335-6; Perez-Torres CJ, 2014, INT J RADIAT ONCOL, V90, P446, DOI 10.1016/j.ijrobp.2014.06.015; Schlemmer HP, 2002, NEURORADIOLOGY, V44, P216, DOI 10.1007/s002340100703; Schollnberger H, 2002, INT J RADIAT BIOL, V78, P1159, DOI 10.1080/0955300021000034693; van der Worp HB, 2007, BRAIN, V130, P3063, DOI 10.1093/brain/awm083; Wong CS, 2004, MOL INTERV, V4, P273, DOI 10.1124/mi.4.5.7; Zeng QS, 2007, INT J RADIAT ONCOL, V68, P151, DOI 10.1016/j.ijrobp.2006.12.001; Zhang H, 2015, J NEUROL SCI, V351, P65, DOI 10.1016/j.jns.2015.02.038; Zhou JY, 2011, NAT MED, V17, P130, DOI 10.1038/nm.2268	24	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139596	10.1371/journal.pone.0139596	http://dx.doi.org/10.1371/journal.pone.0139596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440791	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300035
J	Lo, YC; Tsai, MS; Sun, HY; Hung, CC; Chuang, JH				Lo, Yi-Chun; Tsai, Mao-Song; Sun, Hsin-Yun; Hung, Chien-Ching; Chuang, Jen-Hsiang			National Trend and Characteristics of Acute Hepatitis C among HIV-Infected Individuals: A Matched Case-Control Study-Taiwan, 2001-2014	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FIBROSIS PROGRESSION; LIVER FIBROSIS; POSITIVE MEN; DRUG-USERS; SEX; COINFECTION; EPIDEMIC; IMPACT; COHORT	Background Hepatitis C virus (HCV) infection has been increasingly recognized among HIV-infected men who have sex with men (MSM) worldwide. We investigated the trend of and factors associated with acute hepatitis C (AHC) among HIV-infected individuals in Taiwan. Methods The National Disease Surveillance System collects characteristics of AHC, HIV, syphilis, and gonorrhea cases through mandatory reports and patient interviews. Reported AHC patients in 2014 were interviewed additionally on sexual and parenteral exposures. Information on HCV genotypes were collected from the largest medical center serving HIV-infected Taiwanese. We defined an HIV/AHC case as a documented negative HCV antibody test result followed within 12 months by a positive test in a previously reported HIV-infected individual. Each case was matched to two HIV-infected, non-AHC controls for age, age of HIV diagnosis, sex, transmission route, HIV diagnosis date, and county/city. Conditional logistic regression was used to identify associated characteristics. Results During 2001-2014, 93 of 6,624 AHC reports were HIV/AHC cases; the annual case count increased from one in 2009 to 34 in 2014. All were males (81 [87%] MSM) aged 21-49 years with AHC diagnosed 2-5,923 days after HIV diagnoses. Sixty-eight (73%) lived in the Taipei metropolitan area. Detected HCV genotypes were 2a (n = 6), 1b (n = 5), 1b + 2a (n = 1) and 2b (n = 1). Among 28 HIV/AHC patients interviewed in 2014, 13 (46%) reported engaging in unprotected sex <= 3 months before AHC diagnosis. Seventy-nine HIV/AHC cases were matched to 158 controls. HIV/AHC was associated with recent syphilis (adjusted odds ratio [aOR], 10.9; 95% confidence interval [CI], 4.2-28.6) and last syphilis >6 months (aOR, 2.9; 95% CI, 1.2-6.9). Conclusions HIV/AHC cases continued to increase particularly among sexually active HIV-infected MSM with a syphilis diagnosis in northern Taiwan. We recommend surveillance of associated behavioral and virologic characteristics and HCV counseling and testing for HIV-infected men in Taiwan.	[Lo, Yi-Chun; Chuang, Jen-Hsiang] Taiwan Ctr Dis Control, Taipei, Taiwan; [Lo, Yi-Chun; Sun, Hsin-Yun; Hung, Chien-Ching] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Lo, Yi-Chun; Sun, Hsin-Yun; Hung, Chien-Ching] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Tsai, Mao-Song] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Far Eastern Memorial Hospital	Lo, YC (corresponding author), Taiwan Ctr Dis Control, Taipei, Taiwan.	loyichun@cdc.gov.tw; jhchuang@cdc.gov.tw	Chuang, Jen-Hsiang/G-4356-2010	Chuang, Jen-Hsiang/0000-0002-7114-3418; SUN, HSIN-YUN/0000-0003-0074-7721; Hung, Chien-Ching/0000-0001-7345-0836	Taiwan Centers for Disease Control [MOHW103-CDC-C-315-000110]	Taiwan Centers for Disease Control	Taiwan Centers for Disease Control (www.cdc.gov.tw), YCL, grant number MOHW103-CDC-C-315-000110. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert M, 2011, AIDS, V25, P399, DOI 10.1097/QAD.0b013e328343443b; Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bottieau E, 2010, EUROSURVEILLANCE, V15, P19673; Bradshaw D, 2013, CURR OPIN INFECT DIS, V26, P66, DOI 10.1097/QCO.0b013e32835c2120; Chang YH, 2014, J MICROBIOL IMMUNOL, V47, P533, DOI 10.1016/j.jmii.2013.11.003; Chen CH, 2008, AIDS CARE, V20, P1251, DOI 10.1080/09540120801926985; Chen YC, 2015, JAIDS-J ACQ IMM DEF, V68, P432, DOI 10.1097/QAI.0000000000000477; Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Danta M, 2008, J INFECT DIS, V197, P1558, DOI 10.1086/587843; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; Di Martino V, 2001, HEPATOLOGY, V34, P1193, DOI 10.1053/jhep.2001.29201; Fierer DS, 2008, J INFECT DIS, V198, P683, DOI 10.1086/590430; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Gambotti L, 2005, Euro Surveill, V10, P115, DOI 10.2807/esm.10.05.00535-en; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hsieh MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094791; Huang YF, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001625; Huang YF, 2013, J FORMOS MED ASSOC, V112, P369, DOI 10.1016/j.jfma.2012.10.018; Huo TI, 2004, J MED VIROL, V72, P41, DOI 10.1002/jmv.10554; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Ishikane M, 2013, PROGRAM AND ABSTRACT; Ishikane M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100517; Kang W, 2014, EXPERT REV GASTROENT, V8, P247, DOI 10.1586/17474124.2014.876357; Ko NY, 2013, INVESTIGATION OF E D; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Lin WY, 2013, J INFECT DIS, V207, pS13, DOI 10.1093/infdis/jis926; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Lo YC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003222; Matthews GV, 2009, CLIN INFECT DIS, V48, P650, DOI 10.1086/596770; Peng EYC, 2011, J FORMOS MED ASSOC, V110, P446, DOI 10.1016/S0929-6646(11)60066-1; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Serpaggi J, 2006, AIDS, V20, P233, DOI 10.1097/01.aids.0000200541.40633.56; Sherman KE, 2005, GASTROENTEROLOGY, V128, P313, DOI 10.1053/j.gastro.2004.11.059; Sulkowski MS, 2007, AIDS, V21, P2209, DOI 10.1097/QAD.0b013e3282f10de9; Sun HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090194; Sun HY, 2012, J CLIN MICROBIOL, V50, P781, DOI 10.1128/JCM.06014-11; Sun HY, 2009, AM J GASTROENTEROL, V104, P877, DOI 10.1038/ajg.2008.159; Taiwan Centers for Disease Control (TCDC), 2010, GUIDELINES FOR DIAGN; Taylor LE, 2011, CLIN INFECT DIS, V52, P812, DOI 10.1093/cid/ciq201; Thomson EC, 2009, AIDS, V23, P89, DOI 10.1097/QAD.0b013e32831940a3; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van der Helm JJ, 2011, AIDS, V25, P1083, DOI 10.1097/QAD.0b013e3283471cce; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Ward C, 2014, J INT AIDS SOC, V17, P98, DOI 10.7448/IAS.17.4.19639; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566	55	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139687	10.1371/journal.pone.0139687	http://dx.doi.org/10.1371/journal.pone.0139687			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439381	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300042
J	Okita, R; Wolf, D; Yasuda, K; Maeda, A; Yukawa, T; Saisho, S; Shimizu, K; Yamaguchi, Y; Oka, M; Nakayama, E; Lundqvist, A; Kiessling, R; Seliger, B; Nakata, M				Okita, Riki; Wolf, Diana; Yasuda, Koichiro; Maeda, Ai; Yukawa, Takuro; Saisho, Shinsuke; Shimizu, Katsuhiko; Yamaguchi, Yoshiyuki; Oka, Mikio; Nakayama, Eiichi; Lundqvist, Andreas; Kiessling, Rolf; Seliger, Barbara; Nakata, Masao			Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells	PLOS ONE			English	Article							MHC-CLASS-I; CHAIN-RELATED MOLECULE; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; UP-REGULATION; TUMOR-CELLS; DNA-DAMAGE; EXPRESSION; RECEPTOR; SUSCEPTIBILITY	Introduction Several cytotoxic anticancer drugs inhibit DNA replication and/or mitosis, while EGFR tyrosine kinase inhibitors inactivate EGFR signalling in cancer cell. Both types of anticancer drugs improve the overall survival of the patients with non-small-cell lung cancer (NSCLC), although tumors often become refractory to this treatment. Despite several mechanisms by which the tumors become resistant having been described the effect of these compounds on anti-tumor immunity remains largely unknown. Methods This study examines the effect of the cytotoxic drug Gemcitabine and the EGFR tyrosine kinase inhibitor Gefitinib on the expression of NK group 2 member D (NKG2D) ligands as well as the sensitivity of NSCLC cells to the NK-mediated lysis. Results We demonstrate that Gemcitabine treatment leads to an enhanced expression, while Gefitinib downregulated the expression of molecules that act as key ligands for the activating receptor NKG2D and promote NK cell-mediated recognition and cytolysis. Gemcitabine activated ATM and ATM- and Rad-3-related protein kinase (ATR) pathways. The Gemcitabine-induced phosphorylation of ATM as well as the upregulation of the NKG2D ligand expression could be blocked by an ATM-ATR inhibitor. In contrast, Gefitinib attenuated NKG2D ligand expression. Silencing EGFR using siRNA or addition of the PI3K inhibitor resulted in downregulation of NKG2D ligands. The observations suggest that the EGFR/PI3K pathway also regulates the expression of NKG2D ligands. Additionally, we showed that both ATM-ATR and EGFR regulate MICA/B via miR20a. Conclusion In keeping with the effect on NKG2D expression, Gemcitabine enhanced NK cell-mediated cytotoxicity while Gefitinib attenuated NK cell killing in NSCLC cells.	[Okita, Riki; Yasuda, Koichiro; Maeda, Ai; Yukawa, Takuro; Saisho, Shinsuke; Shimizu, Katsuhiko; Nakata, Masao] Kawasaki Med Sch, Dept Gen Thorac Surg, Kurashiki, Okayama, Japan; [Yamaguchi, Yoshiyuki] Kawasaki Med Sch, Dept Clin Oncol, Kurashiki, Okayama, Japan; [Oka, Mikio] Kawasaki Med Sch, Dept Resp Med, Kurashiki, Okayama, Japan; [Nakayama, Eiichi] Kawasaki Univ Med Welf, Fac Hlth & Welf, Kurashiki, Okayama, Japan; [Okita, Riki; Lundqvist, Andreas; Kiessling, Rolf] Karolinska Inst, Dept Pathol & Oncol, Immune & Gene Therapy Lab, Canc Ctr Karolinska, Stockholm, Sweden; [Wolf, Diana; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06108 Halle, Germany	Kawasaki Medical School; Kawasaki Medical School; Kawasaki Medical School; Karolinska Institutet; Martin Luther University Halle Wittenberg	Okita, R (corresponding author), Kawasaki Med Sch, Dept Gen Thorac Surg, Kurashiki, Okayama, Japan.	riki0716okita@yahoo.co.jp	Okita, Riki/ABD-7413-2020	Okita, Riki/0000-0003-1343-1275; Seliger, Barbara/0000-0002-5544-4958; Lundqvist, Andreas/0000-0002-9709-2970	Astra Zeneca; JSPS Kakenhi Grant [24890284, 25462189]; Kawasaki Medical School Project [24-30, 25-34]; Ryobi Teien Research Grant; Okayama Medical Foundation; Deutsche Forschungsgemeinschaft [BA 4893/2-1, GRK1591 B2, GRK1591 B4, GIF I-1187-69.11]; Swedish Cancer Society [120598]; Cancer Society of Stockholm [121103]; Swedish Medical Research Council [K2011-66X-15387-07-3]; ALF-Project grant from Stockholm City Council [20110070]; Knut and Alice Wallenberg foundation; Strategic Research Foundation from Ministry of Education, Culture, Sport, Science, and Technology [S1291010]	Astra Zeneca(AstraZeneca); JSPS Kakenhi Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kawasaki Medical School Project; Ryobi Teien Research Grant(Ryobi Teien Memory Foundation); Okayama Medical Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Cancer Society(Swedish Cancer Society); Cancer Society of Stockholm; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); ALF-Project grant from Stockholm City Council; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Strategic Research Foundation from Ministry of Education, Culture, Sport, Science, and Technology	Dr. Masao Nakata has received research funding from Astra Zeneca for this study. This work was supported by JSPS Kakenhi Grant (24890284 and 25462189), Kawasaki Medical School Project Grants (24-30 and 25-34), The Ryobi Teien Research Grant (no grant number) and The Okayama Medical Foundation (no grant number) (to R.O.), Deutsche Forschungsgemeinschaft (to D.W.; BA 4893/2-1 and to B.S. GRK1591 B2 and B4, GIF I-1187-69.11), The Swedish Cancer Society (120598), The Cancer Society of Stockholm (121103), The Swedish Medical Research Council (K2011-66X-15387-07-3), an ALF-Project grant from Stockholm City Council (20110070), and Knut and Alice Wallenberg foundation (no number) (to R.K.), and Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sport, Science, and Technology (S1291010)(to M.N.). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggstrom MQ, 2007, J THORAC ONCOL, V2, P845, DOI 10.1097/JTO.0b013e31814617a2; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Boissel N, 2006, J IMMUNOL, V176, P5108, DOI 10.4049/jimmunol.176.8.5108; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Eissmann P, 2010, J IMMUNOL, V184, P6901, DOI 10.4049/jimmunol.0903985; Foukas LC, 2002, J BIOL CHEM, V277, P37124, DOI 10.1074/jbc.M202101200; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Heinemann A, 2012, CANCER RES, V72, P460, DOI 10.1158/0008-5472.CAN-11-1977; HENNEQUIN C, 1995, BRIT J CANCER, V71, P1194, DOI 10.1038/bjc.1995.232; HERTEL LW, 1990, CANCER RES, V50, P4417; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kiessling R, 2012, ONCOIMMUNOLOGY, V1, P1200, DOI 10.4161/onci.20685; Kim H, 2011, J IMMUNOTHER, V34, P372, DOI 10.1097/CJI.0b013e31821b724a; Lanier LL, 2001, NAT MED, V7, P1178, DOI 10.1038/nm1101-1178; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Min D, 2013, BRIT J CANCER, V109, P723, DOI 10.1038/bjc.2013.337; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; MORETTA A, 1990, J EXP MED, V172, P1589, DOI 10.1084/jem.172.6.1589; Morisaki T, 2011, ANTICANCER RES, V31, P2505; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Okita R, 2012, J IMMUNOL, V188, P2136, DOI 10.4049/jimmunol.1102237; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Pollack BP, 2011, CLIN CANCER RES, V17, P4400, DOI 10.1158/1078-0432.CCR-10-3283; Sarkaria JN, 1999, CANCER RES, V59, P4375; Soriani A, 2009, BLOOD, V113, P3503, DOI 10.1182/blood-2008-08-173914; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Tang KF, 2008, J CELL BIOL, V182, P233, DOI 10.1083/jcb.200801169; Tolis C, 1999, EUR J CANCER, V35, P796, DOI 10.1016/S0959-8049(98)00425-0; Tsukerman P, 2012, CANCER RES, V72, P5463, DOI 10.1158/0008-5472.CAN-11-2671; Uno K, 1998, CLIN CANCER RES, V4, P2425; Venkataraman GM, 2007, J IMMUNOL, V178, P961, DOI 10.4049/jimmunol.178.2.961; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wakeling AE, 2002, CANCER RES, V62, P5749; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Wu JM, 2014, CARCINOGENESIS, V35, P155, DOI 10.1093/carcin/bgt268; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; Yarden Y, 2001, NAT REV MOL CELL BIO, V137	45	27	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139809	10.1371/journal.pone.0139809	http://dx.doi.org/10.1371/journal.pone.0139809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439264	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300060
J	Shen, JL; Pan, YP; Fang, YP				Shen, Jilu; Pan, Yaping; Fang, Yaping			Role of the Outer Membrane Protein OprD(2) in Carbapenem-Resistance Mechanisms of Pseudomonas aeruginosa	PLOS ONE			English	Article							PORIN OPRD; IMIPENEM; STRAINS	We investigated the relationship between the outer membrane protein OprD(2) and carbapenem-resistance in 141 clinical isolates of Pseudomonas aeruginosa collected between January and December 2013 from the First Affiliated Hospital of Anhui Medical University in China. Agar dilution methods were employed to determine the minimum inhibitory concentration of meropenem (MEM) and imipenem (IMP) for P. aeruginosa. The gene encoding OprD(2) was amplified from141 P. aeruginosa isolates and analyzed by PCR and DNA sequencing. Differences between the effects of IMPR and IMPS groups on the resistance of the P. aeruginosa were observed by SDS-poly acrylamide gel electrophoresis (SDS-PAGE). Three resistance types were classified in the 141 carbapenem-resistant P. aeruginosa (CRPA) isolates tested, namely (IMPMEMR)-M-R (66.7%), (IMPMEMS)-M-R (32.6%), and (IMPMEMS)-M-R (0.7%). DNA sequencing revealed significant diverse gene mutations in the OprD(2-)encoding gene in these strains. Thirty-four strains had large fragment deletions in the OprD(2)gene, in 6 strains the gene contained fragment inserts, and in 96 resistant strains, the gene featured small fragment deletions or multi-site mutations. Only 4 metallo-beta-lactamase strains and 1 imipenem-sensitive (meropenem-resistant) strain showed a normal OprD(2) gene. Using SDS-PAGE to detect the outer membrane protein in 16 CRPA isolates, it was found that 10 IMPRMEMR strains and 5 (IMPMEMS)-M-R strains had lost the OprD(2) protein, while the (IMPMEMR)-M-S strain contained a normal 46-kDa protein. In conclusion, mutation or loss of the OprD(2)-encoding gene caused the loss of OprD(2), which further led to carbapenem-resistance of P. aeruginosa. Our findings provide insights into the mechanism of carbapenem resistance in P. aeruginosa.	[Shen, Jilu; Pan, Yaping] Anhui Med Univ, Affiliated Hosp 1, Dept Lab Med, Hefei, Anhui, Peoples R China; [Fang, Yaping] Anhui Med Univ, Affiliated Hosp 2, Dept Lab Med, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Shen, JL (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Lab Med, Hefei, Anhui, Peoples R China.	shenjilu@126.com			National Natural Science Fund [81171618]	National Natural Science Fund(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Fund Project (project approval NO: 81171618).	Berges L, 2007, J ANTIMICROB CHEMOTH, V59, P812, DOI 10.1093/jac/dkm001; [陈瑞 Chen Rui], 2006, [中华传染病杂志, Chinese Journal of Infections Diseases], V24, P80; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Fang ZL, 2014, INFECT GENET EVOL, V21, P124, DOI 10.1016/j.meegid.2013.10.027; Fournier D, 2013, J ANTIMICROB CHEMOTH, V68, P1772, DOI 10.1093/jac/dkt098; Jin DY, 1996, MOL CLONING EXPT GUI, P888; [李耘 Li Yun], 2012, [中国临床药理学杂志, The Chinese Journal of Clinical Pharmacology], V28, P883; Lian Z, 1999, Chin Med Sci J, V14, P57; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; LYNCH MJ, 1987, ANTIMICROB AGENTS CH, V31, P1892, DOI 10.1128/AAC.31.12.1892; Meletis G, 2014, EUR J CLIN MICROBIOL, V33, P253, DOI 10.1007/s10096-013-1952-3; Naenna P, 2010, SE ASIAN J TROP MED, V41, P614; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; Paterson DL, 2006, CLIN INFECT DIS, V43, pS43, DOI 10.1086/504476; Poole K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00065; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Rojo-Bezares B, 2014, INT J MED MICROBIOL, V304, P405, DOI 10.1016/j.ijmm.2014.01.001; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Wang J, 2010, INT J ANTIMICROB AG, V35, P486, DOI 10.1016/j.ijantimicag.2009.12.014; YONEYAMA H, 1993, ANTIMICROB AGENTS CH, V37, P2385, DOI 10.1128/AAC.37.11.2385; Zeng ZR, 2014, DIAGN MICR INFEC DIS, V78, P268, DOI 10.1016/j.diagmicrobio.2013.11.014	21	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139995	10.1371/journal.pone.0139995	http://dx.doi.org/10.1371/journal.pone.0139995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440806	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300092
J	Sode, J; Vogel, U; Bank, S; Andersen, PS; Hetland, ML; Locht, H; Heegaard, NHH; Andersen, V				Sode, Jacob; Vogel, Ulla; Bank, Steffen; Andersen, Paal Skytt; Hetland, Merete Lund; Locht, Henning; Heegaard, Niels H. H.; Andersen, Vibeke			Genetic Variations in Pattern Recognition Receptor Loci Are Associated with Anti-TNF Response in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; DISEASE; POLYMORPHISMS; MECHANISMS; EXPRESSION; VARIANTS; THERAPY; GAMMA	Objectives To determine whether genetic variation within genes related to the Toll-like receptor, inflammasome and interferon-gamma. pathways contributes to the differences in treatment response to tumour necrosis factor inhibitors (anti-TNF) in patients with rheumatoid arthritis (RA). Methods In a retrospective case-case study, we assessed 23 functional single nucleotide polymorphisms (SNPs) in 15 genes. We included 538 anti-TNF naive Danish RA patients from the nationwide DANBIO database. Multivariable logistic regression analyses were performed to detect associations (p-value<0.05) between genotypes and European League Against Rheumatism (EULAR) treatment responses. False Discovery Rate corrections for multiple testing (q-value) and stratified analyses were performed to investigate association with individual therapies and IgM-rheumatoid factor (RF) status. Results Six of twenty successfully genotyped polymorphisms were nominally associated with EULAR treatment response. Three of these were in weak to moderate linkage disequilibrium with polymorphisms previously reported associated with anti-TNF treatment response. TLR5(rs5744174) variant allele carriers (odds ratio(OR) = 1.7(1.1-2.5), p = 0.010, q = 0.46) and TLR1(rs4833095) homozygous variant carriers (OR = 2.8(1.1-7.4), p = 0.037, q = 0.46) had higher odds for a positive treatment response. NLRP3(rs10754558) variant allele carriers (odds ratio(OR) = 0.6(0.4-1.0), p = 0.045, q = 0.46) were more likely to have a negative treatment response. The association in TLR5(rs5744174) remained significant after correction for multiple comparisons among patients negative for RF (OR = 6.2(2.4-16.3), p = 0.0002, q = 0.024). No other association withstood correction for multiple testing. Post hoc analyses showed that change in Patient Global score on a visual analogue scale (VAS) and change in pain VAS were the main factors responsible for the association. Conclusions We reproduced previously reported associations between genetic variation in the TLR10/1/6 gene cluster, TLR5, and NLRP3 loci and response to anti-TNF treatment in RA. Changes in VAS pain and patient global scores were the main contributors to the association found for TLR5. Furthermore, we identified other candidate genes that require replication in independent cohorts.	[Sode, Jacob; Heegaard, Niels H. H.] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark; [Sode, Jacob; Locht, Henning] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Sode, Jacob; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Ctr Sonderjylland, Odense, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen] Univ Aarhus, Biomed, Aarhus, Denmark; [Andersen, Paal Skytt] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Andersen, Paal Skytt] Univ Copenhagen, Vet Dis Biol, Copenhagen, Denmark; [Hetland, Merete Lund] Rigshosp, DANBIO Registry, Copenhagen Ctr Arthrit Res, Ctr Rheumatol & Spine Dis, Glostrup, Denmark; [Hetland, Merete Lund] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark; [Heegaard, Niels H. H.] Univ Southern Denmark, Clin Biochem, Inst Clin, Odense, Denmark; [Andersen, Vibeke] Hosp Southern Jutland, Mol Diagnost & Clin Res Unit, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, DK-5000 Odense, Denmark	Statens Serum Institut; University of Southern Denmark; National Research Centre for the Working Environment; Aarhus University; Aarhus University; Statens Serum Institut; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Sode, J (corresponding author), Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark.	jaso@ssi.dk	Andersen, Paal S/H-2087-2015; Andersen, Vibeke/I-7932-2012; Vogel, Ulla B/I-5048-2012; Vogel, Ulla/ABC-2212-2020; Hetland, Merete L/AAE-5297-2019; Sode, Jacob/AAD-9615-2020	Andersen, Paal S/0000-0001-5656-0427; Andersen, Vibeke/0000-0002-0127-2863; Vogel, Ulla B/0000-0001-6807-1524; Vogel, Ulla/0000-0001-6807-1524; Hetland, Merete L/0000-0003-4229-6818; Sode, Jacob/0000-0002-2718-9320	Danish Rheumatism Association [R95-A1913/R99-A1923]; Region of Southern Denmark's PhD Fund [12/7725]; Department of Rheumatology, Frederiksberg Hospital	Danish Rheumatism Association; Region of Southern Denmark's PhD Fund; Department of Rheumatology, Frederiksberg Hospital	This study was supported by the Danish Rheumatism Association, R95-A1913/R99-A1923 (www.gigtforeningen.dk), Region of Southern Denmark's PhD Fund, 12/7725 (www.regionsyddanmark.dk) and the Department of Rheumatology, Frederiksberg Hospital (www.frederiksberghospital.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Colman I, 2013, PHARMACOGENOMICS, V14, P727, DOI [10.2217/PGS.13.60, 10.2217/pgs.13.60]; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Coenen MJH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014326; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; Hetland ML, 2011, RHEUMATOLOGY, V50, P69, DOI 10.1093/rheumatology/keq309; Hitomi Y, 2009, J ALLERGY CLIN IMMUN, V124, P779, DOI 10.1016/j.jaci.2009.07.044; Klimosch SN, 2013, CANCER RES, V73, P7232, DOI 10.1158/0008-5472.CAN-13-1746; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nicotra L, 2012, EXP NEUROL, V234, P316, DOI 10.1016/j.expneurol.2011.09.038; Plant D, 2012, ARTHRITIS RHEUM-US, V64, P665, DOI 10.1002/art.33381; Potter C, 2010, ANN RHEUM DIS, V69, P1315, DOI 10.1136/ard.2009.117309; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sheridan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061326; Sode J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100361; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Uciechowski P, 2011, J LEUKOCYTE BIOL, V90, P377, DOI 10.1189/jlb.0409233; Umicevic MM, 2014, ANN RHEUMATIC DIS; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; Yang CA, 2013, HELICOBACTER, V18, P13, DOI 10.1111/hel.12001	25	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139781	10.1371/journal.pone.0139781	http://dx.doi.org/10.1371/journal.pone.0139781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440629	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300052
J	Cieslak, J; Mackowski, M; Czyzak-Runowska, G; Wojtowski, J; Puppel, K; Kuczynska, B; Pawlak, P				Cieslak, Jakub; Mackowski, Mariusz; Czyzak-Runowska, Grazyna; Wojtowski, Jacek; Puppel, Kamila; Kuczynska, Beata; Pawlak, Piotr			Screening for the Most Suitable Reference Genes for Gene Expression Studies in Equine Milk Somatic Cells	PLOS ONE			English	Article							REVERSE TRANSCRIPTION-PCR; BOVINE MAMMARY-GLAND; REAL-TIME PCR; EPITHELIAL-CELLS; COWS; NORMALIZATION; SELECTION; RNA	Apart from the well-known role of somatic cell count as a parameter reflecting the inflammatory status of the mammary gland, the composition of cells isolated from milk is considered as a valuable material for gene expression studies in mammals. Due to its unique composition, in recent years an increasing interest in mare's milk consumption has been observed. Thus, investigating the genetic background of horse's milk variability presents and interesting study model. Relying on 39 milk samples collected from mares representing three breeds (Polish Primitive Horse, Polish Cold-blooded Horse, Polish Warmblood Horse) we aimed to investigate the utility of equine milk somatic cells as a source of mRNA and to screen the best reference genes for RT-qPCR using geNorm and NormFinder algorithms. The results showed that despite relatively low somatic cell counts in mare's milk, the amount and the quality of the extracted RNA are sufficient for gene expression studies. The analysis of the utility of 7 potential reference genes for RT-qPCR experiments for the normalization of equine milk somatic cells revealed some differences between the outcomes of the applied algorithms, although in both cases the KRT8 and TOP2B genes were pointed as the most stable. Analysis by geNorm showed that the combination of 4 reference genes (ACTB, GAPDH, TOP2B and KRT8) is required for apropriate RT-qPCR experiments normalization, whereas NormFinder algorithm pointed the combination of KRT8 and RPS9 genes as the most suitable. The trial study of the relative transcript abundance of the beta-casein gene with the use of various types and numbers of internal control genes confirmed once again that the selection of proper reference gene combinations is crucial for the final results of each real-time PCR experiment.	[Cieslak, Jakub; Mackowski, Mariusz] Poznan Univ Life Sci, Dept Horse Breeding, Poznan, Poland; [Czyzak-Runowska, Grazyna; Wojtowski, Jacek] Poznan Univ Life Sci, Dept Small Mammals Breeding & Raw Mat Anim Origin, Poznan, Poland; [Puppel, Kamila; Kuczynska, Beata] Warsaw Univ Life Sci, Cattle Breeding Div, Dept Anim Sci, Warsaw, Poland; [Pawlak, Piotr] Poznan Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences; Warsaw University of Life Sciences; Poznan University of Life Sciences	Pawlak, P (corresponding author), Poznan Univ Life Sci, Dept Genet & Anim Breeding, Poznan, Poland.	piotr.pawlak@up.poznan.pl	Pawlak, Piotr/AAX-7094-2020; Kuczyńska, Beata/AAC-7166-2022; Wójtowski, Jacek/V-1464-2019; Beata, Kuczyńska/ABB-3267-2020	Pawlak, Piotr/0000-0003-3489-1684; Wójtowski, Jacek/0000-0002-9186-006X; Beata, Kuczyńska/0000-0002-9093-9905; Mackowski, Mariusz/0000-0003-2214-7284; Czyzak-Runowska, Grazyna/0000-0002-0321-0623; Puppel, Kamila/0000-0003-2909-2087; Cieslak, Jakub/0000-0001-6936-2550	National Science Centre (Poland) [2011/03/D/NZ9/05337]	National Science Centre (Poland)	Study was funded by the National Science Centre (Poland), grant: 2011/03/D/NZ9/05337.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bai WL, 2014, J DAIRY SCI, V97, P902, DOI 10.3168/jds.2012-6437; Bionaz M, 2007, PHYSIOL GENOMICS, V29, P312, DOI 10.1152/physiolgenomics.00223.2006; Bonnefont CMD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-208; Boutinaud M, 2002, REPROD NUTR DEV, V42, P133, DOI 10.1051/rnd:2002013; Boutinaud M, 2002, J ANIM SCI, V80, P1258; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Cagalj M, 2014, MLJEKARSTVO, V64, P3; Canovas A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05297; Caroprese M, 2007, J DAIRY SCI, V90, P2773, DOI 10.3168/jds.2006-603; Dankow R., 2006, Archiv fur Tierzucht, V49, P201; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Jacobs AAA, 2013, J ANIM PHYSIOL AN N, V97, P353, DOI 10.1111/j.1439-0396.2012.01278.x; Jarczak J, 2014, GENE, V549, P280, DOI 10.1016/j.gene.2014.07.063; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kozera B, 2013, J APPL GENET, V54, P391, DOI 10.1007/s13353-013-0173-x; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Markiewicz-Keszycka M, 2013, INT DAIRY J, V31, P62, DOI 10.1016/j.idairyj.2013.02.006; Modesto P, 2013, J DAIRY SCI, V96, P7932, DOI 10.3168/jds.2012-6383; Murrieta CM, 2006, J ANIM SCI, V84, P2399, DOI 10.2527/jas.2005-677; Pecka E, 2012, ANIM SCI J, V83, P162, DOI 10.1111/j.1740-0929.2011.00930.x; Puppel K, 2014, J SCI FOOD AGR, V94, P1253, DOI 10.1002/jsfa.6424; Salimei E, 2012, INT DAIRY J, V24, P130, DOI 10.1016/j.idairyj.2011.11.008; Selvaggi M, 2010, ANIM BIOTECHNOL, V21, P252, DOI 10.1080/10495398.2010.509646; Sigl T, 2012, CZECH J ANIM SCI, V57, P469, DOI 10.17221/6347-CJAS; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney N, 2012, J DAIRY SCI, V95, P2935, DOI 10.3168/jds.2011-4442; Yadav P, 2012, LIVEST SCI, V147, P72, DOI 10.1016/j.livsci.2012.04.004; Zhai ZC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064786	29	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139688	10.1371/journal.pone.0139688	http://dx.doi.org/10.1371/journal.pone.0139688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437076	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200049
J	Kumar, D; Das, B; Sen, R; Kundu, P; Manna, A; Sarkar, A; Chowdhury, C; Chatterjee, M; Das, P				Kumar, Deepak; Das, Bimolendu; Sen, Rupashree; Kundu, Priyanka; Manna, Alak; Sarkar, Avijit; Chowdhury, Chinmay; Chatterjee, Mitali; Das, Padma			Andrographolide Analogue Induces Apoptosis and Autophagy Mediated Cell Death in U937 Cells by Inhibition of PI3K/Akt/mTOR Pathway	PLOS ONE			English	Article							BREAST-CANCER CELLS; PERMEABILITY TRANSITION PORE; PROTEIN-KINASE B; COMBINATION TREATMENT; ARSENIC TRIOXIDE; LEUKEMIC-CELLS; THERAPY; MTOR; MITOCHONDRIA; SUPPRESSION	Background Current chemotherapeutic agents based on apoptosis induction are lacking in desired efficacy. Therefore, there is continuous effort to bring about new dimension in control and gradual eradication of cancer by means of ever evolving therapeutic strategies. Various forms of PCD are being increasingly implicated in anti-cancer therapy and the complex interplay among them is vital for the ultimate fate of proliferating cells. We elaborated and illustrated the underlying mechanism of the most potent Andrographolide analogue (AG-4) mediated action that involved the induction of dual modes of cell death-apoptosis and autophagy in human leukemic U937 cells. Principal Findings AG-4 induced cytotoxicity was associated with redox imbalance and apoptosis which involved mitochondrial depolarisation, altered apoptotic protein expressions, activation of the caspase cascade leading to cell cycle arrest. Incubation with caspase inhibitor Z-VAD-fmk or Bax siRNA decreased cytotoxic efficacy of AG-4 emphasising critical roles of caspase and Bax. In addition, AG-4 induced autophagy as evident from LC3-II accumulation, increased Atg protein expressions and autophagosome formation. Pre-treatment with 3-MA or Atg 5 siRNA suppressed the cytotoxic effect of AG-4 implying the pro-death role of autophagy. Furthermore, incubation with Z-VAD-fmk or Bax siRNA subdued AG-4 induced autophagy and pre-treatment with 3-MA or Atg 5 siRNA curbed AG-4 induced apoptosis-implying that apoptosis and autophagy acted as partners in the context of AG-4 mediated action. AG-4 also inhibited PI3K/Akt/mTOR pathway. Inhibition of mTOR or Akt augmented AG-4 induced apoptosis and autophagy signifying its crucial role in its mechanism of action. Conclusions Thus, these findings prove the dual ability of AG-4 to induce apoptosis and autophagy which provide a new perspective to it as a potential molecule targeting PCD for future cancer therapeutics.	[Kumar, Deepak; Das, Padma] Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, Kolkata 700032, India; [Das, Bimolendu; Kundu, Priyanka; Chowdhury, Chinmay] Indian Inst Chem Biol, CSIR, Div Chem, Kolkata 700032, India; [Sen, Rupashree; Manna, Alak; Sarkar, Avijit; Chatterjee, Mitali] Postgrad Inst Med Educ & Res, Dept Pharmacol, Kolkata 700020, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Das, P (corresponding author), Indian Inst Chem Biol, CSIR, Canc Biol & Inflammatory Disorder Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	padmadas2005@yahoo.co.in	Manna, Alak/AAY-1248-2021; Chatterjee, Mitali/AAV-2129-2021; Sen, Rupashree/AAM-9430-2020; Kumar, Deepak/J-4347-2016; Manna, Alak/AAE-7308-2021	Manna, Alak/0000-0003-3894-3277; Sen, Rupashree/0000-0003-2121-6161; Kundu, Priyanka/0000-0002-4907-2350	Department of Science and Technology, Govt. of India [SR/S1/OC-42/2009]; Department of Biotechnology, Govt. of India [BT/PR13444/PBD/17/670/2009]; Council of Scientific and Industrial Research, Govt. of India [IAP0001]	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by grants from Department of Science and Technology (SR/S1/OC-42/2009), Govt. of India; Department of Biotechnology (BT/PR13444/PBD/17/670/2009), Govt. of India and Council of Scientific and Industrial Research (IAP0001), Govt. of India. DK received Senior Research fellowships from Council of Scientific and Industrial Research, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akar U, 2008, AUTOPHAGY, V4, P669, DOI 10.4161/auto.6083; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Ambjorn M, 2013, AUTOPHAGY, V9, P287, DOI 10.4161/auto.22831; Andrzejak M, 2011, AUTOPHAGY, V7, P979, DOI 10.4161/auto.7.9.15865; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bhattacharya K, 2010, BIOCHEM PHARMACOL, V79, P361, DOI 10.1016/j.bcp.2009.09.007; Bhushan S, 2007, APOPTOSIS, V12, P1911, DOI 10.1007/s10495-007-0105-5; Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D; Chen W, 2012, CARCINOGENESIS, V33, P2190, DOI 10.1093/carcin/bgs264; Chen YJ, 2009, AUTOPHAGY, V5, P173, DOI 10.4161/auto.5.2.7360; Chiu HW, 2010, AUTOPHAGY, V6, P353, DOI 10.4161/auto.6.3.11229; Chiu HW, 2009, AUTOPHAGY, V5, P472, DOI 10.4161/auto.5.4.7759; Das B, 2010, BIOORG MED CHEM LETT, V20, P6947, DOI 10.1016/j.bmcl.2010.09.126; de The H, 2012, J CELL BIOL, V198, P11, DOI 10.1083/jcb.201112044; Dewaele M, 2010, AUTOPHAGY, V6, P838, DOI 10.4161/auto.6.7.12113; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Gills JJ, 2008, AUTOPHAGY, V4, P107, DOI 10.4161/auto.5224; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guo WJ, 2013, AUTOPHAGY, V9, P996, DOI 10.4161/auto.24407; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsu KF, 2009, AUTOPHAGY, V5, P451, DOI 10.4161/auto.5.4.7666; Iruretagoyena MI, 2005, J PHARMACOL EXP THER, V312, P366, DOI 10.1124/jpet.104.072512; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kondo Y, 2006, AUTOPHAGY, V2, P85, DOI 10.4161/auto.2.2.2463; Lee KH, 2010, J NAT PROD, V73, P500, DOI 10.1021/np900821e; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liu WT, 2011, AUTOPHAGY, V7, P166, DOI 10.4161/auto.7.2.14043; Liu YL, 2010, AUTOPHAGY, V6, P1057, DOI 10.4161/auto.6.8.13365; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu HH, 2010, AUTOPHAGY, V6, P725, DOI 10.4161/auto.6.6.12423; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Manna A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036938; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Nag TC, 2009, ANN ANAT, V191, P556, DOI 10.1016/j.aanat.2009.08.004; Narvaez CJ, 2001, J BIOL CHEM, V276, P9101, DOI 10.1074/jbc.M006876200; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Paglin S, 2001, CANCER RES, V61, P439; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Quinsay MN, 2010, AUTOPHAGY, V6, P855, DOI 10.4161/auto.6.7.13005; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Roy R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071672; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sarkar A, 2009, EXP PARASITOL, V122, P299, DOI 10.1016/j.exppara.2009.04.012; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shen YC, 2002, BRIT J PHARMACOL, V135, P399, DOI 10.1038/sj.bjp.0704493; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Suh Y, 2010, CARCINOGENESIS, V31, P1424, DOI 10.1093/carcin/bgq115; Trivedi NP, 2007, INTEGR CANCER THER, V6, P271, DOI 10.1177/1534735407305985; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang K, 2011, AUTOPHAGY, V7, P966, DOI 10.4161/auto.7.9.15863; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Zhou J, 2012, AUTOPHAGY, V8, P338, DOI 10.4161/auto.18721; Zhu S, 2013, AUTOPHAGY, V9, P317, DOI 10.4161/auto.22923; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zinzani PL, 2012, HEMATOL-AM SOC HEMAT, P426, DOI 10.1182/asheducation-2012.1.426	64	50	50	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139657	10.1371/journal.pone.0139657	http://dx.doi.org/10.1371/journal.pone.0139657			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436418	Green Submitted, Green Published, gold			2022-12-27	WOS:000362499200044
J	Chen, C; Yu, XF; Shao, SY				Chen, Cai; Yu, Xuefeng; Shao, Shiying			Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis	PLOS ONE			English	Article							N-3 FATTY-ACIDS; FISH-OIL SUPPLEMENTATION; DIETARY SUPPLEMENTATION; INSULIN SENSITIVITY; METABOLISM; RISK; ASSOCIATION; RESISTANCE; GREENLAND	Background Many studies assessed the impact of marine omega-3 fatty acids on glycemic homeostasis and lipid profiles in patients with type 2 diabetes (T2DM), but reported controversial results. Our goal was to systematically evaluate the effects of omega-3 on glucose control and lipid levels. Methods Medline, Pubmed, Cochrane Library, Embase, the National Research Register, and SIGLE were searched to identify eligible randomized clinical trials (RCTs). Extracted data from RCTs were analyzed using STATA 11.0 statistical software with fixed or random effects model. Effect sizes were presented as weighted mean differences (WMD) with 95% confidence intervals (95% CI). Heterogeneity was assessed using the Chi-square test with significance level set at p < 0.1. Results 20 RCT trials were included into this meta-analysis. Among patients with omega-3 supplementation, triglyceride (TG) levels were significantly decreased by 0.24 mmol/L. No marked change in total cholesterol (TC), HbA1c, fasting plasma glucose, postprandial plasma glucose, BMI or body weight was observed. High ratio of EPA/DHA contributed to a greater decreasing tendency in plasma insulin, HbAc1, TC, TG, and BMI measures, although no statistical significance was identified (except TG). FPG levels were increased by 0.42 mmol/L in Asians. No evidence of publication bias was observed in this meta-analysis. Conclusions The ratio of EPA/DHA and early intervention with omega 3 fatty acids may affect their effects on glucose control and lipid levels, which may serve as a dietary reference for clinicians or nutritionists who manage diabetic patients.	[Chen, Cai; Yu, Xuefeng; Shao, Shiying] Huazhong Univ Sci & Technol, Tongji Hosp, Div Endocrinol, Wuhan 430030, Peoples R China; [Chen, Cai] Huazhong Univ Sci & Technol, Tongji Hosp, Ctr Biomed Res, Wuhan 430030, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Shao, SY (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Div Endocrinol, Wuhan 430030, Peoples R China.	shao@imsb.biol.ethz.ch			National Natural Science Foundation of China [81100581]; China International Medical Foundation (CIMF) - novo nordisk China beta Academy Funding [20110059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China International Medical Foundation (CIMF) - novo nordisk China beta Academy Funding	This work was supported by a grant from National Natural Science Foundation of China (81100581 to S. Shao) and by a grant from China International Medical Foundation (CIMF) - novo nordisk China beta Academy Funding (20110059 to S. Shao). S. Shao is in charge of these two grants.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; American Diabetes Association, 2015, Diabetes Care, V38 Suppl, pS20, DOI 10.2337/dc15-S007; ANNUZZI G, 1991, ATHEROSCLEROSIS, V87, P65, DOI 10.1016/0021-9150(91)90233-S; BANG HO, 1980, AM J CLIN NUTR, V33, P2657, DOI 10.1093/ajcn/33.12.2657; BORKMAN M, 1989, DIABETES, V38, P1314, DOI 10.2337/diabetes.38.10.1314; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GLAUBER H, 1988, ANN INTERN MED, V108, P663, DOI 10.7326/0003-4819-108-5-663; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gubitosi-Klug RA, 2014, DIABETES CARE, V37, P44, DOI 10.2337/dc13-2148; Hartweg J, 2009, CURR OPIN LIPIDOL, V20, P30, DOI 10.1097/MOL.0b013e328321b3be; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kabir M, 2007, AM J CLIN NUTR, V86, P1670; KASIM SE, 1988, J CLIN ENDOCR METAB, V67, P1, DOI 10.1210/jcem-67-1-1; KROMANN N, 1980, ACTA MED SCAND, V208, P401; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Li D, 2015, ASIA PAC J CLIN NUTR, V24, P10, DOI 10.6133/apjcn.2015.24.1.21; Luo J, 1998, DIABETES CARE, V21, P717, DOI 10.2337/diacare.21.5.717; McManus RM, 1996, DIABETES CARE, V19, P463, DOI 10.2337/diacare.19.5.463; MCVEIGH GE, 1993, DIABETOLOGIA, V36, P33, DOI 10.1007/BF00399090; Molinar-Toribio E, 2015, BRIT J NUTR, V113, P878, DOI 10.1017/S0007114514004437; Montori VM, 2000, DIABETES CARE, V23, P1407, DOI 10.2337/diacare.23.9.1407; MORGAN WA, 1995, DIABETES CARE, V18, P83, DOI 10.2337/diacare.18.1.83; Muley A, 2014, CURR DIABETES REV, V10, P158, DOI 10.2174/1573399810666140515113137; Neil HAW, 2010, ATHEROSCLEROSIS, V213, P512, DOI 10.1016/j.atherosclerosis.2010.09.013; Okuda Y, 1996, J DIABETES COMPLICAT, V10, P280, DOI 10.1016/1056-8727(95)00081-X; Patel PS, 2012, AM J CLIN NUTR, V95, P1445, DOI 10.3945/ajcn.111.029314; PELIKANOVA T, 1993, ANN NY ACAD SCI, V683, P272; Pooya S, 2010, NUTR METAB CARDIOVAS, V20, P326, DOI 10.1016/j.numecd.2009.04.002; POPPSNIJDERS C, 1987, DIABETES RES CLIN EX, V4, P141; PUHAKAINEN I, 1995, AM J CLIN NUTR, V61, P121, DOI 10.1093/ajcn/61.1.121; Rivellese AA, 1996, DIABETES CARE, V19, P1207, DOI 10.2337/diacare.19.11.1207; SAGILD U, 1966, ACTA MED SCAND, V179, P29; SCHECTMAN G, 1988, DIABETES, V37, P1567, DOI 10.2337/diabetes.37.11.1567; SCHULZ KF, 1995, ONLINE J CURR CLIN T; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shidfar F, 2008, East Mediterr Health J, V14, P305; Sirtori CR, 1997, AM J CLIN NUTR, V65, P1874, DOI 10.1093/ajcn/65.6.1874; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wong CY, 2010, DIABETIC MED, V27, P54, DOI 10.1111/j.1464-5491.2009.02869.x; Yan YQ, 2013, IMMUNITY, V38, P1154, DOI 10.1016/j.immuni.2013.05.015; Zheng JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044525; Zhou YP, 2012, BRIT J NUTR, V108, P408, DOI 10.1017/S0007114512002036	42	59	65	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139565	10.1371/journal.pone.0139565	http://dx.doi.org/10.1371/journal.pone.0139565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431431	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700078
J	Masato, G; Bone, A; Charlton-Perez, A; Cavany, S; Neal, R; Dankers, R; Dacre, H; Carmichael, K; Murray, V				Masato, Giacomo; Bone, Angie; Charlton-Perez, Andrew; Cavany, Sean; Neal, Robert; Dankers, Rutger; Dacre, Helen; Carmichael, Katie; Murray, Virginia			Improving the Health Forecasting Alert System for Cold Weather and Heat-Waves In England: A Proof-of-Concept Using Temperature-Mortality Relationships	PLOS ONE			English	Article							IMPACT	Objectives In this study a prototype of a new health forecasting alert system is developed, which is aligned to the approach used in the Met Office's (MO) National Severe Weather Warning Service (NSWWS). This is in order to improve information available to responders in the health and social care system by linking temperatures more directly to risks of mortality, and developing a system more coherent with other weather alerts. The prototype is compared to the current system in the Cold Weather and Heatwave plans via a case-study approach to verify its potential advantages and shortcomings. Method The prototype health forecasting alert system introduces an "impact vs likelihood matrix" for the health impacts of hot and cold temperatures which is similar to those used operationally for other weather hazards as part of the NSWWS. The impact axis of this matrix is based on existing epidemiological evidence, which shows an increasing relative risk of death at extremes of outdoor temperature beyond a threshold which can be identified epidemiologically. The likelihood axis is based on a probability measure associated with the temperature forecast. The new method is tested for two case studies (one during summer 2013, one during winter 2013), and compared to the performance of the current alert system. Conclusions The prototype shows some clear improvements over the current alert system. It allows for a much greater degree of flexibility, provides more detailed regional information about the health risks associated with periods of extreme temperatures, and is more coherent with other weather alerts which may make it easier for front line responders to use. It will require validation and engagement with stakeholders before it can be considered for use.	[Masato, Giacomo; Charlton-Perez, Andrew; Cavany, Sean; Dacre, Helen] Univ Reading, Dept Meteorol, Reading, Berks, England; [Bone, Angie; Carmichael, Katie; Murray, Virginia] Publ Hlth England, Dept Hlth, London, England; [Neal, Robert; Dankers, Rutger] Met Off, Exeter, Devon, England	University of Reading; Public Health England; Met Office - UK	Masato, G (corresponding author), Univ Reading, Dept Meteorol, Reading, Berks, England.	g.masato@reading.ac.uk	Charlton-Perez, Andrew/F-4079-2010; Neal, Robert/AAU-2045-2021	Charlton-Perez, Andrew/0000-0001-8179-6220; Neal, Robert/0000-0003-2678-6016; Dankers, Rutger/0000-0003-2375-5468; Cavany, Sean/0000-0002-2559-797X	Natural Environment Research Council; NERC [NE/J017221/1] Funding Source: UKRI; Natural Environment Research Council [NE/J017221/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work of GM, SC, ACP and HD was funded by the Natural Environment Research Council (http://www.nerc.ac.uk) through its PURE Associates and Impact Accelerator funding calls. The funder had no role in study design, data collection and analysis or preparation of the manuscript.	[Anonymous], HEATW PLAN ENGL 2013; [Anonymous], COLD PLAN ENGL 2013; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Bowler NE, 2008, Q J ROY METEOR SOC, V134, P703, DOI 10.1002/qj.234; Buizza R, 2007, Q J ROY METEOR SOC, V133, P681, DOI 10.1002/qj.75; Donaldson GC, 1998, BRIT MED J, V316, P514, DOI 10.1136/bmj.316.7130.514; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fischer EM, 2013, NAT CLIM CHANGE, V3, P1033, DOI [10.1038/NCLIMATE2051, 10.1038/nclimate2051]; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; Golding BW, 2014, B AM METEOROL SOC, V95, P883, DOI 10.1175/BAMS-D-13-00102.1; Hajat S, 2014, J EPIDEMIOL COMMUN H, V68, P641, DOI 10.1136/jech-2013-202449; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Johnson Helen, 2005, Health Stat Q, P6; Kmietowicz Z, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7479; Lloyd-Sherlock P, 2000, SOC SCI MED, V51, P887, DOI 10.1016/S0277-9536(00)00068-X; Martiello MA, 2010, SCAND J PUBLIC HEALT, V38, P826, DOI 10.1177/1403494810377685; McGregor G.R., 2015, HEATWAVES HLTH GUIDA; Medina-Ramon M, 2007, OCCUP ENVIRON MED, V64, P827, DOI 10.1136/oem.2007.033175; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Neal RA, 2014, METEOROL APPL, V21, P563, DOI 10.1002/met.1377; Raisanen J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049758; Tennant W., 2015, Q J ROY METEOR SOC; Travis WR, 2014, CLIM RISK MANAG, V1, P1, DOI 10.1016/j.crm.2014.02.003	25	20	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0137804	10.1371/journal.pone.0137804	http://dx.doi.org/10.1371/journal.pone.0137804			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431427	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700008
J	Xie, J; Yi, SJ; Zhu, JG; Li, P; Liang, BB; Li, H; Yang, XX; Wang, LG; Hao, RZ; Jia, LL; Wu, ZH; Qiu, SF; Song, HB				Xie, Jing; Yi, Shengjie; Zhu, Jiangong; Li, Peng; Liang, Beibei; Li, Hao; Yang, Xiaoxia; Wang, Ligui; Hao, Rongzhang; Jia, Leili; Wu, Zhihao; Qiu, Shaofu; Song, Hongbin			Antimicrobial Resistance and Molecular Investigation of H2S-Negative Salmonella enterica subsp enterica serovar Choleraesuis Isolates in China	PLOS ONE			English	Article							SHORT PALINDROMIC REPEATS; SEROTYPE CHOLERAESUIS; HYDROGEN-SULFIDE; FLUOROQUINOLONE RESISTANCE; QUINOLONE RESISTANCE; ESCHERICHIA-COLI; GLOBAL BURDEN; TAIWAN; TYPHIMURIUM; HUMANS	Salmonella enterica subsp. enterica serovar Choleraesuis is a highly invasive pathogen of swine that frequently causes serious outbreaks, in particular in Asia, and can also cause severe invasive disease in humans. In this study, 21 S. Choleraesuis isolates, detected from 21 patients with diarrhea in China between 2010 and 2011, were found to include 19 H2S-negative S. Choleraesuis isolates and two H2S-positive isolates. This is the first report of H2S-negative S. Choleraesuis isolated from humans. The majority of H2S-negative isolates exhibited high resistance to ampicillin, chloramphenicol, gentamicin, tetracycline, ticarcillin, and trimethoprim-sulfamethoxazole, but only six isolates were resistant to norfloxacin. In contrast, all of the isolates were sensitive to cephalosporins. Fifteen isolates were found to be multidrug resistant. In norfloxacin-resistant isolates, we detected mutations in the gyrA and parC genes and identified two new mutations in the parC gene. Pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), and clustered regularly interspaced short palindromic repeat (CRISPR) analysis were employed to investigate the genetic relatedness of H2S-negative and H2S-positive S. Choleraesuis isolates. PFGE revealed two groups, with all 19 H2S-negative S. Choleraesuis isolates belonging to Group I and H2S-positive isolates belonging to Group II. By MLST analysis, the H2S-negative isolates were all found to belong to ST68 and H2S-positive isolates belong to ST145. By CRISPR analysis, no significant differences in CRISPR 1 were detected; however, one H2S-negative isolate was found to contain three new spacers in CRISPR 2. All 19 H2S-negative isolates also possessed a frame-shift mutation at position 760 of phsA gene compared with H2S-positive isolates, which may be responsible for the H2S-negative phenotype. Moreover, the 19 H2S-negative isolates have similar PFGE patterns and same mutation site in the phsA gene, these results indicated that these H2S-negative isolates may have been prevalent in China. These findings suggested that surveillance should be increased of H(2)Snegative S. Choleraesuis in China.	[Xie, Jing; Yi, Shengjie; Li, Peng; Liang, Beibei; Li, Hao; Yang, Xiaoxia; Wang, Ligui; Hao, Rongzhang; Jia, Leili; Wu, Zhihao; Qiu, Shaofu; Song, Hongbin] Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing 100071, Peoples R China; [Yi, Shengjie] Cent S Univ, Xiangya Basic Med Coll, Changsha 410013, Hunan, Peoples R China; [Zhu, Jiangong] 302 Hosp PLA, Clin Diagnost Ctr, Beijing, Peoples R China; [Liang, Beibei] Shanxi Agr Univ, Coll Anim Sci & Vet Med, Jinzhong 030800, Peoples R China	Academy of Military Medical Sciences - China; Central South University; Fifth Medical Center of Chinese PLA General Hospital; Shanxi Agricultural University	Qiu, SF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing 100071, Peoples R China.	qiushf0613@hotmail.com; hongbinsong@263.net	Qiu, Shaofu/CAJ-0602-2022		Mega-projects of Science and Technology Research of China [2012ZX10004215, 2013ZX10004607, 2013ZX10004218]; National Nature Science Foundation of China [81373053, 81202252, 81371854]; Beijing Science and Technology Nova program [xx2013061]	Mega-projects of Science and Technology Research of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Nova program	This study was supported by the Mega-projects of Science and Technology Research of China (nos. 2012ZX10004215, 2013ZX10004607 and 2013ZX10004218), the National Nature Science Foundation of China (nos. 81373053, 81202252 and 81371854) and the Beijing Science and Technology Nova program (no. xx2013061).	Albert MJ, 2014, J CLIN MICROBIOL, V52, P4090, DOI 10.1128/JCM.01775-14; Asai T, 2010, COMP IMMUNOL MICROB, V33, P109, DOI 10.1016/j.cimid.2008.08.004; Bangtrakulnonth A, 2004, EMERG INFECT DIS, V10, P131, DOI 10.3201/eid1001.02-0781; Camoez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072828; Cantinelli T, 2013, J CLIN MICROBIOL, V51, P3770, DOI 10.1128/JCM.01874-13; Chang CC, 2005, J CLIN MICROBIOL, V43, P2798, DOI 10.1128/JCM.43.6.2798-2804.2005; Chang CF, 2002, J VET DIAGN INVEST, V14, P153, DOI 10.1177/104063870201400210; Chen Yen-Hsu, 1999, Kaohsiung Journal of Medical Sciences, V15, P202; Chen YH, 1999, KAOHSIUNG J MED SCI, V15, P127; Chiu CH, 2006, PEDIATRICS, V117, pE1193, DOI 10.1542/peds.2005-2251; Chiu CH, 2002, NEW ENGL J MED, V346, P413, DOI 10.1056/NEJMoa012261; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; Chiu Shun, 2004, Journal of Microbiology Immunology and Infection, V37, P99; Esaki H, 2004, JPN J INFECT DIS, V57, P287; Fabre L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036995; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Grissa I, 2008, NUCLEIC ACIDS RES, V36, pW145, DOI 10.1093/nar/gkn228; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606; Hsueh PR, 2004, EMERG INFECT DIS, V10, P60, DOI 10.3201/eid1001.030171; Jean Shio-Shin, 2006, Journal of Microbiology Immunology and Infection, V39, P358; Kanematsu E, 1998, ANTIMICROB AGENTS CH, V42, P433; Ko WC, 2005, CLIN INFECT DIS, V40, P315, DOI 10.1086/426593; Kuo HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095772; Levitt MD, 1999, J CLIN INVEST, V104, P1107, DOI 10.1172/JCI7712; Lin DC, 2014, FOOD MICROBIOL, V43, P1, DOI 10.1016/j.fm.2014.04.010; Liu FY, 2011, APPL ENVIRON MICROB, V77, P4520, DOI 10.1128/AEM.00468-11; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; Onyango DM, 2014, J INFECT DEV COUNTR, V8, P1381, DOI 10.3855/jidc.3861; Piddock LJV, 1998, J ANTIMICROB CHEMOTH, V41, P635, DOI 10.1093/jac/41.6.635; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Sakano C, 2013, J CLIN MICROBIOL, V51, P328, DOI 10.1128/JCM.02225-12; Senior K, 2009, LANCET INFECT DIS, V9, P80, DOI 10.1016/S1473-3099(09)70008-8; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Sirichote P, 2010, J CLIN MICROBIOL, V48, P883, DOI 10.1128/JCM.01792-09; Thiennimitr P, 2011, P NATL ACAD SCI USA, V108, P17480, DOI 10.1073/pnas.1107857108; Trees DL, 1999, INT J ANTIMICROB AG, V12, P325, DOI 10.1016/S0924-8579(99)00081-3; Usui M, 2011, J VET MED SCI, V73, P279, DOI 10.1292/jvms.10-0309; Wayne Pa, 2012, M100MS19 CLSI NAT CO; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Yi SJ, 2014, J CLIN MICROBIOL, V52, P2557, DOI 10.1128/JCM.00377-14	43	4	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139115	10.1371/journal.pone.0139115	http://dx.doi.org/10.1371/journal.pone.0139115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431037	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700033
J	Chan, PM; Tan, YS; Chua, KH; Sabaratnam, V; Kuppusamy, UR				Chan, Pui-Mun; Tan, Yee-Shin; Chua, Kek-Heng; Sabaratnam, Vikineswary; Kuppusamy, Umah Rani			Attenuation of Inflammatory Mediators (TNF-alpha and Nitric Oxide) and Up-Regulation of IL-10 by Wild and Domesticated Basidiocarps of Amauroderma rugosum (Blume & T. Nees) Torrend in LPS-Stimulated RAW264.7 Cells	PLOS ONE			English	Article							NF-KAPPA-B; OXIDATIVE STRESS; PATHWAYS; ANTIOXIDANTS; CULTIVATION; ACTIVATION; CYTOKINES; SEIZURES; THERAPY; SYSTEM	Amauroderma rugosum, commonly known as "Jiazi" in China, is a wild mushroom traditionally used by the Chinese to reduce inflammation, to treat diuretic and upset stomach, and to prevent cancer. It is also used by the indigenous communities in Malaysia to prevent epileptic episodes and incessant crying by babies. The aim of this study was to compare the wild and domesticated basidiocarps of A. rugosum for antioxidant and in vitro anti-inflammatory effects in LPS-stimulated RAW264.7 cells. The wild basidiocarps of A. rugosum were collected from the Belum Forest, Perak, Malaysia and the domesticated basidiocarps of A. rugosum were cultivated in the mushroom house located in the University of Malaya, Kuala Lumpur, Malaysia. Both the wild and domesticated basidiocarps were subjected to ethanolic extraction and the extracts were tested for antioxidant and anti-inflammatory activities. In this study, the crude ethanolic extract of wild (WB) and domesticated (DB) basidiocarps of A. rugosum had comparable total phenolic content and DPPH scavenging activity. However, WB (EC50 = 222.90 mu g/mL) displayed a better ABTS cation radical scavenging activity than DB (EC50 = 469.60 mu g/mL). Both WB and DB were able to scavenge nitric oxide (NO) radical and suppress the NO production in LPS-stimulated RAW264.7 cells and this effect was mediated through the down-regulation of inducible nitric oxide synthase (iNOS) gene. In addition, both WB and DB caused down-regulation of the inflammatory gene TNF-alpha and the up-regulation of the anti-inflammatory gene IL-10. There was no inhibitory effect of WB and DB on nuclear translocation of NF-kappa B p65. In conclusion, the wild and domesticated basidiocarps of A. rugosum possessed antioxidant and in vitro anti-inflammatory properties. WB and DB inhibited downstream inflammatory mediators (TNF-alpha and NO) and induced anti-inflammatory cytokine IL-10 production. No inhibitory effects shown on upstream nuclear translocation of NF-kappa B p65. WB and DB exhibited antioxidant activity and attenuation of proinflammatory mediators and therefore, A. rugosum may serve as a potential therapeutic agent in the management of inflammation.	[Chan, Pui-Mun; Tan, Yee-Shin; Chua, Kek-Heng; Sabaratnam, Vikineswary; Kuppusamy, Umah Rani] Univ Malaya, Mushroom Res Ctr, Kuala Lumpur 50603, Malaysia; [Chan, Pui-Mun; Tan, Yee-Shin; Sabaratnam, Vikineswary] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur 50603, Malaysia; [Chua, Kek-Heng; Kuppusamy, Umah Rani] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Kuppusamy, UR (corresponding author), Univ Malaya, Mushroom Res Ctr, Kuala Lumpur 50603, Malaysia.	umah@um.edu.my	CHUA, KEK HENG/B-5261-2010; SABARATNAM, S. VIKINESWARY/B-9648-2010; YEE SHIN, TAN/B-9922-2010; KUPPUSAMY, UMAH RANI/B-9981-2010	CHUA, KEK HENG/0000-0002-0452-9994; SABARATNAM, S. VIKINESWARY/0000-0003-3966-3701; YEE SHIN, TAN/0000-0001-5478-1015; 	Ministry of Education, Malaysia [UM.C/625/1/HIR/MOHE/ASH/01 (UM.0000106/HIR.C3), UM-MOHE UM.C/625/1/HIR/MOHE/SC/02 (HIR F00002-21001), PG071-2012B, RP005B-13AFR]	Ministry of Education, Malaysia	This work was funded by University of Malaya for Postgraduate Research Grant (PG071-2012B) [http://www.ippp.um.edu.my/], University of Malaya Research Grant RP005B-13AFR [http://www.ippp.um.edu.my/] and University of Malaya High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/ASH/01 (UM.0000106/HIR.C3) [http://www.ippp.um.edu.my/] and UM-MOHE UM.C/625/1/HIR/MOHE/SC/02 (HIR F00002-21001) [http://www.ippp.um.edu.my/] from the Ministry of Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah N, 2013, IND CROP PROD, V47, P256, DOI 10.1016/j.indcrop.2013.03.012; Adesina FC, 2011, AFR J BIOTECHNOL, V10, P4608; Alvarez-Parrilla E, 2007, CIENC TEC ALIMENTAR, V5, P329, DOI 10.1080/11358120709487708; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Azliza MA, 2012, STUD ETHNO-MED, V6, P17, DOI 10.1080/09735070.2012.11886415; Barros KV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-68; Bartfai T, 2007, ANN NY ACAD SCI, V1113, P173, DOI 10.1196/annals.1391.022; Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2; Bi Z-S, 1993, MACROFUNGUS FLORA CH, P127; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Chan PM, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/304713; Chang YS, 2004, FUNGAL DIVERS, V15, P15; Chen S, 2005, INT J MED MUSHROOMS, V7, P342; Christ-Crain M, 2010, CRIT CARE, V14, DOI 10.1186/cc8155; [戴玉成 DAI YuCheng], 2008, [菌物学报, Mygosystema], V27, P801; De Silva DD, 2012, FUNGAL DIVERS, V56, P1, DOI 10.1007/s13225-012-0187-4; Desai PB, 2010, EUR REV MED PHARMACO, V14, P959; Ferreira ICFR, 2009, CURR MED CHEM, V16, P1543, DOI 10.2174/092986709787909587; Floegel A, 2011, J FOOD COMPOS ANAL, V24, P1043, DOI 10.1016/j.jfca.2011.01.008; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Gan C. H., 2013, International Food Research Journal, V20, P1095; Gill S.K, 2008, CAN J CLIN PHARM, V15, P275; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hakansson A, 2011, NUTRIENTS, V3, P637, DOI 10.3390/nu3060637; Hovsepian E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079445; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Jedinak A, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-52; Jiao C, 2013, PLOS ONE, V8, P1; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kanagasabapathy G, 2011, J AGR FOOD CHEM, V59, P2618, DOI 10.1021/jf104133g; Kanagasabapathy G, 2012, BMC COMPLEM ALTERN M, V12, P1; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Lee KH, 2012, INT J MOL SCI, V13, P2985, DOI 10.3390/ijms13032985; Lee TH, 2012, INT IMMUNOPHARMACOL, V13, P264, DOI 10.1016/j.intimp.2012.05.005; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magingo FS, 2004, MYCOLOGIA, V96, P197, DOI 10.2307/3762053; Martin KR, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-29; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; Moonmoon Mahbuba, 2010, Saudi J Biol Sci, V17, P341, DOI 10.1016/j.sjbs.2010.05.004; Pathmashini L., 2008, Ceylon Journal of Science, Biological Sciences, V37, P177; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Shah Z. A., 2004, Pakistan Journal of Nutrition, V3, P158; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Sheena N., 2005, Natural Product Radiance, V4, P382; Somera-Molina KC, 2007, EPILEPSIA, V48, P1785, DOI 10.1111/j.1528-1167.2007.01135.x; Theoharides TC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-168; Tripathy A, 2011, BOT RES INT, V4, P19; Tsai TT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-40; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Virta M, 2002, EPILEPSIA, V43, P920, DOI 10.1046/j.1528-1157.2002.02002.x; Wan-Ibrahim WI, 2010, FOOD CHEM, V122, P1139, DOI 10.1016/j.foodchem.2010.03.101; Wen CL, 2011, J ETHNOPHARMACOL, V137, P575, DOI 10.1016/j.jep.2011.06.009; Yang Eun-Jin, 2009, Interdiscip Toxicol, V2, P245, DOI 10.2478/v10102-009-0022-2	54	32	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139593	10.1371/journal.pone.0139593	http://dx.doi.org/10.1371/journal.pone.0139593			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427053	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100079
J	Orro, A; Cappelletti, M; D'Ursi, P; Milanesi, L; Di Canito, A; Zampolli, J; Collina, E; Decorosi, F; Viti, C; Fedi, S; Presentato, A; Zannoni, D; Di Gennaro, P				Orro, Alessandro; Cappelletti, Martina; D'Ursi, Pasqualina; Milanesi, Luciano; Di Canito, Alessandra; Zampolli, Jessica; Collina, Elena; Decorosi, Francesca; Viti, Carlo; Fedi, Stefano; Presentato, Alessandro; Zannoni, Davide; Di Gennaro, Patrizia			Genome and Phenotype Microarray Analyses of Rhodococcus sp BCP1 and Rhodococcus opacus R7: Genetic Determinants and Metabolic Abilities with Environmental Relevance	PLOS ONE			English	Article							SP STRAIN RHA1; AROMATIC-COMPOUNDS; GENUS RHODOCOCCUS; HIGH-THROUGHPUT; PATHWAY; DEGRADATION; BIODEGRADATION; EQUI; PERFORMANCE; CATABOLISM	In this paper comparative genome and phenotype microarray analyses of Rhodococcus sp. BCP1 and Rhodococcus opacus R7 were performed. Rhodococcus sp. BCP1 was selected for its ability to grow on short-chain n-alkanes and R. opacus R7 was isolated for its ability to grow on naphthalene and on o-xylene. Results of genome comparison, including BCP1, R7, along with other Rhodococcus reference strains, showed that at least 30% of the genome of each strain presented unique sequences and only 50% of the predicted proteome was shared. To associate genomic features with metabolic capabilities of BCP1 and R7 strains, hundreds of different growth conditions were tested through Phenotype Microarray, by using Biolog plates and plates manually prepared with additional xenobiotic compounds. Around one-third of the surveyed carbon sources was utilized by both strains although R7 generally showed higher metabolic activity values compared to BCP1. Moreover, R7 showed broader range of nitrogen and sulphur sources. Phenotype Microarray data were combined with genomic analysis to genetically support the metabolic features of the two strains. The genome analysis allowed to identify some gene clusters involved in the metabolism of the main tested xenobiotic compounds. Results show that R7 contains multiple genes for the degradation of a large set of aromatic and PAHs compounds, while a lower variability in terms of genes predicted to be involved in aromatic degradation was found in BCP1. This genetic feature can be related to the strong genetic pressure exerted by the two different environment from which the two strains were isolated. According to this, in the BCP1 genome the smo gene cluster involved in the short-chain n-alkanes degradation, is included in one of the unique regions and it is not conserved in the Rhodococcus strains compared in this work. Data obtained underline the great potential of these two Rhodococcus spp. strains for biodegradation and environmental decontamination processes.	[Orro, Alessandro; D'Ursi, Pasqualina; Milanesi, Luciano] CNR, Inst Biomed Technol, I-20133 Milan, Italy; [Cappelletti, Martina; Fedi, Stefano; Presentato, Alessandro; Zannoni, Davide] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Di Canito, Alessandra; Zampolli, Jessica; Di Gennaro, Patrizia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Zampolli, Jessica; Collina, Elena] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy; [Decorosi, Francesca; Viti, Carlo] Univ Florence, Dept Agrifood Prod & Environm Sci, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Bologna; University of Milano-Bicocca; University of Milano-Bicocca; University of Florence	Di Gennaro, P (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	patrizia.digennaro@unimib.it	CAPPELLETTI, MARTINA/H-5414-2019; Milanesi, Luciano/AAE-7230-2019; Di Canito, Alessandra/AAM-9267-2021; Zampolli, Jessica/HGB-6094-2022; Orro, Alessandro/ABA-3542-2020; Cappelletti, Martina/I-4952-2012	CAPPELLETTI, MARTINA/0000-0002-6238-8296; Milanesi, Luciano/0000-0002-1201-3939; Di Canito, Alessandra/0000-0002-8383-2923; Cappelletti, Martina/0000-0002-6238-8296; ZAMPOLLI, JESSICA/0000-0002-4110-1401; COLLINA, ELENA MARIA/0000-0001-5477-4907; Presentato, Alessandro/0000-0002-4794-0599; VITI, CARLO/0000-0001-7188-549X	Italian Ministry of Education and Research through the Flagship "InterOmics" [PB05]; HIRMA [RBAP11YS7K]	Italian Ministry of Education and Research through the Flagship "InterOmics"; HIRMA	This work has been supported by the Italian Ministry of Education and Research through the Flagship "InterOmics" (PB05) and HIRMA (RBAP11YS7K) Funding.	Adekambi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014792; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; BLAKLEY ER, 1982, CAN J MICROBIOL, V28, P1324, DOI 10.1139/m82-198; Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501; Burton AJ, 2013, EMERG INFECT DIS, V19, P282, DOI 10.3201/eid1902.121210; Cappelletti M, 2012, APPL MICROBIOL BIOT, V96, P1395, DOI 10.1007/s00253-012-4494-1; Cappelletti M, 2011, APPL ENVIRON MICROB, V77, P1619, DOI 10.1128/AEM.01987-10; Cappelletti M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00393; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; Galardini M, 2014, GENOMICS, V103, P1, DOI 10.1016/j.ygeno.2013.11.005; GOODFELLOW M, 1977, J GEN MICROBIOL, V100, P99, DOI 10.1099/00221287-100-1-99; Grippa E, 1999, BIOSCI BIOTECH BIOCH, V63, P1557, DOI 10.1271/bbb.63.1557; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Iwaki H., 2005, MICROBES ENVIRON, V20, P144; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Kim D, 2010, APPL MICROBIOL BIOT, V86, P1841, DOI 10.1007/s00253-009-2418-5; Kostka JE, 2011, APPL ENVIRON MICROB, V77, P7962, DOI 10.1128/AEM.05402-11; Larkin MJ, 2010, MICROBIOL MONOGR, V16, P73, DOI 10.1007/978-3-642-12937-7_3; Masai E, 1997, GENE, V187, P141, DOI 10.1016/S0378-1119(96)00748-2; McFarland BL, 1999, CURR OPIN MICROBIOL, V2, P257, DOI 10.1016/S1369-5274(99)80045-9; Navarro-Llorens JM, 2005, J BACTERIOL, V187, P4497, DOI 10.1128/JB.187.13.4497-4504.2005; NORDMANN P, 1992, INFECT IMMUN, V60, P2748, DOI 10.1128/IAI.60.7.2748-2752.1992; Oldfield C, 1997, MICROBIOL-UK, V143, P2961, DOI 10.1099/00221287-143-9-2961; Paley SM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-243; Patrauchan MA, 2008, J BACTERIOL, V190, P37, DOI 10.1128/JB.01122-07; Pelletier DA, 2000, J BACTERIOL, V182, P2753, DOI 10.1128/JB.182.10.2753-2760.2000; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; Tancsics A, 2015, SYST APPL MICROBIOL, V38, P1, DOI 10.1016/j.syapm.2014.10.010; TSUKAMURA M, 1974, JPN J MICROBIOL, V18, P94, DOI 10.1111/j.1348-0421.1974.tb00749.x; VONGRAEVENITZ A, 1995, MICROBIOL IMMUNOL, V39, P283, DOI 10.1111/j.1348-0421.1995.tb02202.x; Wang YF, 2009, BIOSCIENCE, V59, P113, DOI 10.1525/bio.2009.59.2.5; Yi T, 2011, J HAZARD MATER, V191, P393, DOI 10.1016/j.jhazmat.2011.04.080	37	34	34	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139467	10.1371/journal.pone.0139467	http://dx.doi.org/10.1371/journal.pone.0139467			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426997	Green Published, gold			2022-12-27	WOS:000362177100066
J	Son, JS; Zheng, LJ; Rowehl, LM; Tian, XY; Zhang, YH; Zhu, W; Litcher-Kelly, L; Gadow, KD; Gathungu, G; Robertson, CE; Ir, D; Frank, DN; Li, E				Son, Joshua S.; Zheng, Ling J.; Rowehl, Leahana M.; Tian, Xinyu; Zhang, Yuanhao; Zhu, Wei; Litcher-Kelly, Leighann; Gadow, Kenneth D.; Gathungu, Grace; Robertson, Charles E.; Ir, Diana; Frank, Daniel N.; Li, Ellen			Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; GASTROINTESTINAL DYSFUNCTION; FLORA; GENE; IDENTIFICATION; MANAGEMENT; SIGNATURES; BACTERIA; SAMPLES; FECES	In order to assess potential associations between autism spectrum disorder (ASD) phenotype, functional GI disorders and fecal microbiota, we recruited simplex families, which had only a single ASD proband and neurotypical (NT) siblings, through the Simons Simplex Community at the Interactive Autism Network (SSC@IAN). Fecal samples and metadata related to functional GI disorders and diet were collected from ASD probands and NT siblings of ASD probands (age 7-14). Functional gastrointestinal disorders (FGID) were assessed using the parent-completed ROME III questionnaire for pediatric FGIDs, and problem behaviors were assessed using the Child Behavior Check List (CBCL). Targeted quantitative polymerase chain reaction (qPCR) assays were conducted on selected taxa implicated in ASD, including Sutterella spp., Bacteroidetes spp. and Prevotella spp. Illumina sequencing of the V1V2 and the V1V3 regions of the bacterial 16S rRNA genes from fecal DNA was performed to an average depth of 208,000 and 107,000 high-quality reads respectively. Twenty-five of 59 ASD children and 13 of 44 NT siblings met ROME III criteria for at least one FGID. Functional constipation was more prevalent in ASD (17 of 59) compared to NT siblings (6 of 44, P = 0.035). The mean CBCL scores in NT siblings with FGID, ASD children with FGID and ASD without FGID were comparably higher (58-62 vs. 44, P < 0.0001) when compared to NT children without FGID. There was no significant difference in macronutrient intake between ASD and NT siblings. There was no significant difference in ASD severity scores between ASD children with and without FGID. No significant difference in diversity or overall microbial composition was detected between ASD children with NT siblings. Exploratory analysis of the 16S rRNA sequencing data, however, identified several low abundance taxa binned at the genus level that were associated with ASD and/or first order ASD*FGID interactions (FDR < 0.1).	[Son, Joshua S.; Zheng, Ling J.; Rowehl, Leahana M.; Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Tian, Xinyu; Zhang, Yuanhao; Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Litcher-Kelly, Leighann; Gadow, Kenneth D.] SUNY Stony Brook, Dept Psychiat, Stony Brook, NY 11794 USA; [Gathungu, Grace] SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA; [Robertson, Charles E.; Ir, Diana; Frank, Daniel N.] Univ Colorado Anschutz Med Campus, Dept Med, Aurora, CO USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, E (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	ellen.li@stonybrookmedicine.edu		ROBERTSON, CHARLES/0000-0002-4136-4121	Simons Foundation Autism Research Initiative [239729]	Simons Foundation Autism Research Initiative	This work was supported by the Simons Foundation Autism Research Initiative, grant #239729 to E.L. (https://sfari.org/). The funder had a role in the study design, in that the study participants were from the Simons Simplex Community at the Interactive Autism Network, but otherwise had no role in other aspects of the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; Adams JB, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-22; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Colvert E, 2015, JAMA PSYCHIAT, V72, P415, DOI 10.1001/jamapsychiatry.2014.3028; Curran J.M., 2013, HOTELLING HOTELLINGS; Davis JJ, 2013, INT J SYST EVOL MICR, V63, P2727, DOI 10.1099/ijs.0.048983-0; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Duarte CS, 2003, J AUTISM DEV DISORD, V33, P703, DOI 10.1023/B:JADD.0000006005.31818.1c; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131944; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Furuta GT, 2012, PEDIATRICS, V130, pS98, DOI 10.1542/peds.2012-0900H; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gorrindo P, 2012, AUTISM RES, V5, P101, DOI 10.1002/aur.237; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hsiao EY, 2014, HARVARD REV PSYCHIAT, V22, P104, DOI 10.1097/HRP.0000000000000029; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jones MP, 2006, NEUROGASTROENT MOTIL, V18, P91, DOI 10.1111/j.1365-2982.2005.00730.x; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Karabulut GS, 2013, J NEUROGASTROENTEROL, V19, P90, DOI 10.5056/jnm.2013.19.1.90; Kim RJT, 2015, INT FORUM ALLERGY RH, V5, P877, DOI 10.1002/alr.21600; Kim SE, 2015, J NEUROGASTROENTEROL, V21, P111, DOI 10.5056/jnm14048; Kim YS, 2015, BIOL PSYCHIAT, V77, P66, DOI 10.1016/j.biopsych.2014.11.001; Krajmalnik-Brown Rosa, 2015, Microbial Ecology in Health and Disease, V26, P26914, DOI 10.3402/mehd.v26.26914; Lai QL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106353; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Mazefsky CA, 2011, J PSYCHOPATHOL BEHAV, V33, P31, DOI 10.1007/s10862-010-9198-1; McDonald JH., 2009, HDB BIOL STAT, V2, P64; McElhanon BO, 2014, PEDIATRICS, V133, P872, DOI 10.1542/peds.2013-3995; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Miele E, 2004, PEDIATRICS, V114, P73, DOI 10.1542/peds.114.1.73; Nielsen A, 2015, GEN LINEAR MIXED MOD; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Pandolfi V, 2012, RES AUTISM SPECT DIS, V6, P96, DOI 10.1016/j.rasd.2011.03.009; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Schneider CK, 2006, J AUTISM DEV DISORD, V36, P1053, DOI 10.1007/s10803-006-0141-y; Shankar V, 2013, GUT MICROBES, V4, P347, DOI 10.4161/gmic.24827; Simren M, 2013, GUT, V62, P159, DOI 10.1136/gutjnl-2012-302167; Skokauskas N, 2012, J INTELL DISABIL RES, V56, P248, DOI 10.1111/j.1365-2788.2011.01423.x; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073; Tomova A, 2015, PHYSIOL BEHAV, V138, P179, DOI 10.1016/j.physbeh.2014.10.033; Wade M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/672784; Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42; Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Wu X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-79	71	122	124	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0137725	10.1371/journal.pone.0137725	http://dx.doi.org/10.1371/journal.pone.0137725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427004	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100006
J	Ye, LC; Yin, M; Xia, Y; Jiang, C; Hong, HF; Liu, JF				Ye, Lincai; Yin, Meng; Xia, Yu; Jiang, Chuan; Hong, Haifa; Liu, Jinfen			Decreased Yes-Associated Protein-1 (YAP1) Expression in Pediatric Hearts with Ventricular Septal Defects	PLOS ONE			English	Article							CARDIOMYOCYTE PROLIFERATION; HIPPO PATHWAY; REGENERATION; RENEWAL; DISEASE; CLOSURE; HUMANS; GROWTH; GENES; SIZE	Background Ventricular septal defects (VSDs) are the most common and simplest type of congenital heart diseases (CHDs). Animal studies have suggested that the downregulation of Yes-associated protein 1 (YAP1) during embryonic development causes VSD-associated CHDs. However, how YAP1 contributes to isolated VSD (iVSD) is unclear. Methods and Results Twenty right atrial specimens were obtained from iVSD patients during routine congenital cardiac surgery and we assessed YAP1 expression in these specimens. For controls, six right atrial specimens were obtained from normal hearts of children without heart disease, three of whom died from cerebral palsy, and three who underwent heart transplants. YAP1 mRNA and protein levels and nuclear localization were significantly reduced in iVSD specimens compared to normal heart specimens. Concomitantly, mRNA levels of YAP1 downstream targets CTGF and AXL were also significantly decreased in iVSD specimens. Although Ki67-positive cardiomyocytes in iVSD specimens were comparable to normal heart specimens, Ki67-positive non-cardiomyocytes were significantly decreased. Conclusions YAP1 expression was markedly decreased in hearts of iVSD children. Given the important role of YAP1 during heart development, downregulation of YAP1 expression may contribute to iVSD and affect the proliferation of non-cardiomyocytes.	[Ye, Lincai; Yin, Meng; Jiang, Chuan; Hong, Haifa] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Thorac & Cardiovasc Surg, Shanghai 200030, Peoples R China; [Ye, Lincai] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Inst Pediat Translat Med, Shanghai 200030, Peoples R China; [Ye, Lincai; Jiang, Chuan; Liu, Jinfen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai Pediat Congenital Heart Dis Inst, Shanghai 200030, Peoples R China; [Xia, Yu] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Thorac & Cardiovasc Surg, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hong, HF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Thorac & Cardiovasc Surg, Shanghai 200030, Peoples R China.	hhfsmallboat@163.com; liujinfen2002@126.com	ye, lincai/AAQ-6757-2020	ye, lincai/0000-0001-8808-2810; Hong, Haifa/0000-0002-3418-793X	National Basic Research Program of China [2013CB945304]; Natural Science Foundation of Shanghai Jiaotong University School of Medicine [2013]; Shanghai Young Teachers' Training Subsidy Scheme [ZZjdyx13137]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of Shanghai Jiaotong University School of Medicine; Shanghai Young Teachers' Training Subsidy Scheme	The work was supported by the following funders: 1. National Basic Research Program of China [grant number 2013CB945304] (http://www.most.gov.cn/); 2. Natural Science Foundation of Shanghai Jiaotong University School of Medicine [grant number 2013] (http://kjc.shsmu.edu.cn/); 3. Shanghai Young Teachers' Training Subsidy Scheme [grant number ZZjdyx13137] (http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT BS, 1973, AM J DIS CHILD, V125, P194, DOI 10.1001/archpedi.1973.04160020028005; Benoit G., 2014, CIRC RES, V114, P598; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Dasbiswas K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7085; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Jiao K, 2003, GENE DEV, V17, P2362, DOI 10.1101/gad.1124803; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Mavroudis C, 2013, PEDIAT CARDIAC SURG, P311; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Nemir M, 2014, EUR HEART J, V35, P2174, DOI 10.1093/eurheartj/ehs269; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Quan TH, 2014, AM J PATHOL, V184, P937, DOI 10.1016/j.ajpath.2013.12.017; Vecoli C, 2014, CURR GENOMICS, V15, P390, DOI 10.2174/1389202915666140716175634; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wackerhage H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005096; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Yuen HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054211; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhang H, 2014, J BIOL CHEM, V289, P18681, DOI 10.1074/jbc.M114.554584; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao L, 2014, P NATL ACAD SCI USA, V111, P1403, DOI 10.1073/pnas.1311705111	24	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139712	10.1371/journal.pone.0139712	http://dx.doi.org/10.1371/journal.pone.0139712			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426694	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100087
J	Baena, ML; Escobar, F; Halffter, G; Garcia-Chavez, JH				Baena, Martha L.; Escobar, Federico; Halffter, Gonzalo; Garcia-Chavez, Juan H.			Distribution and Feeding Behavior of Omorgus suberosus (Coleoptera: Trogidae) in Lepidochelys olivacea Turtle Nests	PLOS ONE			English	Article							OLIVE RIDLEY TURTLE; DENSITY	Omorgus suberosus (Fabricius, 1775) has been identified as a potential predator of the eggs of the turtle Lepidochelys olivacea (Eschscholtz, 1829) on one of the main turtle nesting beaches in the world, La Escobilla in Oaxaca, Mexico. This study presents an analysis of the spatio-temporal distribution of the beetle on this beach (in areas of high and low density of L. olivacea nests over two arrival seasons) and an evaluation, under laboratory conditions, of the probability of damage to the turtle eggs by this beetle. O. suberosus adults and larvae exhibited an aggregated pattern at both turtle nest densities; however, aggregation was greater in areas of low nest density, where we found the highest proportion of damaged eggs. Also, there were fluctuations in the temporal distribution of the adult beetles following the arrival of the turtles on the beach. Under laboratory conditions, the beetles quickly damaged both dead eggs and a mixture of live and dead eggs, but were found to consume live eggs more slowly. This suggests that O. suberosus may be recycling organic material; however, its consumption of live eggsmay be sufficient in some cases to interrupt the incubation period of the turtle. We intend to apply these results when making decisions regarding the L. olivacea nests on La Escobilla Beach, one of the most important sites for the conservation of this species.	[Baena, Martha L.] Univ Veracruzana, Inst Invest Biol, Xalapa 91000, Veracruz, Mexico; [Escobar, Federico; Halffter, Gonzalo] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Garcia-Chavez, Juan H.] Benemerita Univ Autonoma Puebla, Escuela Biol, Lab Ecol Poblac, Puebla, Mexico	Universidad Veracruzana; Instituto de Ecologia - Mexico; Benemerita Universidad Autonoma de Puebla	Escobar, F (corresponding author), Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico.	federico.escobar@inecol.mx	Halffter, Gonzalo/R-3652-2018; Escobar, Federico/C-1396-2011; Hurtado, Martha L. Baena/AAE-4998-2020	Escobar, Federico/0000-0003-0179-7528; Hurtado, Martha L. Baena/0000-0002-5684-2771	Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP); Consejo Nacional de Ciencia y Tecnologia, Conacyt (Mexico) [204950]	Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP); Consejo Nacional de Ciencia y Tecnologia, Conacyt (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was financially supported by the Direccion de Especies Prioritarias para la Conservacion of the National Commission of Natural Protected Areas (CONANP) to GH and the Consejo Nacional de Ciencia y Tecnologia, Conacyt (Mexico), grant No. 204950 to MLB.	Abreu-Grobois A, IUCN RED LIST THREAT; Allgower K, 1979, INF ESTAC CI CH DARW, P152; [Anonymous], 2001, DESIGN ANAL ECOLOGIC; Bernardo Joseph, 2007, P58; Bezy VS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118579; Canty A, PACKAGE BOOT R PACKA; Ciechanowski M, 2007, CAN J ZOOL, V85, P1249, DOI 10.1139/Z07-090; Clusella Trullas S, 2007, J ZOOL, V272, P367, DOI 10.1111/j.1469-7998.2006.00277.x; CONANP, ENT SE AL PEL EXT TO; Cornelius S.E., 1991, P111; Cornelius SE., 2007, BIOL CONSERVATION RI, P231; Correa CMA, 2013, ZOOLOGIA-CURITIBA, V30, P238, DOI 10.1590/S1984-46702013000200015; Crawley M.J., 2007, R BOOK; Frazier J., 2007, BIOL CONSERVATION RI, P253; Garcia E, 1981, MODIFICACIONES SISTE, V3rd; Gates Charles E., 1996, Journal of Agricultural Biological and Environmental Statistics, V1, P275, DOI 10.2307/1400519; Gómez Rodrigo S., 2005, Rev. Soc. Entomol. Argent., V64, P103; HARCOURT D. G., 1961, CANADIAN ENTOMOL, V93, P820; Harfush-Melendez M, REUN NAC CONS TORT M; Honarvar S, 2008, OECOLOGIA, V157, P221, DOI 10.1007/s00442-008-1065-3; HURLBERT SH, 1990, OIKOS, V58, P257, DOI 10.2307/3545216; Johnson MD, 2001, J ANIM ECOL, V70, P546, DOI 10.1046/j.1365-2656.2001.00522.x; Lago P. K., 1979, N DAKOTA INSECTS PUB, V12, P1; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Lopez-Reyes E, 2000, P 20 ANN S SEA TURTL, P477; Lumaret J.-P., 1984, Bulletin de la Societe Entomologique de France, V88, P594; Muniz Velez Raul, 2001, Acta Zoologica Mexicana Nueva Serie, V83, P115; Ocana M., 2012, Endangered Species Research, V16, P45, DOI 10.3354/esr00388; Plotkin P.T., 2007, BIOL CONSERVATION RI; Plotkin PT, 1997, J HERPETOL, V31, P17, DOI 10.2307/1565323; PYKE DA, 1986, ECOLOGY, V67, P240, DOI 10.2307/1938523; R Development Core Team, R LANG ENV STAT COMP; Reichart HA., 1993, SYNOPSIS BIOL DATA O; RITCHER PO, 1958, ANNU REV ENTOMOL, V3, P311, DOI 10.1146/annurev.en.03.010158.001523; Rosano HMC, 1998, P 17 ANN SEA TURTL S, P257; Rosano-Hernández María C., 2002, Acta Zool. Mex, P29; SAMPER J R, 1990, Elytron (Barcelona), V4, P101; Sarti L, 2000, P 18 INT SEA TURTL S, P211; SCHOLTZ CH, 1990, J NAT HIST, V24, P1391, DOI 10.1080/00222939000770841; SCHOLTZ CH, 1992, ECOL ENTOMOL, V17, P155, DOI 10.1111/j.1365-2311.1992.tb01173.x; SEVACHERIAN V, 1972, Environmental Entomology, V1, P695, DOI 10.1093/ee/1.6.695; SHUSTER SM, 2003, MG BEH ECOL, pR7; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; TAYLOR LR, 1983, NATURE, V303, P801, DOI 10.1038/303801a0; TAYLOR LR, 1984, ANNU REV ENTOMOL, V29, P321, DOI 10.1146/annurev.en.29.010184.001541; Therneau TM., SURVIVAL SURVIVAL AN; Valverde Roldan A., 1998, Chelonian Conservation and Biology, V3, P58; VAURIE PATRICIA, 1955, BULL AMER MUS NAT HIST, V106, P1; Zunino Mario, 1991, P297	49	5	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139538	10.1371/journal.pone.0139538	http://dx.doi.org/10.1371/journal.pone.0139538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422148	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000362175700126
J	Hoffmann, V; Verboom, GA; Cotterill, FPD				Hoffmann, Vera; Verboom, G. Anthony; Cotterill, Fenton P. D.			Dated Plant Phylogenies Resolve Neogene Climate and Landscape Evolution in the Cape Floristic Region	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; GRASS GENUS EHRHARTA; DIVERGENCE TIMES; SOUTH-AFRICA; BIODIVERSITY HOTSPOT; MIDDLE MIOCENE; WESTERN CAPE; RADIATION; DIVERSIFICATION; FLORA	In the context of molecularly-dated phylogenies, inferences informed by ancestral habitat reconstruction can yield valuable insights into the origins of biomes, palaeoenvironments and landforms. In this paper, we use dated phylogenies of 12 plant clades from the Cape Floristic Region (CFR) in southern Africa to test hypotheses of Neogene climatic and geomorphic evolution. Our combined dataset for the CFR strengthens and refines previous palaeoenvironmental reconstructions based on a sparse, mostly offshore fossil record. Our reconstructions show remarkable consistency across all 12 clades with regard to both the types of environments identified as ancestral, and the timing of shifts to alternative conditions. They reveal that Early Miocene land surfaces of the CFR were wetter than at present and were dominated by quartzitic substrata. These conditions continue to characterize the higher-elevation settings of the Cape Fold Belt, where they have fostered the persistence of ancient fynbos lineages. The Middle Miocene (13-17 Ma) saw the development of perennial to weakly-seasonal arid conditions, with the strongly seasonal rainfall regime of the west coast arising similar to 6.5-8 Ma. Although the Late Miocene may have seen some exposure of the underlying shale substrata, the present-day substrate diversity of the CFR lowlands was shaped by Pliocene-Pleistocene events. Particularly important was renewed erosion, following the post-African II uplift episode, and the reworking of sediments on the coastal platform as a consequence of marine transgressions and tectonic uplift. These changes facilitated adaptive radiations in some, but not all, lineages studied.	[Hoffmann, Vera; Verboom, G. Anthony] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa; [Cotterill, Fenton P. D.] Univ Stellenbosch, AEON, Geoecodynam Res Hub, Dept Bot & Zool, ZA-7600 Stellenbosch, South Africa	University of Cape Town; Stellenbosch University	Hoffmann, V (corresponding author), Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa.	vera.vhoffmann@gmail.com	Verboom, George Anthony/ABA-1499-2022	Verboom, George Anthony/0000-0002-1363-9781	National Research Foundation's Blue Skies Programme [BS2008091600005]; InkabayeAfrika (AEON)	National Research Foundation's Blue Skies Programme; InkabayeAfrika (AEON)	This work was funded by the National Research Foundation's Blue Skies Programme (Grant BS2008091600005) and by InkabayeAfrika (AEON). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, STRELITZIA; Barker NP, 2004, MOL PHYLOGENET EVOL, V33, P845, DOI 10.1016/j.ympev.2004.07.007; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bergh NG, 2009, THESIS; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bierman PR., 2014, GSA TODAY, V24, P4, DOI [DOI 10.1130/GSATG206A.1, 10.1130/GSATG206A.1]; Blyth AJ, 2013, QUATERNARY SCI REV, V75, P143, DOI 10.1016/j.quascirev.2013.06.017; Bremer K, 2002, EVOLUTION, V56, P1374, DOI 10.1111/j.0014-3820.2002.tb01451.x; Britton MN, 2014, MOL PHYLOGENET EVOL, V77, P96, DOI 10.1016/j.ympev.2014.03.024; Brooks SJ, 2006, QUATERNARY SCI REV, V25, P1894, DOI 10.1016/j.quascirev.2005.03.021; Buerki S, 2011, J BIOGEOGR, V38, P531, DOI 10.1111/j.1365-2699.2010.02432.x; Bytebier B, 2011, P ROY SOC B-BIOL SCI, V278, P188, DOI 10.1098/rspb.2010.1035; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chen SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059472; Christin PA, 2008, MOL BIOL EVOL, V25, P2361, DOI 10.1093/molbev/msn178; COETZEE JA, 1982, PALAEOGEOGR PALAEOCL, V39, P71, DOI 10.1016/0031-0182(82)90073-6; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Cotterill FPD, 2011, S AFR J GEOL, V114, P489, DOI 10.2113/gssajg.114.3-4.489; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Craw D, 2008, GEOLOGY, V36, P19, DOI 10.1130/G24126A.1; CREPET WL, 1991, AM J BOT, V78, P1010, DOI 10.2307/2445181; Crisp M, 2004, PHILOS T R SOC B, V359, P1551, DOI 10.1098/rstb.2004.1528; Crisp MD, 2012, NEW PHYTOL, V196, P681, DOI 10.1111/j.1469-8137.2012.04298.x; Deacon H, 1992, ECOLOGY FYNBOS NUTR, P9; Diekmann B, 2003, SEDIMENTOLOGY, V50, P511, DOI 10.1046/j.1365-3091.2003.00562.x; Diester-Haass L, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000933; Diester-Haass L., 1992, GEOL SOC LOND SPEC P, V64, P331, DOI [DOI 10.1144/GSL.SP.1992.064.01.22, 10.1144/GSL.SP.1992.064, DOI 10.1144/GSL.SP.1992.064]; Donoghue MJ, 2008, P NATL ACAD SCI USA, V105, P11549, DOI 10.1073/pnas.0801962105; Drummond A, 2007, TRACER V1 5; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupont LM, 2011, J BIOGEOGR, V38, P1059, DOI 10.1111/j.1365-2699.2011.02476.x; Elias M. K., 1942, 41 GEOL SOC AM, P7; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Forest F, 2009, ANN BOT-LONDON, V104, P789, DOI 10.1093/aob/mcp192; Franceschini G, 2004, S AFR J GEOL, V107, P619, DOI 10.2113/107.4.619; Froyd CA, 2008, QUATERNARY SCI REV, V27, P1723, DOI 10.1016/j.quascirev.2008.06.006; FRUMHOFF PC, 1994, EVOLUTION, V48, P172, DOI 10.1111/j.1558-5646.1994.tb01303.x; GOLDBLATT P, 1978, ANN MO BOT GARD, V65, P369, DOI 10.2307/2398858; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Green PF, 2013, GEOL SURV DEN GREENL, V30, P1; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hardy CR, 2005, SYST BIOL, V54, P299, DOI 10.1080/10635150590923317; Hendey Q. B., 1983, 75 S AFR NAT SCI PRO, V75, P35; Herendeen P.S., 1995, MONOCOTYLEDONS SYSTE, P1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hoffmann V, 2012, THESIS; HOVAN SA, 1992, GEOLOGY, V20, P15, DOI 10.1130/0091-7613(1992)020<0015:PEBCIA>2.3.CO;2; Jansson R, 2002, ANNU REV ECOL SYST, V33, P741, DOI 10.1146/annurev.ecolsys.33.010802.150520; Kidwell SM, 2002, ANNU REV ECOL SYST, V33, P561, DOI 10.1146/annurev.ecolsys.33.030602.152151; King L. C, 1948, Q J GEOL SOC LOND, V104, P439, DOI DOI 10.1144/GSL.JGS.1948.104.01-04.20; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Krammer R, 2006, PALAEOGEOGR PALAEOCL, V230, P319, DOI 10.1016/j.palaeo.2005.07.022; Lamm KS, 2009, J SYST EVOL, V47, P369, DOI 10.1111/j.1759-6831.2009.00042.x; Levyns M.R., 1964, T ROY SOC S AFR, V37, P85, DOI [10.1080/00359196409519059, DOI 10.1080/00359196409519059]; Linder HP, 2010, BOTHALIA, V40, P1; LINDER H P, 1987, Kew Bulletin, V42, P297, DOI 10.2307/4109686; Linder H.P., 1992, P113; Linder HP, 2010, CURR OPIN ENV SUST, V2, P109, DOI 10.1016/j.cosust.2010.02.001; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Linder HP, 2003, EVOLUTION, V57, P2688; Lisker F, 2009, GEOL SOC SPEC PUBL, V324, P1, DOI 10.1144/SP324.1; Losos JB, 1999, ANIM BEHAV, V58, P1319, DOI 10.1006/anbe.1999.1261; Marlow JR, 2000, SCIENCE, V290, P2288; Maslin MA, 2000, SCIENCE, V290, P2285; McKenzie RJ, 2008, MOL PHYLOGENET EVOL, V49, P1, DOI 10.1016/j.ympev.2008.07.007; Mummenhoff K, 2005, ANN MO BOT GARD, V92, P400; NEE S, 1994, PHILOS T ROY SOC B, V344, P77, DOI 10.1098/rstb.1994.0054; Nylander JAA, MRMODELTEST V2 3 PRO; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Partridge TC, 2000, OXFORD MGR GEOL GEOP, P3; PARTRIDGE TC, 1987, S AFR J GEOL, V90, P179; Pennington RT, 2004, PHILOS T R SOC B, V359, P1455, DOI 10.1098/rstb.2004.1539; Picard D, 2008, EARTH PLANET SC LETT, V271, P326, DOI 10.1016/j.epsl.2008.04.024; Pirie MD, 2008, MOL PHYLOGENET EVOL, V48, P1106, DOI 10.1016/j.ympev.2008.05.030; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Renner SS, 2005, TRENDS PLANT SCI, V10, P550, DOI 10.1016/j.tplants.2005.09.010; Richardson JE, 2001, NATURE, V412, P181, DOI 10.1038/35084067; Roberts DL, 2011, EARTH-SCI REV, V106, P191, DOI 10.1016/j.earscirev.2011.02.002; Roberts DL, 2002, S AFR J GEOL, V105, P337, DOI 10.2113/1050337; Rogers J, 1980, 1 REPORT CENOZOIC SE, P136; Rovere A, 2014, EARTH PLANET SC LETT, V387, P27, DOI 10.1016/j.epsl.2013.10.030; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Sauquet H, 2009, MOL PHYLOGENET EVOL, V51, P31, DOI 10.1016/j.ympev.2008.12.013; Scharf TE, 2013, GEOLOGY, V41, P331, DOI 10.1130/G33806.1; Schnitzler J, 2011, SYST BIOL, V60, P343, DOI 10.1093/sysbio/syr006; SCHOLTZ A, 1985, Annals of the South African Museum, V95, P1; Segalen L, 2006, EARTH PLANET SC LETT, V244, P725, DOI 10.1016/j.epsl.2005.12.012; Senut B, 2009, CR GEOSCI, V341, P591, DOI 10.1016/j.crte.2009.03.008; SIESSER WG, 1981, J GEOL, V89, P83, DOI 10.1086/628565; SIESSER WG, 1980, SCIENCE, V208, P283, DOI 10.1126/science.208.4441.283; SILLENTULLBERG B, 1993, EVOLUTION, V47, P1182, DOI [10.1111/j.1558-5646.1993.tb02145.x, 10.2307/2409984]; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Smith SY, 2009, AM J BOT, V96, P1506, DOI 10.3732/ajb.0800427; Stromberg CAE, 2011, PALEOBIOLOGY, V37, P50, DOI 10.1666/09067.1; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Team R. D. C, 2011, R LANG ENV STAT COMP; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Tinker J, 2008, TECTONOPHYSICS, V455, P77, DOI 10.1016/j.tecto.2007.10.009; TYSON PD, 2000, OX MG GEOL, P371, DOI DOI 10.1016/J.PALAE0.2007.10.018; Valente LM, 2010, EVOLUTION, V64, P745, DOI 10.1111/j.1558-5646.2009.00856.x; van der Niet T, 2008, MOL PHYLOGENET EVOL, V47, P154, DOI 10.1016/j.ympev.2007.12.008; Verboom GA, 2009, MOL PHYLOGENET EVOL, V51, P44, DOI 10.1016/j.ympev.2008.01.037; Verboom GA, 2004, AM J BOT, V91, P1364, DOI 10.3732/ajb.91.9.1364; Verboom GA, 2003, EVOLUTION, V57, P1008, DOI 10.1111/j.0014-3820.2003.tb00312.x; Verboom GA, 2014, FYNBOS ECOLOGY EVOLU, P416; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Waterman RJ, 2009, MOL PHYLOGENET EVOL, V51, P100, DOI 10.1016/j.ympev.2008.05.020; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	120	32	34	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137847	10.1371/journal.pone.0137847	http://dx.doi.org/10.1371/journal.pone.0137847			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422465	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700019
J	Kikuchi, K; Ansah, EK; Okawa, S; Enuameh, Y; Yasuoka, J; Nanishi, K; Shibanuma, A; Gyapong, M; Owusu-Agyei, S; Oduro, AR; Asare, GQ; Hodgson, A; Jimba, M				Kikuchi, Kimiyo; Ansah, Evelyn Korkor; Okawa, Sumiyo; Enuameh, Yeetey; Yasuoka, Junko; Nanishi, Keiko; Shibanuma, Akira; Gyapong, Margaret; Owusu-Agyei, Seth; Oduro, Abraham Rexford; Asare, Gloria Quansah; Hodgson, Abraham; Jimba, Masamine		Ghana EMBRACE Implementation Res P	Effective Linkages of Continuum of Care for Improving Neonatal, Perinatal, and Maternal Mortality: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRADITIONAL BIRTH ATTENDANTS; ANTENATAL CARE; HEALTH FACILITIES; QUALITY IMPROVEMENT; NEWBORN HEALTH; WOMENS GROUPS; CHILD HEALTH; HOME-VISITS; SURVIVAL 1	Background Continuum of care has the potential to improve maternal, newborn, and child health (MNCH) by ensuring care for mothers and children. Continuum of care in MNCH is widely accepted as comprising sequential time (from pre-pregnancy to motherhood and childhood) and space dimensions (from community-family care to clinical care). However, it is unclear which linkages of care could have a greater effect on MNCH outcomes. The objective of the present study is to assess the effectiveness of different continuum of care linkages for reducing neonatal, perinatal, and maternal mortality in low- and middle-income countries. Methods We searched for randomized and quasi-randomized controlled trials that addressed two or more linkages of continuum of care and attempted to increase mothers' uptake of antenatal care, skilled birth attendance, and postnatal care. The outcome variables were neonatal, perinatal, and maternal mortality. Results Out of the 7,142 retrieved articles, we selected 19 as eligible for the final analysis. Of these studies, 13 used packages of intervention that linked antenatal care, skilled birth attendance, and postnatal care. One study each used packages that linked antenatal care and skilled birth attendance or skilled birth attendance and postnatal care. Four studies used an intervention package that linked antenatal care and postnatal care. Among the packages that linked antenatal care, skilled birth attendance, and postnatal care, a significant reduction was observed in combined neonatal, perinatal, and maternal mortality risks (RR 0.83; 95% CI 0.77 to 0.89, I-2 79%). Furthermore, this linkage reduced combined neonatal, perinatal, and maternal mortality when integrating the continuum of care space dimension (RR 0.85; 95% CI 0.77 to 0.93, I-2 81%). Conclusions Our review suggests that continuous uptake of antenatal care, skilled birth attendance, and postnatal care is necessary to improve MNCH outcomes in low- and middle-income countries. The review was conclusive for the reduction of neonatal and perinatal deaths. Although maternal deaths were not significantly reduced, composite measures of all mortality were. Thus, the evidence is sufficient to scale up this intervention package for the improvement of MNCH outcomes.	[Kikuchi, Kimiyo; Okawa, Sumiyo; Yasuoka, Junko; Nanishi, Keiko; Shibanuma, Akira; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Ansah, Evelyn Korkor; Hodgson, Abraham] Ghana Hlth Serv, Div Res & Dev, Accra, Ghana; [Gyapong, Margaret] Dodowa Hlth Res Ctr, Dodowa, Greater Accra, Ghana; [Enuameh, Yeetey; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr,Kintampo, Brong Ahafo, Ghana; [Oduro, Abraham Rexford] Navrongo Hlth Res Ctr, Navrongo, Upper East, Ghana; [Asare, Gloria Quansah] Minist Accra, Ghana Hlth Serv, Accra, Ghana	University of Tokyo; Ghana Health Service; Kintampo Health Research Centre; Navrongo Health Research Center; Ghana Health Service	Jimba, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mjimba@m.u-tokyo.ac.jp	Shibanuma, Akira/C-7652-2016; Enuameh, Yeetey/AAO-7304-2020; Jimba, Masamine/AAF-5630-2020; Yasuoka, Junko/GVT-8950-2022	Shibanuma, Akira/0000-0003-2058-1722; Enuameh, Yeetey/0000-0003-3772-7425; Debpuur, Cornelius/0000-0003-0968-5280; Gyapong, Margaret/0000-0002-4818-3497; Ansah, Evelyn/0000-0003-0401-8606; Owusu-Agyei, Seth/0000-0002-0807-1781; Narh, Clement/0000-0002-4025-5433; Nanishi, Keiko/0000-0001-7067-8413; ODURO, ABRAHAM/0000-0002-4191-7419	Human Development Department; Japan International Cooperation Agency; Japan International Cooperation Agency Research Institute	Human Development Department; Japan International Cooperation Agency; Japan International Cooperation Agency Research Institute	Human Development Department, Japan International Cooperation Agency (http://www.jica.go.jp/english/index.html) and Japan International Cooperation Agency Research Institute (http://jica-ri.jica.go.jp/) supported this work. The content is solely the responsibility of the authors and does not necessarily represent their official views.	Adjiwanou V, 2013, SOC SCI MED, V86, P26, DOI 10.1016/j.socscimed.2013.02.047; [Anonymous], 2007, STAND MAT NEON CAR; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bahl R, 2010, SEMIN PERINATOL, V34, P477, DOI 10.1053/j.semperi.2010.09.001; Bank T.W., 2015, COUNTR LEND GROUPS; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Baqui AH, 2008, B WORLD HEALTH ORGAN, V86, P796, DOI 10.2471/BLT.07.042226; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2826; Bashour HN, 2008, PUBLIC HEALTH NURS, V25, P115, DOI 10.1111/j.1525-1446.2008.00688.x; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bhutta ZA, 2011, LANCET, V377, P403, DOI 10.1016/S0140-6736(10)62274-X; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chowdhury HR, 2010, J HEALTH POPUL NUTR, V28, P375; Colbourn T, 2013, INT HEALTH, V5, P180, DOI 10.1093/inthealth/iht011; Collaborative C, 2011, COCHR HDB SYST REV I; Darmstadt GL, 2008, HEALTH POLICY PLANN, V23, P101, DOI 10.1093/heapol/czn001; Darmstadt GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009696; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; de Graft-Johnson J DP, 2005, HOUSEHOLD HOME CONTI; Dowswell Therese, 2010, Cochrane Database Syst Rev, pCD000934, DOI 10.1002/14651858.CD000934.pub2; Fottrell E, 2013, JAMA PEDIATR, V167, P816, DOI 10.1001/jamapediatrics.2013.2534; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Goudar SS, 2012, J MATERN-FETAL NEO M, V25, P568, DOI 10.3109/14767058.2011.584088; Hogberg U, 2005, SCAND J PUBLIC HEALT, V33, P409, DOI 10.1080/14034940500217037; Hoj L, 2003, BJOG-INT J OBSTET GY, V110, P995, DOI 10.1016/S1470-0328(03)03907-7; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kikuchi K, 2015, TRIALS, V16, DOI 10.1186/s13063-014-0539-3; Kirkwood BR, 2013, LANCET, V381, P2184, DOI 10.1016/S0140-6736(13)60095-1; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lassi ZS, 2013, J MATERN-FETAL NEO M, V26, P3, DOI 10.3109/14767058.2013.784737; Lawn J, 2006, OPPORTUNITIES AFRICA; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lewycka S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-88; Magadi MA, 2000, SOC SCI MED, V51, P551, DOI 10.1016/S0277-9536(99)00495-5; Majoko F, 2007, BJOG-INT J OBSTET GY, V114, P802, DOI 10.1111/j.1471-0528.2007.01372.x; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Midhet F, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-30; Moher David, 2009, Open Med, V3, pe123; More NS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001257; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Persson LA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001445; PMNCH, 2010, EN CONT CAR; PMNCH, 2010, PRIOR PROV INT; PMNCH, 2011, STRAT FRAM 2012 2015; Pradhan EK, 2002, B WORLD HEALTH ORGAN, V80, P887; Radeva-Petrova D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub3; Rahman A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-914; Rajindrajith S, 2009, J MATERN-FETAL NEO M, V22, P791, DOI [10.3109/14767050902994549, 10.1080/14767050902994549]; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Siegfried N, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub3; Singh K, 2013, INT J QUAL HEALTH C, V25, P477, DOI 10.1093/intqhc/mzt054; Tinker A, 2005, LANCET, V365, P822, DOI 10.1016/S0140-6736(05)71016-3; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Villar J BP, 2003, WHO ANTENATAL CARE R; Waiswa P, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-213; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO U, 2010, COUNTD 2015 DEC REP; WHO/UNICEF, 2009, HOM VIS NEWB CHILD S; WHO & UNICEF, 2003, ANT CAR DEV COUNTR P; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2004, INT CLASS DIS ICD; World Health Organization, 2006, PREGN CHILDB POSTP N; World Health Organization, 2014, GLOB REF LIST 100 CO; World Health Organization, 2014, WORLD HEALTH STATIST; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 1998, BAS NEWB RES PRACT G; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO; Yonemoto N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009326.pub2	75	47	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139288	10.1371/journal.pone.0139288	http://dx.doi.org/10.1371/journal.pone.0139288			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422685	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700091
J	Kumari, P; Choi, HL; Sudiarto, SIA				Kumari, Priyanka; Choi, Hong L.; Sudiarto, Sartika I. A.			Assessment of Bacterial Community Assembly Patterns and Processes in Pig Manure Slurry	PLOS ONE			English	Article							MICROBIAL COMMUNITY; SWINE MANURE; SOIL; STORAGE; PH; PHYLOGENIES; DIVERSITY; DYNAMICS; FECES; PITS	The bacterial community assembly patterns and processes are poorly understood in pig manure slurry. We collected pig manure slurry samples during the winter and summer seasons from eight commercial pig farms in South Korea. The V3 region of 16S rRNA genes was PCR amplified and sequenced using paired-end Illumina technology for in-depth characterization of bacterial community. Firmicutes, Bacteroidetes, Proteobacteria, Spirochaetes, and Tenericutes were the predominant bacterial phyla present in slurry samples. Bacterial taxonomic community composition was not influenced by the season; however, phylogenetic community composition was affected by seasonal variations. The community composition and diversity patterns were strongly influenced by pH. The bacterial diversity indices showed a unimodal relationship with pH. Phylogenetic signals were detected over only short phylogenetic distances, revealing that closely related bacterial operational taxonomic units (OTUs) tend to co-occur in the same environment; hence, they are ecologically similar. Across all samples, a niche-based process, through strong environmental filtering imposed by pH, primarily governed bacterial community assembly; however, in samples close to the neutral pH range, the role of environmental filtering was decreased due to neutral community assembly. In summary, pH emerged as the major physico-chemical variable in pig manure slurry that regulates the relative importance of niche-based and neutral processes in shaping the community assembly of bacteria.	[Kumari, Priyanka; Choi, Hong L.; Sudiarto, Sartika I. A.] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Choi, Hong L.] Resourcificat Res Ctr Crop Anim Farming ReCAF, Seoul, South Korea	Seoul National University (SNU)	Choi, HL (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul 151921, South Korea.	ulsoo8@snu.ac.kr		Sudiarto, Sartika Indah Amalia/0000-0003-3734-2656; Kumari, Priyanka/0000-0001-9224-4966	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) from the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [312036-03-2-HD030]; Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy (MOTIE) [2012-3020090040]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) from the Ministry of Agriculture, Food, and Rural Affairs (MAFRA)(Ministry of Agriculture, Food & Rural Affairs (MAFRA), Republic of KoreaInstitute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy (MOTIE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) from the Ministry of Agriculture, Food, and Rural Affairs (MAFRA) through project no. 312036-03-2-HD030, and in part by Korea Institute of Energy Technology Evaluation and Planning (KETEP) from the Ministry of Trade, Industry and Energy (MOTIE) through project no. 2012-3020090040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, STANDARD METHODS EXA; Barker JC, 2007, T ASABE, V50, P651, DOI 10.13031/2013.22654; Bradford S. A., 2008, J ENVIRON QUAL, V37, P97; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Cook KL, 2010, ANAEROBE, V16, P74, DOI 10.1016/j.anaerobe.2009.06.003; Cotta MA, 2003, ENVIRON MICROBIOL, V5, P737, DOI 10.1046/j.1467-2920.2003.00467.x; Da Silva MLB, 2014, MICROB ECOL, P1; Degryse F, 2009, EUR J SOIL SCI, V60, P590, DOI 10.1111/j.1365-2389.2009.01142.x; Ducey TF, 2013, ANAEROBE, V21, P50, DOI 10.1016/j.anaerobe.2013.03.005; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fageria NK, 2008, COMMUN SOIL SCI PLAN, V39, P1016, DOI 10.1080/00103620801925422; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fernandez-Calvino D, 2009, J HAZARD MATER, V167, P797, DOI 10.1016/j.jhazmat.2009.01.054; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; Han I, 2011, APPL MICROBIOL BIOT, V89, P835, DOI 10.1007/s00253-010-2893-8; Hong PY, 2013, APPL ENVIRON MICROB, V79, P2620, DOI 10.1128/AEM.03760-12; Hubbell Stephen P., 2001, V32, pi; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Isaacson Richard, 2012, Animal Health Research Reviews, V13, P100, DOI 10.1017/S1466252312000084; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Krapac IG, 2002, ENVIRON POLLUT, V120, P475, DOI 10.1016/S0269-7491(02)00115-X; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leung K, 2001, FEMS MICROBIOL ECOL, V38, P169, DOI 10.1111/j.1574-6941.2001.tb00895.x; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lovanh N, 2009, BIORESOURCE TECHNOL, V100, P3706, DOI 10.1016/j.biortech.2008.09.024; Lu XM, 2014, APPL MICROBIOL BIOT, V98, P2657, DOI 10.1007/s00253-013-5211-4; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; NIAS, 2005, EFF COMP PUR ACC COL; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Peu P, 2006, APPL ENVIRON MICROB, V72, P3578, DOI 10.1128/AEM.72.5.3578-3585.2006; Ren LJ, 2015, APPL ENVIRON MICROB, V81, P3104, DOI 10.1128/AEM.04042-14; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Snell-Castro R, 2005, FEMS MICROBIOL ECOL, V52, P229, DOI 10.1016/j.femsec.2004.11.016; Stegen JC, 2012, ISME J, V6, P1653, DOI 10.1038/ismej.2012.22; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Wang J, 2013, ISME J; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Whitehead TR, 2001, ANAEROBE, V7, P181, DOI 10.1006/anae.2001.0388; Zahn JA, 1997, J ENVIRON QUAL, V26, P1687, DOI 10.2134/jeq1997.00472425002600060032x; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	47	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139437	10.1371/journal.pone.0139437	http://dx.doi.org/10.1371/journal.pone.0139437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422375	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700115
J	Schmithausen, RM; Schulze-Geisthoevel, SV; Stemmer, F; El-Jade, M; Reif, M; Hack, S; Meilaender, A; Montabauer, G; Fimmers, R; Parcina, M; Hoerauf, A; Exner, M; Petersen, B; Bierbaum, G; Bekeredjian-Ding, I				Schmithausen, Ricarda Maria; Schulze-Geisthoevel, Sophia Vernika; Stemmer, Franziska; El-Jade, Mohamed; Reif, Marion; Hack, Sylvia; Meilaender, Alina; Montabauer, Gabriele; Fimmers, Rolf; Parcina, Marijo; Hoerauf, Achim; Exner, Martin; Petersen, Brigitte; Bierbaum, Gabriele; Bekeredjian-Ding, Isabelle			Analysis of Transmission of MRSA and ESBL-E among Pigs and Farm Personnel	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SPECTRUM-BETA-LACTAMASE; LIVESTOCK-ASSOCIATED MRSA; PORK PRODUCTION CHAIN; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; ANTIMICROBIAL RESISTANCE; NASAL COLONIZATION; GENETIC DIVERSITY	Livestock-associated bacteria with resistance to two or more antibiotic drug classes have heightened our awareness for the consequences of antibiotic consumption and spread of resistant bacterial strains in the veterinary field. In this study we assessed the prevalence of concomitant colonization with livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) and enterobacteriaceae expressing extended-spectrum betalactamases (ESBL-E) in farms at the German-Dutch border region. Nasal colonization of pigs with MRSA (113/547 (20.7%)) was less frequent than rectal colonization with ESBL-E (163/540 (30.2%)). On the individual farm level MRSA correlated with ESBL-E recovery. The data further provide information on prevalence at different stages of pig production, including abattoirs, as well as in air samples and humans living and working on the farms. Notably, MRSA was detected in stable air samples of 34 out of 35 pig farms, highlighting air as an important MRSA transmission reservoir. The majority of MRSA isolates, including those from humans, displayed tetracycline resistance and spa types t011 and t034 characteristic for LA-MRSA, demonstrating transmission from pigs to humans. ESBL-E positive air samples were detected on 6 out of 35 farms but no pig-to-human transmission was found. Detection of ESBL-E, e.g. mostly Escherichia coli with CTX-M-type ESBL, was limited to these six farms. Molecular typing revealed transmission of ESBL-E within the pig compartments; however, related strains were also found on unrelated farms. Although our data suggest that acquisition of MRSA and ESBL-E might occur among pigs in the abattoirs, MRSA and ESBL-E were not detected on the carcasses. Altogether, our data define stable air (MRSA), pig compartments (ESBL-E) and abattoir waiting areas (MRSA and ESBL-E) as major hot spots for transmission of MRSA and/or ESBL-E along the pig production chain.	[Schmithausen, Ricarda Maria; El-Jade, Mohamed; Reif, Marion; Meilaender, Alina; Montabauer, Gabriele; Parcina, Marijo; Hoerauf, Achim; Bierbaum, Gabriele] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Schmithausen, Ricarda Maria; Schulze-Geisthoevel, Sophia Vernika; Stemmer, Franziska; Petersen, Brigitte] Univ Bonn, Prevent Hlth Management Grp, Inst Anim Sci, Bonn, Germany; [Fimmers, Rolf] Univ Hosp Bonn, Inst Med Biometry Epidemiol & Comp Sci, Bonn, Germany; [Hack, Sylvia; Exner, Martin] Univ Hosp Bonn, Inst Hyg & Publ Hlth, Bonn, Germany; [Bekeredjian-Ding, Isabelle] Paul Ehrlich Inst, Div EU Cooperat Microbiol, Langen, Germany	University of Bonn; University of Bonn; University of Bonn; University of Bonn; Paul Ehrlich Institute	Bekeredjian-Ding, I (corresponding author), Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.	isabelle.bekeredjian-ding@pei.de	Parcina, Marijo/ABG-4659-2020	Smith, Tara C./0000-0003-3747-1116	FIN-Q NRW research network; European Union; state of North Rhine Westfalia, Germany [005-NA01-030]; LeanIX GmbH	FIN-Q NRW research network; European Union(European Commission); state of North Rhine Westfalia, Germany; LeanIX GmbH	The project was financed by the FIN-Q NRW research network funded by the European Union and the state of North Rhine Westfalia, Germany. Reference number: 005-NA01-030 (http://giqs.org/projekte/abgeschlossene-projekte/fin-qnrw/). LeanIX GmbH provided support in the form of salaries for author Andre Christ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aarestrup FM, 1999, MICROBES INFECT, V1, P639, DOI 10.1016/S1286-4579(99)80064-1; Aarestrup FM, 2001, ANTIMICROB AGENTS CH, V45, P2054, DOI 10.1128/AAC.45.7.2054-2059.2001; Adell E, 2014, ANN AGR ENV MED, V21, P15; Agerso Y, 2014, EPIDEMIOL INFECT, V142, P1727, DOI 10.1017/S095026881300280X; Agerso Y, 2013, J ANTIMICROB CHEMOTH, V68, P569, DOI 10.1093/jac/dks427; Anwar Muhammad Saeed, 2004, J Coll Physicians Surg Pak, V14, P661; Beneke B, 2011, J FOOD PROTECT, V74, P126, DOI 10.4315/0362-028X.JFP-10-250; Blanc V, 2006, VET MICROBIOL, V118, P299, DOI 10.1016/j.vetmic.2006.08.002; Boerlin P, 2001, J CLIN MICROBIOL, V39, P4193, DOI 10.1128/JCM.39.11.4193-4195.2001; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Broens EM, 2011, PREV VET MED, V98, P182, DOI 10.1016/j.prevetmed.2010.10.010; Broens EM, 2012, VET MICROBIOL, V155, P381, DOI 10.1016/j.vetmic.2011.09.010; Broens EM, 2011, VET J, V189, P302, DOI 10.1016/j.tvjl.2010.08.003; Brolund A, 2010, J MICROBIOL METH, V83, P224, DOI 10.1016/j.mimet.2010.09.004; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Cavaco LM, 2008, ANTIMICROB AGENTS CH, V52, P3612, DOI 10.1128/AAC.00354-08; Cormican MG, 1997, DIAGN MICR INFEC DIS, V29, P241, DOI 10.1016/S0732-8893(97)00134-X; Cuny C, 2013, INT J MED MICROBIOL, V303, P331, DOI 10.1016/j.ijmm.2013.02.010; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11; Escudero E, 2010, RES VET SCI, V88, P83, DOI 10.1016/j.rvsc.2009.05.021; EUCAST ECoAST, 2013, CLIN BREAKP BACT V3; FELLER W, 1948, ANN MATH STAT, V19, P177, DOI 10.1214/aoms/1177730243; Friese A, 2013, BERL MUNCH TIERARZTL, V126, P175, DOI 10.2376/0005-9366-126-175; Friese A, 2012, VET MICROBIOL, V158, P129, DOI 10.1016/j.vetmic.2012.01.019; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Geser N, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-21; Geser N, 2012, ANTIMICROB AGENTS CH, V56, P1609, DOI 10.1128/AAC.05539-11; Gilchrist MJ, 2007, ENVIRON HEALTH PERSP, V115, P313, DOI 10.1289/ehp.8837; Goncalves A, 2010, FOODBORNE PATHOG DIS, V7, P1569, DOI 10.1089/fpd.2010.0598; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Grohs P, 2013, J CLIN MICROBIOL, V51, P2713, DOI 10.1128/JCM.00077-13; Hammerum AM, 2007, INT J ANTIMICROB AG, V30, P466, DOI 10.1016/j.ijantimicag.2007.07.012; Hammerum AM, 2014, J ANTIMICROB CHEMOTH, V69, P2650, DOI 10.1093/jac/dku180; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harris D.L, 2000, MULTISITE PIG PRODUC; Harrison EM, 2013, EMBO MOL MED, V5, P509, DOI 10.1002/emmm.201202413; Hiramatsu K, 2002, CURR OPIN INFECT DIS, V15, P407, DOI 10.1097/00001432-200208000-00009; Horton RA, 2011, APPL ENVIRON MICROB, V77, P3715, DOI 10.1128/AEM.02831-10; Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13; Huletsky A, 2005, CLIN INFECT DIS, V40, P976, DOI 10.1086/428579; Hurd HS, 2002, APPL ENVIRON MICROB, V68, P2376, DOI 10.1128/AEM.68.5.2376-2381.2002; Hurd HS, 2001, AM J VET RES, V62, P1194, DOI 10.2460/ajvr.2001.62.1194; Jakobsen L, 2010, FOODBORNE PATHOG DIS, V7, P537, DOI 10.1089/fpd.2009.0409; Kastrup GN, 2011, PREVALENCE METICILLI; Kennedy K, 2010, EUR J CLIN MICROBIOL, V29, P1501, DOI 10.1007/s10096-010-1031-y; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kock R, 2009, EUR J CLIN MICROBIOL, V28, P1375, DOI 10.1007/s10096-009-0795-4; Kock R, 2012, APPL ENVIRON MICROB, V78, P4046, DOI 10.1128/AEM.00212-12; Kock R, 2011, DTSCH ARZTEBL INT, V108, P761, DOI 10.3238/arztebl.2011.0761; Lassok B, 2013, J FOOD PROTECT, V76, P1095, DOI 10.4315/0362-028X.JFP-12-341; LEELAPORN A, 1994, J MED MICROBIOL, V40, P214, DOI 10.1099/00222615-40-3-214; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LITTLEJOHN TG, 1992, FEMS MICROBIOL LETT, V95, P259; Liu BT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073947; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; MARAN, 2009, MARAN 2009 MON ANT R; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066; Meeniken D, 2008, DEUT TIERARZTL WOCH, V115, P132, DOI 10.2377/0341-6593-115-132; Monaco M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-258; Moodley A, 2009, ANTIMICROB AGENTS CH, V53, P1709, DOI 10.1128/AAC.01014-08; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Nedbalcova K, 2014, VET MICROBIOL, V171, P328, DOI 10.1016/j.vetmic.2014.02.004; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Pitout JDD, 1997, AM J MED, V103, P51, DOI 10.1016/S0002-9343(97)00044-2; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; Smith TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004258; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Strommenger B, 2014, J ANTIMICROB CHEMOTH, V69, P616, DOI 10.1093/jac/dkt413; Tenhagen BA, 2009, VET REC, V165, P589, DOI 10.1136/vr.165.20.589; Teuber M, 2001, CURR OPIN MICROBIOL, V4, P493, DOI 10.1016/S1369-5274(00)00241-1; Tian GB, 2009, FOODBORNE PATHOG DIS, V6, P297, DOI 10.1089/fpd.2008.0164; van Cleef BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009385; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vandendriessche S, 2014, J ANTIMICROB CHEMOTH, V69, P355, DOI 10.1093/jac/dkt366; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Voets GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052102; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Wulf MWH, 2012, EUR J CLIN MICROBIOL, V31, P61, DOI 10.1007/s10096-011-1269-z	94	66	69	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138173	10.1371/journal.pone.0138173	http://dx.doi.org/10.1371/journal.pone.0138173			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422606	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700033
J	Wang, J; She, YX; Wang, M; Jin, MJ; Li, YF; Wang, J; Liu, Y				Wang, Jian; She, Yongxin; Wang, Miao; Jin, Maojun; Li, Yongfei; Wang, Jing; Liu, Yuan			Multiresidue Method for Analysis of beta Agonists in Swine Urine by Enzyme Linked Receptor Assay Based on beta(2) Adrenergic Receptor Expressed in HEK293 Cells	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTOR; MASS-SPECTROMETRY; ESCHERICHIA-COLI; BETA-2-ADRENERGIC RECEPTOR; BINDING CHARACTERISTICS; IMMUNOSORBENT-ASSAY; CLENBUTEROL; LIQUID; CHROMATOGRAPHY	A novel enzyme-linked receptor assay (ELRA) based on beta(2)-adrenergic receptor (beta(2)-AR) has been developed for rapid and high-throughput detection of beta-adrenergic agonists (beta-agonists) in urine. Human embryonic kidney cells (HEK293) were introduced as the expression system to enhance the functionality of the recombinant beta(2)-AR, and the attempt to detect beta-agonists in swine urine using such approaches was accomplished unprecedentedly. In this article, a recombinant porcine beta(2)-AR was produced in the inner membrane of HEK293 cells and purified from crude membrane protein by nickel-nitrilotriacetic acid affinity chromatography. After activity identification, the recombinant receptor was used in the development of direct competitive ELRA. Several parameters such as blocking buffer and blocking process were optimized and the performance of the system was determined. The IC50 concentrations of clenbuterol, salbutamol, and ractopamine were 34, 53 and 63 mu g/L, and the average recovery rates were 68.2%, 60.3% and 65.5%, respectively. ELRA based on beta(2)-AR shows a series of advantages such as safety, easy operation, and high efficiency, making it promising for the rapid screening of beta-agonists in animal urine.	[Wang, Jian; She, Yongxin; Wang, Miao; Jin, Maojun; Li, Yongfei; Wang, Jing] CAAS, Minist Agr, Key Lab Agroprod Qual & Safety, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China; [Wang, Jian; Liu, Yuan] Hebei North Univ, Dept Food Sci, Zhangjiakou 075000, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS; Ministry of Agriculture & Rural Affairs; Hebei North University	Wang, J (corresponding author), CAAS, Minist Agr, Key Lab Agroprod Qual & Safety, Inst Qual Stand & Testing Technol Agroprod, Beijing 100081, Peoples R China.	w_jing2001@126.com		Jin, Maojun/0000-0002-9102-8572	Special Fund for Agro scientific Research in the Public Interest of China [201203094]	Special Fund for Agro scientific Research in the Public Interest of China	This work was funded by Special Fund for Agro scientific Research in the Public Interest of China (No. 201203094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D.B., 1989, J ANIM SCI, V67, P222; Bai YH, 2012, J AGR FOOD CHEM, V60, P11618, DOI 10.1021/jf3036066; Bao H, 2012, CHEM LETT, V41, P237, DOI 10.1246/cl.2012.237; Boyd S, 2009, ANAL CHIM ACTA, V637, P24, DOI 10.1016/j.aca.2008.09.035; Brambilla G, 2000, TOXICOL LETT, V114, P47, DOI 10.1016/S0378-4274(99)00270-2; Caban M, 2011, J CHROMATOGR A, V1218, P8110, DOI 10.1016/j.chroma.2011.08.093; Chelikani P, 2006, PROTEIN SCI, V15, P1433, DOI 10.1110/ps.062080006; Cheng GY, 2014, ANAL BIOCHEM, V459, P18, DOI 10.1016/j.ab.2014.05.005; Danyi S, 2007, ANAL CHIM ACTA, V589, P159, DOI 10.1016/j.aca.2007.02.057; Doronin S, 2000, PROTEIN EXPRES PURIF, V20, P451, DOI 10.1006/prep.2000.1322; Du W, 2014, FOOD CHEM, V145, P789, DOI 10.1016/j.foodchem.2013.08.094; Duport C, 2003, BBA-GENE STRUCT EXPR, V1629, P34, DOI 10.1016/S0167-4781(03)00157-X; ENGESETH NJ, 1992, J FOOD SCI, V57, P1060, DOI 10.1111/j.1365-2621.1992.tb11262.x; European Commission, 1996, OFF J EUR COMMUNITIE, VL125, P3; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; HELBO V, 1994, ARCH LEBENSMITTELHYG, V45, P57; KOBILKA BK, 1990, J BIOL CHEM, V265, P7610; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Li CH, 2013, FOOD CONTROL, V34, P725, DOI 10.1016/j.foodcont.2013.06.021; Li LB, 2013, ELECTROPHORESIS, V34, P277, DOI 10.1002/elps.201200385; Li YS, 2015, FOOD CHEM, V167, P40, DOI 10.1016/j.foodchem.2014.06.085; Liang W, 2000, J ANIM SCI, V78, P2329; Mazzanti G, 2003, TOXICOLOGY, V187, P91, DOI 10.1016/S0300-483X(03)00059-3; Meenagh SA, 2001, ANALYST, V126, P491, DOI 10.1039/b008407g; Munch G, 1995, RECEPTOR CHANNEL, V3, P291; Nielen MWF, 2003, RAPID COMMUN MASS SP, V17, P1633, DOI 10.1002/rcm.1099; Pleadin J, 2013, J ANAL TOXICOL, V37, P241, DOI 10.1093/jat/bkt017; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Stanasila L, 1998, BIOCHIMIE, V80, P563, DOI 10.1016/S0300-9084(00)80021-8; Tang JL, 2010, ANAL BIOANAL CHEM, V397, P3015, DOI 10.1007/s00216-010-3878-2; The Ministry of Agriculture of China, 2010, B MIN AGR PEOPL REP; Wang XJ, 2013, J CHROMATOGR A, V1278, P82, DOI 10.1016/j.chroma.2012.12.060; Warne T, 2003, BBA-BIOMEMBRANES, V1610, P133, DOI 10.1016/S0005-2736(02)00716-2; WELLENREITER R H, 1990, Poultry Science, V69, P142; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57; Yang X, 2014, FOOD CHEM, V145, P619, DOI 10.1016/j.foodchem.2013.08.093; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhu GC, 2011, ANAL CHIM ACTA, V697, P61, DOI 10.1016/j.aca.2011.04.031	39	6	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139176	10.1371/journal.pone.0139176	http://dx.doi.org/10.1371/journal.pone.0139176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422475	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700076
J	Alva, O; Roa-Roco, RN; Perez-Diaz, R; Yanez, M; Tapia, J; Moreno, Y; Ruiz-Lara, S; Gonzalez, E				Alva, Orlando; Nair Roa-Roco, Rosa; Perez-Diaz, Ricardo; Yanez, Monica; Tapia, Jaime; Moreno, Yerko; Ruiz-Lara, Simon; Gonzalez, Enrique			Pollen Morphology and Boron Concentration in Floral Tissues as Factors Triggering Natural and GA-Induced Parthenocarpic Fruit Development in Grapevine	PLOS ONE			English	Article							ZINC-FINGER GENE; VITIS-VINIFERA; RHAMNOGALACTURONAN-II; CROSS-LINKING; TUBE GROWTH; TRANSPORTER; GERMINATION; POLYAMINES; PLANTS; FLOWER	Parthenocarpic fruit development (PFD) reduces fruit yield and quality in grapevine. Parthenocarpic seedless berries arise from fruit set without effective fertilization due to defective pollen germination. PFD has been associated to micronutrient deficiency but the relation of this phenomenon with pollen polymorphism has not been reported before. In this work, six grapevine cultivars with different tendency for PFD and grown under micronutrient-sufficient conditions were analyzed to determine pollen structure and germination capability as well as PFD rates. Wide variation in non-germinative abnormal pollen was detected either among cultivars as well as for the same cultivar in different growing seasons. A straight correlation with PFD rates was found (R-2 = 0.9896), suggesting that natural parthenocarpy is related to defective pollen development. Such relation was not observed when PFD was analyzed in grapevine plants exposed to exogenous gibberellin (GA) or abscissic acid (ABA) applications at pre-anthesis. Increase (GA treatment) or reduction (ABA treatment) in PFD rates without significative changes in abnormal pollen was determined. Although these plants were maintained at sufficient boron (B) condition, a down-regulation of the floral genes VvBOR3 and VvBOR4 together with a reduction of floral B content in GA-treated plants was established. These results suggest that impairment in B mobility to reproductive tissues and restriction of pollen tube growth could be involved in the GA-induced parthenocarpy.	[Alva, Orlando; Nair Roa-Roco, Rosa; Perez-Diaz, Ricardo; Yanez, Monica; Ruiz-Lara, Simon; Gonzalez, Enrique] Univ Talca, Inst Ciencias Biol, Talca, Chile; [Tapia, Jaime] Univ Talca, Inst Quim Recursos Nat, Talca, Chile; [Moreno, Yerko] Univ Talca, Fac Ciencias Agr, Ctr Tecnol Vid & Vino, Talca, Chile	Universidad de Talca; Universidad de Talca	Gonzalez, E (corresponding author), Univ Talca, Inst Ciencias Biol, Talca, Chile.	egonzale@utalca.cl	Ruiz-Lara, Simon/Z-5843-2019	Ruiz-Lara, Simon/0000-0001-8476-2288	Fondo Nacional de Ciencia y Tecnologia (Chile) [1120871]; Comision Nacional de Investigacion Cientifica y Tecnologica (Chile) [23071037]	Fondo Nacional de Ciencia y Tecnologia (Chile); Comision Nacional de Investigacion Cientifica y Tecnologica (Chile)	Support was provided by Grant 1120871 Fondo Nacional de Ciencia y Tecnologia (Chile) [www.fondecyt.cl] to EG and a Doctoral fellowship 23071037 Comision Nacional de Investigacion Cientifica y Tecnologica (Chile) [www.conicyt.cl] to OA.	Abreu I, 2006, PROTOPLASMA, V228, P131, DOI 10.1007/s00709-006-0167-1; Almada R, 2009, PLANT CELL REP, V28, P1193, DOI 10.1007/s00299-009-0720-4; Aziz A, 2003, J EXP BOT, V54, P355, DOI [10.1093/jxb/54.381.355, 10.1093/jxb/erg029]; Aziz A, 2001, PHYSIOL PLANTARUM, V113, P50, DOI 10.1034/j.1399-3054.2001.1130107.x; Blevins DG, 1998, ANNU REV PLANT PHYS, V49, P481, DOI 10.1146/annurev.arplant.49.1.481; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Caporali E, 2003, SEX PLANT REPROD, V15, P291, DOI 10.1007/s00497-003-0169-5; CARGNELLO G, 1980, VITIS, V19, P201; CARRARO L, 1981, VITIS, V20, P193; CHENG C, 1993, DEV PLANT SOIL SCI, V45, P405; Christensen L. P., 2006, California Agriculture, V60, P100, DOI 10.3733/ca.v060n02p100; CHRISTENSEN P, 1980, AM J ENOL VITICULT, V31, P53; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Dell B, 1997, PLANT SOIL, V193, P103, DOI 10.1023/A:1004264009230; DOAZAN JP, 1967, ANN AMELIOR PLANT, V17, P105; Dzyuba OF, 2006, PALEONTOL J+, V40, pS590, DOI 10.1134/S0031030106110062; Erdtman, 1952, POLLEN MORPHOLOGY PL, V1; Gallardo A, 2009, VITIS, V48, P59; Gartel W., 1993, NUTR DEFICIENCIES TO, P177; Gustafson FG, 1936, P NATL ACAD SCI USA, V22, P628, DOI 10.1073/pnas.22.11.628; HORNER M, 1978, ANN BOT-LONDON, V42, P763, DOI 10.1093/oxfordjournals.aob.a085515; Huang LB, 2000, ANN BOT-LONDON, V85, P493, DOI 10.1006/anbo.1999.1095; Iwai H, 2006, P NATL ACAD SCI USA, V103, P16592, DOI 10.1073/pnas.0605141103; Jackson R., 2006, WINE SCI PRINCIPLES; Jung CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095634; Kapoor S, 2002, PLANT CELL, V14, P2353, DOI 10.1105/tpc.003061; Kapoor S, 2006, PLANT MOL BIOL, V61, P415, DOI 10.1007/s11103-006-0020-0; Keller M, 2005, AM J ENOL VITICULT, V56, P267; Keller M, 2010, SCIENCE OF GRAPEVINES: ANATOMY AND PHYSIOLOGY, P1; Kimura PH, 1997, AM J ENOL VITICULT, V48, P323; Kobayashi A, 1998, PLANT J, V13, P571, DOI 10.1046/j.1365-313X.1998.00043.x; Kuhn N, 2012, PLANT SIGNAL BEHAV, V7, P7, DOI 10.4161/psb.7.1.18353; LOMBARDO G, 1978, VITIS, V17, P221; Lu J, 1997, HORTSCIENCE, V32, P89, DOI 10.21273/HORTSCI.32.1.89; Malik AU, 2003, J HORTIC SCI BIOTECH, V78, P721, DOI 10.1080/14620316.2003.11511689; MARIA FCSS, 1994, VITIS, V33, P57; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Miwa K, 2013, PLANT PHYSIOL, V163, P1699, DOI 10.1104/pp.113.225995; Miwa K, 2010, ANN BOT-LONDON, V105, P1103, DOI 10.1093/aob/mcq044; Mullins MG., 1992, BIOL GRAPEVINE BIOL; Nakagawa Y, 2007, PLANT CELL, V19, P2624, DOI 10.1105/tpc.106.049015; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Okamoto G, 2005, VITIS, V44, P157; Perez-Castro R, 2012, PLANT CELL PHYSIOL, V53, P485, DOI 10.1093/pcp/pcs001; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Reid R, 2014, PLANT SOIL, V385, P1, DOI 10.1007/s11104-014-2149-y; Sanchez AM, 2004, PLANT CELL, V16, pS98, DOI 10.1105/tpc.017806; Shiozaki S, 1998, PLANT GROWTH REGUL, V25, P187, DOI 10.1023/A:1006043116190; Song JJ, 1999, SCI HORTIC-AMSTERDAM, V80, P203, DOI 10.1016/S0304-4238(98)00254-4; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tanaka M, 2008, PLANT CELL, V20, P2860, DOI 10.1105/tpc.108.058628; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; Tanaka N, 2013, PLANT CELL PHYSIOL, V54, P2011, DOI 10.1093/pcp/pct136; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Vasconcelos MC, 2009, AM J ENOL VITICULT, V60, P411; Wang QL, 2003, TREE PHYSIOL, V23, P345, DOI 10.1093/treephys/23.5.345; Wang ZX, 2013, SCI HORTIC-AMSTERDAM, V162, P11, DOI 10.1016/j.scienta.2013.07.038; Xu PL, 2013, VITIS, V52, P177; ZULUAGA P A, 1968, Vitis, V7, P97	66	26	27	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139503	10.1371/journal.pone.0139503	http://dx.doi.org/10.1371/journal.pone.0139503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440413	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300031
J	Low, D; DeGruttola, AK; Poltrak, A; Mizoguchi, A; Mino-Kenudson, M; Mizoguchi, E				Low, Daren; DeGruttola, Arianna K.; Poltrak, Alexander; Mizoguchi, Atsushi; Mino-Kenudson, Mari; Mizoguchi, Emiko			High Endogenous Expression of Chitinase 3-Like 1 and Excessive Epithelial Proliferation with Colonic Tumor Formation in MOLF/EiJ Mice	PLOS ONE			English	Article							GENETIC-ANALYSIS; COLORECTAL-CANCER; CELLS; COLITIS; RESPONSES; SUSCEPTIBILITY; INFLAMMATION	Colorectal cancer (CRC) development is mediated by uncontrolled survival and proliferation of tumor progenitor cells. Using animal models to identify and study host-derived factors that underlie this process can aid interventions in preventing tumor expansion and metastasis. In healthy steady states in humans and mice (e.g. C57BL/6 strain), colonic Chitinase 3-like 1 (CHI3L1) gene expression is undetectable. However, this expression can be induced during intestinal inflammation and tumorigenesis where CHI3L1 plays an important role in tissue restitution and cell proliferation. Here, we show that a wild-derived mouse strain MOLF/EiJ expresses high levels of colonic epithelial CHI3L1 at the steady state due to several nucleotide polymorphisms in the proximal promoter regions of the CHI3L1 gene. Interestingly, these mice spontaneously developed polypoid nodules in the colon with signs of immune cell infiltrations at steady state. The CHI3L1 positive colonic epithelial cells were highly proliferative and exhibited malignant transformation and expansion when exposed in vivo to azoxymethane, one of the well-known colonic carcinogens.	[Low, Daren; DeGruttola, Arianna K.; Mizoguchi, Emiko] Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Low, Daren; DeGruttola, Arianna K.; Mino-Kenudson, Mari; Mizoguchi, Emiko] Harvard Univ, Sch Med, Boston, MA USA; [Poltrak, Alexander] Petrozavodsk State Univ, Dept Mol Biol, Petrozavodsk 185910, Republic Of Kar, Russia; [Poltrak, Alexander] Tufts Univ, Sackler Sch Biomed Sci, Grad Program Genet, Boston, MA 02111 USA; [Mizoguchi, Atsushi] Kurume Univ, Sch Med, Dept Immunol, Kurume, Fukuoka 830, Japan; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mizoguchi, Emiko] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Petrozavodsk State University; Tufts University; Kurume University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Mizoguchi, E (corresponding author), Massachusetts Gen Hosp, Dept Med, Gastrointestinal Unit, Boston, MA 02114 USA.	emizoguchi@mgh.harvard.edu			National Institutes of Health [R01-DK80070, DK91247, AI81807]; Broad Medical Foundation; American Gastroenterological Association Foundation; A*STAR Graduate Academy (Singapore); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080070, R01DK091247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Broad Medical Foundation; American Gastroenterological Association Foundation; A*STAR Graduate Academy (Singapore)(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by National Institutes of Health (R01-DK80070, DK91247, AI81807), and grants from the Broad Medical Foundation and American Gastroenterological Association Foundation to EM. DL has been awarded the fellowship grant supported by A*STAR Graduate Academy (Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj R, 2015, J IMMUNOL, V194, P2862, DOI 10.4049/jimmunol.1400874; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chen CC, 2011, AM J PATHOL, V179, P1494, DOI 10.1016/j.ajpath.2011.05.038; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Eurich K, 2009, WORLD J GASTROENTERO, V15, P5249, DOI 10.3748/wjg.15.5249; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Haller O, 1998, REV SCI TECH OIE, V17, P220, DOI 10.20506/rst.17.1.1084; Harper JM, 2008, AGE, V30, P135, DOI 10.1007/s11357-008-9057-0; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Janssen KP, 2002, GASTROENTEROLOGY, V123, P492, DOI 10.1053/gast.2002.34786; Khan RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088009; Lee IA, 2014, J GASTROENTEROL, V49, P1206, DOI 10.1007/s00535-013-0865-3; Lee IA, 2014, WORLD J GASTROENTERO, V20, P1127, DOI 10.3748/wjg.v20.i5.1127; Low D, 2013, GASTROENTEROLOGY, V145, P602, DOI 10.1053/j.gastro.2013.05.017; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Moseman AP, 2013, J IMMUNOL, V191, P5615, DOI 10.4049/jimmunol.1301438; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Sancho-Shimizu V, 2007, GENETICS, V177, P1125, DOI 10.1534/genetics.107.075523; Stephan K, 2007, EUR J IMMUNOL, V37, P212, DOI 10.1002/eji.200636156; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026	23	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139149	10.1371/journal.pone.0139149	http://dx.doi.org/10.1371/journal.pone.0139149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440614	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300014
J	Ma, QG; Li, DD; Shen, Q; Qiu, WW				Ma, Qingguo; Li, Diandian; Shen, Qiang; Qiu, Wenwei			Anchors as Semantic Primes in Value Construction: An EEG Study of the Anchoring Effect	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; COGNITIVE-PROCESSES; THREAT; ANTICIPATION; MODULATION; ADJUSTMENT; THETA; SYNCHRONIZATION; EXPECTATION; UNCERTAINTY	Previous research regarding anchoring effects has demonstrated that human judgments are often assimilated to irrelevant information. Studies have demonstrated that anchors influence the economic valuation of various products and experiences; however, the cognitive explanations of this effect remain controversial, and its neural mechanisms have rarely been explored. In the current study, we conducted an electroencephalography (EEG) experiment to investigate the anchoring effect on willingness to accept (WTA) for an aversive hedonic experience and the role of anchors in this judgment heuristic. The behavioral results demonstrated that random numbers affect participants' WTA for listening to pieces of noise. The participants asked for higher pay after comparing their WTA with higher numbers. The EEG results indicated that anchors also influenced the neural underpinnings of the valuation process. Specifically, when a higher anchor number was drawn, larger P2 and late positive potential amplitudes were elicited, reflecting the anticipation of more intensive pain from the subsequent noise. Moreover, higher anchors induced a stronger theta band power increase compared with lower anchors when subjects listened to the noises, indicating that the participants felt more unpleasant during the actual experience of the noise. The levels of unpleasantness during both anticipation and experience were consistent with the semantic information implied by the anchors. Therefore, these data suggest that a semantic priming process underlies the anchoring effect in WTA. This study provides proof for the robustness of the anchoring effect and neural evidence of the semantic priming model. Our findings indicate that activated contextual information, even seemingly irrelevant, can be embedded in the construction of economic value in the brain.	[Ma, Qingguo; Li, Diandian; Shen, Qiang; Qiu, Wenwei] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Ma, Qingguo; Li, Diandian; Shen, Qiang; Qiu, Wenwei] Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ma, QG (corresponding author), Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China.	maqingguo3669@zju.edu.cn			National Natural Science Foundation [90924304, 71371167]; State Education Ministry of China [09JZD0006]; 211 Project of Management Theory and Development Strategy of Entrepreneurship; Innovation and Technology Innovation Program for Students of Zhejiang Province	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); State Education Ministry of China(Ministry of Education, China); 211 Project of Management Theory and Development Strategy of Entrepreneurship; Innovation and Technology Innovation Program for Students of Zhejiang Province	This work was supported by grants (No. 90924304 and 71371167) from the National Natural Science Foundation, and a grant (No. 09JZD0006) from the State Education Ministry of China to QM, and was supported by the 211 Project of Management Theory and Development Strategy of Entrepreneurship to QM. It was also supported by the Innovation and Technology Innovation Program for Students of Zhejiang Province (2013) to DL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaval R, 2011, J MARKETING RES, V48, P355, DOI 10.1509/jmkr.48.2.355; Aftanas L I, 2004, Neurosci Behav Physiol, V34, P859, DOI 10.1023/B:NEAB.0000038139.39812.eb; Aftanas LI, 2003, NEUROSCI LETT, V340, P57, DOI 10.1016/S0304-3940(03)00070-3; Aftanas LI, 2002, INT J PSYCHOPHYSIOL, V44, P67, DOI 10.1016/S0167-8760(01)00194-5; Alevy JE, 2010, FIELD EXPT ANCHORING, DOI [10.2139/ssrn.1824400, DOI 10.2139/SSRN.1824400]; Alevy JE, 2008, ANCHORS AWAY FIELD E; Alves Nelson Torro, 2008, Psychol. Neurosci., V1, P63, DOI 10.1590/S1983-32882008000100010; Ariely D, 2003, Q J ECON, V118, P1996; Baas JMP, 2002, NEUROREPORT, V13, P133, DOI 10.1097/00001756-200201210-00031; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Basar E, 1999, NEUROSCI LETT, V259, P165, DOI 10.1016/S0304-3940(98)00934-3; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Beggs A, 2009, AM ECON REV, V99, P1027, DOI 10.1257/aer.99.3.1027; Bergman O, 2010, ECON LETT, V107, P66, DOI 10.1016/j.econlet.2009.12.028; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bocker KBE, 2004, BIOL PSYCHOL, V67, P343, DOI 10.1016/j.biopsycho.2004.01.001; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Bublatzky F, 2012, SOC COGN AFFECT NEUR, V7, P611, DOI 10.1093/scan/nsr032; Chapman GB, 1999, ORGAN BEHAV HUM DEC, V79, P115, DOI 10.1006/obhd.1999.2841; Cohen MX, 2007, NEUROIMAGE, V35, P968, DOI 10.1016/j.neuroimage.2006.11.056; Critcher CR, 2008, J BEHAV DECIS MAKING, V21, P241, DOI 10.1002/bdm.586; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; De Martino B, 2009, J NEUROSCI, V29, P3833, DOI 10.1523/JNEUROSCI.4832-08.2009; Dogerlioglu-Demir K, 2015, MARKET LETT, V26, P607, DOI 10.1007/s11002-014-9295-0; Epley N, 2005, J BEHAV DECIS MAKING, V18, P199, DOI 10.1002/bdm.495; Epley N, 2001, PSYCHOL SCI, V12, P391, DOI 10.1111/1467-9280.00372; Fudenberg D, 2012, AM ECON J-MICROECON, V4, P131, DOI 10.1257/mic.4.2.131; Gehring W.J., 2004, ERRORS CONFLICTS BRA, V14, P20; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Glista Danielle, 2012, Int J Otolaryngol, V2012, P982894, DOI 10.1155/2012/982894; Gole M, 2012, NEUROSCI LETT, V507, P112, DOI 10.1016/j.neulet.2011.11.054; Green D, 1998, RESOUR ENERGY ECON, V20, P85, DOI 10.1016/S0928-7655(97)00031-6; Heine A, 2013, CORTEX, V49, P2162, DOI 10.1016/j.cortex.2012.11.009; Hu L, 2014, NEUROIMAGE, V84, P876, DOI 10.1016/j.neuroimage.2013.09.055; Hyde DC, 2011, J COGNITIVE NEUROSCI, V23, P2336, DOI 10.1162/jocn.2010.21581; Hyde DC, 2009, J COGNITIVE NEUROSCI, V21, P1039, DOI 10.1162/jocn.2009.21090; Killgore WDS, 2007, SOC COGN AFFECT NEUR, V2, P240, DOI 10.1093/scan/nsm020; Kim JR, 2009, EAR HEARING, V30, P320, DOI 10.1097/AUD.0b013e31819c42b7; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Kroupi E, 2011, LECT NOTES COMPUT SC, V6975, P457, DOI 10.1007/978-3-642-24571-8_58; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Maniadis Z, 2014, AM ECON REV, V104, P277, DOI 10.1257/aer.104.1.277; Marco-Pallares J, 2008, NEUROPSYCHOLOGIA, V46, P241, DOI 10.1016/j.neuropsychologia.2007.07.016; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Moedano L, 2011, BOMB ERP STUDY INVES; Mussweiler T, 1999, J EXP SOC PSYCHOL, V35, P136, DOI 10.1006/jesp.1998.1364; Mussweiler T, 2001, SOC COGNITION, V19, P145, DOI 10.1521/soco.19.2.145.20705; Mussweiler T, 2000, J PERS SOC PSYCHOL, V78, P1038, DOI 10.1037//0022-3514.78.6.1038; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Palmeira MM, 2013, J CONSUM RES, V40, P644, DOI 10.1086/671565; Park J, 2015, RAPID DIRECT ENCODIN; Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Poli S, 2007, INT J PSYCHOPHYSIOL, V65, P32, DOI 10.1016/j.ijpsycho.2007.02.008; Qu C, 2008, NEUROSCI LETT, V445, P199, DOI 10.1016/j.neulet.2008.07.061; Qu C, 2008, PROG NAT SCI-MATER, V18, P1375, DOI 10.1016/j.pnsc.2008.04.007; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; Schafer R, 2007, J PSYCHOSOM RES, V63, P357, DOI 10.1016/j.jpsychores.2007.03.015; SCHKADE DA, 1989, ORGAN BEHAV HUM DEC, V44, P203, DOI 10.1016/0749-5978(89)90025-3; Schmidt LA, 2001, COGNITION EMOTION, V15, P487, DOI 10.1080/0269993004200187; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Seymour B, 2008, CURR OPIN NEUROBIOL, V18, P173, DOI 10.1016/j.conb.2008.07.010; Shahin AJ, 2007, BRAIN TOPOGR, V20, P55, DOI 10.1007/s10548-007-0031-4; Shen J, 2012, INT J APPL RES BUS A, V1, P33; Simonsohn U., 2013, SSRN ELECT J, DOI [10.2139/ssrn.2351926, DOI 10.2139/SSRN.2351926]; Simonson I, 2004, J CONSUM RES, V31, P681, DOI 10.1086/425103; Strack F, 1997, J PERS SOC PSYCHOL, V73, P437, DOI 10.1037/0022-3514.73.3.437; Sugden R, 2013, J ECON PSYCHOL, V39, P21, DOI 10.1016/j.joep.2013.06.008; Tamir DI, 2010, P NATL ACAD SCI USA, V107, P10827, DOI 10.1073/pnas.1003242107; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tufano F, 2010, EXP ECON, V13, P1, DOI 10.1007/s10683-009-9226-8; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Tversky A., 1982, JUDGMENT UNCERTAINTY, P84, DOI DOI 10.1017/CBO9780511809477.007; Vecchiato G, 2011, MED BIOL ENG COMPUT, V49, P579, DOI 10.1007/s11517-011-0747-x; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2006, BRAIN BEHAV IMMUN, V20, P219, DOI 10.1016/j.bbi.2006.01.007; Weber B, 2007, NEUROIMAGE, V35, P441, DOI 10.1016/j.neuroimage.2006.11.034; Weymar M, 2013, CORTEX, V49, P819, DOI 10.1016/j.cortex.2012.02.012; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Wu CS, 2011, ELECTRON COMMER R A, V10, P358, DOI 10.1016/j.elerap.2011.01.002	87	7	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139954	10.1371/journal.pone.0139954	http://dx.doi.org/10.1371/journal.pone.0139954			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439926	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300085
J	Tallus, J; Soveri, A; Hamalainen, H; Tuomainen, J; Laine, M				Tallus, Jussi; Soveri, Anna; Hamalainen, Heikki; Tuomainen, Jyrki; Laine, Matti			Effects of Auditory Attention Training with the Dichotic Listening Task: Behavioural and Neurophysiological Evidence	PLOS ONE			English	Article							WORKING-MEMORY; COGNITIVE CONTROL; HEMISPHERIC-ASYMMETRY; EAR ADVANTAGE; SPEECH SOUNDS; OLDER-ADULTS; PLASTICITY; PERFORMANCE; COMPONENT; FMRI	Facilitation of general cognitive capacities such as executive functions through training has stirred considerable research interest during the last decade. Recently we demonstrated that training of auditory attention with forced attention dichotic listening not only facilitated that performance but also generalized to an untrained attentional task. In the present study, 13 participants underwent a 4-week dichotic listening training programme with instructions to report syllables presented to the left ear (FL training group). Another group (n = 13) was trained using the non-forced instruction, asked to report whichever syllable they heard the best (NF training group). The study aimed to replicate our previous behavioural results, and to explore the neurophysiological correlates of training through event-related brain potentials (ERPs). We partially replicated our previous behavioural training effects, as the FL training group tended to show more allocation of auditory spatial attention to the left ear in a standard dichotic listening task. ERP measures showed diminished N1 and enhanced P2 responses to dichotic stimuli after training in both groups, interpreted as improvement in early perceptual processing of the stimuli. Additionally, enhanced anterior N2 amplitudes were found after training, with relatively larger changes in the FL training group in the forced-left condition, suggesting improved top-down control on the trained task. These results show that top-down cognitive training can modulate the left-right allocation of auditory spatial attention, accompanied by a change in an evoked brain potential related to cognitive control.	[Tallus, Jussi; Hamalainen, Heikki] Univ Turku, Dept Psychol, Ctr Cognit Neurosci, Turku, Finland; [Tallus, Jussi; Hamalainen, Heikki] Univ Turku, Turku Brain & Mind Ctr, Turku, Finland; [Soveri, Anna; Laine, Matti] Abo Akad Univ, Dept Psychol, Turku, Finland; [Tuomainen, Jyrki] UCL, Fac Brain Sci, Div Psychol & Language Sci, London, England	University of Turku; University of Turku; Abo Akademi University; University of London; University College London	Tuomainen, J (corresponding author), UCL, Fac Brain Sci, Div Psychol & Language Sci, London, England.	j.tuomainen@ucl.ac.uk		Soveri, Anna/0000-0002-1443-6097	Finnish National Doctoral Programme of Psychology; Academy of Finland [135688]	Finnish National Doctoral Programme of Psychology; Academy of Finland(Academy of Finland)	AS was funded by the Finnish National Doctoral Programme of Psychology (http://www.dopsy.fi/). ML was financially supported by the Academy of Finland (grant number 135688) (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; ASBJORNSEN AE, 1995, BRAIN LANG, V49, P189, DOI 10.1006/brln.1995.1029; Bayazit O, 2009, NEUROPSYCHOLOGIA, V47, P536, DOI 10.1016/j.neuropsychologia.2008.10.002; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Chan SCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040215; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Dahlin E, 2008, SCIENCE, V320, P1510, DOI 10.1126/science.1155466; Dahlin E, 2008, PSYCHOL AGING, V23, P720, DOI 10.1037/a0014296; Eichele T, 2005, COGNITIVE BRAIN RES, V24, P405, DOI 10.1016/j.cogbrainres.2005.02.017; Eldar S, 2010, PSYCHOL MED, V40, P667, DOI 10.1017/S0033291709990766; Erickson KI, 2007, CEREB CORTEX, V17, P192, DOI 10.1093/cercor/bhj137; Falkenberg LE, 2011, BRAIN COGNITION, V76, P276, DOI 10.1016/j.bandc.2011.02.006; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jerger J, 2004, HEARING RES, V198, P125, DOI 10.1016/j.heares.2004.07.019; Kimura D., 1967, CORTEX, V3, P163, DOI DOI 10.1016/S0010-9452(67)80010-8; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; KNIGHT RT, 1980, ELECTROEN CLIN NEURO, V50, P112, DOI 10.1016/0013-4694(80)90328-4; Kompus K, 2012, BRAIN LANG, V121, P240, DOI 10.1016/j.bandl.2012.03.004; Kundu B, 2013, J NEUROSCI, V33, P8705, DOI 10.1523/JNEUROSCI.5565-12.2013; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; McCourt ME, 2001, NEUROPSYCHOLOGIA, V39, P1065, DOI 10.1016/S0028-3932(01)00044-6; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Millner AJ, 2012, NEUROIMAGE, V63, P742, DOI 10.1016/j.neuroimage.2012.07.032; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ross B, 2010, CEREB CORTEX, V20, P1360, DOI 10.1093/cercor/bhp201; Ross B, 2009, HEARING RES, V248, P48, DOI 10.1016/j.heares.2008.11.012; Sayala S, 2006, CEREB CORTEX, V16, P609, DOI 10.1093/cercor/bhj007; Sheehan KA, 2005, COGNITIVE BRAIN RES, V25, P547, DOI 10.1016/j.cogbrainres.2005.08.007; Soveri A, 2013, EXP PSYCHOL, V60, P44, DOI 10.1027/1618-3169/a000172; Takio F, 2011, DEV NEUROPSYCHOL, V36, P367, DOI 10.1080/87565641.2010.549984; Thomsen T, 2004, NEUROIMAGE, V22, P912, DOI 10.1016/j.neuroimage.2004.02.015; Tremblay KL, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00028; Voyer D, 2011, BRAIN COGNITION, V76, P245, DOI 10.1016/j.bandc.2011.02.001; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028; Wexler BE, 2000, AM J PSYCHIAT, V157, P1694, DOI 10.1176/appi.ajp.157.10.1694; Wild-Wall N, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/529057	48	22	22	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139318	10.1371/journal.pone.0139318	http://dx.doi.org/10.1371/journal.pone.0139318			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26439112	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300021
J	Coombes, B; Basu, S; Guha, S; Schork, N				Coombes, Brandon; Basu, Saonli; Guha, Sharmistha; Schork, Nicholas			Weighted Score Tests Implementing Model-Averaging Schemes in Detection of Rare Variants in Case-Control Studies	PLOS ONE			English	Article							MISSING HERITABILITY; ASSOCIATION; SELECTION; LINKAGE	Multi-locus effect modeling is a powerful approach for detection of genes influencing a complex disease. Especially for rare variants, we need to analyze multiple variants together to achieve adequate power for detection. In this paper, we propose several parsimonious branching model techniques to assess the joint effect of a group of rare variants in a case-control study. These models implement a data reduction strategy within a likelihood framework and use a weighted score test to assess the statistical significance of the effect of the group of variants on the disease. The primary advantage of the proposed approach is that it performs model-averaging over a substantially smaller set of models supported by the data and thus gains power to detect multi-locus effects. We illustrate these proposed approaches on simulated and real data and study their performance compared to several existing rare variant detection approaches. The primary goal of this paper is to assess if there is any gain in power to detect association by averaging over a number of models instead of selecting the best model. Extensive simulations and real data application demonstrate the advantage the proposed approach in presence of causal variants with opposite directional effects along with a moderate number of null variants in linkage disequilibrium.	[Coombes, Brandon; Basu, Saonli; Guha, Sharmistha] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Schork, Nicholas] J Craig Venter Inst, La Jolla, CA USA	University of Minnesota System; University of Minnesota Twin Cities; J. Craig Venter Institute	Basu, S (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA.	saonli@umn.edu	Coombes, Brandon/Y-1263-2019	Coombes, Brandon/0000-0003-4322-5923; Guha, Sharmistha/0000-0002-9335-0952; Basu, Saonli/0000-0003-1200-4546; Schork, Nicholas/0000-0003-0920-5013	National Institutes of Health [R01DA033958, T32GM108557]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM108557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (nih.gov), recipient: SB R01DA033958 and National Institutes of Health (nih.gov), recipient: Wei Pan T32GM108557. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimit JL, 2012, HUM HERED, V73, P84, DOI 10.1159/000336982; Bansal V, 2011, BIOCOMPUT-PAC SYM, P76; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Basu S, 2011, HUM HERED, V71, P234, DOI 10.1159/000328842; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Burnham K, 2002, MODEL SELECTION MULT, P20; Buzkova P, 2011, ANN HUM GENET, V75, P36, DOI 10.1111/j.1469-1809.2010.00572.x; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519; Hoffmann TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013584; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; LEWONTIN RC, 1964, GENETICS, V49, P49; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin DY, 2011, AM J HUM GENET, V89, P354, DOI [10.1016/j.ajhg.2011.07.015., 10.1016/j.ajhg.2011.07.015]; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; MADIGAN D, 1994, J AM STAT ASSOC, V89, P1535, DOI 10.2307/2291017; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Raftery AE, 1997, J AM STAT ASSOC, V92, P179, DOI 10.2307/2291462; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Sun JP, 2013, GENET EPIDEMIOL, V37, P334, DOI 10.1002/gepi.21717; Viallefont V, 2001, STAT MED, V20, P3215, DOI 10.1002/sim.976.abs; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang ZH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-155; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	33	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139355	10.1371/journal.pone.0139355	http://dx.doi.org/10.1371/journal.pone.0139355			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436424	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200017
J	Lin, WS; Huang, CW; Song, YS; Yen, JH; Kuo, PC; Yeh, SR; Lin, HY; Fu, TF; Wu, MS; Wang, HD; Wang, PY				Lin, Wei-Sheng; Huang, Cheng-Wen; Song, You-Sheng; Yen, Jui-Hung; Kuo, Ping-Chang; Yeh, Sheng-Rong; Lin, Hung-Yu; Fu, Tsai-Feng; Wu, Ming-Shiang; Wang, Horng-Dar; Wang, Pei-Yu			Reduced Gut Acidity Induces an Obese-Like Phenotype in Drosophila melanogaster and in Mice	PLOS ONE			English	Article							EXTENDED LIFE-SPAN; STRESS RESISTANCE; APOLIPOPROTEIN-D; FAT STORAGE; WEIGHT-GAIN; HOMEOSTASIS; LONGEVITY; INHIBITORS; MIDGUT; ULTRASTRUCTURE	In order to identify genes involved in stress and metabolic regulation, we carried out a Drosophila P-element-mediated mutagenesis screen for starvation resistance. We isolated a mutant, m2, that showed a 23% increase in survival time under starvation conditions. The P-element insertion was mapped to the region upstream of the vha16-1 gene, which encodes the c subunit of the vacuolar-type H+-ATPase. We found that vha16-1 is highly expressed in the fly midgut, and that m2 mutant flies are hypomorphic for vha16-1 and also exhibit reduced midgut acidity. This deficit is likely to induce altered metabolism and contribute to accelerated aging, since vha16-1 mutant flies are short-lived and display increases in body weight and lipid accumulation. Similar phenotypes were also induced by pharmacological treatment, through feeding normal flies and mice with a carbonic anhydrase inhibitor (acetazolamide) or proton pump inhibitor (PPI, lansoprazole) to suppress gut acid production. Our study may thus provide a useful model for investigating chronic acid suppression in patients.	[Lin, Wei-Sheng; Huang, Cheng-Wen; Yeh, Sheng-Rong; Wang, Pei-Yu] Natl Taiwan Univ, Grad Inst Brain & Mind Sci, Coll Med, Taipei 10764, Taiwan; [Song, You-Sheng] Natl Chengchi Univ, Inst Neurosci, Taipei 11623, Taiwan; [Yen, Jui-Hung; Kuo, Ping-Chang] Indiana Univ Sch Med, Dept Microbiol & Immunol, Ft Wayne, IN USA; [Fu, Tsai-Feng] Natl Chinan Univ, Dept Appl Chem, Nantou, Taiwan; [Wu, Ming-Shiang] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 10764, Taiwan; [Lin, Wei-Sheng] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Pediat, Yunlin, Taiwan; [Huang, Cheng-Wen; Lin, Hung-Yu; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Syst Neurosci, Hsinchu, Taiwan; [Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Taiwan University; National Chengchi University; Purdue University System; Indiana University Purdue University Fort Wayne; National Chi Nan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Wu, MS (corresponding author), Natl Taiwan Univ, Dept Internal Med, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan.	mingshiang@ntu.edu.tw; hdwang@life.nthu.edu.tw; wangpeiyu@ntu.edu.tw	Kuo, Ping-Chang/AAR-8920-2021; Yen, Jui-Hung/AAV-3455-2020; Lin, Wei-Sheng/AAV-9949-2020	Lin, Wei-Sheng/0000-0002-9016-2067; Yen, Jui-Hung Jimmy/0000-0002-7325-9756; WANG, PEI-YU/0000-0002-1792-8935; Wang, Horng-Dar/0000-0001-9570-3611; Fu, Tsai-Feng/0000-0002-0343-3018; Wu, Ming-Shiang/0000-0002-1940-6428	Ministry of Science and Technology (MOST) [102-2311-B-007-008-MY3]; National Taiwan University Hospital [UN102-029, UN103-055]; MOST [100-2311-B-002-017-MY3, 103-2321-B-002-093-]; National Taiwan University Hospital Yun-Lin branch [NTUHYL.103.S006]	Ministry of Science and Technology (MOST)(Ministry of Science and Technology, China); National Taiwan University Hospital(National Taiwan University); MOST; National Taiwan University Hospital Yun-Lin branch	This study was supported by grants from Ministry of Science and Technology (MOST, 102-2311-B-007-008-MY3) to Dr. Horng-Dar Wang, National Taiwan University Hospital (UN102-029 and UN103-055), MOST (100-2311-B-002-017-MY3 and 103-2321-B-002-093-) to Drs. Ming-Shiang Wu and Pei-Yu Wang, and National Taiwan University Hospital Yun-Lin branch (NTUHYL.103.S006) to Dr. Wei-Sheng Lin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canani RB, 2010, CURR OPIN GASTROEN, V26, P31, DOI 10.1097/MOG.0b013e328333d781; Chou HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058441; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Compare D, 2011, EUR J CLIN INVEST, V41, P380, DOI 10.1111/j.1365-2362.2010.02419.x; De Milito A, 2007, CANCER RES, V67, P5408, DOI 10.1158/0008-5472.CAN-06-4095; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Dubreuil RR, 1998, DEV BIOL, V194, P1, DOI 10.1006/dbio.1997.8821; Dubreuil RR, 2001, CELL TISSUE RES, V306, P167, DOI 10.1007/s004410100422; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; FILSHIE BK, 1971, TISSUE CELL, V3, P77, DOI 10.1016/S0040-8166(71)80033-2; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Huang CW, 2015, J GERONTOL A-BIOL, DOI [10.1093/gerona/glv094, DOI 10.1093/GERONA/GLV094]; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Lee KP, 2015, J INSECT PHYSIOL, V75, P12, DOI 10.1016/j.jinsphys.2015.02.007; Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034; Lin WS, 2014, AGE, V36, P689, DOI 10.1007/s11357-013-9606-z; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Phillips MD, 2006, J CELL SCI, V119, P1361, DOI 10.1242/jcs.02839; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; ROSE MR, 1992, EXP GERONTOL, V27, P241, DOI 10.1016/0531-5565(92)90048-5; Royet J, 2011, CELL MOL LIFE SCI, V68, P3651, DOI 10.1007/s00018-011-0828-x; Sanchez D, 2006, CURR BIOL, V16, P680, DOI 10.1016/j.cub.2006.03.024; Shanbhag S, 2009, J EXP BIOL, V212, P1731, DOI 10.1242/jeb.029306; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; Spugnini EP, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-221; Strasburger M, 1932, Z WISS ZOOL ABT A, V140, P539; Syu YF, 2015, OBES SURG, V25, P1071, DOI 10.1007/s11695-015-1659-x; Walker DW, 2006, CURR BIOL, V16, P674, DOI 10.1016/j.cub.2006.01.057; Wang HD, 2004, P NATL ACAD SCI USA, V101, P12610, DOI 10.1073/pnas.0404648101; Wang LF, 2014, J EXP BIOL, V217, P109, DOI 10.1242/jeb.089920; Wang PY, 2009, P NATL ACAD SCI USA, V106, P9262, DOI 10.1073/pnas.0904115106; Ward EK, 2014, OBES SURG, V24, P1567, DOI 10.1007/s11695-014-1275-1; WIECZOREK H, 1991, J BIOL CHEM, V266, P15340; Yoshikawa I, 2009, WORLD J GASTROENTERO, V15, P4794, DOI 10.3748/wjg.15.4794	36	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139722	10.1371/journal.pone.0139722	http://dx.doi.org/10.1371/journal.pone.0139722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436771	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200056
J	Longenecker, K; Bolick, H; Langston, R				Longenecker, Ken; Bolick, Holly; Langston, Ross			Estimating Sustainable Live-Coral Harvest at Kamiali Wildlife Management Area, Papua New Guinea	PLOS ONE			English	Article							REPRODUCTIVE PATTERNS; SEXUAL REPRODUCTION; RED-SEA; REEFS; RESOURCE; ISLAND; NUT	Live coral is harvested throughout the Indo-West Pacific to make lime, used in the consumption of the world's fourth-most consumed drug, betel nut. Coral harvesting is an environmental concern; however, because lime-making is one of the few sources of income in some areas of Papua New Guinea (PNG), the practice is unlikely to stop. To better manage coral harvest, we used standard fishery-yield methods to generate sustainable-harvest guidelines for corymbose Acropora species found on the reef flat and crest at Lababia, PNG. We constructed a yield curve (weight-specific net annual-dry-weight production) by: 1) describing the allometric relationship between colony size and dry weight, and using that relationship to estimate the dry weight of Acropora colonies in situ; 2) estimating annual growth of Acropora colonies by estimating in situ, and describing the relationship between, colony dry weight at the beginning and end of one year; and 3) conducting belt-transect surveys to describe weight-frequencies and ultimately to predict annual weight change per square meter for each weight class. Reef habitat covers a total 2,467,550 m(2) at Lababia and produces an estimated 248,397 kg/y (dry weight) of corymbose Acropora, of which 203,897 kg is produced on the reef flat/crest. We conservatively estimate that 30,706.6 kg of whole, dry, corymbose, Acropora can be sustainably harvested from the reef flat/crest habitat each year provided each culled colony weighs at least 1805 g when dry (or is at least 46 cm along its major axis). Artisanal lime-makers convert 24.8% of whole-colony weight into marketable lime, thus we estimate 7615.2 g of lime can be sustainably produced annually from corymbose Acropora. This value incorporates several safety margins, and should lead to proper management of live coral harvest. Importantly, the guideline recognizes village rights to exploit its marine resources, is consistent with village needs for income, and balances an equally strong village desire to conserve its marine resources for future generations.	[Longenecker, Ken; Bolick, Holly; Langston, Ross] Bernice P Bishop Museum, Dept Nat Sci, Honolulu, HI 96817 USA; [Langston, Ross] Windward Community Coll, Dept Nat Sci, Kaneohe, HI USA	University of Hawaii System	Longenecker, K (corresponding author), Bernice P Bishop Museum, Dept Nat Sci, Honolulu, HI 96817 USA.	klongenecker@bishopmuseum.org			private, US-based foundation	private, US-based foundation	This work was supported by a grant to KL from a private, US-based foundation wishing to remain anonymous. In-kind support was provided to KL by Hawaiian Airlines and the GeoEye Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley N., 1998, Traffic Bulletin, V17, P67; Boucher BJ, 2002, ADDICT BIOL, V7, P103, DOI 10.1080/13556210120091464; Carroll A, 2006, CORAL REEFS, V25, P93, DOI 10.1007/s00338-005-0057-6; Cesar H, 1997, AMBIO, V26, P345; Cesar H.S., 2000, COLLECTED ESSAYS EC, P14; Chu NS, 2002, ADDICT BIOL, V7, P111, DOI 10.1080/13556210120091473; Cinner JE, 2005, CONSERV BIOL, V19, P1469, DOI 10.1111/j.1523-1739.2005.004307.x; DULVY NK, 1995, AMBIO, V24, P358; Everhart WH, 1992, PRINCIPLES FISHERY S; Grigg R. W., 1976, UNIHISEAGRANTTR7703; Guest JR, 2004, THESIS NATL U SINGAP, P192; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; Guzman HM, 2003, CONSERV BIOL, V17, P1396, DOI 10.1046/j.1523-1739.2003.02308.x; Hanafy MH, 2010, CORAL REEFS, V29, P119, DOI 10.1007/s00338-009-0552-2; Harriott VJ, 2003, AMBIO, V32, P130, DOI 10.1639/0044-7447(2003)032[0130:CCBHS]2.0.CO;2; HAYASHIBARA T, 1993, MAR ECOL PROG SER, V101, P253, DOI 10.3354/meps101253; KOJIS BL, 1984, CORAL REEFS, V3, P165, DOI 10.1007/BF00301961; Longenecker K, 2013, 62 BIOSH MUS; Longenecker K, 2014, KAMBANG VIDEO; Mangubhai S, 2008, MAR ECOL PROG SER, V360, P85, DOI 10.3354/meps07385; National Fisheries Authority, 2007, SOC SURV SMALL SCAL; ohman M.C., 2000, COLLECTED ESSAYS EC, P85; Okubo N, 2009, ZOOL STUD, V48, P442; Oliver J, 1985, P 5 INT COR REEF S T, V5, P563; Oliver J.K., 1988, P 6 INT COR REEF S, V2, P803; Raj KD, 2010, INDIAN J MAR SCI, V39, P219; ROSS M A, 1984, Marine Ecology, V5, P75, DOI 10.1111/j.1439-0485.1984.tb00308.x; SHEPHERD ARD, 1992, ENVIRON BIOL FISH, V33, P367, DOI 10.1007/BF00010949; Shlesinger Y, 1998, MAR BIOL, V132, P691, DOI 10.1007/s002270050433; SHLESINGER Y, 1985, SCIENCE, V228, P1333, DOI 10.1126/science.228.4705.1333; Strickland SS, 2002, ADDICT BIOL, V7, P85, DOI 10.1080/13556210120091446; Wagner J, 1999, 24 AUSTR NAT U	32	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0140026	10.1371/journal.pone.0140026	http://dx.doi.org/10.1371/journal.pone.0140026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437445	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200070
J	Paiva, VH; Geraldes, P; Rodrigues, I; Melo, T; Melo, J; Ramos, JA				Paiva, Vitor H.; Geraldes, Pedro; Rodrigues, Isabel; Melo, Tommy; Melo, Jose; Ramos, Jaime A.			The Foraging Ecology of the Endangered Cape Verde Shearwater, a Sentinel Species for Marine Conservation off West Africa	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; TRANS-EQUATORIAL MIGRATION; CORYS SHEARWATERS; STABLE-ISOTOPES; PELAGIC SEABIRD; ROUND DISTRIBUTION; 1ST-PASSAGE TIME; NORTHWEST AFRICA; MAXIMUM-ENTROPY; HABITAT USE	Large Marine Ecosystems such as the Canary Current system off West Africa sustains high abundance of small pelagic prey, which attracts marine predators. Seabirds are top predators often used as biodiversity surrogates and sentinel species of the marine ecosystem health, thus frequently informing marine conservation planning. This study presents the first data on the spatial (GPS-loggers) and trophic (stable isotope analysis) ecology of a tropical seabird-the endangered Cape Verde shearwater Calonectris edwardsii-during both the incubation and the chick-rearing periods of two consecutive years. This information was related with marine environmental predictors (species distribution models), existent areas of conservation concern for seabirds (i.e. marine Important Bird Areas; marine IBAs) and threats to the marine environment in the West African areas heavily used by the shearwaters. There was an apparent inter-annual consistency on the spatial, foraging and trophic ecology of Cape Verde shearwater, but a strong alteration on the foraging strategies of adult breeders among breeding phases (i.e. from incubation to chick-rearing). During incubation, birds mostly targeted a discrete region off West Africa, known by its enhanced productivity profile and thus also highly exploited by international industrial fishery fleets. When chick-rearing, adults exploited the comparatively less productive tropical environment within the islands of Cape Verde, at relatively close distance from their breeding colony. The species enlarged its trophic niche and increased the trophic level of their prey from incubation to chick-rearing, likely to provision their chicks with a more diversified and better quality diet. There was a high overlap between the Cape Verde shearwaters foraging areas with those of European shearwater species that overwinter in this area and known areas of megafauna bycatch off West Africa, but very little overlap with existing Marine Important Bird Areas. Further investigation on the potential nefarious effects of fisheries on seabird communities exploiting the Canary Current system off West Africa is needed. Such negative effects could be alleviated or even dissipated if the 'fisheries-conservation hotspots' identified for the region, would be legislated as Marine Protected Areas.	[Paiva, Vitor H.; Ramos, Jaime A.] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, Coimbra, Portugal; [Geraldes, Pedro] SPEA, Lisbon, Portugal; [Rodrigues, Isabel; Melo, Tommy; Melo, Jose] Biosfera I, Mindelo, Sao Vicente, Cape Verde	Universidade de Coimbra	Paiva, VH (corresponding author), Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, Coimbra, Portugal.	vitorpaiva@ci.uc.pt	Paiva, Vitor Hugo/GRX-9179-2022; Ramos, Jaime/B-6616-2018; Paiva, Vitor H./J-1092-2019	Ramos, Jaime/0000-0002-9533-987X; Paiva, Vitor H./0000-0001-6368-9579; Pinho e Melo, Teresa/0000-0002-0375-0101	Fundacao para a Ciencia e Tecnologia [SFRH/BPD/85024/2012]; Critical Ecosystem Partnership Fund [61459]; FIBA (Fondation Internacional du Banq d'Arguin)	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Critical Ecosystem Partnership Fund; FIBA (Fondation Internacional du Banq d'Arguin)	VHP received a postdoctoral grant given by 'Fundacao para a Ciencia e Tecnologia' (SFRH/BPD/85024/2012). This work was logistically supported by the project "Protecting Threatened and Endemic species in Cape Verde" coordinated by SPEA in partnership with RSPB and Biosfera I, and funded by the Critical Ecosystem Partnership Fund (project 61459). Local travel and equipment were also supported by the project Alcyon funded by FIBA (Fondation Internacional du Banq d'Arguin).	Afan I, 2014, MAR BIOL, V161, P657, DOI 10.1007/s00227-013-2368-4; Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; Alonso H, 2012, MAR BIOL, V159, P1197, DOI 10.1007/s00227-012-1900-2; [Anonymous], 2014, R LANG ENV STAT COMP; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bates D., 2013, LME4 MIXED EFFECTS M; Belhabib D, 2014, FISH RES, V151, P1, DOI 10.1016/j.fishres.2013.12.006; BirdLifeInternational, 2015, CAL EDW IUCN RED LIS; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bugoni L, 2008, FISH RES, V90, P217, DOI 10.1016/j.fishres.2007.10.013; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Camphuysen CJ, 2005, AFR J MAR SCI, V27, P427, DOI 10.2989/18142320509504101; Catry P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026079; CHAURAND T, 1994, J ANIM ECOL, V63, P275, DOI 10.2307/5546; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cressey D, 2015, NATURE, V519, P280, DOI 10.1038/519280a; Dias MP, 2011, P ROY SOC B-BIOL SCI, V278, P1786, DOI 10.1098/rspb.2010.2114; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fauchald P, 1999, AM NAT, V153, P603, DOI 10.1086/303203; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Barcelona SG, 2010, AQUAT LIVING RESOUR, V23, P363, DOI 10.1051/alr/2010022; Gilg O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064614; Gonzalez-Solis J, 2007, FRONT ECOL ENVIRON, V5, P297, DOI 10.1890/1540-9295(2007)5[297:TMAMIT]2.0.CO;2; Gonzalez-Solis J, 2009, MAR ECOL PROG SER, V391, P221, DOI 10.3354/meps08128; Granadeiro JP, 2000, BEHAV ECOL, V11, P274, DOI 10.1093/beheco/11.3.274; Gremillet D, 2008, J APPL ECOLOGY; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Gremillet D, 2015, BIOL CONSERV, V182, P143, DOI 10.1016/j.biocon.2014.12.001; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Hyrenbach KD, 2007, DEEP-SEA RES PT I, V54, P1129, DOI 10.1016/j.dsr.2007.05.002; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kaczynski VM, 2002, MAR POLICY, V26, P75, DOI 10.1016/S0308-597X(01)00039-2; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Karpouzi VS, 2007, MAR ECOL PROG SER, V343, P87, DOI 10.3354/meps06860; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Louzao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035728; Roscales JL, 2011, MAR ECOL PROG SER, V434, P1, DOI 10.3354/meps09211; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Marr Tony, 1998, Bulletin of the African Bird Club, V5, P22; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; Navarro J, 2013, DEEP SEA RES 2, P1, DOI 10.1016/j.dsr2.2013.01.031; Oliveira N, 2015, GLOB ECOL CONSERV, V3, P51, DOI 10.1016/j.gecco.2014.11.006; Paiva VH, 2013, MAR ECOL PROG SER, V477, P15, DOI 10.3354/meps10180; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Pauly D, 2014, FISH FISH, V15, P474, DOI 10.1111/faf.12032; Pena-Izquierdo J, 2012, SCI MAR, V76, P65, DOI 10.3989/scimar.03607.18C; Peron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072713; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; Ramos JA, 2015, DEEP-SEA RES PT I, V104, P60, DOI 10.1016/j.dsr.2015.07.001; Ramos R, 2013, DIVERS DISTRIB, V19, P1284, DOI 10.1111/ddi.12088; Ramos R, 2009, OECOLOGIA, V160, P97, DOI 10.1007/s00442-008-1273-x; Ramos R, 2013, NATURE, V496, P300, DOI 10.1038/496300a; Rodrigues I., 2014, ECOLOGIA TROFICA ALI; Roscales JL, 2010, ENVIRON SCI TECHNOL, V44, P2328, DOI 10.1021/es902994y; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; ter Hofstede R, 2006, FISH RES, V77, P184, DOI 10.1016/j.fishres.2005.08.012; Torres LG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120014; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Warham J., 1996, BEHAV POPULATION BIO; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Weimerskirch H, 2007, DOES PREY CAPTURE IN; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Worm B, 2012, TRENDS ECOL EVOL, V27, P594, DOI 10.1016/j.tree.2012.07.005; Zeeberg J, 2006, FISH RES, V78, P186, DOI 10.1016/j.fishres.2006.01.012; Zino F., 2011, BIRDING WORLD, V24, P216; Zollner PA, 1999, ECOLOGY, V80, P1019, DOI 10.2307/177035; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	80	20	20	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139390	10.1371/journal.pone.0139390	http://dx.doi.org/10.1371/journal.pone.0139390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436804	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200020
J	Sun, L; Liu, H; Zhang, L; Meng, J				Sun, Lei; Liu, Hui; Zhang, Lin; Meng, Jia			lncRScan-SVM: A Tool for Predicting Long Non-Coding RNAs Using Support Vector Machine	PLOS ONE			English	Article							PROTEIN; TRANSCRIPTS; ANNOTATION; REVEALS; IDENTIFICATION; EVOLUTION; GENOMICS; GENCODE	Functional long non-coding RNAs (lncRNAs) have been bringing novel insight into biological study, however it is still not trivial to accurately distinguish the lncRNA transcripts (LNCTs) from the protein coding ones (PCTs). As various information and data about lncRNAs are preserved by previous studies, it is appealing to develop novel methods to identify the lncRNAs more accurately. Our method lncRScan-SVM aims at classifying PCTs and LNCTs using support vector machine (SVM). The gold-standard datasets for lncRScan-SVM model training, lncRNA prediction and method comparison were constructed according to the GENCODE gene annotations of human and mouse respectively. By integrating features derived from gene structure, transcript sequence, potential codon sequence and conservation, lncRScan-SVM outperforms other approaches, which is evaluated by several criteria such as sensitivity, specificity, accuracy, Matthews correlation coefficient (MCC) and area under curve (AUC). In addition, several known human lncRNA datasets were assessed using lncRScan-SVM. LncRScan-SVM is an efficient tool for predicting the lncRNAs, and it is quite useful for current lncRNA study.	[Sun, Lei] Yangzhou Univ, Sch Informat Engn, Yangzhou, Jiangsu, Peoples R China; [Sun, Lei] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Liu, Hui; Zhang, Lin] China Univ Min & Technol, Sch Informat & Elect Engn, Xuzhou, Jiangsu, Peoples R China; [Meng, Jia] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; China University of Mining & Technology; Xi'an Jiaotong-Liverpool University	Sun, L (corresponding author), Yangzhou Univ, Sch Informat Engn, Yangzhou, Jiangsu, Peoples R China.	leisuncumt@yahoo.com		Meng, Jia/0000-0003-3455-205X	National Natural Science Foundation of China [61301220, 61201408, 61401370]; China Fundamental Research Funds for the Central Universities [2014QNA84, 2014QNB47]; Jiangsu Natural Science Foundation [BK20140403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Natural Science Foundation(Natural Science Foundation of Jiangsu Province)	This work was supported by National Natural Science Foundation of China (61301220 to LS, 61201408 to HL, 61401370 to JM), http://www.nsfc.gov.cn/; China Fundamental Research Funds for the Central Universities (2014QNA84 to HL, 2014QNB47 to LZ), http://www.moe.edu.cn/; and Jiangsu Natural Science Foundation (BK20140403 to JM), http://www.jstd.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Dominguez JR, 2014, BLOOD, V123, P570, DOI 10.1182/blood-2013-10-530683; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu JF, 2006, PLOS GENET, V2, P529, DOI 10.1371/journal.pgen.0020029; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Panwar B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-127; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sanchez Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6812; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt006; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222	33	71	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139654	10.1371/journal.pone.0139654	http://dx.doi.org/10.1371/journal.pone.0139654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437338	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200042
J	Sager, M; Benten, WPM; Engelhardt, E; Gougoula, C; Benga, L				Sager, Martin; Benten, W. Peter M.; Engelhardt, Eva; Gougoula, Christina; Benga, Laurentiu			Characterization of Biofilm Formation in [Pasteurella] pneumotropica and [Actinobacillus] muris Isolates of Mouse Origin	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; STAPHYLOCOCCUS-AUREUS; PHYLOGENETIC ANALYSIS; STREPTOCOCCUS-SUIS; EXTRACELLULAR DNA; ESCHERICHIA-COLI; IMMUNE-RESPONSE; IN-VITRO; STRAINS; MICE	[Pasteurella] pneumotropica biotypes Jawetz and Heyl and [Actinobacillus] muris are the most prevalent Pasteurellaceae species isolated from laboratory mouse. However, mechanisms contributing to their high prevalence such as the ability to form biofilms have not been studied yet. In the present investigation we analyze if these bacterial species can produce biofilms in vitro and investigate whether proteins, extracellular DNA and polysaccharides are involved in the biofilm formation and structure by inhibition and dispersal assays using proteinase K, DNase I and sodium periodate. Finally, the capacity of the biofilms to confer resistance to antibiotics is examined. We demonstrate that both [P.] pneumotropica biotypes but not [A.] muris are able to form robust biofilms in vitro, a phenotype which is widely spread among the field isolates. The biofilm inhibition and dispersal assays by proteinase and DNase lead to a strong inhibition in biofilm formation when added at the initiation of the biofilm formation and dispersed pre-formed [P.] pneumotropica biofilms, revealing thus that proteins and extracellular DNA are essential in biofilm formation and structure. Sodium periodate inhibited the bacterial growth when added at the beginning of the biofilm formation assay, making difficult the assessment of the role of beta-1,6-linked polysaccharides in the biofilm formation, and had a biofilm stimulating effect when added on pre-established mature biofilms of [P.] pneumotropica biotype Heyl and a majority of [P.] pneumotropica biotype Jawetz strains, suggesting that the presence of beta-1,6-linked polysaccharides on the bacterial surface might attenuate the biofilm production. Conversely, no effect or a decrease in the biofilm quantity was observed by biofilm dispersal using sodium periodate on further biotype Jawetz isolates, suggesting that polysaccharides might be incorporated in the biofilm structure. We additionally show that [P.] pneumotropica cells enclosed in biofilms were less sensitive to treatment with amoxicillin and enrofloxacin than planktonic bacteria. Taken together, these findings provide a first step in understanding of the biofilm mechanisms in [P.] pneumotropica, which might contribute to elucidation of colonization and pathogenesis mechanisms for these obligate inhabitants of the mouse mucosa.	[Sager, Martin; Benten, W. Peter M.; Engelhardt, Eva; Gougoula, Christina; Benga, Laurentiu] Univ Dusseldorf, Univ Hosp, Cent Anim Res Facil, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Benga, L (corresponding author), Univ Dusseldorf, Univ Hosp, Cent Anim Res Facil, Dusseldorf, Germany.	Laurentiu.Benga@med.uni-duesseldorf.de	Benga, Laurentiu/X-9301-2019					Artwohl JE, 2000, CONTEMP TOP LAB ANIM, V39, P39; Auger E, 2009, INFECT IMMUN, V77, P1426, DOI 10.1128/IAI.00297-08; Bello-Orti B, 2014, VET RES, V45, DOI 10.1186/s13567-014-0104-9; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Benga L, 2015, BERL MUNCH TIERARZTL, V128, P278, DOI 10.2376/0005-9366-128-278; Benga L, 2013, J MICROBIOL METH, V95, P256, DOI 10.1016/j.mimet.2013.09.005; Benga L, 2013, J MICROBIOL METH, V94, P88, DOI 10.1016/j.mimet.2013.05.002; Benga L, 2012, J MICROBIOL METH, V90, P342, DOI 10.1016/j.mimet.2012.06.013; BISGAARD M, 1986, ACTA PATH MICRO IM B, V94, P1; Cerca N, 2005, J ANTIMICROB CHEMOTH, V56, P331, DOI 10.1093/jac/dki217; Christensen H, 2003, J APPL MICROBIOL, V95, P354, DOI 10.1046/j.1365-2672.2003.01986.x; Clutterbuck AL, 2007, VET MICROBIOL, V121, P1, DOI 10.1016/j.vetmic.2006.12.029; Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018; CUADRADOGOMEZ JM, 1995, CLIN INFECT DIS, V21, P445, DOI 10.1093/clinids/21.2.445; D'Urzo N, 2014, APPL ENVIRON MICROB, V80, P2176, DOI 10.1128/AEM.03627-13; Dole VS, 2010, COMPARATIVE MED, V60, P427; Foreman O, 2011, VET PATHOL, V48, P495, DOI 10.1177/0300985810378282; Frebourg NB, 2002, J CLIN MICROBIOL, V40, P687, DOI 10.1128/JCM.40.2.687-689.2002; Fredheim EGA, 2009, J CLIN MICROBIOL, V47, P1172, DOI 10.1128/JCM.01891-08; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Grenier D, 2009, VET J, V179, P292, DOI 10.1016/j.tvjl.2007.09.005; Hart ML, 2003, INFECT IMMUN, V71, P663, DOI 10.1128/IAI.71.2.663-670.2003; Hayashimoto N, 2005, CURR MICROBIOL, V51, P239, DOI 10.1007/s00284-005-4541-6; Hayashimoto N, 2006, EXP ANIM TOKYO, V55, P487, DOI 10.1538/expanim.55.487; HEYL JG, 1963, ANTON VAN LEE J M S, V29, P79, DOI 10.1007/BF02046040; Hu QH, 2010, VET MICROBIOL, V144, P429, DOI 10.1016/j.vetmic.2010.02.023; Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004; Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07; Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004; JAWETZ E, 1950, J INFECT DIS, V86, P172, DOI 10.1093/infdis/86.2.172; Jin H, 2006, VET MICROBIOL, V118, P117, DOI 10.1016/j.vetmic.2006.07.009; Kaplan JB, 2004, J BACTERIOL, V186, P8213, DOI 10.1128/JB.186.24.8213-8220.2004; Kaplan JB, 2005, VET MICROBIOL, V108, P89, DOI 10.1016/j.vetmic.2005.02.011; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; Karwacki MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063844; Kawai T, 2007, ORAL MICROBIOL IMMUN, V22, P208, DOI 10.1111/j.1399-302X.2007.00348.x; Kawamoto E, 2007, LAB ANIM-UK, V41, P285, DOI 10.1258/002367707780378087; Labrie J, 2010, VET RES, V41, DOI 10.1051/vetres/2009051; Lasa I, 2006, RES MICROBIOL, V157, P99, DOI 10.1016/j.resmic.2005.11.003; Macy JD, 2000, COMPARATIVE MED, V50, P49; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051; Murphy TF, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-7; Mutters R CH, 2005, GENUS 1 PASTEURELLA; Nicholson TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073376; Olson ME, 2002, CAN J VET RES, V66, P86; Patten CC, 2010, COMPARATIVE MED, V60, P18; Sahagun-Ruiz A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111194; Sandal I, 2007, J BACTERIOL, V189, P8179, DOI 10.1128/JB.00479-07; Sasaki H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00771-14; Sasaki H, 2013, VACCINE, V31, P5729, DOI 10.1016/j.vaccine.2013.09.033; Sasaki H, 2009, J BACTERIOL, V191, P3698, DOI 10.1128/JB.01527-08; See SB, 2013, MICROBES INFECT, V15, P470, DOI 10.1016/j.micinf.2013.04.003; Shukla SK, 2013, J ANTIBIOT, V66, P55, DOI 10.1038/ja.2012.98; Silva MJB, 2012, J ENDODONT, V38, P346, DOI 10.1016/j.joen.2011.12.029; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Towne JW, 2014, J AM ASSOC LAB ANIM, V53, P517; Ueno Y, 2002, EXP ANIM TOKYO, V51, P401, DOI 10.1538/expanim.51.401; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Yun YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113466	60	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138778	10.1371/journal.pone.0138778	http://dx.doi.org/10.1371/journal.pone.0138778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430880	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700018
J	Thai, C; Lim, YY; Villemagne, VL; Laws, SM; Ames, D; Ellis, KA; Rainey-Smith, SR; Martins, RN; Masters, CL; Rowe, CC; Maruff, P				Thai, Christine; Lim, Yen Ying; Villemagne, Victor L.; Laws, Simon M.; Ames, David; Ellis, Kathryn A.; Rainey-Smith, Stephanie R.; Martins, Ralph N.; Masters, Colin L.; Rowe, Christopher C.; Maruff, Paul		AIBL Res Grp	Amyloid-Related Memory Decline in Preclinical Alzheimer's Disease Is Dependent on APOE epsilon 4 and Is Detectable over 18-Months	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; BETA-PEPTIDE DEPOSITION; COGNITIVE-DECLINE; A-BETA; MITOCHONDRIAL ACTIVITY; LIFE-STYLE; E4; NEURODEGENERATION; BIOMARKERS; OLIGOMERIZATION	High levels of beta-amyloid (A beta) in the brain and carriage of the APOE epsilon 4 allele have each been linked to cognitive impairment in cognitively normal (CN) older adults. However, the relationship between these two biomarkers and cognitive decline is unclear. The aim of this study was to investigate the relationship between cerebral A beta level, APOE epsilon 4 carrier status, and cognitive decline over 18 months, in 317 cognitively healthy (CN) older adults (47.6% males, 52.4% females) aged between 60 and 89 years (Mean = 69.9, SD = 6.8). Cognition was assessed using the Cogstate Brief Battery (CBB) and the California Verbal Learning Test, Second Edition (CVLT-II). Planned comparisons indicated that CN older adults with high A beta who were also APOE epsilon 4 carriers demonstrated the most pronounced decline in learning and working memory. In CN older adults who were APOE epsilon 4 non-carriers, high A beta was unrelated to cognitive decline in learning and working memory. Carriage of APOE epsilon 4 in CN older adults with low A beta was associated with a significantly increased rate of decline in learning and unexpectedly, improved cognitive performance on measures of verbal episodic memory over 18 months. These results suggest that A beta and APOE epsilon 4 interact to increase the rate of cognitive decline in CN older adults and provide further support for the use of A beta and APOE epsilon 4 as biomarkers of early Alzheimer's disease.	[Thai, Christine] RMIT Univ, Dept Psychol, Melbourne, Vic, Australia; [Lim, Yen Ying; Villemagne, Victor L.; Ellis, Kathryn A.; Masters, Colin L.; Maruff, Paul] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Lim, Yen Ying] Brown Univ, Dept Neurol, Warren Alpert Sch Med, Providence, RI 02912 USA; [Lim, Yen Ying] Rhode Isl Hosp, Dept Neurol, Providence, RI USA; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Dept Nucl Med, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Austin Hlth, Ctr PET, Heidelberg, Vic, Australia; [Villemagne, Victor L.; Rowe, Christopher C.] Univ Melbourne, Austin Hlth, Dept Med, Heidelberg, Vic, Australia; [Laws, Simon M.; Rainey-Smith, Stephanie R.; Martins, Ralph N.] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA, Australia; [Laws, Simon M.; Rainey-Smith, Stephanie R.; Martins, Ralph N.] Hollywood Private Hosp, Sir James McCusker Alzheimers Dis Res Unit, Perth, WA, Australia; [Laws, Simon M.] Cooperat Res Ctr Mental Hlth, Perth, WA, Australia; [Ames, David; Ellis, Kathryn A.] Univ Melbourne, Acad Unit Psychiat Old Age, St Vincents Hlth, Kew, Vic, Australia; [Ames, David; Ellis, Kathryn A.] Natl Ageing Res Inst, Parkville, Vic, Australia; [Maruff, Paul] Cogstate Ltd, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); Florey Institute of Neuroscience & Mental Health; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Edith Cowan University; University of Western Australia; University of Melbourne; National Ageing Research Institute; CogState Limited	Lim, YY (corresponding author), Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	yen.lim@florey.edu.au	Rowe, Christopher/AAX-8748-2021; Maruff, Paul/AAD-2454-2021; Maruff, Paul/ABA-1673-2020; Salvado, Olivier/C-8910-2009; Laws, Simon/C-2858-2014; Yates, Paul/AAA-1060-2021; Duesing, Konsta/H-2802-2013; Villemagne, Victor/AAC-5406-2019	Maruff, Paul/0000-0002-6947-9537; Salvado, Olivier/0000-0002-2720-8739; Laws, Simon/0000-0002-4355-7082; Yates, Paul/0000-0001-9317-0145; Duesing, Konsta/0000-0003-3103-0600; Villemagne, Victor/0000-0002-5832-9875; Lautenschlager, Nicola/0000-0003-4850-7794; Rainey-Smith, Stephanie/0000-0001-7328-9624; Ellis, Kathryn/0000-0001-9097-9037; LoGiudice, Dina/0000-0002-0391-3898; Martins, Ralph/0000-0002-4828-9363; Fowler, Christopher/0000-0003-1397-0359; Masters, Colin/0000-0003-3072-7940; Lim, Yen Ying/0000-0002-0308-5156; Hone, Eugene/0000-0001-6708-3718	Commonwealth Scientific Industrial and Research Organization (CSIRO); Edith Cowan University (ECU); Mental Health Research institute (MHRI); National Ageing Research Institute (NARI); Austin Health; CogState Ltd.; National Health and Medical Research Council (NHMRC); Dementia Collaborative Research Centres program (DCRC2); Science and Industry Endowment Fund (SIEF); Cooperative Research Centre for Mental Health (CRCMH)	Commonwealth Scientific Industrial and Research Organization (CSIRO); Edith Cowan University (ECU); Mental Health Research institute (MHRI); National Ageing Research Institute (NARI); Austin Health; CogState Ltd.(CogState Limited); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centres program (DCRC2)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Science and Industry Endowment Fund (SIEF); Cooperative Research Centre for Mental Health (CRCMH)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding for the study was provided in part by the study partners [Commonwealth Scientific Industrial and Research Organization (CSIRO), Edith Cowan University (ECU), Mental Health Research institute (MHRI), National Ageing Research Institute (NARI), Austin Health, CogState Ltd.]. The study also received support from the National Health and Medical Research Council (NHMRC) and the Dementia Collaborative Research Centres program (DCRC2), as well as funding from the Science and Industry Endowment Fund (SIEF) and the Cooperative Research Centre for Mental Health (CRCMH). The funders of this study provided support in the form of salaries for Dr. Victor Villemagne, Dr. Simon Laws, Dr. David Ames, Dr. Kathryn Ellis, Dr. Ralph Martins, Dr. Colin Masters, Dr. Christopher Rowe, and Dr. Paul Maruff, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the 'authors contributions' section.	Belinson H, 2010, J ALZHEIMERS DIS, V22, P959, DOI 10.3233/JAD-2010-101008; Caselli RJ, 2014, ALZHEIMERS DEMENT, V10, P84, DOI 10.1016/j.jalz.2013.01.004; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chetelat G, 2010, ANN NEUROL, V67, P317, DOI 10.1002/ana.21955; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Doraiswamy PM, 2012, NEUROLOGY, V79, P1636, DOI 10.1212/WNL.0b013e3182661f74; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN; Jagust WJ, 2012, J NEUROSCI, V32, P18227, DOI 10.1523/JNEUROSCI.3266-12.2012; Ji ZS, 2006, J BIOL CHEM, V281, P2683, DOI 10.1074/jbc.M506646200; Ji ZS, 2002, J BIOL CHEM, V277, P21821, DOI 10.1074/jbc.M112109200; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kanekiyo T, 2014, NEURON, V81, P740, DOI 10.1016/j.neuron.2014.01.045; Landau SM, 2012, ANN NEUROL, V72, P578, DOI 10.1002/ana.23650; Lim YY, 2015, MOL PSYCHIATR, V20, P1322, DOI 10.1038/mp.2014.123; Lim YY, 2015, NEUROBIOL AGING, V36, P1239, DOI 10.1016/j.neurobiolaging.2014.12.008; Lim YY, 2014, ALZHEIMERS DEMENT, V10, P743, DOI 10.1016/j.jalz.2013.11.005; Lim YY, 2014, BRAIN, V137, P221, DOI 10.1093/brain/awt286; Lim YY, 2012, NEUROLOGY, V79, P1645, DOI 10.1212/WNL.0b013e31826e9ae6; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Mormino EC, 2014, NEUROLOGY, V82, P1760, DOI 10.1212/WNL.0000000000000431; Rowe CC, 2013, ANN NEUROL, V74, P905, DOI 10.1002/ana.24040; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Small BJ, 1998, PSYCHOL AGING, V13, P80, DOI 10.1037/0882-7974.13.1.80; Small BJ, 2004, PSYCHOL AGING, V19, P592, DOI 10.1037/0882-7974.19.4.592; Storandt M, 2009, ARCH NEUROL-CHICAGO, V66, P1476, DOI 10.1001/archneurol.2009.272; Valla J, 2006, MITOCHONDRION, V6, P323, DOI 10.1016/j.mito.2006.10.004; Valla J, 2010, J ALZHEIMERS DIS, V22, P307, DOI 10.3233/JAD-2010-100129; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Villemagne VL, 2013, LANCET NEUROL, V12, P357, DOI 10.1016/S1474-4422(13)70044-9; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248	36	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139082	10.1371/journal.pone.0139082	http://dx.doi.org/10.1371/journal.pone.0139082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430784	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700031
J	Tsai, HJ; Huang, SS; Tsou, MT; Wang, HT; Chiu, JH				Tsai, Hsin-Ju; Huang, Shiang-Suo; Tsou, Meng-Ting; Wang, Hsiao-Ting; Chiu, Jen-Hwey			Role of Opioid Receptors Signaling in Remote Electrostimulation - Induced Protection against Ischemia/Reperfusion Injury in Rat Hearts	PLOS ONE			English	Article							MEDIAN NERVE-STIMULATION; ACUTE CORONARY SYNDROMES; INDUCED CARDIOPROTECTION; ISCHEMIA-REPERFUSION; ACTIVATION; ELECTROACUPUNCTURE; PHOSPHORYLATION; ACUPUNCTURE; INVOLVEMENT; MECHANISMS	Aims Our previous studies demonstrated that remote electro-stimulation (RES) increased myocardial GSK3 phosphorylation and attenuated ischemia/reperfusion (I/R) injury in rat hearts. However, the role of various opioid receptors (OR) subtypes in preconditioned RES-induced myocardial protection remains unknown. We investigated the role of OR subtype signaling in RES-induced cardioprotection against I/R injury of the rat heart. Methods & Results Male Spraque-Dawley rats were used. RES was performed on median nerves area with/without pretreatment with various receptors antagonists such as opioid receptor (OR) subtype receptors (KOR, DOR, and MOR). The expressions of Akt, GSK3, and PKCe expression were analyzed by Western blotting. When RES was preconditioned before the I/R model, the rat's hemodynamic index, infarction size, mortality and serum CK-MB were evaluated. Our results showed that Akt, GSK3 and PKCe expression levels were significantly increased in the RES group compared to the sham group, which were blocked by pretreatment with specific antagonists targeting KOR and DOR, but not MOR subtype. Using the I/R model, the duration of arrhythmia and infarct size were both significantly attenuated in RES group. The mortality rates of the sham RES group, the RES group, RES group + KOR antagonist, RES group + DOR/MOR antagonists (KOR left), RES group + DOR antagonist, and RES group + KOR/MOR antagonists (DOR left) were 50%, 20%, 67%, 13%, 50% and 55%, respectively. Conclusion The mechanism of RES-induced myocardial protection against I/R injury seems to involve multiple target pathways such as Akt, KOR and/or DOR signaling.	[Tsai, Hsin-Ju; Chiu, Jen-Hwey] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Huang, Shiang-Suo; Wang, Hsiao-Ting] Chung Shan Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tsou, Meng-Ting] Mackay Mem Hosp, Dept Family Med, Taipei, Taiwan; [Chiu, Jen-Hwey] Taipei Vet Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Chiu, Jen-Hwey] Cheng Hsin Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chung Shan Medical University; Mackay Memorial Hospital; Taipei Veterans General Hospital; Cheng Hsin General Hospital	Chiu, JH (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	chiujh@mailsrv.ym.edu.tw			Ministry of Science and Technology [NSC 101-2320-B-010-051 -MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	JHC was supported by grants from Ministry of Science and Technology (NSC 101-2320-B-010-051 -MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; BLASZCZYK J, 1994, EXP NEPHROL, V2, P364; Boren J, 2014, CLIN CHIM ACTA, V431, P131, DOI 10.1016/j.cca.2014.01.015; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brook RD, 2013, HYPERTENSION, V61, P1360, DOI 10.1161/HYP.0b013e318293645f; Chiara F, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00016; Chiu JH, 2012, LIFE SCI, V90, P629, DOI 10.1016/j.lfs.2012.02.007; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Fang SD, 2013, NEUROCHEM RES, V38, P2305, DOI 10.1007/s11064-013-1139-4; Giricz Z, 2014, J MOL CELL CARDIOL, V68, P75, DOI 10.1016/j.yjmcc.2014.01.004; Gross ER, 2007, BASIC RES CARDIOL, V102, P341, DOI 10.1007/s00395-007-0651-6; Gross GJ, 2012, J CARDIOVASC PHARM, V59, P194, DOI 10.1097/FJC.0b013e318241e8c7; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; Huang SS, 2005, CLIN BIOCHEM, V38, P943, DOI 10.1016/j.clinbiochem.2005.07.003; Ishii H, 2014, CURRENT PHARM DESIGN; Kaladchibachi Sevag A, 2007, J Circadian Rhythms, V5, P3, DOI 10.1186/1740-3391-5-3; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li P, 1998, CIRCULATION, V97, P1186, DOI 10.1161/01.CIR.97.12.1186; Li P, 2010, AUTON NEUROSCI-BASIC, V157, P24, DOI 10.1016/j.autneu.2010.03.015; Liang J, 2006, PEPTIDES, V27, P3307, DOI 10.1016/j.peptides.2006.08.011; Liao PH, 2011, CIRC J, V75, P443, DOI 10.1253/circj.CJ-10-0381; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lichtenauer M, 2011, BASIC RES CARDIOL, V106, P1283, DOI 10.1007/s00395-011-0224-6; Lin JJ, 2013, CYTOKINE, V61, P842, DOI 10.1016/j.cyto.2013.01.002; Ma T, 2014, J ALZHEIMERS DIS, V39, P707, DOI 10.3233/JAD-131661; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Miki T, 1998, MOL CELL BIOCHEM, V186, P3, DOI 10.1023/A:1006856124501; Minagawa M, 2013, AUTON NEUROSCI-BASIC, V179, P151, DOI 10.1016/j.autneu.2013.03.005; Peart JN, 2008, BASIC RES CARDIOL, V103, P454, DOI 10.1007/s00395-008-0726-z; Pyle WG, 2001, AM J PHYSIOL-HEART C, V281, pH669, DOI 10.1152/ajpheart.2001.281.2.H669; Rodrigo R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/437613; Sayols-Baixeras S, 2014, APPL CLIN GENET, V7, P15, DOI 10.2147/TACG.S35301; Schultz JE, 1998, CIRCULATION, V97, P1282, DOI 10.1161/01.CIR.97.13.1282; SCHULTZ JEJ, 1995, AM J PHYSIOL-HEART C, V268, pH2157, DOI 10.1152/ajpheart.1995.268.5.H2157; Siraskar B, 2011, PFLUG ARCH EUR J PHY, V462, P811, DOI 10.1007/s00424-011-1006-6; Sobanski P, 2014, HEART VESSELS, V29, P855, DOI 10.1007/s00380-013-0456-5; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Surendra H, 2013, J MOL CELL CARDIOL, V60, P142, DOI 10.1016/j.yjmcc.2013.04.010; Tanaka K, 2014, CURR PHARM DESIGN, V20, P5696, DOI 10.2174/1381612820666140204120311; Tjen-A-Looi SC, 2012, AM J PHYSIOL-REG I, V302, pR833, DOI 10.1152/ajpregu.00440.2011; Tong HY, 2002, CIRC RES, V90, P377, DOI 10.1161/01.RES.0000012567.95445.55; Tricoci P, 2012, NEW ENGL J MED, V366, P20, DOI 10.1056/NEJMoa1109719; Tsou MT, 2004, AM J CHINESE MED, V32, P951, DOI 10.1142/S0192415X04002557; Tsou MT, 2004, INT J MOL MED, V14, P553; Vigneron F, 2011, CARDIOVASC RES, V90, P49, DOI 10.1093/cvr/cvr002; Vilimek D, 2006, BIOCHEM CELL BIOL, V84, P20, DOI 10.1139/O05-154; Zhang CG, 2009, BIOCHEM BIOPH RES CO, V390, P258, DOI 10.1016/j.bbrc.2009.09.101	49	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138108	10.1371/journal.pone.0138108	http://dx.doi.org/10.1371/journal.pone.0138108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430750	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700010
J	Liu, GW; Lu, HY; Wang, J; Xia, DY; Sun, YM; Mi, GD; Wang, LM				Liu, Guowu; Lu, Hongyan; Wang, Juan; Xia, Dongyan; Sun, Yanming; Mi, Guodong; Wang, Liming			Incidence of HIV and Syphilis among Men Who Have Sex with Men (MSM) in Beijing: An Open Cohort Study	PLOS ONE			English	Article							HEPATITIS-B; RISK BEHAVIOR; ALCOHOL-USE; MONEY BOYS; INFECTIONS; PREVALENCE; CHINA; RETENTION; SHANGHAI; VIRUS	Background This study investigated HIV and syphilis incidence among men who have sex with men (MSM) in Beijing, China. Methods An open cohort was established from September 2009 to April 2012. Participants were followed up with every three to four months after recruitment and for thirty-one months in total. Chi-square tests were used to compare demographic and behavioral characteristics between participants who were followed up with and those lost to follow up. Univariate and multivariate Cox proportional hazards regression analyses were used to examine demographic and behavioral associations with HIV and syphilis incidence. Results 69.7% (699/1,003) of the participants finished at least two follow-up surveys during the study period. Variables which corresponded to increased loss to follow-up included younger age, less education, non-identification of homosexual identity, and migrant status. A total of 1,045 person-years (PYs) and 1,016.4 PYs were followed up for HIV and syphilis incidence estimation, respectively. The HIV incidence was 5.9 per 100 PYs and 7.8 per 100 PYs for syphilis. The predictors for the high HIV incidence included unsafe anal sex, sex after drinking alcohol and STI infection. Conclusion HIV incidence increased rapidly within the cohort, but syphilis incidence remained stable and decreased. More research is needed to provide multi-pronged HIV prevention interventions among MSM in order to reduce the increasing burden of HIV and sexually transmitted infections (STIs) in China.	[Liu, Guowu; Lu, Hongyan; Wang, Juan; Xia, Dongyan; Sun, Yanming] Beijing Municipal Ctr Dis Control & Prevent, Beijing, Peoples R China; [Wang, Liming] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Mi, Guodong] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Capital Medical University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Mi, GD (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	mgdongcn@outlook.com; liming.wang@outlook.com			National Science and Technology Key Projects on Major Infectious Diseases [2012ZX10001001-003]; Beijing Municipal Science and Technology Commission [D09050703590902]	National Science and Technology Key Projects on Major Infectious Diseases; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission)	This work was partly supported by the National Science and Technology Key Projects on Major Infectious Diseases (2012ZX10001001-003) and partly funded by the Beijing Municipal Science and Technology Commission (D09050703590902).	Chen Qiuling, 2011, OPEN J INORG NONMETA, V1, P1, DOI DOI 10.4236/0JINM.2011.11001; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Chow EPF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-549; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; He N, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000304700.85379.f3; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Jones-Webb R, 2013, ADDICT BEHAV, V38, P1824, DOI 10.1016/j.addbeh.2012.11.011; Li DL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001829; Li DL, 2010, AIDS PATIENT CARE ST, V24, P595, DOI 10.1089/apc.2010.0083; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Lou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090985; Lu HY, 2013, DRUG ALCOHOL DEPEN, V133, P317, DOI 10.1016/j.drugalcdep.2013.06.013; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Mao HY, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005351; Mi G, 2012, 19 INT AIDS C WASH D; Nehl EJ, 2012, AIDS CARE, V24, P324, DOI 10.1080/09540121.2011.608792; Ruan YH, 2007, SEX TRANSM DIS, V34, P592, DOI 10.1097/01.olq.0000253336.64324.ef; Ruan YH, 2009, JAIDS-J ACQ IMM DEF, V52, P604, DOI 10.1097/QAI.0b013e3181b31f5c; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Shi Tong-Xin, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P668; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; [许娟 Xu Juan], 2010, [中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P975; Zhang DP, 2014, AIDS CARE, V26, P1118, DOI 10.1080/09540121.2014.902420; Zheng JD, 2012, AIDS EDUC PREV, V24, P78, DOI 10.1521/aeap.2012.24.1.78	26	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138232	10.1371/journal.pone.0138232	http://dx.doi.org/10.1371/journal.pone.0138232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426271	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100011
J	Ouyang, FY; Zheng, B; Jiang, XF				Ouyang, Fang-Yan; Zheng, Bo; Jiang, Xiong-Fei			Intrinsic Multi-Scale Dynamic Behaviors of Complex Financial Systems	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; NONSTATIONARY TIME-SERIES; CROSS-CORRELATIONS; VOLATILITY; MARKETS; FLUCTUATIONS; MATRICES; MEMORY	The empirical mode decomposition is applied to analyze the intrinsic multi-scale dynamic behaviors of complex financial systems. In this approach, the time series of the price returns of each stock is decomposed into a small number of intrinsic mode functions, which represent the price motion from high frequency to low frequency. These intrinsic mode functions are then grouped into three modes, i.e., the fast mode, medium mode and slow mode. The probability distribution of returns and auto-correlation of volatilities for the fast and medium modes exhibit similar behaviors as those of the full time series, i.e., these characteristics are rather robust in multi time scale. However, the cross-correlation between individual stocks and the return-volatility correlation are time scale dependent. The structure of business sectors is mainly governed by the fast mode when returns are sampled at a couple of days, while by the medium mode when returns are sampled at dozens of days. More importantly, the leverage and anti-leverage effects are dominated by the medium mode.	[Ouyang, Fang-Yan; Zheng, Bo; Jiang, Xiong-Fei] Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China; [Ouyang, Fang-Yan] Zhejiang Univ Media & Commun, Sch Elect & Informat, Hangzhou 310018, Zhejiang, Peoples R China; [Ouyang, Fang-Yan; Zheng, Bo] Collaborat Innovat Ctr Adv Microstruct, Nanjing 210093, Jiangsu, Peoples R China	Zhejiang University; Communication University of Zhejiang	Zheng, B (corresponding author), Zhejiang Univ, Dept Phys, Hangzhou 310027, Zhejiang, Peoples R China.	zhengbo@zju.edu.cn	zheng, bo/E-8351-2011	Zheng, Bo/0000-0001-6080-5503	NNSF of China [11375149, 11075137, 11505099]; Zhejiang Provincial Natural Science Foundation of China [Z6090130]	NNSF of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This work was supported in part by NNSF of China under Grant Nos. 11375149, 11075137 and 11505099, and Zhejiang Provincial Natural Science Foundation of China under Grant No. Z6090130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Black F., 1976, P BUS EC STAT SECT A, P177; Bouchaud J., 2003, THEORY FINANCIAL RIS; Bouchaud JP, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.228701; Buccheri G, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012806; Buraschi A, 2010, J FINANC, V65, P393, DOI 10.1111/j.1540-6261.2009.01533.x; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079531; Cheng CH, 2014, ECON MODEL, V36, P136, DOI 10.1016/j.econmod.2013.09.033; COX JC, 1976, J FINANC ECON, V3, P145, DOI 10.1016/0304-405X(76)90023-4; Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225; Ding Z, 1993, J EMPIR FINANC, V1, P83, DOI [10.1016/0927-5398(93)90006-D, DOI 10.1016/0927-5398(93)90006-D]; Dyson FJ., 1971, DISTRIBUTION EIGENVA; ENGLE RF, 1993, J FINANC, V48, P1749, DOI 10.2307/2329066; Erb C. B., 1994, FINANC ANAL J, V50, P32, DOI DOI 10.2469/FAJ.V50.N6.32; Gopikrishnan P, 1999, PHYS REV E, V60, P5305, DOI 10.1103/PhysRevE.60.5305; Huang NE, 2003, APPL STOCH MODEL BUS, V19, P245, DOI 10.1002/asmb.501; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jiang XF, 2014, SCI REP-UK, V4, DOI 10.1038/srep05321; Jiang XF, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48006; Kenett DY, 2012, INT J BIFURCAT CHAOS, V22, DOI 10.1142/S0218127412501817; Kozic I, 2014, ECON LETT, V123, P287, DOI 10.1016/j.econlet.2014.03.009; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Lin CS, 2012, ECON MODEL, V29, P2583, DOI 10.1016/j.econmod.2012.07.018; Liu YH, 1999, PHYS REV E, V60, P1390, DOI 10.1103/PhysRevE.60.1390; Looney David, 2015, Proc Math Phys Eng Sci, V471, P20140709, DOI 10.1098/rspa.2014.0709; Mantegna R. N., 2000, INTRODUCTION TO ECON; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; Masoliver J, 2006, QUANT FINANC, V6, P423, DOI 10.1080/14697680600727547; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Ouyang FY, 2014, PHYSICA A, V402, P236, DOI 10.1016/j.physa.2014.02.006; Pan RK, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046116; Perez-Rodriguez J.V., 2005, J EMPIR FINANC, V12, P490, DOI [10.1016/j.jempfin.2004.03.001, DOI 10.1016/J.JEMPFIN.2004.03.001]; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; Plerou V, 1999, PHYS REV LETT, V83, P1471, DOI 10.1103/PhysRevLett.83.1471; Podobnik B, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/68001; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00752; Qian B, 2007, APPL INTELL, V26, P25, DOI 10.1007/s10489-006-0001-7; Qiu T, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.065103; Qiu T, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043057; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Ruiz E, 2008, COMPUT STAT DATA AN, V52, P2846, DOI 10.1016/j.csda.2007.09.031; Runkle D., 1993, J FINANC, V46, P1779; Sengupta AM, 1999, PHYS REV E, V60, P3389, DOI 10.1103/PhysRevE.60.3389; Shen J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/28003; Shen J, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/48005; Solnik B., 1996, FINANCIAL ANAL J, V52, P17, DOI [10.2469/faj.v52.n5.2021, DOI 10.2469/FAJ.V52.N5.2021]; Tan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118399; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Utsugi A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.026110; Wu MC, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016118; Wu MC, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/48009; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2007, P NATL ACAD SCI USA, V104, P14889, DOI 10.1073/pnas.0701020104; Yamasaki K, 2005, P NATL ACAD SCI USA, V102, P9424, DOI 10.1073/pnas.0502613102; Yu L, 2010, NEUROCOMPUTING, V73, P716, DOI 10.1016/j.neucom.2008.11.035; Zhang X, 2008, ENERG ECON, V30, P905, DOI 10.1016/j.eneco.2007.02.012	59	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139420	10.1371/journal.pone.0139420	http://dx.doi.org/10.1371/journal.pone.0139420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26427063	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100056
J	Peremyslov, VV; Cole, RA; Fowler, JE; Dolja, VV				Peremyslov, Valera V.; Cole, Rex A.; Fowler, John E.; Dolja, Valerian V.			Myosin-Powered Membrane Compartment Drives Cytoplasmic Streaming, Cell Expansion and Plant Development	PLOS ONE			English	Article							CLASS-XI MYOSINS; F-ACTIN ORGANIZATION; ENDOPLASMIC-RETICULUM; HYDRODYNAMIC FLOW; GOLGI; MOVEMENT; CYTOSKELETON; TRANSPORT; PROTEIN; GROWTH	Using genetic approaches, particle image velocimetry and an inert tracer of cytoplasmic streaming, we have made a mechanistic connection between the motor proteins (myosins XI), cargo transported by these motors (distinct endomembrane compartment defined by membrane-anchored MyoB receptors) and the process of cytoplasmic streaming in plant cells. It is shown that the MyoB compartment in Nicotiana benthamiana is highly dynamic moving with the mean velocity of similar to 3 mu m/sec. In contrast, Golgi, mitochondria, peroxisomes, carrier vesicles and a cytosol flow tracer share distinct velocity profile with mean velocities of 0.6-1.5 mu m/sec. Dominant negative inhibition of the myosins XI or MyoB receptors using overexpression of the N. benthamiana myosin cargo-binding domain or MyoB myosin-binding domain, respectively, resulted in velocity reduction for not only the MyoB compartment, but also each of the tested organelles, vesicles and cytoplasmic streaming. Furthermore, the extents of this reduction were similar for each of these compartments suggesting that MyoB compartment plays primary role in cytosol dynamics. Using gene knockout analysis in Arabidopsis thaliana, it is demonstrated that inactivation of MyoB1-4 results in reduced velocity of mitochondria implying slower cytoplasmic streaming. It is also shown that myosins XI and MyoB receptors genetically interact to contribute to cell expansion, plant growth, morphogenesis and proper onset of flowering. These results support a model according to which myosin-dependent, MyoB receptor-mediated transport of a specialized membrane compartment that is conserved in all land plants drives cytoplasmic streaming that carries organelles and vesicles and facilitates cell growth and plant development.	[Dolja, Valerian V.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Dolja, VV (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	doljav@science.oregonstate.edu	Fowler, John E/U-4529-2017	Fowler, John E/0000-0002-9254-5934	Direct For Biological Sciences [1244633] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Avisar D, 2012, J EXP BOT, V63, P241, DOI 10.1093/jxb/err265; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Bowman JL, 2007, CELL, V129, P229, DOI 10.1016/j.cell.2007.04.004; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Buchnik L, 2015, J INTEGR PLANT BIOL, V57, P23, DOI 10.1111/jipb.12282; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chernyakov I, 2013, CURR BIOL, V23, P1818, DOI 10.1016/j.cub.2013.07.053; Donovan KW, 2012, DEV CELL, V23, P769, DOI 10.1016/j.devcel.2012.09.001; Esseling-Ozdoba A, 2008, J MICROSC-OXFORD, V231, P274, DOI 10.1111/j.1365-2818.2008.02033.x; Eves PT, 2012, J CELL BIOL, V198, P69, DOI 10.1083/jcb.201201024; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Ganguly S, 2012, P NATL ACAD SCI USA, V109, P15109, DOI 10.1073/pnas.1203575109; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Holding DR, 2007, PLANT CELL, V19, P2569, DOI 10.1105/tpc.107.053538; Houtman D, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/18001; Ito K, 2007, J BIOL CHEM, V282, P19534, DOI 10.1074/jbc.M611802200; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Keren K, 2009, NAT CELL BIOL, V11, P1219, DOI 10.1038/ncb1965; Lan P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r67; Lew RR, 2011, NAT REV MICROBIOL, V9, P509, DOI 10.1038/nrmicro2591; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Nebenfuhr A, 2001, TRENDS PLANT SCI, V6, P160, DOI 10.1016/S1360-1385(01)01891-X; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; Ojangu EL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-81; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Peremyslov VV, 2008, PLANT PHYSIOL, V146, P1109, DOI 10.1104/pp.107.113654; Peremyslov VV, 2013, PLANT CELL, V25, P3022, DOI 10.1105/tpc.113.113704; Peremyslov VV, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00184; Peremyslov V, 2011, PLANT PHYSIOL, V155, P1191, DOI 10.1104/pp.110.170720; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; Sparkes I, 2009, PLANT CELL, V21, P3937, DOI 10.1105/tpc.109.072249; Sparkes IA, 2008, J EXP BOT, V59, P2499, DOI 10.1093/jxb/ern114; Stefano G, 2014, J CELL SCI, V127, P947, DOI 10.1242/jcs.139907; Steffens A, 2014, PLANT PHYSIOL, V164, P1879, DOI 10.1104/pp.113.233031; Stephan O, 2014, PLANT CELL, V26, P4426, DOI 10.1105/tpc.114.131078; Tamura K, 2013, CURR BIOL, V23, P1776, DOI 10.1016/j.cub.2013.07.035; Tominaga M, 2013, DEV CELL, V27, P345, DOI 10.1016/j.devcel.2013.10.005; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Wolff K, 2012, J R SOC INTERFACE, V9, P1398, DOI 10.1098/rsif.2011.0868; Woodhouse FG, 2013, P NATL ACAD SCI USA, V110, P14132, DOI 10.1073/pnas.1302736110; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320	50	27	27	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139331	10.1371/journal.pone.0139331	http://dx.doi.org/10.1371/journal.pone.0139331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426395	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100049
J	Badgaiyan, RD; Sinha, S; Sajjad, M; Wack, DS				Badgaiyan, Rajendra D.; Sinha, Sampada; Sajjad, Munawwar; Wack, David S.			Attenuated Tonic and Enhanced Phasic Release of Dopamine in Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							DYNAMIC PET; METHYLPHENIDATE; ADHD; TRANSPORTER; CAUDATE; ADULTS; NEUROTRANSMISSION; INHIBITION; MODULATION; CHILDREN	It is unclear whether attention deficit hyperactive disorder (ADHD) is a hypodopaminergic or hyperdopaminergic condition. Different sets of data suggest either hyperactive or hypoactive dopamine system. Since indirect methods used in earlier studies have arrived at contradictory conclusions, we directly measured the tonic and phasic release of dopamine in ADHD volunteers. The tonic release in ADHD and healthy control volunteers was measured and compared using dynamic molecular imaging technique. The phasic release during performance of Eriksen's flanker task was measured in the two groups using single scan dynamic molecular imaging technique. In these experiments volunteers were positioned in a positron emission tomography (PET) camera and administered a dopamine receptor ligand C-11-raclopride intravenously. After the injection PET data were acquired dynamically while volunteers either stayed still (tonic release experiments) or performed the flanker task (phasic release experiments). PET data were analyzed to measure dynamic changes in ligand binding potential (BP) and other receptor kinetic parameters. The analysis revealed that at rest the ligand BP was significantly higher in the right caudate of ADHD volunteers suggesting reduced tonic release. During task performance significantly lower ligand BP was observed in the same area, indicating increased phasic release. In ADHD tonic release of dopamine is attenuated and the phasic release is enhanced in the right caudate. By characterizing the nature of dysregulated dopamine neurotransmission in ADHD, the results explain earlier findings of reduced or increased dopaminergic activity.	[Badgaiyan, Rajendra D.; Sinha, Sampada] Univ Minnesota, Dept Psychiat, Mol & Funct Imaging Lab, Minneapolis, MN 55455 USA; [Badgaiyan, Rajendra D.] Univ Minnesota, Neuromodulat Program, Minneapolis, MN USA; [Badgaiyan, Rajendra D.] Univ Minnesota, Lab Adv Radiochem, Minneapolis, MN USA; [Sajjad, Munawwar; Wack, David S.] SUNY Buffalo, Dept Nucl Med, Buffalo, NY 14260 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Badgaiyan, RD (corresponding author), Univ Minnesota, Dept Psychiat, Mol & Funct Imaging Lab, Minneapolis, MN 55455 USA.	badgaiyan@gmail.com	Badgaiyan, Rajendra D/B-8183-2012		National Institutes of Neurological Disorder and Stroke [1R01NS073884]; National Institutes of Mental Heath [1R21MH073624]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073884] Funding Source: NIH RePORTER	National Institutes of Neurological Disorder and Stroke; National Institutes of Mental Heath; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Neurological Disorder and Stroke, Grant number 1R01NS073884; National Institutes of Mental Heath, Grant number: 1R21MH073624. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Backman L, 2011, SCIENCE, V333, P718, DOI 10.1126/science.1204978; Badgaiyan RD, 2008, NEUROREPORT, V19, P409, DOI 10.1097/WNR.0b013e3282f6435f; Badgaiyan RD, 2007, NEUROIMAGE, V38, P549, DOI 10.1016/j.neuroimage.2007.07.052; Badgaiyan RD, 2014, PROG BRAIN RES, V211, P165, DOI 10.1016/B978-0-444-63425-2.00007-6; Badgaiyan RD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00125; Badgaiyan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028075; Badgaiyan RD, 2011, CURR MED IMAGING, V7, P98; Badgaiyan RD, 2010, NEUROREPORT, V21, P1172, DOI 10.1097/WNR.0b013e3283410955; Badgaiyan RD, 2009, NEUROIMAGE, V47, P2041, DOI 10.1016/j.neuroimage.2009.06.008; Badgaiyan RD, 2003, NEUROREPORT, V14, P1421, DOI 10.1097/00001756-200308060-00003; Badgaiyan RD, 2005, J NUCL MED S2, V46, P213; Carpenter AC, 2012, DEV NEUROSCI-BASEL, V34, P250, DOI 10.1159/000336824; CASTELLANOS FX, 1994, PSYCHIAT RES, V52, P305, DOI 10.1016/0165-1781(94)90076-0; CASTELLANOS FX, 1994, AM J PSYCHIAT, V151, P1791; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Chamberlain SR, 2006, SCIENCE, V311, P861, DOI 10.1126/science.1121218; Cherkasova MV, 2014, NEUROPSYCHOPHARMACOL, V39, P1498, DOI 10.1038/npp.2013.349; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; DuPaul G. J., 1998, ADHD RATING SCALE 4; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ernst M, 1999, AM J PSYCHIAT, V156, P1209; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Glickstein SB, 2005, CEREB CORTEX, V15, P1016, DOI 10.1093/cercor/bhh202; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Krause KH, 2000, NEUROSCI LETT, V285, P107, DOI 10.1016/S0304-3940(00)01040-5; Krause KH, 2003, NEUROSCI BIOBEHAV R, V27, P605, DOI 10.1016/j.neubiorev.2003.08.012; LANGER DH, 1982, J AM ACAD CHILD PSY, V21, P10, DOI 10.1097/00004583-198201000-00004; Masuo Yoshinori, 2004, Neural Plasticity, V11, P59, DOI 10.1155/NP.2004.59; MENDEZ MF, 1989, NEUROLOGY, V39, P349, DOI 10.1212/WNL.39.3.349; Moreno A, 2014, EUR CHILD ADOLES PSY, V23, P805, DOI 10.1007/s00787-013-0510-y; ORVASCHEL H, 1982, J AM ACAD CHILD PSY, V21, P392, DOI 10.1016/S0002-7138(09)60944-4; Polanczyk GV, 2014, INT J EPIDEMIOL, V43, P434, DOI 10.1093/ije/dyt261; Posner M.I., 1998, COMPUT NEUR; Rosa-Neto P, 2005, NEUROIMAGE, V25, P868, DOI 10.1016/j.neuroimage.2004.11.031; Semrud-Clikeman M, 2017, J ATTEN DISORD, V21, P1040, DOI 10.1177/1087054714559642; Silk TJ, 2009, HUM BRAIN MAPP, V30, P2757, DOI 10.1002/hbm.20703; Spencer T, 2005, BIOL PSYCHIAT, V57, P456, DOI 10.1016/j.biopsych.2004.11.043; Spencer TJ, 2007, BIOL PSYCHIAT, V62, P1059, DOI 10.1016/j.biopsych.2006.12.008; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Tripp G, 2009, NEUROPHARMACOLOGY, V57, P579, DOI 10.1016/j.neuropharm.2009.07.026; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Wack DS, 2011, CURR MED IMAGING REV, V7, P113; Zhou Y, 2006, NEUROIMAGE, V33, P550, DOI 10.1016/j.neuroimage.2006.06.038; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	51	42	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137326	10.1371/journal.pone.0137326	http://dx.doi.org/10.1371/journal.pone.0137326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422146	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700014
J	Ghasemizadeh, R; Yu, X; Butscher, C; Hellweger, F; Padilla, I; Alshawabkeh, A				Ghasemizadeh, Reza; Yu, Xue; Butscher, Christoph; Hellweger, Ferdi; Padilla, Ingrid; Alshawabkeh, Akram			Equivalent Porous Media (EPM) Simulation of Groundwater Hydraulics and Contaminant Transport in Karst Aquifers	PLOS ONE			English	Article							PUERTO-RICO; WATER-RESOURCES; FLOW; SYSTEM; MODEL; FRACTURES; SPRINGS; USA	Karst aquifers have a high degree of heterogeneity and anisotropy in their geologic and hydrogeologic properties which makes predicting their behavior difficult. This paper evaluates the application of the Equivalent Porous Media (EPM) approach to simulate groundwater hydraulics and contaminant transport in karst aquifers using an example from the North Coast limestone aquifer system in Puerto Rico. The goal is to evaluate if the EPM approach, which approximates the karst features with a conceptualized, equivalent continuous medium, is feasible for an actual project, based on available data and the study scale and purpose. Existing National Oceanic Atmospheric Administration (NOAA) data and previous hydrogeological U.S. Geological Survey (USGS) studies were used to define the model input parameters. Hydraulic conductivity and specific yield were estimated using measured groundwater heads over the study area and further calibrated against continuous water level data of three USGS observation wells. The water-table fluctuation results indicate that the model can practically reflect the steady-state groundwater hydraulics (normalized RMSE of 12.4%) and long-term variability (normalized RMSE of 3.0%) at regional and intermediate scales and can be applied to predict future water table behavior under different hydrogeological conditions. The application of the EPM approach to simulate transport is limited because it does not directly consider possible irregular conduit flow pathways. However, the results from the present study suggest that the EPM approach is capable to reproduce the spreading of a TCE plume at intermediate scales with sufficient accuracy (normalized RMSE of 8.45%) for groundwater resources management and the planning of contamination mitigation strategies.	[Ghasemizadeh, Reza; Yu, Xue; Hellweger, Ferdi; Alshawabkeh, Akram] Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA; [Butscher, Christoph] Karlsruhe Inst Technol, Inst Appl Geosci, Dept Geol Engn, D-76131 Karlsruhe, Germany; [Padilla, Ingrid] Univ Puerto Rico, Dept Civil Engn & Surveying, Mayaguez, PR 00682 USA	Northeastern University; Helmholtz Association; Karlsruhe Institute of Technology; University of Puerto Rico; University of Puerto Rico Mayaguez	Alshawabkeh, A (corresponding author), Northeastern Univ, Dept Civil & Environm Engn, Boston, MA 02115 USA.	aalsha@coe.neu.edu	Cao, Bingyang/C-5185-2011	Cao, Bingyang/0000-0003-3588-972X	National Institute of Environmental Health Sciences [P42ES017198]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES017198] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support of the work described is provided through award number P42ES017198 from the National Institute of Environmental Health Sciences (www.niehs.nih.gov) to the PROTECT research project (ANA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusaada M, 2013, GROUND WATER, V51, P641, DOI 10.1111/j.1745-6584.2012.01003.x; Anaya AA, 2014, GROUNDWATER, V52, P584, DOI 10.1111/gwat.12084; Anderson M.P., 1992, APPL GROUNDWATER MOD; [Anonymous], 1999, SPECIAL PUBLICATION; Bodin J, 2012, J HYDROL, P454; Budd DA, 2004, HYDROGEOL J, V12, P531, DOI 10.1007/s10040-004-0341-5; Butscher C, 2011, GROUND WATER, V49, P66, DOI 10.1111/j.1745-6584.2010.00687.x; Chen Z, 2014, J HYDROL, V514, P41, DOI 10.1016/j.jhydrol.2014.04.005; Cherry G.S, 2001, 004266 US GEOL SURV; Chuanmao J, 1982, IAHS PUBL, V136; Ford D.C., 2007, KARST HYDROGEOLOGY G, P576; Ghasemizadeh R, 2012, HYDROGEOL J, V20, P1441, DOI 10.1007/s10040-012-0897-4; Gines A, 2007, INT J SPELEOL, V36, P57, DOI 10.5038/1827-806X.36.2.1; Giusti EV, 1978, 1012 US GEOL SURV; Giusti EV, 1976, 4275 US GEOL SURV WA; Gomez GF, 1988, 874105 US GEOL SURV; Gomez-Gomez F, 2008, 20075194 US GEOL SUR; Gulley JD, 2015, EARTH SURFACE PROCES; Guzman RS, 1984, 8405 US GEOL SURV; Guzman RS, 1986, 8663 US GEOL SURV; Halihan T, 2000, FLOW SAN ANTONIO SEG, P129; Hartmann A, 2014, REV GEOPHYS, V52, P218, DOI 10.1002/2013RG000443; Larsen MC, 2000, PHYS GEOGR, V21, P494, DOI 10.1080/02723646.2000.10642723; Liedl R, 2003, WATER RESOUR RES, V39, DOI 10.1029/2001WR001206; Lindgren R.J., 2004, 20045277 US GEOL SUR; LONG JCS, 1982, WATER RESOUR RES, V18, P645, DOI 10.1029/WR018i003p00645; Lugo A. E., 2001, WO65 USDA FOR SERV; McDonald M. G., 1988, 83875 US GEOL SURV; MEHRAN M, 1987, GROUND WATER, V25, P275, DOI 10.1111/j.1745-6584.1987.tb02131.x; Molina-Rivera W.L., 2008, 20081286 US GEOL SUR; MONROE WH, 1980, 953 US GEOL SURV; Padilla I, 2013, 2013 GSA ANN M DENV; Panagopoulos G, 2012, ENVIRON EARTH SCI, V67, P1877, DOI 10.1007/s12665-012-1630-2; PANKOW J F, 1986, Journal of Contaminant Hydrology, V1, P65, DOI 10.1016/0169-7722(86)90007-0; Putnam L.D., 2009, 20095205 US GEOL SUR; Quinn JJ, 2006, SEDIMENT GEOL, V184, P343, DOI 10.1016/j.sedgeo.2005.11.009; Quinn JJ, 2000, GROUNDWATER FLOW AND CONTAMINANT TRANSPORT IN CARBONATE AQUIFERS, P147; Renken R.A., 2002, US GEOL SURV PROFESS, V1419, P1; Rodriguez JM, 2000, 004147 US GEOL SURV; Rodriguez JM, 1995, 944249 US GEOL SURV; Rodriguez JM, 1994, 93465 US DEP INT US; Rodriguez MJ, 1997, 974122 US GEOL SURV; Romanov D, 2003, ENG GEOL, V70, P17, DOI 10.1016/S0013-7952(03)00073-5; Saller SP, 2013, HYDROGEOL J, V21, P1555, DOI 10.1007/s10040-013-1036-6; Scanlon BR, 2003, J HYDROL, V276, P137, DOI 10.1016/S0022-1694(03)00064-7; Schlumberger, 2011, VIS MODFLOW 2011 1 U; Sepulveda N, 1999, 974170 US GEOL SURV; Sepulveda N, 1996, 954184 US GEOL SURV; Torres-Sierra H, 1985, 854268 US GEOL SURV; US Environmental Protection Agency, 1997, SUP REC DEC EPA REG; Veve T. D., 1996, 944198 US GEOL SURV; Worthington SRH, 2009, HYDROGEOL J, V17, P1665, DOI 10.1007/s10040-009-0489-0; Yu X, 2015, SCI TOTAL ENVIRON, V524, P300, DOI 10.1016/j.scitotenv.2015.04.043; Yu X, 2015, SCI TOTAL ENVIRON, V511, P1, DOI 10.1016/j.scitotenv.2014.12.031; Zack A., 1987, 870749 US GEOL SURV; Zheng C, 1999, SERDP991 US ARM ENG	56	30	30	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138954	10.1371/journal.pone.0138954	http://dx.doi.org/10.1371/journal.pone.0138954			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422202	Green Published, gold			2022-12-27	WOS:000362175700057
J	Moon, HW; Huh, HJ; Oh, GY; Lee, SG; Lee, A; Yun, YM; Hur, M				Moon, Hee-Won; Huh, Hee Jin; Oh, Gwi Young; Lee, Sang Gon; Lee, Anna; Yun, Yeo-Min; Hur, Mina			Evaluation of the Bio-Rad Geenius HIV 1/2 Confirmation Assay as an Alternative to Western Blot in the Korean Population: A Multi-Center Study	PLOS ONE			English	Article							RAPID TEST; PERFORMANCES	Recently updated recommendations for diagnosis of HIV infection suggest a new diagnostic algorithm including HIV-1/HIV-2 antibody differentiation immunoassay instead of western blot (WB) as a confirmatory testing. We evaluated Bio-Rad Geenius HIV1/2 confirmation assay as a simple and reliable alternative to WB in the Korean population with low HIV prevalence. The Geenius HIV1/2 was performed in a total of 192 serum specimens (140 reactive and 52 nonreactive specimens by ARCHITECT HIV Ag/Ab Combo assay) that were prospectively collected from five institutions. HIV-1 nucleic acid amplification test (NAT) was performed in negative or indeterminate specimens by Geenius HIV1/2 or WB. Among 140 reactive specimens by HIV Ag/Ab assay, 82 (58.6%) were positive for HIV-1 Ab by Geenius HIV1/2. Among 58 negative or indeterminate specimens by Geenius HIV1/2, four specimens (6.9%) were positive by HIV-1 NAT. The sensitivity and specificity of Geenius HIV1/2 were 95.3% and 100.0%, respectively. When we considered only WB, the sensitivity and specificity of Geenius HIV1/2 were 100.0% and 99.1%, respectively. Agreement between Geenius HIV1/2 and WB was excellent (weighted Kappa = 0.89). The Geenius HIV1/2 is simple and time-saving compared with WB. It has an excellent performance and can be a reliable alternative to WB. HIV-1 NAT should be performed in negative or indeterminate specimens by Geenius HIV1/2 to detect acute HIV infection as recommended in new HIV testing algorithms.	[Moon, Hee-Won; Yun, Yeo-Min; Hur, Mina] Konkuk Univ, Sch Med, Dept Lab Med, Seoul, South Korea; [Huh, Hee Jin] Dongguk Univ, Dept Lab Med, Ilsan Hosp, Goyang, South Korea; [Oh, Gwi Young] Eone Labs, Inchon, South Korea; [Lee, Sang Gon] Green Cross Labs, Yongin, South Korea; [Lee, Anna] Seoul Clin Labs, Yongin, South Korea	Konkuk University; Konkuk University Medical Center; Dongguk University; NHIS Ilsan Hospital	Hur, M (corresponding author), Konkuk Univ, Sch Med, Dept Lab Med, Seoul, South Korea.	dearmina@hanmail.net	Hur, Mina/AAN-4920-2021	Hur, Mina/0000-0002-4429-9978; Lee, Anna/0000-0002-2865-3869; Yun, Yeo-Min/0000-0002-5485-8331	Eone Laboratories; Green Cross Laboratories; Seoul Clinical Laboratories	Eone Laboratories; Green Cross Laboratories; Seoul Clinical Laboratories	The authors received no specific funding for this work. Eone Laboratories, Green Cross Laboratories, and Seoul Clinical Laboratories provided support in the form of salaries for authors GO, SL and AL, but did not have any additional role in the study design, data collection and analysis, decision of publish, or preparation of the manuscript.	Abbate I, 2014, J CLIN VIROL, V61, P166, DOI 10.1016/j.jcv.2014.06.015; Cardenas AM, 2013, J CLIN VIROL, V58, pE97, DOI 10.1016/j.jcv.2013.08.021; Centers for Disease Control and Prevention and Association of Public Health Laboratories, LAB TEST DIAGN HIV I; Clinical and Laboratory Standards Institute, 2011, M53A CLSI; Gokengin D, 2014, INT J STD AIDS, V25, P695, DOI 10.1177/0956462414531244; Herssens N, 2014, J VIROL METHODS, V208, P11, DOI 10.1016/j.jviromet.2014.07.025; Lai JKC, 2012, INTERN MED J, V42, P43, DOI 10.1111/j.1445-5994.2011.02471.x; Lee JH, 2002, J MICROBIOL BIOTECHN, V12, P1; Malloch L, 2013, J CLIN VIROL, V58, pE85, DOI 10.1016/j.jcv.2013.08.008; Martin EG, 2011, J CLIN VIROL, V52, pS11, DOI 10.1016/j.jcv.2011.09.014; Montesinos I, 2014, J CLIN VIROL, V60, P399, DOI 10.1016/j.jcv.2014.04.025; Mor O, 2014, J CLIN MICROBIOL, V52, P2677, DOI 10.1128/JCM.01184-14; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Song EY, 2012, J MED VIROL, V84, P1884, DOI 10.1002/jmv.23423; Wang JS, 2010, CLIN MICROBIOL INFEC, V16, P482, DOI 10.1111/j.1469-0691.2009.02835.x; Wang Jin-Sook, 2012, Osong Public Health Res Perspect, V3, P245, DOI 10.1016/j.phrp.2012.11.001; Weber B, 2002, J CLIN MICROBIOL, V40, P1938, DOI 10.1128/JCM.40.6.1938-1946.2002	17	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139169	10.1371/journal.pone.0139169	http://dx.doi.org/10.1371/journal.pone.0139169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422281	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700074
J	Leguen, I; Le Cam, A; Montfort, J; Peron, S; Fautrel, A				Leguen, Isabelle; Le Cam, Aurelie; Montfort, Jerome; Peron, Sandrine; Fautrel, Alain			Transcriptomic Analysis of Trout Gill Ionocytes in Fresh Water and Sea Water Using Laser Capture Microdissection Combined with Microarray Analysis	PLOS ONE			English	Article							MITOCHONDRIA-RICH CELLS; RAINBOW-TROUT; FISH GILL; CHLORIDE CHANNEL; MESSENGER-RNA; EURYHALINE TELEOST; EPITHELIAL-CELLS; GENE-EXPRESSION; CLC-2 CHLORIDE; NA+/K+-ATPASE	Fish gills represent a complex organ composed of several cell types that perform multiple physiological functions. Among these cells, ionocytes are implicated in the maintenance of ion homeostasis. However, because the ionocyte represents only a small percent of whole gill tissue, its specific transcriptome can be overlooked among the numerous cell types included in the gill. The objective of this study is to better understand ionocyte functions by comparing the RNA expression of this cell type in freshwater and seawater acclimated rainbow trout. To realize this objective, ionocytes were captured from gill cryosections using laser capture microdissection after immunohistochemistry. Then, transcriptome analyses were performed on an Agilent trout oligonucleotide microarray. Gene expression analysis identified 108 unique annotated genes differentially expressed between freshwater and seawater ionocytes, with a fold change higher than 3. Most of these genes were up-regulated in freshwater cells. Interestingly, several genes implicated in ion transport, extracellular matrix and structural cellular proteins appeared up-regulated in freshwater ionocytes. Among them, several ion transporters, such as CIC2, SLC26A6, and NBC, were validated by qPCR and/or in situ hybridization. The latter technique allowed us to localize the transcripts of these ion transporters in only ionocytes and more particularly in the freshwater cells. Genes involved in metabolism and also several genes implicated in transcriptional regulation, cell signaling and the cell cycle were also enhanced in freshwater ionocytes. In conclusion, laser capture microdissection combined with microarray analysis allowed for the determination of the transcriptional signature of scarce cells in fish gills, such as ionocytes, and aided characterization of the transcriptome of these cells in freshwater and seawater acclimated trout.	[Leguen, Isabelle; Le Cam, Aurelie; Montfort, Jerome; Peron, Sandrine] INRA, UR Fish Physiol & Genom 1037, F-35042 Rennes, France; [Fautrel, Alain] INSERM, UMR991, Rennes, France; [Fautrel, Alain] Univ Rennes 1 Plateforme H2P2, Rennes, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm)	Leguen, I (corresponding author), INRA, UR Fish Physiol & Genom 1037, F-35042 Rennes, France.	Isabelle.Leguen@rennes.inra.fr	Fautrel, Alain/AAL-7391-2020	Leguen, Isabelle/0000-0001-6091-5366; FAUTREL, Alain/0000-0002-3449-0779	European Community's Seventh Framework (FP7) [222719-LIFECYCLE]; INRA-PHASE; IFR140 grant	European Community's Seventh Framework (FP7); INRA-PHASE; IFR140 grant	This work was funded by the European Community's Seventh Framework (FP7/2007-2013) under grant agreement no. 222719-LIFECYCLE (to IL) and by INRA-PHASE (to IL) and IFR140 grants (to IL, AF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVELLA M, 1987, J EXP ZOOL, V241, P159, DOI 10.1002/jez.1402410202; Bai R, 2014, REPRODUCTION, V148, P119, DOI 10.1530/REP-13-0655; Bossus M, 2013, J COMP PHYSIOL B, V183, P641, DOI 10.1007/s00360-012-0737-9; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Boutet I, 2006, GENE, V379, P40, DOI 10.1016/j.gene.2006.04.011; Boyle D, 2015, COMP BIOCHEM PHYS A, V180, P43, DOI 10.1016/j.cbpa.2014.11.001; Bradshaw AD, 2012, INT J BIOCHEM CELL B, V44, P480, DOI 10.1016/j.biocel.2011.12.021; Cal S, 2003, P NATL ACAD SCI USA, V100, P9185, DOI 10.1073/pnas.1633392100; Catalan M, 2004, GASTROENTEROLOGY, V126, P1104, DOI 10.1053/j.gastro.2004.01.010; Catalan M, 2002, AM J PHYSIOL-GASTR L, V283, pG1004, DOI 10.1152/ajpgi.00158.2002; Chen CH, 2010, CARDIOVASC RES, V88, P51, DOI 10.1093/cvr/cvq192; Chen YW, 2014, J NEUROSCI, V34, P2413, DOI 10.1523/JNEUROSCI.3226-13.2014; da Silva TC, 2013, MOL ASPECTS MED, V34, P252, DOI 10.1016/j.mam.2012.07.004; Dymowska AK, 2014, AM J PHYSIOL-CELL PH, V307, pC255, DOI 10.1152/ajpcell.00398.2013; Dymowska AK, 2012, RESP PHYSIOL NEUROBI, V184, P282, DOI 10.1016/j.resp.2012.08.025; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Evans TG, 2008, J EXP BIOL, V211, P3636, DOI 10.1242/jeb.022160; Freeman H, 2006, BIOCHEM SOC T, V34, P806, DOI 10.1042/BST0340806; Furukawa F, 2011, COMP BIOCHEM PHYS A, V158, P468, DOI 10.1016/j.cbpa.2010.12.003; Goss GG, 2001, AM J PHYSIOL-REG I, V281, pR1718, DOI 10.1152/ajpregu.2001.281.5.R1718; Grabbe C, 2011, NAT REV MOL CELL BIO, V12, P295, DOI 10.1038/nrm3099; Guh YJ, 2015, EXCLI J, V14, P627, DOI 10.17179/excli2015-246; Haugarvoll E, 2008, J ANAT, V213, P202, DOI 10.1111/j.1469-7580.2008.00943.x; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hirata T, 2003, AM J PHYSIOL-REG I, V284, pR1199, DOI 10.1152/ajpregu.00267.2002; Hiroi J, 2012, RESP PHYSIOL NEUROBI, V184, P257, DOI 10.1016/j.resp.2012.07.019; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Kalujnaia S, 2007, PHYSIOL GENOMICS, V31, P385, DOI 10.1152/physiolgenomics.00059.2007; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Ladanyi A, 2006, CYTOM PART A, V69A, P947, DOI 10.1002/cyto.a.20322; LAURENT P, 1978, CR ACAD SCI D NAT, V286, P1447; Lee YC, 2011, AM J PHYSIOL-CELL PH, V300, pC295, DOI 10.1152/ajpcell.00263.2010; Leguen I, 2007, COMP BIOCHEM PHYS A, V148, P903, DOI 10.1016/j.cbpa.2007.09.007; Leguen I, 2000, AQUAT TOXICOL, V48, P165, DOI 10.1016/S0166-445X(99)00043-0; Leguen I, 2010, COMP BIOCHEM PHYS A, V156, P211, DOI 10.1016/j.cbpa.2010.02.002; LIN H, 1991, J EXP BIOL, V161, P119; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Madsen SS, 2009, J EXP BIOL, V212, P78, DOI 10.1242/jeb.024612; McCormick SD, 2009, J EXP BIOL, V212, P3994, DOI 10.1242/jeb.037275; Miyazaki H, 1999, BIOCHEM BIOPH RES CO, V255, P175, DOI 10.1006/bbrc.1999.0166; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Notterpek L, 2001, P NATL ACAD SCI USA, V98, P14404, DOI 10.1073/pnas.251548398; Nowak B, 2013, J FISH BIOL, V83, P1459, DOI 10.1111/jfb.12235; Nyska A, 2002, TOXICOL PATHOL, V30, P620, DOI 10.1080/01926230290166724; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Parks SK, 2007, AM J PHYSIOL-CELL PH, V292, pC935, DOI 10.1152/ajpcell.00604.2005; Perez-Rius C, 2015, PFLUG ARCH EUR J PHY, V467, P1769, DOI 10.1007/s00424-014-1614-z; Perry SF, 2003, BBA-BIOMEMBRANES, V1618, P175, DOI 10.1016/j.bbamem.2003.09.015; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; PISAM M, 1995, ANAT REC, V241, P13, DOI 10.1002/ar.1092410104; PISAM M, 1991, INT REV CYTOL, V130, P191, DOI 10.1016/S0074-7696(08)61504-1; PRUNET P, 1985, J EXP ZOOL, V235, P187, DOI 10.1002/jez.1402350205; Ramalingam A, 2008, CANCER RES, V68, P1683, DOI 10.1158/0008-5472.CAN-07-6072; Richards JG, 2003, J EXP BIOL, V206, P4475, DOI 10.1242/jeb.00701; Roux KJ, 2005, MOL BIOL CELL, V16, P1142, DOI 10.1091/mbc.E04-07-0551; Rozen S, 2000, Methods Mol Biol, V132, P365; Seear PJ, 2010, MAR BIOTECHNOL, V12, P126, DOI 10.1007/s10126-009-9218-x; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SOENGAS JL, 1995, J FISH BIOL, V46, P845, DOI 10.1111/j.1095-8649.1995.tb01607.x; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Takahashi M, 2013, HISTOCHEM CELL BIOL, V139, P573, DOI 10.1007/s00418-012-1050-0; Takei Y, 2014, AM J PHYSIOL-REG I, V307, pR778, DOI 10.1152/ajpregu.00104.2014; Tang CH, 2011, PHYSIOL BIOCHEM ZOOL, V84, P54, DOI 10.1086/657161; Tang CH, 2010, J EXP BIOL, V213, P683, DOI 10.1242/jeb.040212; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Thompson O, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-1; Tine M, 2008, MAR GENOM, V1, P37, DOI 10.1016/j.margen.2008.06.001; Tipsmark CK, 2008, COMP BIOCHEM PHYS A, V150, P265, DOI 10.1016/j.cbpa.2008.03.006; Tipsmark CK, 2008, AM J PHYSIOL-REG I, V294, pR1004, DOI 10.1152/ajpregu.00112.2007; Toyoshima C, 2011, STRUCTURE, V19, P1732, DOI 10.1016/j.str.2011.10.016; Tse WKF, 2006, BIOCHEM BIOPH RES CO, V346, P1181, DOI 10.1016/j.bbrc.2006.06.028; Tse WKF, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-3; Tse WKF, 2011, J EXP ZOOL PART A, V315A, P385, DOI 10.1002/jez.681; Tse WKF, 2013, J PROTEOMICS, V89, P81, DOI 10.1016/j.jprot.2013.05.026; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Wilson JM, 2002, J EXP ZOOL, V293, P192, DOI 10.1002/jez.10124; Yanez-Mo M, 2001, J CELL SCI, V114, P577; ZENKER WGE, 1987, COMP BIOCHEM PHYS A, V86, P423, DOI 10.1016/0300-9629(87)90518-4; Zhang SL, 2010, PROTEIN CELL, V1, P656, DOI 10.1007/s13238-010-0083-1	87	17	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139938	10.1371/journal.pone.0139938	http://dx.doi.org/10.1371/journal.pone.0139938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439495	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300081
J	Liu, Y; Fite, BZ; Mahakian, LM; Johnson, SM; Larrat, B; Dumont, E; Ferrara, KW				Liu, Yu; Fite, Brett Z.; Mahakian, Lisa M.; Johnson, Sarah M.; Larrat, Benoit; Dumont, Erik; Ferrara, Katherine W.			Concurrent Visualization of Acoustic Radiation Force Displacement and Shear Wave Propagation with 7T MRI	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; IN-VIVO; BREAST-CANCER; QUANTITATIVE ASSESSMENT; STIFFNESS MEASUREMENTS; TISSUE ELASTICITY; HEPATIC-FIBROSIS; SOFT-TISSUES; FEASIBILITY; ULTRASOUND	Manual palpation is a common and very informative diagnostic tool based on estimation of changes in the stiffness of tissues that result from pathology. In the case of a small lesion or a lesion that is located deep within the body, it is difficult for changes in mechanical properties of tissue to be detected or evaluated via palpation. Furthermore, palpation is non-quantitative and cannot be used to localize the lesion. Magnetic Resonance-guided Focused Ultrasound (MRgFUS) can also be used to evaluate the properties of biological tissues non-invasively. In this study, an MRgFUS system combines high field (7T) MR and 3 MHz focused ultrasound to provide high resolution MR imaging and a small ultrasonic interrogation region (similar to 0.5 x 0.5 x 2 mm), as compared with current clinical systems. MR-Acoustic Radiation Force Imaging (MR-ARFI) provides a reliable and efficient method for beam localization by detecting micron-scale displacements induced by ultrasound mechanical forces. The first aim of this study is to develop a sequence that can concurrently quantify acoustic radiation force displacements and image the resulting transient shear wave. Our motivation in combining these two measurements is to develop a technique that can rapidly provide both ARFI and shear wave velocity estimation data, making it suitable for use in interventional radiology. Secondly, we validate this sequence in vivo by estimating the displacement before and after high intensity focused ultrasound (HIFU) ablation, and we validate the shear wave velocity in vitro using tissue-mimicking gelatin and tofu phantoms. Such rapid acquisitions are especially useful in interventional radiology applications where minimizing scan time is highly desirable.	[Liu, Yu; Fite, Brett Z.; Mahakian, Lisa M.; Johnson, Sarah M.; Ferrara, Katherine W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Larrat, Benoit] CEA, NeuroSpin, UNite Imagerie Resonance Magnet & Spect, Gif Sur Yvette, France; [Dumont, Erik] Image Guided Therapy, Pessac, France	University of California System; University of California Davis; CEA; UDICE-French Research Universities; Universite Paris Saclay	Ferrara, KW (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	kwferrara@ucdavis.edu	Larrat, Benoit/AAC-4920-2019	Larrat, Benoit/0000-0003-1577-6293; Oberai, Assad/0000-0002-7668-7713; Ferrara, Katherine/0000-0002-4976-9107	National Institutes of Health [NIHR01CA199658, R01CA103828, R01CA134659, T32 EB00387]; Image Guided Therapy; NATIONAL CANCER INSTITUTE [R01CA103828, R01CA134659, R01CA199658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003827, R43EB000387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Image Guided Therapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health grants NIHR01CA199658, R01CA103828, R01CA134659, and T32 EB00387 (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding was received for this study. Erik Dumont is an employee of Image Guided Therapy, which company manufactures the focused ultrasound system utilized in this study. Image Guided Therapy provided support in the form of salaries for authors ED, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benech N, 2010, PHYS MED BIOL, V55, P1753, DOI 10.1088/0031-9155/55/6/014; Bercoff J, 2004, ULTRASONIC IMAGING, V26, P71, DOI 10.1177/016173460402600201; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Boulant N, 2015, NMR BIOMED, V28, P101, DOI 10.1002/nbm.3232; Chen J, 2010, MAGN RESON MED, V63, P1050, DOI 10.1002/mrm.22299; CONTURO TE, 1990, MAGN RESON MED, V15, P420, DOI 10.1002/mrm.1910150308; Ehman RL, 2009, RADIOLOGY, V253, P1, DOI 10.1148/radiol.2531091040; Fite BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035509; GROCH MW, 1991, CLIN IMAG, V15, P196, DOI 10.1016/0899-7071(91)90077-9; Hall TJ, 1997, IEEE T ULTRASON FERR, V44, P1355, DOI 10.1109/58.656639; Han Y, 2015, PHYS MED BIOL, V60, P5911, DOI 10.1088/0031-9155/60/15/5911; Huang YX, 2009, MED PHYS, V36, P2016, DOI 10.1118/1.3120289; Kaye EA, 2011, MAGN RESON MED, V65, P738, DOI 10.1002/mrm.22662; Kolipaka A, 2009, MAGN RESON MED, V62, P135, DOI 10.1002/mrm.21991; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Larrat B, 2010, PHYS MED BIOL, V55, P365, DOI 10.1088/0031-9155/55/2/003; Larrat B, 2007, ULTRASON, P676, DOI 10.1109/ULTSYM.2007.175; Manduca A, 2001, MED IMAGE ANAL, V5, P237, DOI 10.1016/S1361-8415(00)00039-6; Mannelli L, 2012, CLIN RADIOL, V67, P258, DOI 10.1016/j.crad.2011.08.022; McDannold N, 2008, MED PHYS, V35, P3748, DOI 10.1118/1.2956712; Mcgee KP, 2008, MAGN RESON MED, V59, P14, DOI 10.1002/mrm.21465; McKnight AL, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781411; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Nightingale K, 2003, ULTRASOUND MED BIOL, V29, P1715, DOI 10.1016/j.ultrasmedbio.2003.08.008; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Nightingale KR, 2001, J ACOUST SOC AM, V110, P625, DOI 10.1121/1.1378344; Plewes DB, 2000, PHYS MED BIOL, V45, P1591, DOI 10.1088/0031-9155/45/6/314; Plewes DB, 1995, JMRI-J MAGN RESON IM, V5, P733, DOI 10.1002/jmri.1880050620; Ringleb SI, 2005, MAGN RESON MED, V53, P1197, DOI 10.1002/mrm.20449; Rouviere O, 2006, RADIOLOGY, V240, P440, DOI 10.1148/radiol.2402050606; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2009, MAGN RESON MED, V61, P668, DOI 10.1002/mrm.21878; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; Sapin-de Brosses E, 2010, PHYS MED BIOL, V55, P1701, DOI 10.1088/0031-9155/55/6/011; Sarvazyan AP, 1998, ULTRASOUND MED BIOL, V24, P1419, DOI 10.1016/S0301-5629(98)00110-0; Shah NS, 2004, MAGN RESON MED, V52, P56, DOI 10.1002/mrm.20101; Shahmirzadi D, 2013, IEEE ENG MED BIO, P6269, DOI 10.1109/EMBC.2013.6610986; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Sinkus R, 2007, MAGN RESON MED, V58, P1135, DOI 10.1002/mrm.21404; Souchon R, 2008, MAGN RESON MED, V60, P871, DOI 10.1002/mrm.21718; Talwalkar JA, 2008, HEPATOLOGY, V47, P332, DOI 10.1002/hep.21972; Talwalkar JA, 2009, AM J ROENTGENOL, V193, P122, DOI 10.2214/AJR.07.3504; Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002; Van Houten EEW, 2003, J MAGN RESON IMAGING, V17, P72, DOI 10.1002/jmri.10232; Vappou J, 2009, PHYS MED BIOL, V54, P3579, DOI 10.1088/0031-9155/54/11/020; Venkatesh SK, 2008, AM J ROENTGENOL, V190, P1534, DOI 10.2214/AJR.07.3123; Wu T, 2000, MAGNET RESON MED, V43, P111, DOI 10.1002/(SICI)1522-2594(200001)43:1<111::AID-MRM13>3.0.CO;2-D; Yin M, 2007, MAGN RESON MED, V58, P346, DOI 10.1002/mrm.21286	49	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139667	10.1371/journal.pone.0139667	http://dx.doi.org/10.1371/journal.pone.0139667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439259	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300041
J	Mehaisen, GMK; Saeed, AM; Gad, A; Abass, AO; Arafa, M; El-Sayed, A				Mehaisen, Gamal M. K.; Saeed, Ayman M.; Gad, Ahmed; Abass, Ahmed O.; Arafa, Mahmoud; El-Sayed, Ashraf			Antioxidant Capacity of Melatonin on Preimplantation Development of Fresh and Vitrified Rabbit Embryos: Morphological and Molecular Aspects	PLOS ONE			English	Article							IN-VITRO MATURATION; GLUTATHIONE S-TRANSFERASES; MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; OXIDATIVE-STRESS; BOVINE EMBRYOS; CULTURE; CRYOPRESERVATION; BLASTOCYSTS; OOCYTES	Embryo cryopreservation remains an important technique to enhance the reconstitution and distribution of animal populations with high genetic merit. One of the major detrimental factors to this technique is the damage caused by oxidative stress. Melatonin is widely known as an antioxidant with multi-faceted ways to counteract the oxidative stress. In this paper, we investigated the role of melatonin in protecting rabbit embryos during preimplantation development from the potential harmful effects of oxidative stress induced by in vitro culture or vitrification. Rabbit embryos at morula stages were cultured for 2 hr with 0 or 10(-3) M melatonin (C or M groups). Embryos of each group were either transferred to fresh culture media (CF and MF groups) or vitrified/devitrified (CV and MV groups), then cultured in vitro for 48 hr until the blastocyst stage. The culture media were used to measure the activity of antioxidant enzymes: glutathione-s-transferase (GST) and superoxide dismutase (SOD), as well as the levels of two oxidative substrates: lipid peroxidation (LPO) and nitric oxide (NO). The blastocysts from each group were used to measure the expression of developmental- related genes (GJA1, POU5F1 and Nanog) and oxidative-stress-response-related genes (NFE2L2, SOD1 and GPX1). The data showed that melatonin promoted significantly (P<0.05) the blastocyst rate by 17% and 12% in MF and MV groups compared to their controls (CF and CV groups). The GST and SOD activity significantly increased by the treatment of melatonin in fresh or vitrified embryos, while the levels of LPO and NO decreased (P<0.05). Additionally, melatonin considerably stimulated the relative expression of GJA1, NFE2L2 and SOD1 genes in MF and MV embryos compared to CF group. Furthermore, melatonin significantly ameliorated the reduction of POU5F1 and GPX1 expression induced by vitrification. The results obtained from the current investigation provide new and clear molecular aspects regarding the mechanisms by which melatonin promotes development of both fresh and vitrified rabbit embryos.	[Mehaisen, Gamal M. K.; Gad, Ahmed; Abass, Ahmed O.; El-Sayed, Ashraf] Cairo Univ, Dept Anim Prod, Fac Agr, Giza, Egypt; [Saeed, Ayman M.] Res Inst Anim Prod, Dept Anim Biotechnol, Giza, Egypt; [Gad, Ahmed; El-Sayed, Ashraf] Cairo Univ, CURP, Fac Agr, Giza, Egypt; [Arafa, Mahmoud] Anim Hlth Res Inst, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Animal Health Research Institute (AHRI)	Mehaisen, GMK (corresponding author), Cairo Univ, Dept Anim Prod, Fac Agr, Giza, Egypt.	gamoka@cu.edu.eg	Gad, Ahmed/M-7273-2013; Mehaisen, Gamal/I-5277-2019	Gad, Ahmed/0000-0001-9741-2105; Mehaisen, Gamal/0000-0003-2006-4290; El-Sayed, Ashraf/0000-0001-8643-1239; Nassar, Farid/0000-0003-0786-0612	Rabbit Embryo Cryobank Project (RECP) [3-2 p11]; Cairo University Research Park (CURP)	Rabbit Embryo Cryobank Project (RECP); Cairo University Research Park (CURP)(Cairo University)	This work was supported by the Rabbit Embryo Cryobank Project (RECP, Code: 3-2 p11) and by funds from Cairo University Research Park (CURP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecia JA, 2002, VET RES COMMUN, V26, P151, DOI 10.1023/A:1014099719034; Ali AA, 2003, THERIOGENOLOGY, V59, P939, DOI 10.1016/S0093-691X(02)01125-1; Amin A, 2014, MOL REPROD DEV, V81, P497, DOI [10.1002/mrd.22316, 1]; Bannerman P, 2000, J NEUROSCI RES, V61, P605, DOI 10.1002/1097-4547(20000915)61:6<605::AID-JNR4>3.0.CO;2-U; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bonnefont-Rousselot D, 2011, J PINEAL RES, V50, P328, DOI 10.1111/j.1600-079X.2010.00847.x; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burton Graham J, 2003, Reprod Biomed Online, V6, P84; Cauffman G, 2005, MOL HUM REPROD, V11, P173, DOI 10.1093/molehr/gah155; Cauffman G, 2009, HUM REPROD, V24, P63, DOI 10.1093/humrep/den351; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Choi J, 2008, MOL REPROD DEV, V75, P1127, DOI 10.1002/mrd.20861; Cruz MHC, 2014, ANIM REPROD SCI, V145, P150, DOI 10.1016/j.anireprosci.2014.01.011; Correa GA, 2008, ANIM REPROD SCI, V104, P132, DOI 10.1016/j.anireprosci.2007.02.002; D'Cruz NT, 2008, REPROD FERT DEVELOP, V20, P589, DOI 10.1071/RD08024; Dair EL, 2008, FERTIL STERIL, V89, P1299, DOI 10.1016/j.fertnstert.2007.03.050; Davies TC, 1996, DEV GENET, V18, P234, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;234::AID-DVG4&gt;3.0.CO;2-A; Dehghani-Mohammadabadi M, 2014, J ASSIST REPROD GEN, V31, P453, DOI 10.1007/s10815-014-0172-9; DESOUSA PA, 1993, DEVELOPMENT, V117, P1355; Dobrinsky JR, 2001, THERIOGENOLOGY, V56, P1333, DOI 10.1016/S0093-691X(01)00634-3; Farombi EO, 2000, FOOD CHEM TOXICOL, V38, P535, DOI 10.1016/S0278-6915(00)00039-9; Fischer B, 2012, REPRODUCTION, V144, P1, DOI 10.1530/REP-12-0091; Gad A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099697; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Gao C, 2012, J PINEAL RES, V52, P305, DOI 10.1111/j.1600-079X.2011.00944.x; Ghanem N, 2014, THERIOGENOLOGY, V82, P238, DOI 10.1016/j.theriogenology.2014.03.024; Gomez E, 2009, REPROD DOMEST ANIM, V44, P194, DOI 10.1111/j.1439-0531.2007.01026.x; Gomez E, 2009, J REPROD DEVELOP, V55, P607, DOI 10.1262/jrd.09-077M; Guerin P, 2001, HUM REPROD UPDATE, V7, P175, DOI 10.1093/humupd/7.2.175; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hardeland R, 2005, ENDOCRINE, V27, P119, DOI 10.1385/ENDO:27:2:119; Harris Craig, 2012, Methods Mol Biol, V889, P325, DOI 10.1007/978-1-61779-867-2_21; Houghton FD, 2002, BIOL REPROD, V66, P1403, DOI 10.1095/biolreprod66.5.1403; Ishizuka B, 2000, J PINEAL RES, V28, P48, DOI 10.1034/j.1600-079x.2000.280107.x; Izawa S, 1996, BIOCHEM J, V320, P61, DOI 10.1042/bj3200061; Jahromi ZK, 2010, YAKHTEH, V12, P113; Kang JT, 2009, J PINEAL RES, V46, P22, DOI 10.1111/j.1600-079X.2008.00602.x; Kawasumi M, 2009, MOL REPROD DEV, V76, P342, DOI 10.1002/mrd.20966; Khalil M. H., 2002, Options Mediterraneennes. Serie B, Etudes et Recherches, P41; Kotler M, 1998, J PINEAL RES, V24, P83, DOI 10.1111/j.1600-079X.1998.tb00371.x; Lane M, 2002, HUM REPROD, V17, P2686, DOI 10.1093/humrep/17.10.2686; Lavara R, 2000, P 7 WORLD RABB C VAL, P173; Leoni GG, 2008, MOL REPROD DEV, V75, P373, DOI 10.1002/mrd.20754; Li RC, 2004, NEUROBIOL DIS, V17, P44, DOI 10.1016/j.nbd.2004.05.006; Lin JHC, 1998, NAT NEUROSCI, V1, P494, DOI 10.1038/2210; Lledias F, 1998, J BIOL CHEM, V273, P10630, DOI 10.1074/jbc.273.17.10630; Lonergan P, 2003, MOL REPROD DEV, V66, P297, DOI 10.1002/mrd.10357; Maity P, 2009, J PINEAL RES, V46, P314, DOI 10.1111/j.1600-079X.2009.00663.x; Manjunatha BM, 2009, REPROD DOMEST ANIM, V44, P12, DOI 10.1111/j.1439-0531.2007.00982.x; Mehaisen GMK, 2015, ZYGOTE, V23, P111, DOI 10.1017/S0967199413000415; Mehaisen GMK, 2006, THERIOGENOLOGY, V65, P1279, DOI 10.1016/j.theriogenology.2005.08.007; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mohseni M, 2012, MUTAT RES-FUND MOL M, V738, P19, DOI 10.1016/j.mrfmmm.2012.08.006; Myatt L, 2010, PLACENTA, V31, pS66, DOI 10.1016/j.placenta.2009.12.021; Nedambale TL, 2006, ANIM REPROD SCI, V93, P61, DOI 10.1016/j.anireprosci.2005.06.027; Nganvongpanit K, 2006, MOL REPROD DEV, V73, P153, DOI 10.1002/mrd.20406; Noguchi H, 2003, J PHARMACOL SCI, V93, P204, DOI 10.1254/jphs.93.204; Palasz AT, 1996, BIOTECHNOL ADV, V14, P127, DOI 10.1016/0734-9750(96)00005-5; Pang YW, 2013, J PINEAL RES, V54, P389, DOI 10.1111/jpi.12024; Papis K, 2007, J PINEAL RES, V43, P321, DOI 10.1111/j.1600-079X.2007.00479.x; POEGGELER B, 1993, J PINEAL RES, V14, P151, DOI 10.1111/j.1600-079X.1993.tb00498.x; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Raijmakers MTM, 2001, HUM REPROD, V16, P2445, DOI 10.1093/humrep/16.11.2445; Reiter RJ, 2009, BIOL REPROD, V81, P445, DOI 10.1095/biolreprod.108.075655; Rizos D, 2003, BIOL REPROD, V68, P236, DOI 10.1095/biolreprod.102.007799; Rodriguez-Osorio N, 2007, J PINEAL RES, V43, P283, DOI 10.1111/j.1600-079X.2007.00475.x; Shi JM, 2009, J PINEAL RES, V47, P318, DOI 10.1111/j.1600-079X.2009.00717.x; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Succu S, 2014, THERIOGENOLOGY, V81, P1058, DOI 10.1016/j.theriogenology.2014.01.032; Tamas S, 2007, CRYOBIOLOGY, V55, P115, DOI 10.1016/j.cryobiol.2007.06.008; Tatone C, 2010, GYNECOL ENDOCRINOL, V26, P563, DOI 10.3109/09513591003686395; Tian XZ, 2010, ENDOCR RES, V35, P17, DOI 10.3109/07435800903539607; VICENTE JS, 1994, THERIOGENOLOGY, V42, P1205, DOI 10.1016/0093-691X(94)90869-9; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093641; Wang F, 2014, J PINEAL RES, V56, P333, DOI 10.1111/jpi.12126; Wang F, 2013, J PINEAL RES, V55, P267, DOI 10.1111/jpi.12069; Wang HF, 2012, J REPROD DEVELOP, V58, P338, DOI 10.1262/jrd.11-113H; Wrenzycki C, 2001, HUM REPROD, V16, P893, DOI 10.1093/humrep/16.5.893; Wrenzycki C, 2003, BIOL REPROD, V68, P2073, DOI 10.1095/biolreprod.102.012104; Yan H, 1997, BIOCHEM J, V328, P599, DOI 10.1042/bj3280599	82	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139814	10.1371/journal.pone.0139814	http://dx.doi.org/10.1371/journal.pone.0139814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439391	gold, Green Published, Green Submitted			2022-12-27	WOS:000362510300061
J	Tu, J; Guo, J; Li, JJ; Gao, S; Yao, B; Lu, ZH				Tu, Jing; Guo, Jing; Li, Junji; Gao, Shen; Yao, Bei; Lu, Zuhong			Systematic Characteristic Exploration of the Chimeras Generated in Multiple Displacement Amplification through Next Generation Sequencing Data Reanalysis	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; WHOLE GENOME AMPLIFICATION; DNA-POLYMERASE; REPLICATION; INVOLVEMENT	Background The chimeric sequences produced by phi29 DNA polymerase, which are named as chimeras, influence the performance of the multiple displacement amplification (MDA) and also increase the difficulty of sequence data process. Despite several articles have reported the existence of chimeric sequence, there was only one research focusing on the structure and generation mechanism of chimeras, and it was merely based on hundreds of chimeras found in the sequence data of E. coli genome. Method We finished data mining towards a series of Next Generation Sequencing (NGS) reads which were used for whole genome haplotype assembling in a primary study. We established a bioinformatics pipeline based on subsection alignment strategy to discover all the chimeras inside and achieve their structural visualization. Then, we artificially defined two statistical indexes (the chimeric distance and the overlap length), and their regular abundance distribution helped illustrate of the structural characteristics of the chimeras. Finally we analyzed the relationship between the chimera type and the average insertion size, so that illustrate a method to decrease the proportion of wasted data in the procedure of DNA library construction. Results/Conclusion 131.4 Gb pair-end (PE) sequence data was reanalyzed for the chimeras. Totally, 40,259,438 read pairs (6.19%) with chimerism were discovered among 650,430,811 read pairs. The chimeric sequences are consisted of two or more parts which locate inconsecutively but adjacently on the chromosome. The chimeric distance between the locations of adjacent parts on the chromosome followed an approximate bimodal distribution ranging from 0 to over 5,000 nt, whose peak was at about 250 to 300 nt. The overlap length of adjacent parts followed an approximate Poisson distribution and revealed a peak at 6 nt. Moreover, unmapped chimeras, which were classified as the wasted data, could be reduced by properly increasing the length of the insertion segment size through a linear correlation analysis. Significance This study exhibited the profile of the phi29MDA chimeras by tens of millions of chimeric sequences, and helped understand the amplification mechanism of the phi29 DNA polymerase. Our work also illustrated the importance of NGS data reanalysis, not only for the improvement of data utilization efficiency, but also for more potential genomic information.	[Tu, Jing; Guo, Jing; Li, Junji; Gao, Shen; Yao, Bei; Lu, Zuhong] Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Lu, ZH (corresponding author), Southeast Univ, State Key Lab Bioelect, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China.	zhlu@seu.edu.cn	Li, Junji/ABG-8222-2020	Lu, Zuhong/0000-0003-3332-2615; Li, Junji/0000-0002-3104-6824; Tu, Jing/0000-0002-1310-5915	National Natural Science Foundation of China [61227803, 61201343]; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation	This work was supported project 61227803 and 61201343 of National Natural Science Foundation of China and Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Han T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-217; Hughes S, 2005, PROG BIOPHYS MOL BIO, V88, P173, DOI 10.1016/j.pbiomolbio.2004.01.007; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Kaper F, 2013, P NATL ACAD SCI USA, V110, P5552, DOI 10.1073/pnas.1218696110; Kittler R, 2002, ANAL BIOCHEM, V300, P237, DOI 10.1006/abio.2001.5460; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Perez-Arnaiz P, 2007, NUCLEIC ACIDS RES, V35, P7061, DOI 10.1093/nar/gkm749; Rodriguez I, 2009, NUCLEIC ACIDS RES, V37, P193, DOI 10.1093/nar/gkn928; Shoaib M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-415; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wang SQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06400; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	19	14	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139857	10.1371/journal.pone.0139857	http://dx.doi.org/10.1371/journal.pone.0139857			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440104	gold, Green Submitted, Green Published			2022-12-27	WOS:000362510300067
J	Eweleit, L; Reinhold, K; Sauer, J				Eweleit, Lucienne; Reinhold, Klaus; Sauer, Jan			Speciation Progress: A Case Study on the Bushcricket Poecilimon veluchianus	PLOS ONE			English	Article							POPULATION-STRUCTURE; MITOCHONDRIAL; PATTERNS; NUCLEAR; SPERMATOPHORE; INTROGRESSION; DIVERGENCE; ORTHOPTERA; SEQUENCES; BARRIERS	Different mechanisms such as selection or genetic drift permitted e.g. by geographical isolation can lead to differentiation of populations and could cause subsequent speciation. The two subspecies of Poecilimon veluchianus, a bushcricket endemic to central Greece, show a parapatric distribution and are partially reproductively isolated. Therefore, P. veluchianus is suitable to investigate an ongoing speciation process. We based our analysis on sequences of the internal transcribed spacer (ITS) and the mitochondrial control region (CR). The population genetic analysis based on the nuclear marker ITS revealed a barrier to gene flow within the range of Poecilimon veluchianus, which corresponds well to the described subspecies. In contrast to the results based on the nuclear ITS marker, the mitochondrial CR marker does not clearly support the separation into two subspecies with restricted gene flow and a clear contact zone. Furthermore, we could identify isolation by distance (IBD) as one important mechanism responsible for the observed genetic structure (based on the ITS marker). The population genetic analysis based on the nuclear marker ITS also suggests the existence of hybrids in the wild. Furthermore, the simultaneous lack of strong prezygotic barriers and the presence of postzygotic mating barriers, observed in previous laboratory experiments, suggest that a secondary contact after an allopatric phase is more likely than parapatric speciation.	[Eweleit, Lucienne; Reinhold, Klaus] Univ Bielefeld, Dept Evolutionary Biol, D-33615 Bielefeld, Germany; [Sauer, Jan] Univ Bielefeld, Dept Chem Ecol, D-33615 Bielefeld, Germany	University of Bielefeld; University of Bielefeld	Eweleit, L (corresponding author), Univ Bielefeld, Dept Evolutionary Biol, D-33615 Bielefeld, Germany.	lewleit@uni-bielefeld.de; jan.sauer@uni-bielefeld.de			Cusanuswerk; German Research Council [SA-22281]	Cusanuswerk; German Research Council(German Research Foundation (DFG))	LE was funded with a scholarship by the Cusanuswerk. JS was financed by the research grant SA-22281 by the German Research Council. The Article Processing Charge is covered by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Alcaide M, 2014, NATURE, V511, P83, DOI 10.1038/nature13285; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2004, DISTML V 5 FORTRAN C; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Bossart JL, 1998, TRENDS ECOL EVOL, V13, P202, DOI 10.1016/S0169-5347(97)01284-6; Brandtmann G, 1999, BEHAVIOUR, V136, P1123, DOI 10.1163/156853999501793; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Eweleit L, 2014, ECOL ENTOMOL, V39, P133, DOI 10.1111/een.12061; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; FU YX, 1993, GENETICS, V133, P693; Grant PR, 2009, P NATL ACAD SCI USA, V106, P20141, DOI 10.1073/pnas.0911761106; HELLER KG, 1994, BIOL J LINN SOC, V53, P153, DOI 10.1006/bijl.1994.1065; Heller KG, 1992, NATURWISSENSCHAFTEN, V393, P1990; Heller Klaus-Gerhard, 1994, Articulata, V8, P23; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hubbell Stephen P., 2001, V32, pi; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Irwin DE, 2002, EVOLUTION, V56, P2383; Irwin DE, 2001, NATURE, V409, P333, DOI 10.1038/35053059; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Kopp M, 2010, BIOESSAYS, V32, P564, DOI 10.1002/bies.201000023; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lehmann AW, 1998, THESIS FRIEDRICH ALE; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Martiniere A, 2013, EUR J NUTR, P1; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Pfeifer B, 2014, MOL BIOL EVOL, V31, P1929, DOI 10.1093/molbev/msu136; R Core Team, 2021, R LANGUAGE ENV STAT; REINHOLD K, 1994, BIOL J LINN SOC, V52, P305, DOI 10.1111/j.1095-8312.1994.tb00993.x; Reinhold K, 2013, BEHAV ECOL SOCIOBIOL, V67, P395, DOI 10.1007/s00265-012-1459-4; Santini F, 2012, EVOL BIOL, V39, P141, DOI 10.1007/s11692-012-9177-4; Sauer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062569; Sauer J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-299; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 1995, GENETICS, V140, P767; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Verardi A, 2009, ANN ZOOL FENN, V46, P247, DOI 10.5735/086.046.0402; Wakeley J, 2000, EVOLUTION, V54, P1092, DOI 10.1111/j.0014-3820.2000.tb00545.x; Weekers PHH, 2001, MOL PHYLOGENET EVOL, V20, P89, DOI 10.1006/mpev.2001.0947; Zhao L, 2011, ZOOL STUD, V50, P385	51	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139494	10.1371/journal.pone.0139494	http://dx.doi.org/10.1371/journal.pone.0139494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436732	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200029
J	Liu, YW; Carmer, R; Zhang, GN; Venkatraman, P; Brown, SA; Pang, CP; Zhang, MZ; Ma, P; Leung, YF				Liu, Yiwen; Carmer, Robert; Zhang, Gaonan; Venkatraman, Prahatha; Brown, Skye Ashton; Pang, Chi-Pui; Zhang, Mingzhi; Ma, Ping; Leung, Yuk Fai			Statistical Analysis of Zebrafish Locomotor Response	PLOS ONE			English	Article							LARVAL ZEBRAFISH; DANIO-RERIO; BEHAVIOR; DRUGS	Zebrafish larvae display rich locomotor behaviour upon external stimulation. The movement can be simultaneously tracked from many larvae arranged in multi-well plates. The resulting time-series locomotor data have been used to reveal new insights into neurobiology and pharmacology. However, the data are of large scale, and the corresponding locomotor behavior is affected by multiple factors. These issues pose a statistical challenge for comparing larval activities. To address this gap, this study has analyzed a visually-driven locomotor behaviour named the visual motor response (VMR) by the Hotelling's T-squared test. This test is congruent with comparing locomotor profiles from a time period. Different wildtype (WT) strains were compared using the test, which shows that they responded differently to light change at different developmental stages. The performance of this test was evaluated by a power analysis, which shows that the test was sensitive for detecting differences between experimental groups with sample numbers that were commonly used in various studies. In addition, this study investigated the effects of various factors that might affect the VMR by multivariate analysis of variance (MANOVA). The results indicate that the larval activity was generally affected by stage, light stimulus, their interaction, and location in the plate. Nonetheless, different factors affected larval activity differently over time, as indicated by a dynamical analysis of the activity at each second. Intriguingly, this analysis also shows that biological and technical repeats had negligible effect on larval activity. This finding is consistent with that from the Hotelling's T-squared test, and suggests that experimental repeats can be combined to enhance statistical power. Together, these investigations have established a statistical framework for analyzing VMR data, a framework that should be generally applicable to other locomotor data with similar structure.	[Liu, Yiwen; Ma, Ping] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Carmer, Robert; Zhang, Gaonan; Venkatraman, Prahatha; Brown, Skye Ashton; Leung, Yuk Fai] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Carmer, Robert] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; [Pang, Chi-Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Mingzhi] Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China; [Zhang, Mingzhi] Chinese Univ Hong Kong, Shantou, Peoples R China; [Leung, Yuk Fai] Indiana Univ Sch Med Lafayette, Dept Biochem & Mol Biol, W Lafayette, IN USA	University System of Georgia; University of Georgia; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese University of Hong Kong; Shantou University	Zhang, MZ (corresponding author), Shantou Univ, Joint Shantou Int Eye Ctr, Shantou, Peoples R China.	zmz@jsiec.org; pingma@uga.edu; yfleung@purdue.edu	liu, yi/GXE-9662-2022; Ma, Ping/M-7746-2015	Ma, Ping/0000-0002-5728-3596	Howard Hughes Medical Institute Undergraduate Research Experience Program from Purdue University; William H. Phillips Summer Research Internship from Purdue University; Faculty for the Future Fellowship by the Schlumberger Foundation; Medical Panel [2041771]; General Research Fund from the Research Grants Council of Hong Kong [2140694]; National Scientific Foundation of China [81486126]; Provincial Natural Scientific Foundation of China [8151503102000019]; Ministry of Health program of Public Welfare [201302015]; National Science Foundation [DMS-1440037, 1440038, 1438957]; Chinese University of Hong Kong; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Undergraduate Research Experience Program from Purdue University; William H. Phillips Summer Research Internship from Purdue University; Faculty for the Future Fellowship by the Schlumberger Foundation(Schlumberger); Medical Panel; General Research Fund from the Research Grants Council of Hong Kong; National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Scientific Foundation of China; Ministry of Health program of Public Welfare; National Science Foundation(National Science Foundation (NSF)); Chinese University of Hong Kong(Chinese University of Hong Kong); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Robert Carmer was partially supported by a Howard Hughes Medical Institute Undergraduate Research Experience Program from Purdue University. Gaonan Zhang was partially supported by a William H. Phillips Summer Research Internship from Purdue University. Prahatha Venkatraman was partially supported by a Faculty for the Future Fellowship by the Schlumberger Foundation. Chi Pui Pang was partially supported by a Direct grant (Grant No. 2041771) from the Medical Panel, The Chinese University of Hong Kong, and a General Research Fund (Grant No. 2140694) from the Research Grants Council of Hong Kong. Mingzhi Zhang was partially supported by the National Scientific Foundation of China (Grant No. 81486126), the Provincial Natural Scientific Foundation of China (Grant No. 8151503102000019), and the Ministry of Health program of Public Welfare (Grant No. 201302015). Ping Ma and Yiwen Liu were partially supported by National Science Foundation (Grant No. DMS-1440037, 1440038, 1438957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2012, BEHAV BRAIN RES, V228, P272, DOI 10.1016/j.bbr.2011.11.020; Ali S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021076; Anderson T. W., 1958, INTRO MULTIVARIATE S; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Deeti S, 2014, J PHARMACOL TOX MET, V69, P1, DOI 10.1016/j.vascn.2013.09.002; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Emran Farida, 2008, J Vis Exp, DOI 10.3791/923; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Gao Y, 2013, IEEE ACM T COMPUT BI; Hensley MR, 2010, ZEBRAFISH, V7, P219, DOI 10.1089/zeb.2010.0652; Kokel D, 2010, NAT CHEM BIOL, V6, P231, DOI 10.1038/NCHEMBIO.307; Lange M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070172; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Maurer CM, 2010, J NEUROSCI, V30, P11962, DOI 10.1523/JNEUROSCI.2848-10.2010; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Rihel J, 2012, DEV NEUROBIOL, V72, P373, DOI 10.1002/dneu.20910; Rihel J, 2010, METHOD CELL BIOL, V100, P281, DOI 10.1016/B978-0-12-384892-5.00011-6; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Scheiner SM., 1993, DES ANAL ECOL EXP, V94; van Woudenberg AB, 2013, REPROD TOXICOL, V41, P35, DOI 10.1016/j.reprotox.2013.06.067; Vignet C, 2013, ZEBRAFISH, V10, P365, DOI 10.1089/zeb.2013.0871; Zhang LY, 2012, ASIA-PAC J OPHTHALMO, V1, P374, DOI 10.1097/APO.0b013e31827a9969; Zhou YZ, 2014, NAT PROTOC, V9, P1533, DOI 10.1038/nprot.2014.094	30	28	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139521	10.1371/journal.pone.0139521	http://dx.doi.org/10.1371/journal.pone.0139521			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437184	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200032
J	Moon, SM; Park, HY; Jeon, K; Kim, SY; Chung, MJ; Huh, HJ; Ki, CS; Lee, NY; Shin, SJ; Koh, WJ				Moon, Seong Mi; Park, Hye Yun; Jeon, Kyeongman; Kim, Su-Young; Chung, Myung Jin; Huh, Hee Jae; Ki, Chang-Seok; Lee, Nam Yong; Shin, Sung Jae; Koh, Won-Jung			Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; LUNG-DISEASE; PULMONARY INFECTIONS; EPIDEMIOLOGY; COMPLEX; AVIUM; CLARITHROMYCIN; INTRACELLULARE; ABSCESSUS; RELEVANCE	The clinical significance of Mycobacterium kansasii respiratory isolates is uncertain. The aims of this study were to determine the clinical relevance of M. kansasii isolates and to identify the clinical features and outcomes of M. kansasii lung disease. We reviewed the medical records of 104 patients from whom at least one respiratory M. kansasii isolate was obtained from January 2003 to July 2014 at Samsung Medical Center, South Korea. Of these 104 patients, 54 (52%) met the diagnostic criteria for nontuberculous mycobacterial lung disease; among them, 41 (76%) patients received antibiotic treatment for a median time of 15.0 months (interquartile range [IQR], 7.0-18.0 months). The remaining 13 (24%) without overt disease progression were observed for a median period of 24.0 months (IQR, 5.0-34.5 months). Patients with M. kansasii lung disease exhibited various radiographic findings of lung disease, including the fibrocavitary form (n = 24, 44%), the nodular bronchiectatic form (n = 17, 32%), and an unclassifiable form (n = 13, 24%). The fibrocavitary form was more common in patients who received treatment (n = 23, 56%), while the nodular bronchiectatic form was more common in patients with M. kansasii lung disease who did not receive treatment (n = 9, 70%). None of the patients with a single sputum isolate (n = 18) developed M. kansasii disease over a median follow-up period of 12.0 months (IQR, 4.0-26.5 months). In total, 52% of all patients with M. kansasii respiratory isolates exhibited clinically significant disease. Moreover, patients with M. kansasii lung disease displayed diverse radiographic findings in addition to the fibrocavitary form. The nodular bronchiectatic form was more common in patients with M. kansasii lung disease with an indolent clinical course. Thus, since the clinical significance of a single M. kansasii respiratory isolate is not definite, strict adherence to recommended diagnostic criteria is advised.	[Moon, Seong Mi; Park, Hye Yun; Jeon, Kyeongman; Kim, Su-Young; Koh, Won-Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Chung, Myung Jin] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Huh, Hee Jae; Ki, Chang-Seok; Lee, Nam Yong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med, Seoul, South Korea; [Shin, Sung Jae] Yonsei Univ, Coll Med, Dept Microbiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Koh, WJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	wjkoh@skku.edu	Ki, Chang-Seok/G-7559-2014; Koh, Won-Jung/D-9586-2018; Koh, Won Jung/C-9595-2011; ki, cs/O-5931-2014; park, hy/O-5934-2014; Jeon, Kyeongman/F-5963-2019	Ki, Chang-Seok/0000-0001-7679-8731; Koh, Won-Jung/0000-0002-4756-3527; Jeon, Kyeongman/0000-0002-4822-1772; Huh, Hee Jae/0000-0001-8999-7561; Shin, Sung Jae/0000-0003-0854-4582; Lee, Nam Yong/0000-0003-3688-0145	grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea [A120647]	grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A120647). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, M24A2 CLSI; Bloch KC, 1998, ANN INTERN MED, V129, P698, DOI 10.7326/0003-4819-129-9-199811010-00004; Bodle EE, 2008, EMERG INFECT DIS, V14, P390, DOI 10.3201/eid1403.061143; Braun E, 2013, INT J TUBERC LUNG D, V17, P96, DOI 10.5588/ijtld.12.0237; BROWN BA, 1992, ANTIMICROB AGENTS CH, V36, P1987, DOI 10.1128/AAC.36.9.1987; Chien JY, 2014, EMERG INFECT DIS, V20, P1382, DOI 10.3201/eid2008.131673; Chung MJ, 2005, J KOREAN MED SCI, V20, P777, DOI 10.3346/jkms.2005.20.5.777; Corbett EL, 1999, AM J RESP CRIT CARE, V160, P15, DOI 10.1164/ajrccm.160.1.9812080; Davies BS, 2012, SCAND J INFECT DIS, V44, P815, DOI 10.3109/00365548.2012.694469; DEBRUNNER M, 1992, CLIN INFECT DIS, V15, P330, DOI 10.1093/clinids/15.2.330; Falkinham JO, 2013, SEMIN RESP CRIT CARE, V34, P95, DOI 10.1055/s-0033-1333568; Falkinham Joseph O 3rd, 2013, Ann Am Thorac Soc, V10, P378, DOI 10.1513/AnnalsATS.201301-013FR; FOGAN L, 1969, ARCH INTERN MED, V124, P49, DOI 10.1001/archinte.124.1.49; Gommans EPAT, 2015, RESP MED, V109, P137, DOI 10.1016/j.rmed.2014.10.013; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Griffith DE, 2003, CLIN INFECT DIS, V37, P1178, DOI 10.1086/378742; Griffith DE, 2002, CLIN CHEST MED, V23, P613, DOI 10.1016/S0272-5231(02)00016-3; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Jang MA, 2014, J CLIN MICROBIOL, V52, P1207, DOI 10.1128/JCM.03053-13; Jankovic M, 2013, INT J TUBERC LUNG D, V17, P836, DOI 10.5588/ijtld.12.0843; JENKINS PA, 1981, REV INFECT DIS, V3, P1021; Jeong BH, 2015, AM J RESP CRIT CARE, V191, P96, DOI 10.1164/rccm.201408-1545OC; Kartalija M, 2013, AM J RESP CRIT CARE, V187, P197, DOI 10.1164/rccm.201206-1035OC; Kendall BA, 2013, SEMIN RESP CRIT CARE, V34, P87, DOI 10.1055/s-0033-1333567; Kim S, 2008, INT J TUBERC LUNG D, V12, P1344; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Koh WJ, 2013, TUBERC RESPIR DIS, V75, P199, DOI 10.4046/trd.2013.75.5.199; Koh WJ, 2012, CHEST, V142, P1482, DOI 10.1378/chest.12-0494; Lee Geewon, 2013, Ann Am Thorac Soc, V10, P299, DOI 10.1513/AnnalsATS.201303-062OC; Matveychuk A, 2012, RESP MED, V106, P1472, DOI 10.1016/j.rmed.2012.06.023; OBRIEN RJ, 1987, AM REV RESPIR DIS, V135, P1007; PANG SC, 1991, RESP MED, V85, P213, DOI 10.1016/S0954-6111(06)80082-X; Prevots DR, 2015, CLIN CHEST MED, V36, P13, DOI 10.1016/j.ccm.2014.10.002; Shin SJ, 2013, CLIN INFECT DIS, V57, P32, DOI 10.1093/cid/cit172; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Stout Jason E, 2006, Expert Rev Anti Infect Ther, V4, P981, DOI 10.1586/14787210.4.6.981; Taillard C, 2003, J CLIN MICROBIOL, V41, P1240, DOI 10.1128/JCM.41.3.1240-1244.2003; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Wang HY, 2014, INT J TUBERC LUNG D, V18, P1114, DOI 10.5588/ijtld.14.0140; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC	41	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139621	10.1371/journal.pone.0139621	http://dx.doi.org/10.1371/journal.pone.0139621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431540	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700086
J	Rinkevich, FD; Margotta, JW; Pittman, JM; Danka, RG; Tarver, MR; Ottea, JA; Healy, KB				Rinkevich, Frank D.; Margotta, Joseph W.; Pittman, Jean M.; Danka, Robert G.; Tarver, Matthew R.; Ottea, James A.; Healy, Kristen B.			Genetics, Synergists, and Age Affect Insecticide Sensitivity of the Honey Bee, Apis mellifera	PLOS ONE			English	Article							NEONICOTINOID INSECTICIDES; TOXICITY; HYMENOPTERA; DETOXIFICATION; METABOLISM; PESTICIDES; PLASTICITY; RESISTANCE; MITICIDES; DIVERSITY	The number of honey bee colonies in the United States has declined to half of its peak level in the 1940s, and colonies lost over the winter have reached levels that are becoming economically unstable. While the causes of these losses are numerous and the interaction between them is very complex, the role of insecticides has garnered much attention. As a result, there is a need to better understand the risk of insecticides to bees, leading to more studies on both toxicity and exposure. While much research has been conducted on insecticides and bees, there have been very limited studies to elucidate the role that bee genotype and age has on the toxicity of these insecticides. The goal of this study was to determine if there are differences in insecticide sensitivity between honey bees of different genetic backgrounds (Carniolan, Italian, and Russian stocks) and assess if insecticide sensitivity varies with age. We found that Italian bees were the most sensitive of these stocks to insecticides, but variation was largely dependent on the class of insecticide tested. There were almost no differences in organophosphate bioassays between honey bee stocks (< 1-fold), moderate differences in pyrethroid bioassays (1.5 to 3-fold), and dramatic differences in neonicotinoid bioassays (3.4 to 33.3-fold). Synergism bioassays with piperonyl butoxide, amitraz, and coumaphos showed increased phenothrin sensitivity in all stocks and also demonstrated further physiological differences between stocks. In addition, as bees aged, the sensitivity to phenothrin significantly decreased, but the sensitivity to naled significantly increased. These results demonstrate the variation arising from the genetic background and physiological transitions in honey bees as they age. This information can be used to determine risk assessment, as well as establishing baseline data for future comparisons to explain the variation in toxicity differences for honey bees reported in the literature.	[Rinkevich, Frank D.; Margotta, Joseph W.; Pittman, Jean M.; Ottea, James A.; Healy, Kristen B.] Louisiana State Univ, Ctr Agr, Dept Entomol, Life Sci Annex, Baton Rouge, LA 70803 USA; [Danka, Robert G.; Tarver, Matthew R.] USDA ARS Honey Bee Breeding, Genet & Physiol Lab, Baton Rouge, LA USA	Louisiana State University System; Louisiana State University	Healy, KB (corresponding author), Louisiana State Univ, Ctr Agr, Dept Entomol, Life Sci Annex, Baton Rouge, LA 70803 USA.	KHealy@agcenter.lsu.edu		Healy, Kristen/0000-0002-3208-6537	US Environmental Protection Agency (EPA) [83558201]; Louisiana State University Agricultural Center	US Environmental Protection Agency (EPA)(United States Environmental Protection Agency); Louisiana State University Agricultural Center	This work was funded by a grant from the US Environmental Protection Agency to assess the effects of mosquito adulticides on bees (EPA Grant#83558201 to JAO and KBH) and by the Louisiana State University Agricultural Center. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; CASIDA JE, 1962, J AGR FOOD CHEM, V10, P370, DOI 10.1021/jf60123a005; Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; DANKA RG, 1986, J ECON ENTOMOL, V79, P18, DOI 10.1093/jee/79.1.18; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Elzen PJ, 2003, SOUTHWEST ENTOMOL, V28, P255; GILBERT MD, 1974, PESTIC BIOCHEM PHYS, V4, P56, DOI 10.1016/0048-3575(74)90084-4; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Harpur BA, 2012, MOL ECOL, V21, P4414, DOI 10.1111/j.1365-294X.2012.05614.x; Harrison JF, 2002, COMP BIOCHEM PHYS A, V133, P323, DOI 10.1016/S1095-6433(02)00163-0; HARRISON JM, 1986, PHYSIOL ZOOL, V59, P175, DOI 10.1086/physzool.59.2.30156031; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; HUANG ZY, 1992, P NATL ACAD SCI USA, V89, P11726, DOI 10.1073/pnas.89.24.11726; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Johnson RM, 2009, J ECON ENTOMOL, V102, P474, DOI 10.1603/029.102.0202; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; JONES D, 1998, PIPERONYL BUTOXIDE I; Kammer A.E., 1978, Advances in Insect Physiology, V13, P133, DOI 10.1016/S0065-2806(08)60266-0; Laurino D, 2013, B INSECTOL, V66, P119; LIU MY, 1992, PESTIC BIOCHEM PHYS, V43, P134, DOI 10.1016/0048-3575(92)90027-W; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333; NATHANSON JA, 1985, P NATL ACAD SCI USA, V82, P599, DOI 10.1073/pnas.82.2.599; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007; Rinkevich FD, 2012, PESTIC BIOCHEM PHYS, V104, P163, DOI 10.1016/j.pestbp.2012.06.008; Robertson J. L., 1992, PESTICIDE BIOASSAYS; ROTHENBUHLER WC, 1958, ANNU REV ENTOMOL, V3, P161, DOI 10.1146/annurev.en.03.010158.001113; Sandrock C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103592; Scott JG, 1999, INSECT BIOCHEM MOLEC, V29, P757, DOI 10.1016/S0965-1748(99)00038-7; Scott JG, 2001, BIOCHEMICAL SITES OF INSECTICIDE ACTION AND RESISTANCE, P255; Seeley T., 1995, WISDOM HIVE SOCIAL P; SMIRLE MJ, 1988, CAN J ZOOL, V66, P1938, DOI 10.1139/z88-283; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; STEVENSON JH, 1978, PLANT PATHOL, V27, P38, DOI 10.1111/j.1365-3059.1978.tb01070.x; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Winston M.L., 1991, BIOL HONEY BEE; WU JT, 2011, PLOS MED, V8, DOI DOI 10.1371/JOURNAL.PONE.0014720; Zhong H, 2003, ARCH ENVIRON CON TOX, V45, P216, DOI 10.1007/s00244-002-0185-8	51	72	74	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139841	10.1371/journal.pone.0139841	http://dx.doi.org/10.1371/journal.pone.0139841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431171	Green Published, gold			2022-12-27	WOS:000362178700125
J	Son, HY; Sohn, SW; Im, SH; Kim, HJ; Lee, MK; Gombojav, B; Kwon, HS; Park, DS; Kim, HL; Min, KU; Sung, J; Seo, JS; Kim, JI				Son, Ho-Young; Sohn, Seong-Wook; Im, Sun-Hwa; Kim, Hyun-Jin; Lee, Mi Kyeong; Gombojav, Bayasgalan; Kwon, Hyouk-Soo; Park, Daniel S.; Kim, Hyung-Lae; Min, Kyung-Up; Sung, Joohon; Seo, Jeong-Sun; Kim, Jong-Il			Family-Based Association Study of Pulmonary Function in a Population in Northeast Asia	PLOS ONE			English	Article							INFLUENCING LUNG-FUNCTION; WIDE LINKAGE ANALYSIS; GENOME-WIDE; HEALTHY TWIN; GENETIC-LOCI; ASTHMA; HEART; MORTALITY; DISEASE; TRAITS	The spirometric measurement of pulmonary function by measuring the forced expiratory volume in one second (FEV1) is a heritable trait that reflects the physiological condition of the lung and airways. Genome-wide linkage and association studies have identified a number of genes and genetic loci associated with pulmonary function. However, limited numbers of studies have been reported for Asian populations. In this study, we aimed to investigate genetic evidence of pulmonary function in a population in northeast Asia. We conducted a family-based association test with 706 GENDISCAN study participants from 72 Mongolian families to determine candidate genetic determinants of pulmonary function. For the replication, we chose seven candidate single nucleotide polymorphisms (SNPs) from the 5 loci, and tested 1062 SNPs for association with FEV1 from 2,729 subjects of the Korea Healthy Twin study. We identified TMEM132C as a potential candidate gene at 12q24.3, which is a previously reported locus of asthma and spirometric indices. We also found two adjacent candidate genes (UNC93A and TTLL2) in the 6q27 region, which has been previously identified as a pulmonary function locus in the Framingham cohort study. Our findings suggest that novel candidate genes (TMEM132C, UNC93A and TTLL2) in two different regions are associated with pulmonary function in a population in northeast Asia.	[Son, Ho-Young; Im, Sun-Hwa; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Sohn, Seong-Wook] Dongguk Univ, Dept Internal Med, Ilsan Hosp, Goyang, South Korea; [Im, Sun-Hwa] Chung Ang Univ, Coll Med, Dept Obstet & Gynecol, Seoul 156756, South Korea; [Kim, Hyun-Jin; Gombojav, Bayasgalan; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst, Seoul, South Korea; [Lee, Mi Kyeong; Gombojav, Bayasgalan; Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol, Seoul, South Korea; [Lee, Mi Kyeong; Gombojav, Bayasgalan; Sung, Joohon] Seoul Natl Univ, Sch Publ Hlth, Inst Environm & Hlth, Seoul, South Korea; [Kwon, Hyouk-Soo] Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Park, Daniel S.] Harvard Univ, Dept Cellular & Dev Biol, Cambridge, MA 02138 USA; [Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea; [Min, Kyung-Up] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kim, Jong-Il] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Dongguk University; NHIS Ilsan Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center; Harvard University; Ewha Womans University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Seo, JS (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jeongsun@snu.ac.kr; jongil@snu.ac.kr	SON, HO YOUNG/AAJ-3905-2020; Seo, Jeong-Sun/J-2763-2012; Lee, Mi Kyeong/C-3046-2017; KIM, JONG-IL/D-1019-2011	Lee, Mi Kyeong/0000-0002-3036-3684; KIM, JONG-IL/0000-0002-7240-3744; Gombojav, Bayasgalan/0000-0002-4129-3140; Ho-young, Son/0000-0001-6326-5071; Son, Hwa-Young/0000-0003-4388-0952; Park, Daniel/0000-0001-5191-1371	Korean Ministry of Education, Science and Technology [2003-2001558]; National Research Foundation of Korea (NRF) - Korea government (MSIP) [2012R1A5A2A44671346]; Research Settlement Fund for the new faculty of SNU	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF) - Korea government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Research Settlement Fund for the new faculty of SNU	This work was supported by the Korean Ministry of Education, Science and Technology (Grant No. 2003-2001558) JIK JSS. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2012R1A5A2A44671346). This work was supported by Research Settlement Fund for the new faculty of SNU.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Arnlov J, 2005, EUR J HEART FAIL, V7, P958, DOI 10.1016/j.ejheart.2004.06.009; Brasch-Andersen C, 2006, THORAX, V61, P874, DOI 10.1136/thx.2005.055475; Crapo RO, 2000, AM J RESP CRIT CARE, V161, P309; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Ferreira MAR, 2005, AM J HUM GENET, V77, P1075, DOI 10.1086/497997; Gombojav B, 2013, TWIN RES HUM GENET, V16, P241, DOI 10.1017/thg.2012.130; Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500; Hansel NN, 2013, HUM GENET, V132, P79, DOI 10.1007/s00439-012-1219-6; Hole DJ, 1996, BRIT MED J, V313, P711; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Ikegami K, 2010, P NATL ACAD SCI USA, V107, P10490, DOI 10.1073/pnas.1002128107; Im SW, 2010, EXP MOL MED, V42, P799, DOI 10.3858/emm.2010.42.12.080; Joost O, 2002, AM J RESP CRIT CARE, V165, P795, DOI 10.1164/ajrccm.165.6.2102057; Kim WJ, 2014, RESPIROLOGY, V19, P360, DOI 10.1111/resp.12230; Kristiansson K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-109; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; LEVIN JZ, 1992, J CELL BIOL, V117, P143, DOI 10.1083/jcb.117.1.143; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; Paik SH, 2012, EXP MOL MED, V44, P241, DOI 10.3858/emm.2012.44.3.020; Palmer LJ, 2001, EUR RESPIR J, V17, P696, DOI 10.1183/09031936.01.17406960; Park H, 2013, KIDNEY INT, V83, P285, DOI 10.1038/ki.2012.389; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501; Shao CC, 2004, J HUM GENET, V49, P115, DOI 10.1007/s10038-003-0118-z; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Soler Artigas M, 2012, THORAX, V67, P271, DOI 10.1136/thoraxjnl-2011-200724; Soler Artigas M, 2011, NAT GENET, V43, P1082, DOI 10.1038/ng.941; STRACHAN DP, 1992, J EPIDEMIOL COMMUN H, V46, P66, DOI 10.1136/jech.46.1.66; Sung J, 2006, TWIN RES HUM GENET, V9, P844, DOI 10.1375/183242706779462822; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Vogel P, 2010, VET PATHOL, V47, P703, DOI 10.1177/0300985810363485; Wilk JB, 2000, GENET EPIDEMIOL, V19, P81, DOI 10.1002/1098-2272(200007)19:1<81::AID-GEPI6>3.0.CO;2-8; Wilk JB, 2003, HUM MOL GENET, V12, P2745, DOI 10.1093/hmg/ddg311; Wilk JB, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S8; Wilk JB, 2007, AM J RESP CRIT CARE, V175, P554, DOI 10.1164/rccm.200601-110OC; Wilk JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000429; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139716	10.1371/journal.pone.0139716	http://dx.doi.org/10.1371/journal.pone.0139716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430897	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700102
J	Gracitelli, CPB; Tatham, AJ; Boer, ER; Abe, RY; Diniz, A; Rosen, PN; Medeiros, FA				Gracitelli, Carolina P. B.; Tatham, Andrew J.; Boer, Erwin R.; Abe, Ricardo Y.; Diniz-Filho, Alberto; Rosen, Peter N.; Medeiros, Felipe A.			Predicting Risk of Motor Vehicle Collisions in Patients with Glaucoma: A Longitudinal Study	PLOS ONE			English	Article							INCREASED DEPRESSIVE SYMPTOMS; VISUAL-FIELD LOSS; QUALITY-OF-LIFE; OLDER DRIVERS; DRIVING PERFORMANCE; EXPLAINED VARIATION; IMPAIRMENT; ASSOCIATION; INVOLVEMENT; PROGRESSION	Purpose To evaluate the ability of longitudinal Useful Field of View (UFOV) and simulated driving measurements to predict future occurrence of motor vehicle collision (MVC) in drivers with glaucoma. Design Prospective observational cohort study. Participants 117 drivers with glaucoma followed for an average of 2.1 +/- 0.5 years. Methods All subjects had standard automated perimetry (SAP), UFOV, driving simulator, and cognitive assessment obtained at baseline and every 6 months during follow-up. The driving simulator evaluated reaction times to high and low contrast peripheral divided attention stimuli presented while negotiating a winding country road, with central driving task performance assessed as "curve coherence". Drivers with MVC during follow-up were identified from Department of Motor Vehicle records. Main Outcome Measures Survival models were used to evaluate the ability of driving simulator and UFOV to predict MVC over time, adjusting for potential confounding factors. Results Mean age at baseline was 64.5 +/- 12.6 years. 11 of 117 (9.4%) drivers had a MVC during follow-up. In the multivariable models, low contrast reaction time was significantly predictive of MVC, with a hazard ratio (HR) of 2.19 per 1 SD slower reaction time (95% CI, 1.30 to 3.69; P = 0.003). UFOV divided attention was also significantly predictive of MVC with a HR of 1.98 per 1 SD worse (95% CI, 1.10 to 3.57; P = 0.022). Global SAP visual field indices in the better or worse eye were not predictive of MVC. The longitudinal model including driving simulator performance was a better predictor of MVC compared to UFOV (R-2 = 0.41 vs R-2 = 0.18). Conclusions Longitudinal divided attention metrics on the UFOV test and during simulated driving were significantly predictive of risk of MVC in glaucoma patients. These findings may help improve the understanding of factors associated with driving impairment related to glaucoma.	[Gracitelli, Carolina P. B.; Tatham, Andrew J.; Boer, Erwin R.; Abe, Ricardo Y.; Diniz-Filho, Alberto; Rosen, Peter N.; Medeiros, Felipe A.] Univ Calif San Diego, Dept Ophthalmol, Visual Performance Lab, San Diego, CA 92103 USA; [Gracitelli, Carolina P. B.] Univ Fed Sao Paulo, Dept Ophthalmol, Sao Paulo, Brazil; [Tatham, Andrew J.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Tatham, Andrew J.] Univ Edinburgh, Dept Ophthalmol, Edinburgh, Midlothian, Scotland; [Boer, Erwin R.] Entropy Control Inc, La Jolla, CA USA; [Abe, Ricardo Y.] Univ Estadual Campinas, Dept Ophthalmol, Sao Paulo, Brazil; [Diniz-Filho, Alberto] Univ Fed Minas Gerais, Dept Ophthalmol & Otorhinolaryngol, Belo Horizonte, MG, Brazil	University of California System; University of California San Diego; Universidade Federal de Sao Paulo (UNIFESP); University of Edinburgh; University of Edinburgh; Universidade Estadual de Campinas; Universidade Federal de Minas Gerais	Medeiros, FA (corresponding author), Univ Calif San Diego, Dept Ophthalmol, Visual Performance Lab, San Diego, CA 92103 USA.	fmedeiros@glaucoma.ucsd.edu	Gracitelli, Carolina/ABI-5387-2020; Filho, Alberto Diniz/C-8564-2015; Abe, Ricardo Y/L-1965-2018	Gracitelli, Carolina/0000-0001-5086-9060; Filho, Alberto Diniz/0000-0002-0371-2359; Abe, Ricardo Y/0000-0002-7023-2144; Tatham, Andrew/0000-0003-0372-3100	National Institutes of Health/National Eye Institute [EY021818, P30EY022589]; Research to Prevent Blindness (New York, NY); Alcon; Allergan; Pfizer; Merck; Santen; Brazilian National Research Council-CAPES [12309-13-3]; Entropy Control, Inc.; NATIONAL EYE INSTITUTE [P30EY022589, R01EY021818] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness (New York, NY)(Research to Prevent Blindness (RPB)); Alcon(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); Merck(Merck & Company); Santen; Brazilian National Research Council-CAPES(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Entropy Control, Inc.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported in part by the National Institutes of Health/National Eye Institute grants EY021818 (F.A.M.), core grant P30EY022589; an unrestricted grant from Research to Prevent Blindness (New York, NY); grants for participants' glaucoma medications from Alcon, Allergan, Pfizer, Merck and Santen; fellowships from Brazilian National Research Council-CAPES 12309-13-3 (CPBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Coauthor Erwin R. Boer is employed by Entropy Control, Inc. Entropy Control, Inc., provided support in the form of salary for author ERB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	BALL K, 1993, INVEST OPHTH VIS SCI, V34, P3110; Ball K, 1993, J Am Optom Assoc, V64, P71; BROOKHUIS K, 1994, ERGONOMICS, V37, P427, DOI 10.1080/00140139408963661; Choodari-Oskooei B, 2012, STAT MED, V31, P2627, DOI 10.1002/sim.4242; DeCarlo DK, 2003, OPTOMETRY VISION SCI, V80, P207, DOI 10.1097/00006324-200303000-00010; Fonda SJ, 2001, J GERONTOL B-PSYCHOL, V56, pS343, DOI 10.1093/geronb/56.6.S343; Friedman C, 2013, INVEST OPHTH VIS SCI, V54, P778, DOI 10.1167/iovs.12-11249; Glen FC, 2015, BRIT J OPHTHALMOL, V99, P613, DOI 10.1136/bjophthalmol-2014-305932; Haymes SA, 2008, INVEST OPHTH VIS SCI, V49, P3035, DOI 10.1167/iovs.07-1609; Haymes SA, 2007, INVEST OPHTH VIS SCI, V48, P1149, DOI 10.1167/iovs.06-0886; Hendricks DL, 1999, RELATIVE FREQUENCY U; Hettinger L J, 1990, Mil Psychol, V2, P171, DOI 10.1207/s15327876mp0203_4; HU PS, 1999, FHWAPL00006 US DEP T; Jampel H D, 2001, Trans Am Ophthalmol Soc, V99, P301; Janz NK, 2009, INVEST OPHTH VIS SCI, V50, P1718, DOI 10.1167/iovs.08-2575; Kleinbaum D.G., 2005, SURVIVAL ANAL SELF L; Kunimatsu-Sanuki S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006379; LERMAN Y, 1993, AVIAT SPACE ENVIR MD, V64, P619; Marottoli RA, 1997, J AM GERIATR SOC, V45, P202, DOI 10.1111/j.1532-5415.1997.tb04508.x; MCCLOSKEY LW, 1994, AGE AGEING, V23, P267, DOI 10.1093/ageing/23.4.267; McGwin G, 2005, INVEST OPHTH VIS SCI, V46, P4437, DOI 10.1167/iovs.05-0750; McGwin G, 2004, INVEST OPHTH VIS SCI, V45, P3934, DOI 10.1167/iovs.04-0524; Medeiros FA, 2012, J GLAUCOMA, V21, P221, DOI 10.1097/IJG.0b013e3182071832; Meira-Freitas D, 2014, OPHTHALMOLOGY, V121, P498, DOI 10.1016/j.ophtha.2013.09.016; Meira-Freitas D, 2013, INVEST OPHTH VIS SCI, V54, P4174, DOI 10.1167/iovs.12-11301; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nelson-Quigg JM, 2000, INVEST OPHTH VIS SCI, V41, P2212; Ono T, 2015, OPTOMETRY VISION SCI, V92, P357, DOI 10.1097/OPX.0000000000000493; Owsley C, 1999, J GERONTOL A-BIOL, V54, pM203, DOI 10.1093/gerona/54.4.M203; Owsley C, 1998, Ophthalmic Epidemiol, V5, P101, DOI 10.1076/opep.5.2.101.1574; OWSLEY C, 1991, PSYCHOL AGING, V6, P403, DOI 10.1037/0882-7974.6.3.403; Owsley C, 1998, JAMA-J AM MED ASSOC, V279, P1083, DOI 10.1001/jama.279.14.1083; Owsley C, 2010, VISION RES, V50, P2348, DOI 10.1016/j.visres.2010.05.021; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Ramulu P, 2009, CURR OPIN OPHTHALMOL, V20, P92, DOI 10.1097/ICU.0b013e32832401a9; Ramulu PY, 2009, OPHTHALMOLOGY, V116, P1846, DOI 10.1016/j.ophtha.2009.03.033; Richman J, 2010, OPHTHAL EPIDEMIOL, V17, P144, DOI 10.3109/09286581003734878; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Rubin GS, 2007, INVEST OPHTH VIS SCI, V48, P1483, DOI 10.1167/iovs.06-0474; Szlyk JP, 2005, J GLAUCOMA, V14, P145, DOI 10.1097/01.ijg.0000151686.89162.28; Tanabe S, 2011, INVEST OPHTH VIS SCI, V52, P4177, DOI 10.1167/iovs.10-6264; Tatham AJ, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.3.5; Tatham AJ, 2014, AM J OPHTHALMOL, V158, P1008, DOI 10.1016/j.ajo.2014.07.028; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192	44	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138288	10.1371/journal.pone.0138288	http://dx.doi.org/10.1371/journal.pone.0138288			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426342	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100012
J	Kokes, M; Valdivia, RH				Kokes, Marcela; Valdivia, Raphael H.			Differential Translocation of Host Cellular Materials into the Chlamydia trachomatis Inclusion Lumen during Chemical Fixation	PLOS ONE			English	Article							ENDOCYTIC MULTIVESICULAR BODIES; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; LIPID DROPLETS; INFECTED CELLS; HELA-CELLS; VACUOLE; MITOCHONDRIA; TRAFFICKING; PATHWAY	Chlamydia trachomatis manipulates host cellular pathways to ensure its proliferation and survival. Translocation of host materials into the pathogenic vacuole (termed 'inclusion') may facilitate nutrient acquisition and various organelles have been observed within the inclusion, including lipid droplets, peroxisomes, multivesicular body components, and membranes of the endoplasmic reticulum (ER). However, few of these processes have been documented in living cells. Here, we survey the localization of a broad panel of subcellular elements and find ER, mitochondria, and inclusion membranes within the inclusion lumen of fixed cells. However, we see little evidence of intraluminal localization of these organelles in live inclusions. Using time-lapse video microscopy we document ER marker translocation into the inclusion lumen during chemical fixation. These intra-inclusion ER elements resist a variety of post-fixation manipulations and are detectable via immunofluorescence microscopy. We speculate that the localization of a subset of organelles may be exaggerated during fixation. Finally, we find similar structures within the pathogenic vacuole of Coxiella burnetti infected cells, suggesting that fixation-induced translocation of cellular materials may occur into the vacuole of a range of intracellular pathogens.	[Valdivia, Raphael H.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA; Duke Univ, Med Ctr, Ctr Genom Microbial Syst, Durham, NC USA	Duke University; Duke University	Valdivia, RH (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27708 USA.	raphael.valdivia@duke.edu	Valdivia, Raphael/R-5377-2019	Valdivia, Raphael/0000-0003-0961-073X; Kokes, Marcela/0000-0002-7218-481X	National Institutes of Health [AI081694]; American Heart Association [11PRE7360030]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants AI081694 to RHV and American Heart Association (http://www.heart.org/HEARTORG/) grant 11PRE7360030 to MK. RHV is a Burroughs Wellcome Scholar in the Pathogenesis of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Beatty WL, 2008, INFECT IMMUN, V76, P2872, DOI 10.1128/IAI.00129-08; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; Boncompain G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086196; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Capmany A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014084; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cox JV, 2012, CELL MICROBIOL, V14, P1497, DOI 10.1111/j.1462-5822.2012.01823.x; Derre I, 2007, PLOS PATHOG, V3, P1446, DOI 10.1371/journal.ppat.0030155; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dumoux M, 2012, TRAFFIC, V13, P1612, DOI 10.1111/tra.12002; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Giles DK, 2008, MICROBES INFECT, V10, P1494, DOI 10.1016/j.micinf.2008.09.001; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; HIGGINS ML, 1976, J BACTERIOL, V127, P1519, DOI 10.1128/JB.127.3.1519-1523.1976; Ji N, 2008, CURR OPIN NEUROBIOL, V18, P605, DOI 10.1016/j.conb.2009.03.009; Kokes M, 2015, CELL HOST MICROBE, V17, P716, DOI 10.1016/j.chom.2015.03.014; Kokes M, 2012, INTERCELLULAR PATHOGENS I: CHLAMYDIALES, P170, DOI 10.1128/9781555817329.ch8; Kumar Y, 2008, CELL HOST MICROBE, V4, P159, DOI 10.1016/j.chom.2008.05.018; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Kumar Y, 2009, CELL HOST MICROBE, V5, P593, DOI 10.1016/j.chom.2009.05.014; Lee K, 2013, CHEM COMMUN, V49, P3028, DOI 10.1039/c3cc40799c; Majeed M, 1999, J CELL SCI, V112, P35; MATSUMOTO A, 1991, J ELECTRON MICROSC, V40, P356; Moorhead AM, 2010, INFECT IMMUN, V78, P1990, DOI 10.1128/IAI.01340-09; NANNINGA N, 1971, J CELL BIOL, V48, P219, DOI 10.1083/jcb.48.1.219; Ouellette S, 2010, FRONT CELL INFECT MI, V1; Ouellette SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016783; Pearse A. G., 1980, HISTOCHEMISTRY THEOR; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schachter J, 1999, CHLAMYDIA, P139; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; SCOTT RE, 1976, SCIENCE, V194, P743, DOI 10.1126/science.982043; Soupene E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036843; STOKES GV, 1980, CAN J MICROBIOL, V26, P396, DOI 10.1139/m80-065; Taraska T, 1996, INFECT IMMUN, V64, P3713, DOI 10.1128/IAI.64.9.3713-3727.1996; Thavarajah Rooban, 2012, J Oral Maxillofac Pathol, V16, P400, DOI 10.4103/0973-029X.102496; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	49	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139153	10.1371/journal.pone.0139153	http://dx.doi.org/10.1371/journal.pone.0139153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426122	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100034
J	Palanisamy, T; Krishnasamy, KN				Palanisamy, Thirumoorthy; Krishnasamy, Karthikeyan N.			Bayes Node Energy Polynomial Distribution to Improve Routing in Wireless Sensor Network	PLOS ONE			English	Article								Wireless Sensor Network monitor and control the physical world via large number of small, low-priced sensor nodes. Existing method on Wireless Sensor Network (WSN) presented sensed data communication through continuous data collection resulting in higher delay and energy consumption. To conquer the routing issue and reduce energy drain rate, Bayes Node Energy and Polynomial Distribution (BNEPD) technique is introduced with energy aware routing in the wireless sensor network. The Bayes Node Energy Distribution initially distributes the sensor nodes that detect an object of similar event (i.e., temperature, pressure, flow) into specific regions with the application of Bayes rule. The object detection of similar events is accomplished based on the bayes probabilities and is sent to the sink node resulting in minimizing the energy consumption. Next, the Polynomial Regression Function is applied to the target object of similar events considered for different sensors are combined. They are based on the minimum and maximum value of object events and are transferred to the sink node. Finally, the Poly Distribute algorithm effectively distributes the sensor nodes. The energy efficient routing path for each sensor nodes are created by data aggregation at the sink based on polynomial regression function which reduces the energy drain rate with minimum communication overhead. Experimental performance is evaluated using Dodgers Loop Sensor Data Set from UCI repository. Simulation results show that the proposed distribution algorithm significantly reduce the node energy drain rate and ensure fairness among different users reducing the communication overhead.	[Palanisamy, Thirumoorthy] Nandha Engn Coll, Dept Comp Sci & Engn, Erode, Tamil Nadu, India; [Krishnasamy, Karthikeyan N.] Sri Krishna Coll Engn & Technol, Dept Informat Technol, Coimbatore, Tamil Nadu, India	Sri Krishna College of Engineering & Technology	Palanisamy, T (corresponding author), Nandha Engn Coll, Dept Comp Sci & Engn, Erode, Tamil Nadu, India.	thiru4u@gmail.com	Thirumoorthy, P/AAD-5947-2021	P, Thirumoorthy/0000-0002-1456-5606				Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Grobler MJ, 2014, INT J DISTRIB SENS N, V2014, P1; Gupta GR, 2010, IEEE ACM T NETWORK, V18, P393, DOI 10.1109/TNET.2009.2032181; Han XF, 2010, IEEE T MOBILE COMPUT, V9, P643, DOI 10.1109/TMC.2009.161; Heidari M, 2015, TURK J ELECENG COMP, DOI [10.3906/elk-1209-18, DOI 10.3906/ELK-1209-18]; Ji SL, 2014, IEEE T MOBILE COMPUT, V13, P626, DOI 10.1109/TMC.2013.30; Kang S, 2010, IEEE T MOBILE COMPUT, V9, P686, DOI 10.1109/TMC.2009.154; Kim J, 2010, IEEE ACM T NETWORK, V18, P515, DOI 10.1109/TNET.2009.2032294; Kim Y, 2014, INFORM SCIENCES, V282, P332, DOI 10.1016/j.ins.2014.05.056; Li XL, 2013, MATCH-COMMUN MATH CO, V70, P85; Melodia T, 2010, IEEE T MOBILE COMPUT, V9, P160, DOI 10.1109/TMC.2009.102; Misra S, 2010, IEEE ACM T NETWORK, V18, P434, DOI 10.1109/TNET.2009.2033273; Mohammadzadeh J, 2014, MATCH-COMMUN MATH CO, V72, P501; Park KJ, 2010, IEEE T MOBILE COMPUT, V9, P87, DOI 10.1109/TMC.2009.98; Ruhrup S, 2010, IEEE ACM T NETWORK, V18, P95, DOI 10.1109/TNET.2009.2022084; Sazak N, 2013, TURK J ELECTR ENG CO, V21, P812, DOI 10.3906/elk-1108-14; Starobinski D, 2010, IEEE ACM T NETWORK, V18, P695, DOI 10.1109/TNET.2009.2032230; Tyrrell A, 2010, IEEE T MOBILE COMPUT, V9, P719, DOI 10.1109/TMC.2009.173; Venkataramanan VJ, 2010, IEEE ACM T NETWORK, V18, P788, DOI 10.1109/TNET.2009.2037896; Villas LA, 2013, IEEE T COMPUT, V62, P676, DOI 10.1109/TC.2012.31; Wang JX, 2014, INFORM SCIENCES, V254, P39, DOI 10.1016/j.ins.2013.08.019; Yu Z, 2010, IEEE ACM T NETWORK, V18, P150, DOI 10.1109/TNET.2009.2026901; Zhang C, 2010, IEEE T MOBILE COMPUT, V9, P850, DOI 10.1109/TMC.2010.29; Zhang DG, 2012, COMPUT MATH APPL, V64, P1044, DOI 10.1016/j.camwa.2012.03.023; Zhang DG, 2014, IEEE T SERV COMPUT, V7, P741, DOI 10.1109/TSC.2014.2370642; Zhang DG, 2014, IEEE T IND INFORM, V10, P766, DOI 10.1109/TII.2013.2250910	27	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138932	10.1371/journal.pone.0138932	http://dx.doi.org/10.1371/journal.pone.0138932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426701	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100027
J	Yang, B; Wei, W; Shi, YY; Huang, ZC; Cai, B; Zhang, JL; Ying, BW; Wang, LL				Yang, Bin; Wei, Wei; Shi, Yunying; Huang, Zhuochun; Cai, Bei; Zhang, Junlong; Ying, Binwu; Wang, Lanlan			Genetic Variation in miR-146a Is Not Associated with Susceptibility to IgA Nephropathy in Adults from a Chinese Han Population	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SAMPLE-SIZE REQUIREMENTS; MICRORNAS; EXPRESSION; POLYMORPHISMS; PROGRESSION; DEPOSITION; CANCER; RISK	Background MicroRNA 146a (miR-146a) is a 19 to 23 nucleotide long, small non-coding RNA with gene regulatory functions that has influence on the pathogenesis of many diseases. A single nucleotide polymorphism (rs2910164 C>G) in pre-miR-146a is correlated with the expression of miR-146a. The aim of this study was to perform an association analysis of rs2910164 with IgA nephropathy in adult patients from a Chinese Han population. Methods A total of 145 patients with renal biopsy-proved IgA nephropathy (IgAN) and 179 healthy controls were recruited to the current study. rs2910164 was genotyped by the polymerase chain reaction (PCR) and high-resolution melting methods (HRM). Clinical characteristics and pathology grading of patients with IgAN were recorded at the time of kidney biopsy. Result There were significant differences among the population of patients grouped by different age of onset in a co-dominant model (CG vs. CCvs. GG) (p = 0.033) and a recessive model (CG+CC vs. GG) (p = 0.001). However, no significant difference was observed in the distribution of genotypes between cases and controls (p = 0.144). There was also no significant difference between rs2910164 and patient quantitative traits (all p > 0.003) or different pathology grading (Lee's grading system and tubular atrophy/interstitial fibrosis in the Oxford classification) (all p > 0.05). Conclusions There was no association of rs2910164 with susceptibility to IgAN in adults from a Chinese Han population. However, rs2910164 was correlated with the age of onset of IgAN in adult patients.	[Yang, Bin; Huang, Zhuochun; Cai, Bei; Zhang, Junlong; Ying, Binwu; Wang, Lanlan] Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610041, Peoples R China; [Wei, Wei] Sichuan Univ, West China Sch Med, Chengdu 610041, Peoples R China; [Shi, Yunying] Sichuan Univ, West China Hosp, Dept Nephrol, Chengdu 610041, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Wang, LL (corresponding author), Sichuan Univ, West China Hosp, Dept Lab Med, Chengdu 610041, Peoples R China.	wanglanlanhx@163.com	Yang, Bin/Q-6463-2019; Yang, Bin/Y-8079-2019; Shi, Yun Ying/GWZ-9476-2022	Yang, Bin/0000-0002-0275-3722; Shi, Yun Ying/0000-0002-4544-5439; Huang, Zhuochun/0000-0002-2957-779X; Wei, Wei/0000-0002-4109-3878	National Natural Science Foundation of China [81301496, 81100536, 81202354]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by the National Natural Science Foundation of China (Nos. 81301496, 81100536, and 81202354) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalaei-Andabili SH, 2013, J INFECTION, V67, P251, DOI 10.1016/j.jinf.2013.07.016; Barbour SJ, 2013, KIDNEY INT, V84, P1017, DOI 10.1038/ki.2013.210; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Chintalacharuvu SR, 2001, CLIN EXP IMMUNOL, V126, P326, DOI 10.1046/j.1365-2249.2001.01678.x; Coppo R, 2014, KIDNEY INT, V86, P828, DOI 10.1038/ki.2014.63; Daha MR, 2013, NEPHROL DIAL TRANSPL, V28, P794, DOI 10.1093/ndt/gfs445; Espinosa M, 2014, CLIN J AM SOC NEPHRO, V9, P897, DOI 10.2215/CJN.09710913; Floege J, 2014, SEMIN IMMUNOPATHOL, V36, P431, DOI 10.1007/s00281-013-0411-7; Gauderman WJ, 2002, STAT MED, V21, P35, DOI 10.1002/sim.973; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Ji JD, 2014, LUPUS, V23, P1023, DOI 10.1177/0961203314534512; Kadkhodazadeh Mahdi, 2013, J Long Term Eff Med Implants, V23, P9; Kobayashi I, 2002, NEPHROL DIAL TRANSPL, V17, P2108, DOI 10.1093/ndt/17.12.2108; Koyama A, 1997, AM J KIDNEY DIS, V29, P526, DOI 10.1016/S0272-6386(97)90333-4; Lai KN, 2011, ADV OTO-RHINO-LARYNG, V72, P40, DOI 10.1159/000324593; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Li KJ, 2014, MED SCI MONITOR, V20, P639, DOI 10.12659/MSM.890686; Lin JH, 2014, PEDIATR NEPHROL, V29, P1979, DOI 10.1007/s00467-014-2818-3; Liu DJ, 2014, DNA CELL BIOL, V33, P345, DOI 10.1089/dna.2013.2236; Liu L, 2014, INT J MOL SCI, V15, P6925, DOI 10.3390/ijms15046925; Lofgren SE, 2012, GENES IMMUN, V13, P268, DOI 10.1038/gene.2011.84; Loktionov A, 2004, CANCER LETT, V208, P1, DOI 10.1016/j.canlet.2004.02.009; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Menghini R, 2014, AGEING RES REV, V17, P68, DOI 10.1016/j.arr.2014.03.005; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Olivieri F, 2014, CURR OPIN IMMUNOL, V29, P29, DOI 10.1016/j.coi.2014.03.006; Ramkaran P, 2014, CELL BIOCHEM BIOPHYS, V68, P259, DOI 10.1007/s12013-013-9704-7; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Shao YM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/916202; Singh S, 2014, RHEUMATOL INT, V34, P1395, DOI 10.1007/s00296-014-3001-7; Sun M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093214; Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P770, DOI 10.1007/s10157-013-0921-6; Tan KB, 2013, GENOME, V56, P161, DOI 10.1139/gen-2012-0159; Wang G, 2011, DIS MARKERS, V30, P171, DOI [10.3233/DMA-2011-0766, 10.1155/2011/304852]; Wang G, 2010, DIS MARKERS, V28, P79, DOI [10.1155/2010/396328, 10.3233/DMA-2010-0687]; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Yu HH, 2014, AUTOIMMUN REV, V13, P556, DOI 10.1016/j.autrev.2014.01.030; Zhang WG, 2014, J CELL MOL MED, V18, P2225, DOI 10.1111/jcmm.12359; Zhou QH, 2015, ANN RHEUM DIS, V74, P1265, DOI 10.1136/annrheumdis-2013-204377	44	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139554	10.1371/journal.pone.0139554	http://dx.doi.org/10.1371/journal.pone.0139554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426696	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100075
J	Wang, J; Madnick, S; Li, XT; Alstott, J; Velu, C				Wang, Jing; Madnick, Stuart; Li, Xitong; Alstott, Jeff; Velu, Chander			Effect of Media Usage Selection on Social Mobilization Speed: Facebook vs E-Mail	PLOS ONE			English	Article								Social mobilization is a process that enlists a large number of people to achieve a goal within a limited time, especially through the use of social media. There is increasing interest in understanding the factors that affect the speed of social mobilization. Based on the Langley Knights competition data set, we analyzed the differences in mobilization speed between users of Facebook and e-mail. We include other factors that may influence mobilization speed (gender, age, timing, and homophily of information source) in our model as control variables in order to isolate the effect of such factors. We show that, in this experiment, although more people used e-mail to recruit, the mobilization speed of Facebook users was faster than that of those that used e-mail. We were also able to measure and show that the mobilization speed for Facebook users was on average seven times faster compared to e-mail before controlling for other factors. After controlling for other factors, we show that Facebook users were 1.84 times more likely to register compared to e-mail users in the next period if they have not done so at any point in time. This finding could provide useful insights for future social mobilization efforts.	[Wang, Jing] Harbin Inst Technol, Management Sci & Engn, Harbin 150006, Peoples R China; [Madnick, Stuart] MIT, Sloan Sch Management, Cambridge, MA 02139 USA; [Madnick, Stuart] MIT, Sch Engn, Cambridge, MA 02139 USA; [Li, Xitong] HEC Paris, Dept MOSI, Jouy En Josas, France; [Alstott, Jeff] Univ Cambridge, Brain Mapping Unit, Cambridge, England; [Velu, Chander] Univ Cambridge, Dept Engn, Inst Mfg, Cambridge CB2 1PZ, England	Harbin Institute of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Hautes Etudes Commerciales (HEC) Paris; University of Cambridge; University of Cambridge	Madnick, S (corresponding author), MIT, Sloan Sch Management, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	smadnick@mit.edu	Velu, Chander/AAM-8917-2020	Velu, Chander/0000-0002-2316-4441	NIH-Oxford-Cambridge Scholarship Program; National Natural Science Foundation of PRC [71328103]; Langley Castle Hotel	NIH-Oxford-Cambridge Scholarship Program; National Natural Science Foundation of PRC(National Natural Science Foundation of China (NSFC)); Langley Castle Hotel	The authors were partially funded by the NIH-Oxford-Cambridge Scholarship Program, the National Natural Science Foundation of PRC (No. 71328103), and by the MIT John Norris Maguire Professorship in Information Technologies Chair account. Langley Castle Hotel funded the awards for the contest used in this study and gathered the data. Other than this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095140; [Anonymous], 2014, DAILY MAIL REPO 0530; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; Apolloni Andrea, 2009, 2009 International Conference on Computational Science and Engineering (CSE), P675, DOI 10.1109/CSE.2009.240; Aral S, 2007, ICIS 2007 P; Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; DAFT RL, 1986, MANAGE SCI, V32, P554, DOI 10.1287/mnsc.32.5.554; Guo L, 2009, KDD-09: 15TH ACM SIGKDD CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P369; Guy I, 2008, CSCW: 2008 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK, CONFERENCE PROCEEDINGS, P393; Hellerstein JM, 2011, COMMUN ACM, V54, P77, DOI 10.1145/1965724.1965744; Matsubara Y., 2012, P 18 ACM SIGKDD INT, P6, DOI 10.1145/2339530.2339537; Okolloh Ory, 2009, PARTICIPATORY LEARNI, V59, P65; Park N, 2012, CYBERPSYCH BEH SOC N, V15, P357, DOI 10.1089/cyber.2012.0121; Phillips R, 2002, GROWTH CHANGE, V33, P497, DOI 10.1111/1468-2257.00208; Pickard G, 2011, SCIENCE, V334, P509, DOI 10.1126/science.1205869; Rahman SB, 2013, THESIS UPPSALA U; Rahwan I, 2013, COMPUTER, V46, P68, DOI 10.1109/MC.2012.295; Ross C, 2009, COMPUT HUM BEHAV, V25, P578, DOI 10.1016/j.chb.2008.12.024; Rutherford A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074628; Rutherford Alex, 2013, Proc Natl Acad Sci U S A, V110, P6281, DOI 10.1073/pnas.1216338110; Shiang-Yen T, 2012, P 14 WSEAS INT C MAT, P25; Tufekci Z, 2012, J COMMUN, V62, P363, DOI 10.1111/j.1460-2466.2012.01629.x; Vascellaro J. E., 2009, WALL STREET J; Webber LR, 2013, THESIS U S FLORIDA	25	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0134811	10.1371/journal.pone.0134811	http://dx.doi.org/10.1371/journal.pone.0134811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422171	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700002
J	Huang, CW; Lee, MJ; Lee, PT; Hsu, CY; Huang, WC; Chen, CL; Chou, KJ; Fang, HC				Huang, Chien-Wei; Lee, Min-Jing; Lee, Po-Tsang; Hsu, Chih-Yang; Huang, Wei-Chieh; Chen, Chien-Liang; Chou, Kang-Ju; Fang, Hua-Chang			Low Potassium Dialysate as a Protective Factor of Sudden Cardiac Death in Hemodialysis Patients with Hyperkalemia	PLOS ONE			English	Article							ARRHYTHMIAS; RISK; VARIABLES; SURVIVAL; ARREST; SERUM	Aim Hyperkalemia increases the risk of sudden cardiac death (SCD) in hemodialysis patients. Our objective was to determine the association between administering low potassium dialysate to hyperkalemic hemodialysis patients and SCD. Methods We conducted a retrospective cohort study with patients undergoing maintenance hemodialysis from May 1, 2006, through December 31, 2013. The dialysate composition was adjusted over time according to monthly laboratory results. A 1.0 mEq/L potassium dialysate was applied in patients with predialysis hyperkalemia (>5.5 mEq/L) and was included as a time-dependent confounding factor. The clinical characteristics of enrolled patients, the incidence and timing of SCD and risk factors for all-cause mortality and SCD were analyzed. Results There were 312 patients on maintenance hemodialysis during the study period. One hundred and fifty-seven patients had been dialyzed against a 1.0 mEq/L potassium dialysate at least once. The rates of all-cause mortality and SCD were 48.17 and 20.74 per 1000 patient-years, respectively. A 1.12-fold increase in the risk of SCD in the 24-hour period starting with the hemodialysis procedure and a 1.36-fold increase in the 24 hours preceding a weekly cycle were found (p = 0.017). Multivariate Cox proportional hazards models showed that age, diabetes mellitus and predialysis hyperkalemia (>5.0 mEq/L) were significant predictors of all-cause mortality and SCD. Exposure to 1.0 mEq/L potassium dialysate, Kt/V, and serum albumin were independent protective factors against all-cause mortality. Only exposure to 1.0 mEq/L potassium dialysate significantly prevented SCD (hazard ratio = 0.33, 95% CI = 0.13-0.85). Conclusions Using low potassium dialysate in hyperkalemic hemodialysis patients may prevent SCD.	[Huang, Chien-Wei; Lee, Po-Tsang; Hsu, Chih-Yang; Huang, Wei-Chieh; Chen, Chien-Liang; Chou, Kang-Ju; Fang, Hua-Chang] Kaohsiung Vet Gen Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Lee, Min-Jing] Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan; [Lee, Min-Jing] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Lee, Po-Tsang; Chen, Chien-Liang; Chou, Kang-Ju; Fang, Hua-Chang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Fang, HC (corresponding author), Kaohsiung Vet Gen Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.	hcfang@vghks.gov.tw	Huang, Chien-Wei/AAN-9838-2020; chen, chien-liang/I-6192-2015	Huang, Chien-Wei/0000-0001-5753-9654; chen, chien-liang/0000-0002-9508-8396				Basile C, 2012, J NEPHROL, V25, P506, DOI 10.5301/jn.5000023; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Buemi M, 2005, NEPHROL DIAL TRANSPL, V20, P1148, DOI 10.1093/ndt/gfh770; DAUGIRDAS JT, 1989, INT J ARTIF ORGANS, V12, P420; Di Iorio B, 2012, J NEPHROL, V25, P653, DOI 10.5301/jn.5000036; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Genovesi S, 2008, EUROPACE, V10, P771, DOI 10.1093/europace/eun028; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Herzog CA, 2008, SEMIN DIALYSIS, V21, P300, DOI 10.1111/j.1525-139X.2008.00455.x; HOU S, 1989, AM J KIDNEY DIS, V13, P137, DOI 10.1016/S0272-6386(89)80132-5; Iseki K, 1996, AM J KIDNEY DIS, V28, P541, DOI 10.1016/S0272-6386(96)90465-5; Jadoul M, 2014, SEMIN DIALYSIS, V27, P16, DOI 10.1111/sdi.12158; Jadoul M, 2012, CLIN J AM SOC NEPHRO, V7, P765, DOI 10.2215/CJN.08850811; Karnik JA, 2001, KIDNEY INT, V60, P350, DOI 10.1046/j.1523-1755.2001.00806.x; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kovesdy CP, 2007, CLIN J AM SOC NEPHRO, V2, P999, DOI 10.2215/CJN.04451206; Labriola L, 2014, SEMIN DIALYSIS, V27, P463, DOI 10.1111/sdi.12252; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; MORRISON G, 1980, KIDNEY INT, V17, P811, DOI 10.1038/ki.1980.93; Parekh RS, 2008, KIDNEY INT, V74, P1335, DOI 10.1038/ki.2008.449; Pun PH, 2012, BLOOD PURIFICAT, V33, P183, DOI 10.1159/000334154; Pun PH, 2011, KIDNEY INT, V79, P218, DOI 10.1038/ki.2010.315; RAMIREZ G, 1984, NEPHRON, V36, P212, DOI 10.1159/000183156; Redaelli B, 1996, KIDNEY INT, V50, P609, DOI 10.1038/ki.1996.356; Redaelli B, 2001, J NEPHROL, V14, pS7; Ritz E, 2008, CLIN J AM SOC NEPHRO, V3, P920, DOI 10.2215/CJN.04571007; Santoro A, 2008, NEPHROL DIAL TRANSPL, V23, P1415, DOI 10.1093/ndt/gfm730; SARAGOCA MA, 1991, J CARDIOVASC PHARM, V17, pS136, DOI 10.1097/00005344-199117002-00032; SFORZINI S, 1992, LANCET, V339, P212, DOI 10.1016/0140-6736(92)90008-Q; Stecker EC, 2014, CIRC-ARRHYTHMIA ELEC, V7, P212, DOI 10.1161/CIRCEP.113.001034; US Renal Data System, 2013, USRDS 2013 ANN DAT R	32	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139886	10.1371/journal.pone.0139886	http://dx.doi.org/10.1371/journal.pone.0139886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440515	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300070
J	Golov, AK; Gavrilov, AA; Razin, SV				Golov, Arkadiy K.; Gavrilov, Alexey A.; Razin, Sergey V.			The Role of Crowding Forces in Juxtaposing beta-Globin Gene Domain Remote Regulatory Elements in Mouse Erythroid Cells	PLOS ONE			English	Article							NUCLEAR-BODIES; SPATIAL-ORGANIZATION; SELF-ASSOCIATION; CHROMATIN; GENOME; COMPARTMENTS; INSIGHTS; TRANSCRIPTION; ACTIVATION; EXPRESSION	The extremely high concentration of macromolecules in a eukaryotic cell nucleus indicates that the nucleoplasm is a crowded macromolecular solution in which large objects tend to gather together due to crowding forces. It has been shown experimentally that crowding forces support the integrity of various nuclear compartments. However, little is known about their role in control of chromatin dynamics in vivo. Here, we experimentally addressed the possible role of crowding forces in spatial organization of the eukaryotic genome. Using the mouse beta-globin domain as a model, we demonstrated that spatial juxtaposition of the remote regulatory elements of this domain in globin-expressing cells may be lost and restored by manipulation of the level of macromolecular crowding. In addition to proving the role of crowding forces in shaping interphase chromatin, our results suggest that the folding of the chromatin fiber is a major determinant in juxtaposing remote genomic elements.	[Golov, Arkadiy K.; Gavrilov, Alexey A.; Razin, Sergey V.] Russian Acad Sci, Inst Gene Biol, Moscow 119334, Russia; [Razin, Sergey V.] Moscow MV Lomonosov State Univ, Dept Mol Biol, Fac Biol, Moscow 119992, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University	Razin, SV (corresponding author), Russian Acad Sci, Inst Gene Biol, Vavilov St 34-5, Moscow 119334, Russia.	sergey.v.razin@usa.net	Gavrilov, Alexey A./K-3396-2013; Golov, Arkadiy/AAD-8380-2020; Gavrilov, Alexey/N-2978-2016; Razin, Sergey V/M-6701-2015	Golov, Arkadiy/0000-0001-7802-3163; Razin, Sergey V/0000-0003-1976-8661; Gavrilov, Alexey/0000-0001-8444-1994	Russian Science Foundation [14-24-00022]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation (project #14-24-00022).	ADAM SA, 1992, METHOD ENZYMOL, V219, P97; ASAKURA S, 1958, J POLYM SCI, V33, P183, DOI 10.1002/pol.1958.1203312618; Bickmore WA, 2002, EMBO J, V21, P1248, DOI 10.1093/emboj/21.6.1248; Bickmore WA, 2013, ANNU REV GENOM HUM G, V14, P67, DOI 10.1146/annurev-genom-091212-153515; Carmo-Fonseca M, 2011, NAT CELL BIOL, V13, P110, DOI 10.1038/ncb0211-110; Cavalli G, 2013, NAT STRUCT MOL BIOL, V20, P290, DOI 10.1038/nsmb.2474; Cho EJ, 2012, BIOPHYS J, V103, P424, DOI 10.1016/j.bpj.2012.07.007; de Graaf CA, 2013, CURR OPIN GENET DEV, V23, P185, DOI 10.1016/j.gde.2012.11.011; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; Dundr M, 2012, CURR OPIN CELL BIOL, V24, P415, DOI 10.1016/j.ceb.2012.03.010; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; GANGULY S, 1985, J BIOL CHEM, V260, P2167; Gavrilov AA, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1322; Gavrilov AA, 2013, NUCLEIC ACIDS RES, V41, P3563, DOI 10.1093/nar/gkt067; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2004, BIOL CELL, V96, P595, DOI 10.1016/j.biolcel.2004.05.003; Hancock R, 2008, EUR BIOPHYS J BIOPHY, V37, P1059, DOI 10.1007/s00249-008-0276-1; Hancock R, 2014, INT REV CEL MOL BIO, V307, P15, DOI 10.1016/B978-0-12-800046-5.00002-3; Hancock R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007560; Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2; Kim JS, 2014, INT REV CEL MOL BIO, V307, P73, DOI 10.1016/B978-0-12-800046-5.00004-7; Kim JS, 2010, J PHYS CHEM C, V114, P20864, DOI 10.1021/jp107598m; Kinoshita M, 2002, CHEM PHYS LETT, V351, P79, DOI 10.1016/S0009-2614(01)01346-X; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Larkin JD, 2013, NUCLEIC ACIDS RES, V41, P2216, DOI 10.1093/nar/gks1441; LI R, 1991, CELL, V65, P493, DOI 10.1016/0092-8674(91)90467-D; Mao YTS, 2011, TRENDS GENET, V27, P295, DOI 10.1016/j.tig.2011.05.006; Marenduzzo D, 2006, BIOPHYS J, V90, P3712, DOI 10.1529/biophysj.105.077685; Miele Adriana, 2008, V464, P105; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rajendra TK, 2010, COLD SH Q B, V75, P365, DOI 10.1101/sqb.2010.75.043; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Razin SV, 2013, FEBS LETT, V587, P1840, DOI 10.1016/j.febslet.2013.04.027; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Sleeman JE, 2014, CURR OPIN CELL BIOL, V28, P76, DOI 10.1016/j.ceb.2014.03.004; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Ulianov SV, 2015, INT REV CEL MOL BIO, V315, P183, DOI 10.1016/bs.ircmb.2014.11.004; Walter A, 2013, J STRUCT BIOL, V184, P445, DOI 10.1016/j.jsb.2013.10.004	42	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139855	10.1371/journal.pone.0139855	http://dx.doi.org/10.1371/journal.pone.0139855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436546	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200063
J	Adebimpe, A; Aarabi, A; Bourel-Ponchel, E; Mahmoudzadeh, M; Wallois, F				Adebimpe, Azeez; Aarabi, Ardalan; Bourel-Ponchel, Emilie; Mahmoudzadeh, Mahdi; Wallois, Fabrice			Functional Brain Dysfunction in Patients with Benign Childhood Epilepsy as Revealed by Graph Theory	PLOS ONE			English	Article							SMALL-WORLD NETWORKS; CENTROTEMPORAL SPIKES; THEORETICAL ANALYSIS; PHASE SYNCHRONIZATION; EEG; CHILDREN; CONNECTIVITY; SEIZURE; TRANSITION; LOBE	There is growing evidence that brain networks are altered in epileptic subjects. In this study, we investigated the functional connectivity and brain network properties of benign childhood epilepsy with centrotemporal spikes using graph theory. Benign childhood epilepsy with centrotemporal spikes is the most common form of idiopathic epilepsy in young children under the age of 16 years. High-density EEG data were recorded from patients and controls in resting state with eyes closed. Data were preprocessed and spike and spike-free segments were selected for analysis. Phase locking value was calculated for all paired combinations of channels and for five frequency bands (delta, theta, alpha, beta(1) and beta(2)). We computed the degree and small-world parameters-clustering coefficient (C) and path length (L)-and compared the two patient conditions to controls. A higher degree at epileptic zones during interictal epileptic spikes (IES) was observed in all frequency bands. Both patient conditions reduced connection at the occipital and right frontal regions close to the epileptic zone in the a band. The "small-world" features (high C and short L) were deviated in patients compared to controls. A changed from an ordered network in the d band to a more randomly organized network in the a band was observed in patients compared to healthy controls. These findings show that the benign epileptic brain network is disrupted not only at the epileptic zone, but also in other brain regions especially frontal regions.	[Adebimpe, Azeez; Aarabi, Ardalan; Bourel-Ponchel, Emilie; Mahmoudzadeh, Mahdi; Wallois, Fabrice] INSERM, U1105, CURS, Univ Hosp, Amiens, France; [Bourel-Ponchel, Emilie; Mahmoudzadeh, Mahdi; Wallois, Fabrice] Explorat Fonct Syst Nerveux EFSN Pediat, Univ Hosp, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Aarabi, A (corresponding author), INSERM, U1105, CURS, Univ Hosp, Amiens, France.	ardalan.aarabi@u-picardie.fr	Aarabi, Ardalan/ABA-8108-2020	Aarabi, Ardalan/0000-0001-5141-9248; Adebimpe, Azeez Ayodeji/0000-0001-9049-0135; Emilie, BOUREL-PONCHEL/0000-0002-7001-0250	INSERM (Institut national de la sante et de la recherche medicale)	INSERM (Institut national de la sante et de la recherche medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	The fund is from INSERM (Institut national de la sante et de la recherche medicale, www.inserm.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkley GL, 2003, J CLIN NEUROPHYSIOL, V20, P163, DOI 10.1097/00004691-200305000-00002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Baumgartner C, 1996, EPILEPSIA, V37, P1164, DOI 10.1111/j.1528-1157.1996.tb00548.x; Blinowska KJ, 2011, MED BIOL ENG COMPUT, V49, P521, DOI 10.1007/s11517-011-0739-x; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Camfield CS, 2014, EPILEPSIA, V55, P16, DOI 10.1111/epi.12706; Coan AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085843; COHEN M, 1992, BRAIN COGNITION, V20, P315, DOI 10.1016/0278-2626(92)90024-G; Cressman JR, 2009, J COMPUT NEUROSCI, V26, P159, DOI 10.1007/s10827-008-0132-4; Danielsson J, 2009, EPILEPSY BEHAV, V16, P646, DOI 10.1016/j.yebeh.2009.08.012; Datta AN, 2013, EPILEPSIA, V54, P487, DOI 10.1111/epi.12067; Doesburg SM, 2010, IFMBE PROC, V28, P250; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Douw L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010839; Hassan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105041; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; He H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038195; Huang W, 2011, J NEURORADIOLOGY, V38, P298, DOI 10.1016/j.neurad.2010.12.007; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ioannides AA, 2007, CURR OPIN NEUROBIOL, V17, P161, DOI 10.1016/j.conb.2007.03.008; Kanemura H, 2011, BRAIN DEV-JPN, V33, P106, DOI 10.1016/j.braindev.2010.03.005; Kanemura H, 2009, BRAIN DEV-JPN, V31, P771, DOI 10.1016/j.braindev.2008.12.007; Kramer MA, 2008, EPILEPSY RES, V79, P173, DOI 10.1016/j.eplepsyres.2008.02.002; Kwon Soonhak, 2012, Korean J Pediatr, V55, P383, DOI 10.3345/kjp.2012.55.10.383; Lachaux JP, 2000, INT J BIFURCAT CHAOS, V10, P2429, DOI 10.1142/S0218127400001560; Li WN, 2015, J CLIN NEUROPHYSIOL, V32, P57, DOI 10.1097/WNP.0000000000000120; Li WJ, 2015, J NEUROL NEUROSUR PS, V86, P1097, DOI 10.1136/jnnp-2014-309180; Liu T, 2014, BIO-MED MATER ENG, V24, P1035, DOI 10.3233/BME-130901; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Netoff TI, 2004, J NEUROSCI, V24, P8075, DOI 10.1523/JNEUROSCI.1509-04.2004; Nolte G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.234101; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Percha B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031909; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Ponten SC, 2009, EXP NEUROL, V217, P197, DOI 10.1016/j.expneurol.2009.02.001; Quraan MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068609; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; Shields WD, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2009.02229.x; Simard D, 2005, PHYS LETT A, V336, P8, DOI 10.1016/j.physleta.2004.12.078; Sohrabpour A, 2015, CLIN NEUROPHYSIOL, V126, P472, DOI 10.1016/j.clinph.2014.05.038; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Stanley ML, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00169; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Tan B, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/976365; Verrotti A, 2014, BRAIN COGNITION, V84, P123, DOI 10.1016/j.bandc.2013.11.014; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Werner FM, 2011, CURR MED CHEM, V18, P4933, DOI 10.2174/092986711797535191; Wilke C, 2008, IEEE T BIO-MED ENG, V55, P2557, DOI 10.1109/TBME.2008.919885; Wilke C, 2011, EPILEPSIA, V52, P84, DOI 10.1111/j.1528-1167.2010.02785.x; Wilke C, 2010, EPILEPSIA, V51, P564, DOI 10.1111/j.1528-1167.2009.02329.x; Wu HH, 2006, LECT NOTES COMPUT SC, V3973, P573; Xiao FL, 2014, J NEUROL SCI, V336, P171, DOI 10.1016/j.jns.2013.10.033; Zhang ZJ, 2011, EPILEPSY RES, V97, P290, DOI 10.1016/j.eplepsyres.2011.09.025; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	64	29	29	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139228	10.1371/journal.pone.0139228	http://dx.doi.org/10.1371/journal.pone.0139228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431333	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700035
J	Eudes, A; Benites, VT; Wang, G; Baidoo, EEK; Lee, TS; Keasling, JD; Loque, D				Eudes, Aymerick; Benites, Veronica Teixeira; Wang, George; Baidoo, Edward E. K.; Lee, Taek Soon; Keasling, Jay D.; Loque, Dominique			Precursor-Directed Combinatorial Biosynthesis of Cinnamoyl, Dihydrocinnamoyl, and Benzoyl Anthranilates in Saccharomyces cerevisiae	PLOS ONE			English	Article							ANTI-FIBROTIC DRUG; RHODOPSEUDOMONAS-PALUSTRIS; ACID-DERIVATIVES; PQSD INHIBITORS; LIGASE; PURIFICATION; DIANTHRAMIDE; EXPRESSION; TRANILAST; FIBROSIS	Biological synthesis of pharmaceuticals and biochemicals offers an environmentally friendly alternative to conventional chemical synthesis. These alternative methods require the design of metabolic pathways and the identification of enzymes exhibiting adequate activities. Cinnamoyl, dihydrocinnamoyl, and benzoyl anthranilates are natural metabolites which possess beneficial activities for human health, and the search is expanding for novel derivatives that might have enhanced biological activity. For example, biosynthesis in Dianthus caryophyllus is catalyzed by hydroxycinnamoyl/benzoyl-CoA:anthranilate N-hydroxycinnamoyl/ benzoyltransferase (HCBT), which couples hydroxycinnamoyl-CoAs and benzoyl-CoAs to anthranilate. We recently demonstrated the potential of using yeast (Saccharomyces cerevisiae) for the biological production of a few cinnamoyl anthranilates by heterologous co-expression of 4-coumaroyl: CoA ligase from Arabidopsis thaliana (4CL5) and HCBT. Here we report that, by exploiting the substrate flexibility of both 4CL5 and HCBT, we achieved rapid biosynthesis of more than 160 cinnamoyl, dihydrocinnamoyl, and benzoyl anthranilates in yeast upon feeding with both natural and non-natural cinnamates, dihydrocinnamates, benzoates, and anthranilates. Our results demonstrate the use of enzyme promiscuity in biological synthesis to achieve high chemical diversity within a defined class of molecules. This work also points to the potential for the combinatorial biosynthesis of diverse and valuable cinnamoylated, dihydrocinnamoylated, and benzoylated products by using the versatile biological enzyme 4CL5 along with characterized cinnamoyl-CoA-and benzoyl-CoA-utilizing transferases.	[Eudes, Aymerick; Benites, Veronica Teixeira; Wang, George; Baidoo, Edward E. K.; Lee, Taek Soon; Keasling, Jay D.; Loque, Dominique] Joint BioEnergy Inst, Emery Stn East, Emeryville, CA 94608 USA; [Eudes, Aymerick; Benites, Veronica Teixeira; Wang, George; Baidoo, Edward E. K.; Lee, Taek Soon; Keasling, Jay D.; Loque, Dominique] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Benites, Veronica Teixeira] San Francisco State Univ, Grad Program, San Francisco, CA 94132 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; California State University System; San Francisco State University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Loque, D (corresponding author), Joint BioEnergy Inst, Emery Stn East, 5885 Hollis St,4th Floor, Emeryville, CA 94608 USA.	dloque@lbl.gov	Eudes, Aymerick/AAH-4909-2021; Keasling, Jay D/J-9162-2012; Loque, Dominique/A-8153-2008	Eudes, Aymerick/0000-0002-1387-6111; Keasling, Jay D/0000-0003-4170-6088; 	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	This work was part of the U.S. Department of Energy Joint BioEnergy Institute (http://www.jbei.org/) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy.	Abe I, 2010, TOP CURR CHEM, V297, P45, DOI 10.1007/128_2009_22; Chan KKJ, 2012, METHOD ENZYMOL, V516, P219, DOI 10.1016/B978-0-12-394291-3.00003-4; CLAUSEN M, 1994, GENE, V142, P107, DOI 10.1016/0378-1119(94)90363-8; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Eudes A, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-62; Eudes A, 2011, APPL MICROBIOL BIOT, V89, P989, DOI 10.1007/s00253-010-2939-y; GEISSLER JF, 1988, J BACTERIOL, V170, P1709, DOI 10.1128/jb.170.4.1709-1714.1988; GIBSON J, 1994, J BACTERIOL, V176, P634, DOI 10.1128/jb.176.3.634-641.1994; Gilbert RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047160; Hamberger B, 2004, P NATL ACAD SCI USA, V101, P2209, DOI 10.1073/pnas.0307307101; Harris MT, 2013, ANTIMICROB AGENTS CH, V57, P3731, DOI 10.1128/AAC.00662-13; Heuschkel S, 2009, EUR J PHARM BIOPHARM, V72, P552, DOI 10.1016/j.ejpb.2009.02.007; Hinsberger S, 2014, EUR J MED CHEM, V76, P343, DOI 10.1016/j.ejmech.2014.02.014; Hsieh PW, 2004, J NAT PROD, V67, P1522, DOI 10.1021/np040036v; Huth JR, 2004, J MED CHEM, V47, P4851, DOI 10.1021/jm0497803; Ibdah M, 2014, PHYTOCHEMISTRY, V107, P24, DOI 10.1016/j.phytochem.2014.07.027; Jiang HX, 2005, APPL ENVIRON MICROB, V71, P2962, DOI 10.1128/AEM.71.6.2962-2969.2005; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kosjek T., 2011, HALOGENATED HETEROCY, P219; Lavoie S, 2013, TETRAHEDRON LETT, V54, P1631, DOI 10.1016/j.tetlet.2012.12.012; Lee YR, 2011, BIOCHEM BIOPH RES CO, V405, P552, DOI 10.1016/j.bbrc.2011.01.065; Lv N, 2009, BIOCHEM BIOPH RES CO, V387, P97, DOI 10.1016/j.bbrc.2009.06.133; Meydani M, 2009, NUTR REV, V67, P731, DOI 10.1111/j.1753-4887.2009.00256.x; Oberg CT, 2012, J MED CHEM, V55, P3170, DOI 10.1021/jm201636v; Pinto YM, 2000, HYPERTENSION, V36, P747, DOI 10.1161/01.HYP.36.5.747; PONCHET M, 1984, PHYTOCHEMISTRY, V23, P1901, DOI 10.1016/S0031-9422(00)84937-7; Qi W, 2006, KIDNEY INT, V69, P989, DOI 10.1038/sj.ki.5000189; Sharlow E., 2010, PROBE REPORTS NIH MO; Sharlow ER, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000659; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Simard F, 2014, PHYTOCHEMISTRY, V100, P141, DOI 10.1016/j.phytochem.2013.12.018; Singh R, 2013, CRIT REV FOOD SCI, V53, P126, DOI 10.1080/10408398.2010.526725; Sinreih M, 2012, BIOORG MED CHEM LETT, V22, P5948, DOI 10.1016/j.bmcl.2012.07.062; Sun HH, 2015, DRUG DES DEV THER, V9, P823, DOI 10.2147/DDDT.S63023; Tan SM, 2012, CLIN EXP PHARMACOL P, V39, P650, DOI 10.1111/j.1440-1681.2012.05726.x; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; Ward MR, 1998, ATHEROSCLEROSIS, V137, P267, DOI 10.1016/S0021-9150(97)00275-X; Weidel E, 2013, J MED CHEM, V56, P6146, DOI 10.1021/jm4006302; Widhalm JR, 2015, MOL PLANT, V8, P83, DOI 10.1016/j.molp.2014.12.001; Williams SJ, 2013, BIOORG MED CHEM LETT, V23, P6868, DOI 10.1016/j.bmcl.2013.09.100; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yamada Haruyoshi, 1995, Journal of Dermatology (Tokyo), V22, P149; Zammit SC, 2009, BIOORG MED CHEM LETT, V19, P7003, DOI 10.1016/j.bmcl.2009.09.120; Zeng J, 2010, CHEMBIOCHEM, V11, P2119, DOI 10.1002/cbic.201000439; Zhang Y, 2013, INT J CARDIOL, V168, P1174, DOI 10.1016/j.ijcard.2012.11.067; Zhang Y, 2012, EUR J HEART FAIL, V14, P549, DOI 10.1093/eurjhf/hfs011	47	12	12	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138972	10.1371/journal.pone.0138972	http://dx.doi.org/10.1371/journal.pone.0138972			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430899	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700025
J	MacDonald, E; White, R; Mexia, R; Bruun, T; Kapperud, G; Lange, H; Nygard, K; Vold, L				MacDonald, Emily; White, Richard; Mexia, Ricardo; Bruun, Tone; Kapperud, Georg; Lange, Heidi; Nygard, Karin; Vold, Line			Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010-2011: A National Prospective Case-Control Study	PLOS ONE			English	Article							WATERBORNE OUTBREAK; JEJUNI; SPP.; ASSOCIATION	Background Campylobacteriosis is the most frequently reported food-and waterborne infection in Norway. We investigated the risk factors for sporadic Campylobacter infections in Norway in order to identify areas where control and prevention measures could be improved. Methods A national prospective case-control study of factors associated with Campylobacter infection was conducted from July 2010 to September 2011. Cases were recruited from the Norwegian Surveillance System of Communicable Diseases (MSIS). Controls were randomly selected from the Norwegian Population Registry. Cases and controls were mailed a paper questionnaire with a prepaid return envelope. Univariable analyses using logistic regression were conducted for all exposures. A final parsimonious multivariable model was developed using regularized/penalized logistic regression, and adjusted odds ratios were calculated. Results A total of 995 cases and 1501 controls were included in the study (response proportion 55% and 30%, respectively). Exposures that had significant increases in odds of Campylobacter infection in multivariable analysis were drinking water directly from river, stream, or lake (OR: 2.96), drinking purchased bottled water (OR: 1.78), eating chicken (1.69), eating meat that was undercooked (OR: 1.77), eating food made on a barbecue (OR: 1.55), living on a farm with livestock (OR: 1.74), having a dog in the household (OR: 1.39), and having household water supply serving fewer than 20 houses (OR: 1.92). Conclusions Consumption of poultry and untreated water remain important sources of Campylobacter infection in Norway, despite ongoing control efforts. The results justify the need for strengthening education for consumers and food handlers about the risks of cross-contamination when preparing poultry and with consuming raw or undercooked chicken. The public should also be reminded to take precautions when drinking untreated water in nature and ensure continued vigilance in order to protect and maintain the quality of water from small-scale water supply systems.	[MacDonald, Emily; White, Richard; Mexia, Ricardo; Bruun, Tone; Lange, Heidi; Nygard, Karin; Vold, Line] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway; [MacDonald, Emily; Mexia, Ricardo; Lange, Heidi] European Ctr Dis Prevent & Control, EPIET, Stockholm, Sweden; [White, Richard] Norwegian Inst Publ Hlth, Dept Hlth Stat, Oslo, Norway; [Kapperud, Georg] Norwegian Inst Publ Hlth, Div Infect Control, Oslo, Norway	Norwegian Institute of Public Health (NIPH); European Centre for Disease Prevention & Control; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH)	MacDonald, E (corresponding author), Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Oslo, Norway.	emily.macdonald@fhi.no	Mexia, Ricardo/O-7945-2014	Mexia, Ricardo/0000-0002-0511-7940; White, Richard Aubrey/0000-0002-6747-1726	Norwegian Food Safety Authority; Norwegian Veterinary Institute	Norwegian Food Safety Authority; Norwegian Veterinary Institute	Funds were provided for the preparation of data collection materials by the Norwegian Food Safety Authority (http://www.mattilsynet.no/language/english/) and the Norwegian Veterinary Institute (http://www.vetinst.no/eng/Norwegian-Veterinary-Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHO M, 1989, EPIDEMIOL INFECT, V103, P133, DOI 10.1017/S0950268800030430; Animalia, 2012, KJOTTETS TILSTAND; [Anonymous], 2001, FORSKRIFT VANNFORSYN; Bach FR., 2008, P 25 INT C MACHINE L, V33, P40, DOI [10.1145/1390156.1390161, DOI 10.1145/1390156.1390161]; Boqvist S, 2009, EPIDEMIOL INFECT, V137, P897, DOI 10.1017/S0950268808001209; Brown PE, 2004, APPL ENVIRON MICROB, V70, P6501, DOI 10.1128/AEM.70.11.6501-6511.2004; Danis K, 2009, EUROSURVEILLANCE, V14, P12; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; Duke LA, 1996, EPIDEMIOL INFECT, V116, P303, DOI 10.1017/S0950268800052614; Eberhart-Phillips J, 1997, J EPIDEMIOL COMMUN H, V51, P686, DOI 10.1136/jech.51.6.686; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Evans MR, 2003, EMERG INFECT DIS, V9, P1219; Faafeng B, 2006, 51672006 LNR NORSK I; Fajo-Pascual M, 2010, EUR J PUBLIC HEALTH, V20, P443, DOI 10.1093/eurpub/ckp206; Friedman CR, 2004, CLIN INFECT DIS, V38, pS285, DOI 10.1086/381598; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Hald B, 1997, J CLIN MICROBIOL, V35, P3351, DOI 10.1128/JCM.35.12.3351-3352.1997; Hauge K, 1996, RISK FACTORS SPORADI; Hilborn ED, 2013, MMWR-MORBID MORTAL W, V62, P714; Hofshagen M, 2005, J FOOD PROTECT, V68, P2220, DOI 10.4315/0362-028X-68.10.2220; Hofshagen M, 2002, SURVEILLANCE CONTROL, P143; Jakopanec I, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-128; KAPPERUD G, 1992, J CLIN MICROBIOL, V30, P3117, DOI 10.1128/JCM.30.12.3117-3121.1992; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Kapperud GN, 2008, BLIR VI SYKE NORSK K; MacRitchie LA, 2013, EPIDEMIOL INFECT, V141, P976, DOI 10.1017/S0950268812001641; Moller-Stray J, 2012, EURO SURVEILL, V17; Myrstad L, 2015, RAPPORT FRA VANNVERK; Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355; Norwegian Food Safety Authority, 2007, RAPP NASJ TILSYNSK D; Norwegian Institute of Public Health, UTBR CAMP NORG; Norwegian Institute of Public Health, 2013, UTBR CAMP BLANT DELT; Nygard K, 2004, EPIDEMIOL INFECT, V132, P317, DOI 10.1017/S0950268803001900; Rodrigues LC, 2001, EPIDEMIOL INFECT, V127, P185, DOI 10.1017/S0950268801006057; Sampers I, 2010, INT J FOOD MICROBIOL, V137, P147, DOI 10.1016/j.ijfoodmicro.2009.11.013; Tam CC, 2009, EMERG INFECT DIS, V15, P1402, DOI 10.3201/eid1509.080773; Torp M VM, 2014, SURVEILLANCE PROGRAM; World Health Organization, 2013, GLOB VIEW CAMP REP E; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	40	30	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139636	10.1371/journal.pone.0139636	http://dx.doi.org/10.1371/journal.pone.0139636			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431341	gold, Green Published			2022-12-27	WOS:000362178700091
J	Schroth, V; Joos, R; Jaschinski, W				Schroth, Volkhard; Joos, Roland; Jaschinski, Wolfgang			Effects of Prism Eyeglasses on Objective and Subjective Fixation Disparity	PLOS ONE			English	Article							BINOCULAR VISUAL-ACUITY; CONVERGENCE-INSUFFICIENCY; VERGENCE ADAPTATION; NATURAL CONDITIONS; RETINAL CORRESPONDENCE; OCULAR VERGENCE; FORCED VERGENCE; EYE-MOVEMENTS; FUSION LOCK; COORDINATION	In optometry of binocular vision, the question may arise whether prisms should be included in eyeglasses to compensate an oculomotor and/or sensory imbalance between the two eyes. The corresponding measures of objective and subjective fixation disparity may be reduced by the prisms, or the adaptability of the binocular vergence system may diminish effects of the prisms over time. This study investigates effects of wearing prisms constantly for about 5 weeks in daily life. Two groups of 12 participants received eyeglasses with prisms having either a base-in direction or a base-out direction with an amount up to 8 prism diopters. Prisms were prescribed based on clinical fixation disparity test plates at 6 m. Two dependent variables were used: (1) subjective fixation disparity was indicated by a perceived offset of dichoptic nonius lines that were superimposed on the fusion stimuli and (2) objective fixation disparity was measured with a video based eye tracker relative to monocular calibration. Stimuli were presented at 6 m and included either central or more peripheral fusion stimuli. Repeated measurements were made without the prisms and with the prisms after about 5 weeks of wearing these prisms. Objective and subjective fixation disparity were correlated, but the type of fusion stimulus and the direction of the required prism may play a role. The prisms did not reduce the fixation disparity to zero, but induced significant changes in fixation disparity with large effect sizes. Participants receiving base-out prisms showed hypothesized effects, which were concurrent in both types of fixation disparity. In participants receiving base- in prisms, the individual effects of subjective and objective effects were negatively correlated: the larger the subjective (sensory) effect, the smaller the objective (motor) effect. This response pattern was related to the vergence adaptability, i.e.theindividual fusional vergence reserves.	[Schroth, Volkhard; Joos, Roland] Univ Appl Sci & Arts Northwestern Switzerland, Olten, Switzerland; [Jaschinski, Wolfgang] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	FHNW University of Applied Sciences & Arts Northwestern Switzerland; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Jaschinski, W (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	Jaschinski@ifado.de		Jaschinski, Wolfgang/0000-0002-2986-0341	Hoya Corporation Vision Care (Tokyo); Institute of Optometry at FHNW; Leibniz Research Centre of Working Environment and Human Factors (IfADo, Dortmund, Germany)	Hoya Corporation Vision Care (Tokyo); Institute of Optometry at FHNW; Leibniz Research Centre of Working Environment and Human Factors (IfADo, Dortmund, Germany)	This study was supported in part by the Hoya Corporation Vision Care (Tokyo), referred to as HOYA (http://www.hoya.co.jp/english/company/japan.html). VS was the grant recipient. The Institute of Optometry at FHNW and Leibniz Research Centre of Working Environment and Human Factors (IfADo, Dortmund, Germany) also provided support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhassan M., 2013, THESIS U WATERLOO WA; Blythe HI, 2006, VISION RES, V46, P3898, DOI 10.1016/j.visres.2006.06.006; Brautaset R L, 2001, Strabismus, V9, P165, DOI 10.1076/stra.9.3.165.6764; Brautaset RL, 2006, MED SCI MONITOR, V12, pMT1; Camellin M, 2005, J CATARACT REFR SURG, V31, P1719, DOI 10.1016/j.jcrs.2005.04.027; CARTER D B, 1958, Am J Optom Arch Am Acad Optom, V35, P590; CARTER DB, 1965, AMER J OPT ARCH AM A, V42, P141; CARTER DB, 1980, AM J OPTOM PHYS OPT, V57, P610; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Collewijn H, 1991, VISION VISUAL DYSF A, V404, P121; Conway ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042832; COOPER J, 1992, OPTOMETRY VISION SCI, V69, P300, DOI 10.1097/00006324-199204000-00008; Cornell ED, 2003, OPTOMETRY VISION SCI, V80, P764, DOI 10.1097/00006324-200311000-00014; Erkelens CJ, 1997, VISION RES, V37, P1735, DOI 10.1016/S0042-6989(96)00323-9; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P441, DOI 10.1098/rspb.1989.0031; ERKELENS CJ, 1989, PROC R SOC SER B-BIO, V236, P417, DOI 10.1098/rspb.1989.0030; Evans BJW, 2007, PICKWELLS BINOCULAR; Fogt N, 1997, OPTOMETRY VISION SCI, V74, P43, DOI 10.1097/00006324-199701000-00019; Fogt N, 1998, VISION RES, V38, P411, DOI 10.1016/S0042-6989(97)00142-9; Fogt N, 1998, VISION RES, V38, P2711, DOI 10.1016/S0042-6989(97)00448-3; Gerling J, 1998, KLIN MONATSBL AUGENH, V212, P226, DOI 10.1055/s-2008-1034869; Haase H- J, 1962, J AM OPTOM ASSOC, V34, P115; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; HEBBARD FW, 1962, J OPT SOC AM, V52, P706, DOI 10.1364/JOSA.52.000706; Heller D, 1998, CURRENT OCULOMOTOR R; Hofmann FB, 1900, ARCH GESAMTE PHYSIOL, V80, P1, DOI 10.1007/BF01661926; Howard I. P, 2012, PERCEIVING DEPTH BAS, V1; International Association for Binocular Vision, 2012, GUID APPL MCH; Jainta S, 2002, HUM FACTORS, V44, P443, DOI 10.1518/0018720024497736; Jainta S, 2010, J EYE MOVEMENT RES, V3; Jainta S, 2012, INVEST OPHTH VIS SCI, V53, P5762, DOI 10.1167/iovs.12-9707; Jainta S, 2011, INVEST OPHTH VIS SCI, V52, P9416, DOI 10.1167/iovs.11-8237; Jaschinski W, 2005, OPTOMETRY VISION SCI, V82, P988, DOI 10.1097/01.opx.0000187843.46805.a4; Jaschinski W, 2002, OPTOMETRY VISION SCI, V79, P158, DOI 10.1097/00006324-200203000-00010; Jaschinski W, 1999, VISION RES, V39, P669, DOI 10.1016/S0042-6989(98)00163-1; Jaschinski W, 2001, VISION RES, V41, P923, DOI 10.1016/S0042-6989(00)00322-9; Jaschinski W, 2001, OPHTHAL PHYSL OPT, V21, P368, DOI 10.1046/j.1475-1313.2001.00600.x; Jaschinski W, 2007, OPHTHAL PHYSL OPT, V27, P85, DOI 10.1111/j.1475-1313.2006.00448.x; Jaschinski W, 2010, OPHTHAL PHYSL OPT, V30, P379, DOI 10.1111/j.1475-1313.2010.00753.x; JENKINS TCA, 1992, OPHTHAL PHYSL OPT, V12, P299, DOI 10.1111/j.1475-1313.1992.tb00401.x; JENKINS TCA, 1989, OPHTHAL PHYSL OPT, V9, P121, DOI 10.1111/j.1475-1313.1989.tb00830.x; JENKINS TCA, 1994, OPHTHAL PHYSL OPT, V14, P129, DOI 10.1111/j.1475-1313.1994.tb00100.x; Juhasz BJ, 2006, Q J EXP PSYCHOL, V59, P1614, DOI 10.1080/17470210500497722; Karania R, 2006, OPHTHAL PHYSL OPT, V26, P507, DOI 10.1111/j.1475-1313.2006.00385.x; KERTESZ AE, 1988, VISION RES, V28, P313, DOI 10.1016/0042-6989(88)90159-9; KERTESZ AE, 1987, AM J OPTOM PHYS OPT, V64, P734; Kirkby JA, 2013, BEHAV RES METHODS, V45, P664, DOI 10.3758/s13428-012-0301-2; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Kirkby JA, 2010, VISION RES, V50, P171, DOI 10.1016/j.visres.2009.11.008; Kromeier M, 2002, KLIN MONATSBL AUGENH, V219, P859; Kromeier M, 2002, KLIN MONATSBL AUGENH, V219, P851, DOI 10.1055/s-2002-36951; Lie I, 1990, J Am Optom Assoc, V61, P491; Lie I, 1985, J Am Optom Assoc, V56, P272; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; London Richard, 2006, Optometry, V77, P590, DOI 10.1016/j.optm.2006.09.006; Mallett RJF, 1974, OPTICIAN, V148, P547; Mallett RJF, 1974, OPHTHALMIC OPT, V14, P1156; McDaniel C, 2010, OPTOMETRY, V81, P469, DOI 10.1016/j.optm.2010.01.012; Methling D, 1996, OPHTHAL PHYSL OPT, V16, P211, DOI 10.1016/0275-5408(95)00045-3; MOHINDRA I, 1977, AM J OPTOM PHYS OPT, V54, P319; Muhlendyck H, 1993, Ophthalmologe, V90, P6; Nuthmann A, 2014, VIS COGN, V22, P259, DOI 10.1080/13506285.2013.876480; Nuthmann A, 2009, J VISION, V9, DOI 10.1167/9.5.31; O'Leary CI, 2006, OPHTHAL PHYSL OPT, V26, P555, DOI 10.1111/j.1475-1313.2006.00400.x; Ogle KN., 1950, FIXATION DISPARITY R; Ogle KN, 1967, OCULOMOTOR IMBALANCE; Pang Y, 2012, CLIN EXP OPTOM, V95, P192, DOI 10.1111/j.1444-0938.2011.00693.x; Payne CR, 1974, OPTOMETRY, V77, P88; PICKWELL D, 1987, OPHTHAL PHYSL OPT, V7, P345, DOI 10.1111/j.1475-1313.1987.tb00758.x; PICKWELL LD, 1987, AM J OPTOM PHYS OPT, V64, P513; PICKWELL LD, 1987, OPHTHAL PHYSL OPT, V7, P37, DOI 10.1111/j.1475-1313.1987.tb00989.x; Pickwell LD., 1977, OPTICIAN, V174, p[8, 11, 35]; Pinheiro J, 2001, MIXED EFFECTS MODELS; REMOLE A, 1985, AM J OPTOM PHYS OPT, V62, P25; ROBERTSON K, 1986, Investigative Ophthalmology and Visual Science, V27, P79; Rosenfield M, 1997, OPTOMETRY VISION SCI, V74, P303, DOI 10.1097/00006324-199705000-00027; Rouse MW, 2004, OPHTHAL PHYSL OPT, V24, P384, DOI 10.1111/j.1475-1313.2004.00202.x; Scheiman M, 2008, CLIN MANAGEMENT BINO; SCHOR CM, 1979, VISION RES, V19, P1359, DOI 10.1016/0042-6989(79)90208-6; SCHOR CM, 1979, VISION RES, V19, P757, DOI 10.1016/0042-6989(79)90151-2; Schroth V., 2012, BINOCULAR CORRECTION; SETHI B, 1987, AM J OPTOM PHYS OPT, V64, P263; SETHI B, 1986, DOC OPHTHALMOL, V63, P247, DOI 10.1007/BF00160760; SETHI B, 1986, OPHTHAL PHYSL OPT, V6, P151, DOI 10.1016/0275-5408(86)90006-2; Sheedy JE, 1983, VERGENCE EYE MOVEMEN, P517; Shimono K, 1998, VISION RES, V38, P591, DOI 10.1016/S0042-6989(97)00168-5; Simonsz H J, 2001, Strabismus, V9, P17, DOI 10.1076/stra.9.1.17.709; SIMONSZ HJ, 1991, DOC OPHTHALMOL, V78, P141, DOI 10.1007/BF00165674; Teitelbaum B, 2009, OPTOMETRY VISION SCI, V86, P153, DOI 10.1097/OPX.0b013e318194e985; Ukwade MT, 2000, OPTOMETRY VISION SCI, V77, P309, DOI 10.1097/00006324-200006000-00011; VANHERICK W, 1969, AM J OPHTHALMOL, V68, P626, DOI 10.1016/0002-9394(69)91241-0; WICK B, 1991, OPTOMETRY VISION SCI, V68, P146, DOI 10.1097/00006324-199102000-00011; WICK B, 1985, AM J OPTOM PHYS OPT, V62, P591; WILDSOET CF, 1985, OPHTHAL PHYSL OPT, V5, P171, DOI 10.1111/j.1475-1313.1985.tb00653.x; Yang YB, 2002, INVEST OPHTH VIS SCI, V43, P2508; YEKTA AA, 1989, OPHTHAL PHYSL OPT, V9, P115, DOI 10.1111/j.1475-1313.1989.tb00829.x; YEKTA AA, 1989, OPTOMETRY VISION SCI, V66, P815, DOI 10.1097/00006324-198912000-00002; YEKTA AA, 1987, OPHTHAL PHYSL OPT, V7, P349, DOI 10.1111/j.1475-1313.1987.tb00759.x	98	8	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138871	10.1371/journal.pone.0138871	http://dx.doi.org/10.1371/journal.pone.0138871			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431525	Green Published, gold			2022-12-27	WOS:000362178700023
J	Sun, W; Lan, XB; Zhang, H; Dong, WW; Wang, ZH; He, L; Zhang, T; Liu, SM				Sun, Wei; Lan, Xiabin; Zhang, Hao; Dong, Wenwu; Wang, Zhihong; He, Liang; Zhang, Ting; Liu, Siming			Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							CENTRAL COMPARTMENT; PREDICTIVE FACTORS; SURGICAL-MANAGEMENT; PROGNOSTIC-FACTORS; NECK DISSECTION; RECURRENCE; INVOLVEMENT; PATTERN; IMPACT; ULTRASONOGRAPHY	Background Central lymph node metastasis (CLNM) is common in papillary thyroid carcinoma (PTC). Prophylactic central lymph node dissection (PCLND) for patients with clinically negative central compartment lymph nodes (CN0) remains controversial. The phrase "clinically negative" is used to indicate that patients exhibited no clinical evidence of CLNM by ultrasonography (US) or computerized tomography (CT) preoperatively. In this study, we analyze the risk factors for CLNM in CN0 patients. Methods The PUBMED and SCIE databases were systematically searched for works published through January 31, 2015. All of the patients included in this study underwent thyroidectomy+PCLND. Revman 5.3 software was used to analyze the data. Results Twenty studies and 9084 patients were included in this meta-analysis. The following variables were associated with an increased risk of CLNM in CN0 patients: age <45 years (OR = 1.59, 95% CI = 1.42-1.78, p<0.00001), male sex (OR = 1.95, 95% CI = 1.63-2.32, p<0.00001), multifocality (OR = 1.43, 95% CI = 1.22-1.67, p<0.00001), tumor size > 2 cm for PTC patients (OR = 2.98, 95% CI 2.08-4.28, p<0.00001) or tumor size > 0.5 cm for papillary thyroid microcarcinoma (PTMC) patients (OR = 2.30, 95% CI = 1.71-3.09, p<0.00001), location of the primary tumor in the central area and low pole (OR = 1.86, 95% CI = 1.48-2.33, p<0.00001), lymphovascular invasion (OR = 4.35, 95% CI = 2.24-8.46, p<0.0001), extrathyroidal extension (OR = 2.27, 95% CI = 1.76-2.94, p<0.00001), and capsular invasion (OR = 1.72, 95% CI = 1.39-2.41, p<0.00001). PTC (tumor size>1cm) exhibited a higher risk factor associated with CLNM than PTMC (tumor size<1cm) (OR = 2.83, 95% CI = 2.15- 3.72, p<0.00001). Bilateral tumors (OR = 1.21, 95% CI = 0.92-1.58, p = 0.17) and lymphocytic thyroiditis (OR = 0.88, 95% CI = 0.71-1.09, p = 0.25) had no association with CLNM in CN0 patients. Conclusions Our systematic review identified several clinical features associated with CLNM in CN0 patients, including age, sex, multifocality, size, location, lymphovascular invasion, capsular invasion, and extrathyroidal extension. These factors should guide the application of PCLND in CN0 patients.	[Sun, Wei; Lan, Xiabin; Zhang, Hao; Dong, Wenwu; Wang, Zhihong; He, Liang; Zhang, Ting; Liu, Siming] China Med Univ, Dept Thyroid Surg, Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China	China Medical University	Zhang, H (corresponding author), China Med Univ, Dept Thyroid Surg, Hosp 1, Shenyang 110001, Liaoning Provin, Peoples R China.	haozhang@mail.cmu.edu.cn	Dong, Wenwu/HGU-6879-2022	Dong, Wenwu/0000-0001-6621-4800	Liaoning BaiQianWan Talents Program [2014921033]	Liaoning BaiQianWan Talents Program	This work was supported by Liaoning BaiQianWan Talents Program (No. 2014921033), URLs: www.ln.hrss.gov.cn/ln/99/10/2014/11/i45652.shtml.	Do BA, 2014, OTOLARYNG HEAD NECK, V151, P746, DOI 10.1177/0194599814547503; Besic N, 2008, J SURG ONCOL, V97, P221, DOI 10.1002/jso.20935; Caliskan M, 2012, ENDOCR J, V59, P305, DOI 10.1507/endocrj.EJ11-0366; Carty SE, 2009, THYROID, V19, P1153, DOI 10.1089/thy.2009.0159; Cavicchi O, 2007, OTOLARYNG HEAD NECK, V137, P654, DOI 10.1016/j.otohns.2007.03.001; Choi JS, 2009, AM J ROENTGENOL, V193, P871, DOI 10.2214/AJR.09.2386; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Dailey ME, AMA ARCH SURG, V70, P291; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fritze D, 2010, OTOLARYNG CLIN N AM, V43, P285, DOI 10.1016/j.otc.2010.01.005; Grebe S K, 1996, Surg Oncol Clin N Am, V5, P43; Guerrero Marlon A, 2011, ISRN Oncol, V2011, P303128, DOI 10.5402/2011/303128; Hegedus L, 2004, NEW ENGL J MED, V351, P1764, DOI 10.1056/NEJMcp031436; Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227; Ito Y, 2006, WORLD J SURG, V30, P91, DOI 10.1007/s00268-005-0113-y; Ito Y, 2013, ENDOCR J, V60, P113; Jiang LH, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/385787; KATOH R, 1992, CANCER-AM CANCER SOC, V70, P1585, DOI 10.1002/1097-0142(19920915)70:6<1585::AID-CNCR2820700623>3.0.CO;2-Z; Kim BY, 2012, YONSEI MED J, V53, P924, DOI 10.3349/ymj.2012.53.5.924; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; Koo BS, 2009, ANN SURG, V249, P840, DOI 10.1097/SLA.0b013e3181a40919; Kouvaraki MA, 2003, SURGERY, V134, P946, DOI 10.1016/S0039-6060(03)00424-0; Lee DW, 2013, EJSO-EUR J SURG ONC, V39, P191, DOI 10.1016/j.ejso.2012.07.119; Lee JH, 2013, EUR J ENDOCRINOL, V168, P343, DOI 10.1530/EJE-12-0903; Lee KE, 2013, HEAD NECK-J SCI SPEC, V35, P672, DOI 10.1002/hed.23016; Lee SH, 2008, LARYNGOSCOPE, V118, P659, DOI 10.1097/MLG.0b013e318161f9d1; Liang KK, 2014, MED SCI MONITOR, V20, P807, DOI 10.12659/MSM.890182; Libutti SK, 2005, CANCER J, V11, P104, DOI 10.1097/00130404-200503000-00003; Lim YC, 2009, BRIT J SURG, V96, P253, DOI 10.1002/bjs.6484; Londero SC, 2015, THYROID, V25, P78, DOI 10.1089/thy.2014.0294; Loyo M, 2013, LARYNGOSCOPE, V123, P2056, DOI 10.1002/lary.23923; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Machens A, 2002, WORLD J SURG, V26, P22; Mao LN, 2015, ONCOL LETT, V9, P103, DOI 10.3892/ol.2014.2667; Mazeh H, 2011, AM J SURG, V201, P770, DOI 10.1016/j.amjsurg.2010.03.004; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Mazzaferri EL, 2009, THYROID, V19, P683, DOI 10.1089/thy.2009.1578; Miao SS, 2013, ORL J OTO-RHINO-LARY, V75, P265, DOI 10.1159/000354267; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moo TA, 2010, WORLD J SURG, V34, P1187, DOI 10.1007/s00268-010-0418-3; Noguchi S, 2008, WORLD J SURG, V32, P747, DOI 10.1007/s00268-007-9453-0; Obregon-Guerrero G, 2010, CIR CIR, V78, P479; Park JP, 2014, AM J SURG, V208, P412, DOI 10.1016/j.amjsurg.2013.10.032; Pelizzo MR, 2007, CLIN NUCL MED, V32, P440, DOI 10.1097/RLU.0b013e31805375ca; Qu N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-914; Rahbari R, 2010, FUTURE ONCOL, V6, P1771, DOI 10.2217/FON.10.127; Raza SN, 2008, OTOLARYNG HEAD NECK, V139, P21, DOI 10.1016/j.otohns.2007.10.021; Roh JL, 2007, ANN SURG, V245, P604, DOI 10.1097/01.sla.0000250451.59685.67; Roh JL, 2011, ANN SURG ONCOL, V18, P2245, DOI 10.1245/s10434-011-1600-z; Saunders BD, 2003, SURGERY, V134, P924, DOI 10.1016/S0039-6060(03)00420-3; Sciuto R, 2009, ANN ONCOL, V20, P1728, DOI 10.1093/annonc/mdp050; Shaha AR, 1996, ANN SURG ONCOL, V3, P534, DOI 10.1007/BF02306085; Shindo M, 2006, ARCH OTOLARYNGOL, V132, P650, DOI 10.1001/archotol.132.6.650; So YK, 2010, SURGERY, V148, P526, DOI 10.1016/j.surg.2010.01.003; Sosa JA, 1998, ANN SURG, V228, P320, DOI 10.1097/00000658-199809000-00005; Takami H, 2011, WORLD J SURG, V35, P111, DOI 10.1007/s00268-010-0832-6; Teixeira G, 2011, SURGERY, V150, P1161, DOI 10.1016/j.surg.2011.09.019; Toniato A, 2008, ANN SURG ONCOL, V15, P1518, DOI 10.1245/s10434-008-9859-4; TSCHOLLDUCOMMUN J, 1982, VIRCHOWS ARCH A, V396, P19, DOI 10.1007/BF00428498; Tuttle RM, 2014, J NATL COMPR CANC NE, V12, P1671, DOI 10.6004/jnccn.2014.0169; Vini L, 2003, CANCER-AM CANCER SOC, V97, P2736, DOI 10.1002/cncr.11410; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Wang Q, 2014, CLIN TRANSL ONCOL, V16, P44, DOI 10.1007/s12094-013-1038-9; White ML, 2007, WORLD J SURG, V31, P895, DOI 10.1007/s00268-006-0907-6; Wu YJ, 2013, J BUON, V18, P733; Yang YL, 2014, CLIN ENDOCRINOL, V81, P282, DOI 10.1111/cen.12417; Zaydfudim V, 2008, SURGERY, V144, P1070, DOI 10.1016/j.surg.2008.08.034; Zhou YL, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-67	69	83	98	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139021	10.1371/journal.pone.0139021	http://dx.doi.org/10.1371/journal.pone.0139021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431346	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700028
J	Tessema, SK; Kassa, M; Kebede, A; Mohammed, H; Leta, GT; Woyessa, A; Guma, GT; Petros, B				Tessema, Sofonias K.; Kassa, Moges; Kebede, Amha; Mohammed, Hussein; Leta, Gemechu Tadesse; Woyessa, Adugna; Guma, Geremew Tasew; Petros, Beyene			Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia	PLOS ONE			English	Article							ANTIMALARIAL-DRUG RESISTANCE; CHLOROQUINE RESISTANCE; HIGH PREVALENCE; MOLECULAR MARKERS; MUTATIONS; MALARIA; SURVEILLANCE; PRESSURE; GENES; TRIMETHOPRIM	Antimalarial drug resistance is one of the major challenges in global efforts of malaria control and elimination. In 1998, chloroquine was abandoned and replaced with sulfadoxine/pyrimethamine, which in turn was replaced with artemether/lumefantrine for the treatment of uncomplicated falciparum malaria in 2004. Sulfadoxine/pyrimethamine resistance is associated with mutations in dihydrofolate reductase (Pfdhfr) and dihydropteroate synthase (Pfdhps) genes. The prevalence of mutation in Pfdhfr and Pfdhps genes were evaluated and compared for a total of 159 isolates collected in two different time points, 2005 and 2007/08, from Pawe hospital, in North Western Ethiopia. The frequency of triple Pfdhfr mutation decreased significantly from 50.8% (32/63) to 15.9%(10/63) (P<0.001), while Pfdhps double mutation remained high and changed only marginally from 69.2% (45/65) to 55.4% (40/65) (P = 0.08). The combined Pfdhfr/Pfdhps quintuple mutation, which is strongly associated with sulfadoxine/pyrimethamine resistance, was significantly decreased from 40.7% (24/59) to 13.6% (8/59) (P<0.0001). On the whole, significant decline in mutant alleles and re-emergence of wild type alleles were observed. The change in the frequency is explained by the reduction of residual drug-resistant parasites caused by the strong drug pressure imposed when sulfadoxine/pyrimethamine was the first-line drug, followed by lower fitness of these resistant parasites in the absence of drug pressure. Despite the decrease in the frequency of mutant alleles, higher percentages of mutation remain prevalent in the study area in 2007/08 in both Pfdhfr and Pfdhps genes. Therefore, further multi-centered studies in different parts of the country will be required to assess the re-emergence of sulfadoxine/pyrimethamine sensitive parasites and to monitor and prevent the establishment of multi drug resistant parasites in this region.	[Tessema, Sofonias K.; Petros, Beyene] Univ Addis Ababa, Dept Biol, Fac Sci, Addis Ababa, Ethiopia; [Kassa, Moges; Kebede, Amha; Mohammed, Hussein; Leta, Gemechu Tadesse; Woyessa, Adugna; Guma, Geremew Tasew] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia	Addis Ababa University	Tessema, SK (corresponding author), Univ Addis Ababa, Dept Biol, Fac Sci, Addis Ababa, Ethiopia.	sofoniaskifle@gmail.com		Tasew, Geremew/0000-0002-2797-824X	International atomic energy agency (IAEA); Addis Ababa University; Ethiopian Health and Nutrition Research Institute (EHNRI)	International atomic energy agency (IAEA)(International Atomic Energy Agency); Addis Ababa University; Ethiopian Health and Nutrition Research Institute (EHNRI)	The project was funded by the International atomic energy agency (IAEA), Addis Ababa University and Ethiopian Health and Nutrition Research Institute (EHNRI). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Muhsin AMA, 2004, J INFECT DIS, V189, P1239, DOI 10.1086/382509; Abdel-Muhsin AMA, 2002, AM J TROP MED HYG, V67, P24, DOI 10.4269/ajtmh.2002.67.24; Alifrangis M, 2009, AM J TROP MED HYG, V80, P523, DOI 10.4269/ajtmh.2009.80.523; [Anonymous], 2004, MAL DIAGN TREATM GUI; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BROOKS DR, 1994, EUR J BIOCHEM, V224, P397, DOI 10.1111/j.1432-1033.1994.00397.x; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; Dicko A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000407; Gebru-Woldearegai T, 2005, AM J TROP MED HYG, V73, P1131, DOI 10.4269/ajtmh.2005.73.1131; Hailemeskel E, 2013, ACTA TROP, V128, P636, DOI 10.1016/j.actatropica.2013.09.010; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; Jima D, 2005, East Afr Med J, V82, P391; Karema C, 2010, ANTIMICROB AGENTS CH, V54, P477, DOI 10.1128/AAC.00498-09; Khalil I, 2003, AM J TROP MED HYG, V68, P586, DOI 10.4269/ajtmh.2003.68.586; Khim N, 2005, ANTIMICROB AGENTS CH, V49, P3147, DOI 10.1128/AAC.49.8.3147-3152.2005; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Laufer MK, 2006, NEW ENGL J MED, V355, P1959, DOI 10.1056/NEJMoa062032; LIU DQ, 1995, B WORLD HEALTH ORGAN, V73, P483; Lynch C, 2008, J INFECT DIS, V197, P1598, DOI 10.1086/587845; Marks F, 2005, ANTIMICROB AGENTS CH, V49, P1101, DOI 10.1128/AAC.49.3.1101-1105.2005; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Mohammed A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-415; Mwai L, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-106; Nzila A, 2005, T ROY SOC TROP MED H, V99, P341, DOI 10.1016/j.trstmh.2004.07.002; Nzila AM, 2000, J INFECT DIS, V181, P2023, DOI 10.1086/315520; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Pearce RJ, 2013, J INFECT DIS, V207, P848, DOI 10.1093/infdis/jis742; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Raman J, 2008, AM J TROP MED HYG, V78, P256, DOI 10.4269/ajtmh.2008.78.256; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Schunk M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-54; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; THAITHONG S, 1988, T ROY SOC TROP MED H, V82, P37, DOI 10.1016/0035-9203(88)90255-6; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; Vacas E, 2012, BBA-MOL CELL RES, V1823, P1676, DOI 10.1016/j.bbamcr.2012.06.018; van Eijk AM, 2011, LANCET INFECT DIS, V11, P190, DOI 10.1016/S1473-3099(10)70295-4; Wang P, 1997, MOL BIOCHEM PARASIT, V89, P161, DOI 10.1016/S0166-6851(97)00114-X; Wang XH, 2005, AM J TROP MED HYG, V72, P410, DOI 10.4269/ajtmh.2005.72.410; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization (WHO), 2010, WHO POL REC INT PREV; Zhou ZY, 2008, ANTIMICROB AGENTS CH, V52, P1900, DOI 10.1128/AAC.00297-08	44	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0126943	10.1371/journal.pone.0126943	http://dx.doi.org/10.1371/journal.pone.0126943			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431464	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700001
J	Gamat, M; Malinowski, RL; Parkhurst, LJ; Steinke, LM; Marker, PC				Gamat, Melissa; Malinowski, Rita L.; Parkhurst, Linnea J.; Steinke, Laura M.; Marker, Paul C.			Ornithine Decarboxylase Activity Is Required for Prostatic Budding in the Developing Mouse Prostate	PLOS ONE			English	Article							UROGENITAL SINUS EPITHELIUM; RAT VENTRAL PROSTATE; ALPHA-DIFLUOROMETHYLORNITHINE; BRANCHING MORPHOGENESIS; S-ADENOSYLMETHIONINE; POLYAMINE BIOSYNTHESIS; IRREVERSIBLE INHIBITOR; ANDROGEN-REGULATION; CELL PROLIFERATION; EXPRESSION	The prostate is a male accessory sex gland that produces secretions in seminal fluid to facilitate fertilization. Prostate secretory function is dependent on androgens, although the mechanism by which androgens exert their effects is still unclear. Polyamines are small cationic molecules that play pivotal roles in DNA transcription, translation and gene regulation. The rate-limiting enzyme in polyamine biosynthesis is ornithine decarboxylase, which is encoded by the gene Odc1. Ornithine decarboxylase mRNA decreases in the prostate upon castration and increases upon administration of androgens. Furthermore, testosterone administered to castrated male mice restores prostate secretory activity, whereas administering testosterone and the ornithine decarboxylase inhibitor D, L-alpha-difluromethylornithine (DFMO) to castrated males does not restore prostate secretory activity, suggesting that polyamines are required for androgens to exert their effects. To date, no one has examined polyamines in prostate development, which is also androgen dependent. In this study, we showed that ornithine decarboxylase protein was expressed in the epithelium of the ventral, dorsolateral and anterior lobes of the adult mouse prostate. Ornithine decarboxylase protein was also expressed in the urogenital sinus (UGS) epithelium of the male and female embryo prior to prostate development, and expression continued in prostatic epithelial buds as they emerged from the UGS. Inhibiting ornithine decarboxylase using DFMO in UGS organ culture blocked the induction of prostatic buds by androgens, and significantly decreased expression of key prostate transcription factor, Nkx3.1, by androgens. DFMO also significantly decreased the expression of developmental regulatory gene Notch1. Other genes implicated in prostatic development including Sox9, Wif1 and Srd5a2 were unaffected by DFMO. Together these results indicate that Odc1 and polyamines are required for androgens to exert their effect in mediating prostatic bud induction, and are required for the expression of a subset of prostatic developmental regulatory genes including Notch1 and Nkx3.1.	[Gamat, Melissa; Malinowski, Rita L.; Parkhurst, Linnea J.; Steinke, Laura M.; Marker, Paul C.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Marker, PC (corresponding author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.	paul.marker@wisc.edu	/AAW-1266-2021	/0000-0003-2943-8156	NCI [CA140217]; NIH/NIDDK [DK091193]; NATIONAL CANCER INSTITUTE [R01CA140217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091193, U54DK104310] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the NCI (CA140217) and the NIH/NIDDK (DK091193) grants that were awarded to PCM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABELOFF MD, 1984, J CLIN ONCOL, V2, P124, DOI 10.1200/JCO.1984.2.2.124; BACHRACH U, 1970, ANN NY ACAD SCI, V171, P939, DOI 10.1111/j.1749-6632.1970.tb39400.x; Bauman TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109102; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bistulfi G, 2009, FASEB J, V23, P2888, DOI 10.1096/fj.09-130708; CHU PJ, 1994, NEUROSCI RES, V19, P155, DOI 10.1016/0168-0102(94)90138-4; CROZAT A, 1992, ENDOCRINOLOGY, V130, P1131, DOI 10.1210/en.130.3.1131; CUNHA GR, 1973, ANAT RECORD, V177, P561, DOI 10.1002/ar.1091770409; DANZIN C, 1982, BIOCHEM J, V202, P175, DOI 10.1042/bj2020175; DANZIN C, 1979, BIOCHEM J, V180, P507, DOI 10.1042/bj1800507; Doles JD, 2005, PROSTATE, V65, P390, DOI 10.1002/pros.20321; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; FOZARD JR, 1980, EUR J PHARMACOL, V65, P379, DOI 10.1016/0014-2999(80)90342-8; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; GERDES J, 1984, J IMMUNOL, V133, P1710; Gritli-Linde A, 2001, DEV DYNAM, V220, P259, DOI 10.1002/1097-0177(20010301)220:3<259::AID-DVDY1100>3.0.CO;2-#; GRITLILINDE A, 1995, INT J DEV BIOL, V39, P383; JANNE OA, 1991, J STEROID BIOCHEM, V40, P307, DOI 10.1016/0960-0760(91)90196-C; Jasuja R, 2013, AGING CELL; KADMON D, 1982, J NUCL MED, V23, P998; Keil KP, 2012, ENDOCRINOLOGY, V153, P6091, DOI 10.1210/en.2012-1564; KORHONEN VP, 1995, DNA CELL BIOL, V14, P841, DOI 10.1089/dna.1995.14.841; Kruithof-de Julio M, 2013, DEV DYNAM, V242, P1160, DOI 10.1002/dvdy.24008; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Kuslak SL, 2007, DIFFERENTIATION, V75, P638, DOI 10.1111/j.1432-0436.2006.00161.x; Lamm MLG, 2001, DEV BIOL, V232, P301, DOI 10.1006/dbio.2001.0187; Loikkanen I, 2005, DIFFERENTIATION, V73, P303, DOI 10.1111/j.1432-0436.2005.00036.x; Lopez-Garcia C, 2008, ENDOCRINOLOGY, V149, P5012, DOI 10.1210/en.2008-0084; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; Mehta V, 2013, DEV BIOL, V376, P125, DOI 10.1016/j.ydbio.2013.01.034; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; PEGG AE, 1970, BIOCHEM J, V117, P17, DOI 10.1042/bj1170017; PEGG AE, 1968, BIOCHEM J, V108, P533, DOI 10.1042/bj1080533; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Podlasek CA, 1999, DEV BIOL, V209, P28, DOI 10.1006/dbio.1999.9229; R Development Core Team, 2012, R LANG ENV STAT COMP; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Schipper RG, 1999, J HISTOCHEM CYTOCHEM, V47, P1395, DOI 10.1177/002215549904701106; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Schneider AJ, 2014, TOXICOL SCI, V141, P176, DOI 10.1093/toxsci/kfu116; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Shou JY, 2001, CANCER RES, V61, P7291; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Stabellini G, 2001, EUR J HISTOCHEM, V45, P151; TAKYI EEK, 1977, BIOCHEM J, V162, P87, DOI 10.1042/bj1620087; TAKYI EEK, 1977, BIOCHIM BIOPHYS ACTA, V497, P652, DOI 10.1016/0304-4165(77)90285-9; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; VANSTEEG H, 1989, NUCLEIC ACIDS RES, V17, P8855, DOI 10.1093/nar/17.21.8855; WAHLFORS J, 1990, DNA CELL BIOL, V9, P103, DOI 10.1089/dna.1990.9.103; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wang XD, 2004, J BIOL CHEM, V279, P24733, DOI 10.1074/jbc.M401602200; Young L, 2006, J HISTOCHEM CYTOCHEM, V54, P223, DOI 10.1369/jhc.5A6672.2005; YU CCW, 1992, HISTOCHEM J, V24, P121, DOI 10.1007/BF01047461	55	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139522	10.1371/journal.pone.0139522	http://dx.doi.org/10.1371/journal.pone.0139522			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426536	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100074
J	Kumar, V; Hart, AJ; Keerthiraju, ER; Waldron, PR; Tucker, GA; Greetham, D				Kumar, Vinod; Hart, Andrew J.; Keerthiraju, Ethiraju R.; Waldron, Paul R.; Tucker, Gregory A.; Greetham, Darren			Expression of Mitochondrial Cytochrome C Oxidase Chaperone Gene (COX20) Improves Tolerance to Weak Acid and Oxidative Stress during Yeast Fermentation	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; ETHANOL-PRODUCTION; ACETIC-ACID; SSF PROCESSES; WHEAT-STRAW; EN-ROUTE; GLUCOSE; GROWTH; XYLOSE	Introduction Saccharomyces cerevisiae is the micro-organism of choice for the conversion of fermentable sugars released by the pre-treatment of lignocellulosic material into bioethanol. Pretreatment of lignocellulosic material releases acetic acid and previous work identified a cytochrome oxidase chaperone gene (COX20) which was significantly up-regulated in yeast cells in the presence of acetic acid. Results A Delta cox20 strain was sensitive to the presence of acetic acid compared with the background strain. Overexpressing COX20 using a tetracycline-regulatable expression vector system in a Delta cox20 strain, resulted in tolerance to the presence of acetic acid and tolerance could be ablated with addition of tetracycline. Assays also revealed that overexpression improved tolerance to the presence of hydrogen peroxide-induced oxidative stress. Conclusion This is a study which has utilised tetracycline-regulated protein expression in a fermentation system, which was characterised by improved (or enhanced) tolerance to acetic acid and oxidative stress.	[Kumar, Vinod; Hart, Andrew J.; Keerthiraju, Ethiraju R.; Waldron, Paul R.; Tucker, Gregory A.; Greetham, Darren] Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	University of Nottingham	Greetham, D (corresponding author), Univ Nottingham, Sch Biosci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	Darren.greetham@nottingham.ac.uk	ETHIRAJU RAVICHANDRAN, KEERTHIRAJU/GSN-3366-2022; Kumar, Vinod/J-2326-2016	Tucker, Gregory/0000-0002-3377-9132; ETHIRAJU RAVICHANDRAN, KEERTHIRAJU/0000-0003-2568-1343; Kumar, Vinod/0000-0001-8967-6119	Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Bioenergy Centre (BSBEC), under the programme for 'Lignocellulosic Conversion to Ethanol' (LACE) [BB/G01616X/1]; European Regional Development Fund project [EMX05568]; Biotechnology and Biological Sciences Research Council [BB/G01616X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Bioenergy Centre (BSBEC), under the programme for 'Lignocellulosic Conversion to Ethanol' (LACE); European Regional Development Fund project; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research reported here was supported (in full or in part) by the Biotechnology and Biological Sciences Research Council (BBSRC) Sustainable Bioenergy Centre (BSBEC), under the programme for 'Lignocellulosic Conversion to Ethanol' (LACE) [Grant Ref: BB/G01616X/1]. This is a large interdisciplinary programme and the views expressed in this paper are those of the authors alone, and do not necessarily reflect the views of the collaborators or the policies of the funding bodies. This project is part financed by the European Regional Development Fund project EMX05568.	Antoni D, 2007, APPL MICROBIOL BIOT, V77, P23, DOI 10.1007/s00253-007-1163-x; Aslankoohi E, 2013, APPL ENV MICROBIOL; Beltran G, 2002, SYST APPL MICROBIOL, V25, P287, DOI 10.1078/072320202320386479; Bode M, 2013, ANTIOXID REDOX SIGN, V18, P1597, DOI 10.1089/ars.2012.4685; CASEY GP, 1986, CRC CR REV MICROBIOL, V13, P219, DOI 10.3109/10408418609108739; Fernandez-Sandoval MT, 2012, APPL MICROBIOL BIOT, V96, P1291, DOI 10.1007/s00253-012-4177-y; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Giannattasio S, 2008, FEBS LETT, V582, P1519, DOI 10.1016/j.febslet.2008.03.048; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Greetham D, 2014, J IND MICROBIOL BIOT; Greetham D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103233; Hell K, 2000, J BIOL CHEM, V275, P4571, DOI 10.1074/jbc.275.7.4571; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hook M., 2010, NAT RESOUR RES, V19, P63, DOI [10.1007/s11053-010-9113-1, DOI 10.1007/S11053-010-9113-1]; Krishnan MS, 1999, APPL BIOCHEM BIOTECH, V77-9, P373, DOI 10.1385/ABAB:78:1-3:373; Kumar V, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0276-7; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; Mollapour M, 2008, YEAST, V25, P169, DOI 10.1002/yea.1576; Puligundla P, 2011, J IND MICROBIOL BIOT, V38, P1133, DOI 10.1007/s10295-011-0999-3; Saha BC, 2005, PROCESS BIOCHEM, V40, P3693, DOI 10.1016/j.procbio.2005.04.006; Taherzadeh MJ, 1996, APPL MICROBIOL BIOT, V46, P176, DOI 10.1007/s002530050801; Tomas-Pejo E, 2010, J IND MICROBIOL BIOT, V37, P1211, DOI 10.1007/s10295-010-0768-8; Tomas-Pejo E, 2008, BIOTECHNOL BIOENG, V100, P1122, DOI 10.1002/bit.21849; Vacca RA, 2006, PLANT PHYSIOL, V141, P208, DOI 10.1104/pp.106.078683; VERDUYN C, 1990, J GEN MICROBIOL, V136, P405, DOI 10.1099/00221287-136-3-405; Walsh J.H., 2000, PROJECTION CUMULATIV; Wimalasena TT, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-47	31	13	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139129	10.1371/journal.pone.0139129	http://dx.doi.org/10.1371/journal.pone.0139129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427054	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100031
J	Luijks, H; Biermans, M; Bor, H; van Weel, C; Lagro-Janssen, T; de Grauw, W; Schermer, T				Luijks, Hilde; Biermans, Marion; Bor, Hans; van Weel, Chris; Lagro-Janssen, Toine; de Grauw, Wim; Schermer, Tjard			The Effect of Comorbidity on Glycemic Control and Systolic Blood Pressure in Type 2 Diabetes: A Cohort Study with 5 Year Follow-Up in Primary Care	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH-CARE; MELLITUS; IMPACT; MULTIMORBIDITY; EPIDEMIOLOGY; DEPRESSION; SYMPTOMS; OUTCOMES; QUALITY	Aims To explore the longitudinal effect of chronic comorbid diseases on glycemic control (HbA1C) and systolic blood pressure (SBP) in type 2 diabetes patients. Methods In a representative primary care cohort of patients with newly diagnosed type 2 diabetes in The Netherlands (n = 610), we tested differences in the five year trend of HbA1C and SBP according to comorbidity profiles. In a mixed model analysis technique we corrected for relevant covariates. Influence of comorbidity (a chronic disease already present when diabetes was diagnosed) was tested as total number of comorbid diseases, and as presence of specific disease groups, i.e. cardiovascular, mental, and musculoskeletal disease, malignancies, and COPD. In subgroup effect analyses we tested if potential differences were modified by age, sex, socioeconomic status, and BMI. Results The number of comorbid diseases significantly influenced the SBP trend, with highest values after five years for diabetes patients without comorbidity (p = 0.005). The number of diseases did not influence the HbA(1)C trend (p = 0.075). Comorbid musculoskeletal disease resulted in lower HbA(1)C at the time of diabetes diagnosis, but in higher values after five years (p = 0.044). Patients with cardiovascular diseases had sustained elevated levels of SBP (p = 0.014). Effect modification by socioeconomic status was observed in some comorbidity subgroups. Conclusions Presence of comorbidity in type 2 diabetes patients affected the long-term course of HbA(1)C and SBP in this primary care cohort. Numbers and types of comorbidity showed differential effects: not the simple sum of diseases, but specific types of comorbid disease had a negative influence on long-term diabetes control parameters. The complex interactions between comorbidity, diabetes control and effect modifiers require further investigation and may help to personalize treatment goals.	[Luijks, Hilde; Biermans, Marion; Bor, Hans; van Weel, Chris; Lagro-Janssen, Toine; de Grauw, Wim; Schermer, Tjard] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [van Weel, Chris] Australian Natl Univ, Australian Primary Hlth Care Res Inst, Canberra, ACT, Australia	Radboud University Nijmegen; Australian National University	Luijks, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	Hilde.Luijks@radboudumc.nl	Bor, Huseyin/AAU-2511-2021; Schermer, Tjard RJ/A-8511-2011; de Grauw, W.J.C./L-4334-2015; Biermans, M.C.J./L-4199-2015; van Weel, Chris/D-4375-2009; Lagro, A.L.M./H-8066-2014; Luijks, Hilde/G-6927-2016	Schermer, Tjard RJ/0000-0002-1391-2995; van Weel, Chris/0000-0003-3653-4701; Luijks, Hilde/0000-0002-2709-5770	SBOH; Foundation for General Practice Residency Training in the Netherlands	SBOH; Foundation for General Practice Residency Training in the Netherlands	HL has received a research grant from SBOH, Foundation for General Practice Residency Training in the Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for the presented work.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Ashton CM, 2003, AM J MANAG CARE, V9, P145; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss EA, 2011, J GEN INTERN MED, V26, P575, DOI 10.1007/s11606-010-1600-x; Bentsen B G, 1986, Scand J Prim Health Care, V4, P43, DOI 10.3109/02813438609013970; Caughey GE, 2010, DIABETES RES CLIN PR, V87, P385, DOI 10.1016/j.diabres.2009.10.019; Chaudhry SI, 2005, J AM GERIATR SOC, V53, P1214, DOI 10.1111/j.1532-5415.2005.53370.x; de Grauw WJC, 2002, J FAM PRACTICE, V51, P459; Souto-Gallardo MD, 2011, NUTR HOSP, V26, P1242, DOI [10.3305/nh.2011.26.6.5244, 10.1590/S0212-16112011000600008]; Dutch College of General Practitioners, 2006, HUISARTS WET, V49, P137; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Hartman TCO, 2004, BRIT J GEN PRACT, V54, P922; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Lugtenberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025987; Luijks H, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-128; Luijks HD, 2015, NPJ PRIM CARE RESP M, V25, DOI 10.1038/npjpcrm.2015.32; Luijks HD, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652373; Niefeld MR, 2003, DIABETES CARE, V26, P1344, DOI 10.2337/diacare.26.5.1344; Peters SAE, 2014, DIABETOLOGIA, V57, P1542, DOI 10.1007/s00125-014-3260-6; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Raz I, 2013, DIABETES CARE, V36, P1779, DOI 10.2337/dc13-0512; Roy T, 2012, J AFFECT DISORDERS, V142, pS8, DOI 10.1016/S0165-0327(12)70004-6; Rutten G.E.H.M., 2013, HUISARTS WETENSCHAP, V56, P512; Schers Henk, 2008, Eur J Gen Pract, V14 Suppl 1, P13, DOI 10.1080/13814780802436051; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Talley NJ, 2001, AM J GASTROENTEROL, V96, P71; Teljeur C, 2013, EUR J GEN PRACT, V19, P17, DOI 10.3109/13814788.2012.714768; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Twisk JWR, 2003, APPL LONGITUDINAL DA; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van Weel C, 2012, J AM BOARD FAM MED, V25, pS12, DOI 10.3122/jabfm.2012.02.110212; Van Weel Chris, 2008, Eur J Gen Pract, V14 Suppl 1, P5, DOI 10.1080/13814780802436028; Van Weel-Baumgarten EM, 2000, BRIT J GEN PRACT, V50, P284; VANWEEL C, 1995, J EPIDEMIOL COMMUN H, V49, P29, DOI 10.1136/jech.49.Suppl_1.29; Voorham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038707; Woodard LD, 2011, MED CARE, V49, P605, DOI 10.1097/MLR.0b013e31820f0ed0; Woolthuis EPK, 2009, ANN FAM MED, V7, P422, DOI 10.1370/afm.997	42	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138662	10.1371/journal.pone.0138662	http://dx.doi.org/10.1371/journal.pone.0138662			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426904	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100017
J	Mattheus, W; Hanquet, G; Collard, JM; Vanhoof, R; Bertrand, S				Mattheus, Wesley; Hanquet, Germaine; Collard, Jean-Marc; Vanhoof, Raymond; Bertrand, Sophie			Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997-2012	PLOS ONE			English	Article							NEISSERIA-MENINGITIDIS; DISEASE; IMPACT; EPIDEMIOLOGY; DIVERSITY	Background Invasive meningococcal disease (IMD) is a major cause of bacterial meningitides and septicaemia. This study shows the results of the laboratory-based surveillance of IMD in Belgium over the period 1997-2012. Methods The results are based on microbiological and molecular laboratory surveillance of 2997 clinical isolates of N. meningitides received by the Belgian Meningococcal Reference Centre (BMRC) over the period 1997-2012. Results Serogroup B has always been a major cause of meningococcal disease in Belgium, with P3.4 as most frequent serotype till 2008, while an increase in non-serotypable strains has been observed in the last few years. Clonal complexes cc-41/44 and cc-269 are most frequently observed in serogroup B strains. In the late nineties, the incidence of serogroup C disease increased considerably and peaked in 2001, mainly associated with phenotypes C:2a:P1.5,2, C:2a:P1.5 and C:2a:P1.2 (ST-11/ET-37 clonal complex). The introduction of the meningococcal C conjugate vaccine has been followed by an 88% significant decrease in serogroup C disease from 2001 to 2004 nationally, yet sharper in Flanders (92%) compared to Wallonia (77%). Since 2008 a difference in incidence of serogroup C was observed in Flanders (0-0.1/100,000) versus Wallonia (0.1-0.3/100,000). Conclusion This study showed the change in epidemiology and strain population over a 16 years period spanning an exhaustive vaccination campaign and highlights the influence of regional vaccination policies with different cohorts sizes on short and long-term IMD incidences.	[Mattheus, Wesley; Collard, Jean-Marc; Vanhoof, Raymond; Bertrand, Sophie] Sci Inst Publ Hlth, Sect Bacterial Dis, Brussels, Belgium; [Hanquet, Germaine] Hlth Care Knowledge Ctr, Med Epidemiol, Brussels, Belgium		Bertrand, S (corresponding author), Sci Inst Publ Hlth, Sect Bacterial Dis, Brussels, Belgium.	sophie.bertrand@wiv-isp.be	Collard, Jean-Marc/Q-2342-2019	Collard, Jean-Marc/0000-0002-1490-3978	Flemish and French Communities; Federal (Program of the Institute of Public Health) [1101]; Belgian Ministry of Social Affairs through a fund within the Health Insurance System	Flemish and French Communities; Federal (Program of the Institute of Public Health); Belgian Ministry of Social Affairs through a fund within the Health Insurance System	This work was supported by the Flemish and French Communities and the Federal (Program 1101 of the Institute of Public Health). The national reference center is partially supported by the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABDILLAHI H, 1987, FEMS MICROBIOL LETT, V48, P367, DOI 10.1016/0378-1097(87)90077-2; Bertrand S, 2011, MICROBES INFECT, V13, P684, DOI 10.1016/j.micinf.2011.02.006; Bijlsma MW, 2014, CLIN INFECT DIS, V59, P1216, DOI 10.1093/cid/ciu601; Campbell H, 2010, CLIN VACCINE IMMUNOL, V17, P840, DOI 10.1128/CVI.00529-09; Cano R, 2004, Euro Surveill, V9, P5, DOI 10.2807/esm.09.07.00474-en; De Schrijver K, 2003, EUR J EPIDEMIOL, V18, P1073, DOI 10.1023/A:1026100321871; DEMAEYER S, 1981, J INFECTION, V3, P63, DOI 10.1016/S0163-4453(81)80010-2; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Hanquet G, 2007, MENINGOCOCCAL SEROGR; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Hubert B, 1997, Euro Surveill, V2, P69; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Khatami A, 2010, EXPERT REV VACCINES, V9, P285, DOI 10.1586/ERV.10.3; Levy-Bruhl D, 2002, Euro Surveill, V7, P74; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Noah N, 2001, SURVEILLANCE BACTERI; Russell JE, 2004, EMERG INFECT DIS, V10, P674, DOI 10.3201/eid1004.030247; Simoes MJ, 2009, EPIDEMIOL INFECT, V137, P161, DOI 10.1017/S0950268808001106; Stefanelli P, 2003, J CLIN MICROBIOL, V41, P5783, DOI 10.1128/JCM.41.12.5783-5786.2003; Taha MK, 2004, J CLIN MICROBIOL, V42, P4158, DOI 10.1128/JCM.42.9.4158-4163.2004; Theeten H, 2003, TIJDSCHR GENEESKD, V59, P1239; Thompson EAL, 2003, MICROBIOL-SGM, V149, P1849, DOI 10.1099/mic.0.26131-0; Van Looveren M, 1998, J CLIN MICROBIOL, V36, P2828, DOI 10.1128/JCM.36.10.2828-2834.1998; Van Looveren Marleen, 1998, Clin Microbiol Infect, V4, P224; Vicente D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008501; Vogel U, 2011, MICROB BIOTECHNOL, V4, P20, DOI 10.1111/j.1751-7915.2010.00178.x; Welte R, 2004, VACCINE, V23, P470, DOI 10.1016/j.vaccine.2004.06.019	29	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139615	10.1371/journal.pone.0139615	http://dx.doi.org/10.1371/journal.pone.0139615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26425857	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100081
J	Pirkle, CM; Peek-Ball, C; Outerbridge, E; Rouja, PM				Pirkle, Catherine McLean; Peek-Ball, Cheryl; Outerbridge, Eugene; Rouja, Philippe Max			Examining the Impact of a Public Health Message on Fish Consumption in Bermuda	PLOS ONE			English	Article							PRENATAL METHYLMERCURY EXPOSURE; MERCURY; RECOMMENDATIONS; CONTAMINANTS; SELENIUM; INFANT; WOMEN; LEAD	Background In 2003 mean cord blood mercury concentrations in pregnant Bermudian women exceeded levels associated with adverse health outcomes in children. The principal mercury source was local fish species. Public health messages were developed suggesting pregnant women reduce consumption of fish species with higher mercury concentrations (e.g. swordfish), substituting species containing lower mercury concentrations, and elevated omega-3 fatty acids (e.g. anchovies). Recent evidence indicates mercury concentrations in Bermuda's pregnant women have fallen five- fold. Objectives Assess whether changes in women's fish eating patterns during pregnancy are consistent with the public health messaging. Determine who is making changes to their diet during pregnancy and why. Methods Mixed methods study with a cross-sectional survey of 121 pregnant women, including 13 opened-ended interviews. Health system, social vulnerability, public health messaging, and socio-demographic variables were characterized and related to changes in fish consumption during pregnancy. Qualitative data were coded according to nutritional advice messages, comprehension of communication strategies, and sources of information. Results 95% of women surveyed encountered recommendations about fish consumption during pregnancy. 75% reported modifying fish eating behaviors because of recommendations. Principal sources of information about fish consumption in pregnancy were health care providers and the Internet. 71% of women reported reducing consumption of large fish species with greater mercury levels, but 60% reported reduced consumption of smaller, low mercury fish. No participant mentioned hearing about the benefits of fish consumption. More frequent exposure to public health messages during pregnancy was associated with lower reported consumption. Bermudian born women were less likely to reduce consumption of large fish species during pregnancy. Conclusions In Bermuda, public health messages advocating reduced consumption of larger, higher mercury-containing fish species appear effective, but masked the nutritional value message of small fish species, with low mercury concentration. Adjustment is needed to better balance the risk communication.	[Pirkle, Catherine McLean] Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA; [Peek-Ball, Cheryl] Dept Hlth, Hamilton, Bermuda; [Outerbridge, Eugene] King Edward VII Mem Hosp, Hamilton, Bermuda; [Rouja, Philippe Max] Dept Conservat Services, Hamilton Parish, Bermuda	University of Hawaii System; University of Hawaii Manoa	Pirkle, CM (corresponding author), Univ Hawaii Manoa, Off Publ Hlth Studies, Honolulu, HI 96822 USA.	cmpirkle@hawaii.edu		, Catherine/0000-0002-1528-5438	LePercq Foundation; Canadian Institutes of Health Research	LePercq Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Partial funding for this study came from the LePercq Foundation (PMR). CMP received a post-doctoral fellowship from the Canadian Institutes of Health Research. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews C, 2012, INT J HERIT STUD, V18, P352, DOI 10.1080/13527258.2011.647535; Baird J, 2009, P NUTR SOC, V68, P195, DOI 10.1017/S0029665109001050; Bickel G, GUIDE MEASURING HOUS; Boucher O, 2014, ENVIRON HEALTH PERSP, V122, P310, DOI 10.1289/ehp.1206323; Boucher O, 2012, ENVIRON HEALTH PERSP, V120, P1456, DOI 10.1289/ehp.1204976; Boucher O, 2011, AM J CLIN NUTR, V93, P1025, DOI 10.3945/ajcn.110.000323; Choi AL, 2014, NEUROTOXICOL TERATOL, V42, P85, DOI 10.1016/j.ntt.2014.02.003; Creswell W. C., 2011, DESIGNING CONDUCTING; Dallaire R, 2013, ENVIRON INT, V54, P85, DOI 10.1016/j.envint.2013.01.013; Department of Health, 2007, RISKS BEN LOC FISH C; Department of Statistics, 2011, 2010 CENSUS OF POPUL; Department of Statistics, 2015, LAB MARK IND; Dewailly E, 2008, FOOD ADDIT CONTAM A, V25, P1328, DOI 10.1080/02652030802175285; Dewailly E, 2007, OCEAN HUMAN HLTH RIS, P670; Dewailly E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047388; FAO, 1996, WORLD FOOD SUMM FOOD; Furgal CM, 2005, ARCTIC, V58, P103, DOI 10.14430/arctic404; Greiner A, 2010, PUBLIC HEALTH NUTR, V13, P1786, DOI 10.1017/S1368980010000923; Harrison PA, 2008, J HEALTH CARE POOR U, V19, P258, DOI 10.1353/hpu.2008.0003; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P91, DOI 10.1111/j.1365-3016.2012.01292.x; Jacobson JL, 2015, ENVIRON HEALTH PERSP, V123, P827, DOI 10.1289/ehp.1408554; Jacques C, 2011, J PEDIATR-US, V158, P73, DOI 10.1016/j.jpeds.2010.06.056; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Legrand M, 2010, CAN J PUBLIC HEALTH, V101, P28, DOI 10.1007/BF03405557; Lemire M, 2010, ENVIRON HEALTH PERSP, V118, P1584, DOI 10.1289/ehp.0901284; Mallard SR, 2014, PUBLIC HEALTH NUTR, V17, P1421, DOI 10.1017/S1368980013001626; Mistry HD, 2012, AM J OBSTET GYNECOL, V206, P21, DOI 10.1016/j.ajog.2011.07.034; Morales S, 2004, APPL NURS RES, V17, P178, DOI 10.1016/j.apnr.2004.06.006; Oken E, 2003, OBSTET GYNECOL, V102, P346, DOI 10.1016/S0029-7844(03)00484-8; Ray JG, 2004, BJOG-INT J OBSTET GY, V111, P399, DOI 10.1111/j.1471-0528.2004.00115.x; Shimshack JP, 2007, J ENVIRON ECON MANAG, V53, P158, DOI 10.1016/j.jeem.2006.10.002; Smith T, 2007, THE ROYAL GAZETTE; Strain JJ, 2012, J NUTR, V142, P1943, DOI 10.3945/jn.112.163493; World Bank, WORLD DEV IND	34	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139459	10.1371/journal.pone.0139459	http://dx.doi.org/10.1371/journal.pone.0139459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426692	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100063
J	Chen, Z; Ye, W; Long, Z; Ding, DX; Peng, HR; Hou, X; Qiu, R; Xia, K; Tang, BS; Jiang, H				Chen, Zhao; Ye, Wei; Long, Zhe; Ding, Dongxue; Peng, Huirong; Hou, Xuan; Qiu, Rong; Xia, Kun; Tang, Beisha; Jiang, Hong			Targeted Next-Generation Sequencing Revealed Novel Mutations in Chinese Ataxia Telangiectasia Patients: A Precision Medicine Perspective	PLOS ONE			English	Article							BRITISH-ISLES; ATM MUTATIONS; GENE	Ataxia telangiectasia (AT) is an autosomal recessive disease characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia and immunodeficiency due to mutations in the ATM gene. We performed targeted next-generation sequencing (NGS) on three unrelated patients and identified five disease-causing variants in three probands, including two pairs of heterozygous variants (FAT-1:c.4396C>T/p.R1466X, c.1608-2A>G; FAT-2:c.4412_4413insT/p.L1472Ffs*19, c.8824C>T/p.Q2942X) and one pair of homozygous variants (FAT-3:c.8110T>G/p.C2704G, Hom). With regard to precision medicine for rare genetic diseases, targeted NGS currently enables the rapid and cost-effective identification of causative mutations and is an updated molecular diagnostic tool that merits further optimization. This high-throughput data-based strategy would propel the development of precision diagnostic methods and establish a foundation for precision medicine.	[Chen, Zhao; Ye, Wei; Long, Zhe; Ding, Dongxue; Peng, Huirong; Hou, Xuan; Tang, Beisha; Jiang, Hong] Cent S Univ, Dept Neurol, Xiangya Hosp, Changsha, Hunan, Peoples R China; [Tang, Beisha; Jiang, Hong] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Xia, Kun; Tang, Beisha; Jiang, Hong] Cent S Univ, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Qiu, Rong] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Jiang, H (corresponding author), Cent S Univ, Dept Neurol, Xiangya Hosp, Changsha, Hunan, Peoples R China.	jianghong73868@126.com	XIA, KUN/AAO-3525-2020		National Basic Research Program (973 Program) [2012CB944601, 2012CB517902, 2011CB510002]; National Natural Science Foundation of China [81410308019, 81471156, 81271260, 30971585, 31401135]; Hunan Funds for Distinguished Young Scientists [14JJ1008]; Xinjiang Natural Science Foundation [201318101-4]; Undergraduate Innovation Project of Central South University [YB13028, 201410533324]; Fundamental Research Funds for the Central Universities of Central South University [2014zzts078]; High-level medical personnel of Hunan province "225" Project	National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Funds for Distinguished Young Scientists; Xinjiang Natural Science Foundation; Undergraduate Innovation Project of Central South University; Fundamental Research Funds for the Central Universities of Central South University; High-level medical personnel of Hunan province "225" Project	This study was supported by the National Basic Research Program (973 Program) (Nos. 2012CB944601, 2012CB517902 and 2011CB510002 to Hong Jiang), the National Natural Science Foundation of China (Nos. 81410308019, 81471156, 81271260, and 30971585 to Hong Jiang; No. 31401135 to Rong Qiu), Hunan Funds for Distinguished Young Scientists (No. 14JJ1008 to Hong Jiang), Xinjiang Natural Science Foundation (No. 201318101-4 to Hong Jiang), the Undergraduate Innovation Project of Central South University (Nos. YB13028 and 201410533324 to Hong Jiang), Fundamental Research Funds for the Central Universities of Central South University (No. 2014zzts078 to Zhao Chen), and High-level medical personnel of Hunan province "225" Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anheim M, 2012, NEW ENGL J MED, V366, P636, DOI 10.1056/NEJMra1006610; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Chen Z, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.04.029; Chessa L, 2009, ANN HUM GENET, V73, P532, DOI 10.1111/j.1469-1809.2009.00535.x; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Huang Y, 2013, NEUROMOL MED, V15, P536, DOI 10.1007/s12017-013-8240-3; Jacquemin V, 2012, EUR J HUM GENET, V20, P305, DOI 10.1038/ejhg.2011.196; Jiang H, 2006, J NEUROL SCI, V241, P1, DOI 10.1016/j.jns.2005.09.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Verhagen MMM, 2012, HUM MUTAT, V33, P561, DOI 10.1002/humu.22016; WOODS CG, 1992, Q J MED, V82, P169	13	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139738	10.1371/journal.pone.0139738	http://dx.doi.org/10.1371/journal.pone.0139738			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439923	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300047
J	Crespo, I; Toledo, D; Soldevila, N; Jordan, I; Solano, R; Castilla, J; Cayla, JA; Godoy, P; Munoz-Almagro, C; Dominguez, A				Crespo, Inma; Toledo, Diana; Soldevila, Nuria; Jordan, Iolanda; Solano, Ruben; Castilla, Jesus; Cayla, Joan A.; Godoy, Pere; Munoz-Almagro, Carmen; Dominguez, Angela		Working Grp Transmission Pertussis	Characteristics of Hospitalized Cases of Pertussis in Catalonia and Navarra, Two Regions in the North of Spain	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; VACCINE; CHILDREN; SURVEILLANCE; INFECTIONS; RESURGENCE; EPIDEMIC	Pertussis causes a large number of cases and hospitalizations in Catalonia and Navarra. We made a study of household cases of pertussis during 2012 and 2013 in order to identify risk factors for hospitalization in pertussis cases. Each primary case reported triggered the study of their contacts. Close contacts at home and people who were in contact for >2 hours during the transmission period of cases were included. The adjusted OR and 95% confidence intervals ( CI) was calculated using logistic regression. A total of 1124 pertussis cases were detected, of which 14.9% were hospitalized. Inspiratory whoop (aOR: 1.64; CI: 1.02-2.65), apnoea (aOR: 2.47; CI: 1.51-4.03) and cyanosis (aOR: 15.51; CI: 1.87-128.09) were more common in hospitalized than in outpatient cases. Hospitalization occurred in 8.7% of correctly-vaccinated cases, 41.1% of non-vaccinated cases and 9.4% of partially-vaccinated cases. In conclusion, inspiratory whoop, apnoea and cyanosis were associated factors to hospitalization while vaccination reduced hospitalizations due to pertussis.	[Crespo, Inma; Soldevila, Nuria; Solano, Ruben; Castilla, Jesus; Cayla, Joan A.; Godoy, Pere; Dominguez, Angela] CIBER Epidemiol & Publ Hlth, Barcelona, Spain; [Crespo, Inma; Toledo, Diana; Soldevila, Nuria; Solano, Ruben; Dominguez, Angela] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Toledo, Diana; Solano, Ruben; Cayla, Joan A.] Publ Hlth Agcy, Barcelona, Spain; [Jordan, Iolanda] Hosp St Joan de Deu, Paediat Intens Care Med, Barcelona, Spain; [Castilla, Jesus] Navarra Inst Hlth Res, Inst Publ Hlth, Pamplona, Spain; [Godoy, Pere] Agcy Publ Hlth Catalonia, Barcelona, Spain; [Munoz-Almagro, Carmen] Hosp St Joan de Deu, Dept Mol Microbiol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Public Health Agency of Barcelona; University of Barcelona; University of Barcelona	Crespo, I (corresponding author), CIBER Epidemiol & Publ Hlth, Barcelona, Spain.	inma.crespo@hotmail.com	Muñoz-Almagro, Carmen/N-7248-2015; Castilla, Jesus/B-9048-2008; Solano, Ruben/H-5104-2017	Muñoz-Almagro, Carmen/0000-0001-5586-404X; Castilla, Jesus/0000-0002-6396-7265; Godoy, Pere/0000-0002-2896-7286; Cayla, Joan A./0000-0003-3891-111X; Hozbor, Daniela/0000-0001-6379-0482	Institute of Health Carlos III [PI11/02557]; Fondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa); Catalan Agency for the Management of Grants for University Research (AGAUR Grant) [2014/SGR 1403]; Agency of Public Health of Catalonia; Public Health Agency; Institute of Public Health of Navarra; Ministry of Science and Innovation	Institute of Health Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa)(European Commission); Catalan Agency for the Management of Grants for University Research (AGAUR Grant); Agency of Public Health of Catalonia; Public Health Agency; Institute of Public Health of Navarra; Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by the Ministry of Science and Innovation, Institute of Health Carlos III (Project PI11/02557) and Fondo Europeo de Desarrollo Regional (FEDER-Una manera de hacer Europa); the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2014/SGR 1403). Agency of Public Health of Catalonia provided support in the form of salaries for author P. Godoy, Public Health Agency provided support in the form of salaries for author J. Cayla and Institute of Public Health of Navarra provided support in the form of salaries for author J. Castilla, but none of the companies had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Other authors have no other funding or conflicts of interest to disclose.	Amirthalingam G, 2013, EUROSURVEILLANCE, V18, P19, DOI 10.2807/1560-7917.ES2013.18.38.20587; [Anonymous], 2013, VACCINES 6; Barlow RS, 2014, CLIN INFECT DIS, V58, P1523, DOI 10.1093/cid/ciu156; Briand V, 2007, VACCINE, V25, P7224, DOI 10.1016/j.vaccine.2007.07.020; Cardenosa N, 2009, VACCINE, V27, P3489, DOI 10.1016/j.vaccine.2009.01.046; Centro Nacional de Epidemiologia, 2012, SIT EP TOS FER ESP; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Cherry JD, 2009, TXB PEDIAT INFECT DI, P1683; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Cortese MM, 2008, PEDIATRICS, V121, P484, DOI 10.1542/peds.2007-1393; Fernandez IC, 2013, HUM VACC IMMUNOTHER, V9, P667, DOI 10.4161/hv.23263; Crespo I, 2013, VACUNAS, V14, P155; Crespo I, 2011, VACCINE, V29, P4244, DOI 10.1016/j.vaccine.2011.03.065; de Greeff SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014183; Departament de Salut, VACC SCHED 2014; DeVincenzo JP, 2013, DIAGN MICR INFEC DIS, V76, P10, DOI 10.1016/j.diagmicrobio.2012.12.015; Fingermann M, 2006, VACCINE, V24, P3513, DOI 10.1016/j.vaccine.2006.02.026; Generalitat de Catalunya, 2006, DEP SAN SEG SOC MAN; Grupo de trabajo de tos ferina, 2012, PON PROGR REG VAC RE; Hochwald O, 2006, ISR MED ASSOC J, V8, P301; Fernandez-Cano MI, 2014, EUR J PEDIATR, V173, P721, DOI 10.1007/s00431-013-2228-8; Juretzko P, 2002, CLIN INFECT DIS, V35, P162, DOI 10.1086/341027; Klein NP, 2012, NEW ENGL J MED, V367, P1012, DOI 10.1056/NEJMoa1200850; Lavine JS, 2012, VACCINE, V30, P544, DOI 10.1016/j.vaccine.2011.11.065; Lurie G, 2009, ACAD PEDIATR, V9, P118, DOI 10.1016/j.acap.2009.01.004; Miyashita N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-129; Roorda Lieuwe, 2011, BMC Res Notes, V4, P11, DOI 10.1186/1756-0500-4-11; Servicio de Epidemiologia, VACC SCHED 2014; Shapiro ED, 2012, JAMA-J AM MED ASSOC, V308, P2149, DOI 10.1001/jama.2012.65031; Sheridan SL, 2014, MED J AUSTRALIA, V200, P334, DOI 10.5694/mja13.11069; Skowronski DM, 2012, CLIN INFECT DIS, V54, P318, DOI 10.1093/cid/cir836; van den Brink G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-526; van Gent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046407; von Konig CHW, 2002, LANCET INFECT DIS, V2, P744, DOI 10.1016/S1473-3099(02)00452-8; Waters V, 2015, PRINCIPLES PRACTICE, P2619; Wymann MN, 2006, EUR J PUBLIC HEALTH, V16, P29	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139993	10.1371/journal.pone.0139993	http://dx.doi.org/10.1371/journal.pone.0139993			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440655	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300091
J	Mehlgarten, C; Krijger, JJ; Lemnian, I; Gohr, A; Kasper, L; Diesing, AK; Grosse, I; Breunig, KD				Mehlgarten, Constance; Krijger, Jorrit-Jan; Lemnian, Ioana; Gohr, Andre; Kasper, Lydia; Diesing, Anne-Kathrin; Grosse, Ivo; Breunig, Karin D.			Divergent Evolution of the Transcriptional Network Controlled by Snf1-Interacting Protein Sip4 in Budding Yeasts	PLOS ONE			English	Article							KLUYVEROMYCES-LACTIS ZYMOCIN; CELLULAR-ENERGY SENSOR; SACCHAROMYCES-CEREVISIAE; GLUCONEOGENIC GENES; GLUCOSE-TRANSPORT; CLUSTER PROTEINS; QUANTITATIVE PCR; KEY ROLE; KINASE; CAT8	Cellular responses to starvation are of ancient origin since nutrient limitation has always been a common challenge to the stability of living systems. Hence, signaling molecules involved in sensing or transducing information about limiting metabolites are highly conserved, whereas transcription factors and the genes they regulate have diverged. In eukaryotes the AMP-activated protein kinase (AMPK) functions as a central regulator of cellular energy homeostasis. The yeast AMPK ortholog SNF1 controls the transcriptional network that counteracts carbon starvation conditions by regulating a set of transcription factors. Among those Cat8 and Sip4 have overlapping DNA-binding specificity for so-called carbon source responsive elements and induce target genes upon SNF1 activation. To analyze the evolution of the Cat8-Sip4 controlled transcriptional network we have compared the response to carbon limitation of Saccharomyces cerevisiae to that of Kluyveromyces lactis. In high glucose, S. cerevisiae displays tumor cell-like aerobic fermentation and repression of respiration (Crabtree-positive) while K. lactis has a respiratory-fermentative life-style, respiration being regulated by oxygen availability (Crabtree-negative), which is typical for many yeasts and for differentiated higher cells. We demonstrate divergent evolution of the Cat8-Sip4 network and present evidence that a role of Sip4 in controlling anabolic metabolism has been lost in the Saccharomyces lineage. We find that in K. lactis, but not in S. cerevisiae, the Sip4 protein plays an essential role in C2 carbon assimilation including induction of the glyoxylate cycle and the carnitine shuttle genes. Induction of KlSIP4 gene expression by KlCat8 is essential under these growth conditions and a primary function of KlCat8. Both KlCat8 and KlSip4 are involved in the regulation of lactose metabolism in K. lactis. In chromatin-immunoprecipitation experiments we demonstrate binding of both, KlSip4 and KlCat8, to selected CSREs and provide evidence that KlSip4 counteracts KlCat8-mediated transcription activation by competing for binding to some but not all CSREs. The finding that the hierarchical relationship of these transcription factors differs between K. lactis and S. cerevisiae and that the sets of target genes have diverged contributes to explaining the phenotypic differences in metabolic life-style.	[Mehlgarten, Constance; Krijger, Jorrit-Jan; Kasper, Lydia; Diesing, Anne-Kathrin; Breunig, Karin D.] Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Germany; [Lemnian, Ioana; Gohr, Andre; Grosse, Ivo] Univ Halle Wittenberg, Inst Comp Sci, D-06108 Halle, Germany; [Grosse, Ivo] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Breunig, KD (corresponding author), Univ Halle Wittenberg, Inst Biol, D-06108 Halle, Germany.	karin.breunig@genetik.uni-halle.de			German Science Foundation (DFG) [BR921/6]; DFG [BR 921/7-2, GR 3526/1-2, 1395]	German Science Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by grants from the German Science Foundation (DFG) BR921/6 to K.D.B. and DFG priority program 1395 to K.D.B (BR 921/7-2) and I.G. (GR 3526/1-2). The sponsors are national funding agencies supporting basic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausubel FM, 1992, CURRENT PROTOCOLS MO; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; Charbon G, 2004, MOL CELL BIOL, V24, P4083, DOI 10.1128/MCB.24.10.4083-4091.2004; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DOHMEN RJ, 1991, YEAST, V7, P691, DOI 10.1002/yea.320070704; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Gasmi N, 2014, GENETICS, V198, P547, DOI 10.1534/genetics.114.168609; Georis I, 2000, MOL GEN GENET, V264, P193, DOI 10.1007/s004380000314; GIETZ RD, 1991, YEAST, V7, P253, DOI 10.1002/yea.320070307; GODECKE A, 1991, NUCLEIC ACIDS RES, V19, P5351, DOI 10.1093/nar/19.19.5351; Godecke A, 1990, THESIS; Gowans GJ, 2014, BIOCHEM SOC T, V42, P71, DOI 10.1042/BST20130244; Hagman A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116942; Hall TA, BIOEDIT USER FRIENDL, V41, P95; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hardie DG, 2014, PHYSIOLOGY, V29, P99, DOI 10.1152/physiol.00050.2013; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; HEDGES D, 1995, MOL CELL BIOL, V15, P1915; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hiesinger M, 2001, CURR GENET, V39, P68, DOI 10.1007/s002940000182; Hong SP, 2005, J BIOL CHEM, V280, P21804, DOI 10.1074/jbc.M501887200; Jablonowski D, 2001, YEAST, V18, P1285, DOI 10.1002/yea.776; KLEBE RJ, 1983, GENE, V25, P333, DOI 10.1016/0378-1119(83)90238-X; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krijger J.-J., 2002, THESIS U HALLE WITTE; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; LEONARDO JM, 1987, MOL CELL BIOL, V7, P4369, DOI 10.1128/MCB.7.12.4369; Liang SD, 1996, MOL CELL BIOL, V16, P3773; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Rahner A, 1996, NUCLEIC ACIDS RES, V24, P2331, DOI 10.1093/nar/24.12.2331; RandezGil F, 1997, MOL CELL BIOL, V17, P2502, DOI 10.1128/MCB.17.5.2502; Rodicio R, 2008, FEBS LETT, V582, P549, DOI 10.1016/j.febslet.2008.01.017; Roth S, 2004, CURR GENET, V45, P121, DOI 10.1007/s00294-003-0476-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmidt T, 1992, YEAST, V8, pS152; Schmidt T., 1995, THESIS HEINRICH HEIN; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SREEKRISHNA K, 1985, P NATL ACAD SCI USA, V82, P7909, DOI 10.1073/pnas.82.23.7909; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thompson DA, 2013, ELIFE, V2, DOI [10.7554/eLife.01114, 10.7554/eLife.00603]; Todd RB, 1997, FUNGAL GENET BIOL, V21, P388, DOI 10.1006/fgbi.1997.0993; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tuomi JM, 2010, METHODS, V50, P313, DOI 10.1016/j.ymeth.2010.02.003; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; VANURK H, 1989, J GEN MICROBIOL, V135, P2399; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; Waterhouse RM, 2013, NUCLEIC ACIDS RES, V41, pD358, DOI 10.1093/nar/gks1116; WESOLOWSKILOUVEL M, 1992, MOL GEN GENET, V233, P89, DOI 10.1007/BF00587565; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Zampar GG, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.11; Zeeman AM, 1998, MICROBIOL-SGM, V144, P3437, DOI 10.1099/00221287-144-12-3437; ZENKE FT, 1993, MOL CELL BIOL, V13, P7566, DOI 10.1128/MCB.13.12.7566; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	67	9	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139464	10.1371/journal.pone.0139464	http://dx.doi.org/10.1371/journal.pone.0139464			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440109	gold, Green Submitted, Green Published			2022-12-27	WOS:000362510300029
J	Vasquez, C; Franco, MA; Angel, J				Vasquez, Camilo; Franco, Manuel A.; Angel, Juana			Rapid Proliferation and Differentiation of a Subset of Circulating IgM Memory B Cells to a CpG/Cytokine Stimulus In Vitro	PLOS ONE			English	Article							SWITCH DNA RECOMBINATION; TOLL-LIKE RECEPTORS; NAIVE; ACTIVATION; RESPONSES; REPERTOIRE; PATHWAY; IL-21; DIVERSIFICATION; STIMULATION	Circulating human IgM expressing memory B cells have been incompletely characterized. Here, we compared the phenotype and in vitro functional response (capacity to proliferate and differentiate to antibody secreting cells) in response to CpG and a cytokine cocktail (IL-2, IL-6, and IL-10) of sorted naive B cells, IgM memory B cells and isotype-switched circulating memory B cells. Compared to naive B cells, IgM memory B cells had lower integrated mean fluorescence intensity (iMFI) of BAFF-R, CD38, CD73, and IL-21R, but higher iMFI of CD95, CD11c, TLR9, PD-1, and CD122. Compared to switched memory B cells, IgM memory B cells had higher iMFI of BAFF-R, PD-1, IL-21R, TLR9, and CD122, but lower iMFI of CD38, CD95, and CD73. Four days after receiving the CpG/cytokine cocktail, higher frequencies of IgM than switched memory B cells-and these in turn greater than naive cells-proliferated and differentiated to antibody secreting cells. At this time point, a small percentage (median of 7.6%) of stimulated IgM memory B cells changed isotype to IgG. Thus, among the heterogeneous population of human circulating IgM memory B cells a subset is capable of a rapid functional response to a CpG/cytokine stimulus in vitro.	[Vasquez, Camilo; Franco, Manuel A.; Angel, Juana] Pontificia Univ Javeriana, Inst Genet Humana, Fac Med, Bogota, Colombia	Pontificia Universidad Javeriana	Angel, J (corresponding author), Pontificia Univ Javeriana, Inst Genet Humana, Fac Med, Bogota, Colombia.	jangel@javeriana.edu.co	CORTES, Manuel Antonio FRANCO/M-7517-2014; Angel, Juana/O-2908-2014	CORTES, Manuel Antonio FRANCO/0000-0002-0265-0563; Angel, Juana/0000-0001-6623-5337	Colciencias [1203-521-28212]; Pontificia Universidad Javeriana [5193]; program "Jovenes Investigadores"	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Pontificia Universidad Javeriana; program "Jovenes Investigadores"	This work was funded by grants 1203-521-28212 from Colciencias and 5193 from Pontificia Universidad Javeriana. CV was funded by the program "Jovenes Investigadores".	Amanna IJ, 2006, J IMMUNOL METHODS, V317, P175, DOI 10.1016/j.jim.2006.09.005; Berkowska MA, 2011, BLOOD, V118, P2150, DOI 10.1182/blood-2011-04-345579; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Bryant VL, 2007, J IMMUNOL, V179, P8180, DOI 10.4049/jimmunol.179.12.8180; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Deenick EK, 2013, J EXP MED, V210, P2739, DOI 10.1084/jem.20130323; Della Valle L, 2014, J IMMUNOL, V193, P1071, DOI 10.4049/jimmunol.1400706; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Geffroy-Luseau A, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00083; Good KL, 2006, J IMMUNOL, V177, P5236, DOI 10.4049/jimmunol.177.8.5236; Good KL, 2009, J IMMUNOL, V182, P890, DOI 10.4049/jimmunol.182.2.890; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; Hawkins ED, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3406; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Herrera D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097087; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Koncz G, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00207; Kotlarz D, 2013, J EXP MED, V210, P433, DOI 10.1084/jem.20111229; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Rojas OL, 2008, VIROLOGY, V380, P234, DOI 10.1016/j.virol.2008.08.004; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Miguel RDV, 2012, J IMMUNOL, V189, P3449, DOI 10.4049/jimmunol.1103054; Moens L, 2008, J IMMUNOL, V181, P5306, DOI 10.4049/jimmunol.181.8.5306; Moens L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00065; Narvaez CF, 2012, J VIROL, V86, P10829, DOI 10.1128/JVI.01466-12; Nutt SL, 2011, NAT IMMUNOL, V12, P472, DOI 10.1038/ni.2019; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Perez ME, 2014, IMMUNOL CELL BIOL; Pone EJ, 2010, CRIT REV IMMUNOL, V30, P1; Quah BJ, 2010, J VIS EXP; Reynaud CA, 2012, CELL MOL LIFE SCI, V69, P1625, DOI 10.1007/s00018-012-0971-z; Reynolds AE, 2014, J IMMUNOL; Ruffin N, 2012, J INTERN MED, V272, P492, DOI 10.1111/j.1365-2796.2012.02550.x; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Seifert M, 2015, P NATL ACAD SCI USA, V112, pE546, DOI 10.1073/pnas.1416276112; Seifert M, 2009, J EXP MED, V206, P2659, DOI 10.1084/jem.20091087; Shi YH, 2003, CLIN IMMUNOL, V108, P128, DOI 10.1016/S1521-6616(03)00092-5; Tangye SG, 2003, J IMMUNOL, V170, P686, DOI 10.4049/jimmunol.170.2.686; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Thibult ML, 2013, INT IMMUNOL, V25, P129, DOI 10.1093/intimm/dxs098; Tian CX, 2008, J IMMUNOL, V180, P3279, DOI 10.4049/jimmunol.180.5.3279; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; Weller S, 2008, J EXP MED, V205, P1331, DOI 10.1084/jem.20071555; Werner-Favre C, 2001, EUR J IMMUNOL, V31, P243, DOI 10.1002/1521-4141(200101)31:1<243::AID-IMMU243>3.3.CO;2-S; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062	54	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139718	10.1371/journal.pone.0139718	http://dx.doi.org/10.1371/journal.pone.0139718			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439739	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300045
J	Yang, YX; Wang, JT; Han, T; Liu, T; Wang, CL; Xiao, J; Mu, CK; Li, RH; Yu, FP; Shi, HL				Yang, Yunxia; Wang, Jiteng; Han, Tao; Liu, Tao; Wang, Chunlin; Xiao, Jia; Mu, Changkao; Li, Ronghua; Yu, Fangping; Shi, Huilai			Ovarian Transcriptome Analysis of Portunus trituberculatus Provides Insights into Genes Expressed during Phase III and IV Development	PLOS ONE			English	Article							FEMALE-SPECIFIC PROTEIN; RNA-SEQ DATA; SWIMMING CRAB; REFERENCE GENOME; QUANTIFICATION; DEPHOSPHORYLATION; VITELLOGENIN; GENERATION; HEMOLYMPH; VITELLIN	Enhancing the production of aquatic animals is crucial for fishery management and aquaculture applications. Ovaries are specialized tissues that play critical roles in producing oocytes and hormones. Significant biochemical changes take place during the sexual maturation of Portunus trituberculatus, but the genetics of this process has not been extensively studied. Transcriptome sequencing can be used to determine gene expression changes within specific periods. In the current study, we used transcriptome sequencing to produce a comprehensive transcript dataset for the ovarian development of P. trituberculatus. Approximately 100 million sequencing reads were generated, and 126,075 transcripts were assembled. Functional annotation of the obtained transcripts revealed important pathways in ovarian development, such as those involving the vitellogenin gene. Also, we performed deep sequencing of ovaries in phases III and IV of sexual maturation in P. trituberculatus. Differential analysis of gene expression identified 506 significantly differentially expressed genes, which belong to 20 pathway, transporters, development, transcription factors, metabolism of other amino acids, carbohydrate and lipid, solute carrier family members, and enzymes. Taken together, our study provides the first comprehensive transcriptomic resource for P. trituberculatus ovaries, which will strengthen understanding of the molecular mechanisms underlying the sexual maturation process and advance molecular nutritional studies of P. trituberculatus.	[Yang, Yunxia; Wang, Jiteng; Han, Tao] Zhejiang Ocean Univ, Coll Fisheries, Zhoushan, Peoples R China; [Liu, Tao] Annoroad Gene Technol Co Ltd, Beijing, Peoples R China; [Wang, Chunlin; Mu, Changkao; Li, Ronghua] Ningbo Univ, Marine Sci Coll, Ningbo 315211, Zhejiang, Peoples R China; [Xiao, Jia] Jinan Univ, Dept Immunobiol, Guangzhou, Guangdong, Peoples R China; [Yu, Fangping; Shi, Huilai] Marine Fisheries Res Inst Zhejiang Prov, Zhoushan, Peoples R China	Zhejiang Ocean University; Ningbo University; Jinan University	Wang, CL (corresponding author), Ningbo Univ, Marine Sci Coll, Ningbo 315211, Zhejiang, Peoples R China.	wangchunlin@nbu.edu.cn	Xiao, Jia/GYU-9660-2022		National Natural Science Foundation of China; Transformation Fund for Agricultural Science; KC Wong Magana Fund in Ningbo University; Public Projects of Zhejiang Province; Zhoushan Science and Technology Bureau project; Scientific Research Foundation of Zhejiang Ocean University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Transformation Fund for Agricultural Science; KC Wong Magana Fund in Ningbo University; Public Projects of Zhejiang Province; Zhoushan Science and Technology Bureau project; Scientific Research Foundation of Zhejiang Ocean University	This work was supported by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), Transformation Fund for Agricultural Science (http://nyt.zj.gov.cn/), KC Wong Magana Fund in Ningbo University (http://www.nbu.edu.cn/), Public Projects of Zhejiang Province (http://www.zjkjt.gov.cn/), Zhoushan Science and Technology Bureau project (http://www.zjkjt.gov.cn/), and Scientific Research Foundation of Zhejiang Ocean University (http://www.zjou.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors YY, JW, TH, CW, JX, CM, RL, FY, HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Beaufort NC, 1968, BIOL BLUE CRAB CALLI, P67; Biason-Lauber A, 2004, NEW ENGL J MED, V351, P792, DOI 10.1056/NEJMoa040533; BYARD EH, 1984, COMP BIOCHEM PHYS A, V77, P749, DOI 10.1016/0300-9629(84)90196-8; Churchill EP, 1919, B US BUR FISH, V36, P95; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Smet H, 2001, ECOTOX ENVIRON SAFE, V48, P255, DOI 10.1006/eesa.2000.2011; Ding X., 2010, J ANIMAL NUTR CHINES; EASTMANREKS SB, 1985, J EXP ZOOL, V233, P111, DOI 10.1002/jez.1402330115; Engelmann F, 1994, COMP ENDOCRINOL, P39; FYFFE WE, 1974, COMP BIOCHEM PHYSIOL, V47, P851, DOI 10.1016/0305-0491(74)90030-3; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HINES AH, 1987, MAR ECOL PROG SER, V36, P55, DOI 10.3354/meps036055; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Janer G, 2007, ECOTOXICOLOGY, V16, P145, DOI 10.1007/s10646-006-0110-4; Jinbo T, 2013, FISHERIES SCI, V79, P459, DOI 10.1007/s12562-013-0618-5; Jordan BK, 2001, AM J HUM GENET, V68, P1102, DOI 10.1086/320125; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim JH, 2012, J PINEAL RES, V52, P244, DOI 10.1111/j.1600-079X.2011.00935.x; LACHAISE F, 1981, H-S Z PHYSIOL CHEM, V362, P521, DOI 10.1515/bchm2.1981.362.1.521; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee FY, 1997, GEN COMP ENDOCR, V108, P406, DOI 10.1006/gcen.1997.6989; Lee HJ, 2013, GENES GENOM, V35, P77, DOI 10.1007/s13258-013-0062-z; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Lu W, 2012, PEPTIDES, V34, P168, DOI 10.1016/j.peptides.2011.04.022; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MUHLEBACH SM, 1994, MOL CELL BIOCHEM, V133, P245, DOI 10.1007/BF01267958; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shiraishi A, 2000, CARCINOGENESIS, V21, P1879, DOI 10.1093/carcin/21.10.1879; Sikdar R, 1999, J BIOSCIENCES, V24, P317, DOI 10.1007/BF02941245; Sricharoen S, 2005, DEV COMP IMMUNOL, V29, P1017, DOI 10.1016/j.dci.2005.03.010; SWEVERS L, 1991, COMP BIOCHEM PHYS B, V99, P35, DOI 10.1016/0305-0491(91)90004-W; Torroja C, 2004, DEVELOPMENT, V131, P2395, DOI 10.1242/dev.01102; Tsukimura B, 2001, AM ZOOL, V41, P465, DOI 10.1668/0003-1569(2001)041[0465:CVIRIO]2.0.CO;2; Uda K, 2006, COMP BIOCHEM PHYS D, V1, P209, DOI 10.1016/j.cbd.2005.10.007; Wainwright G, 2001, EXPTL BIOL REV, P71; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084921; Wei Q, 2013, CONSERV GENET RESOUR, V5, P511, DOI 10.1007/s12686-012-9840-1; Wouters R, 2001, AQUACULTURE, V198, P307, DOI 10.1016/S0044-8486(01)00522-1; Wu XG, 2010, AQUACULTURE, V301, P78, DOI 10.1016/j.aquaculture.2010.01.016; [吴旭干 WU Xugan], 2007, [海洋学报, Acta Oceanologica Sinica], V29, P120; Xie ZM, 2002, PORTUNUS TRITUBERCUL, P1; Yang F, 2005, COMP BIOCHEM PHYS B, V142, P456, DOI 10.1016/j.cbpb.2005.09.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu Gun-Gen, 2006, Oceanologia et Limnologia Sinica, V37, P53	50	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138862	10.1371/journal.pone.0138862	http://dx.doi.org/10.1371/journal.pone.0138862			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431399	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700022
J	Armour, CM; Kersseboom, S; Yoon, G; Visser, TJ				Armour, Christine M.; Kersseboom, Simone; Yoon, Grace; Visser, Theo J.			Further Insights into the Allan-Herndon-Dudley Syndrome: Clinical and Functional Characterization of a Novel MCT8 Mutation	PLOS ONE			English	Article							THYROID-HORMONE TRANSPORTER; MONOCARBOXYLATE TRANSPORTER-8; PSYCHOMOTOR RETARDATION; BRAIN-DEVELOPMENT; GENE; PHENOTYPE; DEFICIENCY; DISEASE; SLC16A2	Background Mutations in the thyroid hormone (TH) transporter MCT8 have been identified as the cause for Allan-Herndon-Dudley Syndrome (AHDS), characterized by severe psychomotor retardation and altered TH serum levels. Here we report a novel MCT8 mutation identified in 4 generations of one family, and its functional characterization. Methods Proband and family members were screened for 60 genes involved in X-linked cognitive impairment and the MCT8 mutation was confirmed. Functional consequences of MCT8 mutations were studied by analysis of [I-125] TH transport in fibroblasts and transiently transfected JEG3 and COS1 cells, and by subcellular localization of the transporter. Results The proband and a male cousin demonstrated clinical findings characteristic of AHDS. Serum analysis showed high T3, low rT3, and normal T4 and TSH levels in the proband. A MCT8 mutation (c.869C>T; p.S290F) was identified in the proband, his cousin, and several female carriers. Functional analysis of the S290F mutant showed decreased TH transport, metabolism and protein expression in the three cell types, whereas the S290A mutation had no effect. Interestingly, both uptake and efflux of T3 and T4 was impaired in fibroblasts of the proband, compared to his healthy brother. However, no effect of the S290F mutation was observed on TH efflux from COS1 and JEG3 cells. Immunocytochemistry showed plasma membrane localization of wild-type MCT8 and the S290A and S290F mutants in JEG3 cells. Conclusions We describe a novel MCT8 mutation (S290F) in 4 generations of a family with Allan-Herndon-Dudley Syndrome. Functional analysis demonstrates loss-of-function of the MCT8 transporter. Furthermore, our results indicate that the function of the S290F mutant is dependent on cell context. Comparison of the S290F and S290A mutants indicates that it is not the loss of Ser but its substitution with Phe, which leads to S290F dysfunction.	[Armour, Christine M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Reg Genet Program, Ottawa, ON, Canada; [Armour, Christine M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Kersseboom, Simone; Visser, Theo J.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Yoon, Grace] Hosp Sick Children, Dept Paediat, Div Neurol, Toronto, ON M5G 1X8, Canada; [Yoon, Grace] Hosp Sick Children, Dept Paediat, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Children's Hospital of Eastern Ontario; Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Visser, TJ (corresponding author), Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands.	t.j.visser@erasmusmc.nl			Sherman family; Smile foundation	Sherman family; Smile foundation	SK was supported by the Sherman family and the Smile foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkemade A, 2005, J CLIN ENDOCR METAB, V90, P4322, DOI 10.1210/jc.2004-2567; Allan W, 1944, AM J MENT DEF, V48, P325; Bernal J, 2007, NAT CLIN PRACT ENDOC, V3, P249, DOI 10.1038/ncpendmet0424; Braun D, 2011, GLIA, V59, P463, DOI 10.1002/glia.21116; Brockmann K, 2005, J NEUROL, V252, P663, DOI 10.1007/s00415-005-0713-3; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friesema ECH, 2006, MOL ENDOCRINOL, V20, P2761, DOI 10.1210/me.2005-0256; Friesema ECH, 2006, NAT CLIN PRACT ENDOC, V2, P512, DOI 10.1038/ncpendmet0262; Friesema ECH, 2010, MOL CELL ENDOCRINOL, V322, P107, DOI 10.1016/j.mce.2010.01.016; Heuer H, 2013, BBA-GEN SUBJECTS, V1830, P3974, DOI 10.1016/j.bbagen.2012.04.009; Holden KR, 2005, J CHILD NEUROL, V20, P852, DOI 10.1177/08830738050200101601; Horn S, 2013, ENDOCRINOLOGY, V154, P968, DOI 10.1210/en.2012-1628; Jansen J, 2008, ENDOCRINOLOGY, V149, P2184, DOI 10.1210/en.2007-1475; Kersseboom S, 2011, ANN ENDOCRINOL-PARIS, V72, P77, DOI 10.1016/j.ando.2011.03.003; Kersseboom S, 2013, MOL ENDOCRINOL, V27, P801, DOI 10.1210/me.2012-1356; Kinne A, 2009, J MOL ENDOCRINOL, V43, P263, DOI 10.1677/JME-09-0043; MOL JA, 1985, ENDOCRINOLOGY, V117, P1; Namba N, 2008, EUR J PEDIATR, V167, P785, DOI 10.1007/s00431-007-0589-6; Price NT, 1998, BIOCHEM J, V329, P321; Roberts LM, 2008, ENDOCRINOLOGY, V149, P6251, DOI 10.1210/en.2008-0378; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Schwartz CE, 2007, BEST PRACT RES CL EN, V21, P307, DOI 10.1016/j.beem.2007.03.009; Tonduti D, 2013, J CHILD NEUROL, V28, P792, DOI 10.1177/0883073812450944; Verge CF, 2012, J CLIN ENDOCR METAB, V97, P4515, DOI 10.1210/jc.2012-2556; Visser WE, 2013, CLIN ENDOCRINOL, V78, P310, DOI 10.1111/cen.12023; Visser WE, 2009, HUM MUTAT, V30, P29, DOI 10.1002/humu.20808; Wirth EK, 2009, J NEUROSCI, V29, P9439, DOI 10.1523/JNEUROSCI.6055-08.2009; Yamamoto Sayaka, 2013, Clin Pediatr Endocrinol, V22, P83, DOI 10.1292/cpe.22.83	30	17	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139343	10.1371/journal.pone.0139343	http://dx.doi.org/10.1371/journal.pone.0139343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426690	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100051
J	Bruno, E; Quattrocchi, G; Gomes, EBC; Sofia, V; Padilla, S; Camargo, M; Zappia, M; Bartoloni, A; Nicoletti, A				Bruno, Elisa; Quattrocchi, Graziella; Gomes, Elizabeth Blanca Crespo; Sofia, Vito; Padilla, Sandra; Camargo, Mario; Zappia, Mario; Bartoloni, Alessandro; Nicoletti, Alessandra			Prevalence and Incidence of Epilepsy Associated with Convulsive Seizures in Rural Bolivia. A Global Campaign against Epilepsy Project	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; EPILEPSY/INTERNATIONAL BUREAU; INTERNATIONAL LEAGUE; REGIONAL PROJECT; COMMUNITY; EPIDEMIOLOGY; POPULATION; DISTRICT; BURDEN	Objective we performed a three-stages door-to-door survey to estimate incidence and prevalence of epilepsy associated with convulsive seizures (EACS) in a rural area of Bolivia. Methods the study was carried out in the Cordillera Province, southern-eastern Bolivia. One hundred fourteen rural communities with a total population of 18,907 inhabitants were included in the survey. In order to identify subjects with EACS, trained fieldworkers administered a validated single screening question to the householders (stage I). A second face-to-face questionnaire was administered to each positive subject (stage II) that, in case of positive answer, underwent a complete neurological examination to confirm the diagnosis (stage III). We estimated age and sex specific life-time and active EACS prevalence at the prevalence day (30th June 2010). Incidence risk was evaluated for the 10-year period between January 2000 and December 2010. Results on prevalence day we identified 136 subjects with EACS, 124 of whom had active epilepsy. The life-time prevalence of EACS was 7.2/1,000 (7.6/1,000 age-adjusted to the world standard population) while the prevalence of active EACS was 6.6/1,000 (6.7/1,000 age-adjusted to the world standard population). Both life-time and active prevalence showed a peak (10.3/1,000) in the 15-24 years age group and, overall, were higher among women. During the incidence study period, 105 patients living in the study area had the onset of EACS. The crude incidence risk was 55.4/100,000 (49.5/100,000 age-adjusted to the world standard population). Incidence was slightly but not significantly higher among women (58.9/100,000 versus 51.9/100,000). Conclusions the present study demonstrated a considerable burden of EACS in the Bolivian Chaco, showing prevalence and incidence estimates close to those reported for low and middle-income countries and underlying the need of treatment programs.	[Bruno, Elisa; Quattrocchi, Graziella; Sofia, Vito; Zappia, Mario; Nicoletti, Alessandra] Univ Catania, Dipartimento Sci Med Chirurg & Tecnol Avanzate GF, I-95123 Catania, Italy; [Gomes, Elizabeth Blanca Crespo; Padilla, Sandra] Serv Dept Salud, Santa Cruz, Camiri, Bolivia; [Camargo, Mario] Bolivian League Epilepsy, Santa Cruz, Bolivia; [Bartoloni, Alessandro] Univ Florence, Dept Expt & Clin Med, Infect & Trop Dis Unit, I-50134 Florence, Italy	University of Catania; University of Florence	Nicoletti, A (corresponding author), Univ Catania, Dipartimento Sci Med Chirurg & Tecnol Avanzate GF, Via Santa Sofia 78, I-95123 Catania, Italy.	anicolet@unict.it	Nicoletti, Alessandra/K-4486-2018; BARTOLONI, ALESSANDRO/K-3403-2018; Zappia, Mario/AAB-7800-2019; Bruno, Elisa/P-4317-2018	Nicoletti, Alessandra/0000-0001-6757-340X; BARTOLONI, ALESSANDRO/0000-0001-9758-1523; Bruno, Elisa/0000-0001-8166-1190; Crespo Gomez, Elizabeth Blanca/0000-0002-8654-3705	Italian Ministry of Foreign Affairs-Development Cooperation within the project Strengthening of Health Services in the Bolivian Chaco: A Community Based Perspective [8759/UCODEP/BOL]	Italian Ministry of Foreign Affairs-Development Cooperation within the project Strengthening of Health Services in the Bolivian Chaco: A Community Based Perspective	This work was supported by a grant from the Italian Ministry of Foreign Affairs-Development Cooperation within the project Strengthening of Health Services in the Bolivian Chaco: A Community Based Perspective (8759/UCODEP/BOL).	Anand K, 2005, EPILEPSIA, V46, P743, DOI 10.1111/j.1528-1167.2005.41104.x; [Anonymous], 1993, EPILEPSIA, V34, P592; [Anonymous], 2002, Epilepsia, V43 Suppl 6, P42; [Anonymous], 1966, CANC INCIDENCE 5 CON, DOI DOI 10.1001/jamaoncol.2019.2996; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Banerjee PN, 2009, EPILEPSY RES, V85, P31, DOI 10.1016/j.eplepsyres.2009.03.003; Bruno E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002480; Bruno E, 2012, EPILEPSY BEHAV, V25, P131, DOI 10.1016/j.yebeh.2012.07.011; Bruno E, 2011, EPILEPSY BEHAV, V22, P346, DOI 10.1016/j.yebeh.2011.07.012; COCKERELL OC, 1995, J NEUROL NEUROSUR PS, V58, P570, DOI 10.1136/jnnp.58.5.570; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; HAUSER WA, 1991, EPILEPSIA, V32, P429, DOI 10.1111/j.1528-1157.1991.tb04675.x; INE (Instituto Nacional de Estadistica), 2001, CENS NAC POBL VIV; Mendizabal JE, 1996, EPILEPSIA, V37, P373, DOI 10.1111/j.1528-1157.1996.tb00574.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Nicoletti A, 1999, NEUROLOGY, V53, P2064, DOI 10.1212/WNL.53.9.2064; Nicoletti A, 2009, EPILEPSIA, V50, P2199, DOI 10.1111/j.1528-1167.2009.02174.x; Organization WH, 1990, IN SUPP PEOPL EP; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; RWIZA HT, 1992, EPILEPSIA, V33, P1051, DOI 10.1111/j.1528-1157.1992.tb01758.x; Schachter SC, 1999, EPILEPSIA, V40, pS20, DOI 10.1111/j.1528-1157.1999.tb02090.x; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x	24	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139108	10.1371/journal.pone.0139108	http://dx.doi.org/10.1371/journal.pone.0139108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427017	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100030
J	Sakai, H; Nagao, H; Sakurai, M; Okumura, T; Nagai, Y; Shikuma, J; Ito, R; Imazu, T; Miwa, T; Odawara, M				Sakai, Hiroyuki; Nagao, Hidenori; Sakurai, Mamoru; Okumura, Takako; Nagai, Yoshiyuki; Shikuma, Junpei; Ito, Rokuro; Imazu, Tetsuya; Miwa, Takashi; Odawara, Masato			Correlation between Serum Levels of 3,3 ',5 '-Triiodothyronine and Thyroid Hormones Measured by Liquid Chromatography-Tandem Mass Spectrometry and Immunoassay	PLOS ONE			English	Article							ANTIBODY INTERFERENCE; THYROXINE; RADIOIMMUNOASSAY; TRIIODOTHYRONINE; DEIODINASE	Objective For measuring serum 3,3',5'-triiodothyronine (rT3) levels, radioimmunoassay (RIA) has traditionally been used owing to the lack of other reliable methods; however, it has recently become difficult to perform. Meanwhile, liquid chromatography-tandem mass spectrometry (LC-MS/MS) has recently been attracting attention as a novel alternative method in clinical chemistry. To the best of our knowledge, there are no studies to date comparing results of the quantification of human serum rT3 between LC-MS/MS and RIA. We therefore examined the feasibility of LC-MS/MS as a novel alternative method for measuring serum rT3, thyroxine (T4), and 3,5,3'-triiodothyronine (T3) levels. Methods Assay validation was performed by LC-MS/MS using quality control samples of rT3, T4, and T3 at 4 various concentrations which were prepared from reference compounds. Serum samples of 50 outpatients in our department were quantified both by LC-MS/MS and conventional immunoassay for rT3, T4, and T3. Correlation coefficients between the 2 measurement methods were statistically analyzed respectively. Results Matrix effects were not observed with our method. Intra-day and inter-day precisions were less than 10.8% and 9.6% for each analyte at each quality control level, respectively. Intra-day and inter-day accuracies were between 96.2% and 110%, and between 98.3% and 108.6%, respectively. The lower limit of quantification was 0.05 ng/mL. Strong correlations were observed between the 2 measurement methods (correlation coefficient, T4: 0.976, p < 0.001; T3: 0.912, p < 0.001; rT3: 0.928, p < 0.001). Conclusions Our LC-MS/MS system requires no manual cleanup operation, and the process after application of a sample is fully automated; furthermore, it was found to be highly sensitive, and superior in both precision and accuracy. The correlation between the 2 methods over a wide range of concentrations was strong. LC-MS/MS is therefore expected to become a useful tool for clinical diagnosis and research.	[Sakai, Hiroyuki; Sakurai, Mamoru; Okumura, Takako; Nagai, Yoshiyuki; Shikuma, Junpei; Ito, Rokuro; Miwa, Takashi; Odawara, Masato] Tokyo Med Univ, Dept Diabet Endocrinol & Metab, Tokyo 1608402, Japan; [Nagao, Hidenori; Imazu, Tetsuya] ASKA Pharmaceut Co Ltd, Pharmacokinet Res Dept, Kawasaki, Kanagawa, Japan	Tokyo Medical University	Sakai, H (corresponding author), Tokyo Med Univ, Dept Diabet Endocrinol & Metab, Tokyo 1608402, Japan.	hirosaka@tokyo-med.ac.jp			ASKA Pharmaceutical Co., Ltd.	ASKA Pharmaceutical Co., Ltd.	The authors declare that ASKA Pharmaceutical Co., Ltd. provided support in the form of salaries for authors HN and TI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Bolstad N, 2013, BEST PRACT RES CL EN, V27, P647, DOI 10.1016/j.beem.2013.05.011; Chace DH, 2009, CLIN CHIM ACTA, V403, P178, DOI 10.1016/j.cca.2009.02.012; CHOPRA IJ, 1974, J CLIN INVEST, V54, P583, DOI 10.1172/JCI107795; Gielen M, 2012, J CLIN ENDOCR METAB, V97, P3569, DOI 10.1210/jc.2012-2240; Halsall DJ, 2013, ANN CLIN BIOCHEM, V50, P397, DOI 10.1177/0004563213499554; Huang SA, 2010, THYROID FUNCTION TES, V28, P13; Ismail AAA, 2009, J CLIN PATHOL, V62, P673, DOI 10.1136/jcp.2008.055848; Jonklaas J, 2014, CLIN BIOCHEM, V47, P1272, DOI 10.1016/j.clinbiochem.2014.06.007; Jonklaas J, 2008, THYROID, V18, P1303, DOI 10.1089/thy.2008.0155; Krasowski MD, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-33; Kricka LJ, 1999, CLIN CHEM, V45, P942; Kumar AP, 2010, J AM SOC MASS SPECTR, V21, P14, DOI 10.1016/j.jasms.2009.07.004; Mebis L, 2007, J CLIN ENDOCR METAB, V92, P3330, DOI 10.1210/jc.2007-0510; Nagao H, 2011, J ENDOCRINOL, V210, P117, DOI 10.1530/JOE-10-0484; Peeters RP, 2005, J CLIN ENDOCR METAB, V90, P4559, DOI 10.1210/jc.2005-0535; PREMACHANDRA BN, 1978, J CLIN ENDOCR METAB, V47, P746, DOI 10.1210/jcem-47-4-746; Sakai H, 2009, ENDOCR J, V56, P435, DOI 10.1507/endocrj.K08E-361; Soldin OP, 2004, CLIN CHIM ACTA, V349, P181, DOI 10.1016/j.cccn.2004.06.021; Soldin OP, 2004, CLIN CHIM ACTA, V347, P61, DOI 10.1016/j.cccn.2004.03.033; Soukhova N, 2004, CLIN CHIM ACTA, V343, P185, DOI 10.1016/j.cccn.2004.01.007; Tai SSC, 2004, ANAL CHEM, V76, P5092, DOI 10.1021/ac049516h; Tai SSC, 2002, CLIN CHEM, V48, P637; Tyan YC, 2013, CLIN CHIM ACTA, V420, P99, DOI 10.1016/j.cca.2012.10.014; Visser WE, 2013, CLIN ENDOCRINOL, V78, P310, DOI 10.1111/cen.12023; Wang DL, 2010, ANAL BIOANAL CHEM, V397, P1831, DOI 10.1007/s00216-010-3705-9; Wu AHB, 2013, CLIN CHIM ACTA, V420, P4, DOI 10.1016/j.cca.2012.10.026; Yue BF, 2008, CLIN CHEM, V54, P642, DOI 10.1373/clinchem.2007.098293; Zhang YT, 2005, J AM SOC MASS SPECTR, V16, P1781, DOI 10.1016/j.jasms.2005.06.017	28	15	15	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138864	10.1371/journal.pone.0138864	http://dx.doi.org/10.1371/journal.pone.0138864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426328	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100024
J	Bjorklund, H; Valkama, J; Tomppo, E; Laaksonen, T				Bjorklund, Heidi; Valkama, Jari; Tomppo, Erkki; Laaksonen, Toni			Habitat Effects on the Breeding Performance of Three Forest-Dwelling Hawks	PLOS ONE			English	Article							GOSHAWK ACCIPITER-GENTILIS; NEST-SITE SELECTION; BUZZARDS BUTEO-BUTEO; NORTHERN GOSHAWK; COMMON BUZZARD; BOREAL FORESTS; REPRODUCTIVE SUCCESS; PERNIS-APIVORUS; TENGMALMS OWLS; MATURE FOREST	Habitat loss causes population declines, but the mechanisms are rarely known. In the European Boreal Zone, loss of old forest due to intensive forestry is suspected to cause declines in forest-dwelling raptors by reducing their breeding performance. We studied the boreal breeding habitat and habitat-associated breeding performance of the northern goshawk (Accipiter gentilis), common buzzard (Buteo buteo) and European honey buzzard (Pernis apivorus). We combined long-term Finnish bird-of-prey data with multi-source national forest inventory data at various distances (100-4000 m) around the hawk nests. We found that breeding success of the goshawk was best explained by the habitat within a 2000-m radius around the nests; breeding was more successful with increasing proportions of old spruce forest and water, and decreasing proportions of young thinning forest. None of the habitat variables affected significantly the breeding success of the common buzzard or the honey buzzard, or the brood size of any of the species. The amount of old spruce forest decreased both around goshawk and common buzzard nests and throughout southern Finland in 1992-2010. In contrast, the area of young forest increased in southern Finland but not around hawk nests. We emphasize the importance of studying habitats at several spatial and temporal scales to determine the relevant species-specific scale and to detect environmental changes. Further effort is needed to reconcile the socioeconomic and ecological functions of forests and habitat requirements of old forest specialists.	[Bjorklund, Heidi; Valkama, Jari] Univ Helsinki, Finnish Museum Nat Hist Luomus, Zool Unit, Helsinki, Finland; [Bjorklund, Heidi] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Tomppo, Erkki] Nat Resources Inst Finland, Vantaa, Finland; [Laaksonen, Toni] Univ Turku, Dept Biol, SF-20500 Turku, Finland	University of Helsinki; University of Helsinki; Natural Resources Institute Finland (Luke); University of Turku	Bjorklund, H (corresponding author), Univ Helsinki, Finnish Museum Nat Hist Luomus, Zool Unit, Helsinki, Finland.	heidi.bjorklund@helsinki.fi	Laaksonen, Toni/B-4241-2014; Björklund, Heidi Maaria Talvikki/AAG-7315-2020; Tomppo, Erkki/ABF-7720-2020	Laaksonen, Toni/0000-0001-9035-7131; Björklund, Heidi Maaria Talvikki/0000-0002-7256-7634; Valkama, Jari/0000-0002-0393-7320	Kone Foundation; Doctoral Programme in Wildlife Biology Research Luova; Finnish Museum of Natural History Luomus; Finnish Ministry of the Environment	Kone Foundation; Doctoral Programme in Wildlife Biology Research Luova; Finnish Museum of Natural History Luomus; Finnish Ministry of the Environment	This study was funded by the Kone Foundation (www.koneensaatio.fi/en), the Doctoral Programme in Wildlife Biology Research Luova (www.helsinki.fi/luova) and the Finnish Museum of Natural History Luomus (http://www.luomus.fi/en), funds to HB. Administration of the Finnish Common Birds-of-Prey Survey was funded by the Finnish Ministry of the Environment and the Finnish Museum of Natural History Luomus. The funders had no role in study design, data collection (except the role of Luomus as an organiser of the Common Birds-of-Prey Survey) and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Agostini N, 2007, ARDEOLA, V54, P339; Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Amar A, 2008, IBIS, V150, P400, DOI 10.1111/j.1474-919X.2007.00765.x; Amcoff Martin, 1994, Ornis Svecica, V4, P145; [Anonymous], 2013, FOR STAT SERV MET; Baillie J. E. M., 2004, 2004 IUCN RED LIST T; Becker Trevor E., 2006, Studies in Avian Biology, P119; Bijlsma Rob G., 2002, Vogelwarte, V41, P240; Bijlsma RG, 2012, ARDEA, V100, P163, DOI 10.5253/078.100.0208; Bijlsma Rob G., 2004, Takkeling, V12, P185; BirdLife International, 2004, BIRDS EUR POP EST TR; Bjorklund H, 2013, ANIM CONSERV, V16, P546, DOI 10.1111/acv.12028; Bloxton Jr TD, 2002, THESIS U WASHINGTON; Bosakowski Thomas, 1994, Studies in Avian Biology, V16, P46; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Byholm P, 2008, ECOLOGY, V89, P1696, DOI 10.1890/07-0675.1; Byholm P, 2007, J ANIM ECOL, V76, P392, DOI 10.1111/j.1365-2656.2007.01211.x; Canty A., 2015, BOOT BOOTSTRAP R S P; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; Carroll Carlos, 2006, Studies in Avian Biology, P288; Chakarov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015229; Coeurdassier M, 2014, CONSERV BIOL, V28, P315, DOI 10.1111/cobi.12230; Cramp S., 1980, HDB BIRDS EUROPE MID; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Doyle Frank I., 2006, Studies in Avian Biology, P135; Finn SP, 2002, FOREST SCI, V48, P427; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Gamauf A, 2013, IBIS, V155, P258, DOI 10.1111/ibi.12023; Graham Russell T., 1994, Studies in Avian Biology, V16, P12; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hakkarainen H, 2004, ECOSCIENCE, V11, P399, DOI 10.1080/11956860.2004.11682848; Hakkarainen H, 2004, OECOLOGIA, V141, P420, DOI 10.1007/s00442-004-1656-6; Hakkarainen H, 2003, OIKOS, V100, P162, DOI 10.1034/j.1600-0706.2003.11906.x; Hakkarainen H, 2008, OECOLOGIA, V155, P479, DOI 10.1007/s00442-007-0929-2; Hanski I, 2000, ANN ZOOL FENN, V37, P271; Hargis Christina D., 1994, Studies in Avian Biology, V16, P66; Honkala J, 2012, YB LINNUT MAGAZINE, V2013, P50; Huhta E, 2004, CONSERV BIOL, V18, P148, DOI 10.1111/j.1523-1739.2004.00270.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; ITAMIES J, 1972, Ornis Fennica, V49, P7; Jonker RM, 2014, IBIS, V156, P97, DOI 10.1111/ibi.12124; Kaila A., 2014, FINNISH STAT YB FORE, P33; Kenward R.E., 2006, THE GOSHAWK; Kostrzewa A, 1996, ETHOL ECOL EVOL, V8, P1, DOI 10.1080/08927014.1996.9522931; KOSTRZEWA A, 1991, ETHOL ECOL EVOL, V3, P127, DOI 10.1080/08927014.1991.9525379; Kruger O, 2004, BIRD STUDY, V51, P125; Kruger O, 2002, OECOLOGIA, V133, P474, DOI 10.1007/s00442-002-1053-y; Kruger O, 2002, OIKOS, V96, P441, DOI 10.1034/j.1600-0706.2002.960306.x; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; Kurki S, 2000, ECOLOGY, V81, P1985, DOI 10.1890/0012-9658(2000)081[1985:LFAFCE]2.0.CO;2; Kuuluvainen T, 2002, SILVA FENN, V36, P169, DOI 10.14214/sf.556; Kuuluvainen T., 2003, BIODIVERS CONSERV, P89; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; Laaksonen T, 2004, P ROY SOC B-BIOL SCI, V271, pS461, DOI 10.1098/rsbl.2004.0221; Lehikoinen A, 2009, OIKOS, V118, P829, DOI 10.1111/j.1600-0706.2008.17440.x; Lofman S, 2001, SCAND J FOREST RES, V16, P44, DOI 10.1080/028275801300004406; Lohmus Asko, 2006, Proceedings of the Estonian Academy of Sciences Biology Ecology, V55, P31; Lopez-Lopez P, 2007, BIRD STUDY, V54, P335, DOI 10.1080/00063650709461493; Lopez-Lopez P, 2014, ECOL APPL, V24, P938, DOI 10.1890/13-2000.1; McDonald JH., 2008, HDB BIOL STAT; McRoberts RE, 2010, SCAND J FOREST RES, V25, P368, DOI 10.1080/02827581.2010.496739; Mikkola-Roos Markku, 2010, P320; Monkkonen M, 2011, EUR J FOREST RES, V130, P717, DOI 10.1007/s10342-010-0461-5; Mykra S, 2000, ANN ZOOL FENN, V37, P79; Myllyntaus T, 2002, ECOL ECON, V41, P271, DOI 10.1016/S0921-8009(02)00034-4; Newton I., 1979, POPULATION ECOLOGY R; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Peltola A, 2012, FINNISH STAT YB FORE, p[37, 431]; Penteriani V, 1997, J RAPTOR RES, V31, P208; Penteriani V, 2002, ORNIS FENNICA, V79, P149; Penteriani V, 1997, BIRD STUDY, V44, P136, DOI 10.1080/00063659709461049; Perasaari J, 2009, WORKING PAPERS FINNI, V111, P1; Reif V, 2001, ECOGRAPHY, V24, P267, DOI 10.1034/j.1600-0587.2001.240304.x; Reynolds R.T., 1992, U S Forest Service General Technical Report RM, P1; Reynolds Richard T., 2006, Studies in Avian Biology, P299; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rouvinen S, 2005, FOREST ECOL MANAG, V208, P45, DOI 10.1016/j.foreco.2004.11.021; Saurola P, 2008, AMBIO, V37, P413, DOI 10.1579/0044-7447(2008)37[416:MBOPIF]2.0.CO;2; Selas V, 1997, J RAPTOR RES, V31, P16; Selas V, 2008, FOREST ECOL MANAG, V256, P446, DOI 10.1016/j.foreco.2008.04.047; Squires John R., 2006, Studies in Avian Biology, P8; Strandberg R, 2012, ARDEA, V100, P157, DOI 10.5253/078.100.0207; Tike Information Centre of the Ministry of Agriculture and Forestry, 2014, UT AGR AR; Tjernberg Martin, 1994, Ornis Svecica, V4, P133; Tomppo E, 2011, MANAG FOR ECOSYST, V21, P1; Tomppo E, 2013, WORKING PAPERS FINNI, V273, P1; Tomppo E., 2008, MULTISOURCE NATL FOR; TOMPPO E., 2001, METSATIETEEN AIKAK B, V1B, P99, DOI DOI 10.14214/MA.6434; Tornberg R, 2013, OECOLOGIA, V171, P863, DOI 10.1007/s00442-012-2448-z; Tornberg R, 2009, IBIS, V151, P396, DOI 10.1111/j.1474-919X.2009.00910.x; Tornberg Risto, 2006, Studies in Avian Biology, P141; Valkama J., 2011, 3 FINNISH BREEDING B; Velmala J., 2013, FINNISH BIRD RINGING, V1; White C.M., 1994, NEW WORLD VULTURES G; WIDEN P, 1989, IBIS, V131, P205, DOI 10.1111/j.1474-919X.1989.tb02763.x; Widen P, 1997, J RAPTOR RES, V31, P107; Woodbridge Brian, 1994, Studies in Avian Biology, V16, P83; Zuur Alain F., 2009, P1	100	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0137877	10.1371/journal.pone.0137877	http://dx.doi.org/10.1371/journal.pone.0137877			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422684	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700021
J	Faggion, CM; Wu, YC; Scheidgen, M; Tu, YK				Faggion, Clovis Mariano, Jr.; Wu, Yun-Chun; Scheidgen, Moritz; Tu, Yu-Kang			Effect of Risk of Bias on the Effect Size of Meta-Analytic Estimates in Randomized Controlled Trials in Periodontology and Implant Dentistry	PLOS ONE			English	Article							SYSTEMATIC REVIEWS; QUALITY	Background Risk of bias (ROB) may threaten the internal validity of a clinical trial by distorting the magnitude of treatment effect estimates, although some conflicting information on this assumption exists. Objective The objective of this study was evaluate the effect of ROB on the magnitude of treatment effect estimates in randomized controlled trials (RCTs) in periodontology and implant dentistry. Methods A search for Cochrane systematic reviews (SRs), including meta-analyses of RCTs published in periodontology and implant dentistry fields, was performed in the Cochrane Library in September 2014. Random-effect meta-analyses were performed by grouping RCTs with different levels of ROBs in three domains (sequence generation, allocation concealment, and blinding of outcome assessment). To increase power and precision, only SRs with meta-analyses including at least 10 RCTs were included. Meta-regression was performed to investigate the association between ROB characteristics and the magnitudes of intervention effects in the meta-analyses. Results Of the 24 initially screened SRs, 21 SRs were excluded because they did not include at least 10 RCTs in the meta-analyses. Three SRs (two from periodontology field) generated information for conducting 27 meta-analyses. Meta-regression did not reveal significant differences in the relationship of the ROB level with the size of treatment effect estimates, although a trend for inflated estimates was observed in domains with unclear ROBs. Conclusion In this sample of RCTs, high and (mainly) unclear risks of selection and detection biases did not seem to influence the size of treatment effect estimates, although several confounders might have influenced the strength of the association.	[Faggion, Clovis Mariano, Jr.; Scheidgen, Moritz] Univ Munster, Fac Dent, Dept Periodontol, D-48149 Munster, Germany; [Wu, Yun-Chun; Tu, Yu-Kang] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	University of Munster; National Taiwan University	Faggion, CM (corresponding author), Univ Munster, Fac Dent, Dept Periodontol, D-48149 Munster, Germany.	clovisfaggion@yahoo.com	Faggion, Clóvis Mariano/V-1987-2019	Tu, Yu-Kang/0000-0002-2461-474X	Ministry of Science and Technology in Taiwan [MOST 103 - 2314 - B - 002 - 032 - MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Y. C. Wu and Y. K. Tu were partly supported by a grant from the Ministry of Science and Technology in Taiwan (grant number: MOST 103 - 2314 - B - 002 - 032 - MY3).	Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Borenstein M., 2009, INTRO METAANALYSIS; Deeks JJ, COCHRANE HDB SYSTEMA; Esposito M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003878.pub5; Faggion CM, 2014, J PERIODONTAL RES, V49, P137, DOI 10.1111/jre.12092; Faggion CM, 2013, J CLIN PERIODONTOL, V40, P883, DOI 10.1111/jcpe.12132; Fu R., 2010, CONDUCTING QUANTITAT; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; RILEY P, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD010514.PUB2; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Yaacob M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002281.pub3	16	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139030	10.1371/journal.pone.0139030	http://dx.doi.org/10.1371/journal.pone.0139030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422698	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700062
J	Angelini, A; Li, ZL; Mericskay, M; Decaux, JF				Angelini, Aude; Li, Zhenlin; Mericskay, Mathias; Decaux, Jean-Francois			Regulation of Connective Tissue Growth Factor and Cardiac Fibrosis by an SRF/MicroRNA-133a Axis	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; MATRIX-METALLOPROTEINASE ACTIVITY; DILATED CARDIOMYOPATHY; GENE-EXPRESSION; MYOCARDIAL FIBROSIS; MYOFIBROBLAST DIFFERENTIATION; TRANSGENIC MICE; ACTIN DYNAMICS; HEART-FAILURE; TGF-BETA	Myocardial fibrosis contributes to the remodeling of heart and the loss of cardiac function leading to heart failure. SRF is a transcription factor implicated in the regulation of a large variety of genes involved in cardiac structure and function. To investigate the impact of an SRF overexpression in heart, we developed a new cardiac-specific and tamoxifen-inducible SRF overexpression mouse model by the Cre/loxP strategy. Here, we report that a high level overexpression of SRF leads to severe modifications of cardiac cytoarchitecture affecting the balance between cardiomyocytes and cardiac fibroblasts and also a profound alteration of cardiac gene expression program. The drastic development of fibrosis was characterized by intense sirius red staining and associated with an increased expression of genes encoding extracellular matrix proteins such as fibronectin, procollagen type 1 alpha 1 and type 3 alpha 1 and especially connective tissue growth factor (CTGF). Furthermore miR-133a, one of the most predominant cardiac miRNAs, is strongly downregulated when SRF is overexpressed. By comparison a low level overexpression of SRF has minor impact on these different processes. Investigation with miR-133a, antimiR-133a and AdSRF-VP16 experiments in H9c2 cardiac cells demonstrated that: 1)-miR-133a acts as a repressor of SRF and CTGF expression; 2)-a simultaneous overexpression of SRF by AdSRF-VP16 and inhibition of miR-133a by a specific antimiR increase CTGF expression; 3)-miR-133a overexpression can block the upregulation of CTGF induced by AdSRF-VP16. Taken together, these findings reveal a key role of the SRF/CTGF/miR-133a axis in the regulation of cardiac fibrosis.	[Angelini, Aude; Li, Zhenlin; Mericskay, Mathias; Decaux, Jean-Francois] Univ Paris 06, DHU FAST Sorbonne Univ, Biol Adaptat & Ageing, IBPS, Paris, France; [Angelini, Aude; Li, Zhenlin; Mericskay, Mathias; Decaux, Jean-Francois] CNRS, UMR8256, Paris, France; [Angelini, Aude; Li, Zhenlin; Mericskay, Mathias; Decaux, Jean-Francois] INSERM, U1164, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm)	Mericskay, M (corresponding author), Univ Paris 06, DHU FAST Sorbonne Univ, Biol Adaptat & Ageing, IBPS, Paris, France.	mathias.mericskay@upmc.fr; jean-francois.decaux@inserm.fr	Li, Zhenlin/E-3937-2016; MERICSKAY, Mathias/M-3477-2018	DECAUX, Jean-Francois/0000-0003-0014-4197; Angelini, Aude/0000-0001-5339-5315; MERICSKAY, Mathias/0000-0002-6779-092X; Samuel, Jane-Lise/0000-0002-7346-2404; LI, Zhenlin/0000-0002-3706-4505	l'Association Francaise contre les Myopathies (AFM: Cardiovascular Functions of Serum Response Factor: Involvement in Cardiomyopathies and Vasculopathies) [13727]; Universite Paris 05; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Societe Francaise de Cardiologie (SFC)	l'Association Francaise contre les Myopathies (AFM: Cardiovascular Functions of Serum Response Factor: Involvement in Cardiomyopathies and Vasculopathies); Universite Paris 05; Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC); Societe Francaise de Cardiologie (SFC)	This work was supported by l'Association Francaise contre les Myopathies (AFM#13727: Cardiovascular Functions of Serum Response Factor: Involvement in Cardiomyopathies and Vasculopathies). AA was supported by a PhD fellowship of Universite Paris 05 and a fellowship of Groupe de Reflexion sur la Recherche Cardiovasculaire (GRRC) and Societe Francaise de Cardiologie (SFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Arimura T, 2013, CIRC J, V77, P2990, DOI 10.1253/circj.CJ-13-0255; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Blom IE, 2002, MATRIX BIOL, V21, P473, DOI 10.1016/S0945-053X(02)00055-0; Brower GL, 2002, AM J PHYSIOL-HEART C, V283, pH518, DOI 10.1152/ajpheart.00218.2000; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chancey AL, 2002, AM J PHYSIOL-HEART C, V282, pH2152, DOI 10.1152/ajpheart.00777.2001; Chen CY, 1996, MOL CELL BIOL, V16, P6372; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; Daniels JT, 2003, AM J PATHOL, V163, P2043, DOI 10.1016/S0002-9440(10)63562-6; Danowski N, 2013, CARDIOLOGY, V125, P125, DOI 10.1159/000348563; Diguet N, 2011, J BIOL CHEM, V286, P35007, DOI 10.1074/jbc.M111.252395; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Grotendorst GR, 2004, FASEB J, V18, P469, DOI 10.1096/fj.03-0699com; Ho CY, 2013, NATURE, V497, P507, DOI 10.1038/nature12105; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Kuwahara K, 2007, J CLIN INVEST, V117, P1324, DOI 10.1172/JCI31240; Lin H, 2007, TOXICOL SCI, V96, P83, DOI 10.1093/toxsci/kfl172; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Matsui Y, 2004, J MOL CELL CARDIOL, V37, P477, DOI 10.1016/j.yjmcc.2004.05.012; Menick DR, 2007, ANN NY ACAD SCI, V1099, P195, DOI 10.1196/annals.1387.058; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Muehlich S, 2007, AM J PHYSIOL-CELL PH, V292, pC1732, DOI 10.1152/ajpcell.00552.2006; Ohnishi H, 1998, J MOL CELL CARDIOL, V30, P2411, DOI 10.1006/jmcc.1998.0799; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; PRYWES R, 1992, NUCLEIC ACIDS RES, V20, P513, DOI 10.1093/nar/20.3.513; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Spencer JA, 1996, J BIOL CHEM, V271, P16535, DOI 10.1074/jbc.271.28.16535; Stewart JA, 2003, J MOL CELL CARDIOL, V35, P311, DOI 10.1016/S0022-2828(03)00013-0; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Touvron M, 2012, DIS MODEL MECH, V5, P481, DOI 10.1242/dmm.009456; Tritsch E, 2013, CARDIOVASC RES, V98, P372, DOI 10.1093/cvr/cvt042; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Yang M, 2004, FASEB J, V18, P1920, DOI 10.1096/fj.04-2357fje; Zhang C, 2004, LIFE SCI, V75, P367, DOI 10.1016/j.lfs.2004.02.005; Zhang XM, 2003, AM J PHYSIOL-REG I, V285, pR552, DOI 10.1152/ajpregu.00631.2002; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang XM, 2001, J BIOL CHEM, V276, P40033, DOI 10.1074/jbc.M104934200	52	34	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139858	10.1371/journal.pone.0139858	http://dx.doi.org/10.1371/journal.pone.0139858			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440278	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300068
J	Hsu, YH; Wu, CY; Hsing, CH; Lai, WT; Wu, LW; Chang, MS				Hsu, Yu-Hsiang; Wu, Cheng-Ying; Hsing, Chung-Hsi; Lai, Wei-Ting; Wu, Li-Wha; Chang, Ming-Shi			Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BREAST-CANCER; CATHEPSIN-G; PROTEIN EXPRESSION; TUMOR-GROWTH; METASTASIS; CELLS; INTERLEUKIN-20; ACTIVATION; RECEPTORS	Interleukin (IL)-20 is a proinflammatory cytokine in the IL-10 family. IL-20 is associated with tumor promotion in the pathogenesis of oral, bladder, and breast cancer. However, little is known about the role of IL-20 in prostate cancer. We hypothesize that IL-20 promotes the growth of prostate cancer cells. Immunohistochemical staining showed that IL-20 and its receptors were expressed in human PC-3 and LNCaP prostate cancer cell lines and in prostate tumor tissue from 40 patients. In vitro, IL-20 upregulated N-cadherin, STAT3, vimentin, fibronectin, RANKL, cathepsin G, and cathepsin K, and increased the migration and colony formation of prostate cancer cells via activated p38, ERK1/2, AKT, and NF-kappa B signals in PC-3 cells. We investigated the effects of anti-IL-20 monoclonal antibody 7E on prostate tumor growth in vivo using SCID mouse subcutaneous and intratibial xenograft tumor models. In vivo, 7E reduced tumor growth, suppressed tumor-mediated osteolysis, and protected bone mineral density after intratibial injection of prostate cancer cells. We conclude that IL-20 is involved in the cell migration, colony formation, and tumor-induced osteolysis of prostate cancer. Therefore, IL-20 might be a novel target for treating prostate cancer.	[Hsu, Yu-Hsiang] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan; [Wu, Cheng-Ying; Lai, Wei-Ting; Chang, Ming-Shi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Hsing, Chung-Hsi] Chi Mei Med Ctr, Dept Anesthesiol, Tainan, Taiwan; [Wu, Li-Wha] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Hsing, Chung-Hsi] Taipei Med Univ, Dept Anesthesiol, Coll Med, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University; Chi Mei Hospital; National Cheng Kung University; Taipei Medical University	Chang, MS (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan.	mschang@mail.ncku.edu.tw	Wu, Li-Wha/AAH-7768-2021	Wu, Li-Wha/0000-0001-7010-6220	Ministry of Science and Technology of Taiwan [MOST 103-2311-B-006-002, MOST 104-2311-B-006-007-MY2]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 103-2311-B-006-002 and MOST 104-2311-B-006-007-MY2).	Adhikary A, 2014, J BIOL CHEM, V289, P25431, DOI 10.1074/jbc.M113.527267; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Armstrong AP, 2008, PROSTATE, V68, P92, DOI 10.1002/pros.20678; Azim H, 2013, EXPERT REV ANTICANC, V13, P195, DOI [10.1586/era.12.177, 10.1586/ERA.12.177]; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Brubaker KD, 2003, J BONE MINER RES, V18, P222, DOI 10.1359/jbmr.2003.18.2.222; Caini S, 2014, CANCER EPIDEMIOL, V38, P329, DOI 10.1016/j.canep.2014.06.002; Carlin Bruce I., 2000, Cancer, V88, P2989, DOI 10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.3.CO;2-H; Casimiro S, 2012, CLIN EXP METASTAS, V29, P155, DOI 10.1007/s10585-011-9438-0; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; Hsu YH, 2012, MOL CANCER RES, V10, P1430, DOI 10.1158/1541-7786.MCR-12-0276; Hsu YH, 2012, J IMMUNOL, V188, P1981, DOI 10.4049/jimmunol.1102843; Hsu YH, 2011, J EXP MED, V208, P1849, DOI 10.1084/jem.20102234; Israeli Ron S, 2008, Rev Urol, V10, P99; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Le Gall C, 2007, CANCER RES, V67, P9894, DOI 10.1158/0008-5472.CAN-06-3940; Lee SJ, 2013, J BIOL CHEM, V288, P5539, DOI 10.1074/jbc.M112.410233; MCCLELLAND RA, 1990, CANCER RES, V50, P3545; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; O'Connor JW, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-23; Olson KB, 1999, ONCOLOGY-NY, V13, P1537; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Shiota M, 2013, CANCER RES, V73, P3109, DOI 10.1158/0008-5472.CAN-12-3979; Sottnik JL, 2013, CURR MOL MED, V13, P626; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wei CC, 2005, CLIN IMMUNOL, V117, P65, DOI 10.1016/j.clim.2005.06.012; Wei CC, 2008, BIOCHEM BIOPH RES CO, V374, P448, DOI 10.1016/j.bbrc.2008.07.039; Whitaker EL, 2012, CYTOKINE GROWTH F R, V23, P323, DOI 10.1016/j.cytogfr.2012.08.004; Wilson TJ, 2008, CANCER RES, V68, P5803, DOI 10.1158/0008-5472.CAN-07-5889; Wilson TJ, 2009, MOL CANCER RES, V7, P1224, DOI 10.1158/1541-7786.MCR-09-0028; Wilson TJ, 2009, CANCER RES, V69, P3188, DOI 10.1158/0008-5472.CAN-08-1956; Xie YF, 2008, CANCER BIOTHER RADIO, V23, P310, DOI 10.1089/cbr.2007.0453; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685	45	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139871	10.1371/journal.pone.0139871	http://dx.doi.org/10.1371/journal.pone.0139871			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440411	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300069
J	Hu, YD; Mi, XJ; Xu, X; Fang, WD; Zeng, KB; Yang, MM; Li, CY; Wang, SS; Li, MH; Wang, XF				Hu, Yida; Mi, Xiujuan; Xu, Xin; Fang, Weidong; Zeng, Kebin; Yang, Mingming; Li, Chenyu; Wang, Shasha; Li, Minghui; Wang, Xuefeng			The Brain Activity in Brodmann Area 17: A Potential Bio-Marker to Predict Patient Responses to Antiepileptic Drugs	PLOS ONE			English	Article							RESTING-STATE FMRI; TEMPORAL-LOBE EPILEPSY; DEFAULT-MODE NETWORK; LOW-FREQUENCY FLUCTUATION; IDIOPATHIC GENERALIZED EPILEPSY; FUNCTIONAL CONNECTIVITY; FEEDBACK CONNECTIONS; MULTIPLE-SCLEROSIS; WAVE DISCHARGES; SPIKE	In this study, we aimed to predict newly diagnosed patient responses to antiepileptic drugs (AEDs) using resting-state functional magnetic resonance imaging tools to explore changes in spontaneous brain activity. We recruited 21 newly diagnosed epileptic patients, 8 drug-resistant (DR) patients, 11 well-healed (WH) patients, and 13 healthy controls. After a 12-month follow-up, 11 newly diagnosed epileptic patients who showed a poor response to AEDs were placed into the seizures uncontrolled (SUC) group, while 10 patients were enrolled in the seizure-controlled (SC) group. By calculating the amplitude of fractional low-frequency fluctuations (fALFF) of blood oxygen level-dependent signals to measure brain activity during rest, we found that the SUC patients showed increased activity in the bilateral occipital lobe, particularly in the cuneus and lingual gyrus compared with the SC group and healthy controls. Interestingly, DR patients also showed increased activity in the identical cuneus and lingual gyrus regions, which comprise Brodmann's area 17 (BA17), compared with the SUC patients; however, these abnormalities were not observed in SC and WH patients. The receiver operating characteristic (ROC) curves indicated that the fALFF value of BA17 could differentiate SUC patients from SC patients and healthy controls with sufficient sensitivity and specificity prior to the administration of medication. Functional connectivity analysis was subsequently performed to evaluate the difference in connectivity between BA17 and other brain regions in the SUC, SC and control groups. Regions nearby the cuneus and lingual gyrus were found positive connectivity increased changes or positive connectivity changes with BA17 in the SUC patients, while remarkably negative connectivity increased changes or positive connectivity decreased changes were found in the SC patients. Additionally, default mode network (DMN) regions showed negative connectivity increased changes or negative changes with BA17 in the SUC patients. The abnormal increased in BA17 activity may be a key point that plays a substantial role in facilitating seizure onset.	[Hu, Yida; Mi, Xiujuan; Xu, Xin; Zeng, Kebin; Wang, Xuefeng] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China; [Fang, Weidong] Chongqing Med Univ, Dept Radiol, Affiliated Hosp 1, Chongqing, Peoples R China; [Yang, Mingming] Chongqing City Hosp Tradit Chinese Med, Dept Pediat, Chongqing, Peoples R China; [Li, Chenyu] Chongqing City Hosp Tradit Chinese Med, Dept Neurol, Chongqing, Peoples R China; [Wang, Shasha] Chongqing Three Gorges Cent Hosp, Dept Nursing, Chongqing, Peoples R China; [Li, Minghui] Shanxi Med Univ, Dept Nursing, Hosp 1, Taiyuan, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Three Gorges University; Shanxi Medical University	Wang, XF (corresponding author), Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China.	kudosai@163.com			National Natural Science of China [81301109, 81071039]; Chongqing Health Bureau funding [2011-2-118]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chongqing Health Bureau funding	This study was funded by National Natural Science of China, Contract grant numbers: 81301109 (Yida Hu), 81071039 (Xuefeng Wang) and the Chongqing Health Bureau funding, Contract grant number: 2011-2-118 (Kebin Zeng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre-Arrizubieta Z, 2009, BRAIN, V132, P3060, DOI 10.1093/brain/awp137; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Barba C, 2005, J NEUROL, V252, P465, DOI 10.1007/s00415-005-0676-4; Bhardwaj RD, 2010, CHILD NERV SYST, V26, P185, DOI 10.1007/s00381-009-1017-1; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonmassar G, 2001, NEUROIMAGE, V13, P1035, DOI 10.1006/nimg.2001.0754; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullier J, 2001, PROG BRAIN RES, V134, P193; Bullier J, 2001, TRENDS COGN SCI, V5, P369, DOI 10.1016/S1364-6613(00)01730-7; Campo P, 2013, NEUROIMAGE, V72, P48, DOI 10.1016/j.neuroimage.2013.01.036; Chen YL, 2013, SCHIZOPHR RES, V149, P26, DOI 10.1016/j.schres.2013.05.029; Dai H, 2013, HUM BRAIN MAPP, V34, P2455, DOI 10.1002/hbm.22079; Delnooz CCS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062877; Deng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033337; Doucet G, 2013, HUM BRAIN MAPP, V34, P2202, DOI 10.1002/hbm.22059; Englot DJ, 2014, NEUROSURGERY, V75, P648, DOI 10.1227/NEU.0000000000000530; Fernandez IS, 2013, J CLIN NEUROPHYSIOL, V30, P554, DOI 10.1097/01.wnp.0000436898.10125.70; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Garcia-Cairasco N, 2009, BRAZ J MED BIOL RES, V42, P76, DOI 10.1590/S0100-879X2009000100012; Garcia-Cairasco N, 2009, EPILEPSY BEHAV, V14, P54, DOI 10.1016/j.yebeh.2008.09.010; Geerts A, 2010, EPILEPSIA, V51, P1189, DOI 10.1111/j.1528-1167.2010.02546.x; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Gour N, 2014, HUM BRAIN MAPP, V35, P2978, DOI 10.1002/hbm.22379; Gravel N, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00339; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guerrini R, 2004, EPILEPSIA, V45, P14, DOI 10.1111/j.0013-9580.2004.451011.x; Hoekzema E, 2014, HUM BRAIN MAPP, V35, P1261, DOI 10.1002/hbm.22250; Hu YD, 2011, SEIZURE-EUR J EPILEP, V20, P208, DOI 10.1016/j.seizure.2010.11.020; Hu YD, 2010, EPILEPSY RES, V90, P278, DOI 10.1016/j.eplepsyres.2010.06.004; Jacoby A, 2002, EPILEPSY BEHAV, V3, pS10; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; Kaltenhauser M, 2007, NEUROIMAGE, V34, P1466, DOI 10.1016/j.neuroimage.2006.11.002; Kay BP, 2013, EPILEPSIA, V54, P461, DOI 10.1111/epi.12057; Kim KK, 2012, BRAIN RES, V1475, P49, DOI 10.1016/j.brainres.2012.07.004; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lehmann TN, 2000, EPILEPSIA, V41, pS190, DOI 10.1111/j.1528-1157.2000.tb01580.x; Leone MA, 2006, NEUROLOGY, V67, P2227, DOI 10.1212/01.wnl.0000249309.80510.63; Li L, 2013, NEUROPSYCHOLOGIA, V51, P1571, DOI 10.1016/j.neuropsychologia.2013.05.011; Loscher W, 2004, EPILEPSY RES, V60, P77, DOI 10.1016/j.eplepsyres.2004.06.004; Luo C, 2011, EPILEPSIA, V52, P1092, DOI 10.1111/j.1528-1167.2011.03045.x; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Magloczky Z, 2010, EPILEPSY RES, V89, P52, DOI 10.1016/j.eplepsyres.2010.01.002; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McGill ML, 2012, EPILEPSY BEHAV, V23, P353, DOI 10.1016/j.yebeh.2012.01.013; Mizobuchi Masahiro, 2013, Brain Nerve, V65, P1031; Norden AD, 2002, EPILEPSY BEHAV, V3, P219, DOI 10.1016/S1525-5050(02)00029-X; Pedreira C, 2014, NEUROIMAGE, V99, P461, DOI 10.1016/j.neuroimage.2014.05.009; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raemaekers M, 2014, NEUROIMAGE, V84, P911, DOI 10.1016/j.neuroimage.2013.09.060; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rocca MA, 2014, NEUROLOGY, V82, P1314, DOI 10.1212/WNL.0000000000000309; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Tona F, 2014, RADIOLOGY, V271, P814, DOI 10.1148/radiol.14131688; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Voets NL, 2012, BRAIN, V135, P2350, DOI 10.1093/brain/aws137; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023460; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yang TH, 2013, HUM BRAIN MAPP, V34, P1761, DOI 10.1002/hbm.22025; Yu CS, 2008, HUM BRAIN MAPP, V29, P533, DOI 10.1002/hbm.20420; Yu L, 2009, ANN NY ACAD SCI, V1157, P48, DOI 10.1111/j.1749-6632.2009.04472.x; Yu RJ, 2014, HUM BRAIN MAPP, V35, P627, DOI 10.1002/hbm.22203; Zhang ZQ, 2010, HUM BRAIN MAPP, V31, P1851, DOI 10.1002/hbm.20982; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	77	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139819	10.1371/journal.pone.0139819	http://dx.doi.org/10.1371/journal.pone.0139819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439500	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300062
J	Tsutsumi, Y; Nomiyama, T; Kawanami, T; Hamaguchi, Y; Terawaki, Y; Tanaka, T; Murase, K; Motonaga, R; Tanabe, M; Yanase, T				Tsutsumi, Yoko; Nomiyama, Takashi; Kawanami, Takako; Hamaguchi, Yuriko; Terawaki, Yuichi; Tanaka, Tomoko; Murase, Kunitaka; Motonaga, Ryoko; Tanabe, Makito; Yanase, Toshihiko			Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; DIABETES-MELLITUS; RECEPTOR AGONIST; RISK; HYPERGLYCEMIA; ASSOCIATION; INHIBITION; EXPRESSION; MORTALITY; COMMITTEE	Introduction Recently, the pleiotropic benefits of incretin-based therapy have been reported. We have previously reported that Exendin-4, a glucagon-like peptide-1 (GLP-1) receptor agonist, attenuates prostate cancer growth. Metformin is known for its anti-cancer effect. Here, we examined the anti-cancer effect of Exendin-4 and metformin using a prostate cancer model. Methods Prostate cancer cells were treated with Exendin-4 and/or metformin. Cell proliferation was quantified by growth curves and 5-bromo-2'-deoxyuridine (BrdU) assay. TUNEL assay and AMP-activated protein kinase (AMPK) phosphorylation were examined in LNCaP cells. For in vivo experiments, LNCaP cells were transplanted subcutaneously into the flank region of athymic mice, which were then treated with Exendin-4 and/or metformin. TUNEL assay and immunohistochemistry were performed on tumors. Results Exendin-4 and metformin additively decreased the growth curve, but not the migration, of prostate cancer cells. The BrdU assay revealed that both Exendin-4 and metformin significantly decreased prostate cancer cell proliferation. Furthermore, metformin, but not Exendin-4, activated AMPK and induced apoptosis in LNCaP cells. The anti-proliferative effect of metformin was abolished by inhibition or knock down of AMPK. In vivo, Exendin-4 and metformin significantly decreased tumor size, and further significant tumor size reduction was observed after combined treatment. Immunohistochemistry on tumors revealed that the P504S and Ki67 expression decreased by Exendin-4 and/or metformin, and that metformin increased phospho-AMPK expression and the apoptotic cell number. Conclusion These data suggest that Exendin-4 and metformin attenuated prostate cancer growth by inhibiting proliferation, and that metformin inhibited proliferation by inducing apoptosis. Combined treatment with Exendin-4 and metformin attenuated prostate cancer growth more than separate treatments.	[Tsutsumi, Yoko; Nomiyama, Takashi; Kawanami, Takako; Hamaguchi, Yuriko; Terawaki, Yuichi; Tanaka, Tomoko; Murase, Kunitaka; Motonaga, Ryoko; Tanabe, Makito; Yanase, Toshihiko] Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Jonan Ku, Fukuoka 8140180, Japan	Fukuoka University	Nomiyama, T (corresponding author), Fukuoka Univ, Sch Med, Dept Endocrinol & Diabet Mellitus, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	tnomiyama@fukuoka-u.ac.jp		Tanaka, Tomoko/0000-0002-3826-3653	MSD; Eli Lilly; MSD endowed a chair	MSD; Eli Lilly(Eli Lilly); MSD endowed a chair	MSD endowed a chair in our department and provided support in the form of salaries for the author, Tomoko Tanaka, PhD. However, Dr. Tanaka is not an employee of MSD. MSD donates an endowed chair to our department, and our department employ her using a part of grant from MSD. Eli Lilly provided financial support as joint research. However, these companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Badrick E, 2014, EUR J CANCER, V50, P2119, DOI 10.1016/j.ejca.2014.04.032; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Bonovas S, 2004, DIABETOLOGIA, V47, P1071, DOI 10.1007/s00125-004-1415-6; Burkewitz K, 2014, CELL METAB, V20, P10, DOI 10.1016/j.cmet.2014.03.002; Clements A, 2011, ANN ONCOL, V22, P2556, DOI 10.1093/annonc/mdr037; Deacon CF, 2012, DIABETES OBES METAB, V14, P762, DOI 10.1111/j.1463-1326.2012.01603.x; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Ellerhorst J, 1999, INT J ONCOL, V14, P217; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Goto H, 2011, BIOCHEM BIOPH RES CO, V405, P79, DOI 10.1016/j.bbrc.2010.12.131; Grossmann M, 2012, ENDOCR-RELAT CANCER, V19, pF47, DOI 10.1530/ERC-12-0067; Hotta Nigishi, 2007, Journal of the Japan Diabetes Society, V50, P47; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Jalving M, 2010, EUR J CANCER, V46, P2369, DOI 10.1016/j.ejca.2010.06.012; Kasper JS, 2009, INT J CANCER, V124, P1398, DOI 10.1002/ijc.24044; Kasuga M, 2013, DIABETOL INT, V4, P81, DOI 10.1007/s13340-013-0121-3; Loubiere C, 2015, ONCOTARGET IN PRESS; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Maida A, 2011, DIABETOLOGIA, V54, P339, DOI 10.1007/s00125-010-1937-z; Malaguarnera R, 2014, ENDOCRINOLOGY, V155, P1207, DOI 10.1210/en.2013-1925; Meier JJ, 2015, DIABETOLOGIA IN PRES; Mitin T, 2011, J UROLOGY, V186, P2233, DOI 10.1016/j.juro.2011.07.072; Monteagudo S, 2012, NANOMEDICINE-UK, V7, P493, DOI [10.2217/NNM.11.61, 10.2217/nnm.11.61]; Moses KA, 2012, PROSTATE CANCER P D, V15, P70, DOI 10.1038/pcan.2011.40; Nauck MA, 2005, REGUL PEPTIDES, V128, P135, DOI 10.1016/j.regpep.2004.07.014; Nomiyama T, 2014, DIABETES, V63, P3891, DOI 10.2337/db13-1169; Nomiyama T, 2012, DIABETES RES CLIN PR, V95, pE27, DOI 10.1016/j.diabres.2011.08.016; Park CW, 2007, J AM SOC NEPHROL, V18, P1227, DOI 10.1681/ASN.2006070778; Ranc K, 2014, DIABETOLOGIA, V57, P927, DOI 10.1007/s00125-014-3186-z; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Terawaki Y, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0154-3; Vilsboll T, 2004, DIABETOLOGIA, V47, P357, DOI 10.1007/s00125-004-1342-6; Xu G, 2007, DIABETES, V56, P1551, DOI 10.2337/db06-1033	37	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139709	10.1371/journal.pone.0139709	http://dx.doi.org/10.1371/journal.pone.0139709			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439622	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300044
J	Varadi, M; Zsolyomi, F; Guharoy, M; Tompa, P				Varadi, Mihaly; Zsolyomi, Fruzsina; Guharoy, Mainak; Tompa, Peter			Functional Advantages of Conserved Intrinsic Disorder in RNA-Binding Proteins	PLOS ONE			English	Article							MOTOR-NEURON SMN; STRUCTURAL BASIS; EXON-7 INCLUSION; MOLECULAR-BASIS; RECOGNITION; RESIDUES; REVEALS; INTERFACES; COMPLEXES; MOTIFS	Proteins form large macromolecular assemblies with RNA that govern essential molecular processes. RNA-binding proteins have often been associated with conformational flexibility, yet the extent and functional implications of their intrinsic disorder have never been fully assessed. Here, through large-scale analysis of comprehensive protein sequence and structure datasets we demonstrate the prevalence of intrinsic structural disorder in RNA-binding proteins and domains. We addressed their functionality through a quantitative description of the evolutionary conservation of disordered segments involved in binding, and investigated the structural implications of flexibility in terms of conformational stability and interface formation. We conclude that the functional role of intrinsically disordered protein segments in RNA-binding is two-fold: first, these regions establish extended, conserved electrostatic interfaces with RNAs via induced fit. Second, conformational flexibility enables them to target different RNA partners, providing multi-functionality, while also ensuring specificity. These findings emphasize the functional importance of intrinsically disordered regions in RNA-binding proteins.	[Varadi, Mihaly; Zsolyomi, Fruzsina; Guharoy, Mainak; Tompa, Peter] Flemish Inst Biotechnol VIB, SBRC, Brussels, Belgium; [Varadi, Mihaly; Zsolyomi, Fruzsina; Guharoy, Mainak; Tompa, Peter] Vrije Univ Brussel, SBB, Brussels, Belgium; [Tompa, Peter] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Tompa, P (corresponding author), Flemish Inst Biotechnol VIB, SBRC, Brussels, Belgium.	ptompa@vub.ac.be		Guharoy, Mainak/0000-0003-1354-2872; Tompa, Peter/0000-0001-8042-9939; Varadi, Mihaly/0000-0002-3687-0839	Odysseus grant [G.0029.12]; VIB	Odysseus grant; VIB	This work was supported by the Odysseus grant G.0029.12 (FWO, Research Foundation Flanders) to Peter Tompa and by a VIB international postdoctoral (omics@VIB) fellowship for Mainak Guharoy.	ABOULELA F, 1995, J MOL BIOL, V253, P313, DOI 10.1006/jmbi.1995.0555; Allain FHT, 2000, EMBO J, V19, P6870, DOI 10.1093/emboj/19.24.6870; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Bellay J, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r14; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burton B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002530; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chen JW, 2006, J PROTEOME RES, V5, P888, DOI 10.1021/pr060049p; Cheng CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S6; Clery A, 2011, NAT STRUCT MOL BIOL, V18, P443, DOI 10.1038/nsmb.2001; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P13260, DOI 10.1073/pnas.0906770106; Frankel AD, 1999, NAT STRUCT BIOL, V6, P1081, DOI 10.1038/70002; Gsponer J, 2009, PROG BIOPHYS MOL BIO, V99, P94, DOI 10.1016/j.pbiomolbio.2009.03.001; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guharoy M, 2007, BIOINFORMATICS, V23, P1909, DOI 10.1093/bioinformatics/btm274; GuhaThakurta D, 2000, J MOL BIOL, V295, P569, DOI 10.1006/jmbi.1999.3372; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Gunasekaran K, 2004, J MOL BIOL, V341, P1327, DOI 10.1016/j.jmb.2004.07.002; Hamelryck T, 2003, BIOINFORMATICS, V19, P2308, DOI 10.1093/bioinformatics/btg299; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Joosten Robbie P, 2011, Nucleic Acids Res, V39, pD411, DOI 10.1093/nar/gkq1105; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Light S, 2013, MOL BIOL EVOL, V30, P2645, DOI 10.1093/molbev/mst157; Moore PB, 2012, ANNU REV BIOPHYS, V41, P1, DOI 10.1146/annurev-biophys-050511-102314; Nagarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091140; Peng ZL, 2014, CELL MOL LIFE SCI, V71, P1477, DOI 10.1007/s00018-013-1446-6; Perez-Canadillas JM, 2006, EMBO J, V25, P3167, DOI 10.1038/sj.emboj.7601190; Possik EJ, 2013, J MOL RECOGNIT, V26, P286, DOI 10.1002/jmr.2272; Ravindranathan S, 2010, J MOL BIOL, V396, P732, DOI 10.1016/j.jmb.2009.12.004; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Smith CA, 2000, MOL CELL, V6, P1067, DOI 10.1016/S1097-2765(00)00105-2; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tsuda K, 2011, NUCLEIC ACIDS RES, V39, P1538, DOI 10.1093/nar/gkq854; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Varadi M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0592-2; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Young PJ, 2002, HUM MOL GENET, V11, P577, DOI 10.1093/hmg/11.5.577	52	73	73	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139731	10.1371/journal.pone.0139731	http://dx.doi.org/10.1371/journal.pone.0139731			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439842	Green Published, Green Accepted, gold			2022-12-27	WOS:000362510300046
J	Verma, P; Goyal, R; Chahota, RK; Sharma, TR; Abdin, MZ; Bhatia, S				Verma, Priyanka; Goyal, Richa; Chahota, R. K.; Sharma, Tilak R.; Abdin, M. Z.; Bhatia, Sabhyata			Construction of a Genetic Linkage Map and Identification of QTLs for Seed Weight and Seed Size Traits in Lentil (Lens culinaris Medik.)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; MICROSATELLITE MARKERS; SSR MARKERS; INTRASPECIFIC MAP; AFLP MARKERS; RAPD; POLYMORPHISM; SEGREGATION; TOMATO; CROSS	Seed weight and seed size both are quantitative traits and have been considered as important components of grain yield, thus identification of quantitative trait loci (QTL) for seed traits in lentil (Lens culinaris) would be beneficial for the improvement of grain yield. Hence the main objective of this study was to identify QTLs for seed traits using an intraspecific mapping population derived from a cross between L. culinaris cv. Precoz (seed weight-5.1g, seed size-5.7mm) and L. culinaris cv. L830 (seed weight-2.2g, seed size-4mm) comprising 126 F-8-RILs. For this, two microsatellite genomic libraries enriched for (GA/CT) and (GAA/CTT) motif were constructed which resulted in the development of 501 new genomic SSR markers. Six hundred forty seven SSR markers (including 146 previously published) were screened for parental polymorphism and 219 (33.8%) were found to be polymorphic among the parents. Of these 216 were mapped on seven linkage groups at LOD4.0 spanning 1183.7cM with an average marker density of 5.48cM. Phenotypic data from the RILs was used to identify QTLs for the seed weight and seed size traits by single marker analysis (SMA) followed by composite interval mapping (CIM) which resulted in one QTL each for the 2 traits (qSW and qSS) that were co-localized on LG4 and explained 48.4% and 27.5% of phenotypic variance respectively. The current study would serve as a strong foundation for further validation and fine mapping for utilization in lentil breeding programs.	[Verma, Priyanka; Goyal, Richa; Bhatia, Sabhyata] Natl Inst Plant Genome Res, New Delhi 110067, India; [Chahota, R. K.; Sharma, Tilak R.] Chaudhary Sarwan Kumar Himachal Pradesh Agr Univ, Dept Agr Biotechnol, Palampur 176062, Himachal Prades, India; [Verma, Priyanka; Abdin, M. Z.] Jamia Hamdard, Fac Sci, Dept Biotechnol, New Delhi 110062, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Ch. Sarwan Kumar Himachal Pradesh Krishi Vishvavidyalaya; Jamia Hamdard University	Bhatia, S (corresponding author), Natl Inst Plant Genome Res, Post Box 10531,Aruna Asaf Ali Marg, New Delhi 110067, India.	sabhyatabhatia@nipgr.ac.in		Zainul Abdin, Malik/0000-0001-7346-0719; Bhatia, Sabhyata/0000-0003-0811-219X	National Institute of Plant Genome Research (NIPGR), New Delhi, India; Department of Biotechnology (DBT), Government of India [BT/01/08/NRC-PBI/01]	National Institute of Plant Genome Research (NIPGR), New Delhi, India; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This research work was supported by the National Institute of Plant Genome Research (NIPGR), New Delhi, India. Financial assistance was supported by The Department of Biotechnology (DBT), Government of India, under the Grant No. BT/01/08/NRC-PBI/01.	AASTVEIT AH, 1993, THEOR APPL GENET, V86, P1007, DOI 10.1007/BF00211054; ABBO S, 1991, EUPHYTICA, V58, P259, DOI 10.1007/BF00025258; Areshchenkova T, 1999, GENOME, V42, P536, DOI 10.1139/gen-42-3-536; Barulina H, 1930, B APPL GENET PLANT B, V40, P1; BARZEN E, 1995, THEOR APPL GENET, V90, P189, DOI 10.1007/BF00222201; BERRY ST, 1995, THEOR APPL GENET, V91, P195, DOI 10.1007/BF00220877; BRADSHAW HD, 1994, THEOR APPL GENET, V89, P551, DOI 10.1007/BF00222447; Chaitieng B, 2006, THEOR APPL GENET, V113, P1261, DOI 10.1007/s00122-006-0380-5; Doerge RW, 1996, GENETICS, V142, P285; Duran Y, 2004, THEOR APPL GENET, V108, P1265, DOI 10.1007/s00122-003-1542-3; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; Erskine W., 2009, LENTIL BOT PRODUCTIO, P13, DOI DOI 10.1079/9781845934873.0013; Erskine W., 2004, ENCY GRAIN SCI, P142; Eujayl I, 1997, EUPHYTICA, V96, P405, DOI 10.1023/A:1003045000568; Fedoruk M.J., 2013, PLANT GENOME, V6, P1, DOI DOI 10.3835/PLANTGEN0ME2013.05.0012; Fratini R, 2007, SPAN J AGRIC RES, V5, P348; Gaur R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-117; Grandillo S, 1996, THEOR APPL GENET, V92, P957, DOI 10.1007/BF00224035; Gupta D, 2012, MOL BREEDING, V30, P429, DOI 10.1007/s11032-011-9634-2; Gupta M, 2012, J GENET, V91, P279, DOI 10.1007/s12041-012-0180-4; Gupta PK, 1996, CURR SCI INDIA, V70, P45; Gupta PK, 2002, MOLECULAR TECHNIQUES IN CROP IMPROVEMENT, P9; Gupta PK, 2000, EUPHYTICA, V113, P163, DOI 10.1023/A:1003910819967; Hamwieh A, 2005, THEOR APPL GENET, V110, P669, DOI 10.1007/s00122-004-1892-5; Hamwieh A, 2009, BREEDING SCI, V59, P77, DOI 10.1270/jsbbs.59.77; HEDRICK PW, 1990, HEREDITY, V64, P67, DOI 10.1038/hdy.1990.8; Hong YB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-17; Hwang TY, 2009, DNA RES, V16, P213, DOI 10.1093/dnares/dsp010; Isemura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041304; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Jones ES, 2007, THEOR APPL GENET, V115, P361, DOI 10.1007/s00122-007-0570-9; Kahraman A, 2004, CROP SCI, V44, P5, DOI 10.2135/cropsci2004.0005; Kasha K J, 1970, Nature, V225, P874, DOI 10.1038/225874a0; Kaur S, 2014, THEOR APPL GENET, V127, P703, DOI 10.1007/s00122-013-2252-0; Liu LL, 2012, G3-GENES GENOM GENET, V2, P357, DOI 10.1534/g3.111.001503; MANGIN B, 1994, GENETICS, V138, P1301; Menendez CM, 1997, THEOR APPL GENET, V95, P1210, DOI 10.1007/s001220050683; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Phan HTT, 2007, THEOR APPL GENET, V114, P549, DOI 10.1007/s00122-006-0455-3; Powell W, 1996, TRENDS PLANT SCI, V1, P215, DOI 10.1016/1360-1385(96)86898-1; Quillet MC, 1995, THEOR APPL GENET, V91, P1195, DOI 10.1007/BF00220929; Radhika P, 2007, THEOR APPL GENET, V115, P209, DOI 10.1007/s00122-007-0556-7; Ramsay L, 2000, GENETICS, V156, P1997; Rubeena, 2003, THEOR APPL GENET, V107, P910, DOI 10.1007/s00122-003-1326-9; Saha GC, 2010, CROP SCI, V50, P1831, DOI 10.2135/cropsci2009.12.0709; Saliba-Colombani V, 2000, GENOME, V43, P29, DOI 10.1139/gen-43-1-29; Sharpe AG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-192; Shi TX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054559; Shokeen B, 2011, ANN BOT-LONDON, V108, P321, DOI 10.1093/aob/mcr162; Shrivastava D, 2014, MOL BIOL REP, V41, P5669, DOI 10.1007/s11033-014-3436-7; Sun F, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-42; Sun XL, 2014, CROP J, V2, P170, DOI 10.1016/j.cj.2014.03.004; Sun YN, 2012, MOL BIOL REP, V39, P9435, DOI 10.1007/s11033-012-1808-4; Supriya A, 2011, THEOR APPL GENET, V123, P239, DOI 10.1007/s00122-011-1580-1; Tahir M., 1995, Journal of Genetics and Breeding, V49, P145; TANKSLEY SD, 1992, GENETICS, V132, P1141; Tanyolac B., 2010, J AGR BIOTECHNOL SUS, V2, P1; Tullu A, 2008, CROP SCI, V48, P2254, DOI 10.2135/cropsci2007.11.0628; Van Ooijen JW, 2006, JOINMAP VERSION 4 0; Varshney RK, 2009, CURR OPIN PLANT BIOL, V12, P202, DOI 10.1016/j.pbi.2008.12.004; Verma P, 2014, MOL BIOL REP, V41, P5607, DOI 10.1007/s11033-014-3431-z; Verma P, 2013, PLANT BIOTECHNOL J, V11, P894, DOI 10.1111/pbi.12082; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Yang M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-653; ZAMIR D, 1986, BOT GAZ, V147, P355, DOI 10.1086/337602; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zavodna M, 2000, SEED SCI TECHNOL, V28, P217; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972	71	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139666	10.1371/journal.pone.0139666	http://dx.doi.org/10.1371/journal.pone.0139666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436554	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200045
J	Cao, B; Zhao, B; Wei, QQ; Chen, K; Yang, J; Ou, RW; Wu, Y; Shang, HF				Cao, Bei; Zhao, Bi; Wei, Qian-Qian; Chen, Ke; Yang, Jing; Ou, Ruwei; Wu, Ying; Shang, Hui-Fang			The Global Cognition, Frontal Lobe Dysfunction and Behavior Changes in Chinese Patients with Multiple System Atrophy	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; MILD ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; DIAGNOSTIC-CRITERIA; ASSESSMENT BATTERY; RATING-SCALE; WHITE-MATTER; TASK-FORCE; MSA-C; DEMENTIA	Background Studies on cognition in multiple system atrophy (MSA) patients are limited. Methods A total of 110 MSA patients were evaluated using Addenbrooke's Cognitive Examination-Revised (ACE-R), Frontal Assessment Battery (FAB), Frontal Behavioral Inventory (FBI), and Unified MSA Rating Scale (UMSARS) tests. Fifty-five age-, sex-, education- and domicile-matched healthy controls were recruited to perform the FAB and ACE-R scales. Results Approximately 32.7% of the patients had global cognitive deficits with the most impaired domain being verbal fluency and visuospatial ability (26.4%), followed by memory (24.5%), language (20%) and orientation/attention (20%) based on a cut-off score of ACE-R <= 70. A total of 41.6% of the patients had frontal lobe dysfunction, with inhibitory control (60.9%) as the most impaired domain based on a cut-off score of FAB <= 14. Most patients (57.2%) showed moderate frontal behavior changes (FBI score 4-15), with incontinence (64.5%) as the most impaired domain. The binary logistic regression model revealed that an education level < 9 years (OR:13.312, 95% CI:2.931-60.469, P = 0.001) and UMSARS >= 40 (OR: 2.444, 95% CI: 1.002-5.962, P < 0.049) were potential determinants of abnormal ACE-R, while MSA-C (OR: 4.326, 95%CI: 1.631-11.477, P = 0.003), an education level < 9 years (OR:2.809 95% CI: 1.060-7.444, P = 0.038) and UMSARS >= 40 (OR: 5.396, 95% CI: 2.103-13.846, P < 0.0001) were potential determinants of abnormal FAB. Conclusions Cognitive impairment is common in Chinese MSA patients. MSA-C patients with low education levels and severe motor symptoms are likely to experience frontal lobe dysfunction, while MSA patients with low education levels and severe motor symptoms are likely to experience global cognitive deficits. These findings strongly suggest that cognitive impairment should not be an exclusion criterion for the diagnosis of MSA.	[Cao, Bei; Zhao, Bi; Wei, Qian-Qian; Chen, Ke; Yang, Jing; Ou, Ruwei; Wu, Ying; Shang, Hui-Fang] Sichuan Univ, Dept Neurol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China	Sichuan University	Shang, HF (corresponding author), Sichuan Univ, Dept Neurol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	hfshang2002@163.com			National Science Fund of China [81371394]; National Basic Research Program of China [2015CB856400]; Science and Technology Bureau Fund of Sichuan Province [2014FZ0072]	National Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science and Technology Bureau Fund of Sichuan Province	The present study was supported by the funding of the National Science Fund of China (Grant No. 81371394), supported in part by the National Basic Research Program of China (No: 2015CB856400), and the Science and Technology Bureau Fund of Sichuan Province (2014FZ0072).	Armstrong RA, 2007, NEUROPATHOLOGY, V27, P221, DOI 10.1111/j.1440-1789.2007.00759.x; Bak TH, 2005, J NEUROL NEUROSUR PS, V76, P420, DOI 10.1136/jnnp.2003.029595; Begeti F, 2013, J NEUROL, V260, P2777, DOI 10.1007/s00415-013-7061-5; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Brenneis C, 2007, J NEUROL, V254, P191, DOI 10.1007/s00415-006-0325-6; Brown RG, 2010, BRAIN, V133, P2382, DOI 10.1093/brain/awq158; Carvalho VA, 2010, COGN BEHAV NEUROL, V23, P8, DOI 10.1097/WNN.0b013e3181c5e2e5; Chang CC, 2009, EUR J NEUROL, V16, P1144, DOI 10.1111/j.1468-1331.2009.02661.x; Colosimo C, 2010, J NEUROL, V257, P5, DOI 10.1007/s00415-009-5255-7; Evans D A, 1993, Ann Epidemiol, V3, P71; Fang R, 2014, DEMENT GERIATR COGN, V37, P223, DOI 10.1159/000353541; Geser F, 2006, MOVEMENT DISORD, V21, P179, DOI 10.1002/mds.20678; Ghosh BCP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074486; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Houck BD, 2014, CEREBELLUM, V13, P378, DOI 10.1007/s12311-013-0543-2; Josephs KA, 2011, MOVEMENT DISORD, V26, P493, DOI 10.1002/mds.23471; Kao AW, 2009, ALZ DIS ASSOC DIS, V23, P365, DOI 10.1097/WAD.0b013e3181b5065d; Kaszas B, 2012, PARKINSONISM RELAT D, V18, P553, DOI 10.1016/j.parkreldis.2012.02.010; Kawai Y, 2008, NEUROLOGY, V70, P1390, DOI 10.1212/01.wnl.0000310413.04462.6a; Kawamura K, 2010, MOVEMENT DISORD, V25, P2891, DOI 10.1002/mds.23260; Kawata KHD, 2012, DEMENT GER COGN D EX, V2, P29, DOI 10.1159/000336909; Kemppainen NM, 2008, ANN NEUROL, V63, P112, DOI 10.1002/ana.21212; Kertesz A, 1997, CAN J NEUROL SCI, V24, P29, DOI 10.1017/S0317167100021053; Kim HJ, 2013, PARKINSONISM RELAT D, V19, P617, DOI 10.1016/j.parkreldis.2013.02.012; Komadina NC, 2011, DEMENT GERIATR COGN, V31, P349, DOI 10.1159/000328165; Konagaya M, 1999, ACTA NEUROPATHOL, V97, P423, DOI 10.1007/s004010051008; Kwak YT, 2010, GERIATR GERONTOL INT, V10, P295, DOI 10.1111/j.1447-0594.2010.00624.x; Langenecker SA, 2004, NEUROIMAGE, V21, P192, DOI 10.1016/j.neuroimage.2003.08.027; Law E, 2013, INT J GERIATR PSYCH, V28, P351, DOI 10.1002/gps.3828; Lima C, 2008, J NEUROL, V255, P1756, DOI 10.1007/s00415-008-0024-6; Litvan I, 2011, MOVEMENT DISORD, V26, P1814, DOI 10.1002/mds.23823; Lyoo CH, 2008, BRAIN, V131, P438, DOI 10.1093/brain/awm328; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Siri C, 2013, J NEURAL TRANSM, V120, P613, DOI 10.1007/s00702-013-0997-x; Stankovic I, 2014, MOVEMENT DISORD, V29, P857, DOI 10.1002/mds.25880; Stefanova N, 2009, LANCET NEUROL, V8, P1172, DOI 10.1016/S1474-4422(09)70288-1; Szeto JYY, 2015, PARKINSONISM RELAT D, V21, P31, DOI 10.1016/j.parkreldis.2014.10.020; Wakabayashi K, 1998, J NEUROL SCI, V156, P114, DOI 10.1016/S0022-510X(98)00018-5; Wei QQ, 2015, AMYOTROPH LAT SCL FR, V16, P40, DOI 10.3109/21678421.2014.966311; Wei QQ, 2014, J NEUROL, V261, P2393, DOI 10.1007/s00415-014-7508-3; Wenning GK, 2004, MOVEMENT DISORD, V19, P1391, DOI 10.1002/mds.20255; Yabe I, 2006, J NEUROL SCI, V249, P115, DOI 10.1016/j.jns.2006.05.064	43	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139773	10.1371/journal.pone.0139773	http://dx.doi.org/10.1371/journal.pone.0139773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431430	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700113
J	Rabodoarivelo, MS; Imperiale, B; Andrianiavomikotroka, R; Brandao, A; Kumar, P; Singh, S; Ferrazoli, L; Morcillo, N; Rasolofo, V; Palomino, JC; Vandamme, P; Martin, A				Rabodoarivelo, Marie Sylvianne; Imperiale, Belen; Andrianiavomikotroka, Rina; Brandao, Angela; Kumar, Parveen; Singh, Sarman; Ferrazoli, Lucilaine; Morcillo, Nora; Rasolofo, Voahangy; Palomino, Juan Carlos; Vandamme, Peter; Martin, Anandi			Performance of Four Transport and Storage Systems for Molecular Detection of Multidrug-Resistant Tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MTBDRPLUS ASSAY; DNA; STRAINS; IDENTIFICATION; SPECIMENS; RIFAMPIN; TISSUES; CARDS	Background Detection of drug-resistant tuberculosis is essential for the control of the disease but it is often hampered by the limitation of transport and storage of samples from remote locations to the reference laboratory. We performed a retrospective field study to evaluate the performance of four supports enabling the transport and storage of samples to be used for molecular detection of drug resistance using the GenoType MTBDRplus. Methods Two hundred Mycobacterium tuberculosis strains were selected and spotted on slides, FTA cards, GenoCards, and in ethanol. GenoType MTBDRplus was subsequently performed with the DNA extracted from these supports. Sensitivity and specificity were calculated and compared to the results obtained by drug susceptibility testing. Results For all supports, the overall sensitivity and specificity for detection of resistance to RIF was between 95% and 100%, and for INH between 95% and 98%. Conclusion The four transport and storage supports showed a good sensitivity and specificity for the detection of resistance to RIF and INH in M. tuberculosis strains using the GenoType MTBDRplus. These supports can be maintained at room temperature and could represent an important alternative cost-effective method useful for rapid molecular detection of drug-resistant TB in low-resource settings.	[Rabodoarivelo, Marie Sylvianne; Andrianiavomikotroka, Rina; Rasolofo, Voahangy] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Imperiale, Belen; Morcillo, Nora] Hosp Dr Cetrangolo, Buenos Aires, DF, Argentina; [Brandao, Angela; Ferrazoli, Lucilaine] Inst Adolfo Lutz Nucleo Tuberculose & Micobacteri, Sao Paulo, Brazil; [Kumar, Parveen; Singh, Sarman] All India Inst Med Sci, Div Clin Microbiol & Mol Med, New Delhi, India; [Rabodoarivelo, Marie Sylvianne; Palomino, Juan Carlos; Vandamme, Peter; Martin, Anandi] Univ Ghent, Dept Biochem & Microbiol, Microbiol Lab, B-9000 Ghent, Belgium; [Brandao, Angela] Fundacao Oswaldo Cruz, IOC, Sao Paulo, Brazil	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; All India Institute of Medical Sciences (AIIMS) New Delhi; Ghent University; Fundacao Oswaldo Cruz	Rabodoarivelo, MS (corresponding author), Inst Pasteur Madagascar, Antananarivo, Madagascar.	msylvianne@pasteur.mg	Vandamme, Peter AR/B-7967-2009; Singh, Sarman/AAR-8914-2020; Brandao, Angela Pires/AAG-2758-2020; Ferrazoli, Lucilaine LF/H-6959-2012; Vandamme, Peter/ABG-3431-2021	Vandamme, Peter AR/0000-0002-5581-7937; Singh, Sarman/0000-0002-0749-9647; Ferrazoli, Lucilaine LF/0000-0002-5389-7056; Vandamme, Peter/0000-0002-5581-7937; Rabodoarivelo, Marie Sylvianne/0000-0002-4630-5446; Rabodoarivelo, Marie Sylvianne/0000-0002-0054-8143	Damien Foundation, Brussels, Belgium	Damien Foundation, Brussels, Belgium	This study was supported by the Damien Foundation, Brussels, Belgium. Belen Imperiale is a fellow of "Consejo Nacional de Investigaciones Cientificas y Tecnicas" (CONICET), Argentina.	Al-Mutairi NM, 2011, INT J TUBERC LUNG D, V15, P110; CANETTI G, 1963, B WORLD HEALTH ORGAN, V29, P565; Cauwelaert ND, 2011, J CLIN MICROBIOL, V49, P3600, DOI 10.1128/JCM.00745-11; Gitti Z, 2011, FUTURE MICROBIOL, V6, P357, DOI [10.2217/fmb.11.8, 10.2217/FMB.11.8]; Guio H, 2006, INT J TUBERC LUNG D, V10, P906; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Jin J, 2012, INT J TUBERC LUNG D, V16, P521, DOI 10.5588/ijtld.11.0269; Kumar Parveen, 2013, Indian J Tuberc, V60, P142; Miotto P, 2008, NEW MICROBIOL, V31, P147; Montenegro SH, 2003, CLIN INFECT DIS, V36, P16, DOI 10.1086/344900; Palomino JC, 2009, FEMS IMMUNOL MED MIC, V56, P103, DOI 10.1111/j.1574-695X.2009.00555.x; Prado I, 2005, J VIROL METHODS, V125, P75, DOI 10.1016/j.jviromet.2005.01.001; Qian LS, 1999, J CLIN MICROBIOL, V37, P471, DOI 10.1128/JCM.37.2.471-474.1999; Rajendram D, 2006, J MICROBIOL METH, V67, P582, DOI 10.1016/j.mimet.2006.05.010; Tortoli E, 2008, NEW MICROBIOL, V31, P151; van der Zanden AGM, 1998, J CLIN PATHOL-MOL PA, V51, P209, DOI 10.1136/mp.51.4.209; Van Der Zanden AGM, 2003, J CLIN MICROBIOL, V41, P1101, DOI 10.1128/JCM.41.3.1101-1108.2003; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; WHO, GLOB TUB REP 2014	19	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139382	10.1371/journal.pone.0139382	http://dx.doi.org/10.1371/journal.pone.0139382			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431352	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700049
J	Sousa-Rocha, D; Thomaz-Tobias, M; Diniz, LFA; Souza, PSS; Pinge, P; Toledo, KA				Sousa-Rocha, Daniel; Thomaz-Tobias, Mariana; Alves Diniz, Larissa Figueiredo; Sampaio Souza, Priscila Silva; Pinge-Filho, Phileno; Toledo, Karina Alves			Trypanosoma cruzi and Its Soluble Antigens Induce NET Release by Stimulating Toll-Like Receptors	PLOS ONE			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; NONTYPABLE HAEMOPHILUS-INFLUENZAE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS; INNATE IMMUNITY; CHROMATIN; EXPRESSION; RESISTANCE	Neutrophils release fibrous traps of DNA, histones, and granule proteins known as neutrophil extracellular traps (NETs), which contribute to microbicidal killing and have been implicated in autoimmunity. The role of NET formation in the host response to nonbacterial pathogens is not well-understood. In this study, we investigated the release of NETs by human neutrophils upon their interaction with Trypanosoma cruzi (Y strain) parasites. Our results showed that human neutrophils stimulated by T. cruzi generate NETs composed of DNA, histones, and elastase. The release occurred in a dose-, time-, and reactive oxygen species-dependent manner to decrease trypomastigote and increase amastigote numbers of the parasites without affecting their viability. NET release was decreased upon blocking with antibodies against Toll-like receptors 2 and 4. In addition, living parasites were not mandatory in the release of NETs induced by T. cruzi, as the same results were obtained when molecules from its soluble extract were tested. Our results increase the understanding of the stimulation of NETs by parasites, particularly T. cruzi. We suggest that contact of T. cruzi with NETs during Chagas's disease can limit infection by affecting the infectivity/pathogenicity of the parasite.	[Sousa-Rocha, Daniel; Thomaz-Tobias, Mariana; Alves Diniz, Larissa Figueiredo; Sampaio Souza, Priscila Silva; Toledo, Karina Alves] Univ Estadual Paulista UNESP FCL Assis, Dept Biol Sci, Assis, Sao Paulo, Brazil; [Pinge-Filho, Phileno] Univ Estadual Londrina, Dept Ciencias Patol, Ctr Ciencias Biol, Londrina, Parana, Brazil	Universidade Estadual de Londrina	Toledo, KA (corresponding author), Univ Estadual Paulista UNESP FCL Assis, Dept Biol Sci, Assis, Sao Paulo, Brazil.	karinafcla@gmail.com	Pinge-Filho, Phileno/G-2844-2012; Toledo, Karina Alves/C-9452-2012	Toledo, Karina Alves/0000-0001-7212-6794	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/01522-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Grant 2012/01522-8) to KAT.	Abi Abdallah DS, INFECTION AND IMMUNI, DOI [10.1128/IAI.05730-11, DOI 10.1128/IAI.05730-11]; Almeida IC, 2001, J LEUKOCYTE BIOL, V70, P467; Barrientos L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00166; Bianchi M, 2009, BLOOD, V114, P2619, DOI 10.1182/blood-2009-05-221606; Bonney KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014571; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2012, J CELL BIOL, V198, P773, DOI 10.1083/jcb.201203170; Campos MA, 2001, J IMMUNOL, V167, P416, DOI 10.4049/jimmunol.167.1.416; Douda DN, 2015, P NATL ACAD SCI USA, V112, P2817, DOI 10.1073/pnas.1414055112; Ermert D, 2009, J INNATE IMMUN, V1, P181, DOI 10.1159/000205281; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabriel C, 2010, J IMMUNOL, V185, P4319, DOI 10.4049/jimmunol.1000893; Guimaraes-Costa AB, 2009, P NATL ACAD SCI USA, V106, P6748, DOI 10.1073/pnas.0900226106; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; Hermosilla C, 2014, PARASITOLOGY, V141, P1489, DOI 10.1017/S0031182014000316; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Kabeya Luciana M., 2002, Research Communications in Molecular Pathology and Pharmacology, V111, P103; Kamoshida G, 2015, J INFECT CHEMOTHER, V21, P43, DOI 10.1016/j.jiac.2014.08.032; Kayama H, MICROBES AND INFECTI, V12, P511, DOI [10.1016/j.micinf.2010.03.005, DOI 10.1016/J.MICINF.2010.03.005]; Kirchner T., 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/849136; KRETTLI AU, 1982, J IMMUNOL, V128, P2009; Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; LUCISANO YM, 1984, J IMMUNOL, V132, P2015; Menegazzi R, 2012, BLOOD, V119, P1214, DOI 10.1182/blood-2011-07-364604; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Neeli I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00038; Osorio L, 2012, MICROBES INFECT, V14, P1390, DOI 10.1016/j.micinf.2012.09.003; Parker LC, 2005, J LEUKOCYTE BIOL, V77, P886, DOI 10.1189/jlb.1104636; Perez-Molina JA, 2012, CURR INFECT DIS REP, V14, P263, DOI 10.1007/s11908-012-0259-3; Rocha JDB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08008; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Seper A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003614; Shoda LKM, 2001, INFECT IMMUN, V69, P2162, DOI 10.1128/IAI.69.4.2162-2171.2001; Boari JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002658; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; VILLALTA F, 1984, BIOCHEM BIOPH RES CO, V119, P228, DOI 10.1016/0006-291X(84)91642-5; von Kockritz-Blickwede M, 2009, BLOOD, V114, P5245, DOI 10.1182/blood-2009-08-240713; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; Wieland CW, 2005, J IMMUNOL, V175, P6042, DOI 10.4049/jimmunol.175.9.6042	41	47	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139569	10.1371/journal.pone.0139569	http://dx.doi.org/10.1371/journal.pone.0139569			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431537	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700079
J	Stromdahl, S; Lu, X; Bengtsson, L; Liljeros, F; Thorson, A				Stromdahl, Susanne; Lu, Xin; Bengtsson, Linus; Liljeros, Fredrik; Thorson, Anna			Implementation of Web-Based Respondent Driven Sampling among Men Who Have Sex with Men in Sweden	PLOS ONE			English	Article							NONRESPONSE; RISK	Background Respondent driven sampling (RDS) was designed to study 'hidden' populations, for which there are no available sampling frame. RDS has been shown to recruit far into social networks of the study population and achieve unbiased estimates when certain assumptions are fulfilled. Web-based respondent driven sampling (WebRDS) has been implemented among MSM in Vietnam and produced a sufficient sample of MSM. In order to see if WebRDS could work in a 'hidden' population in a high-income setting, we performed a WebRDS among MSM in Sweden to study a sensitive topic, sexual risk behaviour for HIV/STI and Internet use. Methods A cross-sectional survey was implemented between July 11, 2012 and January 21, 2013 by using a WebRDS software. Men, fifteen years old or above, who reported having ever had sex with another man were included. The web-survey explored sociodemographics, sexual risk behaviour for HIV/STI and Internet use. Results The WebRDS process created a sample of 123 eligible respondents. The mean age among participants was 32 years old. All respondents reported having had unprotected anal intercourse (UAI) with at least one regular and one casual sex partner during the last 12 months. On average participants reported having had UAI with three casual sexual partners and in total having had seven casual sex partners during the last 12 months. Conclusion The WebRDS produced a sample of Internet-using MSM in Sweden who all reported sexual risk behaviour for HIV/STI during the last 12 months. It holds promise for future online studies among MSM and a possibility to reach MSM at risk for HIV/STI with interventions or information. Some challenges were found including short recruitment chains, and further research need to address how to optimize WebRDS online recruitment methods in high income settings.	[Stromdahl, Susanne; Lu, Xin; Bengtsson, Linus; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lu, Xin] Natl Univ Def Technol, Coll Informat Syst & Management, Changsha, Hunan, Peoples R China; [Liljeros, Fredrik] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden	Karolinska Institutet; National University of Defense Technology - China; Stockholm University	Stromdahl, S (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	susanne.stromdahl@ki.se	lu, xin/C-1940-2009; Liljeros, Fredrik G I/I-2667-2018	lu, xin/0000-0002-3547-6493; Liljeros, Fredrik G I/0000-0001-8642-6624; Thorson, Anna/0000-0002-8703-6561; Stromdahl, Susanne/0000-0002-6706-0177	Swedish Research Council; Swedish Institute for Infectious Disease Control	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute for Infectious Disease Control	The Swedish Research Council (vr.se) and The Swedish Institute for Infectious Disease Control (www.folkhalsomyndigheten.se) have financed the programming of the RDS web-survey system and the technical implementation of the survey among MSM in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A-LsB si, 2005, NATURE, V435; Babbie E., 2010, PRACTICE SOCIAL RES, V10th; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Bengtsson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049417; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2011, SOCIOL METHODOL, V41, P355, DOI 10.1111/j.1467-9531.2011.01244.x; Hill A, 1997, J PUBLIC HEALTH MED, V19, P203, DOI 10.1093/oxfordjournals.pubmed.a024610; Jakopanec I, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-261; Johnston LG, 2013, AIDS BEHAV, V17, P2202, DOI 10.1007/s10461-012-0394-8; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2012, EPIDEMIOLOGY, V23, P148, DOI 10.1097/EDE.0b013e31823b6979; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113711; Stein ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085256; Sullivan PS, 2014, CURR OPIN HIV AIDS, V9, P199, DOI 10.1097/COH.0000000000000039; Sweden S., 2014, USE COMPUTERS INTERN; Sweden's Public Health Institute / Statens Folkhalsoinstitut, 2009, NAT PUBL HLTH SURV H; Swedish Institute for Infectious Disease Control (SMI), 2013, EMIS 2010 SVER; Tikkanen RH, 2010, MSM ENKATEN 2008 RIS; Tikkanen RH, 2008, MSM ENKATEN 2006 PER; Van Loon AJM, 2003, ANN EPIDEMIOL, V13, P105, DOI 10.1016/S1047-2797(02)00257-0; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; White RG, 2015, J CLIN EPIDEMIOL, V68, P1463, DOI 10.1016/j.jclinepi.2015.04.002	29	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138599	10.1371/journal.pone.0138599	http://dx.doi.org/10.1371/journal.pone.0138599			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426802	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100016
J	Chivese, T; Esterhuizen, TM; Basson, AR				Chivese, Tawanda; Esterhuizen, Tonya M.; Basson, Abigail Raffner			The Influence of Second-Hand Cigarette Smoke Exposure during Childhood and Active Cigarette Smoking on Crohn's Disease Phenotype Defined by the Montreal Classification Scheme in a Western Cape Population, South Africa	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; PASSIVE SMOKING; RISK-FACTORS; ENVIRONMENTAL-FACTORS; JEWISH PATIENTS; ASSOCIATION; GENE; LOCATION; BEHAVIOR; IBD	Background Smoking may worsen the disease outcomes in patients with Crohn's disease (CD), however the effect of exposure to second-hand cigarette smoke during childhood is unclear. In South Africa, no such literature exists. The aim of this study was to investigate whether disease phenotype, at time of diagnosis of CD, was associated with exposure to second-hand cigarette during childhood and active cigarette smoking habits. Methods A cross sectional examination of all consecutive CD patients seen during the period September 2011-January 2013 at 2 large inflammatory bowel disease centers in the Western Cape, South Africa was performed. Data were collected via review of patient case notes, interviewer-administered questionnaire and clinical examination by the attending gastroenterologist. Disease phenotype (behavior and location) was evaluated at time of diagnosis, according to the Montreal Classification scheme. In addition, disease behavior was stratified as 'complicated' or 'uncomplicated', using predefined definitions. Passive cigarette smoke exposure was evaluated during 3 age intervals: 0-5, 6-10, and 11-18 years. Results One hundred and ninety four CD patients were identified. Cigarette smoking during the 6 months prior to, or at time of diagnosis was significantly associated with ileo-colonic (L3) disease (RRR = 3.63; 95% CI, 1.32-9.98, p = 0.012) and ileal (L1) disease (RRR = 3.54; 95% CI, 1.06-11.83, p = 0.040) compared with colonic disease. In smokers, childhood passive cigarette smoke exposure during the 0-5 years age interval was significantly associated with ileo-colonic CD location (RRR = 21.3; 95% CI, 1.16-391.55, p = 0.040). No significant association between smoking habits and disease behavior at diagnosis, whether defined by the Montreal scheme, or stratified as 'complicated' vs 'uncomplicated', was observed. Conclusion Smoking habits were associated with ileo-colonic (L3) and ileal (L1) disease at time of diagnosis in a South African cohort.	[Chivese, Tawanda] Univ Stellenbosch, Dept Interdisciplinary Hlth Sci, Community Hlth Div, Cape Town, South Africa; [Esterhuizen, Tonya M.] Univ Stellenbosch, Dept Interdisciplinary Hlth Sci, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Basson, Abigail Raffner] Univ Western Cape, Dept Dietet, Cape Town, South Africa	Stellenbosch University; Stellenbosch University; University of the Western Cape	Chivese, T (corresponding author), Univ Stellenbosch, Dept Interdisciplinary Hlth Sci, Community Hlth Div, Cape Town, South Africa.	tchivese@gmail.com	Chivese, Tawanda/AAU-3287-2021	Chivese, Tawanda/0000-0001-6621-6144; Basson, Abigail/0000-0002-8369-919X	AstraZeneca/South African Gastroenterology Society (SAGES)	AstraZeneca/South African Gastroenterology Society (SAGES)	This study was supported by Scholarship in Gastroenterology; a grant from the AstraZeneca/South African Gastroenterology Society (SAGES) recipient ARB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Aldhous MC, 2010, FRONTLINE GASTROENTE, V1, P156, DOI 10.1136/fg.2010.001487; [Anonymous], 2005, GUT; [Anonymous], 2006, MAYO CLIN P; [Anonymous], 1997, GASTROENTEROLOGY; Aspberg S, 2006, ACTA PAEDIATR, V95, P1001, DOI 10.1080/08035250600573151; Basson A, 2014, ASS RACE CROHNS DIS; Basson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115492; BENONI C, 1990, SCAND J GASTROENTERO, V25, P751, DOI 10.3109/00365529008997603; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P993, DOI 10.1111/j.1572-0241.2006.00381.x; Bhat M, 2009, AM J GASTROENTEROL, V104, P2233, DOI 10.1038/ajg.2009.267; Brant SR, 2007, AM J GASTROENTEROL, V102, P313, DOI 10.1111/j.1572-0241.2006.00926.x; Bridger S, 2002, GUT, V51, P21, DOI 10.1136/gut.51.1.21; Chatzicostas C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-21; Cosnes J, 1996, GASTROENTEROLOGY, V110, P424, DOI 10.1053/gast.1996.v110.pm8566589; Eliakim R, 2002, EUR J GASTROEN HEPAT, V14, P607, DOI 10.1097/00042737-200206000-00005; Fich A, 1997, INFLAMM BOWEL DIS, V3, P6, DOI 10.1002/ibd.3780030103; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Halfvarson J, 2006, INFLAMM BOWEL DIS, V12, P925, DOI 10.1097/01.mib.0000228998.29466.ac; Han DY, 2010, MUTAT RES-FUND MOL M, V690, P116, DOI 10.1016/j.mrfmmm.2009.09.002; Jones DT, 2008, AM J GASTROENTEROL, V103, P2382, DOI 10.1111/j.1572-0241.2008.01999.x; LASHNER BA, 1993, AM J GASTROENTEROL, V88, P356; Leong RWL, 2006, AM J GASTROENTEROL, V101, P1024, DOI 10.1111/j.1572-0241.2006.00503.x; Leong RWL, 2003, ALIMENT PHARM THER, V17, P1465, DOI 10.1046/j.1365-2036.2003.01607.x; LINDBERG E, 1992, GUT, V33, P779, DOI 10.1136/gut.33.6.779; Louis E, 2003, GUT, V52, P552, DOI 10.1136/gut.52.4.552; Mahid SS, 2007, DIGEST DIS SCI, V52, P2897, DOI 10.1007/s10620-006-9624-0; Mahid SS, 2007, INFLAMM BOWEL DIS, V13, P431, DOI 10.1002/ibd.20070; Mwantembe O, 2001, IMMUNOGENETICS, V52, P249; Nunes T, 2013, ALIMENT PHARM THER, V38, P752, DOI 10.1111/apt.12440; Picco MF, 2003, AM J GASTROENTEROL, V98, P363, DOI 10.1016/S0002-9270(02)05908-7; Prideaux L, 2012, J GASTROEN HEPATOL, V27, P1266, DOI 10.1111/j.1440-1746.2012.07150.x; REIF S, 1995, GASTROENTEROLOGY, V108, P1683, DOI 10.1016/0016-5085(95)90129-9; Reif S, 2000, AM J GASTROENTEROL, V95, P474; Russel MGVM, 1998, INFLAMM BOWEL DIS, V4, P182, DOI 10.1097/00054725-199808000-00002; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Scarpa M, 2012, INFLAMM BOWEL DIS, V18, P1982, DOI 10.1002/ibd.22934; Smith BRK, 2004, INFLAMM BOWEL DIS, V10, P521, DOI 10.1097/00054725-200409000-00005; Statistics South Africa, 2012, CENS 2011 STAT REL R; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; TOBIN MV, 1987, GASTROENTEROLOGY, V93, P316, DOI 10.1016/0016-5085(87)91021-3; van der Heide F, 2009, INFLAMM BOWEL DIS, V15, P1199, DOI 10.1002/ibd.20884; Zaahl MG, 2005, MOL CELL PROBE, V19, P278, DOI 10.1016/j.mcp.2005.03.001; Zaahl MG, 2006, INT J COLORECTAL DIS, V21, P402, DOI 10.1007/s00384-005-0019-z	45	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139597	10.1371/journal.pone.0139597	http://dx.doi.org/10.1371/journal.pone.0139597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422615	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700132
J	Cheng, SL; Wiklund, P; Autio, R; Borra, R; Ojanen, XW; Xu, LT; Tormakangas, T; Alen, M				Cheng, Sulin; Wiklund, Petri; Autio, Reija; Borra, Ronald; Ojanen, Xiaowei; Xu, Leiting; Tormakangas, Timo; Alen, Markku			Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							MUSCLE INSULIN-RESISTANCE; HEPATIC STEATOSIS; SKELETAL-MUSCLE; BODY-COMPOSITION; PATHOGENESIS; INFLAMMATION; OVERWEIGHT; PROFILES; BENIGN; WOMEN	Background Fatty liver is a major cause of obesity-related morbidity and mortality. The aim of this study was to identify early metabolic alterations associated with liver fat accumulation in 50- to 55-year-old men (n = 49) and women (n = 52) with and without NAFLD. Methods Hepatic fat content was measured using proton magnetic resonance spectroscopy (H-1 MRS). Serum samples were analyzed using a nuclear magnetic resonance (NMR) metabolomics platform. Global gene expression profiles of adipose tissues and skeletal muscle were analyzed using Affymetrix microarrays and quantitative PCR. Muscle protein expression was analyzed by Western blot. Results Increased branched-chain amino acid (BCAA), aromatic amino acid (AAA) and orosomucoid were associated with liver fat accumulation already in its early stage, independent of sex, obesity or insulin resistance (p<0.05 for all). Significant down-regulation of BCAA catabolism and fatty acid and energy metabolism was observed in the adipose tissue of the NAFLD group (p<0.001 for all), whereas no aberrant gene expression in the skeletal muscle was found. Reduced BCAA catabolic activity was inversely associated with serum BCAA and liver fat content (p<0.05 for all). Conclusions Liver fat accumulation, already in its early stage, is associated with increased serum branched-chain and aromatic amino acids. The observed associations of decreased BCAA catabolism activity, mitochondrial energy metabolism and serum BCAA concentration with liver fat content suggest that adipose tissue dysfunction may have a key role in the systemic nature of NAFLD pathogenesis.	[Cheng, Sulin; Xu, Leiting] Shanghai Jiao Tong Univ, Exercise Hlth & Technol Ctr, Shanghai 200030, Peoples R China; [Cheng, Sulin; Wiklund, Petri; Tormakangas, Timo; Alen, Markku] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Autio, Reija] Tampere Univ Technol, Dept Signal Proc, FIN-33101 Tampere, Finland; [Borra, Ronald] Univ Turku, Dept Diagnost Radiol, Turku, Finland; [Borra, Ronald] Turku Univ Hosp, FIN-20520 Turku, Finland; [Ojanen, Xiaowei] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Xu, Leiting] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Alen, Markku] Oulu Univ Hosp, Dept Rehabil Med, Oulu, Finland; [Autio, Reija] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	Shanghai Jiao Tong University; University of Jyvaskyla; Tampere University; University of Turku; University of Turku; University of Eastern Finland; Ningbo University; University of Oulu; Tampere University	Cheng, SL (corresponding author), Shanghai Jiao Tong Univ, Exercise Hlth & Technol Ctr, Shanghai 200030, Peoples R China.	sulin.cheng@sjtu.edu.cn		Borra, Ronald/0000-0001-8072-1243; Autio, Reija/0000-0002-6519-2715; Tormakangas, Timo/0000-0001-7268-5297	academy of Finland SKID-KIDS program [135038]; Shanghai Jiao Tong University Zhiyuan Foundation [CP2014013]; China State Sport General Adiministration [2013B040]; EVO research grants from Oulu University Hospital	academy of Finland SKID-KIDS program; Shanghai Jiao Tong University Zhiyuan Foundation; China State Sport General Adiministration; EVO research grants from Oulu University Hospital	The study funding is supported by various sources: The academy of Finland SKID-KIDS program (No. 135038); Shanghai Jiao Tong University Zhiyuan Foundation (CP2014013); China State Sport General Adiministration (No: 2013B040); and EVO research grants 2012/2013 from Oulu University Hospital.	Argiles JM, 2005, MED RES REV, V25, P49, DOI 10.1002/med.20010; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beyoglu D, 2013, J HEPATOL, V59, P842, DOI 10.1016/j.jhep.2013.05.030; Borra RJH, 2009, RADIOLOGY, V250, P130, DOI 10.1148/radiol.2501071934; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; Burrill JS, 2015, MOL ENDOCRINOL, V29, P411, DOI 10.1210/me.2014-1275; Cano A, 2014, BIOCHEM SOC T, V42, P1447, DOI 10.1042/BST20140138; Charakida M, 2013, EUR HEART J, V34, P314, DOI 10.1093/eurheartj/ehs429; Chen GZ, 2015, AM J PHYSIOL-ENDOC M, V308, pE97, DOI 10.1152/ajpendo.00366.2014; Cheng S, 2005, AM J CLIN NUTR, V82, P1115, DOI 10.1093/ajcn/82.5.1115; Cheng SL, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-5; Choi ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110680; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Flannery C, 2012, DIABETES, V61, P2711, DOI 10.2337/db12-0206; Furuyama JK, 2014, NMR BIOMED, V27, P1176, DOI 10.1002/nbm.3171; Gastaldelli A, 2010, DIGEST LIVER DIS, V42, P310, DOI 10.1016/j.dld.2010.01.013; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Hyysalo J, 2014, DIABETES, V63, P312, DOI 10.2337/db13-0774; Iwasa M, 2015, OBES RES CLIN PRACT; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Lake AD, 2015, AMINO ACIDS, V47, P603, DOI 10.1007/s00726-014-1894-9; Lehmann R, 2013, DIABETES CARE, V36, P2331, DOI 10.2337/dc12-1760; Libreros S, 2012, INT J CANCER, V131, P377, DOI 10.1002/ijc.26379; Liu WY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-48; Lu CY, 2012, J CLIN ENDOCR METAB, V97, P4106, DOI 10.1210/jc.2012-2045; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; Masoodi M, 2014, BIOCHIM BIOPHYS ACTA, V1851, P503, DOI DOI 10.1016/J.BBALIP.2014.09.023; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munukka E, 2014, J HEPATOL, V61, P132, DOI 10.1016/j.jhep.2014.02.020; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Rodriguez-Gallego E, 2015, INT J OBESITY, V39, P279, DOI 10.1038/ijo.2014.53; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Smith BW, 2011, CRIT REV CL LAB SCI, V48, P97, DOI 10.3109/10408363.2011.596521; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Stefan N, 2011, DIABETES, V60, P2011, DOI 10.2337/db11-0231; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Sunny NE, 2015, AM J PHYSL ENDOCRINO; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Szendroedi J, 2014, DIABETES CARE, V37, P468, DOI 10.2337/dc13-1359; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Tsochatzis EA, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/831670; Volgyi E, 2010, J BONE MINER RES, V25, P1034, DOI 10.1359/jbmr.091115; Wang Q, 2011, J BONE MINER RES, V26, P934, DOI 10.1002/jbmr.291; Wiklund PK, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-40; Wurtz P, 2012, DIABETES, V61, P1372, DOI 10.2337/db11-1355; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4	55	53	60	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138889	10.1371/journal.pone.0138889	http://dx.doi.org/10.1371/journal.pone.0138889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439744	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300007
J	Chevalier, N; Kurth, S; Doucette, MR; Wiseheart, M; Deoni, SCL; Dean, DC; O'Muircheartaigh, J; Blackwell, KA; Munakata, Y; LeBourgeois, MK				Chevalier, Nicolas; Kurth, Salome; Doucette, Margaret Rae; Wiseheart, Melody; Deoni, Sean C. L.; Dean, Douglas C., III; O'Muircheartaigh, Jonathan; Blackwell, Katharine A.; Munakata, Yuko; LeBourgeois, Monique K.			Myelination Is Associated with Processing Speed in Early Childhood: Preliminary Insights	PLOS ONE			English	Article							WHITE-MATTER MATURATION; WORKING-MEMORY; MAGNETIC-RESONANCE; INDIVIDUAL-DIFFERENCES; STRUCTURAL CONNECTIVITY; COGNITIVE PERFORMANCE; FLUID INTELLIGENCE; EXECUTIVE FUNCTION; HUMAN BRAIN; CHILDREN	Processing speed is an important contributor to working memory performance and fluid intelligence in young children. Myelinated white matter plays a central role in brain messaging, and likely mediates processing speed, but little is known about the relationship between myelination and processing speed in young children. In the present study, processing speed was measured through inspection times, and myelin volume fraction (VFM) was quantified using a multicomponent magnetic resonance imaging (MRI) approach in 2- to 5-years of age. Both inspection times and VFM were found to increase with age. Greater VFM in the right and left occipital lobes, the body of the corpus callosum, and the right cerebellum was significantly associated with shorter inspection times, after controlling for age. A hierarchical regression showed that VFM in the left occipital lobe predicted inspection times over and beyond the effects of age and the VFM in the other brain regions. These findings are consistent with the hypothesis that myelin supports processing speed in early childhood.	[Chevalier, Nicolas] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Kurth, Salome; Doucette, Margaret Rae; LeBourgeois, Monique K.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Wiseheart, Melody] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada; [Deoni, Sean C. L.; Dean, Douglas C., III] Brown Univ, Sch Engn, Providence, RI 02912 USA; [O'Muircheartaigh, Jonathan] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Blackwell, Katharine A.] Salem Coll, Dept Psychol, Winston Salem, NC USA; [Munakata, Yuko] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA	University of Edinburgh; University of Colorado System; University of Colorado Boulder; York University - Canada; Brown University; University of London; King's College London; University of Colorado System; University of Colorado Boulder	Chevalier, N (corresponding author), Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland.	nicolas.chevalier@ed.ac.uk	Kurth, Salome/M-4227-2017; Kurth, Salome/AAS-8067-2021	Kurth, Salome/0000-0003-1432-4367; Kurth, Salome/0000-0003-1432-4367; MUNAKATA, YUKO/0000-0001-8192-5379; O'Muircheartaigh, Jonathan/0000-0002-8033-6959	National Institutes of Health (NIH) [MH086566]; Intermountain Neuroimaging Consortium pilot grant; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086566] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intermountain Neuroimaging Consortium pilot grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding was provided by National Institutes of Health (NIH) grant MH086566 to MKL, and an Intermountain Neuroimaging Consortium pilot grant awarded to MKL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burgmans S, 2011, NEUROIMAGE, V55, P1287, DOI 10.1016/j.neuroimage.2011.01.002; Burns NR, 2005, PERS INDIV DIFFER, V39, P439, DOI 10.1016/j.paid.2005.01.022; Carlson SA, 2005, DEV NEUROPSYCHOL, V28, P595, DOI 10.1207/s15326942dn2802_3; Cepeda NJ, 2013, DEVELOPMENTAL SCI, V16, P269, DOI 10.1111/desc.12024; Clark CAC, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00107; Dean DC, 2014, PEDIATR RADIOL, V44, P64, DOI 10.1007/s00247-013-2752-8; Deoni SCL, 2015, MAGN RESON MED, V73, P161, DOI 10.1002/mrm.25108; Deoni SCL, 2013, MAGN RESON MED, V70, P147, DOI 10.1002/mrm.24429; Deoni SCL, 2012, NEUROIMAGE, V63, P1038, DOI 10.1016/j.neuroimage.2012.07.037; Deoni SCL, 2011, J NEUROSCI, V31, P784, DOI 10.1523/JNEUROSCI.2106-10.2011; Deoni SCL, 2011, MAGN RESON MED, V65, P1021, DOI 10.1002/mrm.22685; Dockstader C, 2012, HUM BRAIN MAPP, V33, P179, DOI 10.1002/hbm.21203; Ferrer E, 2013, DEVELOPMENTAL SCI, V16, P941, DOI 10.1111/desc.12088; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Forn C, 2013, BRAIN COGNITION, V82, P152, DOI 10.1016/j.bandc.2013.04.003; Fry AF, 2000, BIOL PSYCHOL, V54, P1, DOI 10.1016/S0301-0511(00)00051-X; Fry AF, 1996, PSYCHOL SCI, V7, P237, DOI 10.1111/j.1467-9280.1996.tb00366.x; Garon N, 2008, PSYCHOL BULL, V134, P31, DOI 10.1037/0033-2909.134.1.31; Jarrold C, 2014, LEARN INDIVID DIFFER, V30, P92, DOI 10.1016/j.lindif.2013.10.016; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kail R, 2000, J SCHOOL PSYCHOL, V38, P51, DOI 10.1016/S0022-4405(99)00036-9; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kochunov P, 2012, NEUROBIOL AGING, V33, P9, DOI 10.1016/j.neurobiolaging.2010.01.014; Leipsic P. F. O., 1901, LANCET, V158, P1027, DOI [10.1016/S0140-6736(01)01429-5, DOI 10.1016/S0140-6736(01)01429-5]; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Liston C, 2006, CEREB CORTEX, V16, P553, DOI 10.1093/cercor/bhj003; Mabbott DJ, 2006, NEUROIMAGE, V33, P936, DOI 10.1016/j.neuroimage.2006.07.024; MACKAY A, 1994, MAGNET RESON MED, V31, P673, DOI 10.1002/mrm.1910310614; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McAuley T, 2010, J EXP CHILD PSYCHOL, P1; Mullen EM, 1995, CIRCLE PINES; Nagy Z, 2004, J COGNITIVE NEUROSCI, V16, P1227, DOI 10.1162/0898929041920441; Nettelbeck T, 2010, PERS INDIV DIFFER, V48, P379, DOI 10.1016/j.paid.2009.10.032; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Muircheartaigh J, 2014, HUM BRAIN MAPP, V35, P4475, DOI 10.1002/hbm.22488; O'Muircheartaigh J, 2013, J NEUROSCI, V33, P16170, DOI 10.1523/JNEUROSCI.1463-13.2013; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Peters BD, 2014, BIOL PSYCHIAT, V75, P248, DOI 10.1016/j.biopsych.2013.05.020; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Scantlebury N, 2014, J INT NEUROPSYCH SOC, V20, P99, DOI 10.1017/S1355617713001148; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spitz G, 2013, BRAIN COGNITION, V83, P34, DOI 10.1016/j.bandc.2013.06.007; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Van Beek L, 2014, NEUROIMAGE, V90, P117, DOI 10.1016/j.neuroimage.2013.12.030; Vestergaard M, 2011, J COGNITIVE NEUROSCI, V23, P2135, DOI 10.1162/jocn.2010.21592; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Yakovlev PI, 1967, MYELOGENETIC CYCLES; Zhang HB, 2011, DEMENT GERIATR COGN, V32, P216, DOI 10.1159/000333372	54	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139897	10.1371/journal.pone.0139897	http://dx.doi.org/10.1371/journal.pone.0139897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0TP	26440654	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300072
J	Chu, H; Lee, D; Cho, KH				Chu, Hyunho; Lee, Daewon; Cho, Kwang-Hyun			Precritical State Transition Dynamics in the Attractor Landscape of a Molecular Interaction Network Underlying Colorectal Tumorigenesis	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; CELL-CYCLE; CANCER; MUTATIONS; APOPTOSIS; HALLMARKS; CHANCE; DRIVER; NOISE; MODEL	From the perspective of systems science, tumorigenesis can be hypothesized as a critical transition (an abrupt shift from one state to another) between proliferative and apoptotic attractors on the state space of a molecular interaction network, for which an attractor is defined as a stable state to which all initial states ultimately converge, and the region of convergence is called the basin of attraction. Before the critical transition, a cellular state might transit between the basin of attraction for an apoptotic attractor and that for a proliferative attractor due to the noise induced by the inherent stochasticity in molecular interactions. Such a flickering state transition (state transition between the basins of attraction for alternative attractors from the impact of noise) would become more frequent as the cellular state approaches near the boundary of the basin of attraction, which can increase the variation in the estimate of the respective basin size. To investigate this for colorectal tumorigenesis, we have constructed a stochastic Boolean network model of the molecular interaction network that contains an important set of proteins known to be involved in cancer. In particular, we considered 100 representative sequences of 20 gene mutations that drive colorectal tumorigenesis. We investigated the appearance of cancerous cells by examining the basin size of apoptotic, quiescent, and proliferative attractors along with the sequential accumulation of gene mutations during colorectal tumorigenesis. We introduced a measure to detect the flickering state transition as the variation in the estimate of the basin sizes for three-phenotype attractors from the impact of noise. Interestingly, we found that this measure abruptly increases before a cell becomes cancerous during colorectal tumorigenesis in most of the gene mutation sequences under a certain level of stochastic noise. This suggests that a frequent flickering state transition can be a precritical phenomenon of colorectal tumorigenesis.	[Chu, Hyunho; Lee, Daewon; Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Cho, KH (corresponding author), Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea.	ckh@kaist.ac.kr	Cho, Kwang-Hyun/C-1684-2011	Lee, Daewon/0000-0002-3004-2901	Ministry of Science, ICT and Future Planning [2014R1A2A1A10052404, 2013M3A9A7046303]; Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C2162]; GIST Systems Biology Infrastructure Establishment Grant; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning; National Research Foundation of Korea (NRF) grants - Korea Government	Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; GIST Systems Biology Infrastructure Establishment Grant; KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea (NRF) grants - Korea Government(National Research Foundation of Korea)	HC, DL and K-HC were supported by the National Research Foundation of Korea (NRF) grants funded by the Korea Government, the Ministry of Science, ICT and Future Planning (2014R1A2A1A10052404 and 2013M3A9A7046303). It was also supported by a grant of the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C2162), the GIST Systems Biology Infrastructure Establishment Grant, and the KAIST Future Systems Healthcare Project from the Ministry of Science, ICT and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Beck GL, 2008, PHYSICA A, V387, P4947, DOI 10.1016/j.physa.2008.04.032; Berg M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013978; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Choi M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003363; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; Creixell P, 2012, NAT BIOTECHNOL, V30, P842, DOI 10.1038/nbt.2345; Davila-Velderrain J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00160; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fumia HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069008; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang S, 2013, CANCER METAST REV, V32, P423, DOI 10.1007/s10555-013-9435-7; Huang S, 2012, PROG BIOPHYS MOL BIO, V110, P69, DOI 10.1016/j.pbiomolbio.2012.05.001; Huepe C, 2002, J STAT PHYS, V108, P527, DOI 10.1023/A:1015777824097; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Marsaglia G., 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i14, DOI 10.18637/JSS.V008.I18, 10.18637/jss.v008.i18]; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Saadatpour A, 2013, METHODS, V62, P3, DOI 10.1016/j.ymeth.2012.10.012; Sahin IH, 2013, J CANCER, V4, P320, DOI 10.7150/jca.3619; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang R, 2012, NATURE, V492, P419, DOI 10.1038/nature11655; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Weinberg RA, 2007, BIOL CANC; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zhu XM, 2015, PROG BIOPHYS MOL BIO, V117, P30, DOI 10.1016/j.pbiomolbio.2015.01.004	49	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140172	10.1371/journal.pone.0140172	http://dx.doi.org/10.1371/journal.pone.0140172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439385	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300099
J	Jacouton, E; Mach, N; Cadiou, J; Lapaque, N; Clement, K; Dore, J; Vlieg, JETV; Smokvina, T; Blottiere, HM				Jacouton, Elsa; Mach, Nuria; Cadiou, Julie; Lapaque, Nicolas; Clement, Karine; Dore, Joel; Vlieg, Johan E. T. van Hylckama; Smokvina, Tamara; Blottiere, Herve M.			Lactobacillus rhamnosus CNCMI-4317 Modulates Fiaf/Angptl4 in Intestinal Epithelial Cells and Circulating Level in Mice	PLOS ONE			English	Article							ANGIOPOIETIN-LIKE PROTEIN-4; LINOLEIC-ACID; INHIBITION; BACTERIA; HYPERLIPIDEMIA; TRIGLYCERIDE; EXPRESSION; PLANTARUM; T266M; E40K	Background and Objectives Identification of new targets for metabolic diseases treatment or prevention is required. In this context, FIAF/ANGPTL4 appears as a crucial regulator of energy homeostasis. Lactobacilli are often considered to display beneficial effect for their hosts, acting on different regulatory pathways. The aim of the present work was to study the effect of several lactobacilli strains on Fiaf gene expression in human intestinal epithelial cells (IECs) and on mice tissues to decipher the underlying mechanisms. Subjects and Methods Nineteen lactobacilli strains have been tested on HT-29 human intestinal epithelial cells for their ability to regulate Fiaf gene expression by RT-qPCR. In order to determine regulated pathways, we analysed the whole genome transcriptome of IECs. We then validated in vivo bacterial effects using C57BL/6 mono-colonized mice fed with normal chow. Results We identified one strain (Lactobacillus rhamnosus CNCMI-4317) that modulated Fiaf expression in IECs. This regulation relied potentially on bacterial surface-exposed molecules and seemed to be PPAR-gamma independent but PPAR-alpha dependent. Transcriptome functional analysis revealed that multiple pathways including cellular function and maintenance, lymphoid tissue structure and development, as well as lipid metabolism were regulated by this strain. The regulation of immune system and lipid and carbohydrate metabolism was also confirmed by overrepresentation of Gene Ontology terms analysis. In vivo, circulating FIAF protein was increased by the strain but this phenomenon was not correlated with modulation Fiaf expression in tissues (except a trend in distal small intestine). Conclusion We showed that Lactobacillus rhamnosus CNCMI-4317 induced Fiaf expression in human IECs, and increased circulating FIAF protein level in mice. Moreover, this effect was accompanied by transcriptome modulation of several pathways including immune response and metabolism in vitro.	[Jacouton, Elsa; Vlieg, Johan E. T. van Hylckama; Smokvina, Tamara] Danone Nutricia Res, Palaiseau, France; [Jacouton, Elsa; Mach, Nuria; Cadiou, Julie; Lapaque, Nicolas; Dore, Joel; Blottiere, Herve M.] INRA, UMR Micalis 1319, Jouy En Josas, France; [Jacouton, Elsa; Mach, Nuria; Cadiou, Julie; Lapaque, Nicolas; Dore, Joel; Blottiere, Herve M.] AgroParistech, UMR Micalis, Jouy En Josas, France; [Dore, Joel; Blottiere, Herve M.] Metagenopolis, INRA, US 1367, Jouy En Josas, France; [Clement, Karine] Ctr Rech Cordeliers, INSERM, U872, Paris, France; [Clement, Karine] UPMC, Paris, France; [Clement, Karine] CNRH Ile France, AP HP, ICAN, Paris, France	Danone Nutricia; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Sorbonne Universite	Blottiere, HM (corresponding author), INRA, UMR Micalis 1319, Jouy En Josas, France.	herve.blottiere@jouy.inra.fr	Clément, karine/R-1120-2017; BLOTTIERE, Hervé M/C-6120-2011; Lapaque, Nicolas/AAB-4530-2021; Dore, Joel/ABA-8921-2020; Mach, Núria/C-5985-2012	BLOTTIERE, Hervé M/0000-0002-8390-0607; Lapaque, Nicolas/0000-0003-0824-0108; Mach, Núria/0000-0002-8001-6314	ANRT; Danone Research	ANRT(French National Research Agency (ANR)); Danone Research(Danone Nutricia)	This study was in part financed by ANRT (via a CIFRE contract) and Danone Research. Coauthors Elsa Jacouton, Johan E.T. van Hylckama Vlieg and Tamara Smokvina are employed by Danone Research. Danone Research provided support in the form of salaries for authors EJ, JvHV and TS, and had a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Alex S, 2014, HISTOCHEM CELL BIOL, V141, P383, DOI 10.1007/s00418-013-1157-y; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Galaup A, 2012, CIRCULATION, V125, P140, DOI 10.1161/CIRCULATIONAHA.111.049072; Gray NE, 2012, J BIOL CHEM, V287, P8444, DOI 10.1074/jbc.M111.294124; Grootaert C, 2011, ENVIRON MICROBIOL, V13, P1778, DOI 10.1111/j.1462-2920.2011.02482.x; Honda K, 2012, J CLIN BIOCHEM NUTR, V51, P96, DOI 10.3164/jcbn.11-07; Kaddatz K, 2010, J BIOL CHEM, V285, P29469, DOI 10.1074/jbc.M110.142018; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Korecka A, 2013, AM J PHYSIOL-GASTR L, V304, pG1025, DOI 10.1152/ajpgi.00293.2012; Lafferty MJ, 2013, J BIOL CHEM, V288, P28524, DOI 10.1074/jbc.M113.497602; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee EC, 2009, J BIOL CHEM, V284, P13735, DOI 10.1074/jbc.M807899200; Lee HY, 2006, BBA-MOL CELL BIOL L, V1761, P736, DOI 10.1016/j.bbalip.2006.05.007; Lee K, 2007, J APPL MICROBIOL, V103, P1140, DOI 10.1111/j.1365-2672.2007.03336.x; Li H, 2011, HEPATOLOGY, V54, P910, DOI 10.1002/hep.24479; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Lichtenstein L, 2010, CELL METAB, V12, P580, DOI 10.1016/j.cmet.2010.11.002; Macia L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034868; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Robciuc MR, 2011, J LIPID RES, V52, P1575, DOI 10.1194/jlr.P015867; Schmidt S, 2008, AM J PHYSIOL-ENDOC M, V5, P1084; Smart-Halajko MC, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-89; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; Tannock GW, 2014, APPL ENVIRON MICROB, V80, P2851, DOI 10.1128/AEM.00336-14; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yan F, 2007, GASTROENTEROLOGY, V132, P562, DOI 10.1053/j.gastro.2006.11.022; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	33	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138880	10.1371/journal.pone.0138880	http://dx.doi.org/10.1371/journal.pone.0138880			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439630	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300006
J	Jiang, SY; Du, JC; Kong, QH; Li, CC; Li, Y; Sun, HD; Pu, JX; Mao, BY				Jiang, Shiyou; Du, Jiacheng; Kong, Qinghua; Li, Chaocui; Li, Yan; Sun, Handong; Pu, Jianxin; Mao, Bingyu			A Group of ent-Kaurane Diterpenoids Inhibit Hedgehog Signaling and Induce Cilia Elongation	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; BASAL-CELL CARCINOMA; TRITERPENE DILACTONES; PATHWAY INHIBITOR; PROTEIN KIF7; MITOSIS; MEDULLOBLASTOMA; CILIOGENESIS; SUPPRESSOR; BINDING	The Hedgehog (Hh) signaling pathway plays important roles in the tumorigenesis of multiple cancers and is a key target for drug discovery. In a screen of natural products extracted from Chinese herbs, we identified eight ent-Kaurane diterpenoids and two triterpene dilactones as novel Hh pathway antagonists. Epistatic analyses suggest that these compounds likely act at the level or downstream of Smoothened (Smo) and upstream of Suppressor of Fused (Sufu). The ent-Kauranoid-treated cells showed elongated cilia, suppressed Smo trafficking to cilia, and mitotic defects, while the triterpene dilactones had no effect on the cilia and ciliary Smo. These ent-Kaurane diterpenoids provide new prototypes of Hh inhibitors, and are valuable probes for deciphering the mechanisms of Smo ciliary transport and ciliogenesis.	[Jiang, Shiyou; Du, Jiacheng; Li, Chaocui; Mao, Bingyu] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Kong, Qinghua; Li, Yan; Sun, Handong; Pu, Jianxin] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China; [Jiang, Shiyou; Du, Jiacheng] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Pu, JX (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Peoples R China.	pujianxin@mail.kib.ac.cn; mao@mail.kiz.ac.cn		Mao, Bingyu/0000-0002-7993-3158; Jiang, Shi-You/0000-0001-9406-4934	NSFC-Yunnan [U1302226, U1302223]; National Natural Science Foundation of China [21322204]	NSFC-Yunnan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC-Yunnan Joint Funds (U1302226 and U1302223), and National Natural Science Foundation of China (21322204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Besschetnova TY, 2010, CURR BIOL, V20, P182, DOI 10.1016/j.cub.2009.11.072; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Buglio D, 2012, BLOOD, V120, P347, DOI 10.1182/blood-2011-07-369397; Chang ALS, 2012, ARCH DERMATOL, V148, P1324, DOI 10.1001/archdermatol.2012.2354; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; CHEN Y, 1990, Acta Botanica Yunnanica, V12, P211; Cheung HOL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000405; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Delaval B, 2011, NAT CELL BIOL, V13, P461, DOI 10.1038/ncb2202; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Haraguchi K, 2006, J BIOL CHEM, V281, P4094, DOI 10.1074/jbc.M507028200; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Jiang B, 2002, J NAT PROD, V65, P1111, DOI 10.1021/np020084k; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Li X, 2006, PHYTOCHEMISTRY, V67, P1336, DOI 10.1016/j.phytochem.2006.05.002; Li XY, 2013, NAT PRODUCT BIOPROSP, V3, P24, DOI 10.1007/s13659-012-0094-0; Liem KF, 2009, P NATL ACAD SCI USA, V106, P13377, DOI 10.1073/pnas.0906944106; Nachtergaele S, 2013, ELIFE, V2, DOI 10.7554/eLife.01340; Nozawa YI, 2013, CURR OPIN GENET DEV, V23, P429, DOI 10.1016/j.gde.2013.04.008; Pu JX, 2006, TETRAHEDRON, V62, P6073, DOI 10.1016/j.tet.2006.03.108; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Rundle NT, 2006, ACS CHEM BIOL, V1, P443, DOI 10.1021/cb600196w; Sharpe HJ, 2015, NAT CHEM BIOL, V11, P246, DOI [10.1038/NCHEMBIO.1776, 10.1038/nchembio.1776]; Sharpe HJ, 2015, CANCER CELL, V27, P327, DOI 10.1016/j.ccell.2015.02.001; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Wang L, 2011, MINI-REV MED CHEM, V11, P910, DOI 10.2174/138955711796575416; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Xie JW, 2010, U.S. patent, Patent No. [20100111955 A1, 20100111955]; Yang JH, 2013, J NAT PROD, V76, P256, DOI 10.1021/np300772e; Yang JH, 2010, J NAT PROD, V73, P12, DOI 10.1021/np900506g; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Yoshio T, 1987, J CHEM SOC PERK T, V1, P2403; Yue S, 2009, ONCOGENE, V28, P492, DOI 10.1038/onc.2008.403	51	0	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139830	10.1371/journal.pone.0139830	http://dx.doi.org/10.1371/journal.pone.0139830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439749	Green Submitted, gold, Green Published			2022-12-27	WOS:000362510300064
J	Sali, M; Buonsenso, D; Goletti, D; D'Alfonso, P; Zumbo, A; Fadda, G; Sanguinetti, M; Delogu, G; Valentini, P				Sali, Michela; Buonsenso, Danilo; Goletti, Delia; D'Alfonso, Pamela; Zumbo, Antonella; Fadda, Giovanni; Sanguinetti, Maurizio; Delogu, Giovanni; Valentini, Piero			Accuracy of QuantiFERON-TB Gold Test for Tuberculosis Diagnosis in Children	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; INTERFERON-GAMMA; ACTIVE TUBERCULOSIS; INFECTION; PERFORMANCE; ANTIGENS; DISEASE	Objectives To evaluate the accuracy of the QuantiFERON-TB Gold assay (QFT-IT) in children with suspected active or latent TB infection (LTBI). Methods A retrospective study was conducted on 621 children (0-14 years old) evaluated for TB infection or disease. Following clinical assessment, children were tested with the QFT-IT assay. Results Among the 140 active TB suspects, we identified 19 cases of active disease. The overall sensitivity for active TB was 87.5%, ranging from 62.5% in children 25-36 months old to 100% in children older than 49 months. The overall specificity for active TB was 93.6%. Among the 481 children tested for LTBI screening, 38 scored positive and all but 2 had at least one risk factor for TB infection. Among the 26 children with indeterminate results, bacterial, viral or fungal pneumonia were later diagnosed in 11 (42.3%) cases and non-TB related extra-pulmonary infections in 12 (46.1%). Conclusions Our results indicate that the children's response to QFT-IT associates to active TB and risk factors for LTBI. Moreover, we show that mitogen response is also found in children of 1 year of age, providing support for QFT-IT use also in young children.	[Sali, Michela; D'Alfonso, Pamela; Zumbo, Antonella; Fadda, Giovanni; Sanguinetti, Maurizio; Delogu, Giovanni] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Buonsenso, Danilo; Valentini, Piero] Univ Cattolica Sacro Cuore, Inst Pediat, Rome, Italy; [Goletti, Delia] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Valentini, P (corresponding author), Univ Cattolica Sacro Cuore, Inst Pediat, Rome, Italy.	pvalentini@rm.unicatt.it	Sanguinetti, Maurizio/A-1453-2019; goletti, delia/AAM-6577-2020; Buonsenso, Danilo/I-8910-2018	Sanguinetti, Maurizio/0000-0002-9780-7059; Goletti, Delia/0000-0001-8360-4376; Buonsenso, Danilo/0000-0001-8567-2639; VALENTINI, Piero/0000-0001-6095-9510				Abubakar I, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6828; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bergamini BM, 2009, PEDIATRICS, V123, pe419, DOI 10.1542/peds.2008-1722; Brooks BM, 2001, BIOCHEM BIOPH RES CO, V288, P1175, DOI 10.1006/bbrc.2001.5896; Buonsenso D, 2012, PEDIATR INFECT DIS J, V31, P1022, DOI 10.1097/INF.0b013e3182615270; Cassone A, 2012, PATHOG GLOB HEALTH, V106, P8, DOI 10.1179/2047773212Y.0000000006; Chiappini E, 2014, PEDIAT INFECT DIS J; Connell TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002624; Critselis E, 2012, J PEDIAT; Cruz AT, 2010, PEDIATR REV, V31, P13, DOI 10.1542/pir.31-1-13; Debord Camille, 2011, Pediatr Infect Dis J, V30, P995, DOI 10.1097/INF.0b013e3182272227; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Dogra S, 2007, J INFECTION, V54, P267, DOI 10.1016/j.jinf.2006.04.007; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; Garazzino S, 2014, PEDIATR INFECT DIS J, V33, pE226, DOI 10.1097/INF.0000000000000353; Getahun H, 2012, J INFECT DIS, V205, pS216, DOI 10.1093/infdis/jis009; Goletti D, 2007, CLIN INFECT DIS, V45, P1652, DOI 10.1086/523012; Goletti D, 2010, J INFECTION, V61, P133, DOI 10.1016/j.jinf.2010.05.002; Haustein T, 2009, PEDIATR INFECT DIS J, V28, P669, DOI 10.1097/INF.0b013e3181a16394; Kabeer BSA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-135; Lalvani A, 2010, BRIT MED BULL, V93, P69, DOI 10.1093/bmb/ldp039; Lighter J, 2009, PEDIATRICS, V123, P30, DOI 10.1542/peds.2007-3618; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Mandalakas AM, 2011, INT J TUBERC LUNG D, V15, P1018, DOI 10.5588/ijtld.10.0631; Echevarria AM, 2010, PEDIATR INFECT DIS J, V29, P683, DOI 10.1097/INF.0b013e3181e218b7; MENZIES RI, 2000, LUNG BIOL HEALTH DIS, V144, P279; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Park JH, 2009, J RHEUMATOL, V36, P2158, DOI 10.3899/jrheum.090150; Riazi S, 2012, ALLERGY ASTHMA PROC, V33, P217, DOI 10.2500/aap.2012.33.3574; Rose MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037851; Rozot V, 2013, EUR J IMMUNOL, V43, P1568, DOI 10.1002/eji.201243262; Tebruegge M, 2013, THORAX, V68, P588, DOI 10.1136/thoraxjnl-2012-202824; Topic RZ, 2011, ARCH MED RES, V42, P138, DOI 10.1016/j.arcmed.2011.02.001; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; [No title captured]	39	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138952	10.1371/journal.pone.0138952	http://dx.doi.org/10.1371/journal.pone.0138952			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439935	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300009
J	Zhang, ZW; Wu, YK; Sheng, SD; Guo, LL; He, B; Fang, PH; Shi, MY; Bo, P; Zhu, Y				Zhang, Zhenwen; Wu, Yongkang; Sheng, Shudong; Guo, Lili; He, Biao; Fang, Penghua; Shi, Mingyi; Bo, Ping; Zhu, Yan			Intracerebroventricular Injection of Alarin Increased Glucose Uptake in Skeletal Muscle of Diabetic Rats	PLOS ONE			English	Article							LUTEINIZING-HORMONE SECRETION; FOOD-INTAKE; INSULIN SENSITIVITY; GALANIN; ADIPOCYTES; PEPTIDE; RESISTANCE; RELEASE; MICE	In order to investigate the central effect of alarin on glucose uptake, we administered alarin and/or its inhibitor, ala6-25Cys into the cerebral ventricles of the type 2 diabetic rats. Then the relative parameters about glucose uptake in skeletal muscles were measured. We found that central treatment with alarin significantly increased the food intake, body weight and glucose infusion rates in hyperinsulinemic euglycemic clamp tests of the animals. Besides, the treatment also enhanced 2-deoxy-[H-3]-D-glucose uptake, vesicle-associated membrane protein 2 contents, glucose transporter 4 protein and mRNA expression, as well as pAkt(Thr308), pAkt(Ser473) and total Akt levels in muscle cells, but reduced plasma glucose and insulin levels of the rats. All of the alarin-inducing events may be antagonised by central injection of ala6-25Cys. These results suggest that central administration of alarin stimulates glucose uptake mediated by activation of Akt signal pathway in type 2 diabetic animals.	[Zhang, Zhenwen; Bo, Ping; Zhu, Yan] Yangzhou Univ, Dept Endocrinol, Clin Med Coll, Yangzhou 225001, Jiangsu, Peoples R China; [Guo, Lili; He, Biao; Fang, Penghua; Shi, Mingyi; Bo, Ping] Yangzhou Univ, Coll Med, Key Lab Gerontal Med, Yangzhou 225001, Jiangsu, Peoples R China; [Wu, Yongkang] Yangzhou Univ, Peoples Hosp 1, Dept Neurosurg, Yangzhou 225001, Jiangsu, Peoples R China; [Sheng, Shudong] Yangzhuo Polytech Coll, Sch Med, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Bo, P (corresponding author), Yangzhou Univ, Dept Endocrinol, Clin Med Coll, Yangzhou 225001, Jiangsu, Peoples R China.	shimyyz@126.com; sbyyzy@medmail.com.cn		Zhang, Zhenwen/0000-0002-8488-8208	National Natural Scientific Fund of China [81173392]; National Health and Family Planning Commission of China [W201309]	National Natural Scientific Fund of China(National Natural Science Foundation of China (NSFC)); National Health and Family Planning Commission of China	This work was supported by grants from National Natural Scientific Fund of China (81173392 to Ping Bo) and National Health and Family Planning Commission of China (W201309 to Zhenwen Zhang).	Best JD, 1996, DIABETES CARE, V19, P1018, DOI 10.2337/diacare.19.9.1018; Boughton CK, 2010, BRIT J PHARMACOL, V161, P601, DOI 10.1111/j.1476-5381.2010.00893.x; Bu L, 2014, J ENDOCRINOL, V221, P157, DOI 10.1530/JOE-13-0444; Chou HH, 2010, METABOLISM, V59, P824, DOI 10.1016/j.metabol.2009.09.030; Christophe J, 1998, ANN NY ACAD SCI, V865, P323, DOI 10.1111/j.1749-6632.1998.tb11192.x; Fang PH, 2012, GEN COMP ENDOCR, V179, P115, DOI 10.1016/j.ygcen.2012.07.029; Fraley GS, 2013, NEUROPEPTIDES, V47, P37, DOI 10.1016/j.npep.2012.08.007; Fraley GS, 2012, NEUROPEPTIDES, V46, P99, DOI 10.1016/j.npep.2011.12.003; Guerra CD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/563463; Guo LL, 2014, J ENDOCRINOL, V223, P217, DOI 10.1530/JOE-14-0102; He BA, 2011, PHYSIOL BEHAV, V103, P284, DOI 10.1016/j.physbeh.2011.02.023; Koch C, 2010, J NEUROSCI, V30, P16180, DOI 10.1523/JNEUROSCI.3202-10.2010; Santic R, 2007, P NATL ACAD SCI USA, V104, P10217, DOI 10.1073/pnas.0608585104; Sharma N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065118; Shen Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095786, 10.1371/journal.pone.0087894]; Torsello A, 1998, EUR J PHARMACOL, V360, P123, DOI 10.1016/S0014-2999(98)00677-3; Wada A, 2013, BIOCHEM BIOPH RES CO, V434, P223, DOI 10.1016/j.bbrc.2013.03.045; Williams D, 2008, J CELL BIOL, V180, P375, DOI 10.1083/jcb.200709108; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723; Zhang ZW, 2012, MOL CELL ENDOCRINOL, V361, P213, DOI 10.1016/j.mce.2012.04.012	20	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139327	10.1371/journal.pone.0139327	http://dx.doi.org/10.1371/journal.pone.0139327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439383	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300023
J	Kim, HS; Kim, SK; Hromas, R; Lee, SH				Kim, Hyun-Suk; Kim, Sung-Kyung; Hromas, Robert; Lee, Suk-Hee			The SET Domain Is Essential for Metnase Functions in Replication Restart and the 5 ' End of SS-Overhang Cleavage	PLOS ONE			English	Article							DNA-REPAIR; TRANSPOSASE DOMAIN; H3K36 METHYLATION; BIOCHEMICAL-CHARACTERIZATION; NHEJ REPAIR; PROTEIN; INTEGRATION; PROMOTERS; ELEMENT; FEN-1	Metnase (also known as SETMAR) is a chimeric SET-transposase protein that plays essential role(s) in non-homologous end joining (NHEJ) repair and replication fork restart. Although the SET domain possesses histone H3 lysine 36 dimethylation (H3K36me2) activity associated with an improved association of early repair components for NHEJ, its role in replication restart is less clear. Here we show that the SET domain is necessary for the recovery from DNA damage at the replication forks following hydroxyurea (HU) treatment. Cells overexpressing the SET deletion mutant caused a delay in fork restart after HU release. Our In vitro study revealed that the SET domain but not the H3K36me2 activity is required for the 5' end of ss-overhang cleavage with fork and non-fork DNA without affecting the Metnase-DNA interaction. Together, our results suggest that the Metnase SET domain has a positive role in restart of replication fork and the 5' end of ss-overhang cleavage, providing a new insight into the functional interaction of the SET and the transposase domains.	[Kim, Hyun-Suk; Kim, Sung-Kyung; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL USA; [Hromas, Robert] Shands Hlth Care Syst, Gainesville, FL USA; [Lee, Suk-Hee] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA	Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis	Lee, SH (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	slee@iu.edu			National Institutes of Health (NIH) [R01 CA151367]; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [R01CA151367] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Institutes of Health (NIH) R01 CA151367 (to S-HL) and the Indiana University Simon Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleva JL, 2000, NUCLEIC ACIDS RES, V28, P2893, DOI 10.1093/nar/28.15.2893; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Beck BD, 2010, ARCH BIOCHEM BIOPHYS, V498, P89, DOI 10.1016/j.abb.2010.04.011; Budzowska M, 2009, CELL BIOCHEM BIOPHYS, V53, P17, DOI 10.1007/s12013-008-9039-y; Chiu TK, 2004, CURR TOP MED CHEM, V4, P965, DOI 10.2174/1568026043388547; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Goodwin KD, 2010, BIOCHEMISTRY-US, V49, P5705, DOI 10.1021/bi100171x; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Kim HS, 2014, J BIOL CHEM, V289, P10930, DOI 10.1074/jbc.M113.533216; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Murti KG, 1996, EXP CELL RES, V223, P279, DOI 10.1006/excr.1996.0083; Okuda H, 2014, NUCLEIC ACIDS RES, V42, P4241, DOI 10.1093/nar/gkt1394; POLARD P, 1995, MOL MICROBIOL, V15, P13, DOI 10.1111/j.1365-2958.1995.tb02217.x; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Saharia A, 2010, J BIOL CHEM, V285, P27057, DOI 10.1074/jbc.M110.112276; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; Sinha I, 2010, EPIGENOMICS-UK, V2, P377, DOI 10.2217/EPI.10.18; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Sui PF, 2012, PLANT J, V70, P340, DOI 10.1111/j.1365-313X.2011.04873.x; Tong Q., 2015, PLOS ONE, V23, P312, DOI DOI 10.1016/J.STR.2014.11.013; Vassin VM, 2004, MOL CELL BIOL, V24, P1930, DOI 10.1128/MCB.24.5.1930-1943.2004; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Williamson EA, 2008, BIOCHIMIE, V90, P1422, DOI 10.1016/j.biochi.2008.05.010; Williamson EA, 2014, CELL DIV, V9, DOI 10.1186/1747-1028-9-1; Williamson EA, 2012, CANCER RES, V72, P6200, DOI 10.1158/0008-5472.CAN-12-0313; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Xu CR, 2008, P NATL ACAD SCI USA, V105, P8685, DOI 10.1073/pnas.0711758105; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139418	10.1371/journal.pone.0139418	http://dx.doi.org/10.1371/journal.pone.0139418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437079	Green Published, gold			2022-12-27	WOS:000362499200022
J	Averna, M; Pellegrini, M; Cervetto, C; Pedrazzi, M; Bavestrello, M; De Tullio, R; Salamino, F; Pontremoli, S; Melloni, E				Averna, Monica; Pellegrini, Matteo; Cervetto, Chiara; Pedrazzi, Marco; Bavestrello, Margherita; De Tullio, Roberta; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon			Physiological Roles of Calpain 1 Associated to Multiprotein NMDA Receptor Complex	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; MEDIATED CLEAVAGE; POSTSYNAPTIC DENSITY-95; GLUTAMATE RELEASE; NR2 SUBUNITS; ACTIVATION; EXCITOTOXICITY; LOCALIZATION; NEUROPROTECTION; EXPRESSION	We have recently demonstrated that in resting conditions calpain 1, but not calpain 2, is specifically associated to the N-Methyl-D-Aspartate receptor (NMDAR) multiprotein complex. We are here reporting that in SKNBE neuroblastoma cells or in freshly isolated nerve terminals from adult rat hippocampus, the proteolytic activity of calpain 1 resident at the NMDAR is very low under basal conditions and greatly increases following NMDAR stimulation. Since the protease resides at the NMDAR in saturating amounts, variations in Ca2+ influx promote an increase in calpain 1 activity without affecting the amount of the protease originally associated to NMDAR. In all the conditions examined, resident calpain 1 specifically cleaves NR2B at the C-terminal region, leading to its internalization together with NR1 subunit. While in basal conditions intracellular membranes include small amounts of NMDAR containing the calpain-digested NR2B, upon NMDAR stimulation nearly all the receptor molecules are internalized. We here propose that resident calpain 1 is involved in NMDAR turnover, and following an increase in Ca2+ influx, the activated protease, by promoting the removal of NMDAR from the plasma membranes, can decrease Ca2+ entrance through this channel. Due to the absence of calpastatin in such cluster, the activity of resident calpain 1 may be under the control of HSP90, whose levels are directly related to the activation of this protease. Observations of different HSP90/calpain 1 ratios in different ultrasynaptic compartments support this conclusion.	[Averna, Monica; Pellegrini, Matteo; Pedrazzi, Marco; Bavestrello, Margherita; De Tullio, Roberta; Salamino, Franca; Pontremoli, Sandro; Melloni, Edon] Univ Genoa, Biochem Sect, Dept Expt Med DIMES, I-16132 Genoa, Italy; [Averna, Monica; De Tullio, Roberta; Salamino, Franca; Melloni, Edon] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Cervetto, Chiara] Univ Genoa, Dept Pharm, Pharmacol & Toxicol Sect, I-16148 Genoa, Italy	University of Genoa; University of Genoa; University of Genoa	Averna, M (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med DIMES, Viale Benedetto XV 1, I-16132 Genoa, Italy.	monica.averna@unige.it	AVERNA, MONICA/R-5719-2019; Cervetto, Chiara/G-6404-2010	AVERNA, MONICA/0000-0002-9463-7533; Cervetto, Chiara/0000-0001-8290-3008; DE TULLIO, ROBERTA/0000-0001-6925-3207	grant PRA from Universita degli Studi di Genova	grant PRA from Universita degli Studi di Genova	This work was supported by the grant PRA 2013 from Universita degli Studi di Genova to MA.	Alloisio S, 2008, FEBS LETT, V582, P3948, DOI 10.1016/j.febslet.2008.10.041; Aronson N N Jr, 1974, Methods Enzymol, V31, P90; Averna M, 2007, J BIOL CHEM, V282, P2656, DOI 10.1074/jbc.M606919200; Averna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116738; Averna M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066089; Averna M, 2009, J NEUROCHEM, V110, P412, DOI 10.1111/j.1471-4159.2009.06149.x; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Cervetto C, 2012, NEUROCHEM INT, V60, P768, DOI 10.1016/j.neuint.2012.02.034; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; De Tullio R, 1999, BIOCHEM J, V343, P467; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Dore K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112170; Doshi Shachee, 2009, Front Biosci (Schol Ed), V1, P466, DOI 10.2741/e38; Feligioni M, 2006, J NEUROCHEM, V99, P549, DOI 10.1111/j.1471-4159.2006.04087.x; Gascon S, 2008, MOL PSYCHIATR, V13, P99, DOI 10.1038/sj.mp.4002017; Gladding CM, 2014, J NEUROCHEM, V130, P145, DOI 10.1111/jnc.12700; Gladding CM, 2011, MOL CELL NEUROSCI, V48, P308, DOI 10.1016/j.mcn.2011.05.001; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jang JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085322; Kambe Y, 2010, J NEUROSCI RES, V88, P2177, DOI 10.1002/jnr.22388; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lo FS, 2011, NEUROSCIENCE, V178, P240, DOI 10.1016/j.neuroscience.2011.01.023; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; Mannelli LD, 2015, NEUROPHARMACOLOGY, V97, P133, DOI 10.1016/j.neuropharm.2015.05.037; Marcoli M, 2008, J NEUROCHEM, V105, P2330, DOI 10.1111/j.1471-4159.2008.05322.x; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; Monnerie H, 2010, NEUROSCIENCE, V171, P1075, DOI 10.1016/j.neuroscience.2010.09.050; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; NAKAMURA Y, 1993, GLIA, V9, P48, DOI 10.1002/glia.440090107; Ono Y, 2012, BBA-PROTEINS PROTEOM, V1824, P224, DOI 10.1016/j.bbapap.2011.08.005; Pedrazzi M, 2006, J NEUROCHEM, V99, P827, DOI 10.1111/j.1471-4159.2006.04120.x; Pedrazzi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044518; Pizzi M, 2002, EUR J NEUROSCI, V16, P2342, DOI 10.1046/j.1460-9568.2002.02403.x; Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; Sasaki T, 1990, J Enzyme Inhib, V3, P195, DOI 10.3109/14756369009035837; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Singh P, 2012, J BIOL CHEM, V287, P4348, DOI 10.1074/jbc.M111.253740; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vinade L, 2001, SYNAPSE, V40, P302, DOI 10.1002/syn.1053; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wei GZ, 2012, J BIOL CHEM, V287, P5797, DOI 10.1074/jbc.M111.260109; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Wu HY, 2005, J BIOL CHEM, V280, P21588, DOI 10.1074/jbc.M501603200; Xu J, 2009, J NEUROSCI, V29, P9330, DOI 10.1523/JNEUROSCI.2212-09.2009; Yildiz-Unal A, 2015, NEUROPSYCH DIS TREAT, V11, P297, DOI 10.2147/NDT.S78226; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813	52	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139750	10.1371/journal.pone.0139750	http://dx.doi.org/10.1371/journal.pone.0139750			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431040	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700110
J	Decorte, I; Steensels, M; Lambrecht, B; Cay, AB; De Regge, N				Decorte, Inge; Steensels, Mieke; Lambrecht, Benedicte; Cay, Ann Brigitte; De Regge, Nick			Detection and Isolation of Swine Influenza A Virus in Spiked Oral Fluid and Samples from Individually Housed, Experimentally Infected Pigs: Potential Role of Porcine Oral Fluid in Active Influenza A Virus Surveillance in Swine	PLOS ONE			English	Article							RESPIRATORY-SYNDROME-VIRUS; PANDEMIC H1N1 2009; UNITED-STATES; GENETIC REASSORTMENT; AGRICULTURAL FAIR; SWAB MATERIALS; CELL TURNOVER; H3N2; TRANSMISSION; POPULATIONS	Background The lack of seasonality of swine influenza A virus (swIAV) in combination with the capacity of swine to harbor a large number of co-circulating IAV lineages, resulting in the risk for the emergence of influenza viruses with pandemic potential, stress the importance of swIAV surveillance. To date, active surveillance of swIAV worldwide is barely done because of the short detection period in nasal swab samples. Therefore, more sensitive diagnostic methods to monitor circulating virus strains are requisite. Methods qRT-PCR and virus isolations were performed on oral fluid and nasal swabs collected from individually housed pigs that were infected sequentially with H1N1 and H3N2 swIAV strains. The same methods were also applied to oral fluid samples spiked with H1N1 to study the influence of conservation time and temperature on swIAV infectivity and detectability in porcine oral fluid. Results All swIAV infected animals were found qRT-PCR positive in both nasal swabs and oral fluid. However, swIAV could be detected for a longer period in oral fluid than in nasal swabs. Despite the high detectability of swIAV in oral fluid, virus isolation from oral fluid collected from infected pigs was rare. These results are supported by laboratory studies showing that the PCR detectability of swIAV remains unaltered during a 24 h incubation period in oral fluid, while swIAV infectivity drops dramatically immediately upon contact with oral fluid (3 log titer reduction) and gets lost after 24 h conservation in oral fluid at ambient temperature. Conclusions Our data indicate that porcine oral fluid has the potential to replace nasal swabs for molecular diagnostic purposes. The difficulty to isolate swIAV from oral fluid could pose a drawback for its use in active surveillance programs.	[Decorte, Inge; Cay, Ann Brigitte; De Regge, Nick] CODA CERVA, Operat Direct Viral Dis Enzoot & Re Emerging Dis, Uccle, Belgium; [Steensels, Mieke; Lambrecht, Benedicte] CODA CERVA, Operat Direct Viral Dis, Avian Virol & Immunol, Uccle, Belgium		De Regge, N (corresponding author), CODA CERVA, Operat Direct Viral Dis Enzoot & Re Emerging Dis, Uccle, Belgium.	nick.deregge@coda-cerva.be			Federal Public Service of Health, Food Chain Safety and Environment, Belgium [10/6235]	Federal Public Service of Health, Food Chain Safety and Environment, Belgium	This work was supported by the Federal Public Service of Health, Food Chain Safety and Environment, Belgium [RF 10/6235].	Bowman AS, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.33; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Chiapponi C, 2010, J VIROL METHODS, V163, P162, DOI 10.1016/j.jviromet.2009.09.017; CLAAS ECJ, 1994, VIROLOGY, V204, P453, DOI 10.1006/viro.1994.1553; Corzo CA, 2013, EMERG INFECT DIS, V19, P954, DOI 10.3201/eid1906.121637; Cox CM, 2011, EMERG INFECT DIS, V17, P1143, DOI [10.3201/eid1706.101488, 10.3201/eid/1706.101488]; Crisci E, 2013, MOL IMMUNOL, V55, P200, DOI 10.1016/j.molimm.2013.02.008; Decorte I, 2015, J VET DIAGN INVEST, V27, P47, DOI 10.1177/1040638714561252; Decorte I, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-134; Decorte I, 2013, VET J, V197, P224, DOI 10.1016/j.tvjl.2013.02.001; Detmer S, 2013, CURR TOP MICROBIOL, V370, P85, DOI 10.1007/82_2012_220; Detmer SE, 2011, J VET DIAGN INVEST, V23, P241, DOI 10.1177/104063871102300207; Ducatez MF, 2011, EMERG INFECT DIS, V17, P1624, DOI 10.3201/eid1709.110338; EATON MD, 1956, P SOC EXP BIOL MED, V92, P289, DOI 10.3181/00379727-92-22454; Edwards JL, 2014, INFLUENZA OTHER RESP, V8, P574, DOI 10.1111/irv.12270; Fabian TK, 2012, INT J MOL SCI, V13, P4295, DOI 10.3390/ijms13044295; Fan XH, 2012, J VIROL, V86, P2375, DOI 10.1128/JVI.06824-11; Fouchier RAM, 2003, VACCINE, V21, P1754, DOI 10.1016/S0264-410X(03)00067-7; Goodell CK, 2013, VET MICROBIOL, V166, P450, DOI 10.1016/j.vetmic.2013.06.029; Hansen AM, 2008, SCAND J CLIN LAB INV, V68, P826, DOI 10.1080/00365510802056207; HANSON BR, 1976, AM J VET RES, V37, P707; Janke BH, 2013, CURR TOP MICROBIOL, V370, P69, DOI 10.1007/82_2013_308; Jung T, 2002, VET PATHOL, V39, P10, DOI 10.1354/vp.39-1-10; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Kitikoon P, 2012, J VIROL, V86, P6804, DOI 10.1128/JVI.00197-12; Kyriakis CS, 2011, ZOONOSES PUBLIC HLTH, V58, P93, DOI 10.1111/j.1863-2378.2009.01301.x; Lindstrom S, 2012, EMERG INFECT DIS, V18, P834, DOI 10.3201/eid1805.111922; Liu QF, 2012, ARCH VIROL, V157, P555, DOI 10.1007/s00705-011-1203-9; LLOYD G, 1978, RES VET SCI, V25, P257, DOI 10.1016/S0034-5288(18)32995-3; Lombardo T, 2012, J VIROL METHODS, V185, P82, DOI 10.1016/j.jviromet.2012.06.008; Mak PWY, 2012, CLIN CHEM, V58, P1527, DOI 10.1373/clinchem.2012.182626; Marshall N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003421; Moreno A, 2011, VET MICROBIOL, V149, P472, DOI 10.1016/j.vetmic.2010.12.011; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Nelson MI, 2012, J VIROL, V86, P8872, DOI 10.1128/JVI.00259-12; Olsen C, 2013, VET J, V198, P158, DOI 10.1016/j.tvjl.2013.06.014; Park NJ, 2006, CLIN CHEM, V52, P988, DOI 10.1373/clinchem.2005.063206; Potts WTW, 1964, OSMOTIC AND IONIC RE; Prickett J, 2008, J VET DIAGN INVEST, V20, P156, DOI 10.1177/104063870802000203; Romagosa A, 2012, INFLUENZA OTHER RESP, V6, P110, DOI 10.1111/j.1750-2659.2011.00276.x; Rubin Bruce K, 2002, Respir Care, V47, P761; SHORTER RG, 1964, DIS CHEST, V46, P138; Song MS, 2010, J CLIN MICROBIOL, V48, P3204, DOI 10.1128/JCM.00053-10; SPENCER H, 1962, NATURE, V194, P880, DOI 10.1038/194880a0; Starick E, 2011, J GEN VIROL, V92, P1184, DOI 10.1099/vir.0.028662-0; Tamura SI, 2005, JPN J INFECT DIS, V58, P195; TOLSKAYA EA, 1966, VIROLOGY, V29, P613, DOI 10.1016/0042-6822(66)90285-6; Van Reeth K, 2004, VIRUS RES, V103, P115, DOI 10.1016/j.virusres.2004.02.023; Van Reeth K, 2009, VACCINE, V27, P6330, DOI 10.1016/j.vaccine.2009.03.021; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Webster RG, 2002, WHO MANUAL ON ANIMAL; Welsh MD, 2010, VET REC, V166, P642, DOI 10.1136/vr.4851; Wong KK, 2012, EMERG INFECT DIS, V18, P1937, DOI 10.3201/eid1812.121097; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	55	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139586	10.1371/journal.pone.0139586	http://dx.doi.org/10.1371/journal.pone.0139586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431039	gold, Green Published, Green Submitted			2022-12-27	WOS:000362178700082
J	Ellingson, BM; Salamon, N; Hardy, AJ; Holly, LT				Ellingson, Benjamin M.; Salamon, Noriko; Hardy, Anthony J.; Holly, Langston T.			Prediction of Neurological Impairment in Cervical Spondylotic Myelopathy using a Combination of Diffusion MRI and Proton MR Spectroscopy	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; INCREASED SIGNAL INTENSITY; SPINAL-CORD; COMPRESSIVE MYELOPATHY; DISEASE SEVERITY; PAVLOV RATIO; INJURY; PATHOPHYSIOLOGY; COEFFICIENT; ANISOTROPY	Purpose In the present study we investigated a combination of diffusion tensor imaging (DTI) and magnetic resonance spectroscopic (MRS) biomarkers in order to predict neurological impairment in patients with cervical spondylosis. Methods Twenty-seven patients with cervical spondylosis were evaluated. DTI and single voxel MRS were performed in the cervical cord. N-acetylaspartate (NAA) and choline (Cho) metabolite concentration ratios with respect to creatine were quantified, as well as the ratio of choline to NAA. The modified mJOA scale was used as a measure of neurologic deficit. Linear regression was performed between DTI and MRS parameters and mJOA scores. Significant predictors from linear regression were used in a multiple linear regression model in order to improve prediction of mJOA. Parameters that did not add value to model performance were removed, then an optimized multiparametric model was established to predict mJOA. Results Significant correlations were observed between the Torg-Pavlov ratio and FA (R-2 = 0.2021, P = 0.019); DTI fiber tract density and FA, MD, Cho/NAA (R-2 = 0.3412, P = 0.0014; R-2 = 0.2112, P = 0.016; and R-2 = 0.2352, P = 0.010 respectively); along with FA and Cho/NAA (R-2 = 0.1695, P = 0.033). DTI fiber tract density, MD and FA at the site of compression, along with Cho/NAA at C2, were significantly correlated with mJOA score (R-2 = 0.05939, P < 0.0001; R-2 = 0.4739, P < 0.0001; R-2 = 0.7034, P < 0.0001; R-2 = 0.4649, P < 0.0001). A combination biomarker consisting of DTI fiber tract density, MD, and Cho/NAA showed the best prediction of mJOA (R-2 = 0.8274, P < 0.0001), with post-hoc tests suggesting fiber tract density, MD, and Cho/NAA were all significant contributors to predicting mJOA (P = 0.00053, P = 0.00085, and P = 0.0019, respectively). Conclusion A linear combination of DTI and MRS measurements within the cervical spinal cord may be useful for accurately predicting neurological deficits in patients with cervical spondylosis. Additional studies may be necessary to validate these observations.	[Ellingson, Benjamin M.; Salamon, Noriko; Hardy, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Ellingson, Benjamin M.; Hardy, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biomed Phys, Los Angeles, CA 90095 USA; [Ellingson, Benjamin M.] Univ Calif Los Angeles, Dept Bioengn, Henri Samueli Sch Engn & Appl Sci, Los Angeles, CA 90024 USA; [Ellingson, Benjamin M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Holly, Langston T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg & Orthopaed, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ellingson, BM (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA.	bellingson@mednet.ucla.edu			NIH/NINDS [1R21NS065419-01A1, 1R01NS078494-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078494, R21NS065419] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was received through the following NIH/NINDS grants: no. 1R21NS065419-01A1 (to LTH and NS) and no. 1R01NS078494-01A1 (to LTH, NS, and BME). The funders played a significant role in the study design, data collection, and analysis, per the goals outlined in the respective grants.	ALMEFTY O, 1988, J NEUROSURG, V68, P217, DOI 10.3171/jns.1988.68.2.0217; Baptiste Darryl C, 2006, Spine J, V6, p190S, DOI 10.1016/j.spinee.2006.04.024; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bieza A, 2013, J BIOMED SCI ENG, V2013, P518, DOI DOI 10.4236/JBISE.2013.65066; Budzik JF, 2011, EUR RADIOL, V21, P426, DOI 10.1007/s00330-010-1927-z; Cooke FJ, 2004, MAGN RESON MED, V51, P1122, DOI 10.1002/mrm.20084; de Rota JJF, 2007, J NEUROSURG-SPINE, V6, P17, DOI 10.3171/spi.2007.6.1.4; Demir A, 2003, RADIOLOGY, V229, P37, DOI 10.1148/radiol.2291020658; Ellingson BM, 2015, J NEUROSURG-SPINE, V22, P631, DOI 10.3171/2014.10.SPINE14222; Erschbamer M, 2011, EUR J NEUROSCI, V33, P678, DOI 10.1111/j.1460-9568.2010.07562.x; Fehlings MG, 1998, SPINE, V23, P2730, DOI 10.1097/00007632-199812150-00012; Holly LT, 2009, J NEUROSURG-SPINE, V10, P194, DOI 10.3171/2008.12.SPINE08367; Holly LT, 2015, J SPINAL DISORD TECH; Hori M, 2012, EUR RADIOL, V22, P1797, DOI 10.1007/s00330-012-2410-9; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Kara B, 2011, NEURORADIOLOGY, V53, P609, DOI 10.1007/s00234-011-0844-4; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Kendi ATK, 2004, NEURORADIOLOGY, V46, P764, DOI 10.1007/s00234-004-1231-1; Mamata H, 2005, J MAGN RESON IMAGING, V22, P38, DOI 10.1002/jmri.20357; Mastronardi L, 2007, J NEUROSURG-SPINE, V7, P615, DOI 10.3171/SPI-07/12/615; MATSUDA Y, 1991, J NEUROSURG, V74, P887, DOI 10.3171/jns.1991.74.6.0887; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; Mccormick WE, 2003, CLEV CLIN J MED, V70, P899, DOI 10.3949/ccjm.70.10.899; MEHALIC TF, 1990, NEUROSURGERY, V26, P217, DOI 10.1227/00006123-199002000-00006; Mizuno J, 2003, J NEUROSURG, V99, P162, DOI 10.3171/spi.2003.99.2.0162; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; MORIO Y, 1994, ARCH ORTHOP TRAUM SU, V113, P254, DOI 10.1007/BF00443813; Nelles M, 2008, AM J NEURORADIOL, V29, P1708, DOI 10.3174/ajnr.A1201; Parker GJM, 2005, PHILOS T R SOC B, V360, P893, DOI 10.1098/rstb.2005.1639; PAVLOV H, 1987, RADIOLOGY, V164, P771, DOI 10.1148/radiology.164.3.3615879; Puzzilli F, 1999, J Neurosurg Sci, V43, P135; Qian JC, 2010, J NEUROTRAUM, V27, P599, DOI 10.1089/neu.2009.1145; RAMANAUSKAS WL, 1989, J COMPUT ASSIST TOMO, V13, P399, DOI 10.1097/00004728-198905000-00005; Salamon N, 2013, SPINAL CORD, V51, P558, DOI 10.1038/sc.2013.31; Schwartz ED, 2005, NEUROREPORT, V16, P73, DOI 10.1097/00001756-200501190-00017; Suk KS, 2009, CLIN ORTHOP SURG, V1, P6, DOI 10.4055/cios.2009.1.1.6; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tu TW, 2010, J NEUROTRAUM, V27, P253, DOI 10.1089/neu.2009.1026; WADA E, 1995, SPINE, V20, P2226, DOI 10.1097/00007632-199510001-00009; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Wen CY, 2014, SPINE J, V14, P1493, DOI 10.1016/j.spinee.2013.08.052; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Yoshikawa T, 2008, RADIAT MED, V26, P481, DOI 10.1007/s11604-008-0262-7; Young WF, 2000, AM FAM PHYSICIAN, V62, P1064; Yue WM, 2001, SPINE, V26, P1760, DOI 10.1097/00007632-200108150-00006	46	29	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139451	10.1371/journal.pone.0139451	http://dx.doi.org/10.1371/journal.pone.0139451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431174	Green Published, gold			2022-12-27	WOS:000362178700062
J	Penesyan, A; Kumar, SS; Kamath, K; Shathili, AM; Venkatakrishnan, V; Krisp, C; Packer, NH; Molloy, MP; Paulsen, IT				Penesyan, Anahit; Kumar, Sheemal S.; Kamath, Karthik; Shathili, Abdulrahman M.; Venkatakrishnan, Vignesh; Krisp, Christoph; Packer, Nicolle H.; Molloy, Mark P.; Paulsen, Ian T.			Genetically and Phenotypically Distinct Pseudomonas aeruginosa Cystic Fibrosis Isolates Share a Core Proteomic Signature	PLOS ONE			English	Article							YOUNG-CHILDREN; IV PILI; GLYCOSYLATION; INFECTION; PATHWAYS; MOTILITY; SEQUENCE; MUCIN; BIOSYNTHESIS; COOPERATION	The opportunistic pathogen Pseudomonas aeruginosa is among the main colonizers of the lungs of cystic fibrosis (CF) patients. We have isolated and sequenced several P. aeruginosa isolates from the sputum of CF patients and compared them with each other and with the model strain PAO1. Phenotypic analysis of CF isolates showed significant variability in colonization and virulence-related traits suggesting different strategies for adaptation to the CF lung. Genomic analysis indicated these strains shared a large set of core genes with the standard laboratory strain PAO1, and identified the genetic basis for some of the observed phenotypic differences. Proteomics revealed that in a conventional laboratory medium PAO1 expressed 827 proteins that were absent in the CF isolates while the CF isolates shared a distinctive signature set of 703 proteins not detected in PAO1. PAO1 expressed many transporters for the uptake of organic nutrients and relatively few biosynthetic pathways. Conversely, the CF isolates expressed a narrower range of transporters and a broader set of metabolic pathways for the biosynthesis of amino acids, carbohydrates, nucleotides and polyamines. The proteomic data suggests that in a common laboratory medium PAO1 may transport a diverse set of "ready-made" nutrients from the rich medium, whereas the CF isolates may only utilize a limited number of nutrients from the medium relying mainly on their own metabolism for synthesis of essential nutrients. These variations indicate significant differences between the metabolism and physiology of P. aeruginosa CF isolates and PAO1 that cannot be detected at the genome level alone. The widening gap between the increasing genomic data and the lack of phenotypic data means that researchers are increasingly reliant on extrapolating from genomic comparisons using experimentally characterized model organisms such as PAO1. While comparative genomics can provide valuable information, our data suggests that such extrapolations may be fraught with peril.	[Penesyan, Anahit; Kumar, Sheemal S.; Kamath, Karthik; Shathili, Abdulrahman M.; Venkatakrishnan, Vignesh; Krisp, Christoph; Packer, Nicolle H.; Molloy, Mark P.; Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Fac Sci & Engn, Sydney, NSW 2109, Australia; [Krisp, Christoph; Molloy, Mark P.] Macquarie Univ, Australian Proteome Anal Facil, Sydney, NSW 2109, Australia	Macquarie University; Macquarie University	Paulsen, IT (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Fac Sci & Engn, Sydney, NSW 2109, Australia.	ian.paulsen@mq.edu.au	Penesyan, Anahit/Y-6884-2019; Penesyan, Anahit/A-9442-2012; Packer, Nicolle/Q-8929-2019; Paulsen, Ian/K-3832-2012	Penesyan, Anahit/0000-0002-2502-0740; Penesyan, Anahit/0000-0002-2502-0740; Kumar, Sheemal/0000-0002-7483-4273; Paulsen, Ian/0000-0001-9015-9418; Packer, Nicolle/0000-0002-7532-4021; Molloy, Mark/0000-0003-4679-5868	Australian Research Council [FS110200026]	Australian Research Council(Australian Research Council)	The project was funded by the Australian Research Council (http://www.arc.gov.au) Super Science grant FS110200026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALLISON JS, 1985, INFECT IMMUN, V49, P770, DOI 10.1128/IAI.49.3.770-774.1985; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arora SK, 1998, INFECT IMMUN, V66, P1000, DOI 10.1128/IAI.66.3.1000-1007.1998; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Ballestriero F, 2010, APPL ENVIRON MICROB, V76, P5710, DOI 10.1128/AEM.00695-10; Bradbury RS, 2011, MICROBIOL IMMUNOL, V55, P224, DOI 10.1111/j.1348-0421.2011.00314.x; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Callaghan M, 2012, CURR OPIN MICROBIOL, V15, P71, DOI 10.1016/j.mib.2011.11.001; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Cezairliyan B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003101; Christensen BB, 1999, METHOD ENZYMOL, V310, P20; Cigana C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/852513; Colvin KM, 2012, ENVIRON MICROBIOL, V14, P1913, DOI 10.1111/j.1462-2920.2011.02657.x; Courtney JM, 2007, PEDIATR PULM, V42, P525, DOI 10.1002/ppul.20619; Czaran T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006655; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; De Soyza A, 2013, MICROBIOLOGYOPEN, V2, P1010, DOI 10.1002/mbo3.141; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; DRAKE D, 1988, J GEN MICROBIOL, V134, P43; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Gillet LC, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.016717; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hare NJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-16; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jeukens J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087611; Konings AF, 2013, INFECT IMMUN, V81, P2697, DOI 10.1128/IAI.00418-13; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; LANYI B, 1970, ACTA MICROBIOL HUNG, V17, P35; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lelong E, 2011, CLIN MICROBIOL INFEC, V17, P1415, DOI 10.1111/j.1469-0691.2010.03431.x; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Merino S, 2014, INT J MOL SCI, V15, P2840, DOI 10.3390/ijms15022840; Meyer JM, 2000, ARCH MICROBIOL, V174, P135, DOI 10.1007/s002030000188; Mowat E, 2011, AM J RESP CRIT CARE, V183, P1674, DOI 10.1164/rccm.201009-1430OC; Murray TS, 2008, J BACTERIOL, V190, P2700, DOI 10.1128/JB.01620-07; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Naughton S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024526; Nguyen AT, 2014, J BACTERIOL, V196, P2265, DOI 10.1128/JB.01491-14; Nixon GM, 2001, J PEDIATR-US, V138, P699, DOI 10.1067/mpd.2001.112897; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Paley SM, 2006, NUCLEIC ACIDS RES, V34, P3771, DOI 10.1093/nar/gkl334; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; SAJJAN U, 1992, J CLIN INVEST, V89, P657, DOI 10.1172/JCI115632; Schulz BL, 2007, GLYCOBIOLOGY, V17, P698, DOI 10.1093/glycob/cwm036; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Stintzi A, 1998, FEMS MICROBIOL LETT, V166, P341, DOI 10.1111/j.1574-6968.1998.tb13910.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Takeuchi K, 2003, J BACTERIOL, V185, P6658, DOI 10.1128/JB.185.22.6658-6665.2003; Thaysen-Andersen M, 2015, J BIOL CHEM, V290, P8789, DOI 10.1074/jbc.M114.631622; Venkatakrishnan V, 2013, EXPERT REV RESP MED, V7, P553, DOI 10.1586/17476348.2013.837752; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang MZ, 2015, P NATL ACAD SCI USA, V112, P2187, DOI 10.1073/pnas.1500704112; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	67	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138527	10.1371/journal.pone.0138527	http://dx.doi.org/10.1371/journal.pone.0138527			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431321	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700014
J	Cho, SF; Yang, YH; Liu, YC; Hsiao, HH; Huang, CT; Wu, CH; Tsai, YF; Wang, HC; Liu, TC				Cho, Shih-Feng; Yang, Yi-Hsin; Liu, Yi-Chang; Hsiao, Hui-Hua; Huang, Chiung-Tang; Wu, Cheng-Han; Tsai, Yu-Fen; Wang, Hui-Ching; Liu, Ta-Chih			Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study	PLOS ONE			English	Article							C VIRUS-INFECTION; CANCER-RISK; TIME TRENDS; CELL; METAANALYSIS; INHIBITORS; SIMVASTATIN; INFLAMMATION; APOPTOSIS; PROLIFERATION	Background The purpose of this study was to investigate the association between previous exposure to statins and the risk of non-Hodgkin lymphoma (NHL). Methods This nationwide population-based case-control study was conducted using the National Health Insurance Research Database of Taiwan. The NHL group consisted of the patients with a first-time diagnosis of NHL between 2005 and 2008. The cases of the control group were pair-matched to the NHL group according to sex, year of birth and date of NHL diagnosis (index date). The statin administration data from both groups were retrospectively collected from the index date to January 1, 1996. The cumulative defined daily dose (cDDD) was estimated to evaluate the statin exposure. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariate logistic regression. Results The study population was composed of 1715 NHL patients and 16942 control subjects. The analysis revealed that previous statin administration was associated with a reduced risk of subsequent NHL with an adjusted OR of 0.52 (95% CI, 0.43-0.62). Additionally, there was a dose-response relationship between statin administration and the risk of NHL. The adjusted ORs were 0.63 (95% CI, 0.46-0.86), 0.58 (95% CI, 0.42-0.79), 0.51 (95% CI, 0.38-0.67), and 0.36 (95% CI, 0.24-0.53) for the subjects with statin administrations of fewer than 28, 28 to 90, 91 to 365, and more than 365 cDDDs, respectively, relative to the subjects without any statin administration. Conclusions The results of this study suggest that previous statin administration is associated with a lower risk of subsequent NHL. As statins are widely used medications, the magnitude of the risk reduction may have a substantial influence on public health. Further studies to confirm our findings are warranted.	[Cho, Shih-Feng; Liu, Ta-Chih] Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan; [Cho, Shih-Feng; Liu, Yi-Chang; Hsiao, Hui-Hua; Huang, Chiung-Tang; Wu, Cheng-Han; Tsai, Yu-Fen; Wang, Hui-Ching; Liu, Ta-Chih] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Kaohsiung, Taiwan; [Yang, Yi-Hsin] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Liu, TC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Clin Med, Kaohsiung, Taiwan.	d730093@cc.kmu.edu.tw	Yang, Yi-Hsin/D-6471-2012	Yang, Yi-Hsin/0000-0002-9581-2778; Cho, Shih-Feng/0000-0002-9884-9429				Adamson P, 2007, EUR J CANCER, V43, P391, DOI 10.1016/j.ejca.2006.10.008; Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Bonovas S, 2007, BRIT J CLIN PHARMACO, V64, P255, DOI 10.1111/j.1365-2125.2007.02959.x; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Brookhart MA, 2007, AM J EPIDEMIOL, V166, P348, DOI 10.1093/aje/kwm070; Carlberg M, 1996, J BIOL CHEM, V271, P17453, DOI 10.1074/jbc.271.29.17453; Castillo JJ, 2012, BLOOD, V119, P4845, DOI 10.1182/blood-2011-06-362830; Chao C, 2011, AIDS, V25, P1771, DOI 10.1097/QAD.0b013e328349c67a; Chen WL, 2010, ANN HEMATOL, V89, P553, DOI 10.1007/s00277-009-0870-z; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Dimitroulakos J, 2002, NEOPLASIA, V4, P337, DOI 10.1038/sj.neo.7900247; Smedby KE, 2006, CANCER EPIDEM BIOMAR, V15, P2069, DOI 10.1158/1055-9965.EPI-06-0300; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Engels EA, 2010, LANCET ONCOL, V11, P827, DOI 10.1016/S1470-2045(10)70167-4; Fortuny J, 2006, CANCER EPIDEM BIOMAR, V15, P921, DOI 10.1158/1055-9965.EPI-05-0866; Fujita M, 2000, PATHOL INT, V50, P696, DOI 10.1046/j.1440-1827.2000.01108.x; Gasztonyi B, 2000, BRIT J HAEMATOL, V110, P497; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Groves FD, 2000, JNCI-J NATL CANCER I, V92, P1240, DOI 10.1093/jnci/92.15.1240; Haukka J, 2010, INT J CANCER, V126, P279, DOI 10.1002/ijc.24536; Hebert PR, 1997, JAMA-J AM MED ASSOC, V278, P313, DOI 10.1001/jama.278.4.313; Hsing AW, 2015, JAMA INTERN MED, V175, P1527, DOI 10.1001/jamainternmed.2015.3540; Islam M, 2013, ORAL ONCOL, V49, P778, DOI 10.1016/j.oraloncology.2013.04.003; Jadhav SB, 2006, J PHARM PHARMACOL, V58, P3, DOI 10.1211/jpp.58.1.0002; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jespersen CG, 2014, CANCER EPIDEMIOL, V38, P42, DOI 10.1016/j.canep.2013.10.010; Katanoda K, 2008, JPN J CLIN ONCOL, V38, P391, DOI [10.1093/jjco/hyn037, 10.1093/jjco/hyn044]; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; KEYOMARSI K, 1991, CANCER RES, V51, P3602; Liu H, 2013, NEOPLASMA, V60, P240, DOI 10.4149/neo_2013_032; Liu YQ, 2014, CANCER CAUSE CONTROL, V25, P237, DOI 10.1007/s10552-013-0326-6; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Mizorogi F, 2000, INTERNAL MED, V39, P112, DOI 10.2169/internalmedicine.39.112; Muller AMS, 2005, ANN HEMATOL, V84, P1, DOI 10.1007/s00277-004-0939-7; Patrick AR, 2011, VALUE HEALTH, V14, P513, DOI 10.1016/j.jval.2010.10.033; Pruefer D, 2002, CIRCULATION, V106, P2104, DOI 10.1161/01.CIR.0000034048.38910.91; Qi XF, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.44; Rejnmark L, 2004, OSTEOPOROSIS INT, V15, P452, DOI 10.1007/s00198-003-1568-z; Schointuch MN, 2014, GYNECOL ONCOL, V134, P346, DOI 10.1016/j.ygyno.2014.05.015; Shachaf CM, 2007, BLOOD, V110, P2674, DOI 10.1182/blood-2006-09-048033; Shi M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005399; Sukpanichnant S, 2004, HUM PATHOL, V35, P224, DOI 10.1016/j.humpath.2003.10.007; Tsan YT, 2013, J CLIN ONCOL, V31, P1514, DOI 10.1200/JCO.2012.44.6831; Vinogradova Y, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-409; Wong WWL, 2002, LEUKEMIA, V16, P508, DOI 10.1038/sj.leu.2402476; Yi X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087019; Yu XF, 2012, ONCOL RES, V20, P351, DOI 10.3727/096504013X13657689382897	51	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139289	10.1371/journal.pone.0139289	http://dx.doi.org/10.1371/journal.pone.0139289			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26425850	gold, Green Submitted, Green Published			2022-12-27	WOS:000362177100045
J	Mangana, J; Cheng, PF; Schindler, K; Weide, B; Held, U; Frauchiger, AL; Romano, E; Kahler, KC; Rozati, S; Rechsteiner, M; Moch, H; Michielin, O; Garbe, C; Hauschild, A; Hoeller, C; Dummer, R; Goldinger, SM				Mangana, Joanna; Cheng, Phil F.; Schindler, Katja; Weide, Benjamin; Held, Ulrike; Frauchiger, Anna L.; Romano, Emanuella; Kaehler, Katharina C.; Rozati, Sima; Rechsteiner, Markus; Moch, Holger; Michielin, Olivier; Garbe, Claus; Hauschild, Axel; Hoeller, Christoph; Dummer, Reinhard; Goldinger, Simone M.			Analysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?	PLOS ONE			English	Article							METASTATIC MELANOMA; CUTANEOUS MELANOMA; CLINICAL-RESPONSE; IPILIMUMAB; TRIAL; IMMUNOTHERAPY; CHEMOTHERAPY; METAANALYSIS; MULTICENTER; VEMURAFENIB	Ipilimumab and tremelimumab are humanmonoclonal antibodies (Abs) against cytotoxic Tlymphocyte antigen-4 (CTLA-4). Ipilimumab was the first agent to show a statistically significant benefit in overall survival in advanced melanoma patients. Currently, there is no proven association between the BRAFV600 mutation and the disease control rate in response to ipilimumab. This analysis was carried out to assess if BRAFV600 and NRAS mutation status affects the clinical outcome of anti-CTLA-4-treated melanoma patients. This is a retrospective multi-center analysis of 101 patients, with confirmed BRAF and NRAS mutation status, treated with anti-CTLA-4 antibodies from December 2006 until August 2012. The median overall survival, defined from the treatment start date with the anti-CTLA-4. Abs-treatment to death or till last follow up, of BRAFV600 or NRAS mutant patients (n = 62) was 10.12 months (95% CI 6.78-13.2) compared to 8.26 months (95% CI 6.02-19.9) in BRAFV600/NRASwt subpopulation (n = 39) (p = 0.67). The median OS of NRAS mutated patients (n = 24) was 12.1 months and although was prolonged compared to the median OS of BRAF mutated patients (n = 38, mOS = 8.03months) or BRAFV600/NRASwt patients (n = 39, mOS = 8.26 months) the difference didn't reach statistical significance (p = 0.56). 69 patients were able to complete 4 cycles of anti-CTLA-4 treatment. Of the 24 patients treated with selected BRAF- or MEK-inhibitors, 16 patients received anti-CTLA 4 Abs following either a BRAF or MEK inhibitor with only 8 of them being able to finish 4 cycles of treatment. Based on our results, there is no difference in the median OS in patients treated with anti-CTLA-4 Abs implying that the BRAF/NRAS mutation status alone is not sufficient to predict the outcome of patients treated with anti-CTLA-4 Abs.	[Mangana, Joanna; Cheng, Phil F.; Frauchiger, Anna L.; Dummer, Reinhard; Goldinger, Simone M.] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; [Schindler, Katja; Hoeller, Christoph] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Weide, Benjamin; Garbe, Claus] Univ Tubingen Hosp, Dept Dermatol, Tubingen, Germany; [Rechsteiner, Markus; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Romano, Emanuella; Michielin, Olivier] CHUV Lausanne, Dept Oncol, Lausanne, Switzerland; [Kaehler, Katharina C.; Hauschild, Axel] Univ Hosp Schleswig Holstein, Dept Dermatol, Kiel, Germany; [Rozati, Sima] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Held, Ulrike] Univ Zurich Hosp, Horten Ctr Patient Oriented Res & Knowledge Trans, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; Medical University of Vienna; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Kiel; Schleswig Holstein University Hospital; Stanford University; University of Zurich; University Zurich Hospital	Dummer, R (corresponding author), Univ Zurich Hosp, Dept Dermatol, Gloriastr 31, CH-8091 Zurich, Switzerland.	reinhard.dummer@usz.ch; simone.goldinger@usz.ch	Michielin, Olivier/ABE-7924-2020; Held, Ulrike/O-8328-2019; Weide, Benjamin/N-3698-2013; Cheng, Phil/AAN-8567-2021; Garbe, Claus/ABH-2128-2021	Cheng, Phil/0000-0003-2940-006X; Garbe, Claus/0000-0001-8530-780X; Romano, Emanuela/0000-0002-1574-5545	Roche; Bristol-Myers Squibb	Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb)	This work was partially funded by Roche and Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascierto PA, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-116; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Bucheit AD, 2013, CANCER-AM CANCER SOC, V119, P3821, DOI 10.1002/cncr.28306; Carlino MS, 2014, BRIT J CANCER, V111, P292, DOI 10.1038/bjc.2014.287; Chang David Z, 2004, J Transl Med, V2, P46, DOI 10.1186/1479-5876-2-46; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ekedahl H, 2013, BRIT J DERMATOL, V169, P1049, DOI 10.1111/bjd.12504; Ellerhorst JA, 2011, CLIN CANCER RES, V17, P229, DOI 10.1158/1078-0432.CCR-10-2276; Flaherty KT, 2014, LANCET ONCOL, V15, P297, DOI 10.1016/S1470-2045(14)70007-5; Frauchiger AL, PROGNOSTIC RELEVANCE; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hocker T, 2007, HUM MUTAT, V28, P578, DOI 10.1002/humu.20481; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; Jakob JA, 2012, CANCER-AM CANCER SOC, V118, P4014, DOI 10.1002/cncr.26724; Johnson DB, 2013, J CLIN ONCOL, V31; Joseph RW, 2012, J IMMUNOTHER, V35, P66, DOI 10.1097/CJI.0b013e3182372636; Komenaka I, 2004, CLIN DERMATOL, V22, P251, DOI 10.1016/j.clindermatol.2003.12.001; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Lee JH, 2011, BRIT J DERMATOL, V164, P776, DOI 10.1111/j.1365-2133.2010.10185.x; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Meckbach D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089218; Meckbach D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086194; RCore Team, 2020, R LANG ENV STAT COMP; Ribas A, 2013, J CLIN ONCOL, V31, P616, DOI 10.1200/JCO.2012.44.6112; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Schlaak M, 2013, BRIT J DERMATOL, V168, P708, DOI 10.1111/bjd.12140; Shahabi V, 2012, CANCER IMMUNOL IMMUN, V61, P733, DOI 10.1007/s00262-012-1227-3; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Sznol M, 2009, CURR ONCOL REP, V11, P397, DOI 10.1007/s11912-009-0053-z; Ugurel S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000236; von Moos R, 2012, ANN ONCOL, V23, P531, DOI 10.1093/annonc/mdr126; Voskens CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053745; Weber JS, 2013, CANCER-AM CANCER SOC, V119, P1675, DOI 10.1002/cncr.27969; Wilson MA, 2014, CLIN CANCER RES, V20, P3328, DOI 10.1158/1078-0432.CCR-14-0093	41	24	25	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139438	10.1371/journal.pone.0139438	http://dx.doi.org/10.1371/journal.pone.0139438			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426340	Green Published, Green Accepted, gold			2022-12-27	WOS:000362177100060
J	Pei, LL; Kang, YJ; Cheng, Y; Yan, H				Pei, Leilei; Kang, Yijun; Cheng, Yue; Yan, Hong			The Association of Maternal Lifestyle with Birth Defects in Shaanxi Province, Northwest China	PLOS ONE			English	Article							PREGNANCY; ALCOHOL; SMOKING; RISK; PREVALENCE; CONSUMPTION; TOBACCO; COHORT	Background The main objective was to investigate the burden of birth defects among alive infants and explore the impact of maternal lifestyle during pregnancy on the burden of birth defects in Northwest China. Methods A stratified multi-stage sampling method was used to study infants born during 2010-2013 (and their mothers) in Shaanxi province of Northwest China. Socio-demographic information was collected using a structured questionnaire, and medical records from the local hospitals were used to determine the final diagnosis of birth defects. Poisson regression analysis was performed to assess the association between maternal lifestyles during pregnancy and the burden of birth defects, while adjusting for potential confounders. Results We sampled 29098 infants, of whom 629 (i.e. 216.17 per 10000) were observed to have congenital defects. Cardiovascular system defects (77.32 per 10000) were found to be the most common. Mothers who had ever consumed alcohol during pregnancy were found to have infants with a higher prevalence of some categories of birth defects, including nervous system (Prevalence Rate Ratio, PRR: 14.67, 95% CI: 1.94, 110.92), cardiovascular system (PRR: 3.22, 95% CI: 1.02, 10.16) and oral clefts (PRR: 9.02, 95% CI: 2.08, 39.10) in contrast to infants of mothers without any alcohol consumption. Maternal passive smoking during pregnancy lead to the increased burden of malformations of eye, ear, face and neck (PRR: 1.95, 95% CI: 1.15, 3.33), cardiovascular system (PRR: 1.70, 95% CI: 1.25, 2.31) and respiratory system (PRR: 9.94, 95% CI: 2.37, 41.76) in their newborns. Further, tea or coffee consumption during pregnancy was positively correlated with the burden of specific birth defects, such as cardiovascular system (PRR: 2.44, 95% CI: 1.33, 4.46) and genital organs (PRR: 14.72, 95% CI: 1.87, 116.11) among infants. Conclusions The prevalence of birth defects was high in Shaanxi province of Northwest China. The unhealthy lifestyles of mothers during pregnancy may increase the prevalence of congenital malformations. These findings in future may have some important implications for prevention of birth defects in Northwest China.	[Pei, Leilei; Kang, Yijun; Yan, Hong] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian, Shaanxi, Peoples R China; [Cheng, Yue] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Nutr & Food Safety Res, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yan, H (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Xian, Shaanxi, Peoples R China.	yhpaper605@sina.com	Cheng, Yue/Z-4456-2019		National Science Foundation of China [81230016]; Research Support Program for Young Teachers in Xi'an Jiaotong University [DWSQc130000033]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Support Program for Young Teachers in Xi'an Jiaotong University	This work was supported by the National Science Foundation of China (81230016) and the Research Support Program for Young Teachers in Xi'an Jiaotong University (DWSQc130000033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE A, 1979, CLIN PHARMACOL THER, V25, P447; Aqrabawi H E, 2008, East Mediterr Health J, V14, P356; ARNAUD MJ, 1983, TOXICOL LETT, V16, P271, DOI 10.1016/0378-4274(83)90187-X; Bower C., REPORT BIRTH DEFECTS; Center for Disease Control and Prevention, 2011, 10 THINGS YOU NEED K; Centers for Disease Control and Prevention, PRAMS SMOK PREGN RIS; Cheng N, 2003, ANN TROP PAEDIATR, V23, P25, DOI 10.1179/000349803125002823; Czeizel Andrew E, 2004, Int J Med Sci, V1, P50; Desrosiers TA, 2012, OCCUP ENVIRON MED, V69, P493, DOI 10.1136/oemed-2011-100245; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; JACOBSON SW, 1991, NEUROTOXICOL TERATOL, V13, P535, DOI 10.1016/0892-0362(91)90062-2; Kim MA, 2012, J KOREAN MED SCI, V27, P1233, DOI 10.3346/jkms.2012.27.10.1233; Knutti R, 1982, Arch Toxicol Suppl, V5, P187; Kvalvik LG, 2012, PEDIATR RES, V72, P101, DOI 10.1038/pr.2012.36; Leite M, 2014, ACTA OBSTET GYN SCAN, V93, P825, DOI 10.1111/aogs.12433; Li Ying, 2009, Beijing Da Xue Xue Bao Yi Xue Ban, V41, P414; Luo YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081369; National Statistics, 2006, STAT SMOK ENGL 2006; Okubo H, 2015, NUTR RES, V35, P309, DOI 10.1016/j.nutres.2015.02.009; Parkington HC, 2014, J PHYSIOL-LONDON, V592, P2591, DOI 10.1113/jphysiol.2013.262873; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Rutstein S. O., 2004, DHS COMP REPORTS; Talbot Prudence, 2008, Birth Defects Research, V84, P61, DOI 10.1002/bdrc.20120; Tu L, 2012, IRAN J PUBLIC HEALTH, V41, P20; Vaktskjold A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-83; Werler MM, 2015, PAEDIATR PERINAT EP, V29, P3, DOI 10.1111/ppe.12163; World Health Organization, 1999, WHO M; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; Yang M, 2015, J MATERN-FETAL NEO M, V28, P799, DOI 10.3109/14767058.2014.932767; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125	31	23	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139452	10.1371/journal.pone.0139452	http://dx.doi.org/10.1371/journal.pone.0139452			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422609	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700117
J	Demers, LA; Olson, EA; Crowley, DJ; Rauch, SL; Rosso, IM				Demers, Lauren A.; Olson, Elizabeth A.; Crowley, David J.; Rauch, Scott L.; Rosso, Isabelle M.			Dorsal Anterior Cingulate Thickness Is Related to Alexithymia in Childhood Trauma-Related PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; EMOTIONAL AWARENESS; CORTICAL THICKNESS; GENERAL-POPULATION; HUMAN BRAIN; CORTEX; ACTIVATION; METAANALYSIS; MATTER	Alexithymia, or "no words for feelings", is highly prevalent in samples with childhood maltreatment and posttraumatic stress disorder (PTSD). The dorsal anterior cingulate cortex (dACC) has been identified as a key region involved in alexithymia, early life trauma, and PTSD. Functional alterations in the dACC also have been associated with alexithymia in PTSD. This study examined whether dACC morphology is a neural correlate of alexithymia in child maltreatment-related PTSD. Sixteen adults with PTSD and a history of childhood sexual abuse, physical abuse, or exposure to domestic violence, and 24 healthy controls (HC) completed the Toronto Alexithymia Scale 20 (TAS-20) and underwent magnetic resonance imaging. Cortical thickness of the dACC was measured using FreeSurfer, and values were correlated with TAS-20 scores, controlling for sex and age, in both groups. Average TAS-20 score was significantly higher in the PTSD than the HC group. TAS-20 scores were significantly positively associated with dACC thickness only in the PTSD group. This association was strongest in the left hemisphere and for TAS-20 subscales that assess difficulty identifying and describing feelings. We found that increasing dACC gray matter thickness is a neural correlate of greater alexithymia in the context of PTSD with childhood maltreatment. While findings are correlational, they motivate further inquiry into the relationships between childhood adversity, emotional awareness and expression, and dACC morphologic development in trauma-related psychopathology.	[Demers, Lauren A.; Olson, Elizabeth A.; Crowley, David J.; Rauch, Scott L.; Rosso, Isabelle M.] McLean Hosp, Ctr Depress Anxiety & Stress Res, Belmont, MA 02178 USA; [Olson, Elizabeth A.; Crowley, David J.; Rauch, Scott L.; Rosso, Isabelle M.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA	Harvard University; McLean Hospital; Harvard University; Harvard Medical School	Rosso, IM (corresponding author), McLean Hosp, Ctr Depress Anxiety & Stress Res, 115 Mill St, Belmont, MA 02178 USA.	irosso@hms.harvard.edu	Rosso, Isabelle M/AAA-6166-2019; Elhai, Jon D/U-1901-2017; Olson, Elizabeth/M-7981-2018	Elhai, Jon D/0000-0001-5205-9010; Olson, Elizabeth/0000-0003-4617-8050; Rosso, Isabelle/0000-0001-6988-3858; Crowley, David/0000-0001-9770-4482	Dana Foundation; NIMH [R01MH096987]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096987] Funding Source: NIH RePORTER	Dana Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the Dana Foundation (IMR) and NIMH R01MH096987 (IMR).	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; Banissy MJ, 2012, NEUROIMAGE, V62, P2034, DOI 10.1016/j.neuroimage.2012.05.081; Berthoz S, 2002, AM J PSYCHIAT, V159, P961, DOI 10.1176/appi.ajp.159.6.961; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Borsci G, 2009, J AFFECT DISORDERS, V114, P208, DOI 10.1016/j.jad.2008.07.013; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Chatterjee D, 2007, BRAIN RES, V1158, P11, DOI 10.1016/j.brainres.2007.04.069; Cohen RA, 2006, BIOL PSYCHIAT, V59, P975, DOI 10.1016/j.biopsych.2005.12.016; Crozier JC, 2014, DEV PSYCHOPATHOL, V26, P491, DOI 10.1017/S095457941400008X; De Bellis MD, 2000, AM J PSYCHIAT, V157, P1175, DOI 10.1176/appi.ajp.157.7.1175; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Frewen P, 2008, PSYCHOSOM MED, V70, P27, DOI 10.1097/PSY.0b013e31815f66d4; Frewen PA, 2008, J TRAUMA STRESS, V21, P243, DOI 10.1002/jts.20320; Frewen PA, 2008, J ABNORM PSYCHOL, V117, P171, DOI 10.1037/0021-843X.117.1.171; Frewen PA, 2006, ANN NY ACAD SCI, V1071, P397, DOI 10.1196/annals.1364.029; Giuliani NR, 2011, BIOL PSYCHOL, V86, P379, DOI 10.1016/j.biopsycho.2010.11.010; Grabe HJ, 2014, HUM BRAIN MAPP, V35, P5932, DOI 10.1002/hbm.22595; Gulec MY, 2013, J AFFECT DISORDERS, V146, P137, DOI 10.1016/j.jad.2012.06.033; Gundel H, 2004, PSYCHOSOM MED, V66, P132, DOI 10.1097/01.PSY.0000097348.45087.96; Heinzel A, 2012, J AFFECT DISORDERS, V136, P1252, DOI 10.1016/j.jad.2011.06.012; Heinzel A, 2010, PSYCHOTHER PSYCHOSOM, V79, P363, DOI 10.1159/000320121; Heinzel A, 2010, NEUROREPORT, V21, P998, DOI 10.1097/WNR.0b013e32833f38e0; Helmeke C, 2001, CEREB CORTEX, V11, P717, DOI 10.1093/cercor/11.8.717; Honkalampi K, 2000, J PSYCHOSOM RES, V48, P99, DOI 10.1016/S0022-3999(99)00083-5; HYER L, 1990, J CLIN PSYCHIAT, V51, P243; Kanai R, 2011, J NEUROSCI, V31, P6620, DOI 10.1523/JNEUROSCI.5864-10.2011; Kano M, 2003, BRAIN, V126, P1474, DOI 10.1093/brain/awg131; Karlsson H, 2008, BRIT J PSYCHIAT, V192, P32, DOI 10.1192/bjp.bp.106.034728; Koven NS, 2011, SOC COGN AFFECT NEUR, V6, P582, DOI 10.1093/scan/nsq084; Krystal H., 1988, INTEGRATION SELF HEA; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Mantani T, 2005, BIOL PSYCHIAT, V57, P982, DOI 10.1016/j.biopsych.2005.01.047; McLaughlin KA, 2014, BIOL PSYCHIAT, V76, P629, DOI 10.1016/j.biopsych.2013.08.016; McRae K, 2008, NEUROIMAGE, V41, P648, DOI 10.1016/j.neuroimage.2008.02.030; Meriau K, 2006, NEUROIMAGE, V33, P1016, DOI 10.1016/j.neuroimage.2006.07.031; Paivio SC, 2004, CHILD ABUSE NEGLECT, V28, P339, DOI 10.1016/j.chiabu.2003.11.018; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Reynolds S, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-83; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Spitzer C, 2007, EUR ARCH PSY CLIN N, V257, P191, DOI 10.1007/s00406-006-0669-z; Taylor G.J., 1997, DISORDERS AFFECT REG; Teicher MH, 2014, BIOL PSYCHIAT, V76, P297, DOI 10.1016/j.biopsych.2013.09.016; Teicher MH, 2003, NEUROSCI BIOBEHAV R, V27, P33, DOI 10.1016/S0149-7634(03)00007-1; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; van der Velde J, 2013, NEUROSCI BIOBEHAV R, V37, P1774, DOI 10.1016/j.neubiorev.2013.07.008; Yates TM., 2009, UNDERSTANDING NONSUI; Zlotnick C, 2001, J TRAUMA STRESS, V14, P177, DOI 10.1023/A:1007899918410	53	14	14	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139807	10.1371/journal.pone.0139807	http://dx.doi.org/10.1371/journal.pone.0139807			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439117	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300059
J	Miethe, S; Rasetti-Escargueil, C; Avril, A; Liu, Y; Chahboun, S; Korkeala, H; Mazuet, C; Popoff, MR; Pelat, T; Thullier, P; Sesardic, D; Hust, M				Miethe, Sebastian; Rasetti-Escargueil, Christine; Avril, Arnaud; Liu, Yvonne; Chahboun, Siham; Korkeala, Hannu; Mazuet, Christelle; Popoff, Michel-Robert; Pelat, Thibaut; Thullier, Philippe; Sesardic, Dorothea; Hust, Michael			Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E	PLOS ONE			English	Article							PHRENIC NERVE-HEMIDIAPHRAGM; FOOD-BORNE BOTULISM; HIGH-AFFINITY; RECOMBINANT ANTIBODIES; ENDOPEPTIDASE ACTIVITY; GERMLINE HUMANIZATION; MONOCLONAL-ANTIBODIES; CLINICAL-APPLICATIONS; BACILLUS-ANTHRACIS; IMMUNE GLOBULIN	Background Botulinum neurotoxins (BoNTs) are considered to be the most toxic substances known on earth and are responsible for human botulism, a life-threatening disease characterized by flaccid muscle paralysis that occurs naturally by food-poisoning or colonization of the gastrointestinal tract by BoNT-producing clostridia. BoNTs have been classified as category A agent by the Centers of Disease Control and Prevention (CDC) and are listed among the six agents with the highest risk to be used as bioweapons. Neutralizing antibodies are required for the development of effective anti-botulism therapies to deal with the potential risk of exposure. Results In this study, a macaque (Macaca fascicularis) was immunized with recombinant light chain of BoNT/E3 and an immune phage display library was constructed. After a multi-step panning, several antibody fragments (scFv, single chain fragment variable) with nanomolar affinities were isolated, that inhibited the endopeptidase activity of pure BoNT/E3 in vitro by targeting its light chain. Furthermore, three scFv were confirmed to neutralize BoNT/E3 induced paralysis in an ex vivo mouse phrenic nerve-hemidiaphragm assay. The most effective neutralization (20LD50/mL, BoNT/E3) was observed with scFv ELC18, with a minimum neutralizing concentration at 0.3 nM. Furthermore, ELC18 was highly effective in vivo when administered as an scFv-Fc construct. Complete protection of 1LD50 BoNT/E3 was observed with 1.6 ng/dose in the mouse flaccid paralysis assay. Conclusion These scFv-Fcs antibodies are the first recombinant antibodies neutralizing BoNT/E by targeting its light chain. The human-like nature of the isolated antibodies is predicting a good tolerance for further clinical development.	[Miethe, Sebastian; Hust, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, D-38106 Braunschweig, Germany; [Rasetti-Escargueil, Christine; Liu, Yvonne; Sesardic, Dorothea] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar EN6 3QG, Herts, England; [Avril, Arnaud; Chahboun, Siham; Pelat, Thibaut; Thullier, Philippe] IRBA, CRSSA, Dept Microbiol, Unite Biotechnol Anticorps & Toxines, F-38702 La Tronche, France; [Korkeala, Hannu] Univ Helsinki, Fac Vet Med, Ctr Excellence Microbial Food Safety Res, Dept Food Hyg & Environm Hlth, FIN-00014 Helsinki, Finland; [Mazuet, Christelle; Popoff, Michel-Robert] Inst Pasteur, Unite Bacteries Anaerobies & Toxines, F-75015 Paris, France	Braunschweig University of Technology; National Institute for Biological Standards & Control; University of Helsinki; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Hust, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Biotechnol & Bioinformat, Abt Biotechnol, Spielmannstr 7, D-38106 Braunschweig, Germany.	m.hust@tu-bs.de	Mazuet, Christelle/O-7731-2016; Popoff, Michel/O-7719-2016	Mazuet, Christelle/0000-0001-7619-9050; Popoff, Michel/0000-0001-9305-8989; Rasetti-Escargueil, Christine/0000-0003-0661-695X; AVRIL, Arnaud/0000-0003-1759-7256; Pelat, thibaut/0000-0003-4312-1032; Korkeala, Hannu/0000-0003-0699-1290; Hust, Michael/0000-0003-3418-6045	European Community [241832]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086566] Funding Source: NIH RePORTER; National Centre for the Replacement [G1000086/1] Funding Source: researchfish	European Community(European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Centre for the Replacement	The authors acknowledge funding from the European Community's Seventh Framework Program (FP7/2007-2013) under agreement no. 241832 granted to the AntiBotABE project (http://www.antibotabe.com).	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P299; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Avril Arnaud, 2014, Curr Drug Discov Technol, V11, P20; Bakherad H, 2013, MOL BIOTECHNOL, V55, P159, DOI 10.1007/s12033-013-9669-1; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Bozheyeva G, 1999, 1 MONTR I INT STUD; Broad WJ, 1998, NY TIMES; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Chahboun S, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-113; Chassagne S, 2004, MOL IMMUNOL, V41, P539, DOI 10.1016/j.molimm.2004.03.040; Dressler D, 2013, J NEUROL, V260, P701, DOI 10.1007/s00415-012-6615-2; Fischer A, 2008, J BIOL CHEM, V283, P3997, DOI 10.1074/jbc.M707917200; Froude JW, 2011, MABS-AUSTIN, V3, P517, DOI 10.4161/mabs.3.6.17621; Froude JW, 2011, TOXINS, V3, P1433, DOI 10.3390/toxins3111433; Fujinaga Y, 2013, CURR TOP MICROBIOL, V364, P45, DOI 10.1007/978-3-642-33570-9_3; Garcia-Rodriguez C, 2011, PROTEIN ENG DES SEL, V24, P321, DOI 10.1093/protein/gzq111; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Gupta A, 2005, NEUROLOGY, V65, P1694, DOI 10.1212/01.wnl.0000187127.92446.4c; Hibbs RG, 1996, CLIN INFECT DIS, V23, P337, DOI 10.1093/clinids/23.2.337; Horowitz BZ, 2010, CLIN TOXICOL, V48, P880, DOI 10.3109/15563650.2010.526943; Hulseweh B, 2014, MABS-AUSTIN, V6, P717, DOI 10.4161/mabs.28170; Hust M, 2011, J BIOTECHNOL, V152, P159, DOI 10.1016/j.jbiotec.2010.09.945; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Jalava K, 2011, EUROSURVEILLANCE, V16, P8; Jones RGA, 2008, J IMMUNOL METHODS, V329, P92, DOI 10.1016/j.jim.2007.09.014; Kubota T, 1997, APPL ENVIRON MICROB, V63, P1214, DOI 10.1128/AEM.63.4.1214-1218.1997; Kugler J, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0125-0; Kukreja RV, 2010, BIOCHEMISTRY-US, V49, P2510, DOI 10.1021/bi902096r; Laffly E, 2005, ANTIMICROB AGENTS CH, V49, P3414, DOI 10.1128/AAC.49.8.3414-3420.2005; Lim ECH, 2010, NAT REV NEUROL, V6, P624, DOI 10.1038/nrneurol.2010.149; Long SS, 2007, PEDIATR INFECT DIS J, V26, P261, DOI 10.1097/01.inf.0000256442.06231.17; Mazuet C, 2015, J CLIN MICROBIOL, V53, P722, DOI 10.1128/JCM.02942-14; Meng Q, 2012, ANAL BIOCHEM, V430, P141, DOI 10.1016/j.ab.2012.08.005; Miethe S, 2014, MABS-AUSTIN, V6, P446, DOI 10.4161/mabs.27773; National Research Council, 2011, GUIDE CARE USE LAB A; Pathan Nuzhat I., 2004, Proceedings of the American Association for Cancer Research Annual Meeting, V45, P163; Pelat T, 2007, ANTIMICROB AGENTS CH, V51, P2758, DOI 10.1128/AAC.01528-06; Pelat T, 2009, MINI-REV MED CHEM, V9, P1633, DOI 10.2174/138955709791012283; Pelat T, 2009, MABS-AUSTIN, V1, P377, DOI 10.4161/mabs.1.4.8635; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pelat T, 2008, J MOL BIOL, V384, P1400, DOI 10.1016/j.jmb.2008.10.033; Pingeon JM, 2011, EUROSURVEILLANCE, V16, P5; Raphael BH, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-192; Rasetti-Escargueil C, 2011, TOXICON, V57, P1008, DOI 10.1016/j.toxicon.2011.04.003; Rasetti-Escargueil C, 2009, TOXICON, V53, P503, DOI 10.1016/j.toxicon.2009.01.019; Rosenwasser LJ, 2003, J ALLERGY CLIN IMMUN, V112, P563, DOI 10.1067/mai.2003.1709; Rulker T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037242; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schuck P, 1996, ANAL BIOCHEM, V240, P262, DOI 10.1006/abio.1996.0356; Schutte M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006625; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Tan P, 2002, J IMMUNOL, V169, P1119, DOI 10.4049/jimmunol.169.2.1119; Thullier P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065855; Thullier P, 2010, MABS-AUSTIN, V2, P528, DOI 10.4161/mabs.2.5.12545; Thullier P, 2010, J MOL BIOL, V396, P1439, DOI 10.1016/j.jmb.2009.12.041; Tonello F, 1996, ADV EXP MED BIOL, V389, P251; WEBER JT, 1993, J INFECT DIS, V167, P451, DOI 10.1093/infdis/167.2.451; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Wheeler A, 2013, TOXICOLOGY, V306, P124, DOI 10.1016/j.tox.2013.02.006	63	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139905	10.1371/journal.pone.0139905	http://dx.doi.org/10.1371/journal.pone.0139905			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440796	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300073
J	Ndunguru, J; Sseruwagi, P; Tairo, F; Stomeo, F; Maina, S; Djinkeng, A; Kehoe, M; Boykin, LM				Ndunguru, Joseph; Sseruwagi, Peter; Tairo, Fred; Stomeo, Francesca; Maina, Solomon; Djinkeng, Appolinaire; Kehoe, Monica; Boykin, Laura M.			Analyses of Twelve New Whole Genome Sequences of Cassava Brown Streak Viruses and Ugandan Cassava Brown Streak Viruses from East Africa: Diversity, Supercomputing and Evidence for Further Speciation	PLOS ONE			English	Article							TABACI SPECIES COMPLEX; RECOMBINANT SEQUENCES; MOSAIC STRUCTURE; DISEASE; IDENTIFICATION; RESISTANCE; EVOLUTION; INFERENCE; TANZANIA; REVEALS	Cassava brown streak disease is caused by two devastating viruses, Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV) which are frequently found infecting cassava, one of sub-Saharan Africa's most important staple food crops. Each year these viruses cause losses of up to $100 million USD and can leave entire families without their primary food source, for an entire year. Twelve new whole genomes, including seven of CBSV and five of UCBSV were uncovered in this research, doubling the genomic sequences available in the public domain for these viruses. These new sequences disprove the assumption that the viruses are limited by agro-ecological zones, show that current diagnostic primers are insufficient to provide confident diagnosis of these viruses and give rise to the possibility that there may be as many as four distinct species of virus. Utilizing NGS sequencing technologies and proper phylogenetic practices will rapidly increase the solution to sustainable cassava production.	[Ndunguru, Joseph; Sseruwagi, Peter; Tairo, Fred] Mikocheni Agr Res Inst, Dar Es Salaam, Tanzania; [Stomeo, Francesca; Maina, Solomon; Djinkeng, Appolinaire] Kenya BecA ILRI Hub, Int Livestock Res Inst Nairobi, Biosci Eastern & Cent Africa, Nairobi 00100, Kenya; [Kehoe, Monica] Dept Agr & Food Western Australia, Crop Protect Branch, Perth, WA 6983, Australia; [Boykin, Laura M.] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia; [Boykin, Laura M.] Sch Chem & Biochem, Perth, WA 6009, Australia	CGIAR; International Livestock Research Institute (ILRI); University of Western Australia	Boykin, LM (corresponding author), Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Perth, WA 6009, Australia.	laura.boykin@uwa.edu.au	Boykin, Laura/H-8876-2014	Boykin, Laura/0000-0002-6101-1921; stomeo, francesca/0000-0003-1776-6128; Djikeng, Appolinaire/0000-0001-9271-3419	Bill and Melinda Gates Foundation "Regional Cassava Virus Diseases Diagnostic Project" [51466]	Bill and Melinda Gates Foundation "Regional Cassava Virus Diseases Diagnostic Project"	This work was funded by the Bill and Melinda Gates Foundation (Grant no. 51466) "Regional Cassava Virus Diseases Diagnostic Project" awarded to Joseph Ndunguru.	Aberer AJ, 2014, MOL BIOL EVOL, V31, P2553, DOI 10.1093/molbev/msu236; Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Chare ER, 2006, ARCH VIROL, V151, P933, DOI 10.1007/s00705-005-0675-x; Dombrovsky A, 2014, PEST MANAG SCI, V70, P1553, DOI 10.1002/ps.3735; Drummond AJ, 2010, GENEIOUS V5 1; Fauquet CM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-64; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; HAHN SK, 1989, CROP PROT, V8, P147, DOI 10.1016/0261-2194(89)90022-7; Hillocks R. J., 1999, African Journal of Root and Tuber Crops, V3, P57; Hillocks RJ, 1996, INT J PEST MANAGE, V42, P285, DOI 10.1080/09670879609372008; ICTV, 2014, COD VIR CLASS; Karasev AV, 2013, ANNU REV PHYTOPATHOL, V51, P571, DOI 10.1146/annurev-phyto-082712-102332; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kehoe MA, 2014, VIRUS RES, V184, P87, DOI 10.1016/j.virusres.2014.02.012; Kehoe MA, 2015, PLANT PATHOL; Kehoe MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105770; Kehoe MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104580; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Legg JP, 2014, VIRUS RES, V186, P61, DOI 10.1016/j.virusres.2013.11.018; Legg JP, 1998, INT J PEST MANAGE, V44, P17, DOI 10.1080/096708798228473; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Mohammed IU, 2012, ADV VIROL, V2012, DOI 10.1155/2012/795697; Monger WA, 2010, ARCH VIROL, V155, P429, DOI 10.1007/s00705-009-0581-8; Mware B, 2009, JGMV, V1, P040, DOI [DOI 10.1007/S007050070078, 10.5897/JGMV.9000003, DOI 10.5897/JGMV.9000003]; Ndunguru J, 2009, P REG CASS VIR DIAGN; Nyalugwe EP, 2015, PLANT PATHOL; Ogwok E, 2015, PLANT PATHOL, V64, P1235, DOI 10.1111/ppa.12343; Ohshima K, 2002, J GEN VIROL, V83, P1511, DOI 10.1099/0022-1317-83-6-1511; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Polston JE, 2014, PEST MANAG SCI, V70, P1547, DOI 10.1002/ps.3738; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rodrigo A, 2008, PHILOS T R SOC B, V363, P3893, DOI 10.1098/rstb.2008.0173; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SMITH JM, 1992, J MOL EVOL, V34, P126; Susko E, 2004, MOL BIOL EVOL, V21, P1629, DOI 10.1093/molbev/msh159; Tromas N, 2014, J GEN VIROL, V95, P724, DOI 10.1099/vir.0.060822-0; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Xu QiuHong, 2010, Jiangsu Journal of Agricultural Sciences, V26, P390	56	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139321	10.1371/journal.pone.0139321	http://dx.doi.org/10.1371/journal.pone.0139321			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439260	gold, Green Submitted, Green Published			2022-12-27	WOS:000362510300022
J	Wong, DVT; Lima, RCP; Carvalho, CBM; Borges, VF; Wanderley, CWS; Bem, AXC; Leite, CAVG; Teixeira, MA; Batista, GLP; Silva, RL; Cunha, TM; Brito, GAC; Almeida, PRC; Cunha, FQ; Ribeiro, RA				Wong, Deysi V. T.; Lima-Junior, Roberto C. P.; Carvalho, Cibele B. M.; Borges, Vanessa F.; Wanderley, Carlos W. S.; Bem, Amanda X. C.; Leite, Caio A. V. G.; Teixeira, Maraiza A.; Batista, Gabriela L. P.; Silva, Rangel L.; Cunha, Thiago M.; Brito, Gerly A. C.; Almeida, Paulo R. C.; Cunha, Fernando Q.; Ribeiro, Ronaldo A.			The Adaptor Protein Myd88 Is a Key Signaling Molecule in the Pathogenesis of Irinotecan-Induced Intestinal Mucositis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHEMOTHERAPY-INDUCED DIARRHEA; NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; FACTOR-KAPPA-B; CANCER-CHEMOTHERAPY; TNF-ALPHA; EXPRESSION; TLR; ACTIVATION	Intestinal mucositis is a common side effect of irinotecan-based anticancer regimens. Mucositis causes cell damage, bacterial/endotoxin translocation and production of cytokines including IL-1 and IL-18. These molecules and toll-like receptors (TLRs) activate a common signaling pathway that involves the Myeloid Differentiation adaptor protein, MyD88, whose role in intestinal mucositis is unknown. Then, we evaluated the involvement of TLRs and MyD88 in the pathogenesis of irinotecan-induced intestinal mucositis. MyD88-, TLR2-or TLR9-knockout mice and C57BL/6 (WT) mice were given either saline or irinotecan (75 mg/kg, i.p. for 4 days). On day 7, animal survival, diarrhea and bacteremia were assessed, and following euthanasia, samples of the ileum were obtained for morphometric analysis, myeloperoxidase (MPO) assay and measurement of pro-inflammatory markers. Irinotecan reduced the animal survival (50%) and induced a pronounced diarrhea, increased bacteremia, neutrophil accumulation in the intestinal tissue, intestinal damage and more than twofold increased expression of MyD88 (200%), TLR9 (400%), TRAF6 (236%), IL-1 beta (405%), IL-18 (365%), COX-2 (2,777%) and NF-kappa B (245%) in the WT animals when compared with saline-injected group (P<0.05). Genetic deletion of MyD88, TLR2 or TLR9 effectively controlled the signs of intestinal injury when compared with irinotecan- administered WT controls (P<0.05). In contrast to the MyD88-/- and TLR2-/-mice, the irinotecan- injected TLR9-/-mice showed a reduced survival, a marked diarrhea and an enhanced expression of IL-18 versus irinotecan-injected WT controls. Additionally, the expression of MyD88 was reduced in the TLR2-/- or TLR9-/-mice. This study shows a critical role of the MyD88-mediated TLR2 and TLR9 signaling in the pathogenesis of irinotecan-induced intestinal mucositis.	[Wong, Deysi V. T.; Lima-Junior, Roberto C. P.; Wanderley, Carlos W. S.; Bem, Amanda X. C.; Leite, Caio A. V. G.; Teixeira, Maraiza A.; Batista, Gabriela L. P.; Ribeiro, Ronaldo A.] Univ Fed Ceara, Nucleus Study Tox Canc Treatment, Dept Physiol & Pharmacol, Fac Med, Fortaleza, Ceara, Brazil; [Wong, Deysi V. T.] Canc Inst Ceara, Mol Biol Lab, Dept Pathol, Fortaleza, Ceara, Brazil; [Carvalho, Cibele B. M.; Almeida, Paulo R. C.] Univ Fed Ceara, Dept Pathol & Forens Med, Fac Med, Fortaleza, Ceara, Brazil; [Borges, Vanessa F.; Silva, Rangel L.; Cunha, Thiago M.; Cunha, Fernando Q.] Univ Sao Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, Sao Paulo, Brazil; [Brito, Gerly A. C.] Univ Fed Ceara, Dept Morphol, Fac Med, Fortaleza, Ceara, Brazil; [Ribeiro, Ronaldo A.] Canc Inst Ceara, Dept Clin Oncol, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade de Sao Paulo; Universidade Federal do Ceara	Ribeiro, RA (corresponding author), Univ Fed Ceara, Nucleus Study Tox Canc Treatment, Dept Physiol & Pharmacol, Fac Med, Fortaleza, Ceara, Brazil.	devite06@gmail.com; ribeiror21@gmail.com	Brito, Gerly/AHB-3965-2022; Teixeira, Maraiza Alves/AAX-8722-2020; Silva, Rangel Leal/G-2009-2016; Cunha, Fernando Q/M-3090-2014; de Castro Brito, Gerly Anne/C-8597-2013; Lima-Júnior, Roberto CP/W-5095-2019; Cunha, Thiago M/B-7729-2012; Wong, Deysi Viviana Tenazoa/AAH-3575-2020; Wanderley, Carlos Wagner/R-4765-2016	Brito, Gerly/0000-0002-8214-4379; Silva, Rangel Leal/0000-0002-1322-7808; de Castro Brito, Gerly Anne/0000-0002-8214-4379; Lima-Júnior, Roberto CP/0000-0002-7033-655X; Cunha, Thiago M/0000-0003-1084-0065; Wong, Deysi Viviana Tenazoa/0000-0002-9741-7560; Wanderley, Carlos/0000-0003-2100-9963; Cunha, Fernando Queiroz/0000-0003-4755-1670	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308879/2009-0]; Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [23038.007544-201131]; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico [11.01.00/08]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico	Grants received by RAR: 308879/2009-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Website: www.cnpq.br; 23038.007544-201131, Fundacao Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, website: www.capes.gov.br; 11.01.00/08, Fundacao Cearense de Apoio ao Desenvolvimento Cientifico, website: www.funcap.ce.gov.br. The above mentioned funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves JC, 2006, CRIT CARE MED, V34, P461, DOI 10.1097/01.CCM.0000198527.71819.E1; Andreyev J, 2014, LANCET ONCOL, V15, pE447, DOI 10.1016/S1470-2045(14)70006-3; Arifa RDN, 2014, AM J PATHOL, V184, P2023, DOI 10.1016/j.ajpath.2014.03.012; Arnold Renee J Goldberg, 2005, J Support Oncol, V3, P227; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330; Chang CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031808; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; CUNHA FQ, 1994, IMMUNOLOGY, V81, P211; Fernandes-Alnemri T, 2013, J IMMUNOL, V191, P3995, DOI 10.4049/jimmunol.1301681; Frank M, 2015, J IMMUNOL, V194, P1983, DOI 10.4049/jimmunol.1402481; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Gibson RJ, 2006, SUPPORT CARE CANCER, V14, P890, DOI 10.1007/s00520-006-0040-y; Gibson RJ, 2013, SUPPORT CARE CANCER, V21, P313, DOI 10.1007/s00520-012-1644-z; Godshall CJ, 2002, J SURG RES, V102, P45, DOI 10.1006/jsre.2001.6319; Hausmann M, 2002, GASTROENTEROLOGY, V122, P1987, DOI 10.1053/gast.2002.33662; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P1349, DOI 10.1177/29.11.6172466; IKUNO N, 1995, J NATL CANCER I, V87, P1876, DOI 10.1093/jnci/87.24.1876; Kaczmarek A, 2012, J PATHOL, V226, P598, DOI 10.1002/path.3009; Kase Y, 1997, JPN J PHARMACOL, V75, P399, DOI 10.1254/jjp.75.399; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Keefe DM, 2007, CANCER-AM CANCER SOC, V109, P820, DOI 10.1002/cncr.22484; Kurita A, 2000, CANCER CHEMOTH PHARM, V46, P211, DOI 10.1007/s002800000151; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lima RCP, 2014, BRIT J PHARMACOL, V171, P2335, DOI 10.1111/bph.12584; Lima RCP, 2012, CANCER CHEMOTH PHARM, V69, P931, DOI 10.1007/s00280-011-1780-z; Lin HY, 2010, INT IMMUNOPHARMACOL, V10, P883, DOI 10.1016/j.intimp.2010.04.026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; MACPHERSON BR, 1978, DIGESTION, V17, P135, DOI 10.1159/000198104; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Melo MLP, 2008, CANCER CHEMOTH PHARM, V61, P775, DOI 10.1007/s00280-007-0534-4; Mullangi R, 2010, BIOMED CHROMATOGR, V24, P104, DOI 10.1002/bmc.1345; Nakao T, 2012, J SURG RES, V173, P341, DOI 10.1016/j.jss.2010.10.003; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reuter BK, 2004, EUR J IMMUNOL, V34, P2347, DOI 10.1002/eji.200425351; Richardson Gillian, 2007, J Oncol Pharm Pract, V13, P181, DOI 10.1177/1078155207077335; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; SAKAI H, 1995, N-S ARCH PHARMACOL, V351, P309; Santaolalla R, 2012, CURR OPIN GASTROEN, V28, P124, DOI 10.1097/MOG.0b013e3283506559; Shi DN, 2006, CELL RES, V16, P70, DOI 10.1038/sj.cr.7310009; Souza GR, 2015, PHARMACOL BIOCHEM BE, V134, P49, DOI 10.1016/j.pbb.2015.04.005; Sukhotnik I, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-17; van Vliet MJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000879; Yeoh ASJ, 2005, INT J RADIAT ONCOL, V63, P1295, DOI 10.1016/j.ijrobp.2005.04.041	46	42	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139985	10.1371/journal.pone.0139985	http://dx.doi.org/10.1371/journal.pone.0139985			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440613	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300090
J	Zhao, S; Wu, D; Wu, P; Wang, Z; Huang, J				Zhao, Shuai; Wu, Dang; Wu, Pin; Wang, Zhen; Huang, Jian			Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis	PLOS ONE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; CHRONIC LYMPHOCYTIC-LEUKEMIA; FAILURE-FREE SURVIVAL; REGULATORY T-CELLS; INTERLEUKIN-10 LEVELS; HODGKINS-DISEASE; CYTOKINE PRODUCTION; PHENOTYPIC CHARACTERISTICS; CLINICAL-SIGNIFICANCE; COLORECTAL-CARCINOMA	Background IL-10 is an important immunosuppressive cytokine which is frequently elevated in tumor microenvironment. Some studies have reported that overexpression of serous IL-10 is correlated with worse outcome in patients with malignant tumor. Here, we conducted a meta-analysis to assess the prognostic impact of serous IL-10 expression in cancer patients. Methods We searched PubMed and EBSCO for studies in evaluating the association of IL-10 expression-in serum and clinical outcome in cancer patients. Overall survival (OS) was the primary prognostic indicator and disease-free survival (DFS) was the secondary indicator. Extracted data were computed into odds ratios (ORs) and 95% confidence interval (CI) or a P value for survival at 1, 3 and 5 years. Pooled data were weighted using the Mantel-Haenszel Fixed-effect model. All statistical tests were two-sided. Results A total of 1788 patients with cancer from 21 published studies were incorporated into this meta-analysis. High level of serum IL-10 was significantly associated with worse OS at 1-year (OR = 3.70, 95% CI = 2.81 to 4.87, P < 0.00001), 3-year (OR = 3.33, 95% CI = 2.53 to 4.39, P < 0.0001) and 5-year (OR = 2.80, 95% CI = 1.90 to 4.10, P < 0.0001) of cancer. Subgroup analysis showed that the correlation between serous IL-10 expression and outcome of patients with solid tumors and hematological malignancies are consistent. The association of IL-10 with worse DFS at 1-year (OR = 3.34, 95% CI = 1.40 to 7.94, P = 0.006) and 2-year (OR = 3.91, 95% CI = 1.79 to 8.53, P = 0.0006) was also identified. Conclusions High expression of serous IL-10 leads to an adverse survival in most types of cancer. IL-10 is a valuable biomarker for prognostic prediction and targeting IL-10 treatment options for both solid tumors and hematological malignancies.	[Zhao, Shuai; Wu, Dang; Wu, Pin; Wang, Zhen; Huang, Jian] Zhejiang Univ, Key Lab Canc Prevent & Intervent, Prov Key Lab Mol Biol Med Sci, Canc Inst,Natl Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Shuai; Wu, Dang; Wang, Zhen; Huang, Jian] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Oncol, Hangzhou 310003, Zhejiang, Peoples R China; [Wu, Pin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Thorac Surg, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Key Lab Canc Prevent & Intervent, Prov Key Lab Mol Biol Med Sci, Canc Inst,Natl Minist Educ, Hangzhou 310003, Zhejiang, Peoples R China.	drhuangjian@zju.edu.cn		Huang, Jian/0000-0003-3340-5007	National Natural Science Foundation of China [81520108024, 81572800]; Natural Science Foundation of Zhejiang Province [LY15H160041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by the National Natural Science Foundation of China (81520108024, JH; 81572800, PW) and Natural Science Foundation of Zhejiang Province (LY15H160041, PW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte RN, 2002, SEMIN CANCER BIOL, V12, P277, DOI 10.1016/S1044-579X(02)00014-7; Axdorph U, 2000, ANN ONCOL, V11, P1405, DOI 10.1023/A:1026551727795; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Baniyash M, 2006, SEMIN CANCER BIOL, V16, P80, DOI 10.1016/j.semcancer.2005.12.002; BLAY JY, 1993, BLOOD, V82, P2169; Bohlen H, 2000, ANN HEMATOL, V79, P110, DOI 10.1007/s002770050564; Chambers SK, 2009, FUTURE ONCOL, V5, P1429, DOI 10.2217/FON.09.103; Chan SL, 2012, CANCER-AM CANCER SOC, V118, P3984, DOI 10.1002/cncr.26726; Chau GY, 2000, ANN SURG, V231, P552, DOI 10.1097/00000658-200004000-00015; CHERNOFF AE, 1995, J IMMUNOL, V154, P5492; CORTES JE, 1995, BLOOD, V85, P2516, DOI 10.1182/blood.V85.9.2516.bloodjournal8592516; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vita F, 2000, CHEST, V117, P365, DOI 10.1378/chest.117.2.365; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; Deeks JJ H. AD J, 2006, COCHRANE HDB SYSTEMA, V425, P6341; DELPRETE G, 1993, J IMMUNOL, V150, P353; Dennis KL, 2013, CURR OPIN ONCOL, V25, P637, DOI 10.1097/CCO.0000000000000006; Duletic AN, 2008, INT J LAB HEMATOL, V30, P230, DOI 10.1111/j.1751-553X.2007.00951.x; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Evans C, 2006, BRIT J CANCER, V94, P1412, DOI 10.1038/sj.bjc.6603104; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Galizia G, 2002, CLIN IMMUNOL, V102, P169, DOI 10.1006/clim.2001.5163; Galizia G, 2002, J INTERF CYTOK RES, V22, P473, DOI 10.1089/10799900252952262; Green VL, 2012, INT J ONCOL, V40, P833, DOI 10.3892/ijo.2011.1259; Hamidullah, 2012, BREAST CANCER RES TR, V133, P11, DOI 10.1007/s10549-011-1855-x; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Hattori E, 2003, HEPATOL RES, V27, P308, DOI 10.1016/j.hepres.2003.07.002; Kaio E, 2003, INT J ONCOL, V23, P901; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kundu N, 1996, JNCI-J NATL CANCER I, V88, P536, DOI 10.1093/jnci/88.8.536; Lech-Maranda E, 2012, ARCH IMMUNOL THER EX, V60, P477, DOI 10.1007/s00005-012-0197-7; Lech-Maranda E, 2010, ARCH IMMUNOL THER EX, V58, P131, DOI 10.1007/s00005-010-0066-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Mocellin S, 2003, TRENDS IMMUNOL, V24, P36, DOI 10.1016/S1471-4906(02)00009-1; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mumm JB, 2013, BIOESSAYS, V35, P623, DOI 10.1002/bies.201300004; Nemunaitis J, 2001, CANCER INVEST, V19, P239, DOI 10.1081/CNV-100102550; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Salgami EV, 2002, HAEMATOLOGIA, V32, P377; Sarris AH, 1999, ANN ONCOL, V10, P433, DOI 10.1023/A:1008301602785; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Soria JC, 2003, CLIN CANCER RES, V9, P1785; Szaflarska A, 2009, ANTICANCER RES, V29, P5005; Terai M, 2009, CANCER IMMUNOL IMMUN, V58, P1307, DOI 10.1007/s00262-008-0644-9; Toiyama Y, 2010, SURG TODAY, V40, P46, DOI 10.1007/s00595-009-4016-7; Vassilakopoulos TP, 2001, HAEMATOLOGICA, V86, P274; Vicari AP, 2004, IMMUNOL REV, V202, P223, DOI 10.1111/j.0105-2896.2004.00216.x; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Villa-Morales M, 2012, EXPERT OPIN THER TAR, V16, P85, DOI 10.1517/14728222.2011.628937; Visco C, 2004, LEUKEMIA LYMPHOMA, V45, P2085, DOI 10.1080/10428190410001712234; Viviani S, 2000, MED ONCOL, V17, P59, DOI 10.1007/BF02826218; Waldner MJ, 2012, EXPERT OPIN THER TAR, V16, P5, DOI 10.1517/14728222.2011.641951	58	89	92	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139598	10.1371/journal.pone.0139598	http://dx.doi.org/10.1371/journal.pone.0139598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440936	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300036
J	Gu, MH; Duan, LM; Wang, ML; Bai, Y; Shao, H; Wang, HY; Liu, FL				Gu, Minghui; Duan, Liming; Wang, Maolin; Bai, Yang; Shao, Hui; Wang, Haoyu; Liu, Fenglin			An Improved Approach of Mesh Segmentation to Extract Feature Regions	PLOS ONE			English	Article							MINIMA RULE; CURVATURE	The objective of this paper is to extract concave and convex feature regions via segmenting surface mesh of a mechanical part whose surface geometry exhibits drastic variations and concave-convex features are equally important when modeling. Referring to the original approach based on the minima rule (MR) in cognitive science, we have created a revised minima rule (RMR) and presented an improved approach based on RMR in the paper. Using the logarithmic function in terms of the minimum curvatures that are normalized by the expectation and the standard deviation on the vertices of the mesh, we determined the solution formulas for the feature vertices according to RMR. Because only a small range of the threshold parameters was selected from in the determined formulas, an iterative process was implemented to realize the automatic selection of thresholds. Finally according to the obtained feature vertices, the feature edges and facets were obtained by growing neighbors. The improved approach overcomes the inherent inadequacies of the original approach for our objective in the paper, realizes full automation without setting parameters, and obtains better results compared with the latest conventional approaches. We demonstrated the feasibility and superiority of our approach by performing certain experimental comparisons.	[Gu, Minghui; Duan, Liming; Wang, Maolin; Bai, Yang; Shao, Hui; Wang, Haoyu; Liu, Fenglin] Chongqing Univ, Coll Mech Engn, Chongqing 630044, Peoples R China; [Gu, Minghui; Duan, Liming; Wang, Maolin; Bai, Yang; Shao, Hui; Wang, Haoyu; Liu, Fenglin] Chongqing Univ, Engn Res Ctr Ind Comp Tomog Nondestruct Testing, Educ Minist China, Chongqing 630044, Peoples R China	Chongqing University; Chongqing University	Duan, LM (corresponding author), Chongqing Univ, Coll Mech Engn, Chongqing 630044, Peoples R China.	duanliming163@163.com	Liu, Fenglin/N-3010-2019	Liu, Fenglin/0000-0002-8952-311X	National Natural Science Foundation of China [61471070]; National Key Scientific Instrument and Equipment Development Projects, China [2013YQ030629]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Scientific Instrument and Equipment Development Projects, China	The work was supported by The National Natural Science Foundation of China (Grant No. 61471070), and the National Key Scientific Instrument and Equipment Development Projects, China (Grant No. 2013YQ030629).	Benhabiles H, 2011, COMPUT GRAPH FORUM, V30, P2170, DOI 10.1111/j.1467-8659.2011.01967.x; Desbrun M, 2002, DISCRETE DIFFERENTIA; Di Angelo L, 2015, COMPUT AIDED DESIGN, V62, P44, DOI 10.1016/j.cad.2014.09.006; Ghosh M, 2013, COMPUT AIDED DESIGN, V45, P494, DOI 10.1016/j.cad.2012.10.032; Hoffman DD, 1997, COGNITION, V63, P29, DOI 10.1016/S0010-0277(96)00791-3; Kalogerakis E, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778839; Katz S, 2005, VISUAL COMPUT, V21, P649, DOI 10.1007/s00371-005-0344-9; Lai HC, 2009, ADV ENG SOFTW, V40, P1011, DOI 10.1016/j.advengsoft.2009.03.017; Lee Y, 2005, COMPUT AIDED GEOM D, V22, P444, DOI 10.1016/j.cagd.2005.04.002; Lim IS, 2012, PSYCHOL REV, V119, P668, DOI 10.1037/a0025962; Mizoguchi T, 2006, LECT NOTES COMPUT SC, V4077, P644; Shamir A, 2004, 2ND INTERNATIONAL SYMPOSIUM ON 3D DATA PROCESSING, VISUALIZATION, AND TRANSMISSION, PROCEEDINGS, P82; Shamir A, 2008, COMPUT GRAPH FORUM, V27, P1539, DOI 10.1111/j.1467-8659.2007.01103.x; Wang H, 2014, GRAPH MODELS, V76, P440, DOI 10.1016/j.gmod.2014.04.009; Wang J, 2011, COMPUT GRAPH-UK, V35, P661, DOI 10.1016/j.cag.2011.03.016; Yamauchi H, 2005, VISUAL COMPUT, V21, P659, DOI 10.1007/s00371-005-0319-x; Yan DM, 2012, COMPUT AIDED DESIGN, V44, P1072, DOI 10.1016/j.cad.2012.04.005	17	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139488	10.1371/journal.pone.0139488	http://dx.doi.org/10.1371/journal.pone.0139488			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436657	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200028
J	Martinez-Urbistondo, D; Alegre, F; Carmona-Torre, F; Huerta, A; Fernandez-Ros, N; Landecho, MF; Garcia-Mouriz, A; Nunez-Cordoba, JM; Garcia, N; Quiroga, J; Lucena, JF				Martinez-Urbistondo, Diego; Alegre, Felix; Carmona-Torre, Francisco; Huerta, Ana; Fernandez-Ros, Nerea; Fortun Landecho, Manuel; Garcia-Mouriz, Alberto; Nunez-Cordoba, Jorge M.; Garcia, Nicolas; Quiroga, Jorge; Felipe Lucena, Juan			Mortality Prediction in Patients Undergoing Non-Invasive Ventilation in Intermediate Care	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; ACUTE RESPIRATORY-FAILURE; MECHANICAL VENTILATION; ACUTE EXACERBATIONS; SAPS-II; COPD; UNIT; HOSPITALS; SUCCESS	Background Intermediate Care Units (ImCU) have become an alternative scenario to perform Non-Invasive Ventilation (NIV). The limited number of prognostic studies in this population support the need of mortality prediction evaluation in this context. Objective The objective of this study is to analyze the performance of Simplified Acute Physiology Score (SAPS) II and 3 in patients undergoing NIV in an ImCU. Additionally, we searched for new variables that could be useful to customize these scores, in order to improve mortality prediction. Design Cohort study with prospectively collected data from all patients admitted to a single center ImCU who received NIV. The SAPS II and 3 scores with their respective predicted mortality rates were calculated. Discrimination and calibration were evaluated by calculating the area under the receiver operating characteristic curve (AUC) and with the Hosmer-Lemeshow goodness of fit test for the models, respectively. Binary logistic regression was used to identify new variables to customize the scores for mortality prediction in this setting. Patients The study included 241 patients consecutively admitted to an ImCU staffed by hospitalists from April 2006 to December 2013. Key Results The observed in-hospital mortality was 32.4% resulting in a Standardized Mortality Ratio (SMR) of 1.35 for SAPS II and 0.68 for SAPS 3. Mortality discrimination based on the AUC was 0.73 for SAPS II and 0.69 for SAPS 3. Customized models including immunosuppression, chronic obstructive pulmonary disease (COPD), acute pulmonary edema (APE), lactic acid, pCO2 and haemoglobin levels showed better discrimination than old scores with similar calibration power. Conclusions These results suggest that SAPS II and 3 should be customized with additional patient-risk factors to improve mortality prediction in patients undergoing NIV in intermediate care.	[Martinez-Urbistondo, Diego; Alegre, Felix; Carmona-Torre, Francisco; Huerta, Ana; Fernandez-Ros, Nerea; Fortun Landecho, Manuel; Garcia, Nicolas; Quiroga, Jorge; Felipe Lucena, Juan] Univ Navarra Clin, Dept Internal Med, Div Intermediate Care, Pamplona, Spain; [Martinez-Urbistondo, Diego; Alegre, Felix; Carmona-Torre, Francisco; Huerta, Ana; Fernandez-Ros, Nerea; Fortun Landecho, Manuel; Garcia, Nicolas; Quiroga, Jorge; Felipe Lucena, Juan] Univ Navarra Clin, Hospitalists Unit, Pamplona, Spain; [Fortun Landecho, Manuel; Quiroga, Jorge] Inst Invest Sanitaria Navarra IdiSNA, Pamplona, Spain; [Garcia-Mouriz, Alberto] Univ Navarra Clin, Informat Technol, Pamplona, Spain; [Nunez-Cordoba, Jorge M.] Univ Navarra Clin, Div Biostat, Res Support Serv, Cent Clin Trials Unit, Pamplona, Spain; [Nunez-Cordoba, Jorge M.] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Nunez-Cordoba, Jorge M.] Inst Invest Sanitaria Navarra IdiSNA, Epidemiol & Publ Hlth Area, Pamplona, Spain; [Quiroga, Jorge] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; University of Navarra; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Lucena, JF (corresponding author), Univ Navarra Clin, Dept Internal Med, Div Intermediate Care, Pamplona, Spain.	flucena@unav.es		Landecho, Manuel F/0000-0003-3234-8805; Martinez-Urbistondo, Diego/0000-0002-0530-7349; Garcia, Nicolas/0000-0002-7804-7234				Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 2007, CRIT CARE MED, V35, P18, DOI 10.1097/01.CCM.0000251821.44259.F3; Apolone G, 1996, INTENS CARE MED, V22, P1368, DOI 10.1007/s001340050266; Auriant I, 1998, CRIT CARE MED, V26, P1368, DOI 10.1097/00003246-199808000-00023; Azoulay E, 2013, INTENS CARE MED, V39, P292, DOI 10.1007/s00134-012-2746-2; Bertolini G, 2005, RESP MED, V99, P894, DOI 10.1016/j.rmed.2004.11.014; BOTT J, 1993, LANCET, V341, P1555, DOI 10.1016/0140-6736(93)90696-E; BROCHARD L, 1990, NEW ENGL J MED, V323, P1523, DOI 10.1056/NEJM199011293232204; Capuzzo M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0551-8; Carron M, 2010, CRIT CARE, V25; Confalonieri M, 2005, EUR RESPIR J, V25, P348, DOI 10.1183/09031936.05.00085304; Conti G, 2002, INTENS CARE MED, V28, P1701, DOI 10.1007/s00134-002-1478-0; Lucena JF, 2012, J HOSP MED, V7, P411, DOI 10.1002/jhm.1905; Garpestad E, 2007, CHEST, V132, P711, DOI 10.1378/chest.06-2643; Gungor G, 2013, RESP CARE, V58, P525, DOI 10.4187/respcare.01734; Hill NS, 2007, CRIT CARE MED, V35, P2402, DOI 10.1097/01.CCM.0000284587.36541.7F; Hunt JP, 1997, CURR PROB SURG, V34, P530; Kollert F, 2013, RESP CARE, V58, P1204, DOI 10.4187/respcare.01961; KRAMER N, 1995, AM J RESP CRIT CARE, V151, P1799, DOI 10.1164/ajrccm.151.6.7767523; Labarere J, 2014, INTENS CARE MED, V40, P513, DOI 10.1007/s00134-014-3227-6; Lefebvre JC, 2012, EUR RESPIR MONOGR, P65, DOI 10.1183/1025448x.10001711; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lucena JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077229; Metnitz PGH, 1999, CRIT CARE MED, V27, P1486, DOI 10.1097/00003246-199908000-00014; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Metnitz PGH, 2009, INTENS CARE MED, V35, P816, DOI 10.1007/s00134-009-1449-9; Moreno R, 1998, CRIT CARE MED, V26, P50, DOI 10.1097/00003246-199801000-00016; Mulero LR, 2005, MED CLIN-BARCELONA, V124, P126, DOI 10.1157/13071006; Nasraway SA, 1998, CRIT CARE MED, V26, P607, DOI 10.1097/00003246-199803000-00039; Nava Stefano, 2004, Respir Care, V49, P295; Nicolini A, 2012, MINERVA ANESTESIOL, V78, P1333; Phua J, 2005, INTENS CARE MED, V31, P533, DOI 10.1007/s00134-005-2582-8; Plant PK, 2000, LANCET, V355, P1931, DOI 10.1016/S0140-6736(00)02323-0; Ugurlu AO, 2014, CHEST, V145, P964, DOI 10.1378/chest.13-1707; Walkey Allan J, 2013, Ann Am Thorac Soc, V10, P10, DOI 10.1513/AnnalsATS.201206-034OC; Wu JY, 2009, NEUROCRIT CARE, V10, P35, DOI 10.1007/s12028-008-9139-y; Yoshida Y, 2008, J ANESTH, V22, P201, DOI 10.1007/s00540-008-0637-z; ZIMMERMAN JE, 1995, CHEST, V108, P490, DOI 10.1378/chest.108.2.490; ZWEIG MH, 1993, CLIN CHEM, V39, P561	40	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139702	10.1371/journal.pone.0139702	http://dx.doi.org/10.1371/journal.pone.0139702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436420	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200053
J	Ali, Q; Bauch, CT; Anand, M				Ali, Qasim; Bauch, Chris T.; Anand, Madhur			Coupled Human-Environment Dynamics of Forest Pest Spread and Control in a Multi-Patch, Stochastic Setting	PLOS ONE			English	Article							EMERALD ASH BORER; AGRILUS-PLANIPENNIS; MANAGEMENT OPTIONS; COLEOPTERA; DISPERSAL; CULTURES; IMPACTS; ECOLOGY; SYSTEM; SITES	Background The transportation of camp firewood infested by non-native forest pests such as Asian long-horned beetle (ALB) and emerald ash borer (EAB) has severe impacts on North American forests. Once invasive forest pests are established, it can be difficult to eradicate them. Hence, preventing the long-distance transport of firewood by individuals is crucial. Methods Here we develop a stochastic simulation model that captures the interaction between forest pest infestations and human decisions regarding firewood transportation. The population of trees is distributed across 10 patches (parks) comprising a "low volume" partition of 5 patches that experience a low volume of park visitors, and a "high volume" partition of 5 patches experiencing a high visitor volume. The infestation spreads within a patch-and also between patches-according to the probability of between-patch firewood transportation. Individuals decide to transport firewood or buy it locally based on the costs of locally purchased versus transported firewood, social norms, social learning, and level of concern for observed infestations. Results We find that the average time until a patch becomes infested depends nonlinearly on many model parameters. In particular, modest increases in the tree removal rate, modest increases in public concern for infestation, and modest decreases in the cost of locally purchased firewood, relative to baseline (current) values, cause very large increases in the average time until a patch becomes infested due to firewood transport from other patches, thereby better preventing long-distance spread. Patches that experience lower visitor volumes benefit more from firewood movement restrictions than patches that experience higher visitor volumes. Also, cross-patch infestations not only seed new infestations, they can also worsen existing infestations to a surprising extent: long-term infestations are more intense in the high volume patches than the low volume patches, even when infestation is already endemic everywhere. Conclusions The success of efforts to prevent long-distance spread of forest pests may depend sensitively on the interaction between outbreak dynamics and human social processes, with similar levels of effort producing very different outcomes depending on where the coupled human and natural system exists in parameter space. Further development of such modeling approaches through better empirical validation should yield more precise recommendations for ways to optimally prevent the long-distance spread of invasive forest pests.	[Ali, Qasim] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada; [Bauch, Chris T.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON N2L 3G1, Canada; [Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	Western University (University of Western Ontario); University of Guelph; University of Waterloo; University of Guelph	Ali, Q (corresponding author), Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada.	qali6@uwo.ca						Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Barlow LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090511; Canada G., 2015, EMERALD ASH BORER; Dillon KA, 2010, AM J PREV MED, V39, pS37, DOI 10.1016/j.amepre.2010.08.011; Gelfand MJ, 2012, CURR DIR PSYCHOL SCI, V21, P420, DOI 10.1177/0963721412460048; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Haack R.A., 2002, EMERALD ASH BORER NE; Herms DA, 2014, ANNU REV ENTOMOL, V59, P13, DOI 10.1146/annurev-ento-011613-162051; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Innes C, 2013, SCI REP-UK, V3, DOI 10.1038/srep02689; Jacobi W. R., 2011, Arboriculture & Urban Forestry, V37, P126; Koch FH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102105; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; McCullough DG, 2012, INT J PEST MANAGE, V58, P9, DOI 10.1080/09670874.2011.637138; McKenney D. W., 2012, ESTIMATES POTENTIAL; Mercader RJ, 2011, CAN J FOREST RES, V41, P254, DOI 10.1139/X10-201; Mercader RJ, 2009, AGR FOREST ENTOMOL, V11, P421, DOI 10.1111/j.1461-9563.2009.00451.x; Ministry of Natural Resources, 2011, ONT PARKS STAT 2010; Ministry of Natural Resources, 2014, ONT PARKS LOC; Moser WK, 2009, J FOREST, V107, P320; MURATORI S, 1989, APPL MATH MODEL, V13, P674, DOI 10.1016/0307-904X(89)90160-1; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Peterson K, 2009, RES FIND, V61, P4; Rinaldi S, 2012, THEOR POPUL BIOL, V81, P1, DOI 10.1016/j.tpb.2011.08.002; Smith MT, 2004, ENVIRON ENTOMOL, V33, P435, DOI 10.1603/0046-225X-33.2.435; Stephens T, 2001, TOB CONTROL, V10, P317, DOI 10.1136/tc.10.4.317; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8080, DOI 10.1073/pnas.1231334100; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Vannatta AR, 2012, J ECON ENTOMOL, V105, P196, DOI 10.1603/EC11130; Woodall CW, 2005, FOREST ECOL MANAG, V216, P367, DOI 10.1016/j.foreco.2005.05.050	31	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139353	10.1371/journal.pone.0139353	http://dx.doi.org/10.1371/journal.pone.0139353			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430902	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700046
J	duPont, W; Noy, I; Okuyama, Y; Sawada, Y				duPont, William; Noy, Ilan; Okuyama, Yoko; Sawada, Yasuyuki			The Long-Run Socio-Economic Consequences of a Large Disaster: The 1995 Earthquake in Kobe	PLOS ONE			English	Article							NATURAL DISASTERS; ECONOMIC-IMPACT; RECOVERY	We quantify the 'permanent' socio-economic impacts of the Great Hanshin-Awaji (Kobe) earthquake in 1995 by employing a large-scale panel dataset of 1,719 cities, towns, and wards from Japan over three decades. In order to estimate the counterfactual-i.e., the Kobe economy without the earthquake-we use the synthetic control method. Three important empirical patterns emerge: First, the population size and especially the average income level in Kobe have been lower than the counterfactual level without the earthquake for over fifteen years, indicating a permanent negative effect of the earthquake. Such a negative impact can be found especially in the central areas which are closer to the epicenter. Second, the surrounding areas experienced some positive permanent impacts in spite of short-run negative effects of the earthquake. Much of this is associated with movement of people to East Kobe, and consequent movement of jobs to the metropolitan center of Osaka, that is located immediately to the East of Kobe. Third, the furthest areas in the vicinity of Kobe seem to have been insulated from the large direct and indirect impacts of the earthquake.	[duPont, William] St Johns Univ, Dept Econ, Coll St Benedict|, St Joseph, MN USA; [Noy, Ilan] Victoria Univ Wellington, Sch Econ & Finance, Wellington, New Zealand; [Okuyama, Yoko] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Sawada, Yasuyuki] Univ Tokyo, Grad Sch Econ, Tokyo, Japan; [Sawada, Yasuyuki] Res Inst Econ Trade & Ind, Tokyo, Japan	College of Saint Benedict & Saint Johns University; Saint Johns University Collegeville; Victoria University Wellington; Yale University; University of Tokyo	Noy, I (corresponding author), Victoria Univ Wellington, Sch Econ & Finance, Wellington, New Zealand.	Ilan.Noy@vuw.ac.nz		Noy, Ilan/0000-0003-3214-6568; Sawada, Yasuyuki/0000-0002-4167-7697	Research Institute of Economy, Trade and Industry (Japan); NOAA-USA [NA09OAR4170060]	Research Institute of Economy, Trade and Industry (Japan); NOAA-USA(National Oceanic Atmospheric Admin (NOAA) - USA)	YS received funding from the Research Institute of Economy, Trade and Industry (Japan). IN received funding from NOAA-USA (Sea Grant NA09OAR4170060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Aldrich DP, 2011, NAT HAZARDS, V56, P595, DOI 10.1007/s11069-010-9577-7; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; [Anonymous], 2003, 21 SESS IPCC VIENN A, DOI DOI 10.4324/9781315270326-109; Beniya S., 2007, 2 INT C URB DIS RED; Cavallo E, 2013, REV ECON STAT, V95, P1549, DOI 10.1162/REST_a_00413; Chang S.E., 2000, J TRANSPORT GEOGR, V8, P53; Chang SE, 2010, DISASTERS, V34, P303, DOI 10.1111/j.1467-7717.2009.01130.x; City of Kobe, 2011, GREAT HANSHIN AWAJI; Coffman M, 2012, ENVIRON DEV ECON, V17, P187, DOI 10.1017/S1355770X11000350; Davis DR, 2008, J REGIONAL SCI, V48, P29, DOI 10.1111/j.1467-9787.2008.00545.x; Davis DR, 2002, AM ECON REV, V92, P1269, DOI 10.1257/000282802762024502; duPont W, 2015, ECON DEV CULT CHANGE, V63, P777, DOI 10.1086/681129; Edgington D.W., 2010, RECONSTRUCTING KOBE; Evans RW, 2010, J POPUL ECON, V23, P1, DOI 10.1007/s00148-008-0219-2; Fujiki H, 2015, J ECONOMETRICS, V186, P66, DOI 10.1016/j.jeconom.2014.10.010; Hirayama Y, 2000, HOUSING STUD, V15, P111, DOI 10.1080/02673030082504; Hornbeck R, 2014, AM ECON REV, V104, P963, DOI 10.1257/aer.104.3.963; Hornbeck R, 2012, AM ECON REV, V102, P1477, DOI 10.1257/aer.102.4.1477; Horwich G, 2000, ECON DEV CULT CHANGE, V48, P521, DOI 10.1086/452609; Karim A, 2013, POVERTY NATURAL DISA; Klomp J, 2014, GLOBAL ENVIRON CHANG, V26, P183, DOI 10.1016/j.gloenvcha.2014.02.006; Kohara M, 2006, HITOTSUB J ECON, V47, P219, DOI 10.15057/13777; Ohtake F, 2012, E W CTR DEC; Ohtake F, 2012, E W CTR; Oishi S, 2015, J RES PERS, V55, P84, DOI 10.1016/j.jrp.2015.02.001; Okuyama Y, 2014, ECON SYST RES, V26, P1, DOI 10.1080/09535314.2013.871505; Sasaki M., 2012, JAPAN LABOR REV, V9, P42; Sawada Y, 2011, REV ECON HOUSEHOLD, V9, P429, DOI 10.1007/s11150-011-9124-7; Schultz J, 2013, POPUL ENVIRON, V34, P293, DOI 10.1007/s11111-012-0171-7; Takeda J, 2003, NAT HAZARDS, V29, P565; UNISDR, 2013, GLOB ASS REP DIS RIS; Xiao Y, 2011, J REGIONAL SCI, V51, P804, DOI 10.1111/j.1467-9787.2011.00717.x; Yamamura E., 2013, 44493 MPRA U LIB MUN	36	24	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0138714	10.1371/journal.pone.0138714	http://dx.doi.org/10.1371/journal.pone.0138714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426998	Green Published, Green Submitted, gold			2022-12-27	WOS:000362177100018
J	Li, T; Ma, L; Geng, YK; Hao, CY; Chen, XH; Zhang, XY				Li, Tian; Ma, Lin; Geng, Yuke; Hao, Chenyang; Chen, Xinhong; Zhang, Xueyong			Small RNA and Degradome Sequencing Reveal Complex Roles of miRNAs and Their Targets in Developing Wheat Grains	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; AUXIN RESPONSE; DIVERSE SET; MICRORNAS; EXPRESSION; GENE; IDENTIFICATION; SIZE; PROLIFERATION; BIOGENESIS	Plant microRNAs (miRNAs) have been shown to play critical roles in plant development. In this study, we employed small RNA combined with degradome sequencing to survey development-related miRNAs and their validated targets during wheat grain development. A total of 186 known miRNAs and 37 novel miRNAs were identified in four small RNA libraries. Moreover, a miRNA-like long hairpin locus was first identified to produce 21 similar to 22-nt phased siRNAs that act in trans to cleave target mRNAs. A comparison of the miRNAomes revealed that 55 miRNA families were differentially expressed during the grain development. Predicted and validated targets of these development-related miRNAs are involved in different cellular responses and metabolic processes including cell proliferation, auxin signaling, nutrient metabolism and gene expression. This study provides insight into the complex roles of miRNAs and their targets in regulating wheat grain development.	[Li, Tian; Geng, Yuke; Hao, Chenyang; Zhang, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Beijing 100193, Peoples R China; [Ma, Lin; Chen, Xinhong] Northwest A&F Univ, Coll Agron, Shaanxi Key Lab Genet Engn Plant Breeding, Yangling, Shaanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Minist Agr, Key Lab Crop Gene Resources & Germplasm Enhanceme, Beijing 100193, Peoples R China.	zhangxueyong@caas.cn			National Natural Science Foundation of China [31301313]; Hi-Tech Research and Development Program of China [2012AA10A308]; CAAS-Innovation Team Project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); CAAS-Innovation Team Project	This work was supported by the National Natural Science Foundation of China (31301313), Hi-Tech Research and Development Program of China (2012AA10A308) and CAAS-Innovation Team Project.	Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bazin J, 2013, PLANT J, V74, P920, DOI 10.1111/tpj.12178; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Duan K, 2005, PLANT MOL BIOL, V57, P785, DOI 10.1007/s11103-005-1803-4; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hammani K, 2014, NUCLEIC ACIDS RES, V42, P5033, DOI 10.1093/nar/gku112; Han R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-289; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kant S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002021; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Li T, 2011, NUCLEIC ACIDS RES, V39, P2821, DOI 10.1093/nar/gkq1047; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu NA, 2014, PLANT J, V80, P331, DOI 10.1111/tpj.12636; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZR, 2010, PLANT CELL, V22, P1090, DOI 10.1105/tpc.110.073882; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Meng FR, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-140; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Peer WA, 2013, CURR OPIN PLANT BIOL, V16, P561, DOI 10.1016/j.pbi.2013.08.003; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Rogers K, 2013, PLANT CELL, V25, P2383, DOI 10.1105/tpc.113.113159; Rubio-Somoza I, 2011, TRENDS PLANT SCI, V16, P258, DOI 10.1016/j.tplants.2011.03.001; Sauer M, 2013, J EXP BOT, V64, P2565, DOI 10.1093/jxb/ert139; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Sun FL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-142; Tang ZH, 2012, PLANT PHYSIOL, V159, P721, DOI 10.1104/pp.112.196048; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang ZM, 2012, MOL PLANT, V5, P889, DOI 10.1093/mp/ssr094; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Xue W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-629; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yu N, 2010, PLANT CELL, V22, P2322, DOI 10.1105/tpc.109.072579; Zhang YC, 2013, NAT BIOTECHNOL, V31, P848, DOI 10.1038/nbt.2646; Zhou M., 2010, FRONT BIOL, V5, P67, DOI [DOI 10.1007/S11515-010-0007-8, 10.1007/s11515-010-0007-8]; Zhou SR, 2013, CURR OPIN PLANT BIOL, V16, P236, DOI 10.1016/j.pbi.2013.03.001; Zhu QH, 2008, GENOME RES, V18, P1456, DOI 10.1101/gr.075572.107; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	37	38	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139658	10.1371/journal.pone.0139658	http://dx.doi.org/10.1371/journal.pone.0139658			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426440	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100085
J	Patel, K; Giese, AP; Grossheim, JM; Hegde, RS; Delio, M; Samanich, J; Riazuddin, S; Frolenkov, GI; Cai, JL; Ahmed, ZM; Morrow, BE				Patel, Kunjan; Giese, Arnaud P.; Grossheim, J. M.; Hegde, Rashima S.; Delio, Maria; Samanich, Joy; Riazuddin, Saima; Frolenkov, Gregory I.; Cai, Jinlu; Ahmed, Zubair M.; Morrow, Bernice E.			A Novel C-Terminal CIB2 (Calcium and Integrin Binding Protein 2) Mutation Associated with Non-Syndromic Hearing Loss in a Hispanic Family	PLOS ONE			English	Article							DEAFNESS; GENE; GJB2; DIAGNOSIS; DNA	Hearing loss is a complex disorder caused by both genetic and environmental factors. Previously, mutations in CIB2 have been identified as a common cause of genetic hearing loss in Pakistani and Turkish populations. Here we report a novel (c.556C>T; p.(Arg186Trp)) transition mutation in the CIB2 gene identified through whole exome sequencing (WES) in a Caribbean Hispanic family with non-syndromic hearing loss. CIB2 belongs to the family of calcium- and integrin-binding (CIB) proteins. The carboxy-termini of CIB proteins are associated with calcium binding and intracellular signaling. The p.(Arg186Trp) mutation is localized within predicted type II PDZ binding ligand at the carboxy terminus. Our ex vivo studies revealed that the mutation did not alter the interactions of CIB2 with Whirlin, nor its targeting to the tips of hair cell stereocilia. However, we found that the mutation disrupts inhibition of ATP-induced Ca2+ responses by CIB2 in a heterologous expression system. Our findings support p. (Arg186Trp) mutation as a cause for hearing loss in this Hispanic family. In addition, it further highlights the necessity of the calcium binding property of CIB2 for normal hearing.	[Patel, Kunjan; Cai, Jinlu; Morrow, Bernice E.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Giese, Arnaud P.; Riazuddin, Saima; Ahmed, Zubair M.] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Grossheim, J. M.; Frolenkov, Gregory I.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY USA; [Hegde, Rashima S.] Cincinnati Childrens Hosp Med Ctr Cincinnati, Div Dev Biol, Cincinnati, OH USA; [Delio, Maria] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Samanich, Joy] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pediat Clin Genet, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland Baltimore; University of Kentucky; Icahn School of Medicine at Mount Sinai; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Ahmed, ZM (corresponding author), Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA.	zahmed@smail.umaryland.edu; Bernice.Morrow@Einstein.yu.edu	Giese, Arnaud P.J./P-1683-2019	Morrow, Bernice/0000-0002-8076-4726; Giese, Arnaud/0000-0001-7228-9542; Frolenkov, Gregory/0000-0002-9810-5024	National Institute on Deafness and Other Communication Disorders (NIDCD/NIH) [R01 DC012564, R01 DC011803]; NATIONAL EYE INSTITUTE [R01EY014648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011803, R01DC012564] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was partially sponsored by the National Institute on Deafness and Other Communication Disorders (NIDCD/NIH) research grants R01 DC012564 to Z.M.A. and R01 DC011803 to S.R. Support for this work was provided by a gift from the Department of Pediatrics at Montefiore Medical Center and the Human Genetics Program in the Department of Genetics at Albert Einstein College of Medicine (K.P. and B.E.M.). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Atik T, 2015, GENET RES, V97, DOI 10.1017/S001667231500004X; Avraham Karen B., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P93, DOI 10.1515/jbcpp-2012-0033; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Cohen BE, 2014, TRENDS HEAR, V18, DOI 10.1177/2331216514541361; CREMERS CWRJ, 1991, ANN NY ACAD SCI, V630, P191, DOI 10.1111/j.1749-6632.1991.tb19587.x; Deltenre P, 2013, HAND CLINIC, V113, P1527, DOI 10.1016/B978-0-444-59565-2.00023-X; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Fettiplace R, 2014, PHYSIOL REV, V94, P951, DOI 10.1152/physrev.00038.2013; Fischer TC, 2009, INT J PEDIATR OTORHI, V73, P195, DOI 10.1016/j.ijporl.2008.10.002; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Glazov EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002027; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hager M, 2008, J BIOL CHEM, V283, P24760, DOI 10.1074/jbc.M801166200; Haraksingh RR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1155; Huang H, 2012, BIOCHEM CELL BIOL, V90, P646, DOI [10.1139/O2012-021, 10.1139/o2012-021]; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kim KX, 2013, J GEN PHYSIOL, V142, P493, DOI 10.1085/jgp.201311068; Kim NKD, 2015, GENET MED, V17, P901, DOI 10.1038/gim.2014.213; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Maheshwari M, 2003, AM J MED GENET A, V120A, P180, DOI 10.1002/ajmg.a.20014; Makrythanasis P, 2014, HUM MUTAT, V35, P1203, DOI 10.1002/humu.22617; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Najmabadi H, 2014, INT J PEDIATR OTORHI, V78, P2026, DOI 10.1016/j.ijporl.2014.08.036; Okou DT, 2014, J PEDIATR GASTR NUTR, V58, P561, DOI 10.1097/MPG.0000000000000302; Pepermans E, 2015, HEARING RES, V330, P10, DOI 10.1016/j.heares.2015.05.005; Phillips KR, 2008, CURR OPIN OTOLARYNGO, V16, P445, DOI 10.1097/MOO.0b013e32830f4ac8; Qing J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109178; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Samanich J, 2007, AM J MED GENET A, V143A, P830, DOI 10.1002/ajmg.a.31668; Shamseldin HE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0681-6; Shan JD, 2010, INT J PEDIATR OTORHI, V74, P611, DOI 10.1016/j.ijporl.2010.03.004; Shearer AE, 2012, CURR OPIN PEDIATR, V24, P679, DOI 10.1097/MOP.0b013e3283588f5e; Tsukada K, 2015, ANN OTO RHINOL LARYN, V124, p61S, DOI 10.1177/0003489415575060; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zhang XJ, 2014, FRONT MED-PRC, V8, P42, DOI 10.1007/s11684-014-0303-9	43	21	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0133082	10.1371/journal.pone.0133082	http://dx.doi.org/10.1371/journal.pone.0133082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426422	gold, Green Published			2022-12-27	WOS:000362177100002
J	Rougier, T; Lassalle, G; Drouineau, H; Dumoulin, N; Faure, T; Deffuant, G; Rochard, E; Lambert, P				Rougier, Thibaud; Lassalle, Geraldine; Drouineau, Hilaire; Dumoulin, Nicolas; Faure, Thierry; Deffuant, Guillaume; Rochard, Eric; Lambert, Patrick			The Combined Use of Correlative and Mechanistic Species Distribution Models Benefits Low Conservation Status Species	PLOS ONE			English	Article							SHAD ALOSA-ALOSA; LIFE-HISTORY TRAITS; ALLIS-SHAD; CLIMATE-CHANGE; DIADROMOUS FISH; UPSTREAM MIGRATION; RANGE SHIFTS; POPULATION; NICHE; RESPONSES	Species can respond to climate change by tracking appropriate environmental conditions in space, resulting in a range shift. Species Distribution Models (SDMs) can help forecast such range shift responses. For few species, both correlative and mechanistic SDMs were built, but allis shad (Alosa alosa), an endangered anadromous fish species, is one of them. The main purpose of this study was to provide a framework for joint analyses of correlative and mechanistic SDMs projections in order to strengthen conservation measures for species of conservation concern. Guidelines for joint representation and subsequent interpretation of models outputs were defined and applied. The present joint analysis was based on the novel mechanistic model GR3D (Global Repositioning Dynamics of Diadromous fish Distribution) which was parameterized on allis shad and then used to predict its future distribution along the European Atlantic coast under different climate change scenarios (RCP 4.5 and RCP 8.5). We then used a correlative SDM for this species to forecast its distribution across the same geographic area and under the same climate change scenarios. First, projections from correlative and mechanistic models provided congruent trends in probability of habitat suitability and population dynamics. This agreement was preferentially interpreted as referring to the species vulnerability to climate change. Climate change could not be accordingly listed as a major threat for allis shad. The congruence in predicted range limits between SDMs projections was the next point of interest. The difference, when noticed, required to deepen our understanding of the niche modelled by each approach. In this respect, the relative position of the northern range limit between the two methods strongly suggested here that a key biological process related to intraspecific variability was potentially lacking in the mechanistic SDM. Based on our knowledge, we hypothesized that local adaptations to cold temperatures deserved more attention in terms of modelling, but further in conservation planning as well.	[Rougier, Thibaud; Lassalle, Geraldine; Drouineau, Hilaire; Rochard, Eric; Lambert, Patrick] Irstea, EABX, Aquat Ecosyst & Global Changes Res Unit, F-33612 Gazinet Cestas, Cestas, France; [Dumoulin, Nicolas; Faure, Thierry; Deffuant, Guillaume] Irstea, LISC, Complex Syst Engn Lab, F-63178 Aubiere, France	INRAE; INRAE	Rougier, T (corresponding author), Irstea, EABX, Aquat Ecosyst & Global Changes Res Unit, 50 Ave Verdun, F-33612 Gazinet Cestas, Cestas, France.	thibaud.rougier@irstea.fr	Lassalle, Géraldine/P-4638-2019; Lassalle, Geraldine/H-7150-2014	Lassalle, Géraldine/0000-0002-8548-7254; Lassalle, Geraldine/0000-0002-8548-7254; Drouineau, Hilaire/0000-0001-9206-0040	French National Research Institute of Science and Technology for Environment and Agriculture (Irstea); French National Agency for Water and Aquatic Environments (ONEMA)	French National Research Institute of Science and Technology for Environment and Agriculture (Irstea); French National Agency for Water and Aquatic Environments (ONEMA)	This study was supported by grants from the French National Research Institute of Science and Technology for Environment and Agriculture (Irstea) and the French National Agency for Water and Aquatic Environments (ONEMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acolas ML, 2006, ICES J MAR SCI, V63, P476, DOI 10.1016/j.icesjms.2005.05.022; Acolas ML, 2004, ICES J MAR SCI, V61, P1291, DOI 10.1016/j.icesjms.2004.07.023; Ai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068927; Allee W.C, 1931, ANIMAL AGGREGATION S; Aprahamian MW, 2010, J FISH BIOL, V77, P1912, DOI 10.1111/j.1095-8649.2010.02775.x; Aprahamian MW, 2002, W1014 RD ENV AG; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bagliniere J-L, 2000, ALOSES ALOSA ALOSA A; Bagliniere JL, 2003, AM FISH S S, V35, P85; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Boisneau C, 2008, HYDROBIOLOGIA, V602, P179, DOI 10.1007/s10750-008-9291-6; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cassou-Leins JJ, 2000, HYDRO AQUA, P73; CASWELL H, 1992, INDIVIDUAL-BASED MODELS AND APPROACHES IN ECOLOGY, P36; Chen IC, 2011, GLOBAL ECOL BIOGEOGR, V20, P34, DOI 10.1111/j.1466-8238.2010.00594.x; Chessman BC, 2013, BIOL CONSERV, V160, P40, DOI 10.1016/j.biocon.2012.12.032; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Costa-Dias S., 2009, FISH MANAGE, P67; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Diamond SE, 2011, ECOLOGY, V92, P1005, DOI 10.1890/i0012-9658-92-5-1005; Dormann CF, 2012, J BIOGEOGR, V39, P2119, DOI 10.1111/j.1365-2699.2011.02659.x; DOUCHEMENT C, 1981, THESIS U SCI TECHNIQ; Drouineau H, 2006, AQUAT LIVING RESOUR, V19, P15, DOI 10.1051/alr:2006002; Estes LD, 2013, GLOBAL ECOL BIOGEOGR, V22, P1007, DOI 10.1111/geb.12034; Faivre R., 2013, ANAL SENSIBILITE EXP; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fordham DA, 2013, GLOBAL CHANGE BIOL, V19, P3224, DOI 10.1111/gcb.12289; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Frimpong EA, 2009, FISHERIES, V34, P487, DOI 10.1577/1548-8446-34.10.487; FROESE R, 2000, FISHBASE 2000 CONCEP; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Genard M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079948; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanski I, 2012, ANN NY ACAD SCI, V1249, P1, DOI 10.1111/j.1749-6632.2011.06419.x; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hartig F, 2012, J BIOGEOGR, V39, P2240, DOI 10.1111/j.1365-2699.2012.02745.x; Hasselman DJ, 2012, FISHERIES, V37, P115, DOI 10.1080/03632415.2012.659941; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Hundt M, 2015, J FISH BIOL, V87, P487, DOI 10.1111/jfb.12721; Hunter ML, 2007, CONSERV BIOL, V21, P1356, DOI 10.1111/j.1523-1739.2007.00780.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Kearney M, 2006, OIKOS, V115, P186, DOI 10.1111/j.2006.0030-1299.14908.x; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Keefer ML, 2014, REV FISH BIOL FISHER, V24, P333, DOI 10.1007/s11160-013-9334-6; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Kotlarski S., 2014, GEOSCI MODEL DEV DIS, V7, P217, DOI DOI 10.5194/GMDD-7-217-2014; Lambert P, 2001, B FR PECHE PISCIC, P973, DOI 10.1051/kmae:2001031; LANUV, 2010, REINTR ALL SHAD AL A; Lassalle G, 2008, J FISH BIOL, V73, P1799, DOI 10.1111/j.1095-8649.2008.02036.x; Lassalle G, 2009, GLOBAL CHANGE BIOL, V15, P1072, DOI 10.1111/j.1365-2486.2008.01794.x; Lassalle G, 2008, BIOL CONSERV, V141, P1105, DOI 10.1016/j.biocon.2008.02.010; Lassalle G, 2010, BIOL CONSERV, V143, P2441, DOI 10.1016/j.biocon.2010.06.008; Lawler JJ, 2011, FRONT ECOL ENVIRON, V9, P569, DOI 10.1890/100106; Lehuta S, 2010, ICES J MAR SCI, V67, P1063, DOI 10.1093/icesjms/fsq002; Lenormand M, 2013, COMPUTATION STAT, V28, P2777, DOI 10.1007/s00180-013-0428-3; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; LEVINS R, 1966, AM SCI, V54, P421; Limburg KE, 2009, BIOSCIENCE, V59, P955, DOI 10.1525/bio.2009.59.11.7; Lochet A, 2008, J FISH BIOL, V72, P946, DOI 10.1111/j.1095-8649.2007.01776.x; Lochet A, 2009, ECOL FRESHW FISH, V18, P323, DOI 10.1111/j.1600-0633.2008.00350.x; Lochet A, 2008, HYDROBIOLOGIA, V602, P99, DOI 10.1007/s10750-008-9281-8; Loss SR, 2011, BIOL CONSERV, V144, P92, DOI 10.1016/j.biocon.2010.11.016; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Martin J, 2015, CAN J FISH AQUAT SCI, V72, P991, DOI 10.1139/cjfas-2014-0510; Martin Vandembulcke D., 1999, THESIS ECOLE NATL PO; Martinez I, 2012, GLOBAL CHANGE BIOL, V18, P1714, DOI 10.1111/j.1365-2486.2012.02660.x; McDowall R.M., 1988, DIADROMY FISHES; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Mennesson-Boisneau C, 2000, HYDRO AQUA, P55; Mennesson-Boisneau C, 2000, ALOSES ALOSA ALOSA A, P33; Mennesson-Boisneau C, 1990, THESIS U RENNES 1 PA; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Nikolic N, 2011, SCIENTOMETRICS, V88, P929, DOI 10.1007/s11192-011-0422-x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2014, NAT CLIM CHANGE, V4, P217, DOI [10.1038/NCLIMATE2113, 10.1038/nclimate2113]; Piou C, 2013, GLOBAL CHANGE BIOL, V19, P711, DOI 10.1111/gcb.12085; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; PROUZET P, 1994, AQUAT LIVING RESOUR, V7, P1, DOI 10.1051/alr:1994001; Reisenbichler RR, 1999, ICES J MAR SCI, V56, P459, DOI 10.1006/jmsc.1999.0455; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995; Rougier T, 2014, ECOL MODEL, V283, P31, DOI 10.1016/j.ecolmodel.2014.03.019; Rougier T, 2012, ICES J MAR SCI, V69, P1802, DOI 10.1093/icesjms/fss149; Sax DF, 2009, TRENDS ECOL EVOL, V24, P472, DOI 10.1016/j.tree.2009.05.004; Seddon PJ, 2009, CONSERV BIOL, V23, P788, DOI 10.1111/j.1523-1739.2009.01200.x; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Tomas J, 2005, ECOL FRESHW FISH, V14, P185, DOI 10.1111/j.1600-0633.2005.00090.x; Travis JMJ, 2013, OIKOS, V122, P1532, DOI 10.1111/j.1600-0706.2013.00399.x; Travis JMJ, 2012, METHODS ECOL EVOL, V3, P628, DOI 10.1111/j.2041-210X.2012.00193.x; van der Vaart E, 2015, ECOL MODEL, V312, P182, DOI 10.1016/j.ecolmodel.2015.05.020; WAPLES RS, 1991, CAN J FISH AQUAT SCI, V48, P124, DOI 10.1139/f91-311; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; Zhivotovsky LA, 2012, ENVIRON BIOL FISH, V94, P249, DOI 10.1007/s10641-011-9873-4; [No title captured]	106	21	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139194	10.1371/journal.pone.0139194	http://dx.doi.org/10.1371/journal.pone.0139194			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426280	gold, Green Published, Green Submitted			2022-12-27	WOS:000362177100035
J	Abed, SA; Tiun, S; Omar, N				Abed, Saad Adnan; Tiun, Sabrina; Omar, Nazlia			Harmony Search Algorithm for Word Sense Disambiguation	PLOS ONE			English	Article							CONTEXT	Word Sense Disambiguation (WSD) is the task of determining which sense of an ambiguous word (word with multiple meanings) is chosen in a particular use of that word, by considering its context. A sentence is considered ambiguous if it contains ambiguous word(s). Practically, any sentence that has been classified as ambiguous usually has multiple interpretations, but just one of them presents the correct interpretation. We propose an unsupervised method that exploits knowledge based approaches for word sense disambiguation using Harmony Search Algorithm (HSA) based on a Stanford dependencies generator (HSDG). The role of the dependency generator is to parse sentences to obtain their dependency relations. Whereas, the goal of using the HSA is to maximize the overall semantic similarity of the set of parsed words. HSA invokes a combination of semantic similarity and relatedness measurements, i.e., Jiang and Conrath (jcn) and an adapted Lesk algorithm, to perform the HSA fitness function. Our proposed method was experimented on benchmark datasets, which yielded results comparable to the state-of-the-art WSD methods. In order to evaluate the effectiveness of the dependency generator, we perform the same methodology without the parser, but with a window of words. The empirical results demonstrate that the proposed method is able to produce effective solutions for most instances of the datasets used.	[Abed, Saad Adnan; Tiun, Sabrina; Omar, Nazlia] Univ Kebangsaan Malaysia, Ctr Artificial Intelligent CAIT, Knowledge Technol Res Grp KT, Ukm Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Abed, SA (corresponding author), Univ Kebangsaan Malaysia, Ctr Artificial Intelligent CAIT, Knowledge Technol Res Grp KT, Ukm Bangi 43600, Selangor, Malaysia.	saadadn@gmail.com	tiun, sabrina/M-4315-2019; Omar, Nazlia/L-9901-2019	Omar, Nazlia/0000-0002-8173-8933; tiun, sabrina/0000-0002-1134-973X; Abed, Saad/0000-0002-8780-812X	Malaysian Government [ERGS/1/2013/ICT07/UKM/03/1]	Malaysian Government	This work was supported by the Malaysian Government under research grant ERGS/1/2013/ICT07/UKM/03/1.	Agirre E, 2006, TEXT SPEECH LANG TEC, V33, P1, DOI 10.1007/978-1-4020-4809-8; Agirre E., 1996, P 16 C COMP LING VOL, V1, P16, DOI DOI 10.3115/992628.992635; [Anonymous], 2006, P LREC; Banerjee S., 2002, Computational Linguistics and Intelligent Text Processing. Third International Conference, CICLing 2002. Proceedings (Lecture Notes in Computer Science Vol.2276), P136; Chapman R L, 1977, ROGETS INT THESAURUS; Cowie J, P 14 C COMP LING, V1, P359; Escudero G, 2000, ARXIVPREPRINTCS00070; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Gelbukh A., 2003, WSEAS Transactions on Computers, V2, P257; Hirst G, 1998, LANG SPEECH & COMMUN, P305; Jiang JJ, 1997, ARXIVPREPRINTCMPLG97; Nguyen KH, 2013, ARTIF INTELL REV, V40, P405, DOI 10.1007/s10462-011-9288-9; Klein D, 2003, 41ST ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P423, DOI 10.3115/1075096.1075150; Leacock C, 1998, LANG SPEECH & COMMUN, P265; Lesk M., 1986, P 5 ANN INT C SYST D, P24, DOI DOI 10.1145/318723.318728; LIN D, ICML, V98, P296; Lin D., P 35 ANN M ASS COMP, P64; Lu WP, 2012, PRZ ELEKTROTECHNICZN, V88, P82; Masterman Margaret, 1957, MECH TRANSLATION, V4, P35; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Miller GA, P WORKSH HUM LANG TE, P303; Ng HT, 1997, ARXIVPREPRINTCMPLG97; Palmer Martha, 2001, P INT WORKSHOP EVALU, P21; Pedersen T., 2005, 200525 UMSI, V25, P2005; Pedersen T, AAAI IAAI, P604; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P., 1995, ARXIV PREPRINT CMP L; Rosso P, P 2003 INT C NAT LAN, P120; Schutze H, 1998, COMPUT LINGUIST, V24, P97; Schwab D, COLING, P2389; Sinha R, 2007, ICSC 2007: INTERNATIONAL CONFERENCE ON SEMANTIC COMPUTING, PROCEEDINGS, P363, DOI 10.1109/ICSC.2007.87; Stevenson M, 2001, COMPUT LINGUIST, V27, P321, DOI 10.1162/089120101317066104; Wu Z., P 32 ANN M ASS COMP, P133; Yang X., 2008, NATURE INSPIRED META, V2nd; Zhang CH, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL I, PROCEEDINGS, P123, DOI 10.1109/IITA.2008.13	35	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0136614	10.1371/journal.pone.0136614	http://dx.doi.org/10.1371/journal.pone.0136614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422368	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700006
J	Guo, ZJ; Liu, XM; Huang, HM				Guo, Zhanjing; Liu, Xiongmin; Huang, Hongmiao			Kinetics and Thermodynamics of Reserpine Adsorption onto Strong Acidic Cationic Exchange Fiber	PLOS ONE			English	Article							CARBON NANOTUBES; AQUEOUS-SOLUTIONS; RESIN; EQUILIBRIUM; ADSORBENT; ISOTHERM; SORPTION; INDIA	The kinetics and thermodynamics of the adsorption process of reserpine adsorbed onto the strong acidic cationic exchange fiber (SACEF) were studied by batch adsorption experiments. The adsorption capacity strongly depended on pH values, and the optimum reserpine adsorption onto the SACEF occurred at pH = 5 of reserpine solution. With the increase of temperature and initial concentration, the adsorption capacity increased. The equilibrium was attained within 20 mins. The adsorption process could be better described by the pseudo-second-order model and the Freundlich isotherm model. The calculated activation energy Ea was 4.35 kJ/mol. And the thermodynamic parameters were: 4.97<Delta H<7.44 kJ/mol, -15.29<Delta G<-11.87 kJ/mol and 41.97<Delta S<47.35 J/mol.K. The thermodynamic parameters demonstrated that the adsorption was an endothermic, spontaneous and feasible process of physisorption within the temperature range between 283 K and 323 K and the initial concentration range between 100 mg/L and 300 mg/L. All the results showed that the SACEF had a good adsorption performance for the adsorption of reserpine from alcoholic solution.	[Guo, Zhanjing; Liu, Xiongmin] Guangxi Univ, Coll Chem & Chem Engn, Nanning 530004, Guangxi, Peoples R China; [Guo, Zhanjing; Huang, Hongmiao] Guangxi Univ Chinese Med, Coll Pharm, Key Lab Gener Technol Res & Dev Tradit Chinese Me, Nanning, Guangxi, Peoples R China	Guangxi University; Guangxi University of Chinese Medicine	Guo, ZJ (corresponding author), Guangxi Univ, Coll Chem & Chem Engn, Nanning 530004, Guangxi, Peoples R China.	youjihuahewu@126.com; xmliu1@gxu.edu.cn			National Natural Science Foundation of China [11462001]; Natural Science Foundation of Guangxi Zhuang Autonomous Region, China [2014GXNSFBA118181]; Key laboratory of generic technology research and development of traditional Chinese medicine preparation in Guangxi colleges and universities [70-ZJGX201401005]; Open Project Foundation of Doctoral Degree Construction Discipline from Guangxi University of Chinese Medicine, China [J13047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangxi Zhuang Autonomous Region, China(National Natural Science Foundation of Guangxi Province); Key laboratory of generic technology research and development of traditional Chinese medicine preparation in Guangxi colleges and universities; Open Project Foundation of Doctoral Degree Construction Discipline from Guangxi University of Chinese Medicine, China	The authors sincerely appreciate the financial support of Project of the National Natural Science Foundation of China (Project No. 11462001), the Natural Science Foundation of Guangxi Zhuang Autonomous Region, China (no. 2014GXNSFBA118181), Key laboratory of generic technology research and development of traditional Chinese medicine preparation in Guangxi colleges and universities (no. 70-ZJGX201401005), and the Open Project Foundation of Doctoral Degree Construction Discipline from Guangxi University of Chinese Medicine, China (J13047).	Anirudhan TS, 2009, APPL SURF SCI, V255, P4983, DOI 10.1016/j.apsusc.2008.12.047; Awual MR, 2011, J HAZARD MATER, V188, P164, DOI 10.1016/j.jhazmat.2011.01.092; Bindu S, 2014, IND CROP PROD, V62, P430, DOI 10.1016/j.indcrop.2014.09.018; Cantu Y, 2014, CHEM ENG J, V254, P374, DOI 10.1016/j.cej.2014.05.110; Chen YY, 2014, CHEM ENG J, V254, P579, DOI 10.1016/j.cej.2014.05.120; Damaris G., 2014, J HAZARD MATER, V280, P209, DOI [10.1016/j.jhazmat.2014.07.071, DOI 10.1016/J.JHAZMAT.2014.07.071]; Ding L, 2012, CHEM ENG J, V181, P360, DOI 10.1016/j.cej.2011.11.096; Dong H. H., 2014, J SW CHINA NORMAL U, V32, P7; Dubinin M. M, 1947, PROC ACAD SCI USSR C, V55, P327, DOI DOI 10.4236/OJS.2014.41001; Freundlich HMF, 1996, J PHYS CHEM-US, V57, P385; Gao ZP, 2013, J FOOD ENG, V116, P195, DOI 10.1016/j.jfoodeng.2012.10.037; Guo Z.J., 2014, GUANGXI J TRADITIONA, V37, P64; HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011; Ho YS, 1998, CAN J CHEM ENG, V76, P822, DOI 10.1002/cjce.5450760419; Huang JH, 2013, CHEM ENG J, V218, P267, DOI 10.1016/j.cej.2012.12.032; Kavakli C, 2014, RADIAT PHYS CHEM, V102, P84, DOI 10.1016/j.radphyschem.2014.04.011; Kumar PS, 2011, CHEM ENG J, V167, P122, DOI 10.1016/j.cej.2010.12.010; Kyzar E, 2013, BRAIN RES, V1527, P108, DOI 10.1016/j.brainres.2013.06.033; Lagergren S.K., 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Li M. Y., 2005, J CHEM IND ENG, V7, P1164; Li M. Y., 2012, CHIN J NONFERROUS ME, V10, P2846; Liu CM, 2002, SEPARATION EFFECTIVE; Liu Y., 2008, CHINESE J PHARM BIOT, V15, P393; Lopez-Munoz F, 2004, ACTAS ESP PSIQUIATRI, V32, P387; Ma XJ, 2010, ACTA PHARMACOL SIN, V31, P938, DOI 10.1038/aps.2010.74; Niu S. S., 2009, CHINESE J NEW DRUG, V18, P2183; Rengaraj S, 2007, J HAZARD MATER, V143, P469, DOI 10.1016/j.jhazmat.2006.09.064; Sharma SK, 2008, IN VITRO CELL DEV-PL, V44, P360; Shi Y, 2013, CHEM ENG J, V215, P113, DOI 10.1016/j.cej.2012.10.100; Sun L., 2008, STUDY PURIFICATION P; Tao L., 2013, PURIFICATION ALKALOI; Temkin M.I., 1940, ACTA PHYSIOCHIM, V2, P217, DOI DOI 10.1016/J.JHAZMAT.2008.12.093; Vasiliu S, 2011, CARBOHYD POLYM, V85, P376, DOI 10.1016/j.carbpol.2011.02.039; Walter J. W., 1963, J SANITARY ENG DIV, V89, P53; Wang C. Y., 2004, NEW CHEM MAT, V32, P27; [王闯 Wang Chuang], 2012, [北京化工大学学报. 自然科学版, Journal of Beijing University of Chemical Technology. Natural Science Edition], V39, P17; Wang WQ, 2012, T NONFERR METAL SOC, V22, P2831, DOI 10.1016/S1003-6326(11)61539-2; Wu CH, 2007, J HAZARD MATER, V144, P93, DOI 10.1016/j.jhazmat.2006.09.083; Xun R.S., 2004, CHEM NATURAL PRODUCT; Yao YJ, 2011, CHEM ENG J, V170, P82, DOI 10.1016/j.cej.2011.03.031; Yao YJ, 2010, BIORESOURCE TECHNOL, V101, P3040, DOI 10.1016/j.biortech.2009.12.042; [张阳 Zhang Yang], 2011, [高校化学工程学报, Journal of Chemical Engineering of Chinese Universities], V25, P356; [张阳 ZHANG Yang], 2011, [化工进展, Chemical Industry and Engineering Progress], V30, P1188; Zhang Z. X., 2004, CHINESE J PHARM BIOT, V11, P157	45	16	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138619	10.1371/journal.pone.0138619	http://dx.doi.org/10.1371/journal.pone.0138619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422265	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700046
J	Kelso, AA; Say, AF; Sharma, D; Ledford, LL; Turchick, A; Saski, CA; King, AV; Attaway, CC; Temesvari, LA; Sehorn, MG				Kelso, Andrew A.; Say, Amanda F.; Sharma, Deepti; Ledford, LeAnna L.; Turchick, Audrey; Saski, Christopher A.; King, Ada V.; Attaway, Christopher C.; Temesvari, Lesly A.; Sehorn, Michael G.			Entamoeba histolytica Dmc1 Catalyzes Homologous DNA Pairing and Strand Exchange That Is Stimulated by Calcium and Hop2-Mnd1	PLOS ONE			English	Article							HUMAN RAD51 PROTEIN; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; GENETIC EXCHANGE; RECA PROTEIN; MECHANISTIC INSIGHTS; RECOMBINATION GENE; TRYPANOSOMA-BRUCEI; FISSION YEAST; CELL-CYCLE	Meiosis depends on homologous recombination (HR) in most sexually reproducing organisms. Efficient meiotic HR requires the activity of the meiosis-specific recombinase, Dmc1. Previous work shows Dmc1 is expressed in Entamoeba histolytica, a eukaryotic parasite responsible for amoebiasis throughout the world, suggesting this organism undergoes meiosis. Here, we demonstrate Dmc1 protein is expressed in E. histolytica. We show that purified ehDmc1 forms presynaptic filaments and catalyzes ATP-dependent homologous DNA pairing and DNA strand exchange over at least several thousand base pairs. The DNA pairing and strand exchange activities are enhanced by the presence of calcium and the meiosis-specific recombination accessory factor, Hop2-Mnd1. In combination, calcium and Hop2-Mnd1 dramatically increase the rate of DNA strand exchange activity of ehDmc1. The biochemical system described herein provides a basis on which to better understand the role of ehDmc1 and other HR proteins in E. histolytica.	[Kelso, Andrew A.; Say, Amanda F.; Sharma, Deepti; Ledford, LeAnna L.; Turchick, Audrey; Sehorn, Michael G.] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA; [Saski, Christopher A.] Clemson Univ, Genom & Computat Biol Lab, Inst Translat Genom, Clemson, SC USA; [King, Ada V.; Attaway, Christopher C.; Temesvari, Lesly A.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Temesvari, Lesly A.; Sehorn, Michael G.] Clemson Univ, Sch Hlth Res, Clemson, SC USA; [Temesvari, Lesly A.] Clemson Univ, Eukaryot Pathogens Innovat Ctr, Clemson, SC USA; [Sehorn, Michael G.] Clemson Univ, Ctr Opt Mat Sci & Engn Technol, Clemson, SC USA	Clemson University; Clemson University; Clemson University; Clemson University; Clemson University; Clemson University	Sehorn, MG (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	msehorn@clemson.edu	Attaway, Christopher Charles/GYJ-7363-2022	Attaway, Christopher Charles/0000-0002-9135-7747; Turchick, Audrey/0000-0001-5699-0267	Departmental Honors Research Grant from the Calhoun Honors College at Clemson University, National Institutes of Health [R01 GM098510, R03 AI107950, R21 AI108287]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI108287, R03AI107950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098510] Funding Source: NIH RePORTER	Departmental Honors Research Grant from the Calhoun Honors College at Clemson University, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by a Departmental Honors Research Grant from the Calhoun Honors College at Clemson University (AT), National Institutes of Health grant R01 GM098510 (MGS), R03 AI107950 (LAT) and R21 AI108287 (LAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Budke B, 2013, J MED CHEM, V56, P254, DOI 10.1021/jm301565b; Budke B, 2012, NUCLEIC ACIDS RES, V40, P7347, DOI 10.1093/nar/gks353; Bugreev DV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5198; Bugreev DV, 2005, J BIOL CHEM, V280, P26886, DOI 10.1074/jbc.M502248200; Busygina V, 2013, DNA REPAIR, V12, P707, DOI 10.1016/j.dnarep.2013.05.004; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Ceballos SJ, 2011, BBA-GENE REGUL MECH, V1809, P509, DOI 10.1016/j.bbagrm.2011.06.006; CEDENO JR, 1983, J INFECT DIS, V148, P1090, DOI 10.1093/infdis/148.6.1090; Chan YL, 2014, J BIOL CHEM, V289, P18076, DOI 10.1074/jbc.M114.558601; Chang YC, 2005, BIOCHEMISTRY-US, V44, P6052, DOI 10.1021/bi048897q; Chi P, 2006, DNA REPAIR, V5, P381, DOI 10.1016/j.dnarep.2005.11.005; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; CHOW SA, 1986, J BIOL CHEM, V261, P6961; Cleveland LR, 1930, SCIENCE, V72, P149, DOI 10.1126/science.72.1858.149; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Cole F, 2012, ANN NY ACAD SCI, V1267, P95, DOI 10.1111/j.1749-6632.2012.06595.x; CUNNINGHAM L, 1950, J GEN PHYSIOL, V34, P59, DOI 10.1085/jgp.34.1.59; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; DOBELL CLIFFORD, 1928, PARASITOLOGY, V20, P357, DOI 10.1017/S003118200001177X; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehrenkaufer GM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r77; Erenpreisa J, 2005, CELL BIOL INT, V29, P1005, DOI 10.1016/j.cellbi.2005.10.008; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; GIBSON W, 1994, MOL BIOCHEM PARASIT, V64, P241, DOI 10.1016/0166-6851(94)00017-4; Habu T, 1996, NUCLEIC ACIDS RES, V24, P470, DOI 10.1093/nar/24.3.470; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Huang F, 2014, BIOORG MED CHEM LETT, V24, P3006, DOI 10.1016/j.bmcl.2014.04.088; Huang F, 2012, J MED CHEM, V55, P3011, DOI 10.1021/jm201173g; Huang F, 2011, ACS CHEM BIOL, V6, P628, DOI 10.1021/cb100428c; Ianzini F, 2009, CANCER RES, V69, P2296, DOI 10.1158/0008-5472.CAN-08-3364; Ishida T, 2009, NUCLEIC ACIDS RES, V37, P3367, DOI 10.1093/nar/gkp200; Jackson T, 2000, ARCH MED RES, V31, pS36, DOI 10.1016/S0188-4409(00)00150-8; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; JUKES T H, 1969, P21; Kang HA, 2015, NUCLEIC ACIDS RES, V43, P3841, DOI 10.1093/nar/gkv172; Kant CR, 2005, PLANT MOL BIOL, V57, P1, DOI 10.1007/s11103-004-5828-x; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Lamont KR, 2013, J EXP MED, V210, P1021, DOI 10.1084/jem.20121258; Lee MH, 2005, J BIOL CHEM, V280, P40980, DOI 10.1074/jbc.M505896200; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lopez-Casamichana M, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-35; LOPEZROMERO E, 1993, PARASITOL TODAY, V9, P225, DOI 10.1016/0169-4758(93)90019-C; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; OROZCO E, 1988, EXP PARASITOL, V67, P85, DOI 10.1016/0014-4894(88)90011-2; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; Peacock L, 2014, CURR BIOL, V24, P181, DOI 10.1016/j.cub.2013.11.044; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Pezza RJ, 2010, BIOPHYS J, V99, P3763, DOI 10.1016/j.bpj.2010.10.028; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Ploquin M, 2007, NUCLEIC ACIDS RES, V35, P2719, DOI 10.1093/nar/gkm174; Poxleitner MK, 2008, SCIENCE, V319, P1530, DOI 10.1126/science.1153752; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Ratcliffe HL, 1934, SCIENCE, V79, P324, DOI 10.1126/science.79.2049.324; SAGA Y, 1983, J CELL SCI, V60, P157; Sakane I, 2008, NUCLEIC ACIDS RES, V36, P4266, DOI 10.1093/nar/gkn405; SANDBERG AA, 1963, CANCER, V16, P1246, DOI 10.1002/1097-0142(196310)16:10<1246::AID-CNCR2820161004>3.0.CO;2-Q; Scott DE, 2015, CHEMMEDCHEM, V10, P296, DOI 10.1002/cmdc.201402428; Sehorn MG, 2004, NATURE, V429, P433, DOI 10.1038/nature02563; Sharma D, 2013, DNA REPAIR, V12, P53, DOI 10.1016/j.dnarep.2012.10.005; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; SHINOHARA A, 1993, NAT GENET, V4, P239, DOI 10.1038/ng0793-239; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Sigurdsson S, 2001, J BIOL CHEM, V276, P8798, DOI 10.1074/jbc.M010011200; Singh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074465; Singh N, 2011, EXP PARASITOL, V127, P329, DOI 10.1016/j.exppara.2010.08.013; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1995, CELL, V82, P453, DOI 10.1016/0092-8674(95)90434-4; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Tombline G, 2002, J BIOL CHEM, V277, P14417, DOI 10.1074/jbc.M109915200; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weber C, 2009, MOL BIOCHEM PARASIT, V164, P165, DOI 10.1016/j.molbiopara.2008.12.005; Weedall GD, 2015, PARASITOLOGY, V142, pS120, DOI 10.1017/S0031182014001693; WEINSTOCK GM, 1981, J BIOL CHEM, V256, P8845; Weinstock GM, 1981, J BIOL CHEM, P256; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L; Zhao WX, 2015, NUCLEIC ACIDS RES, V43, P4055, DOI 10.1093/nar/gkv259; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924; Zhu JW, 2015, EUR J MED CHEM, V96, P196, DOI 10.1016/j.ejmech.2015.04.021	95	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139399	10.1371/journal.pone.0139399	http://dx.doi.org/10.1371/journal.pone.0139399			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422142	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700112
J	Udo, H				Udo, Hiroshi			An Alternative Method to Facilitate cDNA Cloning for Expression Studies in Mammalian Cells by Introducing Positive Blue White Selection in Vaccinia Topoisomerase I-Mediated Recombination	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA TOPOISOMERASE; PCR PRODUCTS; GENE; IDENTIFICATION; VECTORS; VITRO; VIVO	One of the most basic techniques in biomedical research is cDNA cloning for expression studies in mammalian cells. Vaccinia topoisomerase I-mediated cloning (TOPO cloning by Invitrogen) allows fast and efficient recombination of PCR-amplified DNAs. Among TOPO vectors, a pcDNA3.1 directional cloning vector is particularly convenient, since it can be used for expression analysis immediately after cloning. However, I found that the cloning efficiency was reduced when RT-PCR products were used as inserts (about one-quarter). Since TOPO vectors accept any PCR products, contaminating fragments in the insert DNA create negative clones. Therefore, I designed a new mammalian expression vector enabling positive blue white selection in Vaccinia topoisomerase I-mediated cloning. The method utilized a short nontoxic LacZ alpha peptide as a linker for GFP fusion. When cDNAs were properly inserted into the vector, minimal expression of the fusion proteins in E. coli (harboring lacZ Delta M15) resulted in formation of blue colonies on X-gal plates. This method improved both cloning efficiency (75%) and directional cloning (99%) by distinguishing some of the negative clones having non-cording sequences, since these inserts often disturbed translation of lacZ alpha. Recombinant plasmids were directly applied to expression studies using GFP as a reporter. Utilization of the P2A peptide allowed for separate expression of GFP. In addition, the preparation of Vaccinia topoisomerase I-linked vectors was streamlined, which consisted of successive enzymatic reactions with a single precipitation step, completing in 3 hr. The arrangement of unique restriction sites enabled further modification of vector components for specific applications. This system provides an alternative method for cDNA cloning and expression in mammalian cells.	Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 812, Japan	Kyushu University	Udo, H (corresponding author), Kyushu Univ, Grad Sch Sci, Dept Biol, Fukuoka 812, Japan.	udo.hiroshi.571@m.kyushu-u.ac.jp			Japan Society for the Promotion of Science [24500383]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (#24500383). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; GAREN A, 1968, SCIENCE, V160, P149, DOI 10.1126/science.160.3824.149; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Heyman JA, 1999, GENOME RES, V9, P383; HOLTON TA, 1991, NUCLEIC ACIDS RES, V19, P1156, DOI 10.1093/nar/19.5.1156; Irwin C. R., 2012, METHOD MOL BIOL, V890, P23, DOI DOI 10.1007/978-1-61779-876-4_; Keese P, 1996, NUCLEIC ACIDS RES, V24, P3474, DOI 10.1093/nar/24.17.3474; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; LIM PS, 1990, J INFECT DIS, V162, P1263, DOI 10.1093/infdis/162.6.1263; Shevtsova Z, 2006, EUR J NEUROSCI, V23, P1961, DOI 10.1111/j.1460-9568.2006.04725.x; SHUMAN S, 1991, J BIOL CHEM, V266, P11372; SHUMAN S, 1992, J BIOL CHEM, V267, P8620; SHUMAN S, 1987, P NATL ACAD SCI USA, V84, P7478, DOI 10.1073/pnas.84.21.7478; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; ULLMANN A, 1967, J MOL BIOL, V24, P339, DOI 10.1016/0022-2836(67)90341-5; Yakovleva L, 2008, J BIOL CHEM, V283, P16093, DOI 10.1074/jbc.M801595200; Zhang PH, 2010, PROTEIN EXPRES PURIF, V69, P226, DOI 10.1016/j.pep.2009.09.003	22	2	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139349	10.1371/journal.pone.0139349	http://dx.doi.org/10.1371/journal.pone.0139349			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422141	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700098
J	Yang, Y; Wang, ZD; Sun, L; Shao, LP; Yang, N; Yu, DW; Zhang, X; Han, X; Sun, YJ				Yang, Yin; Wang, Zongdan; Sun, Luan; Shao, Lipei; Yang, Nan; Yu, Dawei; Zhang, Xin; Han, Xiao; Sun, Yujie			SATB1 Mediates Long-Range Chromatin Interactions: A Dual Regulator of Anti-Apoptotic BCL2 and Pro-Apoptotic NOXA Genes	PLOS ONE			English	Article							DNA-BINDING-PROTEIN; CELL DIFFERENTIATION; MULTIDRUG-RESISTANCE; MULTIPLE GENES; EXPRESSION; CANCER; FAMILY; PROGNOSIS; REGION; OVEREXPRESSION	Aberrant expression of special AT-rich binding protein 1 (SATB1), a global genomic organizer, has been associated with various cancers, which raises the question of how higher-order chromatin structure contributes to carcinogenesis. Disruption of apoptosis is one of the hallmarks of cancer. We previously demonstrated that SATB1 mediated specific long-range chromosomal interactions between the mbr enhancer located within 3'-UTR of the BCL2 gene and the promoter to regulate BCL2 expression during early apoptosis. In the present study, we used chromosome conformation capture (3C) assays and molecular analyses to further investigate the function of the SATB1-mediated higher-order chromatin structure in co-regulation of the anti-apoptotic BCL2 gene and the pro-apoptotic NOXA gene located 3.4Mb downstream on Chromosome 18. We demonstrated that the mbr enhancer spatially juxtaposed the promoters of BCL2 and NOXA genes through SATB1-mediated chromatin-loop in Jurkat cells. Decreased SATB1 levels switched the mbr-BCL2 loop to mbr-NOXA loop, and thus changed expression of these two genes. The SATB1-mediated dynamic switch of the chromatin loop structures was essential for the cooperative expression of the BCL2 and NOXA genes in apoptosis. Notably, the role of SATB1 was specific, since inhibition of SATB1 degradation by caspase-6 inhibitor or caspase-6-resistant SATB1 mutant reversed expression of BCL-2 and NOXA in response to apoptotic stimulation. This study reveals the critical role of SATB1-organized higher-order chromatin structure in regulating the dynamic equilibrium of apoptosis-controlling genes with antagonistic functions and suggests that aberrant SATB1 expression might contribute to cancer development by disrupting the co-regulated genes in apoptosis pathways.	[Yang, Yin; Wang, Zongdan; Sun, Luan; Shao, Lipei; Yang, Nan; Yu, Dawei; Han, Xiao; Sun, Yujie] Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Yang, Yin; Wang, Zongdan; Sun, Luan; Shao, Lipei; Yang, Nan; Yu, Dawei; Sun, Yujie] Nanjing Med Univ, Dept Cell Biol, Nanjing, Jiangsu, Peoples R China; [Zhang, Xin] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Norman, OK 73019 USA; [Zhang, Xin] Univ Oklahoma, Hlth Sci Ctr, Stephenson Canc Ctr, Norman, OK 73019 USA; [Sun, Yujie] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Ctr Canc, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma - Norman; Nanjing Medical University	Sun, YJ (corresponding author), Nanjing Med Univ, Key Lab Human Funct Genom Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	yujiesun@njmu.edu.cn	Yu, Dawei/J-3492-2013	Yu, Dawei/0000-0002-1105-4077; Shao, Lipei/0000-0003-3009-7096	Major National Natural Science Foundation of China [90919051]; National Natural Science Foundation of China [81172091]; youth project of National Natural Science Fund [81301897]	Major National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); youth project of National Natural Science Fund	This study was supported by the Major National Natural Science Foundation of China (90919051), the National Natural Science Foundation of China (81172091) and the youth project of National Natural Science Fund (81301897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Ahlfors H, 2010, BLOOD, V116, P1443, DOI 10.1182/blood-2009-11-252205; Alvarez JD, 2000, GENE DEV, V14, P521; Balamotis MA, 2012, MOL CELL BIOL, V32, P333, DOI 10.1128/MCB.05917-11; Banan M, 1997, J BIOL CHEM, V272, P18440, DOI 10.1074/jbc.272.29.18440; Brendel A, 2013, RESTOR NEUROL NEUROS, V31, P199, DOI 10.3233/RNN-120272; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Chiarugi V, 1997, PHARMACOL RES, V35, P257, DOI 10.1006/phrs.1997.0140; Chu SH, 2013, J CLIN NEUROSCI, V20, P543, DOI 10.1016/j.jocn.2012.05.033; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Gong FR, 2011, NUCLEIC ACIDS RES, V39, P4640, DOI 10.1093/nar/gkr023; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; HANADA M, 1993, BLOOD, V82, P1820; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanker LC, 2011, BREAST, V20, P309, DOI 10.1016/j.breast.2010.10.002; Herrscher RF, 1995, GENE DEV, V9, P3067, DOI 10.1101/gad.9.24.3067; Hui KY, 2014, CANCER LETT, V354, P189, DOI 10.1016/j.canlet.2014.08.009; Kang J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002094; Li QQ, 2010, CANCER SCI, V101, P80, DOI 10.1111/j.1349-7006.2009.01372.x; Liu JQ, 1999, MOL CELL BIOL, V19, P4918; Ma C, 2007, ONCOGENE, V26, P2649, DOI 10.1038/sj.onc.1210069; Mai JC, 2008, NEUROSURGERY, V63, pN6, DOI 10.1227/01.NEU.0000335794.95631.3C; Mao LJ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-111; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nodin B, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-24; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Ruvolo PP, 2001, LEUKEMIA, V15, P515, DOI 10.1038/sj.leu.2402090; Savarese F, 2009, GENE DEV, V23, P2625, DOI 10.1101/gad.1815709; Sun FQ, 2012, ONCOL LETT, V4, P156, DOI 10.3892/ol.2012.681; Wang Y, 2014, BLOOD, V123, P3452, DOI 10.1182/blood-2013-10-534693; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zhang JJ, 2006, GENE, V379, P127, DOI 10.1016/j.gene.2006.05.002	39	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139170	10.1371/journal.pone.0139170	http://dx.doi.org/10.1371/journal.pone.0139170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422397	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700075
J	Haws, DC; Rish, I; Teyssedre, S; He, D; Lozano, AC; Kambadur, P; Karaman, Z; Parida, L				Haws, David C.; Rish, Irina; Teyssedre, Simon; He, Dan; Lozano, Aurelie C.; Kambadur, Prabhanjan; Karaman, Zivan; Parida, Laxmi			Variable-Selection Emerges on Top in Empirical Comparison of Whole-Genome Complex-Trait Prediction Methods	PLOS ONE			English	Article							GENETIC ARCHITECTURE; RIDGE-REGRESSION; PLANT; ACCURACY; REGULARIZATION; HERITABILITY; INFORMATION; PERFORMANCE; MODEL	Accurate prediction of complex traits based on whole-genome data is a computational problem of paramount importance, particularly to plant and animal breeders. However, the number of genetic markers is typically orders of magnitude larger than the number of samples (p >> n), amongst other challenges. We assessed the effectiveness of a diverse set of state-of-the-art methods on publicly accessible real data. The most surprising finding was that approaches with feature selection performed better than others on average, in contrast to the expectation in the community that variable selection is mostly ineffective, i.e. that it does not improve accuracy of prediction, in spite of p >> n. We observed superior performance despite a somewhat simplistic approach to variable selection, possibly suggesting an inherent robustness. This bodes well in general since the variable selection methods usually improve interpretability without loss of prediction power. Apart from identifying a set of benchmark data sets (including one simulated data), we also discuss the performance analysis for each data set in terms of the input characteristics.	[Haws, David C.; Rish, Irina; He, Dan; Parida, Laxmi] IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Lozano, Aurelie C.; Kambadur, Prabhanjan] IBM Corp, Thomas J Watson Res Ctr, Business Analyt & Math Sci Dept, Yorktown Hts, NY 10598 USA; [Teyssedre, Simon; Karaman, Zivan] Ctr Rech Chappes, Limagrain Europe, F-63720 Chappes, France	International Business Machines (IBM); International Business Machines (IBM)	Rish, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA.	rish@us.ibm.com		Karaman, Zivan/0000-0002-8933-4589	IBM T. J. Watson Research; Limagrain	IBM T. J. Watson Research(International Business Machines (IBM)); Limagrain	The authors received no specific funding for this work. LP, DCH, IR, DH, ACL, and PK are employed by IBM T. J. Watson Research. ST and ZK are employed by Limagrain Europe. IBM T. J. Watson Research provided support in the form of salaries for authors LP, DCH, IR, DH, ACL, and PK, and Limagrain provided salaries for ST and ZK, but neither IBM T. J. Watson Research nor Limagrain had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2010, QTL MAS WORKSHOP; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Balding DJ, 2008, HANDBOOK OF STATISTI, V1; Barron AR, 2008, ANN STAT, V36, P64, DOI 10.1214/009053607000000631; Bernardo R, 2009, CROP SCI, V49, P419, DOI 10.2135/cropsci2008.08.0452; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Cleveland MA, 2012, G3-GENES GENOM GENET, V2, P429, DOI 10.1534/g3.111.001453; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Daetwyler HD, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-33; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de Roos APW, 2009, GENETICS, V183, P1545, DOI 10.1534/genetics.109.104935; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Guyon I, 1993, ADV NEURAL INFORM PR, V5, P147; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; He D, 2015, IEEE ACM TRANSACTION; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Hicky JM, 2012, GENET SEL EVOL, V19; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Kang MS, 2001, QUANTITATIVE GENETIC; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Legarra A, 2011, GENET RES, V93, P77, DOI 10.1017/S0016672310000534; Lorenz AJ, 2011, ADV AGRON, V110, P77, DOI 10.1016/B978-0-12-385531-2.00002-5; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meier L, 2008, JOURNAL OF THE ROYAL; Meuwissen THE, 2001, GENETICS, V157, P1819; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Nakaya A, 2012, ANN BOT-LONDON, V110, P1303, DOI 10.1093/aob/mcs109; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rincent R, 2012, GENETICS, V192, P715, DOI 10.1534/genetics.112.141473; Rish I, 2014, NEURAL INF PROCESS S, P1; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scholkopf B., 1997, SUPPORT VECTOR LEARN; Sjostrand K., 2005, MATLAB IMPLEMENTATIO; Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vapnik V, 1997, ADV NEUR IN, V9, P281; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2010, GENET RES, V92, P371, DOI 10.1017/S0016672310000571; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Wray N.R, 2008, NAT EDU, V1, P29; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Zhang T, 2011, IEEE T INFORM THEORY, V57, P4689, DOI 10.1109/TIT.2011.2146690; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	59	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138903	10.1371/journal.pone.0138903	http://dx.doi.org/10.1371/journal.pone.0138903			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439851	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300008
J	Szinwelski, N; Rosa, CS; Solar, RRD; Sperber, CF				Szinwelski, Neucir; Rosa, Cassiano Sousa; de Castro Solar, Ricardo Ribeiro; Sperber, Carlos Frankl			Aggregation of Cricket Activity in Response to Resource Addition Increases Local Diversity	PLOS ONE			English	Article							SPECIES RICHNESS; ENVIRONMENTAL GRADIENT; GRYLLIDEA ORTHOPTERA; NEOTROPICAL GENERA; COMMUNITY ECOLOGY; MALE GENITALIA; PITFALL TRAPS; GRYLLOIDEA; PRODUCTIVITY; PHALANGOPSIDAE	Crickets are often found feeding on fallen fruits among forest litter. Fruits and other sugar-rich resources are not homogeneously distributed, nor are they always available. We therefore expect that crickets dwelling in forest litter have a limited supply of sugar-rich resource, and will perceive this and displace towards resource-supplemented sites. Here we evaluate how sugar availability affects cricket species richness and abundance in old-growth Atlantic forest by spraying sugarcane syrup on leaf litter, simulating increasing availability, and collecting crickets via pitfall trapping. We found an asymptotic positive association between resource addition and species richness, and an interaction between resource addition and species identity on cricket abundance, which indicates differential effects of resource addition among cricket species. Our results indicate that 12 of the 13 cricket species present in forest litter are maintained at low densities by resource scarcity; this highlights sugar-rich resource as a short-term driver of litter cricket community structure in tropical forests. When resource was experimentally increased, species richness increased due to behavioral displacement. We present evidence that the density of many species is limited by resource scarcity and, when resources are added, behavioral displacement promotes increased species packing and alters species composition. Further, our findings have technical applicability for increasing sampling efficiency of local cricket diversity in studies aiming to estimate species richness, but with no regard to local environmental drivers or species-abundance characteristics.	[Szinwelski, Neucir] Univ Estadual Oeste Parana, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil; [Rosa, Cassiano Sousa] Univ Fed Triangulo Mineiro, Iturama, MG, Brazil; [de Castro Solar, Ricardo Ribeiro] Univ Fed Vicosa, Programa Posgrad Ecol, Vicosa, MG, Brazil; [Sperber, Carlos Frankl] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Estadual do Oeste do Parana; Universidade Federal do Triangulo Mineiro; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Szinwelski, N (corresponding author), Univ Estadual Oeste Parana, Programa Posgrad Conservacao & Manejo Recursos Na, Cascavel, Parana, Brazil.	neucir.szinwelski@unioeste.br	Sperber, Carlos Frankl/AAH-4443-2021; de Castro Solar, Ricardo Ribeiro/F-2043-2010; Sperber, Carlos Frankl/F-9298-2012; Rosa, Cassiano S/A-1780-2011; Szinwelski, Neucir/I-2523-2012	de Castro Solar, Ricardo Ribeiro/0000-0001-5627-4017; Sperber, Carlos Frankl/0000-0002-0334-7216; Rosa, Cassiano S/0000-0003-3294-5677; Szinwelski, Neucir/0000-0003-4049-3121	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [BPD-00196-12, CRA-APQ 01478-11]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [PDJ-150362/2012-9, PQ-309787/2012-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [Edital PNPD/2014]; Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-Brasil, CNPQ) [5653360/2010-0]; Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-Brasil, FAPEMIG) [CRA-APQ-00003-11]; CCBS-Unioeste [010/2015-GD/CCBS]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-Brasil, CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-Brasil, FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CCBS-Unioeste	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Award Number: BPD-00196-12 (recipient: Neucir Szinwelski); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Award Number: PDJ-150362/2012-9 (recipient: Cassiano Sousa Rosa); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Award Number: Edital PNPD/2014 (recipient: Ricardo Ribeiro de Castro Solar); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Award Number: PQ-309787/2012-2 (recipient: Carlos Frankl Sperber); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-Brasil, CNPQ) Award Number: 5653360/2010-0 (recipient: not applicable); Sistema Nacional de Pesquisa em Biodiversidade (SISBIOTA-Brasil, FAPEMIG) Award Number: CRA-APQ-00003-11 (recipient: not applicable); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) Award Number: CRA-APQ 01478-11 (recipient: not applicable); and CCBS-Unioeste Award Number: 010/2015-GD/CCBS (recipient: Neucir Szinwelski).	Araujo APA, 2007, SOCIOBIOLOGY, V49, P93; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Brouwers NC, 2009, J INSECT CONSERV, V13, P529, DOI 10.1007/s10841-008-9199-5; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Chase Jonathan M., 2010, P57; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Codling EA, 2008, J R SOC INTERFACE, V5, P813, DOI 10.1098/rsif.2008.0014; Crawley M.J., 2007, R BOOK; de A.G. de Mello Francisco, 1994, Journal of Orthoptera Research, V2, P21; De Geer C., 1773, MEMOIRES SERVIR HIST; de Mello F. de A.G., 1992, J ORTHOPTERA RES, V1, P50, DOI [10.2307/3503560, DOI 10.2307/3503560]; de Mello FAG, 1994, J ORTHOPTERA RES, V2, P25, DOI 10.2307/3503604; DESUTTER L, 1987, ANN SOC ENTOMOL FR, V23, P213; DESUTTER L, 1988, ANN SOC ENTOMOL FR, V24, P343; Desutter-Grandcolas L., 1995, B MUSEUM NATL HIST N, V16, P453; Desutter-Grandcolas Laure, 1992, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V14, P93; DESUTTERGRANDCOLAS L, 1994, ENTOMOL SCAND, V25, P321, DOI 10.1163/187631294X00126; Dias PGBS, 2010, ZOOTAXA, P48; Epps MJ, 2014, PEERJ, V2, DOI 10.7717/peerj.523; FISHER JL, 1973, AM ECON REV, V63, P79; Fukami Tadashi, 2010, P45; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gilbert B, 2009, AM NAT, V174, P850, DOI 10.1086/647903; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Gotelli NJ, 2013, ECOSIMR 1 00; Guerin-Meneville F. E., 1844, ICONOGRAPHIE REGNE A; Guo QF, 1998, ECOLOGY, V79, P2555, DOI 10.1890/0012-9658(1998)079[2555:SRABDO]2.0.CO;2; Hendriks RJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071736; Huber F., 1989, CRICKET BEHAV NEUROB; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Korfanta NM, 2012, ECOLOGY, V93, P2548, DOI 10.1890/11-1345.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lessard JP, 2011, OIKOS, V120, P333, DOI 10.1111/j.1600-0706.2010.18772.x; Matsumoto Y, 2006, BIOL LETT-UK, V2, P608, DOI 10.1098/rsbl.2006.0540; McCluney KE, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3201; Mesa A, 2004, NEOTROP ENTOMOL, V33, P327, DOI 10.1590/S1519-566X2004000300008; Miller TEX, 2009, ECOL MONOGR, V79, P155, DOI 10.1890/07-1550.1; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Ortiz RA, 2010, AMBIENTALIA, V1, P141; Payne LX, 2005, ECOL APPL, V15, P507, DOI 10.1890/03-5029; Pereira MR, 2011, ZOOTAXA, P29; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; R Development Core Team, 2014, R LANG ENV STAT COMP; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rizzini CT, 1997, TRATADO FITOGEOGRAFI; Robillard T, 2013, RAFFLES B ZOOL, V61, P705; Rosenzweig Michael L., 1993, P52; Sauss ure H. de, 1878, MEMOIRES SOC PHYS HI, V25, P369; Schmid B, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02422-3; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Szinwelski N, 2013, ENVIRON ENTOMOL, V42, P758, DOI 10.1603/EN13030; Szinwelski N, 2012, ZOOKEYS, P11, DOI 10.3897/zookeys.196.3130; Tiegs SD, 2008, J N AM BENTHOL SOC, V27, P321, DOI 10.1899/07-054.1; Tilman D, 2003, PERSPECTIVES PLANT C, P117; Tilman D, 1993, HIST GEOGRAPHICAL PE, P13; Vanschoenwinkel B, 2010, J N AM BENTHOL SOC, V29, P1267, DOI 10.1899/09-114.1; Walker T.J., 1989, P1	58	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139669	10.1371/journal.pone.0139669	http://dx.doi.org/10.1371/journal.pone.0139669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436669	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200046
J	Alqahtani, S; Kaddoumi, A				Alqahtani, Saeed; Kaddoumi, Amal			Development of Physiologically Based Pharmacokinetic/Pharmacodynamic Model for Indomethacin Disposition in Pregnancy	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN LIVER-MICROSOMES; PREMATURE LABOR; CLINICAL PHARMACOKINETICS; METABOLIZING-ENZYMES; PREDICT DISPOSITION; WOMEN; GLUCURONIDATION; INHIBITION; TRANSPORT	Findings of a recent clinical study showed indomethacin has lower plasma levels and higher steady-state apparent clearance in pregnant subjects when compared to those in non-pregnant subjects reported in separate studies. Thus, in the current work we developed a pregnancy physiological based pharmacokinetic/pharmacodynamic (PBPK/PD) model for indomethacin to explain the differences in indomethacin pharmacokinetics between pregnancy and non-pregnancy. A whole-body PBPK model with key pregnancy-related physiological changes was developed to characterize indomethacin PK in pregnant women and compare these parameters to those in non-pregnant subjects. Data related to maternal physiological and biological changes were obtained from literature and incorporated into the structural PBPK model that describes non-pregnant PK data. Changes in indomethacin area under the curve (AUC), maximum concentration (C-max) and average steady-state concentration (C-ave) in pregnant women were predicted. Model-simulated PK profiles were in agreement with observed data. The predicted mean ratio (non-pregnant: second trimester (T-2)) of indomethacin C-ave was 1.6 compared to the observed value of 1.59. In addition, the predicted steady-state apparent clearance (CL/F-ss) ratio was almost similar to the observed value (0.46 vs. 0.42). Sensitivity analysis suggested changes in CYP2C9 activity, and to a lesser extent UGT2B7, as the primary factor contributing to differences in indomethacin disposition between pregnancy and non-pregnancy. The developed PBPK model which integrates prior physiological knowledge, in vitro and in vivo data, allowed the successful prediction of indomethacin disposition during T-2. Our PBPK/PD model suggested a higher indomethacin dosing requirement during pregnancy.	[Alqahtani, Saeed; Kaddoumi, Amal] Univ Louisiana Monroe, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA	University of Louisiana System; University of Louisiana Monroe	Kaddoumi, A (corresponding author), Univ Louisiana Monroe, Sch Pharm, Dept Basic Pharmaceut Sci, Monroe, LA 71209 USA.	kaddoumi@ulm.edu	Alqahtani, Saeed/S-9211-2019	Alqahtani, Saeed/0000-0002-3839-8187				Abduljalil K, 2012, CLIN PHARMACOKINET, V51, P365, DOI 10.2165/11597440-000000000-00000; ADAMS KRH, 1982, BRIT J CLIN PHARMACO, V14, P286, DOI 10.1111/j.1365-2125.1982.tb01977.x; ALVAN G, 1975, CLIN PHARMACOL THER, V18, P364; Apiwattanakul N, 1999, MOL PHARMACOL, V55, P847; BEDWANI JR, 1975, BRIT J PHARMACOL, V53, P547, DOI 10.1111/j.1476-5381.1975.tb07393.x; BLACKWELL GJ, 1976, BRIT J PHARMACOL, V56, pP343; De Buck SS, 2007, DRUG METAB DISPOS, V35, P1766, DOI 10.1124/dmd.107.015644; DUGGAN DE, 1972, J PHARMACOL EXP THER, V181, P563; Faasen F, 2003, INT J PHARMACEUT, V263, P113, DOI 10.1016/S0378-5173(03)00372-7; FREED MI, 1994, J CLIN PHARMACOL, V34, P1098, DOI 10.1002/j.1552-4604.1994.tb01987.x; GERDIN E, 1990, J PERINAT MED, V18, P479, DOI 10.1515/jpme.1990.18.6.479; Giagoudakis G, 2005, PHARMACOTHERAPY, V25, P18, DOI 10.1592/phco.25.1.18.55618; Hauss DJ, 2007, ADV DRUG DELIVER REV, V59, P667, DOI 10.1016/j.addr.2007.05.006; HELLEBERG L, 1976, J CHROMATOGR, V117, P167, DOI 10.1016/S0021-9673(00)81078-X; HELLEBERG L, 1981, CLIN PHARMACOKINET, V6, P245, DOI 10.2165/00003088-198106040-00001; Hubinont C, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/941057; Jeong H, 2010, EXPERT OPIN DRUG MET, V6, P689, DOI 10.1517/17425251003677755; Ke AB, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.2; Ke AB, 2014, BRIT J CLIN PHARMACO, V77, P554, DOI 10.1111/bcp.12207; Ke AB, 2014, ANNU REV PHARMACOL, V54, P53, DOI 10.1146/annurev-pharmtox-011613-140009; Ke AB, 2013, DRUG METAB DISPOS, V41, P801, DOI 10.1124/dmd.112.050161; Kouzuki H, 2000, PHARMACEUT RES, V17, P432, DOI 10.1023/A:1007576903935; Kuehl GE, 2005, DRUG METAB DISPOS, V33, P1027, DOI 10.1124/dmd.104.002527; Lu GH, 2012, BRIT J CLIN PHARMACO, V74, P873, DOI 10.1111/j.1365-2125.2012.04363.x; Mano Y, 2007, EUR J CLIN PHARMACOL, V63, P289, DOI 10.1007/s00228-007-0261-0; Moodley J, 1998, J INFECT DIS, V178, P1327, DOI 10.1086/314431; Morita N, 2001, J PHARMACOL EXP THER, V298, P1179; Nakajima M, 1998, DRUG METAB DISPOS, V26, P261; NIEBYL JR, 1980, AM J OBSTET GYNECOL, V136, P1014, DOI 10.1016/0002-9378(80)90629-8; Okita RT, 1996, CRIT REV BIOCHEM MOL, V31, P101, DOI 10.3109/10409239609106581; OSULLIVAN GM, 1984, BRIT J OBSTET GYNAEC, V91, P973, DOI 10.1111/j.1471-0528.1984.tb03673.x; Papini O, 2006, J PHARMACEUT BIOMED, V40, P397, DOI 10.1016/j.jpba.2005.07.021; RANE A, 1978, CLIN PHARMACOL THER, V23, P658; Rodgers T, 2006, J PHARM SCI-US, V95, P1238, DOI 10.1002/jps.20502; Rytting E, 2014, CLIN PHARMACOKINET, V53, P545, DOI 10.1007/s40262-014-0133-6; Sawdy RJ, 2003, AM J OBSTET GYNECOL, V188, P1046, DOI 10.1067/mob.2003.255; SEPPALA E, 1985, CLIN RHEUMATOL, V4, P315, DOI 10.1007/BF02031615; TOMSON G, 1979, CLIN PHARMACOL THER, V25, P74; Tran TA, 2002, NEUROLOGY, V59, P251, DOI 10.1212/WNL.59.2.251; Tsatsaris V, 2004, CLIN PHARMACOKINET, V43, P833, DOI 10.2165/00003088-200443130-00001; VANTHIEL DH, 1977, GASTROENTEROLOGY, V72, P666; VERBEECK RK, 1983, CLIN PHARMACOKINET, V8, P297, DOI 10.2165/00003088-198308040-00003; VREE TB, 1993, J CHROMATOGR-BIOMED, V616, P271, DOI 10.1016/0378-4347(93)80395-K; WATTS DH, 1991, J INFECT DIS, V163, P226, DOI 10.1093/infdis/163.2.226; Wiqvist N, 1974, Acta Obstet Gynecol Scand Suppl, V37, P7; Xia BF, 2013, AAPS J, V15, P1012, DOI 10.1208/s12248-013-9505-3; ZUCKERMAN H, 1974, OBSTET GYNECOL, V44, P787; ZUCKERMAN H, 1984, J PERINAT MED, V12, P25, DOI 10.1515/jpme.1984.12.1.25; ZUCKERMAN H, 1984, J PERINAT MED, V12, P19, DOI 10.1515/jpme.1984.12.1.19	49	23	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139762	10.1371/journal.pone.0139762	http://dx.doi.org/10.1371/journal.pone.0139762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431339	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700112
J	Cumberland, PM; Bao, YC; Hysi, PG; Foster, PJ; Hammond, CJ; Rahi, JS				Cumberland, Phillippa M.; Bao, Yanchun; Hysi, Pirro G.; Foster, Paul J.; Hammond, Christopher J.; Rahi, Jugnoo S.		UK Blobank Eyes Vision Consortium	Frequency and Distribution of Refractive Error in Adult Life: Methodology and Findings of the UK Biobank Study	PLOS ONE			English	Article							BEAVER DAM EYE; UNITED-STATES; RISK-FACTORS; INCREASED PREVALENCE; MYOPIA; POPULATION; EPIDEMIOLOGY; ASSOCIATION; IMPAIRMENT; DOMINANCE	Purpose To report the methodology and findings of a large scale investigation of burden and distribution of refractive error, from a contemporary and ethnically diverse study of health and disease in adults, in the UK. Methods U K Biobank, a unique contemporary resource for the study of health and disease, recruited more than half a million people aged 40-69 years. A subsample of 107,452 subjects undertook an enhanced ophthalmic examination which provided autorefraction data (a measure of refractive error). Refractive error status was categorised using the mean spherical equivalent refraction measure. Information on socio-demographic factors (age, gender, ethnicity, educational qualifications and accommodation tenure) was reported at the time of recruitment by questionnaire and face-to-face interview. Results Fifty four percent of participants aged 40-69 years had refractive error. Specifically 27% had myopia (4% high myopia), which was more common amongst younger people, those of higher socio-economic status, higher educational attainment, or of White or Chinese ethnicity. The frequency of hypermetropia increased with age (7% at 40-44 years increasing to 46% at 65-69 years), was higher in women and its severity was associated with ethnicity (moderate or high hypermetropia at least 30% less likely in non-White ethnic groups compared to White). Conclusions Refractive error is a significant public health issue for the UK and this study provides contemporary data on adults for planning services, health economic modelling and monitoring of secular trends. Further investigation of risk factors is necessary to inform strategies for prevention. There is scope to do this through the planned longitudinal extension of the UK Biobank study.	[Cumberland, Phillippa M.; Bao, Yanchun; Rahi, Jugnoo S.] UCL, Inst Child Hlth, Life Course Epidemiol & Biostat Sect, London, England; [Cumberland, Phillippa M.; Bao, Yanchun; Rahi, Jugnoo S.] UCL Inst Child Hlth, Ulverscroft Vis Res Grp, London, England; [Hysi, Pirro G.; Hammond, Christopher J.] Univ London, Kings Coll London, St Thomas Hosp Campus, Dept Ophthalmol, London SW3 6LX, England; [Foster, Paul J.; Rahi, Jugnoo S.] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Foster, Paul J.; Rahi, Jugnoo S.] UCL Inst Ophthalmol, London, England; [Hammond, Christopher J.] Univ London, Kings Coll London, Dept Twin Res & Genet Epidemiol, London SW3 6LX, England; [Rahi, Jugnoo S.] Great Ormond St Hosp Children NHS Fdn Trust, London, England	University of London; University College London; University of London; University College London; University of London; King's College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; King's College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Cumberland, PM (corresponding author), UCL, Inst Child Hlth, Life Course Epidemiol & Biostat Sect, London, England.	p.cumberland@ucl.ac.uk	Foster, Paul/V-7288-2019; Cipriani, Valentina/A-8549-2012; Aslam, Tariq/A-8532-2016	Foster, Paul/0000-0002-4755-177X; Cipriani, Valentina/0000-0002-0839-9955; Aslam, Tariq/0000-0002-9739-7280; Yates, Max/0000-0003-3977-8920; Bunce, Catey/0000-0002-0935-3713; Garway-Heath, David/0000-0003-2907-6992; Sudlow, Cathie/0000-0002-7725-7520; Khaw, Sir Peng Tee/0000-0002-8087-2268; Hysi, Pirro/0000-0001-5752-2510; Rahi, Jugnoo/0000-0002-5718-9209; Hammond, Christopher/0000-0002-3227-2620; Khawaja, Anthony/0000-0001-6802-8585	National Eye Research Centre [SCIAD 066]; Ulverscroft Foundation; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; Department of Health's NIHR Biomedical Research Centres funding scheme; Medical Research Council [MC_qA137853, G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10170, CL-2010-18-004, CS-2014-14-023, NF-SI-0512-10101] Funding Source: researchfish; Fight for Sight [1495/96] Funding Source: researchfish; MRC [G0400546] Funding Source: UKRI	National Eye Research Centre; Ulverscroft Foundation; NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; Department of Health's NIHR Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the National Eye Research Centre (SCIAD 066) (http://www.nerc-charity.org.uk/) to YB, the Ulverscroft Foundation (http://www.foundation.ulverscroft.com/) to PMC, JSR receives part funding from the NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The UK Biobank Eye and Vision Consortium is supported by a grant from The Special Trustees of Moorfields Eye Hospital. The study was undertaken at UCL Institute of Child Health which receives a proportion of its funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Attebo K, 1999, OPHTHALMOLOGY, V106, P1066, DOI 10.1016/S0161-6420(99)90251-8; Bourne RRA, 2014, BRIT J OPHTHALMOL, V98, P629, DOI 10.1136/bjophthalmol-2013-304033; Carey DP, 2013, CORTEX, V49, P2542, DOI 10.1016/j.cortex.2012.11.011; Cheng CY, 2004, INVEST OPHTH VIS SCI, V45, P2856, DOI 10.1167/iovs.03-0878; Cochrane GM, 2010, BMJ, V340; FITZMAURICE GM, 1995, AM J EPIDEMIOL, V142, P1194, DOI 10.1093/oxfordjournals.aje.a117578; Flitcroft DI, 2012, PROG RETIN EYE RES, V31, P622, DOI 10.1016/j.preteyeres.2012.06.004; Fotouhi A, 2012, ACTA OPHTHALMOL, V90, P380, DOI 10.1111/j.1755-3768.2010.01983.x; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P2903, DOI 10.1167/iovs.07-0804; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Krantz EM, 2010, ARCH OPHTHALMOL-CHIC, V128, P88, DOI 10.1001/archophthalmol.2009.349; Lee KE, 2002, INVEST OPHTH VIS SCI, V43, P2566; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Lin Z, 2014, INVEST OPHTHALMOL VI; Mahroo OA, 2015, OPHTHALMOLOGY, V122, P648, DOI 10.1016/j.ophtha.2014.10.021; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Pan CW, 2013, AM J OPHTHALMOL, V155, P1129, DOI 10.1016/j.ajo.2013.01.009; Pan CW, 2013, INVEST OPHTH VIS SCI, V54, P2590, DOI 10.1167/iovs.13-11725; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Pan CW, 2011, INVEST OPHTH VIS SCI, V52, P3166, DOI 10.1167/iovs.10-6210; Parssinen O, 2012, ACTA OPHTHALMOL, V90, P497, DOI 10.1111/j.1755-3768.2011.02210.x; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Rein DB, 2006, ARCH OPHTHALMOL-CHIC, V124, P1754, DOI 10.1001/archopht.124.12.1754; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Sanfilippo PG, 2014, ACTA OPHTHALMOL, V92, pE458, DOI 10.1111/aos.12388; Sherwin JC, 2012, INVEST OPHTH VIS SCI, V53, P4363, DOI 10.1167/iovs.11-8677; Sherwin JC, 2012, BRIT J OPHTHALMOL, V96, P991, DOI 10.1136/bjophthalmol-2011-301430; Smith TST, 2009, B WORLD HEALTH ORGAN, V87, P431, DOI 10.2471/BLT.08.055673; Vitale S, 2008, ARCH OPHTHALMOL-CHIC, V126, P1111, DOI 10.1001/archopht.126.8.1111; Vitale S, 2006, OPHTHALMOLOGY, V113, P2163, DOI 10.1016/j.ophtha.2006.06.033; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; WANG Q, 1994, INVEST OPHTH VIS SCI, V35, P4344; Wensor M, 1999, ARCH OPHTHALMOL-CHIC, V117, P658; Williams C, 2008, BRIT J OPHTHALMOL, V92, P1117, DOI 10.1136/bjo.2007.128256; Williams KM, 2015, EUR J EPIDEMIOL, V30, P305, DOI 10.1007/s10654-015-0010-0; Williams KM, 2015, OPHTHALMOLOGY; Wolfram C, 2014, BRIT J OPHTHALMOL, V98, P857, DOI 10.1136/bjophthalmol-2013-304228; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015	43	31	31	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139780	10.1371/journal.pone.0139780	http://dx.doi.org/10.1371/journal.pone.0139780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430771	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700115
J	Muschter, D; Schafer, N; Stangl, H; Straub, RH; Grassel, S				Muschter, Dominique; Schaefer, Nicole; Stangl, Hubert; Straub, Rainer H.; Graessel, Susanne			Sympathetic Neurotransmitters Modulate Osteoclastogenesis and Osteoclast Activity in the Context of Collagen-Induced Arthritis	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; ADENYLATE-CYCLASE; BONE-RESORPTION; NERVOUS-SYSTEM; CATHEPSIN-K; CELLS; MICE; OSTEOPROTEGERIN	Excessive synovial osteoclastogenesis is a hallmark of rheumatoid arthritis (RA). Concomitantly, local synovial changes comprise neuronal components of the peripheral sympathetic nervous system. Here, we wanted to analyze if collagen-induced arthritis (CIA) alters bone marrow-derived macrophage (BMM) osteoclastogenesis and osteoclast activity, and how sympathetic neurotransmitters participate in this process. Therefore, BMMs from Dark Agouti rats at different CIA stages were differentiated into osteoclasts in vitro and osteoclast number, cathepsin K activity, matrix resorption and apoptosis were analyzed in the presence of acetylcholine (ACh), noradrenaline (NA) vasoactive intestinal peptide (VIP) and assay-dependent, adenylyl cyclase activator NKH477. We observed modulation of neurotransmitter receptor mRNA expression in CIA osteoclasts without affecting protein level. CIA stage-dependently altered marker gene expression associated with osteoclast differentiation and activity without affecting osteoclast number or activity. Neurotransmitter stimulation modulated osteoclast differentiation, apoptosis and activity. VIP, NA and adenylyl cyclase activator NKH477 inhibited cathepsin K activity and osteoclastogenesis (NKH477, 10-6M NA) whereas ACh mostly acted pro-osteoclastogenic. We conclude that CIA alone does not affect metabolism of in vitro generated osteoclasts whereas stimulation with NA, VIP plus specific activation of adenylyl cyclase induced anti-resorptive effects probably mediated via cAMP signaling. Contrary, we suggest pro-osteoclastogenic and pro-resorptive properties of ACh mediated via muscarinic receptors.	[Muschter, Dominique; Schaefer, Nicole; Graessel, Susanne] Univ Hosp Regensburg, Dept Orthoped Surg Expt Orthoped, Regensburg, Bavaria, Germany; [Stangl, Hubert; Straub, Rainer H.] Univ Hosp Regensburg, Lab Expt Rheumatol & Neuroendocrine Immunol, Dept Internal Med 1, Regensburg, Bavaria, Germany; [Muschter, Dominique; Graessel, Susanne] BioPark I, Ctr Med Biotechnol, Regensburg, Bavaria, Germany	University of Regensburg; University of Regensburg	Grassel, S (corresponding author), Univ Hosp Regensburg, Dept Orthoped Surg Expt Orthoped, Regensburg, Bavaria, Germany.	susanne.graessel@ukr.de		Straub, Rainer H/0000-0003-1165-4555	Deutsche Forschungsgemeinschaft [GR 1301/10-1, STR 511/26-1, SPP1468]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by funds of the Deutsche Forschungsgemeinschaft to SG (GR 1301/10-1) and to RHS (STR 511/26-1) as part of the priority program SPP1468 "Immunobone". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED M, 1995, NEUROPEPTIDES, V29, P33, DOI 10.1016/0143-4179(95)90054-3; Akchurin T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002104; Arai M, 2003, BBA-MOL CELL RES, V1640, P137, DOI 10.1016/S0167-4889(03)00042-9; Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Budd DC, 2003, J BIOL CHEM, V278, P19565, DOI 10.1074/jbc.M211670200; Capellino S, 2012, ARTHRITIS RHEUM-US, V64, P1110, DOI 10.1002/art.33431; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Fonseca TL, 2011, J BONE MINER RES, V26, P591, DOI 10.1002/jbmr.243; Granholm S, 2007, J ENDOCRINOL, V195, P415, DOI 10.1677/JOE-07-0338; Grimsholm O, 2008, NEUROSCI LETT, V442, P128, DOI 10.1016/j.neulet.2008.06.082; Guizzetti M, 1996, EUR J PHARMACOL, V297, P265, DOI 10.1016/0014-2999(95)00746-6; Harle P, 2005, ARTHRITIS RHEUM-US, V52, P1305, DOI 10.1002/art.20987; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Ikic M, 2014, INT ORTHOP, V38, P183, DOI 10.1007/s00264-013-2121-0; Kishimoto Y, 2004, RHEUMATOLOGY, V43, P1496, DOI 10.1093/rheumatology/keh395; Kondo H, 2013, AM J PHYSIOL-ENDOC M, V304, pE507, DOI 10.1152/ajpendo.00191.2012; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee YJ, 2014, CHEMOSPHERE, V94, P121, DOI 10.1016/j.chemosphere.2013.09.059; Li P, 2004, ARTHRITIS RHEUM, V50, P265, DOI 10.1002/art.11419; Liu PS, 2011, EUR J PHARMACOL, V650, P34, DOI 10.1016/j.ejphar.2010.09.031; Lorton D, 2015, INT J MOL SCI, V16, P5635, DOI 10.3390/ijms16035635; Lutter AH, 2010, J CELL BIOCHEM, V109, P1025, DOI 10.1002/jcb.22485; Mukohyama H, 2000, BIOCHEM BIOPH RES CO, V271, P158, DOI 10.1006/bbrc.2000.2599; Muschter D, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0684-4; NICHOLSON GC, 1987, ENDOCRINOLOGY, V120, P1902, DOI 10.1210/endo-120-5-1902; Perlman H, 2001, ARTHRITIS RHEUM, V44, P2899, DOI 10.1002/1529-0131(200112)44:12<2899::AID-ART478>3.0.CO;2-X; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pongratz G, 2013, NAT REV RHEUMATOL, V9, P117, DOI 10.1038/nrrheum.2012.181; Sato T, 2010, THE JOURNAL OF PHARM, V334, P99, DOI [10.1124/jpet.110.167643, DOI 10.1124/JPET.110.167643]; Scatizzi JC, 2010, ARTHRITIS RHEUM-US, V62, P441, DOI 10.1002/art.27198; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Sethi V, 2013, MOL PHARMACEUT, V10, P728, DOI 10.1021/mp300539f; Skoumal M, 2008, RHEUMATOL INT, V28, P637, DOI 10.1007/s00296-007-0506-3; Stangl H, 2015, BRAIN BEHAV IMMUN, V46, P180, DOI 10.1016/j.bbi.2015.02.022; Stralberg F, 2013, FASEB J, V27, P2687, DOI 10.1096/fj.12-211748; Svelander L, 2009, EUR J PHARMACOL, V613, P155, DOI 10.1016/j.ejphar.2009.03.074; Tanaka H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059402; Togari A, 2008, J PHARMACOL SCI, V106, P542, DOI 10.1254/jphs.FM0070227; van Maanen MA, 2009, ARTHRITIS RHEUM-US, V60, P114, DOI 10.1002/art.24177; Winding B, 1997, EXP PHYSIOL, V82, P871, DOI 10.1113/expphysiol.1997.sp004070; Wittrant Y, 2003, BIOCHEM BIOPH RES CO, V310, P774, DOI 10.1016/j.bbrc.2003.09.084; Yamazaki H, 2001, EXP HEMATOL, V29, P68, DOI 10.1016/S0301-472X(00)00626-3; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0	45	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139726	10.1371/journal.pone.0139726	http://dx.doi.org/10.1371/journal.pone.0139726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431344	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700105
J	Shah, KG; Guelig, D; Diesburg, S; Buser, J; Burton, R; LaBarre, P; Richards-Kortum, R; Weigl, B				Shah, Kamal G.; Guelig, Dylan; Diesburg, Steven; Buser, Joshua; Burton, Robert; LaBarre, Paul; Richards-Kortum, Rebecca; Weigl, Bernhard			Design of a New Type of Compact Chemical Heater for Isothermal Nucleic Acid Amplification	PLOS ONE			English	Article								Previous chemical heater designs for isothermal nucleic acid amplification have been based on solid-liquid phase transition, but using this approach, developers have identified design challenges en route to developing a low-cost, disposable device. Here, we demonstrate the feasibility of a new heater configuration suitable for isothermal amplification in which one reactant of an exothermic reaction is a liquid-gas phase-change material, thereby eliminating the need for a separate phase-change compartment. This design offers potentially enhanced performance and energy density compared to other chemical and electric heaters.	[Shah, Kamal G.; Richards-Kortum, Rebecca] Rice Univ, Dept Bioengn, Houston, TX USA; [Shah, Kamal G.; Guelig, Dylan; Diesburg, Steven; Burton, Robert; LaBarre, Paul; Weigl, Bernhard] PATH, Seattle, WA USA; [Shah, Kamal G.; Buser, Joshua] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	Rice University; University of Washington; University of Washington Seattle	Shah, KG (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	kgshah.4@gmail.com		Shah, Kamal/0000-0003-3644-5290	National Institutes of Health [NIAID R01 AI097038]; Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education program [52006938]; Arnold and Mabel Beckman Foundation through the Beckman Scholars Program; Defense Advanced Research Projects Agency at the University of Washington [HR0011-11-2-0007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education program; Arnold and Mabel Beckman Foundation through the Beckman Scholars Program; Defense Advanced Research Projects Agency at the University of Washington; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by the National Institutes of Health to support this work (NIAID R01 AI097038). Partial salary support to Shah was provided by a grant to Rice University from the Howard Hughes Medical Institute through the Precollege and Undergraduate Science Education program (52006938) and the Arnold and Mabel Beckman Foundation through the Beckman Scholars Program. Salary support was provided to Buser from a Defense Advanced Research Projects Agency grant to Paul Yager (who is not an author on this paper) at the University of Washington (HR0011-11-2-0007), and partial salary support to Shah, Guelig, Diesburg, and Weigl was provided via a subcontract from that grant to PATH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; Lillis L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108189; Liu CC, 2011, LAB CHIP, V11, P2686, DOI 10.1039/c1lc20345b; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Rohrman BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045611; Singleton J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113693; Taub I, 2002, J PHYS CHEM A, V106, P35; Waters RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105630; Xu GL, 2012, SCI REP-UK, V2, DOI [10.1038/srep00246, 10.1038/srep00986]; Zanoli LM, 2013, BIOSENSORS-BASEL, V3, P18, DOI 10.3390/bios3010018	12	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139449	10.1371/journal.pone.0139449	http://dx.doi.org/10.1371/journal.pone.0139449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430883	gold, Green Published			2022-12-27	WOS:000362178700060
J	Thron, C; Akhyari, P; Godehardt, E; Lichtenberg, A; Ruther, U; Seehaus, S				Thron, Cindy; Akhyari, Payam; Godehardt, Erhard; Lichtenberg, Artur; Ruether, Ulrich; Seehaus, Stefanie			FTO Is Associated with Aortic Valve Stenosis in a Gender Specific Manner of Heterozygote Advantage: A Population-Based Case-Control Study	PLOS ONE			English	Article							HARDY-WEINBERG EQUILIBRIUM; OBESITY-ASSOCIATED FTO; BODY-MASS INDEX; DIABETES ACCELERATE; PHYSICAL-ACTIVITY; GENE-EXPRESSION; ADULT OBESITY; VARIANT; DISEASE; RISK	Background Single nucleotide polymorphisms (SNPs) within the Fat mass and obesity associated (FTO) gene have been linked with increased body weight. However, the data on an association of FTO with cardiovascular diseases remains conflicting. Therefore, we ascertained whether FTO is associated with aortic valve stenosis (AVS), one of the most frequent cardiovascular diseases in the Western world. Methods and Findings In this population-based case-control study the FTO SNP rs9939609 was analyzed in 300 German patients with AVS and 429 German controls of the KORA survey S4, representing a random population. Blood samples were collected prior to aortic valve replacement in AVS cases and FTO rs9939609 was genotyped via ARMS-PCR. Genotype frequencies differed significantly between AVS cases and KORA controls (p = 0.004). Separate gender-analyses uncovered an association of FTO with AVS exclusively in males; homozygote carriers for the risk-allele (A) had a higher risk to develop AVS (p = 0.017, odds ratio (OR) 1.727; 95% confidence interval (CI) 1.087-2.747, recessive model), whereas heterozygote carriers for the risk-allele showed a lower risk (p = 0.002, OR 0.565, 95% CI 0.384-0.828, overdominant model). After adjustment for multiple co-variables, the odds ratios of heterozygotes remained significant for an association with AVS (p = 0.008, OR 0.565, 95% CI 0.369-0.861). Conclusions This study revealed an association of FTO rs9939609 with AVS. Furthermore, this association was restricted to men, with heterozygotes having a significantly lower chance to develop AVS. Lastly, the association between FTO and AVS was independent of BMI and other variables such as diabetes mellitus.	[Thron, Cindy; Ruether, Ulrich; Seehaus, Stefanie] Univ Dusseldorf, Inst Anim Dev & Mol Biol, Dusseldorf, Germany; [Akhyari, Payam; Godehardt, Erhard; Lichtenberg, Artur] Univ Dusseldorf, Dept Cardiovasc Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Seehaus, S (corresponding author), Univ Dusseldorf, Inst Anim Dev & Mol Biol, Dusseldorf, Germany.	Stefanie.Seehaus@hhu.de	Akhyari, Payam/AAK-8866-2020	Akhyari, Payam/0000-0002-6452-8678	Federal Ministry of Education and Research; National Genome Research Network-PLUS, Molecular Mechanisms in Obesity [GF-GFGS01084508]; Strategic Research Fund of the Heinrich-Heine-University [F2012/279-5]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Genome Research Network-PLUS, Molecular Mechanisms in Obesity; Strategic Research Fund of the Heinrich-Heine-University	This study was supported by a grant of the Federal Ministry of Education and Research (http://www.bmbf.de), National Genome Research Network-PLUS, Molecular Mechanisms in Obesity (GF-GFGS01084508) to Ulrich Ruther and a grant of the Strategic Research Fund of the Heinrich-Heine-University (http://www.forschung.uni-duesseldorf.de/forschungsservice/strategischer-forschungsfonds.html; F2012/279-5) to Stefanie Seehaus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2010, AM HEART J, V160, P1163, DOI 10.1016/j.ahj.2010.08.002; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Bergman SM, 1997, BEHAV GENET, V27, P33; Berulava T, 2010, EUR J HUM GENET, V18, P1054, DOI 10.1038/ejhg.2010.71; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cornes BK, 2009, INT J OBESITY, V33, P75, DOI 10.1038/ijo.2008.223; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Doney ASF, 2009, CIRC-CARDIOVASC GENE, V2, P255, DOI 10.1161/CIRCGENETICS.108.822320; Dvorakova V, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-13; Falcao-Pires I, 2011, CIRCULATION, V124, P1151, DOI 10.1161/CIRCULATIONAHA.111.025270; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Funkat A, 2014, THORAC CARDIOV SURG, V62, P380, DOI 10.1055/s-0034-1383430; Gaborit N, 2010, J MOL CELL CARDIOL, V49, P639, DOI 10.1016/j.yjmcc.2010.06.005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gomes I, 1999, ANN HUM GENET, V63, P535, DOI 10.1017/S0003480099007824; Graffelman J, 2008, HUM HERED, V65, P77, DOI 10.1159/000108939; Hamm CW, 2014, EUR HEART J, V35, P1588, DOI 10.1093/eurheartj/eht381; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Hosking L, 2004, EUR J HUM GENET, V12, P395, DOI 10.1038/sj.ejhg.5201164; Hubacek JA, 2010, CLIN CHIM ACTA, V411, P1069, DOI 10.1016/j.cca.2010.03.037; Jacobsson JA, 2008, BIOCHEM BIOPH RES CO, V368, P476, DOI 10.1016/j.bbrc.2008.01.087; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Kamalesh M, 2009, EUR J ECHOCARDIOGR, V10, P723, DOI 10.1093/ejechocard/jep048; Kivimaki M, 2008, EUR HEART J, V29, P2552, DOI 10.1093/eurheartj/ehn252; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Kostin S, 2004, CARDIOVASC RES, V62, P426, DOI 10.1016/j.cardiores.2003.12.010; Lappalainen T, 2011, NUTR METAB CARDIOVAS, V21, P691, DOI 10.1016/j.numecd.2010.01.006; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; Madrid GA, 2001, ALCOHOL, V23, P117, DOI 10.1016/S0741-8329(00)00138-5; Maganti K, 2010, MAYO CLIN PROC, V85, P483, DOI 10.4065/mcp.2009.0706; Makkar RR, 2012, NEW ENGL J MED, V366, P1696, DOI 10.1056/NEJMoa1202277; Natorska J, 2012, INFLAMMATION, V35, P834, DOI 10.1007/s10753-011-9384-7; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Olszewski PK, 2011, PHYSIOL BEHAV, V103, P248, DOI 10.1016/j.physbeh.2011.01.022; Otto CM, 2014, NEW ENGL J MED, V371, P744, DOI 10.1056/NEJMra1313875; Owens DS, 2010, AM J CARDIOL, V105, P701, DOI 10.1016/j.amjcard.2009.10.071; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Probst V, 2006, CIRCULATION, V113, P856, DOI 10.1161/CIRCULATIONAHA.105.569467; Salanti G, 2005, EUR J HUM GENET, V13, P840, DOI 10.1038/sj.ejhg.5201410; Scott RA, 2010, EUR J HUM GENET, V18, P1339, DOI 10.1038/ejhg.2010.131; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shahid A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/324093; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Tan JT, 2008, DIABETES, V57, P2851, DOI 10.2337/db08-0214; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zhang MX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097545; Zhang SS, 2011, P NATL ACAD SCI USA, V108, P13576, DOI 10.1073/pnas.1106911108	55	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139419	10.1371/journal.pone.0139419	http://dx.doi.org/10.1371/journal.pone.0139419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431034	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700054
J	Zhong, ZDA; Sun, WH; Chen, HY; Zhang, HL; Lane, NE; Yao, W				Zhong, Zhendong A.; Sun, Weihua; Chen, Haiyan; Zhang, Hongliang; Lane, Nancy E.; Yao, Wei			Inactivation of the Progesterone Receptor in Mx1+Cells Potentiates Osteogenesis in Calvaria but Not in Long Bone	PLOS ONE			English	Article							DIFFERENTIATION; PROLIFERATION; ESTROGEN; GROWTH; CELLS; ASSOCIATION; OSTEOBLASTS; DENSITY; DISEASE	The effect of progesterone on bone remains elusive. We previously reported that global progesterone receptor (PR) knockout mice displayed high bone mass phenotype, suggesting that PR influences bone growth and modeling. Recently, Mx1+ cells were characterized to be mesenchymal stem cell-like pluripotent Cells. The aim of this study was to evaluate whether the PR in Mx1+ cells regulates osteogenesis. Using the Mx1-Cre; mT/mG reporter mouse model, we found that the calvarial cells exhibited minimal background Mx1-Cre activity prior to Cre activation by IFN alpha treatment as compared to the bone marrow stromal cells. IFN alpha treatment significantly activated Mx1-Cre in the calvarial cells. When the PR gene was deleted in the Mx1-Cre; PR-flox calvarial cells in vitro, significantly higher levels of expression of osteoblast maturation marker genes (RUNX2, Osteocalcin, and Dmp1) and osteogenic potential were detected. The PR-deficient calvariae exhibited greater bone volume, especially in the males. Although Mx1-Cre activity could be induced on the bone surface in vivo, the Mx1+ cells did not differentiate into osteocytes in long bones. Bone volumes at the distal femurs and the bone turnover marker serum Osteocalcin were similar between the Mx1-Cre; PR-flox mutant mice and the corresponding wild types in both sexes. In conclusion, our data demonstrates that blocking progesterone signaling via PRs in calvarial Mx1+ cells promoted osteoblast differentiation in the calvaria. Mx1+ was expressed by heterogeneous cells in bone marrow and did not differentiate into osteocyte during long bone development in vivo. Selectively inactivating the PR gene in Mx1+ cells affected the membrane bone formation but did not affect peripheral skeletal homeostasis.	[Zhong, Zhendong A.; Sun, Weihua; Chen, Haiyan; Zhang, Hongliang; Lane, Nancy E.; Yao, Wei] Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Musculoskeletal Hlth, Sacramento, CA 95817 USA; [Zhang, Hongliang] Cent S Univ, Xiangya Hosp 2, Dept Emergency Med, Changsha, Hunan, Peoples R China	University of California System; University of California Davis; Central South University	Yao, W (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Musculoskeletal Hlth, Sacramento, CA 95817 USA.	yao@ucdavis.edu	yao, wei/GVS-3913-2022; Chen, Haiyan/HGB-6216-2022; Yao, Wei/O-8187-2019	yao, wei/0000-0002-1198-1161; Yao, Wei/0000-0002-1198-1161	NIH [P50 AR063043, R01 AR061366]; SCOR Pilot Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063043, R01AR061366] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCOR Pilot Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by NIH grant P50 AR063043 (to NEL), R01 AR061366 (to WY), and SCOR Pilot Award (to ZAZ).	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897; BARENGOLTS EI, 1995, BONE, V17, P21, DOI 10.1016/8756-3282(95)00138-4; Boonyaratanakornkit V, 1999, J BIOL CHEM, V274, P26431, DOI 10.1074/jbc.274.37.26431; Callewaert F, 2010, J BONE MINER RES, V25, P617, DOI 10.1359/jbmr.090828; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Dishowitz MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068726; Fernandez-Valdivia R, 2010, GENESIS, V48, P106, DOI 10.1002/dvg.20586; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gonzalez-Mariscal JA, 2014, FISH SHELLFISH IMMUN, V38, P311, DOI 10.1016/j.fsi.2014.03.031; Heffner LJ, 2010, THE REPRODUCTIVE SYS, P16; Ishida Y, 1997, BONE, V20, P17, DOI 10.1016/S8756-3282(96)00315-8; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee H, 2007, NEUROGENETICS, V8, P195, DOI 10.1007/s10048-007-0091-3; Li XT, 2003, J BIOL CHEM, V278, P39261, DOI 10.1074/jbc.R300024200; Liu JH, 2005, AM J OBSTET GYNECOL, V192, P1316, DOI 10.1016/j.ajog.2004.12.067; MACNAMARA P, 1995, CALCIFIED TISSUE INT, V57, P436, DOI 10.1007/BF00301947; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Rickard DJ, 2008, ENDOCRINOLOGY, V149, P2383, DOI 10.1210/en.2007-1247; Rickard DJ, 2002, J BONE MINER RES, V17, P580, DOI 10.1359/jbmr.2002.17.4.580; SCHEVEN BAA, 1992, BIOCHEM BIOPH RES CO, V186, P54, DOI 10.1016/S0006-291X(05)80774-0; Schloot NC, 2002, DIABETES-METAB RES, V18, P64, DOI 10.1002/dmrr.256; Seeman E, 2003, NEW ENGL J MED, V349, P320, DOI 10.1056/NEJMp038101; Singh M, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00159; TESARIK J, 1992, FERTIL STERIL, V58, P793; Thompson AR, 2008, EUR J VASC ENDOVASC, V35, P19, DOI 10.1016/j.ejvs.2007.07.022; TREMOLLIERES FA, 1992, ACTA ENDOCRINOL-COP, V126, P329, DOI 10.1530/acta.0.1260329; WEI LL, 1993, BIOCHEM BIOPH RES CO, V195, P525, DOI 10.1006/bbrc.1993.2077; Yao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011410; Zaidi M, 2012, CELL STEM CELL, V10, P233, DOI 10.1016/j.stem.2012.02.012; Zhong ZD, 2012, P NATL ACAD SCI USA, V109, pE2197, DOI 10.1073/pnas.1120407109	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139490	10.1371/journal.pone.0139490	http://dx.doi.org/10.1371/journal.pone.0139490			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431032	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700068
J	Liuzzi, R; Savino, F; D'Avino, V; Pugliese, M; Cella, L				Liuzzi, Raffaele; Savino, Federica; D'Avino, Vittoria; Pugliese, Mariagabriella; Cella, Laura			Evaluation of LiF:Mg,Ti (TLD-100) for Intraoperative Electron Radiation Therapy Quality Assurance	PLOS ONE			English	Article							IN-VIVO DOSIMETRY; BREAST-CONSERVING SURGERY; CO-60 GAMMA-RAYS; RADIOCHROMIC FILMS; RADIOTHERAPY; CANCER; THERMOLUMINESCENCE; BOOST; IORT	Background Purpose of the present work was to investigate thermoluminescent dosimeters (TLDs) response to intraoperative electron radiation therapy (IOERT) beams. In an IOERT treatment, a large single radiation dose is delivered with a high dose-per-pulse electron beam (2-12 cGy/pulse) during surgery. To verify and to record the delivered dose, in vivo dosimetry is a mandatory procedure for quality assurance. The TLDs feature many advantages such as a small detector size and close tissue equivalence that make them attractive for IOERT as in vivo dosimeters. Methods LiF: Mg, Ti dosimeters (TLD-100) were irradiated with different IOERT electron beam energies (5, 7 and 9 MeV) and with a 6 MV conventional photon beam. For each energy, the TLDs were irradiated in the dose range of 0-10 Gy in step of 2Gy. Regression analysis was performed to establish the response variation of thermoluminescent signals with dose and energy. Results The TLD-100 dose-response curves were obtained. In the dose range of 0-10 Gy, the calibration curve was confirmed to be linear for the conventional photon beam. In the same dose region, the quadratic model performs better than the linear model when high dose-perpulse electron beams were used (F test; p<0.05). Conclusions This study demonstrates that the TLD dose response, for doses <= 10Gy, has a parabolic behavior in high dose-per-pulse electron beams. TLD-100 can be useful detectors for IOERT patient dosimetry if a proper calibration is provided.	[Liuzzi, Raffaele; D'Avino, Vittoria; Cella, Laura] Natl Res Council CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Savino, Federica; Pugliese, Mariagabriella] Univ Naples Federico II, Dept Phys, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); University of Naples Federico II	Liuzzi, R (corresponding author), Natl Res Council CNR, Inst Biostruct & Bioimaging, Naples, Italy.	Raffaele.liuzzi@cnr.it	D'Avino, Vittoria/ABG-1242-2020; Pugliese, Mariagabriella/F-1343-2014; Liuzzi, Raffaele/AIC-0886-2022; Cella, Laura/L-5802-2019	D'Avino, Vittoria/0000-0001-8925-1022; Pugliese, Mariagabriella/0000-0003-4489-5048; Liuzzi, Raffaele/0000-0002-2350-6691; Cella, Laura/0000-0003-0058-4029; Multhoff, Gabriele/0000-0002-2616-3137; Savino, Federica/0000-0001-5733-4325	Ministero dell'Istruzione, dell'Universita' e della Ricerca (MIUR) in the framework of Fondo per gli Interventi alla Ricerca di Base (FIRB) [RBFR10Q0PT_001]	Ministero dell'Istruzione, dell'Universita' e della Ricerca (MIUR) in the framework of Fondo per gli Interventi alla Ricerca di Base (FIRB)	This work was partially supported by grants from Ministero dell'Istruzione, dell'Universita' e della Ricerca (MIUR) in the framework of Fondo per gli Interventi alla Ricerca di Base (FIRB, RBFR10Q0PT_001).	ABE M, 1995, WORLD J SURG, V19, P554, DOI 10.1007/BF00294720; Alajerami YSM, 2013, APPL RADIAT ISOTOPES, V78, P21, DOI 10.1016/j.apradiso.2013.03.095; Calvo FA, 2013, CLIN TRANSL ONCOL, V15, P443, DOI 10.1007/s12094-012-0949-1; Cella L, 2010, MED PHYS, V37, P2918, DOI 10.1118/1.3432601; Chen R, 2001, RADIAT MEAS, V33, P475, DOI 10.1016/S1350-4487(01)00034-8; Ciocca M, 2006, RADIOTHER ONCOL, V78, P213, DOI 10.1016/j.radonc.2005.11.011; Ciocca M, 2003, RADIOTHER ONCOL, V69, P285, DOI 10.1016/j.radonc.2003.09.001; Consorti R, 2005, INT J RADIAT ONCOL, V63, P952, DOI 10.1016/j.ijrobp.2005.02.049; Datz H, 2011, RADIAT MEAS, V43, P4; Desrosiers M, 2013, J RES NATL INST STAN, V118, DOI 10.6028/jres.118.021; Fastner G, 2015, INT J CANCER, V136, P1193, DOI 10.1002/ijc.29064; Fogg P, 2010, AUSTRALAS PHYS ENG S, V33, P211, DOI 10.1007/s13246-010-0019-3; Furetta C., 2003, HDB THERMOLUMINESCEN; Gatzemeier W, 2001, STRAHLENTHER ONKOL, V177, P330, DOI 10.1007/PL00002415; Holmes DR, 2014, J SURG ONCOL, V110, P68, DOI 10.1002/jso.23620; International Atomic Energy Agency, 2000, INT AR EN AG TECHN R, V398; ISS, 2003, 0301 ISS; KHAN FM, 1991, MED PHYS, V18, P73, DOI 10.1118/1.596695; Krengli M, 2014, TRANSL CANCER RES, V3, P48, DOI 10.3978/j.issn.2218-676X.2014.01.02; Krengli M, 2010, INT J RADIAT ONCOL, V76, P1073, DOI 10.1016/j.ijrobp.2009.03.037; Kron Tomas, 1995, Australasian Physical and Engineering Sciences in Medicine, V18, P1; Lawless MJ, 2013, MED PHYS, V40, DOI 10.1118/1.4773030; Lopez-Tarjuelo J, 2014, STRAHLENTHER ONKOL, V190, P1060, DOI 10.1007/s00066-014-0689-y; Massillon-JL G, 2006, J PHYS D APPL PHYS, V39, P262, DOI 10.1088/0022-3727/39/2/005; Mijnheer B, 2013, MED PHYS, V40, DOI 10.1118/1.4811216; Montano-Garcia C, 2006, RADIAT PROT DOSIM, V119, P230, DOI 10.1093/rpd/nci653; Niroomand-Rad A, 1998, MED PHYS, V25, P2093, DOI 10.1118/1.598407; Orecchia R, 2005, BREAST, V14, P541, DOI 10.1016/j.breast.2005.08.038; Pan E, 2014, J SURG ONCOL, V110, P817, DOI 10.1002/jso.23741; Qin HL, 2006, WORLD J GASTROENTERO, V12, P7033, DOI 10.3748/wjg.v12.i43.7033; Robatjazi M, 2015, PHYS MEDICA, V31, P314, DOI 10.1016/j.ejmp.2015.01.020; Sedlmayer F, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/472516; Seemann KM, 2015, J CONTROL RELEASE, V197, P131, DOI 10.1016/j.jconrel.2014.11.007; Troncalli Andrew J, 2002, Med Dosim, V27, P295, DOI 10.1016/S0958-3947(02)00152-8; Van Dam J, 1994, PHYS CLIN RADIOTHERA	35	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139287	10.1371/journal.pone.0139287	http://dx.doi.org/10.1371/journal.pone.0139287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26427065	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100044
J	Zhang, L; Wang, XM; Liu, T; Wang, GL; Chi, S; Liu, C; Wang, HY				Zhang, Lei; Wang, Xumin; Liu, Tao; Wang, Guoliang; Chi, Shan; Liu, Cui; Wang, Haiyang			Complete Plastid Genome Sequence of the Brown Alga Undaria pinnatifida	PLOS ONE			English	Article							CHLOROPLAST GENOME; ORIGINS; ORGANIZATION; GENERATION; EVOLUTION; SEAWEED; PROTEIN	In this study, we fully sequenced the circular plastid genome of a brown alga, Undaria pinnatifida. The genome is 130,383 base pairs (bp) in size; it contains a large single-copy (LSC, 76,598 bp) and a small single-copy region (SSC, 42,977 bp), separated by two inverted repeats (IRa and IRb: 5,404 bp). The genome contains 139 protein-coding, 28 tRNA, and 6 rRNA genes; none of these genes contains introns. Organization and gene contents of the U. pinnatifida plastid genome were similar to those of Saccharina japonica. There is a co-linear relationship between the plastid genome of U. pinnatifida and that of three previously sequenced large brown algal species. Phylogenetic analyses of 43 taxa based on 23 plastid protein-coding genes grouped all plastids into a red or green lineage. In the large brown algae branch, U. pinnatifida and S. japonica formed a sister clade with much closer relationship to Ectocarpus siliculosus than to Fucus vesiculosus. For the first time, the start codon ATT was identified in the plastid genome of large brown algae, in the atpA gene of U. pinnatifida. In addition, we found a gene-length change induced by a 3-bp repetitive DNA in ycf35 and ilvB genes of the U. pinnatifida plastid genome.	[Zhang, Lei; Liu, Tao; Chi, Shan; Liu, Cui; Wang, Haiyang] Ocean Univ China, Coll Marine Life Sci, Lab Genet & Breeding Marine Organism, Qingdao, Peoples R China; [Wang, Xumin; Wang, Guoliang] Chinese Acad Sci, Beijing Inst Genom, Beijing Key Lab Genome & Precis Med Technol, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China	Ocean University of China; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Liu, T (corresponding author), Ocean Univ China, Coll Marine Life Sci, Lab Genet & Breeding Marine Organism, Qingdao, Peoples R China.	liutao@ouc.edu.cn	wang, xumin/HII-8627-2022		Special Fund for Agro-scientific Research in the Public Interest [201203063]; Project of Shandong Province Science and Technology Development Program [2014GGE29091]; Fundamental Research Funds for the Central Universities [201362040]	Special Fund for Agro-scientific Research in the Public Interest; Project of Shandong Province Science and Technology Development Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (Grant No. 201203063), Project of Shandong Province Science and Technology Development Program (Grant No. 2014GGE29091) and the Fundamental Research Funds for the Central Universities (Grant No. 201362040).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BHATTACHARYA D, 1995, J PHYCOL, V31, P489, DOI 10.1111/j.1529-8817.1995.tb02542.x; Cavalier-Smith T, 1999, J EUKARYOT MICROBIOL, V46, P347, DOI 10.1111/j.1550-7408.1999.tb04614.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dreyer Hermann, 2006, Frontiers in Zoology, V3, P1; Green BR, 2011, PHOTOSYNTH RES, V107, P103, DOI 10.1007/s11120-010-9584-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khan H, 2007, MOL BIOL EVOL, V24, P1832, DOI 10.1093/molbev/msm101; Kim E., 2009, V13, P1, DOI 10.1007/7089_2008_17; Kimura J, 2002, J NAT PROD, V65, P57, DOI 10.1021/np0103057; Le Corguille G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-253; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Li TY, 2014, MITOCHONDR DNA, P1; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pronicki M, 2008, J CLIN PATHOL, V61, P460, DOI 10.1136/jcp.2007.051060; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanchez-Puerta MV, 2007, MOL PHYLOGENET EVOL, V44, P885, DOI 10.1016/j.ympev.2007.03.003; SHINOZAKI K, 1986, EMBO J, V5, P2043, DOI 10.1002/j.1460-2075.1986.tb04464.x; Silva Paul C., 2002, Biological Invasions, V4, P333, DOI 10.1023/A:1020991726710; Synytsya A, 2010, CARBOHYD POLYM, V81, P41, DOI 10.1016/j.carbpol.2010.01.052; Tajima N, 2014, J PLANT RES, V127, P389, DOI 10.1007/s10265-014-0627-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065902; Wang XL, 2013, MAR GENOM, V10, P1, DOI 10.1016/j.margen.2012.12.002; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899; Zhang L, 2012, J ENG FIBER FABR, V7, P7	36	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139366	10.1371/journal.pone.0139366	http://dx.doi.org/10.1371/journal.pone.0139366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426800	Green Submitted, gold, Green Published			2022-12-27	WOS:000362177100052
J	Chen, MJ; Tian, XL; Qin, F; Zhou, J; Liu, JJ; Wang, MZ; Xu, KF				Chen, Minjiang; Tian, Xinlun; Qin, Fang; Zhou, Jiong; Liu, Jinjing; Wang, Mengzhao; Xu, Kai-Feng			Pneumocystis Pneumonia in Patients with Autoimmune Diseases: A Retrospective Study Focused on Clinical Characteristics and Prognostic Factors Related to Death	PLOS ONE			English	Article							HIV-NEGATIVE PATIENTS; REAL-TIME PCR; JIROVECII PNEUMONIA; CARINII-PNEUMONIA; IMMUNOCOMPROMISED PATIENTS; INFECTION; THERAPIES; FEATURES	Background With the increasing use of immunosuppressive agents, the number of opportunistic infections has risen in patients with autoimmune diseases. Pneumocystis pneumonia (PCP) is one of these opportunistic infections that have a high mortality rate. However, only a few studies have described PCP in these patients, and these studies are limited in scope. We conducted this retrospective study to describe the clinical characteristics and factors associated with outcomes of PCP in patients with autoimmune diseases. Methods A retrospective study was performed in laboratory diagnosed PCP patients with autoimmune diseases in an academic hospital over a 10-year period. Patients with human immunodeficiency virus (HIV) infection were not included. Clinical characteristics were collected and the factors related to death were analysed. Results A total of 69 patients with PCP during the study period were included. Common clinical features included fever (81%), cough (56%), and dyspnea (35%). Ground glass opacity (81%) and reticulation (52%) were the most common radiological findings. Concurrent pulmonary infections including bacterium, aspergillus and cytomegalovirus were found in 34% of the patients. The overall in-hospital mortality rate was 32%. High mortality was associated with lower PaO2/FiO(2) ratios and albumin levels. The lymphocyte count, CD4+ T cell count, previous usage of immunosuppressive agents, the duration and dose of glucocorticoids did not affect the outcome. Conclusions The mortality rate in PCP patients with autoimmune diseases is high. Low PaO2/FiO(2) ratios and albumin levels are independent prognostic factors of mortality.	[Chen, Minjiang; Tian, Xinlun; Wang, Mengzhao; Xu, Kai-Feng] Beijing Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China; [Qin, Fang] China Meitan Gen Hosp, Dept Resp Med, Beijing, Peoples R China; [Zhou, Jiong] Beijing Union Med Coll Hosp, Off Infect Control, Beijing, Peoples R China; [Liu, Jinjing] Beijing Union Med Coll Hosp, Dept Rheumatol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Tian, XL (corresponding author), Beijing Union Med Coll Hosp, Dept Resp Med, Beijing, Peoples R China.	xinlun_t@sina.com	Tian, Xinlun/AAF-5444-2019; Xu, Kai-Feng/AAO-2445-2020	Tian, Xinlun/0000-0003-4307-6665; 				Ainoda Y, 2012, J INFECT CHEMOTHER, V18, P722, DOI 10.1007/s10156-012-0408-5; Aman J, 2011, CRIT CARE MED, V39, P89, DOI 10.1097/CCM.0b013e3181feb46a; Aoki Y, 2009, RHEUMATOL INT, V29, P1327, DOI 10.1007/s00296-009-0857-z; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; EWIG S, 1995, EUR RESPIR J, V8, P1548; Gilroy SA, 2011, SEMIN RESP CRIT CARE, V32, P775, DOI 10.1055/s-0031-1295725; GODEAU B, 1994, J RHEUMATOL, V21, P246; Guo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101943; Hardak E, 2012, RESPIROLOGY, V17, P681, DOI 10.1111/j.1440-1843.2012.02158.x; Kim SJ, 2014, J INFECTION, V69, P88, DOI 10.1016/j.jinf.2014.02.015; Ko Y, 2014, J CRIT CARE, V29, P356, DOI 10.1016/j.jcrc.2013.12.005; Li X, 2006, JCR-J CLIN RHEUMATOL, V12, P114, DOI 10.1097/01.rhu.0000221794.24431.36; Mansharamani NG, 2000, CHEST, V118, P704, DOI 10.1378/chest.118.3.704; Orsi CF, 2015, NEW MICROBIOL, V38, P75; Robert-Gangneux F, 2014, J CLIN MICROBIOL, V52, P3370, DOI 10.1128/JCM.01480-14; Roblot F, 2002, EUR J CLIN MICROBIOL, V21, P523, DOI 10.1007/s10096-002-0758-5; Sepkowitz KA, 2002, CLIN INFECT DIS, V34, P1098, DOI 10.1086/339548; Takeuchi T, 2010, NAT REV RHEUMATOL, V6, P644, DOI 10.1038/nrrheum.2010.154; Tasaka S, 2012, J INFECT CHEMOTHER, V18, P793, DOI 10.1007/s10156-012-0453-0; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Tiwari LK, 2014, INDIAN J CRIT CARE M, V18, P565, DOI 10.4103/0972-5229.140143; Vananuvat P, 2011, SEMIN ARTHRITIS RHEU, V41, P497, DOI 10.1016/j.semarthrit.2011.05.004; Vogel MN, 2012, EUR J RADIOL, V81, P1315, DOI 10.1016/j.ejrad.2011.02.052; Wang LDR, 2014, SEMIN ARTHRITIS RHEU, V44, P325, DOI 10.1016/j.semarthrit.2014.06.001; Wang XL, 2011, J MED MICROBIOL, V60, P631, DOI 10.1099/jmm.0.026302-0	26	25	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139144	10.1371/journal.pone.0139144	http://dx.doi.org/10.1371/journal.pone.0139144			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422246	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700073
J	Dubert, M; Pourbaix, A; Alkhoder, S; Mabileau, G; Lescure, FX; Ghodhbane, W; Belorgey, S; Rioux, C; Armand-Lefevre, L; Wolff, M; Raffoul, R; Nataf, P; Yazdanpanah, Y; Lucet, JC				Dubert, Marie; Pourbaix, Annabelle; Alkhoder, Soleiman; Mabileau, Guillaume; Lescure, Francois-Xavier; Ghodhbane, Walid; Belorgey, Sabine; Rioux, Christophe; Armand-Lefevre, Laurence; Wolff, Michel; Raffoul, Richard; Nataf, Patrick; Yazdanpanah, Yazdan; Lucet, Jean-Christophe			Sternal Wound Infection after Cardiac Surgery: Management and Outcome	PLOS ONE			English	Article							VACUUM-ASSISTED CLOSURE; POSTSTERNOTOMY MEDIASTINITIS; REDON CATHETERS; RISK-FACTORS; DRAINS	Background Sternal Wound Infection (SWI) is a severe complication after cardiac surgery. Debridement associated with primary closure using Redon drains (RD) is an effective treatment, but data on RD management and antibiotic treatment are scarce. Methods We performed a single-center analysis of consecutive patients who were re-operated for SWI between 01/2009 and 12/2012. All patients underwent a closed drainage with RD (CDRD). Patients with endocarditis or those who died within the first 45 days were excluded from management analysis. RD fluid was cultured twice weekly. Variables recorded were clinical and biological data at SWI diagnosis, severity of SWI based on criteria for mediastinitis as defined by the Centers for Disease Control (CDC), antibiotic therapy, RD management and patient's outcome. Results 160 patients developed SWI, 102 (64%) fulfilled CDC criteria (CDC+) and 58 (36%) did not (CDC-SWI). Initial antibiotic treatment and surgical management were similar in CDC+ and CDC-SWI. Patients with CDC+ SWI had a longer duration of antibiotic therapy and a mortality rate of 17% as compared to 3% in patients with CDC-SWI (p = 0.025). Rates of superinfection (10% and 9%) and need for second reoperation (12% and 17%) were similar. Failure (death or need for another reoperation) was associated with female gender, higher EuroScore for prediction of operative mortality, and stay in the ICU. Conclusion In patients with SWI, initial one-stage surgical debridement with CDRD is associated with favorable outcomes. CDC+ and CDC- SWI received essentially the same management, but CDC+ SWI has a more severe outcome.	[Dubert, Marie; Pourbaix, Annabelle; Lescure, Francois-Xavier; Rioux, Christophe; Yazdanpanah, Yazdan] Bichat Claude Bernard Hosp, AP HP, Dept Infect Dis, Paris, France; [Alkhoder, Soleiman; Ghodhbane, Walid; Raffoul, Richard; Nataf, Patrick] Bichat Claude Bernard Hosp, AP HP, Dept Cardiac Surg, Paris, France; [Mabileau, Guillaume; Lescure, Francois-Xavier; Wolff, Michel; Yazdanpanah, Yazdan; Lucet, Jean-Christophe] Univ Paris 07, INSERM, IAME, UMR 1137, F-75018 Paris, France; [Mabileau, Guillaume; Lescure, Francois-Xavier; Wolff, Michel; Yazdanpanah, Yazdan; Lucet, Jean-Christophe] Univ Paris Diderot, Sorbonne Paris Cite, F-75018 Paris, France; [Belorgey, Sabine; Lucet, Jean-Christophe] Bichat Claude Bernard Hosp, AP HP, Infect Control Unit, Paris, France; [Armand-Lefevre, Laurence] Bichat Claude Bernard Hosp, AP HP, Bacteriol Lab, Paris, France; [Wolff, Michel] Bichat Claude Bernard Hosp, AP HP, Med Intens Care Unit, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Lucet, JC (corresponding author), Univ Paris 07, INSERM, IAME, UMR 1137, F-75018 Paris, France.	jean-christophe.lucet@bch.aphp.fr	Lescure, Xavier/AAM-5261-2020; ARMAND-LEFEVRE, Laurence/A-4751-2018	ARMAND-LEFEVRE, Laurence/0000-0002-2013-3252; Mabileau, Guillaume/0000-0003-1691-7625; patrick, nataf/0000-0002-8412-6182				Baillot R, 2010, EUR J CARDIO-THORAC, V37, P880, DOI 10.1016/j.ejcts.2009.09.023; Braxton JH, 2000, ANN THORAC SURG, V70, P2004, DOI 10.1016/S0003-4975(00)01814-2; Brunet F, 1996, J THORAC CARDIOV SUR, V111, P1200; Calvat S, 1996, ANN THORAC SURG, V61, P195, DOI 10.1016/0003-4975(95)00921-3; Dessap AM, 2011, CLIN MICROBIOL INFEC, V17, P292, DOI 10.1111/j.1469-0691.2010.03197.x; DURANDY Y, 1989, J THORAC CARDIOV SUR, V97, P282; Eklund AM, 2006, ANN THORAC SURG, V82, P1784, DOI 10.1016/j.athoracsur.2006.05.097; ElOakley RM, 1996, ANN THORAC SURG, V61, P1030, DOI 10.1016/0003-4975(95)01035-1; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kirmani BH, 2013, INTERACT CARDIOV TH, V17, P479, DOI 10.1093/icvts/ivt222; Kirsch M, 2001, ANN THORAC SURG, V71, P1580, DOI 10.1016/S0003-4975(01)02452-3; Kubota H, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-132; Lepelletier D, 2009, ARCH CARDIOVASC DIS, V102, P119, DOI 10.1016/j.acvd.2008.11.003; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Lucet JC, 2006, INFECT CONT HOSP EP, V27, P1393, DOI 10.1086/509853; Merrill WH, 2004, ANN THORAC SURG, V78, P608, DOI 10.1016/j.athoracsur.2004.02.089; MILANO CA, 1995, CIRCULATION, V92, P2245, DOI 10.1161/01.CIR.92.8.2245; Molina JE, 2004, ANN THORAC SURG, V78, P912, DOI 10.1016/j.athoracsur.2004.03.038; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Trouillet JL, 2005, J THORAC CARDIOV SUR, V129, P518, DOI 10.1016/j.jtcvs.2004.07.027; Vos RJ, 2014, INTERACT CARDIOV TH, V18, P33, DOI 10.1093/icvts/ivt385; Vos RJ, 2012, EUR J CARDIO-THORAC, V42, pE53, DOI 10.1093/ejcts/ezs404; Yu AW, 2013, INTERACT CARDIOV TH, V17, P861, DOI 10.1093/icvts/ivt326	23	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139122	10.1371/journal.pone.0139122	http://dx.doi.org/10.1371/journal.pone.0139122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422144	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700070
J	Matsumoto, S; Tanuma, J; Mizushima, D; Nguyen, NCT; Pham, TTT; Do, CD; Nguyen, TQ; Nguyen, DT; Nguyen, HDT; Nguyen, LT; Van Nguyen, K; Oka, S				Matsumoto, Shoko; Tanuma, Junko; Mizushima, Daisuke; Ngoc Chi Thi Nguyen; Thanh Thuy Thi Pham; Cuong Duy Do; Tuan Quang Nguyen; Dung Thi Nguyen; Hoai Dung Thi Nguyen; Lam Tien Nguyen; Kinh Van Nguyen; Oka, Shinichi			High Treatment Retention Rate in HIV-Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi, Vietnam	PLOS ONE			English	Article							FOLLOW-UP; DRUG-USERS; RISK BEHAVIORS; PATIENTS LOST; CARE; SUPPORT; PEOPLE; STIGMA; ADHERENCE; SERVICES	Background Loss to follow-up (LTFU) is viewed as a major challenge in improving retention in HIV treatment. In Vietnam, the reasons for disengagement from clinics and the effect of injection drug use (IDU) on LTFU with unknown outcome (true LTFU) are not well known. Methods Patients receiving antiretroviral therapy (ART) from two HIV clinics in Hanoi were included in this observational study between 2007 and 2012, and followed up every 6 months until the end of 2013. The reasons for disengagement from the clinic, and ART status during imprisonment were investigated in patients with a history of IDU to identify true LTFU. The retention rate at 6-54 months and true LTFU rate were calculated. Cox proportional hazards regression models were performed to identify factors associated with true LTFU. Results There were 1,431 patients, with a follow-up time of 4,371 person-years (median 2.49 years). At the end of the follow-up period, 71 (5.0%) patients died, 79 (5.5%) transferred to other clinics, 16 (1.1%) disengaged from the clinics, and the calculated true LTFU was 45 (3.1%), with 12-month ART retention rate of 95.3% for the entire study population. Imprisonment was the most frequent reason for disengagement from the clinics. True LTFU correlated significantly with low CD4 count and high plasma viral load, but not history of IDU. Conclusion Imprisonment is a major cause of disengagement from HIV care among patients with a history of IDU.	[Matsumoto, Shoko; Tanuma, Junko; Mizushima, Daisuke; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Matsumoto, Shoko] Teikyo Univ, Grad Sch Publ Hlth, Tokyo 173, Japan; [Mizushima, Daisuke] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Ngoc Chi Thi Nguyen; Thanh Thuy Thi Pham; Cuong Duy Do; Tuan Quang Nguyen] Bach Mai Hosp, Dept Infect Dis, Hanoi, Vietnam; [Dung Thi Nguyen; Hoai Dung Thi Nguyen; Lam Tien Nguyen; Kinh Van Nguyen] Natl Hosp Trop Dis, Hanoi, Vietnam	National Center for Global Health & Medicine - Japan; Teikyo University; Kumamoto University; National Hospital of Tropical Diseases	Matsumoto, S (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	smatsumo@acc.ncgm.go.jp	Tanuma, Junko/AAE-5395-2020	Paraskevis, Dimitrios/0000-0001-6167-7152; Oka, Shinichi/0000-0002-9283-2167	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Agency for Medical Research and development, AMED	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported by the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from Japan Agency for Medical Research and development, AMED. The granting agency had no role in the study design, data collection, data analysis, data interpretation, writing of the manuscript, or decision to submit the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], 2006, PAT MON GUID HIV CAR; Tran BX, 2012, AIDS BEHAV, V16, P1988, DOI 10.1007/s10461-012-0271-5; Cabral HJ, 2007, AIDS PATIENT CARE ST, V21, pS59, DOI 10.1089/apc.2007.9986; Catz SL, 1999, AIDS CARE, V11, P361, DOI 10.1080/09540129947983; Cunningham WE, 2005, J HEALTH CARE POOR U, V16, P655; Tran DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073181; Do TN, 2012, CLIN INFECT DIS, V54, pS306, DOI 10.1093/cid/cir1045; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; Thanh DC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-428; FHI360 United States Agency for International Development (USAID) President's Emergency Plan For AIDS Relief (PEFPAR), 2012, ENR RET HIV CAR TREA; Geng EH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021797; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Hicks PL, 2007, AIDS CARE, V19, P1134, DOI 10.1080/09540120701351888; Kamarulzaman A, 2015, CURR OPIN INFECT DIS, V28, P10, DOI 10.1097/QCO.0000000000000125; Milloy MJS, 2012, AIDS, V26, P1049, DOI 10.1097/QAD.0b013e32835221cc; Ministry of Health Vietnam Administration of HIV/AIDS Control (VAAC), VIET NAM AIDS RESP P; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072310; Onoka CA, 2012, PATHOG GLOB HEALTH, V106, P46, DOI 10.1179/2047773211Y.0000000018; Organization WH, 2012, RET HIV PROGR DEF CH; Thanh DC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-98; Thi MDA, 2008, AIDS BEHAV, V12, pS63, DOI 10.1007/s10461-008-9374-4; Tuan NA, 2007, B WORLD HEALTH ORGAN, V85, P35, DOI 10.2471/BLT.05.026153; United Nations office on Drugs and Crime, PROJ SUMM HIV PREV C; Wohl AR, 2011, AIDS BEHAV, V15, P1098, DOI 10.1007/s10461-010-9833-6; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; World Health Organization, 2011, TREATM 2 0 FRAM ACT; Zhou JL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/375217	29	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139594	10.1371/journal.pone.0139594	http://dx.doi.org/10.1371/journal.pone.0139594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GF	26422474	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700131
J	Sami, M; Mohri, M; Seifi, HA				Sami, Mehrdad; Mohri, Mehrdad; Seifi, Hesam A.			Effects of Dexamethasone and Insulin Alone or in Combination on Energy and Protein Metabolism Indicators and Milk Production in Dairy Cows in Early Lactation - A Randomized Controlled Trial	PLOS ONE			English	Article							BIOCHEMICAL MEASUREMENTS; ISOFLUPREDONE ACETATE; SUBCLINICAL KETOSIS; HEPATIC KETOGENESIS; CATTLE; LIVER; GLUCOCORTICOIDS; YIELD; PERFORMANCE; PARAMETERS	Objectives This study investigated the effects of dexamethasone and insulin, when administered at 3rd or 10th day of lactation on energy and protein metabolism in dairy cows. Materials and Methods Two hundred Holstein cows were enrolled in a randomized controlled clinical trial. The cows were randomly assigned to receive 1 of 4 treatments at 3 or 10 days in milk: control group, 10-mL i.m. injection of sterile water, group insulin, s.c. injection of 100 units of insulin, group dexamethasone, i.m. injection of 20 mg of dexamethasone, group insulin plus dexamethasone, i.m. injection of 20 mg of dexamethasone and 100 units of insulin. The cows randomly assigned to receive the treatments on 3 or 10 days of lactation. Serum samples obtained at the time of enrollment, time of treatment and at 2, 4, 7 and 14 days after intervention. The sera were analyzed for beta-hydroxybutyrate (BHBA), nonesterified fatty acids (NEFA), glucose, cholesterol, albumin, urea, and aspartate amino transferase (AST). Data were analyzed using a repeated measures mixed model that accounted for the effects of parity, body condition score, dystocia, retained placenta, metritis and the random effect of cow. Results There was no significant interaction of group of treatment and time of intervention (day 3 or 10 post-partum) on serum components. Cows that received insulin or dexamethasone alone or in combination, had lower BHBA 2 days after treatment compared with control cows, whereas concentrations of NEFA, were unaffected suggesting that glucocorticoids lipolytic effects do not appear to be important in healthy cows. AST activities significantly reduced in cows that received dexamethasone with or without insulin at 2 and 4 days after treatment. Albumin and urea concentrations 2 days after treatment were higher for cows that received dexamethasone only or dexamethasone plus insulin compared with control and Ins received cows. There were no treatment effects on test-day milk production, milk fat and protein percentages. Conclusions The results suggested that administration of glucocorticoids in early lactation resulted in short-term improvement of metabolism in postpartum dairy cows in biochemical terms.	[Sami, Mehrdad; Mohri, Mehrdad; Seifi, Hesam A.] Ferdowsi Univ Mashhad, Sch Vet Med, Dept Clin Sci, Mashhad, Iran	Ferdowsi University Mashhad	Seifi, HA (corresponding author), Ferdowsi Univ Mashhad, Sch Vet Med, Dept Clin Sci, POB 91775-1793, Mashhad, Iran.	haseifi@um.ac.ir	sami, mehrdad/J-4358-2019; Mohri, Mehrdad/B-2355-2009	Seifi, Hesam A./0000-0003-3460-2301	Ferdowsi University of Mashhad [3/22099, 1391/3/2]	Ferdowsi University of Mashhad	This work was supported by Ferdowsi University of Mashhad. Grant number: 3/22099, 1391/3/2. HAS received the fund.	Adams HR, 2001, VET PHARM THERAPEUTI; BAIRD GD, 1971, BIOCHIM BIOPHYS ACTA, V252, P184, DOI 10.1016/0304-4165(71)90107-3; Bruss M. L., 1997, Clinical biochemistry of domestic animals., P83, DOI 10.1016/B978-012396305-5/50005-1; Coffer NJ, 2006, AM J VET RES, V67, P1244, DOI 10.2460/ajvr.67.7.1244; Drift SGA, 2015, VET J; Duffield TF, 1999, J DAIRY SCI, V82, P2377, DOI 10.3168/jds.S0022-0302(99)75488-3; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Engelking LR., 2011, TXB VET PHYSL CHEM, P371; FOSTER LA, 1988, VET CLIN N AM-FOOD A, V4, P253, DOI 10.1016/S0749-0720(15)31047-1; Furll M, 2005, BERL MUNCH TIERARZTL, V118, P247; Furll M, 1993, Tierarztl Prax, V21, P399; Furll M, 1998, TIERARZTL PRAX G N, V26, P262; Genuth SM., 1993, PHYSIOLOGY, P851; Gordon JL, 2013, VET CLIN N AM-FOOD A, V29, P433, DOI 10.1016/j.cvfa.2013.03.001; GRANTHAM BD, 1988, BIOCHEM J, V249, P409, DOI 10.1042/bj2490409; Guyton AC, 2006, TXB MED PHYSL, P952; Hasselgren P O, 1999, Curr Opin Clin Nutr Metab Care, V2, P201, DOI 10.1097/00075197-199905000-00002; Hayirli A, 2006, VET RES COMMUN, V30, P749, DOI 10.1007/s11259-006-3320-6; Hayirli A, 2002, J DAIRY SCI, V85, P2180, DOI 10.3168/jds.S0022-0302(02)74297-5; Herdt TH, 2000, VET CLIN N AM-FOOD A, V16, P215, DOI 10.1016/S0749-0720(15)30102-X; HERDT TH, 1988, VET CLIN N AM-FOOD A, V4, P213, DOI 10.1016/S0749-0720(15)31045-8; Hungerford T.G, 1990, DIS LIVESTOCK, P34; Jorritsma R, 2004, VET REC, V155, P521, DOI 10.1136/vr.155.17.521; KRONFELD DS, 1973, J DAIRY SCI, V56, P903, DOI 10.3168/jds.S0022-0302(73)85275-0; MAXWELL SRJ, 1994, POSTGRAD MED J, V70, P863, DOI 10.1136/pgmj.70.830.863; McArt JAA, 2012, J DAIRY SCI, V95, P5056, DOI 10.3168/jds.2012-5443; Mcart JAA, 2011, J DAIRY SCI, V94, P6011, DOI 10.3168/jds.2011-4463; Ospina PA, 2013, VET CLIN N AM-FOOD A, V29, P387, DOI 10.1016/j.cvfa.2013.04.003; Patton RA, 2014, VET CLIN N AM-FOOD A, V30, P599, DOI 10.1016/j.cvfa.2014.07.005; REILLY PEB, 1973, AM J PHYSIOL, V225, P689, DOI 10.1152/ajplegacy.1973.225.3.689; RINGS DM, 1985, MOD VET PRACT, V66, P523; Seifi HA, 2007, J DAIRY SCI, V90, P4181, DOI 10.3168/jds.2006-897; Seifi H.A., 2007, COMP CLIN PATHOL, V16, P253, DOI [10.1007/s00580-007-0682-2, DOI 10.1007/S00580-007-0682-2]; Van Saun RJ, 2014, VET CLIN N AM-FOOD A, V30, P689, DOI 10.1016/j.cvfa.2014.07.009; WIERDA A, 1987, VET REC, V120, P297, DOI 10.1136/vr.120.13.297; Zammit VA, 1996, BIOCHEM J, V314, P1, DOI 10.1042/bj3140001; Zimmerman HJ, 1986, COMP BIOCH PHYSL, V25, P1081	37	7	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139276	10.1371/journal.pone.0139276	http://dx.doi.org/10.1371/journal.pone.0139276			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422371	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700088
J	de Courten, B; Kurdiova, T; de Courten, MPJ; Belan, V; Everaert, I; Vician, M; Teede, H; Gasperikova, D; Aldini, G; Derave, W; Ukropec, J; Ukropcova, B				de Courten, Barbora; Kurdiova, Timea; de Courten, Maximilian P. J.; Belan, Vitazoslav; Everaert, Inge; Vician, Marek; Teede, Helena; Gasperikova, Daniela; Aldini, Giancarlo; Derave, Wim; Ukropec, Jozef; Ukropcova, Barbara			Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; INSULIN-SECRETION; ELDERLY SUBJECTS; DOUBLE-BLIND; SUPPLEMENTATION; RATS; METABOLISM; HISTIDINE; EXERCISE; TYPE-2	Background Carnosine is a naturally present dipeptide abundant in skeletal muscle and an over-the counter food additive. Animal data suggest a role of carnosine supplementation in the prevention and treatment of obesity, insulin resistance, type 2 diabetes and cardiovascular disease but only limited human data exists. Methods and Results Samples of vastus lateralis muscle were obtained by needle biopsy. We measured muscle carnosine levels (high-performance liquid chromatography), % body fat (bioimpedance), abdominal subcutaneous and visceral adiposity (magnetic resonance imaging), insulin sensitivity (euglycaemic hyperinsulinemic clamp), resting energy expenditure (REE, indirect calorimetry), free-living ambulatory physical activity (accelerometers) and lipid profile in 36 sedentary non-vegetarian middle aged men (45 +/- 7 years) with varying degrees of adiposity and glucose tolerance. Muscle carnosine content was positively related to % body fat (r = 0.35, p = 0.04) and subcutaneous (r = 0.38, p = 0.02) but not visceral fat (r = 0.17, p = 0.33). Muscle carnosine content was inversely associated with insulin sensitivity (r = -0.44, p = 0.008), REE (r = -0.58, p< 0.001) and HDL-cholesterol levels (r = -0.34, p = 0.048). Insulin sensitivity and physical activity were the best predictors of muscle carnosine content after adjustment for adiposity. Conclusion Our data shows that higher carnosine content in human skeletal muscle is positively associated with insulin resistance and fasting metabolic preference for glucose. Moreover, it is negatively associated with HDL-cholesterol and basal energy expenditure. Intervention studies targeting insulin resistance, metabolic and cardiovascular disease risk factors are necessary to evaluate its putative role in the prevention and management of type 2 diabetes and cardiovascular disease.	[de Courten, Barbora; Teede, Helena] Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Kurdiova, Timea; Gasperikova, Daniela; Ukropec, Jozef; Ukropcova, Barbara] Slovak Acad Sci, Inst Expt Endocrinol, Bratislava, Slovakia; [de Courten, Maximilian P. J.] Victoria Univ, Ctr Chron Dis, Melbourne, Vic 8001, Australia; [Belan, Vitazoslav] Comenius Univ, Univ Hosp Bratislava, Dept Radiol, Bratislava, Slovakia; [Everaert, Inge; Derave, Wim] Univ Ghent, Dept Movement & Sport Sci, B-9000 Ghent, Belgium; [Vician, Marek] Slovak Med Univ, Dept Surg, Bratislava, Slovakia; [Aldini, Giancarlo] Univ Milan, Dept Pharmaceut Sci, Milan, Italy; [Ukropcova, Barbara] Comenius Univ, Fac Med, Bratislava, Slovakia	Slovak Academy of Sciences; Victoria University; Comenius University Bratislava; Slovak Medical University Bratislava; Ghent University; Slovak Medical University Bratislava; University of Milan; Comenius University Bratislava	de Courten, B (corresponding author), Monash Ctr Hlth Res & Implementat, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia.	barbora.decourten@monash.edu; barbara.ukropcova@savba.sk	Ukropcova, Barbara/ABE-6186-2020; de Courten, Maximilian P. J./AAH-5104-2020; de Courten, Maximilian/B-3300-2012; Ukropec, Jozef/AAI-5590-2020; Ukropec, Jozef/D-5960-2018; Derave, Wim/B-2554-2014; Gasperikova, Daniela/E-7824-2018; Ukropcova, Barbara/E-7644-2018; aldini, giancarlo/C-3533-2013; de Courten, Barbora/B-3308-2012	Ukropcova, Barbara/0000-0002-3309-7713; de Courten, Maximilian/0000-0001-9997-9359; Ukropec, Jozef/0000-0001-8401-6621; Derave, Wim/0000-0002-2225-5587; Gasperikova, Daniela/0000-0002-5725-6424; aldini, giancarlo/0000-0002-2355-6744; Teede, Helena/0000-0001-7609-577X; de Courten, Barbora/0000-0001-8760-2511	EFSD New Horizons Grant; Grant Agency of the Slovak Academy of Sciences [VEGA2/0192/14]; Research Foundation Flanders [FWO G035213N, G024311]; Royal Australasian College of Physicians and Diabetes Australia Research Trust; Australian National Health, Medical Research Council	EFSD New Horizons Grant; Grant Agency of the Slovak Academy of Sciences(Slovak Academy of Sciences); Research Foundation Flanders(FWO); Royal Australasian College of Physicians and Diabetes Australia Research Trust; Australian National Health, Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors wish to thank all volunteers for their participation in the study. This work was supported by the EFSD New Horizons Grant (JU), the Grant Agency of the Slovak Academy of Sciences VEGA2/0192/14 (JU) and by Research Foundation Flanders (FWO G035213N and G024311). Barbora de Courten was supported by Australian National Health, Medical Research Council and Royal Australasian College of Physicians and Diabetes Australia Research Trust. Helena Teede was supported by Australian National Health, Medical Research Council.	Aldini G, 2005, BIOFACTORS, V24, P77, DOI 10.1002/biof.5520240109; Aldini G, 2002, BIOCHEM BIOPH RES CO, V298, P699, DOI 10.1016/S0006-291X(02)02545-7; Aldini G, 2002, J MASS SPECTROM, V37, P1219, DOI 10.1002/jms.381; Aldini G, 2011, J CELL MOL MED, V15, P1339, DOI 10.1111/j.1582-4934.2010.01101.x; Aydin AF, 2010, PHARMACOL REP, V62, P733; Baba SP, 2013, J BIOL CHEM, V288, P28163, DOI 10.1074/jbc.M113.504753; Baguet A, 2014, J APPL PHYSIOL, V116, P553, DOI 10.1152/japplphysiol.01218.2013; Boldyrev A, 2008, REJUV RES, V11, P821, DOI 10.1089/rej.2008.0716; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Brown BE, 2014, ATHEROSCLEROSIS, V232, P403, DOI 10.1016/j.atherosclerosis.2013.11.068; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Cheng KK, 2014, J PROTEOME RES; Chengappa KNR, 2012, SCHIZOPHR RES, V142, P145, DOI 10.1016/j.schres.2012.10.001; Chez MG, 2002, J CHILD NEUROL, V17, P833, DOI 10.1177/08830738020170111501; del Favero S, 2012, AMINO ACIDS, V43, P49, DOI 10.1007/s00726-011-1190-x; Despres JP, 2000, ATHEROSCLEROSIS, V153, P263, DOI 10.1016/S0021-9150(00)00603-1; Everaert I, 2011, AMINO ACIDS, V40, P1221, DOI 10.1007/s00726-010-0749-2; Forbes JM, 2014, AMINO ACIDS, V46, P321, DOI 10.1007/s00726-013-1542-9; Geiselman PJ, 1998, PHYSIOL BEHAV, V63, P919, DOI 10.1016/S0031-9384(97)00542-8; GREENE SM, 1984, EUR J PHARMACOL, V99, P79, DOI 10.1016/0014-2999(84)90434-5; Gualano B, 2012, AMINO ACIDS, V43, P21, DOI 10.1007/s00726-011-1165-y; HIPKISS AR, 1995, FEBS LETT, V371, P81, DOI 10.1016/0014-5793(95)00849-5; Kim MY, 2011, NUTR RES PRACT, V5, P421, DOI 10.4162/nrp.2011.5.5.421; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lombardi C, 2015, NUTRITION, V31, P72, DOI 10.1016/j.nut.2014.04.021; Mark AB, 2014, DIABETES CARE, V37, P88, DOI 10.2337/dc13-0842; Nagai K, 2003, EXP BIOL MED, V228, P1138, DOI 10.1177/153537020322801007; Nagai K, 2012, AMINO ACIDS, V43, P97, DOI 10.1007/s00726-012-1251-9; Niijima A, 2002, AUTON NEUROSCI-BASIC, V97, P99, DOI 10.1016/S1566-0702(02)00048-6; Oriolli M, 2007, ANAL CHEM, V79, P9174, DOI 10.1021/ac7016184; PAVLOV AR, 1993, BIOCHIM BIOPHYS ACTA, V1157, P304, DOI 10.1016/0304-4165(93)90114-N; Pfister F, 2011, CELL PHYSIOL BIOCHEM, V28, P125, DOI 10.1159/000331721; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; Riedl E, 2011, CELL PHYSIOL BIOCHEM, V28, P279, DOI 10.1159/000331740; Ririe DG, 2000, NUTRITION, V16, P168, DOI 10.1016/S0899-9007(99)00268-3; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; Slowinska-Lisowska M, 2014, ACTA PHYSIOL HUNG, V101, P461, DOI 10.1556/APhysiol.101.2014.008; Soliman KM, 2007, MED SCI MONITOR, V13, pBR73; Srikanthan P, 2012, MAGN RESON INSIGHTS, V5, P29, DOI 10.4137/MRI.S10489; Stegen S, 2015, PLOS ONE IN PRESS; Stuart CA, 2013, J CLIN ENDOCR METAB, V98, P2027, DOI 10.1210/jc.2012-3876; Szwergold BS, 2005, BIOCHEM BIOPH RES CO, V336, P36, DOI 10.1016/j.bbrc.2005.08.033; Tallon MJ, 2007, BIOGERONTOLOGY, V8, P129, DOI 10.1007/s10522-006-9038-6; Vozarova B, 2002, DIABETOLOGIA, V45, P1739, DOI 10.1007/s00125-002-0896-4; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Yapislar Hande, 2014, Med Sci Monit, V20, P399, DOI 10.12659/MSM.890528; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	49	24	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0138707	10.1371/journal.pone.0138707	http://dx.doi.org/10.1371/journal.pone.0138707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439389	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000362510300004
J	Marshall, PWM; Finn, HT; Siegler, JC				Marshall, Paul W. M.; Finn, Harrison T.; Siegler, Jason C.			The Magnitude of Peripheral Muscle Fatigue Induced by High and Low Intensity Single-Joint Exercise Does Not Lead to Central Motor Output Reductions in Resistance Trained Men	PLOS ONE			English	Article							EVOKED CONTRACTILE PROPERTIES; ISOMETRIC CONTRACTIONS; NEURAL ADAPTATION; H-REFLEX; V-WAVE; HUMANS; MECHANISMS; VOLUNTARY; STRENGTH; FORCE	Purpose To examine quadriceps muscle fatigue and central motor output during fatiguing single joint exercise at 40% and 80% maximal torque output in resistance trained men. Method Ten resistance trained men performed fatiguing isometric knee extensor exercise at 40% and 80% of maximal torque output. Maximal torque, rate of torque development, and measures of central motor output and peripheral muscle fatigue were recorded at two matched volumes of exercise, and after a final contraction performed to exhaustion. Central motor output was quantified from changes in voluntary activation, normalized surface electromyograms (EMG), and V-waves. Quadriceps muscle fatigue was assessed from changes in the size and shape of the resting potentiated twitch (Q.(pot.tw)). Central motor output during the exercise protocols was estimated from EMG and interpolated twitches applied during the task (VA(sub)). Results Greater reductions in maximal torque and rate of torque development were observed during the 40% protocol (p<0.05). Maximal central motor output did not change for either protocol. For the 40% protocol reductions from pre-exercise in rate and amplitude variables calculated from the Q.(pot.tw) between 66.2 to 70.8% (p<0.001) exceeded those observed during the 80% protocol (p<0.01). V-waves only declined during the 80% protocol between 56.8 +/- 35.8% to 53.6 +/- 37.4%(p<0.05). At the end of the final 80% contraction VA(sub) had increased from 91.2 +/- 6.2% to 94.9 +/- 4.7% (p = 0.005), but a greater increase was observed during the 40% contraction where VAsub had increased from 67.1 +/- 6.1% to 88.9 +/- 9.6%(p<0.001). Conclusion Maximal central motor output in resistance trained men is well preserved despite varying levels of peripheral muscle fatigue. Upregulated central motor output during the 40% contraction protocol appeared to elicit greater peripheral fatigue. V-waves declines during the 80% protocol suggest intensity dependent modulation of the Ia afferent pathway.	[Marshall, Paul W. M.; Finn, Harrison T.; Siegler, Jason C.] Univ Western Sydney, Sch Sci & Hlth, Human Performance Lab, Sydney, NSW, Australia; [Finn, Harrison T.] NeuRA, Sydney, NSW, Australia	Western Sydney University; Neuroscience Research Australia	Marshall, PWM (corresponding author), Univ Western Sydney, Sch Sci & Hlth, Human Performance Lab, Sydney, NSW, Australia.	p.marshall@uws.edu.au		Siegler, Jason/0000-0003-1346-4982; Finn, Harrison/0000-0003-3412-0273	School of Science and Health, University of Western Sydney	School of Science and Health, University of Western Sydney	Funding for this project was provided by the School of Science and Health, University of Western Sydney.	Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Adam A, 2005, J APPL PHYSIOL, V99, P268, DOI 10.1152/japplphysiol.01344.2004; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Allison GT, 2008, J ORTHOP SPORT PHYS, V38, P228, DOI 10.2519/jospt.2008.2703; Amann M, 2011, MED SCI SPORT EXER, V43, P2039, DOI 10.1249/MSS.0b013e31821f59ab; Baudry S, 2011, J NEUROPHYSIOL, V106, P265, DOI 10.1152/jn.00954.2010; Behm DG, 1997, J APPL PHYSIOL, V82, P1654, DOI 10.1152/jappl.1997.82.5.1654; Behm DG, 2002, J STRENGTH COND RES, V16, P209; Carroll TJ, 2009, ACTA PHYSIOL, V197, P161, DOI 10.1111/j.1748-1716.2009.01992.x; Carroll TJ, 2002, J PHYSIOL-LONDON, V544, P641, DOI 10.1113/jphysiol.2002.024463; Christian RJ, 2014, J APPL PHYSIOL, V117, P1063, DOI 10.1152/japplphysiol.00988.2013; Christie A, 2009, EUR J APPL PHYSIOL, V107, P177, DOI 10.1007/s00421-009-1113-7; del Olmo MF, 2006, EUR J APPL PHYSIOL, V96, P722, DOI 10.1007/s00421-006-0153-5; Dideriksen JL, 2011, J APPL PHYSIOL, V111, P485, DOI 10.1152/japplphysiol.00186.2011; Ekblom MMN, 2010, J APPL PHYSIOL, V109, P19, DOI 10.1152/japplphysiol.01307.2009; Farina D, 2008, J NEUROPHYSIOL, V100, P431, DOI 10.1152/jn.90365.2008; Gabriel DA, 2006, SPORTS MED, V36, P133, DOI 10.2165/00007256-200636020-00004; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gauche E, 2009, J ELECTROMYOGR KINES, V19, pE481, DOI 10.1016/j.jelekin.2009.01.006; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Johnson ST, 2015, SCAND J MED SCI SPOR, V25, P623, DOI 10.1111/sms.12283; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; METZGER JM, 1989, J GEN PHYSIOL, V93, P855, DOI 10.1085/jgp.93.5.855; Misiaszek JE, 2003, MUSCLE NERVE, V28, P144, DOI 10.1002/mus.10372; Mitchell CJ, 2012, J APPL PHYSIOL, V113, P71, DOI 10.1152/japplphysiol.00307.2012; Nordlund MM, 2004, J APPL PHYSIOL, V96, P218, DOI 10.1152/japplphysiol.00650.2003; Rossman MJ, 2014, AM J PHYSIOL-REG I, V306, pR934, DOI 10.1152/ajpregu.00043.2014; Siegler JC, 2015, EXP PHYSIOL, V100, P519, DOI 10.1113/EP085054; Siegler JC, 2015, EUR J APPL PHYSIOL, V115, P565, DOI 10.1007/s00421-014-3027-2; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Vila-Cha C, 2012, J APPL PHYSIOL, V112, P54, DOI 10.1152/japplphysiol.00802.2011; Yoon T, 2007, MUSCLE NERVE, V36, P515, DOI 10.1002/mus.20844	35	16	16	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0140108	10.1371/journal.pone.0140108	http://dx.doi.org/10.1371/journal.pone.0140108			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439261	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300098
J	Dammers, C; Gremer, L; Neudecker, P; Demuth, HU; Schwarten, M; Willbold, D				Dammers, Christina; Gremer, Lothar; Neudecker, Philipp; Demuth, Hans-Ulrich; Schwarten, Melanie; Willbold, Dieter			Purification and Characterization of Recombinant N-Terminally Pyroglutamate-Modified Amyloid-beta Variants and Structural Analysis by Solution NMR Spectroscopy	PLOS ONE			English	Article							PEPTIDES IN-VITRO; ALZHEIMERS-DISEASE; A-BETA; GLUTAMINYL CYCLASES; MAJOR COMPONENT; MOUSE MODEL; PROTEIN; DEPOSITS; IDENTIFICATION; ACID	Alzheimer's disease (AD) is the leading cause of dementia in the elderly and is characterized by memory loss and cognitive decline. Pathological hallmark of AD brains are intracellular neurofibrillary tangles and extracellular amyloid plaques. The major component of these plaques is the highly heterogeneous amyloid-beta (A beta) peptide, varying in length and modification. In recent years pyroglutamate-modified amyloid-beta (pEA beta) peptides have increasingly moved into the focus since they have been described to be the predominant species of all N-terminally truncated A beta. Compared to unmodified A beta, pEA beta is known to show increased hydrophobicity, higher toxicity, faster aggregation and beta-sheet stabilization and is more resistant to degradation. Nuclear magnetic resonance (NMR) spectroscopy is a particularly powerful method to investigate the conformations of pEA beta isoforms in solution and to study peptide/ligand interactions for drug development. However, biophysical characterization of pEA beta and comparison to its non-modified variant has so far been seriously hampered by the lack of highly pure recombinant and isotope-enriched protein. Here we present, to our knowledge, for the first time a reproducible protocol for the production of pEA beta from a recombinant precursor expressed in E. coli in natural isotope abundance as well as in uniformly [U-N-15]-or [U-C-13, N-15]-labeled form, with yields of up to 15 mg/l E. coli culture broth. The chemical state of the purified protein was evaluated by RP-HPLC and formation of pyroglutamate was verified by mass spectroscopy. The recombinant pyroglutamate-modified A beta peptides showed characteristic sigmoidal aggregation kinetics as monitored by thioflavin-T assays. The quality and quantity of produced pEA beta 40 and pEA beta 42 allowed us to perform heteronuclear multidimensional NMR spectroscopy in solution and to sequence-specifically assign the backbone resonances under near-physiological conditions. Our results suggest that the presented method will be useful in obtaining cost-effective high-quality recombinant pEA beta 40 and pEA beta 42 for further physiological and biochemical studies.	[Dammers, Christina; Gremer, Lothar; Neudecker, Philipp; Schwarten, Melanie; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany; [Gremer, Lothar; Neudecker, Philipp; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Demuth, Hans-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Biochem & Therapy, D-06120 Halle, Saale, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Fraunhofer Gesellschaft	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS Struct Biochem 6, D-52425 Julich, Germany.	d.willbold@fz-juelich.de	Schwarten, Melanie/G-6407-2013; Gremer, Lothar/H-9128-2013; Neudecker, Philipp/G-5265-2013; Willbold, Dieter/A-6280-2013; Neudecker, Philipp/AAP-9005-2020	Schwarten, Melanie/0000-0001-8920-9668; Gremer, Lothar/0000-0001-7065-5027; Neudecker, Philipp/0000-0002-0557-966X; Willbold, Dieter/0000-0002-0065-7366; Neudecker, Philipp/0000-0002-0557-966X; Dammers, Christina/0000-0001-5650-090X	International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich-Heine-University of Dusseldorf; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft	International NRW Research School BioStruct - Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich-Heine-University of Dusseldorf; Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; Portfolio Technology and Medicine; Portfolio Drug Research; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft	The authors gratefully acknowledge support of CD from the International NRW Research School BioStruct, granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich-Heine-University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf. DW was supported by grants from the "Portfolio Technology and Medicine", the "Portfolio Drug Research" and the Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acero G, 2009, J NEUROIMMUNOL, V213, P39, DOI 10.1016/j.jneuroim.2009.06.003; Bayer TA, 2014, ACTA NEUROPATHOL, V127, P787, DOI 10.1007/s00401-014-1287-x; Bolder SG, 2007, LANGMUIR, V23, P4144, DOI 10.1021/la063048k; Chelius D, 2006, ANAL CHEM, V78, P2370, DOI 10.1021/ac051827k; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; Day RM, 2003, PROTEIN SCI, V12, P794, DOI 10.1110/ps.0235203; De Kimpe L, 2013, AGE, V35, P673, DOI 10.1007/s11357-012-9403-0; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Gil-Caballero S, 2014, J BIOMOL NMR, V60, P1, DOI 10.1007/s10858-014-9847-x; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Gunn AP, 2010, INT J BIOCHEM CELL B, V42, P1915, DOI 10.1016/j.biocel.2010.08.015; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jawhar S, 2011, J BIOL CHEM, V286, P38825, DOI 10.1074/jbc.R111.288308; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Meissner JN, 2015, J ALZHEIMERS DIS, V45, P471, DOI 10.3233/JAD-142868; MORI H, 1992, J BIOL CHEM, V267, P17082; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Perez-Garmendia R, 2013, CURR NEUROPHARMACOL, V11, P491, DOI 10.2174/1570159X11311050004; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Rezaei-Ghaleh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020289; ROHER AE, 1993, P NATL ACAD SCI USA, V90, P10836, DOI 10.1073/pnas.90.22.10836; Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2003, J BIOL CHEM, V278, P49773, DOI 10.1074/jbc.M309077200; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; SELKOE DJ, 1993, TRENDS NEUROSCI, V16, P403, DOI 10.1016/0166-2236(93)90008-A; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; Sullivan CP, 2011, NEUROSCI LETT, V505, P109, DOI 10.1016/j.neulet.2011.09.071; TWARDZIK DR, 1972, P NATL ACAD SCI USA, V69, P274, DOI 10.1073/pnas.69.1.274; Venkataramani V, 2012, J ALZHEIMERS DIS, V29, P361, DOI 10.3233/JAD-2011-111379; Weber DK, 2014, AMINO ACIDS, V46, P2415, DOI 10.1007/s00726-014-1796-x; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	48	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139710	10.1371/journal.pone.0139710	http://dx.doi.org/10.1371/journal.pone.0139710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436664	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200055
J	Foong, J; Girdea, M; Stavropoulos, J; Brudno, M				Foong, Justin; Girdea, Marta; Stavropoulos, James; Brudno, Michael			Prioritizing Clinically Relevant Copy Number Variation from Genetic Interactions and Gene Function Data	PLOS ONE			English	Article							SEMANTIC SIMILARITY; SYNONYMOUS VARIANTS; HUMAN GENOME; ONTOLOGY; DISEASE; IDENTIFICATION; ASSOCIATION; RESOURCE	It is becoming increasingly necessary to develop computerized methods for identifying the few disease-causing variants from hundreds discovered in each individual patient. This problem is especially relevant for Copy Number Variants (CNVs), which can be cheaply interrogated via low-cost hybridization arrays commonly used in clinical practice. We present a method to predict the disease relevance of CNVs that combines functional context and clinical phenotype to discover clinically harmful CNVs (and likely causative genes) in patients with a variety of phenotypes. We compare several feature and gene weighing systems for classifying both genes and CNVs. We combined the best performing methodologies and parameters on over 2,500 Agilent CGH 180k Microarray CNVs derived from 140 patients. Our method achieved an F-score of 91.59%, with 87.08% precision and 97.00% recall.	[Foong, Justin; Girdea, Marta; Brudno, Michael] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Foong, Justin; Girdea, Marta; Stavropoulos, James; Brudno, Michael] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Brudno, M (corresponding author), Univ Toronto, Dept Comp Sci, 100 Coll St, Toronto, ON, Canada.	brudno@cs.toronto.edu			Ontario Research Fund (ORF) Genomes To Life (GL2) program	Ontario Research Fund (ORF) Genomes To Life (GL2) program	This research was funded by the Ontario Research Fund (ORF) Genomes To Life (GL2) program.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buske OJ, 2013, BIOINFORMATICS, V29, P1843, DOI 10.1093/bioinformatics/btt308; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Chen Y, 2011, BIOINFORMATICS, V27, pI167, DOI 10.1093/bioinformatics/btr213; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Doelken SC, 2013, DIS MODEL MECH, V6, P358, DOI 10.1242/dmm.010322; Freund Y., 1996, P 13 INT C MACH LEAR, V96, P148, DOI DOI 10.5555/3091696.3091715; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hehir-Kwa JY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000752; Hwang TH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-440; Hwang TH, 2012, NUCLEIC ACIDS RES, V1, P16; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Kohler Sebastian, 2014, Nucleic Acids Res, V42, pD966, DOI 10.1093/nar/gkt1026; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Maoqiang Xie, 2012, Advances in Knowledge Discovery and Data Mining. Proceedings 16th Pacific-Asia Conference (PAKDD 2012), P292, DOI 10.1007/978-3-642-30220-6_25; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Zhao YH, 2008, ADV SPACE RES, V41, P1955, DOI 10.1016/j.asr.2007.07.020	32	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139656	10.1371/journal.pone.0139656	http://dx.doi.org/10.1371/journal.pone.0139656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437450	Green Published, Green Submitted, gold			2022-12-27	WOS:000362499200043
J	Burt, AJ; William, HM; Perry, G; Khanal, R; Pauls, KP; Kelly, JD; Navabi, A				Burt, Andrew J.; Manilal William, H.; Perry, Gregory; Khanal, Raja; Pauls, K. Peter; Kelly, James D.; Navabi, Alireza			Candidate Gene Identification with SNP Marker-Based Fine Mapping of Anthracnose Resistance Gene Co-4 in Common Bean	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DISEASE RESISTANCE; COLLETOTRICHUM-LINDEMUTHIANUM; PHASEOLUS-VULGARIS; BLUE MOLD; LOCUS; CLUSTER; RACES; BETA-1,3-GLUCANASE; PATHOGENS	Anthracnose, caused by Colletotrichum lindemuthianum, is an important fungal disease of common bean (Phaseolus vulgaris). Alleles at the Co-4 locus confer resistance to a number of races of C. lindemuthianum. A population of 94 F-4:5 recombinant inbred lines of a cross between resistant black bean genotype B09197 and susceptible navy bean cultivar Nautica was used to identify markers associated with resistance in bean chromosome 8 (Pv08) where Co-4 is localized. Three SCAR markers with known linkage to Co-4 and a panel of single nucleotide markers were used for genotyping. A refined physical region on Pv08 with significant association with anthracnose resistance identified by markers was used in BLAST searches with the genomic sequence of common bean accession G19833. Thirty two unique annotated candidate genes were identified that spanned a physical region of 936.46 kb. A majority of the annotated genes identified had functional similarity to leucine rich repeats/receptor like kinase domains. Three annotated genes had similarity to 1, 3-beta-glucanase domains. There were sequence similarities between some of the annotated genes found in the study and the genes associated with phosphoinositide-specific phosphilipases C associated with Co-x and the COK-4 loci found in previous studies. It is possible that the Co-4 locus is structured as a group of genes with functional domains dominated by protein tyrosine kinase along with leucine rich repeats/nucleotide binding site, phosphilipases C as well as beta-glucanases.	[Burt, Andrew J.; Perry, Gregory; Khanal, Raja; Pauls, K. Peter; Navabi, Alireza] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Manilal William, H.] Ctr Int Mejoramiento Maiz & Trigo CIMMYT, Integrated Breeding Platform, El Batan 56237, Texcoco, Mexico; [Kelly, James D.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Navabi, Alireza] Agr & Agri Food Canada, Greenhouse & Proc Crops Res Ctr, Harrow, ON N0R 1G0, Canada	University of Guelph; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Michigan State University; Agriculture & Agri Food Canada	Navabi, A (corresponding author), Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada.	anavabi@uoguelph.ca			Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)/University of Guelph Program; Agriculture and Agri-Food Canada; Ontario Ministry of Research and Innovation; Ontario Bean Growers	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)/University of Guelph Program; Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Bean Growers	The work was supported by Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA)/University of Guelph Program; Agriculture and Agri-Food Canada; Ontario Ministry of Research and Innovation; and Ontario Bean Growers.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alzate-Marin AL, 2001, J PHYTOPATHOL, V149, P259, DOI 10.1046/j.1439-0434.2001.00612.x; Balardin RS, 1998, J AM SOC HORTIC SCI, V123, P1038, DOI 10.21273/JASHS.123.6.1038; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Conner RL, 2005, PULSE BEAT, V44, P30; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; del Rio LE, 2003, PLANT DIS, V87, P263, DOI 10.1094/PDIS.2003.87.3.263; Dilbirligi M, 2004, GENETICS, V166, P461, DOI 10.1534/genetics.166.1.461; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Dongfang YF, 2008, CAN J PLANT SCI, V88, P771, DOI 10.4141/CJPS07145; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Geffroy V, 2000, MOL PLANT MICROBE IN, V13, P287, DOI 10.1094/MPMI.2000.13.3.287; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Goswami RS, 2011, PLANT DIS, V95, P408, DOI 10.1094/PDIS-06-10-0429; Graham MA, 2002, GENETICS, V162, P1961; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-475; JORGENSEN JH, 1992, PLANT BREEDING, V108, P53, DOI 10.1111/j.1439-0523.1992.tb00099.x; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; KELLY JD, 1994, PLANT DIS, V78, P892, DOI 10.1094/PD-78-0892; Kelly JD, 2004, HORTSCIENCE, V39, P1196, DOI 10.21273/HORTSCI.39.6.1196; Kelly JD, 2003, FIELD CROP RES, V82, P135, DOI 10.1016/S0378-4290(03)00034-0; Kelly JD., 2001, ANN REP BEAN IMPROV, V44, P119; Lopez CE, 2003, PHYTOPATHOLOGY, V93, P88, DOI 10.1094/PHYTO.2003.93.1.88; Lusso M, 1996, PHYSIOL MOL PLANT P, V49, P267, DOI 10.1006/pmpp.1996.0054; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Melotto M, 2004, THEOR APPL GENET, V109, P690, DOI 10.1007/s00122-004-1697-6; Melotto M, 2000, COLLETOTRICHUM, P346; Melotto M, 2001, THEOR APPL GENET, V103, P508, DOI 10.1007/s001220100609; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Michelmore RW, 2013, ANNU REV PHYTOPATHOL, V51, P291, DOI 10.1146/annurev-phyto-082712-102334; MINDRINOS M, 1994, CELL, V78, P1089, DOI 10.1016/0092-8674(94)90282-8; Oblessuc PR, 2015, THEOR APPL GENET, V128, P1193, DOI 10.1007/s00122-015-2500-6; PAN SQ, 1991, PHYSIOL MOL PLANT P, V39, P25, DOI 10.1016/0885-5765(91)90029-H; Park SJ, 2007, J PLANT REGIST, V1, P109, DOI 10.3198/jpr2006.12.0840crc; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; PASTORCORRALES MA, 1995, PLANT DIS, V79, P63, DOI 10.1094/PD-79-0063; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Rodriguez-Suarez C, 2007, THEOR APPL GENET, V114, P713, DOI 10.1007/s00122-006-0471-3; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; Silvaria L, 2002, GENETIC RESISTANCE C, V45, P74; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Spielmeyer W, 2008, THEOR APPL GENET, V116, P481, DOI 10.1007/s00122-007-0684-0; TU JC, 1981, PLANT DIS, V65, P477, DOI 10.1094/PD-65-477; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang L, 2009, PHYTOPATHOLOGY, V99, P900, DOI 10.1094/PHYTO-99-8-0900; Wang S., 2007, WINDOWS QTL CARTOGRA; Wisser RJ, 2011, P NATL ACAD SCI USA, V108, P7339, DOI 10.1073/pnas.1011739108; WYATT SE, 1991, PHYSIOL MOL PLANT P, V39, P433, DOI 10.1016/0885-5765(91)90009-7; Xue L, 1998, PHYTOPATHOLOGY, V88, P359, DOI 10.1094/PHYTO.1998.88.4.359; Young RA, 1998, THEOR APPL GENET, V96, P87, DOI 10.1007/s001220050713; Yuete-Lisbona F, 2012, BMC PLANT BIOL, V12, P136, DOI [10.1186/1471-2229-12-136, DOI 10.1186/1471-2229-12-136]	58	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139450	10.1371/journal.pone.0139450	http://dx.doi.org/10.1371/journal.pone.0139450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431031	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700061
J	Hwang, JC; Sung, WW; Tu, HP; Hsieh, KC; Yeh, CM; Chen, CJ; Tai, HC; Hsu, CT; Shieh, GS; Chang, JG; Yeh, KT; Liu, TC				Hwang, Jau-Chung; Sung, Wen-Wei; Tu, Hung-Pin; Hsieh, Kun-Chou; Yeh, Chung-Min; Chen, Chih-Jung; Tai, Hui-Chun; Hsu, Chao-Tien; Shieh, Grace S.; Chang, Jan-Gowth; Yeh, Kun-Tu; Liu, Ta-Chih			The Overexpression of FEN1 and RAD54B May Act as Independent Prognostic Factors of Lung Adenocarcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; SYNTHETIC LETHALITY; GENOMIC INSTABILITY; FLAP ENDONUCLEASE-1; TARGETED THERAPIES; REPAIR; INHIBITION; RISK; CHEMOPREVENTION; MUTATIONS	Synthetic lethality arises when a combination of mutations in two or more genes leads to cell death. However, the prognostic role of concordant overexpression of synthetic lethality genes in protein level rather than a combination of mutations is not clear. In this study, we explore the prognostic role of combined overexpression of paired genes in lung adenocarcinoma. We used immunohistochemical staining to investigate 24 paired genes in 93 lung adenocarcinoma patients and Kaplan-Meier analysis and Cox proportional hazards models to evaluate their prognostic roles. Among 24 paired genes, only FEN1 (Flap endonuclease 1) and RAD54B (RAD54 homolog B) were overexpressed in lung adenocarcinoma patients with poor prognosis. Patients with expression of both FEN1 and RAD54B were prone to have advanced nodal involvement and significantly poor prognosis (HR = 2.35, P = 0.0230). These results suggest that intensive follow up and targeted therapy might improve clinical outcome for patients who show expression of both FEN1 and RAD54B.	[Hwang, Jau-Chung; Liu, Ta-Chih] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan; [Hwang, Jau-Chung] Lin Shin Hosp, Dept Pathol, Taichung, Taiwan; [Sung, Wen-Wei; Chen, Chih-Jung; Yeh, Kun-Tu] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Sung, Wen-Wei] Chung Shan Med Univ Hosp, Dept Med Educ, Taichung, Taiwan; [Sung, Wen-Wei; Chen, Chih-Jung] Jen Teh Jr Coll Med Nurisng & Management, Dept Med Technol, Miaoli, Taiwan; [Tu, Hung-Pin] Kaohsiung Med Univ, Sch Med, Dept Publ Hlth & Environm Med, Coll Med, Kaohsiung, Taiwan; [Hsieh, Kun-Chou] E Da Hosp, Div Thorac Surg, Dept Surg, Kaohsiung, Taiwan; [Yeh, Chung-Min; Chen, Chih-Jung; Tai, Hui-Chun; Yeh, Kun-Tu] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan; [Hsu, Chao-Tien] E Da Hosp, Dept Pathol, Kaohsiung, Taiwan; [Hsu, Chao-Tien] I Shou Univ, Kaohsiung, Taiwan; [Shieh, Grace S.] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chang, Jan-Gowth] China Med Univ, Dept Lab Med, China Med Univ Hosp, Taichung, Taiwan; [Chang, Jan-Gowth] China Med Univ, Ctr RNA Biol & Clin Applicat, China Med Univ Hosp, Taichung, Taiwan; [Liu, Ta-Chih] Kaohsiung Med Univ Hosp, Div Hematol Oncol, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Kaohsiung Medical University; E-Da Hospital; Changhua Christian Hospital; E-Da Hospital; I Shou University; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Yeh, KT (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	10159@cch.org.tw; d730093@kmu.edu.tw	Shieh, Grace S./AAP-2912-2021; Sung, Wen-Wei/P-5053-2019	Sung, Wen-Wei/0000-0002-2375-0029; Tu, Hung-Pin/0000-0003-1044-2673				Abdel-Fatah T, 2013, ANTIOXID REDOX SIGN, V18, P2392, DOI 10.1089/ars.2012.4873; Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P1326, DOI 10.1016/j.molonc.2014.04.009; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P982, DOI [10.1001/jama.2013.5289, DOI 10.1001/JAMA.2013.5289]; Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Chung L, 2015, ONCOGENE, V34, P902, DOI 10.1038/onc.2014.19; Cooper WA, 2013, J THORAC DIS, V5, pS479, DOI 10.3978/j.issn.2072-1439.2013.08.03; Dai BB, 2013, CANCER RES, V73, P5532, DOI 10.1158/0008-5472.CAN-13-0712; Etemadmoghadam D, 2013, P NATL ACAD SCI USA, V110, P19489, DOI 10.1073/pnas.1314302110; Fajersztajn L, 2013, NAT REV CANCER, V13, P674, DOI 10.1038/nrc3572; Gazdar AF, 2010, ANN ONCOL, V21, P225, DOI 10.1093/annonc/mdq372; Gilad O, 2010, CANCER RES, V70, P9693, DOI 10.1158/0008-5472.CAN-10-2286; Guo W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028487; Hiramoto T, 1999, ONCOGENE, V18, P3422, DOI 10.1038/sj.onc.1202691; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Huang SY, 2011, CANCER PREV RES, V4, P666, DOI 10.1158/1940-6207.CAPR-10-0235; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; McLaughlin-Drubin ME, 2013, P NATL ACAD SCI USA, V110, P16175, DOI 10.1073/pnas.1310432110; McManus KJ, 2009, P NATL ACAD SCI USA, V106, P3276, DOI 10.1073/pnas.0813414106; Meyskens FL, 2011, CANCER PREV RES, V4, P628, DOI 10.1158/1940-6207.CAPR-11-0162; Mulshine JL, 2003, NAT REV CANCER, V3, P65, DOI 10.1038/nrc972; Nikolova T, 2009, ANTICANCER RES, V29, P2453; Oike T, 2013, CANCER RES, V73, P5508, DOI 10.1158/0008-5472.CAN-12-4593; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Paul I, 2011, J PATHOL, V224, P564, DOI 10.1002/path.2925; Postel-Vinay S, 2012, NAT REV CLIN ONCOL, V9, P144, DOI 10.1038/nrclinonc.2012.3; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; Sarai N, 2008, NUCLEIC ACIDS RES, V36, P5441, DOI 10.1093/nar/gkn516; Sen B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003513; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shen ZY, 2011, J MOL CELL BIOL, V3, P1, DOI 10.1093/jmcb/mjq057; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Sung WW, 2013, CLIN CANCER RES, V19, P4092, DOI 10.1158/1078-0432.CCR-12-3439; Tiong KL, 2014, NEOPLASIA, V16, P441, DOI 10.1016/j.neo.2014.04.007; Tucker CL, 2003, NAT GENET, V35, P204, DOI 10.1038/ng1103-204; Vasan N, 2014, CLIN CANCER RES, V20, P3921, DOI 10.1158/1078-0432.CCR-13-1762; Wang YC, 2013, ANTICANCER RES, V33, P2729; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; Wilson PM, 2012, MOL CANCER THER, V11, P616, DOI 10.1158/1535-7163.MCT-11-0781; Wu ZX, 2012, MUTAT RES-FUND MOL M, V731, P85, DOI 10.1016/j.mrfmmm.2011.11.009; Yasuhara T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6426; Zhang B, 2014, NAT GENET, V46, P533, DOI 10.1038/ng.2985; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884	44	16	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139435	10.1371/journal.pone.0139435	http://dx.doi.org/10.1371/journal.pone.0139435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431531	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700058
J	Ji, GH; Deng, YQ; Yu, XJ; Jiang, T; Wang, HJ; Shi, X; Zhang, DP; Li, XF; Zhu, SY; Zhao, H; Dai, JX; Qin, CF; Guo, YJ				Ji, Guang-Hui; Deng, Yong-Qiang; Yu, Xiao-Jie; Jiang, Tao; Wang, Hua-Jing; Shi, Xin; Zhang, Da-Peng; Li, Xiao-Feng; Zhu, Shun-Ya; Zhao, Hui; Dai, Jian-Xin; Qin, Cheng-Feng; Guo, Ya-Jun			Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III	PLOS ONE			English	Article							WEST-NILE-VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; E-GLYCOPROTEIN; FUSION-LOOP; TYPE-2; PROTECTION; INFECTION; DETERMINANTS; THAILAND	The dengue virus (DENV) envelope protein domain III (ED3) has been suggested to contain receptor recognition sites and the critical neutralizing epitopes. Up to date, relatively little work has been done on fine mapping of neutralizing epitopes on ED3 for DENV4. In this study, a novel mouse type-specific neutralizing antibody 1G6 against DENV4 was obtained with both prophylactic and therapeutic effects. The epitope was mapped to residues 387390 of DENV4 envelope protein. Furthermore, site-directed mutagenesis assay identified two critical residues (T388 and H390). The epitope is variable among different DENV serotypes but is highly conserved among four DENV4 genotypes. Affinity measurement showed that naturally occurring variations in ED3 outside the epitope region did not alter the binding of mAb 1G6. These findings expand our understanding of the interactions between neutralizing antibodies and the DENV4 and may be valuable for rational design of DENV vaccines and antiviral drugs.	[Ji, Guang-Hui] Navy Gen Hosp, Dept Tradit Chinese Med, Beijing, Peoples R China; [Ji, Guang-Hui; Yu, Xiao-Jie; Wang, Hua-Jing; Shi, Xin; Zhang, Da-Peng; Dai, Jian-Xin; Guo, Ya-Jun] Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China; [Deng, Yong-Qiang; Jiang, Tao; Li, Xiao-Feng; Zhu, Shun-Ya; Zhao, Hui; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Naval Medical University; Beijing Institute of Microbiology & Epidemiology	Dai, JX (corresponding author), Second Mil Med Univ, Int Joint Canc Inst, Shanghai, Peoples R China.	jxdai@smmu.edu.cn; qincf@bmi.ac.cn; yajunguo@smmu.edu.cn	Tao, Jiang/AAE-6623-2019; yu, xiaojie/GSI-9676-2022; Qin, Cheng-Feng/I-6839-2019	Tao, Jiang/0000-0003-1908-2926; Qin, Cheng-Feng/0000-0002-0632-2807; Ji, Guanghui/0000-0003-3763-2311	Ministry of Science and Technology of China (973 project) [2010CB833605]; Ministry of Science and Technology of China (863 project) [2011AA020114, 2014AA021004]; State Key Project for New Drug Development [2013ZX09101021, 2013ZX09401303]; Shanghai Commission of Science and Technology (Key Laboratory and Projects) [13DZ1930100]; National Natural Science Foundation of China [31270974, U1132002, 81101243]; National Basic Research Project of China [2012CB518904];  [13XD1424000]	Ministry of Science and Technology of China (973 project)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); Ministry of Science and Technology of China (863 project); State Key Project for New Drug Development; Shanghai Commission of Science and Technology (Key Laboratory and Projects); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Project of China(National Basic Research Program of China); 	This work was supported by grants from Ministry of Science and Technology of China (973 projects 2010CB833605 and 863 projects 2011AA020114, 2014AA021004), State Key Project for New Drug Development (2013ZX09101021; 2013ZX09401303), Shanghai Commission of Science and Technology (Key Laboratory and Projects 13DZ1930100), Shanghai Excellent technical leader (13XD1424000), National Natural Science Foundation of China (31270974, U1132002 and 81101243), and the National Basic Research Project of China (No.2012CB518904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilla AA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-113; Batra G, 2010, J VIROL METHODS; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Chen SP, 2007, DNA CELL BIOL, V26, P361, DOI 10.1089/dna.2006.0547; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009; Coffey LL, 2009, MICROBES INFECT, V11, P143, DOI 10.1016/j.micinf.2008.12.006; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; Deng Y, 2011, CONTROL THEORY APPL, V6, P6, DOI DOI 10.1371/J0URNAL.P0NE.0016059; Diamond MS, 2008, IMMUNOL REV, V225, P212, DOI 10.1111/j.1600-065X.2008.00676.x; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Etemad B, 2008, AM J TROP MED HYG, V79, P353, DOI 10.4269/ajtmh.2008.79.353; Goncalvez AP, 2004, J VIROL, V78, P12919, DOI 10.1128/JVI.78.23.12919-12928.2004; Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Holmes EC, 2000, TRENDS MICROBIOL, V8, P74, DOI 10.1016/S0966-842X(99)01669-8; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050; Klungthong C, 2008, J VIROL METHODS, V154, P175, DOI 10.1016/j.jviromet.2008.07.021; Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003; Kohler G, 1992, Biotechnology, V24, P524; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; Lisova O, 2007, J GEN VIROL, V88, P2387, DOI 10.1099/vir.0.83028-0; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665; Pitcher TJ, 2014, J GEN VIROL; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Rajamanonmani R, 2009, J GEN VIROL, V90, P799, DOI 10.1099/vir.0.006874-0; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4; Roehrig JT, 2001, ANN NY ACAD SCI, V951, P286; Rossi SL, 2012, VIROLOGY, V423, P58, DOI 10.1016/j.virol.2011.11.018; Sanchez IJ, 1996, J GEN VIROL, V77, P2541, DOI 10.1099/0022-1317-77-10-2541; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Toh YX, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00388; Volk DE, 2007, VIROLOGY, V364, P147, DOI 10.1016/j.virol.2007.02.023; Wahala WMPB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000821; Wahala WM, 2012, VIRUSES, V3, P2374; Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	48	5	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139741	10.1371/journal.pone.0139741	http://dx.doi.org/10.1371/journal.pone.0139741			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430770	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700108
J	Kim, J; Gao, JY; Cohen, IS; Mathias, RT				Kim, Jeremy; Gao, Junyuan; Cohen, Ira S.; Mathias, Richard T.			Angiotensin II Type 1 Receptor-Mediated Electrical Remodeling in Mouse Cardiac Myocytes	PLOS ONE			English	Article							CANINE LEFT-VENTRICLE; CA2+ CURRENT; K+ CURRENTS; HYPERTROPHY; OVEREXPRESSION; INTERNALIZATION; INHIBITION; ACTIVATION; COMPONENT; SYSTEM	We recently characterized an autocrine renin angiotensin system (RAS) in canine heart. Activation of Angiotensin II Type 1 Receptors (AT(1)Rs) induced electrical remodeling, including inhibition of the transient outward potassium current I-to, prolongation of the action potential (AP), increased calcium entry and increased contractility. Electrical properties of the mouse heart are very different from those of dog heart, but if a similar system existed in mouse, it could be uniquely studied through genetic manipulations. To investigate the presence of a RAS in mouse, we measured APs and I-to in isolated myocytes. Application of angiotensin II (A2) for 2 or more hours reduced I-to magnitude, without affecting voltage dependence, and prolonged APs in a dose-dependent manner. Based on dose-inhibition curves, the fast and slow components of I-to (I-to,I- fast and I-K,I- slow) appeared to be coherently regulated by [A2], with 50% inhibition at an A2 concentration of about 400 nM. This very high K-0.5 is inconsistent with systemic A2 effects, but is consistent with an autocrine RAS in mouse heart. Pre-application of the microtubule destabilizing agent colchicine eliminated A2 effects on I-to and AP duration, suggesting these effects depend on intracellular trafficking. Application of the biased agonist SII ([Sar(1)-Ile(4)-Ile(8)]A2), which stimulates receptor internalization without G protein activation, caused Ito reduction and AP prolongation similar to A2-induced changes. These data demonstrate AT(1)R mediated regulation of I-to in mouse heart. Moreover, all measured properties parallel those measured in dog heart, suggesting an autocrine RAS may be a fundamental feedback system that is present across species.	[Kim, Jeremy; Gao, Junyuan; Cohen, Ira S.; Mathias, Richard T.] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Mathias, RT (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	richard.mathias@sunysb.edu			National Institutes of Health [HL85221, HL094910, HL111401]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111401, R01HL085221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants No. HL85221, No. HL094910, and No. HL111401. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Aiello EA, 2001, AM J PHYSIOL-HEART C, V280, pH1528, DOI 10.1152/ajpheart.2001.280.4.H1528; Aplin M, 2007, BASIC CLIN PHARMACOL, V100, P296, DOI 10.1111/j.1742-7843.2007.00064.x; BROWN VI, 1991, DNA CELL BIOL, V10, P399, DOI 10.1089/dna.1991.10.399; Cordeiro JM, 2004, AM J PHYSIOL-HEART C, V286, pH1471, DOI 10.1152/ajpheart.00748.2003; Cordeiro JM, 2010, CAN J PHYSIOL PHARM, V88, P1181, DOI 10.1139/Y10-094; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; Dong M, 2010, J CARDIOVASC ELECTR, V21, P697, DOI 10.1111/j.1540-8167.2009.01708.x; Doronin SV, 2004, J BIOL CHEM, V279, P48231, DOI 10.1074/jbc.M405789200; DOSTAL DE, 1992, AM J PHYSIOL, V263, pC851, DOI 10.1152/ajpcell.1992.263.4.C851; Feng YH, 2005, HYPERTENSION, V46, P419, DOI 10.1161/01.HYP.0000172621.68061.22; Gao JY, 2014, BIOPHYS J, V106, P2364, DOI 10.1016/j.bpj.2014.04.042; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 2002, CIRC RES, V90, P586, DOI 10.1161/01.RES.0000012664.05949.E0; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Ichiyanagi O, 2002, PFLUG ARCH EUR J PHY, V444, P107, DOI 10.1007/s00424-002-0808-y; LITOVSKY SH, 1988, CIRC RES, V62, P116, DOI 10.1161/01.RES.62.1.116; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Matsuda H, 2004, PFLUG ARCH EUR J PHY, V448, P54, DOI 10.1007/s00424-003-1217-6; Ozgen N, 2012, HEART RHYTHM, V9, P1865, DOI 10.1016/j.hrthm.2012.07.014; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rivard K, 2008, CARDIOVASC RES, V78, P53, DOI 10.1093/cvr/cvn020; SADOSHIMA J, 1993, CELL, V75, P977, DOI 10.1016/0092-8674(93)90541-W; Shimoni Y, 2001, J PHYSIOL-LONDON, V537, P83, DOI 10.1111/j.1469-7793.2001.0083k.x; STREETER DD, 1970, BIOPHYS J, V10, P345, DOI 10.1016/S0006-3495(70)86306-8; van Kats JP, 1998, CIRCULATION, V98, P73, DOI 10.1161/01.CIR.98.1.73; WALDMAN LK, 1985, CIRC RES, V57, P152, DOI 10.1161/01.RES.57.1.152; Wang YH, 2008, BRIT J PHARMACOL, V154, P429, DOI 10.1038/bjp.2008.95; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yu HG, 2000, CIRC RES, V86, P1062, DOI 10.1161/01.RES.86.10.1062	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138711	10.1371/journal.pone.0138711	http://dx.doi.org/10.1371/journal.pone.0138711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430746	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700017
J	Yang, G; Jia, YL; Li, CL; Cheng, QL; Yue, W; Pei, XT				Yang, Guang; Jia, Yali; Li, Chunlin; Cheng, Qingli; Yue, Wen; Pei, Xuetao			Hyperglycemic Stress Impairs the Stemness Capacity of Kidney Stem Cells in Rats	PLOS ONE			English	Article							RENAL PAPILLA; INJURY; DIFFERENTIATION; PREVALENCE; DISEASE; CHINA; BONE	The incidence of acute kidney injury in patients with diabetes is significantly higher than that of patients without diabetes, and may be associated with the poor stemness capacity of kidney stem cells (KSCs) and limited recovery of injured renal tubules. To investigate the effects of hyperglycemic stress on KSC stemness, KSCs were isolated from the rat renal papilla and analyzed for their self-renewal and differentiation abilities. Our results showed that isolated KSCs expressed the mesenchymal stem cell markers N-cadherin, Nestin, CD133, CD29, CD90, and CD73. Moreover, KSCs co-cultured with hypoxia-injured renal tubular epithelial cell (RTECs) induced the expression of the mature epithelial cell marker CK18, suggesting that the KSCs could differentiate into RTECs in vitro. However, KSC proliferation, differentiation ability and tolerance to hypoxia were decreased in high-glucose cultures. Taken together, these results suggest the high-glucose microenvironment can damage the reparative ability of KSCs. It may result in a decreased of recovery capability of renal tubules from injury.	[Yang, Guang; Cheng, Qingli] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China; [Jia, Yali; Yue, Wen; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China; [Li, Chunlin] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Endocrinol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Cheng, QL (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Nephrol, State Key Lab Kidney Dis, Beijing, Peoples R China.	qlcheng64@163.com; yuewen26@163.com; peixt@nic.bmi.ac.cn	Jia, Yali/AFL-9551-2022; Jia, Yali/AAH-1668-2022	Cheng, Qingli/0000-0002-6672-084X; Yang, Guang/0000-0001-5075-401X; Jia, Yali/0000-0002-2896-6021	National Natural Science Foundation of China [81170312, 30772296]; National Natural Science Foundation of Beijing [7122163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (81170312, 30772296) and National Natural Science Foundation of Beijing (7122163), granted to Q.L.C.	Adams DC, 2009, AM J PHYSIOL-RENAL, V297, pF809, DOI 10.1152/ajprenal.90650.2008; Amini S, 2014, ANAT CELL BIOL, V47, P1, DOI 10.5115/acb.2014.47.1.1; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Chawla LS, 2011, CONTRIB NEPHROL, V174, P182, DOI 10.1159/000329396; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Girman CJ, 2012, DIABETIC MED, V29, P614, DOI 10.1111/j.1464-5491.2011.03498.x; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888; Karaoz E, 2011, J CELL PHYSIOL, V226, P1367, DOI 10.1002/jcp.22468; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Liu Yang, 2015, Zhonghua Yi Xue Za Zhi, V95, P289; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Morigi M, 2013, NEPHROL DIAL TRANSPL, V28, P788, DOI 10.1093/ndt/gfs556; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Oliver JA, 2009, J AM SOC NEPHROL, V20, P2315, DOI 10.1681/ASN.2008111203; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Singaravelu K, 2009, RENAL FAILURE, V31, P492, DOI 10.1080/08860220902928981; Stolzing A, 2010, CELLS TISSUES ORGANS, V191, P453, DOI 10.1159/000281826; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; Tian SF, 2012, ZHONGGUO ZHONG XI YI, V13, P1058; Wang WW, 2010, MOL CELL BIOCHEM, V338, P115, DOI 10.1007/s11010-009-0344-6; Ward HH, 2011, BBA-MOL BASIS DIS, V1812, P1344, DOI 10.1016/j.bbadis.2011.01.010; Wen Jing, 2013, Beijing Da Xue Xue Bao Yi Xue Ban, V45, P619; [温静 Wen Jing], 2012, [中国组织工程研究, Journal of Clinical Rehabilitative Tissue Engineering Research], V16, P3502; [徐薇 Xu Wei], 2012, [中国组织工程研究, Chinese Journal of Tissue Engineering Research], V16, P5001; Yang Guang, 2015, Nan Fang Yi Ke Da Xue Xue Bao, V35, P163; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	27	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139607	10.1371/journal.pone.0139607	http://dx.doi.org/10.1371/journal.pone.0139607			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431335	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700084
J	Zhao, HJ; Li, C; Lin, L; Pan, YP; Wang, HY; Zhao, J; Tan, LS; Pan, CL; Song, J; Zhang, DM				Zhao, Haijiao; Li, Chen; Lin, Li; Pan, Yaping; Wang, Hongyan; Zhao, Jian; Tan, Lisi; Pan, Chunling; Song, Jia; Zhang, Dongmei			Assessment of Alveolar Bone Status in Middle Aged Chinese (40-59 Years) with Chronic Periodontitis-Using CBCT	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; CLINICAL ATTACHMENT LOSS; PANORAMIC RADIOGRAPHS; URBAN-POPULATION; RISK-ASSESSMENT; ADULTS; ACCURACY; TISSUE	Objective This study used con-beam computed tomography (CBCT) to investigate the prevalence and severity of alveolar bone loss in middle-aged (40-59 years) Chinese with chronic periodontitis. Materials and Methods The study group comprised 145 dentate individuals aged 40 to 59 years residing in China who suffered from chronic periodontitis. CBCT and the application of NNT software were used to examine the level and location of alveolar bone loss. Results The study revealed that 40-59 year old patients with chronic periodontitis had severe bone loss. At 5,286 sites (34.7%), alveolar bone loss was mild; severe alveolar bone loss was found at 5,978 sites (39.2%). A comparison of bone loss in different jaws revealed that the area with the highest degree of bone loss was on the lingual side of the maxillary molar (56.3 +/- 7.2%), and that the area with the lowest degree was primarily on the lingual side of the mandibular canine (27.5 +/- 6.3%). There was a lower degree of alveolar bone loss in males than females. Differences were observed when comparing the incidence of bone loss between males and females (P < 0.05). Menopause in females and smoking in both genders may affect the level of bone loss. Male smokers experienced a greater degree of bone loss (41.67 +/- 5.76%) than male non-smokers (32.95 +/- 4.31%). A 42.23 +/- 6.34% bone loss was found in menopausal females versus 31.35 +/- 3.62% in non-menopausal females. Conclusions The study revealed that different sites and teeth exhibited a diverse degree of bone loss. In middle-aged patients with chronic periodontitis, the highest degrees of bone loss in the incisors, premolars, and molars were on the lingual side, mesial side and lingual side, respectively. Menopause in females and smoking may affect the level of bone loss.	[Zhao, Haijiao; Li, Chen; Lin, Li; Pan, Yaping; Wang, Hongyan; Zhao, Jian; Tan, Lisi; Pan, Chunling; Song, Jia; Zhang, Dongmei] China Med Univ, Dept Periodont & Oral Biol, Sch Stomatol, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Pan, YP (corresponding author), China Med Univ, Dept Periodont & Oral Biol, Sch Stomatol, 117 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China.	yppan@mail.cmu.edu.cn	shi, zhensheng/GXN-3967-2022		Health and Discipline Commission of Liaoning Province Major Support Project [2015-16]; National Special Fund of Medical Scientific Research for Public Interest of China [201502031]; Liaoning Province Science Foundation [2013225090]	Health and Discipline Commission of Liaoning Province Major Support Project; National Special Fund of Medical Scientific Research for Public Interest of China; Liaoning Province Science Foundation(Natural Science Foundation of Liaoning Province)	This study was supported by a grant from the Health and Discipline Commission of Liaoning Province Major Support Project (No: 2015-16), National Special Fund of Medical Scientific Research for Public Interest of China (No: 201502031) and Liaoning Province Science Foundation (No: 2013225090)".	Anand Pradeep S, 2010, J Contemp Dent Pract, V11, P041; Armitage GC, 2004, PERIODONTOL 2000, V34, P22, DOI 10.1046/j.0906-6713.2002.003422.x; Bahrami Golnosh, 2006, Oral Health Prev Dent, V4, P215; Bouchard P, 2006, J PERIODONTOL, V77, P479, DOI 10.1902/jop.2006.050128; Bourgeois D, 2007, J PERIODONTAL RES, V42, P219, DOI 10.1111/j.1600-0765.2006.00936.x; Bragger U, 2005, PERIODONTOL 2000, V39, P73, DOI 10.1111/j.1600-0757.2005.00128.x; Choel L, 2003, ORAL SURG ORAL MED O, V95, P364, DOI 10.1067/moe.2003.119; Feijo CV, 2012, INT J PERIODONT REST, V32, P162; Fukuda Cassia Tiemi, 2008, Bull Tokyo Dent Coll, V49, P99; Hou GL, 2003, DENTOMAXILLOFAC RAD, V32, P104, DOI 10.1259/dmfr/67162332; Hyman JJ, 2003, J CLIN PERIODONTOL, V30, P230, DOI 10.1034/j.1600-051X.2003.00157.x; Jervoe-Storm PM, 2010, ORAL SURG ORAL MED O, V109, pE95, DOI 10.1016/j.tripleo.2009.10.023; Kasaj A, 2008, EUR J MED RES, V13, P26; Misch KA, 2006, J PERIODONTOL, V77, P1261, DOI 10.1902/jop.2006.050367; Mol A, 2008, DENTOMAXILLOFAC RAD, V37, P319, DOI 10.1259/dmfr/26475758; Muller HP, 2005, CLIN ORAL INVEST, V9, P105, DOI 10.1007/s00784-005-0304-9; Muller HP, 2005, CLIN ORAL INVEST, V9, P98, DOI 10.1007/s00784-005-0303-x; PAPAPANOU PN, 1991, J CLIN PERIODONTOL, V18, P611, DOI 10.1111/j.1600-051X.1991.tb00098.x; Paulander J, 2004, J CLIN PERIODONTOL, V31, P489, DOI 10.1111/j.1600-051X.2004.00514.x; Pinsky HM, 2006, DENTOMAXILLOFAC RAD, V35, P410, DOI 10.1259/dmfr/20987648; Rheu GB, 2011, J ADV PROSTHODONT, V3, P25, DOI 10.4047/jap.2011.3.1.25; Sarajlic N, 2009, COLLEGIUM ANTROPOL, V33, P1165; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Sultan N, 2011, MED ORAL PATOL ORAL, V16, pE440, DOI 10.4317/medoral.16.e440; Susin C, 2005, ACTA ODONTOL SCAND, V63, P85, DOI 10.1080/00016350510019694; Susin C, 2004, J PERIODONTOL, V75, P1033, DOI 10.1902/jop.2004.75.7.1033; Teeuw WJ, 2009, J PERIODONTAL RES, V44, P94, DOI 10.1111/j.1600-0765.2008.01111.x; Tomar SL, 2000, J PERIODONTOL, V71, P743, DOI 10.1902/jop.2000.71.5.743; Tyndall Donald A, 2008, Dent Clin North Am, V52, P825, DOI 10.1016/j.cden.2008.05.002; Vandenberghe B, 2008, DENTOMAXILLOFAC RAD, V37, P252, DOI 10.1259/dmfr/57711133; Wu X, 2015, J PERIODONTAL RES, V50, P52, DOI 10.1111/jre.12181; Zhao H, 2014, J PERIODONTAL RES, V49, P213, DOI 10.1111/jre.12097	32	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139553	10.1371/journal.pone.0139553	http://dx.doi.org/10.1371/journal.pone.0139553			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431206	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700076
J	Berglund, M; Adiels, M; Taskinen, MR; Boren, J; Wennberg, B				Berglund, Martin; Adiels, Martin; Taskinen, Marja-Riitta; Boren, Jan; Wennberg, Bernt			Improved Estimation of Human Lipoprotein Kinetics with Mixed Effects Models	PLOS ONE			English	Article							POPULATION PHARMACOKINETIC PARAMETERS; APOLIPOPROTEIN-B METABOLISM; MULTICOMPARTMENTAL MODEL; DIABETIC DYSLIPIDEMIA; TRIGLYCERIDE KINETICS; VLDL; OVERPRODUCTION; SUBFRACTIONS; DRIVEN	Context Mathematical models may help the analysis of biological systems by providing estimates of otherwise un-measurable quantities such as concentrations and fluxes. The variability in such systems makes it difficult to translate individual characteristics to group behavior. Mixed effects models offer a tool to simultaneously assess individual and population behavior from experimental data. Lipoproteins and plasma lipids are key mediators for cardiovascular disease in metabolic disorders such as diabetes mellitus type 2. By the use of mathematical models and tracer experiments fluxes and production rates of lipoproteins may be estimated. Results We developed a mixed effects model to study lipoprotein kinetics in a data set of 15 healthy individuals and 15 patients with type 2 diabetes. We compare the traditional and the mixed effects approach in terms of group estimates at various sample and data set sizes. Conclusion We conclude that the mixed effects approach provided better estimates using the full data set as well as with both sparse and truncated data sets. Sample size estimates showed that to compare lipoprotein secretion the mixed effects approach needed almost half the sample size as the traditional method.	[Berglund, Martin; Adiels, Martin; Wennberg, Bernt] Chalmers, Dept Math Sci, S-41296 Gothenburg, Sweden; [Berglund, Martin; Adiels, Martin; Wennberg, Bernt] Univ Gothenburg, Gothenburg, Sweden; [Adiels, Martin; Boren, Jan] Univ Gothenburg, Dept Mol & Clin Med, Gothenburg, Sweden; [Taskinen, Marja-Riitta] Univ Helsinki, Heart & Lung Ctr, Diabet & Obes Res Program, Dept Med,Cardiovasc Res Unit, Helsinki, Finland	Chalmers University of Technology; University of Gothenburg; University of Gothenburg; University of Helsinki	Adiels, M (corresponding author), Univ Gothenburg, Ctr Appl Biostat Occupat & Environm Med, Gothenburg, Sweden.	martin.adiels@wlab.gu.se	Taskinen, Marja-Riitta/AAN-5432-2020; Wennberg, Bernt/F-9824-2013	Taskinen, Marja-Riitta/0000-0002-6229-3588; Wennberg, Bernt/0000-0002-0779-6959	Swedish foundation for strategic research [AM13-0046, A3 05: 188]; Knut and Alice Wallenbergs Stiftelse [KAW 2012.0067]; Sigrid Juselius Foundation	Swedish foundation for strategic research(Swedish Foundation for Strategic Research); Knut and Alice Wallenbergs Stiftelse; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by Swedish foundation for strategic research, AM13-0046, BW MA; Swedish foundation for strategic research, A3 05: 188, JB, BW, MA, MB; Knut and Alice Wallenbergs Stiftelse, KAW 2012.0067, BW; and Sigrid Juselius Foundation, MRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Adiels M, 2005, ARTERIOSCL THROM VAS, V25, P1697, DOI 10.1161/01.ATV.0000172689.53992.25; Adiels M, 2005, J LIPID RES, V46, P58, DOI 10.1194/jlr.M400108-JLR200; Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Berglund M, 2012, MATH MED BIOL, V29, P361, DOI 10.1093/imammb/dqr021; BLACKWOOD LG, 1992, ENVIRON MONIT ASSESS, V21, P193, DOI 10.1007/BF00399687; Boren J, 2012, J INTERN MED, V271, P166, DOI 10.1111/j.1365-2796.2011.02497.x; Cobelli C, 2001, TRACER KINETICS BIOM; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; Davidian M., 1995, NONLINEAR MODELS REP; Demant T, 1996, AM J PHYSIOL-ENDOC M, V270, pE1022, DOI 10.1152/ajpendo.1996.270.6.E1022; Denti P, 2009, IEEE T BIO-MED ENG, V56, P2156, DOI 10.1109/TBME.2009.2020171; Duvillard L, 2000, EUR J CLIN INVEST, V30, P685, DOI 10.1046/j.1365-2362.2000.00702.x; GINSBERG H, 1982, DIABETOLOGIA, V23, P421, DOI 10.1007/BF00260955; GINSBERG H N, 1987, Diabetes Metabolism Reviews, V3, P571; Hugh P, 2006, J LIPID RES, V47, P1607, DOI 10.1194/jlr.R600017-JLR200; JACQUEZ JA, 1996, COMPARTMENTAL ANAL B; Jonsson EN, 2000, AAPS PHARMSCI, V2, part. no.; Lang W, 2009, MIXED EFFECTS MODELS; Lemieux S, 1999, J LIPID RES, V40, P2111; Nocedal J, 1999, NUMMERICAL OPTIMIZAT; Omuto TC, 2006, J HYDROL, V330, P748, DOI 10.1016/j.jhydrol.2006.05.006; Packard CJ, 2000, J LIPID RES, V41, P305; PACKARD CJ, 1995, J LIPID RES, V36, P172; Patterson BW, 2002, J LIPID RES, V43, P223; Pillai G, 2005, J PHARMACOKINET PHAR, V32, P161, DOI 10.1007/s10928-005-0062-y; Pinheiro J, 2001, MIXED EFFECTS MODELS; SHEINER LB, 1980, J PHARMACOKINET BIOP, V8, P553, DOI 10.1007/BF01060053; SHEINER LB, 1984, DRUG METAB REV, V15, P153, DOI 10.3109/03602538409015063; Sondermeijer BM, 2013, ATHEROSCLEROSIS, V228, P443, DOI 10.1016/j.atherosclerosis.2013.02.040; Sorensen LP, 2011, DIABETES, V60, P88, DOI 10.2337/db10-0564; STEIMER JL, 1984, DRUG METAB REV, V15, P265, DOI 10.3109/03602538409015066; Sun FF, 2013, AM J PHYSIOL-ENDOC M, V305, pE1041, DOI 10.1152/ajpendo.00105.2013; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Wang YN, 2007, J PHARMACOKINET PHAR, V34, P575, DOI 10.1007/s10928-007-9060-6	35	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138538	10.1371/journal.pone.0138538	http://dx.doi.org/10.1371/journal.pone.0138538			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422201	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700043
J	Burunat, I; Brattico, E; Puolivali, T; Ristaniemi, T; Sams, M; Toiviainen, P				Burunat, Iballa; Brattico, Elvira; Puolivali, Tuomas; Ristaniemi, Tapani; Sams, Mikko; Toiviainen, Petri			Action in Perception: Prominent Visuo-Motor Functional Symmetry in Musicians during Music Listening	PLOS ONE			English	Article							CORPUS-CALLOSUM SIZE; INTERHEMISPHERIC-TRANSFER; CORTICAL REPRESENTATION; AUDITORY-CORTEX; BRAIN; SEGMENTATION; PLASTICITY; CONNECTIVITY; COORDINATION; NETWORKS	Musical training leads to sensory and motor neuroplastic changes in the human brain. Motivated by findings on enlarged corpus callosum in musicians and asymmetric somatomotor representation in string players, we investigated the relationship between musical training, callosal anatomy, and interhemispheric functional symmetry during music listening. Functional symmetry was increased in musicians compared to nonmusicians, and in keyboardists compared to string players. This increased functional symmetry was prominent in visual and motor brain networks. Callosal size did not significantly differ between groups except for the posterior callosum in musicians compared to nonmusicians. We conclude that the distinctive postural and kinematic symmetry in instrument playing cross-modally shapes information processing in sensory-motor cortical areas during music listening. This cross-modal plasticity suggests that motor training affects music perception.	[Burunat, Iballa; Toiviainen, Petri] Univ Jyvaskyla, Dept Mus, Finnish Ctr Interdisciplinary Mus Res, Jyvaskyla, Finland; [Burunat, Iballa; Puolivali, Tuomas; Ristaniemi, Tapani] Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland; [Brattico, Elvira] Aarhus Univ, Dept Clin Med, Ctr Mus Brain MIB, Aarhus, Denmark; [Sams, Mikko] Aalto Univ, Sch Sci, Dept Neurosci & Biomed Engn, Espoo, Finland; [Brattico, Elvira] Univ Helsinki, Inst Behav Sci, CBRU, Helsinki, Finland; [Brattico, Elvira] Aalto Univ, Sch Sci, Adv Magnet Imaging AMI Ctr, Espoo, Finland	University of Jyvaskyla; University of Jyvaskyla; Aarhus University; Aalto University; University of Helsinki; Aalto University	Burunat, I (corresponding author), Univ Jyvaskyla, Dept Mus, Finnish Ctr Interdisciplinary Mus Res, Jyvaskyla, Finland.	Iballa.burunat@jyu.fi	Brattico, Elvira/M-1455-2019; Sams, Mikko E/G-7060-2012	Burunat, Iballa/0000-0003-3948-1414; Brattico, Elvira/0000-0003-0676-6464; Toiviainen, Petri/0000-0001-6962-2957	Academy of Finland [272250, 274037]; TEKES [40334/10]; AivoAALTO research project of the Aalto University	Academy of Finland(Academy of Finland); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); AivoAALTO research project of the Aalto University	This study was supported by the Academy of Finland (project numbers 272250 and 274037), TEKES (as part of the project 'Machine Learning for Future Music and Learning Technologies'; grant 40334/10), and the AivoAALTO research project of the Aalto University. PT, TR, MS are the recipients of the first, second, and third funding sources, respectively.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; Alluri V, 2012, NEUROIMAGE, V59, P3677, DOI 10.1016/j.neuroimage.2011.11.019; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baader AP, 2005, COGNITIVE BRAIN RES, V23, P436, DOI 10.1016/j.cogbrainres.2004.11.008; Bangert M, 2006, EUR J NEUROSCI, V24, P1832, DOI 10.1111/j.1460-9568.2006.05031.x; Banich M.T., 1994, NEUROPSYCHOLOGY, V8, P263, DOI DOI 10.1037/0894-4105.8.2.263; BARBAS H, 1984, EXP BRAIN RES, V55, P187; Baumann S, 2005, ANN NY ACAD SCI, V1060, P186, DOI 10.1196/annals.1360.038; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; EVANS AC, 1994, NATO ADV SCI INST SE, V264, P263; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fortney PM, 2014, STUDY MIDDLE SCH BAN, V41, P28; Gaser C, 2003, J NEUROSCI, V23, P9240; Gold BP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00541; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Han X, 2007, IEEE T MED IMAGING, V26, P479, DOI 10.1109/TMI.2007.893282; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Hutchinson S, 2003, CEREB CORTEX, V13, P943, DOI 10.1093/cercor/13.9.943; Hyde KL, 2009, ANN NY ACAD SCI, V1169, P182, DOI 10.1111/j.1749-6632.2009.04852.x; Jancke L, 1997, CEREB CORTEX, V7, P48, DOI 10.1093/cercor/7.1.48; JANCKE L, 1994, NEUROREPORT, V5, P2385; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Jovicich J, 2009, NEUROIMAGE, V46, P177, DOI 10.1016/j.neuroimage.2009.02.010; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lappe C, 2008, J NEUROSCI, V28, P9632, DOI 10.1523/JNEUROSCI.2254-08.2008; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lee DJ, 2003, NEUROREPORT, V14, P205, DOI 10.1097/00001756-200302100-00009; Moore E, 2014, BRAIN SCI, V4, P405, DOI 10.3390/brainsci4020405; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Pantev C, 2001, ANN NY ACAD SCI, V930, P300, DOI 10.1111/j.1749-6632.2001.tb05740.x; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Patel AD, 2014, HEARING RES, V308, P98, DOI 10.1016/j.heares.2013.08.011; Patston LLM, 2007, LATERALITY, V12, P262, DOI 10.1080/13576500701251981; Patston LLM, 2007, NEUROPSYCHOLOGIA, V45, P2059, DOI 10.1016/j.neuropsychologia.2007.02.001; Pizoli CE, 2011, RESTING STATE ACTIVI; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Reilly JXO, 2013, CAUSAL EFFECT DISCON; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; ROLLS ET, 1994, REV NEUROL-FRANCE, V150, P648; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Russeler J, 2001, NEUROSCI LETT, V308, P33, DOI 10.1016/S0304-3940(01)01977-2; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; Schlaug G, 2001, ANN NY ACAD SCI, V930, P281, DOI 10.1111/j.1749-6632.2001.tb05739.x; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schwenkreis P, 2007, EUR J NEUROSCI, V26, P3291, DOI 10.1111/j.1460-9568.2007.05894.x; Tervaniemi M, 2012, MUSICAL IMAGINATIONS, P285; Tervaniemi M, 2009, ANN NY ACAD SCI, V1169, P151, DOI 10.1111/j.1749-6632.2009.04591.x; Trainor LJ, 2009, ANN NY ACAD SCI, V1169, P133, DOI 10.1111/j.1749-6632.2009.04589.x; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2008, NEUROREPORT, V19, P703, DOI 10.1097/WNR.0b013e3282fb8203; van der Knaap LJ, 2011, BEHAV BRAIN RES, V223, P211, DOI 10.1016/j.bbr.2011.04.018; Vink M, 2005, HUM BRAIN MAPP, V25, P336, DOI 10.1002/hbm.20111; Vollmann H, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00245; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Wan CY, 2010, NEUROSCIENTIST, V16, P566, DOI 10.1177/1073858410377805; Wang Z, 2014, NEUROSCIENTIST; Waters AJ, 1998, BRIT J PSYCHOL, V89, P123, DOI 10.1111/j.2044-8295.1998.tb02676.x; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152; Zuo XN, 2010, J NEUROSCI, V30, P15034, DOI 10.1523/JNEUROSCI.2612-10.2010	71	33	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0138238	10.1371/journal.pone.0138238	http://dx.doi.org/10.1371/journal.pone.0138238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422790	Green Published, gold			2022-12-27	WOS:000362175700035
J	Quibod, IL; Grande, G; Oreiro, EG; Borja, FN; Dossa, GS; Mauleon, R; Cruz, CV; Oliva, R				Quibod, Ian Lorenzo; Grande, Genelou; Oreiro, Eula Gems; Borja, Frances Nikki; Dossa, Gerbert Sylvestre; Mauleon, Ramil; Cruz, Casiana Vera; Oliva, Ricardo			Rice-Infecting Pseudomonas Genomes Are Highly Accessorized and Harbor Multiple Putative Virulence Mechanisms to Cause Sheath Brown Rot	PLOS ONE			English	Article							III SECRETION SYSTEM; GRAIN DISCOLORATION; FUSCOVAGINAE; PATHOGEN; SEQUENCE; HOST; IDENTIFICATION; EVOLUTION; AERUGINOSA; DIVERSITY	Sheath rot complex and seed discoloration in rice involve a number of pathogenic bacteria that cannot be associated with distinctive symptoms. These pathogens can easily travel on asymptomatic seeds and therefore represent a threat to rice cropping systems. Among the rice-infecting Pseudomonas, P. fuscovaginae has been associated with sheath brown rot disease in several rice growing areas around the world. The appearance of a similar Pseudomonas population, which here we named P. fuscovaginae-like, represents a perfect opportunity to understand common genomic features that can explain the infection mechanism in rice. We showed that the novel population is indeed closely related to P. fuscovaginae. A comparative genomics approach on eight rice-infecting Pseudomonas revealed heterogeneous genomes and a high number of strain-specific genes. The genomes of P. fuscovaginae-like harbor four secretion systems (Type I, II, III, and VI) and other important pathogenicity machinery that could probably facilitate rice colonization. We identified 123 core secreted proteins, most of which have strong signatures of positive selection suggesting functional adaptation. Transcript accumulation of putative pathogenicity-related genes during rice colonization revealed a concerted virulence mechanism. The study suggests that rice-infecting Pseudomonas causing sheath brown rot are intrinsically diverse and maintain a variable set of metabolic capabilities as a potential strategy to occupy a range of environments.	[Quibod, Ian Lorenzo; Grande, Genelou; Oreiro, Eula Gems; Dossa, Gerbert Sylvestre; Cruz, Casiana Vera; Oliva, Ricardo] Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines; [Borja, Frances Nikki; Mauleon, Ramil] Int Rice Res Inst, TT Chang Genet Resources Ctr, Los Banos, Philippines; [Dossa, Gerbert Sylvestre] Leibniz Univ Hannover, Dept Phytomed, D-30167 Hannover, Germany	CGIAR; International Rice Research Institute (IRRI); CGIAR; International Rice Research Institute (IRRI); Leibniz University Hannover	Oliva, R (corresponding author), Int Rice Res Inst, Plant Breeding Genet & Biotechnol Div, Los Banos, Philippines.	r.oliva@irri.org	Dossa, Gerbert/AAS-4915-2021; Mauleon, Ramil/AAW-1697-2020	Mauleon, Ramil/0000-0001-8512-144X	Global Rice Science Partnership (GRiSP); Consortium for International Agricultural Research (CGIAR) with headquarters in Montpellier, France	Global Rice Science Partnership (GRiSP); Consortium for International Agricultural Research (CGIAR) with headquarters in Montpellier, France(CGIAR)	Scientists at the International Rice Research Institute are partially funded by the Global Rice Science Partnership (GRiSP). The program is supported by the Consortium for International Agricultural Research (CGIAR) with headquarters in Montpellier, France. More information can be found at http://www.cgiar.org/. No additional funding source is declared.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Abramovitch RB, 2006, NAT REV MOL CELL BIO, V7, P601, DOI 10.1038/nrm1984; Adorada DL, 2015, PLANT PATHOL, V64, P43, DOI 10.1111/ppa.12243; Alavi SM, 2008, APPL ENVIRON MICROB, V74, P3295, DOI 10.1128/AEM.02507-07; Alfano JR, 2009, MOL PLANT PATHOL, V10, P805, DOI 10.1111/j.1364-3703.2009.00588.x; Alfano JR, 1996, PLANT CELL, V8, P1683, DOI 10.1105/tpc.8.10.1683; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ash GJ, 2014, PLANT DIS, V98, P909, DOI 10.1094/PDIS-09-13-0957-RE; Autrique A., 1983, FAO Plant Protection Bulletin, V31, P94; Ballio A, 1996, FEBS LETT, V381, P213, DOI 10.1016/0014-5793(96)00043-9; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barret M, 2013, ENV MICROBIOL REP, V5, P377, DOI 10.1111/1758-2229.12039; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Batoko H, 1998, BBA-BIOMEMBRANES, V1372, P216, DOI 10.1016/S0005-2736(98)00060-1; Berti AD, 2009, J BACTERIOL, V191, P4594, DOI 10.1128/JB.00457-09; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charkowski A, 2012, ANNU REV PHYTOPATHOL, V50, P425, DOI 10.1146/annurev-phyto-081211-173013; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Correa VR, 2012, APPL ENVIRON MICROB, V78, P6327, DOI 10.1128/AEM.00892-12; Cother EJ, 2009, AUSTRALAS PLANT PATH, V38, P247, DOI 10.1071/AP08103; Cottyn B, 1996, PLANT DIS, V80, P438, DOI 10.1094/PD-80-0438; Cottyn B., 2002, International Rice Research Notes, V27, P39; Cronin D, 1997, FEMS MICROBIOL ECOL, V23, P95, DOI 10.1111/j.1574-6941.1997.tb00394.x; DUVEILLER E, 1990, TROP PEST MANAGE, V36, P151, DOI 10.1080/09670879009371461; DUVEILLER E, 1989, PLANT DIS, V73, P514, DOI 10.1094/PD-73-0514; DUVEILLER E, 1988, J PHYTOPATHOL, V122, P97, DOI 10.1111/j.1439-0434.1988.tb00995.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egan F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00034; Filloux A, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00155; Flamand MC, 1996, PHYSIOL MOL PLANT P, V48, P217, DOI 10.1006/pmpp.1996.0019; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Grant SR, 2006, ANNU REV MICROBIOL, V60, P425, DOI 10.1146/annurev.micro.60.080805.142251; Guttman DS, 2006, MOL BIOL EVOL, V23, P2342, DOI 10.1093/molbev/msl103; Guyon K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-336; GUZZO J, 1991, J BACTERIOL, V173, P5290, DOI 10.1128/jb.173.17.5290-5297.1991; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Haywood-Farmer E, 2003, EVOLUTION, V57, P1783; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Kimbrel JA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-522; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liang WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045346; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Marzukhi H, 1991, TEKNOLOGI PADI, V7, P49; Mattiuzzo M, 2011, ENVIRON MICROBIOL, V13, P145, DOI 10.1111/j.1462-2920.2010.02316.x; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MIYAJIMA K, 1983, INT J SYST BACTERIOL, V33, P656, DOI 10.1099/00207713-33-3-656; Mole BM, 2007, TRENDS MICROBIOL, V15, P363, DOI 10.1016/j.tim.2007.06.005; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Patel HK, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0274-7; Patel HK, 2012, J BACTERIOL, V194, P2765, DOI 10.1128/JB.00341-12; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Rokicki J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-65; ROTT P, 1989, PLANT DIS, V73, P133, DOI 10.1094/PD-73-0133; ROTT P, 1991, PLANT DIS, V75, P843, DOI 10.1094/PD-75-0843; Schikora A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024112; Shirron N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018855; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TANII A, 1976, Annals of the Phytopathological Society of Japan, V42, P540, DOI 10.3186/jjphytopath.42.540; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tian YL, 2015, MOL PLANT PATHOL, V16, P38, DOI 10.1111/mpp.12159; Triplett LR, 2006, APPL ENVIRON MICROB, V72, P7359, DOI 10.1128/AEM.01159-06; Visca P, 2007, TRENDS MICROBIOL, V15, P22, DOI 10.1016/j.tim.2006.11.004; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang YJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-66; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Xie GL, 2012, J BACTERIOL, V194, P5479, DOI 10.1128/JB.01273-12; Xie GuanLin, 2003, International Rice Research Notes, V28, P50; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yin C, 2014, MOL PLANT MICROBE IN, V27, P227, DOI 10.1094/MPMI-09-13-0289-FI; ZEIGLER RS, 1987, PLANT DIS, V71, P592, DOI 10.1094/PD-71-0592; ZEIGLER RS, 1990, PLANT DIS, V74, P917, DOI 10.1094/PD-74-0917; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	94	7	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139256	10.1371/journal.pone.0139256	http://dx.doi.org/10.1371/journal.pone.0139256			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422147	Green Published, gold			2022-12-27	WOS:000362175700084
J	Berlincourt, M; Angel, LP; Arnould, JPY				Berlincourt, Maud; Angel, Lauren P.; Arnould, John P. Y.			Combined Use of GPS and Accelerometry Reveals Fine Scale Three-Dimensional Foraging Behaviour in the Short-Tailed Shearwater	PLOS ONE			English	Article							PUFFINUS-TENUIROSTRIS; SATELLITE TRACKING; ACTIVITY PATTERN; SOUTHERN-OCEAN; DIVING DEPTHS; TOP PREDATOR; HABITAT USE; FLIGHT; SEABIRDS; STRATEGIES	Determining the foraging behaviour of free-ranging marine animals is fundamental for assessing their habitat use and how they may respond to changes in the environment. However, despite recent advances in bio-logging technology, collecting information on both at-sea movement patterns and activity budgets still remains difficult in small pelagic seabird species due to the constraints of instrument size. The short-tailed shearwater, the most abundant seabird species in Australia (ca 23 million individuals), is a highly pelagic procellariiform. Despite its ecological importance to the region, almost nothing is known about its at-sea behaviour, in particular, its foraging activity. Using a combination of GPS and tri-axial accelerometer data-loggers, the fine scale three-dimensional foraging behaviour of 10 breeding individuals from two colonies was investigated. Five at-sea behaviours were identified: (1) resting on water, (2) flapping flight, (3) gliding flight, (4) foraging (i.e., surface foraging and diving events), and (5) taking-off. There were substantial intra-and inter-individual variations in activity patterns, with individuals spending on average 45.8% (range: 17.1-70.0%) of time at sea resting on water and 18.2%(range: 2.3-49.6%) foraging. Individuals made 76.4 +/- 65.3 dives (range: 8-237) per foraging trip (mean duration 9.0 +/- 1.9 s), with dives also recorded during night-time. With the continued miniaturisation of recording devices, the use of combined data-loggers could provide us with further insights into the foraging behaviour of small procellariiforms, helping to better understand interactions with their prey.	[Berlincourt, Maud; Angel, Lauren P.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia	Deakin University	Berlincourt, M (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.	mberlinc@deakin.edu.au		Angel, Lauren/0000-0002-8696-3945	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment [RM23947]; MA Ingram Trust Application [RM25024]; Birds Australia [RM23896]	ANZ Trustees Foundation - Holsworth Wildlife Research Endowment; MA Ingram Trust Application; Birds Australia	This work was funded by ANZ Trustees Foundation - Holsworth Wildlife Research Endowment (grant RM23947) (http://www.anz.com/personal/private-bank-trustees/trustees/granting/granting-programs/small-grants/), MA Ingram Trust Application (grant RM25024) (https://www.statetrustees.com.au/uploads/content/142-MA_Ingram_Trust_Guidelines_Application_Form.pdf), and Birds Australia (grant RM23896) (http://birdlife.org.au/who-we-are/ourorganisation/awards-scholarships).	Amelineau F, 2014, J EXP BIOL, V217, P876, DOI 10.1242/jeb.097915; Bowker G.M., 1980, Corella, V4, P104; BROWN RGB, 1978, CONDOR, V80, P123, DOI 10.2307/1367911; Burger AE, 2001, AUK, V118, P755, DOI 10.1642/0004-8038(2001)118[0755:DDOS]2.0.CO;2; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Cleeland JB, 2014, J EXP MAR BIOL ECOL, V450, P109, DOI 10.1016/j.jembe.2013.10.012; Davies RD, 2013, MAR ECOL PROG SER, V485, P287, DOI 10.3354/meps10348; Einoder LD, 2011, AUSTRAL ECOL, V36, P461, DOI 10.1111/j.1442-9993.2010.02176.x; Einoder LD, 2005, T ROY SOC SOUTH AUST, V129, P209; Einoder LD, 2013, CONDOR, V115, P777, DOI 10.1525/cond.2013.120197; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fullagar PJ, 1996, GABO ISLAND SHEARWAT; Georges JY, 1997, IBIS, V139, P403, DOI 10.1111/j.1474-919X.1997.tb04644.x; Hamer KC, 2001, MAR ECOL PROG SER, V224, P283, DOI 10.3354/meps224283; Hunt GL, 1996, MAR ECOL PROG SER, V141, P1, DOI 10.3354/meps141001; Hyrenbach KD, 2003, DEEP-SEA RES PT II, V50, P2537, DOI 10.1016/S0967-0645(03)00123-1; Hyrenbach KD, 2014, ELEPAIO, V74, P1; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; Marchant S, 1990, HANDBOOK OF AUSTRALI; Matsumoto K, 2012, ORNITHOL SCI, V11, P9, DOI 10.2326/osj.11.9; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Paiva VH, 2010, ZOOLOGY, V113, P47, DOI 10.1016/j.zool.2009.05.003; Peck DR, 2006, J AVIAN BIOL, V37, P245, DOI 10.1111/j.2006.0908-8857.03558.x; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Pinheiro J, 2020, R PACKAGE VERSION 31; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Raymond B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010960; Rayner MJ, 2011, J AVIAN BIOL, V42, P266, DOI 10.1111/j.1600-048X.2010.05238.x; Rishworth GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116544; Rishworth GM, 2014, METHODS ECOL EVOL, V5, P854, DOI 10.1111/2041-210X.12213; Ronconi RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015508; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Y, 2009, J AVIAN BIOL, V40, P380, DOI 10.1111/j.1600-048X.2008.04592.x; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Shaffer SA, 2001, J ANIM ECOL, V70, P864, DOI 10.1046/j.0021-8790.2001.00548.x; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SKIRA IJ, 1979, EMU, V79, P43, DOI 10.1071/MU9790043a; Spear LB, 1997, IBIS, V139, P221, DOI 10.1111/j.1474-919X.1997.tb04620.x; Spivey RJ, 2014, PROG OCEANOGR, V125, P62, DOI 10.1016/j.pocean.2014.04.005; Sumner MD., 2012, TRIP SPATIAL ANALYSI; Taylor G. A., 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P89; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; Vandenabeele SP, 2012, MAR BIOL, V159, P1, DOI 10.1007/s00227-011-1784-6; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Vertigan C, 2012, ANIM WELFARE, V21, P101, DOI 10.7120/096272812799129493; Wakefield ED, 2013, SCIENCE, V341, P68, DOI 10.1126/science.1236077; WARHAM J, 1977, NEW ZEAL J ZOOL, V4, P73, DOI 10.1080/03014223.1977.9517938; Weimerskirch H, 1999, BIOL CONSERV, V87, P273, DOI 10.1016/S0006-3207(98)00039-1; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; WEIMERSKIRCH H, 1994, P ROY SOC B-BIOL SCI, V255, P91, DOI 10.1098/rspb.1994.0013; Weimerskirch H, 2005, P ROY SOC B-BIOL SCI, V272, P53, DOI 10.1098/rspb.2004.2918; Weimerskirch H, 1996, IBIS, V138, P786, DOI 10.1111/j.1474-919X.1996.tb08837.x; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2009, OECOLOGIA, V161, P637, DOI 10.1007/s00442-009-1397-7; Wilson RP, 2013, ECOL LETT, V16, P1145, DOI 10.1111/ele.12149; Woehler EJ, 1996, POLAR BIOL, V16, P379; Wynn RB, 2007, BIOL LETTERS, V3, P529, DOI 10.1098/rsbl.2007.0162; Yen PPW, 2005, DEEP-SEA RES PT II, V52, P799, DOI 10.1016/j.dsr2.2004.12.018	64	10	11	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139351	10.1371/journal.pone.0139351	http://dx.doi.org/10.1371/journal.pone.0139351			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439491	Green Published, gold, Green Submitted			2022-12-27	WOS:000362510300024
J	Blume, C; Reale, R; Held, M; Millar, TM; Collins, JE; Davies, DE; Morgan, H; Swindle, EJ				Blume, Cornelia; Reale, Riccardo; Held, Marie; Millar, Timothy M.; Collins, Jane E.; Davies, Donna E.; Morgan, Hywel; Swindle, Emily J.			Temporal Monitoring of Differentiated Human Airway Epithelial Cells Using Microfluidics	PLOS ONE			English	Article							ON-A-CHIP; IN-VITRO MODEL; INTERSTITIAL CONVECTION; LUNG INJURY; BARRIER; ASTHMA; PERMEABILITY; INTERFACE; TRANSPORT; PERFUSION	The airway epithelium is exposed to a variety of harmful agents during breathing and appropriate cellular responses are essential to maintain tissue homeostasis. Recent evidence has highlighted the contribution of epithelial barrier dysfunction in the development of many chronic respiratory diseases. Despite intense research efforts, the responses of the airway barrier to environmental agents are not fully understood, mainly due to lack of suitable in vitro models that recapitulate the complex in vivo situation accurately. Using an interdisciplinary approach, we describe a novel dynamic 3D in vitro model of the airway epithelium, incorporating fully differentiated primary human airway epithelial cells at the air-liquid interface and a basolateral microfluidic supply of nutrients simulating the interstitial flow observed in vivo. Through combination of the microfluidic culture system with an automated fraction collector the kinetics of cellular responses by the airway epithelium to environmental agents can be analysed at the early phases for the first time and with much higher sensitivity compared to common static in vitro models. Following exposure of primary differentiated epithelial cells to pollen we show that CXCL8/IL-8 release is detectable within the first 2h and peaks at 4-6h under microfluidic conditions, a response which was not observed in conventional static culture conditions. Such a microfluidic culture model is likely to have utility for high resolution temporal profiling of toxicological and pharmacological responses of the airway epithelial barrier, as well as for studies of disease mechanisms.	[Blume, Cornelia; Millar, Timothy M.; Collins, Jane E.; Davies, Donna E.; Swindle, Emily J.] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Reale, Riccardo; Held, Marie; Morgan, Hywel] Univ Southampton, Elect & Comp Sci, Fac Phys Sci & Engn, Southampton, Hants, England; [Davies, Donna E.; Morgan, Hywel; Swindle, Emily J.] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Davies, Donna E.; Swindle, Emily J.] Southampton Univ Hosp, Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton, Hants, England	University of Southampton; University of Southampton; University of Southampton; University of Southampton	Blume, C (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	c.blume@soton.ac.uk	Millar, Timothy M/ABC-7427-2021; Reale, Riccardo/AAI-1308-2020; Davies, Donna E/H-2993-2012	Morgan, Hywel/0000-0003-4850-5676; Millar, Timothy/0000-0002-4539-2445; Davies, Donna/0000-0002-5117-2991; Collins, Jane/0000-0002-9914-3890; Blume, Cornelia/0000-0001-6133-7318; Reale, Riccardo/0000-0002-7697-8895; Held, Marie/0000-0003-0118-5898; Swindle, Emily/0000-0003-3644-7747	National Centre for the Replacement, Refinement & Reduction of Animals in Research, UK (NC3Rs) [G1001598/1]; Asthma UK [10/060]; Asthma, Allergy and Inflammation Research (AAIR) charity; University of Southampton Faculty of Medicine postdoctoral career track award; Wellcome Trust Value in People Award; MRC [G0900453] Funding Source: UKRI; Medical Research Council [G0900453] Funding Source: researchfish; National Centre for the Replacement [G1001598/1] Funding Source: researchfish	National Centre for the Replacement, Refinement & Reduction of Animals in Research, UK (NC3Rs); Asthma UK; Asthma, Allergy and Inflammation Research (AAIR) charity; University of Southampton Faculty of Medicine postdoctoral career track award; Wellcome Trust Value in People Award(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This project was supported by the National Centre for the Replacement, Refinement & Reduction of Animals in Research, UK (NC3Rs, Project Code: G1001598/1), Asthma UK (Project Code 10/060) and the Asthma, Allergy and Inflammation Research (AAIR) charity. Dr Emily J Swindle was supported by a University of Southampton Faculty of Medicine postdoctoral career track award supported by the Wellcome Trust Value in People Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atac B, 2013, LAB CHIP, V13, P3555, DOI 10.1039/c3lc50227a; Balda MS, 2000, J CELL BIOCHEM, V78, P85, DOI 10.1002/(SICI)1097-4644(20000701)78:1<85::AID-JCB8>3.3.CO;2-6; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Blume C, 2013, EUR RESPIR J, V42, P87, DOI 10.1183/09031936.00075612; Blume C, 2013, EUR J PHARM BIOPHARM, V84, P394, DOI 10.1016/j.ejpb.2012.12.014; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Dafni H, 2002, CANCER RES, V62, P6731; Ehrhardt C, 2002, CELL TISSUE RES, V308, P391, DOI 10.1007/s00441-002-0548-5; Gao D, 2013, LAB CHIP, V13, P978, DOI 10.1039/c2lc41215b; Hardyman MA, 2013, J ALLERGY CLIN IMMUN, V132, P665, DOI 10.1016/j.jaci.2013.03.005; Holmes AM, 2011, DRUG DISCOV TODAY, V16, P659, DOI 10.1016/j.drudis.2011.05.014; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; Loxham M, 2014, CLIN EXP ALLERGY, V44, P1299, DOI 10.1111/cea.12309; Mahto SK, 2015, NANOTOXICOLOGY, V9, P381, DOI 10.3109/17435390.2014.940402; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Nalayanda DD, 2007, EXP LUNG RES, V33, P321, DOI 10.1080/01902140701557754; Nalayanda DD, 2014, J PEDIATR SURG, V49, P61, DOI 10.1016/j.jpedsurg.2013.09.030; Nalayanda DD, 2009, BIOMED MICRODEVICES, V11, P1081, DOI 10.1007/s10544-009-9325-5; Nalayanda DD, 2013, INTEGR BIOL-UK, V5, P1141, DOI 10.1039/c3ib40037a; Ng CP, 2003, AM J PHYSIOL-HEART C, V284, pH1771, DOI 10.1152/ajpheart.01008.2002; Nichols JE, 2014, EXP BIOL MED, V239, P1135, DOI 10.1177/1535370214536679; Stucki AO, 2015, LAB CHIP, V15, P1302, DOI 10.1039/c4lc01252f; Tarbell JM, 2005, ANN BIOMED ENG, V33, P1719, DOI 10.1007/s10439-005-8775-z; Tavana H, 2011, BIOMED MICRODEVICES, V13, P731, DOI 10.1007/s10544-011-9543-5; Tavana H, 2010, LANGMUIR, V26, P3744, DOI 10.1021/la903038a; Thuenauer R, 2014, ANALYST, V139, P3206, DOI 10.1039/c4an00056k; Trieu D, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4901930; Van Itallie CM, 2010, J CELL SCI, V123, P2844, DOI 10.1242/jcs.065581; Wagner I, 2013, LAB CHIP, V13, P3538, DOI 10.1039/c3lc50234a; Wang W, 2014, LAB CHIP, V14, P677, DOI 10.1039/c3lc51208h; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	32	29	30	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139872	10.1371/journal.pone.0139872	http://dx.doi.org/10.1371/journal.pone.0139872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436734	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000362499200065
J	da Silva, FC; Ferreira, JRD; Torrezan, GT; Figueiredo, MCP; Santos, EMM; Nakagawa, WT; Brianese, RC; de Oliveira, LP; Begnani, MD; Aguiar, S; Rossi, BM; Ferreira, FD; Carraro, DM				da Silva, Felipe Carneiro; de Oliveira Ferreira, Jose Roberto; Torrezan, Giovana Tardin; Pena Figueiredo, Marcia Cristina; Monteiro Santos, Erika Maria; Nakagawa, Wilson Toshihiko; Brianese, Rafael Canfield; de Oliveira, Ligia Petrolini; Begnani, Maria Dirlei; Aguiar-Junior, Samuel; Rossi, Benedito Mauro; Ferreira, Fabio de Oliveira; Carraro, Dirce Maria			Clinical and Molecular Characterization of Brazilian Patients Suspected to Have Lynch Syndrome	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; DNA MISMATCH REPAIR; MSH6 GERMLINE MUTATIONS; MICROSATELLITE INSTABILITY; ENDOMETRIAL CANCERS; BETHESDA GUIDELINES; MLH1 VARIANTS; MUTL HOMOLOG; COLON-CANCER; DEFICIENCY	Lynch syndrome (LS) accounts for 3-5% of all colorectal cancers (CRC) and is inherited in an autosomal dominant fashion. This syndrome is characterized by early CRC onset, high incidence of tumors in the ascending colon, excess of synchronous/metachronous tumors and extra-colonic tumors. Nowadays, LS is regarded of patients who carry deleterious germline mutations in one of the five mismatch repair genes (MMR), mostly in MLH1 and MSH2, but also in MSH6, PMS1 and PMS2. To comprehensively characterize 116 Brazilian patients suspected for LS, we assessed the frequency of germline mutations in the three minor genes MSH6, PMS1 and PMS2 in 82 patients negative for point mutations in MLH1 and MSH2. We also assessed large genomic rearrangements by MLPA for detecting copy number variations (CNVs) in MLH1, MSH2 and MSH6 generating a broad characterization of MMR genes. The complete analysis of the five MMR genes revealed 45 carriers of pathogenic mutations, including 25 in MSH2, 15 in MLH1, four in MSH6 and one in PMS2. Eleven novel pathogenic mutations (6 in MSH2, 4 in MSH6 and one in PMS2), and 11 variants of unknown significance (VUS) were found. Mutations in the MLH1 and MSH2 genes represented 89% of all mutations (40/45), whereas the three MMR genes (MSH6, PMS1 and PMS2) accounted for 11% (5/45). We also investigated the MLH1 p. Leu676Pro VUS located in the PMS2 interaction domain and our results revealed that this variant displayed no defective function in terms of cellular location and heterodimer interaction. Additionally, we assessed the tumor phenotype of a subset of patients and also the frequency of CRC and extra-colonic tumors in 2,365 individuals of the 116 families, generating the first comprehensive portrait of the genetic and clinical aspects of patients suspected of LS in a Brazilian cohort.	[da Silva, Felipe Carneiro; de Oliveira Ferreira, Jose Roberto; Torrezan, Giovana Tardin; Pena Figueiredo, Marcia Cristina; Brianese, Rafael Canfield; Carraro, Dirce Maria] AC Camargo Canc Ctr, Int Res Ctr CIPE, Lab Genom & Mol Biol, Sao Paulo, Brazil; [Monteiro Santos, Erika Maria; Nakagawa, Wilson Toshihiko; de Oliveira, Ligia Petrolini; Aguiar-Junior, Samuel; Rossi, Benedito Mauro; Ferreira, Fabio de Oliveira] AC Camargo Canc Ctr, Dept Colorectal Tumors, Sao Paulo, Brazil; [Begnani, Maria Dirlei] AC Camargo Canc Ctr, Dept Anat Pathol, Sao Paulo, Brazil; [Carraro, Dirce Maria] Natl Inst Sci & Technol Oncogen INCITO, Sao Paulo, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center	Carraro, DM (corresponding author), AC Camargo Canc Ctr, Int Res Ctr CIPE, Lab Genom & Mol Biol, Sao Paulo, Brazil.	dirce.carraro@cipe.accamargo.org.br	Silva, Felipe/B-2943-2011; Ferreira, Jose Roberto de Oliveira/D-6451-2013; Ferreira, Fabio/E-7942-2018; Junior, Samuel Aguiar/A-7388-2011; de Oliveira, Ligia Petrolini/B-1143-2012; carraro, dirce/C-9179-2009; Brianese, Rafael Canfield/P-3153-2019; TORREZAN, GIOVANA/AAB-9992-2020; torrezan, giovana T/F-6126-2012; Rossi, Mauro/R-1715-2019; , Erika/H-1654-2012	Silva, Felipe/0000-0002-4241-3036; Ferreira, Jose Roberto de Oliveira/0000-0002-1503-9528; Ferreira, Fabio/0000-0002-5340-2578; Junior, Samuel Aguiar/0000-0003-3476-727X; de Oliveira, Ligia Petrolini/0000-0002-7315-3062; carraro, dirce/0000-0001-5667-1418; Brianese, Rafael Canfield/0000-0003-1724-9024; torrezan, giovana T/0000-0002-8659-5329; Rossi, Mauro/0000-0002-0252-4321; , Erika/0000-0002-7315-9843	Fundacao de Amparo a pesquisa do estado de Sao Paulo [2008/57887-9]; Conselho Nacional de Ciencia e Tecnologia [408833/2006-8]	Fundacao de Amparo a pesquisa do estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Ciencia e Tecnologia	Support was provided by Fundacao de Amparo a pesquisa do estado de Sao Paulo, grant number 2008/57887-9, [http://www.fapesp.br/], DMC; Conselho Nacional de Ciencia e Tecnologia, grant number 408833/2006-8, [http://cnpq.br/], BMR.	Baglietto L, 2010, JNCI-J NATL CANCER I, V102, P193, DOI 10.1093/jnci/djp473; Boland CR, 2008, FAM CANCER, V7, P41, DOI 10.1007/s10689-007-9145-9; Borras E, 2012, HUM MUTAT, V33, P1576, DOI 10.1002/humu.22142; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Buttin BM, 2004, AM J HUM GENET, V74, P1262, DOI 10.1086/421332; Cederquist K, 2004, INT J CANCER, V109, P370, DOI 10.1002/ijc.11718; Chadwick R B, 2000, Hum Mutat, V16, P530; Clendenning M, 2006, HUM MUTAT, V27, P490, DOI 10.1002/humu.20318; Felton KEA, 2007, CLIN GENET, V71, P483, DOI 10.1111/j.1399-0004.2007.00803.x; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Haraldsdottir S, 2014, GASTROENTEROLOGY, V147, P1308, DOI 10.1053/j.gastro.2014.08.041; Hayward BE, 2007, HUM MUTAT, V28, P424, DOI 10.1002/humu.20457; Hendriks YMC, 2004, GASTROENTEROLOGY, V127, P17, DOI 10.1053/j.gastro.2004.03.068; Hinrichsen I, 2013, CLIN CANCER RES, V19, P2432, DOI 10.1158/1078-0432.CCR-12-3299; Jenkins MA, 2009, SURG ONCOL CLIN N AM, V18, P625, DOI 10.1016/j.soc.2009.07.007; Kosinski J, 2010, HUM MUTAT, V31, P975, DOI 10.1002/humu.21301; Kovacs ME, 2009, HUM MUTAT, V30, P197, DOI 10.1002/humu.20942; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Lotsari JE, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3205; Lynch HT, 2006, EUR J HUM GENET, V14, P390, DOI 10.1038/sj.ejhg.5201584; Medina-Arana V, 2012, J SURG ONCOL, V106, P10, DOI 10.1002/jso.23054; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Moreira L, 2015, CANCER-AM CANCER SOC, V121, P1395, DOI 10.1002/cncr.29190; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Park JG, 1999, INT J CANCER, V82, P516, DOI 10.1002/(SICI)1097-0215(19990812)82:4<516::AID-IJC8>3.0.CO;2-U; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Perez-Cabornero L, 2011, CANCER PREV RES, V4, P1556, DOI 10.1158/1940-6207.CAPR-11-0080; Pineda M, 2015, CLIN GENET, V87, P543, DOI 10.1111/cge.12467; Plaschke J, 2004, J CLIN ONCOL, V22, P4486, DOI 10.1200/JCO.2004.02.033; Ripperger T, 2010, HAEMATOL-HEMATOL J, V95, P841, DOI 10.3324/haematol.2009.015503; RodriguezBigas MA, 1997, J NATL CANCER I, V89, P1758, DOI 10.1093/jnci/89.23.1758; Serrano M, 2012, FAM CANCER, V11, P571, DOI 10.1007/s10689-012-9550-6; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; ten Broeke SW, 2015, J CLIN ONCOL, V33, P319, DOI 10.1200/JCO.2014.57.8088; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Valentin MD, 2011, FAM CANCER, V10, P641, DOI 10.1007/s10689-011-9461-y; Vasen HFA, 2013, GUT, V62, P812, DOI 10.1136/gutjnl-2012-304356; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2001, J MED GENET, V38, P318, DOI 10.1136/jmg.38.5.318; Wimmer K, 2014, J MED GENET, V51, P355, DOI 10.1136/jmedgenet-2014-102284; Win AK, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3405; Win AK, 2012, JNCI-J NATL CANCER I, V104, P1363, DOI 10.1093/jnci/djs351	44	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139753	10.1371/journal.pone.0139753	http://dx.doi.org/10.1371/journal.pone.0139753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26437257	Green Published, gold, Green Submitted			2022-12-27	WOS:000362499200059
J	Petersen, J; Austin, D; Mattek, N; Kaye, J				Petersen, Johanna; Austin, Daniel; Mattek, Nora; Kaye, Jeffrey			Time Out-of-Home and Cognitive, Physical, and Emotional Wellbeing of Older Adults: A Longitudinal Mixed Effects Model	PLOS ONE			English	Article							UCLA LONELINESS SCALE; LIFE-SPACE; IMPAIRMENT; MOBILITY; DECLINE; PARTICIPATION; ASSOCIATIONS; AMERICAN; VALIDITY; WEATHER	Background Time out-of-home has been linked with numerous health outcomes, including cognitive decline, poor physical ability and low emotional state. Comprehensive characterization of this important health metric would potentially enable objective monitoring of key health outcomes. The objective of this study is to determine the relationship between time out-of-home and cognitive status, physical ability and emotional state. Methods and Findings Participants included 85 independent older adults, age 65-96 years (M = 86.36; SD = 6.79) who lived alone, from the Intelligent Systems for Assessing Aging Changes (ISAAC) and the ORCATECH Life Laboratory cohorts. Factors hypothesized to affect time out-of-home were assessed on three different temporal levels: yearly (cognitive status, loneliness, clinical walking speed), weekly (pain and mood) or daily (time out-of-home, in-home walking speed, weather, and season). Subject characteristics including age, race, and gender were assessed at baseline. Total daily time out-of-home in hours was assessed objectively and unobtrusively for up to one year using an in-home activity sensor platform. A longitudinal tobit mixed effects regression model was used to relate daily time out-of-home to cognitive status, physical ability and emotional state. More hours spend outside the home was associated with better cognitive function as assessed using the Clinical Dementia Rating (CDR) Scale, where higher scores indicate lower cognitive function (beta(CDR) = -1.69, p < 0.001). More hours outside the home was also associated with superior physical ability (beta(Pain) = -0.123, p < 0.001) and improved emotional state (beta(Lonely) = -0.046, p < 0.001; beta(Low mood) = -0.520, p < 0.001). Weather, season, and weekday also affected the daily time out-of-home. Conclusions These results suggest that objective longitudinal monitoring of time out-of-home may enable unobtrusive assessment of cognitive, physical and emotional state. In addition, these results indicate that the factors affecting out-of-home behavior are complex, with factors such as living environment, weather and season significantly affecting time out-of-home. Studies investigating the relationship between time out-of-home and health outcomes may be optimized by taking into account the environment and life factors presented here.	[Petersen, Johanna] Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA; [Austin, Daniel; Mattek, Nora; Kaye, Jeffrey] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Petersen, J (corresponding author), Oregon Hlth & Sci Univ, Dept Biomed Engn, Portland, OR 97201 USA.	peterjo@ohsu.edu			National Institutes of Health [P30AG024978, R01AG024059, P30AG008017]; Intel Corporation; NATIONAL INSTITUTE ON AGING [R01AG024059, P30AG008017, R01AG042191, P30AG024978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intel Corporation(Intel Corporation); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors gratefully acknowledge the funding sources for this research: grants from the National Institutes of Health (P30AG024978 JK, R01AG024059 JK, P30AG008017 JK) and the Intel Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P., 2012, CAN YOU SAFELY IGNOR; Austin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090256; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Cacioppo JT, 2002, PSYCHOL SCI, V13, P384, DOI 10.1111/j.0956-7976.2002.00469.x; Cress ME, 2011, GERONTOLOGY, V57, P287, DOI 10.1159/000322195; Crowe M, 2008, J GERONTOL A-BIOL, V63, P1241, DOI 10.1093/gerona/63.11.1241; Denissen JJA, 2008, EMOTION, V8, P662, DOI 10.1037/a0013497; Dodge HH, 2012, NEUROLOGY, V78, P1946, DOI 10.1212/WNL.0b013e318259e1de; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gagliardi C, 2010, ARCH GERONTOL GERIAT, V50, P42, DOI 10.1016/j.archger.2009.01.007; Hagler S, 2010, IEEE T BIO-MED ENG, V57, P813, DOI 10.1109/TBME.2009.2036732; Heyl V, 2005, SOC INDIC RES, V74, P159, DOI 10.1007/s11205-005-6522-3; James BD, 2011, AM J GERIAT PSYCHIAT, V19, P961, DOI 10.1097/JGP.0b013e318211c219; Kaspar R, 2015, J APPL GERONTOL, V34, P26, DOI 10.1177/0733464812466290; Kaye J, 2014, ALZHEIMERS DEMENT, V10, P10, DOI 10.1016/j.jalz.2013.01.011; Kaye J, 2012, GAIT POSTURE, V35, P197, DOI 10.1016/j.gaitpost.2011.09.006; Kaye JA, 2011, J GERONTOL B-PSYCHOL, V66, P180, DOI [10.1093/geronb/ghq095, 10.1093/geronb/gbq095]; Leech JA, 2002, J EXPO ANAL ENV EPID, V12, P427, DOI 10.1038/sj.jea.7500244; Levasseur M, 2011, ARCH PHYS MED REHAB, V92, P1979, DOI 10.1016/j.apmr.2011.06.035; MCDONALD JF, 1980, REV ECON STAT, V62, P318, DOI 10.2307/1924766; McKenna K, 2007, AUST OCCUP THER J, V54, P273, DOI 10.1111/j.1440-1630.2007.00642.x; Molin J, 1996, J AFFECT DISORDERS, V37, P151, DOI 10.1016/0165-0327(95)00090-9; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mukamal KJ, 2009, NEUROLOGY, V72, P922, DOI 10.1212/01.wnl.0000344152.56020.94; Petersen J, 2013, BIOMETRIKA, P1; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; RONCEK DW, 1992, AM SOCIOL REV, V57, P503, DOI 10.2307/2096097; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Shoval N, 2011, AGEING SOC, V31, P849, DOI 10.1017/S0144686X10001455; Suzuki T, 2010, TELEMED J E-HEALTH, V16, P686, DOI 10.1089/tmj.2009.0175; Thielke SM, 2014, J AM GERIATR SOC, V62, P685, DOI 10.1111/jgs.12744; Tunstall J, 1966, OLD ALONE SOCIOLOGIC; Twisk J, 2009, J CLIN EPIDEMIOL, V62, P953, DOI 10.1016/j.jclinepi.2008.10.003; U.S. Naval Observatory AAD, 2013, SUN MOOM RIS SET TAB; Wahl HW, 2013, J GERONTOL B-PSYCHOL, V68, P691, DOI 10.1093/geronb/gbs106; Webber SC, 2010, GERONTOLOGIST, V50, P443, DOI 10.1093/geront/gnq013; Wettstein M, 2015, J APPL GERONTOL, V34, P3, DOI 10.1177/0733464812459373; Ziegler F, 2011, AGEING SOC, V31, P758, DOI 10.1017/S0144686X10000498	39	20	20	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0139643	10.1371/journal.pone.0139643	http://dx.doi.org/10.1371/journal.pone.0139643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CT0PR	26437228	gold, Green Submitted, Green Published			2022-12-27	WOS:000362499200041
J	Ali, R; Apte, S; Vilalta, M; Subbarayan, M; Miao, Z; Chin, FT; Graves, EE				Ali, Rehan; Apte, Sandeep; Vilalta, Marta; Subbarayan, Murugesan; Miao, Zheng; Chin, Frederick T.; Graves, Edward E.			F-18-EF5 PET Is Predictive of Response to Fractionated Radiotherapy in Preclinical Tumor Models	PLOS ONE			English	Article							RADIATION RESPONSE; EF5 BINDING; HYPOXIA; CANCER; TRACER; CELLS	We evaluated the relationship between pre-treatment positron emission tomography (PET) using the hypoxic tracer F-18-[2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] (F-18-EF5) and the response of preclinical tumor models to a range of fractionated radiotherapies. Subcutaneous HT29, A549 and RKO tumors grown in nude mice were imaged using F-18-EF5 positron emission tomography (PET) in order to characterize the extent and heterogeneity of hypoxia in these systems. Based on these results, 80 A549 tumors were subsequently grown and imaged using F-18-EF5 PET, and then treated with one, two, or four fraction radiation treatments to a total dose of 10-40 Gy. Response was monitored by serial caliper measurements of tumor volume. Longitudinal post-treatment F-18-EF5 PET imaging was performed on a subset of tumors. Terminal histologic analysis was performed to validate F-18-EF5 PET measures of hypoxia. EF5-positive tumors responded more poorly to low dose single fraction irradiation relative to EF5-negative tumors, however both groups responded similarly to larger single fraction doses. Irradiated tumors exhibited reduced F-18-EF5 uptake one month after treatment compared to control tumors. These findings indicate that pre-treatment F-18-EF5 PET can predict the response of tumors to single fraction radiation treatment. However, increasing the number of fractions delivered abrogates the difference in response between tumors with high and low EF5 uptake pre-treatment, in agreement with traditional radiobiology.	[Ali, Rehan; Apte, Sandeep; Vilalta, Marta; Graves, Edward E.] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Subbarayan, Murugesan; Miao, Zheng; Chin, Frederick T.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Graves, EE (corresponding author), Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA.	egraves@stanford.edu		Graves, Edward/0000-0003-4265-9041	NIH/NCI [R01 CA131199]; NIH [R25 CA118681]; Varian Biosynergy; NATIONAL CANCER INSTITUTE [R25CA118681, R01CA131199] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Varian Biosynergy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NCI R01 CA131199: Supported execution of the experiments and salary for RA, SA, MV, and EEG. NIH R25 CA118681: Supported salary for RA. Varian Biosynergy: Supported execution of the experiments and salary for RA, SA, and EEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazalova M, 2014, MED PHYS, V41, DOI 10.1118/1.4842415; Beck R, 2007, J NUCL MED, V48, P973, DOI 10.2967/jnumed.106.038570; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Busk M, 2013, EUR J NUCL MED MOL I, V40, P186, DOI 10.1007/s00259-012-2258-x; Cairns RA, 2009, CLIN CANCER RES, V15, P7170, DOI 10.1158/1078-0432.CCR-09-1676; Carlson DJ, 2011, INT J RADIAT ONCOL, V79, P1188, DOI 10.1016/j.ijrobp.2010.10.007; Chitneni SK, 2013, J NUCL MED, V54, P1339, DOI 10.2967/jnumed.112.116293; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Evans SM, 2000, CANCER RES, V60, P2018; Finger EC, 2010, CANCER METAST REV, V29, P285, DOI 10.1007/s10555-010-9224-5; Graves EE, 2007, TECHNOL CANCER RES T, V6, P111, DOI 10.1177/153303460700600207; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Jenkins WT, 2000, INT J RADIAT ONCOL, V46, P1005, DOI 10.1016/S0360-3016(99)00342-9; KALLMAN RF, 1972, RADIOLOGY, V105, P135, DOI 10.1148/105.1.135; Koch CJ, 2009, INT J RADIAT BIOL, V85, P1137, DOI 10.3109/09553000903242172; Komar G, 2008, J NUCL MED, V49, P1944, DOI 10.2967/jnumed.108.053785; LORD EM, 1993, CANCER RES, V53, P5721; Tran LBA, 2012, RADIOTHER ONCOL, V105, P29, DOI 10.1016/j.radonc.2012.04.011; Mortensen LS, 2011, RADIOTHER ONCOL, V99, P418, DOI 10.1016/j.radonc.2011.06.034; Oehler C, 2011, J NUCL MED, V52, P437, DOI 10.2967/jnumed.110.081372; Ziemer LS, 2003, EUR J NUCL MED MOL I, V30, P259, DOI 10.1007/s00259-002-1037-5	23	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139425	10.1371/journal.pone.0139425	http://dx.doi.org/10.1371/journal.pone.0139425			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431331	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700056
J	Gernand, AD; Schulze, KJ; Nanayakkara-Bind, A; Arguello, M; Shamim, AA; Ali, H; Wu, L; West, KP; Christian, P				Gernand, Alison D.; Schulze, Kerry J.; Nanayakkara-Bind, Ashika; Arguello, Margia; Shamim, Abu Ahmed; Ali, Hasmot; Wu, Lee; West, Keith P., Jr.; Christian, Parul			Effects of Prenatal Multiple Micronutrient Supplementation on Fetal Growth Factors: A Cluster-Randomized, Controlled Trial in Rural Bangladesh	PLOS ONE			English	Article							PLACENTAL-LACTOGEN EXPRESSION; BIRTH-WEIGHT; IGF-I; PREGNANCY; OUTCOMES; ACID; ZINC	Prenatal multiple micronutrient (MM) supplementation improves birth weight through increased fetal growth and gestational age, but whether maternal or fetal growth factors are involved is unclear. Our objective was to examine the effect of prenatal MM supplementation on intrauterine growth factors and the associations between growth factors and birth outcomes in a rural setting in Bangladesh. In a double-blind, cluster-randomized, controlled trial of MM vs. iron and folic acid (IFA) supplementation, we measured placental growth hormone (PGH) at 10 weeks and PGH and human placental lactogen (hPL) at 32 weeks gestation in maternal plasma (n = 396) and insulin, insulin-like growth factor-1 (IGF-1), and IGF binding protein-1 (IGFBP-1) in cord plasma (n = 325). Birth size and gestational age were also assessed. Early pregnancy mean (SD) BMI was 19.5 (2.4) kg/m(2) and birth weight was 2.68 (0.41) kg. There was no effect of MM on concentrations of maternal hPL or PGH, or cord insulin, IGF-1, or IGFBP-1. However, among pregnancies of female offspring, hPL concentration was higher by 1.1 mg/L in the third trimester (95% CI: 0.2, 2.0 mg/L; p = 0.09 for interaction); and among women with height < 145 cm, insulin was higher by 59% (95% CI: 3, 115%; p = 0.05 for interaction) in the MM vs. IFA group. Maternal hPL and cord blood insulin and IGF-1 were positively, and IGFBP-1 was negatively, associated with birth weight z score and other measures of birth size (all p < 0.05). IGF-1 was inversely associated with gestational age (p < 0.05), but other growth factors were not associated with gestational age or preterm birth. Prenatal MM supplementation had no overall impact on intrauterine growth factors. MM supplementation altered some growth factors differentially by maternal early pregnancy nutritional status and sex of the offspring, but this should be examined in other studies.	[Gernand, Alison D.; Schulze, Kerry J.; Nanayakkara-Bind, Ashika; Arguello, Margia; Wu, Lee; West, Keith P., Jr.; Christian, Parul] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA; [Gernand, Alison D.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Shamim, Abu Ahmed; Ali, Hasmot] JiVitA Project, Gaibandha, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Christian, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA.	pchristi@jhsph.edu	Gernand, Alison/W-8158-2019; Ali, Hasmot/I-8700-2019	Gernand, Alison/0000-0002-5661-7785; Ali, Hasmot/0000-0003-0044-1992; Abu Ahmed, Shamim/0000-0002-7071-8558	Bill and Melinda Gates Foundation, Seattle, WA, USA [GHOPP614]; Thrasher Research Fund [9179]; Sight and Life Research Institute, Baltimore, MD; National Institutes of Health [T32HD046405]; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH [K12HD055882]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD055882] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046405] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation, Seattle, WA, USA(Bill & Melinda Gates Foundation); Thrasher Research Fund; Sight and Life Research Institute, Baltimore, MD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The parent trial and field data collection for the substudy was funded through Grant GHOPP614 (Global Control of Micronutrient Deficiency) from the Bill and Melinda Gates Foundation, Seattle, WA, USA (http://www.gatesfoundation.org/). The laboratory study and analysis of maternal and fetal growth factors was funded by Thrasher Research Fund grant award 9179 (https://www.thrasherresearch.org/default.aspx). DSM N.V., Kaiseraugst Switzerland provided micronutrient premixes and tested supplement potency throughout the trial gratis. Beximco Pharmaceuticals, Ltd, Dhaka produced, bottled, labeled and delivered to the field site gratis. Additional support was received from the Sight and Life Research Institute, Baltimore, MD. National Institutes of Health grant T32HD046405 provided doctoral support to ADG. Dr. Gernand's research is supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the NIH under BIRCWH award number K12HD055882, "Career Development Program in Women's Health Research at Penn State." The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram SK, 2008, ACTA PAEDIATR, V97, P1443, DOI 10.1111/j.1651-2227.2008.00930.x; Ameri P, 2013, CLIN ENDOCRINOL, V79, P457, DOI 10.1111/cen.12268; Boyne MS, 2003, J CLIN ENDOCR METAB, V88, P1687, DOI 10.1210/jc.2002-020633; Chimienti F, 2013, NUTR RES REV, V26, P1, DOI 10.1017/S0954422412000212; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Fall CHD, 2009, FOOD NUTR BULL, V30, pS533, DOI 10.1177/15648265090304S408; Fuglsang J, 2006, GROWTH HORM IGF RES, V16, P67, DOI 10.1016/j.ghir.2006.03.010; Gernand AD, 2013, AM J CLIN NUTR, V98, P383, DOI 10.3945/ajcn.112.055426; Gernand AD, 2012, J NUTR, V142, P2010, DOI 10.3945/jn.112.163634; Gernand AD, 2012, J NUTR, V142, P1109, DOI 10.3945/jn.111.155978; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gray B, 2011, NUTR REV, V69, P155, DOI 10.1111/j.1753-4887.2011.00377.x; Haider BA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004905.pub3; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; MIRLESSE V, 1993, PEDIATR RES, V34, P439, DOI 10.1203/00006450-199310000-00011; Moller UK, 2013, OSTEOPOROSIS INT, V24, P1307, DOI 10.1007/s00198-012-2062-2; Murphy VE, 2006, ENDOCR REV, V27, P141, DOI 10.1210/er.2005-0011; Ong S, 2000, BEST PRACT RES CL OB, V14, P969, DOI 10.1053/beog.2000.0138; Ozaki T, 2001, J PHYSIOL-LONDON, V530, P141, DOI 10.1111/j.1469-7793.2001.0141m.x; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P153, DOI 10.1111/j.1365-3016.2012.01276.x; Ravelli ACJ, 1999, AM J CLIN NUTR, V70, P811; Roberfroid D, 2010, AM J CLIN NUTR, V91, P1649, DOI 10.3945/ajcn.2009.28855; STEPHANOU A, 1995, ENDOCRINOLOGY, V136, P933, DOI 10.1210/en.136.3.933; STEPHANOU A, 1994, ENDOCRINOLOGY, V135, P2651, DOI 10.1210/en.135.6.2651; UNICEF/ WHO/UNU, 1999, COMP MULT SUPPL BE U; Watson CS, 2006, ENDOCRINOLOGY, V147, P1175, DOI 10.1210/en.2005-0606; West KP, 2014, JAMA-J AM MED ASSOC, V312, P2649, DOI 10.1001/jama.2014.16819	30	10	10	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0137269	10.1371/journal.pone.0137269	http://dx.doi.org/10.1371/journal.pone.0137269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431336	Green Published, gold, Green Submitted			2022-12-27	WOS:000362178700007
J	Mayne, R; Adamatzky, A				Mayne, Richard; Adamatzky, Andrew			On the Computing Potential of Intracellular Vesicles	PLOS ONE			English	Article							PHYSARUM-POLYCEPHALUM; MECHANICAL-PROPERTIES; IN-VITRO; ACTIN; TRANSPORT; BINDING; MICROSCOPY; DIFFUSION; CELLS	Collision-based computing (CBC) is a form of unconventional computing in which travelling localisations represent data and conditional routing of signals determines the output state; collisions between localisations represent logical operations. We investigated patterns of Ca2+-containing vesicle distribution within a live organism, slime mould Physarum polycephalum, with confocal microscopy and observed them colliding regularly. Vesicles travel down cytoskeletal 'circuitry' and their collisions may result in reflection, fusion or annihilation. We demonstrate through experimental observations that naturally-occurring vesicle dynamics may be characterised as a computationally-universal set of Boolean logical operations and present a 'vesicle modification' of the archetypal CBC 'billiard ball model' of computation. We proceed to discuss the viability of intracellular vesicles as an unconventional computing substrate in which we delineate practical considerations for reliable vesicle 'programming' in both in vivo and in vitro vesicle computing architectures and present optimised designs for both single logical gates and combinatorial logic circuits based on cytoskeletal network conformations. The results presented here demonstrate the first characterisation of intracelluar phenomena as collision-based computing and hence the viability of biological substrates for computing.	[Mayne, Richard; Adamatzky, Andrew] Univ W England, Unconvent Comp Grp, Fac Environm & Technol, Bristol BS16 1QY, Avon, England	University of West England	Mayne, R (corresponding author), Univ W England, Unconvent Comp Grp, Fac Environm & Technol, Bristol BS16 1QY, Avon, England.	richard.mayne@uwe.ac.uk		Mayne, Richard/0000-0003-1915-4993	EU commission seventh framework program [316366]	EU commission seventh framework program	This work was funded by EU commission seventh framework program, grant number 316366, project name "Physarum chip (Phychip): growing computers from slime mould" (http://www.phychip.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH F, 1984, J HISTOCHEM CYTOCHEM, V32, P1177, DOI 10.1177/32.11.6386974; Adamatzky A, 2007, NATURWISSENSCHAFTEN, V94, P975, DOI 10.1007/s00114-007-0276-5; Adamatzky A, 2011, INT J BIFURCAT CHAOS, V21, P3083, DOI 10.1142/S0218127411030611; Alexopoulos C, 1982, CELL BIOL SERIES MON, V1; Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Baluska F, 2005, TRENDS PLANT SCI, V10, P106, DOI 10.1016/j.tplants.2005.01.002; Berridge MJ, 2004, BBA-MOL CELL RES, V1742, P3, DOI 10.1016/j.bbamcr.2004.08.012; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; DESNOS C, 1995, J CELL BIOL, V130, P1041, DOI 10.1083/jcb.130.5.1041; Duirand-Lose J, 2002, COLLISION BASED COMP; Egelman DM, 1998, J NEUROSCI, V18, P8580; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; FREDKIN E, 1982, INT J THEOR PHYS, V21, P219, DOI 10.1007/BF01857727; Gunji YP, 2011, COMPLEX SYST, V20, P93, DOI 10.25088/ComplexSystems.20.2.93; Hentschel HGE, 2004, MATH BIOSCI ENG, V1, P147, DOI 10.3934/mbe.2004.1.147; HOLMES RP, 1979, J GEN MICROBIOL, V113, P275, DOI 10.1099/00221287-113-2-275; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Kikushima K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01913; Kim SH, 2009, BBA-BIOMEMBRANES, V1788, P2150, DOI 10.1016/j.bbamem.2009.08.001; KURODA R, 1980, J CELL SCI, V44, P75; Lala P. K., 2010, WSEAS Transactions on Circuits and Systems, V9, P369; LIN EC, 1993, BIOPHYS J, V65, P1371, DOI 10.1016/S0006-3495(93)81188-3; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; MARGOLUS N, 1984, PHYSICA D, V10, P81, DOI 10.1016/0167-2789(84)90252-5; Margolus N, 2002, COLLISION BASED COMP; Matosevic S, 2011, J AM CHEM SOC, V133, P2798, DOI 10.1021/ja109137s; Mayne R., 2014, COMMUNICATIVE INTEGR, V7; Mayne R, 2015, NANO LIFE, V5, DOI 10.1142/S179398441450007X; Pak CW, 2008, NAT REV NEUROSCI, V9, P136, DOI 10.1038/nrn2236; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Soga H, 2014, ACS SYNTH BIOL, V3, P372, DOI 10.1021/sb400094c; SOLL DR, 1990, DEV GENET, V11, P341, DOI 10.1002/dvg.1020110505; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Toffoli T., 1980, Automata, Languages and Programming, Seventh Colloquium, P632; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VANDERSLUIJS P, 1990, J CELL SCI, V95, P545; Vinzenz M, 2012, J CELL SCI, V125, P2775, DOI 10.1242/jcs.107623; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106132; Yoshiyama S, 2010, CELL BIOL INT, V34, P35, DOI 10.1042/CBI20090158	41	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139617	10.1371/journal.pone.0139617	http://dx.doi.org/10.1371/journal.pone.0139617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431435	Green Submitted, Green Published, gold			2022-12-27	WOS:000362178700085
J	Qu, RJ; Feng, MB; Wang, XH; Huang, QG; Lu, JH; Wang, LS; Wang, ZY				Qu, Ruijuan; Feng, Mingbao; Wang, Xinghao; Huang, Qingguo; Lu, Junhe; Wang, Liansheng; Wang, Zunyao			Rapid Removal of Tetrabromobisphenol A by Ozonation in Water: Oxidation Products, Reaction Pathways and Toxicity Assessment	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; BROMATE FORMATION; RATE CONSTANTS; AQUEOUS-SOLUTION; DRINKING-WATER; DEGRADATION; KINETICS; MECHANISM; BROMIDE; TBBPA	Tetrabromobisphenol A (TBBPA) is one of the most widely used brominated flame retardants and has attracted more and more attention. In this work, the parent TBBPA with an initial concentration of 100 mg/L was completely removed after 6 min of ozonation at pH 8.0, and alkaline conditions favored a more rapid removal than acidic and neutral conditions. The presence of typical anions and humic acid did not significantly affect the degradation of TBBPA. The quenching test using isopropanol indicated that direct ozone oxidation played a dominant role during this process. Seventeen reaction intermediates and products were identified using an electrospray time-of-flight mass spectrometer. Notably, the generation of 2,4,6-tribromophenol was first observed in the degradation process of TBBPA. The evolution of reaction products showed that ozonation is an efficient treatment for removal of both TBBPA and intermediates. Sequential transformation of organic bromine to bromide and bromate was confirmed by ion chromatography analysis. Two primary reaction pathways that involve cleavage of central carbon atom and benzene ring cleavage concomitant with debromination were thus proposed and further justified by calculations of frontier electron densities. Furthermore, the total organic carbon data suggested a low mineralization rate, even after the complete removal of TBBPA. Meanwhile, the acute aqueous toxicity of reaction solutions to Photobacterium Phosphoreum and Daphnia magna was rapidly decreased during ozonation. In addition, no obvious difference in the attenuation of TBBPA was found by ozone oxidation using different water matrices, and the effectiveness in natural waters further demonstrates that ozonation can be adopted as a promising technique to treat TBBPA-contaminated waters.	[Qu, Ruijuan; Feng, Mingbao; Wang, Xinghao; Wang, Liansheng; Wang, Zunyao] Nanjing Univ, State Key Lab Pollut Control & Resources Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China; [Huang, Qingguo] Univ Georgia, Coll Agr & Environm Sci, Dept Crop & Soil Sci, Griffin, GA USA; [Lu, Junhe] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China	Nanjing University; University System of Georgia; University of Georgia; Nanjing Agricultural University	Wang, ZY (corresponding author), Nanjing Univ, State Key Lab Pollut Control & Resources Reuse, Sch Environm, Nanjing 210008, Jiangsu, Peoples R China.	wangzy@nju.edu.cn	Qu, Ruijuan/AAG-6705-2021; Lu, Junhe/D-7658-2015; Feng, Mingbao/R-2627-2019; Wang, Xinghao/H-7914-2016; Wang, Zunyao/H-8526-2016	Lu, Junhe/0000-0001-6068-5820; Wang, Xinghao/0000-0001-6205-4889; Wang, Zunyao/0000-0002-7655-9244	National Natural Science Foundation of China [21377051]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07506-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of China	This research was financially supported by the National Natural Science Foundation of China (No. 21377051) and the Major Science and Technology Program for Water Pollution Control and Treatment of China (No. 2012ZX07506-001).	Al-Mousa F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033059; An TC, 2010, APPL CATAL B-ENVIRON, V94, P288, DOI 10.1016/j.apcatb.2009.12.002; Benitez FJ, 2007, WATER RES, V41, P4073, DOI 10.1016/j.watres.2007.05.041; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Colnot T, 2014, ARCH TOXICOL, V88, P553, DOI 10.1007/s00204-013-1180-8; Cruz R, 2015, ENVIRON INT, V77, P116, DOI 10.1016/j.envint.2015.01.001; Dang J, 2015, CHEMOSPHERE, V119, P387, DOI 10.1016/j.chemosphere.2014.07.001; Dantas RF, 2007, WATER RES, V41, P2525, DOI 10.1016/j.watres.2007.03.011; Dean JA., 1991, LANGES HDB CHEM, Veleventh; Ding YB, 2013, APPL CATAL B-ENVIRON, V129, P153, DOI 10.1016/j.apcatb.2012.09.015; Evans RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043606; Fang JY, 2012, ENVIRON SCI TECHNOL, V46, P8976, DOI 10.1021/es300658u; Feng MB, 2013, AQUAT TOXICOL, V140, P314, DOI 10.1016/j.aquatox.2013.07.001; Harrad S, 2009, ENVIRON SCI TECHNOL, V43, P9077, DOI 10.1021/es902185u; Horikoshi S, 2008, APPL CATAL B-ENVIRON, V84, P797, DOI 10.1016/j.apcatb.2008.06.023; Hu RP, 2015, APPL CATAL B-ENVIRON, V163, P510, DOI 10.1016/j.apcatb.2014.08.025; Benitez FJ, 2009, CHEMOSPHERE, V77, P53, DOI 10.1016/j.chemosphere.2009.05.035; Jin XH, 2012, WATER RES, V46, P6519, DOI 10.1016/j.watres.2012.09.026; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125213; Kuang JM, 2013, WATER RES, V47, P2863, DOI 10.1016/j.watres.2013.02.048; Kuiper RV, 2007, ARCH TOXICOL, V81, P1, DOI 10.1007/s00204-006-0117-x; Li YW, 2014, ENVIRON SCI TECHNOL, V48, P5008, DOI 10.1021/es405230j; Li ZB, 2015, WATER RES, V83, P132, DOI 10.1016/j.watres.2015.06.019; Lin KD, 2009, ENVIRON SCI TECHNOL, V43, P4480, DOI 10.1021/es803622t; Liu C, 2013, WATER RES, V47, P5307, DOI 10.1016/j.watres.2013.06.010; Liu C, 2012, WATER RES, V46, P5235, DOI 10.1016/j.watres.2012.07.005; Liu GB, 2009, J HAZARD MATER, V169, P1150, DOI 10.1016/j.jhazmat.2009.03.114; Luo S, 2010, CHEMOSPHERE, V79, P672, DOI 10.1016/j.chemosphere.2010.02.011; Miao HF, 2015, CHEMOSPHERE, V119, P326, DOI 10.1016/j.chemosphere.2014.06.082; Naushad M, 2013, CLEAN-SOIL AIR WATER, V41, P528, DOI 10.1002/clen.201200461; Niu JF, 2013, ENVIRON SCI TECHNOL, V47, P14341, DOI 10.1021/es402987t; Nyholm JR, 2010, ENVIRON POLLUT, V158, P2235, DOI 10.1016/j.envpol.2010.02.010; Ortuno N., 2011, ORGANOHALOGEN COMPOU, V73, P511; Ortuno N, 2014, ENVIRON POLLUT, V191, P31, DOI 10.1016/j.envpol.2014.04.006; Pang SY, 2014, ENVIRON SCI TECHNOL, V48, P615, DOI 10.1021/es4041094; Prasse C, 2012, ENVIRON SCI TECHNOL, V46, P2169, DOI 10.1021/es203712z; Rokhina EV, 2012, SCI TOTAL ENVIRON, V417, P280, DOI 10.1016/j.scitotenv.2011.12.008; Rosal R, 2009, J HAZARD MATER, V172, P1061, DOI 10.1016/j.jhazmat.2009.07.110; Sun XM, 2012, ENVIRON SCI TECHNOL, V46, P8148, DOI 10.1021/es301413v; Suzuki S, 2006, ANAL SCI, V22, P469, DOI 10.2116/analsci.22.469; Tay KS, 2012, MAEJO INT J SCI TECH, V6, P77; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; TOMIYASU H, 1985, INORG CHEM, V24, P2962, DOI 10.1021/ic00213a018; US EPA, 2006, NAT PRIM DRINK WAT R; von Gunten U, 2003, WATER RES, V37, P1469, DOI 10.1016/S0043-1354(02)00458-X; Wang XW, 2015, ENVIRON SCI TECHNOL, V49, P6683, DOI 10.1021/acs.est.5b00382; WHO, 2011, GUID DRINK WAT QUAL; Wu SM, 2016, ENVIRON TOXICOL, V31, P1241, DOI 10.1002/tox.22131; Yang SW, 2013, AQUAT TOXICOL, V142, P248, DOI 10.1016/j.aquatox.2013.08.013; Zhang J, 2012, ADV MATER RES-SWITZ, V383-390, P2945, DOI 10.4028/www.scientific.net/AMR.383-390.2945; Zhang QZ, 2014, ENVIRON SCI TECHNOL, V48, P5051, DOI 10.1021/es500453g; Zhong YH, 2012, WATER RES, V46, P4633, DOI 10.1016/j.watres.2012.06.025	52	29	31	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139580	10.1371/journal.pone.0139580	http://dx.doi.org/10.1371/journal.pone.0139580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26430733	Green Submitted, gold, Green Published			2022-12-27	WOS:000362178700080
J	Shi, XD; Yan, CH; Liu, BQ; Yang, CX; Nie, XD; Wang, XK; Zheng, JL; Wang, Y; Zhu, YL				Shi, Xiaodong; Yan, Chunhua; Liu, Baoquan; Yang, Chunxiao; Nie, Xuedan; Wang, Xiaokun; Zheng, Jiaolin; Wang, Yue; Zhu, Yulan			miR-381 Regulates Neural Stem Cell Proliferation and Differentiation via Regulating Hes1 Expression	PLOS ONE			English	Article							NEURONAL DIFFERENTIATION; SIGNALING PATHWAY; PROGENITOR CELLS; GASTRIC-CANCER; SELF-RENEWAL; APOPTOSIS; TARGETS; GROWTH; MICRORNA-381; PROGRESSION	Neural stem cells are self-renewing, multipotent and undifferentiated precursors that retain the capacity for differentiation into both glial (astrocytes and oligodendrocytes) and neuronal lineages. Neural stem cells offer cell-based therapies for neurological disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease and spinal cord injuries. However, their cellular behavior is poorly understood. MicroRNAs (miRNAs) are a class of small noncoding RNAs involved in cell development, proliferation and differentiation through regulating gene expression at post-transcriptional level. The role of miR-381 in the development of neural stem cells remains unknown. In this study, we showed that overexpression of miR-381 promoted neural stem cells proliferation. It induced the neural stem cells differentiation to neurons and inhibited their differentiation to astrocytes. Furthermore, we identified HES1 as a direct target of miR-381 in neural stem cells. Moreover, re-expression of HES1 impaired miR-381-induced promotion of neural stem cells proliferation and induce neural stem cells differentiation to neurons. In conclusion, miR-381 played important role in neural stem cells proliferation and differentiation.	[Shi, Xiaodong; Yang, Chunxiao; Nie, Xuedan; Wang, Xiaokun; Zheng, Jiaolin; Zhu, Yulan] Harbin Med Univ, Dept Neurol, Affiliated Hosp 2, Harbin 150081, Peoples R China; [Yan, Chunhua] Harbin Med Univ, Dept Resp, Affiliated Hosp 2, Harbin 150081, Peoples R China; [Liu, Baoquan] Harbin Med Univ, Dept Anat, Harbin 150081, Peoples R China; [Wang, Yue] Harbin Med Univ, Dept Occupat Hlth, Coll Publ Hlth, Harbin 150081, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhu, YL (corresponding author), Harbin Med Univ, Dept Neurol, Affiliated Hosp 2, Harbin 150081, Peoples R China.	yu1lan1@163.com	WANG, XIAOKUN/GQR-1904-2022					Aranha MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021396; Castella P, 1999, J NEUROSCI RES, V56, P229, DOI 10.1002/(SICI)1097-4547(19990501)56:3<229::AID-JNR2>3.0.CO;2-Z; Chen BH, 2013, CLINICS, V68, P825, DOI 10.6061/clinics/2013(06)17; Dailey DD, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-130; Dong RF, 2014, ONCOTARGET, V5, P10816, DOI 10.18632/oncotarget.2522; Garg N, 2013, EMBO J, V32, P2819, DOI 10.1038/emboj.2013.214; Gonzalez C, 2015, CURRENT STEM CELL RE; Hou CH, 2015, CELL PHYSIOL BIOCHEM, V36, P1753, DOI 10.1159/000430148; Huang J, 2014, CELL PROLIFERAT, V47, P277, DOI 10.1111/cpr.12109; Indulekha CL, 2012, CELL MOL LIFE SCI, V69, P611, DOI 10.1007/s00018-011-0765-8; Keohane A, 2010, MOL CELL NEUROSCI, V43, P127, DOI 10.1016/j.mcn.2009.10.003; Kobayashi T, 2015, FEBS J, V282, P2475, DOI 10.1111/febs.13290; Lee JB, 2013, BLOOD, V122, P1162, DOI 10.1182/blood-2012-12-471649; Lee YN, 2011, BLOOD, V117, P3629, DOI 10.1182/blood-2010-07-293548; Lei T, 2013, DOMEST ANIM ENDOCRIN, V45, P28, DOI 10.1016/j.domaniend.2013.03.003; Li J, 2014, CELL PROLIFERAT, V47, P152, DOI 10.1111/cpr.12093; Li M, 2013, CELL PROLIFERAT, V46, P223, DOI 10.1111/cpr.12013; Li SS, 2016, J BIOL PHYS, V42, P53, DOI 10.1007/s10867-015-9391-2; Li X, 2012, RNA BIOL, V9, P292, DOI 10.4161/rna.19100; Li Z, 2015, ONCOTARGET; Li Z, 2015, ONCOTARGET, V6, P17559, DOI 10.18632/oncotarget.2755; Li Z, 2015, ONCOTARGET, V6, P13914, DOI 10.18632/oncotarget.4227; Li Z, 2015, CELL PROLIFERAT, V48, P278, DOI 10.1111/cpr.12180; Li Z, 2015, GASTRIC CANCER, V18, P43, DOI 10.1007/s10120-014-0340-8; Lillycrop KA, 2015, INT J EPIDEMIOL, V44, P1263, DOI 10.1093/ije/dyv052; Liu S, 2014, J CELL BIOCHEM, V115, P1368, DOI 10.1002/jcb.24786; Lopez-Ramirez MA, 2014, EPIGENETICS-US, V9, P90, DOI 10.4161/epi.27536; Luo Y., 2014, BIOMED RES INT, V2014; Morgado AL, 2015, MOL NEUROBIOL, V51, P1168, DOI 10.1007/s12035-014-8794-6; Nakahara F, 2014, BLOOD, V123, P3932, DOI 10.1182/blood-2013-01-476747; Pfeuty B, 2015, DEVELOPMENT, V142, P477, DOI 10.1242/dev.112649; Pham JT, 2012, AM J STEM CELLS, V1, P182; Rolando C, 2014, CURR TOP DEV BIOL, V107, P183, DOI 10.1016/B978-0-12-416022-4.00007-X; Rossignol J, 2014, STEM CELLS, V32, P500, DOI 10.1002/stem.1508; Saurat N, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-14; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Tan SL, 2012, GENES CELLS, V17, P952, DOI 10.1111/gtc.12009; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084146; Tang HL, 2011, BRAIN RES, V1390, P21, DOI 10.1016/j.brainres.2011.03.034; Wang WH, 2014, INT J MOL MED, V34, P788, DOI 10.3892/ijmm.2014.1835; Xie Q, 2014, NEUROPATHOLOGY, V34, P455, DOI 10.1111/neup.12129; Yang Z, 2014, CELL PROLIFERAT, V47, P587, DOI 10.1111/cpr.12146; You Y, 2015, SPINE; Yu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091661; Yu X, 2015, ONCOTARGET; Yu X, 2015, CELL PROLIFERAT, V48, P271, DOI 10.1111/cpr.12179; Zhang Z, 2014, BRAIN RES, V1583, P65, DOI 10.1016/j.brainres.2014.07.037; Zhou S, 2015, AM J CANCER RES, V5, P267; Zhou Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.195; Zhu N, 2015, INT J CLIN EXP PATHO, V8, P6425	50	30	34	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138973	10.1371/journal.pone.0138973	http://dx.doi.org/10.1371/journal.pone.0138973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431046	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700026
J	Ying, LY; Wu, LH; Loke, AY				Ying, Li-Ying; Wu, Lai Har; Loke, Alice Yuen			The Experience of Chinese Couples Undergoing In Vitro Fertilization Treatment: Perception of the Treatment Process and Partner Support	PLOS ONE			English	Article							INFERTILE COUPLES; ASSISTED REPRODUCTION; QUALITATIVE-ANALYSIS; SPERM INJECTION; SOCIAL SUPPORT; HONG-KONG; FERTILITY; WOMEN; TIME; LIFE	Background Couples undergoing In Vitro Fertilization (IVF) Treatment suffer as dyads from the stressful experience of the painful treatment and the fear that the IVF cycle will fail. They are likely to report that their marital relationship has become unstable due to the prolonged period of treatment. Methods This is a qualitative study that was conducted to explore the experiences that Chinese couples have had with IVF treatment, especially their perceptions of the process and the support between couples. Results The interviews revealed that couples suffered from the process, experiencing physical and emotional pain, struggling with the urgency and inflexibility of bearing a child, and experiencing disturbances in their daily routines and work. The participants described how they endured the hardships as a couple and how it affected their relationship. The couples felt that sharing feelings and supporting each other contribute to psychological well-being and improves the marital relationship. They also identified some unfavorable aspects in their partner relationship. They were ambivalent about receiving social support from friends and family members. Conclusions With the couples indicating that the support that they received from each other affected their experience during the treatment process, it is suggested that a supportive intervention that focuses on enhancing the partnership of the couples and dealing with their inflexibility on the issue of bearing a child might result in improvements in the psychological status and marital relationship of infertile couples undergoing IVF treatment.	[Ying, Li-Ying; Wu, Lai Har; Loke, Alice Yuen] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China; [Ying, Li-Ying] Zhejiang Chinese Med Univ, Sch Nursing, Hangzhou, Zhejiang, Peoples R China	Hong Kong Polytechnic University; Zhejiang Chinese Medical University	Loke, AY (corresponding author), Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Hong Kong, Peoples R China.	alice.yuen.loke@polyu.edu.hk	LOKE, Alice Yuen/GRS-0462-2022	LOKE, Alice Yuen/0000-0002-0676-8139; Ying, Liying/0000-0001-9251-9771; WU, Candy Lai Har/0000-0003-0546-2653				[Anonymous], J RES MED SCI; Asazawa K, 2012, J JAPANESE SOC FERTI, V9, P5; Beckmann C, 2014, INFERTILITY OBSTET G, P371; Beevers CG, 1999, CLIN PSYCHOL-SCI PR, V6, P133, DOI 10.1093/clipsy/6.2.133; Boivin J, 2010, WOMENS HEALTH, V6, P59, DOI 10.2217/WHE.09.79; Brucker PS, 2004, JOGNN-J OBST GYN NEO, V33, P597, DOI 10.1177/0884217504268943; Cai LB, 2012, REPROD BIOMED ONLINE, V24, P186, DOI 10.1016/j.rbmo.2011.11.002; Chochovski J, 2013, J PSYCHOSOM OBST GYN, V34, P122, DOI 10.3109/0167482X.2013.829034; Chuang CC, 2003, FERTIL STERIL, V79, P63, DOI 10.1016/S0015-0282(02)04562-4; Cipolletta S, 2013, J REPROD INFANT PSYC, V31, P285, DOI 10.1080/02646838.2013.813627; Daniluk JC, 2001, J COUNS DEV, V79, P439, DOI 10.1002/j.1556-6676.2001.tb01991.x; Dimka Ritgak A, 2013, Afr J Reprod Health, V17, P102; Domar AD, 2004, FERTIL STERIL, V81, P271, DOI 10.1016/j.fertnstert.2003.08.013; Domar AD, 2010, FERTIL STERIL, V94, P1457, DOI 10.1016/j.fertnstert.2009.06.020; Dong YZ, 2013, J INT MED RES, V41, P1258, DOI 10.1177/0300060513483416; Greil AL, 2010, SOCIOL HEALTH ILL, V32, P140, DOI 10.1111/j.1467-9566.2009.01213.x; Hjelmstedt A, 1999, ACTA OBSTET GYN SCAN, V78, P42, DOI 10.1034/j.1600-0412.1999.780110.x; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Ismail WA, 2004, J ASSIST REPROD GEN, V21, P323, DOI 10.1023/B:JARG.0000045471.61107.5b; Isupova OG, 2011, INT J QUAL STUD HEAL, V6, P1; Jin X, 2013, BIOMED RES INT, V2013, P1, DOI DOI 10.3760/CMA.J.ISSN.0253-3766.2013.01.016; Johansson M, 2005, SCAND J CARING SCI, V19, P58, DOI 10.1111/j.1471-6712.2005.00319.x; Lampley TM, 2010, INTERIM WINDOW WOMEN; Lau JTF, 2008, J SEX MARITAL THER, V34, P248, DOI 10.1080/00926230701866117; Lee GL, 2009, HUM REPROD, V24, P1920, DOI 10.1093/humrep/dep091; Loke AY, 2012, J CLIN NURS, V21, P504, DOI 10.1111/j.1365-2702.2010.03632.x; Lowyck B, 2009, FERTIL STERIL, V91, P387, DOI 10.1016/j.fertnstert.2007.11.052; Martins MV, 2014, HUM REPROD, V29, P83, DOI 10.1093/humrep/det403; Mascarenhas M. N., 2012, PLOS MED, V9, P12, DOI DOI 10.1371/JOURNAL.PMED.1001356; Newton CR, 2006, INFERTILITY COUNSELING: A COMPREHENSIVE HANDBOOK FOR CLINICIANS, 2ND EDITION, P143; Pasch L. A., 2000, PSYCHOL COUPLES ILLN, P241, DOI 10.1037/10360-009; Poehl M, 1999, J ASSIST REPROD GEN, V16, P302, DOI 10.1023/A:1020449831333; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schanz S, 2011, FERTIL STERIL, V96, P416, DOI 10.1016/j.fertnstert.2011.05.064; Schmidt L, 2005, HUM REPROD, V20, P3248, DOI 10.1093/humrep/dei193; Schmidt L, 2006, LANCET, V367, P379, DOI 10.1016/S0140-6736(06)68117-8; Su Tsann-Juu, 2006, J Nurs Res, V14, P46; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Volgsten H, 2010, ACTA OBSTET GYN SCAN, V89, P1290, DOI 10.3109/00016349.2010.512063; Wang KH, 2007, FERTIL STERIL, V87, P792, DOI 10.1016/j.fertnstert.2006.07.1534; Widge Anjali, 2005, Patient Educ Couns, V59, P226, DOI 10.1016/j.pec.2005.07.014; Wischmann T, 2001, HUM REPROD, V16, P1753, DOI 10.1093/humrep/16.8.1753; Wu AK, 2013, FERTIL STERIL, V99, P2025, DOI 10.1016/j.fertnstert.2013.01.145; Ying LY, 2016, J SEX MARITAL THER, V42, P243, DOI 10.1080/0092623X.2015.1010676	44	31	33	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139691	10.1371/journal.pone.0139691	http://dx.doi.org/10.1371/journal.pone.0139691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26431545	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700100
J	D'Souza, D; D'Souza, H; Johnson, MH; Karmiloff-Smith, A				D'Souza, Dean; D'Souza, Hana; Johnson, Mark H.; Karmiloff-Smith, Annette			Concurrent Relations between Face Scanning and Language: A Cross-Syndrome Infant Study	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; WILLIAMS-SYNDROME; DEVELOPMENTAL-CHANGES; SPEECH-PERCEPTION; DOWN-SYNDROME; EYE-MOVEMENT; ATTENTION; GAZE; INFORMATION; INTEGRATION	Typically developing (TD) infants enhance their learning of spoken language by observing speakers' mouth movements. Given the fact that word learning is seriously delayed in most children with neurodevelopmental disorders, we hypothesized that this delay partly results from differences in visual face scanning, e.g., focusing attention away from the mouth. To test this hypothesis, we used an eye tracker to measure visual attention in 95 infants and toddlers with Down syndrome (DS), fragile X syndrome (FXS), and Williams syndrome (WS), and compared their data to 25 chronological-and mental-age matched 16-month-old TD controls. We presented participants with two talking faces (one on each side of the screen) and a sound (/ga/). One face (the congruent face) mouthed the syllable that the participants could hear (i.e., /ga/), while the other face (the incongruent face) mouthed a different syllable (/ba/) from the one they could hear. As expected, we found that TD children with a relatively large vocabulary made more fixations to the mouth region of the incongruent face than elsewhere. However, toddlers with FXS or WS who had a relatively large receptive vocabulary made more fixations to the eyes (rather than the mouth) of the incongruent face. In DS, by contrast, fixations to the speaker's overall face (rather than to her eyes or mouth) predicted vocabulary size. These findings suggest that, at some point in development, different processes or strategies relating to visual attention are involved in language acquisition in DS, FXS, and WS. This knowledge may help further explain why language is delayed in children with neurodevelopmental disorders. It also raises the possibility that syndrome-specific interventions should include an early focus on efficient face-scanning behaviour.	[D'Souza, Dean; Johnson, Mark H.; Karmiloff-Smith, Annette] Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England; [D'Souza, Hana] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of London; Birkbeck University London; University of Oxford	Karmiloff-Smith, A (corresponding author), Univ London, Dept Psychol Sci, Ctr Brain & Cognit Dev, London, England.	a.karmiloff-smith@bbk.ac.uk	D'Souza, Dean/P-5820-2019	D'Souza, Hana/0000-0001-8841-8644; Johnson, Mark/0000-0003-4229-2585; D'Souza, Dean/0000-0002-3053-2484	BASIS funding consortium; United Kingdom Medical Research Council [G0701484]; Waterloo Foundation; Williams Syndrome Foundation United Kingdom; Autour des Williams France; Wellcome Trust [098330/Z/12/Z]; Williams Syndrome Foundation; Down Syndrome Association; Down Syndrome Education International; Autistica [7221] Funding Source: researchfish; Medical Research Council [MR/K021389/1, G0701484] Funding Source: researchfish; MRC [G0701484, MR/K021389/1] Funding Source: UKRI	BASIS funding consortium; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Waterloo Foundation; Williams Syndrome Foundation United Kingdom; Autour des Williams France; Wellcome Trust(Wellcome TrustEuropean Commission); Williams Syndrome Foundation; Down Syndrome Association; Down Syndrome Education International; Autistica(Autistica); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are very grateful for the contributions families have made towards this study. The participation of the TD control participants in the research was supported by awards from the BASIS funding consortium led by Autistica (www.basisnetwork.org) and from the United Kingdom Medical Research Council (G0701484). The BASIS Team consists of (in alphabetical order): Tony Charman, Simon Baron-Cohen, Patrick Bolton, Kim Davies, Janice Fernandes, Jeanne Guiraud, Mark H. Johnson, Helen Maris, Helena Ribeiro and Leslie Tucker. The participation of participants with neurodevelopmental disorders was funded by the Waterloo Foundation (http://www.waterloofoundation.org.uk/), Williams Syndrome Foundation United Kingdom (http://www.williams-syndrome.org.uk/), Autour des Williams France (http://www.autourdeswilliams.org/), and a Wellcome Trust Strategic Award (grant number: 098330/Z/12/Z). The recruiting of participants was supported by the Williams Syndrome Foundation, the Down Syndrome Association, and Down Syndrome Education International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsius A, 2005, CURR BIOL, V15, P839, DOI 10.1016/j.cub.2005.03.046; Amso D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085701; Bailey DB, 2009, PEDIATRICS, V124, P527, DOI 10.1542/peds.2008-2992; Brenner LA, 2007, J AUTISM DEV DISORD, V37, P1289, DOI 10.1007/s10803-006-0277-9; Burnham D, 2004, DEV PSYCHOBIOL, V45, P204, DOI 10.1002/dev.20032; Cornish KM, 2004, J CHILD PSYCHOL PSYC, V45, P1042, DOI 10.1111/j.1469-7610.2004.t01-1-00297.x; Crumrine D, 2010, P 6 ANN GRASP S, P93; DODD B, 1979, COGNITIVE PSYCHOL, V11, P478, DOI 10.1016/0010-0285(79)90021-5; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; FANTZ RL, 1961, SCI AM, V204, P66, DOI 10.1038/scientificamerican0561-66; Fenson L., 1993, MACARTHUR COMMUNICAT; Field A., 2013, DISCOVERING STAT USI; Gliga T, 2009, INFANCY, V14, P550, DOI 10.1080/15250000903144199; Guastella AJ, 2008, BIOL PSYCHIAT, V63, P3, DOI 10.1016/j.biopsych.2007.06.026; Guiraud JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036428; HAITH MM, 1977, SCIENCE, V198, P853, DOI 10.1126/science.918670; Hall S, 2006, J AUTISM DEV DISORD, V36, P935, DOI 10.1007/s10803-006-0132-z; Jarrold C, 2002, J SPEECH LANG HEAR R, V45, P531, DOI 10.1044/1092-4388(2002/042); Karmiloff-Smith A, 2012, P NATL ACAD SCI USA, V109, P17261, DOI 10.1073/pnas.1121087109; Key APF, 2009, INFANT CHILD DEV, V18, P149, DOI 10.1002/icd.600; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; KUHL PK, 1991, J EXP PSYCHOL HUMAN, V17, P829, DOI 10.1037/0096-1523.17.3.829; Kushnerenko E, 2008, P NATL ACAD SCI USA, V105, P11442, DOI 10.1073/pnas.0804275105; Laws G, 2004, J CHILD PSYCHOL PSYC, V45, P326, DOI 10.1111/j.1469-7610.2004.00224.x; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Lewkowicz DJ, 2010, INFANCY, V15, P46, DOI 10.1111/j.1532-7078.2009.00005.x; Lewkowicz DJ, 2010, DEV PSYCHOL, V46, P66, DOI 10.1037/a0015579; Ludman CN, 2000, BRIT J AUDIOL, V34, P225, DOI 10.3109/03005364000000132; MAURER D, 1976, CHILD DEV, V47, P523, DOI 10.2307/1128813; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Morales M, 1998, INFANT BEHAV DEV, V21, P373, DOI 10.1016/S0163-6383(98)90014-5; Morales M, 2000, INFANT BEHAV DEV, V23, P231, DOI 10.1016/S0163-6383(01)00038-8; Morrongiello BA, 1998, INFANT BEHAV DEV, V21, P543, DOI 10.1016/S0163-6383(98)90028-5; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Mueller JL, 2012, P NATL ACAD SCI USA, V109, P15953, DOI 10.1073/pnas.1204319109; Mullen E.M., 1995, MULLEN SCALES OF EAR; Paterson SJ, 1999, SCIENCE, V286, P2355, DOI 10.1126/science.286.5448.2355; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Pober Barbara R, 2010, N Engl J Med, V362, P239, DOI 10.1056/NEJMra0903074; Poole A., 2004, PEOPLE COMPUTERS 18; Porter MA, 2010, COGN NEUROPSYCHIATRY, V15, P505, DOI 10.1080/13546801003644486; Reid VM, 2005, EUR J NEUROSCI, V21, P1763, DOI 10.1111/j.1460-9568.2005.03986.x; Riby D, 2009, J INTELL DISABIL RES, V53, P169, DOI 10.1111/j.1365-2788.2008.01142.x; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2009, J AUTISM DEV DISORD, V39, P421, DOI 10.1007/s10803-008-0641-z; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Schietecatte I, 2012, BRIT J DEV PSYCHOL, V30, P267, DOI 10.1111/j.2044-835X.2011.02039.x; Schwartz JL, 2004, COGNITION, V93, pB69, DOI 10.1016/j.cognition.2004.01.006; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; SUMMERFIELD Q, 1992, PHILOS T ROY SOC B, V335, P71, DOI 10.1098/rstb.1992.0009; Teinonen T, 2008, COGNITION, V108, P850, DOI 10.1016/j.cognition.2008.05.009; Terracciano A, 2005, AM J MED GENET C, V137C, P32, DOI 10.1002/ajmg.c.30062; Tomalski P, 2013, EUR J DEV PSYCHOL, V10, P611, DOI 10.1080/17405629.2012.728076; Tsao FM, 2004, CHILD DEV, V75, P1067, DOI 10.1111/j.1467-8624.2004.00726.x; Vatikiotis-Bateson E, 1998, PERCEPT PSYCHOPHYS, V60, P926, DOI 10.3758/BF03211929; Vouloumanos A, 2004, DEVELOPMENTAL SCI, V7, P270, DOI 10.1111/j.1467-7687.2004.00345.x; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vouloumanos A, 2013, DEV PSYCHOL, V49, P815, DOI 10.1037/a0029055; Vouloumanos A, 2009, P NATL ACAD SCI USA, V106, P18867, DOI 10.1073/pnas.0906049106; Weikum WM, 2007, SCIENCE, V316, P1159, DOI 10.1126/science.1137686; Werker JF, 1999, ANNU REV PSYCHOL, V50, P509, DOI 10.1146/annurev.psych.50.1.509; Yeung HH, 2013, PSYCHOL SCI, V24, P603, DOI 10.1177/0956797612458802; Young GS, 2009, DEVELOPMENTAL SCI, V12, P798, DOI 10.1111/j.1467-7687.2009.00833.x	64	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139319	10.1371/journal.pone.0139319	http://dx.doi.org/10.1371/journal.pone.0139319			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6GT	26426329	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000362177100048
J	Dossett, ML; Mu, L; Davis, RB; Bell, IR; Lembo, AJ; Kaptchuk, TJ; Yeh, GY				Dossett, Michelle L.; Mu, Lin; Davis, Roger B.; Bell, Iris R.; Lembo, Anthony J.; Kaptchuk, Ted J.; Yeh, Gloria Y.			Patient-Provider Interactions Affect Symptoms in Gastroesophageal Reflux Disease: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial	PLOS ONE			English	Article							ALTERNATIVE MEDICINE; RELATIONAL EMPATHY; CARE; COMPLEMENTARY; CONSULTATION; QUALITY; RELIABILITY; SEVERITY; TIME	Background It is unclear whether the benefits that some patients derive from complementary and integrative medicine (CIM) are related to the therapies recommended or to the consultation process as some CIM provider visits are more involved than conventional medical visits. Many patients with gastrointestinal conditions seek out CIM therapies, and prior work has demonstrated that the quality of the patient-provider interaction can improve health outcomes in irritable bowel syndrome, however, the impact of this interaction on gastroesophageal reflux disease (GERD) is unknown. We aimed to assess the safety and feasibility of conducting a 2x2 factorial design study preliminarily exploring the impact of the patient-provider interaction, and the effect of an over-the-counter homeopathic product, Acidil, on symptoms and health-related quality of life in subjects with GERD. Methods 24 subjects with GERD-related symptoms were randomized in a 2x2 factorial design to receive 1) either a standard visit based on an empathic conventional primary care evaluation or an expanded visit with questions modeled after a CIM consultation and 2) either Acidil or placebo for two weeks. Subjects completed a daily GERD symptom diary and additional measures of symptom severity and health-related quality of life. Results There was no significant difference in GERD symptom severity between the Acidil and placebo groups from baseline to follow-up (p = 0.41), however, subjects who received the expanded visit were significantly more likely to report a 50% or greater improvement in symptom severity compared to subjects who received the standard visit (p = 0.01). Total consultation length, perceived empathy, and baseline beliefs in CIM were not associated with treatment outcomes. Conclusion An expanded patient-provider visit resulted in greater GERD symptom improvement than a standard empathic medical visit. CIM consultations may have enhanced placebo effects, and further studies to assess the active components of this visit-based intervention are warranted.	[Dossett, Michelle L.; Mu, Lin; Davis, Roger B.; Kaptchuk, Ted J.; Yeh, Gloria Y.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Mu, Lin] Beth Israel Deaconess Med Ctr, Clin Res Ctr, Boston, MA 02215 USA; [Davis, Roger B.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Bell, Iris R.] Univ Arizona, Coll Med, Dept Family & Community Med, Tucson, AZ USA; [Lembo, Anthony J.] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA; [Kaptchuk, Ted J.] Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA 02215 USA; [Kaptchuk, Ted J.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard T.H. Chan School of Public Health; University of Arizona; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Dossett, ML (corresponding author), Massachusetts Gen Hosp, Benson Henry Inst Mind Body Med, Boston, MA 02114 USA.	mdossett@mgh.harvard.edu	Dossett, Michelle/U-1166-2019		National Center for Complementary and Integrative Health (NCCIH) at the NIH [T32 AT000051]; Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center (BIDMC); NCCIH [K24 AT004095]; BIDMC Research Pharmacy and Clinical Research Center, Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH) [1UL1 TR001102-01]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095, T32AT000051] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health (NCCIH) at the NIH; Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center (BIDMC); NCCIH; BIDMC Research Pharmacy and Clinical Research Center, Harvard Catalyst; Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MLD was supported by an institutional National Research Service Award T32 AT000051 from the National Center for Complementary and Integrative Health (NCCIH) at the NIH and by the Division of General Medicine and Primary Care at Beth Israel Deaconess Medical Center (BIDMC). TJK was supported by a K24 AT004095 (NCCIH). This work was conducted with support from the BIDMC Research Pharmacy and Clinical Research Center, Harvard Catalyst, The Harvard Clinical and Translational Science Center (NIH Award 1UL1 TR001102-01 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, or the National Institutes of Health. No funding or support was received from Boiron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H M, 1997, J Am Board Fam Pract, V10, P28; Agreus L, 2001, AM J GASTROENTEROL, V96, P2905; Bikker AP, 2005, J ALTERN COMPLEM MED, V11, P591, DOI 10.1089/acm.2005.11.591; Bishop FL, 2005, COMPLEMENT THER MED, V13, P144, DOI 10.1016/j.ctim.2005.01.005; Busato A, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-63; Chen LM, 2009, ARCH INTERN MED, V169, P1866, DOI 10.1001/archinternmed.2009.341; Chey DW, 2012, CLIN DRUG INVEST, V23, P69, DOI [10.2165/00044011-200323020-00001, DOI 10.2165/00044011-200323020-00001]; Cohen E, 2014, DIGEST DIS SCI, V59, P2488, DOI 10.1007/s10620-014-3181-8; Cremonini F, 2010, ALIMENT PHARM THER, V32, P29, DOI 10.1111/j.1365-2036.2010.04315.x; Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6; Dossett ML, 2014, AM J GASTROENTEROL, V109, P1705, DOI 10.1038/ajg.2014.108; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hyland M E, 2002, Homeopathy, V91, P145, DOI 10.1054/homp.2002.0025; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P817, DOI 10.7326/0003-4819-136-11-200206040-00011; Kelley JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094207; Koithan M, 2014, J MED PERS, V13, P23; Lin CT, 2001, ARCH INTERN MED, V161, P1437, DOI 10.1001/archinte.161.11.1437; Mercer SW, 2004, FAM PRACT, V21, P699, DOI 10.1093/fampra/cmh621; Miller FG, 2009, PERSPECT BIOL MED, V52, P518, DOI 10.1353/pbm.0.0115; Miner P, 2002, AM J GASTROENTEROL, V97, P1332, DOI 10.1016/S0002-9270(02)04125-4; Miwa H, 2015, J GASTROENTEROL, V50, P125, DOI 10.1007/s00535-014-1022-3; Mulkins Andrea L, 2004, Integr Cancer Ther, V3, P230, DOI 10.1177/1534735404268054; Niggemann B, 2003, PEDIATR ALLERGY IMMU, V14, P149, DOI 10.1034/j.1399-3038.2003.00020.x; Overland MK, 2014, MED CLIN N AM, V98, P549, DOI 10.1016/j.mcna.2014.01.007; Pereira RD, 2006, J PINEAL RES, V41, P195, DOI 10.1111/j.1600-079X.2006.00359.x; Rakel D, 2011, PATIENT EDUC COUNS, V85, P390, DOI 10.1016/j.pec.2011.01.009; Revicki DA, 1998, QUAL LIFE RES, V7, P75; Rubenstein JH, 2014, GASTROENTEROL CLIN N, V43, P1, DOI 10.1016/j.gtc.2013.11.006; Steinsbekk Aslak, 2005, Integr Cancer Ther, V4, P195, DOI 10.1177/1534735405276721; Tack J, 2012, ALIMENT PHARM THER, V35, P1257, DOI 10.1111/j.1365-2036.2012.05086.x; Vakil N, 2012, DRUGS, V72, P437, DOI 10.2165/11599320-000000000-00000; Velanovich V, 2007, DIS ESOPHAGUS, V20, P130, DOI 10.1111/j.1442-2050.2007.00658.x; Whale CA, 2009, ACUPUNCT MED, V27, P13, DOI 10.1136/aim.2008.000232; Wilson A, 2002, BRIT J GEN PRACT, V52, P1012	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0136855	10.1371/journal.pone.0136855	http://dx.doi.org/10.1371/journal.pone.0136855			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422466	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700007
J	Froehlich, CYM; Kline, RJ				Froehlich, Catheline Y. M.; Kline, Richard J.			Using Fish Population Metrics to Compare the Effects of Artificial Reef Density	PLOS ONE			English	Article							GULF-OF-MEXICO; JUVENILE RED SNAPPER; LUTJANUS-CAMPECHANUS; HABITAT COMPLEXITY; SITE FIDELITY; COMMUNITY STRUCTURE; GROWTH; PATTERNS; TEXAS; AGE	Artificial reefs continue to be added as habitat throughout the world, yet questions remain about how reef design affects fish diversity and abundance. In the present study, the effects of reef density were assessed for fish communities and sizes of economically valuable Lutjanus campechanus 13 km off Port Mansfield, Texas, at a reef composed of more than 4000 concrete culverts. The study spanned from May to June in 2013 and 2014, and sites sampled included natural reefs, bare areas, and varying culvert patch density categories, ranging from 1-190 culverts. Abundances of adults and species evenness of juvenile populations differed between the years. Fish communities did not significantly differ among density categories; however, highest species richness and total abundances were observed at intermediate culvert densities and at natural reefs. Whereas the abundance of L. campechanus did not differ among density categories, mean total lengths of L. campechanus were greatest at the lower density. Our findings suggest that reefs should be deployed with intermediate patch density of 71-120 culverts in a 30-m radius to yield the highest fish abundances.	[Froehlich, Catheline Y. M.; Kline, Richard J.] Univ Texas Brownsville, Dept Biol Sci, Brownsville, TX 78520 USA	University of Texas System; University of Texas Rio Grande Valley	Froehlich, CYM (corresponding author), Univ Texas Brownsville, Dept Biol Sci, Brownsville, TX 78520 USA.	Catheline.Froehlich@gmail.com; Richard.Kline@utrgv.edu	Froehlich, Catheline/AAM-4106-2020	Froehlich, Catheline/0000-0002-8731-1367; Kline, Richard/0000-0002-4116-2060	Texas Parks and Wildlife Department Artificial Reef Program; Coastal Conservation Association Texas	Texas Parks and Wildlife Department Artificial Reef Program; Coastal Conservation Association Texas	Funding for this research was provided by the Texas Parks and Wildlife Department Artificial Reef Program to RJK and the Coastal Conservation Association Texas to RJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arney RN, 2014, THESIS U TEXAS BROWN; Ault JS, 2013, FISH RES, V144, P28, DOI 10.1016/j.fishres.2012.10.007; Bailey H. Killabrew, 2001, Gulf of Mexico Science, V19, P119; Baine M, 2001, OCEAN COAST MANAGE, V44, P241, DOI 10.1016/S0964-5691(01)00048-5; Bohnsack J.A., 1986, NOAA Technical Report NMFS, V41, P1; BOHNSACK JA, 1985, B MAR SCI, V37, P11; Bortone SA, 1986, 821152TREL824 US DOI; Campbell MD, 2011, ECOL MODEL, V222, P3895, DOI 10.1016/j.ecolmodel.2011.10.009; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Causey BD, 1969, THESIS TEXAS A I U; Charbonnel E, 2002, ICES J MAR SCI, V59, pS208, DOI 10.1006/jmsc.2002.1263; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coleman FC, 2000, FISHERIES, V25, P14, DOI 10.1577/1548-8446(2000)025<0014:LRF>2.0.CO;2; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cowan JH, 2011, REV FISH BIOL FISHER, V21, P187, DOI 10.1007/s11160-010-9165-7; Diamond SL, 2007, AM FISH S S, V60, P163; FELDER DL, 1979, CONTRIB MAR SCI, V22, P1; Fischer AJ, 2004, FISH B-NOAA, V102, P593; Gallaway BJ, 2009, REV FISH SCI, V17, P48, DOI 10.1080/10641260802160717; Gallaway BJ, 1999, T AM FISH SOC, V128, P713, DOI 10.1577/1548-8659(1999)128<0713:DOEHFJ>2.0.CO;2; Gatts PV, 2014, OCEAN COAST MANAGE, V98, P111, DOI 10.1016/j.ocecoaman.2014.06.022; Gazey WJ, 2008, N AM J FISH MANAGE, V28, P1828, DOI 10.1577/M07-216.1; Gillig D, 2001, T AM FISH SOC, V130, P117, DOI 10.1577/1548-8659(2001)130&lt;0117:ABAOGO&gt;2.0.CO;2; GMFMC, 2013, FRAM ACT SET 2013 RE, P89; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Gutierrez L, 1998, OECOLOGIA, V115, P268, DOI 10.1007/s004420050516; Hanner SE, 2006, B MAR SCI, V78, P57; Johnson DW, 2007, ECOLOGY, V88, P1716, DOI 10.1890/06-0591.1; Lindberg WJ, 2006, ECOL APPL, V16, P731, DOI 10.1890/1051-0761(2006)016[0731:DHSAPB]2.0.CO;2; Lingo ME, 2006, ENVIRON BIOL FISH, V76, P71, DOI 10.1007/s10641-006-9009-4; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Lukens Ronald R., 2004, GUIDELINES MARINE AR, V121; MOFFITT RB, 1989, B MAR SCI, V44, P616; Nash Harriet L., 2013, Gulf and Caribbean Research, V25, P9; Patterson WF, 2001, FISH B-NOAA, V99, P617; Perkol-Finkel S, 2005, MAR ENVIRON RES, V59, P79, DOI 10.1016/j.marenvres.2004.03.122; Rezak R, 1983, 831T MMS; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; Rouphael AB, 2002, ECOL APPL, V12, P427, DOI 10.1890/1051-0761(2002)012[0427:ISATVI]2.0.CO;2; Syc TS, 2012, FISH B, P110; Syc TS, 2011, THESIS AUBURN U; SZEDLMAYER ST, 1994, B MAR SCI, V55, P887; TALBOT FH, 1978, ECOL MONOGR, V48, P425, DOI 10.2307/2937241; Tolan JM, 2009, FISH B-NOAA, V107, P36; Topping DT, 2011, MAR ECOL PROG SER, V437, P183, DOI 10.3354/meps09293; TUNNELL JW, 1970, CONTRIB MAR SCI, V15, P193; Walker BK, 2009, J COASTAL RES, V25, P39, DOI [10.2112/S153-005.1, 10.2112/SI53-005.1]; WALSH WJ, 1985, B MAR SCI, V36, P357; Hackradt CW, 2011, MAR ENVIRON RES, V72, P235, DOI 10.1016/j.marenvres.2011.09.006; Willis TJ, 2001, NEW ZEAL J MAR FRESH, V35, P581, DOI 10.1080/00288330.2001.9517024; Wilson CA, 2001, FISH B-NOAA, V99, P653; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z	54	19	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139444	10.1371/journal.pone.0139444	http://dx.doi.org/10.1371/journal.pone.0139444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422472	gold, Green Published, Green Submitted			2022-12-27	WOS:000362175700116
J	Kiang, JG; Smith, JT; Anderson, MN; Swift, JM; Christensen, CL; Gupta, P; Balakathiresan, N; Maheshwari, RK				Kiang, Juliann G.; Smith, Joan T.; Anderson, Marsha N.; Swift, Joshua M.; Christensen, Christine L.; Gupta, Paridhi; Balakathiresan, Nagaraja; Maheshwari, Radha K.			Hemorrhage Exacerbates Radiation Effects on Survival, Leukocytopenia, Thrombopenia, Erythropenia, Bone Marrow Cell Depletion and Hematopoiesis, and Inflammation-Associated microRNAs Expression in Kidney	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; COMBINED INJURY; INDUCED INCREASES; ERYTHROPOIETIN; IRRADIATION; MICE; ACTIVATION; MECHANISMS; INOS; BLOOD	Exposure to high-dose radiation results in detrimental effects on survival. The effects of combined trauma, such as radiation in combination with hemorrhage, the typical injury of victims exposed to a radiation blast, on survival and hematopoietic effects have yet to be understood. The purpose of this study was to evaluate the effects of radiation injury (RI) combined with hemorrhage (i.e., combined injury, CI) on survival and hematopoietic effects, and to investigate whether hemorrhage (Hemo) enhanced RI-induced mortality and hematopoietic syndrome. Male CD2F1 mice (10 weeks old) were given one single exposure of gamma-radiation (Co-60) at various doses (0.6 Gy/min). Within 2 hr after RI, animals under anesthesia were bled 0% (Sham) or 20% (Hemo) of total blood volume via the submandibular vein. In these mice, Hemo reduced the LD50/30 for 30-day survival from 9.1 Gy (RI) to 8.75 Gy (CI) with a DMF of 1.046. RI resulted in leukocytopenia, thrombopenia, erythropenia, and bone marrow cell depletion, but decreased the caspase-3 activation response. RI increased IL-1 beta, IL-6, IL-17A, and TNF-alpha concentrations in serum, bone marrow, ileum, spleen, and kidney. Some of these adverse alterations were magnified by CI. Erythropoietin production was increased in kidney and blood more after CI than RI. Furthermore, CI altered the global miRNAs expression in kidney and the ingenuity pathway analysis showed that miRNAs viz., let-7e, miR-30e and miR-29b that were associated with hematopoiesis and inflammation. This study provides preliminary evidence that non-lethal Hemo exacerbates RI-induced mortality and cell losses associated with high-dose gamma-radiation. We identified some of the initial changes occurring due to CI which may have facilitated in worsening the injury and hampering the recovery of animals ultimately resulting in higher mortality.	[Kiang, Juliann G.; Smith, Joan T.; Anderson, Marsha N.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20814 USA; [Kiang, Juliann G.; Swift, Joshua M.] Uniformed Serv Univ Hlth Sci, Dept Radiat Biol, Bethesda, MD 20814 USA; [Kiang, Juliann G.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Swift, Joshua M.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; [Swift, Joshua M.] Naval Med Res Ctr, Undersea Med Dept, Silver Spring, MD USA; [Christensen, Christine L.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Dept Vet Sci, Comparat Pathol Div, Bethesda, MD 20814 USA; [Gupta, Paridhi; Balakathiresan, Nagaraja; Maheshwari, Radha K.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Naval Medical Research Center (NMRC); Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA	Kiang, JG (corresponding author), Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Combined Injury Program, Bethesda, MD 20814 USA.	Juliann.kiang@usuhs.edu	Balakathiresan, Nagaraja Sethuraman/O-3213-2019	Balakathiresan, Nagaraja Sethuraman/0000-0001-5756-6070	Armed Forces Radiobiology Research Institute Intramural Funding [RAB3AL, RAB33336]	Armed Forces Radiobiology Research Institute Intramural Funding	JGK received the Armed Forces Radiobiology Research Institute Intramural Funding RAB3AL and RAB33336 to conduct experiments presented in this manuscript (URL: www.usuhs.edu/AFRRI). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPEN EL, 1954, ANN SURG, V140, P113, DOI 10.1097/00000658-195407000-00013; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bandarra DR, 2013, OA MOL CELL BIOL, V1, P6, DOI DOI 10.13172/2054-7331-1-1-924; Barabanova Anzhelika V, 2006, Vojnosanit Pregl, V63, P477, DOI 10.2298/VSP0605477B; Barshishat-Kupper M, 2011, EXP HEMATOL, V39, P293, DOI 10.1016/j.exphem.2010.12.002; Bastard JP, 1999, CIRCULATION, V99, P2221; BAXTER H, 1953, PLAST RECONSTR SURG, V12, P439, DOI 10.1097/00006534-195312000-00007; BROOKS JW, 1952, ANN SURG, V136, P533, DOI 10.1097/00000658-195210000-00018; Chen X, 2015, J FORMOS MED ASSOC, V114, P430, DOI 10.1016/j.jfma.2015.01.007; Chiricozzi A, 2011, J INVEST DERMATOL, V131, P677, DOI 10.1038/jid.2010.340; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; de la Rica L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0561-5; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Fisher JW, 2003, EXP BIOL MED, V228, P1; GERY I, 1972, J EXP MED, V136, P128, DOI 10.1084/jem.136.1.128; Golde WT, 2005, LAB ANIMAL, V34, P39, DOI 10.1038/laban1005-39; Ha CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109249; Iijima S, 1982, Acta Pathol Jpn, V32 Suppl 2, P237; Jiang LL, 2012, J CLIN INVEST, V122, P33, DOI 10.1172/JCI58849; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kiang JG, 2005, J APPL PHYSIOL, V98, P550, DOI 10.1152/japplphysiol.00858.2004; Kiang JG, 2004, CELL RES, V14, P450, DOI 10.1038/sj.cr.7290247; Kiang JG, 2004, J APPL PHYSIOL, V97, P564, DOI 10.1152/japplphysiol.00194.2004; Kiang JG, 2003, MOL CELL BIOCHEM, V254, P211, DOI 10.1023/A:1027363900317; Kiang JG, 2007, J APPL PHYSIOL, V103, P1045, DOI 10.1152/japplphysiol.00100.2007; Kiang Juliann G, 2014, J Cell Sci Ther, V5, DOI 10.4172/2157-7013.1000190; Kiang JG, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/215858; Kiang JG, 2014, HEALTH PHYS, V106, P720, DOI 10.1097/HP.0000000000000108; Kiang JG, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/821541; Kiang JG, 2012, LIPID PEROXIDATION, P261, DOI 10.5772/48189; Kiang JG, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-20; Kiang JG, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-21; Kiang Juliann G, 2010, Adapt Med, V2, P1, DOI 10.4247/AM.2010.ABA004; Kiang JG, 2010, RADIAT RES, V173, P319, DOI 10.1667/RR1892.1; Kiang JG, 2009, RADIAT RES, V172, P321, DOI 10.1667/RR1585.1; Kishi H, 2000, NEUROSURGERY, V47, P441, DOI 10.1097/00006123-200008000-00034; KORLOF B, 1956, Acta Chir Scand Suppl, V209, P1; Kuby J, 2007, KUBY IMMUNOLOGY, P396; Kunwar A, 2012, TOXICOL APPL PHARM, V264, P202, DOI 10.1016/j.taap.2012.08.002; Ledney GD, 2010, HEALTH PHYS, V98, P145, DOI 10.1097/01.HP.0000348466.09978.77; Ledney GD, 1992, BIOL BASIS RAD PROTE, P202; Lee Jin-Hee, 2013, Lab Anim Res, V29, P55, DOI 10.5625/lar.2013.29.1.55; Li XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122258; Li XH, 2010, HAEMATOL-HEMATOL J, V95, P1996, DOI 10.3324/haematol.2010.026492; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Lu XY, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-36; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Metheetrairut C, 2013, CURR OPIN GENET DEV, V23, P12, DOI 10.1016/j.gde.2013.01.002; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Moore E, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-3; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; PELLMAR TC, 2005, 0502 AFRRI CD; Sakurai T, 2007, J RADIAT RES, V48, P515, DOI 10.1269/jrr.07012; Shin DH, 2009, FEBS J, V276, P3470, DOI 10.1111/j.1742-4658.2009.07069.x; Swift JM, 2015, RADIAT RES, V183, P578, DOI 10.1667/RR13960.1; VALERIOTE FA, 1964, RADIAT RES, V22, P693, DOI 10.2307/3571550; VILCEK J, 1991, J BIOL CHEM, V266, P7313; Wagner S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/376326; Willam C, 2014, KIDNEY INT, V85, P232, DOI 10.1038/ki.2013.362; Willey JS, 2008, RADIAT RES, V170, P388, DOI 10.1667/RR1388.1; Zhu X, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003088	63	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139271	10.1371/journal.pone.0139271	http://dx.doi.org/10.1371/journal.pone.0139271			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422254	Green Published, Green Submitted, gold			2022-12-27	WOS:000362175700087
J	Li, ZD; Marinova, D; Guo, XM; Gao, Y				Li, Zhidong; Marinova, Dora; Guo, Xiumei; Gao, Yuan			Evaluating Pillar Industry's Transformation Capability: A Case Study of Two Chinese Steel-Based Cities	PLOS ONE			English	Article							SUSTAINABILITY; POLICIES	Many steel-based cities in China were established between the 1950s and 1960s. After more than half a century of development and boom, these cities are starting to decline and industrial transformation is urgently needed. This paper focuses on evaluating the transformation capability of resource-based cities building an evaluation model. Using Text Mining and the Document Explorer technique as a way of extracting text features, the 200 most frequently used words are derived from 100 publications related to steel-and other resourcebased cities. The Expert Evaluation Method (EEM) and Analytic Hierarchy Process (AHP) techniques are then applied to select 53 indicators, determine their weights and establish an index system for evaluating the transformation capability of the pillar industry of China's steel-based cities. Using real data and expert reviews, the improved Fuzzy Relation Matrix (FRM) method is applied to two case studies in China, namely Panzhihua and Daye, and the evaluation model is developed using Fuzzy Comprehensive Evaluation (FCE). The cities' abilities to carry out industrial transformation are evaluated with concerns expressed for the case of Daye. The findings have policy implications for the potential and required industrial transformation in the two selected cities and other resource-based towns.	[Li, Zhidong] Hefei Univ Technol, Sch Management, Hefei, Peoples R China; [Li, Zhidong] Minist Educ, Key Lab Proc Optimizat & Intelligent Decis Making, Hefei, Peoples R China; [Li, Zhidong; Marinova, Dora; Guo, Xiumei; Gao, Yuan] Curtin Univ, Curtin Univ Sustainabil Policy CUSP Inst, Perth, WA 6845, Australia	Hefei University of Technology; Curtin University	Marinova, D (corresponding author), Curtin Univ, Curtin Univ Sustainabil Policy CUSP Inst, Perth, WA 6845, Australia.	D.Marinova@curtin.edu.au	Marinova, Dora/H-2093-2013; Guo, Xiumei/R-5110-2016	Marinova, Dora/0000-0001-5125-8878; Li, Zhidong/0000-0003-4458-6616	National Natural Science Foundation of China [71301041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper is financially supported by the National Natural Science Foundation of China (No. 71301041).	Barnes TJ, 2000, CAN GEOGR-GEOGR CAN, V44, P4, DOI 10.1111/j.1541-0064.2000.tb00690.x; Bech Soren, 2007, PERCEPTUAL AUDIO EVA; Bector CR, 2005, FUZZY MATH PROGRAMMI; Bhushan N., 2004, STRATEGIC DECISION M; BRADBURY JH, 1983, CAN GEOGR-GEOGR CAN, V27, P128, DOI 10.1111/j.1541-0064.1983.tb01468.x; Cheng J., 2009, J DONGBEI U FINANCE, V63, P56; Deutz P, 2015, SUSTAINABILITY-BASEL, V7, P2259, DOI 10.3390/su7022259; Du JM, 2013, RES IND TRANSITION C; Employment Canada and Immigration Advisory Council, 1987, CAN SINGL IND COMM P; Feldman R, 1997, LECT NOTES ARTIF INT, V1263, P112; Fujii M, 2016, J CLEAN PROD, V114, P376, DOI 10.1016/j.jclepro.2015.04.027; Garnaut G., 2015, RESOURCES SECURITY A; Ge YQ, 2004, J LANZHOU U SOCIAL S, V32, P120; Golden BL, 2003, ANAL HIERARCHY PROCE; Guo XM, 2013, J CONTEMP CHINA, V22, P428, DOI 10.1080/10670564.2012.748962; Haggett P., 1977, LOCATIONAL ANAL HUMA; Han X.J., 2013, CHINA SOFT SCI, V6, P127; Herendeen RA, 2002, ECOL ECON, V42, P243, DOI 10.1016/S0921-8009(02)00056-3; International Council of Science, 2015, REV TARG SUST DEV GO; Jiao WT, 2014, J CLEAN PROD, V67, P14, DOI 10.1016/j.jclepro.2013.12.050; Li H, 2015, J CLEAN PROD, V107, P252, DOI 10.1016/j.jclepro.2015.04.089; Li HJ, 2013, ENERG POLICY, V55, P251, DOI 10.1016/j.enpol.2012.12.007; Liu YJ, 2004, J NE U, V6, P184; [刘云刚 LIU Yungang], 2009, [地理研究, Geographical Research], V28, P153; Liu Z., 2011, CHINA POPULATION RES, V21, P161; Lu YD, 2012, ADV MATER RES-SWITZ, V361-363, P1535, DOI 10.4028/www.scientific.net/AMR.361-363.1535; Lucas R., 2008, MINETOWN MILLTOWN RA; Luo YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104013; Mao J, 2014, INT J FINANCIAL RES, V5, DOI [10.5430/ijfr.v5n3p116, DOI 10.5430/IJFR.V5N3P116]; Meilgaard M. C., 2007, SENSORY EVAL TECHN, V4th; Mikhailov L, 2004, APPL SOFT COMPUT, V5, P23, DOI 10.1016/j.asoc.2004.04.001; National Bureau of Statistics (NBS),, 2000, CHIN STAT YB; National Bureau of Statistics of China, 2000, DAYE STAT YB; National Bureau of Statistics of China, 2000, CHIN IND EC YB; National Bureau of Statistics of China, 2000, PANZH STAT YB; National Bureau of Statistics of China, 2000, CHIN CIT STAT YB; O'Hagan S, 2007, J RURAL COMMUNITY D, V2, P18; Parker P, 1997, CAN GEOGR-GEOGR CAN, V41, P248, DOI 10.1111/j.1541-0064.1997.tb01312.x; Power A, 2010, PHOENIX CITIES: THE FALL AND RISE OF GREAT INDUSTRIAL CITIES, P1, DOI 10.1332/policypress/9781847426833.001.0001; Qi JZ, 2004, STUDY TRANSFORMATION; Ragin Charles C., 2000, FUZZY SET SOCIAL SCI; SAATY TL, 1990, EUR J OPER RES, V48, P9, DOI 10.1016/0377-2217(90)90057-I; Sadiq R, 2004, J ENVIRON MANAGE, V73, P1, DOI 10.1016/j.jenvman.2004.04.014; State Council of People's Republic of China, 2013, SUST DEV PLAN RES BA; [汤建影 Tang Jianying], 2003, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V32, P79; Tanguay GA, 2010, ECOL INDIC, V10, P407, DOI 10.1016/j.ecolind.2009.07.013; Tsaur RC, 2005, COMPUT MATH APPL, V49, P539, DOI 10.1016/j.camwa.2004.07.014; Wang SJ, 2010, ENV PROTECTION, P63; Wang Zhongya, 2011, URBAN STUD, V18, P85; West J, 2013, RESOURCE EFFICIENCY; Wu SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121594; Yao P., 2012, SCI MANAGEMENT RES, V30, P1; Ye DS, 2003, RESOURCE IND, V12, P10; Zhang H, 1999, J LANZHOU COMMERCIAL, V15, P27; Zhang W., 2011, B CHIN ACAD SCI, V26, P134; Zhang YJ, 2005, HUMAN GEOGRAPHY, V6, P83; Zhao J., 2006, URBAN STUD, V3, P86; Zhao XF, 2004, NATURAL RESOURCE CHA, V17, P21; Zhu L., 2014, J INEQUAL APPL, V2014, P1, DOI DOI 10.1681/ASN.2014010096	59	9	9	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139576	10.1371/journal.pone.0139576	http://dx.doi.org/10.1371/journal.pone.0139576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422266	gold, Green Submitted, Green Published			2022-12-27	WOS:000362175700129
J	Lin, HF; Hsi, E; Liao, YC; Chhor, B; Hung, J; Juo, SHH; Lin, RT				Lin, Hsiu-Fen; Hsi, Edward; Liao, Yi-Chu; Chhor, Brian; Hung, Jessica; Juo, Suh-Hang H.; Lin, Ruey-Tay			Demethylation of Circulating Estrogen Receptor Alpha Gene in Cerebral Ischemic Stroke	PLOS ONE			English	Article							ESTRADIOL-MEDIATED PROTECTION; BRAIN-INJURY; MYOCARDIAL-INFARCTION; EPIGENETIC REGULATION; ENDOTHELIAL-CELLS; DNA METHYLATION; NEUROPROTECTION; EXPRESSION; RISK; RATS	Background Estrogen is involved in neuron plasticity and can promote neuronal survival in stroke. Its actions are mostly exerted via estrogen receptor alpha (ER alpha). Previous animal studies have shown that ER alpha is upregulated by DNA demethylation following ischemic injury. This study investigated the methylation levels in the ERa promoter in the peripheral blood of ischemic stroke patients. Methods The study included 201 ischemic stroke patients, and 217 age-and sex-comparable healthy controls. The quantitative methylation level in the 14 CpG sites of the ERa promoter was measured by pyrosequencing in each participant. Multivariate regression model was used to adjust for stroke traditional risk factors. Stroke subtypes and sex-specific analysis were also conducted. Results The results demonstrated that the stroke cases had a lower ERa methylation level than controls in all 14 CpG sites, and site13 and site14 had significant adjusted p-values of 0.035 and 0.026, respectively. Stroke subtypes analysis showed that large-artery atherosclerosis and cardio-embolic subtypes had significantly lower methylation levels than the healthy controls at CpG site5, site9, site12, site13 and site14 with adjusted p = 0.039, 0.009, 0.025, 0.046 and 0.027 respectively. However, the methylation level for the patients with small vessel subtype was not significant. We combined the methylation data from the above five sites for further sex-specific analysis. The results showed that the significant association only existed in women (adjusted p = 0.011), but not in men (adjusted p = 0.300). Conclusions Female stroke cases have lower ER alpha methylation levels than those in the controls, especially in large-artery and cardio-embolic stroke subtypes. The study implies that women suffering from ischemic stroke of specific subtype may undergo different protective mechanisms to reduce the brain injury.	[Lin, Hsiu-Fen; Lin, Ruey-Tay] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Lin, Hsiu-Fen; Lin, Ruey-Tay] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Hsi, Edward; Juo, Suh-Hang H.] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Hsi, Edward; Juo, Suh-Hang H.] Kaohsiung Med Univ, Dept Med Genet, Coll Med, Kaohsiung, Taiwan; [Liao, Yi-Chu] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Liao, Yi-Chu] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei 112, Taiwan; [Chhor, Brian] Stanford Univ, Dept Human Biol, Stanford, CA 94305 USA; [Hung, Jessica] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Stanford University; University of Washington; University of Washington Seattle	Lin, RT (corresponding author), Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan.	tay@kmu.edu.tw		Liao, Yi-Chu/0000-0002-9644-2086; Lin, Hsiu-Fen/0000-0001-6343-826X	Ministry of Science and Technology (Taiwan, R.O.C.) [101-2628-B-037-003-MY2, 103-2314-B-075A-003-MY3]; National Health Research Institutes (Taiwan, R.O.C.) [NHRI-Ex101-10107PI]; Academia Sinica [BM 104010092]; Kaohsiung Medical University Hospital [KMUH100-0R47]; Kaohsiung Medical University [KMU-DT103003, KMU-TP103C003]	Ministry of Science and Technology (Taiwan, R.O.C.)(Ministry of Science and Technology, Taiwan); National Health Research Institutes (Taiwan, R.O.C.)(National Health Research Institutes - Taiwan); Academia Sinica(Academia Sinica - Taiwan); Kaohsiung Medical University Hospital; Kaohsiung Medical University	The work was supported by the following: Ministry of Science and Technology (Taiwan, R.O.C. 101-2628-B-037-003-MY2, and 103-2314-B-075A-003-MY3), SHJ; National Health Research Institutes (Taiwan, R.O.C. NHRI-Ex101-10107PI), SHJ; Academia Sinica (BM 104010092), SHJ; Kaohsiung Medical University Hospital (KMUH100-0R47), HFL; and Kaohsiung Medical University (Aim for the Top 500 Universities grant KMU-DT103003, KMU-TP103C003), SHJ.	Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; Alkayed NJ, 1998, STROKE, V29, P159, DOI 10.1161/01.STR.29.1.159; Baccarelli A, 2010, EPIDEMIOLOGY, V21, P819, DOI 10.1097/EDE.0b013e3181f20457; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; Chang PY, 2013, CARDIOVASC RES, V99, P137, DOI 10.1093/cvr/cvt062; Dubal DB, 1998, J CEREBR BLOOD F MET, V18, P1253, DOI 10.1097/00004647-199811000-00012; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Dubal DB, 2006, ENDOCRINOLOGY, V147, P3076, DOI 10.1210/en.2005-1177; Fuso A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118318; Fuso A, 2010, CELL CYCLE, V9, P3965, DOI 10.4161/cc.9.19.13193; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Kim JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051280; Lavados PM, 2007, LANCET NEUROL, V6, P140, DOI 10.1016/S1474-4422(06)70684-6; Li LC, 2000, CANCER RES, V60, P702; Lin HF, 2011, J INVEST MED, V59, P926, DOI 10.2310/JIM.0b013e318214ea49; Lin HF, 2010, ATHEROSCLEROSIS, V210, P155, DOI 10.1016/j.atherosclerosis.2009.11.027; Lin RT, 2014, CURR NEUROVASC RES, V11, P4, DOI 10.2174/1567202610666131202145530; Liu R, 2010, J PHARMACOL EXP THER, V332, P1006, DOI 10.1124/jpet.109.160937; Lodder J, 1993, Adv Neurol, V62, P213; Marsh BJ, 2009, NEUROSCIENCE, V158, P1007, DOI 10.1016/j.neuroscience.2008.07.067; Pereira MA, 2004, CARCINOGENESIS, V25, P1917, DOI 10.1093/carcin/bgh209; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; Schreihofer DA, 2013, BRAIN RES, V1514, P107, DOI 10.1016/j.brainres.2013.02.051; Simpkins JW, 1997, J NEUROSURG, V87, P724, DOI 10.3171/jns.1997.87.5.0724; Tian YF, 2012, J CEREBR BLOOD F MET, V32, P780, DOI 10.1038/jcbfm.2011.179; Toung TJK, 1998, STROKE, V29, P1666, DOI 10.1161/01.STR.29.8.1666; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Turtzo LC, 2010, FUTUR NEUROL, V5, P47, DOI 10.2217/FNL.09.66; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302, 10.1371/journal.pone.0048669]; Westberry JM, 2008, NEUROSCIENCE, V152, P982, DOI 10.1016/j.neuroscience.2008.01.048; Westberry JM, 2010, ENDOCRINOLOGY, V151, P731, DOI 10.1210/en.2009-0955; Wise PM, 2000, BIOL REPROD, V63, P982, DOI 10.1095/biolreprod63.4.982; Yoshida T, 2000, CARCINOGENESIS, V21, P2193, DOI 10.1093/carcin/21.12.2193	35	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139608	10.1371/journal.pone.0139608	http://dx.doi.org/10.1371/journal.pone.0139608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422690	Green Published, gold, Green Submitted			2022-12-27	WOS:000362175700133
J	Gupta, AK; Parasar, D; Sagar, A; Choudhary, V; Chopra, BS; Garg, R; Ashish; Khatri, N				Gupta, Ashok Kumar; Parasar, Devraj; Sagar, Amin; Choudhary, Vikas; Chopra, Bhupinder Singh; Garg, Renu; Ashish; Khatri, Neeraj			Analgesic and Anti-Inflammatory Properties of Gelsolin in Acetic Acid Induced Writhing, Tail Immersion and Carrageenan Induced Paw Edema in Mice	PLOS ONE			English	Article							PLASMA GELSOLIN; INFLAMMATORY RESPONSE; LYSOPHOSPHATIDIC ACID; SUBSTANCE-P; DRUGS; RAT; INTERLEUKIN-1-BETA; INHIBITION; EXTRACT; SEPSIS	Plasma gelsolin levels significantly decline in several disease conditions, since gelsolin gets scavenged when it depolymerizes and caps filamentous actin released in the circulation following tissue injury. It is well established that our body require/implement inflammatory and analgesic responses to protect against cell damage and injury to the tissue. This study was envisaged to examine analgesic and anti-inflammatory activity of exogenous gelsolin (8 mg/mouse) in mice models of pain and acute inflammation. Administration of gelsolin in acetic acid-induced writhing and tail immersion tests not only demonstrated a significant reduction in the number of acetic acid-induced writhing effects, but also exhibited an analgesic activity in tail immersion test in mice as compared to placebo treated mice. Additionally, anti-inflammatory function of gelsolin (8 mg/mouse) compared with anti-inflammatory drug diclofenac sodium (10 mg/kg)] was confirmed in the carrageenan injection induced paw edema where latter was measured by vernier caliper and fluorescent tomography imaging. Interestingly, results showed that plasma gelsolin was capable of reducing severity of inflammation in mice comparable to diclofenac sodium. Analysis of cytokines and histo-pathological examinations of tissue revealed administration of gelsolin and diclofenac sodium significantly reduced production of pro-inflammatory cytokines, TNF-alpha and IL-6. Additionally, carrageenan groups pretreated with diclofenac sodium or gelsolin showed a marked decrease in edema and infiltration of inflammatory cells in paw tissue. Our study provides evidence that administration of gelsolin can effectively reduce the pain and inflammation in mice model.	[Gupta, Ashok Kumar; Parasar, Devraj; Chopra, Bhupinder Singh; Khatri, Neeraj] Inst Microbial Technol, Council Sci & Ind Res, Div Anim Facil, Chandigarh, India; [Sagar, Amin; Choudhary, Vikas; Garg, Renu; Ashish] Inst Microbial Technol, Council Sci & Ind Res, Div Prot Sci & Engn, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Khatri, N (corresponding author), Inst Microbial Technol, Council Sci & Ind Res, Div Anim Facil, Chandigarh, India.	neeraj@imtech.res.in	Gupta, Ashok Kumar/AGL-1835-2022; Kumar, Ashok/AGJ-0027-2022; Sagar, Amin/AAF-4044-2021	Sagar, Amin/0000-0002-6207-9557; Gupta, Ashok Kumar/0000-0002-5657-7699; Chopra, Bhupinder Singh/0000-0002-1707-1169	CSIR Network Project BioDiscovery [BSC0120, OLP-0113/OLP107]; DST [SR/WOS-A/LS-220/2012]	CSIR Network Project BioDiscovery; DST(Department of Science & Technology (India))	Primary funding for this work was provided from CSIR Network Project BioDiscovery (BSC0120) and OLP-0113/OLP107. RG is supported by a grant from DST under Women Scientist Scheme-A (SR/WOS-A/LS-220/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan R, 2010, J ETHNOPHARMACOL, V131, P28, DOI 10.1016/j.jep.2010.05.060; Aydin S, 1999, PHYTOTHER RES, V13, P20, DOI 10.1002/(SICI)1099-1573(199902)13:1&lt;20::AID-PTR380&gt;3.0.CO;2-J; BROOKS PM, 1991, NEW ENGL J MED, V324, P1716; Chiu YJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/508137; Choi JH, 2012, J ETHNOPHARMACOL, V144, P379, DOI 10.1016/j.jep.2012.09.023; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Cohen TS, 2011, CYTOKINE, V54, P235, DOI 10.1016/j.cyto.2011.02.006; Delgado AV, 2003, NEUROPEPTIDES, V37, P355, DOI 10.1016/j.npep.2003.09.005; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Emanueli C, 1998, HYPERTENSION, V31, P1299, DOI 10.1161/01.HYP.31.6.1299; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Ferrero-Miliani L, 2007, CLIN EXP IMMUNOL, V147, P227, DOI 10.1111/j.1365-2249.2006.03261.x; Garg V, 2014, PHARMA INNOVATION J, V3, P16; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Huang GJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/709483; Huang MH, 2011, J ETHNOPHARMACOL, V133, P743, DOI 10.1016/j.jep.2010.11.005; Khatri N, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/152075; KOSTER R, 1959, FED PROC, V18, P412; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; Lawrence T, 2010, INT J BIOCHEM CELL B, V42, P519, DOI 10.1016/j.biocel.2009.12.016; Le Huong T, 2011, Exp Transl Stroke Med, V3, P13, DOI 10.1186/2040-7378-3-13; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Mahmoodi Mehdi, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P150; Mizushima Y, 1966, LANCET, V2, P343; MONCADA S, 1991, PHARMACOL REV, V43, P109; Mothana RAA, 2011, FOOD CHEM TOXICOL, V49, P2594, DOI 10.1016/j.fct.2011.06.079; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Omoigui S, 2007, MED HYPOTHESES, V69, P1169, DOI 10.1016/j.mehy.2007.06.033; Osadebe PO, 2003, J ETHNOPHARMACOL, V89, P19, DOI 10.1016/S0378-8741(03)00195-8; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Peddada N, 2013, J BIOL CHEM, V288, P28266, DOI 10.1074/jbc.M113.463224; Peddada N, 2012, MED HYPOTHESES, V78, P203, DOI 10.1016/j.mehy.2011.10.024; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; SMITH DB, 1988, BLOOD, V72, P214; SMITH DB, 1988, AM J PATHOL, V130, P261; Sostres C, 2010, BEST PRACT RES CL GA, V24, P121, DOI 10.1016/j.bpg.2009.11.005; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Yu XZM., 2002, TOXICOL SCI, V68, P488; Yun KJ, 2008, INT IMMUNOPHARMACOL, V8, P431, DOI 10.1016/j.intimp.2007.11.003; Zhang QH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-118	44	51	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2015	10	8							e0135558	10.1371/journal.pone.0135558	http://dx.doi.org/10.1371/journal.pone.0135558			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO9KD	26426535	Green Published, Green Submitted, gold			2022-12-27	WOS:000359493600077
J	Mazzoni, R; da Silva, RC; Pinto, MP				Mazzoni, Rosana; da Silva, Raquel Costa; Pinto, Miriam Plaza			Invasion and Colonisation of a Tropical Stream by an Exotic Loricariid Fish: Indices of Gradual Displacement of the Native Common Pleco (Hypostomus punctatus) by the Red Fin Dwarf Pleco (Parotocinclus maculicauda) over Fifteen Years	PLOS ONE			English	Article							FRESH-WATER FISH; CONSEQUENCES; COMMUNITIES; DISTURBANCE; DISPERSAL; RECOVERY; RATES; RIVER	The introduction of invasive species represents a major threat to the integrity of stream-dwelling fish populations worldwide, and this issue is receiving increasing attention from scientists, in particular because of potential impact on biodiversity. In this study, we analysed the dispersal of an exotic loricariid fish the red fin dwarf pleco (Parotocinclus maculicauda) in a stream of the Atlantic Forest biome in coastal south-eastern Brazil and evaluated the effects of this invasion on the native loricariid common pleco (Hypostomus punctatus). Specimens were collected at eight sites located along the course of the stream over a 15-year period. The distribution and density of the two species were determined by the Successive Removal Method. The introduction of P. maculicauda occurred in the medium sector of the stream, and during the course of the study, the species dispersed to new sites further upstream. By the end of the study, it was found at all points upstream from the original site. Hypostomus punctatus was registered at all sample sites both before and after the introduction of P. maculicauda, but its density decreased at all upstream sites after the arrival of the exotic species. Our analysis shows that colonisation by P. maculicauda seems to have a negative effect on H. punctatus densities. The maintenance of H. punctatus densities at the sites not colonised by P. maculicauda reinforces the conclusion that the colonisation of the stream by the exotic species had deleterious effects on the density of the resident H. punctatus populations, either by direct or indirect action.	[Mazzoni, Rosana; da Silva, Raquel Costa] Univ Estado Rio De Janeiro, IBRAG, Lab Ecol Peixes, BR-22550013 Rio De Janeiro, Brazil; [da Silva, Raquel Costa] Univ Estado Rio De Janeiro, IBRAG, Programa Posgrad Ecol & Evolucao, BR-22550013 Rio De Janeiro, Brazil; [Pinto, Miriam Plaza] Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio Grande do Norte	Mazzoni, R (corresponding author), Univ Estado Rio De Janeiro, IBRAG, Lab Ecol Peixes, Rua Sao Francisco Xavier 524, BR-22550013 Rio De Janeiro, Brazil.	mazzoni@uerj.br	Mazzoni, Rosana/B-3461-2013; Mazzoni, Rosana/O-7241-2015; Pinto, Míriam Plaza/B-8000-2013	Mazzoni, Rosana/0000-0001-8780-7779; Pinto, Míriam Plaza/0000-0002-4030-5015; Prentis, Peter/0000-0001-6587-8875	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - Research grant to RM (http://www.faperj.br/) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Personal Grant to RM (http://www.cnpq.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese B, 2009, FRESHWATER BIOL, V54, P1444, DOI 10.1111/j.1365-2427.2009.02194.x; BAYLEY PB, 1993, FRESHWATER BIOL, V29, P295, DOI 10.1111/j.1365-2427.1993.tb00765.x; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bomford M, 2004, RISK ASSESSMENT IMPO; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Curry RA, 2007, ENVIRON BIOL FISH, V79, P49, DOI 10.1007/s10641-007-9187-8; Davis SM, 2005, WETLANDS, V25, P821, DOI 10.1672/0277-5212(2005)025[0821:SMPCEM]2.0.CO;2; de Menezes MS, 2000, BRAZ ARCH BIOL TECHN, V43, P229, DOI 10.1590/S1516-89132000000200013; Deacon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024416; DETENBECK NE, 1992, ENVIRON MANAGE, V16, P33, DOI 10.1007/BF02393907; Duggan IC, 2010, BIOL INVASIONS, V12, P3757, DOI 10.1007/s10530-010-9768-x; FAUSCH KD, 1991, COPEIA, P659, DOI 10.2307/1446392; Ficetola GF, 2007, DIVERS DISTRIB, V13, P476, DOI 10.1111/j.1472-4642.2007.00377.x; Gido KB, 1999, FRESHWATER BIOL, V42, P387, DOI 10.1046/j.1365-2427.1999.444490.x; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; Hohausova E, 2010, MAR FRESHWATER RES, V61, P682, DOI 10.1071/MF09140; Hoover JJ, 2004, AQUAT NUIS SPECIES R, V4, P1; Larimore R. W., 1959, T AM FISH SOC, V88, P261, DOI DOI 10.1577/1548-8659(1959)88[261:DAROSF]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; LOBONCERVIA J, 1994, ARCH HYDROBIOL, V130, P371; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mazzoni R, 2000, ECOGRAPHY, V23, P588, DOI 10.1034/j.1600-0587.2000.230510.x; Mazzoni R., 2000, Revista Brasileira de Biologia, V60, P205, DOI 10.1590/S0034-71082000000200003; Mazzoni R, 2012, REV BIOL TROP, V60, P1837; MEFFE GK, 1990, ECOLOGY, V71, P657, DOI 10.2307/1940320; Nilsson E, 2012, FRESHWATER BIOL, V57, P10, DOI 10.1111/j.1365-2427.2011.02688.x; Osunkoya OO, 2011, BIOL INVASIONS, V13, P2289, DOI 10.1007/s10530-011-0040-9; PETERSON JT, 1993, T AM FISH SOC, V122, P199, DOI 10.1577/1548-8659(1993)122<0199:CROFIE>2.3.CO;2; Piazzini S, 2010, BIOL INVASIONS, V12, P2959, DOI 10.1007/s10530-010-9695-x; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Rehage JS, 2004, BIOL INVASIONS, V6, P379, DOI 10.1023/B:BINV.0000034618.93140.a5; Richter-Boix A, 2012, BIOL INVASIONS, V14, P1; Sheldon A. L., 1994, COPEIA, V1994, P828; Vitule JRS, 2009, FISH FISH, V10, P98, DOI 10.1111/j.1467-2979.2008.00312.x; Suzuki HI, 2000, J FISH BIOL, V57, P791, DOI 10.1006/jfbi.2000.1352; Vander Zanden MJ, 2005, P NATL ACAD SCI USA, V102, P7055, DOI 10.1073/pnas.0502549102; WATERS TF, 1983, T AM FISH SOC, V112, P137, DOI 10.1577/1548-8659(1983)112<137:ROBTBB>2.0.CO;2; ZIPPIN CALVIN, 1958, JOUR WILDLIFE MANAGEMENT, V22, P82, DOI 10.2307/3797301	43	3	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139968	10.1371/journal.pone.0139968	http://dx.doi.org/10.1371/journal.pone.0139968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26440412	Green Submitted, Green Published, gold			2022-12-27	WOS:000362510300088
J	Yuk, JS; Shin, JS; Shin, JY; Oh, E; Kim, H; Park, WI				Yuk, Jin-Sung; Shin, Jong Seung; Shin, Ji-Yeon; Oh, Eunsuk; Kim, Hyunmee; Park, Won I.			Nickel Allergy Is a Risk Factor for Endometriosis: An 11-Year Population-Based Nested Case-Control Study	PLOS ONE			English	Article							CONTACT-DERMATITIS; AUTOIMMUNE-DISEASE; PATHOGENESIS; BREAST; WOMEN; METALLOESTROGENS; RECEPTOR; CADMIUM; METALS; BLOOD	Background A cross-sectional study has reported that nickel allergy is associated with endometriosis. However, causal studies of this association are limited. Objective The objective of this study was to compare the prevalence of nickel allergy in women with and without endometriosis. Methods We used a National Health Insurance Service (NHIS) sample cohort dataset that included approximately 1 million individuals from South Korea; the data were obtained between January 01, 2002, and December 31, 2013. We selected the endometriosis group according to diagnosis code (N80.X), surgery codes, and drug codes during the years 2009 similar to 2013. The controls were randomly matched to the endometriosis patients at a ratio of 4:1 by age and socioeconomic status. Patients with nickel allergy were defined in the cohort dataset as those with a simultaneous diagnosis code (L23.0) and patch test code during 2002 similar to 2008. Results In total, 4,985 women were selected from the NHIS cohort database and divided into an endometriosis group (997 women) and a control group (3,988 women). The number of patients with nickel allergy in the endometriosis group was eight (0.8%), and that in the control group was thirteen (0.3%). After adjustment for age and socioeconomic status, the rate of nickel allergy in was higher in the endometriosis group than in the control group [odds ratio: 2.474; 95% confidence interval: 1.023 similar to 5.988; p = 0.044]. Conclusions We found that nickel allergy is a risk factor for endometriosis.	[Yuk, Jin-Sung; Park, Won I.] Eulji Univ, Sch Med, Dept Obstet & Gynecol, Daejeon, South Korea; [Yuk, Jin-Sung] MizMedi Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Shin, Jong Seung] Hyundai UVIS Hosp, Dept Obstet & Gynecol, Inchon, South Korea; [Shin, Ji-Yeon] Eulji Univ, Sch Med, Dept Prevent Med, Daejeon, South Korea; [Oh, Eunsuk] MizMedi Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Hyunmee] MizMedi Hosp, Dept Family Med, Seoul, South Korea	Eulji University; Eulji University	Park, WI (corresponding author), Eulji Univ, Sch Med, Dept Obstet & Gynecol, Daejeon, South Korea.	pwi3110@eulji.ac.kr		Yuk, Jin-Sung/0000-0002-5478-634X				Aquino NB, 2012, J ENVIRON SCI HEAL C, V30, P189, DOI 10.1080/10590501.2012.705159; ATSDR, 2015, ATSDR TOX PROF NICK; Becker D, 2013, J DTSCH DERMATOL GES, V11, P607, DOI 10.1111/ddg.12143; Boscolo P, 1998, LIFE SCI, V63, P1417, DOI 10.1016/S0024-3205(98)00408-1; Bruner-Tran KL, 2008, FERTIL STERIL, V89, P1287, DOI 10.1016/j.fertnstert.2008.02.102; Burney RO, 2012, FERTIL STERIL, V98, P511, DOI 10.1016/j.fertnstert.2012.06.029; Cheng TY, 2008, CONTACT DERMATITIS, V59, P353, DOI 10.1111/j.1600-0536.2008.01468.x; Darbre PD, 2006, J APPL TOXICOL, V26, P191, DOI 10.1002/jat.1135; Darlenski R, 2012, INT J DERMATOL, V51, P523, DOI 10.1111/j.1365-4632.2011.05233.x; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; GAMMELGAARD B, 1990, ACTA DERM-VENEREOL, V70, P417; Heilier JF, 2006, INT ARCH OCC ENV HEA, V80, P149, DOI 10.1007/s00420-006-0114-7; Hybenova M, 2010, NEUROENDOCRINOL LETT, V31, P283; Martin MB, 2003, ENDOCRINOLOGY, V144, P2425, DOI 10.1210/en.2002-221054; Matarese G, 2003, TRENDS MOL MED, V9, P223, DOI 10.1016/S1471-4914(03)00051-0; MEDICI N, 1989, BIOCHEMISTRY-US, V28, P212, DOI 10.1021/bi00427a029; Peiser M, 2012, CELL MOL LIFE SCI, V69, P763, DOI 10.1007/s00018-011-0846-8; Podgaec S, 2010, REV ASSOC MED BRAS, V56, P92, DOI 10.1590/S0104-42302010000100022; Rier Sherry E, 2008, Fertil Steril, V89, pe103, DOI 10.1016/j.fertnstert.2007.12.040; Sampson J, 1927, AM J OBSTET GYNECOL, V14, P93; Silva Nalinda, 2013, BMC Res Notes, V6, P13, DOI 10.1186/1756-0500-6-13; Sundqvist J, 2011, FERTIL STERIL, V95, P437, DOI 10.1016/j.fertnstert.2010.07.1060; Thyssen JP, 2009, CONTACT DERMATITIS, V61, P281, DOI 10.1111/j.1600-0536.2009.01624.x; Thyssen JP, 2009, J AM ACAD DERMATOL, V61, P799, DOI 10.1016/j.jaad.2009.03.030; Upson K, 2013, ENVIRON HEALTH PERSP, V121, P1319, DOI 10.1289/ehp.1306648; Usatine RP, 2010, AM FAM PHYSICIAN, V82, P249; Yuk J-S, 2015, J OBSTET GYNAECOL RE	27	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2015	10	10							e0139388	10.1371/journal.pone.0139388	http://dx.doi.org/10.1371/journal.pone.0139388			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0TP	26439741	Green Published, Green Submitted, gold			2022-12-27	WOS:000362510300026
J	Jurak, E; Punt, AM; Arts, W; Kabel, MA; Gruppen, H				Jurak, Edita; Punt, Arjen M.; Arts, Wim; Kabel, Mirjam A.; Gruppen, Harry			Fate of Carbohydrates and Lignin during Composting and Mycelium Growth of Agaricus bisporus on Wheat Straw Based Compost	PLOS ONE			English	Article							GENOME SEQUENCE; BUTTON MUSHROOM; LIFE-CYCLE; ACIDS; CULTIVATION; DEGRADATION	In wheat straw based composting, enabling growth of Agaricus bisporus mushrooms, it is unknown to which extent the carbohydrate-lignin matrix changes and how much is metabolized. In this paper we report yields and remaining structures of the major components. During the Phase II of composting 50% of both xylan and cellulose were metabolized by microbial activity, while lignin structures were unaltered. During A. bisporus' mycelium growth (Phase III) carbohydrates were only slightly consumed and xylan was found to be partially degraded. At the same time, lignin was metabolized for 45% based on pyrolysis GC/MS. Remaining lignin was found to be modified by an increase in the ratio of syringyl (S) to guaiacyl (G) units from 0.5 to 0.7 during mycelium growth, while fewer decorations on the phenolic skeleton of both S and G units remained.	[Jurak, Edita; Punt, Arjen M.; Kabel, Mirjam A.; Gruppen, Harry] Wageningen Univ, Food Chem Lab, NL-6708 WG Wageningen, Netherlands; [Arts, Wim] C4C Grondstoffen BV, NL-6596 MA Milsbeek, Netherlands	Wageningen University & Research	Gruppen, H (corresponding author), Wageningen Univ, Food Chem Lab, Bornse Weilanden 9, NL-6708 WG Wageningen, Netherlands.	harry.gruppen@wur.nl	; Kabel, Mirjam/M-1051-2016	Jurak, Edita/0000-0003-4253-4556; Kabel, Mirjam/0000-0002-2787-7852	Technology Foundation STW, applied science division of NWO [11108]; technology programme of the Ministry of Economic Affairs (The Netherlands); Walkro International B.V.; Sylvan Inc.; DSM Food Specialities; C4C Grondstoffen B.V.	Technology Foundation STW, applied science division of NWO(Technologiestichting STWNetherlands Organization for Scientific Research (NWO)); technology programme of the Ministry of Economic Affairs (The Netherlands); Walkro International B.V.; Sylvan Inc.; DSM Food Specialities; C4C Grondstoffen B.V.	The work described in this manuscript was performed at the Laboratory of Food Chemistry, Wageningen University, The Netherlands. EJ, WA, MK and GH were financially supported by the Technology Foundation STW (grant number 11108), applied science division of NWO and the technology programme of the Ministry of Economic Affairs (The Netherlands) and by Walkro International B.V., Sylvan Inc. and DSM Food Specialities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wim Arts is employed by C4C Grondstoffen B.V. C4C Grondstoffen B.V. provided support in the form of salary for author WA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akinyle B, 2011, AFR J BIOTECHNOL, V4, P979; BISARIA R, 1990, APPL MICROBIOL BIOT, V33, P607; BONNEN AM, 1994, APPL ENVIRON MICROB, V60, P960, DOI 10.1128/AEM.60.3.960-965.1994; Chen Y, 2000, COMPOST SCI UTIL, V8, P347; del Rio JC, 2007, J ANAL APPL PYROL, V79, P39, DOI 10.1016/j.jaap.2006.09.003; del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n; DURRANT AJ, 1991, J GEN MICROBIOL, V137, P751, DOI 10.1099/00221287-137-4-751; FERMOR TR, 1981, J GEN MICROBIOL, V126, P377; GERRITS J. P. G., 1967, Mushroom Science, V6, P225; Gerrits JPG, 1988, CULTIVATION MUSHROOM, P29; HAMMOND JBW, 1976, J GEN MICROBIOL, V93, P309, DOI 10.1099/00221287-93-2-309; Hilden K, 2013, FUNGAL GENET BIOL, V55, P32, DOI 10.1016/j.fgb.2013.02.002; IIYAMA K, 1994, APPL ENVIRON MICROB, V60, P1538, DOI 10.1128/AEM.60.5.1538-1546.1994; JONES D. B., 1931, U.S. Dept. Agric., Circular; Jurak E, 2014, CARBOHYD POLYM, V101, P281, DOI 10.1016/j.carbpol.2013.09.050; Kerrigan RW, 2013, FUNGAL GENET BIOL, V55, P2, DOI 10.1016/j.fgb.2013.03.002; Kurtzman R.H., 1982, TROPICAL MUSHROOMS B, P299; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Pan GX, 1998, J AGR FOOD CHEM, V46, P5283, DOI 10.1021/jf980608f; Patyshakuliyeva A, 2015, ENVIRON MICROBIOL, V17, P3098, DOI 10.1111/1462-2920.12967; RALPH J, 1991, J AGR FOOD CHEM, V39, P1426, DOI 10.1021/jf00008a014; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Sales-Campos C, 2010, INTERCIENCIA, V35, P70; Savoie JM, 1998, MYCOL RES, V102, P1113, DOI 10.1017/S0953756298006121; SCALBERT A, 1985, PHYTOCHEMISTRY, V24, P1359, DOI 10.1016/S0031-9422(00)81133-4; WOOD DA, 1983, FEMS MICROBIOL LETT, V20, P421	26	53	62	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2015	10	10							e0138909	10.1371/journal.pone.0138909	http://dx.doi.org/10.1371/journal.pone.0138909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT0PR	26436656	gold, Green Published, Green Submitted			2022-12-27	WOS:000362499200010
J	Basu, S; Combe, K; Kwiatkowski, F; Caldefie-Chezet, F; Penault-Llorca, F; Bignon, YJ; Vasson, MP				Basu, Samar; Combe, Kristell; Kwiatkowski, Fabrice; Caldefie-Chezet, Florence; Penault-Llorca, Frederique; Bignon, Yves-Jean; Vasson, Marie-Paule			Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen	PLOS ONE			English	Article							CATALYZED LIPID-PEROXIDATION; IN-VITRO; MOLECULAR-MECHANISMS; DUCTAL CARCINOMA; LEPTIN RECEPTOR; ADIPONECTIN; OBESITY; COX-2; TISSUE; RADIOIMMUNOASSAY	Current evidences suggest that expression of Ki67, cyclooxygenase (COX), aromatase, adipokines, prostaglandins, free radicals, beta-catenin and alpha-SMA might be involved in breast cancer pathogenesis. The main objective of this study was to compare expression/localization of these potential compounds in breast cancer tissues with tissues collected adjacent to the tumor using immunohistochemistry and correlated with clinical pathology. The breast cancer specimens were collected from 30 women aged between 49 and 89 years who underwent breast surgery following cancer diagnosis. Expression levels of molecules by different stainings were graded as a score on a scale based upon staining intensity and proportion of positive cells/area or individually. AdipoR1, adiponectin, Ob-R, leptin, COX-1, COX-2, aromatase, PGF(2a), F-2-isoprostanes and alpha-SMA were localised on higher levels in the breast tissues adjacent to the tumor compared to tumor specimens when considering either score or staining area whereas COX-2 and AdipoR2 were found to be higher considering staining intensity and Ki67 on score level in the tumor tissue. There was no significant difference observed on beta-catenin either on score nor on staining area and intensity between tissues adjacent to the tumor and tumor tissues. A positive correlation was found between COX-1 and COX-2 in the tumor tissues. In conclusion, these suggest that Ki67, COXs, aromatase, prostaglandin, free radicals, adipokines, beta-catenin and alpha-SMA are involved in breast cancer. These further focus the need of examination of tissues adjacent to tumor, tumor itself and compare them with normal or benign breast tissues for a better understanding of breast cancer pathology and future evaluation of therapeutic benefit.	[Basu, Samar; Combe, Kristell; Caldefie-Chezet, Florence; Vasson, Marie-Paule] Univ Auvergne, Univ Clermont Ferrand 2, UMR 1019, CRNH Auvergne,Unite Nutr Humaine, F-63000 Clermont Ferrand, France; [Basu, Samar] Uppsala Univ, Dept Publ Hlth & Caring Sci, Oxidat Stress & Inflammat, Fac Med, Uppsala, Sweden; [Kwiatkowski, Fabrice; Penault-Llorca, Frederique; Bignon, Yves-Jean; Vasson, Marie-Paule] Ctr Jean Perrin, F-63000 Clermont Ferrand, France; [Vasson, Marie-Paule] CHU Clermont Ferrand, Unite Explorat Nutr, F-63003 Clermont Ferrand, France	Universite Clermont Auvergne (UCA); Uppsala University; UNICANCER; Centre Jean Perrin; CHU Clermont Ferrand	Basu, S (corresponding author), Univ Auvergne, Univ Clermont Ferrand 2, UMR 1019, CRNH Auvergne,Unite Nutr Humaine, BP 10448, F-63000 Clermont Ferrand, France.	samar.basu@udamail.fr	FLORENCE, CALDEFIE-CHEZET FCC/U-3378-2018; , bignon/Y-3243-2019; vasson, marie-paule/ABA-2486-2021		Conseil d'Auvergne, Clermont-Ferrand	Conseil d'Auvergne, Clermont-Ferrand	This work was supported by Conseil d'Auvergne, Clermont-Ferrand (SB M-PV).	Atkinson RL, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3471; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P319, DOI 10.1016/S0952-3278(98)90042-4; Basu S, 1998, PROSTAG LEUKOTR ESS, V58, P347, DOI 10.1016/S0952-3278(98)90070-9; Basu S, 2007, MED RES REV, V27, P435, DOI 10.1002/med.20098; Basu S, 2013, ANTIOXID REDOX SIGN, V18, P323, DOI 10.1089/ars.2011.4408; Brodie AMH, 2001, J STEROID BIOCHEM, V79, P41, DOI 10.1016/S0960-0760(01)00131-5; Brow KA, 2010, CANCER RES, V70, P4, DOI 10.1158/0008-5472.CAN-09-2257; Brown Kristy A, 2012, Front Biosci (Elite Ed), V4, P2515; Brueggemeier RW, 2007, J STEROID BIOCHEM, V106, P16, DOI 10.1016/j.jsbmb.2007.05.021; Cai JC, 2013, J CLIN INVEST, V123, P566, DOI 10.1172/JCI65871; Caldefie-Chezet F, 2005, BIOCHEM BIOPH RES CO, V334, P737, DOI 10.1016/j.bbrc.2005.06.077; Chen Y, 2011, J BIOL CHEM, V286, P42575, DOI 10.1074/jbc.M111.294595; Clare SE, 2012, CANC RES S3, V12, P3; Dai Qi, 2009, N Am J Med Sci (Boston), V2, P106; Dai Q, 2009, J CLIN ONCOL, V27, P2482, DOI 10.1200/JCO.2008.19.7970; Fiorio E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-305; Gunnarsson C, 2006, ONCOL REP, V16, P219; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jarde T, 2008, HISTOPATHOLOGY, V53, P484, DOI 10.1111/j.1365-2559.2008.03121.x; Jarde T, 2009, ENDOCR-RELAT CANCER, V16, P1197, DOI 10.1677/ERC-09-0043; Jarde T, 2008, ONCOL REP, V19, P905; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Jeong YJ, 2011, J BREAST CANCER, V14, P96, DOI 10.4048/jbc.2011.14.2.96; Maccio A, 2010, J MOL MED, V88, P677, DOI 10.1007/s00109-010-0611-8; MANNAIONI PF, 1991, INT J TISSUE REACT, V13, P271; McFadden DW, 2006, INT J ONCOL, V29, P1019; Nachat-Kappes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051525; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Potemski P, 2006, PATHOL RES PRACT, V202, P491, DOI 10.1016/j.prp.2006.02.005; Richardsen Elin, 2012, BMC Res Notes, V5, P110, DOI 10.1186/1756-0500-5-110; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Vona-Davis L, 2013, J MAMMARY GLAND BIOL, V18, P291, DOI 10.1007/s10911-013-9299-z; Wiesner FG, 2009, BREAST, V18, P135, DOI 10.1016/j.breast.2009.02.009; World Cancer Research Fund, 2007, FOOD N PHYS ACT PREV; Yan D, 2012, J BIOL CHEM, V287, P8598, DOI 10.1074/jbc.M111.322800	39	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138443	10.1371/journal.pone.0138443	http://dx.doi.org/10.1371/journal.pone.0138443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431176	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700013
J	Coudert, E; Pascal, G; Dupont, J; Simon, J; Cailleau-Audouin, E; Crochet, S; Duclos, MJ; Tesseraud, S; Metayer-Coustard, S				Coudert, Edouard; Pascal, Geraldine; Dupont, Joelle; Simon, Jean; Cailleau-Audouin, Estelle; Crochet, Sabine; Duclos, Michel Jacques; Tesseraud, Sophie; Metayer-Coustard, Sonia			Phylogenesis and Biological Characterization of a New Glucose Transporter in the Chicken (Gallus gallus), GLUT12	PLOS ONE			English	Article							SKELETAL-MUSCLE; BROILER-CHICKENS; GENE-EXPRESSION; N-GLYCOSYLATION; INSULIN; PROTEIN; TRANSLOCATION; LOCALIZATION; TRAFFICKING; ZEBRAFISH	In mammals, insulin-sensitive GLUTs, including GLUT4, are recruited to the plasma membrane of adipose and muscle tissues in response to insulin. The GLUT4 gene is absent from the chicken genome, and no functional insulin-sensitive GLUTs have been characterized in chicken tissues to date. A nucleotide sequence is predicted to encode a chicken GLUT12 ortholog and, interestingly, GLUT12 has been described to act as an insulin-sensitive GLUT in mammals. It encodes a 596 amino acid protein exhibiting 71% identity with human GLUT12. First, we present the results of a phylogenetic study showing the stability of this gene during evolution of vertebrates. Second, tissue distribution of chicken SLC2A12 mRNA was characterized by RT-PCR. It was predominantly expressed in skeletal muscle and heart. Protein distribution was analysed by Western blotting using an anti-human GLUT12 antibody directed against a highly conserved region (87% of identity). An immunoreactive band of the expected size (75kDa) was detected in the same tissues. Third a physiological characterization was performed: SLC2A12 mRNA levels were significantly lowered in fed chickens subjected to insulin immuno-neutralization. Finally, recruitment of immunoreactive GLUT12 to the muscle plasma membrane was increased following 1h of intraperitoneal insulin administration (compared to a control fasted state). Thus insulin administration elicited membrane GLUT12 recruitment. In conclusion, these results suggest that the facilitative glucose transporter protein GLUT12 could act in chicken muscle as an insulin-sensitive transporter that is qualitatively similar to GLUT4 in mammals.	[Coudert, Edouard; Simon, Jean; Cailleau-Audouin, Estelle; Crochet, Sabine; Duclos, Michel Jacques; Tesseraud, Sophie; Metayer-Coustard, Sonia] INRA, Rech Avicoles UR83, Nouzilly, France; [Pascal, Geraldine] INRA, Bioinformat Genom Comparat & Evolut, Castanet Tolosan, France; [Dupont, Joelle] Univ Tours Haras Nationaux, CNRS, INRA, UMR 7247, Nouzilly, France	INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE	Metayer-Coustard, S (corresponding author), INRA, Rech Avicoles UR83, Nouzilly, France.	Sonia.Metayer@tours.inra.fr	Pascal, Geraldine/P-8125-2019; PASCAL, Géraldine/L-4519-2013; Metayer-Coustard, Sonia/AAO-7503-2020; DUCLOS, Michel/AAQ-3957-2021	Pascal, Geraldine/0000-0002-5250-6594; PASCAL, Géraldine/0000-0002-5250-6594; DUCLOS, Michel/0000-0002-9305-3982	INRA (Institut National de la Recherche Agronomique) and Region Centre; INRA	INRA (Institut National de la Recherche Agronomique) and Region Centre(Region Centre-Val de Loire); INRA	EC is a PhD student supported by a grant from INRA (Institut National de la Recherche Agronomique) and Region Centre. This study was funded by INRA.	Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Akiba Y, 1999, BRIT POULTRY SCI, V40, P701, DOI 10.1080/00071669987124; Al-Khalili L, 2003, FEBS LETT, V536, P198, DOI 10.1016/S0014-5793(03)00047-4; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Busset J, 2011, NUCLEIC ACIDS RES, V39, pW479, DOI 10.1093/nar/gkr243; Capilla E, 2004, AM J PHYSIOL-ENDOC M, V287, pE348, DOI 10.1152/ajpendo.00538.2003; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Cohen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080231; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, P108; Diaz M, 2007, ENDOCRINOLOGY, V148, P5248, DOI 10.1210/en.2007-0265; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; DUCLOS MJ, 1993, J ENDOCRINOL, V137, P465, DOI 10.1677/joe.0.1370465; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fam BC, 2012, J ENDOCRINOL, V214, P313, DOI 10.1530/JOE-12-0032; GIBSON WR, 1980, COMP BIOCHEM PHYS C, V67, P41, DOI 10.1016/0306-4492(80)90056-8; Girmatsion Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026967; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hall JR, 2006, J EXP BIOL, V209, P4490, DOI 10.1242/jeb.02532; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jimenez-Amilburu V, 2015, J ENDOCRINOL, V224, P1, DOI 10.1530/JOE-14-0539; Joubert R, 2010, DOMEST ANIM ENDOCRIN, V38, P115, DOI 10.1016/j.domaniend.2009.08.002; Katz EB, 1995, NATURE, V377, P51; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Louis A, 2013, NUCLEIC ACIDS RES, V41, pD700, DOI 10.1093/nar/gks1156; Miller PJ, 2005, MAMM GENOME, V16, P873, DOI 10.1007/s00335-005-0080-5; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pujol-Gimenez J, 2013, J PHYSIOL BIOCHEM, V69, P325, DOI 10.1007/s13105-012-0213-8; Purcell SH, 2011, DIABETES, V60, P1478, DOI 10.2337/db11-0033; Rogers S, 2002, AM J PHYSIOL-ENDOC M, V282, pE733, DOI 10.1152/ajpendo.2002.282.3.E733; Sadler JBA, 2013, INT J MOL SCI, V14, P9963, DOI 10.3390/ijms14059963; SASAKI S, 1990, HORM METAB RES, V22, P457, DOI 10.1055/s-2007-1004947; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; SIMON J, 1989, Critical Reviews in Poultry Biology, V2, P121; Stuart CA, 2009, J CLIN ENDOCR METAB, V94, P3535, DOI 10.1210/jc.2009-0162; Sweazea KL, 2005, J EXP ZOOL PART A, V303A, P143, DOI 10.1002/jez.a.131; Thomas-Delloye V, 1999, AM J PHYSIOL-REG I, V277, pR1733, DOI 10.1152/ajpregu.1999.277.6.R1733; Tokushima Y, 2005, COMP BIOCHEM PHYS B, V141, P43, DOI 10.1016/j.cbpc.2005.01.008; Tseng YC, 2009, AM J PHYSIOL-REG I, V297, pR275, DOI 10.1152/ajpregu.00180.2009; Waller AP, 2013, BBA-MOL BASIS DIS, V1832, P121, DOI 10.1016/j.bbadis.2012.09.013; Weng TY, 2013, BBA-MOL CELL RES, V1833, P1133, DOI 10.1016/j.bbamcr.2013.01.018; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065013; Zaarour N, 2012, BIOCHEM J, V445, P265, DOI 10.1042/BJ20120232; Zhang W, 2013, PHYSIOL GENOMICS, V45, P1084, DOI 10.1152/physiolgenomics.00102.2013; Zhao JP, 2012, J ANIM SCI, V90, P4337, DOI 10.2527/jas.2012-5100	48	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0139517	10.1371/journal.pone.0139517	http://dx.doi.org/10.1371/journal.pone.0139517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431526	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700072
J	Heesen, C; Kasper, J; Fischer, K; Kopke, S; Rahn, A; Backhus, I; Poettgen, J; Vahter, L; Drulovic, J; Van Nunen, A; Beckmann, Y; Liethmann, K; Giordano, A; Fulcher, G; Solari, A				Heesen, C.; Kasper, J.; Fischer, K.; Koepke, S.; Rahn, A.; Backhus, I.; Poettgen, J.; Vahter, L.; Drulovic, J.; Van Nunen, A.; Beckmann, Y.; Liethmann, K.; Giordano, A.; Fulcher, G.; Solari, A.		AutoMS-Grp	Risk Knowledge in Relapsing Multiple Sclerosis (RIKNO 1.0) - Development of an Outcome Instrument for Educational Interventions	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; SHARED DECISION-MAKING; PATIENT INFORMATION; SCALE; CARE; ALEMTUZUMAB; PREFERENCES; PERCEPTION; PROGRAM; AID	Background Adequate risk knowledge of patients is a prerequisite for shared decision making but few attempts have been made to develop assessment tools. Multiple Sclerosis (MS) is a chronic inflammatory disease of young adults with an increasing number of partially effective immunotherapies and therefore a paradigmatic disease to study patient involvement. Objective/methods Based on an item bank of MS risk knowledge items and patient feedback including perceived relevance we developed a risk knowledge questionnaire for relapsing remitting (RR) MS (RIKNO 1.0) which was a primary outcome measure in a patient education trial (192 early RRMS patients). Results Fourteen of the RIKNO 1.0 multiple-choice items were selected based on patient perceived relevance and item difficulty indices, and five on expert opinion. Mean item difficulty was 0.58, ranging from 0.14 to 0.79. Mean RIKNO 1.0 score increased after the educational intervention from 10.6 to 12.4 (p = 0.0003). Selected items were particularly difficult (e.g. those on absolute risk reductions of having a second relapse) and were answered correctly in only 30% of the patients, even after the intervention. Conclusion Despite its high difficulty, RIKNO 1.0 is a responsive instrument to assess risk knowledge in RRMS patients participating in educational interventions.	[Heesen, C.; Kasper, J.; Fischer, K.; Rahn, A.; Backhus, I.; Poettgen, J.; Liethmann, K.] Univ Med Ctr Eppendorf, Inst Neuroimmunol & MS Res INIMS, Hamburg, Germany; [Heesen, C.] Univ Med Ctr Eppendorf, Dept Neurol, Hamburg, Germany; [Kasper, J.] Univ Tromso, Dept Hlth & Caring Sci, Fac Hlth Sci, Tromso, Norway; [Koepke, S.] Med Univ Lubeck, Inst Social Med & Epidemiol, D-23538 Lubeck, Germany; [Rahn, A.] Univ Hamburg, MIN Fac, Unit Hlth Sci & Educ, Hamburg, Germany; [Vahter, L.] West Tallinn Cent Hosp, Dept Neurol, Tallinn, Estonia; [Drulovic, J.] Univ Belgrade, Clin Ctr Serbia, Inst Neurol, Belgrade, Serbia; [Van Nunen, A.] Natl MS Ctr, Melsbroek, Belgium; [Beckmann, Y.] Ataturk Training & Res Hosp, Dept Neurol, Fac Med, Izmir, Turkey; [Giordano, A.; Solari, A.] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy; [Fulcher, G.] Psychlinx, Sydney, NSW, Australia	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; UiT The Arctic University of Tromso; University of Lubeck; University of Hamburg; Clinical Centre of Serbia; University of Belgrade; Izmir Ataturk Training & Research Hospital	Heesen, C (corresponding author), Univ Med Ctr Eppendorf, Inst Neuroimmunol & MS Res INIMS, Hamburg, Germany.	heesen@uke.de	Giordano, Andrea/AAN-3738-2021; pietrolongo, erika/AAC-5694-2020; Antozzi, Carlo/AAB-8787-2019; Solari, Alessandra/AAO-1741-2021	Giordano, Andrea/0000-0003-4466-9788; pietrolongo, erika/0000-0002-6311-5994; Antozzi, Carlo/0000-0001-9270-5224; Solari, Alessandra/0000-0001-9930-7579	Fondazione Italiana Sclerosi Multipla (FISM) [2010/R/37]; Geminnutzige Hertie-Stftung	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Geminnutzige Hertie-Stftung	AS received support from the Fondazione Italiana Sclerosi Multipla (FISM) (grant No. 2010/R/37). http://www.aism.it. CH received support from the Geminnutzige Hertie-Stftung. http://www.ghst.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt A, 2008, PATIENT EDUC COUNS, V73, P407, DOI 10.1016/j.pec.2008.07.054; Bodemer N, 2014, MED DECIS MAKING, V34, P615, DOI 10.1177/0272989X14526305; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Coles AJ, 2012, NEUROLOGY, V78, P1069, DOI 10.1212/WNL.0b013e31824e8ee7; Degner L F, 1997, Can J Nurs Res, V29, P21; Edwards A, 2001, EVIDENCE BASED PATIE, P3; Elwyn G, 1999, BRIT J GEN PRACT, V49, P477; Erikli N., 2011, VERLAUFSFORMEN THERA; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2013, BETTER DOCTORS BETTE, V6, P3; Giordano A, 2014, MULT SCLER J, V20, P1234, DOI 10.1177/1352458513519180; Giordano A, 2010, MULT SCLER J, V16, P100, DOI 10.1177/1352458509352865; GMC Council, 2008, CONS GUID PAT DOCT M; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; Heesen C, 2009, MULT SCLER J, V15, P1103, DOI 10.1177/1352458509106508; Heesen C, 2010, MULT SCLER J, V16, P1507, DOI 10.1177/1352458510379819; Herrmann-Lingen C, 2001, HOSP ANXIETY DEPRESS; Hofmann A, 2013, MULT SCLER J, V19, P920, DOI 10.1177/1352458512461967; Karussis D, 2013, BIODRUGS, V27, P113, DOI 10.1007/s40259-013-0011-z; Kasper J, 2006, PATIENT EDUC COUNS, V62, P56, DOI 10.1016/j.pec.2005.06.002; Kopke S, 2009, MULT SCLER J, V15, P96, DOI 10.1177/1352458508095921; Kopke S, 2014, J NEUROL NEUROSUR PS, V85, P411, DOI 10.1136/jnnp-2013-306441; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lohaus A, 1989, DIAGNOSTICA, V35, P59; Ontaneda D, 2013, EXPERT REV CLIN IMMU, V9, P189, DOI [10.1586/eci.13.1, 10.1586/ECI.13.1]; Sharrack B, 1999, MULT SCLER, V5, P223, DOI 10.1191/135245899678846131; Solari A, 2010, MULT SCLER, V16, P1393, DOI 10.1177/1352458510380417; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0138364	10.1371/journal.pone.0138364	http://dx.doi.org/10.1371/journal.pone.0138364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CS6HH	26430887	Green Published, Green Submitted, gold			2022-12-27	WOS:000362178700011
J	Song, XZ; Zhang, CW; Zhao, MK; Chen, H; Liu, X; Chen, JW; Lonard, DM; Qin, L; Xu, JM; Wang, XS; Li, F; O'Malley, BW; Wang, J				Song, Xianzhou; Zhang, Chengwei; Zhao, Mingkun; Chen, Hui; Liu, Xing; Chen, Jianwei; Lonard, David M.; Qin, Li; Xu, Jianming; Wang, Xiaosong; Li, Feng; O'Malley, Bert W.; Wang, Jin			Steroid Receptor Coactivator-3 (SRC-3/AIB1) as a Novel Therapeutic Target in Triple Negative Breast Cancer and Its Inhibition with a Phospho-Bufalin Prodrug	PLOS ONE			English	Article							TAMOXIFEN RESISTANCE; PHASE-II; CARDIAC-GLYCOSIDES; PRECLINICAL MODELS; PROMOTE METASTASIS; CELL-MIGRATION; OVARIAN-CANCER; AIB1; GROWTH; EXPRESSION	Triple negative breast cancer (TNBC) has the poorest prognosis of all types of breast cancer and currently lacks efficient targeted therapy. Chemotherapy is the traditional standard-of-care for TNBC, but is frequently accompanied by severe side effects. Despite the fact that high expression of steroid receptor coactivator 3 (SRC-3) is correlated with poor survival in estrogen receptor positive breast cancer patients, its role in TNBC has not been extensively investigated. Here, we show that high expression of SRC-3 correlates with both poor overall survival and post progression survival in TNBC patients, suggesting that SRC-3 can serve as a prognostic marker for TNBC. Furthermore, we demonstrated that bufalin, a SRC-3 small molecule inhibitor, when introduced even at nM concentrations, can significantly reduce TNBC cell viability and motility. However, because bufalin has minimal water solubility, its in vivo application is limited. Therefore, we developed a water soluble prodrug, 3-phospho-bufalin, to facilitate its in vivo administration. In addition, we demonstrated that 3-phospho-bufalin can effectively inhibit tumor growth in an orthotopic TNBC mouse model, suggesting its potential application as a targeted therapy for TNBC treatment.	[Song, Xianzhou; Zhang, Chengwei; Zhao, Mingkun; Chen, Hui; Liu, Xing; Chen, Jianwei; Wang, Jin] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Lonard, David M.; Qin, Li; Xu, Jianming; Li, Feng; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Wang, Xiaosong] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Wang, Jin] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Zhao, Mingkun] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu; wangj@bcm.edu	Li, Feng/M-5334-2016; Wang, Jin/M-4036-2014; Wang, Jin/AAC-7292-2019	Li, Feng/0000-0002-9680-4614; Wang, Jin/0000-0003-3625-7919; Wang, Jin/0000-0003-3625-7919; Qin, Li/0000-0003-0099-4992	National Institutes of Health [HD076596, DK059820, R01CA112403, 1R01CA181368, 1R01CA183976]; Cancer Prevention and Research Institute of Texas [R1104, RP100348, RP101251, RP120732-P5]; Welch Foundation [Q-1798]; Susan G. Komen Foundation [PG12221410]; Prostate Cancer Foundation; Clayton Foundation; Dunn Foundation; Center for Drug Discovery and the Metabolomics Core Facility at Baylor College of Medicine; Dan L. Duncan Cancer Center; Texas Medical Center Digestive Diseases Center; John S. Dunn Gulf Coast Consortium; Shared Equipment Authority instrumentation at Rice University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD076596, R01HD008188] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA112403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Welch Foundation(The Welch Foundation); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Prostate Cancer Foundation; Clayton Foundation; Dunn Foundation; Center for Drug Discovery and the Metabolomics Core Facility at Baylor College of Medicine; Dan L. Duncan Cancer Center; Texas Medical Center Digestive Diseases Center; John S. Dunn Gulf Coast Consortium; Shared Equipment Authority instrumentation at Rice University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by the National Institutes of Health [HD076596 to D.M.L.; DK059820 to B.W.O.; R01CA112403 to J.X.; and 1R01CA181368 and 1R01CA183976 to X-S.W.], the Cancer Prevention and Research Institute of Texas [R1104 to J.W.; RP100348 and RP101251 to B.W.O.; and RP120732-P5 to J.X.], the Welch Foundation [Q-1798 to J.W.], the Susan G. Komen Foundation [PG12221410 to B.W.O.], the Prostate Cancer Foundation [to B.W.O.], the Clayton Foundation and the Dunn Foundation [to B.W.O.], the Center for Drug Discovery and the Metabolomics Core Facility [to F.L.] at Baylor College of Medicine, the Dan L. Duncan Cancer Center, the Texas Medical Center Digestive Diseases Center, the John S. Dunn Gulf Coast Consortium for Chemical Genomics, and the Shared Equipment Authority instrumentation at Rice University. The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Alkner S, 2010, ANN ONCOL, V21, P238, DOI 10.1093/annonc/mdp293; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bandyopadhyay A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010365; Baselga J, 2005, J CLIN ONCOL, V23, P5323, DOI 10.1200/JCO.2005.08.326; Ben-Eliyahu S, 2002, LANCET ONCOL, V3, P578; Burandt E, 2013, BREAST CANCER RES TR, V137, P745, DOI 10.1007/s10549-013-2406-4; Cai D, 2010, CANCER RES, V70, P6477, DOI 10.1158/0008-5472.CAN-10-0005; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cenik BK, 2013, MOL CANCER THER, V12, P992, DOI 10.1158/1535-7163.MCT-12-0995; Chang JC, 2009, CANCER INVEST, V27, P699, DOI 10.1080/07357900903152473; Chu V, 2001, BMC Physiol, V1, P6, DOI 10.1186/1472-6793-1-6; Chugh R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004334; Farraj AK, 2011, TOXICOL SCI, V121, P11, DOI 10.1093/toxsci/kfr021; Fu T, 2012, P NATL ACAD SCI USA, V109, P16137, DOI 10.1073/pnas.1205951109; Galanis E, 2013, CLIN CANCER RES, V19, P4816, DOI 10.1158/1078-0432.CCR-13-0708; Grunwald MR, 2013, INT J HEMATOL, V97, P683, DOI 10.1007/s12185-013-1334-8; Helman EE, 2010, CANCER BIOL THER, V10, P166, DOI 10.4161/cbt.10.2.12164; Henke RT, 2004, CLIN CANCER RES, V10, P6134, DOI 10.1158/1078-0432.CCR-04-0561; Kang SP, 2008, CURR OPIN OBSTET GYN, V20, P40, DOI 10.1097/GCO.0b013e3282f40de9; Karmakar S, 2011, ENDOCR-RELAT CANCER, V18, P113, DOI 10.1677/ERC-09-0285; Kayser S, 2014, LEUKEMIA LYMPHOMA, V55, P243, DOI 10.3109/10428194.2013.800198; Korsching E, 2008, J CLIN PATHOL, V61, P553, DOI 10.1136/jcp.2008.055475; Kuang SQ, 2005, CANCER RES, V65, P7993, DOI 10.1158/0008-5472.CAN-05-1179; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Lam ET, 2008, MOL CANCER THER, V7, P3685, DOI 10.1158/1535-7163.MCT-08-0436; Lee JW, 2009, CLIN CANCER RES, V15, P2695, DOI 10.1158/1078-0432.CCR-08-2966; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Levis MJ, 2010, BEST PRACT RES CL HA, V23, P489, DOI 10.1016/j.beha.2010.09.008; Li W, 2014, PATHOL RES PRACT, V210, P1005, DOI 10.1016/j.prp.2014.04.012; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Lonard DM, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.113pe16; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Malorni L, 2012, BREAST CANCER RES TR, V136, P795, DOI 10.1007/s10549-012-2315-y; Markman JL, 2013, ADV DRUG DELIVER REV, V65, P1866, DOI 10.1016/j.addr.2013.09.019; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mueller KL, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3224; Neary MT, 2013, DIS MODEL MECH, V6, P503, DOI 10.1242/dmm.010587; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Norden AD, 2010, J NEURO-ONCOL, V96, P211, DOI 10.1007/s11060-009-9948-7; O'Dwyer PJ, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.35643; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Palmieri C, 2013, BRIT J CANCER, V108, P2039, DOI 10.1038/bjc.2013.199; Park Y, 2011, ONCOLOGY-BASEL, V81, P199, DOI 10.1159/000333455; Penault-Llorca F, 2012, ANN ONCOL, V23, P19, DOI 10.1093/annonc/mds190; Pili R, 2013, CLIN GENITOURIN CANC, V11, P477, DOI 10.1016/j.clgc.2013.05.005; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Sakakura C, 2000, INT J CANCER, V89, P217; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Su QB, 2008, ONCOLOGY-BASEL, V75, P159, DOI 10.1159/000159267; Sweeny L, 2012, ORAL ONCOL, V48, P1242, DOI 10.1016/j.oraloncology.2012.06.011; Tien JCY, 2012, EXPERT OPINION THERA, P1; Tien JCY, 2013, CANCER RES, V73, P3997, DOI 10.1158/0008-5472.CAN-12-3929; TOMA S, 1991, YAKUGAKU ZASSHI, V111, P676, DOI 10.1248/yakushi1947.111.11_676; Tong ZT, 2013, BRIT J CANCER, V108, P1470, DOI 10.1038/bjc.2013.81; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Wang Y, 2014, CANCER RES, V74, P1506, DOI 10.1158/0008-5472.CAN-13-2939; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yoshida H, 2005, MOL CELL ENDOCRINOL, V245, P77, DOI 10.1016/j.mce.2005.10.008; Zhao WH, 2009, BIOCHEM BIOPH RES CO, V380, P699, DOI 10.1016/j.bbrc.2009.01.155	65	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2015	10	10							e0140011	10.1371/journal.pone.0140011	http://dx.doi.org/10.1371/journal.pone.0140011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6HH	26431029	gold, Green Submitted, Green Published			2022-12-27	WOS:000362178700131
J	Ku, JH; Kim, M; Byun, SS; Jeong, H; Kwak, C; Kim, HH; Lee, SE				Ku, Ja Hyeon; Kim, Myong; Byun, Seok-Soo; Jeong, Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Sang Eun			External Validation of Models for Prediction of Lymph Node Metastasis in Urothelial Carcinoma of the Bladder	PLOS ONE			English	Article							RADICAL CYSTECTOMY; STAGING SCORES; CANCER; RISK; SURVIVAL; NOMOGRAM; PROPOSAL	Purpose To externally validate models to predict LN metastsis; Karakiewicz nomogram, clinical nodal staging score (cNSS), and pathologic nodal staging score (pNSS) using a different cohort Materials and Methods Clinicopathologic data from 500 patients who underwent radical cystectomy and pelvic lymphadenectomy were analyzed. The overall predictive values of models were compared with the criteria of overall performance, discrimination, calibration, and clinical usefulness. Results Presence of pN+ stages was recorded in 117 patients (23.4%). Agreement between clinical and pathologic stage was noted in 174 (34.8%). Based on Nagelkerke's peudo-R2 and brier score, pNSS demonstrated best overall performance. Area under the receiver operating characteristics curve, showed that pNSS had the best discriminatory ability. In all models, calibration was on average correct (calibration-in-the-large coefficient = zero). On decision curve analysis, pNSS performed better than other models across a wide range of threshold probabilities. Conclusions When compared to pNSS, current precystectomy models such as the Karakiewicz nomogram and cNSS cannot predict the probability of LN metastases accurately. The findings suggest that the application of pNSS to Asian patients is feasible.	[Ku, Ja Hyeon; Kim, Myong; Kwak, Cheol; Kim, Hyeon Hoe] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Jeong, Hyeon] SMG SNU Boramae Med Ctr, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kim, HH (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea.	hhkim@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016	Kim, Myong/0000-0001-6995-6850				Bochner BH, 2006, J CLIN ONCOL, V24, P3967, DOI 10.1200/JCO.2005.05.3884; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Feifer AH, 2011, EUR UROL, V59, P978, DOI 10.1016/j.eururo.2011.01.014; Ficarra V, 2005, BJU INT, V95, P786, DOI 10.1111/j.1464-410X.2005.05401.x; Gierth M, 2014, WORLD J UROL, V32, P365, DOI 10.1007/s00345-013-1105-4; Karakiewicz PI, 2006, EUR UROL, V50, P1254, DOI 10.1016/j.eururo.2006.06.010; Karl A, 2009, EUR UROL, V55, P826, DOI 10.1016/j.eururo.2009.01.004; Kassouf W, 2008, J CLIN ONCOL, V26, P121, DOI 10.1200/JCO.2007.12.9247; Kassouf W, 2013, UROL ONCOL-SEMIN ORI, V31, P480, DOI 10.1016/j.urolonc.2011.02.011; Koppie TM, 2006, CANCER-AM CANCER SOC, V107, P2368, DOI 10.1002/cncr.22250; Ku JH, 2013, UROL ONCOL-SEMIN ORI, V31, P1731, DOI 10.1016/j.urolonc.2012.06.012; May M, 2011, UROLOGE, V50, P706, DOI 10.1007/s00120-011-2506-x; MILLER ME, 1993, MED DECIS MAKING, V13, P49, DOI 10.1177/0272989X9301300107; Mostofi FK, 1973, HISTOLOGICAL TYPING; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Shariat SF, 2006, CLIN CANCER RES, V12, P6663, DOI 10.1158/1078-0432.CCR-06-0372; Shariat SF, 2013, EUR UROL, V63, P371, DOI 10.1016/j.eururo.2012.06.008; Shariat SF, 2012, EUR UROL, V61, P237, DOI 10.1016/j.eururo.2011.10.011; Sobin, 2009, UICC TNM CLASSIFICAT; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Studer UE, 2012, EUR UROL, V62, pE61, DOI 10.1016/j.eururo.2012.04.039; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0120552	10.1371/journal.pone.0120552	http://dx.doi.org/10.1371/journal.pone.0120552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426341	Green Published, gold, Green Submitted			2022-12-27	WOS:000362177100001
J	Lugli, G; Cohen, AM; Bennett, DA; Shah, RC; Fields, CJ; Hernandez, AG; Smalheiser, NR				Lugli, Giovanni; Cohen, Aaron M.; Bennett, David A.; Shah, Raj C.; Fields, Christopher J.; Hernandez, Alvaro G.; Smalheiser, Neil R.			Plasma Exosomal miRNAs in Persons with and without Alzheimer Disease: Altered Expression and Prospects for Biomarkers	PLOS ONE			English	Article							MICRORNA EXPRESSION; CEREBROSPINAL-FLUID; TAU-PHOSPHORYLATION; CLINICAL-DIAGNOSIS; DEMENTIA; PIPELINE; TARGETS; MARKERS; RULES; BRAIN	To assess the value of exosomal miRNAs as biomarkers for Alzheimer disease (AD), the expression of microRNAs was measured in a plasma fraction enriched in exosomes by differential centrifugation, using Illumina deep sequencing. Samples from 35 persons with a clinical diagnosis of AD dementia were compared to 35 age and sex matched controls. Although these samples contained less than 0.1 microgram of total RNA, deep sequencing gave reliable and informative results. Twenty miRNAs showed significant differences in the AD group in initial screening (miR-23b-3p, miR-24-3p, miR-29b-3p, miR-125b-5p, miR-1385p, miR-139-5p, miR-141-3p, miR-150-5p, miR-152-3p, miR-185-5p, miR-338-3p, miR342-3p, miR-342-5p, miR-548at-5p, miR-659-5p, miR-3065-5p, miR-3613-3p, miR-3916, miR-4772-3p, miR-5001-3p), many of which satisfied additional biological and statistical criteria, and among which a panel of seven miRNAs were highly informative in a machine learning model for predicting AD status of individual samples with 83-89% accuracy. This performance is not due to over-fitting, because a) we used separate samples for training and testing, and b) similar performance was achieved when tested on technical replicate data. Perhaps the most interesting single miRNA was miR-342-3p, which was a) expressed in the AD group at about 60% of control levels, b) highly correlated with several of the other miRNAs that were significantly down-regulated in AD, and c) was also reported to be down-regulated in AD in two previous studies. The findings warrant replication and follow-up with a larger cohort of patients and controls who have been carefully characterized in terms of cognitive and imaging data, other biomarkers (e.g., CSF amyloid and tau levels) and risk factors (e.g., apoE4 status), and who are sampled repeatedly over time. Integrating miRNA expression data with other data is likely to provide informative and robust biomarkers in Alzheimer disease.	[Lugli, Giovanni] Univ Illinois, Dept Pathol, Chicago, IL USA; [Cohen, Aaron M.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Bennett, David A.; Shah, Raj C.] Rush Univ, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Fields, Christopher J.] Univ Illinois, HPCBio, Urbana, IL 61801 USA; [Hernandez, Alvaro G.] Roy J Carver Biotechnol Ctr, Urbana, IL USA; [Smalheiser, Neil R.] Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA; [Smalheiser, Neil R.] Univ Illinois, Inst Psychiat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Oregon Health & Science University; Rush University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Smalheiser, NR (corresponding author), Univ Illinois, Dept Psychiat, Chicago, IL 60612 USA.	neils@uic.edu	Shah, Raj/AAS-2210-2021	Shah, Raj/0000-0001-9706-9730; Fields, Christopher/0000-0002-7749-5844	Alzheimer's Association [IIRG-11-202853]; National Institute of Aging [P30AG10161]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [P30AG010161] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the Alzheimer's Association IIRG-11-202853 (http://www.alz.org/) NRS; National Institute of Aging P30AG10161 (www.nia.nih.gov) DAB; Illinois Department of Public Health (http://www.idph.state.il.us/) DAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon S, 2013, J NEUROSCI, V33, P14645, DOI 10.1523/JNEUROSCI.1327-13.2013; Bekris LM, 2013, BIOMARKERS, V18, P455, DOI 10.3109/1354750X.2013.814073; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett DA, 2014, BIOCHEM PHARMACOL, V88, P617, DOI 10.1016/j.bcp.2014.01.037; Bicker S, 2014, CELL MOL LIFE SCI, V71, P3987, DOI 10.1007/s00018-014-1671-7; Bryniarski K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122991; Cheng L., 2014, MOL PSYCHIAT; Cheng Lesley, 2013, Frontiers in Genetics, V4, P150, DOI [10.3389/fgene.2013.00150, 10.3389/fimmu.2013.00388]; Fagan AM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007901; Faux NG, 2014, MOL PSYCHIATR, V19, P1227, DOI 10.1038/mp.2013.178; Femminella GD, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00040; Fiandaca MS, 2014, ALZHEIMERS DEMENT; Galimberti D, 2014, J ALZHEIMERS DIS, V42, P1261, DOI 10.3233/JAD-140756; Geekiyanage H, 2012, EXP NEUROL, V235, P491, DOI 10.1016/j.expneurol.2011.11.026; Hall DA, 2014, NEUROBIOL AGING, V35, P2637, DOI 10.1016/j.neurobiolaging.2014.04.027; Hebert SS, 2013, J ALZHEIMERS DIS, V35, P335, DOI 10.3233/JAD-122350; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Kiko T, 2014, J ALZHEIMERS DIS, V39, P253, DOI 10.3233/JAD-130932; Kim DH, 2014, GENE, V545, P185, DOI 10.1016/j.gene.2014.05.031; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; Kumar P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069807; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Liu YP, 2015, J CLIN NEUROSCI, V22, P291, DOI 10.1016/j.jocn.2014.05.042; Lugli G, 2012, J NEUROCHEM, V123, P459, DOI 10.1111/j.1471-4159.2012.07921.x; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Sheinerman KS, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00150; Park M, 2011, SLEEP MED, V12, P397, DOI 10.1016/j.sleep.2010.09.006; Santa-Maria I, 2015, J CLIN INVEST, V125, P681, DOI 10.1172/JCI78421; Satoh J, 2015, BIOMARK INSIGHTS, V10, P21, DOI [10.4137/BMI.S25132, 10.4137/BMIMI.S25132]; Satoh J, 2012, EXP NEUROL, V235, P436, DOI 10.1016/j.expneurol.2011.09.003; Schipper HM, 2007, GENE REGUL SYST BIO, V1, P263; Schroeder J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00501; Shi M, 2014, ACTA NEUROPATHOL, V128, P639, DOI 10.1007/s00401-014-1314-y; Smalheiser NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086469; Smalheiser NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033201; Somel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001214; Tan L, 2014, J ALZHEIMERS DIS, V40, P1017, DOI 10.3233/JAD-132144; Tan L, 2014, J NEUROL SCI, V336, P52, DOI 10.1016/j.jns.2013.10.002; Villa C, 2013, J ALZHEIMERS DIS, V35, P487, DOI 10.3233/JAD-122263; Wang T, 2015, J CLIN PSYCHIAT, V76, P135, DOI 10.4088/JCP.13m08812; Wang WX, 2011, ACTA NEUROPATHOL, V121, P193, DOI 10.1007/s00401-010-0756-0; Wang X, 2015, FEBS LETT, V589, P726, DOI 10.1016/j.febslet.2015.02.001	45	245	258	5	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2015	10	10							e0139233	10.1371/journal.pone.0139233	http://dx.doi.org/10.1371/journal.pone.0139233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GT	26426747	Green Submitted, Green Published, gold			2022-12-27	WOS:000362177100039
J	Lee, DH; Lee, JH; Ahn, SE; Park, MJ				Lee, Dae-Hee; Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji			Effect of Time after Anterior Cruciate Ligament Tears on Proprioception and Postural Stability	PLOS ONE			English	Article							KNEE-JOINT; MUSCLE STRENGTH; DEFICIENT KNEES; ACL INJURY; MECHANORECEPTORS; RECONSTRUCTION; ANATOMY; BALANCE; LAXITY; ANGLE	This study was designed to compare proprioception and postural stability in patients with acute (time from injury <= 3 months) and chronic (time from injury > 3 months) ACL tears, and to evaluate the correlation between time interval after ACL injury and proprioception. Thigh muscle strength, postural stability, and joint position sense were compared in 48 patients with acute ACL tears and in 28 with chronic ACL tears. Maximal torque (60 degrees/sec) of the quadriceps and hamstring was evaluated using an isokinetic testing device. Postural stability was determined from the anterior-posterior (APSI), medial-lateral (MLSI), and overall (OSI) stability indices using stabilometry. Joint position sense was also tested by reproduction of passive positioning (RPP). Muscle strengths and stability indices on both the involved and uninvolved sides were similar in the acute and chronic ACL tear groups. RPP on the involved side was significantly greater in the chronic than in the acute ACL tear group (7.8 degrees vs. 5.6 degrees, P = 0.041). Two of three stability indices (APSI, OSI) and RPP were significantly greater on the involved than the uninvolved side in the chronic ACL tear group.	[Lee, Dae-Hee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea; [Lee, Jin-Hyuck; Ahn, Sung-Eun; Park, Min-Ji] Korea Univ, Coll Med, Anam Hosp, Dept Sports Med Ctr, Seoul 136705, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine)	Lee, DH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthopaed Surg, Seoul, South Korea.	eoak22@empal.com	lee, dae hee/I-9390-2017					Ageberg E, 2005, AM J SPORT MED, V33, P1527, DOI 10.1177/0363546505274934; Arockiaraj J, 2013, BONE JOINT J, V95B, P188, DOI 10.1302/0301-620X.95B2.30566; Aydog ST, 2006, KNEE SURG SPORT TR A, V14, P325, DOI 10.1007/s00167-005-0673-2; BARRACK RL, 1989, AM J SPORT MED, V17, P1, DOI 10.1177/036354658901700101; DENTI M, 1994, CLIN ORTHOP RELAT R, P29; FERRELL WR, 1980, J PHYSIOL-LONDON, V299, P85, DOI 10.1113/jphysiol.1980.sp013112; Fremerey RW, 2000, J BONE JOINT SURG BR, V82B, P801, DOI 10.1302/0301-620X.82B6.10306; Friden T, 1996, Knee Surg Sports Traumatol Arthrosc, V4, P217, DOI 10.1007/BF01567966; Gokeler A, 2012, BRIT J SPORT MED, V46, P180, DOI 10.1136/bjsm.2010.082578; HORCH KW, 1975, J NEUROPHYSIOL, V38, P1436, DOI 10.1152/jn.1975.38.6.1436; HUGHSTON JC, 1976, J BONE JOINT SURG AM, V58, P173, DOI 10.2106/00004623-197658020-00002; Ihara H, 2008, GAIT POSTURE, V28, P478, DOI 10.1016/j.gaitpost.2008.03.009; Jensen TO, 2002, J REHABIL MED, V34, P141, DOI 10.1080/165019702753714174; Katonis P, 2008, J INT MED RES, V36, P387, DOI 10.1177/147323000803600302; KENNEDY JC, 1974, J BONE JOINT SURG AM, VA 56, P223, DOI 10.2106/00004623-197456020-00001; Ko Min Soo, 2012, Knee Surg Relat Res, V24, P113, DOI 10.5792/ksrr.2012.24.2.113; Lee HM, 2009, KNEE, V16, P387, DOI 10.1016/j.knee.2009.01.006; Park JH, 2015, KNEE SURG SPORT TR A, V23, P240, DOI 10.1007/s00167-013-2675-9; Reider B, 2003, ARTHROSCOPY, V19, P2, DOI 10.1053/jars.2003.50006; Relph N, 2014, PHYSIOTHERAPY, V100, P187, DOI 10.1016/j.physio.2013.11.002; Roberts D, 1999, J ORTHOP SPORT PHYS, V29, P587, DOI 10.2519/jospt.1999.29.10.587; Roberts D, 2000, J ORTHOPAED RES, V18, P565, DOI 10.1002/jor.1100180408; SCHUTTE MJ, 1987, J BONE JOINT SURG AM, V69A, P243, DOI 10.2106/00004623-198769020-00011; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tsepis E, 2006, CLIN ORTHOP RELAT R, P211, DOI 10.1097/01.blo.0000223977.98712.30; Valeriani M, 1999, ACTA NEUROL SCAND, V99, P303, DOI 10.1111/j.1600-0404.1999.tb00680.x; Yoon JP, 2013, CLIN ORTHOP SURG, V5, P19, DOI 10.4055/cios.2013.5.1.19; Zhou MW, 2008, CHINESE MED J-PEKING, V121, P2224, DOI 10.1097/00029330-200811020-00003	28	27	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139038	10.1371/journal.pone.0139038	http://dx.doi.org/10.1371/journal.pone.0139038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422800	Green Submitted, gold, Green Published			2022-12-27	WOS:000362175700063
J	Passari, AK; Mishra, VK; Gupta, VK; Yadav, MK; Saikia, R; Singh, BP				Passari, Ajit Kumar; Mishra, Vineet Kumar; Gupta, Vijai Kumar; Yadav, Mukesh Kumar; Saikia, Ratul; Singh, Bhim Pratap			In Vitro and In Vivo Plant Growth Promoting Activities and DNA Fingerprinting of Antagonistic Endophytic Actinomycetes Associates with Medicinal Plants	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; MICROBIAL DIVERSITY; DIFFERENT CULTIVARS; WILT PATHOGEN; STREPTOMYCES; SOIL; CHITINASE; BACTERIA; ECOLOGY; TOMATO	Endophytic actinomycetes have shown unique plant growth promoting as well as antagonistic activity against fungal phytopathogens. In the present study forty-two endophytic actinomycetes recovered from medicinal plants were evaluated for their antagonistic potential and plant growth-promoting abilities. Twenty-two isolates which showed the inhibitory activity against at least one pathogen were subsequently tested for their plant-growth promoting activities and were compared genotypically using DNA based fingerprinting, including enterobacterial repetitive intergenic consensus (ERIC) and BOX repetitive elements. Genetic relatedness based on both ERIC and BOX-PCR generates specific patterns corresponding to particular genotypes. Exponentially grown antagonistic isolates were used to evaluate phosphate solubilization, siderophores, HCN, ammonia, chitinase, indole-3-acetic acid production, as well as antifungal activities. Out of 22 isolates, the amount of indole-3-acetic acid (IAA) ranging between 10-32 mu g/ml was produced by 20 isolates and all isolates were positive for ammonia production ranging between 5.2 to 54 mg/ml. Among 22 isolates tested, the amount of hydroxamate-type siderophores were produced by 16 isolates ranging between 5.2 to 36.4 mu g/ml, while catechols-type siderophores produced by 5 isolates ranging from 3.2 to 5.4 mu g/ml. Fourteen isolates showed the solubilisation of inorganic phosphorous ranging from 3.2 to 32.6 mg/100ml. Chitinase and HCN production was shown by 19 and 15 different isolates, respectively. In addition, genes of indole acetic acid (iaaM) and chitinase (chiC) were successively amplified from 20 and 19 isolates respectively. The two potential strains Streptomyces sp. (BPSAC34) and Leifsonia xyli (BPSAC24) were tested in vivo and improved a range of growth parameters in chilli (Capsicum annuum L.) under greenhouse conditions. This study is the first published report that actinomycetes can be isolated as endophytes from within these plants and were shown to have antagonistic and plant growth promoting abilities. These results clearly suggest the possibility of using endophytic actinomycetes as bioinoculant for plant growth promotion, nutrient mobilization or as biocontrol agent against fungal phytopathogens for sustainable agriculture.	[Passari, Ajit Kumar; Mishra, Vineet Kumar; Singh, Bhim Pratap] Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Mizoram 796004, India; [Gupta, Vijai Kumar] Natl Univ Ireland Galway, Dept Biochem, Mol Glyco Biotechnol Grp, Galway, Ireland; [Yadav, Mukesh Kumar] Korea Univ, Coll Med, Seoul 136705, South Korea; [Saikia, Ratul] CSIR North East Inst Sci & Technol, Div Biotechnol, Jorhat 785006, Assam, India	Mizoram University; Ollscoil na Gaillimhe-University of Galway; Korea University; Korea University Medicine (KU Medicine); Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST)	Singh, BP (corresponding author), Mizoram Univ, Dept Biotechnol, Mol Microbiol & Systemat Lab, Mizoram 796004, India.	bhimpratap@gmail.com	Passardi, Alessandro/AAH-4786-2019; Gupta, Vijai Kumar/O-2445-2014; Singh, Bhim Pratap/G-7268-2016; Passari, Ajit Kumar/X-9807-2019; Cavanna, Luigi/AAL-5251-2020; Scarpi, Emanuela/AAD-7036-2019; Yadav, Mukesh Kumar/M-9154-2015; Tassinari, Davide/AAC-5780-2022	Passardi, Alessandro/0000-0002-7099-240X; Gupta, Vijai Kumar/0000-0003-1565-5918; Singh, Bhim Pratap/0000-0002-9911-4125; Passari, Ajit Kumar/0000-0002-1150-8075; Cavanna, Luigi/0000-0002-0303-3778; Scarpi, Emanuela/0000-0001-7230-9267; Yadav, Mukesh Kumar/0000-0002-4703-8554; Frassineti, Giovanni Luca/0000-0002-0277-5622; Ulivi, Paola/0000-0002-4334-9662; Tamberi, Stefano/0000-0002-7087-9116	Department of Biotechnology, Government of India, through the DBT-Twinning project [BT/209/NE/TBP/2011]	Department of Biotechnology, Government of India, through the DBT-Twinning project	This work was supported by grants sanctioned to BPS from the Department of Biotechnology, Government of India, through the DBT-Twinning project (No. BT/209/NE/TBP/2011). This funding did not include any publication charges. The funding agency had no role in performing the experiments or in writing the manuscript.	Arnow LE, 1937, J BIOL CHEM, V118, P531; BASHAN Y, 1980, PHYSIOL PLANT PATHOL, V17, P111, DOI 10.1016/0048-4059(80)90012-0; Berg G, 2001, J APPL MICROBIOL, V91, P963, DOI 10.1046/j.1365-2672.2001.01462.x; Bergey D.H., 2000, BERGEYS MANUAL DETER; Bredholdt H, 2007, ENVIRON MICROBIOL, V9, P2756, DOI 10.1111/j.1462-2920.2007.01387.x; Cao LX, 2005, FEMS MICROBIOL LETT, V247, P147, DOI 10.1016/j.femsle.2005.05.006; Cappuccino J. C., 1992, MICROBIOLOGY LAB MAN, Vthird, P125, DOI DOI 10.2307/1309615; Chen YP, 2006, APPL SOIL ECOL, V34, P33, DOI 10.1016/j.apsoil.2005.12.002; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; Cui XL, 2001, INT J SYST EVOL MICR, V51, P357, DOI 10.1099/00207713-51-2-357; DEBRUIJN FJ, 1992, APPL ENVIRON MICROB, V58, P2180, DOI 10.1128/AEM.58.7.2180-2187.1992; Dorneles EMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098758; Doumbou CL, 2001, PHYTOPROTECTION, V82, P85, DOI 10.7202/706219ar; El-Sayed WS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00651; El-Tarabily KA, 2006, SOIL BIOL BIOCHEM, V38, P1505, DOI 10.1016/j.soilbio.2005.12.017; FRANCO CMM, 1991, CRIT REV BIOTECHNOL, V11, P193, DOI 10.3109/07388559109069184; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; GOODFELLOW M, 1983, ANNU REV MICROBIOL, V37, P189, DOI 10.1146/annurev.mi.37.100183.001201; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Graner G, 2003, FEMS MICROBIOL LETT, V224, P269, DOI 10.1016/S0378-1097(03)00449-X; Hamdali H, 2008, APPL SOIL ECOL, V40, P510, DOI 10.1016/j.apsoil.2008.08.001; Hardoim PR, 2008, TRENDS MICROBIOL, V16, P463, DOI 10.1016/j.tim.2008.07.008; Hastuti R. D., 2012, Hayati Journal of Biosciences, V19, P155; Hoang KC, 2011, INT J MOL SCI, V12, P56, DOI 10.3390/ijms12010056; Indananda C, 2010, INT J SYST EVOL MICR, V60, P1141, DOI 10.1099/ijs.0.008417-0; Ishii S, 2009, ENVIRON MICROBIOL, V11, P733, DOI 10.1111/j.1462-2920.2008.01856.x; Kabir L, 2013, J MICROBIOL BIOTECHN, V23, P897, DOI 10.4014/jmb.1209.09069; Karki HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045376; Kaur T, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0227-1; Khamna S, 2009, WORLD J MICROB BIOT, V25, P649, DOI 10.1007/s11274-008-9933-x; Kumar A, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-312; Kumar V, 2011, SCANNING, V33, P446, DOI 10.1002/sca.20261; Kumaran S, 2012, CHITINASE APPL REV; Lanoot B, 2004, SYST APPL MICROBIOL, V27, P84, DOI 10.1078/0723-2020-00257; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051410; Lin L, 2013, CURR MICROBIOL, V67, P209, DOI 10.1007/s00284-013-0348-z; Lopez AC, 2009, LWT-FOOD SCI TECHNOL, V42, P212, DOI 10.1016/j.lwt.2008.05.001; LORCK H, 1948, PHYSIOL PLANTARUM, V1, P142, DOI 10.1111/j.1399-3054.1948.tb07118.x; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; MERCKX R, 1987, BIOL FERT SOILS, V5, P126, DOI 10.1007/BF00257647; Miller KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035953; Mukherjee G, 2006, CURR MICROBIOL, V53, P265, DOI 10.1007/s00284-005-0412-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; Nimnoi P., 2009, Research Journal of Agriculture and Biological Sciences, V5, P29; Nimnoi P, 2010, WORLD J MICROB BIOT, V26, P193, DOI 10.1007/s11274-009-0159-3; Ningthoujam DS, 2009, AFR J MICROBIOL RES, V3, P737; Omar I, 2006, PLANT PATHOL, V55, P92, DOI 10.1111/j.1365-3059.2005.01315.x; Oteino N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00745; Ozbay N., 2004, Plant Pathology Journal, V3, P9; Parrent JL, 2010, NEW PHYTOL, V185, P882, DOI 10.1111/j.1469-8137.2010.03190.x; Passari AK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00273; Qin S, 2011, APPL MICROBIOL BIOT, V89, P457, DOI 10.1007/s00253-010-2923-6; Qin S, 2009, APPL ENVIRON MICROB, V75, P6176, DOI 10.1128/AEM.01034-09; Rademaker JLW, 2000, INT J SYST EVOL MICR, V50, P665, DOI 10.1099/00207713-50-2-665; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sharma HK, 2001, FITOTERAPIA, V72, P146, DOI 10.1016/S0367-326X(00)00278-1; Siddiqui ZA, 2006, PGPR: BIOCONTROL AND BIOFERTILIZATION, P111, DOI 10.1007/1-4020-4152-7_4; Singh LS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0278-3; SKUJINS JJ, 1965, ARCH BIOCHEM BIOPHYS, V111, P358, DOI 10.1016/0003-9861(65)90197-9; Sneath Peter H.A, 1973, NUMERICAL TAXONOMY; Strobel G, 2004, J NAT PROD, V67, P257, DOI 10.1021/np030397v; Taechowisan T, 2003, ANN MICROBIOL, V53, P447; Taechowisan T, 2003, ANN MICROBIOL, V53, P291; Tan HM, 2006, WORLD J MICROB BIOT, V22, P1275, DOI 10.1007/s11274-006-9172-y; Thomas P, 2009, MICROB ECOL, V58, P952, DOI 10.1007/s00248-009-9559-z; Verma VC, 2011, J BASIC MICROB, V51, P550, DOI 10.1002/jobm.201000155; Verma VC, 2009, MICROB ECOL, V57, P749, DOI 10.1007/s00248-008-9450-3; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Watanabe T, 1999, MICROBIOL-SGM, V145, P3353, DOI 10.1099/00221287-145-12-3353; WEI G, 1991, Phytopathology, V81, P1508, DOI 10.1094/Phyto-81-1508; You JL, 2005, WORLD J MICROB BIOT, V21, P679, DOI 10.1007/s11274-004-3851-3; Zhao K, 2011, CURR MICROBIOL, V62, P182, DOI 10.1007/s00284-010-9685-3	73	122	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2015	10	9							e0139468	10.1371/journal.pone.0139468	http://dx.doi.org/10.1371/journal.pone.0139468			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS6GF	26422789	Green Submitted, Green Published, gold			2022-12-27	WOS:000362175700119
J	Passardi, A; Scarpi, E; Tamberi, S; Cavanna, L; Tassinari, D; Fontana, A; Pini, S; Bernardini, I; Accettura, C; Ulivi, P; Frassineti, GL; Amadori, D				Passardi, Alessandro; Scarpi, Emanuela; Tamberi, Stefano; Cavanna, Luigi; Tassinari, Davide; Fontana, Annalisa; Pini, Sara; Bernardini, Ilaria; Accettura, Caterina; Ulivi, Paola; Frassineti, Giovanni Luca; Amadori, Dino			Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							1ST-LINE TREATMENT; CARCINOMA; SURVIVAL; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; TRIALS	Background To investigate the impact of pre-treatment lactate dehydrogenase (LDH) levels on the outcome of patients with metastatic colorectal cancer treated with first-line chemotherapy with or without the anti-VEGF monoclonal antibody, bevacizumab, in a phase III prospective multicentre randomized ITACa (Italian Trial in Advanced Colorectal Cancer) trial. Methods Three hundred and seventy patients enrolled onto the ITACa first-line trial were considered for this study, 176 receiving chemotherapy (either FOLFIRI or FOLFOX) plus bevacizumab and 194 receiving chemotherapy only. Pre-treatment LDH levels were evaluated to identify a potential correlation with progression-free survival (PFS), overall survival (OS) and objective response rate. Results Information on pre-treatment LDH levels was available for 344 patients. High LDH levels were predictive of a lower median PFS (8.1 months vs. 9.2 months, p<0.0001) and median OS (16.1 months vs. 25.2 months, p<0.0001) in the overall population. In the chemotherapy plus bevacizumab group, median PFS was 9.1 and 9.8 months in patients with high LDH and low LDH, respectively (p=0.073), whereas in the chemotherapy-only arm it was 6.9 and 9.1 months, respectively (p < 0.0001). In patients with high LDH, the addition of bevacizumab to chemotherapy led to a reduction in the rate of progressive disease (16.4 vs. 30.5%, p=0.081) and to a prolonged PFS (p=0.028). Conclusion A high LDH value was confirmed as a marker of poor prognosis. Bevacizumab reduced the progressive disease rate and improved PFS in the high-LDH subgroup, making serum LDH a potentially effective an easily available and marker to select patients who benefit from bevacizumab.	[Passardi, Alessandro; Pini, Sara; Frassineti, Giovanni Luca; Amadori, Dino] IRCCS, Dept Med Oncol, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy; [Scarpi, Emanuela] IRCCS, Unit Biostat & Clin Trials, IRST, Meldola, Italy; [Tamberi, Stefano] Infermi Hosp, Oncol Unit, Faenza, Italy; [Cavanna, Luigi] Guglielmo da Saliceto Hosp, Med Oncol Unit, Piacenza, Italy; [Tassinari, Davide] Gli Infermi Hosp, Dept Oncol, Rimini, Italy; [Fontana, Annalisa] Univ Hosp Modena, Oncol Unit, Modena, Italy; [Bernardini, Ilaria] Ramazzini Hosp, Med Oncol Unit, Carpi, Italy; [Accettura, Caterina] Vito Fazzi Hosp, Med Oncol Unit, Lecce, Italy; [Ulivi, Paola] IRCCS, Biosci Lab, IRST, Meldola, Italy	IRCCS Meldola (IRST); IRCCS Meldola (IRST); Hospital of Rimini; Guglielmo da Saliceto Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Azienda Ospedaliera Vito Fazzi; IRCCS Meldola (IRST)	Passardi, A (corresponding author), IRCCS, Dept Med Oncol, Ist Sci Romagnolo Studio & Cura Tumori IRST, Meldola, Italy.	alessandro.passardi@irst.emr.it	Passardi, Alessandro/AAH-4786-2019; Gupta, Vijai Kumar/O-2445-2014; Singh, Bhim Pratap/G-7268-2016; Passari, Ajit Kumar/X-9807-2019; Cavanna, Luigi/AAL-5251-2020; Scarpi, Emanuela/AAD-7036-2019; Yadav, Mukesh Kumar/M-9154-2015; Tassinari, Davide/AAC-5780-2022	Passardi, Alessandro/0000-0002-7099-240X; Gupta, Vijai Kumar/0000-0003-1565-5918; Singh, Bhim Pratap/0000-0002-9911-4125; Passari, Ajit Kumar/0000-0002-1150-8075; Cavanna, Luigi/0000-0002-0303-3778; Scarpi, Emanuela/0000-0001-7230-9267; Yadav, Mukesh Kumar/0000-0002-4703-8554; Frassineti, Giovanni Luca/0000-0002-0277-5622; Ulivi, Paola/0000-0002-4334-9662; Tamberi, Stefano/0000-0002-7087-9116	Italian Medicines Agency (AIFA) [FARM6FJJAY]	Italian Medicines Agency (AIFA)	This trial was partially supported by the Italian Medicines Agency (AIFA - research grant no. FARM6FJJAY). AIFA was involved in the design of the clinical study but not in the collection, analysis and interpretation of data, in the writing of the report, or in the decision to submit the article for publication. No other funding or sources of support to be declared.	Agarwala SS, 2009, EUR J CANCER, V45, P1807, DOI 10.1016/j.ejca.2009.04.016; Bar J, 2014, CLIN COLORECTAL CANC, V13, P46, DOI 10.1016/j.clcc.2013.11.002; Cetin B, 2012, ASIAN PAC J CANCER P, V13, P1059, DOI 10.7314/APJCP.2012.13.3.1059; COIFFIER B, 1991, J CLIN ONCOL, V9, P211, DOI 10.1200/JCO.1991.9.2.211; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Diaz Roberto, 2005, Clin Colorectal Cancer, V5, P197, DOI 10.3816/CCC.2005.n.031; DIMOPOULOS MA, 1991, ANN INTERN MED, V115, P931, DOI 10.7326/0003-4819-115-12-931; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; KEMENY N, 1983, AM J MED, V74, P786, DOI 10.1016/0002-9343(83)91066-5; Lin JT, 2005, J GASTROEN HEPATOL, V20, P900, DOI 10.1111/j.1400-1746.2005.03893.x; Major P, 2006, J CLIN ONCOL S, V24, P3529; Miao P, 2013, IUBMB LIFE, V65, P904, DOI 10.1002/iub.1216; Passardi A, 2015, ANN ONCOL, V26, P1201, DOI 10.1093/annonc/mdv130; Saltz LB, 2000, NEW ENGL J MED, V343, P905, DOI 10.1056/NEJM200009283431302; Scartozzi M, 2012, BRIT J CANCER, V106, P799, DOI 10.1038/bjc.2012.17; Silvestris N, 2015, EXPERT OPIN BIOL TH, V15, P155, DOI 10.1517/14712598.2015.986452; Tas F, 2001, AM J CLIN ONCOL-CANC, V24, P547, DOI 10.1097/00000421-200112000-00003; Tas F, 2001, AM J CLIN ONCOL-CANC, V24, P376, DOI 10.1097/00000421-200108000-00013; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Watine J, 2004, CLIN CHIM ACTA, V345, P1, DOI 10.1016/j.cccn.2004.02.017; Yin CX, 2014, ONCOTARGETS THER, V7, P1415, DOI 10.2147/OTT.S64559	22	122	127	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 5	2015	10	8							e0134732	10.1371/journal.pone.0134732	http://dx.doi.org/10.1371/journal.pone.0134732			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CO3MH	26422789	Green Published, Green Submitted, gold			2022-12-27	WOS:000359061400100
